Citrus Sinensis ID: 038768

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380------
Protein Sequence
SFFNKRRKTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPASLSTELASLESSSS
Secondary Structure (PSIPRED)
cccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccEEEEEcccccEEEEEEccccccccHHHHHHHHHHHcccccEEccEEEEEccccEEEEEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccEEEEccccccccccHHHHHcccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHcccccEEEEEEEEcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccEEEccccc
Secondary Structure Prediction (SSPRO)
cccccccccHEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHccccccccccccccEcHHHHHHHHHccccEEEEccccEEEEEEEcccEEEEEEccccccccHHHHHHHHHHHHHcccccEccEEEEEccccccEEEEEcccccEHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEccccccHHHEEEEHHHEEEEccccHHHHcccHHcEEccEEEEEccccccHHHHHcccccEEEcccHHHHHEEEEEEEcccccccccccccccccHHHHHHHHHHcccEEEEEEEEEcccHcccccHHHHHHHHcccccccccccccEEEEEcccccccccccccccccccccccc
Coil and Loop (DISEMBL)
sffnkrrktsfgiAAGVVGIIVILVILLLVGLRHIRkkktendqndfgfgrfrkkntenENAEAAFIRNYVSlapkrynysdvkRMTNSfsnklgqggfgsvykgklpdgrLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYefmpngsldqfiydeessninrKLEWRTMCQIAVGIARGLEYlhrgcnirivhfdikphnillgedfcpkisdfGLAKLSEKKESFISMLgargtigyiapevfcrnfggvshksdvySYGMMILEMVVGRKNAEVKVSLSseiyfpnsiykhiepgnefqlagVVTEEEKEMAKKMILVLEMLegstedlqippkpslssprrsaqqsppaslSTELASLESSSS
Flexible Loop (DISEMBL)
sffnkrrktsfgiaagvvgIIVILVILLLVGLRHirkkktendqndfgfgrfrkkntenenaeaaFIRNYVSLAPKRYNYSDVKRMTNSfsnklgqggfGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEvasmsktshVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIppkpslssprrsaqqsppaslstelaslessss
Low Complexity Region (SEG)
SFFNKRRKTSFgiaagvvgiivilvilllvglRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIppkpslssprrsaqqsppaslstelaslessss
Disordered region (IsUnstruct)
*********SFGIAAGVVGIIVILVILLLVGLRHIRK**********GF*************EAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEE***MAKKMILVLEM*******************************************
Disordered Region (DISOPRED)
*************AAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKN*E**NAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKN*****EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA******SS*IYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP*****************************
Disordered Region (DISEMBL)
********TSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGST**************************************
Disordered Region (DISPRO)
******RKTSFGIAAGVVGIIVILVILLLVGLRHIRKKK********************************SLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPR***********************
Transmembrane Helix (TMHMM)
oooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SFFNKRRKTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPASLSTELASLESSSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	386	2.2.26 [Sep-21-2011]
Q9FID6	813	Probable receptor-like pr	no	no	0.860	0.408	0.489	2e-94
Q3ECH2	892	Probable receptor-like pr	no	no	0.919	0.397	0.457	1e-91
Q9FID5	806	Probable receptor-like pr	no	no	0.720	0.344	0.557	3e-90
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.852	0.377	0.368	5e-61
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.764	0.359	0.409	4e-57
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.826	0.308	0.387	2e-55
Q9XID3	829	G-type lectin S-receptor-	no	no	0.730	0.340	0.410	2e-54
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.803	0.300	0.382	2e-54
O65238	872	G-type lectin S-receptor-	no	no	0.834	0.369	0.358	9e-52
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.707	0.324	0.407	1e-51

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  345 bits (886), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 192/392 (48%), Positives = 254/392 (64%), Gaps = 60/392 (15%)

Query: 13  IAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVS 72
           +   V+G+   +VI++L+    IR+ K             RKKN + EN+   F      
Sbjct: 444 VVGSVIGLATFIVIIMLL----IRQMK-------------RKKN-KKENSVIMF-----K 480

Query: 73  LAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEV 132
           L  K+Y Y+++K++T SFS+ +G+GGFG+VY+G L +GR VAVKVLK+ K NG++FINEV
Sbjct: 481 LLLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEV 540

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQI 192
            SMS+TSHVN+VS LGFCYE  KRA+I EF+ +GSLDQFI   +S   N      T+  I
Sbjct: 541 TSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT----TLYGI 596

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A+GIARGLEYLH GC  RIVHFDIKP NILL ++FCPK++DFGLAKL EK+ES +S++  
Sbjct: 597 ALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDT 656

Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYK 312
           RGTIGYIAPEV  R +GG+SHKSDVYSYGM++L+M+  R   E      S  YFP+ IYK
Sbjct: 657 RGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYK 716

Query: 313 HIEPGNEFQLAGV-VTEEEKEMAKKMIL------------------VLEMLEGSTEDLQI 353
            +E G++  + G  + EE+ ++ KKMIL                  V+EM+EGS + L++
Sbjct: 717 DLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALEL 776

Query: 354 PPKPSLSSPRRSAQQSPPASLSTELASLESSS 385
           PPKPS               +STEL  LESSS
Sbjct: 777 PPKPS-------------RHISTELV-LESSS 794

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  337 bits (863), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 194/424 (45%), Positives = 260/424 (61%), Gaps = 69/424 (16%)

Query: 2   FFNKRRK-------TSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRK 54
           FF + R+        +F     + G++++ ++LL    R                  FRK
Sbjct: 481 FFRRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFR---------------VQIFRK 525

Query: 55  KNTENENAEAAFIRNYVSLAP-KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLV 113
           + T +E      ++   +L P K Y Y++VK+MT SF+  +G+GGFG VY G L D  +V
Sbjct: 526 RKTSDE----VRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMV 581

Query: 114 AVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI 172
           AVKVLK+SK  +GE+FINEVASMS+TSHVN+VS LGFC E  +RA+IYEF+ NGSLD+FI
Sbjct: 582 AVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFI 641

Query: 173 YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS 232
            D+ S N    L+ +T+  IA+G+ARGLEYLH GC  RIVHFDIKP N+LL ++ CPK+S
Sbjct: 642 SDKSSVN----LDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVS 697

Query: 233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           DFGLAKL EKKES +S+L  RGTIGYIAPE+  R +G VSHKSDVYSYGM++LEM+  RK
Sbjct: 698 DFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARK 757

Query: 293 NAEVKV---SLSSEIYFPNSIYKHIEPGN-----EFQLAGV----VTEEEKEMAKKMIL- 339
                    S  S IYFP  IYK +E  N     + +  G+    ++ EE+E+A+KM L 
Sbjct: 758 KERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLV 817

Query: 340 -----------------VLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPASLSTELASLE 382
                            V+EM+EGS + L++PP+P L       QQ   +S+S    + E
Sbjct: 818 GLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL-------QQISASSVSDSFWNSE 870

Query: 383 SSSS 386
            SSS
Sbjct: 871 ESSS 874

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  332 bits (850), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 169/303 (55%), Positives = 220/303 (72%), Gaps = 25/303 (8%)

Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK 137
           Y Y+++K++T SFS  +G+GGFG+VY G L +GR VAVKVLK+ K + E+FINEVASMS+
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           TSHVN+VS LGFC+E  KRA++YEF+ NGSLDQF+    S N +   +  T+  IA+GIA
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFM----SRNKSLTQDVTTLYGIALGIA 603

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGLEYLH GC  RIVHFDIKP NILL  + CPK+SDFGLAKL EK+ES +S++  RGTIG
Sbjct: 604 RGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIG 663

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV--SLSSEIYFPNSIYKHIE 315
           YIAPEVF R +G VSHKSDVYS+GM++++M+  R    V+   S +S  YFP+ IYK +E
Sbjct: 664 YIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLE 723

Query: 316 PGNEFQLAG-VVTEEEKEMAKKMIL------------------VLEMLEGSTEDLQIPPK 356
            G +  + G  +T+EEKE+AKKMI+                  V+EM+EGS + L+IPPK
Sbjct: 724 DGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPK 783

Query: 357 PSL 359
           PS+
Sbjct: 784 PSM 786

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  235 bits (599), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 137/372 (36%), Positives = 213/372 (57%), Gaps = 43/372 (11%)

Query: 8   KTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFI 67
           + S G+   V+ I +++ +L+LV L  +             +    +K T    A+ + I
Sbjct: 464 RKSHGLRQKVLVIPIVVGMLVLVALLGM-----------LLYYNLDRKRTLKRAAKNSLI 512

Query: 68  RNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE- 126
              +  +P  + Y D++  TN+FS  LG GGFG+VYKG +    LVAVK L  +  +GE 
Sbjct: 513 ---LCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGER 569

Query: 127 EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD-EESSNINRKLE 185
           EFI EV ++    H+N+V   G+C E   R L+YE+M NGSLD++I+  E+++N+   L+
Sbjct: 570 EFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANL---LD 626

Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
           WRT  +IAV  A+G+ Y H  C  RI+H DIKP NILL ++FCPK+SDFGLAK+  ++ S
Sbjct: 627 WRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHS 686

Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY 305
            +  +  RGT GY+APE        ++ K+DVYSYGM++LE+V GR+N ++    + + +
Sbjct: 687 HVVTM-IRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSYD-AEDFF 742

Query: 306 FPNSIYKHIEPGNEFQ-----LAGVVTEEEKEMAKKMIL---------------VLEMLE 345
           +P   YK +  G   +     L GV  EEE   A K+                 V+++LE
Sbjct: 743 YPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLE 802

Query: 346 GSTEDLQIPPKP 357
           G+++++ +PP P
Sbjct: 803 GTSDEINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  222 bits (565), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 134/327 (40%), Positives = 194/327 (59%), Gaps = 32/327 (9%)

Query: 58  ENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKV 117
           +  + E  F+ N +S  P R+ Y D++  TN+FS KLGQGGFGSVY+G LPDG  +AVK 
Sbjct: 464 QESSEEDNFLEN-LSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKK 522

Query: 118 LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES 177
           L+      +EF  EV+ +    H+++V   GFC E   R L YEF+  GSL+++I+ ++ 
Sbjct: 523 LEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKD 582

Query: 178 SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
            ++   L+W T   IA+G A+GL YLH  C+ RIVH DIKP NILL ++F  K+SDFGLA
Sbjct: 583 GDV--LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLA 640

Query: 238 KLSEKKES--FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
           KL  +++S  F +M   RGT GY+APE +  N+  +S KSDVYSYGM++LE++ GRKN +
Sbjct: 641 KLMTREQSHVFTTM---RGTRGYLAPE-WITNY-AISEKSDVYSYGMVLLELIGGRKNYD 695

Query: 296 VKVSLSSEIYFPNSIYKHIEPGNEFQLAG------VVTEEEKEMAKKMIL---------- 339
              + S + +FP+  +K +E G    +         VT+E  + A K  L          
Sbjct: 696 PSET-SEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTR 754

Query: 340 -----VLEMLEGSTEDLQIPPKPSLSS 361
                V++MLEG    +Q P   ++ S
Sbjct: 755 PSMSKVVQMLEGVFPVVQPPSSSTMGS 781

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  216 bits (551), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 136/351 (38%), Positives = 202/351 (57%), Gaps = 32/351 (9%)

Query: 8   KTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFI 67
           K+  G   GV+  + +L I+  V +  IRK+              RK+ T++E   +  +
Sbjct: 631 KSMTGTIVGVIVGVGLLSIISGVVIFIIRKR--------------RKRYTDDEEILSMDV 676

Query: 68  RNYVSLAPKRYNYSDVKRMTNSF--SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG 125
           +      P  + YS++K  T  F  SNKLG+GGFG VYKGKL DGR VAVK+L      G
Sbjct: 677 K------PYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQG 730

Query: 126 E-EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL 184
           + +F+ E+ ++S   H N+V   G CYE + R L+YE++PNGSLDQ ++ E++ +    L
Sbjct: 731 KGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLH----L 786

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
           +W T  +I +G+ARGL YLH    +RIVH D+K  NILL     PK+SDFGLAKL + K+
Sbjct: 787 DWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKK 846

Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI 304
           + IS   A GTIGY+APE   R  G ++ K+DVY++G++ LE+V GR N++  +    + 
Sbjct: 847 THISTRVA-GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLE-DEKR 902

Query: 305 YFPNSIYKHIEPGNEFQLAG-VVTEEEKEMAKKMILVLEMLEGSTEDLQIP 354
           Y     +   E G E +L    +TE   E  K+MI +  +   ++  L+ P
Sbjct: 903 YLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPP 953

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  213 bits (542), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 120/292 (41%), Positives = 179/292 (61%), Gaps = 10/292 (3%)

Query: 70  YVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFI 129
           Y S AP ++ Y +++R T SF  KLG GGFG+VY+G L +  +VAVK L+  +   ++F 
Sbjct: 466 YASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFR 525

Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTM 189
            EVA++S T H+N+V  +GFC + + R L+YEFM NGSLD F++  +S+     L W   
Sbjct: 526 MEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKF---LTWEYR 582

Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
             IA+G A+G+ YLH  C   IVH DIKP NIL+ ++F  K+SDFGLAKL   K++  +M
Sbjct: 583 FNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNM 642

Query: 250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNS 309
              RGT GY+APE +  N   ++ KSDVYSYGM++LE+V G++N +V    ++   F   
Sbjct: 643 SSVRGTRGYLAPE-WLANL-PITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSIW 699

Query: 310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP--KPSL 359
            Y+  E GN   +      E++ +   M  V+ M++ S   +Q  P  +P++
Sbjct: 700 AYEEFEKGNTKAILDTRLSEDQTV--DMEQVMRMVKTSFWCIQEQPLQRPTM 749

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  213 bits (542), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 132/345 (38%), Positives = 202/345 (58%), Gaps = 35/345 (10%)

Query: 17  VVGIIV---ILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVSL 73
           +VG+IV   +L IL  V +  IRK+              RK+ T++E      ++ Y+  
Sbjct: 638 IVGVIVGVGLLSILAGVVMFTIRKR--------------RKRYTDDEELLGMDVKPYI-- 681

Query: 74  APKRYNYSDVKRMTNSF--SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE-EFIN 130
               + YS++K  T  F  SNKLG+GGFG VYKG L DGR+VAVK+L      G+ +F+ 
Sbjct: 682 ----FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVA 737

Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMC 190
           E+ ++S   H N+V   G C+E + R L+YE++PNGSLDQ ++ +++ +    L+W T  
Sbjct: 738 EIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLH----LDWSTRY 793

Query: 191 QIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML 250
           +I +G+ARGL YLH   ++RIVH D+K  NILL     P+ISDFGLAKL + K++ IS  
Sbjct: 794 EICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTR 853

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI 310
            A GTIGY+APE   R  G ++ K+DVY++G++ LE+V GR N++  +    + Y     
Sbjct: 854 VA-GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLE-EEKKYLLEWA 909

Query: 311 YKHIEPGNEFQLA-GVVTEEEKEMAKKMILVLEMLEGSTEDLQIP 354
           +   E   + +L    +T+   E AK+MI +  +   ++  L+ P
Sbjct: 910 WNLHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPP 954

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  204 bits (519), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 131/365 (35%), Positives = 198/365 (54%), Gaps = 43/365 (11%)

Query: 4   NKRRKTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKN-TENENA 62
           N R  +SF + A V+       +L+ +GL   R+           +   R+K  T   + 
Sbjct: 435 NNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMR------YSSIREKQVTRPGSF 488

Query: 63  EAAFIRNY-VSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNS 121
           E+  + ++ +   P+++ + ++++ T +F  ++G GGFGSVYKG LPD  L+AVK + N 
Sbjct: 489 ESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNH 548

Query: 122 KVNG-EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNI 180
            ++G +EF  E+A +    H N+V   GFC   ++  L+YE+M +GSL++ ++    S  
Sbjct: 549 GLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF----SGN 604

Query: 181 NRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS 240
              LEW+    IA+G ARGL YLH GC+ +I+H D+KP NILL + F PKISDFGL+KL 
Sbjct: 605 GPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLL 664

Query: 241 EKKES--FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV 298
            ++ES  F +M   RGT GY+APE        +S K+DVYSYGM++LE+V GRKN   + 
Sbjct: 665 NQEESSLFTTM---RGTRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKNCSFRS 719

Query: 299 SLSSE------------------IYFPNSIYKHIEPGNEFQLA-----GVVTEEEKEMAK 335
             +S                   +YFP       E G   +LA     G VT +E E   
Sbjct: 720 RSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLV 779

Query: 336 KMILV 340
           ++ L 
Sbjct: 780 RIALC 784

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  204 bits (518), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 169/287 (58%), Gaps = 14/287 (4%)

Query: 13  IAAGVVGIIVILVILLLVGLRHIRKKKT--ENDQNDFGFGRFRKKNTENENAEAAFIRNY 70
           IAA V+G+++I  + +L+  R  +K+    ++   +  F R     ++NE+A        
Sbjct: 449 IAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKE 508

Query: 71  VSLAPKRYNYSDVKRMTNSFS--NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG-EE 127
           + L    + +  +   T+SFS  NKLGQGGFG VYKGKLP+G+ +AVK L      G EE
Sbjct: 509 LPL----FEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEE 564

Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
            +NEV  +SK  H N+V  LG C E ++R L+YE+MP  SLD +++D     I   L+W+
Sbjct: 565 LMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKI---LDWK 621

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
           T   I  GI RGL YLHR   ++I+H D+K  NILL E+  PKISDFGLA++    E   
Sbjct: 622 TRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEA 681

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA 294
           +     GT GY++PE     F   S KSDV+S G++ LE++ GR+N+
Sbjct: 682 NTRRVVGTYGYMSPEYAMEGF--FSEKSDVFSLGVIFLEIISGRRNS 726

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	386
225452094	858	PREDICTED: probable receptor-like protei	0.914	0.411	0.609	1e-130
147812634	917	hypothetical protein VITISV_036944 [Viti	0.909	0.382	0.613	1e-125
224095678	365	predicted protein [Populus trichocarpa]	0.847	0.895	0.625	1e-122
224111934	661	predicted protein [Populus trichocarpa]	0.818	0.478	0.644	1e-121
255551426	638	serine/threonine kinase, putative [Ricin	0.932	0.564	0.569	1e-120
224108429	365	predicted protein [Populus trichocarpa]	0.816	0.863	0.642	1e-119
147769927	1001	hypothetical protein VITISV_010117 [Viti	0.839	0.323	0.622	1e-119
147795963	624	hypothetical protein VITISV_039936 [Viti	0.922	0.570	0.563	1e-117
359472674	637	PREDICTED: probable receptor-like protei	0.922	0.558	0.563	1e-117
224108441	324	predicted protein [Populus trichocarpa]	0.790	0.941	0.653	1e-117

>gi|225452094|ref|XP_002280747.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  470 bits (1209), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/382 (60%), Positives = 284/382 (74%), Gaps = 29/382 (7%)

Query: 10  SFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFIRN 69
           + GI+AGV GIIV+L ++       +R+K        F    ++K+  +N+N EA F+RN
Sbjct: 487 ALGISAGVAGIIVVLAVICC-----LRRKCLLGKTLVF----WKKETGDNQNVEA-FVRN 536

Query: 70  YVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFI 129
           Y SLAPKRY YS VK+MTNSF+ KLGQGGFG VY+GKLPDGR VAVK+L  SK NGEEFI
Sbjct: 537 YGSLAPKRYKYSVVKKMTNSFTCKLGQGGFGCVYQGKLPDGRQVAVKLLSESKGNGEEFI 596

Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTM 189
           NEVAS S+TSHVN+V+ +GFC+E  +RALIYEFMPNGSLD+ IY + S N N KLEW+TM
Sbjct: 597 NEVASFSRTSHVNIVTLVGFCFEGTRRALIYEFMPNGSLDKLIYQKGSPNANLKLEWKTM 656

Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            QIAVGIARGLEYL+RGCN RI+HFDIKPHNILL EDFCPKISDFGLAKL ++KES +SM
Sbjct: 657 YQIAVGIARGLEYLYRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKLCQRKESMVSM 716

Query: 250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNS 309
             ARGT GYIAPEVFCRNFGGVSHKSDVYSYGM++ EM+ GRKN + +VS +S+IYFP  
Sbjct: 717 AHARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVFEMIGGRKNIDAQVSHTSQIYFPTW 776

Query: 310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMIL------------------VLEMLEGSTEDL 351
           IYK ++PG +  L  +  EEE+E A+KM+L                  V+EMLEGS + L
Sbjct: 777 IYKQLQPGEDLILHSITNEEEEETARKMVLVSLWCIQLNPSDRPSIDKVVEMLEGSLQSL 836

Query: 352 QIPPKPSLSSPRRSAQQSPPAS 373
           +IPP P +  P ++A Q P  S
Sbjct: 837 EIPPNPFM-FPTQNATQDPSTS 857

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147812634|emb|CAN75059.1| hypothetical protein VITISV_036944 [Vitis vinifera]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 225/367 (61%), Positives = 275/367 (74%), Gaps = 16/367 (4%)

Query: 8   KTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENAEAAFI 67
           K + GI+AGV GIIV+L ++       +R+K        F    ++K+  +N+N EA F+
Sbjct: 519 KKAIGISAGVAGIIVVLAVICC-----LRRKCLLGKTLVF----WKKETGDNQNVEA-FV 568

Query: 68  RNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE 127
           RNY SLAPKRY YS VK+MTNSF+ KLGQGGFG VY+GKLPDGR VAVK+L  SK NGEE
Sbjct: 569 RNYGSLAPKRYKYSVVKKMTNSFTCKLGQGGFGCVYQGKLPDGRQVAVKLLSESKGNGEE 628

Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           FINEVAS S+TSHVN+V+ +GFC+E  +RALIYEFMPNGSLD+ IY + S N N KLEW+
Sbjct: 629 FINEVASFSRTSHVNIVTLVGFCFEGTRRALIYEFMPNGSLDKLIYQKGSPNANLKLEWK 688

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
           TM QIAVGIARGLEYL+RGCN RI+HFDIKPHNILL EDFCPKISDFGLAKL ++KES +
Sbjct: 689 TMYQIAVGIARGLEYLYRGCNTRILHFDIKPHNILLDEDFCPKISDFGLAKLCQRKESMV 748

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
           SM  ARGT GYIAPEVFCRNFGGVSHKSDVYSYGM++ EM+ GRKN + +VS +S+IYFP
Sbjct: 749 SMAHARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVFEMIGGRKNIDAQVSHTSQIYFP 808

Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPRRSAQ 367
             IYK ++PG +  L  +  EEE+E A+KM+LV      S   +Q+ P    S  +R   
Sbjct: 809 TWIYKQLQPGEDLILHSITNEEEEETARKMVLV------SLWCIQLNPSDRPSIDKRQFS 862

Query: 368 QSPPASL 374
           +  P +L
Sbjct: 863 KLQPLTL 869

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224095678|ref|XP_002334738.1| predicted protein [Populus trichocarpa] gi|222874466|gb|EEF11597.1| predicted protein [Populus trichocarpa]

 Score =  446 bits (1146), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 219/350 (62%), Positives = 271/350 (77%), Gaps = 23/350 (6%)

Query: 55  KNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVA 114
           KN+++ ++   F+ +Y SL PKRY+YSD+K+MT+SF+N LGQGGFG+VY+GKLP+GRLVA
Sbjct: 6   KNSQHVDSVETFMMDYHSLTPKRYSYSDIKKMTSSFANILGQGGFGNVYRGKLPEGRLVA 65

Query: 115 VKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD 174
           VKVLK SK +GEEF+NEVAS+S+TSHVNVV+ LGFCYE+ KRALIYEFMPNGSLD FI D
Sbjct: 66  VKVLKESKDDGEEFMNEVASISRTSHVNVVTLLGFCYERNKRALIYEFMPNGSLDSFISD 125

Query: 175 EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF 234
           + S + N +LEW+ + +IAV IARGLEYLHRGCN RIVHFDIKPHNILL ++FCPKISDF
Sbjct: 126 KGSPHTNCRLEWKKLYEIAVSIARGLEYLHRGCNTRIVHFDIKPHNILLDDEFCPKISDF 185

Query: 235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA 294
           GLAKL + K S ISM+GARGT+GYIAPEVFCR+FGGV++KSDVYSYGMM+LEMV   K+ 
Sbjct: 186 GLAKLCQSKVSKISMIGARGTVGYIAPEVFCRSFGGVTYKSDVYSYGMMVLEMVGQSKDF 245

Query: 295 EVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL--------------- 339
           ++    ++E+YFP+  Y ++EPG    L G  TEEEKE+ KKMIL               
Sbjct: 246 DMGSLETNEMYFPDWFYMYLEPGKISTLHGGTTEEEKEIVKKMILVGLWCIQTIPSHRPS 305

Query: 340 ---VLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPASLSTELASLESSSS 386
              V+EM EGS + LQIPP+PS SSPRRSAQ+      S  ++SL   SS
Sbjct: 306 MTKVVEMFEGSLQSLQIPPRPSFSSPRRSAQEQ-----SCTVSSLPCVSS 350

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111934|ref|XP_002332866.1| predicted protein [Populus trichocarpa] gi|222833668|gb|EEE72145.1| predicted protein [Populus trichocarpa]

 Score =  441 bits (1133), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 216/335 (64%), Positives = 260/335 (77%), Gaps = 19/335 (5%)

Query: 52  FRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-G 110
           FR K  ++      F+ +Y SL PKRY+YSD+K+MT SF N LG+GGFG+VY+GKLPD G
Sbjct: 298 FRLKKPQHVGRVETFMMDYHSLTPKRYSYSDIKKMTKSFVNTLGEGGFGNVYRGKLPDDG 357

Query: 111 RLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ 170
           RLVAVKVLK SK +GEEF+NEVAS+S+TSHVNVV+ LGFCYE+ KRALIYEFMPNGSLD 
Sbjct: 358 RLVAVKVLKESKGDGEEFMNEVASISRTSHVNVVTLLGFCYERNKRALIYEFMPNGSLDS 417

Query: 171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK 230
           FI ++ S + N +LEW+ + +IAVGIARGLEYLHRGCN RIVHFDIKPHNILL EDFCPK
Sbjct: 418 FISNKGSPHTNCRLEWKKLYEIAVGIARGLEYLHRGCNTRIVHFDIKPHNILLDEDFCPK 477

Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ISDFGLAKL + K S ISM+GARGT GYIAPEVFCR+FGGV++KSDVYSYGMM+LEMV  
Sbjct: 478 ISDFGLAKLCKSKVSKISMIGARGTAGYIAPEVFCRSFGGVTYKSDVYSYGMMVLEMVGK 537

Query: 291 RKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL----------- 339
            K+ ++    ++E+YFP+  Y +++PG      G +TEEEKE+ KKMIL           
Sbjct: 538 SKDFDMGSLETNELYFPDWFYMYLDPGEISTFHGGITEEEKEIVKKMILVGLWCIQTIPS 597

Query: 340 -------VLEMLEGSTEDLQIPPKPSLSSPRRSAQ 367
                  V+EM EGS + LQIPP+PSLSSPRRSAQ
Sbjct: 598 HRPSMTKVVEMFEGSLQSLQIPPRPSLSSPRRSAQ 632

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255551426|ref|XP_002516759.1| serine/threonine kinase, putative [Ricinus communis] gi|223544132|gb|EEF45657.1| serine/threonine kinase, putative [Ricinus communis]

 Score =  437 bits (1124), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 226/397 (56%), Positives = 278/397 (70%), Gaps = 37/397 (9%)

Query: 3   FNKRRKTSFGIAAGVVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKNTENENA 62
           F+  R  S G+ A       +L I L +     R+ +  +D         R KN + +  
Sbjct: 254 FSCGRSQSSGLGAAAA----VLTICLGIYYCFTRRVRFLSDT--------RWKNVKKDEK 301

Query: 63  EAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK 122
              FI NY S  PKRY+YSD++RMTNSF++KLGQGGFG VYKGKL DGR+VAVKVL  S 
Sbjct: 302 IENFILNYQSFMPKRYSYSDIQRMTNSFNHKLGQGGFGGVYKGKLLDGRVVAVKVLSKST 361

Query: 123 VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINR 182
            +GEEFINEVAS+S+TSH+NVV+ LGFCYE+ KRALIYE+MPNGSLD+FIYD+ S  +N+
Sbjct: 362 GDGEEFINEVASISRTSHINVVTLLGFCYERSKRALIYEYMPNGSLDKFIYDQGSQGVNK 421

Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L+W+T+  I VGIARGLEYLHRGCN RIVHFDIKPHNILL +DFCPK+SDFGLAKL + 
Sbjct: 422 HLDWKTLYDITVGIARGLEYLHRGCNTRIVHFDIKPHNILLDKDFCPKVSDFGLAKLCKG 481

Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS 302
           KES I+MLGARGTIGYIAPE+F RNFGGVS+KSDVYSYGMMILE+  GR  ++V VS S 
Sbjct: 482 KESIITMLGARGTIGYIAPEIFIRNFGGVSYKSDVYSYGMMILEICGGRNKSDVGVSHSG 541

Query: 303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL------------------VLEML 344
           E+YFP  IYK+IE      L   +T+EE EM +++ +                  V+EML
Sbjct: 542 EVYFPECIYKYIESEQVSTLHEKITDEEGEMVRRLTIVGLWCIQTNPSDRPSMTKVVEML 601

Query: 345 EGST-EDLQIPPKPSLSSPRRSAQQSPPASLSTELAS 380
           EGS+ E LQIPPKPSL +P      + P   S+ L+S
Sbjct: 602 EGSSLESLQIPPKPSLFAP------TTPQHYSSTLSS 632

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108429|ref|XP_002314844.1| predicted protein [Populus trichocarpa] gi|222863884|gb|EEF01015.1| predicted protein [Populus trichocarpa]

 Score =  434 bits (1117), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 214/333 (64%), Positives = 253/333 (75%), Gaps = 18/333 (5%)

Query: 55  KNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVA 114
           + T    +   F+RNY +LAP+RY+YS++K+MT +F  KLGQGGFGSV+KG L DGRLVA
Sbjct: 29  RKTRGSQSIEVFLRNYGTLAPERYSYSELKKMTKNFKEKLGQGGFGSVFKGNLLDGRLVA 88

Query: 115 VKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD 174
           VKVLK SK NGEEF+NEV+S+ +TSHVN+V+ LGFC+E  KRALIYEFM NGSLD+ IY+
Sbjct: 89  VKVLKKSKSNGEEFVNEVSSIGRTSHVNIVTLLGFCFEGPKRALIYEFMSNGSLDKHIYE 148

Query: 175 EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF 234
           E  S  + KL W T+ QIAVGIARGLEYLHRGCN RI+HFDIKPHNILL E+FCPKISDF
Sbjct: 149 ENLSKAHPKLGWETLYQIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISDF 208

Query: 235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA 294
           GLAK+   KES +SMLGARGT GYIAPEVFCRNFGGVSHKSDVYSYGM++LEM+ GRKN 
Sbjct: 209 GLAKICPSKESIVSMLGARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVLEMIGGRKNF 268

Query: 295 EVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL--------------- 339
            V V  +SEIYFP+ IY+ +E G E QL G   E E++ A+KMIL               
Sbjct: 269 RVGVDNTSEIYFPHWIYRRLEIGEELQLRGAGNEVEEQNARKMILASLWCIQTDPSNRPP 328

Query: 340 ---VLEMLEGSTEDLQIPPKPSLSSPRRSAQQS 369
              V++ML+GS E L IPPKP LSSP RS   S
Sbjct: 329 MSRVVDMLQGSLESLPIPPKPYLSSPPRSPHGS 361

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera]

 Score =  433 bits (1114), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 213/342 (62%), Positives = 259/342 (75%), Gaps = 18/342 (5%)

Query: 52   FRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR 111
            F++K T N      F+RN+ SLAPKRY YS+V++MT+SF +++G+GG+G+VYKGKL +G 
Sbjct: 660  FKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGD 719

Query: 112  LVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF 171
            LVAVKVL  +K NGEEFINE+AS+S+TSHVN+VS LGFC++  KRALIYEFMPNGSL++F
Sbjct: 720  LVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKF 779

Query: 172  IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI 231
            IYD+ SS    KL W T+  IA+GIARGLEYLHRGCN RI+H DIKPHNILL +DFCPKI
Sbjct: 780  IYDKNSSMTYHKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKI 839

Query: 232  SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            SDFGL+KL  +KES ISM GARGT GYIAPEVFCRNFG VS KSDVYSYGMM+LEMV GR
Sbjct: 840  SDFGLSKLCTRKESIISMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGR 899

Query: 292  KNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL------------ 339
            KN +  ++ +SEIYFP+ IYK +E   E  L G + EEE+  A+KMI+            
Sbjct: 900  KNTDDGINHTSEIYFPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSN 959

Query: 340  ------VLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPASLS 375
                  V++MLEGS E LQIPPKP L SP RS +    AS+S
Sbjct: 960  RPPMNGVVDMLEGSLESLQIPPKPFLYSPPRSMRDLSTASVS 1001

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera]

 Score =  429 bits (1103), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 221/392 (56%), Positives = 274/392 (69%), Gaps = 36/392 (9%)

Query: 4   NKRRKTSFGIAAGVVGIIVILVILLLVG--LRHIRKKKTENDQNDFGFGRFRKKNTENEN 61
           +K  K + G+A  + GI + L +        R I                F++K T N  
Sbjct: 249 DKTLKLALGLAISITGIGIPLALTFYFSKKFRSI----------------FKEKQTGNHL 292

Query: 62  AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNS 121
               F+RN+ SLAPKRY YS+V++MT+SF +++G+GG+G+VYKGKL +G LVAVKVL  +
Sbjct: 293 NVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSET 352

Query: 122 KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN 181
           K NGEEFINE+AS+S+TSHVN+VS LGFC++  KRALIYEFMPNGSL++FIYD+ SS   
Sbjct: 353 KGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTY 412

Query: 182 RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
            KL W T+  IA+GIARGLEYLHRGCN RI+H DIKPHNILL +DFCPKISDFGL+KL  
Sbjct: 413 DKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCT 472

Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS 301
           +KES +SM GARGT GYIAPEVFCRNFG VS KSDVYSYGMM+LEMV GRKN +  ++ +
Sbjct: 473 RKESIVSMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHT 532

Query: 302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL------------------VLEM 343
           SEIYFP+ IYK +E   E  L G + EEE+  A+KMI+                  V++M
Sbjct: 533 SEIYFPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDM 592

Query: 344 LEGSTEDLQIPPKPSLSSPRRSAQQSPPASLS 375
           LEGS E LQIPPKP L SP RS +    AS+S
Sbjct: 593 LEGSLESLQIPPKPFLYSPPRSMRDLSIASVS 624

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  428 bits (1101), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 221/392 (56%), Positives = 274/392 (69%), Gaps = 36/392 (9%)

Query: 4   NKRRKTSFGIAAGVVGIIVILVILLLVG--LRHIRKKKTENDQNDFGFGRFRKKNTENEN 61
           +K  K + G+A  + GI + L +        R I                F++K T N  
Sbjct: 262 DKTLKLALGLAISITGIGIPLALTFYFSKKFRSI----------------FKEKQTGNHL 305

Query: 62  AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNS 121
               F+RN+ SLAPKRY YS+V++MT+SF +++G+GG+G+VYKGKL +G LVAVKVL  +
Sbjct: 306 NVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSET 365

Query: 122 KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN 181
           K NGEEFINE+AS+S+TSHVN+VS LGFC++  KRALIYEFMPNGSL++FIYD+ SS   
Sbjct: 366 KGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTY 425

Query: 182 RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
            KL W T+  IA+GIARGLEYLHRGCN RI+H DIKPHNILL +DFCPKISDFGL+KL  
Sbjct: 426 DKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCT 485

Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS 301
           +KES +SM GARGT GYIAPEVFCRNFG VS KSDVYSYGMM+LEMV GRKN +  ++ +
Sbjct: 486 RKESIVSMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHT 545

Query: 302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL------------------VLEM 343
           SEIYFP+ IYK +E   E  L G + EEE+  A+KMI+                  V++M
Sbjct: 546 SEIYFPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDM 605

Query: 344 LEGSTEDLQIPPKPSLSSPRRSAQQSPPASLS 375
           LEGS E LQIPPKP L SP RS +    AS+S
Sbjct: 606 LEGSLESLQIPPKPFLYSPPRSMRDLSIASVS 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108441|ref|XP_002314847.1| predicted protein [Populus trichocarpa] gi|222863887|gb|EEF01018.1| predicted protein [Populus trichocarpa]

 Score =  427 bits (1098), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 211/323 (65%), Positives = 246/323 (76%), Gaps = 18/323 (5%)

Query: 55  KNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVA 114
           + T    +  AF+RNY +LAPKRY+YS++K+MT +F  KLGQGG+GSV+KG L DGRLVA
Sbjct: 2   RKTRGSQSMEAFLRNYGTLAPKRYSYSELKKMTKNFKEKLGQGGYGSVFKGNLLDGRLVA 61

Query: 115 VKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD 174
           VKVLK SK NGEEF+NEV+S+  TSHVN+V+ LGFC+E  KRALIYEFM NGSLD+ IY+
Sbjct: 62  VKVLKKSKSNGEEFVNEVSSIGMTSHVNIVTLLGFCFEGPKRALIYEFMSNGSLDKHIYE 121

Query: 175 EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF 234
           E  S    KL W T+ QIAVGIARGLEYLHRGCN RI+HFDIKPHNILL E+FCPKISDF
Sbjct: 122 ENLSKAQPKLGWETLYQIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISDF 181

Query: 235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA 294
           GLAK+   KES +SMLGARGT GYIAPEVFCRNFGGVSHKSDVYSYGM++LEM+ GRKN 
Sbjct: 182 GLAKICPGKESIVSMLGARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVLEMIGGRKNF 241

Query: 295 EVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL--------------- 339
            V V  +SEIYFP+ IYK +E G E QL G   E E+E A+KMIL               
Sbjct: 242 RVGVDNTSEIYFPHWIYKRLEIGEELQLRGAGNEVEEENARKMILASLWCIQTDPSNRPP 301

Query: 340 ---VLEMLEGSTEDLQIPPKPSL 359
              V++ML+GS E L IPPKP L
Sbjct: 302 MSRVVDMLQGSLESLPIPPKPYL 324

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	386
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.717	0.324	0.596	2.9e-92
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.727	0.422	0.614	1.1e-91
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.738	0.356	0.597	5.6e-90
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.730	0.442	0.578	3.9e-87
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.720	0.341	0.567	2.5e-83
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.753	0.326	0.541	4.5e-82
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.694	0.402	0.575	9.4e-82
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.670	0.321	0.590	5.1e-81
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.756	0.433	0.535	1.2e-79
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.613	0.403	0.604	1.2e-72

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 876 (313.4 bits), Expect = 2.9e-92, Sum P(3) = 2.9e-92
 Identities = 176/295 (59%), Positives = 222/295 (75%)

Query:    53 RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD--G 110
             RK    +EN EA      V L  KRY++  VK+MTNSF + +G+GGFG+VYKGKLPD  G
Sbjct:   491 RKSELNDENIEAV-----VML--KRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASG 543

Query:   111 RLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ 170
             R +A+K+LK SK NGEEFINE+ SMS+ SHVN+VS  GFCYE  +RA+IYEFMPNGSLD+
Sbjct:   544 RDIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDK 603

Query:   171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK 230
             FI    S N++ K+EW+T+  IAVG+ARGLEYLH  C  +IVHFDIKP NIL+ ED CPK
Sbjct:   604 FI----SENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPK 659

Query:   231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ISDFGLAKL +KKES ISML ARGT+GYIAPE+F +N+GGVSHKSDVYSYGM++LEM+  
Sbjct:   660 ISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGA 719

Query:   291 RKNAEVKVSLS--SEIYFPNSIYKHIEPGNEFQLAG--VVTEEEKE-MAKKMILV 340
              K  EV+ S +  S +YFP+ +Y+ +E     +L    ++ EEE+E + K+M LV
Sbjct:   720 TKREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLV 774

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 880 (314.8 bits), Expect = 1.1e-91, Sum P(2) = 1.1e-91
 Identities = 180/293 (61%), Positives = 223/293 (76%)

Query:    53 RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GR 111
             R KN  N       +     L  KRY+Y+ VK+MTNSF++ LG+GGFG+VYKGKL D GR
Sbjct:   298 RTKNMRNSEWNDQNVEAVAML--KRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGR 355

Query:   112 LVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF 171
              VAVK+LK S+ NGEEFINEVASMS+TSHVN+VS LGFCYEK KRA+IYEFMPNGSLD++
Sbjct:   356 DVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKY 415

Query:   172 IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI 231
             I    S+N++ K+EW  +  +AVGI+RGLEYLH  C  RIVHFDIKP NIL+ E+ CPKI
Sbjct:   416 I----SANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKI 471

Query:   232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             SDFGLAKL + KES ISML  RGT GYIAPE+F +NFG VSHKSDVYSYGM++LEM+ G 
Sbjct:   472 SDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMI-GA 530

Query:   292 KNAE-VKVSLSSE--IYFPNSIYKHIEPGNEFQLAG-VVTEEEKEMAKKMILV 340
             KN E V+ S S+   +YFP  +YK  E G   ++ G  +T+EE+++AKK++LV
Sbjct:   531 KNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLVLV 583

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 867 (310.3 bits), Expect = 5.6e-90, Sum P(2) = 5.6e-90
 Identities = 177/296 (59%), Positives = 217/296 (73%)

Query:    50 GRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD 109
             G+ R  N    +     +   V L  KR++Y  VK+MT SF N LG+GGFG+VYKGKLPD
Sbjct:   423 GKVRANNMRKSDLNEKNMEAVVML--KRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPD 480

Query:   110 G-RLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL 168
             G R VAVK+LK S  +GE+FINE+ASMS+TSH N+VS LGFCYE +K+A+IYE MPNGSL
Sbjct:   481 GSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSL 540

Query:   169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC 228
             D+FI    S N++ K+EW+T+  IAVG++ GLEYLH  C  RIVHFDIKP NIL+  D C
Sbjct:   541 DKFI----SKNMSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLC 596

Query:   229 PKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
             PKISDFGLAKL +  ES ISML ARGTIGYIAPEVF +NFGGVSHKSDVYSYGM++LEM+
Sbjct:   597 PKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMI 656

Query:   289 VGRK--NAEVKVSLSSEIYFPNSIYKHIEPGNEFQ-LAGVVTEEEKE-MAKKMILV 340
               R    A+   S ++ +YFP+ IYK +E G     LA  +TEEE E + KKM+LV
Sbjct:   657 GARNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLV 712

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 852 (305.0 bits), Expect = 3.9e-87, Sum P(2) = 3.9e-87
 Identities = 170/294 (57%), Positives = 224/294 (76%)

Query:    52 FRKKNTENE-NAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDG 110
             F+K+ T +        ++  V L  K+Y+Y++V+++T  FS+ LG+GGFG+VY G L DG
Sbjct:   286 FQKRRTSHHLRPRDNNLKGLVQL--KQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDG 343

Query:   111 RLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ 170
             R VAVK+LK+ K NGE+FINEVASMS+TSHVN+VS LGFCYE  KRA++YEF+ NGSLDQ
Sbjct:   344 RKVAVKILKDFKSNGEDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQ 403

Query:   171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK 230
             F+ +++S N    L+  T+ +IA+G+ARGL+YLH GC  RIVHFDIKP NILL + FCPK
Sbjct:   404 FLSEKKSLN----LDVSTLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPK 459

Query:   231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +SDFGLAKL EK+ES +S+L ARGTIGYIAPEVF   +G VSHKSDVYSYGM++LEM+ G
Sbjct:   460 VSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMI-G 518

Query:   291 RKNAEVK---VSLSSEIYFPNSIYKHIEPGNE-FQLAGVVTEEEKEMAKKMILV 340
              KN E++    S SS  YFP+ IYK++E G + ++    ++ E+KE+AKKM LV
Sbjct:   519 AKNKEIEETAASNSSSAYFPDWIYKNLENGEDTWKFGDEISREDKEVAKKMTLV 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 815 (292.0 bits), Expect = 2.5e-83, Sum P(2) = 2.5e-83
 Identities = 164/289 (56%), Positives = 212/289 (73%)

Query:    53 RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL 112
             RKKN + EN+   F      L  K+Y Y+++K++T SFS+ +G+GGFG+VY+G L +GR 
Sbjct:   467 RKKN-KKENSVIMF-----KLLLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRT 520

Query:   113 VAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI 172
             VAVKVLK+ K NG++FINEV SMS+TSHVN+VS LGFCYE  KRA+I EF+ +GSLDQFI
Sbjct:   521 VAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI 580

Query:   173 YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS 232
                +S   N      T+  IA+GIARGLEYLH GC  RIVHFDIKP NILL ++FCPK++
Sbjct:   581 SRNKSLTPNVT----TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVA 636

Query:   233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
             DFGLAKL EK+ES +S++  RGTIGYIAPEV  R +GG+SHKSDVYSYGM++L+M+  R 
Sbjct:   637 DFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARN 696

Query:   293 NAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG-VVTEEEKEMAKKMILV 340
               E      S  YFP+ IYK +E G++  + G  + EE+ ++ KKMILV
Sbjct:   697 KVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILV 745

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 802 (287.4 bits), Expect = 4.5e-82, Sum P(2) = 4.5e-82
 Identities = 170/314 (54%), Positives = 221/314 (70%)

Query:    52 FRKKNTENENAEAAFIRNYVSLAP-KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDG 110
             FRK+ T +E      ++   +L P K Y Y++VK+MT SF+  +G+GGFG VY G L D 
Sbjct:   523 FRKRKTSDE----VRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDS 578

Query:   111 RLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
              +VAVKVLK+SK  +GE+FINEVASMS+TSHVN+VS LGFC E  +RA+IYEF+ NGSLD
Sbjct:   579 SMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLD 638

Query:   170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP 229
             +FI D+ S N++ K    T+  IA+G+ARGLEYLH GC  RIVHFDIKP N+LL ++ CP
Sbjct:   639 KFISDKSSVNLDLK----TLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCP 694

Query:   230 KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             K+SDFGLAKL EKKES +S+L  RGTIGYIAPE+  R +G VSHKSDVYSYGM++LEM+ 
Sbjct:   695 KVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIG 754

Query:   290 GRKNAEVKVSLSSE---IYFPNSIYKHIEPGN-----EFQLAGVV----TEEEKEMAKKM 337
              RK      +  S+   IYFP  IYK +E  N     + +  G++    + EE+E+A+KM
Sbjct:   755 ARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKM 814

Query:   338 ILV-LEMLEGSTED 350
              LV L  ++ S  D
Sbjct:   815 TLVGLWCIQSSPSD 828

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 802 (287.4 bits), Expect = 9.4e-82, Sum P(2) = 9.4e-82
 Identities = 160/278 (57%), Positives = 207/278 (74%)

Query:    68 RNYVSLAP-KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE 126
             +N  +L P K Y+Y+ V  +T SF+  +G+GGFG+VY+G L DGR VAVKVLK S+ NGE
Sbjct:   327 QNLKALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGE 386

Query:   127 EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             +FINEVASMS+TSHVN+V+ LGFC E  KRA+IYEFM NGSLD+FI  ++SS     ++W
Sbjct:   387 DFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSST----MDW 442

Query:   187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
             R +  IA+G+ARGLEYLH GC  RIVHFDIKP N+LL ++  PK+SDFGLAKL E+KES 
Sbjct:   443 RELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESI 502

Query:   247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKN---AEVKVSLSSE 303
             +S++  RGTIGYIAPEVF R +G VSHKSDVYSYGM++L+ ++G +N    E   S +S 
Sbjct:   503 LSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLD-IIGARNKTSTEDTTSSTSS 561

Query:   304 IYFPNSIYKHIEPG-NEFQLAGVVTEEEKEMAKKMILV 340
             +YFP  IY+ +E   N   +   ++ EE E+AKKM LV
Sbjct:   562 MYFPEWIYRDLEKAHNGKSIETAISNEEDEIAKKMTLV 599

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 791 (283.5 bits), Expect = 5.1e-81, Sum P(2) = 5.1e-81
 Identities = 157/266 (59%), Positives = 203/266 (76%)

Query:    78 YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK 137
             Y Y+++K++T SFS  +G+GGFG+VY G L +GR VAVKVLK+ K + E+FINEVASMS+
Sbjct:   488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query:   138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             TSHVN+VS LGFC+E  KRA++YEF+ NGSLDQF+    S N +   +  T+  IA+GIA
Sbjct:   548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFM----SRNKSLTQDVTTLYGIALGIA 603

Query:   198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
             RGLEYLH GC  RIVHFDIKP NILL  + CPK+SDFGLAKL EK+ES +S++  RGTIG
Sbjct:   604 RGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIG 663

Query:   258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV--SLSSEIYFPNSIYKHIE 315
             YIAPEVF R +G VSHKSDVYS+GM++++M+  R    V+   S +S  YFP+ IYK +E
Sbjct:   664 YIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLE 723

Query:   316 PGNEFQLAG-VVTEEEKEMAKKMILV 340
              G +  + G  +T+EEKE+AKKMI+V
Sbjct:   724 DGEQTWIFGDEITKEEKEIAKKMIVV 749

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 779 (279.3 bits), Expect = 1.2e-79, Sum P(2) = 1.2e-79
 Identities = 164/306 (53%), Positives = 215/306 (70%)

Query:    52 FRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR 111
             FR + T ++  +   ++  + L  K Y Y+ VKRMT SF+  +G+GGFG VY+G L DGR
Sbjct:   313 FRNRKTSDDRRQEK-LKALIPL--KHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGR 369

Query:   112 LVAVKVLKNSKVNG-EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ 170
             +VAVKVLK SK N  E+FINEV+SMS+TSHVN+VS LGFC E  +RA+IYEF+ NGSLD+
Sbjct:   370 MVAVKVLKESKGNNSEDFINEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDK 429

Query:   171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK 230
             FI  E++S I   L+   +  IA+G+ARGLEYLH GC  RIVHFDIKP N+LL ++  PK
Sbjct:   430 FI-SEKTSVI---LDLTALYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPK 485

Query:   231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +SDFGLAKL EKKES +S++  RGTIGYIAPE+  R +G VSHKSDVYSYGM++ EM+  
Sbjct:   486 VSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGA 545

Query:   291 RKNAEVKVSLS--SEIYFPNSIYKHIEPGNEFQLAGV---VTEEEKEMAKKMILV-LEML 344
             RK      + +  S +YFP  IYK +E  +   L  +   ++ EE+E+AKKM LV L  +
Sbjct:   546 RKKERFGQNSANGSSMYFPEWIYKDLEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCI 605

Query:   345 EGSTED 350
             + S  D
Sbjct:   606 QSSPSD 611

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
 Identities = 151/250 (60%), Positives = 191/250 (76%)

Query:    94 LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
             +G+GGFG+VYKG L DGR VAVK+LK+S  N E+FINEVAS+S+TSHVN+VS LGFC+EK
Sbjct:   287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346

Query:   154 KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVH 213
              KRA++YEF+ NGSLDQ      SSN    L+  T+  IA+G+ARG+EYLH GC  RIVH
Sbjct:   347 SKRAIVYEFLENGSLDQ------SSN----LDVSTLYGIALGVARGIEYLHFGCKKRIVH 396

Query:   214 FDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSH 273
             FDIKP N+LL E+  PK++DFGLAKL EK+ES +S+L  RGTIGYIAPE+F R +G VSH
Sbjct:   397 FDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSH 456

Query:   274 KSDVYSYGMMILEMVVGRKNAEVKV--SLSSEIYFPNSIYKHIEPGNEFQL-AGVVTEEE 330
             KSDVYSYGM++LEM   R    V+   S +S  YFP+ I+K +E G+  +L A  +T EE
Sbjct:   457 KSDVYSYGMLVLEMTGARNKERVQNADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREE 516

Query:   331 KEMAKKMILV 340
             +++AKKMILV
Sbjct:   517 EDIAKKMILV 526

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_scaffold_1822000003 hypothetical protein (365 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	386
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-53
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-41
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-33
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-32
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-29
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-26
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-17
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (444), Expect = 6e-53
 Identities = 69/198 (34%), Positives = 105/198 (53%), Gaps = 15/198 (7%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLGFC 150
           LG+GGFG+VY  +    G+ VA+K++K    +   EE + E+  + K +H N+V   G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            ++    L+ E+   GSL   +          KL    + +I + I  GLEYLH   +  
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDEILRILLQILEGLEYLH---SNG 112

Query: 211 IVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           I+H D+KP NILL  D    K++DFGL+KL    +S   +    GT  Y+APEV     G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKG 169

Query: 270 GVSHKSDVYSYGMMILEM 287
             S KSD++S G+++ E+
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (445), Expect = 1e-52
 Identities = 77/222 (34%), Positives = 112/222 (50%), Gaps = 24/222 (10%)

Query: 90  FSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
              KLG+G FG VYKG L          VAVK LK   S+   EEF+ E + M K SH N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +V  LG C + +   ++ E+MP G L  F+          KL  + + Q+A+ IA+G+EY
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-----GEKLTLKDLLQMALQIAKGMEY 117

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           L        VH D+   N L+ E+   KISDFGL++   + + +    G +  I ++APE
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEVK 297
                 G  + KSDV+S+G+++ E+         G  N EV 
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 214

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  175 bits (445), Expect = 2e-52
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 16/203 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI---NEVASMSKTSHVNVVSFLG 148
           KLG G FG+VYK K    G++VAVK+LK      ++      E+  + + SH N+V  + 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +K    L+ E+   G L  ++           L      +IA+ I RGLEYLH    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR------GGPLSEDEAKKIALQILRGLEYLHS--- 116

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             I+H D+KP NILL E+   KI+DFGLAK   K  S  S+    GT  Y+APEV     
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEV-LLGG 173

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
            G   K DV+S G+++ E++ G+
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  174 bits (444), Expect = 2e-52
 Identities = 72/206 (34%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHV 141
           +   KLG+G FG VYKGKL          VAVK LK        EEF+ E   M K  H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           NVV  LG C E++   ++ E+M  G L  ++          KL    +   A+ IARG+E
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGME 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL        +H D+   N L+GE+   KISDFGL++     +      G +  I ++AP
Sbjct: 117 YLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAP 172

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           E      G  + KSDV+S+G+++ E+
Sbjct: 173 ESL--KEGKFTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  173 bits (442), Expect = 4e-52
 Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHV 141
           +   KLG+G FG VYKG L          VAVK LK        EEF+ E   M K  H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           N+V  LG C E++   ++ E+MP G L  ++      N  ++L    +   A+ IARG+E
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGME 117

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL        +H D+   N L+GE+   KISDFGL++     +    + G +  I ++AP
Sbjct: 118 YLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAP 173

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           E      G  + KSDV+S+G+++ E+
Sbjct: 174 ESL--KEGKFTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  166 bits (424), Expect = 3e-49
 Identities = 73/206 (35%), Positives = 105/206 (50%), Gaps = 14/206 (6%)

Query: 92  NKLGQGGFGSVYKGKLPDG----RLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVS 145
            KLG+G FG VYKGKL         VAVK LK      E  +F+ E   M K  H NVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFI---YDEESSNINRKLEWRTMCQIAVGIARGLEY 202
            LG C E++   L+ E+M  G L  ++        S     L  + +   A+ IA+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           L    + + VH D+   N L+GED   KISDFGL++     + +    G +  I ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV 288
                 G  + KSDV+S+G+++ E+ 
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  164 bits (418), Expect = 1e-48
 Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLG 148
            KLG+G FG VY  +    G+LVA+KV+K  K+    E  + E+  + K  H N+V    
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              ++ K  L+ E+   G L   +          +L           I   LEYLH    
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK------RGRLSEDEARFYLRQILSALEYLHS--- 115

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             IVH D+KP NILL ED   K++DFGLA+  +  E   + +   GT  Y+APEV     
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGK- 171

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
            G     D++S G+++ E++ G+
Sbjct: 172 -GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  151 bits (383), Expect = 2e-43
 Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 17/206 (8%)

Query: 92  NKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFL 147
             LG+G FGSVY     D G L+AVK ++ S  + EE      E+  +S   H N+V + 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 148 GFCYEKKKRAL-IY-EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           G   +++K  L I+ E++  GSL   +          KL    + +    I  GL YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK------FGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                IVH DIK  NIL+  D   K++DFG AK     E+       RGT  ++APEV  
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-I 175

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
           R        +D++S G  ++EM  G+
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  145 bits (369), Expect = 2e-41
 Identities = 74/206 (35%), Positives = 111/206 (53%), Gaps = 25/206 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           K+G+GGFG VYK +    G+ VA+KV+K  SK   E+ INE+  + K  H N+V + G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-S 65

Query: 151 YEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYLHRG 206
           Y KK    ++ EF   GSL   +      + N+ L   T  QIA     + +GLEYLH  
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLL-----KSTNQTL---TESQIAYVCKELLKGLEYLH-- 115

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV-FC 265
            +  I+H DIK  NILL  D   K+ DFGL+      ++  +M+   GT  ++APEV   
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
           + +     K+D++S G+  +E+  G+
Sbjct: 172 KPYDY---KADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  126 bits (319), Expect = 4e-34
 Identities = 75/211 (35%), Positives = 108/211 (51%), Gaps = 17/211 (8%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           KLG G FG V+ G       VAVK LK   ++ E F+ E   M K  H  +V     C E
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 153 KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
           ++   ++ E+M  GSL  F+   E     +KL    +  +A  IA G+ YL        +
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLES---RNYI 125

Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   NIL+GE+   KI+DFGLA+L E  E + +  GA+  I + APE    N+G  +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA--NYGRFT 182

Query: 273 HKSDVYSYGMMILEMVV-------GRKNAEV 296
            KSDV+S+G+++ E+V        G  N EV
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREV 213

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  125 bits (316), Expect = 1e-33
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 25/207 (12%)

Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLK-NSKVNGEEFI-NEVASMSKTSHVNVVSFLGF 149
            LGQG  G VYK +  P G++ A+K +  +      + +  E+ ++       VV   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
            Y++ + +++ E+M  GSL   +          K+    +  IA  I +GL+YLH     
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLK------KVGKIPEPVLAYIARQILKGLDYLHT--KR 119

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSE----KKESFISMLGARGTIGYIAPEVF- 264
            I+H DIKP N+L+      KI+DFG++K+ E    +  +F+      GT+ Y++PE   
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSPERIQ 173

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
             ++   S+ +D++S G+ +LE  +G+
Sbjct: 174 GESY---SYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 1e-32
 Identities = 74/209 (35%), Positives = 104/209 (49%), Gaps = 23/209 (11%)

Query: 94  LGQGGFGSVYKGK-LPDGRL----VAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+KVL+   S    +E ++E   M+   H +VV  
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C    +  LI + MP G L  ++      NI  +  L W       V IA+G+ YL 
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                R+VH D+   N+L+      KI+DFGLAKL +  E      G +  I ++A E  
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE-- 181

Query: 265 CRNFGGVSHKSDVYSYGMMILE-MVVGRK 292
                  +HKSDV+SYG+ + E M  G K
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 1e-31
 Identities = 69/235 (29%), Positives = 115/235 (48%), Gaps = 20/235 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V+ GK      VA+K+++   ++ ++FI E   M K SH N+V   G
Sbjct: 7   TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   ++ E+M NG L  ++ + +      KL    +  +   +   +EYL     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGF 121

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           I   H D+   N L+GED   K+SDFGLA+     + + S  G +  + +  PEVF  ++
Sbjct: 122 I---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVF--DY 175

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEV--KVSLSSEIYFPNSIYKHI 314
              S KSDV+S+G+++ E+            N+EV   VS    +Y P      +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEV 230

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  120 bits (302), Expect = 2e-31
 Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 90  FSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           F  +LG+G FG V   +        G  VAVK L +S       +F  E+  +    H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 143 VVSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           +V + G C +   R+  LI E++P+GSL  ++       IN K     +   +  I +G+
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLK----RLLLFSSQICKGM 122

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    + R +H D+   NIL+  +   KISDFGLAK L E K+ +         I + 
Sbjct: 123 DYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEM 287
           APE  C      S  SDV+S+G+ + E+
Sbjct: 180 APE--CLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 9e-31
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTSHVNVVS 145
             + +G+G FG VYKG  L  G  VA+K +   K+  E     + E+  +    H N+V 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           ++G         +I E+  NGSL Q I  ++       L    + Q    + +GL YLH 
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQ----VLQGLAYLHE 117

Query: 206 -GCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPEV 263
            G    ++H DIK  NIL  +D   K++DFG+A KL++  +   S++   GT  ++APEV
Sbjct: 118 QG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV---GTPYWMAPEV 170

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                 G S  SD++S G  ++E++ G 
Sbjct: 171 I--EMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (297), Expect = 4e-30
 Identities = 87/314 (27%), Positives = 125/314 (39%), Gaps = 28/314 (8%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSH-VNVVSFL 147
           KLG+G FG VY  +  D +LVA+KVL     +     E F+ E+  ++  +H  N+V   
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
            F  ++    L+ E++  GSL+  +   +       L       I   I   LEYLH   
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQILSALEYLHS-- 119

Query: 208 NIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESFISMLGAR----GTIGYIAPE 262
              I+H DIKP NILL  D    K+ DFGLAKL     S  S+        GT GY+APE
Sbjct: 120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 263 VF-CRNFGGVSHKSDVYSYGMMILEMVVGR--KNAEVKVSLSSEIY-------FPNSIYK 312
           V    +    S  SD++S G+ + E++ G      E   S +S+          P+    
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPA 372
                 E          +K +AK     L      + DL    K   S      +    A
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Query: 373 SLSTELASLESSSS 386
            L   L     +  
Sbjct: 299 PLRLSLPPSLEALI 312

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (290), Expect = 6e-30
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 19/213 (8%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
            KLG G FG V++G   +   VA+K+LK +  +  ++F  EV ++ +  H +++S    C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
              +   +I E M  GSL  F+   E     + L   ++  +A  +A G+ YL       
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---N 124

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG 270
            +H D+   NIL+GED   K++DFGLA+L   KE        +    + APE    + G 
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA--SHGT 180

Query: 271 VSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            S KSDV+S+G+++ EM         G  N EV
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  115 bits (288), Expect = 9e-30
 Identities = 65/235 (27%), Positives = 118/235 (50%), Gaps = 20/235 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +   ++G G FG V+ G   + R VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C E+    L++EFM +G L  ++  +       K    T+  + + +  G+ YL     
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESSN- 120

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVF--SF 175

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
              S KSDV+S+G+++ E+          R N+EV  ++++   +Y P    + +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSV 230

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 15/198 (7%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
               +G+G FG V  G    G+ VAVK LK+     + F+ E + M+   H N+V  LG 
Sbjct: 10  LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
             +     ++ E+M  GSL  ++     + I            A+ +  G+EYL      
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL----AQQLGFALDVCEGMEYLEEK--- 121

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             VH D+   N+L+ ED   K+SDFGLAK + + +        +  + + APE   R   
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEAL-RE-K 174

Query: 270 GVSHKSDVYSYGMMILEM 287
             S KSDV+S+G+++ E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  114 bits (288), Expect = 1e-29
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSH 140
           +++R   +  +KLG G +G VY+G        VAVK LK   +  EEF+ E A M +  H
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V  LG C  +    +I EFM  G+L  ++ +     +N       +  +A  I+  +
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQISSAM 117

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I + A
Sbjct: 118 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 173

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    N    S KSDV+++G+++ E+
Sbjct: 174 PESLAYN--KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  114 bits (286), Expect = 2e-29
 Identities = 77/222 (34%), Positives = 112/222 (50%), Gaps = 18/222 (8%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           +V R T     KLG G FG V+ G       VA+K LK   ++ E F+ E   M +  H 
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V  L     ++   +I E+M NGSL  F+   E      KL    +  +A  IA G+ 
Sbjct: 62  RLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMA 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           ++ R   I   H D++  NIL+ E  C KI+DFGLA+L E  E + +  GA+  I + AP
Sbjct: 117 FIERKNYI---HRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAP 172

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           E    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 173 EAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 3e-29
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 26/219 (11%)

Query: 92  NKLGQGGFGSVYKG--KLPDGRL--VAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVS 145
            +LG G FGSV KG   +  G+   VAVK LK   +    +EF+ E + M++  H  +V 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +G C + +   L+ E  P G L +++       ++   E     Q+A     G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVA----MGMAYLE- 112

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF 264
             +   VH D+   N+LL      KISDFG+++ L    + + +    R  + + APE  
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-- 168

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           C N+G  S KSDV+SYG+ + E            K AEV
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (284), Expect = 8e-29
 Identities = 70/204 (34%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           K+G+G  G VYK      G+ VA+K ++  K N E  INE+  M    H N+V +    Y
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SY 84

Query: 152 EKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYLHRGC 207
                  ++ E+M  GSL   I                  QIA     + +GLEYLH   
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCREVLQGLEYLHSQ- 135

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCR 266
              ++H DIK  NILL +D   K++DFG  A+L+++K    S++   GT  ++APEV  R
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVIKR 190

Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
              G   K D++S G+M +EM  G
Sbjct: 191 KDYG--PKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  112 bits (281), Expect = 1e-28
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 93  KLGQGGFGSVYKG--KLPDGRL--VAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSF 146
           KLG G FG V +G      G++  VAVK LK+ K++   ++F+ E A M    H N++  
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G         ++ E  P GSL     D    +        T+C  AV IA G+ YL   
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
              R +H D+   NILL  D   KI DFGL + L + ++ ++     +    + APE   
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--S 171

Query: 266 RNFGGVSHKSDVYSYGMMILEM 287
                 SH SDV+ +G+ + EM
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 17/222 (7%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLG G FG V++G   +   VAVK LK   ++ ++F+ E   M K  H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            ++     C  ++   ++ E M  GSL +++       +  KL    +  +A  +A G+ 
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL--KLP--QLIDMAAQVASGMA 117

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL     I   H D+   N+L+GE+   K++DFGLA++  K++ + +  GA+  I + AP
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAP 173

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           E     +   S KSDV+S+G+++ E+V        G  NAEV
Sbjct: 174 EAA--LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (275), Expect = 9e-28
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 29/213 (13%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFL 147
            ++G+G FG VY  +   DG+L  +K +  S ++ +E    +NEV  + K +H N++ + 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE----WRTMCQIAVGIARGLEYL 203
               EK K  ++ E+   G L Q I  ++     +            Q+ +     L+YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLA----LKYL 119

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKE---SFISMLGARGTIGYI 259
           H     +I+H DIKP NI L  +   K+ DFG++K LS   +   + +      GT  Y+
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV------GTPYYL 170

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           +PE+ C+N    ++KSD++S G ++ E+   + 
Sbjct: 171 SPEL-CQN-KPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  109 bits (274), Expect = 2e-27
 Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 23/216 (10%)

Query: 90  FSNKLGQGGFGSVYKGKL--PDGRL----VAVKVLK--NSKVNGEEFINEVASMSKTSHV 141
           F  +LG+G FG VYKG+L  P+ RL    VA+K LK        +EF  E   MS   H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFI----------YDEESSNINRKLEWRTMCQ 191
           N+V  LG C +++   +++E++ +G L +F+           +     +   L+      
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           IA+ IA G+EYL        VH D+   N L+GE    KISDFGL++     + +     
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           +   + ++ PE     +G  + +SD++S+G+++ E+
Sbjct: 186 SLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  108 bits (271), Expect = 2e-27
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 18/222 (8%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLG G FG V+ G       VAVK LK   ++ E F+ E   M K  H 
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+ D E     R L+   +  +A  +A G+ 
Sbjct: 62  KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMA 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  +H D++  NIL+G+    KI+DFGLA+L E  E + +  GA+  I + AP
Sbjct: 117 YIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           E     +G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 173 EAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 3e-27
 Identities = 71/208 (34%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKV--LKNSKVNGEEFIN----EVASMSKTSHVNVVSF 146
           LG G FGSVY+G  L DG   AVK   L +    G+E +     E+A +SK  H N+V +
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYL 203
           LG   E+    +  E +P GSL         + + +K        I +    I  GLEYL
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL---------AKLLKKYGSFPEPVIRLYTRQILLGLEYL 118

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H   +   VH DIK  NIL+  +   K++DFG+AK   +   F      +G+  ++APEV
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYWMAPEV 172

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                GG    +D++S G  +LEM  G+
Sbjct: 173 -IAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 3e-27
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 17/206 (8%)

Query: 94  LGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V +G  KLP  +   VA+K LK    + +  +F+ E + M +  H N++   
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   + +   +I E+M NGSLD+F+ + +      K     +  +  GIA G++YL    
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYL---S 123

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
            +  VH D+   NIL+  +   K+SDFGL++  E  E+  +  G +  I + APE     
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI--A 181

Query: 268 FGGVSHKSDVYSYGMMILE-MVVGRK 292
           +   +  SDV+S+G+++ E M  G +
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  107 bits (267), Expect = 1e-26
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 17/233 (7%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLG G FG V+ G   +   VAVK LK   ++ + F+ E   M    H 
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       +++   +I E+M  GSL  F+  +E      K+    +   +  IA G+ 
Sbjct: 62  KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG----KVLLPKLIDFSAQIAEGMA 117

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R      +H D++  N+L+ E    KI+DFGLA++ E  E + +  GA+  I + AP
Sbjct: 118 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 173

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFP 307
           E    NFG  + KSDV+S+G+++ E+V        G  N++V  +L      P
Sbjct: 174 EAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  107 bits (268), Expect = 1e-26
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 31/226 (13%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKL----PDG--RLVAVKVLKNSKVNG--EEFINEVAS 134
           V+R T     +LG+G FG V+ G+     P+    LVAVK LK +  N   ++F  E   
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINR----KLEW 186
           ++   H N+V F G C E     +++E+M +G L++F+     D            +L  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
             + QIAV IA G+ YL    +   VH D+   N L+G D   KI DFG+++     + +
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 247 ----ISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                +ML  R    ++ PE +  R F   + +SDV+S+G+++ E+
Sbjct: 179 RVGGHTMLPIR----WMPPESIMYRKF---TTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (265), Expect = 3e-26
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 91  SNKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSF 146
            NK+G G FG VY    L  G L+AVK ++   N     +E  +E+  +    H N+V +
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G    ++K  +  E+   G+L      EE     R L+   +    + +  GL YLH  
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTL------EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISML-GARGTIGYIAPEVF 264
               IVH DIKP NI L  +   K+ DFG A  L     +    +    GT  Y+APEV 
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 265 CRNFG-GVSHKSDVYSYGMMILEMVVGRK 292
               G G    +D++S G ++LEM  G++
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-26
 Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 12/196 (6%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLGFC 150
           K+G+G FG VYKG L     VAVK  +++       +F+ E   + +  H N+V  +G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            +K+   ++ E +P GSL  F+  +++     +L  + + Q+++  A G+EYL     I 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKNCI- 115

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG 270
             H D+   N L+GE+   KISDFG+++  E     +S    +  I + APE    N+G 
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--NYGR 171

Query: 271 VSHKSDVYSYGMMILE 286
            + +SDV+SYG+++ E
Sbjct: 172 YTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  105 bits (263), Expect = 4e-26
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 11/206 (5%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 62  KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMA 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 117 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           E     +G  + KSDV+S+G+++ E+
Sbjct: 173 EAAL--YGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  104 bits (260), Expect = 9e-26
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 11/199 (5%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V+ GK      VA+K +    ++ E+FI E   M K SH  +V   G
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C ++K   ++ EFM NG L  ++  +    +++ +   +MCQ    +  G+EYL R   
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDM-LLSMCQ---DVCEGMEYLERN-- 119

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
              +H D+   N L+      K+SDFG+ +     E + S  GA+  + +  PEVF  NF
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVF--NF 175

Query: 269 GGVSHKSDVYSYGMMILEM 287
              S KSDV+S+G+++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 73/234 (31%), Positives = 112/234 (47%), Gaps = 35/234 (14%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INEVASMSKTSHVNVVSFLG 148
           LG+G FG V   +  D G+L A+KVLK  K+      E  + E   +S+ +H  +V  L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59

Query: 149 FCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIARGLEYLH 204
           + ++ ++K  L+ E+ P G L   +     S   R  E R      +I +     LEYLH
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLA----LEYLH 110

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
               + I++ D+KP NILL  D   K++DFGLAK    + S  +     GT  Y+APEV 
Sbjct: 111 S---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN--TFCGTPEYLAPEVL 165

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR------KNAEV--KVSLSSEIYFPNSI 310
                G     D +S G+++ EM+ G+         E+  K+ L   + FP  +
Sbjct: 166 LG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI-LKDPLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (258), Expect = 2e-25
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 32/209 (15%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLGF 149
           KLG+G +GSVYK      G++VA+KV+    V    +E I E++ + +     +V + G 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYLHRG 206
            ++     ++ E+   GS+   +        N+ L   T  +IA       +GLEYLH  
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIM-----KITNKTL---TEEEIAAILYQTLKGLEYLH-- 116

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPE 262
            + + +H DIK  NILL E+   K++DFG++ +L++   K+ + I      GT  ++APE
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWMAPE 169

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           V      G ++K+D++S G+  +EM  G+
Sbjct: 170 VIQEI--GYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 4e-25
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 40/215 (18%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN-----EVASMSKTSHVNVVSF 146
           KLG+G +G VYK +    G +VA+K ++    N EE I      E++ + +  H N+V  
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT----MCQIAVGIARGLEY 202
           L   + ++K  L++E+     L +++           L        M Q+     RGL Y
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMYQLL----RGLAY 113

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFIS--MLGARGTIGYI 259
            H     RI+H D+KP NIL+  D   K++DFGLA+       ++    +     T+ Y 
Sbjct: 114 CHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYR 165

Query: 260 APEVF--CRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           APE+    +++   V    D++S G +  EM+ G+
Sbjct: 166 APEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  102 bits (254), Expect = 6e-25
 Identities = 70/211 (33%), Positives = 111/211 (52%), Gaps = 12/211 (5%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   +  E F+ E   M K  H 
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ EFM  GSL  F+ + +     + L+   +  +A  IA G+ 
Sbjct: 62  KLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMA 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  +H D++  NIL+G++   KI+DFGLA+L E  E + +  GA+  I + AP
Sbjct: 117 YIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-GR 291
           E     +G  + KSDV+S+G+++ E+V  GR
Sbjct: 173 EAAL--YGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 8e-25
 Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 21/203 (10%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGF 149
            ++G G +G VYK + +  G LVA+KV+K    +  E I  E++ + +  H N+V++ G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              + K  ++ E+   GSL Q IY          L    +  +     +GL YLH     
Sbjct: 69  YLRRDKLWIVMEYCGGGSL-QDIYQV----TRGPLSELQIAYVCRETLKGLAYLH---ET 120

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPEVFC 265
             +H DIK  NILL ED   K++DFG+ A+L+    K++SFI      GT  ++APEV  
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAPEVAA 174

Query: 266 RNF-GGVSHKSDVYSYGMMILEM 287
               GG   K D+++ G+  +E+
Sbjct: 175 VERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (253), Expect = 1e-24
 Identities = 72/216 (33%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVK--VLKNSKVNGEE-----FINEVASMSKTSHVNVV 144
             LG+G +G+VY G    G+L+AVK   L  S V   E        EV  +    HVN+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEY 202
            +LG C +    ++  EF+P GS+        SS +NR   L     C+    I  G+ Y
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSI--------SSILNRFGPLPEPVFCKYTKQILDGVAY 117

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL-------SEKKESFISMLGARGT 255
           LH  C   +VH DIK +N++L  +   K+ DFG A+                SM    GT
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM---HGT 171

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             ++APEV   N  G   KSD++S G  + EM  G+
Sbjct: 172 PYWMAPEVI--NESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  101 bits (253), Expect = 2e-24
 Identities = 71/203 (34%), Positives = 111/203 (54%), Gaps = 20/203 (9%)

Query: 94  LGQGGFGSVYKGK-LPDGRLV----AVKVLKNS---KVNGEEFINEVASMSKTSHVNVVS 145
           LG G FG+VYKG  +P+G  V    A+K+L  +   K N  EF++E   M+   H ++V 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHLVR 73

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            LG C     + L+ + MP+G L  +++ E   NI  +L    +    V IA+G+ YL  
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQL----LLNWCVQIAKGMMYLEE 127

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
               R+VH D+   N+L+      KI+DFGLA+L E  E   +  G +  I ++A E  C
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 182

Query: 266 RNFGGVSHKSDVYSYGMMILEMV 288
            ++   +H+SDV+SYG+ I E++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 24/207 (11%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---INEVASMSKTSHVNVVSFL 147
            +LG G  G V K    P G+++AVK ++  ++N       + E+  + K +   +V F 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G  Y     ++  E+M  GSLD+ I  E    I      R + +IAV + +GL YLH   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE----RILGKIAVAVLKGLTYLHE-- 118

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFC 265
             +I+H D+KP NIL+      K+ DFG++   ++   ++F+      GT  Y+APE   
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPE--- 169

Query: 266 RNFGGV-SHKSDVYSYGMMILEMVVGR 291
           R  G   S KSD++S G+ ++E+  GR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 56/199 (28%), Positives = 105/199 (52%), Gaps = 11/199 (5%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M K SH  +V   G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   ++ E+M NG L  ++ +       ++ +   + ++   +  G+ YL    +
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLE---S 118

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+ +  C K+SDFGL++     E + S +G++  + +  PEV    +
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVL--LY 175

Query: 269 GGVSHKSDVYSYGMMILEM 287
              S KSDV+++G+++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNSKVNG-EEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S      +F  E+  +    H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 144 VSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   L+ E++P GSL  ++          +L+ R +   A  I +G+E
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-----QKHRERLDHRKLLLYASQICKGME 122

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL    + R VH D+   NIL+  +   KI DFGL K L + KE +         I + A
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +    S  SDV+S+G+++ E+
Sbjct: 180 PESLTESK--FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.7 bits (241), Expect = 7e-23
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTSHVNVVSFLG 148
           ++LG+G  GSV K +L +  ++       +  N +   + + E+          +V + G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 149 FCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
              ++      +  E+   GSLD  IY +      R  E + + +IA  + +GL YLH  
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGE-KVLGKIAESVLKGLSYLHSR 124

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA-RGTIGYIAPEVFC 265
              +I+H DIKP NILL      K+ DFG++      E   S+ G   GT  Y+APE   
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPE--- 173

Query: 266 RNFGG-VSHKSDVYSYGMMILEMVVGR 291
           R  G   S  SDV+S G+ +LE+   R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 96.4 bits (240), Expect = 8e-23
 Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 25/223 (11%)

Query: 94  LGQGGFGSVYKGKL--PDGRL--VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FGSV +G+L   DG    VAVK +K   ++    EEF++E A M    H NV+  
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 147 LGFCYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           +G C+E           +I  FM +G L  F+       +  KL  +T+ +  V IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL    N   +H D+   N +L ED    ++DFGL+K     + +     A+  + +IA
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            E         + KSDV+++G+ + E+         G +N E+
Sbjct: 184 IESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 18/206 (8%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFL 147
             +G+G FG+V K +   DG+++  K +    +  +E    ++EV  + +  H N+V + 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 148 GFCYEKKKRAL--IYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
               ++  + L  + E+   G L Q I    +E   I  +  WR + Q+       L   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL----LALYEC 121

Query: 204 HRGCNI--RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           H   +    ++H D+KP NI L  +   K+ DFGLAK+     SF       GT  Y++P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGTPYYMSP 179

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           E           KSD++S G +I E+
Sbjct: 180 EQLNHM--SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 71/226 (31%), Positives = 110/226 (48%), Gaps = 18/226 (7%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLG G FG V+         VAVK +K   ++ E F+ E   M    H 
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V  L     K+   +I EFM  GSL  F+  +E S    K     +   +  IA G+ 
Sbjct: 62  KLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMA 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           ++ +      +H D++  NIL+      KI+DFGLA++ E  E + +  GA+  I + AP
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSL 300
           E    NFG  + KSDV+S+G++++E+V        G  N EV  +L
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 26/215 (12%)

Query: 94  LGQGGFGSVYKGKL-----PDGRL-VAVKVLKNSKVNGE--EFINEVASMSKT-SHVNVV 144
           LG+G FG V K +      P+    VAVK+LK+     +  + ++E+  M     H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWRTMCQIAV 194
           + LG C ++    ++ E+  +G+L  F+          S +  R     L  + +   A 
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            +ARG+E+L    + + +H D+   N+L+ ED   KI+DFGLA+     + +      R 
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 255 TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMV 288
            + ++APE +F R +   +H+SDV+S+G+++ E+ 
Sbjct: 197 PVKWMAPEALFDRVY---THQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 5e-22
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 15/203 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
           KLG+G +GSVYK K L D +  A+K +    ++    E+ +NE+  ++  +H N++S+  
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +  K  ++ E+ P G L + I   +     + +  + + +I + + RGL+ LH    
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRGLQALH---E 121

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            +I+H D+K  NILL  +   KI D G++K+ +K  +   +    GT  Y+APEV+    
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR- 176

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
              S+KSD++S G ++ EM    
Sbjct: 177 -PYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 93.9 bits (233), Expect = 5e-22
 Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 17/195 (8%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
            +G+G FG+V +G+   G+ VAVK +K   V  + F+ E A M+K  H N+V  LG    
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 153 KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
                ++ E M  G+L  F+     + ++       + Q ++ +A G+EYL    + ++V
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVI----QLLQFSLDVAEGMEYLE---SKKLV 122

Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   NIL+ ED   K+SDFGLA++         +  ++  + + APE         S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSM-----GVDNSKLPVKWTAPEAL--KHKKFS 175

Query: 273 HKSDVYSYGMMILEM 287
            KSDV+SYG+++ E+
Sbjct: 176 SKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.7 bits (233), Expect = 6e-22
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 15/204 (7%)

Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFL 147
           NK+G+G FG V+K  +  D R+ A+K +  SK+N    EE I+E   ++K     ++ + 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
               +K K  ++ E+  NG L + +  +    +     WR   QI +    GL +LH   
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLHSK- 120

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             +I+H DIK  N+ L      KI D G+AKL     +F + +   GT  Y++PE+ C +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPEL-CED 175

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               + KSDV++ G+++ E   G+
Sbjct: 176 -KPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 21/205 (10%)

Query: 94  LGQGGFGSVYKGKL-PDGR---LVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G FG V +G+L   G+    VA+K LK+  ++    +F++E + M +  H N++   
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   + +   +I EFM NG+LD F+   +      +     +  +  GIA G++YL    
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYL---S 123

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES---FISMLGARGTIGYIAPEVF 264
            +  VH D+   NIL+  +   K+SDFGL++  E   S   + S LG +  I + APE  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 265 C-RNFGGVSHKSDVYSYGMMILEMV 288
             R F   +  SDV+SYG+++ E++
Sbjct: 184 AYRKF---TSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLG 148
             +G G    VY    LP+   VA+K +   K     +E   EV +MS+ +H NVV +  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHRGC 207
                 +  L+  ++  GSL     D   S+  R  L+   +  +   + +GLEYLH   
Sbjct: 67  SFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-- 120

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA--------KLSEKKESFISMLGARGTIGYI 259
           N +I H DIK  NILLGED   KI+DFG++        +  + +++F+      GT  ++
Sbjct: 121 NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV------GTPCWM 173

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APEV      G   K+D++S+G+  +E+  G 
Sbjct: 174 APEVM-EQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)

Query: 90  FSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLK--NSKVNGEEFINEVASMSKTSHVN 142
           F  +LG+  FG +YKG L        +LVA+K LK  N+     EF  E + M++  H N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIY-----------DEESSNINRKLEWRTMCQ 191
           +V  LG   +++   +++E++  G L +F+             +E   +   L+      
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           IA+ IA G+EYL    +   VH D+   NIL+GE    KISD GL++     + +     
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           +   I ++ PE     +G  S  SD++S+G+++ E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN--EVASMSK-TSHVNVVSFLG 148
           +LG G FGSVY  +    G LVA+K +K    + EE +N  EV S+ K   H N+V    
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GC 207
              E  +   ++E+M  G+L Q + D +     +      +  I   I +GL ++H+ G 
Sbjct: 66  VFRENDELYFVFEYM-EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHG- 119

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
                H D+KP N+L+      KI+DFGLA+    +  +   +  R    Y APE+  R+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR---WYRAPEILLRS 173

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               S   D+++ G ++ E+   R
Sbjct: 174 -TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 2e-21
 Identities = 71/230 (30%), Positives = 121/230 (52%), Gaps = 28/230 (12%)

Query: 94  LGQGGFGSVYKG--KLPDGR---LVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSF 146
           +G G FG V++G  K+P GR    VA+K LK   ++   ++F++E + M + SH N++  
Sbjct: 13  IGAGEFGEVFRGILKMP-GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G   + K   +I E+M NG+LD+++ D +    + +L       +  GIA G++YL   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL--- 123

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
            ++  VH D+   NIL+  +   K+SDFGL++ L +  E   +  G +  I + APE   
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 266 -RNFGGVSHKSDVYSYGMMILE-MVVGRK------NAEVKVSLSSEIYFP 307
            R F   +  SDV+S+G+++ E M  G +      N EV  +++     P
Sbjct: 184 YRKF---TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 73/211 (34%), Positives = 107/211 (50%), Gaps = 27/211 (12%)

Query: 94  LGQGGFGSVYKGK-LPDGR----LVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVS 145
           LG G FG+VYKG  +P+G      VA+K L+ +   K N +E ++E   M+   + +V  
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCR 73

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYL 203
            LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL
Sbjct: 74  LLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYL 125

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE- 262
                 R+VH D+   N+L+      KI+DFGLAKL    E      G +  I ++A E 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 263 VFCRNFGGVSHKSDVYSYGMMILE-MVVGRK 292
           +  R +   +H+SDV+SYG+ + E M  G K
Sbjct: 183 ILHRIY---THQSDVWSYGVTVWELMTFGSK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 23/200 (11%)

Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNS-----KVNGEEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG V+KG L D   VAVK  K       K+   +F++E   + +  H N+V  +G
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI---KFLSEARILKQYDHPNIVKLIG 59

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RGC 207
            C +++   ++ E +P G    F+  ++      +L+ + + + A+  A G+ YL  + C
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEVFCR 266
               +H D+   N L+GE+   KISDFG+++  ++ +   S  G +   I + APE    
Sbjct: 115 ----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL-- 166

Query: 267 NFGGVSHKSDVYSYGMMILE 286
           N+G  S +SDV+SYG+++ E
Sbjct: 167 NYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 27/225 (12%)

Query: 94  LGQGGFGSVYKGKLPD------GRL-VAVKVLKNSKVNGE--EFINEVASMSKTSHVNVV 144
           LG G FG VY+G   D      G + VAVK L+    + E  EF+ E   MS  +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYL 203
             LG C   + + +I E M  G L  ++ D          L  + +  I + +A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 204 HRGCNIRIVHFDIKPHNILLGED--FCP---KISDFGLAKLSEKKESFISMLGARGTIGY 258
            +   +  +H D+   N L+ E         KI DFGLA+   K + +         + +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           +APE      G  + +SDV+S+G+++ E++           N EV
Sbjct: 180 MAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLK-----NSKVNGEEFINEVASMSKTSHVNVVSF 146
           K+G+G F  VYK   L DGR+VA+K ++     ++K   ++ + E+  + +  H NV+ +
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQLDHPNVIKY 67

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           L    E  +  ++ E    G L + I  +      R +  RT+ +  V +   LE++H  
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
              RI+H DIKP N+ +      K+ D GL +  S K  +  S++   GT  Y++PE   
Sbjct: 126 ---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIH 179

Query: 266 RNFGGVSHKSDVYSYGMMILEM 287
            N  G + KSD++S G ++ EM
Sbjct: 180 EN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 37/223 (16%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEV----ASMSKTS-HVNVVSFL 147
           +G+G F +V   K     +  A+K+L   ++  E+ +  V      +++ + H  ++  L
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK-L 67

Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            + ++ ++    + E+ PNG L Q+I           L+ +     A  I   LEYLH  
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYI------RKYGSLDEKCTRFYAAEILLALEYLH-- 119

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL-------------SEKKESFISMLGAR 253
            +  I+H D+KP NILL +D   KI+DFG AK+             +   +S I     R
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 254 -----GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                GT  Y++PE+   N       SD+++ G +I +M+ G+
Sbjct: 179 FASFVGTAEYVSPELL--NEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.7 bits (228), Expect = 5e-21
 Identities = 71/238 (29%), Positives = 108/238 (45%), Gaps = 34/238 (14%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKG----------KLPDGRLVAVKVLKN--SKVNGEEFIN 130
           V R + +    LG G FG VY+G          +L     VAVK L    S+ +  +F+ 
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQ----VAVKTLPESCSEQDESDFLM 58

Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRT 188
           E   MSK +H N+V  +G  +E+  R ++ E M  G L  F+  E      R   L  + 
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKD 117

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKES 245
           +   A  +A+G +YL        +H DI   N LL   G     KI+DFG+A+   +   
Sbjct: 118 LLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174

Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           +     A   I ++ PE F    G  + K+DV+S+G+++ E+         GR N EV
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 91.2 bits (226), Expect = 7e-21
 Identities = 69/209 (33%), Positives = 109/209 (52%), Gaps = 23/209 (11%)

Query: 94  LGQGGFGSVYKGK-LPDGR----LVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVS 145
           LG G FG+VYKG  +PDG      VA+KVL+ +   K N +E ++E   M+      V  
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVCR 73

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            LG C     + L+ + MP G L  ++ + +      ++  + +    V IA+G+ YL  
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLE- 126

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE-VF 264
              +R+VH D+   N+L+      KI+DFGLA+L +  E+     G +  I ++A E + 
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 265 CRNFGGVSHKSDVYSYGMMILE-MVVGRK 292
            R F   +H+SDV+SYG+ + E M  G K
Sbjct: 185 HRRF---THQSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 9e-21
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN-GEEFIN--EVASMSKTSHVNVVSFLG 148
           K+G+G +G VYK +    G +VA+K +K    + G       E+  + + +H N++  L 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
               K    L++EFM +  L + I D       R L    +      + +GL + H    
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHSH-- 117

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             I+H D+KP N+L+  +   K++DFGLA+         +      T  Y APE+   + 
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAPELLLGD- 173

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
            G S   D++S G +  E++  R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 31/211 (14%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           LG G FG VYK +  + G   A K+++  S+   E+F+ E+  +S+  H N+V      +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR----GLEYLHRGC 207
            + K  ++ EF   G+LD  + + E     R L   T  QI   + R     L +LH   
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELE-----RGL---TEPQIRY-VCRQMLEALNFLHSH- 122

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLS---EKKESFISMLGARGTIGYIAPEV 263
             +++H D+K  NILL  D   K++DFG+ AK     +K+++FI      GT  ++APEV
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174

Query: 264 F-CRNFGG--VSHKSDVYSYGMMILEMVVGR 291
             C  F      +K+D++S G+ ++E+    
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 27/224 (12%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGK----LP--DGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +    LP  D  LVAVK LK +  +  ++F  E   +
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61

Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF---------IYDEESSNINRKLEW 186
           +   H ++V F G C E +   +++E+M +G L++F         I          +L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
             M  IA  IA G+ YL    ++  VH D+   N L+G+    KI DFG+++     + +
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178

Query: 247 ISMLGARGT--IGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              +G R    I ++ PE +  R F   + +SD++S+G+++ E+
Sbjct: 179 --RVGGRTMLPIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 25/213 (11%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVK-VLKNSKVNG----------EEFINEVASMSKTSHV 141
           +G+G +G VY    +  G ++AVK V   + + G          +   +E+ ++    H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARG 199
           N+V +LGF   ++  ++  E++P GS+   +  Y      + R    + +         G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--------EG 120

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           L YLH   +  I+H D+K  N+L+  D   KISDFG++K S+        +  +G++ ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           APEV      G S K D++S G ++LEM  GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 22/221 (9%)

Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVNG--EEFI 129
           +  S+++ +T      LG+G FG V+  K           LV VK L+ +K      EF 
Sbjct: 2   FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56

Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK---LEW 186
            E+    K SH NVV  LG C E +   +I E+   G L QF+   +S +   K   L  
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
           +    +   IA G+++L      R VH D+   N L+      K+S   L+K     E +
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             +  A   + ++APE         S KSDV+S+G+++ E+
Sbjct: 174 -KLRNALIPLRWLAPE--AVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 49/228 (21%)

Query: 94  LGQGGFGSVYKGKLP------DGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVS 145
           +GQG FG V++ + P         +VAVK+LK   S     +F  E A M++  H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMC--------------- 190
            LG C   K   L++E+M  G L++F+               +                 
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 191 -QIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA---------KLS 240
             IA  +A G+ YL      + VH D+   N L+GE+   KI+DFGL+         K S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 241 EKKESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           E     I        I ++ PE +F   +   + +SDV++YG+++ E+
Sbjct: 190 EN--DAIP-------IRWMPPESIFYNRY---TTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 23/205 (11%)

Query: 94  LGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G  KLP  R   VA+K LK      +  +F++E + M +  H N++   
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G++YL  
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ-------LVGMLRGIASGMKYL-- 122

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF 264
             ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + APE  
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 265 C-RNFGGVSHKSDVYSYGMMILEMV 288
             R F   +  SDV+SYG+++ E++
Sbjct: 182 AYRKF---TSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 64/204 (31%), Positives = 111/204 (54%), Gaps = 23/204 (11%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK K  + G L A KV++  S+   E+++ E+  ++  +H  +V  LG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y   K  ++ EF P G++D  + +     ++R L    +  I   +   L+YLH   +++
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-----LDRGLTEPQIQVICRQMLEALQYLH---SMK 130

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  N+LL  D   K++DFG++    K  ++++SFI      GT  ++APE V C
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMC 184

Query: 266 RNFGGV--SHKSDVYSYGMMILEM 287
                    +K+D++S G+ ++EM
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 63/226 (27%), Positives = 114/226 (50%), Gaps = 29/226 (12%)

Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL---VAVKVLKN--SKVNGEEFINEVA 133
            ++D+K     F + +G+G FG V K ++    L    A+K +K   SK +  +F  E+ 
Sbjct: 5   EWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 59

Query: 134 SMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----------SSNINR 182
            + K   H N+++ LG C  +    L  E+ P+G+L  F+              +++   
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L  + +   A  +ARG++YL +    + +H D+   NIL+GE++  KI+DFG   LS  
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG---LSRG 173

Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +E ++     R  + ++A E    N+   +  SDV+SYG+++ E+V
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 94  LGQGGFGSVYKGK-LPDGRL----VAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+V+KG  +P+G      VA+K +++   +   +E  + + +M    H  +V  
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYLHR 205
           LG C       L+ +  P GSL   +     S +  R L W       V IA+G+ YL  
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEV 263
                +VH ++   NILL  D   +I+DFG+A L   + K+ F S    +  I ++A E 
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE--HKTPIKWMALES 182

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMV 288
               FG  +H+SDV+SYG+ + EM+
Sbjct: 183 I--LFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.8 bits (217), Expect = 8e-20
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGF 149
           ++G+G FG V+ G+L  D   VAVK  + +       +F+ E   + + SH N+V  +G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
           C +K+   ++ E +  G    F+  E       +L+ + + Q+    A G+EYL     I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEVFCRNF 268
              H D+   N L+ E    KISDFG+++  E+   + S  G +   + + APE    N+
Sbjct: 117 ---HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEAL--NY 170

Query: 269 GGVSHKSDVYSYGMMILE 286
           G  S +SDV+S+G+++ E
Sbjct: 171 GRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 25/207 (12%)

Query: 94  LGQGGFGSVYKGKL--PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFL 147
           +G+G FG VY G L   DG+ +   V   +++      E+F+ E   M   SH NV+S L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 148 GFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG--IARGLEYLH 204
           G C   +   L+   +M +G L  FI  E  +   + L       I  G  +A+G+EYL 
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-------IGFGLQVAKGMEYL- 114

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIAPE 262
              + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 263 VF-CRNFGGVSHKSDVYSYGMMILEMV 288
               + F   + KSDV+S+G+++ E++
Sbjct: 173 SLQTQKF---TTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 25/221 (11%)

Query: 89  SFSNKLGQGGFGSVYKG----KLPDGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
           +    +G+G FG VY+G       +   VAVK  KN  S    E+F+ E   M +  H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +V  +G    +    ++ E  P G L  ++   + S     L+  ++   +  ++  L Y
Sbjct: 69  IVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-----LDLASLILYSYQLSTALAY 122

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           L    + R VH DI   N+L+    C K+ DFGL++  E +  + +  G +  I ++APE
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIKWMAPE 178

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
               NF   +  SDV+ +G+ + E+++       G KN +V
Sbjct: 179 SI--NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           +G+G +G VYK +    G+LVA+K++   +   EE   E   + K S H N+ +F G  +
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-AF 72

Query: 152 EKKKRA-------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            KK          L+ E    GS+   +  +      ++L+   +  I     RGL YLH
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFG----LAKLSEKKESFISMLGARGTIGYIA 260
                +++H DIK  NILL ++   K+ DFG    L     ++ +FI      GT  ++A
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMA 181

Query: 261 PEVF-CRNFGGVS--HKSDVYSYGMMILEM 287
           PEV  C      S   +SDV+S G+  +E+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 36/228 (15%)

Query: 94  LGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVV 144
           LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE + M + +  +VV
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRTMCQIAVGIARGL 200
             LG     +   ++ E M  G L  ++     + E++        +   Q+A  IA G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
            YL      + VH D+   N ++ ED   KI DFG+ +   + + +         + ++A
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 261 PE-----VFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           PE     VF       + KSDV+S+G+++ EM         G  N EV
Sbjct: 190 PESLKDGVF-------TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 73/235 (31%), Positives = 108/235 (45%), Gaps = 34/235 (14%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L   ++    GE+  +NE   + K S   +VS L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59

Query: 149 FCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G L   IY+                  A  I  GLE+LH   
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLH--- 112

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPEVFCR 266
             RIV+ D+KP N+LL +    +ISD GLA +L   K+    + G  GT GY+APEV   
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----IKGRAGTPGYMAPEVL-- 166

Query: 267 NFGGV-SHKSDVYSYGMMILEMVVGR----------KNAEVK-VSLSSEIYFPNS 309
             G V     D ++ G  + EM+ GR          +  E+K  +L   + +P+ 
Sbjct: 167 -QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 85.7 bits (212), Expect = 8e-19
 Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 26/227 (11%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG 125
           +R  VS+   +  Y+  +        K+GQG  G+VY    +  G+ VA+K +   +   
Sbjct: 8   LRTIVSVGDPKKKYTRFE--------KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK 59

Query: 126 EEFI-NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL 184
           +E I NE+  M +  H N+V++L       +  ++ E++  GSL   + +         +
Sbjct: 60  KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-------M 112

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKK 243
           +   +  +     + LE+LH     +++H DIK  NILLG D   K++DFG  A+++ ++
Sbjct: 113 DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169

Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +M+   GT  ++APEV  R   G   K D++S G+M +EMV G
Sbjct: 170 SKRSTMV---GTPYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 33/213 (15%)

Query: 91  SNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE-----FINEVASMSKT---SHV 141
             ++G+G +G+VYK + L  GR VA+K ++      EE      + E+A + +     H 
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLREIALLKQLESFEHP 61

Query: 142 NVVSFLGFCY-----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           N+V  L  C+      + K  L++E + +  L  ++       +  +     M Q+    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
            RG+++LH   + RIVH D+KP NIL+  D   KI+DFGLA++   + +  S++    T+
Sbjct: 118 -RGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---VTL 170

Query: 257 GYIAPEVFCRNFGGVSHKS--DVYSYGMMILEM 287
            Y APEV        S+ +  D++S G +  E+
Sbjct: 171 WYRAPEVLL----QSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 23/205 (11%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGE------EFINEVASMSKTSHVNVVSF 146
           LGQG FG VY     D GR +AVK +     + E          E+  +    H  +V +
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G   + +  ++  E+MP GS+   +  Y   +  + RK   +        I  G+EYLH
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ--------ILEGVEYLH 121

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
                 IVH DIK  NIL       K+ DFG +K L     S   M    GT  +++PEV
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMV 288
              +  G   K+DV+S G  ++EM+
Sbjct: 179 I--SGEGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 73/254 (28%), Positives = 113/254 (44%), Gaps = 52/254 (20%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-------EEFINEVASMSKTSHVNVVS 145
           LG G F S Y+ + +  G L+AVK +   +          E    E+  M++ +H +++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYD----EESSNINRKLEWRTMCQIAVGIARGLE 201
            LG   E     L  E+M  GS+   +      +E+  IN   +          + RGL 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ----------LLRGLS 117

Query: 202 YLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLA-----KLSEKKESFISMLGAR 253
           YLH     +I+H D+K  N+L+   G+    +I+DFG A     K +   E    +L   
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLL--- 169

Query: 254 GTIGYIAPEVF-CRNFGGVSHKSDVYSYGMMILEMVVGRK--NAEVKVSLSSEIYF---- 306
           GTI ++APEV     +G      DV+S G +I+EM   +   NAE K S    + F    
Sbjct: 170 GTIAFMAPEVLRGEQYG---RSCDVWSVGCVIIEMATAKPPWNAE-KHSNHLALIFKIAS 225

Query: 307 ---PNSIYKHIEPG 317
                SI +H+ PG
Sbjct: 226 ATTAPSIPEHLSPG 239

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVL--KNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           LG+G +G VY  + L     +A+K +  ++S+   +    E+A  S   H N+V +LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E     +  E +P GSL   +    S     K   +T+      I  GL+YLH   + +
Sbjct: 75  SENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQ 128

Query: 211 IVHFDIKPHNILLGE-DFCPKISDFG----LAKLSEKKESFISMLGARGTIGYIAPEVFC 265
           IVH DIK  N+L+       KISDFG    LA ++   E+F       GT+ Y+APEV  
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEVID 182

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
           +   G    +D++S G  I+EM  G+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 25/220 (11%)

Query: 87  TNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNG---EEFINEVASMSK 137
           T  F  +LG+  FG VYKG L         + VA+K LK+ K  G   EEF +E    S+
Sbjct: 6   TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEAMMRSR 64

Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----------DEESSNINRKLEWR 187
             H N+V  LG   +++  ++I+ +  +  L +F+            ++   +   LE  
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
               I   IA G+E+L    +  +VH D+   N+L+ +    KISD GL +     + + 
Sbjct: 125 DFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            M  +   I +++PE     +G  S  SD++SYG+++ E+
Sbjct: 182 LMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 60/228 (26%), Positives = 115/228 (50%), Gaps = 28/228 (12%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINE 131
           ++ R   +    LG+G FG V         K K      VAVK+LK+   + +  + ++E
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 132 VASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI---------YDEESSNI- 180
           +  M     H N+++ LG C +     ++ E+   G+L +++         Y  ++  + 
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 181 NRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS 240
             +L ++ +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+  
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 241 EKKESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              + +      R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 33/225 (14%)

Query: 89  SFSNKLGQGGFGSVY------------KGKLPDG-----RLVAVKVLK-NSKVNG-EEFI 129
           +F  KLG+G FG V+            K    +       LVAVKVL+ ++  N  E+F+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----SSNINRK-L 184
            EV  +S+ S  N+   LG C       +I E+M NG L+QF+            N K L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
            + T+  +A  IA G+ YL    ++  VH D+   N L+G+++  KI+DFG++       
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS--RNLYS 182

Query: 245 SFISMLGARGT--IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           S    +  R    I ++A E      G  + KSDV+++G+ + E+
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 37/231 (16%)

Query: 90  FSNKLGQGGFGSVY------KGKLP---------DGR--LVAVKVLK--NSKVNGEEFIN 130
           F  KLG+G FG V+         LP          GR  LVAVK+L+   +K    +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI----YDEESSNINRK--- 183
           EV  +S+    N++  LG C ++    +I E+M NG L+QF+     D++  N N     
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 184 ------LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
                 + + ++  +A+ IA G++YL    ++  VH D+   N L+GE+   KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +     + +     A   I ++A E  C   G  +  SDV+++G+ + E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWE--CILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.6 bits (206), Expect = 3e-18
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 21/220 (9%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +        D  LVAVK LK++  N  ++F  E   +
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE-------ESSNINRKLEWRT 188
           +   H ++V F G C E     +++E+M +G L++F+             N   +L    
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M  IA  IA G+ YL    +   VH D+   N L+GE+   KI DFG+++     + +  
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                  I ++ PE +  R F   + +SDV+S G+++ E+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKG-------KLPDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 60

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +      + 
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 175

Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 176 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 43/219 (19%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE-----FINEVASMSKTSHVNVVS 145
            ++G+G +G VYK +    G LVA+K ++    N +E      I E+  + K  H N+V 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 146 FLGFCYEKKKRA--LIYEFMP---NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
                  K K +  +++E+M     G LD        S I        M Q+      GL
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC-----YMKQLL----EGL 113

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF------ISMLGARG 254
           +YLH   +  I+H DIK  NIL+  D   K++DFGLA+   K+ S       I       
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI------- 163

Query: 255 TIGYIAPEVF--CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           T+ Y  PE+      +G    + D++S G ++ E+ +G+
Sbjct: 164 TLWYRPPELLLGATRYGP---EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 94  LGQGGFGSVYKG--KLPDGRL--VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FGSV +   K  DG    VAVK+LK    S  + EEF+ E A M +  H NV+  
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 147 LGFCYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           +G     + +       +I  FM +G L  F+           L  +T+ +  + IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL    +   +H D+   N +L E+    ++DFGL+K     + +     ++  + ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            E    N       SDV+++G+ + E++        G +N+E+
Sbjct: 184 LESLADNVYTT--HSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 63/216 (29%), Positives = 117/216 (54%), Gaps = 28/216 (12%)

Query: 94  LGQGGFGSVYKGKL-------PDGRL-VAVKVLKNSKVNGE--EFINEVASMSKTS-HVN 142
           LG+G FG V + +        PD  + VAVK+LK++  + +  + I+E+  M     H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWRTMCQI 192
           +++ LG C ++    +I E+   G+L +F+        + + +I +    +L ++ +   
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  +ARG+EYL    + R +H D+   N+L+ ED   KI+DFGLA+     + +      
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 27/206 (13%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
            +G+G FG VYK       ++VA+KV  L+ ++   E+   E+  +S+     +  + G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 150 CYEKKKRALIYEFMPNGS-LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             +  K  +I E+   GS LD             KL+   +  I   +  GLEYLH    
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEE-- 117

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEVF 264
              +H DIK  NILL E+   K++DFG++ +L+    K+ +F+      GT  ++APEV 
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPEVI 170

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            +   G   K+D++S G+  +E+  G
Sbjct: 171 KQ--SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.0 bits (202), Expect = 7e-18
 Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 17/195 (8%)

Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG   E+
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71

Query: 154 KKRALIY-EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
           K    I  E+M  GSL  ++     S +        + + ++ +   +EYL        V
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLEAN---NFV 124

Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   N+L+ ED   K+SDFGL      KE+  +    +  + + APE         S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKK--FS 177

Query: 273 HKSDVYSYGMMILEM 287
            KSDV+S+G+++ E+
Sbjct: 178 TKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 8e-18
 Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 38/219 (17%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG----------EEFINEVASMSKTSHVN 142
           +G G FGSVY G     G L+AVK ++   V+           +    E+A + +  H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGS----LDQFIYDEES--SNINRKLEWRTMCQIAVGI 196
           +V +LG   +     +  E++P GS    L+ +   EE+   N  R+            I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------------I 115

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--- 253
            +GL YLH   N  I+H DIK  NIL+      KISDFG++K  E         GAR   
Sbjct: 116 LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 254 -GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            G++ ++APEV  +     + K+D++S G +++EM+ G+
Sbjct: 173 QGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 31/235 (13%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFI-NEVASMSKTSHVNVVSFLG 148
           LG GGFG V   K+    R  A+K +K   +     +E I +E   + + +H  +V    
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +KK   ++ E+   G L   + D    +     E+     IA  +    EYLH   N
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIA-CVVLAFEYLH---N 111

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE---SFISMLGARGTIGYIAPEVFC 265
             I++ D+KP N+LL  +   K+ DFG AK  +  +   +F       GT  Y+APE+  
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEIIL 165

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF 320
               G     D +S G+++ E++ GR           +   P  IY  I  GN  
Sbjct: 166 NK--GYDFSVDYWSLGILLYELLTGR------PPFGEDDEDPMEIYNDILKGNGK 212

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.6 bits (205), Expect = 9e-18
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 39/217 (17%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV-NGEEFIN-----EVASMSKTSHVNVV 144
            KLG+G +  VYK +    GR+VA+K +K  +    ++ IN     E+  + +  H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 145 SFLGFCYEKKKR-ALIYEFMPNGSLDQFIYDEES--SNINRKLEWRTMCQIAVGIARGLE 201
             L   +  K    L++EFM    L++ I D+    +  + K          +   RGLE
Sbjct: 66  GLLD-VFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK-------SYMLMTLRGLE 116

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS----MLGARGTIG 257
           YLH      I+H D+KP+N+L+  D   K++DFGLA+      SF S    M     T  
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQVVTRW 167

Query: 258 YIAPEVF--CRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           Y APE+    R++G GV    D++S G +  E+++  
Sbjct: 168 YRAPELLFGARHYGVGV----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 18/224 (8%)

Query: 94  LGQGGFGSVYKGKL--PDGRL-VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FGSV +G+L   D  L VAVK +K    ++   E+F++E   M +  H NV+  +
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 148 GFCYEKKKR------ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           G C +  +        +I  FM +G L  F+      +  + L  + + +    IA G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL    +   +H D+   N +L E+    ++DFGL+K     + +     A+  + +IA 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY 305
           E         + KSDV+S+G+ + E+    +     V  +SEIY
Sbjct: 184 ESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 32/213 (15%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           + +G +G V+   K   G + A+KV+K + +  +  +++V +    +S+     VV    
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
               KK   L+ E++P G L   +      DE+ + I               I   LEYL
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-----------YIAEIVLALEYL 109

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL-SEKKESFISMLGAR-----GTIG 257
           H   +  I+H D+KP NIL+  +   K++DFGL+K+   +++  ++          GT  
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           YIAPEV      G S   D +S G ++ E +VG
Sbjct: 167 YIAPEVILGQ--GHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 71/230 (30%), Positives = 112/230 (48%), Gaps = 34/230 (14%)

Query: 72  SLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI- 129
           S      + S+++R+     N++G G  G+VYK    P GRL A+KV+     N E+ + 
Sbjct: 65  SAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYG---NHEDTVR 116

Query: 130 ----NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE 185
                E+  +   +H NVV          +  ++ EFM  GSL       E ++I  +  
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-------EGTHIADEQF 169

Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKE 244
              +  +A  I  G+ YLHR     IVH DIKP N+L+      KI+DFG+++ L++  +
Sbjct: 170 ---LADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223

Query: 245 SFISMLGARGTIGYIAPEVFCR--NFGGVS-HKSDVYSYGMMILEMVVGR 291
              S +   GTI Y++PE      N G    +  D++S G+ ILE  +GR
Sbjct: 224 PCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 94  LGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGEE--FINEVASMSKTSHVNVVSFL 147
           LG G FG + +G  KLP  R   VA+  L+    + +   F+ E  ++ +  H N+V   
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G         ++ E+M NG+LD F+   E      +L    +  +  G+A G++YL    
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYL---S 124

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
            +  VH  +  H +L+  D   KIS F   +  +K E+  + +  +  + + APE     
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAI--Q 181

Query: 268 FGGVSHKSDVYSYGMMILEMV 288
           +   S  SDV+S+G+++ E++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 32/227 (14%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGK------LPDGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +        D  LVAVK LK+  +   ++F  E   +
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61

Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLE 185
           +   H ++V F G C +     +++E+M +G L++F          + D +      +L 
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
              M  IA  IA G+ YL    +   VH D+   N L+G +   KI DFG+++     + 
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 246 FI----SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           +     +ML  R    ++ PE +  R F   + +SDV+S+G+++ E+
Sbjct: 179 YRVGGHTMLPIR----WMPPESIMYRKF---TTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 28/216 (12%)

Query: 94  LGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS-HVN 142
           LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M     H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWRTMCQI 192
           +++ LG C +     +I E+   G+L +++        E S +I R    ++ ++ +   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
              +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + +      
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 200 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 39/226 (17%)

Query: 95  GQGGFGSVYKGKLPDGRLV-------AVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           G+G FG V   +  D + +         K ++   V     +NE   + + +H  +V+  
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR--NVLNERRILQELNHPFLVNL- 65

Query: 148 GFCYEKKKRALIY---EFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
              Y  +    +Y   + +  G L      +  + EE         W  +C+I +     
Sbjct: 66  --WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-----W--ICEIVLA---- 112

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           LEYLH   +  I+H DIKP NILL E     I+DF +A          S     GT GY+
Sbjct: 113 LEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGTPGYM 166

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY 305
           APEV CR   G S   D +S G+   E + G++          +  
Sbjct: 167 APEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
           ++G+G  G V+K K    G  VA+K +   ++ G    + + E+ ++    H  VV  L 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
                    L+ E+MP   L + + DEE     R L    +      + +G+ Y+H    
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMH---A 117

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF--CR 266
             I+H D+KP N+L+  D   KI+DFGLA+L  ++E          T  Y APE+    R
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGAR 176

Query: 267 NFG-GVSHKSDVYSYGMMILEMVVGR 291
            +  GV    D+++ G +  E++ G 
Sbjct: 177 KYDPGV----DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 30/222 (13%)

Query: 90  FSNKLGQGGFGSV----------YKGKLP---DGR--LVAVKVLKN--SKVNGEEFINEV 132
              KLG+G FG V          + G+     DG+  LVAVK+L+   +K    +F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE-------SSNINRKLE 185
             MS+  + N++  LG C       +I E+M NG L+QF+   E       ++NI   + 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP-SVS 127

Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
              +  +AV IA G++YL    ++  VH D+   N L+G  +  KI+DFG+++     + 
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           +     A   I ++A E      G  +  SDV+++G+ + EM
Sbjct: 185 YRIQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 93  KLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSF 146
           +LG G FG+V KG        + VAVK+LKN   +    +E + E   M +  +  +V  
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G C E +   L+ E    G L++F+        N+ +  + + ++   ++ G++YL   
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQK------NKHVTEKNITELVHQVSMGMKYLEET 114

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
                VH D+   N+LL      KISDFGL+K L   +  + +    +  + + APE  C
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169

Query: 266 RNFGGVSHKSDVYSYGMMILE 286
            N+   S KSDV+S+G+++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 30/208 (14%)

Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGF 149
            K+G+G  G V        GR VAVK +   K    E + NEV  M    H N+V     
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA---VGIARGLEYLHRG 206
                +  ++ EF+  G+L   +     + +N +       QIA   + + + L +LH  
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIV---THTRMNEE-------QIATVCLAVLKALSFLH-- 132

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPE 262
               ++H DIK  +ILL  D   K+SDFG  A++S+   +++S +      GT  ++APE
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPE 185

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V  R   G   + D++S G+M++EMV G
Sbjct: 186 VISRLPYGT--EVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 28/212 (13%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFCY 151
           +G G +G VYKG+ +  G+L A+KV+  +    EE   E+  + K SH  N+ ++ G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           +K          L+ EF   GS+   I + + + +  K EW  +  I   I RGL +LH+
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL--KEEW--IAYICREILRGLSHLHQ 129

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAP 261
               +++H DIK  N+LL E+   K+ DFG+ A+L     ++ +FI      GT  ++AP
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 180

Query: 262 EVF-CRNFGGVSH--KSDVYSYGMMILEMVVG 290
           EV  C      ++  KSD++S G+  +EM  G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 31/176 (17%)

Query: 89  SFSNKLGQGGFGSVY-------------------KGKLPDGRLVAVKVLKN--SKVNGEE 127
           +F  KLG+G FG V+                    G  P   LVAVK+L+   +K    +
Sbjct: 8   TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQP--VLVAVKMLREDANKNARND 65

Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE-- 185
           F+ E+  MS+    N++  L  C       +I E+M NG L+QF+   E      K +  
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 186 ---WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
              + T+  +A  IA G++YL    ++  VH D+   N L+G+++  KI+DFG+++
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 31/221 (14%)

Query: 94  LGQGGFGSVYKGK------LPDGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVS 145
           LG+G FG V K              VAVK+LK   S     + ++E   + + +H +V+ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFI---------YDEESSNIN---------RKLEWR 187
             G C +     LI E+   GSL  F+         Y     N N         R L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +   A  I+RG++YL     +++VH D+   N+L+ E    KISDFGL++   +++S++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
                R  + ++A E    +    + +SDV+S+G+++ E+V
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 26/203 (12%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           LG G  G+VYK   L   R++AVKV  L  +    ++ ++E+  + K     ++ F G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           + + + ++  EFM  GSLD +          RK+    + +IAV + +GL YL    +++
Sbjct: 69  FVENRISICTEFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYL---WSLK 115

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           I+H D+KP N+L+      K+ DFG++   ++   ++++      GT  Y+APE      
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV------GTNAYMAPERISGEQ 169

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
            G+   SDV+S G+  +E+ +GR
Sbjct: 170 YGI--HSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 79.6 bits (196), Expect = 7e-17
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE-----EFINEVASMSKTSHVNVVSFL 147
           ++G G FG V  G++  G   A  V+K  +V+       +F+ E        H N++  L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G C E     L+ EF P G L  ++     +      +  T+ ++A  IA GL +LH+  
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
               +H D+   N LL  D   KI D+GL+    K++ +++       + +IAPE+    
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 268 FGGV-----SHKSDVYSYGMMILEM 287
            G +     + +S+V+S G+ I E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 22/208 (10%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEV-ASMSKTSHVNVVSFLG 148
           LG+G +G V K + +P G ++AVK ++ + VN +E    + ++  SM        V+F G
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT-VNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 149 FCYEKKKRALIYEFMPNGSLDQF---IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             + +    +  E M + SLD+F   +YD         +    + +IAV I + LEYLH 
Sbjct: 68  ALFREGDVWICMEVM-DTSLDKFYKKVYD-----KGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
              + ++H D+KP N+L+  +   K+ DFG++      +S    + A G   Y+APE   
Sbjct: 122 --KLSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDA-GCKPYMAPERIN 176

Query: 265 -CRNFGGVSHKSDVYSYGMMILEMVVGR 291
              N  G   KSDV+S G+ ++E+  GR
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.2 bits (195), Expect = 8e-17
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 25/204 (12%)

Query: 93  KLGQGGFGSVYKG--KLPDGRL-VAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +LG G FG V KG  K+   ++ VA+KVLK  N K   +E + E   M +  +  +V  +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEES----SNINRKLEWRTMCQIAVGIARGLEYL 203
           G C E +   L+ E    G L++F+  ++     SN+   +   +M         G++YL
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM---------GMKYL 111

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
             G N   VH D+   N+LL      KISDFGL+K L      + +    +  + + APE
Sbjct: 112 E-GKNF--VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168

Query: 263 VFCRNFGGVSHKSDVYSYGMMILE 286
             C NF   S +SDV+SYG+ + E
Sbjct: 169 --CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 23/221 (10%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   +   +LGQG FG VY+G          + R VAVK +  S    E  EF+NE 
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEA 60

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M   +  +VV  LG   + +   ++ E M +G L  ++     + E++        + 
Sbjct: 61  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+   
Sbjct: 121 MIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYY 175

Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + ++APE      G  +  SD++S+G+++ E+
Sbjct: 176 RKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 33/212 (15%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLG 148
            +G+G +G V K +    G +VA+K  K S   +   +  + EV  + +  H N+V+   
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSN-----INRKLEWRTMCQIAVGIARGLEYL 203
               K +  L++E++    L+     E S         R   W+        + + + Y 
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQ--------LLQAIAYC 116

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H      I+H DIKP NIL+ E    K+ DFG A+ L  +  S ++   A  T  Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA--TRWYRAPE 171

Query: 263 VFC--RNFG-GVSHKSDVYSYGMMILEMVVGR 291
           +     N+G  V    DV++ G ++ E++ G 
Sbjct: 172 LLVGDTNYGKPV----DVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 28/216 (12%)

Query: 94  LGQGGFGSVY--------KGKLPDGRLVAVKVLKN--SKVNGEEFINEVASMSKT-SHVN 142
           LG+G FG V         K K      VAVK+LK+  ++ +  + I+E+  M     H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----------SSNINRKLEWRTMCQI 192
           +++ LG C +     +I E+   G+L +++              +     +L ++ +   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +      
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 203 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 24/216 (11%)

Query: 89  SFSNKLGQGGFGSVYKGKLP-DGRLV--AVKVLKN--SKVNGEEFINEVASMSKTS-HVN 142
            F + +G+G FG V +  +  DG  +  A+K+LK   S+ +  +F  E+  + K   H N
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRTMCQI 192
           +++ LG C  +    +  E+ P G+L  F+             +       L  + + Q 
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  +A G++YL      + +H D+   N+L+GE+   KI+DFG   LS  +E ++     
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG---LSRGEEVYVKKTMG 178

Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           R  + ++A E    N+   + KSDV+S+G+++ E+V
Sbjct: 179 RLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 24/206 (11%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVL---KNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
            +G+G +G V K K  + G++VA+K     ++ K+  +  + E+  + +  H N+V+ + 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSN-INRKLEWRTMCQIAVGIARGLEYLHRGC 207
               KK+  L++EF+ +  LD     E+  N ++     + + QI     RG+E+ H   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQIL----RGIEFCH--- 117

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
           +  I+H DIKP NIL+ +    K+ DFG A+ L+   E +   +  R    Y APE+   
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELL-- 172

Query: 267 NFGGVSHKS--DVYSYGMMILEMVVG 290
             G   +    D+++ G ++ EM+ G
Sbjct: 173 -VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 69/214 (32%), Positives = 112/214 (52%), Gaps = 40/214 (18%)

Query: 94  LGQGGFGSVY---KGKLPD-GRLVAVKVLKNSKVNGEEFI---NEVASMSKTSHVNVVSF 146
           LGQG FG V+   K   PD G+L A+KVLK + +   + +    E   +++ +H  +V  
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK- 62

Query: 147 LGFCYEKK-KRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           L + ++ + K  LI +F+  G L      + ++ EE                   +A  L
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----------YLAELALAL 111

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS---EKKE-SFISMLGARGTI 256
           ++LH   ++ I++ D+KP NILL E+   K++DFGL+K S   EKK  SF       GT+
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTV 162

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            Y+APEV  R   G +  +D +S+G+++ EM+ G
Sbjct: 163 EYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 94  LGQGGFGSVYKGKLPDG--RLVAVKVL-----------KNSKVNGEEFINEVASMSKT-S 139
           LG G FG VYK +  +    L+A+K +           +    +  + ++EV  + +   
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI-YDEESSNINRKLEWRTMCQIAVGIA 197
           H N+V +     E  +  ++ + +    L + F    E+      +  W    Q+ +   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
             L YLH+    RIVH D+ P+NI+LGED    I+DFGLAK  + +    S++   GTI 
Sbjct: 126 --LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTIL 178

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           Y  PE+      G   K+DV+++G ++ +M 
Sbjct: 179 YSCPEIVKNEPYG--EKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 94  LGQGGFGSV----YKGKLPD-GRLVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FG V    Y       G +VAVK LK    + N   +  E+  +    H N+V +
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 147 LGFCYEK--KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G C E+  K   LI E++P GSL  ++          KL    +   A  I  G+ YLH
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL-------PKHKLNLAQLLLFAQQICEGMAYLH 124

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
                  +H D+   N+LL  D   KI DFGLAK + E  E +         + + A E 
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE- 180

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMV 288
            C      S+ SDV+S+G+ + E++
Sbjct: 181 -CLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 25/233 (10%)

Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
            YV + P +  Y    +  R   SF   LG G FG V +       K      VAVK+LK
Sbjct: 15  EYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK 74

Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            +  + E    ++E+  MS   +H N+V+ LG C       +I E+   G L  F+    
Sbjct: 75  PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--- 131

Query: 177 SSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
                  L    +   +  +A+G+ +L  + C    +H D+   N+LL      KI DFG
Sbjct: 132 -RKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFG 186

Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEM 287
           LA+      +++    AR  + ++APE     F  V + +SDV+SYG+++ E+
Sbjct: 187 LARDIMNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.8 bits (190), Expect = 7e-16
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 31/207 (14%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   +    G+  A+K+L  +K+      E  +NE   +    H  +V+  G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +     L+ E++P G L   +        + +         A  +   LEYLH   +
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL------RKSGRFPEPVARFYAAQVVLALEYLH---S 119

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           + IV+ D+KP N+LL  D   KI+DFG AK  + +   +      GT  Y+APE+     
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GTPEYLAPEI----- 169

Query: 269 GGVSHK-----SDVYSYGMMILEMVVG 290
             +  K      D ++ G++I EM+ G
Sbjct: 170 --ILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 21/205 (10%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VV+ L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY+      N   E       A  I  GLE LHR  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE- 121

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPEVFCR 266
               V+ D+KP NILL +    +ISD GLA K+ E +    S+ G  GT+GY+APEV   
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLNN 175

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               +S   D +  G +I EM+ G+
Sbjct: 176 QRYTLS--PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 76.7 bits (188), Expect = 1e-15
 Identities = 63/227 (27%), Positives = 114/227 (50%), Gaps = 26/227 (11%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVN 124
           +R+ VS+   +  Y+  +        K+GQG  G+VY    +  G+ VA+K +    +  
Sbjct: 8   LRSIVSVGDPKKKYTRFE--------KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK 59

Query: 125 GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL 184
            E  INE+  M +  + N+V++L       +  ++ E++  GSL   + +         +
Sbjct: 60  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-------CM 112

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKK 243
           +   +  +     + L++LH     +++H DIK  NILLG D   K++DFG  A+++ ++
Sbjct: 113 DEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169

Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +M+   GT  ++APEV  R   G   K D++S G+M +EMV G
Sbjct: 170 SKRSTMV---GTPYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 94  LGQGGFGSVYKGKL-PDG----RLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVV 144
           LG+G FG V   +  P+G      VAVK LK    +G   I     E+  +    H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIV 69

Query: 145 SFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
            + G C E       LI EF+P+GSL +++      N N K+  +   + AV I +G++Y
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKN-KINLKQQLKYAVQICKGMDY 124

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAP 261
           L    + + VH D+   N+L+  +   KI DFGL K  E  + + ++     + + + AP
Sbjct: 125 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMV 288
           E  C         SDV+S+G+ + E++
Sbjct: 182 E--CLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 30/213 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFCY 151
           +G G +G VYKG+ +  G+L A+KV+  ++   EE   E+  + K SH  N+ ++ G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG-AF 82

Query: 152 EKKKRA-------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            KK          L+ EF   GS+   + + + + +  K +W  +  I   I RGL +LH
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL--KEDW--IAYICREILRGLAHLH 138

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIA 260
                +++H DIK  N+LL E+   K+ DFG+ A+L     ++ +FI      GT  ++A
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMA 189

Query: 261 PEVF-CRNFGGVS--HKSDVYSYGMMILEMVVG 290
           PEV  C      +  ++SD++S G+  +EM  G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVA---VKVLKNSKVNGEE--FINEVASMSKTSHVNVVSF 146
           +++G G FG V  G+   G   A   VK L+ S    E+  F+ EV    + +H NV+  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDE---ESSNINRKLEWRTMCQIAVGIARGLEYL 203
           LG C E     L+ EF P G L  ++       +    + +  R  C++A G+     +L
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL----WL 116

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H+      +H D+   N  L  D   KI D+GLA     ++ +I+       + ++APE+
Sbjct: 117 HQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173

Query: 264 FCRNFGG------VSHKSDVYSYGMMILEM 287
                G        + KS+++S G+ + E+
Sbjct: 174 V-EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLKN--SKVNGEEFINEVASMSKTSH-VNVVSFL 147
           +G+G FG V K ++    L    A+K +K   SK +  +F  E+  + K  H  N+++ L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYD----EESSNINRK------LEWRTMCQIAVGIA 197
           G C  +    L  E+ P+G+L  F+      E              L  + +   A  +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RG++YL +    + +H D+   NIL+GE++  KI+DFG   LS  +E ++     R  + 
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRLPVR 176

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           ++A E    N+   +  SDV+SYG+++ E+V
Sbjct: 177 WMAIESL--NYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 33/210 (15%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHV---NVVSFL 147
           +G+G +G+VY+GK +P GR+VA+K+  L     +  +   EVA +S+       N+  + 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           G  Y K  R  +I E+   GS+   +           +  + +  I   +   L+Y+H+ 
Sbjct: 69  G-SYLKGPRLWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHK- 119

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPE 262
             + ++H DIK  NIL+      K+ DFG+A L    S K+ +F+      GT  ++APE
Sbjct: 120 --VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV------GTPYWMAPE 171

Query: 263 VFCRNFGGVSH--KSDVYSYGMMILEMVVG 290
           V      G  +  K+D++S G+ I EM  G
Sbjct: 172 VI---TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 23/204 (11%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK +  + G L A KV+   S+   E+++ E+  ++   H N+V  L   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y +    ++ EF   G++D  + + E      ++  R +C+  +     L YLH     +
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTL---EALNYLHEN---K 123

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  NIL   D   K++DFG++    +  ++++SFI      GT  ++APE V C
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMC 177

Query: 266 RNFGG--VSHKSDVYSYGMMILEM 287
                    +K+DV+S G+ ++EM
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 47/289 (16%)

Query: 17  VVGIIVILVILLLVGLRHIRKKKTENDQNDFGFGRFRKKN------TENENA--EAAFIR 68
           +   +   ++L LV                FGF   R +N       ENE+   E  F  
Sbjct: 632 ITCTLGAFLVLALVA---------------FGFVFIRGRNNLELKRVENEDGTWELQFFD 676

Query: 69  NYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEF 128
           + VS   K    +D+        N + +G  G+ YKGK     +  V V + + VN    
Sbjct: 677 SKVS---KSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFV-VKEINDVNSIP- 730

Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
            +E+A M K  H N+V  +G C  +K   LI+E++   +L         S + R L W  
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL---------SEVLRNLSWER 781

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
             +IA+GIA+ L +LH  C+  +V  ++ P  I++     P +       L    + FIS
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFIS 841

Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK 297
                    Y+APE   R    ++ KSD+Y +G++++E++ G+  A+ +
Sbjct: 842 S-------AYVAPET--RETKDITEKSDIYGFGLILIELLTGKSPADAE 881

Length = 968

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 70/204 (34%), Positives = 102/204 (50%), Gaps = 19/204 (9%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VVS L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY+  +   +   E R +   A  +  GLE L R  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIF-YAAELCCGLEDLQRE- 121

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             RIV+ D+KP NILL +    +ISD GLA    + E   ++ G  GT+GY+APEV   N
Sbjct: 122 --RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVI--N 174

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D +  G +I EM+ G+
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 62/227 (27%), Positives = 114/227 (50%), Gaps = 26/227 (11%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVN 124
           +R+ VS+   +  Y+  +        K+GQG  G+VY    +  G+ VA++ +    +  
Sbjct: 9   LRSIVSVGDPKKKYTRFE--------KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 125 GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL 184
            E  INE+  M +  + N+V++L       +  ++ E++  GSL   + +         +
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-------CM 113

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKK 243
           +   +  +     + LE+LH     +++H DIK  NILLG D   K++DFG  A+++ ++
Sbjct: 114 DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +M+   GT  ++APEV  R   G   K D++S G+M +EM+ G
Sbjct: 171 SKRSTMV---GTPYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 23/204 (11%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVL---KNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           LG G  GSV K K +P G ++A KV+     S V  ++ + E+  M +     +VSF G 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-KQILRELQIMHECRSPYIVSFYGA 71

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +    +  EFM  GSLD+ IY +        +    + +IAV +  GL YL+     
Sbjct: 72  FLNENNICMCMEFMDCGSLDR-IYKKGGP-----IPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCRN 267
           RI+H DIKP NIL+      K+ DFG++   ++   ++F+      GT  Y++PE     
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERI--Q 175

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
            G  + KSDV+S G+ I+E+ +G+
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 21/201 (10%)

Query: 94  LGQGGFGSVY--KGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLG 148
           +G+G FG V+  + K  D +LV +K +   ++  +E     NE   +   SH N++ +  
Sbjct: 8   VGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              E K   ++ E+ P G+L ++I        N  L+  T+    V I   L ++H    
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVH---T 119

Query: 209 IRIVHFDIKPHNILLGE-DFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
             I+H D+K  NILL +     KI DFG++K LS K +++  +    GT  YI+PE+ C 
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV----GTPCYISPEL-CE 174

Query: 267 NFGGVSHKSDVYSYGMMILEM 287
                + KSD+++ G ++ E+
Sbjct: 175 G-KPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 35/207 (16%)

Query: 96  QGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVAS-----MSKTSHVNVVSFLGF 149
           +G FGSVY   K   G   A+KVLK S +  +  +  V +     M +     V      
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL-----EWRTMCQIAVGIARGLEYLH 204
              K    L+ E++  G     I         + L     +W    Q    +  G+E LH
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI---------KTLGGLPEDW--AKQYIAEVVLGVEDLH 114

Query: 205 -RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
            RG    I+H DIKP N+L+ +    K++DFGL++   + + F+      GT  Y+APE 
Sbjct: 115 QRG----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPET 164

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
                 G    SD +S G +I E + G
Sbjct: 165 ILGV--GDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 57/208 (27%), Positives = 108/208 (51%), Gaps = 25/208 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE-----FINEVASMSKTSHVNVVSF 146
           KLG+G + +VYKG+    G +VA+K +    ++ EE      I E++ M +  H N+V  
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               + + K  L++E+M +  L +++   ++  +   L+  T+      + +G+ + H  
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF- 264
              R++H D+KP N+L+ +    K++DFGLA+       +F + +    T+ Y AP+V  
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV---VTLWYRAPDVLL 173

Query: 265 -CRNFGGVSHKSDVYSYGMMILEMVVGR 291
             R +   S   D++S G ++ EM+ GR
Sbjct: 174 GSRTY---STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 25/203 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           ++G G FG+VY  + +    +VA+K +    K S    ++ I EV  + +  H N + + 
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
           G CY ++  A L+ E+    + D          +++K L+   +  I  G  +GL YLH 
Sbjct: 82  G-CYLREHTAWLVMEYCLGSASDIL-------EVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV-F 264
              I   H DIK  NILL E    K++DFG A L     SF+      GT  ++APEV  
Sbjct: 134 HERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVIL 184

Query: 265 CRNFGGVSHKSDVYSYGMMILEM 287
             + G    K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 41/216 (18%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFLG 148
           K+G+G +G VYK +    G +VA+K ++ +++  G     I E++ + + +H N+V  L 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             + + K  L++EF+ +  L +F+     S I   L    + Q+  G+A    + H    
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCHSH-- 119

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG-----------TIG 257
            R++H D+KP N+L+  +   K++DFGLA+             A G           T+ 
Sbjct: 120 -RVLHRDLKPQNLLINTEGAIKLADFGLAR-------------AFGVPVRTYTHEVVTLW 165

Query: 258 YIAPEVF--CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   C+ +   S   D++S G +  EMV  R
Sbjct: 166 YRAPEILLGCKYY---STAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 5e-15
 Identities = 65/227 (28%), Positives = 116/227 (51%), Gaps = 26/227 (11%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG 125
           +R  VS+   +  Y+  +        K+GQG  G+V+    +  G+ VA+K +   K   
Sbjct: 8   LRTIVSIGDPKKKYTRYE--------KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK 59

Query: 126 EEFI-NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL 184
           +E I NE+  M +  + N+V+FL       +  ++ E++  GSL   +    +     + 
Sbjct: 60  KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEA 115

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKK 243
           +   +C+  +   + LE+LH     +++H DIK  N+LLG D   K++DFG  A+++ ++
Sbjct: 116 QIAAVCRECL---QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169

Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +M+   GT  ++APEV  R   G   K D++S G+M +EMV G
Sbjct: 170 SKRSTMV---GTPYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 26/204 (12%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFI---NEVASMSKTSHVNVVSFLG 148
           ++G G +G VYK   L  G L AVK++K     G++F     E+  + +  H N+V++ G
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
               ++K  +  E+   GSL Q IY    +    +L+   +C+  +   +GL YLH    
Sbjct: 74  SYLSREKLWICMEYCGGGSL-QDIY--HVTGPLSELQIAYVCRETL---QGLAYLHSKGK 127

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGL-AKLS---EKKESFISMLGARGTIGYIAPEVF 264
           +   H DIK  NILL ++   K++DFG+ AK++    K++SFI      GT  ++APEV 
Sbjct: 128 M---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI------GTPYWMAPEVA 178

Query: 265 C-RNFGGVSHKSDVYSYGMMILEM 287
                GG +   D+++ G+  +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 19/204 (9%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VVS L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY    +      E R +   A  I  GLE LH+  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVF-YAAEICCGLEDLHQE- 121

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             RIV+ D+KP NILL +    +ISD GLA    + +   ++ G  GT+GY+APEV  +N
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEV-VKN 175

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D ++ G ++ EM+ G+
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEE---FINEV-ASMSKTSHVNVVSFLG 148
           +G+G FG+V K      G ++AVK ++ S V+ +E    + ++   M  +    +V F G
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 149 FCYEKKKRALIYEFMPNGSLDQF---IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             + +    +  E M + SLD+F   +Y+   S I        + +IAV   + L YL  
Sbjct: 71  ALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE----EILGKIAVATVKALNYLKE 125

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
              ++I+H D+KP NILL  +   K+ DFG++   +  +S      A G   Y+APE   
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSIAKTRDA-GCRPYMAPERID 180

Query: 266 RNFG-GVSHKSDVYSYGMMILEMVVGR 291
            +   G   +SDV+S G+ + E+  G+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 26/204 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI---NEVASMSKTSHVNVVSFLG 148
           ++G G +G VYK + +  G L A+KV+K     GE+F     E+  M    H N+V++ G
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
               + K  +  EF   GSL Q IY     ++   L    +  ++    +GL YLH   +
Sbjct: 74  SYLRRDKLWICMEFCGGGSL-QDIY-----HVTGPLSESQIAYVSRETLQGLYYLH---S 124

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGL-AKLS---EKKESFISMLGARGTIGYIAPEVF 264
              +H DIK  NILL ++   K++DFG+ A+++    K++SFI      GT  ++APEV 
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------GTPYWMAPEVA 178

Query: 265 C-RNFGGVSHKSDVYSYGMMILEM 287
                GG +   D+++ G+  +E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKV-----LKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           K+G+G F  VY+   L DG  VA+K      L ++K    + I E+  + + +H NV+ +
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKY 67

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                E  +  ++ E    G L + I  + ++   I  K  W+   Q+       LE++H
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R++H DIKP N+ +      K+ D GL +    K +    L   GT  Y++PE  
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERI 178

Query: 265 CRNFGGVSHKSDVYSYGMMILEM 287
             N  G + KSD++S G ++ EM
Sbjct: 179 HEN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 70/204 (34%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VVS L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY+      N   +       A  I  GLE LHR  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNM----GNPGFDEERAVFYAAEITCGLEDLHRE- 121

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             RIV+ D+KP NILL +    +ISD GLA    + E   ++ G  GT+GY+APEV    
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVV--K 174

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D +  G +I EM+ G+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 26/205 (12%)

Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V   +    GR VAVK++   K    E + NEV  M    H NVV      
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RGCNI 209
              ++  ++ EF+  G+L   +     + +N + +  T+C+    + + L YLH +G   
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRLNEE-QIATVCE---SVLQALCYLHSQG--- 137

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPEVFC 265
            ++H DIK  +ILL  D   K+SDFG  A++S+   K++S +      GT  ++APEV  
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS 190

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           R   G   + D++S G+M++EMV G
Sbjct: 191 RTPYGT--EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 26/222 (11%)

Query: 92  NKLGQGGFGSVY-KGKLPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSF 146
           +++G G FG+VY         +VAVK +    K +    ++ I EV  + +  H N + +
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 147 LGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLH 204
            G CY K+  A L+ E+    + D          +++K L+   +  I  G  +GL YLH
Sbjct: 87  KG-CYLKEHTAWLVMEYCLGSASDLL-------EVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV- 263
                 ++H DIK  NILL E    K++DFG A  S    SF+      GT  ++APEV 
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY 305
              + G    K DV+S G+  +E+   RK     ++  S +Y
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALY 230

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 25/203 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           ++G G FG+VY  + + +  +VA+K +    K S    ++ I EV  + K  H N + + 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
           G CY ++  A L+ E+    + D          +++K L+   +  +  G  +GL YLH 
Sbjct: 82  G-CYLREHTAWLVMEYCLGSASDLL-------EVHKKPLQEVEIAAVTHGALQGLAYLH- 132

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV-F 264
             +  ++H D+K  NILL E    K+ DFG A +      F+      GT  ++APEV  
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVIL 184

Query: 265 CRNFGGVSHKSDVYSYGMMILEM 287
             + G    K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVK----VLKNSKVNGEEFINEVASMSKTSHVNVV 144
             ++LG+G +GSVYK    P G  +A+K     L  SK N    I E+  + K     +V
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ--IIMELDILHKAVSPYIV 62

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            F G  + +    +  E+M  GSLD+ +Y           E   + +I   + +GL++L 
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDK-LYAG-GVATEGIPE-DVLRRITYAVVKGLKFLK 119

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              NI  +H D+KP N+L+  +   K+ DFG++       +  ++    G   Y+APE  
Sbjct: 120 EEHNI--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERI 173

Query: 265 ----CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                      + +SDV+S G+ ILEM +GR
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 41/212 (19%)

Query: 94  LGQGGFGSVYKGKLPDGR-LVAVKVLKNSKVNGEEFINEVASMSKTSHV----NVVSFLG 148
           +G G FG V+  +        A+KV+          I EV  + +  HV     V+  + 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMA---------IPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 149 -------FCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
                  F  E  +R L  + E++P G L  F Y   S     +    T    A  I   
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNS----GRFSNSTGLFYASEIVCA 113

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGY 258
           LEYLH   +  IV+ D+KP NILL ++   K++DFG AK L ++  +        GT  Y
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC------GTPEY 164

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +APEV      G +   D ++ G++I EM+VG
Sbjct: 165 LAPEVIQSK--GHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSFLGF 149
           KLG+G + +VYKGK   +G+LVA+KV++  +  G  F  I E + +    H N+V     
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNI---NRKLEWRTMCQIAVGIARGLEYLHRG 206
            + K+   L++E++ +  L Q++ D+    +   N KL           + RGL Y+H+ 
Sbjct: 72  IHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKL-------FLFQLLRGLSYIHQR 122

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I+H D+KP N+L+ +    K++DFGLA+         S      T+ Y  P+V   
Sbjct: 123 ---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS--NEVVTLWYRPPDVL-- 175

Query: 267 NFGGVSHKS--DVYSYGMMILEMVVG 290
             G   + +  D++  G + +EM+ G
Sbjct: 176 -LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLK-----NSKVNGEEFINEVASMSKTSHVNVVSF 146
           K+G+G F  VY+   L D + VA+K ++     ++K   ++ + E+  + + +H NV+ +
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKY 67

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           L    E  +  ++ E    G L Q I   +     R +  RT+ +  V +   +E++H  
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQK--RLIPERTVWKYFVQLCSAVEHMH-- 123

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            + R++H DIKP N+ +      K+ D GL +    K +    L   GT  Y++PE    
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHE 180

Query: 267 NFGGVSHKSDVYSYGMMILEMVV 289
           N  G + KSD++S G ++ EM  
Sbjct: 181 N--GYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 53/222 (23%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVS 145
           K+G+G +G VYK +    G +VA   LK  ++  E+       I E++ + + +H N+V 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVA---LKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSN--INRKLEWRTMCQIAVGIARGLEYL 203
            L   + + K  L++EF+    LD   Y + S    ++  L    + Q+  GIA    Y 
Sbjct: 63  LLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA----YC 115

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG--------- 254
           H     R++H D+KP N+L+  +   K++DFGLA+             A G         
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLAR-------------AFGVPVRTYTHE 159

Query: 255 --TIGYIAPEVFCRNFGGVSHKS---DVYSYGMMILEMVVGR 291
             T+ Y APE+      G    S   D++S G +  EMV  R
Sbjct: 160 VVTLWYRAPEILL----GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +LG G  G V K +     L+  + L + ++      + I E+  + + +   +V F G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
            Y   + ++  E M  GSLDQ + +       +++    + ++++ + RGL YL      
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE--KH 123

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCRN 267
           +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE     
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT 177

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
              V  +SD++S G+ ++E+ +GR
Sbjct: 178 HYSV--QSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 26/207 (12%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE--VASMSKTSHVNVVSF 146
           +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE  + S+  T     +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 147 LGFCYEK-KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           + + +    K + I + M  G L    Y      +  + E R     A  I  GLE++H 
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEAEMRFY---AAEIILGLEHMH- 114

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
             N  +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT GY+APEV  
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168

Query: 266 RNFGGVSHKS--DVYSYGMMILEMVVG 290
           +   GV++ S  D +S G M+ +++ G
Sbjct: 169 K---GVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +G V        GR VA+K L     S ++ +    E+  +    H NV+  L  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 150 CYEKKKRALIYEFMPNGSLDQF--IY------DEESSNINR--KLEWRTMCQIAVGIARG 199
                       F P  SL+ F  +Y        + +NI +  KL    +  +   I RG
Sbjct: 83  ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           L+Y+H   +  I+H D+KP NI + ED   KI DFGLA+ ++ +     M G   T  Y 
Sbjct: 131 LKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 182

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+   N+   +   D++S G ++ E++ G+
Sbjct: 183 APEIML-NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 26/206 (12%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN--EVASMSK-TSHVNVVSFL 147
            K+G+G F  V K +    G+  A+K +K    + E+  N  E+ ++ + + H N++  +
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 148 GFCYEKK--KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
              +++K  + AL++E M     D  +Y E      R L  + +      + + L+++HR
Sbjct: 65  EVLFDRKTGRLALVFELM-----DMNLY-ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF---ISMLGARGTIGYIAPE 262
                I H DIKP NIL+ +D   K++DFG  +    K  +   IS      T  Y APE
Sbjct: 119 ---NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS------TRWYRAPE 168

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV 288
               + G    K D+++ G +  E++
Sbjct: 169 CLLTD-GYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 68/212 (32%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLK--------NSKVNGEEFINEVASMSKTSHVNVV 144
           LGQG FG VY     D GR +AVK ++        + +VN  E   E+  +    H  +V
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKNLLHERIV 67

Query: 145 SFLGFCYEKKKRAL--IYEFMPNGSL-DQF-IYDEESSNINRKLEWRTMCQIAVGIARGL 200
            + G   +  +R L    E MP GS+ DQ   Y   + N+ RK   +        I  G+
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ--------ILEGV 119

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
            YLH      IVH DIK  NIL       K+ DFG +K L     S   M    GT  ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +PEV      G   K+D++S G  ++EM+  +
Sbjct: 177 SPEVISGE--GYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 92  NKLGQGGFGSVYKG--KLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +KLG+G + +VYKG  KL D  LVA+K ++     G     I EV+ +    H N+V+  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + +K   L++E++ +  L Q++ D+  ++IN       + Q+     RGL Y HR  
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLL----RGLNYCHRR- 123

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             +++H D+KP N+L+ E    K++DFGLA+         S      T+ Y  P++    
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS--NEVVTLWYRPPDIL--- 176

Query: 268 FGGVSHKS--DVYSYGMMILEMVVGR 291
            G   + +  D++  G +  EM  GR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 93  KLGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+ VAVK +   K    E + NEV  M    H NVV      
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + R L YLH   N  
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIATVCLSVLRALSYLH---NQG 138

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPEVFCR 266
           ++H DIK  +ILL  D   K+SDFG  A++S+   K++S +      GT  ++APEV  R
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISR 192

Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
              G   + D++S G+M++EM+ G
Sbjct: 193 LPYGT--EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 45/254 (17%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           LG G  G V K    P G ++A K++    K +  N  + I E+  + + +   +V F G
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRELKVLHECNSPYIVGFYG 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +          ++    + +I++ + RGL YL     
Sbjct: 67  AFYSDGEISICMEHMDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLRE--K 118

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 172

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV 326
               V   SD++S G+ ++EM +GR              +P      I P +  +L  + 
Sbjct: 173 THYTVQ--SDIWSLGLSLVEMAIGR--------------YP------IPPPDAKELEAMF 210

Query: 327 TEEEKEMAKKMILV 340
                E   K    
Sbjct: 211 GRPVSEGEAKESHR 224

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 53/208 (25%), Positives = 105/208 (50%), Gaps = 25/208 (12%)

Query: 94  LGQGGFGS--VYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLG 148
           LG+G FG   +Y+ +  D  LV  K +  ++++ +E    +NE+  +S   H N++++  
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 149 FCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
             +      LI  E+   G+L   I  ++      ++    + QI   ++    Y+H+  
Sbjct: 67  H-FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS----YIHK-- 119

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
              I+H DIK  NI L +    K+ DFG++K L  +     +++   GT  Y++PE+ C+
Sbjct: 120 -AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV---GTPYYMSPEL-CQ 174

Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRK 292
              GV +  KSD+++ G ++ E++  ++
Sbjct: 175 ---GVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 29/205 (14%)

Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVS 145
           ++G G FG+VY  +  D R   +VA+K +    K S    ++ I EV  + +  H N + 
Sbjct: 32  EIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 146 FLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYL 203
           + G CY ++  A L+ E+    + D          +++K L+   +  I  G  +GL YL
Sbjct: 90  YKG-CYLREHTAWLVMEYCLGSASDLL-------EVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H   +  ++H DIK  NILL E    K++DFG A ++    SF+      GT  ++APEV
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEV 192

Query: 264 -FCRNFGGVSHKSDVYSYGMMILEM 287
               + G    K DV+S G+  +E+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 35/213 (16%)

Query: 94  LGQGGFGSVYKGKL---PDGRL--------VAVKVLKNSKVNGEEFINEVASMSKTSHVN 142
           LGQG F ++YKG L    D  +        V +KVL +   +   F    + MS+ SH +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +V   G C  + +  ++ E++  G LD F++  E +N++  L W+    +A  +A  L Y
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVS--LHWKL--DVAKQLASALHY 116

Query: 203 LHRGCNIRIVHFDIKPHNILL-------GEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           L    + ++VH ++   NIL+       G     K+SD G+      +E  +        
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------R 167

Query: 256 IGYIAPEVFCRNFGG-VSHKSDVYSYGMMILEM 287
           I +IAPE   RN    ++  +D +S+G  +LE+
Sbjct: 168 IPWIAPE-CIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 39/170 (22%)

Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVK--VLKNSKVNGEEF----INEVASMSKTSHVN 142
              KLG+G FG VYK  ++  GR+VA+K  ++ N K   + F    + E+  + K  H N
Sbjct: 12  ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHPN 68

Query: 143 VVSFLGFCYEK-----KKRALIYEFMP------NGSLDQFIYDEESSNINRKLEWRTMCQ 191
           VV  +    E+     +KR  +Y   P      +G L+         N + KL   T  Q
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE---------NPSVKL---TESQ 116

Query: 192 IA---VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
           I    + +  G+ YLH   N  I+H DIK  NIL+      KI+DFGLA+
Sbjct: 117 IKCYMLQLLEGINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 94  LGQGGFGSVYK-GKLPDGRLVAVKVLKNSKVNGEEFINEVASM-SKTSHVNVVSFLGFCY 151
           +G+G +G VYK     DG L AVK+L       EE   E   + S  +H NVV F G  Y
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 152 EKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +  K       L+ E    GS+ + +  +      ++L+   +  I  G   GL++LH  
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQHLH-- 145

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVF- 264
            N RI+H D+K +NILL  +   K+ DFG+ A+L+  +   +    + GT  ++APEV  
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIA 201

Query: 265 CRNFGGVSH--KSDVYSYGMMILEMVVG 290
           C      S+  + DV+S G+  +E+  G
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 31/210 (14%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSFLGF 149
           KLG+G + +VYKG    +G+LVA+KV+      G  F  I E + +    H N+V     
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESS--NINRKLEWRTMCQIAVGIARGLEYLHRGC 207
            + K+    ++E+M +  L Q++          N +L    M Q+     RGL Y+H   
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL---FMFQLL----RGLAYIHGQ- 122

Query: 208 NIRIVHFDIKPHNIL---LGEDFCPKISDFGLAKL-SEKKESFISMLGARGTIGYIAPEV 263
              I+H D+KP N+L   LGE    K++DFGLA+  S   +++ S +    T+ Y  P+V
Sbjct: 123 --HILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEV---VTLWYRPPDV 174

Query: 264 FCRNFGGVSHKS--DVYSYGMMILEMVVGR 291
                G   + S  D++  G + +EM+ G+
Sbjct: 175 L---LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE--VASMSKTSHVNVVSF 146
           +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE  + S+  T     +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 147 LGFCYEK-KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           + + +    K   I + M  G L    Y      +  + E R     A  I  GLE++H 
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFSEKEMRFY---ATEIILGLEHMH- 114

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
             N  +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT GY+APEV  
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168

Query: 266 RNFGGVSHKS--DVYSYGMMILEMVVG 290
           +   G ++ S  D +S G M+ +++ G
Sbjct: 169 K---GTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 40/219 (18%)

Query: 91  SNKLGQGGFGSVYKGK-LPDGRLVAVK--VLKNSKVNGEEF----INEVASMSKTSHVNV 143
             K+GQG FG V+K +     ++VA+K  +++N K   E F    + E+  +    H NV
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENV 73

Query: 144 VSFLGFCYEKKK-----RA---LIYEFMPNGSLDQFIYDEESSNINRKL---EWRTMCQI 192
           V+ +  C  K       +    L++EF  +  L   +     SN N K    E + + ++
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-----SNKNVKFTLSEIKKVMKM 127

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLG 251
              +  GL Y+HR    +I+H D+K  NIL+ +D   K++DFGLA+  S  K S  +   
Sbjct: 128 ---LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 252 AR-GTIGYIAPEVF--CRNFGGVSHKSDVYSYGMMILEM 287
            R  T+ Y  PE+    R++G      D++  G ++ EM
Sbjct: 182 NRVVTLWYRPPELLLGERDYG---PPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 46/219 (21%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVS 145
           K+G+G +G VYKG+    G++VA   +K  ++  EE       I E++ + +  H N+V 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVA---MKKIRLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
                 ++ +  LI+EF+   S+D   Y  +S    + ++   +      I +G+ + H 
Sbjct: 64  LQDVLMQESRLYLIFEFL---SMDLKKY-LDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG----------- 254
               R++H D+KP N+L+      K++DFGLA+             A G           
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-------------AFGIPVRVYTHEVV 163

Query: 255 TIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGR 291
           T+ Y APEV     G   + +  D++S G +  EM   +
Sbjct: 164 TLWYRAPEVL---LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 32/243 (13%)

Query: 92  NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFLG 148
           +KLG+G + +V+KG+      LVA+K ++     G     I EV+ +    H N+V+   
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             + ++   L++E++ +  L Q++      N    +    +      + RGL Y H+   
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYL-----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            +I+H D+KP N+L+ E    K++DFGLA+         S      T+ Y  P+V     
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVL---L 176

Query: 269 GGVSHKS--DVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV 326
           G   + +  D++  G ++ EM  GR              FP S  K  E    F+L G  
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRP------------MFPGSTVKE-ELHLIFRLLGTP 223

Query: 327 TEE 329
           TEE
Sbjct: 224 TEE 226

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 24/222 (10%)

Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL--VAVKVLKNSKVNGEEFINEV 132
           PKR N   +K    +F   LG G FG V      +     VA+K  + SK+  ++ ++ V
Sbjct: 21  PKRKN--KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78

Query: 133 ASMSKT----SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
            S  K     +H   V+  G   ++    L+ EF+  G    F+        N++     
Sbjct: 79  FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------NKRFPNDV 132

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
            C  A  I    EYL    ++ IV+ D+KP N+LL +D   K++DFG AK+ + +   + 
Sbjct: 133 GCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC 189

Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
                GT  YIAPE+      G    +D ++ G+ I E++VG
Sbjct: 190 -----GTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 25/206 (12%)

Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
            ++G+G FG VYKG       +VA+K+  L+ ++   E+   E+  +S+     +  + G
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +  K  +I E++  GS    +           LE   +  I   I +GL+YLH   +
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLH---S 119

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEVF 264
            R +H DIK  N+LL E    K++DFG+A +L++   K+ +F+      GT  ++APEV 
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 173

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            ++      K+D++S G+  +E+  G
Sbjct: 174 KQS--AYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 20/202 (9%)

Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RGCNI 209
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH +G   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLKALSVLHAQG--- 136

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            ++H DIK  +ILL  D   K+SDFG  A++S++     S++   GT  ++APE+  R  
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV---GTPYWMAPELISRLP 192

Query: 269 GGVSHKSDVYSYGMMILEMVVG 290
            G   + D++S G+M++EMV G
Sbjct: 193 YG--PEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 17/204 (8%)

Query: 92  NKLGQGGFGSVYKG--KLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
            KLG+G + +V+KG  KL +  LVA+K ++     G     I EV+ +    H N+V+  
Sbjct: 12  EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              +  K   L++E++ +  L Q++  ++  NI   +    +      I RGL Y HR  
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYM--DDCGNI---MSMHNVKIFLYQILRGLAYCHRR- 123

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             +++H D+KP N+L+ E    K++DFGLA+         S      T+ Y  P+V   +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVLLGS 179

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               S + D++  G +  EM  GR
Sbjct: 180 -SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 21/205 (10%)

Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 122

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 176

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM +GR
Sbjct: 177 THYSV--QSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 31/209 (14%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVA---VKVLKNSKVNGEEFINEVAS-------MSKTSHVN 142
           +LG+G FG+VY  K  D + VA   +KVLK   V GE   NE          +SK  H  
Sbjct: 7   RLGKGSFGTVYLVK--DKKAVAEERLKVLKEIPV-GELNPNETVQANQEAQLLSKLDHPA 63

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLD----QFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           +V F     E+    +I E+     LD    +  +  ++ + N+  EW    Q+ +G+  
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLLGV-- 119

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
              Y+H+    RI+H D+K  NI L  +   KI DFG+++L        +     GT  Y
Sbjct: 120 --HYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF--TGTPYY 171

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           ++PE       G   KSD++S G ++ EM
Sbjct: 172 MSPEALKHQ--GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 39/214 (18%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVL--------KNSKVNGEEFINEVASMSKTSHVNVV 144
           LG+G FG VY     D GR +AVK +         + +VN  E   E+  +    H  +V
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC--EIQLLKNLRHDRIV 67

Query: 145 SFLGFC---YEKKKRALIYEFMPNGSL-DQF-IYDEESSNINRKLEWRTMCQIAVGIARG 199
            + G C    E+KK ++  E+MP GS+ DQ   Y   + N+ R+   +        I +G
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ--------ILQG 118

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA-----RG 254
           + YLH      IVH DIK  NIL       K+ DFG    + K+   I M G       G
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG----ASKRIQTICMSGTGIKSVTG 171

Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           T  +++PEV   +  G   K+DV+S    ++EM+
Sbjct: 172 TPYWMSPEVI--SGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 24/216 (11%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++ + G++ A K L   ++    GE+  + E   + K +   +V+ L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G L   IY+       R LE   +   +  I  G+ +LH   
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLH--- 112

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPEVFCR 266
           ++ IV+ D+KP N+LL +    ++SD GLA +L + K    ++    GT GY+APE+   
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKE 168

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR---KNAEVKVS 299
                S+  D ++ G  I EMV GR   K+ + KV+
Sbjct: 169 E--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV-NGEE-----FINEVASMSKTS---HVN 142
           ++G G +G+VYK + P  G  VA   LK+ +V   E+      + EVA + +     H N
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVA---LKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 143 VVSFLGFCYEKK-----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           +V  +  C   +     K  L++E      +DQ +           L   T+  +     
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFE-----HVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL++LH  C   IVH D+KP NIL+      K++DFGLA++   + +   ++    T+ 
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVV---VTLW 172

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           Y APEV  ++    +   D++S G +  EM
Sbjct: 173 YRAPEVLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 53/193 (27%), Positives = 79/193 (40%), Gaps = 31/193 (16%)

Query: 90  FSNKLGQGGFGSVYKGKL---PDGRLVAVKVLKNSKVNGEEF----INEVASMSKTSHVN 142
               +G+G +G VYK K     DG+  A+K  K  K            E+A + +  H N
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63

Query: 143 VVSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           VVS +    E   ++  L++++  +  L Q I           +    +  +   I  G+
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFH-RQAKRVSIPPSMVKSLLWQILNGV 121

Query: 201 EYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISML------ 250
            YLH      ++H D+KP NIL+     E    KI D GLA+L      F + L      
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL------FNAPLKPLADL 172

Query: 251 -GARGTIGYIAPE 262
                TI Y APE
Sbjct: 173 DPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 45/254 (17%)

Query: 92  NKLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSF 146
            ++G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  +
Sbjct: 10  ERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFI----YDEESSNINRKLEWRTMCQIAVGIARGLEY 202
            G   +  K  +I E++  GS    +    +DE         +  TM +    I +GL+Y
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--------FQIATMLK---EILKGLDY 116

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGY 258
           LH   + + +H DIK  N+LL E    K++DFG+A +L++   K+ +F+      GT  +
Sbjct: 117 LH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFW 167

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN 318
           +APEV  ++      K+D++S G+  +E+  G          +S+++ P  +   I   N
Sbjct: 168 MAPEVIQQS--AYDSKADIWSLGITAIELAKGEPP-------NSDMH-PMRVLFLIPKNN 217

Query: 319 EFQLAGVVTEEEKE 332
              L G  ++  KE
Sbjct: 218 PPTLTGEFSKPFKE 231

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 25/221 (11%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDG-----RLVAVKVLKN--SKVNGEEFINEVASM 135
           + R   + S+ L +G FG ++ G L D        V VK +K+  S++     + E   +
Sbjct: 3   ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62

Query: 136 SKTSHVNVVSFLGFCYEKKKRALI-YEFMPNGSLDQFIYD--EESSNINRKLEWRTMCQI 192
              SH N++  L  C E  +   + Y +M  G+L  F+       +N  + L  + +  +
Sbjct: 63  YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A+ IA G+ YLH+     ++H DI   N ++ E+   KI+D  L++     + F      
Sbjct: 123 AIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR-----DLFPMDYHC 174

Query: 253 RGT-----IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G      + ++A E         S  SDV+S+G+++ E++
Sbjct: 175 LGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G+L A K L   ++      E  + E   ++K     +VS L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LA 59

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIY--DEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           + ++ K    L+   M  G L   IY  DEE    N        C     I  GLE+LH+
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE----NPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPEVF 264
               RI++ D+KP N+LL  D   +ISD GLA +L + +       G  GT G++APE+ 
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELL 169

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                  S   D ++ G+ + EM+  R
Sbjct: 170 QGEEYDFS--VDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 20/153 (13%)

Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSFLGF 149
           KLG+G + +VYKG+    G+LVA+K ++     G  F  I E + +    H N+V+    
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNI----NRKLEWRTMCQIAVGIARGLEYLHR 205
            + KK   L++E++ +  L Q  Y ++        N +L    + Q+     RGL Y H+
Sbjct: 72  IHTKKTLTLVFEYL-DTDLKQ--YMDDCGGGLSMHNVRL---FLFQLL----RGLAYCHQ 121

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
               R++H D+KP N+L+ E    K++DFGLA+
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 43/224 (19%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVN-VV 144
           K+G+G +G VYK +    G+LVA   LK +++  +E       + E++ +   S    +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 145 SFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
             L   + ++K       L++E++ +  L +F+ D       R L  +T+      + +G
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESFISMLGARG--- 254
           + + H  G    ++H D+KP N+L+ +     KI+D GL +      +F   + +     
Sbjct: 123 VAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEI 172

Query: 255 -TIGYIAPEVFCRNFGGVSHKS---DVYSYGMMILEMVVGRKNA 294
            T+ Y APEV      G +H S   D++S G +  EM   RK  
Sbjct: 173 VTLWYRAPEVLL----GSTHYSTPVDIWSVGCIFAEMS--RKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 23/204 (11%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFL 147
           ++GQGG+G V+  K  D G +VA+K +K S +     +  V +    ++ T    +V  L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
               + +   L  E++P G     +     +N+    E      +A      ++ LH   
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSEDHARFYMAEMFE-AVDALHE-- 119

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +  +H D+KP N L+      K++DFGL+K +     S +      G+  Y+APEV   
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVL-- 170

Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
              G     D +S G M+ E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           I RGL+YLH      I+H DIKP N+L+  +   KI DFGLA++ E  ES   M     T
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVT 167

Query: 256 IGYIAPEVF--CRNFGGVSHKSDVYSYGMMILEMVVGR 291
             Y APE+    R++       D++S G +  E++  R
Sbjct: 168 QYYRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 55/303 (18%)

Query: 93  KLGQGGFGSVYKGK-LPDG-RLVAVKVLKNSKVNGEE------FINEVA---SMSKTSHV 141
           ++G+G +G V+K + L +G R VA   LK  +V   E       I EVA    +    H 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 142 NVVSFLGFCY-----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           NVV     C       + K  L++E +     D   Y ++        E  T+  +   +
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTE--TIKDMMFQL 119

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
            RGL++LH   + R+VH D+KP NIL+      K++DFGLA++   + +  S++    T+
Sbjct: 120 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTL 173

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV----VGRKNAEVK--------VSLSSEI 304
            Y APEV  ++    +   D++S G +  EM     + R +++V         + L  E 
Sbjct: 174 WYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231

Query: 305 YFPNSIYKHIEPGNEF-----QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSL 359
            +P  +     P   F     Q       +  E+ K ++L       +    +I    +L
Sbjct: 232 DWPRDVAL---PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK---RISAYSAL 285

Query: 360 SSP 362
           S P
Sbjct: 286 SHP 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 38/241 (15%)

Query: 94  LGQGGFGSVY---KGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKT--SHVNVVSFL 147
           LG G +G V+   K    D G+L A+KVL+ + +  +    E     +    HV    FL
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 148 ---GFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG-IARGLEY 202
               + ++ + K  LI +++  G +   +Y  ++ +           +   G I   LE+
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-------EDEVRFYSGEIILALEH 120

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIA 260
           LH+   + IV+ DIK  NILL  +    ++DFGL+K  LSE+KE   S     GTI Y+A
Sbjct: 121 LHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYMA 174

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV--------GRKNAEVKVS---LSSEIYFPNS 309
           PE+  R  GG     D +S G++I E++         G +N + +VS   L  +  FP+ 
Sbjct: 175 PEII-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233

Query: 310 I 310
           I
Sbjct: 234 I 234

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 29/207 (14%)

Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           K+G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  + 
Sbjct: 11  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +  K  +I E++  GS    +           L+   +  I   I +GL+YLH   
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLH--- 118

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEV 263
           + + +H DIK  N+LL E    K++DFG+A +L++   K+ +F+      GT  ++APEV
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 172

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++      K+D++S G+  +E+  G
Sbjct: 173 IKQS--AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 39/242 (16%)

Query: 94  LGQGGFGSVY----KGKLPDGRLVAVKVLKNSKV-----NGEEFINE--VASMSKTSHVN 142
           LG G +G V+     G    G+L A+KVLK + +       E    E  V    +     
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG-IARGLE 201
           V     F  + K   LI +++  G L   +Y  E    +         ++ +  I   L+
Sbjct: 68  VTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHFTESE-------VRVYIAEIVLALD 119

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYI 259
           +LH+   + I++ DIK  NILL  +    ++DFGL+K  L+E++E   S     GTI Y+
Sbjct: 120 HLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYM 173

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEM--------VVGRKNAEVKVS---LSSEIYFPN 308
           APEV     GG     D +S G++  E+        V G +N++ ++S   L S+  FP 
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233

Query: 309 SI 310
           ++
Sbjct: 234 TM 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 28/206 (13%)

Query: 93  KLGQGGFGSVY--KGKLPDGRLV--AVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           K+G+G FG +Y  K K      V   + + K      E    EV  ++K  H N+V+F  
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL---EWRTMCQIAVGIARGLEYLHR 205
              E  +  ++ E+   G L + I      N  R +   E + +    V I+ GL+++H 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRI------NRQRGVLFSEDQILSWF-VQISLGLKHIH- 118

Query: 206 GCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESFISMLGARGTIG---YIAP 261
             + +I+H DIK  NI L ++    K+ DFG+A+         SM  A   +G   Y++P
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSP 171

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           E+ C+N    ++K+D++S G ++ E+
Sbjct: 172 EI-CQN-RPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLK--------NSKVNGEEFINEVASMSKTSHVNVV 144
           LGQG FG VY     D GR +A K ++        + +V+  E   E+  +    H  +V
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERIV 67

Query: 145 SFLGFCYEKKKRAL--IYEFMPNGSL-DQF-IYDEESSNINRKLEWRTMCQIAVGIARGL 200
            + G   ++ ++ L    E+MP GS+ DQ   Y   + ++ RK   +        I  G+
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--------ILEGM 119

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
            YLH      IVH DIK  NIL       K+ DFG +K L     S   +    GT  ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +PEV      G   K+DV+S G  ++EM+
Sbjct: 177 SPEVISGE--GYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 44/222 (19%)

Query: 87  TNSFSN--KLGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSH 140
           TN + +   +G G FG V   +    G+ VA+K +     + V  +    E+  +    H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 141 VNVVS----FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ----- 191
            N++S    F+           IY          F+ +   ++++R L  R + +     
Sbjct: 69  ENIISLSDIFI------SPLEDIY----------FVTELLGTDLHRLLTSRPLEKQFIQY 112

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
               I RGL+Y+H      +VH D+KP NIL+ E+   KI DFGLA++ + +     M G
Sbjct: 113 FLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTG 164

Query: 252 ARGTIGYIAPEVFC--RNFGGVSHKSDVYSYGMMILEMVVGR 291
              T  Y APE+    + +     + D++S G +  EM+ G+
Sbjct: 165 YVSTRYYRAPEIMLTWQKYD---VEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 57/245 (23%), Positives = 101/245 (41%), Gaps = 75/245 (30%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV--------- 143
           +G+G FG V+  +  D G++ A+KVL+ S         ++   ++ +HV           
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKS---------DMIKRNQIAHVRAERDILADAD 59

Query: 144 ---VSFLGFCYEKKKRA-LIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAV 194
              +  L + ++ ++   L+ E+MP G L      + ++ EE++                
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-----------YIA 108

Query: 195 GIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGA 252
            +   L+ +H+ G     +H DIKP NIL+  D   K++DFGL  K+++ K+     L  
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE-YYLND 163

Query: 253 R---------------------------GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
                                       GT  YIAPEV          + D +S G+++ 
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILY 221

Query: 286 EMVVG 290
           EM+ G
Sbjct: 222 EMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 93  KLGQGGFG-SVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
           K+G+G FG ++      DG+   +K +  SK++    EE   EVA +S   H N+V +  
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLHRG 206
              E     ++ ++   G L + I  +          L+W       V I   L+++H  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH-- 118

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG---YIAPEV 263
            + +I+H DIK  NI L +D   K+ DFG+A++        ++  AR  IG   Y++PE+
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEI 172

Query: 264 FCRNFGGVSHKSDVYSYGMMILEM 287
            C N    ++KSD+++ G ++ EM
Sbjct: 173 -CEN-RPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 60/224 (26%)

Query: 94  LGQGGFGSV----YKGKLPDGRLVAVKVLKNSKVNGEEFI---NEVASM----------S 136
           LG+G FG V    YK     G L A+K LK      +  I   +EV S+          +
Sbjct: 7   LGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEKRIFETAN 57

Query: 137 KTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
              H  +V+    C++ +     + E+   G L   I+ +  S      E R +   A  
Sbjct: 58  SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS------EPRAVFYAAC- 109

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK----LSEKKESFISMLG 251
           +  GL+YLH     +IV+ D+K  N+LL  +   KI+DFGL K      ++  +F     
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---- 162

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKS-----DVYSYGMMILEMVVG 290
             GT  ++APEV       ++  S     D +  G++I EM+VG
Sbjct: 163 --GTPEFLAPEV-------LTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 46/218 (21%)

Query: 94  LGQGGFGSVYKGKLPDG----RLVAVKVLKNSKVNGEEFINEVASMSKTSHV----NVVS 145
           LG+GG+G V++ +   G    ++ A+KVLK + +        V +   T+H     N++ 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI--------VRNQKDTAHTKAERNILE 55

Query: 146 F--------LGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
                    L + ++   K  LI E++  G L  F++ E        +E  T C     I
Sbjct: 56  AVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIF---ME-DTACFYLSEI 109

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS----EKKESFISMLGA 252
           +  LE+LH+     I++ D+KP NILL      K++DFGL K S        +F      
Sbjct: 110 SLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC----- 161

Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GTI Y+APE+  R+  G     D +S G ++ +M+ G
Sbjct: 162 -GTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 47/261 (18%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGE----EFINEVASMSKTSHVNVVSFL 147
            +G+GG G VY    P   R VA+K ++            F+ E    +   H  +V   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 148 GFCYEKKKRALIYEFMP--NG----SLDQFIYDEES--SNINRKLEWRTMCQIAVGIARG 199
             C +      +Y  MP   G    SL + ++ +ES    +  K        I   I   
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR----- 253
           +EY+H +G    ++H D+KP NILLG      I D+G A   + +E  +  +        
Sbjct: 126 IEYVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 254 -----------GTIGYIAPEVFCRNFGG-VSHKSDVYSYGMMILEMVV----GRKNAEVK 297
                      GT  Y+APE   R  G   S  +D+Y+ G+++ +M+      R+    K
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 298 VSLSSEIYFPNSI--YKHIEP 316
           +S    I  P  +  Y+ I P
Sbjct: 239 ISYRDVILSPIEVAPYREIPP 259

Length = 932

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 27/212 (12%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF----INEVASMSKTSHVNVVSF 146
           + +G+G +G V      P G  VA+K  K S    + F    + E+  + +  H N++  
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILRRFKHENIIGI 68

Query: 147 L------GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           L       F        ++ E M    L + I  +  SN +       +      I RGL
Sbjct: 69  LDIIRPPSFE-SFNDVYIVQELMET-DLYKLIKTQHLSNDH-------IQYFLYQILRGL 119

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYI 259
           +Y+H   N+  +H D+KP N+LL  +   KI DFGLA++++ +      L     T  Y 
Sbjct: 120 KYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+   N  G +   D++S G ++ EM+  R
Sbjct: 177 APEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 150 CYEKKKRALIYEFMPNGSLDQF--------IYDEESSNINR--KLEWRTMCQIAVGIARG 199
                       F P  SL++F        +   + +NI +  KL    +  +   I RG
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           L+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  Y 
Sbjct: 133 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 184

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+   N+   +   D++S G ++ E++ GR
Sbjct: 185 APEIML-NWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 80/267 (29%)

Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH-VNVV 144
           LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H +NVV
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 145 SFLGFCYEKK-KRALIYEFMPNGSLDQFI-----------------------YDEESSNI 180
           + LG C +      +I EF   G+L  ++                       Y + S ++
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 181 NRKL---------------EWRTMCQI-----------------------AVGIARGLEY 202
            R+L               E +++  +                       +  +A+G+E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194

Query: 203 L-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           L  R C    +H D+   NILL E+   KI DFGLA+   K   ++    AR  + ++AP
Sbjct: 195 LASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250

Query: 262 E-VFCRNFGGVSHKSDVYSYGMMILEM 287
           E +F R +   + +SDV+S+G+++ E+
Sbjct: 251 ETIFDRVY---TIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 68/269 (25%), Positives = 106/269 (39%), Gaps = 72/269 (26%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVL------KNSKVNGEEFINEVASMSKTSHVNVVS 145
            LG+G  G V+  +L   G+L A+KVL      K +KV       E+  ++   H  + +
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR------- 198
                  +    L+ ++ P G L             R L+ +    ++  +AR       
Sbjct: 66  LYASFQTETYLCLVMDYCPGGEL------------FRLLQRQPGKCLSEEVARFYAAEVL 113

Query: 199 -GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR---- 253
             LEYLH    + IV+ D+KP NILL E     +SDF L+K S+ +   +S    +    
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 254 -----------------------GTIGYIAPEVFCRNFGGVSHKSDV--YSYGMMILEMV 288
                                  GT  YIAPEV      G  H S V  ++ G+++ EM+
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV----ISGDGHGSAVDWWTLGILLYEML 226

Query: 289 VGR-------KNAEVKVSLSSEIYFPNSI 310
            G        ++      L  E+ FP S 
Sbjct: 227 YGTTPFKGSNRDETFSNILKKEVTFPGSP 255

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 11/101 (10%)

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLG 251
           + RGL+Y+H      ++H D+KP N+L+ ED   +I DFG+A+       + + F++   
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           A  T  Y APE+   +    +   D++S G +  EM +GR+
Sbjct: 173 A--TRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEM-LGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 77/334 (23%), Positives = 136/334 (40%), Gaps = 60/334 (17%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G FG V   +  D G + A+K+L+ + +  +E +  + +    + +     VV    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +K+   LI EF+P G +   +  +++ +      +     +A+     L ++HR   
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR--- 125

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKE-------------SFISMLGA 252
                 DIKP N+LL      K+SDFGL    K + + E             SF +M   
Sbjct: 126 ------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 253 R-----------------GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
           R                 GT  YIAPEVF +   G +   D +S G+++ EM++G     
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYP--- 234

Query: 296 VKVSLSSEIYFPNSIYKHIEPGNE---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQ 352
                 SE   P   Y+ +    E   F     ++E+ K++  +     E   GS    +
Sbjct: 235 ---PFCSET--PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEE 289

Query: 353 IPPKPSLSSPRRSAQQSPPASLSTELASLESSSS 386
           I   P          +  PA++  E+ S++ +S+
Sbjct: 290 IKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSN 323

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 83/266 (31%)

Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-------SH 140
           LG G FG V +       K      VAVK+LK      E      A MS+        +H
Sbjct: 15  LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH----KALMSELKILIHIGNH 70

Query: 141 VNVVSFLGFCYEKKKRAL-IYEFMPNGSLDQFI---------YDEES------------- 177
           +NVV+ LG C +     + I EF   G+L  F+         Y E+S             
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 178 SNINRKLE----------------------------WRTMCQI------AVGIARGLEYL 203
           S ++R++E                            W++   +      +  +ARG+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 204 -HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
             R C    +H D+   NILL E+   KI DFGLA+   K   ++    AR  + ++APE
Sbjct: 191 ASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246

Query: 263 -VFCRNFGGVSHKSDVYSYGMMILEM 287
            +F + +   + +SDV+S+G+++ E+
Sbjct: 247 SIFDKVY---TTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 28/228 (12%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG V   +L   GRL AVKVLK   +    + E  + E   +S   +   ++ L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++   R   + EF+  G L   I        +R+ +       A  I   L +LH +G
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQK------SRRFDEARARFYAAEITSALMFLHDKG 116

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  +   K++DFG+ K  E   +  +     GT  YIAPE+   
Sbjct: 117 ----IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS-------LSSEIYFP 307
              G S   D ++ G+++ EM+ G    E +         L+ E+ +P
Sbjct: 171 MLYGPS--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG-----EEFINEVASMSKTSHVNVVSFL 147
           ++G G FG V   ++     VA  V+K  K N       EF+ +        H N++  L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEES--SNINRKLEWRTMCQIAVGIARGLEYLHR 205
           G C E     L++E+   G L  ++  E+    N    L  R  C+IA G+     ++H+
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT----HMHK 117

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEVF 264
                 +H D+   N  L  D   K+ D+G+   S  KE +I     +   + ++APE+ 
Sbjct: 118 ---HNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELV 173

Query: 265 CRNFGGV-----SHKSDVYSYGMMILEM 287
               GG+     +  S+V++ G+ + E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 36/215 (16%)

Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFI---NEVASMSKTSHVNVVSFLGFC 150
                   + K K P   LVAVK +     + E+      E+ +  +  H N++ ++   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNI 209
               +  ++   M  GS +  +     ++    L    +  I   +   L+Y+H  G   
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSKGF-- 122

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML--GARGT------------ 255
             +H  +K  +ILL  D        G   LS  + S +SM+  G R              
Sbjct: 123 --IHRSVKASHILLSGD--------GKVVLSGLRYS-VSMIKHGKRQRVVHDFPKSSVKN 171

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           + +++PEV  +N  G + KSD+YS G+   E+  G
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV---SFLG- 148
           LG+G FG V+  +L    +  A+K LK   V  ++ +    +M +   +++     FL  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVE--CTMVEKRVLSLAWEHPFLTH 60

Query: 149 -FCYEKKKRALIY--EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH- 204
            +C  + K  L +  E++  G L   I      ++ R   +      A  I  GL++LH 
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY------AAEIICGLQFLHS 114

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK---LSEKKESFISMLGARGTIGYIAP 261
           +G    IV+ D+K  NILL  D   KI+DFG+ K   L + K          GT  YIAP
Sbjct: 115 KG----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-----GTPDYIAP 165

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           E+        +   D +S+G+++ EM++G+
Sbjct: 166 EILLGQ--KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 94  LGQGGFGSVYKGKLPD----GRL----VAVKVLKNSKVNGEEFINEVAS-MSKTSHVNVV 144
           LGQG F  ++KG   +    G L    V +KVL  S  N  E   E AS MS+ SH ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYL 203
              G C    +  ++ E++  GSLD ++   ++  NI+ KLE      +A  +A  L +L
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE------VAKQLAWALHFL 116

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI----SMLGARGTIGYI 259
               +  + H ++   N+LL  +   K  +    KLS+   S       +L  R  I ++
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER--IPWV 171

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE    N   +S  +D +S+G  + E+  G
Sbjct: 172 PPECI-ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVSF 146
           K+G+G +G VYK +  D        LK  ++  E+       I E++ + +  H N+V  
Sbjct: 9   KIGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               + +K+  L++E++    LD   + + S +  +    R +      I RG+ Y H  
Sbjct: 67  QDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNP--RLIKTYLYQILRGIAYCH-- 119

Query: 207 CNIRIVHFDIKPHNILLGEDFCP-KISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF 264
            + R++H D+KP N+L+       K++DFGLA+       +F   +    T+ Y APE+ 
Sbjct: 120 -SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV---VTLWYRAPEIL 175

Query: 265 CRNFGGVSHKS---DVYSYGMMILEMV 288
                G  H S   D++S G +  EMV
Sbjct: 176 L----GSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 33/221 (14%)

Query: 110 GRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVVSFL--GFCYEKKKRALIYEFM 163
           G  VA+K+L+      E     F  E A  ++  H N+V+ L  G        A ++E++
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61

Query: 164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL 223
           P  +L + +  + +  +      R M Q+   +A      H      IVH D+KP NI++
Sbjct: 62  PGRTLREVLAADGA--LPAGETGRLMLQVLDALACA----HNQ---GIVHRDLKPQNIMV 112

Query: 224 ---GEDFCPKISDFGL-AKLSEKKESFISMLGAR----GTIGYIAPEVFCRNFGGVSHKS 275
              G     K+ DFG+   L   +++ ++ L       GT  Y APE   R    V+  S
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RG-EPVTPNS 170

Query: 276 DVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP 316
           D+Y++G++ LE + G++   V+ +  +EI      Y+ + P
Sbjct: 171 DLYAWGLIFLECLTGQR--VVQGASVAEIL-----YQQLSP 204

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    G+  A+K+LK   +  ++ +    + S+    T H  + S L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS-LK 61

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + ++ K R   + E++  G L   +  E   + +R   +         I   L+YLH G 
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFY------GAEIVSALDYLHSG- 114

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             +IV+ D+K  N++L +D   KI+DFGL K  E      +M    GT  Y+APEV   N
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
             G     D +  G+++ EM+ GR
Sbjct: 171 DYG--RAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 9/94 (9%)

Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +ARG+E+L  R C    +H D+   NILL E+   KI DFGLA+   K   ++    AR 
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 255 TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            + ++APE +F + +   + +SDV+S+G+++ E+
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.5 bits (140), Expect = 3e-09
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 29/212 (13%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +G V        GR VA+K + N     ++ +  + E+  +    H N++  L  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 150 CYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                        ++ E M    L + I         + L    +      I RGL+YLH
Sbjct: 68  LRPPSPEDFNDVYIVTELMET-DLHKVIKS------PQPLTDDHIQYFLYQILRGLKYLH 120

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG-----YI 259
              N+  +H D+KP NIL+  +   KI DFGLA+  +  E     L    T       Y 
Sbjct: 121 S-ANV--IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL----TEYVVTRWYR 173

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+   +    +   D++S G +  E++  +
Sbjct: 174 APELLL-SSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 31/212 (14%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G+G +G V   K  +    VA+K + N+   +++ +  + E+  +    H NV++    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 150 CYEKKKRA-----LIYEFMPNGSLDQFIYDEES-SNINRKLEWRTMCQIAV-GIARGLEY 202
                + A     ++YE M +  L Q I   ++ S+          CQ  +  + RGL+Y
Sbjct: 73  MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSD--------DHCQYFLYQLLRGLKY 123

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           +H      ++H D+KP N+LL  +   KI DFGLA+ + +K  F  M     T  Y APE
Sbjct: 124 IHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPE 178

Query: 263 VF--CRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           +   C  +       DV+S G +  E+ +GRK
Sbjct: 179 LLLNCSEYTTA---IDVWSVGCIFAEL-LGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 37/241 (15%)

Query: 94  LGQGGFGSVYKGKL----PDGRLVAVKVLKNSKVNGEEFINEVASMSKT--SHVNVVSFL 147
           LG G +G V+  +       G+L A+KVLK + +  +    E     +    H+    FL
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 148 ---GFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG-IARGLEY 202
               + ++   K  LI +++  G L   +   E              QI  G I   LE+
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE-------VQIYSGEIVLALEH 120

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIA 260
           LH+   + I++ DIK  NILL  +    ++DFGL+K    ++ E   S  G   TI Y+A
Sbjct: 121 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG---TIEYMA 174

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM--------VVGRKNAEVKVS---LSSEIYFPNS 309
           P++     GG     D +S G+++ E+        V G KN++ ++S   L SE  +P  
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234

Query: 310 I 310
           +
Sbjct: 235 M 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVN---------GEEFINEVASMSKTSHVNV 143
           +G+G FG VY+ +  D  R+ A+KVL   ++          GE  I     + ++     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP---F 57

Query: 144 VSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +  L F ++      L+ ++M  G L   +  E      R  E R    IA  +   LE+
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIA-ELVLALEH 111

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH+     IV+ D+KP NILL       + DFGL+K +       +     GT  Y+APE
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYLAPE 166

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V     G   H  D +S G+++ EM  G
Sbjct: 167 VLLDEKGYTKH-VDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 8/111 (7%)

Query: 178 SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
           +  +R L       I   I  GL YLH     RI+H D+K  NI + +     I D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA 204

Query: 238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +      +F   LG  GT+   APEV  R+    + K+D++S G+++ EM+
Sbjct: 205 QFPVVAPAF---LGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G +GSV      D RL   VAVK L     S ++      E+  +    H NV+  L
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQ-----IAVGIA 197
                         F P  S++ F     + +   +++N  ++ + +       +   + 
Sbjct: 81  DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   +I DFGLA+ ++ +     M G   T  
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ G+
Sbjct: 181 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 47/218 (21%)

Query: 94  LGQGGFGSV----YKGKLPDGRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVS 145
           LG+G FG V     KG      L AVKVLK   +  ++ +     E   ++       ++
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 146 FLGFCYEKKKRA-LIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
            L  C++ K R   + E++  G L   I     +DE  +              A  I  G
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----------YAAEIVLG 108

Query: 200 LEYLH-RGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLS----EKKESFISMLGAR 253
           L++LH RG    I++ D+K  N+LL  E    KI+DFG+ K          +F       
Sbjct: 109 LQFLHERG----IIYRDLKLDNVLLDSEGHI-KIADFGMCKEGILGGVTTSTFC------ 157

Query: 254 GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           GT  YIAPE+   ++       D ++ G+++ EM+ G+
Sbjct: 158 GTPDYIAPEIL--SYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 44/219 (20%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVS-- 145
           N++G+G +G VY+ +    G +VA+K ++         I+   E+  +    H N+V   
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 146 -----------FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
                      FL   Y ++  A + + MP      F             E +  C + +
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPT----PFS------------ESQVKC-LML 115

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            + RGL+YLH      I+H D+K  N+LL +  C KI+DFGLA+          M     
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVV 170

Query: 255 TIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGR 291
           T+ Y APE+     G  ++ +  D+++ G ++ E++  +
Sbjct: 171 TLWYRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 78/334 (23%), Positives = 139/334 (41%), Gaps = 60/334 (17%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G FG V   +  D G + A+K+L+ + +  +E +  + +    + +   + VV    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +K    LI EF+P G +   +  +++       E  T   IA  +   ++ +H+   
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT-----EEETQFYIAETVL-AIDSIHQ--- 119

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKE-------------SFISMLGA 252
           +  +H DIKP N+LL      K+SDFGL    K + + E             +F +M   
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 253 R-----------------GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
           R                 GT  YIAPEVF +   G +   D +S G+++ EM++G     
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYP--- 234

Query: 296 VKVSLSSEIYFPNSIYKHIEPGNE---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQ 352
                 SE   P   YK +    E   F     ++E+ K++  +     E   G+    +
Sbjct: 235 ---PFCSET--PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289

Query: 353 IPPKPSLSSPRRSAQQSPPASLSTELASLESSSS 386
           I   P          +  PA++  E+ S++ +S+
Sbjct: 290 IKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSN 323

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           + +GL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVT 178

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             Y APEV   N+   +   D++S G ++ EM+ G+
Sbjct: 179 RWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 43/293 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++     + E   +  T H   ++ L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 61

Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + ++   R   + E+   G L   +  E      R   +         I   LEYLH   
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY------GAEIVSALEYLH--- 112

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           +  +V+ DIK  N++L +D   KI+DFGL K      +  +M    GT  Y+APEV   N
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN 170

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIEPGNEF 320
             G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + P  + 
Sbjct: 171 DYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKS 224

Query: 321 QLAGVVTEEEKE------------MAKKMILVLEMLEGSTEDLQIPPKPSLSS 361
            LAG++ ++ K+            M  +  L +   +   + L  P KP ++S
Sbjct: 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 277

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 19/196 (9%)

Query: 98  GFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA 157
           G  S  +GK    RL+A K +K       +  NE+ ++ + +H N++       E+  R+
Sbjct: 181 GVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKI-----EEILRS 234

Query: 158 LIYEFMPNGSLD----QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVH 213
               +M     D     F+YDE     +R L  +T   I   +   +EY+H   + +++H
Sbjct: 235 EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIH 290

Query: 214 FDIKPHNILLGEDFCPKISDFGLAKLSEK-KESFISMLGARGTIGYIAPEVFCRNFGGVS 272
            DIK  NI L  D    + DFG A   EK +E+F    G  GT+   +PE+   +  G  
Sbjct: 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGD--GYC 346

Query: 273 HKSDVYSYGMMILEMV 288
             +D++S G+++L+M+
Sbjct: 347 EITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 26/207 (12%)

Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +GSV        G  VA+K L     S++  +    E+  +    H NV+  L  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 150 CYEKKKRALIYEF---MP--NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                      +F   MP     L + +    S +  + L ++ +C        GL+Y+H
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC--------GLKYIH 134

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                 I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  Y APEV 
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI 186

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
             N+   +   D++S G ++ EM+ G+
Sbjct: 187 L-NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 66/245 (26%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G FG V   +  D G + A+K L+ S++  +E +  V +    +++  +  VV    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68

Query: 149 FCYEKKKRALIYEFMPNGSL-------DQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
              ++    LI E++P G +       D F  +E    I           +A+     L 
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE-------TILAIDSIHKLG 121

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-------------------AKLSEK 242
           Y+HR         DIKP N+LL      K+SDFGL                      +  
Sbjct: 122 YIHR---------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 243 KESFISMLGAR-----------------GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
                 M   R                 GT  YIAPEVF +   G + + D +S G+++ 
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMY 230

Query: 286 EMVVG 290
           EM+VG
Sbjct: 231 EMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 14/197 (7%)

Query: 94  LGQGGFGS--VYKGKLPDGRLVAVKV-LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +G+G FG   + +    D +    ++ L  S    E+   E   ++K  H N+V+F    
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
                  ++ E+   G L Q I  +      +     T+ Q  V +  G++++H     R
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---R 120

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG 270
           ++H DIK  NI L ++   K+ DFG A+L     ++       GT  Y+ PE++  N   
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEIW-ENM-P 176

Query: 271 VSHKSDVYSYGMMILEM 287
            ++KSD++S G ++ E+
Sbjct: 177 YNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 30/255 (11%)

Query: 46  DFGFGRFRK-KNTEN-ENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVY 103
           D  F   RK KN +N  N     +R    L  K  +Y  VK         +G+G FG V 
Sbjct: 9   DLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVK--------VIGRGAFGEVQ 60

Query: 104 KGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL 158
             +    + V A+K+L       + +   F  E   M+  +   VV       + K   +
Sbjct: 61  LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120

Query: 159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP 218
           + E+MP G L   +     SN +   +W       V +A  L+ +H   ++ ++H D+KP
Sbjct: 121 VMEYMPGGDLVNLM-----SNYDVPEKWAKFYTAEVVLA--LDAIH---SMGLIHRDVKP 170

Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSH---KS 275
            N+LL +    K++DFG   +   +   +    A GT  YI+PEV  ++ GG  +   + 
Sbjct: 171 DNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGREC 228

Query: 276 DVYSYGMMILEMVVG 290
           D +S G+ + EM+VG
Sbjct: 229 DWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 33/233 (14%)

Query: 94  LGQGGFGSVY--KGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV------NVVS 145
           LG+G FG V   + K   G+  A+K+LK   +  ++   EVA     S V        ++
Sbjct: 3   LGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKD---EVAHTLTESRVLQNTRHPFLT 58

Query: 146 FLGFCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            L + ++   R   + E+   G L   +  E   + +R   +         I   L YLH
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALGYLH 112

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                 +V+ D+K  N++L +D   KI+DFGL K  E      +M    GT  Y+APEV 
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 167

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAEV--KVSLSSEIYFPNSI 310
             N  G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP ++
Sbjct: 168 EDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 218

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 37/163 (22%)

Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEE-------FINEVASMSKTSHVNVV 144
           K+G+G +G V+K +  + G++VA+K      V  E+        + E+  + +  H N+V
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN-------RKLEWRTMCQIAVGIA 197
           + +     K+K  L++E+      D  + +E   N         +K+ W+T+        
Sbjct: 64  NLIEVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTL-------- 110

Query: 198 RGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL 239
           + + + H+  C    +H D+KP NIL+ +    K+ DFG A++
Sbjct: 111 QAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 38/219 (17%)

Query: 92  NKLGQGGFGSVY--KGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSF 146
           + +G+G FG V   + K   G + A+KV+K S +  +E   F  E   +   S+   +  
Sbjct: 7   SLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 147 LGFCYEKKKRA-LIYEFMPNGSL--------DQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           L + ++ K    L+ E+ P G L        DQF  DE+            M Q    +A
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DED------------MAQFY--LA 109

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG-LAKLSEKKESFISMLGARGTI 256
             +  +H    +  VH DIKP N+L+      K++DFG  A+L+  K     +    GT 
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL--PVGTP 167

Query: 257 GYIAPEVFC--RNFGGVSH--KSDVYSYGMMILEMVVGR 291
            YIAPEV       G  ++  + D +S G++  EM+ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 92  NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSF 146
             LG G FG V   K    G   A+K LK  ++      +    E + + + SH  +V+ 
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +    ++ +   + EF+  G L  F +  ++      +      ++ +      EYLH  
Sbjct: 84  MCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLA----FEYLH-- 135

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
            +  I++ D+KP N+LL      K++DFG AK + ++  +        GT  Y+APEV  
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC------GTPEYLAPEVIQ 188

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
               G     D ++ G+++ E + G
Sbjct: 189 SK--GHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 40/150 (26%), Positives = 79/150 (52%), Gaps = 13/150 (8%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNG--EEFINEVASMSKTSHVNVVSFLG 148
           K+G+G +G+V+K K      +VA+K V  +    G     + E+  + +  H N+V    
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             +  KK  L++E+  +  L ++ +D  + +I+ ++    M Q+     +GL + H    
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQLL----KGLAFCHSH-- 118

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
             ++H D+KP N+L+ ++   K++DFGLA+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 22/204 (10%)

Query: 94  LGQGGFGSVYKGKLPDG-RLVAVKVLKNSK-VNGEEFINEVASMSKTSHVN--VVSFLGF 149
           +G+G FG V + +  D  R+ A+K ++ +  V+  E  + +A  +  + VN   +  L F
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 150 CYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            ++  +K  L+  F+  G L   +  E   +++R   +      A      LE LH+   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA------LENLHK--- 111

Query: 209 IRIVHFDIKPHNILLGEDFCPKIS--DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
             +++ D+KP NILL  D+   I+  DFGL KL+ K +   +     GT  Y+APE+   
Sbjct: 112 FNVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYLAPELLLG 167

Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
           +  G +   D ++ G+++ EM+ G
Sbjct: 168 H--GYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 35/174 (20%)

Query: 92  NKLGQGGFGSVYKGKLPD-GRLVAVKV--LKNSKVNGEEF----INEVASMSKTSHVNVV 144
            ++G+G +G VYK +  D G LVA+K   L N K   E F    I E+  + + +H N+V
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIV 69

Query: 145 SFLGFC--------YEKKKRA--LIYEFMPN---GSLDQFIYDEESSNINRKLEWRTMCQ 191
           +             ++K K A  L++E+M +   G L+  +      +I           
Sbjct: 70  NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI---------KS 120

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
               +  GL Y H       +H DIK  NILL      K++DFGLA+L   +ES
Sbjct: 121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 74/283 (26%)

Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G FG V    K   G++ A+K L  S++  ++ +  V +    ++++    VVS   
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68

Query: 149 FCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
              + +   LI EF+P G L   +  YD  S ++ R   +   C +A+     L ++HR 
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF--YMAECVLAIEAVHKLGFIHR- 125

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLA-------------KLSEKKES-------- 245
                   DIKP NIL+      K+SDFGL+             KL + K +        
Sbjct: 126 --------DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 246 -----FISM----------------LGARGTIG---YIAPEVFCRNFGGVSHKSDVYSYG 281
                 I++                L A  T+G   YIAPE+F +   G   + D +S G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLG 235

Query: 282 MMILEMVVG-----RKNAEVK----VSLSSEIYFPNSIYKHIE 315
            ++ E ++G      +N+       ++    +YFP+ I+  +E
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 34/195 (17%)

Query: 110 GRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG 166
           G+ VA+K L     N    +    E+  M   +H N++  L              F P  
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88

Query: 167 SLDQF--IY---DEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIK 217
           SL++F  +Y   +   +N    I   L+   M  +   +  G+++LH   +  I+H D+K
Sbjct: 89  SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLK 145

Query: 218 PHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG-GVSHKSD 276
           P NI++  D   KI DFGLA+      SF  M     T  Y APEV     G G     D
Sbjct: 146 PSNIVVKSDCTLKILDFGLAR--TAGTSF-MMTPYVVTRYYRAPEVI---LGMGYKENVD 199

Query: 277 VYSYGMMILEMVVGR 291
           ++S G ++ EM+ G 
Sbjct: 200 IWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   +    R V A+K+L       + +   F  E   M+  +   VV    
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              + +   ++ E+MP G L   +     SN +   +W       V +A  L+ +H   +
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWARFYTAEVVLA--LDAIH---S 160

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  +H D+KP N+LL +    K++DFG   +   KE  +    A GT  YI+PEV  ++ 
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVL-KSQ 218

Query: 269 GGVSH---KSDVYSYGMMILEMVVG 290
           GG  +   + D +S G+ + EM+VG
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 23/183 (12%)

Query: 113 VAVKVLKNSKVNGEEFINEVAS-MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF 171
           V +KVL  S  +      E AS MS+ SH+++    G C    +  ++ EF+ +G LD  
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 172 IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL-----LGED 226
           +  E+       + W+    +A  +A  L YL    +  +VH ++   NIL     L E 
Sbjct: 107 LRKEKG---RVPVAWKIT--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158

Query: 227 FCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMI 284
             P  K+SD G++  +  +E  +        I +IAPE        +S  +D +S+G  +
Sbjct: 159 TSPFIKLSDPGVSFTALSREERVE------RIPWIAPECV-PGGNSLSTAADKWSFGTTL 211

Query: 285 LEM 287
           LE+
Sbjct: 212 LEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 94  LGQGGFGSVYK-GKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           +G+G +G V+K     +G   AVK+L       EE   E   +   S H NVV F G  Y
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 152 EKKKRA-----LIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEYLH 204
           +K  +      L+ E    GS    + D     + R  ++E   +  I      GL++LH
Sbjct: 86  KKDVKNGDQLWLVLELCNGGS----VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEV 263
                + +H D+K +NILL  +   K+ DFG+ A+L+  +    + +   GT  ++APEV
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFWMAPEV 195

Query: 264 F-CRNFGGVSH--KSDVYSYGMMILEM 287
             C      ++  + DV+S G+  +E+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVS----FLG 148
           LG+G FG V   +L       A+K LK   V  ++   +V        V  ++    FL 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFLT 59

Query: 149 --FCYEKKKRALIY--EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             FC  + K  L +  E++  G L   I         R  E R     A  I  GL++LH
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-----SGRFDEARARF-YAAEIICGLQFLH 113

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           +     I++ D+K  N+LL +D   KI+DFG+ K +   E   S     GT  YIAPE+ 
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEIL 168

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                  +   D +S+G+++ EM++G+
Sbjct: 169 KGQ--KYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 7/99 (7%)

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSE-KKESFISMLGAR 253
           I  GL+Y+H      ++H D+KP N+L+  D   KI DFGLA+  SE   E+   M    
Sbjct: 114 ILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 254 GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
            T  Y APE+   +F   +   DV+S G  IL  ++GRK
Sbjct: 171 ATRWYRAPEIML-SFQSYTKAIDVWSVG-CILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 49/233 (21%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---------------INEVASM 135
             LG+G +G V K      G++VA+K +K  +++ +                 + E+  M
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
           ++  H N++  +    E     L+ + M    L + +       I R  E +  C I + 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV----DRKI-RLTESQVKC-ILLQ 127

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA---------------KLS 240
           I  GL  LH       +H D+ P NI +      KI+DFGLA               +  
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 241 EKKESFISMLGARGTIGYIAPEVFCRNFGG--VSHKSDVYSYGMMILEMVVGR 291
           +++E   S +    T+ Y APE+     G        D++S G +  E++ G+
Sbjct: 185 QRREEMTSKV---VTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 55/272 (20%)

Query: 54  KKNTENENAEAAFIRNYVSLAPKRYNYS---------------DVKRMTN---SFSNKLG 95
           K +  N+     F  N   L  +  +++               D+ R  N      N +G
Sbjct: 16  KNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIG 75

Query: 96  QGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF---- 149
            G FG VY+    D    VA+K VL++ +    E +     M   +H+N++    +    
Sbjct: 76  NGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYYTE 131

Query: 150 CYEKKKRAL----IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           C++K ++ +    + EF+P        Y +  +  N  L    +   +  + R L Y+H 
Sbjct: 132 CFKKNEKNIFLNVVMEFIPQTVHK---YMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 206 GCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESFISMLGARGTIGYI----- 259
                I H D+KP N+L+  +    K+ DFG AK         ++L  + ++ YI     
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---------NLLAGQRSVSYICSRFY 236

Query: 260 -APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            APE+        +H  D++S G +I EM++G
Sbjct: 237 RAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G +  V   +L    R+ A+KV+K   VN +E I+ V +      + S+   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++ + R   + E++  G L  F    +     RKL        +  I+  L YLH RG
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL-MFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG 116

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  +   K++D+G+ K   +     S     GT  YIAPE+   
Sbjct: 117 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPEILRG 170

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
              G S   D ++ G+++ EM+ GR
Sbjct: 171 EDYGFS--VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 68/267 (25%), Positives = 116/267 (43%), Gaps = 41/267 (15%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSF--LG 148
           K+G+G +G VYK K  DG+      LK  +  G       E+A + +  H NV+S   + 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK---LEWRTMCQIAVGIARGLEYLHR 205
             +  +K  L++++  +  L   I    +S  N+K   L    +  +   I  G+ YLH 
Sbjct: 68  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 206 GCNIRIVHFDIKPHNIL-LGEDFCP-----KISDFGLAKL-SEKKESFISMLGARGTIGY 258
                ++H D+KP NIL +GE   P     KI+D G A+L +   +    +     T  Y
Sbjct: 127 NW---VLHRDLKPANILVMGEG--PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 259 IAPEVFCRNFGGVSHKS---DVYSYGMMILEMVVGR-----KNAEVKVSLSSEIYFPNSI 310
            APE+      G  H +   D+++ G +  E++        +  ++K S         + 
Sbjct: 182 RAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS---------NP 228

Query: 311 YKHIEPGNEFQLAGVVTEEEKEMAKKM 337
           Y H +    F + G   +++ E  KKM
Sbjct: 229 YHHDQLDRIFNVMGFPADKDWEDIKKM 255

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 23/206 (11%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASM-----SKTSHVNVVSFL 147
           +G+G +  V   +L    R+ A+KV+K   VN +E I+ V +      + ++H  +V  L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG-L 61

Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-R 205
             C++ + R   + EF+  G L  F    +     RKL        +  I+  L +LH R
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDL-MFHMQRQ-----RKLPEEHARFYSAEISLALNFLHER 115

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
           G    I++ D+K  N+LL  +   K++D+G+ K   +     S     GT  YIAPE+  
Sbjct: 116 G----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEILR 169

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
               G S   D ++ G+++ EM+ GR
Sbjct: 170 GEDYGFS--VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 25/214 (11%)

Query: 87  TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHV 141
             +F   LG+G FG V   +      L A+K+LK   V  ++ +     E   ++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 142 NVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
             ++ L  C++   R   + E++  G L   +Y  +      K +       A  I+ GL
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVG---KFKEPQAVFYAAEISVGL 114

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR---GTIG 257
            +LHR     I++ D+K  N++L  +   KI+DFG+      KE  +  +  R   GT  
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTFCGTPD 166

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           YIAPE+      G S   D ++YG+++ EM+ G+
Sbjct: 167 YIAPEIIAYQPYGKS--VDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG V   +L   G   AVK LK   V    + E  + E   ++       ++ L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61

Query: 149 FCYEKKKRALIY--EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +C  + K  L +  EF+  G L   I D+   ++ R   +      A  I  GL++LH  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY------AAEIVCGLQFLHSK 115

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N++L  D   KI+DFG+ K +   ++  S     GT  YIAPE+   
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC--GTPDYIAPEI--- 167

Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGR 291
              G+ +    D +S+G+++ EM++G+
Sbjct: 168 -LQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 13/107 (12%)

Query: 181 NRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS 240
           N+ +EW       V IA  L+YLH      I+H D+K  N+ L      K+ D G+A++ 
Sbjct: 102 NQVVEW------FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Query: 241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           E +    S L   GT  Y++PE+F       ++KSDV++ G  + EM
Sbjct: 153 ENQCDMASTL--IGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 42/293 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK---TSHVNVVSFLGF 149
           LG+G FG V   K    GR  A+K+LK   +  ++ +    + ++    S    ++ L +
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 150 CYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
            ++   R   + E+   G L      + ++ E+ +                 I   L+YL
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-----------YGAEIVSALDYL 111

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H   N+  V+ D+K  N++L +D   KI+DFGL K  E  +   +M    GT  Y+APEV
Sbjct: 112 HSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEV 167

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFP-------NS 309
              N  G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP        S
Sbjct: 168 LEDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS 225

Query: 310 IYKHIEPGNEFQLAGVVTEEEKE-MAKKMILVLEMLEGSTEDLQIPPKPSLSS 361
           +   +   +  Q  G   ++ KE M  K    +   +   + L  P KP ++S
Sbjct: 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTS 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 37/104 (35%), Positives = 50/104 (48%), Gaps = 18/104 (17%)

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS-------------EKKESF 246
           LEYLH   N  IVH D+KP N+L+      K++DFGL+K+              EK    
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
                  GT  YIAPEV  R   G     D ++ G+++ E +VG
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 24/159 (15%)

Query: 96  QGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK 154
           +G FG VY G K  + +L AVKV+K + +  +  +++V +      ++   F+   Y   
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 155 KRA----LIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           + A    L+ E++  G +   +     +DEE +    K        I+  +A  L+YLHR
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA---VKY-------IS-EVALALDYLHR 122

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
                I+H D+KP N+L+  +   K++DFGL+K++  +E
Sbjct: 123 H---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 68/262 (25%), Positives = 109/262 (41%), Gaps = 42/262 (16%)

Query: 45  NDFGFGRFRK-KNTENENAEAAFIRNYVSLAPK----RYNYSDVKRMTNSFSNKLGQGGF 99
            D      RK KN +N      F+  Y   A K    R    D   +       +G+G F
Sbjct: 8   YDCDIPALRKNKNIDN------FLSRYEKAAEKITKLRMKAEDFDVI-----KVIGRGAF 56

Query: 100 GSVYKGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLGFCY--- 151
           G V   +    + V A+K+L       + +   F  E   M+   H N    +   Y   
Sbjct: 57  GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---HANSEWIVQLHYAFQ 113

Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
           + K   ++ E+MP G L   +     SN +   +W       V +A  L+ +H   ++  
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLM-----SNYDIPEKWARFYTAEVVLA--LDAIH---SMGF 163

Query: 212 VHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG- 270
           +H D+KP N+LL +    K++DFG   +       +    A GT  YI+PEV  ++ GG 
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVL-KSQGGD 221

Query: 271 --VSHKSDVYSYGMMILEMVVG 290
                + D +S G+ + EM+VG
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 44/223 (19%)

Query: 101 SVYKGKLPDGRLVAVKVLK----NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-- 154
           S+YKG   + + V ++  K      KV  +   NE+ ++ +    N++   GF  +    
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 155 --KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
             + +LI E+   G L + +  E      + L ++T   +A+   +GL  L++       
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYK------- 140

Query: 213 HFDIKPH------NILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
            +  KP+      + L+ E++  KI   GL K LS      ++ +       Y + ++  
Sbjct: 141 -YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM------VYFSYKMLN 193

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR---KNAEVKVSLSSEIY 305
             F   + K D+YS G+++ E+  G+   +N   K     EIY
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIY 231

Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G +  V   +L  + ++ A+KV+K   V+ +E I+ V +      + S    +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++   R  L+ E++  G L  F    +     RKL        A  I   L +LH RG
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL-MFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG 116

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  D   K++D+G+ K         S     GT  YIAPE+   
Sbjct: 117 ----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC--GTPNYIAPEILRG 170

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
              G S   D ++ G+++ EM+ GR
Sbjct: 171 EEYGFS--VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 34/116 (29%), Positives = 64/116 (55%), Gaps = 9/116 (7%)

Query: 174 DEESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKIS 232
           DEE +  +  L+   + + +  +A+G+++L  + C    +H D+   N+LL +    KI 
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKIC 254

Query: 233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEM 287
           DFGLA+      +++    AR  + ++APE     F  V + +SDV+SYG+++ E+
Sbjct: 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 36/192 (18%)

Query: 111 RLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS 167
           R VA+K L     ++ + +    E+  M   +H N++S L              F P  S
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90

Query: 168 LDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP 218
           L++F     + +   +N    I  +L+   M  +   +  G+++LH      I+H D+KP
Sbjct: 91  LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKP 147

Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKS--D 276
            NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV      G+ +K   D
Sbjct: 148 SNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL----GMGYKENVD 200

Query: 277 VYSYGMMILEMV 288
           ++S G ++ EMV
Sbjct: 201 IWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 36/195 (18%)

Query: 111 RLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS 167
           R VA+K L     ++ + +    E+  M   +H N++  L              F P  S
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97

Query: 168 LDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP 218
           L++F     + +   +N    I  +L+   M  +   +  G+++LH      I+H D+KP
Sbjct: 98  LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKP 154

Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKS--D 276
            NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV      G+ +K   D
Sbjct: 155 SNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL----GMGYKENVD 207

Query: 277 VYSYGMMILEMVVGR 291
           ++S G ++ EM+ G 
Sbjct: 208 IWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 53/225 (23%), Positives = 86/225 (38%), Gaps = 59/225 (26%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN-----EVASMSKTSHVNVVSF- 146
           +G G  G VYK +    G ++AVK ++ +  N EE        +V   S      V  + 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 147 --------------LGFCYEK-KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
                         +  C +K  KR  I   +P                        + +
Sbjct: 82  YFITDSDVFICMELMSTCLDKLLKR--IQGPIPE---------------------DILGK 118

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISML 250
           + V I + L YL     +  +H D+KP NILL      K+ DFG++ +L +      S  
Sbjct: 119 MTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVD------SKA 170

Query: 251 GAR--GTIGYIAPEVFCRN--FGGVSHKSDVYSYGMMILEMVVGR 291
             R  G   Y+APE             ++DV+S G+ ++E+  G+
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/129 (27%), Positives = 61/129 (47%), Gaps = 11/129 (8%)

Query: 160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKP 218
           Y+   +  +   + D+ S      L    +      +ARG+E+L  + C    VH D+  
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG----LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAA 265

Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVY 278
            N+LL +    KI DFGLA+      +++S       + ++APE    N    +  SDV+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVW 323

Query: 279 SYGMMILEM 287
           SYG+++ E+
Sbjct: 324 SYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 36/192 (18%)

Query: 113 VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
           VAVK L     ++ + +    E+  +   +H N++S            L+  F P  SL+
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS------------LLNVFTPQKSLE 96

Query: 170 QF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           +F     + +   +N    I+ +L+   M  +   +  G+++LH      I+H D+KP N
Sbjct: 97  EFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 153

Query: 221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVY 278
           I++  D   KI DFGLA+ +         +  R    Y APEV      G+ +K   D++
Sbjct: 154 IVVKSDCTLKILDFGLARTACTNFMMTPYVVTR---YYRAPEVIL----GMGYKENVDIW 206

Query: 279 SYGMMILEMVVG 290
           S G ++ E+V G
Sbjct: 207 SVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 27/170 (15%)

Query: 129 INEVASMSKTSHVNVVSFLG-FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
             E   +   +H +++   G F Y K    LI   +P    D + Y        R +   
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFT-CLI---LPRYKTDLYCYLAA----KRNIAIC 182

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE--DFCPKISDFGLA----KLSE 241
            +  I   + R ++YLH     RI+H DIK  NI +    D C  + DFG A     ++ 
Sbjct: 183 DILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDINA 237

Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            K       G  GTI   APE+  R+  G +   D++S G+++ EM    
Sbjct: 238 NK-----YYGWAGTIATNAPELLARDPYGPA--VDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 19/177 (10%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS-----MSKTSHVNVVSFL 147
           +G+G FG V   K   DG+  AVKVL+   +  ++    + +     +    H  +V  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG-L 61

Query: 148 GFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            + ++   K   + +++  G L   +  E S    R   +      A  IA  L YLH  
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY------AAEIASALGYLH-- 113

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
            ++ I++ D+KP NILL       ++DFGL K   +     S     GT  Y+APEV
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVAS----MSKTSHVNVVSFL 147
           +G+G FG V   K   DG+  AVKVL+   V N +E  + +A     +    H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                 +K   + +F+  G L   +  E S       E R     A  IA  L YLH   
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAA-EIASALGYLH--- 113

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK----LSEKKESFISMLGARGTIGYIAPEV 263
           +I IV+ D+KP NILL       ++DFGL K     S+   +F       GT  Y+APEV
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC------GTPEYLAPEV 167

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +      +  D +  G ++ EM+ G
Sbjct: 168 IRKQ--PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 31/262 (11%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSF--LG 148
           K+G+G +G VYK K  DG+      LK  +  G       E+A + +  H NV++   + 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK---LEWRTMCQIAVGIARGLEYLHR 205
             +  +K  L++++  +  L   I    +S  N+K   L    +  +   I  G+ YLH 
Sbjct: 68  LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 206 GCNIRIVHFDIKPHNIL-LGEDFCP-----KISDFGLAKL-SEKKESFISMLGARGTIGY 258
                ++H D+KP NIL +GE   P     KI+D G A+L +   +    +     T  Y
Sbjct: 127 NW---VLHRDLKPANILVMGEG--PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 259 IAPEVFCRNFGGVSHKS---DVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE 315
            APE+      G  H +   D+++ G +  E++     +E       E    ++ + H +
Sbjct: 182 RAPELLL----GARHYTKAIDIWAIGCIFAELL----TSEPIFHCRQEDIKTSNPFHHDQ 233

Query: 316 PGNEFQLAGVVTEEEKEMAKKM 337
               F + G   +++ E  +KM
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKM 255

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 15/103 (14%)

Query: 193 AVGIARGLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           A  IA GL +LH +G    I++ D+K  N++L  +   KI+DFG+      KE+      
Sbjct: 107 AAEIAIGLFFLHSKG----IIYRDLKLDNVMLDAEGHIKIADFGMC-----KENIFGGKT 157

Query: 252 AR---GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            R   GT  YIAPE+      G S   D +++G+++ EM+ G+
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 34/133 (25%), Positives = 53/133 (39%), Gaps = 46/133 (34%)

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL----------------------- 236
           +E +H    +  +H DIKP NIL+  D   K++DFGL                       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 237 -------AKLSEKKESFISMLGAR-----------GTIGYIAPEVFCRNFGGVSHKSDVY 278
                  +++   +   +     R           GT  YIAPEV  R   G +   D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWW 228

Query: 279 SYGMMILEMVVGR 291
           S G+++ EM+VG+
Sbjct: 229 SVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 4/95 (4%)

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS-EKKESFISMLGARGTI 256
           R L+Y+H      + H D+KP NIL   D   KI DFGLA+++     + I       T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            Y APE+    F   +   D++S G +  E++ G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+      +++    AR 
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 255 TIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEM 287
            + ++APE     F  V + +SDV+SYG+++ E+
Sbjct: 279 PVKWMAPESI---FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 25/106 (23%)

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG--- 254
           + L+Y+H G    ++H D+KP NILL  D   K++DFGLA+      S   +        
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPV 168

Query: 255 ------TIGYIAPEVF--CRNFG-GVSHKSDVYSYGMMILEMVVGR 291
                 T  Y APE+      +  GV    D++S G ++ EM++G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 33/219 (15%)

Query: 83  VKRMTNSFSNKLGQGGFGSVY---KGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS 139
           V RM  +  + L  G  G V+   K      + V VK +   K  G E I+ + ++S  +
Sbjct: 89  VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGRE-IDILKTISHRA 147

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
            +N++      +  + ++ +   MP    D F Y + S  +  +        I   +   
Sbjct: 148 IINLI------HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE----QAITIQRRLLEA 197

Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIG 257
           L YLH RG    I+H D+K  NI L E     + DFG A KL    ++     G  GT+ 
Sbjct: 198 LAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLE 252

Query: 258 YIAPEV-----FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             +PE+     +C        K+D++S G+++ EM V  
Sbjct: 253 TNSPELLALDPYCA-------KTDIWSAGLVLFEMSVKN 284

Length = 392

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 42/215 (19%)

Query: 94  LGQGGFGSVYKGKLPDGR-LVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVS---- 145
           +G+G +G V K +  + + +VA+K  K+S+ N    E  + E+  +      N+V     
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 146 -------FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
                  +L F Y +K    + E MPNG       ++  S I +             + +
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----EKVRSYIYQ-------------LIK 111

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIG 257
            + + H+     IVH DIKP N+L+  +   K+ DFG A+ LSE   +  +   A  T  
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRW 166

Query: 258 YIAPEVFCRNFGGVSHKS-DVYSYGMMILEMVVGR 291
           Y +PE+     G    K+ D++S G ++ E+  G+
Sbjct: 167 YRSPELL---LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 14/100 (14%)

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKISDFGLAKLSEKKES---FISMLGAR 253
           RGL+Y+H      ++H D+KP N+ +  ED   KI DFGLA++ +   S   ++S     
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE--GL 179

Query: 254 GTIGYIAPEVFC--RNFGGVSHKSDVYSYGMMILEMVVGR 291
            T  Y +P +     N+   +   D+++ G +  EM+ G+
Sbjct: 180 VTKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +A G+E+L  + C    VH D+   N+L+ E    KI DFGLA+   +  ++IS      
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            + ++APE    N    +  SDV+S+G+++ E+
Sbjct: 304 PLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 46/220 (20%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF----INEVASMSKTSHVNVV-- 144
           N++ +G +G VY+ +    G +VA+K LK  K   E F    + E+  + K  H N+V  
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVTV 69

Query: 145 ------SFLGFCYEKKKRALIYEFMPN---GSLDQFIYDEESSNINRKLEWRT-MCQIAV 194
                 S L   Y      ++ E++ +     ++        S      E +  M Q+  
Sbjct: 70  KEVVVGSNLDKIY------MVMEYVEHDLKSLMETMKQPFLQS------EVKCLMLQLLS 117

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGAR 253
           G+A    +LH      I+H D+K  N+LL      KI DFGLA +     + +  ++   
Sbjct: 118 GVA----HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV--- 167

Query: 254 GTIGYIAPEVFCRNFGG--VSHKSDVYSYGMMILEMVVGR 291
            T+ Y APE+     G    S   D++S G +  E++  +
Sbjct: 168 VTLWYRAPELL---LGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 42/249 (16%)

Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDG------RLVAVKVLKNSKVNGEEF 128
           P +Y+  + +        K+G G FG V+  K          + ++ + LK  + +  + 
Sbjct: 2   PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS--QL 59

Query: 129 INEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEFMPNGSLDQFIYDEESSNINRKLEW 186
           + EV  M +  H N+V ++     K  +K  ++ EF   G L + I  ++   +  K+E 
Sbjct: 60  VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFGKIEE 117

Query: 187 RTMCQIAVGIARGLEYLHR---GCN-IRIVHFDIKPHNILLGEDF--------------- 227
             +  I   +   L Y H    G N  R++H D+KP NI L                   
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 228 --CPKISDFGLAK---LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGM 282
               KI DFGL+K   +     S +      GT  Y +PE+          KSD+++ G 
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCV------GTPYYWSPELLLHETKSYDDKSDMWALGC 231

Query: 283 MILEMVVGR 291
           +I E+  G+
Sbjct: 232 IIYELCSGK 240

Length = 1021

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 33/185 (17%)

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           +H    +  VH DIKP N+LL  +   +++DFG + L   ++  +    A GT  YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 263 VFCR---NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE 319
           +        G    + D +S G+ + EM+ G    E      S +     I  H E    
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG----ETPFYAESLVETYGKIMNHEE---R 226

Query: 320 FQLA---GVVTEEEKEMAKKMILVLE---------------MLEG----STEDLQIPPKP 357
           FQ       V+EE K++ +++I   E                 EG    +  +L+ P  P
Sbjct: 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIP 286

Query: 358 SLSSP 362
            +SSP
Sbjct: 287 DVSSP 291

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 21/204 (10%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS-----MSKTSHVNVVSFL 147
           +G+G FG V   +   + +  AVKVL+   +  ++    + S     +    H  +V  L
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-L 61

Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            F ++   +   + +++  G L   +  E        LE R     A  IA  L YLH  
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCF-----LEPRARF-YAAEIASALGYLH-- 113

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            ++ IV+ D+KP NILL       ++DFGL K + +     S     GT  Y+APEV  +
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC--GTPEYLAPEVLHK 170

Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
                    D +  G ++ EM+ G
Sbjct: 171 Q--PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 38/220 (17%)

Query: 93  KLGQG--GFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---INEVASMSKTSHVNVVSF 146
           ++G+G     SVY  +  P G LV V++        E      NEV       H N+++ 
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR- 205
                      +I  FM  GS +  +       ++  L    +  I  G  RGL YLH+ 
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEAL----IGNILFGALRGLNYLHQN 120

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML--GARGTIGY----- 258
           G     +H +IK  +IL+  D        GL  LS     + S++  G +  + Y     
Sbjct: 121 GY----IHRNIKASHILISGD--------GLVSLSGLSHLY-SLVRNGQKAKVVYDFPQF 167

Query: 259 -------IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                  ++PE+  ++  G + KSD+YS G+   E+  GR
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 14/105 (13%)

Query: 191 QIAVGIARGL----EYLHRGCNIRIVHFDIKPHNILLG--EDFCPKISDFGLAKLSEKKE 244
           Q+   +AR L    +Y+H      I+H DIK  N+L+   ED C  + DFG A  +    
Sbjct: 261 QVT-AVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSW 314

Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           S     G  GT+   APEV   +    +   D++S G++I E  V
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAV 357

Length = 461

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 89  SFSNKLGQGGFGSVY----KGKLPDGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSH 140
           +F   LG+G FG V     KG      L A+K+LK   V  ++ +     E   ++ +  
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 141 VNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
              ++ L  C++   R   + E++  G L   I       + R  E   +   A  IA G
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVF-YAAEIAIG 113

Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           L +LH +G    I++ D+K  N++L  +   KI+DFG+ K  E     ++     GT  Y
Sbjct: 114 LFFLHSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           IAPE+      G S   D +++G+++ EM+ G+
Sbjct: 168 IAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 19/203 (9%)

Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS-----MSKTSHVNVVSFL 147
           +G+G FG V   K   DG   AVKVL+   +  ++  N + +     +    H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                 +K   + +++  G L   +  E        LE R     A  +A  + YLH   
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRER-----CFLEPRARF-YAAEVASAIGYLH--- 113

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ I++ D+KP NILL       ++DFGL K   + E   S     GT  Y+APEV  + 
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTPEYLAPEVLRKE 171

Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
                   D +  G ++ EM+ G
Sbjct: 172 --PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 29/216 (13%)

Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVVSFLG 148
           LG G  G+V    ++ DG   AVKV+    ++  +  N    EV  +      ++V    
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD-KNRAQAEVCCLLNCDFFSIVK--- 95

Query: 149 FCYE----KKKR--------ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
            C+E    K  R        AL+ ++   G L Q I  +  +  NR         + + +
Sbjct: 96  -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI--KSRAKTNRTFREHEAGLLFIQV 152

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              + ++H   +  ++H DIK  NILL  +   K+ DFG +K+     S        GT 
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
            Y+APE++ R     S K+D++S G+++ E++  ++
Sbjct: 210 YYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNGEEFIN----EVASMSKTSHVNVVSFLG 148
           LG+G FG V   +L     V A+KVLK   +  ++ ++    E   ++  +    ++ L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
            C++ K R   + E++  G L   ++  + S   RK +       A  +   L +LHR  
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDL---MFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH- 115

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              +++ D+K  NILL  +   K++DFG+ K         +     GT  YIAPE+    
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDYIAPEILQEL 171

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
             G S   D ++ G+++ EM+ G+
Sbjct: 172 EYGPS--VDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 19/191 (9%)

Query: 104 KGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM 163
           +G  P  ++VA  V+ N +       +E+  ++   H  +V          K  LI E+ 
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147

Query: 164 PNGSLDQFIYDEESSNINRKLEWRTMCQ-IAVG-----IARGLEYLHRGCNIRIVHFDIK 217
             G L++         I ++L+     Q   VG     I   L+ +H      ++H D+K
Sbjct: 148 SGGDLNK--------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLK 196

Query: 218 PHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDV 277
             NI L      K+ DFG +K      S        GT  Y+APE++ R     S K+D+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADM 254

Query: 278 YSYGMMILEMV 288
           +S G+++ E++
Sbjct: 255 WSLGVILYELL 265

Length = 478

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 47/176 (26%), Positives = 68/176 (38%), Gaps = 28/176 (15%)

Query: 93  KLGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           KL  G FG  SV K K P  +L   K++K    N  E +  V  + K  + N +      
Sbjct: 23  KLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNAIEPM--VHQLMK-DNPNFIKLYYSV 78

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
              K   LI +++ +G L   +          KL    + +I   +   L  LH      
Sbjct: 79  TTLKGHVLIMDYIKDGDLFDLL------KKEGKLSEAEVKKIIRQLVEALNDLH---KHN 129

Query: 211 IVHFDIKPHNILLGEDFCPK----ISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           I+H DIK  N+L       K    + D+GL K      S        GT+ Y +PE
Sbjct: 130 IIHNDIKLENVLY---DRAKDRIYLCDYGLCK-IIGTPSCY-----DGTLDYFSPE 176

Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 21/144 (14%)

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           +H+   +  VH DIKP N+LL ++   +++DFG + L    +  +    A GT  YI+PE
Sbjct: 118 VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 263 VFCRNFGGVSH---KSDVYSYGMMILEMVVGRKN--AEVKVSLSSEIYFPNSIYKHIEPG 317
           +      G      + D +S G+ + EM+ G     AE  V    E Y    I  H    
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETY--GKIMNH---K 224

Query: 318 NEFQLAGVVT---EEEKEMAKKMI 338
             FQ    VT   EE K++ +++I
Sbjct: 225 EHFQFPPDVTDVSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 43/205 (20%)

Query: 108 PDGRLVAVKVLKNSKVNGEEFINEVASMSKT--------SHVNVVSFLGFCYEKKKRALI 159
           P G  V V+     ++N E   NE+ +  +         +H N+V +        +  ++
Sbjct: 23  PTGEYVTVR-----RINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77

Query: 160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPH 219
             FM  GS    I       ++       +  I  G+ + L+Y+H   ++  VH  +K  
Sbjct: 78  TSFMAYGSAKDLICTHFMDGMSE----LAIAYILQGVLKALDYIH---HMGYVHRSVKAS 130

Query: 220 NILLGEDFCPKISDFGLAKLSEKKESFISML--GARG------------TIGYIAPEVFC 265
           +IL+  D   K+   GL        S +SM+  G R              + +++PEV  
Sbjct: 131 HILISVD--GKVYLSGL-------RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           +N  G   KSD+YS G+   E+  G
Sbjct: 182 QNLQGYDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 25/172 (14%)

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           IA+     L Y+HR         DIKP NIL+  +   +++DFG + L   ++  +    
Sbjct: 113 IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV 162

Query: 252 ARGTIGYIAPEVFCR---NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN 308
           A GT  YI+PE+        G    + D +S G+ + EM+ G    E      S +    
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG----ETPFYAESLVETYG 218

Query: 309 SIYKHIEPGNEFQLAGVVT---EEEKEMAKKMILVLEMLEGST--EDLQIPP 355
            I  H E    FQ    VT   E+ K++ +++I   E   G    ED +  P
Sbjct: 219 KIMNHKE---RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 46/220 (20%)

Query: 94  LGQGGFGSVYKGKLPDGR-------------LVAVKVLKNSKVNGEEFINEVASMSK-TS 139
           LG+G    +Y G L                  V +KVL  S  +      E ASM +  S
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE-----WRTMCQIAV 194
           H ++V   G C    +  ++ EF+  G LD F++        RK +     W+   ++A 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--------RKSDVLTTPWKF--KVAK 112

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGED-----FCP--KISDFGLAKLSEKKESFI 247
            +A  L YL    +  +VH ++   NILL  +       P  K+SD G+      ++  +
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV 169

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
                   I +IAPE    +   +S  +D +S+G  + E+
Sbjct: 170 E------RIPWIAPEC-VEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 9e-04
 Identities = 41/129 (31%), Positives = 58/129 (44%), Gaps = 12/129 (9%)

Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSV-----YKGKLPDGRL-VAVKVLK 119
           NYV + P +  Y    +  R   SF   LG G FG V     Y     D  + VAVK+LK
Sbjct: 15  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK 74

Query: 120 NSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 75  PSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKR 134

Query: 177 SSNINRKLE 185
            S I  K E
Sbjct: 135 DSFICPKHE 143

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 59/248 (23%), Positives = 99/248 (39%), Gaps = 61/248 (24%)

Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           LG G FG V    K+    L A+K L+   V     +  V +    +++  +  VV    
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +K     + +++P G +   +   E       L    + ++ + I    E +H+   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAI----ESVHK--- 119

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGL---------AKLSEK-----KESF-------- 246
           +  +H DIKP NIL+  D   K++DFGL         +K  +K     ++S         
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 247 ---------ISMLGARGT-----------IG---YIAPEVFCRNFGGVSHKSDVYSYGMM 283
                    +  L  R T           +G   YIAPEV  R   G +   D +S G++
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVI 237

Query: 284 ILEMVVGR 291
           + EM+VG+
Sbjct: 238 LFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	386
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
KOG1243	690	consensus Protein kinase [General function predict	99.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.06
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.9
PRK09902	216	hypothetical protein; Provisional	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.77
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.65
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.63
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.45
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.4
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
PRK10593	297	hypothetical protein; Provisional	98.29
PLN02876	822	acyl-CoA dehydrogenase	98.27
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.22
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.09
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.05
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.03
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.96
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.9
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.88
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.86
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
PRK05231	319	homoserine kinase; Provisional	97.65
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.64
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.56
KOG2270	520	consensus Serine/threonine protein kinase involved	97.53
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.51
PLN02236	344	choline kinase	97.37
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.24
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.23
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
PLN02756	418	S-methyl-5-thioribose kinase	97.11
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.06
COG2334	331	Putative homoserine kinase type II (protein kinase	96.95
PRK11768	325	serine/threonine protein kinase; Provisional	96.94
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.86
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.8
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.6
PTZ00384	383	choline kinase; Provisional	96.57
PRK06148	1013	hypothetical protein; Provisional	96.43
PRK12396	409	5-methylribose kinase; Reviewed	96.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.33
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	96.27
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.89
PTZ00296	442	choline kinase; Provisional	95.82
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.36

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-51  Score=381.65  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=224.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecC----CCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .++..++.||+|+|..||.++. .+|+.||+|++.+    .....+.+.+|+++.++|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3445567899999999999987 8899999999987    4556678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      |+|++++|..+++..      ..+++.+++.++.||+.||.|||+.   +|+|||||..|+|++++.++||+|||||..+
T Consensus        98 ELC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence            999999999999643      6799999999999999999999999   9999999999999999999999999999988


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ..+..  +..+.+||+.|+|||++...  ..+..+||||+||+||-||+|++||+....        .+.+.+|+... +
T Consensus       169 e~~~E--rk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~-Y  235 (592)
T KOG0575|consen  169 EYDGE--RKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNE-Y  235 (592)
T ss_pred             cCccc--ccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcC-c
Confidence            75532  23467899999999999864  789999999999999999999999998744        67778887665 8


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+|..+|.++++||.+||.-+|.-|++++++..++--
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            8889999999999999999999999999999888753

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=370.06  Aligned_cols=234  Identities=45%  Similarity=0.810  Sum_probs=200.3

Q ss_pred             CCccccHHHHHHHHhhhh--hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           74 APKRYNYSDVKRMTNSFS--NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      ....|++.++..+|++|.  +.||+|+||.||+|.+.+|+.||||++...... .++|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            567899999999999998  699999999999999999999999988876554 66799999999999999999999999


Q ss_pred             EecC-ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCce
Q 038768          151 YEKK-KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP  229 (386)
Q Consensus       151 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  229 (386)
                      .+.+ ..+|||||+++|+|.++|+.....    .++|..+++|+.++|+||+|||..+.+.|||||||++|||+|+++++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999 499999999999999999876422    78999999999999999999999988899999999999999999999


Q ss_pred             EEeeccCCcccCc-ccceeeeccc-cCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccch
Q 038768          230 KISDFGLAKLSEK-KESFISMLGA-RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP  307 (386)
Q Consensus       230 kl~Dfgl~~~~~~-~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  307 (386)
                      ||+|||+++.... .....   .. .||.+|+|||++..  +..+.|+|||||||+|+||+||+.|.+.... ..+..+.
T Consensus       217 KlsDFGLa~~~~~~~~~~~---~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~  290 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVS---TTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLV  290 (361)
T ss_pred             EccCccCcccCCcccccee---eecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHH
Confidence            9999999976654 32211   12 69999999999865  5799999999999999999999998886531 2222244


Q ss_pred             hhhhhhcCCC
Q 038768          308 NSIYKHIEPG  317 (386)
Q Consensus       308 ~~~~~~i~~~  317 (386)
                      .+.+..+.++
T Consensus       291 ~w~~~~~~~~  300 (361)
T KOG1187|consen  291 EWAKPLLEEG  300 (361)
T ss_pred             HHHHHHHHCc
Confidence            4444454444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-52  Score=367.07  Aligned_cols=249  Identities=28%  Similarity=0.361  Sum_probs=212.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      +-+.+.||+|+||.|-+|.. ++|+.||||++++...        ......+|+++|++|+|||||++++++...+..|+
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym  253 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM  253 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence            34468999999999999974 5799999999986322        12345799999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CceEEeecc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKISDFG  235 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg  235 (386)
                      ||||++||+|.+.+-.+      ..+.+.....++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||
T Consensus       254 VlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  254 VLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             EEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999654      5677888899999999999999999   99999999999999766   679999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCC-CCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG-VSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      +|+......   .+.+.+||+.|.|||++.+.... +..++|+||+||+||-+++|.+||....       -+..+.++|
T Consensus       325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~-------~~~sl~eQI  394 (475)
T KOG0615|consen  325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY-------TDPSLKEQI  394 (475)
T ss_pred             hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc-------CCccHHHHH
Confidence            999887433   25578899999999999765323 3458999999999999999999998652       234567888


Q ss_pred             CCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 EPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 ~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+|+   .+..+..+|++..+||.+||.|+|.-|+++.++..||
T Consensus       395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            8888   3345778999999999999999999999999877766

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=356.13  Aligned_cols=257  Identities=26%  Similarity=0.360  Sum_probs=223.2

Q ss_pred             ccHHHHHHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecC--CCCChHHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           78 YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        78 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      .+.+|++.     .+.||+|+.|+||++.++ +++.+|+|++..  ++...+++.+|+++++..+||+||.++|.|....
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            44555543     378999999999999874 688999999953  3344578999999999999999999999999999


Q ss_pred             c-eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          155 K-RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       155 ~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                      . .+++||||++|+|+.++...      +.+++..+-.++.+|++||.|||+.  .+||||||||+|||++..|.+||||
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecc
Confidence            5 99999999999999999653      5689999999999999999999973  2999999999999999999999999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ||.+..+-..    ...+.+||..|||||.+.+.  .|+.++||||||+.++|+.+|+.|+...   ......+-++...
T Consensus       223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~  293 (364)
T KOG0581|consen  223 FGVSGILVNS----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCA  293 (364)
T ss_pred             ccccHHhhhh----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHH
Confidence            9999866554    23467899999999999875  7999999999999999999999999865   2223345667788


Q ss_pred             cCCCcccccccc-CChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 IEPGNEFQLAGV-VTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 i~~~~~~~~~~~-~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      |..+..+.++.. +|+++++++..||..++..|+++.++..||-
T Consensus       294 Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf  337 (364)
T KOG0581|consen  294 IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF  337 (364)
T ss_pred             HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence            888888999887 9999999999999999999999999988874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-50  Score=356.35  Aligned_cols=229  Identities=28%  Similarity=0.458  Sum_probs=195.4

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.++||+|+||+||+|+++ ++..||||.+.+....   .+.+..|+.+|+.++|||||.+++++.+++..|||||||.+
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            3467999999999999864 5799999999865433   35678999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC------CceEEeeccCCcc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED------FCPKISDFGLAKL  239 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgl~~~  239 (386)
                      |+|.+|++..      +.+++..++.++.|+|.||++||++   +||||||||.||||+.+      -.+||+|||+|+.
T Consensus        94 GDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   94 GDLSDYIRRR------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999765      4799999999999999999999999   99999999999999764      4689999999998


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      +.....   ..+.+|++-|||||++..  .+|+.|+|+||+|+|+|++++|+.||+....        .+++..++++.+
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~--------~eL~~~~~k~~~  231 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETP--------KELLLYIKKGNE  231 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCH--------HHHHHHHhcccc
Confidence            875543   345789999999999965  4899999999999999999999999997643        556666666653


Q ss_pred             --ccccccCChHHHHHHHHHHHH
Q 038768          320 --FQLAGVVTEEEKEMAKKMILV  340 (386)
Q Consensus       320 --~~~~~~~s~~~~~li~~ml~v  340 (386)
                        +.++..++.+..+++...+..
T Consensus       232 ~~~~~~~~~s~~~~~Ll~~ll~~  254 (429)
T KOG0595|consen  232 IVPVLPAELSNPLRELLISLLQR  254 (429)
T ss_pred             ccCchhhhccCchhhhhhHHHhc
Confidence              344666777777777777664

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=354.40  Aligned_cols=246  Identities=27%  Similarity=0.402  Sum_probs=217.2

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||+||.++. ++++.+|+|++++...    ..+...+|..+|.+++||.||+++-.|++.+.+|+|+||+.
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence            347899999999999974 5689999999987432    34568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ||.|..+|.+.      ..+++..++.++.+|+.||.|||++   +||||||||+|||+|++|.++|+|||+++..-...
T Consensus       109 GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  109 GGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             CccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999654      5789999999999999999999999   99999999999999999999999999998554432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .  ...+.+||+.|||||++.+.  .|+..+|+||||+++|||++|.+||...+.        ..+.++|..++.+..+.
T Consensus       180 ~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  180 D--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGKLPLPPG  247 (357)
T ss_pred             C--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCcCCCCCc
Confidence            2  12357899999999999876  899999999999999999999999998744        66778888888777788


Q ss_pred             cCChHHHHHHHHHHHHHHHhc----CCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLE----GSTEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~----~~~~~~~~~p~  356 (386)
                      .+|.+.++++.++|..++..|    ..+.+++.||.
T Consensus       248 ~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf  283 (357)
T KOG0598|consen  248 YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF  283 (357)
T ss_pred             cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence            899999999999999999888    56777888874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-51  Score=346.53  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=212.4

Q ss_pred             hhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEE-EEecCc-eeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGF-CYEKKK-RALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~-~~lv~e~  162 (386)
                      .+.++||+|.||+||++. ..+|..||.|.++-...+   .+++..|+.+|++|+|||||+++++ +.++.. .++||||
T Consensus        22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~  101 (375)
T KOG0591|consen   22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL  101 (375)
T ss_pred             HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence            345789999999999996 568999999998854433   4678999999999999999999994 444444 7899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN-IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |.+|+|...++.-+.  ....+++..+|.++.|++.||..+|++.. ..|.||||||.||+++.+|.+||+|||+++.+.
T Consensus       102 c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  102 CDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999976543  34679999999999999999999999421 139999999999999999999999999999988


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ....+.  ...+|||.||+||.+.+.  .|+.+|||||+||++|||+.-+.||.+.+-        .++.++|..+..+.
T Consensus       180 s~~tfA--~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI~qgd~~~  247 (375)
T KOG0591|consen  180 SKTTFA--HSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKIEQGDYPP  247 (375)
T ss_pred             chhHHH--HhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHHHcCCCCC
Confidence            766543  356899999999999775  899999999999999999999999998732        56788999998777


Q ss_pred             cc-ccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          322 LA-GVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       322 ~~-~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ++ ..+|.++.+++..|+.|++..||++
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            77 8899999999999999999999864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-48  Score=328.45  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=219.9

Q ss_pred             ccccHHHHHHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           76 KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      ..+++.|.+.     .+.||.|+||.|.+++.+ +|..+|+|++++...    ..+...+|..+|+.+.||+++++++.|
T Consensus        39 ~~~~l~dfe~-----~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   39 NPYSLQDFER-----LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             CCcchhhhhh-----eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            3377777653     478999999999999864 688999999987543    235678899999999999999999999


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      .+.+..|+||||.+||-|.+++++.      +.+++..++.++.||+.||+|||+.   +|++|||||+|||+|.+|.+|
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEE
Confidence            9999999999999999999999764      5799999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      |+|||+|+.....     ..+.+||+.|+|||.+..+  .+..++|.|||||++|||+.|.+||.....        ..+
T Consensus       185 itDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~i  249 (355)
T KOG0616|consen  185 ITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQI  249 (355)
T ss_pred             EEeccceEEecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHH
Confidence            9999999977655     3467899999999999765  789999999999999999999999987643        678


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhc-CC----CCCCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLE-GS----TEDLQIPP  355 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~-~~----~~~~~~~p  355 (386)
                      +++|.+++ ..+|..++.++++|++++|+|+...| +.    .+++..||
T Consensus       250 Y~KI~~~~-v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~  298 (355)
T KOG0616|consen  250 YEKILEGK-VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHP  298 (355)
T ss_pred             HHHHHhCc-ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCc
Confidence            89999987 88999999999999999999999988 33    44555555

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=356.46  Aligned_cols=251  Identities=29%  Similarity=0.459  Sum_probs=220.8

Q ss_pred             HHHHHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           80 YSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        80 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      ..++.+....+.++||+|.||.|+.|.+++...||+|.++......++|.+|+++|++|+|+|||+++|+|..++..|||
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            34566666778899999999999999997777999999998888889999999999999999999999999998999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      ||||+.|+|.++|....    ...+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||||+.
T Consensus       280 tE~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             EEecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence            99999999999998732    35688899999999999999999999   999999999999999999999999999995


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ..++ .+....+..-+..|.|||.+..  +.++.|||||||||+||||+| |+.|+.....        .++.+.+.+|.
T Consensus       353 ~~d~-~Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~Gy  421 (468)
T KOG0197|consen  353 IGDD-EYTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGY  421 (468)
T ss_pred             cCCC-ceeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccC
Confidence            5444 3344445666789999999965  489999999999999999999 8888886533        66889999999


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ...-|..++++.=++...|=.-.+.-||+-
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF  451 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTF  451 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCH
Confidence            888899999999999998887777666653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=353.24  Aligned_cols=242  Identities=32%  Similarity=0.496  Sum_probs=199.9

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecC-ceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKK-KRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~  165 (386)
                      +.+.||+|+||+||+|.+.+...||||++......   .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            44669999999999999954444999999865433   458999999999999999999999999888 79999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeEeCCCC-ceEEeeccCCcccCcc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR-IVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKK  243 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~  243 (386)
                      |+|..+++..    ....+++..++.++.|||+||.|||+.   + ||||||||+|||++.++ ++||+|||+++.....
T Consensus       125 GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  125 GSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999774    136799999999999999999999998   7 99999999999999997 9999999999876643


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .  .......||..|||||++.+....++.|+||||||+++|||+||+.||+.....       .........+..+.++
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~Rp~~p  268 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLRPPIP  268 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCCC
Confidence            2  123346799999999999742237999999999999999999999999976431       2223334455566777


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ..+.+.+.+++.+|-..++..||+
T Consensus       269 ~~~~~~l~~l~~~CW~~dp~~RP~  292 (362)
T KOG0192|consen  269 KECPPHLSSLMERCWLVDPSRRPS  292 (362)
T ss_pred             ccCCHHHHHHHHHhCCCCCCcCCC
Confidence            778889999988876655555543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=351.26  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=216.1

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .|++.||.|+|++|++|+. ..++.+|||++.+.-.-    .+-+..|-+.|.+| .||.|++|+-.|.|...+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            5789999999999999975 56899999999764322    23466788889999 799999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++++.      +.+++...+.++.||+.||+|||+.   |||||||||+|||+|.|+++||+|||.|+.+..
T Consensus       156 A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  156 APNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999765      5799999999999999999999998   999999999999999999999999999998754


Q ss_pred             ccce---------ee--eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhh
Q 038768          243 KESF---------IS--MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       243 ~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      ....         ..  ....+||..|.+||++.+.  ..+..+|+|+||||+|.|+.|++||.+.+.        ..++
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yliF  296 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLIF  296 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH--------HHHH
Confidence            3211         11  1457899999999999765  788999999999999999999999997644        5577


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ++|.+.. +.++...++++++|++++|..++.-|-+.++|..||.
T Consensus       297 qkI~~l~-y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF  340 (604)
T KOG0592|consen  297 QKIQALD-YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF  340 (604)
T ss_pred             HHHHHhc-ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence            8887665 8899999999999999999999999988888887774

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.9e-46  Score=342.75  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=210.6

Q ss_pred             ccccHHHHHHHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           76 KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      .+....|...     .+.||+|+||.||+|+- .+|..+|+|+++++..    ..+.++.|-++|...++++||+++-.|
T Consensus       136 ~r~~~~DFe~-----Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  136 TRLSLDDFEL-----LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             ccCCcccchh-----heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            3444454432     37899999999999974 5799999999998654    335688999999999999999999999


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      ++.+.+||||||++||++..+|...      ..|++..++.++.+++.|++.||+.   |+|||||||+|+|||..|++|
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiK  281 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIK  281 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEe
Confidence            9999999999999999999999665      6799999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCcccCcc---------------------ccee-----e-------------------eccccCccccccccccc
Q 038768          231 ISDFGLAKLSEKK---------------------ESFI-----S-------------------MLGARGTIGYIAPEVFC  265 (386)
Q Consensus       231 l~Dfgl~~~~~~~---------------------~~~~-----~-------------------~~~~~g~~~y~aPE~~~  265 (386)
                      |+||||+.-+...                     ....     .                   ....+|||.|||||++.
T Consensus       282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll  361 (550)
T KOG0605|consen  282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL  361 (550)
T ss_pred             eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence            9999998633210                     0000     0                   01235999999999998


Q ss_pred             hhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cccccccCChHHHHHHHHHHH-HH
Q 038768          266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EFQLAGVVTEEEKEMAKKMIL-VL  341 (386)
Q Consensus       266 ~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~li~~ml~-v~  341 (386)
                      +.  .|+..+|+||||||+||||.|-+||....        |.++|++|..-+   .+.-...++++++|||++++. +.
T Consensus       362 ~k--gY~~~cDwWSLG~ImyEmLvGyPPF~s~t--------p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~  431 (550)
T KOG0605|consen  362 GK--GYGKECDWWSLGCIMYEMLVGYPPFCSET--------PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPE  431 (550)
T ss_pred             cC--CCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHH
Confidence            86  69999999999999999999999999863        477777765444   333455678999999999987 44


Q ss_pred             HHhc-CCCCCCCCCCC
Q 038768          342 EMLE-GSTEDLQIPPK  356 (386)
Q Consensus       342 ~~L~-~~~~~~~~~p~  356 (386)
                      ..|. +.++++.-||-
T Consensus       432 ~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  432 NRLGSKGAEEIKKHPF  447 (550)
T ss_pred             HhcCcccHHHHhcCCc
Confidence            4554 35777777773

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8e-47  Score=364.32  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=217.1

Q ss_pred             HHHHHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           83 VKRMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        83 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      +.+....+.++||+|+||+||+|+..      +.+.||||.++.....  .++|.+|++++..++|||||+|+|+|..++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            33444456688999999999999753      3457999999975443  578999999999999999999999999999


Q ss_pred             ceeEEEEeCCCCCHHHHhccccccc--------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSN--------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      .+++|+|||..|||.++|.......        ...+++..+.+.|+.|||.||.||.+.   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            9999999999999999997643321        134488999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCccc
Q 038768          227 FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIY  305 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  305 (386)
                      ..|||+|||+++.....+.+.......-+.+|||||.+..  +++|.+||||||||+|||+++ |+.|+...+.      
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence            9999999999998888777654444556789999999964  589999999999999999998 9999987644      


Q ss_pred             chhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          306 FPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       306 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                        +++.+.|..|+....+..++.+.-++...|=.-.+.-|++..+
T Consensus       712 --~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  712 --QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             --HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence              7889999999988889999999999998887655555554443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-46  Score=347.08  Aligned_cols=245  Identities=25%  Similarity=0.396  Sum_probs=217.8

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +++.||.|+-|.|.+|+. .+|+.+|||++.+.    ......+.+|+-+|+.+.||||+++++++.+..++|+|.||++
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence            467799999999999985 57999999999764    2233568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|-|.+++..+      +++.+.++..++.||+.|+.|+|..   +|+||||||+|+|+|..+.+||+|||+|.+-..+.
T Consensus        96 gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   96 GGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             CchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999664      6799999999999999999999998   99999999999999999999999999998665544


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .   ..+.+|++.|.|||++.+. ...+.++||||.|||||.||||+.||++.+.        ..+..+++.|. +.++.
T Consensus       167 l---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G~-f~MPs  233 (786)
T KOG0588|consen  167 L---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRGV-FEMPS  233 (786)
T ss_pred             c---ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCc-ccCCC
Confidence            3   2356799999999999887 4568899999999999999999999996533        45667888887 88999


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +++.++++|+++|+.|++.-|-+++++.-||-
T Consensus       234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  234 NISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            99999999999999999999999998888874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-46  Score=331.75  Aligned_cols=258  Identities=30%  Similarity=0.394  Sum_probs=212.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceEEEEEEecC--ceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSFLGFCYEKK--KRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~  164 (386)
                      ...+.||+|+||.||++... +|...|||.+...... .+.+.+|+.+|.+++|||||+++|......  .+++.|||++
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~   99 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP   99 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence            34578999999999999864 4899999998754221 466899999999999999999999855544  5889999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCc-
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEK-  242 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~-  242 (386)
                      +|+|.+++...+     ..+++..+..+..||++||.|||++   +++||||||+|||++. ++.+||+|||+++.... 
T Consensus       100 ~GsL~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen  100 GGSLSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             CCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            999999997653     2599999999999999999999998   9999999999999999 79999999999987664 


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...........||+.|||||++... .....++|||||||++.||+||+.||....      .....+.........+.+
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~~P~i  244 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDSLPEI  244 (313)
T ss_pred             cccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCCCCCC
Confidence            1111223356799999999999752 123359999999999999999999998641      122334444444456788


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSS  361 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~~~~  361 (386)
                      +..+|+++++++.+|+..++..|++++++..||......
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            999999999999999999999999999999998764433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=341.67  Aligned_cols=247  Identities=25%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CC--ChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KV--NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||+|+.|.. .+|..||+|++.+.    ..  ..+.+.+|+.++++++ ||||+++++++......++|
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv   98 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV   98 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence            34567899999999999975 46899999987653    11  2345678999999999 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAK  238 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~  238 (386)
                      |||+.+|+|.+++...      ..+.+..+..++.|++.|++|||+.   +|+||||||+|+|++.+ +++||+|||++.
T Consensus        99 mEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999663      5788899999999999999999998   99999999999999999 999999999999


Q ss_pred             ccC-cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          239 LSE-KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       239 ~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ... ...   ...+.+|++.|+|||++.+.......++||||+||+||.|++|+.||+...        ...++.+|..+
T Consensus       170 ~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~  238 (370)
T KOG0583|consen  170 ISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKG  238 (370)
T ss_pred             ccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcC
Confidence            874 222   245678999999999998762234689999999999999999999999742        24566777777


Q ss_pred             ccccccccC-ChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 NEFQLAGVV-TEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 ~~~~~~~~~-s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      . +.++..+ |.+.++++.+|+..++.-|.+..++..+|
T Consensus       239 ~-~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~  276 (370)
T KOG0583|consen  239 E-FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP  276 (370)
T ss_pred             C-ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence            6 7788888 99999999999999999888877776554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=338.35  Aligned_cols=245  Identities=28%  Similarity=0.381  Sum_probs=213.0

Q ss_pred             hhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCCh-HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           91 SNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ..+||+|+.|.||.|. ..+++.||||.+....... +-+.+|+.+|+..+|+|||.+++.|...+..++||||+++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            3689999999999996 4678999999998765554 5678999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+.+..       ..+++.++..|+.+++.||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       358 TDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  358 TDVVTK-------TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             hhhhhc-------ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            999855       3489999999999999999999999   999999999999999999999999999987765543  2


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc--cccccC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF--QLAGVV  326 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~  326 (386)
                      ..+.+||+.|||||++...  .|+.++||||||++++||+.|++||-....        ......|.....+  ..+..+
T Consensus       426 R~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--------lrAlyLIa~ng~P~lk~~~kl  495 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNGTPKLKNPEKL  495 (550)
T ss_pred             cccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCCh--------HHHHHHHhhcCCCCcCCcccc
Confidence            3467899999999999765  799999999999999999999999976433        3333444444333  347889


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      |..+++++.+||+++..-|+++.+|..||.=
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            9999999999999999999999999998864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=332.98  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...+.||+|.||.||||+-+ +.+.||+|.+.+.....   +.+.+|++++++++||||+.++++|+...+.++|.||+.
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~   84 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV   84 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence            34567999999999999753 68899999998765554   457899999999999999999999999999999999996


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      | +|..+|...      ..++++.+..++.++..||.|||+.   +|.|||+||.|||++.++.+|+||||+|+.+..+.
T Consensus        85 g-~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   85 G-DLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             h-hHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            5 999999554      6799999999999999999999998   99999999999999999999999999999887755


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..  .....||+-|||||...+.  .|+..+|+||||||+||+++|++||...+.        ..+.+.|.... ...+.
T Consensus       155 ~v--ltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~si--------~~Lv~~I~~d~-v~~p~  221 (808)
T KOG0597|consen  155 SV--LTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARSI--------TQLVKSILKDP-VKPPS  221 (808)
T ss_pred             ee--eeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHHH--------HHHHHHHhcCC-CCCcc
Confidence            43  3356799999999999864  899999999999999999999999987643        34446665554 55667


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..|.+..+++.-+|..++..|-+=.++..||
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            8999999999999998888875533343333

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=338.54  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=209.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .|.++||+|+||+|+++..+ +++.+|||++++..    .+.+....|-+++... +||.++.++.+|+..++.|+||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            45689999999999999874 57899999999854    3346677888887776 599999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +.||++..+.+.       ..+++..+..++..|+.||+|||++   +|||||||.+|||+|.+|.+||+|||+++..-.
T Consensus       451 ~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  451 VAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             cCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            999995444432       5699999999999999999999999   999999999999999999999999999985432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  ...+.+||+.|||||++.+.  .|+..+|+|||||+|||||.|+.||.+++.        +++++.|.... +.+
T Consensus       521 ~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee~FdsI~~d~-~~y  587 (694)
T KOG0694|consen  521 QGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EEVFDSIVNDE-VRY  587 (694)
T ss_pred             CCC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC-CCC
Confidence            222  34578999999999999875  899999999999999999999999997754        77888887664 889


Q ss_pred             cccCChHHHHHHHHHHHHHHHhc-CC----CCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLE-GS----TEDLQIPPK  356 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~-~~----~~~~~~~p~  356 (386)
                      |..+|.++.+++++|+...+.-| ++    ++++..||-
T Consensus       588 P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF  626 (694)
T KOG0694|consen  588 PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF  626 (694)
T ss_pred             CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence            99999999999999999887766 33    666776763

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=327.56  Aligned_cols=259  Identities=27%  Similarity=0.363  Sum_probs=212.2

Q ss_pred             HHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHH--HHHHHHhhcCC-CCccceEEEEEEecC-ceeEEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEF--INEVASMSKTS-HVNVVSFLGFCYEKK-KRALIY  160 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~  160 (386)
                      .+|...++||.|.||.||+|+- ..|..||||.+++.-..-++.  ++|+..|++++ ||||+++.+++.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            3455678999999999999974 578999999998765555544  68999999999 999999999999988 899999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||| ..+|.++++..+     ..+++..++.|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+||..
T Consensus        90 E~M-d~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   90 EFM-DCNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             Hhh-hhhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            999 679999997653     7899999999999999999999999   9999999999999998899999999999988


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------cccchh
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EIYFPN  308 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~~~~~  308 (386)
                      .....+.   ..+.|.+|+|||++... +.|+.+.|+||+|||++|+.+-++-|.+.+..+.            ...++.
T Consensus       161 ~SkpPYT---eYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  161 RSKPPYT---EYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccCCCcc---hhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            8776544   34589999999999876 6899999999999999999999999987654321            111111


Q ss_pred             --hhhhhc-------CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          309 --SIYKHI-------EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       309 --~~~~~i-------~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                        .+...+       ..-....+-...+.+..+++.+|+..++.-|+++.+...+|..
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff  294 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF  294 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence              111110       0011112333489999999999999999999999988777754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=319.94  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=219.2

Q ss_pred             HHHHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChH----HHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           83 VKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGE----EFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        83 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      -.+-++.+.+.||+|.||.|-+|.. ..|+.||||.++++....+    .+.+|+++|+.|+||||+.++.+|...+...
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            3456677788999999999999975 6799999999998665432    3679999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||..+|.|.+|+...      +.+++.+++.+++||..|+.|+|.+   +++|||||.+|||+|+|+++||+|||++
T Consensus       130 ivMEYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEEecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchh
Confidence            999999999999999664      6799999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      .++.....   ..+++|++-|.+||.+.+. ..-.+.+|-|||||+||-|+.|..||++.+.        +.+.++|..|
T Consensus       201 Nly~~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~G  268 (668)
T KOG0611|consen  201 NLYADKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRG  268 (668)
T ss_pred             hhhccccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhcc
Confidence            88776654   3467899999999999876 3557899999999999999999999998755        6677899888


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....-.  -..++.-||+.||-|.+.-|.+.+++..|.
T Consensus       269 aYrEP~--~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  269 AYREPE--TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cccCCC--CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            733322  366789999999999999999888887775

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-43  Score=323.38  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=204.1

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  161 (386)
                      +.-.++||+|.||.||+|+. .+|+.||+|.++-+.   ....-..+||.+|++|+||||+++.+...+.  ...|||+|
T Consensus       119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe  198 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE  198 (560)
T ss_pred             HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence            33357899999999999974 679999999997543   2335678999999999999999999999877  68999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      ||+ -+|..++....     -.+++.++..++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||||+++.
T Consensus       199 YMd-hDL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  199 YMD-HDLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             ccc-chhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            994 58888875432     5699999999999999999999999   99999999999999999999999999999776


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC------------Ccccchhh
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS------------SEIYFPNS  309 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~------------~~~~~~~~  309 (386)
                      ..... .....+-|.+|.|||.+.+. ..|+.++|+||.||||.||++|++.|.+.....            .+.+|+..
T Consensus       270 ~~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  270 PSGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            55432 24456689999999999987 589999999999999999999999997664321            12222200


Q ss_pred             --hh-hhcCCCc-----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          310 --IY-KHIEPGN-----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       310 --~~-~~i~~~~-----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                        .+ ...+...     ....-..++...-+|+..||.+++.-|+++.+...+..
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey  402 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY  402 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence              00 0000000     00114467899999999999999999988776655543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=320.53  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=205.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---------------ChHHHHHHHHHhhcCCCCccceEEEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---------------NGEEFINEVASMSKTSHVNVVSFLGFCY  151 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~~~~~~  151 (386)
                      +.+.+.||+|.||.|-+|.. .+++.||||++.+.+.               ..+...+||.+|++++|||||+|+++..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            34568899999999999985 4689999999975322               1257889999999999999999999987


Q ss_pred             ec--CceeEEEEeCCCCCHHHHhccccccccccc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc
Q 038768          152 EK--KKRALIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC  228 (386)
Q Consensus       152 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  228 (386)
                      +.  +..|||+|||..|.+...--       ... +.+.+++.++.++..||+|||.+   +||||||||+|+||+++|+
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p~-------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCPP-------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             CcccCceEEEEEeccCCccccCCC-------CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            65  57899999999887754321       133 89999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCCcccCcc---cceeeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCc
Q 038768          229 PKISDFGLAKLSEKK---ESFISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE  303 (386)
Q Consensus       229 ~kl~Dfgl~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  303 (386)
                      +||+|||.+......   ..........||+.|+|||.+.+..  ...+.+.||||+||+||.|+.|+.||-++..    
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----  324 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----  324 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----
Confidence            999999999866221   1111223467999999999987621  2346789999999999999999999987643    


Q ss_pred             ccchhhhhhhcCCCc-cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          304 IYFPNSIYKHIEPGN-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                          .+++++|.... .+.-.+.+.++++++|.+||+.++..|....++..||-..
T Consensus       325 ----~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  325 ----LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             ----HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence                55677775544 2333445899999999999999999999999998888653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-43  Score=296.36  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=206.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...++||+|.||.||+|+. .+|+.||||.++..+..   .....+|++.|+.++|+||+.++++|-+.+...||+||+ 
T Consensus         5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-   83 (318)
T KOG0659|consen    5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-   83 (318)
T ss_pred             hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-
Confidence            3357899999999999985 57999999999865433   357889999999999999999999999999999999999 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ..+|...++...     ..+...++..++.++++|++|||++   .|+||||||.|+|++++|.+||+|||+++.+....
T Consensus        84 ~tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   84 PTDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             cccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            569999997653     6789999999999999999999999   99999999999999999999999999999887654


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------cccc------
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EIYF------  306 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~~~------  306 (386)
                      ....  ..+-|..|.|||.+.+. ..|+..+|+||.|||+.||+-|.+-|.+.++.+.            +..+      
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             cccc--cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            4322  23678999999999887 5899999999999999999999888876654321            1111      


Q ss_pred             hhhh-hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          307 PNSI-YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       307 ~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      |+.+ ++.........+-...++++-+++.+|+...+.-|-++.+...++.
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence            1111 1111111111134457888999999999999998888877766654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=310.22  Aligned_cols=252  Identities=19%  Similarity=0.293  Sum_probs=201.6

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      .++|+|+||+||+++.+ +|+.||||.+..++.+.   +-.++|+++|++++|+|+|.++++|.....++||+|||+..-
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            57999999999999875 59999999998765543   456899999999999999999999999999999999997655


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc-ccce
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK-KESF  246 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~  246 (386)
                      |.++- .     ....++...+..++.|++.|+.|+|++   ++|||||||+||||+.++.+||||||+|+.+.. .+.+
T Consensus        88 L~eLe-~-----~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   88 LHELE-R-----YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             HHHHH-h-----ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            55544 2     235688999999999999999999999   999999999999999999999999999998773 3332


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccc-------hhhhhhhcCCCc-
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-------PNSIYKHIEPGN-  318 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~i~~~~-  318 (386)
                         ...+.|.+|+|||.+.+. ..|...+||||+||++.||++|.+-|.+.++.+.-+.+       ...-.+-..... 
T Consensus       159 ---TDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  159 ---TDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             ---hhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence               244678999999999886 48999999999999999999999999887664321111       111001111111 


Q ss_pred             ----------cc----cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 ----------EF----QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 ----------~~----~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                ++    .--..++.-.-++++.||..++.-|.+.+++..||.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence                      00    012246778899999999999998888888877774

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=316.20  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=210.6

Q ss_pred             hhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      |.+..+||.|..++||+|+ .+.+..||||+++-+..+  -+.+.+|+..|+.++||||+.++..|..+..+++||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            4456789999999999997 467899999999864433  3688999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|++.+++...    ....+++..+..|++++++||.|||.+   |.||||||+.||||+++|.|||+|||.+-.+....
T Consensus       108 ~GS~ldIik~~----~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  108 GGSLLDIIKTY----YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             CCcHHHHHHHH----ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999764    345699999999999999999999999   99999999999999999999999999876554332


Q ss_pred             c-ee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc----
Q 038768          245 S-FI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN----  318 (386)
Q Consensus       245 ~-~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~----  318 (386)
                      . .. ......||+.|||||++.++...|+.|+||||||++..||.+|..||......       +-+..+++...    
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCCCcc
Confidence            1 11 11456899999999998777788999999999999999999999999865331       11222222211    


Q ss_pred             ----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 ----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          +..-...++..+++++..||+-++..|++++++.-|+
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence                2223445677899999999999999999999887776

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=322.66  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=204.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            34578999999999999864 68999999986532    22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          84 PGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999998543      4588899999999999999999998   9999999999999999999999999999865432


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .     ....|++.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ..+.+.+..+. ..++
T Consensus       155 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~-~~~~  218 (291)
T cd05612         155 T-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK-LEFP  218 (291)
T ss_pred             c-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-cCCC
Confidence            2     234589999999998664  678999999999999999999999976422        34445554443 4567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPPK  356 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p~  356 (386)
                      ..+++.+++++.+|+..++.-|.+     ++++..+|-
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  256 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW  256 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence            778999999999999999999984     666666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-44  Score=298.86  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=215.0

Q ss_pred             ccccHHHHHHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           76 KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      +.++++++     ++++.||+|.||.||.|+.+ ++-.||+|++.++.    ...+++.+|+++-+.|+||||++++++|
T Consensus        17 ~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            45555555     35789999999999999864 57799999997653    3346889999999999999999999999


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      .+....||++||.++|.|...|+....    ..+++.....+..|+|.||.|+|.+   +++||||||+|+|++.++..|
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lk  164 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELK  164 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCee
Confidence            999999999999999999999975432    5688888999999999999999998   999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      |+|||-+.....+.    ..+.+||..|.+||+..+.  ..+..+|+|++|++.||++.|.+||+....        .+.
T Consensus       165 iAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~et  230 (281)
T KOG0580|consen  165 IADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SET  230 (281)
T ss_pred             ccCCCceeecCCCC----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHH
Confidence            99999876544222    3456799999999999775  789999999999999999999999997753        667


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.|.+-+ ..++..++.+++++|.+|+...+.-|....++..+|
T Consensus       231 YkrI~k~~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  231 YKRIRKVD-LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             HHHHHHcc-ccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            78877665 667899999999999999998887776555554443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-42  Score=321.85  Aligned_cols=242  Identities=24%  Similarity=0.371  Sum_probs=204.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++....    ...+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  100 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV  100 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence            45678999999999999874 58899999997532    23356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus       101 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263        101 VGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             CCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999998653      4578889999999999999999998   9999999999999999999999999999866443


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..     ...|++.|+|||++.+.  .++.++|||||||++|||++|+.||....        +...++.+..+. ..++
T Consensus       172 ~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~-~~~p  235 (329)
T PTZ00263        172 TF-----TLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILAGR-LKFP  235 (329)
T ss_pred             cc-----eecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcCC-cCCC
Confidence            21     34589999999998764  67899999999999999999999997542        234555665554 5567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      ..++.++++++.+|+..++.-|.+     ++++..||
T Consensus       236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence            779999999999999999998875     34455454

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=349.12  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=211.6

Q ss_pred             HHHHHHHHhhhhhccCcCCceEEEEEEeC--CCc----EEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEE
Q 038768           80 YSDVKRMTNSFSNKLGQGGFGSVYKGKLP--DGR----LVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCY  151 (386)
Q Consensus        80 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  151 (386)
                      +.++.+....+...||+|+||.||.|...  +|.    .||||.+++.  .....+|++|..+|+.++|||||+++|+|.
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            44566666677889999999999999763  343    4999999864  334578999999999999999999999999


Q ss_pred             ecCceeEEEEeCCCCCHHHHhccccccc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          152 EKKKRALIYEFMPNGSLDQFIYDEESSN-INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      +....++++|||++|+|..+|++.+... ....+...+++.++.|||+|+.||+++   ++|||||.++|+||++...+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence            9999999999999999999998764322 235688999999999999999999999   999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNS  309 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  309 (386)
                      |+|||+|+.+...+.+.......-+.+|||||.+.+  +.++.|+|||||||++||++| |..||...+.        .+
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~  912 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FE  912 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch--------HH
Confidence            999999997776666554444456789999999976  489999999999999999999 8888876533        34


Q ss_pred             hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       310 ~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      +...+.++-....+..+.+..-+++.+|-..++..||+
T Consensus       913 v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~  950 (1025)
T KOG1095|consen  913 VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPS  950 (1025)
T ss_pred             HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCcc
Confidence            44544444456668888888888888888777766664

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.7e-43  Score=323.75  Aligned_cols=233  Identities=24%  Similarity=0.308  Sum_probs=194.9

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||++.. .+|+.||+|+++...    .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999986 468999999997532    22246788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++...      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-  150 (323)
T cd05571          81 ELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence            999998543      4688999999999999999999998   999999999999999999999999999875322211 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+..+ ...++..+
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~-~~~~p~~~  218 (323)
T cd05571         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-EIRFPRTL  218 (323)
T ss_pred             -cccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcC-CCCCCCCC
Confidence             12234689999999998664  688999999999999999999999975422        2333333333 35567789


Q ss_pred             ChHHHHHHHHHHHHHHHhcC
Q 038768          327 TEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~  346 (386)
                      ++++.+++.+|+..++.-|+
T Consensus       219 ~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-42  Score=324.83  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=201.8

Q ss_pred             HHHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEEEEEecC-
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLGFCYEKK-  154 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-  154 (386)
                      ...+.+.++||+|+||.||+|..      .+++.||+|+++....  ..+.+.+|+.++..+ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            34455678999999999999964      2356899999975432  235688999999999 8999999999987654 


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccc--------------------------------------------------------
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESS--------------------------------------------------------  178 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  178 (386)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999998653210                                                        


Q ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCcccc
Q 038768          179 NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY  258 (386)
Q Consensus       179 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y  258 (386)
                      .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence            0023578889999999999999999998   9999999999999999999999999999865443322222234467789


Q ss_pred             ccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHH
Q 038768          259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKM  337 (386)
Q Consensus       259 ~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~m  337 (386)
                      +|||++.+.  .++.++|||||||++|||++ |..||.....       .....+.+..+.....+..+++++.+++.+|
T Consensus       243 ~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         243 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NEEFCQRLKDGTRMRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            999998654  68999999999999999997 9999976422       1233444555555566778899999999999


Q ss_pred             HHHHHHhcCCCCCC
Q 038768          338 ILVLEMLEGSTEDL  351 (386)
Q Consensus       338 l~v~~~L~~~~~~~  351 (386)
                      +..++.-|+++.++
T Consensus       314 l~~dp~~RPs~~el  327 (338)
T cd05102         314 WQGDPKERPTFSAL  327 (338)
T ss_pred             ccCChhhCcCHHHH
Confidence            99999999876553

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-42  Score=323.69  Aligned_cols=243  Identities=26%  Similarity=0.374  Sum_probs=203.2

Q ss_pred             hhhhhccCcCCceEEEEEEeCC--CcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD--GRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|...+  +..||+|++....    ...+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4456889999999999997543  3689999986432    234568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++...      ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       112 y~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        112 FVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999653      4588999999999999999999998   99999999999999999999999999998664


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+..+. ..
T Consensus       183 ~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~-~~  246 (340)
T PTZ00426        183 TRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGI-IY  246 (340)
T ss_pred             CCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCC-CC
Confidence            322     234689999999998654  678999999999999999999999986432        34455555544 45


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p  355 (386)
                      ++..++++.++++.+|+..++.-|.     +++++..+|
T Consensus       247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp  285 (340)
T PTZ00426        247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP  285 (340)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence            6778899999999999999888774     566665555

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=318.69  Aligned_cols=240  Identities=21%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||+|+||.||++... +++.||+|+++..    ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999864 5889999998753    22335678899999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++...      ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  149 (312)
T cd05585          81 FHHLQRE------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K  149 (312)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence            9998643      4588999999999999999999998   999999999999999999999999999985433221  1


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...++.+..+. ..++..+++
T Consensus       150 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~-~~~~~~~~~  218 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEP-LRFPDGFDR  218 (312)
T ss_pred             cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC-CCCCCcCCH
Confidence            2235689999999998764  689999999999999999999999975422        33444444433 556778999


Q ss_pred             HHHHHHHHHHHHHHHhcCC---CCCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGS---TEDLQIPP  355 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~---~~~~~~~p  355 (386)
                      ++++++.+|+..++.-|.+   +.++..+|
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp  248 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHP  248 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence            9999999999999999964   34455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.2e-42  Score=312.49  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=202.4

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.||+|+||.||++.. .+|+.||+|.+....    .....+.+|+.++..++|+||+.+++++.+.+..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence            347899999999999985 578999999987532    223457899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|..++....    ...+++..++.++.|++.||+|||+.   +++||||||+|||+++++.++|+|||++.......
T Consensus        84 ~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          84 GGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             CCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999998875432    23588999999999999999999998   99999999999999999999999999998654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .   .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+...+... ...++.
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~-~~~~~~  226 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVDRRVKED-QEEYSE  226 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHHHHhhcc-cccCCc
Confidence            2   1244689999999999754  78899999999999999999999998643211    112233333322 244566


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      .++++..+++++|+..++.-|.+     ++++..+|
T Consensus       227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence            78999999999999999999976     45555555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.2e-42  Score=318.44  Aligned_cols=233  Identities=25%  Similarity=0.321  Sum_probs=193.9

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||++.. .+|+.||+|+++...    .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999986 468999999997532    22345778999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  150 (323)
T cd05595          81 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence            999888543      4688999999999999999999998   999999999999999999999999999875322211 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                       ......|++.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+... ...++..+
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~-~~~~p~~~  218 (323)
T cd05595         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-EIRFPRTL  218 (323)
T ss_pred             -ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-CCCCCCCC
Confidence             12235689999999998654  688999999999999999999999975422        2333333322 24567789


Q ss_pred             ChHHHHHHHHHHHHHHHhcC
Q 038768          327 TEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~  346 (386)
                      ++++++++.+|+..++.-|.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhC
Confidence            99999999999999999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.2e-42  Score=318.12  Aligned_cols=233  Identities=25%  Similarity=0.345  Sum_probs=195.0

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||++.. .+|+.||+|++....    .....+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999986 468999999997532    22356788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-  150 (328)
T cd05593          81 ELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-  150 (328)
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence            999888543      4688999999999999999999998   999999999999999999999999999875432211 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+... ...++..+
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~-~~~~p~~~  218 (328)
T cd05593         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-DIKFPRTL  218 (328)
T ss_pred             -ccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccC-CccCCCCC
Confidence             12235689999999998654  688999999999999999999999975422        2333344333 35567789


Q ss_pred             ChHHHHHHHHHHHHHHHhcC
Q 038768          327 TEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~  346 (386)
                      ++++.+++.+|+..++.-|.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~  238 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRL  238 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcC
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-42  Score=316.93  Aligned_cols=233  Identities=28%  Similarity=0.397  Sum_probs=194.0

Q ss_pred             hccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK-----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.||+|+||.||+++.    .+++.||+|+++...     .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5699999999999975    357899999997532     2234577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+.+..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            9999999998543      4577888999999999999999998   999999999999999999999999999875432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ....  .....|++.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+..+. ..+
T Consensus       153 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~-~~~  219 (323)
T cd05584         153 EGTV--THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGK-LNL  219 (323)
T ss_pred             CCCc--ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-CCC
Confidence            2211  1234689999999998654  678899999999999999999999976432        23334444443 456


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      +..+++++.+++.+|+..++.-|.
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~  243 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRL  243 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcC
Confidence            778899999999999999999887

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-41  Score=315.20  Aligned_cols=235  Identities=24%  Similarity=0.339  Sum_probs=196.2

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|+.. +++.||+|++++.    ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 5889999998753    22335677888888776 699999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          81 GDLMFHIQKS------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             chHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            9999988543      4588999999999999999999998   999999999999999999999999999875432211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+..+. ..++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~-~~~~~~  218 (320)
T cd05590         152 --TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE-VVYPTW  218 (320)
T ss_pred             --cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCC-CCCCCC
Confidence              12234689999999998654  688999999999999999999999986432        34445554443 456677


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ++++.++++.+|+..++.-|.++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            89999999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=316.98  Aligned_cols=243  Identities=25%  Similarity=0.343  Sum_probs=212.3

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.||+|.||.||+|.. ..++.||+|++.-..  ...+++.+|+.++.+++++||.++||.+..+..++++||||.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            5699999999999985 468899999998643  3447889999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+.+...      ..+++..+.-++++++.||.|||.+   +.+|||||+.|||+..+|.+||+|||.+-.+......  
T Consensus        99 ~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--  167 (467)
T KOG0201|consen   99 LDLLKSG------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--  167 (467)
T ss_pred             hhhhccC------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence            9999553      3457788888999999999999999   9999999999999999999999999999766554432  


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      ..+.+||+.|||||++.+.  .|+.|+||||||++.+||.+|.+|+...+.        ..+.-.|.+...|.+.+.+|+
T Consensus       168 r~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hP--------mrvlflIpk~~PP~L~~~~S~  237 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHP--------MRVLFLIPKSAPPRLDGDFSP  237 (467)
T ss_pred             cccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCc--------ceEEEeccCCCCCccccccCH
Confidence            2577899999999999854  799999999999999999999999987654        445556777778899999999


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++|++..||..+|.-|+++.++.-|+
T Consensus       238 ~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  238 PFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence            999999999999988888888775554

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=334.17  Aligned_cols=241  Identities=27%  Similarity=0.423  Sum_probs=204.9

Q ss_pred             hhhccCcCCceEEEEEEeC----CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           90 FSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      +.++||.|.||.||+|+++    ....||||.++...  ..+.+|+.|..+|.+++||||++|-|+........+|+|||
T Consensus       633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM  712 (996)
T KOG0196|consen  633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM  712 (996)
T ss_pred             EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence            3468999999999999874    23489999999743  44578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|+.+|+.+.     ..+++.++..++++||.||.||.+-   ++|||||.++|||++.+..+|++|||+++.++++
T Consensus       713 ENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  713 ENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999998765     4588899999999999999999997   9999999999999999999999999999988655


Q ss_pred             c-ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          244 E-SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       244 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      . ......+..-+.+|.|||.+.-  .++|.++||||||++|||.++ |.+||=..+.        ..+.+.|.++-...
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIkaIe~gyRLP  854 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKAIEQGYRLP  854 (996)
T ss_pred             CCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccch--------HHHHHHHHhccCCC
Confidence            4 3334445555789999999965  489999999999999999776 9999754422        56778888887677


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      -+-++...+-+|...|=+.++..||.-
T Consensus       855 pPmDCP~aL~qLMldCWqkdR~~RP~F  881 (996)
T KOG0196|consen  855 PPMDCPAALYQLMLDCWQKDRNRRPKF  881 (996)
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhcCCCH
Confidence            777888988888888887777666643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-41  Score=309.56  Aligned_cols=238  Identities=20%  Similarity=0.309  Sum_probs=197.7

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh----HHHHHHHHHhhcCCCCccceEEEEEEe----cCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLGFCYE----KKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  163 (386)
                      ..||+|++|.||+|.+ +|+.||||.++......    +.+.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4699999999999998 78999999998654333    567799999999999999999999987    34678999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++.....++.|++.||.|||+.  .+++||||||+|||+++++.+||+|||+++.....
T Consensus       105 ~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        105 TRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             CCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            999999999653      4578899999999999999999973  27889999999999999999999999999865433


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc-CCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI-EPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i-~~~~~~~~  322 (386)
                      .     ....|+..|+|||++.+....++.++|||||||++|||++|+.||.....        ..+...+ ..+..+.+
T Consensus       177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~  243 (283)
T PHA02988        177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINKNNSLKL  243 (283)
T ss_pred             c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCC
Confidence            2     13457889999999876435789999999999999999999999985422        3333443 23334556


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++++++++.+|++.++.-|+++.++
T Consensus       244 ~~~~~~~l~~li~~cl~~dp~~Rps~~el  272 (283)
T PHA02988        244 PLDCPLEIKCIVEACTSHDSIKRPNIKEI  272 (283)
T ss_pred             CCcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence            66789999999999999999999876654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=294.09  Aligned_cols=245  Identities=25%  Similarity=0.361  Sum_probs=209.8

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC---CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|.|+.||++.. .+|+.+|+|+++..   ..+-+++.+|+++.+.|+||||+++.+........|+|+|++.
T Consensus        14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~   93 (355)
T KOG0033|consen   14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   93 (355)
T ss_pred             hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence            3457799999999999864 57999999988642   3355788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccC
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSE  241 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~  241 (386)
                      |++|..-+-..      ..+++..+-..+.||+++|.|+|.+   +|||||+||+|+|+.+   .--+||+|||++..+.
T Consensus        94 G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   94 GGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             chHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99998776432      4577888889999999999999999   9999999999999953   3359999999999887


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---  318 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---  318 (386)
                      ....   ..+..||+.|||||++...  .|+..+|||+.|||||-|+.|..||.+.+.        ..++++|..+.   
T Consensus       165 ~g~~---~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~I~~g~yd~  231 (355)
T KOG0033|consen  165 DGEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQIKAGAYDY  231 (355)
T ss_pred             Cccc---cccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHHHhccccCC
Confidence            4332   3467899999999999764  899999999999999999999999987533        66888888887   


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +......+++++++|+++||.++|.-|-++.+...||
T Consensus       232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            3345678999999999999999999998888877776

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.1e-41  Score=315.25  Aligned_cols=242  Identities=20%  Similarity=0.294  Sum_probs=196.5

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||++... +++.||+|+++....    ..+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999864 688999999985322    234577899999888 699999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            9999888543      4689999999999999999999998   999999999999999999999999999874322111


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-cccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-EIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                        ......||..|+|||++.+.  .++.++|||||||++|||++|+.||+....... .........+.+.... ..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~  226 (329)
T cd05588         152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRIPR  226 (329)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CCCCC
Confidence              12235689999999998764  688999999999999999999999975432211 1112223444444433 56778


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      .++.++.+++.+|+..++.-|.+
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~  249 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLG  249 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCC
Confidence            89999999999999999999976

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=321.54  Aligned_cols=235  Identities=28%  Similarity=0.422  Sum_probs=196.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF  171 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  171 (386)
                      +-||+|+.|.||+|++ .++.||||.++.-+      ..+|+-|++|+|+||+.|.|+|.....+|||||||+.|-|.+.
T Consensus       130 eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            4699999999999999 67899999876422      3578889999999999999999999999999999999999999


Q ss_pred             hcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeecc
Q 038768          172 IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG  251 (386)
Q Consensus       172 l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  251 (386)
                      |+..      ..++...+..|..+||.||.|||..   .|||||||.-||||+.+..|||+|||-++.......   ...
T Consensus       203 Lka~------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMS  270 (904)
T KOG4721|consen  203 LKAG------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMS  270 (904)
T ss_pred             Hhcc------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhh
Confidence            9654      5788899999999999999999998   999999999999999999999999999987665422   346


Q ss_pred             ccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHH
Q 038768          252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEK  331 (386)
Q Consensus       252 ~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~  331 (386)
                      +.||..|||||++.+.  ..++|+|||||||+|||||||..||..-+..       ..+|--=..-.....+..+.+-++
T Consensus       271 FaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwGVGsNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWGVGSNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             hhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchh-------eeEEeccCCcccccCcccCchHHH
Confidence            7899999999999875  7899999999999999999999999865331       112221111223456788899999


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC
Q 038768          332 EMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       332 ~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      -|+++|..-.+.-|++-..+..|
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHH
Confidence            99999998777777765554443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-41  Score=299.89  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=203.7

Q ss_pred             hhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCCCh----HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|.-|+||++++.+ +...|+|++.+.....    .+...|-+||+.++||.++.||+.+..+...|+|||||+
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence            34789999999999999854 5899999998754332    356679999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ||+|..++++..    ...+++..++.++.+|+-||+|||-.   |||+|||||+||||.++|++.|+||.|+.......
T Consensus       161 GGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  161 GGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             CccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999997753    46799999999999999999999998   99999999999999999999999999875321100


Q ss_pred             ---------------------------------c---------------------eeeeccccCccccccccccchhcCC
Q 038768          245 ---------------------------------S---------------------FISMLGARGTIGYIAPEVFCRNFGG  270 (386)
Q Consensus       245 ---------------------------------~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~  270 (386)
                                                       .                     .......+||-.|+|||++.+.  .
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--G  311 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--G  311 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--C
Confidence                                             0                     0011234689999999999886  6


Q ss_pred             CCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC-CCccccccccCChHHHHHHHHHHHHHHHhcCC--
Q 038768          271 VSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE-PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS--  347 (386)
Q Consensus       271 ~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~--  347 (386)
                      .+.++|+|+|||++|||+.|..||.+...        ++.+.+|. +...+.-...++.+++|||+++|..++.-|--  
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~--------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN--------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCc--------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            88999999999999999999999997643        33344432 22233334478999999999999998887632  


Q ss_pred             --CCCCCCCCC
Q 038768          348 --TEDLQIPPK  356 (386)
Q Consensus       348 --~~~~~~~p~  356 (386)
                        +.++..||-
T Consensus       384 rGA~eIK~HpF  394 (459)
T KOG0610|consen  384 RGAAEIKRHPF  394 (459)
T ss_pred             cchHHhhcCcc
Confidence              666777774

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=320.49  Aligned_cols=251  Identities=28%  Similarity=0.428  Sum_probs=198.3

Q ss_pred             cHHHHHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCc
Q 038768           79 NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKK  155 (386)
Q Consensus        79 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  155 (386)
                      .++|+......+...||+|.||+||+|.|.+  .||||+++-.....   +.|++|+..+++-+|.||+-|+|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            3445555555567899999999999999843  59999998654433   679999999999999999999999988776


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                       .+|+-+|+|-+|..+++..+     ..++....+.|+.|||.||.|||.+   +|||||||..|||+.++++|||+|||
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             -eeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence             99999999999999998764     6788999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      ++..-..-..........|...|||||++..+ ...|++++||||||+++|||+||..||.....        +.+.-.+
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--------dqIifmV  605 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--------DQIIFMV  605 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--------hheEEEe
Confidence            98643221111112233478899999999632 24689999999999999999999999983321        2222233


Q ss_pred             CCCc----cccccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          315 EPGN----EFQLAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       315 ~~~~----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      -.|.    .......+..++++|+..|...++.-||.-
T Consensus       606 GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F  643 (678)
T KOG0193|consen  606 GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF  643 (678)
T ss_pred             cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence            3331    122344566799999999998777777643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-41  Score=314.61  Aligned_cols=233  Identities=23%  Similarity=0.296  Sum_probs=194.0

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|+.. +++.||+|+++...    ...+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 57899999997532    2335577888888765 799999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          81 GDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            9999988543      4588999999999999999999998   999999999999999999999999999875432221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .  .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+..+. ...+..
T Consensus       152 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~-~~~p~~  218 (321)
T cd05591         152 T--TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDD-VLYPVW  218 (321)
T ss_pred             c--ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-CCCCCC
Confidence            1  2234689999999998654  688999999999999999999999986532        34445554443 445667


Q ss_pred             CChHHHHHHHHHHHHHHHhcC
Q 038768          326 VTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ++.+..+++.+|+..++.-|.
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcC
Confidence            899999999999999999887

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-42  Score=318.02  Aligned_cols=249  Identities=26%  Similarity=0.361  Sum_probs=217.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCc-eeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKK-RALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~  162 (386)
                      +...+++|+|+||.++..+.+ +++.+++|.+.-...   .++...+|+.++++++|||||.+.+.|..++. .++||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            344578999999999988753 577999999875433   33567899999999999999999999999888 8999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |+||+|.+.+.+.+    ...++++.++.++.|++.|+.|||++   .|+|||||+.|||++.++.|+|+|||+|+.+..
T Consensus        86 ~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             cCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999997754    35689999999999999999999988   999999999999999999999999999999887


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ....  ..+..||+.||.||.+.+.  .|..|+|||||||++|||++-+++|...+.        ..+..+|.++.-..+
T Consensus       159 ~~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~~~~Pl  226 (426)
T KOG0589|consen  159 EDSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRGLYSPL  226 (426)
T ss_pred             chhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhccCCCC
Confidence            6532  2356799999999999875  899999999999999999999999998743        445567777777889


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..++.+++.+++.|+...+..|+++.++...|
T Consensus       227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            999999999999999999999999888765554

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-41  Score=312.78  Aligned_cols=235  Identities=23%  Similarity=0.334  Sum_probs=192.8

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHh---hcCCCCccceEEEEEEecCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASM---SKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.||+|+||.||+|... +|+.||||+++...    ...+.+.+|++++   +.++||||+++++++.+.+..|+|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            4578999999999999864 68999999997532    2234566666554   56789999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++++|..++..       ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          83 YAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             CCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999988743       3588999999999999999999998   99999999999999999999999999987533


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ....  ......|++.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+..+. ..
T Consensus       153 ~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~-~~  219 (324)
T cd05589         153 GFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDE-VR  219 (324)
T ss_pred             CCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CC
Confidence            2211  12245689999999998764  688999999999999999999999975432        33344444433 44


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ++..++.+..+++.+|+..++.-|++
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~  245 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLG  245 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence            67788999999999999999998874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-41  Score=312.82  Aligned_cols=237  Identities=27%  Similarity=0.349  Sum_probs=197.6

Q ss_pred             hccCcCCceEEEEEEe----CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           92 NKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.||+|+||.||+++.    .+|+.||+|++....   .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999864    357899999997532   223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            99999998543      4588999999999999999999998   99999999999999999999999999997654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .  ......|+..|+|||.+.+.  .++.++|||||||++|||++|+.||.....        ......+.... ..++.
T Consensus       153 ~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~-~~~p~  219 (318)
T cd05582         153 K--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAK-LGMPQ  219 (318)
T ss_pred             C--ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCC-CCCCC
Confidence            1  12245689999999998654  678899999999999999999999975422        33334443333 44677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+++++.+++++|+..++.-|+++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            78999999999999999999988544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.9e-41  Score=314.87  Aligned_cols=243  Identities=23%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             hhhhccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK-----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  158 (386)
                      .+.+.||+|+||.||+++.    .+|+.||+|++.+..     ...+.+..|+.++..+ +|+||+.+++++...+..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            3467899999999999875    357899999987522     2235678899999999 59999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++|+|.+++...      ..+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus        83 v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          83 ILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999998643      4588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ........ ......||..|+|||++.+. ..++.++|||||||++|||++|+.||.......    ....+.+.+... 
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~-  226 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILKC-  226 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhcC-
Confidence            65332221 12235689999999998654 347889999999999999999999997543211    122333344333 


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      .+.++..+++.+++++.+|+..++.-|++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~  255 (332)
T cd05614         227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLG  255 (332)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            35567789999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.5e-41  Score=310.12  Aligned_cols=236  Identities=24%  Similarity=0.328  Sum_probs=192.8

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHH-HhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVA-SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||+||+|... +|+.||+|++....    .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999864 68999999997532    12234555554 46789999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            9999998543      4688899999999999999999998   999999999999999999999999999875322211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+..+. ..+...
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-~~~~~~  218 (323)
T cd05575         152 --TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKP-LRLKPN  218 (323)
T ss_pred             --ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC-CCCCCC
Confidence              12234689999999998654  688999999999999999999999975422        33444444333 445667


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE  349 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~  349 (386)
                      ++.+..+++.+|+..++.-|+++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            899999999999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.6e-41  Score=312.34  Aligned_cols=238  Identities=22%  Similarity=0.304  Sum_probs=195.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCC-ccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHV-NVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|... +++.||+|++...    ....+.+..|.+++..++|+ +|+.+++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            35678999999999999864 5789999999753    22345678899999999765 588899999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++...      ..+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          83 VNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999998543      4578899999999999999999998   999999999999999999999999999874322


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+.... ..+
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~-~~~  220 (324)
T cd05587         154 GGK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN-VSY  220 (324)
T ss_pred             CCC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-CCC
Confidence            211  12234689999999999764  688999999999999999999999975432        33444454443 456


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      +..++.+..+++.+|+..++.-|.+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            77899999999999999999988754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-41  Score=315.93  Aligned_cols=233  Identities=25%  Similarity=0.321  Sum_probs=193.3

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||++.. .+|+.||+|++....    .....+..|++++..++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 468999999997532    22356778999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      +|..++...      ..+++..+..++.||+.||+|||+ .   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          81 ELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            999888543      468899999999999999999997 6   999999999999999999999999999875432221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+... ...++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~-~~~~p~~  218 (325)
T cd05594         152 --TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-EIRFPRT  218 (325)
T ss_pred             --ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcC-CCCCCCC
Confidence              11234689999999998654  688999999999999999999999975422        2333333332 3456778


Q ss_pred             CChHHHHHHHHHHHHHHHhcC
Q 038768          326 VTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~  346 (386)
                      +++++.+++.+|+..++.-|.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhC
Confidence            899999999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.4e-41  Score=311.27  Aligned_cols=242  Identities=24%  Similarity=0.344  Sum_probs=196.3

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhc-CCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|... +++.||+|+++...    ...+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 57899999997532    223455667777664 4899999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          81 GDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence            9999988543      4588899999999999999999998   999999999999999999999999999975433221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+... .+.++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~~~~~~  218 (316)
T cd05592         152 --KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILND-RPHFPRW  218 (316)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CCCCCCC
Confidence              12234689999999998764  688999999999999999999999986432        3344444333 3556778


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC-CCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE-DLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~-~~~~~p  355 (386)
                      ++.+..+++.+|+..++.-|++.. ++..+|
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~  249 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQHP  249 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence            999999999999999999998653 454443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.8e-41  Score=313.37  Aligned_cols=243  Identities=20%  Similarity=0.290  Sum_probs=196.2

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||++... +++.||+|++++..    ...+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 57899999997632    1224577888888776 799999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            9999888543      4688999999999999999999998   999999999999999999999999999875322211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-ccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~  324 (386)
                        ......||..|+|||++.+.  .++.++|||||||++|||++|+.||......... ......+++.+... ...++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~  226 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR  226 (329)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-CCCCCC
Confidence              11235689999999998764  6889999999999999999999999743222111 11122344444443 355778


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      .++.++.+++.+|+..++.-|.+.
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            899999999999999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.8e-41  Score=309.80  Aligned_cols=235  Identities=25%  Similarity=0.313  Sum_probs=191.3

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHH-HhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVA-SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|+.. +|+.||+|++.+..    .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 68899999987532    12234555554 57889999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|..++...      ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            9998888543      4578889999999999999999998   999999999999999999999999999875322221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......|++.|+|||++.+.  .++.++|||||||++|||++|+.||...+.        ..+.+.+.... ..++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~-~~~~~~  218 (321)
T cd05603         152 --TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKP-LQLPGG  218 (321)
T ss_pred             --ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCC-CCCCCC
Confidence              12234689999999998654  688999999999999999999999976432        23334444332 456677


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      .+.+..+++.+|+..++.-|.++
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~  241 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGA  241 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCC
Confidence            89999999999999999988754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=316.91  Aligned_cols=244  Identities=24%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +|+.||+|+++...    ...+.+.+|++++..++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            34578999999999999875 58899999997532    22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          84 PGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            999999999543      4588999999999999999999998   9999999999999999999999999999865431


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc----c
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN----E  319 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~----~  319 (386)
                           .....|++.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...+..+....    .
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~  219 (333)
T cd05600         155 -----ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWKETLQR  219 (333)
T ss_pred             -----cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhccccccC
Confidence                 2245689999999998764  788999999999999999999999975432        22222221111    1


Q ss_pred             ccc---cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          320 FQL---AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       320 ~~~---~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +..   ...+++++.+++.+|+...+..|++++++..+|-
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            111   1256899999999999988888888888776654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-41  Score=319.21  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||+||++... +++.||+|++.+..    .....+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus         5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence            4578999999999999764 58899999997532    223567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          85 GGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999653      4688999999999999999999998   99999999999999999999999999987543211


Q ss_pred             ce---------------------------------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC
Q 038768          245 SF---------------------------------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR  291 (386)
Q Consensus       245 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~  291 (386)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCC
Confidence            00                                 001234699999999998764  6889999999999999999999


Q ss_pred             CCcccccccCCcccchhhhhhhcCCCc-ccccc--ccCChHHHHHHHHHHHHHHHh---cCCCCCCCCCC
Q 038768          292 KNAEVKVSLSSEIYFPNSIYKHIEPGN-EFQLA--GVVTEEEKEMAKKMILVLEML---EGSTEDLQIPP  355 (386)
Q Consensus       292 ~p~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~--~~~s~~~~~li~~ml~v~~~L---~~~~~~~~~~p  355 (386)
                      .||.....        ...++.+.... ...++  ..+++++++++.+|+. .+.-   |++++++..+|
T Consensus       234 ~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp  294 (363)
T cd05628         234 PPFCSETP--------QETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNP  294 (363)
T ss_pred             CCCCCCCH--------HHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCC
Confidence            99975432        33444443321 12222  3478999999999875 2222   34555555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.9e-41  Score=310.36  Aligned_cols=242  Identities=26%  Similarity=0.357  Sum_probs=198.1

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhc-CCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|... +++.||+|+++..    ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 5789999999753    2233456678888775 4899999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...      ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          81 GDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            9999998543      4578899999999999999999998   999999999999999999999999999875322211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+.... +.++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~-~~~~~~  218 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDN-PCYPRW  218 (316)
T ss_pred             --ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCCCcc
Confidence              11234689999999998754  688999999999999999999999975422        34444444333 446677


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC-CCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE-DLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~-~~~~~p  355 (386)
                      ++.+.++++.+|+..++.-|.++. ++..+|
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~  249 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQHP  249 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence            899999999999999999998775 565554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-41  Score=311.40  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhc-CCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|... +|+.||+|+++..    ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999864 6889999999753    2233556778888765 4899999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||+++.......
T Consensus        81 g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          81 GDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            9999988543      4578899999999999999999998   999999999999999999999999999874322111


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+++.+.... +.++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~~-~~~~~~  218 (316)
T cd05620         152 --RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVDT-PHYPRW  218 (316)
T ss_pred             --ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCCCCC
Confidence              12245689999999998764  688999999999999999999999975422        34444444333 556777


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC-CCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE-DLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~-~~~~~p  355 (386)
                      ++.++++++.+|+..++.-|.++. ++..||
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~  249 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIRGHP  249 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence            999999999999999999998763 555454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-41  Score=310.03  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=198.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.++||.|+||.||+|... +++.||+|.++...  .....+.+|+.++++++||||+++++++.+.+..++||||++ 
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   86 (288)
T cd07871           8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-   86 (288)
T ss_pred             eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-
Confidence            34578999999999999864 68899999987532  234567899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          87 SDLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            58998885432     3578899999999999999999998   999999999999999999999999999976543221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhcCCC-
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHIEPG-  317 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i~~~-  317 (386)
                        ......++..|+|||++.+. ..++.++|||||||++|||++|+.||........-       ...+...|..+... 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              11234578999999998653 36789999999999999999999999754321100       00011112111111 


Q ss_pred             -------------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 -------------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 -------------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                   ........++++..+++.+||..++.-|++++++..||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence                         01112345789999999999999999999998887776

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-41  Score=320.51  Aligned_cols=247  Identities=23%  Similarity=0.309  Sum_probs=191.9

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||+||+|.. .+++.||+|++.....    ..+.+.+|++++..++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            457899999999999975 4688999999975322    23568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          85 GGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999998653      4578899999999999999999998   99999999999999999999999999976431100


Q ss_pred             c---------------------------------------------eeeeccccCccccccccccchhcCCCCccchhHh
Q 038768          245 S---------------------------------------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYS  279 (386)
Q Consensus       245 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  279 (386)
                      .                                             ........||..|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            0                                             0001234699999999998764  6889999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC-Cccccc--cccCChHHHHHHHHHHHHHHHh--cCCCCCCCCC
Q 038768          280 YGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP-GNEFQL--AGVVTEEEKEMAKKMILVLEML--EGSTEDLQIP  354 (386)
Q Consensus       280 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~--~~~~s~~~~~li~~ml~v~~~L--~~~~~~~~~~  354 (386)
                      |||++|||++|+.||.....        ......+.. ......  ...+++++.+++.+|+...+.-  |++++++..|
T Consensus       234 lG~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTP--------TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCH--------HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999999999976432        222122211 111222  3357999999999987543322  4555555554


Q ss_pred             C
Q 038768          355 P  355 (386)
Q Consensus       355 p  355 (386)
                      |
T Consensus       306 p  306 (381)
T cd05626         306 P  306 (381)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-40  Score=313.65  Aligned_cols=247  Identities=27%  Similarity=0.356  Sum_probs=198.2

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.++||+|+||.||+|... +|+.||||++......  .+.+.+|+++++.++|+||+++++++.+.+..++||||++++
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            4578999999999999864 6899999999654322  357889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|....          ...+..+..++.||+.||.|||+.   +++||||||+|||+++++.+||+|||+++....... 
T Consensus       158 ~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        158 SLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             cccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            986432          345677889999999999999998   999999999999999999999999999986643321 


Q ss_pred             eeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                       ......|+..|+|||++...   ....+.++|||||||++|||++|+.||......  +  + ......+........+
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~--~-~~~~~~~~~~~~~~~~  297 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--D--W-ASLMCAICMSQPPEAP  297 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--c--H-HHHHHHHhccCCCCCC
Confidence             12234689999999987432   113456899999999999999999999833211  1  1 1122223333345556


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..++.++++++.+|+..++.-|+++.++..+|-
T Consensus       298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            778999999999999999999999998877764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=313.25  Aligned_cols=263  Identities=24%  Similarity=0.343  Sum_probs=211.2

Q ss_pred             cHHHHHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCce
Q 038768           79 NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        79 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  156 (386)
                      ...|+.+....|.++||+|-||.|.++....+..||||.++...  ....+|.+|+++|.+++||||++++|+|..++.+
T Consensus       531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            34567777778889999999999999999778999999998643  3347899999999999999999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++|+||+++|+|.+++..++...    +......+|+.||+.||+||.+.   ++|||||.++|||++.++++||+|||+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence            99999999999999998765322    34456677999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh--CCCCcccccccCCcccchhhhhhhc
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV--GRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      ++.+...+.+......+-+.+|||+|.+..  ++++.++|||+||+++||+++  ...||......+. .....++...-
T Consensus       684 sR~lysg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven~~~~~~~~  760 (807)
T KOG1094|consen  684 SRNLYSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VENAGEFFRDQ  760 (807)
T ss_pred             ccccccCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHhhhhhcCCC
Confidence            998877776665555667889999999976  489999999999999999754  7889875432110 00011111111


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ....-+..+..+...+-+++.+|-..+..-||+-+++
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l  797 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL  797 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence            1111233467788888888888888888888776654

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-41  Score=294.63  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCc-cceEEEEEEecC------ceeEE
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVN-VVSFLGFCYEKK------KRALI  159 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~lv  159 (386)
                      .++||+|+||+||+|+. .+|+.||+|.++-...   ......+|+.++++++|+| |+.+++++.+.+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            46799999999999975 5789999999986433   4466789999999999999 999999999887      78999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      +||+ .-+|..++.......  ..++...++.+..||+.||+|||++   +|+||||||.||||+++|.+||+|||+|+.
T Consensus        96 fe~~-d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   96 FEFL-DRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             EEee-cccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence            9999 679999996654221  4567789999999999999999999   999999999999999999999999999996


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC------------Ccccch
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS------------SEIYFP  307 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~------------~~~~~~  307 (386)
                      ..-+...  ....++|..|.|||++.+. ..|+...||||+|||+.||++++.-|.+.+..+            .+..+|
T Consensus       170 ~~ip~~~--yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  170 FSIPMRT--YTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             hcCCccc--ccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            6533221  2345689999999999987 469999999999999999999999888765421            112222


Q ss_pred             hhh--------hhhcC-CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          308 NSI--------YKHIE-PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       308 ~~~--------~~~i~-~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ...        +..+. ...........+++..+++.+||+.++..|-++.....||.-
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf  305 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF  305 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence            211        11111 000011123345799999999999999999888888777764

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-41  Score=328.35  Aligned_cols=251  Identities=20%  Similarity=0.236  Sum_probs=204.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-C-CcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-D-GRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.+.||+|+||.||+|... + ++.||+|.+..... ....+.+|+.+++.++||||++++++|...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            445688999999999999753 3 67888887754332 23457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       149 gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        149 GGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999886432  1124688999999999999999999998   99999999999999999999999999998765433


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+..+....++.
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~~~  293 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPFPC  293 (478)
T ss_pred             ccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCc
Confidence            22222345699999999998654  689999999999999999999999975422        33444554454445667


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQI  353 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~  353 (386)
                      .++.++.+++.+|+..++..|+++.++..
T Consensus       294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        294 PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            78999999999999999999988666543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=324.24  Aligned_cols=246  Identities=29%  Similarity=0.440  Sum_probs=195.1

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeC--CC--cE-EEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEe
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLP--DG--RL-VAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYE  152 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  152 (386)
                      ++......+.++||+|+||.||+|++.  ++  .. ||||..+.+.    ....+|.+|.++|++++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            344444455689999999999999863  23  23 8999998522    234689999999999999999999999999


Q ss_pred             cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      ....++|||+|+||+|.++|.+..     ..++..+...++.+.|.||+|||++   +++||||.++|+|++.++.+||+
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence            999999999999999999997653     3589999999999999999999999   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||+++....-.  .......-+.+|+|||.+..  +.++.++|||||||++||+++ |..||.....        ..+.
T Consensus       305 DFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v~  372 (474)
T KOG0194|consen  305 DFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEVK  372 (474)
T ss_pred             ccccccCCccee--eccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCH--------HHHH
Confidence            999987554111  11111235678999999965  489999999999999999999 8889986633        4555


Q ss_pred             hhc-CCCccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          312 KHI-EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       312 ~~i-~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      .+| ..+.....+.....+...+..+|-.+++.-|++
T Consensus       373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~t  409 (474)
T KOG0194|consen  373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPT  409 (474)
T ss_pred             HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccC
Confidence            666 445445556666667777777766655555543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=312.62  Aligned_cols=247  Identities=27%  Similarity=0.364  Sum_probs=210.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCC----ChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  159 (386)
                      ..+.+.++||+|.||.||++..+. |+.+|+|.+.+...    ..+.+.+|+.+|+++. |||||.+.+.+.+.+..++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            345556889999999999998754 99999999986543    3468999999999998 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC----CCceEEeecc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE----DFCPKISDFG  235 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg  235 (386)
                      ||+|.||.|.+.+...       .+++..+..++.|++.++.|||+.   +++||||||+|+|+..    ++.+|++|||
T Consensus       115 mEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999654       289999999999999999999998   9999999999999963    3579999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++.......   .....+||+.|+|||++...  .|+..+||||+||++|.|++|..||.....        ......|.
T Consensus       185 la~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~--------~~~~~~i~  251 (382)
T KOG0032|consen  185 LAKFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETE--------FEIFLAIL  251 (382)
T ss_pred             CceEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCCh--------hHHHHHHH
Confidence            999877632   24467899999999999754  799999999999999999999999997753        23344555


Q ss_pred             CCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 PGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 ~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+.   .......+|+.+++++++|+..++..|.++.+...||
T Consensus       252 ~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  252 RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence            554   2234667899999999999999999998888776663

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.5e-41  Score=290.40  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=198.4

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEeCC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEFMP  164 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  164 (386)
                      .++|++|.||.||+|++ ++++.||+|+++-+...   .-..++||++|.+++|||||.+-.+....  +..|+|||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            37899999999999986 46889999999864422   13568999999999999999999988754  57899999994


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                       .+|..++....     .++...++..+..|+++|++|||++   .|+|||||++|+|++..|.+||+|||+|+.+....
T Consensus       161 -hDLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  161 -HDLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             -hhHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence             58999986543     6788999999999999999999998   99999999999999999999999999999887663


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------ccch-hhhhhhcCCC
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------IYFP-NSIYKHIEPG  317 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~~~-~~~~~~i~~~  317 (386)
                      .  .....+-|..|.|||.+.+. ..|+...|+||+|||+.||+++++-|.+.+..+.-      ...| +.+|..+.+.
T Consensus       232 k--~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  232 K--PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             c--cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            2  23456689999999999987 58999999999999999999999999876543210      0011 1122222111


Q ss_pred             c---------------cccccc-cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          318 N---------------EFQLAG-VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       318 ~---------------~~~~~~-~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .               ...+.. .+|+..-+++..++..++.-|-++++.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~  358 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG  358 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence            1               011122 277999999999999999888776664

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=318.74  Aligned_cols=246  Identities=24%  Similarity=0.332  Sum_probs=194.8

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||+||+|+.. +|+.||||++....    .....+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (364)
T cd05599           5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence            4578999999999999864 68999999997532    223457889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++..+....
T Consensus        85 ~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          85 GGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999998653      4588999999999999999999998   99999999999999999999999999987543211


Q ss_pred             ce------------------------------------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHH
Q 038768          245 SF------------------------------------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV  288 (386)
Q Consensus       245 ~~------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ell  288 (386)
                      ..                                    .......||+.|+|||++.+.  .++.++|||||||++|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhh
Confidence            00                                    001124589999999998654  6899999999999999999


Q ss_pred             hCCCCcccccccCCcccchhhhhhhcCCCc-cccc--cccCChHHHHHHHHHHHHHHHhcCC---CCCCCCCC
Q 038768          289 VGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-EFQL--AGVVTEEEKEMAKKMILVLEMLEGS---TEDLQIPP  355 (386)
Q Consensus       289 tg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~--~~~~s~~~~~li~~ml~v~~~L~~~---~~~~~~~p  355 (386)
                      +|+.||.....        ......+.... ...+  ...++++.++++.+|+. ++.-|..   +.++..+|
T Consensus       234 ~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         234 VGYPPFCSDNP--------QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             cCCCCCCCCCH--------HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            99999976532        22222222211 1222  23578999999999996 6666665   55555544

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-40  Score=309.92  Aligned_cols=238  Identities=22%  Similarity=0.294  Sum_probs=195.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|... +++.||+|++.+..    ...+.+..|..++..+ +|++|+.+++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            34578999999999999864 57899999997532    1224566788888776 589999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|..++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          83 VNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999988543      4588899999999999999999998   999999999999999999999999999875432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+.... ..+
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~-~~~  220 (323)
T cd05616         154 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN-VAY  220 (323)
T ss_pred             CCC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCC
Confidence            211  12235689999999999764  689999999999999999999999986432        34445554443 456


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      +..++.++.+++.+|+..++.-|.+.
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            77899999999999999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-40  Score=299.49  Aligned_cols=245  Identities=28%  Similarity=0.425  Sum_probs=204.7

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||++.+.++..+|+|.+.......+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC   85 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence            34567899999999999998888899999988766677889999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.++........ 
T Consensus        86 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          86 LLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999986532     3578999999999999999999998   9999999999999999999999999999865433221 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......++..|+|||++...  .++.++||||||+++|||++ |+.||.....        ....+.+..+.....+...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~~  226 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRLYRPKLA  226 (256)
T ss_pred             ccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCC
Confidence            11233456689999998654  68899999999999999999 8999975422        3344455555444456667


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+++.+|+..++..|+++.++
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l  251 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAEL  251 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHH
Confidence            8899999999999999999876654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-40  Score=314.54  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=200.6

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.+.||+|+||.||+++.. +++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            4455688999999999999864 68899999997532    233457789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++..       ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       124 y~~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         124 YMPGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999854       2477888999999999999999998   99999999999999999999999999998654


Q ss_pred             cccceeeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-  318 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-  318 (386)
                      ..... ......||+.|+|||++.+..  ..++.++|||||||++|||++|+.||.....        ...+..+.... 
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~  264 (370)
T cd05596         194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKN  264 (370)
T ss_pred             CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC
Confidence            33211 122456999999999986531  2478899999999999999999999986532        23334443322 


Q ss_pred             ccccc--ccCChHHHHHHHHHHHHHHHh--cCCCCCCCCCCC
Q 038768          319 EFQLA--GVVTEEEKEMAKKMILVLEML--EGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~--~~~s~~~~~li~~ml~v~~~L--~~~~~~~~~~p~  356 (386)
                      ...++  ..++.++++++++||...+.-  |.+++++..+|-
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            22233  357999999999999876654  667777766653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-40  Score=302.51  Aligned_cols=248  Identities=26%  Similarity=0.360  Sum_probs=198.9

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||+|+||+||++... +|+.||+|.+.....    ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999864 688999999875322    224577899999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      ..++....  .....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++.........  
T Consensus        81 ~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--  153 (280)
T cd05608          81 RYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--  153 (280)
T ss_pred             HHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence            98875432  1225689999999999999999999998   9999999999999999999999999999765443221  


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....|++.|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+...+... ...++..+++
T Consensus       154 ~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~  226 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILND-SVTYPDKFSP  226 (280)
T ss_pred             ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhccc-CCCCcccCCH
Confidence            2234689999999999764  68899999999999999999999997543211    112222333222 2345667899


Q ss_pred             HHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      +..+++.+|+..++.-|.+     ++++..+|
T Consensus       227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~  258 (280)
T cd05608         227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP  258 (280)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence            9999999999999999984     45555555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-40  Score=309.20  Aligned_cols=235  Identities=24%  Similarity=0.325  Sum_probs=195.4

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||+||++... +++.||+|++++..    .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 57899999997532    2335677888888877 699999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          81 GDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            9999888543      4688999999999999999999998   999999999999999999999999999875322211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......|+..|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ......+.... ..++..
T Consensus       152 --~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~-~~~~~~  218 (318)
T cd05570         152 --TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDE-VRYPRW  218 (318)
T ss_pred             --cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC-CCCCCc
Confidence              11234589999999999764  688999999999999999999999975432        33444444333 456677


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ++++..+++++|+..++.-|+++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCC
Confidence            89999999999999999999887

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=318.63  Aligned_cols=231  Identities=25%  Similarity=0.348  Sum_probs=184.8

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.++||+|+||.||++.. .+|+.||||++.....    ..+.+.+|++++.+++||||+++++++.+.+..|+||||++
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~   84 (377)
T cd05629           5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP   84 (377)
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence            457899999999999975 4689999999865321    22567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          85 GGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999998543      4578899999999999999999998   99999999999999999999999999986332100


Q ss_pred             ce------------e---------------------------------eeccccCccccccccccchhcCCCCccchhHh
Q 038768          245 SF------------I---------------------------------SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYS  279 (386)
Q Consensus       245 ~~------------~---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  279 (386)
                      ..            .                                 ......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS  233 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEe
Confidence            00            0                                 00124589999999998654  6889999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-cccccc--ccCChHHHHHHHHHHH
Q 038768          280 YGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-NEFQLA--GVVTEEEKEMAKKMIL  339 (386)
Q Consensus       280 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~--~~~s~~~~~li~~ml~  339 (386)
                      |||++|||++|+.||.....        ...+..+... ....++  ..++.++++++.+|+.
T Consensus       234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~  288 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENS--------HETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT  288 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999999999975432        2222333221 112222  2578999999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-40  Score=314.59  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.+.||+|+||.||++... +++.+|+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            3455688999999999999864 58899999986421    233457899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++..       ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++....
T Consensus       124 y~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         124 YMPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999853       2478889999999999999999998   99999999999999999999999999998664


Q ss_pred             cccceeeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-c
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-N  318 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~  318 (386)
                      .... .......||+.|+|||++.+..  +.++.++|||||||++|||++|+.||.....        ......+... .
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~  264 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKN  264 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCc
Confidence            3322 1223456999999999986532  2378899999999999999999999986532        2223333322 1


Q ss_pred             ccccc--ccCChHHHHHHHHHHHHHHHh--cCCCCCCCCCCC
Q 038768          319 EFQLA--GVVTEEEKEMAKKMILVLEML--EGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~--~~~s~~~~~li~~ml~v~~~L--~~~~~~~~~~p~  356 (386)
                      ...++  ..++...++++.+|+...+.-  |.+++++..||-
T Consensus       265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            22233  357999999999999632221  345555555553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-40  Score=299.29  Aligned_cols=241  Identities=25%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||+|+||.||++... +|+.+|+|++.....    ....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999864 589999999864321    234556799999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........   
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---  150 (277)
T cd05607          81 KYHIYNVG----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---  150 (277)
T ss_pred             HHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence            98885432    24588999999999999999999998   999999999999999999999999999876654322   


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+.+.............+++
T Consensus       151 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  224 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLEDEVKFEHQNFTE  224 (277)
T ss_pred             eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhccccccccccCCH
Confidence            1234588999999998764  58899999999999999999999997542211    11222233222222222346899


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +.++++.+|+..++.-|+++.+
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~  246 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSRE  246 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCcc
Confidence            9999999999999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=307.45  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=213.6

Q ss_pred             hhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ++.+.||+|.|..|-+|+ .-+|..||||++.+.+.+   ...+.+|++.|+.++|||||++|++.......|||+|.-+
T Consensus        21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD  100 (864)
T KOG4717|consen   21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD  100 (864)
T ss_pred             hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence            345679999999999996 358999999999886554   3678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~  243 (386)
                      +|+|.+|+.+++     ..+.+..+.+++.||+.|+.|+|..   .+|||||||+||.+. .-|-+||.|||++..+...
T Consensus       101 ~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen  101 GGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             CchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999998765     5689999999999999999999998   999999999999886 4678999999999877665


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..   ..+.+|+..|-|||.+.+. ....+++||||||||||.|++|+.||+..++        .+....|..-+ +.++
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeAND--------SETLTmImDCK-YtvP  239 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEAND--------SETLTMIMDCK-YTVP  239 (864)
T ss_pred             ch---hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccc--------hhhhhhhhccc-ccCc
Confidence            44   3466799999999999886 3556899999999999999999999986544        44556666665 7789


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+|.+.++||.+||.-++.-|.+.+++..++
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~  271 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEEIVSTS  271 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence            99999999999999999999998888876553

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.4e-41  Score=326.33  Aligned_cols=253  Identities=24%  Similarity=0.290  Sum_probs=206.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecC--------c
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKK--------K  155 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~  155 (386)
                      +.+.+.||+|+||+||+|+. .+|+.||||++......   ...+.+|+..+..++|+|++++.+.+...+        .
T Consensus        34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~  113 (496)
T PTZ00283         34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM  113 (496)
T ss_pred             EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence            34567899999999999975 57899999999764433   245788999999999999999988775432        3


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .++||||+++|+|.+++.....  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       114 i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        114 IALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             EEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence            5799999999999999865431  235688999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      +++...............||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+.
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~~~  258 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHKTL  258 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHh
Confidence            99865443222222345699999999999764  689999999999999999999999975422        34445555


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+....++..+++++.+++.+|+..++..|++..++..+|
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            5555567788999999999999999999999888766554

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-40  Score=315.65  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=201.4

Q ss_pred             HHHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEEEEEecCc
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKK  155 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  155 (386)
                      ...+.+.+.||+|+||.||+|..      .++..||||+++....  ..+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            33456678999999999999963      2456899999975432  335688999999999 89999999999999999


Q ss_pred             eeEEEEeCCCCCHHHHhcccccc---------------------------------------------------------
Q 038768          156 RALIYEFMPNGSLDQFIYDEESS---------------------------------------------------------  178 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  178 (386)
                      .++||||+++|+|.+++......                                                         
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999999999998653210                                                         


Q ss_pred             ------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          179 ------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       179 ------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                                  .....+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                        0012578899999999999999999998   9999999999999999999999999999866543322


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .......++..|+|||++.+.  .++.++|||||||++|||++ |..||.....       .....+.+..+.....+..
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~  341 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIKEGYRMLSPEC  341 (375)
T ss_pred             cccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHHhCccCCCCCC
Confidence            212223456789999998654  68899999999999999998 8888865321       1233444444444445566


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.++++++.+|+..++.-|+++.++
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~ei  367 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQI  367 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHH
Confidence            78899999999999999988876654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=299.49  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=207.0

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecC---CCCChHHHHHHHHHhhcCCCCccceEEEEEEe-----cCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGFCYE-----KKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~  162 (386)
                      +.||+|+||.|+.+.. .+|+.||||.+.+   .....++-.+|+++|+.++|+||+.+++++..     -...|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            5699999999999986 4689999999874   33445778899999999999999999999876     2467999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      | ..+|...++..      ..++...+..++.|+++||.|+|+.   +++||||||+|+|++.+..+||+|||+|+....
T Consensus       108 M-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  108 M-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             H-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence            9 78999999653      4589999999999999999999999   999999999999999999999999999998765


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhcC
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHIE  315 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i~  315 (386)
                      ......+...+.|..|.|||.+... ..|+.+.||||.|||+.||++|++-|.+.+....-       ...+.+....|.
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3222234556789999999999765 68999999999999999999999999877542110       001122222322


Q ss_pred             CCc---------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          316 PGN---------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       316 ~~~---------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ...               ...+-...++++-+|+.+||..++.-|.++++...||.-
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl  313 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL  313 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence            111               112345789999999999999999999999999999864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-40  Score=300.78  Aligned_cols=247  Identities=21%  Similarity=0.350  Sum_probs=200.9

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      ..+.+.+.||+|+||.||+|.+.    .+..||+|.++.....  ...+.+|+..+.+++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34556788999999999999753    3568999999864322  35688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++|+|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++|||.+..
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999986532     4688999999999999999999998   999999999999999999999999998765


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ....... ......++..|+|||.+.+.  .++.++|||||||++||+++ |+.||.....        ....+.+..+.
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~  225 (266)
T cd05064         157 DKSEAIY-TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAVEDGF  225 (266)
T ss_pred             ccccchh-cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCC
Confidence            4322211 11223456789999998653  78899999999999999875 9999975432        33445555555


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ....+..++..+.+++.+|+...+.-|++.+++
T Consensus       226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i  258 (266)
T cd05064         226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI  258 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            555677889999999999999998888876554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.9e-40  Score=305.63  Aligned_cols=236  Identities=24%  Similarity=0.320  Sum_probs=191.0

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHH-HhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVA-SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|+.. +++.||+|++....    .....+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 57899999997532    12234444544 56788999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...      ..+.+..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          81 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            9999998543      4577888899999999999999998   999999999999999999999999999875432211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...++.+.... ..+...
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~-~~~~~~  218 (325)
T cd05602         152 --TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-LQLKPN  218 (325)
T ss_pred             --CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-cCCCCC
Confidence              12245689999999998764  688999999999999999999999975432        23334443332 345567


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE  349 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~  349 (386)
                      ++.++++++.+|++.++.-|.++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAK  242 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCC
Confidence            899999999999999999988665

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.3e-41  Score=307.46  Aligned_cols=257  Identities=23%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||.||+|... +++.||+|+++....  ....+.+|+.+++.++||||+++++++.+....++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   86 (303)
T cd07869           8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-   86 (303)
T ss_pred             eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence            34578999999999999875 688999999875432  23467889999999999999999999999999999999994 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus        87 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          87 TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            68888775432     4578899999999999999999998   999999999999999999999999999875433221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------c-hhhhhhhcC--
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------F-PNSIYKHIE--  315 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~-~~~~~~~i~--  315 (386)
                        ......+++.|+|||++.+. ..++.++|||||||++|||++|+.||...........       . ....|..+.  
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              12234578999999998654 3578899999999999999999999975422110000       0 000000000  


Q ss_pred             ----CCc-----cc----c-ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          316 ----PGN-----EF----Q-LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       316 ----~~~-----~~----~-~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                          +..     ..    . -...++.++++++.+|++.++.-|.+++++..||--
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f  291 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF  291 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence                000     00    0 011246789999999999999999999998888764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.5e-40  Score=307.70  Aligned_cols=243  Identities=21%  Similarity=0.296  Sum_probs=197.4

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||++... +++.||+|+++....    ..+.+.+|+.++.++ +|+||+.+++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 578999999986422    234577899998888 699999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          81 GDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            9999888543      4689999999999999999999998   999999999999999999999999999875322211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||....... .......+++.+... ...++..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~-~~~~p~~  225 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEK-PIRIPRF  225 (327)
T ss_pred             --ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhC-CCCCCCC
Confidence              12245689999999998654  68899999999999999999999997542211 111223344444433 3557788


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE  349 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~  349 (386)
                      ++.++.+++.+|+..++.-|.+..
T Consensus       226 ~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         226 LSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCC
Confidence            999999999999999999997653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-40  Score=302.11  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=206.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCC------CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      ..+.+.+.||+|+||.||+|...+      +..||+|.++.....  .+.+.+|++++..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            345567889999999999997633      478999999765433  468999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccccc--------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCce
Q 038768          158 LIYEFMPNGSLDQFIYDEES--------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP  229 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  229 (386)
                      +||||+++++|.+++.....        ......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999975432        12234588999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchh
Q 038768          230 KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPN  308 (386)
Q Consensus       230 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  308 (386)
                      +|+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~  231 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------E  231 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------H
Confidence            99999999765433322212233457789999998654  68899999999999999998 9999875422        3


Q ss_pred             hhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          309 SIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       309 ~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ...+.+..+.....+..++.+..+++.+|+..++.-|++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  274 (280)
T cd05049         232 EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI  274 (280)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            3445555665555677889999999999999998888876553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=298.14  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      ....+.+.+.||+|+||.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34445667899999999999999877889999999876666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+++.....
T Consensus        84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999986532    24688999999999999999999998   9999999999999999999999999999876532


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      .. ....+...+..|+|||++.+.  .++.++||||||+++|||++ |+.||....        +..+...+........
T Consensus       157 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~  225 (261)
T cd05068         157 IY-EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAEVLQQVDQGYRMPC  225 (261)
T ss_pred             cc-cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCC
Confidence            21 111122334579999998654  68899999999999999999 999997542        2334445544433445


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++++.+++.+|+..++.-|+++.++
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l  254 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETL  254 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            66789999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-40  Score=315.14  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             HHHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCc
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKK  155 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  155 (386)
                      ...+.+.+.||+|+||.||+|..      .++..||+|+++.....  .+.+.+|+++++.+ +|+||++++++|.+.+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            34455678999999999999874      23458999999754322  35688999999999 89999999999999999


Q ss_pred             eeEEEEeCCCCCHHHHhcccccc---------------------------------------------------------
Q 038768          156 RALIYEFMPNGSLDQFIYDEESS---------------------------------------------------------  178 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  178 (386)
                      .++||||+++|+|.+++......                                                         
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999998643210                                                         


Q ss_pred             -------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeecc
Q 038768          179 -------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG  251 (386)
Q Consensus       179 -------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  251 (386)
                             .....+++..++.++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                   0113478889999999999999999998   999999999999999999999999999986544332222222


Q ss_pred             ccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCChHH
Q 038768          252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEE  330 (386)
Q Consensus       252 ~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~  330 (386)
                      ..++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....       ....++.+..+.....+..+++++
T Consensus       274 ~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l  344 (374)
T cd05106         274 ARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQMSRPDFAPPEI  344 (374)
T ss_pred             CCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccCccCCCCCCHHH
Confidence            3456789999998653  68999999999999999997 9999975422       122333333443444566678999


Q ss_pred             HHHHHHHHHHHHHhcCCCCCC
Q 038768          331 KEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       331 ~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++.+|+..++.-|++..++
T Consensus       345 ~~li~~cl~~dp~~RPs~~~l  365 (374)
T cd05106         345 YSIMKMCWNLEPTERPTFSQI  365 (374)
T ss_pred             HHHHHHHcCCChhhCcCHHHH
Confidence            999999999999988876543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.8e-40  Score=307.22  Aligned_cols=236  Identities=25%  Similarity=0.300  Sum_probs=192.1

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHH-HhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVA-SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||+||+|.. .+|+.||+|++....    .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3699999999999986 468999999997532    22244555655 46779999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            9999888543      4688999999999999999999998   999999999999999999999999999875322211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......|+..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+.... ..+...
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~-~~~~~~  218 (325)
T cd05604         152 --TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKP-LVLRPG  218 (325)
T ss_pred             --CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCC-ccCCCC
Confidence              12245689999999998664  688999999999999999999999976432        33444444433 344556


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTE  349 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~  349 (386)
                      .+.+..+++++|+..++.-|++..
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCC
Confidence            899999999999999998887654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-40  Score=306.42  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=195.6

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC-----------------CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD-----------------GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFL  147 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~  147 (386)
                      .+.+.++||+|+||.||+|.+.+                 +..||+|.+.....  ...++.+|++++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            34456889999999999997532                 33799999876432  235789999999999999999999


Q ss_pred             EEEEecCceeEEEEeCCCCCHHHHhcccccc-------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 038768          148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESS-------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHF  214 (386)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~  214 (386)
                      +++.+.+..++||||+++|+|.+++......             .....+++..++.++.||+.||.|||+.   +++||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence            9999999999999999999999998653211             1123478889999999999999999998   99999


Q ss_pred             CCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh--CCC
Q 038768          215 DIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV--GRK  292 (386)
Q Consensus       215 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt--g~~  292 (386)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++...  .++.++||||||+++|||++  +..
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999866544332222234467889999998653  68999999999999999987  456


Q ss_pred             CcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          293 NAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       293 p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ||........ ...................+..++.++.+++.+|+..++.-|++++++
T Consensus       241 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i  298 (304)
T cd05096         241 PYGELTDEQV-IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI  298 (304)
T ss_pred             CCCcCCHHHH-HHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            7764321100 000000111111111222345678899999999999999999887654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=315.22  Aligned_cols=248  Identities=24%  Similarity=0.319  Sum_probs=202.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||+||+|... +|+.||+|+++...    .....+..|++++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            34578999999999999864 68999999997532    33456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          84 PGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999653      4688999999999999999999998   9999999999999999999999999999866543


Q ss_pred             c---------------------------ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccc
Q 038768          244 E---------------------------SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV  296 (386)
Q Consensus       244 ~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~  296 (386)
                      .                           .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00112234689999999999764  789999999999999999999999986


Q ss_pred             ccccCCcccchhhhhhhcCC---CccccccccCChHHHHHHHHHHHHHHHhcCC-CCCCCCCCC
Q 038768          297 KVSLSSEIYFPNSIYKHIEP---GNEFQLAGVVTEEEKEMAKKMILVLEMLEGS-TEDLQIPPK  356 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~-~~~~~~~p~  356 (386)
                      ...        ...+..+..   .........+++++.+++.+|+. ++.-|.+ ++++..+|-
T Consensus       233 ~~~--------~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         233 DTL--------QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CCH--------HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            532        222333322   11122233369999999999997 8888888 777766653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-40  Score=315.83  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=193.5

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+++. .+++.||+|++....    .....+.+|++++.+++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            3457899999999999986 458999999986532    23456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        84 ~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          84 PGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999653      4578889999999999999999998   9999999999999999999999999997532100


Q ss_pred             c-----------------------------------------ceeeeccccCccccccccccchhcCCCCccchhHhHHH
Q 038768          244 E-----------------------------------------SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGM  282 (386)
Q Consensus       244 ~-----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGv  282 (386)
                      .                                         .........||+.|+|||++.+.  .++.++|||||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  232 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccc
Confidence            0                                         00001134699999999998764  6889999999999


Q ss_pred             HHHHHHhCCCCcccccccCCcccchhhhhhhcC---CCccccccccCChHHHHHHHHHHHHHHHhcC---CCCCCCCCC
Q 038768          283 MILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE---PGNEFQLAGVVTEEEKEMAKKMILVLEMLEG---STEDLQIPP  355 (386)
Q Consensus       283 il~elltg~~p~~~~~~~~~~~~~~~~~~~~i~---~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~---~~~~~~~~p  355 (386)
                      ++|||++|+.||.....        ......+.   ..........++.+..+++.+|+. .+.-|.   ++.++..+|
T Consensus       233 ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~  302 (376)
T cd05598         233 ILYEMLVGQPPFLADTP--------AETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHP  302 (376)
T ss_pred             eeeehhhCCCCCCCCCH--------HHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCC
Confidence            99999999999986532        12222221   111222334689999999999764 666665   556665554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-41  Score=302.81  Aligned_cols=244  Identities=30%  Similarity=0.519  Sum_probs=197.5

Q ss_pred             hhhccCcCCceEEEEEEeC-----CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.||.|+||.||+|.+.     .+..|+||.++.....  .+.+.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999875     2568999999653322  47899999999999999999999999988889999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++....    ...+++..++.++.||+.||.|||+.   +++|+||+++|||+++++.+||+|||++.....
T Consensus        83 ~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             -TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999997651    25689999999999999999999998   999999999999999999999999999987743


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...............|+|||.+.+.  .++.++||||||+++|||++ |+.||....        ...+...+.++....
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~~~~~~~~  225 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKLKQGQRLP  225 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHHHTTEETT
T ss_pred             ccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc--------cccccccccccccce
Confidence            3333333344577899999998764  58999999999999999999 678886542        244556666666666


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+..++.+..+++.+|+..++..||+..+
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~  254 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQE  254 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHH
Confidence            77789999999999999999999987654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.8e-40  Score=315.28  Aligned_cols=246  Identities=22%  Similarity=0.285  Sum_probs=191.4

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.++||+|+||.||+|+. .+++.||+|++.....    ..+.+.+|++++++++|+||+++++.+.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            457899999999999986 4688999999975322    23567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          85 GGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999998653      3578889999999999999999998   99999999999999999999999999975321100


Q ss_pred             c---------------------------------------------eeeeccccCccccccccccchhcCCCCccchhHh
Q 038768          245 S---------------------------------------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYS  279 (386)
Q Consensus       245 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  279 (386)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001124689999999998764  6889999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC-Cc--cccccccCChHHHHHHHHHHHHHHHhcCC---CCCCCC
Q 038768          280 YGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP-GN--EFQLAGVVTEEEKEMAKKMILVLEMLEGS---TEDLQI  353 (386)
Q Consensus       280 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~-~~--~~~~~~~~s~~~~~li~~ml~v~~~L~~~---~~~~~~  353 (386)
                      |||++|||++|+.||.....        ......+.. ..  .......++++..+++.+|+. ++.-|..   ++++..
T Consensus       234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  304 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTP--------LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKA  304 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCH--------HHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhc
Confidence            99999999999999976432        222222211 11  122234679999999999864 5554443   455555


Q ss_pred             CC
Q 038768          354 PP  355 (386)
Q Consensus       354 ~p  355 (386)
                      ||
T Consensus       305 hp  306 (382)
T cd05625         305 HP  306 (382)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.5e-41  Score=312.21  Aligned_cols=250  Identities=24%  Similarity=0.279  Sum_probs=201.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++... +|+.||+|+++....    ..+.+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            34578999999999999864 689999999985432    3356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....     ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          84 PGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999996542     4688999999999999999999998   9999999999999999999999999999876543


Q ss_pred             cceeeeccccCccccccccccchh----cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN----FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-  318 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-  318 (386)
                      ... ......||+.|+|||++...    ...++.++|||||||++|||++|+.||.....        ...+..+.... 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~  226 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQR  226 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            322 12234689999999998631    23578899999999999999999999975432        22233332221 


Q ss_pred             --cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 --EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 --~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                        .......++.++.+++.+|+. ++.-|++.+++..||.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence              122234579999999999998 8888888887776653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=294.90  Aligned_cols=245  Identities=27%  Similarity=0.431  Sum_probs=203.4

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      ..+.+.||+|+||.||++.+.++..+|+|.+.........+.+|+++++.++|+||+++++++.+.+..++||||+++++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC   85 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence            34568899999999999998777889999998766667789999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........ 
T Consensus        86 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          86 LLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            999986532     3588999999999999999999998   9999999999999999999999999999865433221 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ......+..+.....+..+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  226 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVSAGYRLYRPKLA  226 (256)
T ss_pred             ccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHHcCCcCCCCCCC
Confidence            11122345579999998654  68889999999999999999 8999975422        2334455555445556678


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+++.+|+...+.-|++++++
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~  251 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKL  251 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHH
Confidence            9999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-40  Score=311.68  Aligned_cols=235  Identities=23%  Similarity=0.312  Sum_probs=189.8

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      ..+.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            34455689999999999999864 57899999986422    22345778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++|+|.+++..       ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       123 Ey~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         123 EYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             cCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999854       2477888999999999999999998   9999999999999999999999999999866


Q ss_pred             CcccceeeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ..... .......||+.|+|||++....  +.++.++|||||||++|||++|+.||.....        ...++.+....
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~  263 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHK  263 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC
Confidence            43321 1123456999999999986532  2378899999999999999999999986532        22334443222


Q ss_pred             ---cccccccCChHHHHHHHHHHH
Q 038768          319 ---EFQLAGVVTEEEKEMAKKMIL  339 (386)
Q Consensus       319 ---~~~~~~~~s~~~~~li~~ml~  339 (386)
                         .+.....++.++++++.+|+.
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~  287 (371)
T cd05622         264 NSLTFPDDNDISKEAKNLICAFLT  287 (371)
T ss_pred             CcccCCCcCCCCHHHHHHHHHHcC
Confidence               122234689999999999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.4e-40  Score=298.40  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=204.3

Q ss_pred             hhhhccCcCCceEEEEEEeCC------CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.||+|+||.||+|....      ...||+|.++....  ....+.+|+..+..++||||+++++++.+....+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            456789999999999997532      25799999875432  2356889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          161 EFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      ||+++++|.+++......          .....+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence            999999999999654221          1124588899999999999999999998   999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNS  309 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  309 (386)
                      |+|||+++...............++..|+|||.+.+.  .++.++|||||||++|||++ |..||....        +..
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~--------~~~  234 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------NQE  234 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence            9999999865443322222234567889999998653  68899999999999999998 999997542        244


Q ss_pred             hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       310 ~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+.+..+.....+..++.++.+++.+|+..++.-|+++.++
T Consensus       235 ~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i  276 (283)
T cd05048         235 VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI  276 (283)
T ss_pred             HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            556666666566678899999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-40  Score=302.55  Aligned_cols=255  Identities=20%  Similarity=0.263  Sum_probs=198.5

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+++.. +++.||+|+++...   ...+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            44678999999999999875 57899999997543   234568899999999999999999999999999999999998


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ++.+..+...      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          84 KNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            8777655422      24588999999999999999999998   99999999999999999999999999998764322


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhcCCC
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHIEPG  317 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i~~~  317 (386)
                      .. ......|+..|+|||++.+.  .++.++|||||||++|||++|+.||......+..       ...+...++.+...
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             cc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence            11 11234588999999998654  6889999999999999999999999764321100       00111111110000


Q ss_pred             ------c----------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 ------N----------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 ------~----------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                            .          .......++.++.+++++|+..++.-|++++++..||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence                  0          1112334788999999999999999999998887766

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-40  Score=296.12  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=203.3

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS   87 (261)
T ss_pred             eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence            34568899999999999998888899999988666667889999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......... 
T Consensus        88 L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          88 LLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             HHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            999986532    24578889999999999999999998   9999999999999999999999999999876543221 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......++..|+|||++...  .++.++|||||||++|+|++ |+.||.....        ......+..+........+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  229 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSALQRGYRMPRMENC  229 (261)
T ss_pred             ccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC
Confidence            11223456789999998653  67889999999999999998 9999975421        2333444444334445568


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+++.+|+...+.-|++++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i  254 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYL  254 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHH
Confidence            8999999999999999888877654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.2e-40  Score=304.12  Aligned_cols=238  Identities=23%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ++.+.||+|+||+||+|... +|+.||+|++.+..    ...+.+..|..++..+. |++|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            45688999999999999864 68899999997532    22345778888888875 57788899999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          83 VNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999998543      4588999999999999999999998   999999999999999999999999999875432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+.... ..+
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~-~~~  220 (323)
T cd05615         154 DGV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN-VSY  220 (323)
T ss_pred             CCc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCC
Confidence            221  11234589999999998654  688999999999999999999999986422        33444444433 456


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      +..++.+..+++.+|+..++.-|.+.
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            77889999999999999999888754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.7e-40  Score=300.23  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             hhhhccCcCCceEEEEEEe--CCCcEEEEEEecCCC---CChHHHHHHHHHhhcC---CCCccceEEEEEEe-----cCc
Q 038768           89 SFSNKLGQGGFGSVYKGKL--PDGRLVAVKVLKNSK---VNGEEFINEVASMSKT---SHVNVVSFLGFCYE-----KKK  155 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~  155 (386)
                      .+.+.||+|+||.||+|..  .+|+.||+|.++...   .....+.+|+.+++.+   +||||++++++|..     ...
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~   83 (290)
T cd07862           4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   83 (290)
T ss_pred             ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence            4557899999999999986  246889999987532   2234566777777665   69999999999863     346


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .++||||++ ++|.+++....    ...+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          84 LTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             EEEEEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            889999995 69999886532    24588999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------c
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------E  303 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~  303 (386)
                      +++.......   .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||........            .
T Consensus       156 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         156 LARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             ceEeccCCcc---cccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            9976543321   2234589999999998654  688999999999999999999999986532110            0


Q ss_pred             ccchh------hhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          304 IYFPN------SIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       304 ~~~~~------~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..++.      ..+..........+...+++..++++.+|+..++.-|+++.++..+|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp  288 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  288 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence            00000      00000000001112345789999999999999999999988877666

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-40  Score=294.70  Aligned_cols=245  Identities=25%  Similarity=0.436  Sum_probs=203.7

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||+|...++..+|+|.+.......+++.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC   85 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence            34567899999999999988777789999998766667889999999999999999999999999889999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..++.++.||+.||+|||+.   +++|+||||+||++++++.+||+|||.++....... .
T Consensus        86 l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          86 LLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            999986532     3588999999999999999999998   999999999999999999999999999886544322 1


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......++..|+|||++.+.  .++.++|||||||++|+|++ |+.||.....        ..+...+..+.....+...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  226 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLYRPHLA  226 (256)
T ss_pred             ecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCCCCCCCC
Confidence            22233456789999998653  68889999999999999999 9999875422        3344455555445556667


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+++.+|+..++.-|+++.++
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~l  251 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQL  251 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHH
Confidence            8999999999999999888876554

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.8e-40  Score=305.81  Aligned_cols=254  Identities=24%  Similarity=0.333  Sum_probs=200.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ...+.||+|+||.||++... +|..+|+|.+.....  ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (331)
T cd06649           8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   87 (331)
T ss_pred             eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence            34578999999999999864 688999999875422  235789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++...      ..+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||++....... 
T Consensus        88 ~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          88 GSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999998553      4588999999999999999999985  269999999999999999999999999987654322 


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC-----------Ccccch-------
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS-----------SEIYFP-------  307 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-----------~~~~~~-------  307 (386)
                         .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||.......           +....+       
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence               1234589999999998754  68899999999999999999999996432100           000000       


Q ss_pred             --------------------hhhhhhcCCCccccc-cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          308 --------------------NSIYKHIEPGNEFQL-AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       308 --------------------~~~~~~i~~~~~~~~-~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                          ......+.....+.. ...+++++++++.+|+..++.-|++++++..+|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                001111111111111 2357899999999999999999999999888774

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-39  Score=304.23  Aligned_cols=236  Identities=21%  Similarity=0.278  Sum_probs=187.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.++||+|+||.||+++.. +++.+|+|++.+.    ......+..|+.++..++|+||+.+++++.+.+..++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            34578999999999999875 4788999998642    122345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....     ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999996532     4588899999999999999999998   9999999999999999999999999998754332


Q ss_pred             cceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--  318 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--  318 (386)
                      ... ......||+.|+|||++...   ...++.++|||||||++|||++|+.||.....        ......+....  
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~  226 (332)
T cd05623         156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKER  226 (332)
T ss_pred             Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCcc
Confidence            221 11234689999999998531   23578899999999999999999999975432        22233332221  


Q ss_pred             --cccccccCChHHHHHHHHHHHHH
Q 038768          319 --EFQLAGVVTEEEKEMAKKMILVL  341 (386)
Q Consensus       319 --~~~~~~~~s~~~~~li~~ml~v~  341 (386)
                        .+.....++++.++++++|+...
T Consensus       227 ~~~p~~~~~~s~~~~~li~~ll~~~  251 (332)
T cd05623         227 FQFPAQVTDVSEDAKDLIRRLICSR  251 (332)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCh
Confidence              12223467999999999999643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.4e-40  Score=303.71  Aligned_cols=245  Identities=28%  Similarity=0.438  Sum_probs=197.0

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCc----EEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +...+.||+|+||.||+|.+. +|.    .||+|.++...  ...+++.+|+.+++.++||||++++|+|... ..++|+
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            344578999999999999853 343    48999987533  2346788999999999999999999999764 578999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++|+|.+++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++..
T Consensus        88 e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          88 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999996542     4578899999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      .............++..|+|||++.+.  .++.++|||||||++|||++ |+.||+....        ..+.+.+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~  229 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGER  229 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence            544332222233456789999998654  68999999999999999998 9999975421        233344444444


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..++.+..+++.+|+..++.-|++..++
T Consensus       230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l  261 (316)
T cd05108         230 LPQPPICTIDVYMIMVKCWMIDADSRPKFREL  261 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            45566788999999999999888888876654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=300.01  Aligned_cols=250  Identities=27%  Similarity=0.395  Sum_probs=202.5

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.||+|+||.||++.. .+++.||+|++.....    ....+.+|+.+++.++|+||+.+++++.+.+..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05605           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence            457899999999999986 4689999999875322    22457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....    ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          84 GGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             CCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999998885432    24588999999999999999999998   99999999999999999999999999998654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .   .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+...+... ....+.
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~-~~~~~~  226 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKED-QEEYSE  226 (285)
T ss_pred             c---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhc-ccccCc
Confidence            2   1234688999999998654  68899999999999999999999998543211    112222333332 244566


Q ss_pred             cCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEG-----STEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p~  356 (386)
                      .+++...+++.+|+..++.-|+     +++++..+|-
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence            7899999999999999999999     6666666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.1e-41  Score=294.92  Aligned_cols=252  Identities=27%  Similarity=0.335  Sum_probs=195.3

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCc-----eeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK-----RALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~  165 (386)
                      +.+|+|+||.||+|... ++..||||..-.+..-   --+|+.+|+.++|||||++.-+|.....     ..+||||+| 
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-  105 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-  105 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-
Confidence            67999999999999864 4789999987654321   1379999999999999999988875432     348999995 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCcccCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~  244 (386)
                      .+|..+++...  ..+..++...+.-+..||++||.|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.+..++
T Consensus       106 ~tL~~~~r~~~--~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  106 ETLYRVIRHYT--RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             HHHHHHHHHHh--hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            58888886432  2235677788888999999999999998   99999999999999965 899999999999886655


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------------------cc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------------------IY  305 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------------------~~  305 (386)
                      ...+   -..|..|+|||.+.+. ..|+.+.||||.||++.||+-|++-|.+.+..+.-                   ..
T Consensus       181 pniS---YicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  181 PNIS---YICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             Ccee---EEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            4332   2367889999999887 58999999999999999999999999876542210                   00


Q ss_pred             chhhhhhhcCCCcccc-ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          306 FPNSIYKHIEPGNEFQ-LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       306 ~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+..+.++....... +....+++.-+++.+++...+..|-++.++-.+|.
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence            0011122333333222 56778999999999999999999987776666553

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=309.41  Aligned_cols=234  Identities=25%  Similarity=0.343  Sum_probs=188.8

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcC---CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKT---SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ||+|+||+||+|+.. +|+.||+|++.+...    ....+..|..++...   +||||+.+++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999864 589999999864321    123345566666554   699999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|..++...      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++........
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence            9999988543      4688999999999999999999998   999999999999999999999999999875432221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......||..|+|||++.+. ..++.++|||||||++|+|++|+.||.....        ...++.+..+........
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~  220 (330)
T cd05586         152 --TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGKVRFPKNV  220 (330)
T ss_pred             --CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCcc
Confidence              12245689999999998654 3578999999999999999999999975422        344455554442222345


Q ss_pred             CChHHHHHHHHHHHHHHHhcCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ++++.++++.+|+..++.-|++
T Consensus       221 ~~~~~~~li~~~L~~~P~~R~~  242 (330)
T cd05586         221 LSDEGRQFVKGLLNRNPQHRLG  242 (330)
T ss_pred             CCHHHHHHHHHHcCCCHHHCCC
Confidence            7999999999999999999973

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-39  Score=302.22  Aligned_cols=237  Identities=23%  Similarity=0.310  Sum_probs=188.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+++.. +++.||+|++.+..    .....+.+|..++..++|+||+.+++++.+.+..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            34578999999999999864 57899999987522    22345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          84 VGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999996532     4578899999999999999999998   9999999999999999999999999999766543


Q ss_pred             cceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-NE  319 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~~  319 (386)
                      .... .....|++.|+|||++.+.   .+.++.++|||||||++|||++|+.||.....        ......+... ..
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~  226 (331)
T cd05624         156 GTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEER  226 (331)
T ss_pred             Ccee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCc
Confidence            3211 1234689999999998542   13578899999999999999999999975432        2222333221 11


Q ss_pred             ccc---cccCChHHHHHHHHHHHHHH
Q 038768          320 FQL---AGVVTEEEKEMAKKMILVLE  342 (386)
Q Consensus       320 ~~~---~~~~s~~~~~li~~ml~v~~  342 (386)
                      ..+   ...+++++++++.+|+...+
T Consensus       227 ~~~p~~~~~~~~~~~~li~~ll~~~~  252 (331)
T cd05624         227 FQFPSHITDVSEEAKDLIQRLICSRE  252 (331)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCch
Confidence            222   23578999999999987544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.1e-40  Score=311.17  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=194.1

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||.||++... +++.||+|+++..    ......+.+|+.++..++|+||+++++.+.+.+..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            3578999999999999864 6899999999742    2233567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++.......
T Consensus        85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          85 GGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999998643      4588999999999999999999998   99999999999999999999999999987543211


Q ss_pred             ce---------------------------------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC
Q 038768          245 SF---------------------------------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR  291 (386)
Q Consensus       245 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~  291 (386)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001134689999999998764  6889999999999999999999


Q ss_pred             CCcccccccCCcccchhhhhhhcCCCc-ccccc--ccCChHHHHHHHHHHHHHHHhcCC---CCCCCCCC
Q 038768          292 KNAEVKVSLSSEIYFPNSIYKHIEPGN-EFQLA--GVVTEEEKEMAKKMILVLEMLEGS---TEDLQIPP  355 (386)
Q Consensus       292 ~p~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~--~~~s~~~~~li~~ml~v~~~L~~~---~~~~~~~p  355 (386)
                      .||.....        ...+..+.... ...++  ..+++++++++.+|+. ++.-|..   ++++..||
T Consensus       234 ~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp  294 (360)
T cd05627         234 PPFCSETP--------QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP  294 (360)
T ss_pred             CCCCCCCH--------HHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence            99976432        33334433211 12222  2478999999999763 5555542   44555555

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.7e-40  Score=294.80  Aligned_cols=246  Identities=28%  Similarity=0.438  Sum_probs=203.6

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.++||+|+||.||+|... +++.||+|.+..+.....++.+|++++++++|+||+++++++...+..++||||++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   87 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence            345678999999999999864 5889999999876555678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....    ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.........
T Consensus        88 ~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          88 NLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             cHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999986532    24588999999999999999999998   9999999999999999999999999999866543221


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                       ......++..|+|||.+.+.  .++.++|||||||++|||++ |..||....        ....++.+..+..+..+..
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~  229 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKGYRMERPEG  229 (263)
T ss_pred             -ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCCCCCCCC
Confidence             11122345679999988654  68889999999999999998 999987542        2344555555545566778


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++.++.+++.+|+..++.-|+++.++
T Consensus       230 ~~~~~~~li~~cl~~~p~~Rp~~~~l  255 (263)
T cd05052         230 CPPKVYELMRACWQWNPSDRPSFAEI  255 (263)
T ss_pred             CCHHHHHHHHHHccCCcccCCCHHHH
Confidence            89999999999999888888776543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.4e-40  Score=310.41  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCC-CCccceEEEEEEecCce
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV--NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  156 (386)
                      ..+.+.+.||+|+||.||+|...      .+..||||+++....  ..+.+.+|+++++++. ||||++++++|.+.+..
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            34455688999999999999752      134799999975332  2467899999999996 99999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccc----------------------------------------------------------
Q 038768          157 ALIYEFMPNGSLDQFIYDEESS----------------------------------------------------------  178 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------  178 (386)
                      ++|||||++|+|.+++......                                                          
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999998653210                                                          


Q ss_pred             --------------------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          179 --------------------------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       179 --------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                                                      .....+++..++.++.||+.||.|||+.   +++|+||||+|||++++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence                                            0113478888999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCccc
Q 038768          227 FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIY  305 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  305 (386)
                      +.+||+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||.....      
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~------  345 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIV------  345 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccch------
Confidence            99999999999865443322222234467889999998654  68899999999999999997 9999875421      


Q ss_pred             chhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          306 FPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       306 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                       .......+..+..+..+..++.++.+++.+|+..++.-|++..+
T Consensus       346 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~  389 (400)
T cd05105         346 -DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLH  389 (400)
T ss_pred             -hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence             12233444444445556778999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=321.27  Aligned_cols=238  Identities=29%  Similarity=0.461  Sum_probs=203.8

Q ss_pred             hhccCcCCceEEEEEEe-CCCc----EEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGR----LVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .++||+|+||+||+|.+ +.|+    +||||++......  ..++++|+-+|.+++|||+++++|+|.... ..||++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            47899999999999975 4444    7999999865443  578999999999999999999999998766 88999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      +.|+|.++++.++     ..+..+..+.|+.|||+||.|||.+   ++|||||.++||||..-..+||.|||+++.....
T Consensus       780 P~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             ccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999998754     5688899999999999999999998   9999999999999999999999999999988776


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      .......+..-.+.|||-|.+..  ..++.++|||||||.+||++| |..|++....        .++.+.+.++.....
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLsq  921 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLSQ  921 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCCC
Confidence            65555555566788999999865  489999999999999999999 9999987644        567677778877777


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      +..++-|.--++-+|.-++.+.|+.
T Consensus       922 PpiCtiDVy~~mvkCwmid~~~rp~  946 (1177)
T KOG1025|consen  922 PPICTIDVYMVMVKCWMIDADSRPT  946 (1177)
T ss_pred             CCCccHHHHHHHHHHhccCcccCcc
Confidence            8888888888887777666655553

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.6e-40  Score=305.16  Aligned_cols=257  Identities=23%  Similarity=0.332  Sum_probs=200.9

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ..+.+.++||+|+||.||++... ++..+|+|.+.....  ....+.+|+++++.++|+||++++++|.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            34455688999999999999875 588999998875422  235788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..+..++.|++.||.|||+.  .+++|+||||+|||+++++.+||+|||++.....
T Consensus        85 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          85 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999998543      4578899999999999999999974  2799999999999999999999999999875533


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-----------------
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-----------------  305 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-----------------  305 (386)
                      ..    .....|+..|+|||++.+.  .++.++|||||||++|||++|+.||...........                 
T Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         157 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            21    1234588999999998654  688999999999999999999999874321100000                 


Q ss_pred             -------------------chhhhhhhcCCCccccc-cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          306 -------------------FPNSIYKHIEPGNEFQL-AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       306 -------------------~~~~~~~~i~~~~~~~~-~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                         ........+.....+.+ ...++.++++++.+|+..++.-|+++.++..+|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~  301 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF  301 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence                               00001111111111222 2246789999999999999999999998877764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-40  Score=306.18  Aligned_cols=235  Identities=22%  Similarity=0.277  Sum_probs=187.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+++.. +++.||+|++.+.    ....+.+.+|+.++..++|+||+.+++++.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY   83 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence            34678999999999999864 5899999999742    223356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....     ..+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999995432     4588999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-c-
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-N-  318 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~-  318 (386)
                      .... .....||+.|+|||++...   ...++.++|||||||++|||++|+.||.....        ...+..+... . 
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~  226 (331)
T cd05597         156 GTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKEH  226 (331)
T ss_pred             CCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCc
Confidence            2211 1123589999999998631   23578899999999999999999999975422        1222222211 1 


Q ss_pred             --cccccccCChHHHHHHHHHHHH
Q 038768          319 --EFQLAGVVTEEEKEMAKKMILV  340 (386)
Q Consensus       319 --~~~~~~~~s~~~~~li~~ml~v  340 (386)
                        .+.....+++++++++++|+..
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~  250 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICS  250 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccC
Confidence              1222345799999999999864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-39  Score=291.03  Aligned_cols=242  Identities=24%  Similarity=0.381  Sum_probs=194.9

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.||+|+||.||+|... +|+.||+|.+.....  ....+.+|+++++.++|+||++++++|.+....++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999864 689999998864322  235789999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99985432     3578999999999999999999998   999999999999999999999999999876543211111


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      ......+..|+|||.+.+.  .++.++||||||+++|||++ |..||.....        ......+........+..++
T Consensus       153 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~  222 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRLPCPELCP  222 (252)
T ss_pred             CCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCCCcccCC
Confidence            1111234579999998653  68899999999999999998 8888865422        22333333333345566789


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+++.+|+..++.-|+++.++
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~  246 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTV  246 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHH
Confidence            999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-39  Score=297.15  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             hhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.+.+.||+|+||.||++...      ++..+|+|.+..... ..+.+.+|++++.+++|+||+++++++...+..++||
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   86 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            345678999999999999742      345689999875432 3457899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccccc-------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          161 EFMPNGSLDQFIYDEES-------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                      ||+++++|.+++.....       ......+++..++.++.|++.||+|||+.   +++||||||+||++++++.++|+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence            99999999999865421       11223589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||+++...............++..|+|||++.+.  .++.++|||||||++|+|++ |+.||.....        .....
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~~  233 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE  233 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence            9999866443322222233457789999998654  68899999999999999998 8999875422        33445


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+.....+..++.++.+++.+|+..++..|++.+++
T Consensus       234 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v  272 (288)
T cd05093         234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI  272 (288)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            566665556667789999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-39  Score=292.50  Aligned_cols=250  Identities=31%  Similarity=0.456  Sum_probs=206.3

Q ss_pred             HHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           83 VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        83 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +....+.+.++||+|+||.||+|...+++.||+|.+.......+++.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            44556677889999999999999988899999999987777778999999999999999999999986 45678999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++....    ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          82 MENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             CCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999986532    24688999999999999999999998   999999999999999999999999999976653


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      .... ......++..|+|||++...  .++.++||||||+++|||++ |+.||.....        ....+.+..+....
T Consensus       155 ~~~~-~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  223 (260)
T cd05067         155 NEYT-AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLERGYRMP  223 (260)
T ss_pred             CCcc-cccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHcCCCCC
Confidence            2211 11233456789999998653  67889999999999999999 9999975432        33344444444445


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..++.++.+++.+|+...+.-|++++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  253 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYL  253 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            567788999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-41  Score=283.69  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=207.1

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-----CCh----HHHHHHHHHhhcC-CCCccceEEEEEEecCceeEE
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-----VNG----EEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  159 (386)
                      .+.||+|..++|.++.. .+|...|+|++....     .+.    ++-.+|+.+|+++ .||+|+.+.+++..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            36799999999998865 468889999886321     112    3346799999998 599999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      +|.|+.|.|.++|...      -.+++....+|..|+..|+.|||..   +||||||||+|||++++.++||+|||++..
T Consensus       102 Fdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence            9999999999999554      5789999999999999999999998   999999999999999999999999999998


Q ss_pred             cCcccceeeeccccCccccccccccchh----cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRN----FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      +.....   ....+||++|+|||.+..+    ...|+..+|+|++|||||-|+.|-+||-....        ..+.+.|.
T Consensus       173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~Im  241 (411)
T KOG0599|consen  173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRMIM  241 (411)
T ss_pred             cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHHHH
Confidence            877654   3356799999999998533    24688999999999999999999999975422        34566777


Q ss_pred             CCccc---cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 PGNEF---QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 ~~~~~---~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +|+..   .-+.++|.+.++||.++|+|++.-|-++++...||-
T Consensus       242 eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf  285 (411)
T KOG0599|consen  242 EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF  285 (411)
T ss_pred             hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence            77721   225678999999999999999999998888777764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-39  Score=290.20  Aligned_cols=239  Identities=26%  Similarity=0.424  Sum_probs=197.4

Q ss_pred             ccCcCCceEEEEEEe---CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           93 KLGQGGFGSVYKGKL---PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +||+|+||.||+|.+   .++..+|+|+++.....   .+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999965   35789999998754332   357889999999999999999999885 45678999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++...      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            999998543      4588999999999999999999998   9999999999999999999999999999876544332


Q ss_pred             ee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          247 IS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       247 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .. .....++..|+|||.+..  ..++.++|||||||++|||++ |+.||.....        ..+.+.+..+..+..+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~  221 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMIESGERMECPQ  221 (257)
T ss_pred             eeecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCCCC
Confidence            11 122334678999998854  367889999999999999998 9999975422        34455666666666778


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++++++++.+|+..++..|++..++
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i  248 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVV  248 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHH
Confidence            899999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=310.22  Aligned_cols=248  Identities=25%  Similarity=0.343  Sum_probs=210.0

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||.|+||.||-|+. .+.+.||||.+.-+...    -++++.|+..|.+++|||++.+.|||......+|||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            5799999999999975 57889999998754322    267999999999999999999999999999999999999 67


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +-.+++.-.     ..++.+.++..|+.+.+.||+|||+.   +.||||||+.|||+++.|.|||+|||.+.......  
T Consensus       111 SAsDlleVh-----kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--  180 (948)
T KOG0577|consen  111 SASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--  180 (948)
T ss_pred             cHHHHHHHH-----hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence            777777433     36788999999999999999999998   99999999999999999999999999998776553  


Q ss_pred             eeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-cc
Q 038768          247 ISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-AG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~  324 (386)
                          .++||+.|||||++.. ..+.|+-++||||||++..||...++|.-..+.        .....+|..+..|.+ .+
T Consensus       181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------MSALYHIAQNesPtLqs~  248 (948)
T KOG0577|consen  181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPTLQSN  248 (948)
T ss_pred             ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--------HHHHHHHHhcCCCCCCCc
Confidence                4679999999999853 226799999999999999999999999654433        445567777777776 55


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSP  362 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~~~~~  362 (386)
                      .+|+.+++++..||...+.-|++.+++.-|+.....+|
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            78999999999999999999999888877775443333

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-39  Score=296.89  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=201.6

Q ss_pred             hhhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      ..+.+.||+|+||.||+|.+     .++..|++|.+......  ...+.+|++++++++|+||+++++++...+..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            34568899999999999974     24678999999754332  256889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccccc-----------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCce
Q 038768          161 EFMPNGSLDQFIYDEES-----------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP  229 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~-----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  229 (386)
                      ||+++++|.+++.....           ......+++..++.++.|++.||.|||++   +++|+||||+|||+++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence            99999999999854321           01123578899999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchh
Q 038768          230 KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPN  308 (386)
Q Consensus       230 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  308 (386)
                      ||+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||....        +.
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------~~  233 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------NQ  233 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence            99999999866443322222233456789999998653  68899999999999999998 988986532        13


Q ss_pred             hhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          309 SIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       309 ~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.+.+........+..+++++++++.+|+..++.-|++..++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  276 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI  276 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            3444555555555677889999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-39  Score=295.76  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      ..+.+.+.||+|+||.||+|...      .+..||+|.+.....  ...++.+|+.+++.++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            34556688999999999998752      246799999865332  2356889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccccccc----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          158 LIYEFMPNGSLDQFIYDEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                      +||||+++++|.+++.......    ....+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999986532211    123467889999999999999999998   999999999999999999999999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||....        +....+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~~  232 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVLR  232 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH
Confidence            9999865443332222223457789999998653  68899999999999999999 688886432        233444


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+..+..+..+++.+++++.+|+..++.-|++..++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  271 (277)
T cd05062         233 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  271 (277)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            444444455677788999999999999999999876553

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-39  Score=300.38  Aligned_cols=258  Identities=24%  Similarity=0.313  Sum_probs=200.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ...++||+|+||.||+|... +++.||+|.++...  .....+.+|+.++++++|+||+++++++...+..++||||++ 
T Consensus         9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   87 (309)
T cd07872           9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-   87 (309)
T ss_pred             EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-
Confidence            34578999999999999864 67899999987532  233567899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        88 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          88 KDLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            58888875432     3578899999999999999999998   999999999999999999999999999975443221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhcCCCc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHIEPGN  318 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i~~~~  318 (386)
                      .  .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||......+.-       ...+...|..+....
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             c--cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            1  1234578899999998654 36789999999999999999999999754321100       000111122211110


Q ss_pred             --------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          319 --------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       319 --------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                                    .......++++.++++.+|+..++.-|+++.++..+|--.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence                          0112235789999999999999999999999988887654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=293.85  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=201.1

Q ss_pred             hhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCc------e
Q 038768           90 FSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKK------R  156 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~  156 (386)
                      +.+.||+|+||.||+|....    +..||+|.++.....   .+.+.+|++.++.++|+||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            45789999999999998632    367999998764333   2468899999999999999999999876554      6


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++++||+++|+|..++...........+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence            89999999999999986654333345789999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++...............++..|+|||++...  .++.++|||||||++|||++ |..||.....        ..+.+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~  229 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLR  229 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence            9866544322212223356789999998653  68899999999999999999 8888865421        33445555


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.....+..++.++.+++.+|+..++.-|++..++
T Consensus       230 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~  265 (273)
T cd05035         230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL  265 (273)
T ss_pred             cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            555566677899999999999999999999876553

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.1e-40  Score=305.80  Aligned_cols=258  Identities=20%  Similarity=0.263  Sum_probs=197.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecC-----ceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-----KRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  159 (386)
                      .+.+.||+|+||.||+|... +|+.||||.+....   .....+.+|+++++.++||||+++++++...+     ..++|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            44678999999999999864 68999999987432   23356889999999999999999999886543     47899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+ +++|.+++...      ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        83 ~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          83 FELM-ESDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EecC-CCCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999 57899888543      4588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhh
Q 038768          240 SEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIY  311 (386)
Q Consensus       240 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~  311 (386)
                      ...... ........|+..|+|||++.+....++.++|||||||++|||++|+.||.........       ...+....
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            533221 1111235689999999998653346889999999999999999999999754321000       00011111


Q ss_pred             hh------------cCCCccc---cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 KH------------IEPGNEF---QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~~------------i~~~~~~---~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..            +.+....   .....+++++.+++.+|+..++.-|++++++..+|-
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence            11            1111111   112346788999999999999999999999888774

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-39  Score=292.90  Aligned_cols=247  Identities=27%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.+.++||.|+||.||+|...++..+++|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            34556788999999999999988899999999986544 45678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        86 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          86 KGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999997643    24588999999999999999999998   99999999999999999999999999998664432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..  .....++..|+|||.+...  .++.++||||||+++|+|++ |+.||....        ..+..+.+..+.....+
T Consensus       159 ~~--~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~  226 (261)
T cd05148         159 YL--SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGYRMPCP  226 (261)
T ss_pred             cc--ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhCCcCCCC
Confidence            21  1133466789999998653  68889999999999999998 899997543        23444455444445556


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+++++.+++.+|+..++.-|+++.++
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (261)
T cd05148         227 AKCPQEIYKIMLECWAAEPEDRPSFKAL  254 (261)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            7889999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-40  Score=295.32  Aligned_cols=191  Identities=35%  Similarity=0.570  Sum_probs=163.6

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhc--CCCCccceEEEEEEecC----ceeEEEEeC
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK--TSHVNVVSFLGFCYEKK----KRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~  163 (386)
                      +.+.||+|+||.||+|.+ +++.||||++..  .+.+.|.+|-++.+.  ++|+||++|++.-...+    .++||+||.
T Consensus       214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hHHHhhcCccceeehhhc-cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            346699999999999999 569999999974  345678888777665  57999999999876655    789999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG------CNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +.|+|.+||..       ..++|....+++..+++||+|||+.      .+++|+|||||++||||.+|++..|+|||+|
T Consensus       291 ~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  291 PKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             cCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999966       4689999999999999999999974      3568999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCC-----ccchhHhHHHHHHHHHhCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS-----HKSDVYSYGMMILEMVVGR  291 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-----~~~DvwslGvil~elltg~  291 (386)
                      ..+..........+.+||.+|||||++.+.. .+.     .+.||||+|.+||||++.-
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            9887665555566788999999999997652 222     4689999999999999964

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.4e-39  Score=291.41  Aligned_cols=247  Identities=30%  Similarity=0.437  Sum_probs=203.2

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..+.+.++||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            345567889999999999999888889999999876667788999999999999999999999874 5668899999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          85 GSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999986532    24588999999999999999999998   999999999999999999999999999986654322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      . ......++..|+|||++...  .++.++||||||+++|+|++ |+.||.....        ....+.+..+..+..+.
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~  226 (260)
T cd05070         158 T-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYRMPCPQ  226 (260)
T ss_pred             c-cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence            1 11223356689999988543  68899999999999999999 8899975422        23344454444455667


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+.++++++.+|+..++.-|+++.++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l  253 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYL  253 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            789999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-39  Score=307.77  Aligned_cols=252  Identities=22%  Similarity=0.251  Sum_probs=194.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||.||++.. .+++.||+|...     .+.+.+|++++++++||||+++++++......++|+|++ .+
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~  167 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KT  167 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CC
Confidence            44568899999999999986 468899999654     245789999999999999999999999999999999999 57


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       168 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        168 DLYCYLAAK------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            888888543      4578999999999999999999998   999999999999999999999999999975432211 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc------------------ch-
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY------------------FP-  307 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~------------------~~-  307 (386)
                      .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||-......+...                  ++ 
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            112345699999999998654  689999999999999999999988754322111100                  00 


Q ss_pred             ------hhhhhhcCC------Cccc--cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          308 ------NSIYKHIEP------GNEF--QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       308 ------~~~~~~i~~------~~~~--~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                            ...+.....      ...+  .....++.++.+++.+||..++.-|++++++..+|--
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence                  000000000      0000  0011356789999999999999999999998777754

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.6e-39  Score=293.00  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=197.6

Q ss_pred             hhhccCcCCceEEEEEEeCC-Cc--EEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec------Ccee
Q 038768           90 FSNKLGQGGFGSVYKGKLPD-GR--LVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK------KKRA  157 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  157 (386)
                      +.+.||+|+||.||+|.+.+ +.  .||+|.++.....   .+.+..|+.+++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999998754 33  6999998754322   35688899999999999999999988643      2468


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      ++|||+++|+|.+++...........+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999999885443323335689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      +...............++..|+|||++.+.  .++.++||||||+++|||++ |+.||....        +..+++.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYDYLRQ  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHc
Confidence            876543322111223456789999998654  68899999999999999999 788987532        1344555555


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..+..++++..+++.+|+..++.-|++++++
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  264 (272)
T cd05075         230 GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL  264 (272)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            55455666788999999999999998888876554

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.8e-39  Score=294.65  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.++||+|+||.||+|...      ++..||+|+++.....  .+.+.+|+.++..++||||+++++++.+.+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            445688999999999999753      2478999999854332  35688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccccc----------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCce
Q 038768          160 YEFMPNGSLDQFIYDEES----------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP  229 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  229 (386)
                      +||+++++|.+++.....          ......+++..++.++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence            999999999999853211          01124578889999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchh
Q 038768          230 KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPN  308 (386)
Q Consensus       230 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  308 (386)
                      ||+|||+++...............+++.|+|||++...  .++.++|||||||++|||++ |..||....        +.
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~  233 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ  233 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence            99999998866443322222234467789999998653  68899999999999999998 888887542        24


Q ss_pred             hhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          309 SIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       309 ~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.+.+..+.....+..++....+++.+|++.++.-||+..++
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            4556666666556677899999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-39  Score=293.58  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=201.4

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.||+|+||.||++... +++.||+|.+......    ...+.+|+.++++++|+|++.+++.+.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            3467999999999999864 6889999998753222    2457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        84 g~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          84 GGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             CCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999885432    24588999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..   ....|+..|+|||++.+.  .++.++|||||||++|+|++|+.||.......     .......+.......++.
T Consensus       157 ~~---~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~  226 (285)
T cd05630         157 TI---KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEVQEEYSE  226 (285)
T ss_pred             cc---cCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhhhhhcCc
Confidence            21   234689999999998654  68899999999999999999999997542210     011112221222234566


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p~~  357 (386)
                      .++++.++++.+|+..++.-|++     ++++..+|--
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence            78999999999999999999987     6677766643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=290.83  Aligned_cols=246  Identities=26%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             hhhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|.+..    ...||+|.++.....  ..++.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            3456889999999999998742    358999998754322  3578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||+++...
T Consensus        86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          86 YMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             cCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999986532     3688999999999999999999998   99999999999999999999999999998775


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||....        .....+.+..+...
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVEDGYRL  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence            32222222233456789999998654  68899999999999999998 999986432        13344555544444


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+++++.+++.+|+..++.-|++++++
T Consensus       228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei  258 (266)
T cd05033         228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQI  258 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            4566789999999999999999888876654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.2e-39  Score=290.98  Aligned_cols=246  Identities=29%  Similarity=0.427  Sum_probs=200.5

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..+.+.++||+|+||.||+|...++..||+|.++......+.+.+|+++++.++|+||+++++++. .+..++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   84 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence            345667899999999999998877778999999876666778999999999999999999999874 4568999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++....    ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.++.......
T Consensus        85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          85 GSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999996532    24578999999999999999999998   999999999999999999999999999986654332


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .. .....++..|+|||+..+.  .++.++||||||+++|||++ |+.||....        +..+...+..+.......
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~  226 (262)
T cd05071         158 TA-RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMPCPP  226 (262)
T ss_pred             cc-ccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------hHHHHHHHhcCCCCCCcc
Confidence            11 1223466789999988543  68999999999999999999 888887542        233444444444344566


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .++.++.+++.+|+..++.-|++..+
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~  252 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEY  252 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHH
Confidence            78899999999999998888876554

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-39  Score=313.20  Aligned_cols=256  Identities=20%  Similarity=0.289  Sum_probs=192.8

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEec--------CceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK--------KKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~l  158 (386)
                      +.+.+.||+|+||.||+|.. .+++.||||.+....   ....+|+.+++.++|+||+++++++...        ...++
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            44568899999999999986 468899999886432   2345799999999999999999987542        13568


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCC
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLA  237 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~  237 (386)
                      ||||++ ++|.+++....  .....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||++
T Consensus       145 vmE~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        145 VMEFIP-QTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEecCC-ccHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            999996 57777764322  1225688999999999999999999998   999999999999998654 7999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSI  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~  310 (386)
                      +.......   .....||+.|+|||++.+. ..++.++|||||||++|||++|..||........-.       ..+...
T Consensus       219 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        219 KNLLAGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             hhccCCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            86644322   1234578999999998654 368899999999999999999999997653211000       000000


Q ss_pred             hhh------------cC-CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 YKH------------IE-PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~~~------------i~-~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +..            +. ......++...++++.+++.+||..++.-|.++.++..||-
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            000            00 00011234567899999999999999999999988887775

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=310.47  Aligned_cols=247  Identities=28%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             ccCcCCceEEEEEEeC-CCcEEEEEEecCC-CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHH
Q 038768           93 KLGQGGFGSVYKGKLP-DGRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ  170 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  170 (386)
                      +||+|.||+||-|++. +...+|||.+... ....+-+..|+.+.++|+|.|||+++|.|-.++..-+.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999864 4567999998743 3344668899999999999999999999999998899999999999999


Q ss_pred             HhcccccccccccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceEEeeccCCcccCccccee
Q 038768          171 FIYDEESSNINRKL--EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       171 ~l~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      +|..+-     +++  ++..+-.+..||++||.|||++   .|||||||-+||||+ -.|.+||+|||-++.+..-... 
T Consensus       662 LLrskW-----GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-  732 (1226)
T KOG4279|consen  662 LLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-  732 (1226)
T ss_pred             HHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence            997653     455  7788889999999999999999   999999999999996 4789999999999876543221 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                       ..+..||..|||||++......|..++|||||||++.||.||++||.......      ..+++-=.=...+.++..+|
T Consensus       733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkVGmyKvHP~iPeels  805 (1226)
T KOG4279|consen  733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKVGMYKVHPPIPEELS  805 (1226)
T ss_pred             -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------HhhhhhcceecCCCCcHHHH
Confidence             22456999999999998776789999999999999999999999997442211      12222222223577899999


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+.+++|.+|.+.+++.|+++.++..-|
T Consensus       806 aeak~FilrcFepd~~~R~sA~~LL~Dp  833 (1226)
T KOG4279|consen  806 AEAKNFILRCFEPDPCDRPSAKDLLQDP  833 (1226)
T ss_pred             HHHHHHHHHHcCCCcccCccHHHhccCc
Confidence            9999999999999999999988875544

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.2e-39  Score=288.29  Aligned_cols=247  Identities=26%  Similarity=0.361  Sum_probs=205.8

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||+|++|.||++... +|+.|++|.+....   ...+++.+|+++++.++|||++++++++.+.+..++||||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            4578999999999999864 68999999987532   2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.......
T Consensus        84 ~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          84 GDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999997532    24688999999999999999999998   999999999999999999999999999886654332


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      ..  ....|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||....        .......+..+..+.+...
T Consensus       157 ~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~  224 (256)
T cd08529         157 FA--NTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRGVFPPVSQM  224 (256)
T ss_pred             hh--hccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCCccc
Confidence            11  234578899999998654  67899999999999999999999997543        1334445555554556668


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.++.+++.+|+...+.-|+++.++..+|
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  254 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNP  254 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence            899999999999999999998877765543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.1e-39  Score=294.04  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=200.9

Q ss_pred             hhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.||+|+||.||+|...      ....+++|.+......  .+++.+|+.+++.++||||+++++.|...+..++++|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            4578999999999999752      2357999988754332  3578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccc------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          162 FMPNGSLDQFIYDEESS------------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      |+++++|.+++......                  .....+++..++.++.|++.||.|||+.   +++||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence            99999999998653211                  1124588999999999999999999998   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCC
Q 038768          224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSS  302 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  302 (386)
                      ++++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..||....    
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~----  234 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA----  234 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC----
Confidence            99999999999999865443322222234466789999988654  68899999999999999998 999997542    


Q ss_pred             cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       303 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                          +..+++.+..+.....+..++.++.+++.+|+..++.-|++..++
T Consensus       235 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i  279 (290)
T cd05045         235 ----PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI  279 (290)
T ss_pred             ----HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                345556655555555677889999999999999988888876543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-39  Score=310.31  Aligned_cols=251  Identities=20%  Similarity=0.222  Sum_probs=193.4

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.+.||+|+||.||++... .++.||||...     ...+.+|++++++++|+||+++++++...+..++|||++ .++|
T Consensus       173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L  246 (461)
T PHA03211        173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL  246 (461)
T ss_pred             EEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence            4478999999999999874 47899999643     234678999999999999999999999999999999999 5788


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      ..++....     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       247 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        247 YTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            88885432     3689999999999999999999998   999999999999999999999999999986644322112


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc----------
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN----------  318 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~----------  318 (386)
                      .....||..|+|||++.+.  .++.++|||||||++|||++|..|+-..............+.+.+....          
T Consensus       319 ~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2245699999999999764  6899999999999999999988665322111111111111111111100          


Q ss_pred             -----------------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 -----------------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 -----------------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                             .+.....++.+..+++++||..++..|+++.++..+|-
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence                                   00001135678999999999999999999998877764

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=326.14  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=199.9

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec--Ccee
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRA  157 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  157 (386)
                      ....+.+.++||.|+||+||++... ++..||+|++......   ...+..|+.++.+++||||++++++|.+.  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3334556688999999999999864 5778999998754322   35688999999999999999999988654  4688


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCeEeCC--------
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN----IRIVHFDIKPHNILLGE--------  225 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~dlk~~Nill~~--------  225 (386)
                      +||||+++|+|.++|.....  ....+++..++.|+.||+.||.|||+...    .+||||||||+||||+.        
T Consensus        91 IVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999999865321  12468999999999999999999998521    25999999999999964        


Q ss_pred             ---------CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccc
Q 038768          226 ---------DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV  296 (386)
Q Consensus       226 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~  296 (386)
                               .+.+||+|||++........   .....||+.|+|||++.+....++.++||||||||||||++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     23489999999986643322   123468999999999865434688999999999999999999999975


Q ss_pred             ccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          297 KVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      ...       ...+...+..+.... ...++.++.++|..||..++.-|+++.++..+
T Consensus       246 ~~~-------~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        246 ANN-------FSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCc-------HHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            322       122333443333222 24578999999999999999999987776443

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6e-39  Score=293.72  Aligned_cols=250  Identities=24%  Similarity=0.414  Sum_probs=202.9

Q ss_pred             hhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.||+|+||.||+|...      ++..+++|.+...... .+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            34578999999999999742      3457899998754433 3578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEE
Q 038768          162 FMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI  231 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  231 (386)
                      |+++++|.+++......          .....+++..++.++.||+.||+|||++   +++||||||+||+++.++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence            99999999999654321          1224588999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhh
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  310 (386)
                      +|||++................++..|+|||++.+.  .++.++|||||||++|||+| |+.||.....        ...
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~  234 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------TEV  234 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence            999999866543322222234567889999998764  68889999999999999999 9999865422        334


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.+..+..+..+..++.++.+++.+|+..++.-|+++.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v  275 (291)
T cd05094         235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI  275 (291)
T ss_pred             HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            55555665555666788999999999999999988876554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=307.23  Aligned_cols=243  Identities=28%  Similarity=0.447  Sum_probs=208.7

Q ss_pred             cHHHHHHHHhhhhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           79 NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        79 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      .-+|+++....+..+||.|.||.||.|.|+. .-.||||.++.+.+..++|+.|..+|+.++|||+|+++|+|..+...|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            4457777777778999999999999999864 668999999999999999999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      ||+|||..|+|.+||.....    ..++.-.+++++.||+.||+||..+   ++|||||.++|+|+.++..+|++|||++
T Consensus       340 IiTEfM~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEecccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence            99999999999999987642    4567778899999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      +++..+.. ....+..-...|.|||.+.-  ..++.|+|||+|||+|||+.| |..||...+.        ..++..+.+
T Consensus       413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEk  481 (1157)
T KOG4278|consen  413 RLMTGDTY-TAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEK  481 (1157)
T ss_pred             hhhcCCce-ecccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhc
Confidence            99876543 33344556778999999854  479999999999999999988 8888876533        556777777


Q ss_pred             CccccccccCChHHHHHHHHHHH
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMIL  339 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~  339 (386)
                      +-...-+..+.+..-+|.+.|-.
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~  504 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWN  504 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhc
Confidence            76666677788877777776544

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-39  Score=288.27  Aligned_cols=247  Identities=30%  Similarity=0.486  Sum_probs=206.8

Q ss_pred             hccCcCCceEEEEEEeCC----CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|....    +..|++|.+......  .+.+.+|++.+..++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998743    789999999865443  57889999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccc---cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESS---NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ++|.+++......   .....+++..++.++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999664210   0125689999999999999999999998   999999999999999999999999999987765


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...........++..|+|||.+...  .++.++||||||+++|||++ |+.||....        +..+.+.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~  227 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYRLP  227 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence            4432233345678899999998654  68899999999999999999 699998652        244556666566666


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..++.++.+++.+|+...+.-|+++.++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  257 (262)
T cd00192         228 KPEYCPDELYELMLSCWQLDPEDRPTFSEL  257 (262)
T ss_pred             CCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence            778889999999999999999888876654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=289.26  Aligned_cols=248  Identities=31%  Similarity=0.459  Sum_probs=204.7

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...+.+.++||+|+||.||+|...+++.||+|.+.......+++.+|+.++++++|+||+++++++......++||||++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            33445668899999999999998788899999998777777889999999999999999999999998899999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          85 KGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             CCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999996542    24588999999999999999999998   99999999999999999999999999998665322


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      . .......++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||.....        ....+.+..+.....+
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  226 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRP  226 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            1 111122345689999998654  68899999999999999999 9999965321        3344445444434455


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+.+..+++.+|+...+.-|++.++
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~  253 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEY  253 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            667899999999999998888887654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6e-39  Score=302.39  Aligned_cols=252  Identities=25%  Similarity=0.290  Sum_probs=192.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecC------cee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  157 (386)
                      +...+.||+|+||.||++.. .+|..||+|++....   .....+.+|+.+++.++||||+++++++...+      ..+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            34457899999999999986 458999999997532   23456789999999999999999999987543      468


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||++ ++|...+.        ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       103 lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         103 LVMELMD-ANLCQVIH--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             EEEeCCC-cCHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            9999995 46666653        2477888999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------cccc-hhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------EIYF-PNSI  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------~~~~-~~~~  310 (386)
                      +.......   .....||..|+|||++.+.  .++.++|||||||++|+|++|+.||........      .... +...
T Consensus       171 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             cccccCcc---CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            75433221   1234688999999999764  688999999999999999999999975432100      0000 0000


Q ss_pred             h-------hhc-CC------------------CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 Y-------KHI-EP------------------GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~-------~~i-~~------------------~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .       ..+ ..                  ..........++++++++.+|+..++.-|+++.++..+|-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            0       000 00                  0001122345788999999999999999999999888874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=292.63  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=204.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      ..+.+.+.||+|+||.||+|...      .+..||+|.+.....  ....+.+|+.++..++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            34455688999999999999763      236899999875432  2356889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccccccc----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          158 LIYEFMPNGSLDQFIYDEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                      +||||+++++|.+++.......    ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence            9999999999999996543211    123578899999999999999999998   999999999999999999999999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||+++...............++..|+|||.+.+.  .++.++|||||||++|||++ |+.||.....        ....+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~  232 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLK  232 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHH
Confidence            9999866544322222234467889999998653  68899999999999999998 9999875422        34455


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+.....+..++.++.+++.+|+...+.-|++..++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  271 (277)
T cd05032         233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI  271 (277)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            555555566677789999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=286.11  Aligned_cols=248  Identities=27%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ..+.||+|++|.||++.. .+++.||+|.+.....      ..+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   85 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY   85 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence            357899999999999985 4689999999875322      124678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++....
T Consensus        86 ~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          86 MPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999998543      4578899999999999999999998   999999999999999999999999999875543


Q ss_pred             ccceee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFIS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...... .....++..|+|||++.+.  .++.++||||||+++|||++|+.||.....       .....+.........
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~  227 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNPQ  227 (263)
T ss_pred             cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHHHhccCCCCC
Confidence            211111 0123477889999999764  588999999999999999999999975422       122223333333456


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++..++.+..+++.+|+..++.-|++..++..+|
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            7778999999999999999999999887765554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.5e-38  Score=287.81  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=199.4

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.||+|+||.||+|.. .+++.||+|.+.....  ..+++.+|++++.+++||||+++++++...+..++||||++++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619           5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            457899999999999985 4688999999875422  2356889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..+.          .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.......  
T Consensus        85 ~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          85 SLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             ChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            996542          367788899999999999999998   99999999999999999999999999997654322  


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-ccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-AGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~  325 (386)
                        .....|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||......... ..+....+.+.......+ ...
T Consensus       150 --~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  224 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDEDPPVLPVGQ  224 (279)
T ss_pred             --ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccCCCCCCCCc
Confidence              1234688999999998754  6889999999999999999999999754322211 122233333333322332 345


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +++++.+++.+|+..++.-|++.+++..+|-
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            7889999999999999999999888766654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=313.24  Aligned_cols=241  Identities=22%  Similarity=0.260  Sum_probs=190.2

Q ss_pred             hhhhccCcCCceEEEEEEeCCC-cEEEEEEecCC-CCChHHHHHHHHHhhcCC-CCccceEEE-EEEec------CceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDG-RLVAVKVLKNS-KVNGEEFINEVASMSKTS-HVNVVSFLG-FCYEK------KKRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~------~~~~l  158 (386)
                      .+.+.|.+|||+.||.|....+ ..+|+|++-.. +..-+.+.+|+++|+.|+ |+|||.+++ .....      -+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            3457899999999999997665 99999987644 333477899999999997 999999999 33321      24678


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      .||||++|.|-+++.....    ..|++.++++|+.|+++|+.+||.. .++|||||||-+||||+.++..||||||.+.
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             ehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            9999999999999976532    4599999999999999999999986 5689999999999999999999999999987


Q ss_pred             ccCcccce-------eeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          239 LSEKKESF-------ISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       239 ~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      -.-.....       .......-|+.|+|||++.-. ....++|+|||+|||+||-||....||+....           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            43222110       001122468999999998432 12579999999999999999999999996522           


Q ss_pred             hhhcCCCccccc--cccCChHHHHHHHHHHHHHHHhcCC
Q 038768          311 YKHIEPGNEFQL--AGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       311 ~~~i~~~~~~~~--~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                       -.|..++ +.+  ...++..+++||+.||+.++..|+.
T Consensus       264 -laIlng~-Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPn  300 (738)
T KOG1989|consen  264 -LAILNGN-YSFPPFPNYSDRLKDLIRTMLQPNPDERPN  300 (738)
T ss_pred             -eeEEecc-ccCCCCccHHHHHHHHHHHHhccCcccCCC
Confidence             1233333 222  2468999999999999988888874

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.6e-39  Score=295.69  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC--------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEEEEEec
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLGFCYEK  153 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  153 (386)
                      ...+.+.+.||+|+||.||++...        ++..+|+|.++....  ...++.+|+.++..+ +|+||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            345566789999999999999752        235799999975432  235688899999999 799999999999999


Q ss_pred             CceeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          154 KKRALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      +..++||||+++|+|.+++......          .....+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            9999999999999999999764321          1123588999999999999999999998   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCC
Q 038768          224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSS  302 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  302 (386)
                      +.++.+||+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||....    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~----  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence            99999999999999765432221112223345689999998654  68899999999999999998 888886532    


Q ss_pred             cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       303 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                          ...+.+.+..+.....+..++.++++++.+|+..++.-|+++.++
T Consensus       248 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev  292 (307)
T cd05098         248 ----VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  292 (307)
T ss_pred             ----HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                234445555554455667789999999999999998888876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=277.99  Aligned_cols=263  Identities=23%  Similarity=0.376  Sum_probs=210.6

Q ss_pred             HHHHHHHHhhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCC-hHHHHHHHHHhhcCC-CCccceEEEEEEecCce
Q 038768           80 YSDVKRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN-GEEFINEVASMSKTS-HVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        80 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  156 (386)
                      +.|+.+.|   .+.||+|+|+.|--++ +.+|..+|||++.+.+.. +..+.+|++++.+.+ |+||+.++++|+++...
T Consensus        75 F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            45555444   4689999999999986 578999999999876544 467899999999885 99999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ceEEee
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISD  233 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D  233 (386)
                      |||||-|.||+|..++++.      ..+++.++.++..+|+.||.|||.+   ||.||||||+|||.....   -+||+|
T Consensus       152 YLVfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             EEEEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence            9999999999999999664      5689999999999999999999999   999999999999996544   389999


Q ss_pred             ccCCcccCccc-----ceeeeccccCccccccccccc---hhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC---C
Q 038768          234 FGLAKLSEKKE-----SFISMLGARGTIGYIAPEVFC---RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS---S  302 (386)
Q Consensus       234 fgl~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~---~  302 (386)
                      |.+..-...+.     ......+.+|+..|||||+..   ++...|+.++|.||||||+|-|++|..||-+.-..+   +
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            99886443222     122334567999999999973   333468899999999999999999999997543221   1


Q ss_pred             cc----cchhhhhhhcCCCccccc----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          303 EI----YFPNSIYKHIEPGNEFQL----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       303 ~~----~~~~~~~~~i~~~~~~~~----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +-    .-.+.+++.|++|. +.+    +..+|.+.++++..++..+..-|-++.....+|
T Consensus       303 rGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             CCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            11    12456788888888 333    567999999999999997777665555544444

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-38  Score=285.75  Aligned_cols=239  Identities=26%  Similarity=0.417  Sum_probs=195.2

Q ss_pred             ccCcCCceEEEEEEeC---CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           93 KLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      .||+|+||.||+|.+.   ++..||+|++......  .+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999763   3557999998754322  356889999999999999999999885 457889999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999986432     4688999999999999999999998   99999999999999999999999999998654433221


Q ss_pred             -eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          248 -SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       248 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                       ......++..|+|||++...  .++.++|||||||++||+++ |+.||.....        ..+...+..+..+..+..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  222 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKRLDCPAE  222 (257)
T ss_pred             eccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCCCCC
Confidence             11222345789999998653  68889999999999999996 9999975422        345556666666677788


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .++++.+++.+|+..++.-|++..+
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~  247 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAK  247 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHH
Confidence            8999999999999998888876554

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.6e-39  Score=287.82  Aligned_cols=245  Identities=30%  Similarity=0.442  Sum_probs=199.6

Q ss_pred             HhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+..+||+|+||.||++...++..+|+|.+.......+.+.+|+.+++.++|+|++++++++. .+..++||||++++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            34556789999999999999877778999998776666678999999999999999999999875 56688999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        86 ~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          86 SLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999996532    24578999999999999999999998   9999999999999999999999999999866443221


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                       ......++..|+|||...+.  .++.++||||||+++|||++ |+.||.....        ......+..+.....+..
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  227 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERGYRMPCPQG  227 (260)
T ss_pred             -ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCcc
Confidence             11223456789999988653  68899999999999999999 8999975422        333444444433445667


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++..+++++.+|+..++..|+++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEY  252 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHH
Confidence            8899999999999999888886554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.2e-39  Score=298.89  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=199.5

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEec-C
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEK-K  154 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  154 (386)
                      ...+.+.+.||+|+||.||+|...      +++.||+|+++.....  .+.+.+|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            345566789999999999999632      3578999998754322  24678899999999 799999999988754 5


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccc-------------------------------------------------------c
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESS-------------------------------------------------------N  179 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------~  179 (386)
                      ..+++|||+++++|.+++......                                                       .
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            678999999999999998643210                                                       0


Q ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccc
Q 038768          180 INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI  259 (386)
Q Consensus       180 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~  259 (386)
                      ....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.++|+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            113688999999999999999999998   99999999999999999999999999998764433222222344677899


Q ss_pred             cccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHH
Q 038768          260 APEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMI  338 (386)
Q Consensus       260 aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml  338 (386)
                      |||++.+.  .++.++|||||||++|||++ |+.||.....       .....+.+..+.....+..+++++.+++.+|+
T Consensus       243 aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl  313 (337)
T cd05054         243 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW  313 (337)
T ss_pred             CcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCc-------cHHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence            99998664  78999999999999999998 9999975321       11223344444444456678899999999999


Q ss_pred             HHHHHhcCCCCCC
Q 038768          339 LVLEMLEGSTEDL  351 (386)
Q Consensus       339 ~v~~~L~~~~~~~  351 (386)
                      +..+.-|++++++
T Consensus       314 ~~~p~~RPs~~el  326 (337)
T cd05054         314 HNNPEDRPTFSEL  326 (337)
T ss_pred             cCChhhCcCHHHH
Confidence            9999988877654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-38  Score=290.38  Aligned_cols=244  Identities=29%  Similarity=0.473  Sum_probs=196.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCc----EEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGR----LVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.++||+|+||+||+|.+ .+|+    .||+|+++....  ..+.+.+|+.++..++|+||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence            4457899999999999975 3454    489999875332  23578899999999999999999999875 45789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....     ..+++..++.++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++...
T Consensus        89 ~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          89 LMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             cCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999986532     4588999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ............++..|+|||.+.+.  .++.++|||||||++|||++ |..||+....        ..+...+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEKGERL  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcC
Confidence            43332222233456789999998654  68899999999999999998 8999875321        2333444445445


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..++.+..+++.+|+..++.-|++..++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l  261 (279)
T cd05109         231 PQPPICTIDVYMIMVKCWMIDSECRPRFREL  261 (279)
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            5566789999999999999999999877665

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-40  Score=283.08  Aligned_cols=242  Identities=25%  Similarity=0.333  Sum_probs=203.1

Q ss_pred             cccHHHHHHHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChH---HHHHHHHHhhcCCCCccceEEEEEE
Q 038768           77 RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGE---EFINEVASMSKTSHVNVVSFLGFCY  151 (386)
Q Consensus        77 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~---~~~~E~~~l~~l~h~niv~~~~~~~  151 (386)
                      +.+..++     +|.+.||+|.||+|.+++- ..|+.+|+|++++.-. .++   .-+.|-++|+..+||.+..+.-.|+
T Consensus       164 kvTm~dF-----dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  164 KVTMEDF-----DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             eeccchh-----hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            4455444     3568899999999999975 4689999999987532 222   3456889999999999999999999


Q ss_pred             ecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEE
Q 038768          152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI  231 (386)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  231 (386)
                      ..+..|+||||..||.|.-+|.+.      ..+++...+.+-.+|..||.|||++   +||.||||.+|+|+|.+|.+||
T Consensus       239 t~drlCFVMeyanGGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEe
Confidence            999999999999999999888654      5688899999999999999999998   9999999999999999999999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhh
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      +|||+++.--...  ..+.+.+||+.|+|||++.+.  .|..++|+|.+||++|||++|+.||...+.        +.++
T Consensus       310 tDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLF  377 (516)
T KOG0690|consen  310 TDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLF  377 (516)
T ss_pred             eecccchhccccc--ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccch--------hHHH
Confidence            9999998432221  234578899999999999875  799999999999999999999999997644        4455


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhc
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLE  345 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~  345 (386)
                      ..|.-+ +..++..+|++++.|+.-+|..++.-|
T Consensus       378 eLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kR  410 (516)
T KOG0690|consen  378 ELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKR  410 (516)
T ss_pred             HHHHhh-hccCCccCCHHHHHHHHHHhhcChHhh
Confidence            655544 477899999999999999998666544

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.3e-39  Score=296.74  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=191.5

Q ss_pred             hhccCcCCceEEEEEEeC---CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEEEEeCCC
Q 038768           91 SNKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALIYEFMPN  165 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  165 (386)
                      +++||+|+||.||+|...   +++.||+|.+.... ....+.+|+.++++++||||+++++++..  ....++||||+ +
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-E   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-C
Confidence            468999999999999864   46789999987543 33567899999999999999999999865  34578999998 4


Q ss_pred             CCHHHHhcccccc---cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCceEEeeccCCc
Q 038768          166 GSLDQFIYDEESS---NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAK  238 (386)
Q Consensus       166 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~  238 (386)
                      ++|.+++......   .....+++..+..++.||+.||+|||+.   +++||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            6888877543211   1123588999999999999999999998   99999999999999    456789999999998


Q ss_pred             ccCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC--cccc---------
Q 038768          239 LSEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS--EIYF---------  306 (386)
Q Consensus       239 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--~~~~---------  306 (386)
                      ....... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||........  ....         
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            7654321 1122345689999999998754 3578999999999999999999999975432100  0000         


Q ss_pred             -----hhhhhhhcCCCcc----------------------ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          307 -----PNSIYKHIEPGNE----------------------FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       307 -----~~~~~~~i~~~~~----------------------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                           ....|..+.....                      .......+.++.+++++||..++.-|.+++++..+|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                 0001111100000                      000122456789999999999999999998887766

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.1e-39  Score=290.87  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             hhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.++||+|+||.||++...      ++..+++|.+.... ...+.+.+|+++++.++|+||+++++++.+.+..+++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            44678999999999999632      35689999887543 234678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccc---------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          162 FMPNGSLDQFIYDEESS---------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      |+++++|.+++......         .....+++..++.++.|++.||+|||+.   +++|+||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence            99999999998754311         1113578999999999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||++................++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ....
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~  234 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEAI  234 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHHH
Confidence            99999765443322222223356789999998664  68899999999999999998 8999865422        2233


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+.....+..++++..+++.+|+..++.-|++.+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  274 (280)
T cd05092         235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI  274 (280)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            4444444455566789999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=287.95  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=211.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      ++..+||+|+||.||++..+ .|+.||||.+.-+ .+-+++..|+.++.+.+.+++|++||.+.....+++|||||..|+
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            44578999999999999764 6999999988643 456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      ..+.+...+     .++.++++..++...++||+|||..   .-+|||||+.|||++-+|.+||+|||.+-.+....  .
T Consensus       115 iSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A  184 (502)
T KOG0574|consen  115 ISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A  184 (502)
T ss_pred             HHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence            999997654     6899999999999999999999998   88999999999999999999999999997554332  2


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      ...+..||+.|||||++..-  .|..++||||||+...||..|++||.+.+....-+.+|...-      ..+.-+..+|
T Consensus       185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PP------PTF~KPE~WS  256 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPP------PTFKKPEEWS  256 (502)
T ss_pred             hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCC------CCCCChHhhh
Confidence            23467799999999999764  789999999999999999999999998876655555444321      1234477889


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +++.+++++||...+.-|.++..+-.||.
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence            99999999999988888777666666654

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-38  Score=283.97  Aligned_cols=241  Identities=26%  Similarity=0.418  Sum_probs=196.1

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      +.||+|+||.||+|...+++.+|+|.+......  ...+.+|+++++.++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999888899999998754322  346889999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      +++....     ..+++..++.++.|++.+|.|||+.   +++|+||+|+||++++++.+||+|||++......... ..
T Consensus        81 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~  151 (250)
T cd05085          81 SFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS  151 (250)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence            9985432     3578999999999999999999998   9999999999999999999999999998754332211 11


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      ....++..|+|||++..  +.++.++||||||+++|++++ |..||.....        ......+..+.....+..++.
T Consensus       152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  221 (250)
T cd05085         152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQVEKGYRMSCPQKCPD  221 (250)
T ss_pred             CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCCCH
Confidence            11234567999999865  368899999999999999998 9999975422        223334444444445667889


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++.+|+...+.-|++..++
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l  244 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSEL  244 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHH
Confidence            99999999999999988876553

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-38  Score=291.42  Aligned_cols=254  Identities=23%  Similarity=0.361  Sum_probs=200.0

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCce
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  156 (386)
                      ...+.+.+.||+|+||.||+|...      .+..||+|.+......  ...+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            445556789999999999999643      2458999998754322  24678899999999999999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhccccccc----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSN----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      ++||||+++|+|.+++.......    .....++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999996532111    123456778899999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||+++...............++..|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ..+.
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~~  231 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVL  231 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence            99999865443322222223456789999998653  68899999999999999998 7888864321        2333


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+.....+..+++++++++.+|+..++.-|+++.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  271 (288)
T cd05061         232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI  271 (288)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            4444444455566778999999999999999999877655

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-38  Score=301.91  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=202.4

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCC-CCccceEEEEEEe
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTS-HVNVVSFLGFCYE  152 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~  152 (386)
                      ++......+.++||+|+||.||+|++.      .+..||+|+++.....  .+.+.+|++++.++. ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344444556689999999999999863      2458999999764322  357889999999997 9999999999999


Q ss_pred             cCceeEEEEeCCCCCHHHHhcccccc------------------------------------------------------
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESS------------------------------------------------------  178 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  178 (386)
                      .+..++||||+++|+|.++++.....                                                      
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            99999999999999999999754210                                                      


Q ss_pred             --------------------------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 038768          179 --------------------------------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN  220 (386)
Q Consensus       179 --------------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~N  220 (386)
                                                            .....+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                  0112467788899999999999999998   99999999999


Q ss_pred             eEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccc
Q 038768          221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVS  299 (386)
Q Consensus       221 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~  299 (386)
                      ||+++++.+||+|||+++...............++..|+|||.+.+.  .++.++|||||||++|||++ |+.||.....
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999999999999865433222222233467889999998654  67899999999999999998 8889864321


Q ss_pred             cCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          300 LSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       300 ~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                             .......+..+..+..+..++.++.+++.+|+..++.-|++..++
T Consensus       348 -------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el  392 (401)
T cd05107         348 -------NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL  392 (401)
T ss_pred             -------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                   122333344444445566789999999999999999888876654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-38  Score=289.50  Aligned_cols=243  Identities=26%  Similarity=0.387  Sum_probs=193.6

Q ss_pred             hhhccCcCCceEEEEEEeC-CCc----EEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.||+|+||.||+|.+. +|+    .+++|.+.....  ...++..|+..+.+++||||+++++++. ....++++||
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~   89 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL   89 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence            4578999999999999863 454    477787754322  2256778888999999999999999875 4567889999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++....     ..+++..++.++.||+.||+|||+.   +++|+||||+|||+++++.+||+|||+++....
T Consensus        90 ~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          90 SPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             CCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999996532     4588999999999999999999998   999999999999999999999999999986543


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...........++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ....+.+..+..+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERLA  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcCC
Confidence            3221122234467789999998653  68999999999999999998 9999975422        33334455555555


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..++.+..+++.+|+..++.-|++..++
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el  261 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKEL  261 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            566678899999999999999988877665

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.9e-39  Score=292.48  Aligned_cols=252  Identities=24%  Similarity=0.435  Sum_probs=202.1

Q ss_pred             HhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCcee
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  157 (386)
                      .+.+.+.||+|+||.||++...      +...+|+|.+......  ..++.+|+.++.++ +|+||+++++++...+..+
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   92 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY   92 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence            3445678999999999999753      2368999998754322  24688999999999 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccccc----------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC
Q 038768          158 LIYEFMPNGSLDQFIYDEES----------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF  227 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  227 (386)
                      ++|||+++|+|..++.....          ......+++..++.++.|++.||.|||+.   +++||||||+|||+++++
T Consensus        93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~  169 (293)
T cd05053          93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDH  169 (293)
T ss_pred             EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCC
Confidence            99999999999999965321          01235688999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccc
Q 038768          228 CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYF  306 (386)
Q Consensus       228 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  306 (386)
                      .+||+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||.....       
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------  240 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------  240 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCH-------
Confidence            9999999999876554332222333456789999988654  68899999999999999998 9999875422       


Q ss_pred             hhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          307 PNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       307 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                       ..+++.+..+..+..+..++.++.+++.+|+..++.-|+++.++
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei  284 (293)
T cd05053         241 -EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL  284 (293)
T ss_pred             -HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence             33445555554445566788999999999999998888876654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.3e-39  Score=303.65  Aligned_cols=254  Identities=27%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecC-----ceeEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKK-----KRALIY  160 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~  160 (386)
                      ..+.||+|+||.||++.. .+|+.||+|.+.....   ..+.+.+|+++++.++|+||+++++++...+     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            357899999999999986 4789999999865322   2357889999999999999999999998776     789999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+. ++|.+++...      ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        84 e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          84 ELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             eccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9995 6888877442      4688999999999999999999998   9999999999999999999999999999865


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--------cchhh---
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--------YFPNS---  309 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~---  309 (386)
                      ...... ......++..|+|||++.+. ..++.++|||||||++|||++|+.||........-.        .....   
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            433211 12234578899999998764 357899999999999999999999997653211000        00000   


Q ss_pred             ----hhhhcCCCc--------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          310 ----IYKHIEPGN--------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       310 ----~~~~i~~~~--------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          ....+....        ...+....+++..+++.+|+..++.-|++++++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence                000010000        0123445689999999999999999999988877766

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-40  Score=305.31  Aligned_cols=245  Identities=29%  Similarity=0.416  Sum_probs=204.1

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEec-----CCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCc--eeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLK-----NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK--RALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e  161 (386)
                      |..+||+|+|-+||+|.+. +|-.||.-.++     +++...+.|..|+.+|+.|+|+||++++.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3457999999999999763 57777754443     233334789999999999999999999999998876  668999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCccc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLS  240 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~  240 (386)
                      .+..|+|..|+++.      +..+...+..|++||++||.|||++ .|+|||||||.+||||+. .|.|||+|+|||...
T Consensus       124 L~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             cccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            99999999999765      4577889999999999999999997 679999999999999975 589999999999988


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .....    ....|||.|||||++..   .|++.+||||||++|+||+|+..||....       .|..+++++-.|..|
T Consensus       197 r~s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  197 RKSHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIKP  262 (632)
T ss_pred             hcccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCCH
Confidence            76643    23679999999999874   68999999999999999999999997542       357888888887755


Q ss_pred             c-ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          321 Q-LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       321 ~-~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      . +..--.++.+++|.+||.. ...|.++.++..+|-
T Consensus       263 ~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~F  298 (632)
T KOG0584|consen  263 AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPF  298 (632)
T ss_pred             HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence            3 4555588999999999997 566777777766654

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-38  Score=286.30  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEec------CceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEK------KKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv  159 (386)
                      +.+.+.||+|+||.||+|... +++.||+|++.........+.+|+.++.++ +|+||+++++++...      ...++|
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            344577999999999999864 588999999987666667889999999998 699999999998763      357899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        88 ~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          88 MEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            99999999999986532    24588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ......  ......|+..|+|||++...   ...++.++|||||||++|||++|+.||.......       ........
T Consensus       161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~  231 (272)
T cd06637         161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRN  231 (272)
T ss_pred             cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhcC
Confidence            543221  12234588899999998532   2357889999999999999999999997542211       11111111


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .........++.++.+++.+|+..++.-|+++.++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  270 (272)
T cd06637         232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP  270 (272)
T ss_pred             CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence            122223456789999999999999999999887766554

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-38  Score=289.44  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             hhhhccCcCCceEEEEEEeCC------CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.||+|+||.||+|.+.+      +..|++|.+......  ...+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            345789999999999998743      568999988754322  356899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccc-cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ceEEeeccC
Q 038768          161 EFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISDFGL  236 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl  236 (386)
                      ||+++++|.+++...... .....+++..++.++.||+.||+|||+.   +++|+||||+||+++.++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence            999999999999765421 1223589999999999999999999998   999999999999998654   599999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++................+..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+.+.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~~~~  235 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEFVT  235 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence            9876433222212222345689999998653  68999999999999999997 9999975422        23334444


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .......+..++.+..+++.+|+...+.-|++..++
T Consensus       236 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v  271 (277)
T cd05036         236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI  271 (277)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            444455567789999999999999999988876654

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-38  Score=292.61  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEe--------CCCcEEEEEEecCCC--CChHHHHHHHHHhhcC-CCCccceEEEEEEe
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKL--------PDGRLVAVKVLKNSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYE  152 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  152 (386)
                      ....+.+.+.||+|+||.||+|..        .++..||+|.+....  ...+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            344455668899999999999964        124579999987532  2236788999999999 89999999999999


Q ss_pred             cCceeEEEEeCCCCCHHHHhccccccc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESSN----------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      ....++||||+++|+|.+++.......          ....+++..++.++.||+.||.|||+.   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            999999999999999999997643211          123578889999999999999999998   9999999999999


Q ss_pred             eCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccC
Q 038768          223 LGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLS  301 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~  301 (386)
                      +++++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|+|++ |..||....   
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~---  244 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---  244 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence            999999999999999876543322222234466789999998653  68899999999999999998 788886442   


Q ss_pred             CcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       302 ~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                           ...+.+.+..+.....+..++.++++++.+|+...+.-|+++.++
T Consensus       245 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~  289 (304)
T cd05101         245 -----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL  289 (304)
T ss_pred             -----HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence                 244555555555455567789999999999999888877765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-38  Score=294.04  Aligned_cols=253  Identities=25%  Similarity=0.432  Sum_probs=199.8

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC--------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKK  154 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  154 (386)
                      ..+.+.++||+|+||.||++...        .+..+|+|.++.....  ...+.+|+++++++ +||||++++++|.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            34456789999999999999641        2457999998754322  35688999999999 6999999999999999


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG  224 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~  224 (386)
                      ..++||||+++|+|.+++......          .....+++..+..++.|++.||.|||+.   +++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            999999999999999999664311          1124588999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCc
Q 038768          225 EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSE  303 (386)
Q Consensus       225 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  303 (386)
                      +++.+||+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||....     
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----  241 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----  241 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCC-----
Confidence            9999999999999866543222112222345679999998653  68899999999999999999 888886542     


Q ss_pred             ccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          304 IYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                         +..+++.+..+.....+..++.++.+++.+|+..++.-|+++.++
T Consensus       242 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l  286 (314)
T cd05099         242 ---VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL  286 (314)
T ss_pred             ---HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence               234445555554445567788999999999999888888765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.6e-38  Score=285.09  Aligned_cols=244  Identities=23%  Similarity=0.294  Sum_probs=201.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||.|+||.||++... +++.+|+|.++...  ...+.+.+|+.+++.++|+||+++++.+.+.+..++||||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            34578999999999999864 68899999986432  2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++++|||++........
T Consensus        83 ~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          83 GDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999885432    24578899999999999999999998   999999999999999999999999999976644322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .  .....|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||.....        ......+..+....++..
T Consensus       156 ~--~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  223 (255)
T cd08219         156 Y--ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQGSYKPLPSH  223 (255)
T ss_pred             c--cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcCCCCCCCcc
Confidence            1  1234588899999998654  688999999999999999999999975422        223334444554556778


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++.++.+++.+|+..++.-|+++.++
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~i  249 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTI  249 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHH
Confidence            89999999999999999999877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=303.72  Aligned_cols=258  Identities=21%  Similarity=0.262  Sum_probs=200.1

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeC---CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      ....+.+.+.||.|+||.||++...   .+..||+|.+...    ....+|+++++.++|+||+++++++......++||
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3344666789999999999999753   3578999988643    24568999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      |++ .++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++..
T Consensus       166 e~~-~~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        166 PKY-KCDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             hhc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999 47888888332      5689999999999999999999998   9999999999999999999999999999766


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc--------------ccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE--------------IYF  306 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--------------~~~  306 (386)
                      .............||..|+|||++...  .++.++|||||||++|||++|+.||.........              ..+
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            544332223345699999999998654  6889999999999999999999999654321100              000


Q ss_pred             hh----hh---hhhcCCCcc--cc-----ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          307 PN----SI---YKHIEPGNE--FQ-----LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       307 ~~----~~---~~~i~~~~~--~~-----~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      +.    ..   +........  ..     ....++.++++++.+|+..++.-|+++.++..+|-.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence            00    00   011110000  00     123467889999999999999999999998888754

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=299.79  Aligned_cols=238  Identities=27%  Similarity=0.479  Sum_probs=199.0

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeCC---Cc--EEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLPD---GR--LVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      ++.+......+.||.|-||.||+|.+.+   |.  .||||+.+.+  ..+.+.|+.|..+|++++||||++++|+|. ..
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQ  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-cc
Confidence            4566666778899999999999998632   33  6999999874  345688999999999999999999999996 45


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ..++|||.++.|.|..||+...     ..++...+.-++.||+.||.|||+.   .+|||||..+|||+.+...+||+||
T Consensus       464 P~WivmEL~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence            7899999999999999997654     5688899999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhh
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      |+++.+.....+... ...-+..|||||.+.-  ..++.++|||-|||.+||++. |..||..-..        ..+.-+
T Consensus       536 GLSR~~ed~~yYkaS-~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--------sDVI~~  604 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKAS-RGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--------SDVIGH  604 (974)
T ss_pred             chhhhccccchhhcc-ccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccc--------cceEEE
Confidence            999999887665544 4556789999999943  489999999999999999876 9999985422        335566


Q ss_pred             cCCCccccccccCChHHHHHHHHHHH
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMIL  339 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~  339 (386)
                      |..|.....+..+.+.+=.+..+|=.
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWa  630 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWA  630 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhc
Confidence            77777777777777776666666544

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=283.54  Aligned_cols=240  Identities=27%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             hccCcCCceEEEEEEeC--C--CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP--D--GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ++||+|+||.||+|.+.  +  +..+|+|.+.....  ..+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999752  2  26899999986554  3467899999999999999999999875 4568999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++...      ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          80 GPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999653      3588999999999999999999998   999999999999999999999999999986644332


Q ss_pred             ee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          246 FI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       246 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .. ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ..+.+.+..+.....+
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  220 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLESGERLPRP  220 (257)
T ss_pred             ccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCcCCCC
Confidence            21 11222345679999998653  68899999999999999998 9999975422        3344555555545566


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..++..+++++.+|+...+.-|+++.++
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l  248 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSEL  248 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            7789999999999999999888876543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-38  Score=286.94  Aligned_cols=247  Identities=27%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...+.+.++||+|+||.||++...++..+|+|.+.......+.+.+|+.+++.++|+||+++++++.+ ...+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            34456678999999999999998778889999988665556789999999999999999999999887 77899999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||.+.......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          84 KGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999996532    24578889999999999999999998   99999999999999999999999999997654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .. ......++..|+|||++...  .++.++|+|||||++|++++ |+.||.....        ....+.+..+.....+
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  225 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYRMPRP  225 (260)
T ss_pred             cc-cccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCCCCCc
Confidence            21 11223456779999998653  68889999999999999999 8999975422        2233444444444456


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+.++.+++.+|+...+.-|++..+
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~  252 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEY  252 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHH
Confidence            678899999999999999888876543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-38  Score=289.84  Aligned_cols=248  Identities=28%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.||+|+||+||++.. .+++.||+|.+.....    ....+.+|+++++.++|+|++.+.+++.+.+..++||||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            46799999999999986 4688999999875432    224578899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++........
T Consensus        85 ~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          85 GDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99998886432    24689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                         .....|+..|+|||++.+.  .++.++|+|||||++|+|++|+.||.......    ....+...+.... ......
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----~~~~~~~~~~~~~-~~~~~~  227 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----KREEVDRRVLETE-EVYSAK  227 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhhhccc-cccCcc
Confidence               1234689999999998654  68899999999999999999999997542210    1122223333322 345667


Q ss_pred             CChHHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      ++++..+++.+|+..++.-|++     +.++..++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP  262 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence            8999999999999999998887     44555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-38  Score=284.20  Aligned_cols=241  Identities=27%  Similarity=0.455  Sum_probs=201.1

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||+|.. .|+.||+|.+.......+++.+|+.+++.++|+||+++++++.+.+..++||||+++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS   86 (256)
T ss_pred             ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence            34568899999999999987 58999999998765556789999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.++.......  
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          87 LVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999986542    13689999999999999999999998   999999999999999999999999999987643221  


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                         ....+..|+|||++...  .++.++||||||+++|||++ |+.||.....        ..+...+..+.....+..+
T Consensus       158 ---~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  224 (256)
T cd05039         158 ---SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRMEAPEGC  224 (256)
T ss_pred             ---cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCccCC
Confidence               23356679999998653  68889999999999999997 9999875421        3344444444334456678


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++++.+++.+|+...+.-|++++++
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l  249 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQL  249 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHH
Confidence            9999999999999999888876553

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-38  Score=291.58  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=200.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||.||++...      ++..||+|.+.....  ..+++.+|+.+++.++||||+++++++.+.+..++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            344578999999999999753      467899999875432  235688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccc----------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          160 YEFMPNGSLDQFIYDEESS----------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      |||+++|+|.+++......                .....+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence            9999999999999643210                1113478899999999999999999998   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCC
Q 038768          224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSS  302 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  302 (386)
                      ++++.++|+|||++.................+..|+|||.+.+.  .++.++|||||||++|||++ |..||....    
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~----  237 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMA----  237 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence            99999999999998765433222112223346679999988653  68899999999999999998 888886432    


Q ss_pred             cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       303 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                          +.++...+..+.....+..++.++.+++.+|+..++.-|+++.++
T Consensus       238 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         238 ----HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             ----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence                234445565555555566788999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=276.52  Aligned_cols=257  Identities=25%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             HHhhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCc-----eeE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK-----RAL  158 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~l  158 (386)
                      .++.+.+.||.|+|+-||+++ ..++..+|+|++.-.. .+.+..++|++..++++||||+++++++..+..     .|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            345567889999999999997 5788999999987554 455778999999999999999999998875543     899


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      +++|+..|+|.+.+....  ..+..+++.+++.|+.+|++||++||+. .+++.||||||.|||+++.+.++|.|||.+.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EeehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999997654  2335799999999999999999999997 3359999999999999999999999999997


Q ss_pred             ccCcccc-------eeeeccccCccccccccccchhc-CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          239 LSEKKES-------FISMLGARGTIGYIAPEVFCRNF-GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       239 ~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      ...-...       ...-.....|..|+|||.+.-+. ...++++|||||||+||+|+.|..||+......+...+.   
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA---  254 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA---  254 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe---
Confidence            5532110       01111234688999999985432 357899999999999999999999998664433222111   


Q ss_pred             hhhcCCCc-cccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          311 YKHIEPGN-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       311 ~~~i~~~~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                         +..+. .+.-...+|+.+.++++.|+++++.-||++.++
T Consensus       255 ---v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l  293 (302)
T KOG2345|consen  255 ---VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL  293 (302)
T ss_pred             ---eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence               11111 122233499999999999999999999977654

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-38  Score=283.49  Aligned_cols=244  Identities=27%  Similarity=0.487  Sum_probs=201.7

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.+.||+|+||.||++.+.++..+|+|.+........++.+|++++++++|||++++++++......++||||+++++|
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            45678999999999999887788999999987766778899999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....     ..+++..++.++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  157 (256)
T cd05112          87 SDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS  157 (256)
T ss_pred             HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence            99986532     3578899999999999999999998   999999999999999999999999999875543221 11


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      .....++..|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ....+.+.++.....+...+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGFRLYKPRLAS  227 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCCCCCCCCCCC
Confidence            1223356789999998653  68889999999999999998 9999975422        33444444443334455678


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++..+++.+|+...+.-|+++.++
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~  251 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLL  251 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHH
Confidence            999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-38  Score=288.62  Aligned_cols=256  Identities=22%  Similarity=0.327  Sum_probs=198.0

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||+|++|.||+|... +++.||+|.++...   .....+.+|+.++++++||||+++++++.+++..++||||++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            4578999999999999864 68999999986532   223678899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++.....   ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          83 MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            689888854321   24688999999999999999999998   999999999999999999999999999976543321


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhh------
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYK------  312 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~------  312 (386)
                        ......++..|+|||.+.+. ..++.++|||||||++|+|+||+.||..........       ...+..|.      
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              11233568899999988654 357889999999999999999999997543211000       00000110      


Q ss_pred             -------hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          313 -------HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       313 -------~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                             .+..+........++++.++++.+|+..++.-|+++.++..+|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~  283 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP  283 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence                   1111111122345899999999999999999999888876665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-38  Score=294.25  Aligned_cols=257  Identities=24%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeC--------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEEEE
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLGFC  150 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~  150 (386)
                      ++...++.+.+.||+|+||.||++...        .+..||+|.++....  ..+++.+|+++++++ +|+||++++++|
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            344455667889999999999999642        123689998875432  235788999999999 799999999999


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN  220 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~N  220 (386)
                      .+.+..++++||+++|+|.+++......          .....+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            9999999999999999999999754311          1124578899999999999999999998   99999999999


Q ss_pred             eEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccc
Q 038768          221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVS  299 (386)
Q Consensus       221 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~  299 (386)
                      ||++.++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..||.... 
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~-  241 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-  241 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCC-
Confidence            99999999999999999866543322222233455679999998654  68889999999999999998 888886542 


Q ss_pred             cCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          300 LSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       300 ~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                             .....+.+..+.....+..++.++.+++.+|+..++.-|+++.++
T Consensus       242 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~el  286 (334)
T cd05100         242 -------VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL  286 (334)
T ss_pred             -------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                   233444554444445566788999999999999888888765544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-38  Score=290.39  Aligned_cols=247  Identities=24%  Similarity=0.419  Sum_probs=197.0

Q ss_pred             hhhhccCcCCceEEEEEEeCC-Cc--EEEEEEecCCC--CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD-GR--LVAVKVLKNSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|...+ +.  .+++|.++...  ...+.+.+|+.++.++ +||||+++++++.+.+..++|+||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            355789999999999998643 33  57888887422  2235788999999999 799999999999999999999999


Q ss_pred             CCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          163 MPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      +++++|.+++......          .....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence            9999999999653211          1123588999999999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||++.......   .......+..|+|||++...  .++.++|||||||++|||++ |+.||.....        ..+.
T Consensus       162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~  228 (297)
T cd05089         162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY  228 (297)
T ss_pred             CcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            999986432211   11112235579999998654  68899999999999999997 9999975422        3344


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+..+..+..++.+..+++.+|+..++.-|++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  268 (297)
T cd05089         229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI  268 (297)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            5555554455667789999999999999999999887765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=319.25  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=206.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||.|..++.+ +++.+|+|++++-.    ....-|..|-++|...+.+-|+.+.-.|.+..++|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            345689999999999999874 58899999998732    3345688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |+||+|..++.+.      ..+++.-++.++..|.-||.-||+-   |+|||||||+|||||..|++||+|||.+-.+..
T Consensus       157 ~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            9999999999553      3689999999999999999999998   999999999999999999999999999988776


Q ss_pred             ccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-  318 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-  318 (386)
                      +... .....+|||.|++||++...   .+.|+..+|+||+||++|||+.|..||...+-        -+.+.+|..-+ 
T Consensus       228 dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY~KIm~hk~  298 (1317)
T KOG0612|consen  228 DGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETYGKIMNHKE  298 (1317)
T ss_pred             CCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHHHHHhchhh
Confidence            5443 34467899999999999532   25689999999999999999999999997654        23444443322 


Q ss_pred             ccccc--ccCChHHHHHHHHHHHHHHHh--cCCCCCCCCCCC
Q 038768          319 EFQLA--GVVTEEEKEMAKKMILVLEML--EGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~--~~~s~~~~~li~~ml~v~~~L--~~~~~~~~~~p~  356 (386)
                      .+.+|  ..+|+++++||++++.--+.-  |...+++..||-
T Consensus       299 ~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpF  340 (1317)
T KOG0612|consen  299 SLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPF  340 (1317)
T ss_pred             hcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCcc
Confidence            23333  569999999999999744332  345677777774

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.1e-38  Score=284.45  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=198.1

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.+++||||+++++++...+..++||||++
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~   89 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG   89 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence            345568899999999999986 568899999987543 234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        90 ~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          90 GGSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999998543      4578999999999999999999998   99999999999999999999999999998654322


Q ss_pred             ceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .  ......++..|+|||.+... ...++.++|||||||++|||++|+.||..............   ..+.. ......
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~-~~~~~~  234 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK---SNFQP-PKLKDK  234 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec---CCCCC-CCCccc
Confidence            1  11234578899999987432 23577899999999999999999999864432111100000   00110 111123


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      ..++..+.+++++|+..++..|++.+++..+
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            4578999999999999999999987776544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3e-38  Score=287.39  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=201.1

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeCC-----CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEe-cCce
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLPD-----GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYE-KKKR  156 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  156 (386)
                      ...+.+.+.||+|+||.||+|...+     +..|++|.+.....  ..+.+.+|+.+++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3344556889999999999998755     68899999875422  23568899999999999999999998876 4678


Q ss_pred             eEEEEeCCCCCHHHHhcccccc--cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          157 ALIYEFMPNGSLDQFIYDEESS--NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ++++||+++++|.+++......  .....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            8999999999999998654321  1124688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhh
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      |+++.+.............++..|+|||++.+.  .++.++|||||||++||+++ |+.||.....        ..+...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~  231 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAY  231 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHH
Confidence            999866443322111223456789999998654  68899999999999999999 9999975422        334444


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..+..+..++++..+++.+|+..++.-|++..++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  269 (280)
T cd05043         232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL  269 (280)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            54454444556678999999999999988888876543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-38  Score=291.83  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=199.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.++||+|+||.||+|... +++.||+|.++...  .....+.+|+.+++.++|+||+++++++.+.+..++||||++ 
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-   87 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   87 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence            34578999999999999864 57899999987532  234567899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        88 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          88 KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            68988886532     4578899999999999999999998   999999999999999999999999999975443221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------c-cchhhhhhhcCCCc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------I-YFPNSIYKHIEPGN  318 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~-~~~~~~~~~i~~~~  318 (386)
                      .  .....++..|+|||++.+. ..++.++|||||||++|||++|+.||.........      . ......|..+....
T Consensus       160 ~--~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 T--YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             c--ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            1  1233468899999998654 35788999999999999999999999754321000      0 00011111111110


Q ss_pred             --------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          319 --------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       319 --------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                                    .......++++.++++.+|+..++.-|++++++..+|--
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                          011234578899999999999999999999988777643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-39  Score=300.50  Aligned_cols=243  Identities=21%  Similarity=0.366  Sum_probs=209.7

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||+|.|+.|.+|+. .++..||||.+.++..+.   +.+.+|+++|+.++|||||+++.+.......|+||||+.+
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            357899999999999975 468999999998865543   4588999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |.+.+++.+.      ....+..+..++.|+.+|++|||++   .|||||||++|||++.+..+||+|||++..+.....
T Consensus       140 ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  140 GELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             chhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccc
Confidence            9999999665      4455688899999999999999999   999999999999999999999999999998875443


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                         ..+.+|++.|.|||++.+. ...++++|+||+|+++|-|++|..||++...        .++.++...++ +.++-.
T Consensus       211 ---lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk-~rIp~~  277 (596)
T KOG0586|consen  211 ---LQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGK-YRIPFY  277 (596)
T ss_pred             ---ccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeee-ecccce
Confidence               3467899999999999887 4678999999999999999999999997643        23333444444 778889


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      ++-+.+++|++||...+.-|+..+++..+
T Consensus       278 ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  278 MSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eechhHHHHHHhhccCccccCCHHHhhhh
Confidence            99999999999999988888877766555

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.3e-38  Score=297.95  Aligned_cols=252  Identities=23%  Similarity=0.278  Sum_probs=192.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEec------Ccee
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEK------KKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  157 (386)
                      +.+.+.||+|+||.||++... .++.||||++....   .....+.+|+.+++.++||||+++++++...      ...+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            344578999999999999864 58899999997532   2335678999999999999999999987643      3468


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||++ ++|..++.        ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       106 lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         106 IVMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             EEEeCCC-CCHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            9999995 57777763        2477889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc------c-chhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI------Y-FPNSI  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~------~-~~~~~  310 (386)
                      +.......   .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||........-.      . ...+.
T Consensus       174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             cccCCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            86544322   1234689999999998664  68899999999999999999999997543210000      0 00000


Q ss_pred             hhhcC----------------------C----CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 YKHIE----------------------P----GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~~~i~----------------------~----~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+.+.                      .    ..+.......++++++++.+|+..++.-|+++.++..||-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            00000                      0    0011112234678999999999999999999999887764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-38  Score=289.76  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=191.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcC---CCCccceEEEEEEec-----Cce
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKT---SHVNVVSFLGFCYEK-----KKR  156 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~~~  156 (386)
                      .+.+.||+|+||.||+|... +|+.||+|.++...   .....+.+|+.+++.+   +||||+++++++...     ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            34578999999999999864 68999999987532   2234566777777655   799999999998753     357


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++||||++ ++|.+++....    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            89999996 58988886432    23588999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------cc
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EI  304 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~  304 (386)
                      ++.......   .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||........            ..
T Consensus       155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            986653322   1234578899999998654  689999999999999999999999965422100            00


Q ss_pred             cchhhh------hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          305 YFPNSI------YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       305 ~~~~~~------~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++...      +..........+...++++.++++.+|++.++.-|+++.++..+|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            000000      000000001122345788999999999999999999988877765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.8e-38  Score=283.71  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=200.6

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC-------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ..+.||+|+||.||+|...+|+.+|+|.+......       .+.+.+|+++++.++|+||++++++|.+.+..++|+||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            45779999999999998888999999998753321       14578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          84 VPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999543      3578899999999999999999998   999999999999999999999999999875432


Q ss_pred             ccc----eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          243 KES----FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       243 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ...    ........++..|+|||++.+.  .++.++|||||||++|+|++|+.||.......      ......-....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCC
Confidence            110    0111234588899999998654  67899999999999999999999997542210      10101111122


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+.++..++++..+++++|+..++.-|+++.++..+|
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  263 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHD  263 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence            3456777899999999999999999999888776655

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.9e-38  Score=291.45  Aligned_cols=261  Identities=17%  Similarity=0.198  Sum_probs=196.3

Q ss_pred             hhhccCcC--CceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           90 FSNKLGQG--GFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      +.++||+|  +||+||++.. .+|+.||+|.++.....   .+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34679999  6899999976 57899999999754322   245778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....    ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++||+........
T Consensus        82 ~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          82 AYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             CCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            9999999985432    13588999999999999999999998   9999999999999999999999999865433211


Q ss_pred             ccee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------c-------c
Q 038768          244 ESFI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------E-------I  304 (386)
Q Consensus       244 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~-------~  304 (386)
                      ....     ......++..|+|||++.+....++.++|||||||++|||++|+.||........       .       .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence            1000     0112246678999999875434688999999999999999999999974321100       0       0


Q ss_pred             cchhh-hh---------hhcCCC-------------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          305 YFPNS-IY---------KHIEPG-------------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       305 ~~~~~-~~---------~~i~~~-------------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..+.+ ..         ..+..+             ........+++++.+++.+|++.++..|++++++..+|--
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence            00000 00         000000             0011233467899999999999999999999998877754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.8e-38  Score=288.25  Aligned_cols=242  Identities=28%  Similarity=0.428  Sum_probs=202.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++... +++.||+|++....    ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            34578999999999999864 58999999987532    23356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        84 ~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          84 PGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999998553      4688999999999999999999998   9999999999999999999999999999876544


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .     ....+++.|+|||.+.+.  ..+.++||||||+++|+|++|+.||....        +....+.+..+. ..++
T Consensus       155 ~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~  218 (290)
T cd05580         155 T-----YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILEGK-VRFP  218 (290)
T ss_pred             C-----CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-ccCC
Confidence            1     234588899999998654  67889999999999999999999997543        233444444333 5567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p  355 (386)
                      ..++.++++++.+|+..++.-|.     +++++..+|
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence            77899999999999999998886     445555555

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.4e-38  Score=282.49  Aligned_cols=240  Identities=27%  Similarity=0.431  Sum_probs=196.5

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEE-ecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY-EKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++||||++++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            44568899999999999987 57889999987543 4567899999999999999999999765 445789999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....    ...+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++....... 
T Consensus        86 ~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          86 SLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            9999986532    13578999999999999999999998   999999999999999999999999999875443221 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                          ...++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+..+.....+..
T Consensus       158 ----~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  223 (256)
T cd05082         158 ----TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPDG  223 (256)
T ss_pred             ----CCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC
Confidence                22345679999998654  68899999999999999998 9999874321        334444544544556677


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +++...+++.+|+..++.-|+++.++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l  249 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQL  249 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            89999999999999999999876543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-38  Score=315.74  Aligned_cols=248  Identities=23%  Similarity=0.265  Sum_probs=192.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.++||+|+||.||+|... +|+.||+|++.....    ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            34578999999999999864 589999999975422    2357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccccc-----ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          164 PNGSLDQFIYDEES-----SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       164 ~~gsL~~~l~~~~~-----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ++|+|.+++.....     .......++..++.++.||+.||+|||+.   +++||||||+|||++.++.++|+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence            99999999864211     11123466778899999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccc----------------eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC
Q 038768          239 LSEKKES----------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS  302 (386)
Q Consensus       239 ~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  302 (386)
                      .......                ........||+.|+|||++.+.  .++.++|||||||++|||+||+.||....... 
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-  238 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK-  238 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence            6521110                0011124689999999998664  68999999999999999999999997642211 


Q ss_pred             cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       303 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                       ..    ....+...........+++.+.+++.+|+..++.-|.+
T Consensus       239 -i~----~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        239 -IS----YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             -hh----hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence             00    00111111111223467888999999999988887753

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.6e-38  Score=284.49  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=184.8

Q ss_pred             hccCcCCceEEEEEEeCC---CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ++||+|+||.||+|...+   ...+++|.+......  ...+.+|+..++.++|+||+++++.|.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   347888887643322  356789999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++..... ......++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          81 DLKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             cHHHHHHhccc-cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999976532 1123456788899999999999999998   9999999999999999999999999998754333222


Q ss_pred             eeeccccCccccccccccchh-----cCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc--
Q 038768          247 ISMLGARGTIGYIAPEVFCRN-----FGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN--  318 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~--  318 (386)
                      .......++..|+|||++...     ...++.++|||||||++|||++ |+.||......       ......+....  
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~  229 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQDIK  229 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccCcc
Confidence            222233466789999987432     1246789999999999999999 77888644211       11112222221  


Q ss_pred             --cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          319 --EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       319 --~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                        .+.++..++....+++..|. .++.-|+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~  262 (269)
T cd05042         230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE  262 (269)
T ss_pred             CCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence              23445567888888887766 46666665544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-38  Score=284.11  Aligned_cols=246  Identities=26%  Similarity=0.316  Sum_probs=204.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||.|+||.||+|... +++.||+|.+....  .....+.+|+++++.++|+|++++++++.+....++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            44578999999999999864 68899999987543  2335788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++..       ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.......
T Consensus        84 ~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          84 GSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999854       2688999999999999999999998   999999999999999999999999999987654321


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......++..|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+.....+.+...
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  221 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLIPKNNPPSLEGN  221 (274)
T ss_pred             --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHhhhcCCCCCccc
Confidence              12234578889999998764  589999999999999999999999975432        223334444444455545


Q ss_pred             -CChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          326 -VTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       326 -~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                       ++++..+++.+|+..++.-|++.+++..+|-
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~  253 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKF  253 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence             8999999999999999999998888766653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-38  Score=288.18  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=196.9

Q ss_pred             ccCcCCceEEEEEEeCC-------CcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           93 KLGQGGFGSVYKGKLPD-------GRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .||+|+||.||+|+..+       +..+|+|.+....  .....+.+|+.+++.++||||++++++|.+.+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            59999999999997632       2579999886543  33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccccccc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-----ceEEeeccCC
Q 038768          164 PNGSLDQFIYDEESSN-INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-----CPKISDFGLA  237 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl~  237 (386)
                      ++++|.+++....... ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997543211 224578899999999999999999998   999999999999999877     8999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ................++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ......+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~  228 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVTA  228 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHhc
Confidence            765443322222223456789999998653  68999999999999999998 9999974422        233444444


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..+..++.++.+++.+|+...+.-|++..++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  263 (269)
T cd05044         229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRI  263 (269)
T ss_pred             CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence            44455667788999999999999888888766543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-38  Score=285.64  Aligned_cols=245  Identities=30%  Similarity=0.457  Sum_probs=199.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCc----EEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.+.+.||+|+||.||+|... +|.    .+|+|.+......  ..++.+|+.++++++|+||++++++|.. ...++||
T Consensus         9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   87 (279)
T cd05057           9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT   87 (279)
T ss_pred             cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence            345688999999999999853 333    6899988765432  3578899999999999999999999987 7889999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++|+|.+++....     ..+++..++.++.||+.||+|||+.   +++|+||+|+||++++++.+||+|||+++..
T Consensus        88 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          88 QLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             ecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999986542     3588999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      .............++..|+|||.+..  ..++.++|+||||+++||+++ |+.||+...        +..+.+.+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGER  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCC
Confidence            54433222222334668999998854  368899999999999999998 999997642        2445556666655


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ...+...+.+..+++.+|+..++.-|++..++
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l  261 (279)
T cd05057         230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKEL  261 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            66677788999999999999988888765543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.8e-38  Score=281.01  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             hhhhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||++++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   83 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG   83 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence            3455789999999999998754 78999999875433 678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        84 ~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          84 SVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             cHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999985432     5689999999999999999999998   9999999999999999999999999999866543211


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC--CCccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE--PGNEFQLAG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~--~~~~~~~~~  324 (386)
                        .....++..|+|||++.+.  .++.++||||||+++|+|++|+.||........        ...+.  .......+.
T Consensus       156 --~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~  223 (256)
T cd06612         156 --RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMIPNKPPPTLSDPE  223 (256)
T ss_pred             --cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhhccCCCCCCCchh
Confidence              1223478899999998654  688999999999999999999999975432111        11111  111223345


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++.++.+++.+|+..++.-|++++++..+|
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~  254 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQHP  254 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence            6788999999999999999999888766554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.6e-38  Score=287.98  Aligned_cols=252  Identities=26%  Similarity=0.341  Sum_probs=201.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.++||.|+||.||+|... +++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++......++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            345678999999999999874 588999999875432 246788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|..++....     ..+++..++.++.|++.+|.|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        94 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          94 GAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            99988875432     4588999999999999999999998   999999999999999999999999999875432211


Q ss_pred             eeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--cc
Q 038768          246 FISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EF  320 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~  320 (386)
                        ......++..|+|||++...   ...++.++|||||||++|||++|+.||.....        ......+....  ..
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  235 (292)
T cd06644         166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPTL  235 (292)
T ss_pred             --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCCccC
Confidence              11233578899999998531   13467899999999999999999999975432        22222222222  22


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..+..++.+..+++.+|+..++.-|++.+++..+|--
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            3356788999999999999999999988887776653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.1e-38  Score=282.90  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=189.2

Q ss_pred             hccCcCCceEEEEEEeCC---CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||+|.+.+   +..+|+|.++.....  ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            359999999999997643   457999988754332  246889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++...... .....++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999654321 123466778889999999999999998   9999999999999999999999999999765443322


Q ss_pred             eeeccccCccccccccccchhc-----CCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNF-----GGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .......++..|+|||++.+..     ..++.++||||||+++|||++ |+.||.......   .....+.....+...+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  233 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTVREQQLKLPKP  233 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHhhcccCCCCCC
Confidence            2222345678899999985421     135789999999999999996 999997542211   0001111111111223


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+....++...+++..|. .++.-|++++++
T Consensus       234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l  263 (269)
T cd05087         234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV  263 (269)
T ss_pred             ccCCCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence            344457888899998886 567777776654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-38  Score=284.10  Aligned_cols=248  Identities=26%  Similarity=0.407  Sum_probs=201.2

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----------hHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      .+.+.||+|+||.||+|.. .+++.+|+|.+......          .+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            3457899999999999976 46789999988653221          145788999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||+++++|.+++...      ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          83 IFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             EEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999543      4578889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCccccee----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          238 KLSEKKESFI----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       238 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      +.........    ......|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||.....        ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~  223 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFK  223 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHH
Confidence            8665321110    11123478899999998654  678899999999999999999999975422        111223


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +.....+.++..++.+..+++.+|+..++.-|++..++..+|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  265 (267)
T cd06628         224 IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP  265 (267)
T ss_pred             HhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence            333444566778899999999999999999998887766554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.4e-38  Score=288.89  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCce
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  156 (386)
                      ..+.+.+.||+|+||.||++...      .+..||+|+++.....  .+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            34456789999999999999641      2457999998754322  35688999999999 799999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.++|+|||+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999965321    3389999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++...............++..|+|||++.+.  .++.++|||||||++|||++ |..||.....       .....+.+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~~~  258 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKLIK  258 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHHHH
Confidence            9865443322222223467789999998654  68899999999999999998 9999875422       122223333


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.....+...++++.+++.+|+..++.-|+++.++
T Consensus       259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el  294 (302)
T cd05055         259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI  294 (302)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            333334455678999999999999888888876553

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-38  Score=282.76  Aligned_cols=244  Identities=25%  Similarity=0.432  Sum_probs=193.3

Q ss_pred             hccCcCCceEEEEEEeCC-Cc--EEEEEEecCCC--CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLPD-GR--LVAVKVLKNSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||+|.+.+ +.  .+++|.++...  ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            359999999999998743 43  57888887532  2336788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          166 GSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       166 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      |+|.+++......          .....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            9999999654311          1123578999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhc
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      ++.......   .......+..|+|||++...  .++.++|||||||++|||++ |+.||.....        ....+.+
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~  224 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKL  224 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHH
Confidence            986322111   11112345679999998654  68899999999999999997 9999965422        2344455


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+.....+..++.+..+++.+|+..++.-|++..++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  261 (270)
T cd05047         225 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  261 (270)
T ss_pred             hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            4444444566688999999999999999988876653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=278.94  Aligned_cols=242  Identities=28%  Similarity=0.436  Sum_probs=196.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      ++||.|+||.||++...+++.|++|.+......  ...+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            369999999999999867999999998764433  467899999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      +++....     ..+++..++.++.+++.+|.|||++   +++||||+|+||+++.++.++|+|||++............
T Consensus        81 ~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          81 TFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9986532     3578899999999999999999998   9999999999999999999999999999865432211111


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....+..|+|||.+.+.  .++.++|+|||||++|||++ |..||.....        ......+..+.....+..++.
T Consensus       153 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  222 (251)
T cd05041         153 GLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAPQLCPE  222 (251)
T ss_pred             ccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCCccCCH
Confidence            122245679999998653  68899999999999999999 8888865422        223334433333445667889


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++.+|+...+.-|++++++
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~el  245 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEI  245 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHH
Confidence            99999999999988888876654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.5e-38  Score=286.52  Aligned_cols=246  Identities=25%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +...+.||+|+||.||+|... +++.||+|.+.....  ..+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            334577999999999999864 578999999875432  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++..       ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        86 ~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          86 GGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999998843       3578899999999999999999998   99999999999999999999999999997654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..  .....++..|+|||++.+.  .++.++|||||||++|||++|+.|+.....        ......+..+..+.+..
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~  223 (277)
T cd06642         156 IK--RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHP--------MRVLFLIPKNSPPTLEG  223 (277)
T ss_pred             hh--hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccch--------hhHHhhhhcCCCCCCCc
Confidence            11  1123578899999998654  678899999999999999999999874422        22223344444455667


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++.+..+++.+|+..++.-|++..++..+|
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            7889999999999999999999887765554

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-37  Score=282.88  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+++++.++|+|++++++++...+..++|+||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            34577999999999999875 47788999986533 23357889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..++....     ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++........ 
T Consensus        88 ~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          88 AVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            9998875432     4689999999999999999999998   999999999999999999999999999875533221 


Q ss_pred             eeeccccCccccccccccch---hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--ccc
Q 038768          247 ISMLGARGTIGYIAPEVFCR---NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EFQ  321 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~~  321 (386)
                       ......++..|+|||++..   ....++.++|||||||++|||++|+.||.....        ......+....  ...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  229 (282)
T cd06643         159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPTLA  229 (282)
T ss_pred             -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCCCCCC
Confidence             1223458889999999742   113567899999999999999999999975432        11112222221  223


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                      .+..++.++++++.+|+..++.-|++..++..+|--.
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            4556889999999999999999999998888777643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.7e-38  Score=291.96  Aligned_cols=258  Identities=21%  Similarity=0.255  Sum_probs=190.5

Q ss_pred             hccCcCCceEEEEEEeC---CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g  166 (386)
                      .+||+|+||.||+|...   ++..||+|.+.... ....+.+|+++++.++||||+++++++..  ....++||||++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            57999999999999864   35789999987543 33467899999999999999999999864  456789999985 5


Q ss_pred             CHHHHhcccccc---cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCceEEeeccCCcc
Q 038768          167 SLDQFIYDEESS---NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKL  239 (386)
Q Consensus       167 sL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~~  239 (386)
                      +|.+++......   .....+++..++.++.||+.||.|||+.   +++||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            787777532211   1224588999999999999999999998   99999999999999    5667999999999986


Q ss_pred             cCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC--ccc-----------
Q 038768          240 SEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS--EIY-----------  305 (386)
Q Consensus       240 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--~~~-----------  305 (386)
                      ....... .......+|..|+|||++.+. ..++.++|||||||++|||+||+.||........  ...           
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543211 112234688999999998653 3578999999999999999999999975421100  000           


Q ss_pred             ---chhhhhhhcCCCc----------------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          306 ---FPNSIYKHIEPGN----------------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       306 ---~~~~~~~~i~~~~----------------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         .....|+.+....                      ........+.+..+++.+|+..++.-|++++++..+|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence               0001111110000                      0001123466788999999999999999998887766

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.9e-38  Score=282.68  Aligned_cols=245  Identities=26%  Similarity=0.411  Sum_probs=196.9

Q ss_pred             hhhhhccCcCCceEEEEEEeC-C---CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-D---GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|... +   +..+|+|.++.....  .+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            345678999999999999753 2   347999998754322  3578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++....
T Consensus        86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          86 YMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             cCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999996532     3578899999999999999999998   99999999999999999999999999998765


Q ss_pred             ccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          242 KKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       242 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ...... ......++..|+|||++.+.  .++.++|+||||+++||+++ |+.||.....        ....+.+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEEGYR  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhCCCc
Confidence            432211 11122345689999998653  68899999999999999886 9999975422        223344444443


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +.....++++..+++.+|++.++.-|++..+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (267)
T cd05066         228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQ  258 (267)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence            4455677899999999999999988887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5e-38  Score=288.31  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=201.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +...+.||+|+||.||+|.. .+++.|++|.+..... ..+.+.+|+.+++.++|+||+++++.+......++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            33457899999999999985 4688999999875433 346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++..       ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus       102 ~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999853       3478889999999999999999998   999999999999999999999999999876543321


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-ccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-NEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~  324 (386)
                      .  .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......       ........+ .....+.
T Consensus       172 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~  240 (296)
T cd06654         172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPELQNPE  240 (296)
T ss_pred             c--cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCCCCCCCCcc
Confidence            1  1234578899999998653  67899999999999999999999997543211       111111111 1223355


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .++..+.+++.+|+..++.-|++++++..+|--
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~  273 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence            688999999999999999999998888776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4e-38  Score=289.94  Aligned_cols=247  Identities=26%  Similarity=0.443  Sum_probs=193.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCc--EEEEEEecCCC--CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGR--LVAVKVLKNSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|.+. ++.  .+++|.++...  ...+.+.+|++++.++ +|+||+++++++.+.+..++||||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            45678999999999999864 454  46777776432  2235788999999999 899999999999999999999999


Q ss_pred             CCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          163 MPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      +++++|.+++......          .....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence            9999999999754321          1123588999999999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||++.......   ......++..|+|||++.+.  .++.++|||||||++|||+| |..||.....        ....
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~  233 (303)
T cd05088         167 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY  233 (303)
T ss_pred             ccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHHH
Confidence            999986432111   11112345679999988654  57899999999999999998 9999975432        2233


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+.....+..+++++.+++.+|+...+.-|++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  273 (303)
T cd05088         234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  273 (303)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            4443333334455678999999999999888888876654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=283.50  Aligned_cols=261  Identities=26%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             HHHHhhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCCh--------HHHHHHHHHhhcCCCCccceEEEEEE-ec
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--------EEFINEVASMSKTSHVNVVSFLGFCY-EK  153 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~-~~  153 (386)
                      ...++-+...||+|+|+.||+|. +...+.||||+-.-...++        +...+|.++.+.|+||.||++|+++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            34455556789999999999996 4678899999875443333        23678999999999999999999986 56


Q ss_pred             CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCceE
Q 038768          154 KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPK  230 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~k  230 (386)
                      +..|-|+|||+|.+|.-||+..      ..+++.+++.|+.||+.||.||... .++|||-||||.|||+-   ..|.+|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence            7889999999999999999765      5688999999999999999999986 56999999999999994   457899


Q ss_pred             EeeccCCcccCcccce-----eeeccccCccccccccccchh--cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc
Q 038768          231 ISDFGLAKLSEKKESF-----ISMLGARGTIGYIAPEVFCRN--FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE  303 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  303 (386)
                      |+|||+++.+......     .-.....||.+|++||.+.-.  ....+.++||||.|||+|.++.|+.||..+....+.
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            9999999988654321     122346799999999998532  356899999999999999999999999865332211


Q ss_pred             ccchhhhhhhcCCCcc--ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          304 IYFPNSIYKHIEPGNE--FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                       .-.    ..|.+..+  +.....+|.+++++|++||.....-|....++.-+|.
T Consensus       694 -Lqe----NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy  743 (775)
T KOG1151|consen  694 -LQE----NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY  743 (775)
T ss_pred             -Hhh----hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence             001    12222332  3345679999999999999987777766666655554

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.4e-38  Score=293.49  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=197.7

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEec-
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEK-  153 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-  153 (386)
                      ....+.+.+.||+|+||.||+|..      .+++.||||+++.....  .+.+.+|+.++.++ +|+||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            344566778999999999999963      35789999999754322  35688999999999 689999999988755 


Q ss_pred             CceeEEEEeCCCCCHHHHhccccccc------------------------------------------------------
Q 038768          154 KKRALIYEFMPNGSLDQFIYDEESSN------------------------------------------------------  179 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------  179 (386)
                      ...++||||+++|+|.+++.......                                                      
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            45789999999999999986532100                                                      


Q ss_pred             -------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccc
Q 038768          180 -------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA  252 (386)
Q Consensus       180 -------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  252 (386)
                             ....+++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||++...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                   013468888999999999999999998   9999999999999999999999999999865433222222233


Q ss_pred             cCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHH
Q 038768          253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEK  331 (386)
Q Consensus       253 ~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~  331 (386)
                      .++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....       .......+..+.....+..+++++.
T Consensus       242 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  312 (343)
T cd05103         242 RLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDYTTPEMY  312 (343)
T ss_pred             CCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHHHhccCCCCCCCCCCHHHH
Confidence            456789999998654  68899999999999999997 8999865321       1223333444444445566788999


Q ss_pred             HHHHHHHHHHHHhcCCCCCC
Q 038768          332 EMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       332 ~li~~ml~v~~~L~~~~~~~  351 (386)
                      +++.+|+..++.-|+++.++
T Consensus       313 ~~~~~cl~~~p~~Rps~~ei  332 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSEL  332 (343)
T ss_pred             HHHHHHccCChhhCcCHHHH
Confidence            99999999888888876654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=283.53  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=203.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.+.||.|+||.||++... ++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.+....++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            445678999999999999864 688999999875432 335788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        87 ~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          87 GALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999986532     4689999999999999999999998   999999999999999999999999999875433221


Q ss_pred             eeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc--
Q 038768          246 FISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF--  320 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~--  320 (386)
                        ......++..|+|||++...   ...++.++|+||||+++|+|++|+.||.....        ......+..+..+  
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  228 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSEPPTL  228 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhcCCCCCc
Confidence              11234578899999997522   13467899999999999999999999975422        2222333333322  


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+..++.++.+++.+|+..++.-|++.+++..+|-
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence            235568899999999999999999999888766654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.5e-38  Score=284.38  Aligned_cols=248  Identities=27%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      ..||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            57999999999999854 578899998875433 3467889999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCcccce
Q 038768          170 QFIYDEESSNINRKL--EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +++....     ..+  ++..+..++.||+.||.|||+.   +++||||||+||+++. ++.++|+|||++.........
T Consensus        94 ~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          94 ALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             HHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            9986532     234  7788899999999999999998   9999999999999976 679999999998765432211


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                        .....++..|+|||++......++.++||||||+++|+|++|+.||.......      ...+........+.++..+
T Consensus       166 --~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06624         166 --TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAMFKVGMFKIHPEIPESL  237 (268)
T ss_pred             --cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhHhhhhhhccCCCCCccc
Confidence              11234788999999986543357889999999999999999999996432111      1112221122234567778


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +++.++++.+|+...+.-|+++.++..+|
T Consensus       238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         238 SAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            99999999999999999999888776665

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-38  Score=286.55  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=204.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +++.+.||+|+||.||++... +|..||+|.+.....  ....+.+|++++.+++|+||+++++.+...+..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            345678999999999999875 689999998875322  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|..++....   ....+++..+..++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          83 AGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            999999886531   124689999999999999999999973  289999999999999999999999999987553322


Q ss_pred             ceeeeccccCccccccccccchhc----CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNF----GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .    ....++..|+|||.+.+..    ..++.++|+|||||++|+|++|+.||......     ........+..+..+
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~  228 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVDGDPP  228 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhhcCCC
Confidence            1    2335788999999985431    13578999999999999999999999753210     011122334444555


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++..++++..+++.+|+..++.-|++.+++..+|
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            66777999999999999999999999888877665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.6e-38  Score=295.98  Aligned_cols=251  Identities=24%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  158 (386)
                      ...+.||+|+||.||++.. ..++.||+|.+.....   ....+.+|+.+++.++||||+++++++....      ..++
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   99 (355)
T cd07874          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL   99 (355)
T ss_pred             eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence            3457899999999999975 3588999999975432   2356788999999999999999999986543      4689


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||++ ++|...+.        ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       100 v~e~~~-~~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874         100 VMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             Ehhhhc-ccHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            999995 46766663        2477889999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------c-cchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------I-YFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~-~~~~~~~  311 (386)
                      .......   .....||..|+|||++.+.  .++.++|||||||++|+|++|+.||........-      . ....+.+
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         168 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cCCCccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6544322   1234689999999998664  6889999999999999999999999754311000      0 0000000


Q ss_pred             hhcC--------C------------------CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 KHIE--------P------------------GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~~i~--------~------------------~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+.        .                  ..+.......+.++++++.+|+..++.-|+++.++..+|-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~  313 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY  313 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence            0000        0                  0001122335678899999999999999999999888773

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-38  Score=294.33  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=194.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEec------Ccee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEK------KKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  157 (386)
                      +...+.||+|+||.||+|.. .+++.||||.+.....   ..+.+.+|+.+++.++|+||+++++++...      ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            33457899999999999985 4688999999875322   235677899999999999999999987643      3468


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +++|++ +++|.+++..       ..+++..+..++.||+.||.|||+.   +++||||||+|||+++++.+||+|||++
T Consensus        97 ~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          97 LVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             EEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence            999988 8899888743       3588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSI  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~  310 (386)
                      +......     ....|+..|+|||++.+. ..++.++|||||||++|+|++|+.||........-       ...+...
T Consensus       166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         166 RQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             eecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8654322     244689999999998653 36789999999999999999999999754211000       0000111


Q ss_pred             hhhcCCCc---------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 YKHIEPGN---------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~~~i~~~~---------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ...+....               ........++...+++.+|+..++.-|+++.++..+|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~  300 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY  300 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            11111100               00112346778899999999999999999999888874

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-38  Score=284.56  Aligned_cols=246  Identities=26%  Similarity=0.423  Sum_probs=196.0

Q ss_pred             hhhhhccCcCCceEEEEEEeCC-C---cEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD-G---RLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|.... +   ..||+|.+.....  ...+|..|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            3456889999999999998642 3   3699999875422  23578999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          86 FMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             cCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999986542     4578999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccceee---eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCC
Q 038768          242 KKESFIS---MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       242 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      .......   ......+..|+|||++...  .++.++|||||||++||+++ |..||.....        ....+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcC
Confidence            3322111   1111224579999998653  68899999999999999886 9999975432        2334444444


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .....+..++.+..+++.+|+...+.-|++..++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  261 (269)
T cd05065         228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQI  261 (269)
T ss_pred             CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            3344456778999999999999888888876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-37  Score=279.00  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=204.3

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||.|+||.||.++. .+++.+++|.+....   ...+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            3457899999999999875 468899999986533   234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          83 GGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             CCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999986532    24588999999999999999999998   99999999999999999999999999998664433


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .  ......++..|+|||++.+.  .++.++||||||+++|||++|+.||+....        .+....+..+.....+.
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~~  223 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQGNYTPVVS  223 (256)
T ss_pred             c--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCcc
Confidence            2  12234588999999998654  578899999999999999999999975422        33334444455445557


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++.+..+++.+|+..++.-|++++++..+|
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            7899999999999999888888877665443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.2e-38  Score=283.01  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=196.9

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      ..+.+.+.||+|+||.||+|...+    ...|++|.......  ..+.+.+|+.+++.++|+||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            334566889999999999998643    24799998875432  34578999999999999999999999875 557899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          85 MELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            99999999999996532     3588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ........ .....++..|+|||.+...  .++.++||||||+++||+++ |..||.....        ......+..+.
T Consensus       157 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~~~  225 (270)
T cd05056         157 LEDESYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGRIENGE  225 (270)
T ss_pred             ccccccee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcCC
Confidence            65442221 1123345689999998654  68899999999999999986 9999975432        23334455555


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ....+..++.++.+++.+|+...+.-|+++.+
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  257 (270)
T cd05056         226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTE  257 (270)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            55667788999999999999998888887654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-37  Score=279.86  Aligned_cols=248  Identities=24%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEec-CceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEK-KKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~  163 (386)
                      .+.+.||.|++|.||++... +++.||+|.+.....   ..+.+.+|++++++++|+|++++++.+... ...+++|||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC   82 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence            45678999999999999864 578999999875432   235688999999999999999999987644 4578999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++....    ...+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          83 EGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             CCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999986532    24588999999999999999999998   9999999999999999999999999999866433


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ...  .....+++.|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+..+..+.++
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~  223 (257)
T cd08223         156 CDM--ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIEGKLPPMP  223 (257)
T ss_pred             CCc--cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcCCCCCc
Confidence            221  1234578899999998654  678899999999999999999999975421        2222334344444566


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..++++..+++.+|+..++.-|++..++..+|
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  255 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILRQP  255 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            77899999999999999999999887776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-37  Score=285.80  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=197.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.||+|+||.||++... +|..+|+|.+.....  ...++.+|++++.+++||||++++++|.+.+..++||||++++
T Consensus         5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~   84 (308)
T cd06615           5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   84 (308)
T ss_pred             EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence            4578999999999999864 578899999875322  2356889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++...      ..+++..+..++.|++.||.|||+.  .+++|+||+|+|||++.++.++|+|||++.......  
T Consensus        85 ~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          85 SLDQVLKKA------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            999999643      4578999999999999999999973  289999999999999999999999999987553321  


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccch-------------------
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP-------------------  307 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------------------  307 (386)
                        .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||...........+.                   
T Consensus       155 --~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence              1234578899999998653  68889999999999999999999986432111000000                   


Q ss_pred             ---------hhhhhhcCCCcccccc-ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          308 ---------NSIYKHIEPGNEFQLA-GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       308 ---------~~~~~~i~~~~~~~~~-~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                               ....+.+.....+.++ ..++.++++++.+|+..++.-|+++.++..+|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                     0011111111112222 247889999999999999999999988877764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-37  Score=280.88  Aligned_cols=245  Identities=25%  Similarity=0.329  Sum_probs=192.7

Q ss_pred             ccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHHH---hhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           93 KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVAS---MSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .||+|+||.||++.. .+++.+|+|.+......    ...+.+|..+   +...+|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999986 46899999998754321    2234445433   334579999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..+..++.|++.||+|||+.   +++|+||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            99999988543      4689999999999999999999998   99999999999999999999999999987554322


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .    ....|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||.......     ...+ ..........++.
T Consensus       152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~~~~~  220 (279)
T cd05633         152 P----HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEI-DRMTLTVNVELPD  220 (279)
T ss_pred             c----cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----HHHH-HHHhhcCCcCCcc
Confidence            1    234589999999987532 357889999999999999999999997543211     1122 2222222345677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEG-----STEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p~~  357 (386)
                      .+++++++++.+|+..++.-|.     +++++..||--
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence            7899999999999999999998     46767666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-37  Score=279.62  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=197.8

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||+|.. .+++.||+|.++.... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            344567899999999999986 4688999999875432 23567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        90 ~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          90 GGSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999998543      4688999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-cc--
Q 038768          245 SFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-EF--  320 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-~~--  320 (386)
                      .  ......|+..|+|||++... ...++.++|+|||||++|+|++|+.||......       ...+....... .+  
T Consensus       161 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~  231 (267)
T cd06645         161 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFLMTKSNFQPPKL  231 (267)
T ss_pred             c--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hhHHhhhccCCCCCcc
Confidence            1  12234588999999997421 235788999999999999999999998643221       11111111110 11  


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .-...+++.+.+++.+|+..++.-|++++++..+|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~  266 (267)
T cd06645         232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP  266 (267)
T ss_pred             cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence            11224688999999999999999998887765554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-37  Score=281.61  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=196.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CC---cEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DG---RLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +..+.||+|+||.||+|... ++   ..+++|.+.....  ..+.+.+|++++..++|+|++++.+++.+.+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            34578999999999999864 23   3799999875432  246788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++....     ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          88 MENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999986532     4588999999999999999999998   999999999999999999999999999976543


Q ss_pred             cccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          243 KESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       243 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ..... .......+..|+|||++...  .++.++|||||||++|||++ |+.||.....        ..+.+.+..+...
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~~  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFRL  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCCC
Confidence            22111 11122234579999998654  67899999999999999997 9999965422        3344555444434


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .....++.+..+++.+|+..++.-|++..++
T Consensus       230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            4455678999999999999988888876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-37  Score=282.73  Aligned_cols=251  Identities=26%  Similarity=0.356  Sum_probs=193.8

Q ss_pred             hhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecC--ceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKK--KRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  159 (386)
                      .+.+.||+|+||+||++..     .+++.||+|.++....  ....+.+|+++++.++||||+++++++...+  ..++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            3457899999999988653     3578999999976432  3467889999999999999999999987643  57899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++..       ..+++..++.++.|++.||.|||+.   +++|+||||+|||+++++.++|+|||+++.
T Consensus        87 ~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          87 MEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            999999999999854       3489999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhh
Q 038768          240 SEKKESFIS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIY  311 (386)
Q Consensus       240 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~  311 (386)
                      ......... .....++..|+|||.+.+.  .++.++||||||+++|||++|..|+......-.+       ......+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            654322111 1122356679999998653  6889999999999999999999998643211000       00011112


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+.....+..++.+..+++.+|+..++.-|++.+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  274 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL  274 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            2222333334466788999999999999999999876653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-37  Score=279.24  Aligned_cols=246  Identities=29%  Similarity=0.407  Sum_probs=201.1

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ..+.||+|+||.||+|... +++.|++|.+.....      ..+.+.+|+.+++.++|+||+++++++.+....++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            3467999999999999875 789999999865331      235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          84 VPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999998543      3578999999999999999999998   999999999999999999999999999876544


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...   .....++..|+|||.+... ..++.++|+||||+++|+|++|+.||......       ...++.......+.+
T Consensus       155 ~~~---~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~  223 (258)
T cd06632         155 FSF---AKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELPPI  223 (258)
T ss_pred             ccc---ccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCCCc
Confidence            331   1234578899999998654 23789999999999999999999999754311       112221111223445


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..+++++++++.+|+...+.-|++++++..+|
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  256 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP  256 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence            677899999999999999999998887766555

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.6e-37  Score=284.82  Aligned_cols=252  Identities=26%  Similarity=0.373  Sum_probs=196.9

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC-----------------CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD-----------------GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFL  147 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~  147 (386)
                      .+.+.++||+|+||.||++...+                 +..||+|.+.....  ..+.+.+|++++.+++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            34556889999999999987532                 24689999875432  346788999999999999999999


Q ss_pred             EEEEecCceeEEEEeCCCCCHHHHhcccccc-----cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESS-----NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      +++...+..+++|||+++++|.+++......     .....+++..++.++.|++.||.|||+.   +++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence            9999999999999999999999998654311     1123689999999999999999999998   9999999999999


Q ss_pred             eCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh--CCCCccccccc
Q 038768          223 LGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV--GRKNAEVKVSL  300 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~  300 (386)
                      ++.++.++|+|||+++...............++..|+|||++.+.  .++.++|||||||++|||++  |..||..... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            999999999999999865544332222234467789999998653  68899999999999999998  6677764321 


Q ss_pred             CCcccchhhhhhhcC-------CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          301 SSEIYFPNSIYKHIE-------PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       301 ~~~~~~~~~~~~~i~-------~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                             ..+++.+.       .......+..+++++.+++.+|+..++.-|+++.++
T Consensus       240 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         240 -------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             -------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence                   11222211       111122345678999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.1e-37  Score=281.46  Aligned_cols=246  Identities=24%  Similarity=0.334  Sum_probs=202.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ...+.||.|+||.||+|... ++..||+|++.....  ....+.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus         7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06640           7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence            34577999999999999864 588999999875432  235788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++..       ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        87 ~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          87 GSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999998853       3478889999999999999999998   999999999999999999999999999976544321


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .  .....++..|+|||++.+.  .++.++|+|||||++|||++|+.||.....        ......+..+..+.+...
T Consensus       157 ~--~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  224 (277)
T cd06640         157 K--RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHP--------MRVLFLIPKNNPPTLTGE  224 (277)
T ss_pred             c--cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcCh--------HhHhhhhhcCCCCCCchh
Confidence            1  1223578889999998654  678999999999999999999999975422        222233344444556677


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ++.+..+++.+|+..++.-|++..++..+|-
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             hhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            8899999999999999999998887766653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-37  Score=279.45  Aligned_cols=247  Identities=26%  Similarity=0.339  Sum_probs=194.7

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---C---hHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---N---GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIY  160 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  160 (386)
                      ..+.||+|+||.||+|.. .+|..||+|.+.....   .   .+.+.+|+.++++++|+||+++++++.+.  ...+++|
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            357899999999999986 4589999998864221   1   24678899999999999999999988764  4577999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++++|.+++...      ..+++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          86 EHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            999999999998543      3477888999999999999999998   9999999999999999999999999998865


Q ss_pred             Ccccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          241 EKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       241 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ...... .......++..|+|||++.+.  .++.++|||||||++|||++|+.||.....       .....+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~  227 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTN  227 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHHHHHhcCCCC
Confidence            432111 111234578899999998654  678999999999999999999999975421       1222222222333


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..+..++....+++.+|+. .+..|++.+++..+|
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            45667788999999999984 778888887776655

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-37  Score=280.10  Aligned_cols=242  Identities=29%  Similarity=0.428  Sum_probs=194.3

Q ss_pred             hccCcCCceEEEEEEeCC--Cc--EEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLPD--GR--LVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||+|++|.||+|.+.+  ++  .||+|.+.....  ..+.+.+|+.++++++|+||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998633  33  699999987554  34678999999999999999999999988 888999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++.....    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999966421    4688999999999999999999998   999999999999999999999999999987654322


Q ss_pred             ee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcC-CCccccc
Q 038768          246 FI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIE-PGNEFQL  322 (386)
Q Consensus       246 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~  322 (386)
                      .. ......++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+.+.+. .......
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  222 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGERLER  222 (257)
T ss_pred             ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCCcCCC
Confidence            11 11124467889999998654  68899999999999999999 9999964322        12222222 2222334


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..++.+..+++.+|+...+..|++..++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            55678999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-37  Score=284.33  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=202.6

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||++.. .+|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA   99 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence            344567899999999999986 4789999999875433 34668899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++..       ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus       100 ~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656         100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             CCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999853       3478889999999999999999998   99999999999999999999999999987654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC--Cccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP--GNEFQL  322 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~  322 (386)
                      ..  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||........       . ..+..  ......
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~-~~~~~~~~~~~~~  237 (297)
T cd06656         170 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------L-YLIATNGTPELQN  237 (297)
T ss_pred             cC--cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------e-eeeccCCCCCCCC
Confidence            21  1233578899999998654  678999999999999999999999975432111       0 11111  111223


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      +..++..+++++.+|+..++.-|++++++..+|--
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL  272 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence            55678999999999999999999999988777653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-37  Score=280.82  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=197.5

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---C--------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---N--------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      .+.||.|+||.||+|.. .+|+.||+|.++....   .        .+.+.+|+.+++.++|+|++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            46799999999999975 4689999998863211   1        1357789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        86 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             EEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            99999999999998653      4588899999999999999999998   99999999999999999999999999997


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ...............++..|+|||.+......++.++|+||||+++|++++|+.||......       ....+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKRS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhcccc
Confidence            65432221112234578899999998654234788999999999999999999999643221       11111111111


Q ss_pred             ----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 ----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          .......++.+.++++.+|+..++..|++.+++..+|
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence                1123345789999999999999999999888776665

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=305.66  Aligned_cols=254  Identities=18%  Similarity=0.221  Sum_probs=188.0

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCC------CccceEEEEEEec-CceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH------VNVVSFLGFCYEK-KKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~-~~~~lv  159 (386)
                      +.+.++||+|+||+||+|.. .+++.||||+++......+++..|+.++..++|      .+++.+++++... ...++|
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv  210 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV  210 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence            44567899999999999986 457899999997644444556677777766654      4588899988765 467899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC------------
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF------------  227 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~------------  227 (386)
                      ||++ +++|.+++...      ..+++..+..++.||+.||+|||++  .+||||||||+|||++.++            
T Consensus       211 ~~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        211 MPKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             Eecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence            9988 78898888543      4688999999999999999999973  2999999999999998765            


Q ss_pred             ----ceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-
Q 038768          228 ----CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-  302 (386)
Q Consensus       228 ----~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-  302 (386)
                          .+||+|||.+......     .....||..|+|||++.+.  .++.++|||||||++|||++|+.||+....... 
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                4999999988643322     1245689999999999764  689999999999999999999999975432100 


Q ss_pred             ------cccchhhhhh------------hcCC---Ccc-----------ccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          303 ------EIYFPNSIYK------------HIEP---GNE-----------FQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       303 ------~~~~~~~~~~------------~i~~---~~~-----------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                            ...+|..+..            ....   ...           .......++.+.++|.+||..++.-|+++++
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence                  0001111100            0000   000           0001112566789999999999999999999


Q ss_pred             CCCCCCC
Q 038768          351 LQIPPKP  357 (386)
Q Consensus       351 ~~~~p~~  357 (386)
                      +..||--
T Consensus       435 ~L~Hp~~  441 (467)
T PTZ00284        435 MTTHPYV  441 (467)
T ss_pred             HhcCccc
Confidence            9888753

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-37  Score=283.86  Aligned_cols=246  Identities=27%  Similarity=0.383  Sum_probs=201.2

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||.|+||.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++|+|++++++++...+..++|+||++++
T Consensus        22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence            3457899999999999975 578999999987543 33467889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..++..       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus       102 ~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655         102 SLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             cHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99998843       3578999999999999999999998   9999999999999999999999999998765443221


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC--ccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG--NEFQLAG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~  324 (386)
                        .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+...  .....+.
T Consensus       172 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~  239 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNGTPELQNPE  239 (296)
T ss_pred             --CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCcccCCcc
Confidence              1234578899999998654  67889999999999999999999997653211        11111111  1223456


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+++.+.+++.+|+..++.-|+++.++..+|-
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~  271 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence            68899999999999999999999888766654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=285.08  Aligned_cols=259  Identities=23%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC---------------CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD---------------GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGF  149 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~  149 (386)
                      .+.+.++||+|+||.||++...+               ...||+|.++....  ..+.+.+|++++++++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            44556889999999999987532               23589999875422  23568899999999999999999999


Q ss_pred             EEecCceeEEEEeCCCCCHHHHhcccccc------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          150 CYEKKKRALIYEFMPNGSLDQFIYDEESS------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      +...+..++||||+++++|.+++......      .....+++..++.++.|++.||+|||+.   +++|+||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEE
Confidence            99999999999999999999998653211      0112468889999999999999999998   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh--CCCCcccccccC
Q 038768          224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV--GRKNAEVKVSLS  301 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~  301 (386)
                      ++++.+||+|||++................++..|+|||++...  .++.++|||||||++|+|++  |..||.......
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999765433322222223456789999998653  68999999999999999998  566776432210


Q ss_pred             CcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       302 ~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .. ......+...........+..+++++.+++.+|+..++.-|++..++
T Consensus       241 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         241 VI-ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             HH-HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            00 00000011111111122345578999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.7e-37  Score=278.76  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             ccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHH---HhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           93 KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVA---SMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .||+|+||.||++.. .+++.||+|.+......    ...+..|..   .+....|+||+.+.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999976 45889999998754322    122344433   4445679999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|..++...      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            99999988542      4689999999999999999999998   99999999999999999999999999987554322


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .    ....|+..|+|||++.+. ..++.++|||||||++|||++|+.||........     ....+.+ ....+.++.
T Consensus       152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~~~~~~~  220 (278)
T cd05606         152 P----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTMAVELPD  220 (278)
T ss_pred             C----cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHh-hccCCCCCC
Confidence            1    234588999999998643 2578899999999999999999999976432111     1222222 222355677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEG-----STEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p~  356 (386)
                      .++.+..+++.+|+..++.-|+     +..++..+|-
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~  257 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF  257 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence            7899999999999999999888     6666665554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.1e-37  Score=277.91  Aligned_cols=244  Identities=30%  Similarity=0.495  Sum_probs=201.4

Q ss_pred             hhhccCcCCceEEEEEEeCC-----CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLPD-----GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.||.|+||.||++...+     +..||+|++.....  ..+.+.+|+..+..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999998643     38899999976544  356889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++.....    ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        83 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       83 MEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             cCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999965421    1289999999999999999999998   999999999999999999999999999987655


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ....... ...++..|+|||.+.+  ..++.++||||||+++|+|++ |+.||+....        ..+.+.+..+....
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  224 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLP  224 (258)
T ss_pred             ccccccc-cCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCC
Confidence            4332221 2336789999999844  368899999999999999998 7888875321        33444555555555


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..++.++.+++.+|+..++.-|+++.++
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSEL  254 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            666789999999999999999988876543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-38  Score=295.71  Aligned_cols=197  Identities=26%  Similarity=0.378  Sum_probs=170.3

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-C-----CccceEEEEEEecCceeEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-H-----VNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv  159 (386)
                      ++.+.+.||+|+||+|.+|.. .+++.||||++++...--++...|+.+|..++ |     -|+|+++++|...++.|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            445568899999999999975 56999999999987766677788999999987 4     3899999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC--CceEEeeccCC
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED--FCPKISDFGLA  237 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~  237 (386)
                      +|.+ ..+|.++++....    ..++...++.++.||+.||.+||..   +|||+||||+||||.+-  ..+||+|||.+
T Consensus       267 fELL-~~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ehhh-hhhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999 7899999987543    5689999999999999999999998   99999999999999753  36999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccc
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV  298 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  298 (386)
                      ........     ....+..|+|||++.+-  .|+.+.||||||||+.||++|.+-|.+.+
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence            87665432     33467789999999985  89999999999999999999987775543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-37  Score=282.08  Aligned_cols=256  Identities=26%  Similarity=0.315  Sum_probs=202.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ..+.+.+.||+|+||+||++... +|+.||+|++....  ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            34455688999999999999864 68899999886532  2346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..+..++.+++.+|.|||+.  .+++|+||+|+||++++++.++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          85 MDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             CCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999988543      4588999999999999999999973  2899999999999999999999999999875432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchh---hhhhhcCCCcc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN---SIYKHIEPGNE  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~i~~~~~  319 (386)
                      ...    ....|+..|+|||++.+.  .++.++|||||||++|+|++|+.||............+.   ...+.+.....
T Consensus       157 ~~~----~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd06620         157 SIA----DTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP  230 (284)
T ss_pred             hcc----CccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence            211    134588999999998653  688899999999999999999999986543211111111   12222322222


Q ss_pred             ccccc-cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          320 FQLAG-VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       320 ~~~~~-~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +.++. .++.++.+++.+|+..++.-|++++++..+|
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            33333 3778999999999999999999888876554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-37  Score=282.16  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=196.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  158 (386)
                      +...+.||+|+||.||++..     .++..||+|.++....  ..+.+.+|+.+++.++|+|++++++++.+.  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            34457899999999999974     3578899999875432  235788999999999999999999998875  56789


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++++|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        86 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            999999999999985431     3588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc--------CCcccchhh
Q 038768          239 LSEKKESFIS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL--------SSEIYFPNS  309 (386)
Q Consensus       239 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~--------~~~~~~~~~  309 (386)
                      .......... .....++..|+|||++.+.  .++.++|||||||++|||++++.|+......        ..+. ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM-TVTR  234 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc-cHHH
Confidence            7654332211 1234467789999998654  6889999999999999999987765322110        0111 1112


Q ss_pred             hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       310 ~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+.+..+.....+..++.++.+++.+|+...+.-|++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  276 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL  276 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence            223333444444566789999999999999999988876553

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-37  Score=279.48  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=206.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  162 (386)
                      .+.+.||.|+||.||++.. .+|+.+|+|++......   .+.+.+|+++++.++|+||+++++++...  ...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            3457899999999999975 46889999998754332   35678899999999999999999988643  457899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-----RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +++++|.+++....  .....+++..++.++.|++.||.|||     +.   +++|+||+|+||++++++.+||+|||++
T Consensus        83 ~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          83 CEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             ccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999986542  22356899999999999999999999     65   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ..........  ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||....        ...+.+.+..+
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~  225 (265)
T cd08217         158 KILGHDSSFA--KTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIKEG  225 (265)
T ss_pred             ccccCCcccc--cccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHhcC
Confidence            8765543211  234588899999998654  57899999999999999999999998643        13444566666


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....++..++.++.+++.+|+..++.-|++.+++..+|
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~  263 (265)
T cd08217         226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP  263 (265)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence            66667888999999999999999999999888776665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-37  Score=279.72  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=199.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|.++...    ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            345678999999999999875 78999999886422    2246788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|..++....  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          84 ADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             CCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999986432  1224588999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||.....      ....+.+.+..+.....
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~  228 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPPL  228 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCCC
Confidence            3211  1234578889999998654  688999999999999999999999964421      11223344444443434


Q ss_pred             cc-cCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          323 AG-VVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       323 ~~-~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +. .++.+..+++.+|+...+.-|++..+
T Consensus       229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~  257 (267)
T cd08224         229 PADHYSEELRDLVSRCINPDPEKRPDISY  257 (267)
T ss_pred             ChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence            43 67889999999999988888887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.6e-37  Score=280.11  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=195.1

Q ss_pred             hhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecC------ce
Q 038768           90 FSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKK------KR  156 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~  156 (386)
                      +.+.||+|+||.||+|.+.    +++.||||++......   .+++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4578999999999999753    3678999999764332   356889999999999999999999887543      23


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++++||+++|+|..++...........+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence            68899999999998875433222234578899999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++...............++..|++||.+.+.  .++.++||||||+++|||++ |+.||.....        ......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~  229 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYLI  229 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHHH
Confidence            9866443322222233456789999998654  67889999999999999999 8888874422        23344444


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.....+...+.+..+++.+|+...+.-|+++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~  265 (273)
T cd05074         230 KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL  265 (273)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            444444556678999999999999999888876543

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=297.06  Aligned_cols=243  Identities=28%  Similarity=0.431  Sum_probs=206.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC--CCc--EEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP--DGR--LVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      ......++||+|.||.|++|.|+  +|+  .||||+++.+...  -.+|++|+.+|.+|+|+|+++|||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            33445688999999999999874  354  6999999876554  3789999999999999999999999987 778899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      ||.++.|+|.+.|++.    ....+-...+..++.|||.||+||.++   ++|||||.++|+|+.....+||+||||.+-
T Consensus       189 ~ELaplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhhcccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence            9999999999999772    235678889999999999999999999   999999999999999999999999999998


Q ss_pred             cCcccceeeeccc-cCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCC
Q 038768          240 SEKKESFISMLGA-RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       240 ~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      +..++....+... .-...|.|||.+..  ..++.++|||+|||++|||+| |..||-+...        ..+.++|.++
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~  331 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAG  331 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhcccc
Confidence            8877665555433 34567999999965  489999999999999999999 7899987643        5678889888


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ....-+..+++++=+++.+|=...+.-|+
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRp  360 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRP  360 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccc
Confidence            87888999999999998887664444443

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-37  Score=278.04  Aligned_cols=242  Identities=27%  Similarity=0.412  Sum_probs=188.4

Q ss_pred             hccCcCCceEEEEEEeC----CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEe-cCceeEEEEeCC
Q 038768           92 NKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYE-KKKRALIYEFMP  164 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  164 (386)
                      +.||+|+||.||+|.+.    ++..||+|.+.....  ..+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36999999999999753    235799999864322  23578899999999999999999998764 556789999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....     ....+..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999986532     3456778889999999999999998   99999999999999999999999999997654322


Q ss_pred             ce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhC-CCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          245 SF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG-RKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       245 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ..  .......++..|+|||.+...  .++.++|||||||++|||++| ..||.....        ......+..+..+.
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  222 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRLL  222 (262)
T ss_pred             ceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCCC
Confidence            11  111233467789999998653  688999999999999999995 555654321        22334444444455


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+++...+++.+|+..++.-|++..++
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  252 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSEL  252 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            566678999999999999988888876543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-37  Score=280.42  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=197.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|.. .+++.||||.+....    .....+.+|+++++.++||||+++++++.+.+..++|+||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            3457899999999999986 478999999886422    12246889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++.....  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          85 DAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            99999998854321  124578899999999999999999998   9999999999999999999999999998866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  322 (386)
                      ...  .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.||.....      ......+.+.....+.. 
T Consensus       160 ~~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~  229 (267)
T cd08228         160 TTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCDYPPLP  229 (267)
T ss_pred             hHH--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCCCCCCC
Confidence            221  1234578899999998654  678899999999999999999999864321      11233344444333333 


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ...++.+..+++.+|+..++.-|++..++
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~v  258 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYV  258 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence            34678899999999999888888876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2e-37  Score=278.06  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=204.1

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.+|++.. .+|+.||+|.+....   ...+++.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            3457899999999999975 468899999987532   233578999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          83 GGDLYKKINAQR----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999886532    13578899999999999999999998   99999999999999999999999999997654432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..  .....|+..|+|||++.+.  ..+.++|+|||||++|+|++|+.||....        +......+..+..+..+.
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~~~  223 (256)
T cd08218         156 EL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSYPPVSS  223 (256)
T ss_pred             hh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCCCCCcc
Confidence            21  1123478889999998654  67889999999999999999999997532        133334444555555677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++.++.+++.+|+..++.-|++..++..+|
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~  254 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKN  254 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence            8899999999999999999998887765554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.2e-37  Score=324.01  Aligned_cols=187  Identities=28%  Similarity=0.535  Sum_probs=157.9

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ..+.||+|+||.||+|.. .+|..||||.+.......   ..|++.+++++||||++++|+|.+.+..++||||+++|+|
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence            346899999999999986 578999999987543222   3568889999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .++++         .++|..+..++.|++.||+|||..+.++++||||||+||+++.++..++. ||........     
T Consensus       771 ~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----  835 (968)
T PLN00113        771 SEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----  835 (968)
T ss_pred             HHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence            99993         37899999999999999999996655699999999999999999888875 6655433221     


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                       ....++..|+|||++.+.  .++.++|||||||++|||+||+.||+..
T Consensus       836 -~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        836 -TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             -CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence             123578899999998654  6899999999999999999999999643

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=284.28  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=200.2

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.||+|+||.||+|... +++.||+|.+......    .+.+..|++++..++|+||+++++++.+....++||||+.
T Consensus         5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (316)
T cd05574           5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP   84 (316)
T ss_pred             EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence            4578999999999999865 4899999999765433    2568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          85 GGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             CCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999986432    24688999999999999999999998   99999999999999999999999999987543221


Q ss_pred             cee---------------------------eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          245 SFI---------------------------SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       245 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                      ...                           ......|+..|+|||++.+.  .++.++||||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            100                           01123578899999998754  6789999999999999999999999754


Q ss_pred             cccCCcccchhhhhhhcCC-CccccccccCChHHHHHHHHHHHHHHHhcCC----CCCCCCCCC
Q 038768          298 VSLSSEIYFPNSIYKHIEP-GNEFQLAGVVTEEEKEMAKKMILVLEMLEGS----TEDLQIPPK  356 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~----~~~~~~~p~  356 (386)
                      ..        ...+..+.. .........+++++.+++.+|+..++.-|++    ++++..+|-
T Consensus       236 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         236 NR--------DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             ch--------HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            32        122222221 1112222237999999999999999999998    777776653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-37  Score=292.75  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=190.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||.||+|... +++.||+|+....     ....|+.++++++|+||+++++++.+....++|+||+ .+
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~  141 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS  141 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence            455689999999999999864 5678999985432     2357999999999999999999999999999999999 57


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       142 ~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  212 (357)
T PHA03209        142 DLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-  212 (357)
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence            8888885432     4688999999999999999999998   999999999999999999999999999975433221 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCc-ccccccCCcccc---hhhhhhhcC-------
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA-EVKVSLSSEIYF---PNSIYKHIE-------  315 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~-~~~~~~~~~~~~---~~~~~~~i~-------  315 (386)
                        ..+..||..|+|||++.+.  .++.++|||||||++|||+++..|+ +.... ..+...   ...+.+.+.       
T Consensus       213 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        213 --FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPS-TPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             --cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccCCCC-cHHHHHHHHHHHHHHHHHHhccChh
Confidence              2244689999999998764  6899999999999999999865554 32211 100000   000000000       


Q ss_pred             -------------------CCcc-----c-cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 -------------------PGNE-----F-QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 -------------------~~~~-----~-~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                         ....     . .-...++.+..+++.+|+..++.-|+++.++..||.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~  353 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM  353 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence                               0000     0 001246778889999999999999999999888874

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5e-37  Score=279.00  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.++||+|+||.||+|.. .++..||+|.+.....  ..+.+.+|+.++.+++|+||+++++++.+++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            34457899999999999976 4688999999865432  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++..       ..+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        86 ~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          86 GGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            9999999853       3578999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||.....        ......+..+..+.++.
T Consensus       156 ~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~  223 (277)
T cd06641         156 IK--RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNNPPTLEG  223 (277)
T ss_pred             hh--hccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcCCCCCCCc
Confidence            11  1123578889999998653  678899999999999999999999975321        23333444444556677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++.++.+++.+|+..++.-|++..++..+|
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            8899999999999999999999888876665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-37  Score=277.35  Aligned_cols=244  Identities=21%  Similarity=0.315  Sum_probs=181.6

Q ss_pred             hccCcCCceEEEEEEeCCC---cEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDG---RLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ++||+|+||.||+|...++   ..+++|.+....  ...+.+.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433   356677766433  23467899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++......  ....++..++.++.||+.||+|||+.   +++||||||+|||++.++.++|+|||++.........
T Consensus        81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          81 DLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             cHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            999999764321  23466778889999999999999998   9999999999999999999999999998643222211


Q ss_pred             eeeccccCccccccccccchh-----cCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhc-CCC--
Q 038768          247 ISMLGARGTIGYIAPEVFCRN-----FGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHI-EPG--  317 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i-~~~--  317 (386)
                      .......++..|+|||++...     ...++.++|||||||++|||++ |..||.....        .+...++ ...  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKDQQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhhccc
Confidence            112234578899999997432     1235789999999999999997 4667764321        1222221 111  


Q ss_pred             --ccccccccCChHHHHHHHHHHHHHHHhcCCCC
Q 038768          318 --NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTE  349 (386)
Q Consensus       318 --~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~  349 (386)
                        ..+.+...+++...+++..|+ ..+.-|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~  260 (268)
T cd05086         228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAE  260 (268)
T ss_pred             ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHH
Confidence              123445568889999998887 4455555444

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-37  Score=284.48  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=194.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-----------------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-----------------DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLG  148 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~  148 (386)
                      +.+.++||+|+||.||++...                 ++..||+|.+.....  ...++.+|+.+++.++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            455688999999999998532                 234699999875432  2367899999999999999999999


Q ss_pred             EEEecCceeEEEEeCCCCCHHHHhccccccc-----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSN-----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      ++.+.+..++||||+++++|.+++.......     ....+++..++.++.|++.||+|||+.   +++|+||||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence            9999999999999999999999997643211     123478889999999999999999998   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh--CCCCcccccccC
Q 038768          224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV--GRKNAEVKVSLS  301 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~  301 (386)
                      ++++.++|+|||+++.+.............++..|+|||....  +.++.++|||||||++|||++  |..||.......
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999986544322211112334678999998755  368899999999999999998  677886432211


Q ss_pred             CcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       302 ~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      . .......+...........+..+++.+.+++.+|+..++.-|+++.++
T Consensus       242 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         242 V-IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             H-HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            0 000011111111111223345678999999999999999988876653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.3e-37  Score=277.11  Aligned_cols=248  Identities=27%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC------ChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV------NGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIY  160 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  160 (386)
                      ..+.||+|+||.||+|.. .++..|++|.+.....      ..+.+.+|+.++++++|+||+++++++.+.  ...++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            347899999999999986 4688999999864321      124578899999999999999999988763  5678999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++++|.+++...      ..+++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++..
T Consensus        86 e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          86 EYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            999999999998543      3578899999999999999999998   9999999999999999999999999998765


Q ss_pred             Ccccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          241 EKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       241 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ...... .......++..|+|||++.+.  .++.++|||||||++|||++|+.||.....       ...+.+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~~~  227 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTN  227 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCCCC
Confidence            432111 111224578899999998654  688999999999999999999999975421       1233333334445


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +.++..+++..++++ +|+..++.-|++.+++..+|.
T Consensus       228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~  263 (266)
T cd06651         228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF  263 (266)
T ss_pred             CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence            666778899999999 566678888998888877774

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=294.78  Aligned_cols=198  Identities=29%  Similarity=0.451  Sum_probs=171.5

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~  162 (386)
                      +.||+|+||.||+|+. ..|+.||||.++..  ....+...+|+++|++++|+|||+++++-.+..      ...+||||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            5699999999999995 57999999999873  345577899999999999999999999865443      56799999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCC--ceEEeeccCCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG--EDF--CPKISDFGLAK  238 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgl~~  238 (386)
                      |.+|||...+.+.+   ....+++.+.+.++.+++.||.|||.+   +|+||||||.||++-  ++|  ..||+|||.|+
T Consensus        99 C~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             cCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999997754   346799999999999999999999998   999999999999984  333  47999999999


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                      ....+..   ....+||..|.+||++..+ ..|+..+|.|||||++|++.||..||.....
T Consensus       173 el~d~s~---~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  173 ELDDNSL---FTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cCCCCCe---eeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            8887764   4466799999999999753 4789999999999999999999999986544

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.4e-37  Score=275.72  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=202.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||++.. .+++.+|+|.+.....   ..+.+.+|++++++++|+|++++++.+...+..++||||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            3457899999999999976 4688999999875432   23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~  243 (386)
                      +++|.+++....    ...+++..++.++.|++.+|.|||++   +++|+||+|+||+++++ +.++|+|||++......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          83 GGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999996532    24588999999999999999999998   99999999999999854 46899999999866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||+....        ......+..+....++
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  222 (256)
T cd08220         156 SK---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGTFAPIS  222 (256)
T ss_pred             cc---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcCCCCCC
Confidence            22   1234578899999998654  678899999999999999999999975422        2223333334444566


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..++.++++++.+|+..++.-|++..++..+|
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p  254 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP  254 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence            77899999999999999999999988877665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=298.05  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=208.9

Q ss_pred             hhhhccCcCCceEEEEEEeCC-CcEEEEEEecC-CCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ++...||.|+||.||+|..++ +-..|-|++.. +...-++|+-||++|...+||+||++++.|...+.++++.|||+||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            345679999999999998754 44566787754 3334478999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      -...++..-     ...+++.++..++.|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+-.....  .
T Consensus       115 AVDaimlEL-----~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~  184 (1187)
T KOG0579|consen  115 AVDAIMLEL-----GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R  184 (1187)
T ss_pred             hHhHHHHHh-----ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence            998887543     36799999999999999999999999   9999999999999999999999999987533221  1


Q ss_pred             eeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-
Q 038768          247 ISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-  322 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  322 (386)
                      .....+.||+.|||||+....   ...|+.++||||||+.|.||..+.+|...-+        |..+.=+|.+...+.+ 
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKSePPTLl  256 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPPTLL  256 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhcCCCccc
Confidence            122356799999999998532   2468999999999999999999999987542        3556666766666665 


Q ss_pred             -cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          323 -AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       323 -~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                       +..++..+.+++.+||...+.-|+.+.++.-||-.
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv  292 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV  292 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence             77899999999999999999999998888777753

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-37  Score=280.81  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEe------cCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYE------KKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~  160 (386)
                      .+.+.||.|+||.||+|.. .+++.+|+|++........++..|+.++.++ +|+||+++++++..      .+..+++|
T Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~   98 (282)
T cd06636          19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM   98 (282)
T ss_pred             hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence            3457899999999999986 4688999999876655556788999999998 69999999999863      35678999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++|+|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        99 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          99 EFCGAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EeCCCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            9999999999986533    24578888999999999999999998   9999999999999999999999999998755


Q ss_pred             CcccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      .....  ......|+..|+|||++...   ...++.++|||||||++|||++|+.||......       ..........
T Consensus       172 ~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~~  242 (282)
T cd06636         172 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRNP  242 (282)
T ss_pred             hcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hhhhhHhhCC
Confidence            43221  11234588899999998532   235788999999999999999999999754221       1111111111


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ........++.++.+++.+|+..++.-|+++.++..+|
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~  280 (282)
T cd06636         243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP  280 (282)
T ss_pred             CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence            11122446889999999999999999999988876655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=278.93  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=200.9

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecC------ceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKK------KRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~lv  159 (386)
                      +.+.+.||+|+||.||+|... +++.+++|++.......+.+.+|+.+++++ +|+||+++++++.+..      ..++|
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv   87 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV   87 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence            344678999999999999874 578999999987666667899999999999 6999999999997654      47999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....  .....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          88 MELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999986532  1125688999999999999999999998   999999999999999999999999999876


Q ss_pred             cCcccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ......  ......++..|+|||++...   ...++.++|||||||++|+|++|+.||.....        ......+..
T Consensus       163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~  232 (275)
T cd06608         163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--------MRALFKIPR  232 (275)
T ss_pred             cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--------HHHHHHhhc
Confidence            543221  11234588899999987532   12467899999999999999999999974322        111122222


Q ss_pred             Cccc--cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 GNEF--QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ~~~~--~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....  ..+..++.++++++.+|+..++.-|+++.++..+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~  273 (275)
T cd06608         233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP  273 (275)
T ss_pred             cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence            2211  12334788999999999999999999988876655

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-37  Score=279.80  Aligned_cols=247  Identities=25%  Similarity=0.345  Sum_probs=197.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++.. .+|+.++||.+.....    ...++.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA   84 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence            4557899999999999985 5789999998865322    2357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++....  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          85 DAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999986432  1224688999999999999999999998   9999999999999999999999999998766443


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  322 (386)
                      ...  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||......      .....+.+.....+.. 
T Consensus       160 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  229 (267)
T cd08229         160 TTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPLP  229 (267)
T ss_pred             Ccc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCCCCC
Confidence            221  1234588899999998654  6788999999999999999999999643210      1223334433333323 


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+++++++++.+|+..++.-|+++.+
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~  257 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITY  257 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHH
Confidence            3457899999999999988888877653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.3e-37  Score=276.49  Aligned_cols=239  Identities=28%  Similarity=0.439  Sum_probs=194.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.+++.++|+|++++++++... ..++||||+++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~   84 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN   84 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence            44568899999999999986 7788999998653 3456789999999999999999999998654 5799999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......   
T Consensus        85 L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          85 LVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             HHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999996532    24578999999999999999999998   99999999999999999999999999987543321   


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                        .....+..|+|||.+.+  +.++.++|+||||+++|||++ |+.||.....        ......+..+..+..+..+
T Consensus       155 --~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         155 --DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECVEKGYRMEPPEGC  222 (254)
T ss_pred             --CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhCCCCCCCCCcC
Confidence              12234567999999865  368899999999999999998 9999975422        2333444444434456678


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++++.+++++|+...+.-|++..++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l  247 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKL  247 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHH
Confidence            8999999999999999888876543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-37  Score=277.97  Aligned_cols=235  Identities=23%  Similarity=0.302  Sum_probs=183.3

Q ss_pred             hccCcCCceEEEEEEeCC-------------CcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           92 NKLGQGGFGSVYKGKLPD-------------GRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      +.||+|+||.||+|.+.+             ...|++|.+..... ....+.+|+.++..++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999997532             22588998765432 2356888999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc-------eE
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC-------PK  230 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~k  230 (386)
                      +||||+++++|..++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.       ++
T Consensus        81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999998885432     4588999999999999999999998   9999999999999987654       89


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHH-hCCCCcccccccCCcccchhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-VGRKNAEVKVSLSSEIYFPNS  309 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~  309 (386)
                      ++|||++.......      ...++..|+|||.+... ..++.++|||||||++|||+ +|+.||.....        .+
T Consensus       153 l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~  217 (262)
T cd05077         153 LSDPGIPITVLSRQ------ECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AE  217 (262)
T ss_pred             eCCCCCCccccCcc------cccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hH
Confidence            99999987553321      23477889999988643 46889999999999999998 58888764322        11


Q ss_pred             hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       310 ~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      . ..+..+. .......++++.+++.+|+..++.-|++..++
T Consensus       218 ~-~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i  257 (262)
T cd05077         218 K-ERFYEGQ-CMLVTPSCKELADLMTHCMNYDPNQRPFFRAI  257 (262)
T ss_pred             H-HHHHhcC-ccCCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1 1111111 12223346789999999999999998876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.6e-37  Score=277.25  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||.|+||+||+|.. .++..+++|++.....  ..+.+.+|+..++.++|+|++++++.+...+..++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            4567899999999999985 4678999999875432  346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++.....   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          84 GSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             CcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999965421   24588999999999999999999998   999999999999999999999999999876654332


Q ss_pred             ee--eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-
Q 038768          246 FI--SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-  322 (386)
Q Consensus       246 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  322 (386)
                      ..  ......|+..|+|||++... ..++.++|+|||||++|+|++|+.||......       ....+.+. .....+ 
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~  228 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLTLQ-NDPPSLE  228 (267)
T ss_pred             ccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHHhc-CCCCCcC
Confidence            21  11234588899999998654 36789999999999999999999999754321       11111111 111212 


Q ss_pred             ----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 ----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          ...++++..+++.+|+..++..|++.+++..+|
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p  265 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK  265 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence                236789999999999999999999988877765

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=279.30  Aligned_cols=246  Identities=25%  Similarity=0.341  Sum_probs=198.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|.. .+++.||+|.++...  ....++.+|+.++++++   |+|++++++++.+....++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            3456799999999999986 568999999987532  23457889999999986   99999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++..       ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          84 AEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999998843       2588999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ....  .....|+..|+|||.+.+. ..++.++|+|||||++|+|++|+.||......        .....+.....+.+
T Consensus       154 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~~  222 (277)
T cd06917         154 NSSK--RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLIPKSKPPRL  222 (277)
T ss_pred             Cccc--cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhccccCCCCCC
Confidence            4321  2234588899999988543 35688999999999999999999999754321        11122222222333


Q ss_pred             cc-cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AG-VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~-~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .. .++.++.+++.+|+..++.-|++..++..+|
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~  256 (277)
T cd06917         223 EDNGYSKLLREFVAACLDEEPKERLSAEELLKSK  256 (277)
T ss_pred             CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence            33 3788999999999999999999887776554

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-37  Score=284.23  Aligned_cols=242  Identities=29%  Similarity=0.474  Sum_probs=191.2

Q ss_pred             hhccCcCCceEEEEEEeC-CCc----EEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.||+|+||.||+|.+. +|.    .||+|.+......  ..++.+|+.+++.++|+||++++++|... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            467999999999999753 444    5788988754322  24688999999999999999999998754 567999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++.....
T Consensus        91 ~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          91 PHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence            9999999986532     3578899999999999999999998   9999999999999999999999999999876543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ..........++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ....+.+..+..+..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~  232 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLLEKGERLPQ  232 (303)
T ss_pred             ccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCC
Confidence            322222233456789999998653  68899999999999999997 8999975421        223333444444445


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..++.+..+++.+|+..++.-|++..++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l  261 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKFKEL  261 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            56678899999999998888777765554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-37  Score=282.52  Aligned_cols=255  Identities=21%  Similarity=0.301  Sum_probs=196.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++....   ...+.+.+|+.+++.++|+|++++++++......++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            34578999999999999875 58999999986532   223567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|..++...      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          84 HTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            98888776432      4588999999999999999999998   99999999999999999999999999998765433


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchh----------hhh---
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN----------SIY---  311 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~---  311 (386)
                      ..  .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||......+.......          ..+   
T Consensus       155 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 DD--YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc--ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            11  1123477889999998653 3578899999999999999999999975432110000000          000   


Q ss_pred             ---hhc--CCCc----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          312 ---KHI--EPGN----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       312 ---~~i--~~~~----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         ..+  ....    .......++.+..+++.+|+..++.-|++..++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence               000  0000    0011235689999999999999999999888776665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-37  Score=279.99  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=193.5

Q ss_pred             hhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  160 (386)
                      .+.+.||+|+||.||++..     .++..||+|.+..... ..+.+.+|+++++.++||||+++++++...  ...++||
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            3457899999999999974     3578999999875432 235788999999999999999999987643  4678999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++...
T Consensus        87 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          87 EYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999999999986432     3588999999999999999999998   9999999999999999999999999999876


Q ss_pred             Ccccceee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc-----CCcc---cchhhhh
Q 038768          241 EKKESFIS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL-----SSEI---YFPNSIY  311 (386)
Q Consensus       241 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-----~~~~---~~~~~~~  311 (386)
                      ........ .....++..|+|||++.+.  .++.++|||||||++|||++|..|+......     ....   .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            54332111 1112244569999998653  6889999999999999999987765432110     0000   0111122


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+.....+..+..++.++.+++.+|+...+.-|+++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL  276 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            2233333344556788999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-38  Score=284.06  Aligned_cols=251  Identities=33%  Similarity=0.462  Sum_probs=195.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHH---HHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||+||+++.. +++.+|+|++.........   ..+|+.++.+++|+||+++++++.+....++||||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            35678999999999999875 4668999999876544432   3459999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++..      ...+++..++.++.|++.||.+||+.   +++|+||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   82 GGSLQDYLQK------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TEBHHHHHHH------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccc------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999962      25689999999999999999999998   99999999999999999999999999997542111


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc--
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL--  322 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--  322 (386)
                        .......++..|+|||++... ..++.++||||||+++|+|++|..||......+...    ...+..........  
T Consensus       153 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~  225 (260)
T PF00069_consen  153 --ENFNPFVGTPEYMAPEVLQQG-KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE----IIEKILKRPLPSSSQQ  225 (260)
T ss_dssp             --SEBSSSSSSGGGSCHHHHTTT-SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH----HHHHHHHTHHHHHTTS
T ss_pred             --ccccccccccccccccccccc-ccccccccccccccccccccccccccccccchhhhh----hhhhcccccccccccc
Confidence              122345688999999998622 378999999999999999999999998652111111    11111111111111  


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ......++.+++.+|+..++.-|+++.++..+|
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence            111238999999999999999998877654443

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=282.63  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=192.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|++|.||+|... +++.||+|.+.....  ....+.+|++++++++|+||+++++++.+.+..++||||++ 
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-   86 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-
Confidence            34578999999999999865 689999999875322  23457789999999999999999999999999999999997 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++.......
T Consensus        87 ~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          87 TDLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            59999886532     3578999999999999999999998   999999999999999999999999999875432211


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc--------chhhhhhhcCCC
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY--------FPNSIYKHIEPG  317 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~--------~~~~~~~~i~~~  317 (386)
                      .  .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||...........        .....+..+...
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             c--ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            1  1123467889999998653 3578899999999999999999999965431100000        000111111000


Q ss_pred             --------------ccccccccCC--hHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 --------------NEFQLAGVVT--EEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 --------------~~~~~~~~~s--~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                    ........++  .+..+++.+|+..++..|+++.++..+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence                          0000111234  8889999999999999999888766554

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=275.93  Aligned_cols=249  Identities=26%  Similarity=0.332  Sum_probs=198.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC------CChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK------VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  159 (386)
                      .+.+.||+|+||.||+|.. .++..||+|.+....      .....+.+|++++++++|+||+++++++.+.  ...+++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            3467899999999999986 468999999875321      1124688999999999999999999998764  457899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      +||+++++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++.
T Consensus        85 ~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          85 VEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            9999999999998543      3478889999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          240 SEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       240 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ...... ........++..|+|||++.+.  .++.++|+|||||++|+|++|+.||.....       ...+.+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIFKIATQPT  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHHHHHcCCC
Confidence            532111 0111234578899999998764  678999999999999999999999975321       123333343444


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+.++..++++.++++.+|+.. +..|+++.++..||.
T Consensus       227 ~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~~~  263 (264)
T cd06653         227 KPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRHPF  263 (264)
T ss_pred             CCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcCCC
Confidence            5667888999999999999994 577888887777663

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.1e-37  Score=281.51  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=196.7

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEE-----ecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCY-----EKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~  162 (386)
                      +.+.||+|+||.||++.. .+++.+|+|++........++.+|+.++..+ +|+||+++++++.     .++..++||||
T Consensus        22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~  101 (286)
T cd06638          22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL  101 (286)
T ss_pred             eeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence            347899999999999976 4588999999876544556788999999999 6999999999885     33568999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++....  .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.....
T Consensus       102 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638         102 CNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             cCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            99999999875422  1124688899999999999999999998   999999999999999999999999999876543


Q ss_pred             ccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-  318 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-  318 (386)
                      ...  ......|+..|+|||++...   ...++.++|||||||++|||++|+.||......       ... ..+.... 
T Consensus       177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------~~~-~~~~~~~~  246 (286)
T cd06638         177 TRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------RAL-FKIPRNPP  246 (286)
T ss_pred             CCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------HHH-hhccccCC
Confidence            221  11234588999999998532   134788999999999999999999999754321       111 1121221 


Q ss_pred             -cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 -EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 -~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       ....+..++.++.+++.+|+..++.-|+++.++..++
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             1223455788999999999999999999887765554

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.5e-37  Score=279.44  Aligned_cols=251  Identities=25%  Similarity=0.304  Sum_probs=198.2

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecC-----ceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKK-----KRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----~~~lv~e~  162 (386)
                      +.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++.++ +|||++++++++...+     ..++||||
T Consensus        26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey  105 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL  105 (291)
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence            347899999999999986 4688999999976555567788999999998 7999999999987543     57899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++....  .....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.....
T Consensus       106 ~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         106 CNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             CCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            99999999886432  1124688999999999999999999998   999999999999999999999999999886543


Q ss_pred             ccceeeeccccCccccccccccchhc---CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNF---GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ....  .....|+..|+|||++....   ..++.++|||||||++|||++|+.||......       ..+ ..+.....
T Consensus       181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~-~~~~~~~~  250 (291)
T cd06639         181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTL-FKIPRNPP  250 (291)
T ss_pred             cccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHH-HHHhcCCC
Confidence            2211  12345788999999975321   13678999999999999999999999754221       111 12222211


Q ss_pred             c--cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          320 F--QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       320 ~--~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +  ..+..++.++++++.+|+..++.-|++..++..+|
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence            1  22445678899999999999999999988877765

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.5e-37  Score=275.81  Aligned_cols=242  Identities=25%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||.|+||.||++... +++.+|+|++.....    ..+.+.+|+.+++.++|+||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999874 488999999975432    336788999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........   
T Consensus        81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---  148 (262)
T cd05572          81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---  148 (262)
T ss_pred             HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence            9999653      3478899999999999999999998   999999999999999999999999999986654321   


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC-CccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP-GNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~s  327 (386)
                      .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.....      .+....+.+.. ......+...+
T Consensus       149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  220 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFPNYID  220 (262)
T ss_pred             cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCCcccC
Confidence            1234578899999998653  678999999999999999999999976532      12333344332 23455566678


Q ss_pred             hHHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      ++..+++.+|+..++.-|++     +.++..+|
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~  253 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK  253 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence            99999999999999999987     55555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-37  Score=278.27  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=204.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||.|+||.||++... +++.||+|.+....    ...+.+.+|++++++++||||+++++++.+....++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            34578999999999999875 58999999997533    23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          83 LGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999998543      4688999999999999999999998   9999999999999999999999999998866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..   .....|+..|+|||.+...  .++.++|+||||+++|+|++|+.||......     ......+.... .....+
T Consensus       154 ~~---~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~  222 (258)
T cd05578         154 TL---TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-ADVLYP  222 (258)
T ss_pred             cc---ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-ccccCc
Confidence            21   1234578899999998664  5789999999999999999999999865321     12222223222 335566


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCC--CCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGST--EDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~--~~~~~~p  355 (386)
                      ..++.+..+++.+|+..++.-|++.  +++..+|
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~  256 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP  256 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence            7788999999999999999999988  6665554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.2e-37  Score=282.41  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=196.7

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      ..||+|+||.||++.. .++..||||.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5699999999999986 468899999986533 23456889999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      +++..       ..+++..++.++.||+.||.|||+.   +++||||||+||++++++.++|+|||++........  ..
T Consensus       108 ~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         108 DIVTH-------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            98843       3478899999999999999999998   999999999999999999999999999875533221  11


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc--cccccCC
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF--QLAGVVT  327 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~s  327 (386)
                      ....|+..|+|||.+.+.  .++.++||||||+++|||++|+.||.....        ......+......  .....++
T Consensus       176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQAMRRIRDNLPPRVKDSHKVS  245 (292)
T ss_pred             ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCCCccccccccC
Confidence            234578899999998653  678899999999999999999999975422        1111222211111  2233578


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ...++++.+|+..++.-|++++++..+|-
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~  274 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQHPF  274 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            89999999999999999999888776643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=285.54  Aligned_cols=236  Identities=28%  Similarity=0.400  Sum_probs=194.0

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCC---CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.||+|-||+||-|+. ++|+.||||++.+.   .....++.+|+.+|.+++||.||.+..-|+..+..++|||-+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            6899999999999986 57999999999863   334578899999999999999999999999999999999999 677


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CceEEeeccCCcccCccc
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~  244 (386)
                      ..+.+...+    ...+++..-..++.||+.||.|||.+   +|+|+||||+|||+.+.   -.+||||||+|+.+....
T Consensus       649 MLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  649 MLEMILSSE----KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             HHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            777665443    35688888899999999999999999   99999999999999653   369999999999887754


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---ccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EFQ  321 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~~  321 (386)
                      .   ....+||+.|+|||++.++  .|....|+||.|||+|.-++|..||+...+..          ++|+...   .+.
T Consensus       722 F---RrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn----------dQIQNAaFMyPp~  786 (888)
T KOG4236|consen  722 F---RRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN----------DQIQNAAFMYPPN  786 (888)
T ss_pred             h---hhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchh----------HHhhccccccCCC
Confidence            3   2356799999999999876  78899999999999999999999998664432          2332222   222


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      -+..+|+++-|+|..+|+|.=.-|-+.+.
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence            34567899999999999976555544443

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-37  Score=282.43  Aligned_cols=243  Identities=26%  Similarity=0.369  Sum_probs=198.1

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      ..||+|+||.||++... +++.||+|++.... ...+.+.+|+.++..++|||++++++++...+..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            46999999999999864 68999999986533 33467889999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      .++..       ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  ..
T Consensus       107 ~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  174 (297)
T cd06659         107 DIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  174 (297)
T ss_pred             HHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence            88743       3478999999999999999999998   999999999999999999999999999875543221  11


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--cccccccCC
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EFQLAGVVT  327 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~s  327 (386)
                      ....++..|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+....  .......++
T Consensus       175 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T cd06659         175 KSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRLRDSPPPKLKNAHKIS  244 (297)
T ss_pred             cceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhccCCCCccccCCCC
Confidence            234588899999998654  678999999999999999999999974422        11122222221  122344678


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +++.+++.+|+..++.-|++.+++..+|.
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~  273 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDHPF  273 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence            89999999999999999998888766653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.6e-37  Score=278.20  Aligned_cols=245  Identities=26%  Similarity=0.360  Sum_probs=196.8

Q ss_pred             cCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||+|+||+||++.. .+|+.||+|.+....    .....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999975 468999999986532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++.....    ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+........   
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---  150 (277)
T cd05577          81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---  150 (277)
T ss_pred             HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence            999865421    3688999999999999999999998   999999999999999999999999999876543221   


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....++..|+|||++.+.  .++.++||||||+++|+|++|+.||.......    ....+.+.+.. .....+..+++
T Consensus       151 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~  223 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLE-MAVEYPDKFSP  223 (277)
T ss_pred             cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhcccc-ccccCCccCCH
Confidence            1234577899999998654  58889999999999999999999997543211    11222222222 23445667899


Q ss_pred             HHHHHHHHHHHHHHHhcCCC-----CCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGST-----EDLQIPP  355 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~-----~~~~~~p  355 (386)
                      +..+++.+|+..++.-|++.     .++..+|
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~  255 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVREHP  255 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence            99999999999999999844     4465555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-37  Score=278.86  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=203.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||.||++... +++.+++|.+.....  ..+++.+|++++++++||||+++++.+...+..++++||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            34578999999999999875 589999999876432  336788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ++|.+++....     ..+++..+..++.|++.||.|||+ .   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        84 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          84 GSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999986532     468889999999999999999999 7   99999999999999999999999999987654322


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..    ...++..|+|||.+.+.  .++.++||||||+++|+|++|+.||........   ......+.+.....+.++.
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  226 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPS  226 (265)
T ss_pred             hh----cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHhcCCCCCCCh
Confidence            11    14578899999998654  788999999999999999999999975432111   1122233333333344444


Q ss_pred             c-CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 V-VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~-~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      . ++.++.+++.+|+..++.-|+++.++..+|
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  258 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEHP  258 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence            4 899999999999999999999887765554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-37  Score=283.49  Aligned_cols=255  Identities=18%  Similarity=0.289  Sum_probs=194.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|... +|+.||+|.++....   ....+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            34578999999999999864 689999999875322   23567889999999999999999999999999999999996


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                       ++|.+++....     ..+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        83 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          83 -QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             -CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence             58888775432     4589999999999999999999998   99999999999999999999999999998654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--------cchhhhhhhcCC
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--------YFPNSIYKHIEP  316 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~i~~  316 (386)
                      ..  .....++..|+|||++.+. ..++.++|||||||++|+|++|..|+..........        ..+...+..+..
T Consensus       154 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CC--cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            11  1234578899999998654 357889999999999999999998864322110000        000000111000


Q ss_pred             Cc-------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 GN-------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ~~-------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..             .......+++++++++.+|+..++.-|++++++..+|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            00             0112345789999999999999999999988876654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.5e-37  Score=275.42  Aligned_cols=248  Identities=26%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.||.|++|.||++... +++.|++|.+.....  ..+.+.+|+..+.+++|+|++++++++......++||||++++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            4578999999999999875 589999999876543  3567999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      +|.+++...      ..+++..++.++.|++.||+|||+ .   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          85 SLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999999643      568899999999999999999999 8   999999999999999999999999999986654332


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      ..  ....++..|+|||.+...  .++.++|+||||+++|+|++|+.||......     ......+.+.....+.++..
T Consensus       156 ~~--~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  226 (264)
T cd06623         156 QC--NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDGPPPSLPAE  226 (264)
T ss_pred             cc--cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcCCCCCCCcc
Confidence            21  133478899999998654  6888999999999999999999999765320     11233444445555556666


Q ss_pred             -CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          326 -VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       326 -~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       ++..+.+++.+|+...+..|+++.++..+|
T Consensus       227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~  257 (264)
T cd06623         227 EFSPEFRDFISACLQKDPKKRPSAAELLQHP  257 (264)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence             899999999999999999999888776654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.9e-37  Score=279.57  Aligned_cols=256  Identities=22%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|++.....   ..+.+.+|+.++++++|+||+++++++.+....++|+||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            4567899999999999986 4689999999875432   2467899999999999999999999999999999999999 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....     ..+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          82 PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            999999986532     4689999999999999999999998   99999999999999999999999999998665432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------cc-chhhhhhhcCC-
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------IY-FPNSIYKHIEP-  316 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~-~~~~~~~~i~~-  316 (386)
                      . .......++..|+|||++.+. ..++.++||||||+++|||++|+.||........-      .. .....|..... 
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             C-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence            1 111234588899999998654 35688999999999999999998888644221000      00 00000000000 


Q ss_pred             --------Cc-----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 --------GN-----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 --------~~-----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                              ..     ........+.++.+++.+|+..++.-|++++++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                    00     0012235679999999999999999999988876665

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-37  Score=277.59  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=201.7

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      ..+.||+|+||.||++.. .+++.||+|++.....       ..+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            346799999999999975 5689999999874321       12568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCccc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLS  240 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~  240 (386)
                      |+++++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++ .++|+|||++...
T Consensus        84 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          84 WMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             ccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999998543      4688999999999999999999998   999999999999998775 6999999998766


Q ss_pred             Cccccee--eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          241 EKKESFI--SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       241 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......    ....+.+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~  228 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKIASATT  228 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHHhccCC
Confidence            4431110  01123578899999998654  67899999999999999999999997543211    1112222222223


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+..+..++.++.+++.+|+..++.-|+++.++..+|.
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence            35566778999999999999999999999888877764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-37  Score=275.64  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=199.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||.|+||.||+|... +++.+++|++..... ..+.+.+|+.++++++||||+++++++.+.+..+++|||++++
T Consensus         6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            45578999999999999864 578999999875432 3467899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        86 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          86 SLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             cHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            9999886532     4688999999999999999999998   999999999999999999999999999876543221 


Q ss_pred             eeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC----cccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG----NEFQ  321 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~----~~~~  321 (386)
                       ......++..|+|||.+... ...++.++|+||||+++|+|++|+.||.......       .. ..+...    ....
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~-~~~~~~~~~~~~~~  227 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------AL-FLISKSNFPPPKLK  227 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HH-HHHHhccCCCcccc
Confidence             11234578889999998542 1257889999999999999999999997543211       11 111111    1112


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....++.++++++.+|+..++..|++++++..++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            2345678899999999999999999888776554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=319.50  Aligned_cols=242  Identities=28%  Similarity=0.378  Sum_probs=204.1

Q ss_pred             hhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           91 SNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +..||.|.||.||-|. .++|...|+|.++-....   -..+.+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4689999999999997 467999999998754332   256789999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc-
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES-  245 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-  245 (386)
                      +|.+++...      ...++.....+..|++.|+.|||+.   |||||||||.||+++.+|.+|++|||.|..+..+.. 
T Consensus      1320 sLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             cHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999553      4567777888899999999999998   999999999999999999999999999987765421 


Q ss_pred             -eeeeccccCccccccccccchhc-CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          246 -FISMLGARGTIGYIAPEVFCRNF-GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       246 -~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                       ........||+.|||||++.+.. .+..-+.|||||||++.||+||++||...+.   +    -.+.-++..|..|++|
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e----~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---E----WAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---h----hHHHhHHhccCCCCCc
Confidence             11233567999999999997653 2456789999999999999999999985432   1    3355677888889999


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ..+|.+.++++.+||+.+|..|=.+
T Consensus      1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred             hhhhHhHHHHHHHHHhcCchhhhHH
Confidence            9999999999999999887766333

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.9e-37  Score=274.72  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=201.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...+.||+|+||.||+|... +++.|++|.++....   ..+.+.+|+.+++.++|+||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            34578999999999999864 688999999986554   34678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          83 GGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999998643      3478889999999999999999998   99999999999999999999999999998765433


Q ss_pred             ceee--eccccCccccccccccchhc-CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          245 SFIS--MLGARGTIGYIAPEVFCRNF-GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       245 ~~~~--~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ....  .....++..|+|||++.+.. ...+.++||||||+++|++++|+.||.....       .......+..+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~  226 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMFHVGAGHKPP  226 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHHHHhcCCCCC
Confidence            2111  11245788999999986542 2378899999999999999999999974321       111112222233334


Q ss_pred             cccc--CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          322 LAGV--VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       322 ~~~~--~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++..  ++.+..+++.+|+..++.-|++.+++..+|
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~  262 (264)
T cd06626         227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHP  262 (264)
T ss_pred             CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence            4443  489999999999999999998887766554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.8e-37  Score=280.27  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=197.5

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.||+|+||.||+|... +|+.||+|.+......      ...+..|++++++++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34578999999999999864 6899999999764332      3456789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+ +++|.+++....     ..+++..++.++.||++||+|||+.   +++|+||+|+||+++.++.++|+|||+++...
T Consensus        83 ~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          83 FM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             cc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            99 999999996532     3689999999999999999999998   99999999999999999999999999998665


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------cc-chhhhhhhc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------IY-FPNSIYKHI  314 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~-~~~~~~~~i  314 (386)
                      .....  .....++..|+|||.+.+. ..++.++|||||||++|||++|..||.........      .. .....+...
T Consensus       154 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         154 SPNRK--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCCcc--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            43211  1223467789999988543 35788999999999999999998887654321100      00 000000000


Q ss_pred             CCC------------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          315 EPG------------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       315 ~~~------------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ...            .........+.++.+++.+|+..++.-|+++.++..+|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~  284 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY  284 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence            000            001122456789999999999999999999888776654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-36  Score=273.59  Aligned_cols=234  Identities=24%  Similarity=0.338  Sum_probs=184.6

Q ss_pred             hccCcCCceEEEEEEeCCCc-----------EEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           92 NKLGQGGFGSVYKGKLPDGR-----------LVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.||+|+||.||+|.+.+..           .|++|.+.........+.+|+.+++.++|+||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            36999999999999875422           58888877554446789999999999999999999999988 7889999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-------ceEEee
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-------CPKISD  233 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~D  233 (386)
                      ||+++|+|.+++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++       .+||+|
T Consensus        80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999996542     2688899999999999999999998   999999999999999887       799999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||++.......      ...++..|+|||++.+....++.++||||||+++|||++ |..||......        ....
T Consensus       152 fg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~  217 (259)
T cd05037         152 PGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKER  217 (259)
T ss_pred             CCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHH
Confidence            99998654321      233667899999986542368899999999999999999 57777654211        1111


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .....  ...+.....++.+++.+|+...+.-|++..+
T Consensus       218 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  253 (259)
T cd05037         218 FYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRA  253 (259)
T ss_pred             HHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHH
Confidence            11111  1122223489999999999999988886554

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=281.14  Aligned_cols=248  Identities=27%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ++||+|+||.||-+.. .+|+.+|.|.+.+.    .......++|-.+|.+++.+.||.+--.|.+.+.+++|+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            6899999999999975 46999999988653    233455789999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.-+|.+.+    +..+++..++.++.+|+-||++||+.   +||+||+||+|||+|+.|++.|+|.|+|..+......
T Consensus       271 DLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  271 DLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             ceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            9999997654    25799999999999999999999999   9999999999999999999999999999988776543


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                         .+.+||.+|||||++.+.  .|+...|+|||||++|||+.|+.||.......    -.+++-+.+... ...++...
T Consensus       344 ---~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----k~eEvdrr~~~~-~~ey~~kF  413 (591)
T KOG0986|consen  344 ---RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----KREEVDRRTLED-PEEYSDKF  413 (591)
T ss_pred             ---ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhh----hHHHHHHHHhcc-hhhccccc
Confidence               244799999999999775  69999999999999999999999997543221    223444444433 36677889


Q ss_pred             ChHHHHHHHHHHHHHHHhc-----CCCCCCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLE-----GSTEDLQIPPK  356 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~-----~~~~~~~~~p~  356 (386)
                      |++++++.+.+|.-++.-|     ..+.++..||-
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf  448 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF  448 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence            9999999998888665544     35666777764

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-37  Score=278.05  Aligned_cols=234  Identities=24%  Similarity=0.342  Sum_probs=182.8

Q ss_pred             ccCcCCceEEEEEEeCC-------------------------CcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceE
Q 038768           93 KLGQGGFGSVYKGKLPD-------------------------GRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSF  146 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~  146 (386)
                      .||+|+||.||+|.+..                         ...|++|++...... ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997411                         135889988653322 3568889999999999999999


Q ss_pred             EEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      +++|.+....++||||+++|+|..++....     ..+++..+..++.||+.||+|||++   +++||||||+|||++.+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999999999999999999999999986432     4578899999999999999999998   99999999999999754


Q ss_pred             C-------ceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHH-hCCCCccccc
Q 038768          227 F-------CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-VGRKNAEVKV  298 (386)
Q Consensus       227 ~-------~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ell-tg~~p~~~~~  298 (386)
                      +       .+|++|||++.......      ...++..|+|||.+.+. ..++.++|||||||++|||+ +|+.||....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             CcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            3       38999999876433221      22467789999988654 46889999999999999985 6899997543


Q ss_pred             ccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          299 SLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       299 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .        ......+..  ....+...+.++.+++.+|+...+.-|++..++
T Consensus       227 ~--------~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  269 (274)
T cd05076         227 P--------SEKERFYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTI  269 (274)
T ss_pred             h--------HHHHHHHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHH
Confidence            2        111111111  122344467789999999999999988876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-36  Score=280.76  Aligned_cols=247  Identities=20%  Similarity=0.282  Sum_probs=196.4

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||.||++... .++.|++|.+.....    ..+.+.+|+++++.++||||+++++.+...+..++||||++
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (305)
T cd05609           5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE   84 (305)
T ss_pred             EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            4578999999999999864 578999999875432    23467899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        85 g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          85 GGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999543      4588999999999999999999998   99999999999999999999999999987421110


Q ss_pred             c-------------eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhh
Q 038768          245 S-------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       245 ~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      .             ........++..|+|||.+.+.  .++.++|+|||||++|||++|+.||....        +..+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELF  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence            0             0001123477889999998654  68899999999999999999999997432        23334


Q ss_pred             hhcCCCc--cccccccCChHHHHHHHHHHHHHHHhcCCC---CCCCCCC
Q 038768          312 KHIEPGN--EFQLAGVVTEEEKEMAKKMILVLEMLEGST---EDLQIPP  355 (386)
Q Consensus       312 ~~i~~~~--~~~~~~~~s~~~~~li~~ml~v~~~L~~~~---~~~~~~p  355 (386)
                      +.+..+.  .+.....++.++.+++.+|+..++.-|++.   .++..+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            4433332  222334678999999999999999999874   4444554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-36  Score=276.51  Aligned_cols=247  Identities=29%  Similarity=0.373  Sum_probs=201.3

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.+.||+|+||.||+|... ++..+++|++.......+.+.+|++.++.++|+|++++++++...+..++|+||+++++|
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  102 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL  102 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence            3467999999999999875 688999999986544567889999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  .
T Consensus       103 ~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  172 (286)
T cd06614         103 TDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K  172 (286)
T ss_pred             HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence            99996542     3689999999999999999999998   999999999999999999999999998865543221  1


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc--cccccC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF--QLAGVV  326 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~  326 (386)
                      .....++..|+|||++.+.  .++.++|+|||||++|+|++|+.||.....        ......+......  .....+
T Consensus       173 ~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  242 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLITTKGIPPLKNPEKW  242 (286)
T ss_pred             hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCCCCCcchhhC
Confidence            1233477889999998654  678999999999999999999999975422        1111112111111  123347


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +.++++++.+|+...+.-|++..++..+|-
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence            899999999999999999998888766654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-37  Score=277.96  Aligned_cols=235  Identities=23%  Similarity=0.303  Sum_probs=185.7

Q ss_pred             hccCcCCceEEEEEEeCC--------CcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPD--------GRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.||+|+||.||+|....        ...|++|.+..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999997532        23488888765432 235788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc--------eEEeec
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC--------PKISDF  234 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df  234 (386)
                      +++|+|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999996543     3578899999999999999999998   9999999999999987765        699999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC-CCcccccccCCcccchhhhhhh
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR-KNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      |++.......      ...++..|+|||++.+. ..++.++|||||||++|||++|. .|+.....        ... ..
T Consensus       153 g~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~-~~  216 (258)
T cd05078         153 GISITVLPKE------ILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKK-LQ  216 (258)
T ss_pred             ccccccCCch------hccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHH-HH
Confidence            9987554322      23477889999998653 35788999999999999999995 55543321        111 11


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +... ...++...+.++.+++.+|+..++.-|++.+++
T Consensus       217 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  253 (258)
T cd05078         217 FYED-RHQLPAPKWTELANLINQCMDYEPDFRPSFRAI  253 (258)
T ss_pred             HHHc-cccCCCCCcHHHHHHHHHHhccChhhCCCHHHH
Confidence            1111 234556677899999999999999999877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-36  Score=277.48  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=198.7

Q ss_pred             hhhccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEE
Q 038768           90 FSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK-----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.||.|+||.||++..    .+|..||+|+++...     ...+.+.+|++++.++ +|+||+.+++++..+...++|
T Consensus         4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (290)
T cd05613           4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI   83 (290)
T ss_pred             eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence            457899999999999975    368899999997532     2235678899999999 599999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++...      ..+++..+..++.|++.||.|||+.   +++||||+|+|||+++++.+||+|||++..
T Consensus        84 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          84 LDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999998543      4578899999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ....... ......|+..|+|||.+......++.++||||||+++|+|++|+.||.......    ....+.+.+.... 
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~-  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE-  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhhccC-
Confidence            5433211 112345788999999986543457889999999999999999999997432211    1122323332222 


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPPK  356 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p~  356 (386)
                      +..+..++..+.+++.+|+..++.-|.     ..+++..+|.
T Consensus       229 ~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~  270 (290)
T cd05613         229 PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF  270 (290)
T ss_pred             CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence            345667899999999999999998885     3444444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-36  Score=276.51  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=198.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-----CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  159 (386)
                      .+.+.||+|+||.||++.+.     ++..+|+|.+......  .+.+.+|+++++.++|+||+++++++..  ....++|
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            45578999999999999853     3679999999866553  5789999999999999999999999987  5578999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....     ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        87 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          87 MEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999996542     3589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhh
Q 038768          240 SEKKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIY  311 (386)
Q Consensus       240 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~  311 (386)
                      ........ ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.........+       .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            65332211 11123355679999998654  68889999999999999999999986432211000       0111222


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+.....+..++.+..+++.+|+...+.-|+++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL  276 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            3333333344455677899999999999999988876654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.8e-36  Score=273.69  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=200.1

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.||+|++|.||++.. .+++.+++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            36899999999999985 4688999999865332 345688999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++..       ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+........  .
T Consensus       104 ~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         104 TDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             HHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999854       3478899999999999999999998   999999999999999999999999998875543221  1


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc--cccC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL--AGVV  326 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~  326 (386)
                      .....|+..|+|||.+.+.  .++.++|||||||++|||++|+.||.....        ....+.+.....+..  ...+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  241 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDNLPPKLKNLHKV  241 (285)
T ss_pred             cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhcCCCCCcccccC
Confidence            1234588899999998654  578899999999999999999999975322        222233333322222  3347


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      +.++.+++.+|+..++.-|++..++..+|--
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFL  272 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence            8999999999999999999999888877653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6e-37  Score=279.37  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=195.7

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..+.||.|++|.||+|... +|+.||||.+.....   ....+.+|++++++++||||+++++++.+.+..++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            3468999999999999864 688999999875322   23578899999999999999999999999999999999995 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        83 ~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          83 QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            68988886532    24688999999999999999999998   999999999999999999999999999876543321


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------chhhhhh------
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------FPNSIYK------  312 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~------  312 (386)
                      .  .....++..|+|||++.+. ..++.++||||||+++|||+||+.||...........       .+...+.      
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             c--cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            1  1223467889999988654 3468899999999999999999999975432110000       0000000      


Q ss_pred             -------hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          313 -------HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       313 -------~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                             .+...........++.+.++++.+|+..++.-|++++++..+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  282 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP  282 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence                   0001111112335788999999999999999999888776665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-36  Score=277.58  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=196.1

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-C---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-N---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +...+.||+|+||.||+|... +|+.||+|.+..... .   .+++.+|+++++.++||||+++.++|.+.+..++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445578999999999999864 689999999864322 1   24688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ++ |+|.+++....     ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        97 ~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          97 CL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             hC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            96 67777764322     4588999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccceeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ..      ...++..|+|||++.+ ....++.++||||||+++|||++|+.||.....        ......+.....+.
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~  233 (307)
T cd06607         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNDSPT  233 (307)
T ss_pred             CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcCCCCC
Confidence            32      2347788999998742 124578899999999999999999999875422        11111222222122


Q ss_pred             c-cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          322 L-AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       322 ~-~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      + ...++.++.+++.+|+..++.-|++..++-.+|-
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            2 3347889999999999999999999888776654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-36  Score=275.15  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=195.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHH-hhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVAS-MSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||+|+||.||++... +|+.||+|+++....  ....+..|+.. ++.++|+||+++++++...+..+++|||++ 
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-   83 (283)
T cd06617           5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-   83 (283)
T ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence            4578999999999999864 689999999976433  23456667665 566789999999999999999999999995 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++.....  ....+++..++.++.||+.||+|||++  .+++||||||+||+++.++.+||+|||++........
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          84 TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            788888754321  125689999999999999999999985  2899999999999999999999999999986543221


Q ss_pred             eeeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-
Q 038768          246 FISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-  322 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  322 (386)
                         .....++..|+|||++.+..  ..++.++|+|||||++|+|++|+.||......      .......+ .+..+.+ 
T Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~  229 (283)
T cd06617         160 ---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVV-EEPSPQLP  229 (283)
T ss_pred             ---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHHHHHHH-hcCCCCCC
Confidence               11235788899999885421  24688999999999999999999999642110      01122222 2222223 


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ...++.++.+++.+|+..++.-|++..++..+|-
T Consensus       230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  263 (283)
T cd06617         230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF  263 (283)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence            3457899999999999999999999988877664

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.9e-37  Score=281.71  Aligned_cols=255  Identities=22%  Similarity=0.274  Sum_probs=196.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.++||+|+||.||+|... +++.||+|.+.....   ..+.+.+|+++++.++|+||+++++++.+.+..++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            34578999999999999875 589999999865332   23568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|..+....      ..+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          84 HTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99888876432      3588999999999999999999998   99999999999999999999999999987654432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhcC--
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHIE--  315 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i~--  315 (386)
                      ..  .....++..|+|||++.+. ..++.++||||||+++|||++|+.||........-       ..+.........  
T Consensus       155 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 EV--YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             cc--cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            21  1234578899999998653 35778999999999999999999999644321000       000000000000  


Q ss_pred             -------------CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 -------------PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 -------------~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                   ..........++.+..+++++|+..++.-|++..++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  284 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE  284 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence                         0000112346789999999999999999999887765554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-36  Score=273.04  Aligned_cols=242  Identities=27%  Similarity=0.430  Sum_probs=196.8

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||.|+||.||++... +|+.+++|.+.....    ..+.+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999875 489999999976433    335788999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc---
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES---  245 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---  245 (386)
                      .+++...      ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........   
T Consensus        81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            9999653      3688999999999999999999998   999999999999999999999999999875443211   


Q ss_pred             ---eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          246 ---FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       246 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                         ........++..|+|||.....  ..+.++||||||+++|+|++|+.||....        +......+..+. ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~  220 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILNGK-IEW  220 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-cCC
Confidence               0112234577889999998654  57889999999999999999999997543        233334443332 223


Q ss_pred             ccc--CChHHHHHHHHHHHHHHHhcCCC---CCCCCCC
Q 038768          323 AGV--VTEEEKEMAKKMILVLEMLEGST---EDLQIPP  355 (386)
Q Consensus       323 ~~~--~s~~~~~li~~ml~v~~~L~~~~---~~~~~~p  355 (386)
                      +..  ++.++.+++.+|+...+.-|++.   .++..+|
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence            333  48999999999999999999888   5555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-36  Score=277.26  Aligned_cols=256  Identities=21%  Similarity=0.265  Sum_probs=196.0

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|... +++.+++|.++.....   ...+.+|+.++.+++||||+++++++...  +..++|||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            344578999999999999875 5889999999754322   24567899999999999999999999887  88999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |++ ++|.+++....     ..+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        87 ~~~-~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          87 YVE-HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             hcC-cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            996 59998886532     3589999999999999999999998   99999999999999999999999999998665


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHI  314 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i  314 (386)
                      ....  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..........       ......|..+
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         158 SPLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             CCcc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            4321  11233477889999998654 246889999999999999999999997543211000       0000001100


Q ss_pred             -----------CCCc----ccccccc-CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 -----------EPGN----EFQLAGV-VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 -----------~~~~----~~~~~~~-~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                 ....    ...++.. +++...+++++|+..++.-|+++.++..+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~  291 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP  291 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence                       0000    1112333 688999999999999999999888776554

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.5e-36  Score=270.76  Aligned_cols=249  Identities=29%  Similarity=0.376  Sum_probs=206.4

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEeC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  163 (386)
                      ..+.||+|++|.||+|... +++.|++|++.....   ..+.+.+|+..+++++|+||+++++++.+.  ...++++||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            3467999999999999875 689999999876542   356789999999999999999999999988  8899999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        84 ~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          84 SGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999998653      3689999999999999999999998   9999999999999999999999999999876654


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..........++..|+|||.+.+.  ..+.++||||||+++|+|++|+.||.....      .....++.........++
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~  226 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGSSGEPPEIP  226 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccccCCCcCCC
Confidence            321112234588899999998654  588999999999999999999999986531      112233333334445667


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..++.++.+++.+|+..++.-|++..++..+|
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence            77899999999999999999999887766554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=259.38  Aligned_cols=249  Identities=20%  Similarity=0.310  Sum_probs=201.9

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ...||+|..|+|+++... .|...|||.+..+...  .+.++..++++..- +.|.||+.+|||..+....+.||.| ..
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence            467999999999999864 5899999999865433  24566777776555 4899999999999999999999988 55


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      .+..++...     ..++++..+-.+...+.+||.||-++  .+|+|||+||+|||+|+.|.+|+||||.+-.+-.....
T Consensus       176 C~ekLlkri-----k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  176 CAEKLLKRI-----KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHHHHHHh-----cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            666666543     36788999999999999999999987  49999999999999999999999999999766544332


Q ss_pred             eeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc-
Q 038768          247 ISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG-  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-  324 (386)
                      .   ...|-+.|||||-+.-. ...|+.++||||||+.++||.||+.||....-       ..++..++.....+.++. 
T Consensus       249 t---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------dFe~ltkvln~ePP~L~~~  318 (391)
T KOG0983|consen  249 T---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------DFEVLTKVLNEEPPLLPGH  318 (391)
T ss_pred             c---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------cHHHHHHHHhcCCCCCCcc
Confidence            2   34588899999998533 35789999999999999999999999987532       234555665555566644 


Q ss_pred             -cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          325 -VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       325 -~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                       .+|+++++++..||..+..-|+...++..||.-
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi  352 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI  352 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence             379999999999999999999999888888753

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-37  Score=280.92  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=204.5

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEE
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  159 (386)
                      ....+...++||+||.+.||++...+.+.+|+|.+.....+   .+-|.+|+..|.+|+ |.+|+++++|-..++..|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            33445556899999999999999878888998887643333   367999999999995 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||= ..+|..+|.....     ..+...++.+..||+.++.++|..   ||||.||||.|.|+- .|.+||+|||.|..
T Consensus       439 mE~G-d~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             eecc-cccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            9975 6799999976542     233237888999999999999999   999999999999984 56999999999998


Q ss_pred             cCcccceeeeccccCccccccccccchhcC---------CCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFG---------GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---------~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      +..+.........+||+.||+||.+.....         ..+.++||||||||||+|+.|+.||...          ...
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~n~  578 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------INQ  578 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------HHH
Confidence            887776666667889999999999954322         2578999999999999999999999854          122


Q ss_pred             hhhc----CCCccccccccCChH-HHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 YKHI----EPGNEFQLAGVVTEE-EKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~~~i----~~~~~~~~~~~~s~~-~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +.++    .++....++..-+.. +.++++.||.-++.-|.+..++..+|.
T Consensus       579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence            2332    222334555555454 999999999999999999998877765

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-36  Score=274.44  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=193.3

Q ss_pred             hhhhccCcCCceEEEEEEeCC--CcEEEEEEecCCC-----------CChHHHHHHHHHhhc-CCCCccceEEEEEEecC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD--GRLVAVKVLKNSK-----------VNGEEFINEVASMSK-TSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~  154 (386)
                      .+.+.||+|+||.||+|....  ++.+|+|.+....           ....++.+|+.++.+ ++|+||+++++++.+.+
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            345779999999999998754  6889999886321           112456788888865 79999999999999999


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ..++||||+++++|.+++....  .....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999885422  1124688999999999999999999963  18999999999999999999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      |.+........   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+
T Consensus       159 g~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~  225 (269)
T cd08528         159 GLAKQKQPESK---LTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKI  225 (269)
T ss_pred             cceeecccccc---cccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHH
Confidence            99987654431   2234588899999998653  688999999999999999999999975422        2222233


Q ss_pred             CCCccc-cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          315 EPGNEF-QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       315 ~~~~~~-~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+... .....+++++.+++.+|+..++.-|++..++
T Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~  263 (269)
T cd08528         226 VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV  263 (269)
T ss_pred             hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence            223222 2233678999999999999999888876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-36  Score=272.25  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=200.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||++... +|..+|+|.+....   ...+.+.+|+.+++.++|+||+++++.+.+.+..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            34578999999999999864 58899999986532   334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~  243 (386)
                      +++|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++ .++|+|||.+......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          83 GGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999986532    23578999999999999999999998   999999999999999875 4699999999866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ...  .....|+..|+|||++.+.  .++.++|+||||+++|||++|+.||.....        ......+..+......
T Consensus       156 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  223 (257)
T cd08225         156 MEL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQGYFAPIS  223 (257)
T ss_pred             ccc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcccCCCCC
Confidence            221  1123588899999988653  688999999999999999999999975422        1222223333333445


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..++.++.+++.+|+...+.-|++..++..+|
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence            67889999999999999999999887765554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-36  Score=276.69  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=191.1

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.||+|+||.||+|.. .+|+.||+|++.....  ....+.+|+.+++.++|+||+++++++.+.+..++|+||++ +
T Consensus         9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07870           9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T   87 (291)
T ss_pred             EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence            357899999999999976 4688999999875432  23467899999999999999999999999999999999995 7


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+.+..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++........
T Consensus        88 ~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          88 DLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            7877764431     3467888999999999999999998   9999999999999999999999999998754332211


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------cc-chhhhhhhcC---
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IY-FPNSIYKHIE---  315 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~-~~~~~~~~i~---  315 (386)
                        .....++..|+|||++.+. ..++.++|||||||++|||++|+.||+........       .. .+...+..+.   
T Consensus       160 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         160 --YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              1233468899999998653 35788999999999999999999999754321000       00 0000000000   


Q ss_pred             -----------CCcccccc--ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 -----------PGNEFQLA--GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 -----------~~~~~~~~--~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                 ........  ...+.+..+++.+|+..++.-|++++++..+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~  289 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP  289 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence                       00000000  11367899999999999999999888776665

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.4e-36  Score=274.08  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=194.8

Q ss_pred             hhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      ..+.||+|+||.||+|+..      +.+.|++|.+......  .+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3467999999999999853      3467999998754433  3678999999999999999999999999899999999


Q ss_pred             eCCCCCHHHHhccccccc---ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSN---INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      |+++|+|.+++.......   ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999996543111   112589999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCC
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ....... .......++..|+|||.+.+.  ..+.++||||||+++|+|++ |..||.....        ......+..+
T Consensus       166 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~~~~~  234 (275)
T cd05046         166 DVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRLQAG  234 (275)
T ss_pred             ccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHHHHcC
Confidence            5433221 112233466789999988654  57889999999999999999 7888864321        2223333322


Q ss_pred             c-cccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          318 N-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       318 ~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      . ....+..++..+.+++.+|+..++.-|+++.++
T Consensus       235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~  269 (275)
T cd05046         235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL  269 (275)
T ss_pred             CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            2 223355678999999999999999888776543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-36  Score=269.04  Aligned_cols=239  Identities=25%  Similarity=0.351  Sum_probs=190.4

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh----HHHHHHHHH-hhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVAS-MSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.||.|+||.||+|.. .+|+.||+|++.......    ..+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999986 458899999987543211    234455444 4456899999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.....  
T Consensus        82 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  150 (260)
T cd05611          82 GDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--  150 (260)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence            9999998543      4588999999999999999999998   9999999999999999999999999998754332  


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EFQL  322 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~~~  322 (386)
                          ....++..|+|||.+.+.  .++.++||||||+++|+|++|..||.....        ..++..+..+.   ....
T Consensus       151 ----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  216 (260)
T cd05611         151 ----KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRINWPEEV  216 (260)
T ss_pred             ----ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcccCCCCcc
Confidence                133478889999998764  478999999999999999999999975422        22333332222   2233


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCC---CCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTE---DLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~---~~~~~p  355 (386)
                      ...++.++.+++.+|+..++.-|+++.   ++..+|
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~  252 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP  252 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence            446899999999999999999998664   554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.1e-36  Score=266.73  Aligned_cols=245  Identities=30%  Similarity=0.446  Sum_probs=200.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      ..+.||+|++|.||++... ++..+++|++..... ..+.+.+|++.++.++|+|++++++++......++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            3467999999999999875 688999999976544 45788999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||.+........  
T Consensus        84 L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          84 LKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             HHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999986532     4689999999999999999999998   999999999999999999999999999987655432  


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc--ccc
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL--AGV  325 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~  325 (386)
                       .....++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.||......       ... ..........+  ...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~-~~~~~~~~~~~~~~~~  222 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPM-------KAL-FKIATNGPPGLRNPEK  222 (253)
T ss_pred             -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHH-HHHHhcCCCCcCcccc
Confidence             1234578899999998654  5788999999999999999999999754221       111 11111221222  223


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.++.+++.+|+..++.-|+++.++..+|
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~  252 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKHP  252 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            489999999999999999999888776664

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-36  Score=278.96  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=195.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|... +|+.||+|.++.....   ...+.+|+.++++++|+|++++++++.+.  +..++||||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY   89 (309)
T ss_pred             eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence            34578999999999999864 6899999998743222   23567899999999999999999998765  467999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +. ++|.+++....     ..+++..++.++.||+.||+|||+.   +++||||+|+||++++++.+||+|||++.....
T Consensus        90 ~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          90 CE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             CC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            95 58888885432     4689999999999999999999998   999999999999999999999999999986654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------cc-chhhhhhhcC
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------IY-FPNSIYKHIE  315 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~-~~~~~~~~i~  315 (386)
                      ....  .....++..|+|||.+.+. ..++.++|||||||++|||++|+.||........-      .. .....|..+.
T Consensus       161 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         161 PAKP--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             ccCC--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            3211  1223357789999998653 35788999999999999999999999754321100      00 0001111000


Q ss_pred             CC---ccc-----------cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          316 PG---NEF-----------QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       316 ~~---~~~-----------~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..   ...           .....++++..+++.+|+..++.-|++++++..+|--
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            00   000           0112368899999999999999999999988877653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=269.46  Aligned_cols=201  Identities=26%  Similarity=0.418  Sum_probs=162.5

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhc--CCCCccceEEEEEEec----CceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK--TSHVNVVSFLGFCYEK----KKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~e~  162 (386)
                      .+.+.||+|.||.||+|.+ .|..||||++...  +++.+.+|.++++.  |+|+||+.|++.-..+    ..++||++|
T Consensus       214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             EEEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            3458899999999999999 7899999999753  45667777777765  5999999999865433    257899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-----GCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      .+.|||.+||..       ..++....++++..+|.||++||.     +..|.|.|||||+.||||..++...|+|+|||
T Consensus       291 He~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  291 HEHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             ccCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999965       468889999999999999999996     35678999999999999999999999999999


Q ss_pred             cccCcccce--eeeccccCccccccccccchhcCC----CCccchhHhHHHHHHHHHhC----------CCCcccccc
Q 038768          238 KLSEKKESF--ISMLGARGTIGYIAPEVFCRNFGG----VSHKSDVYSYGMMILEMVVG----------RKNAEVKVS  299 (386)
Q Consensus       238 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~----~~~~~DvwslGvil~elltg----------~~p~~~~~~  299 (386)
                      .........  ......+||.+|||||++......    .-..+||||||.++||+...          +.||....+
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            766544221  223456799999999999654211    12468999999999998763          467765543

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-35  Score=268.47  Aligned_cols=236  Identities=22%  Similarity=0.299  Sum_probs=186.5

Q ss_pred             cCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCCCHHHH
Q 038768           94 LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF  171 (386)
Q Consensus        94 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  171 (386)
                      ||+|+||.||++.. .++..+|+|.+........    |+.....+ +|+|++++++++...+..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            59999999999985 4688999999875433221    22222212 799999999999999999999999999999999


Q ss_pred             hcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCcccCcccceeeec
Q 038768          172 IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKKESFISML  250 (386)
Q Consensus       172 l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~~~~  250 (386)
                      +...      ..+++..++.++.|++.||.|||+.   +++||||+|+||+++.++ .++|+|||++.......      
T Consensus       100 l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------  164 (267)
T PHA03390        100 LKKE------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------  164 (267)
T ss_pred             HHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------
Confidence            9543      3689999999999999999999998   999999999999999988 99999999987654332      


Q ss_pred             cccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHH
Q 038768          251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEE  330 (386)
Q Consensus       251 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~  330 (386)
                      ...++..|+|||++.+.  .++.++||||||+++|||++|+.||......  + .....+....  .........+++++
T Consensus       165 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~-~~~~~~~~~~--~~~~~~~~~~~~~~  237 (267)
T PHA03390        165 CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--E-LDLESLLKRQ--QKKLPFIKNVSKNA  237 (267)
T ss_pred             cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--h-hhHHHHHHhh--cccCCcccccCHHH
Confidence            23478899999998654  6788999999999999999999999843221  1 1112222222  22334556799999


Q ss_pred             HHHHHHHHHHHHHhcCCC-CCCCCCC
Q 038768          331 KEMAKKMILVLEMLEGST-EDLQIPP  355 (386)
Q Consensus       331 ~~li~~ml~v~~~L~~~~-~~~~~~p  355 (386)
                      .+++.+|++.++.-|++. +++..+|
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCC
Confidence            999999999999999853 6665554

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-37  Score=299.99  Aligned_cols=263  Identities=21%  Similarity=0.260  Sum_probs=188.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCC--CcEEEEE------------------EecCCCCChHHHHHHHHHhhcCCCCccce
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPD--GRLVAVK------------------VLKNSKVNGEEFINEVASMSKTSHVNVVS  145 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~niv~  145 (386)
                      ..+.+.++||+|+||+||++....  +..+++|                  .+.........+.+|+.++++++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            345566899999999999986532  2222222                  11111222356789999999999999999


Q ss_pred             EEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 038768          146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~  225 (386)
                      +++++.+.+..|+|+|++ .++|.+++....... ........++.++.||+.||+|||+.   +|+||||||+|||++.
T Consensus       228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             EeEEEEECCeeEEEEecc-ccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            999999999999999998 567877775432211 12234567788999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCC-cccccccCC--
Q 038768          226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKN-AEVKVSLSS--  302 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~~--  302 (386)
                      ++.+||+|||+++.+...... ......||..|+|||++.+.  .++.++|||||||++|||++|..+ +........  
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999876543221 12235689999999998764  689999999999999999998754 332211000  


Q ss_pred             -----------cccch---hhhhhhcCCCcc---------ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          303 -----------EIYFP---NSIYKHIEPGNE---------FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       303 -----------~~~~~---~~~~~~i~~~~~---------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                 ...++   ...++.+.....         ......++.++.+++.+||..++..|+++.++..+|-
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence                       00011   112222211110         0012246778899999999999999999999877765

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-36  Score=274.76  Aligned_cols=253  Identities=25%  Similarity=0.295  Sum_probs=197.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  164 (386)
                      +.++||.|++|.||++... +++.+|+|.+.....  ....+.+|++++++++|+||++++++|.+.  +..++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            3578999999999999874 588999999875433  346789999999999999999999998754  36789999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++.....  ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          85 GGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             CCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            9999998754321  235578899999999999999999998   99999999999999999999999999987554322


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc--
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL--  322 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--  322 (386)
                      .    ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||......   ...+.+....+.....+.+  
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNMPNPELKD  230 (287)
T ss_pred             c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcCCchhhcc
Confidence            1    123467889999998653  6889999999999999999999999865321   1111222232222121222  


Q ss_pred             ----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          323 ----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       323 ----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                          ...+++++.+++.+|+...+.-|+++.++..+|-
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence                1335678999999999999999998887766653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-36  Score=274.15  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=192.8

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCC-CCccceEEEEEEec--CceeEEEEeC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTS-HVNVVSFLGFCYEK--KKRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~  163 (386)
                      +.++||+|+||.||+|.. .+++.||+|.++...  .......+|+.++.++. |+|++++++++.+.  +..++||||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            457899999999999986 468899999987642  22334567899998885 99999999999988  8899999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      + ++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.+||+|||+++.....
T Consensus        83 ~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          83 D-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             C-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            6 68888875432     4689999999999999999999998   9999999999999999 99999999999866443


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhhhhcCC
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIYKHIEP  316 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~i~~  316 (386)
                      ...   ....++..|+|||++... ..++.++|||||||++|||++|..||...+..+.       ....+..+.+....
T Consensus       153 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         153 PPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             CCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            321   123478899999986543 3578899999999999999999999975432110       00001111111111


Q ss_pred             Cc--c-----------ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 GN--E-----------FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ~~--~-----------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..  .           ..+...++.++.+++.+|+..++.-|++++++..+|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~  280 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP  280 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence            11  0           111235789999999999999999999888776665

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.3e-36  Score=268.14  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||.|+||.||++... +++.+++|++.....   ..+.+.+|+++++.++|+|++++.+.+...+..++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence            3567999999999999864 588999999976433   346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++.....  ....+++..++.++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          84 GDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            999999866421  225689999999999999999999998   999999999999999999999999999986655431


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .  .....|++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||+...        +..+...+.......++..
T Consensus       159 ~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~  226 (258)
T cd08215         159 L--AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQYPPIPSQ  226 (258)
T ss_pred             e--ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCCCCCCCCC
Confidence            1  1234578899999988654  57889999999999999999999997543        2334444444545666778


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.+..+++.+|+...+.-|+++.++..+|
T Consensus       227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  256 (258)
T cd08215         227 YSSELRNLVSSLLQKDPEERPSIAQILQSP  256 (258)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence            899999999999999999999988876665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-35  Score=275.42  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=196.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +...+.||+|+||.||+++. .+|..||+|.+......    ...+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            33457899999999999986 46889999998753222    24688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ++ |+|.+++....     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       107 ~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         107 CL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            96 57877775432     4588999999999999999999998   999999999999999999999999999875443


Q ss_pred             ccceeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-ccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-NEF  320 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~~~  320 (386)
                      ..      ...++..|+|||++.. ..+.++.++|||||||++|||++|+.||.....        ......+..+ ...
T Consensus       178 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~  243 (317)
T cd06635         178 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPT  243 (317)
T ss_pred             cc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhccCCC
Confidence            22      3357889999999742 123578899999999999999999999875321        2222222222 222


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .....++..+++++.+|+..++.-|++..++..++-
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            234567889999999999999999998887766554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-36  Score=273.33  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||.|++|.||+|... +|..||+|++....   .....+.+|+++++.++|+|++++++++.+.+..+++|||+ +
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-D   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-C
Confidence            3578999999999999864 78999999987543   22357889999999999999999999999999999999999 4


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++.....    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          82 LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            789998865321    3689999999999999999999998   999999999999999999999999999976543221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhc----
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHI----  314 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i----  314 (386)
                      .  .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||..........       ...+..|..+    
T Consensus       155 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T--YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c--cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            1  1223467889999988653 356889999999999999999999997543211000       0000111010    


Q ss_pred             ---------CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 ---------EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 ---------~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                               ...........++.+..+++.+|+..++.-|++.+++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~  281 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP  281 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence                     00111122456789999999999999999999887765554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=278.47  Aligned_cols=261  Identities=23%  Similarity=0.291  Sum_probs=195.9

Q ss_pred             hhhhccCcCCceEEEEEEeC---CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  159 (386)
                      .+.++||+|+||.||+|...   +++.||+|.+....    ...+.+.+|+.++..++||||+++++++.+.  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            34578999999999999864   47899999998632    2235678899999999999999999999988  789999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC----CCceEEeecc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE----DFCPKISDFG  235 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg  235 (386)
                      |||++ ++|.+++..... .....+++..++.++.||+.||+|||+.   +++||||||+||+++.    ++.+||+|||
T Consensus        83 ~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          83 FDYAE-HDLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EeCCC-cCHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99996 577776643321 1123688999999999999999999998   9999999999999999    9999999999


Q ss_pred             CCcccCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-ccchh----h
Q 038768          236 LAKLSEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPN----S  309 (386)
Q Consensus       236 l~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~----~  309 (386)
                      ++........ ........++..|+|||++.+. ..++.++|||||||++|+|++|+.||......... .....    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            9986644322 1122234578899999987653 35788999999999999999999999755332100 00000    0


Q ss_pred             hhh------------------------hcCCCc--------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          310 IYK------------------------HIEPGN--------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       310 ~~~------------------------~i~~~~--------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..                        ......        ........+.+..+++.+|+..+|.-|+++.++..+|
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            000                        000000        0001125678899999999999999999988877665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-36  Score=275.34  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=199.6

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||++.. .+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            344567899999999999975 468899999986433 334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++..       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647         100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999854       3477889999999999999999998   99999999999999999999999999887554332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC-Ccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP-GNEFQLA  323 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~  323 (386)
                      ..  .....++..|+|||.+...  .++.++|+||||+++|++++|+.||........       +...... ......+
T Consensus       170 ~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~  238 (293)
T cd06647         170 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTPELQNP  238 (293)
T ss_pred             cc--cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-------eeehhcCCCCCCCCc
Confidence            21  1223578889999998653  678899999999999999999999975432111       0000001 1112234


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..++...++++.+|+..++.-|++.+++-.+|-
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            457889999999999999999988887776653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-36  Score=271.45  Aligned_cols=247  Identities=27%  Similarity=0.435  Sum_probs=206.0

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.++||+|+||.||++.. .+++.+++|.+.....   ....+.+|+.+++.++|+||+++.+++.+....++|+||+++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530           4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence            457899999999999975 4688999999875432   235678899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....  .....+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        84 ~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  158 (256)
T cd08530          84 GDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA  158 (256)
T ss_pred             CCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence            99999986532  1225688999999999999999999998   999999999999999999999999999987655411


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                          ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.....        ......+..+..+.++..
T Consensus       159 ----~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  224 (256)
T cd08530         159 ----KTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKVQRGKYPPIPPI  224 (256)
T ss_pred             ----ccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCCchh
Confidence                234578899999998654  678899999999999999999999975432        233344455555566678


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.++++++.+|+...+.-|++..++..+|
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         225 YSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             hCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence            899999999999999999999988877765

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=264.87  Aligned_cols=243  Identities=25%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEec----CceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEK----KKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~  165 (386)
                      ++||-|-.|.|-.+.. .+|+.+|+|++..+.    ...+|+++.-.. .|+|||.++++|...    ..+.+|||+++|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            6899999999999975 468999999997543    456777765444 599999999998743    456789999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~  242 (386)
                      |.|.+.+...+.    ..+++.++-+|..||+.|+.|||+.   +|.||||||+|+|...   |-.+||+|||+|+....
T Consensus       144 GeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  144 GELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             hHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            999999987653    5699999999999999999999998   9999999999999964   55799999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...   ..+.+-|+.|.|||++...  .|+..+|+||+||++|-|++|.+||..+...    .++.-+..+|..|. +.+
T Consensus       217 ~~~---L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~gq-y~F  286 (400)
T KOG0604|consen  217 PGD---LMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTGQ-YEF  286 (400)
T ss_pred             Ccc---ccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhccC-ccC
Confidence            332   3456789999999998654  7999999999999999999999999987653    23444556666666 222


Q ss_pred             ----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 ----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          +..+|++.+++|+.||.+.+.-|-+.++...+|
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence                345899999999999999998887777765554

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-36  Score=274.58  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||++... +|+.||+|++....    ...+.+.+|+.++.+++ |+||+++++++.+.+..++||||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            34578999999999999864 68999999987532    22356888999999998 99999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          84 APNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999653      3689999999999999999999998   999999999999999999999999999886544


Q ss_pred             ccce------------------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc
Q 038768          243 KESF------------------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI  304 (386)
Q Consensus       243 ~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~  304 (386)
                      ....                  .......++..|+|||.....  .++.++|+||||+++|++++|+.||.....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----  227 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----  227 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccH-----
Confidence            3211                  111234578899999988654  588899999999999999999999986532     


Q ss_pred             cchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCC----CCCCCCC
Q 038768          305 YFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGST----EDLQIPP  355 (386)
Q Consensus       305 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~----~~~~~~p  355 (386)
                         ....+.+... ...++..+++...+++.+|+..++.-|++.    +++..+|
T Consensus       228 ---~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         228 ---YLTFQKILKL-EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             ---HHHHHHHHhc-CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence               2222333222 245666789999999999999999999988    7766655

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-35  Score=272.15  Aligned_cols=243  Identities=26%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .+||+|+||.||++.. .+|+.||+|.+.... .....+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999986 468999999986433 23456889999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      +++..       ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  .
T Consensus       106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~  173 (292)
T cd06657         106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R  173 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--c
Confidence            98743       3478899999999999999999998   9999999999999999999999999998755432211  1


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc--ccccccCC
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE--FQLAGVVT  327 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~s  327 (386)
                      ....++..|+|||++.+.  .++.++|+||||+++|+|++|+.||.....        ......+.....  ......++
T Consensus       174 ~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06657         174 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPKLKNLHKVS  243 (292)
T ss_pred             cccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhhCCcccCCcccCC
Confidence            224578899999988643  678899999999999999999999975422        111122221111  11234578


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .++.+++.+|+..++.-|++..++..+|-
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~  272 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKHPF  272 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence            99999999999999999998888777653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-37  Score=266.38  Aligned_cols=263  Identities=24%  Similarity=0.283  Sum_probs=199.4

Q ss_pred             hhhhccCcCCceEEEEEEeC---C--CcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEe-cCceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP---D--GRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYE-KKKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  159 (386)
                      +....||+|.||.||+|.-.   +  ...+|+|.++.+..   -.....+|+.+++.++|+||+.+..++.. +...+++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            34578999999999999532   2  23799999986532   23678899999999999999999999988 6788999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC----CceEEeecc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED----FCPKISDFG  235 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg  235 (386)
                      +||.+ -+|...++-.+.... ..++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.|||+|||
T Consensus       107 fdYAE-hDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  107 FDYAE-HDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             ehhhh-hhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence            99995 588888876655443 5789999999999999999999998   89999999999999877    899999999


Q ss_pred             CCcccCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--c-------
Q 038768          236 LAKLSEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--Y-------  305 (386)
Q Consensus       236 l~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--~-------  305 (386)
                      +++.+...-.. ......+-|..|.|||.+.+. ..||.+.||||.|||+.||+|-++-|.+....-...  +       
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            99988765332 233456689999999999987 589999999999999999999877775432110000  0       


Q ss_pred             ------ch-hhhhhhcCCCc---------------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          306 ------FP-NSIYKHIEPGN---------------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       306 ------~~-~~~~~~i~~~~---------------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                            .| ...|..+.+-.                     .......-++..-+|+.+||.+++.=|-++++...++..
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence                  00 01111111111                     111133346668899999999999998888877666653

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.3e-36  Score=273.71  Aligned_cols=258  Identities=22%  Similarity=0.288  Sum_probs=193.3

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCC-CCccceEEEEEEecCc-----eeEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKK-----RALI  159 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~lv  159 (386)
                      ..+.||+|+||.||+|... +|+.||+|.+.....   ....+.+|+.+++.++ |+||+++++++...+.     .++|
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv   84 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV   84 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence            4578999999999999864 689999999865322   2357889999999995 6999999999987666     7999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAK  238 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~  238 (386)
                      |||+++ +|.+++...... ....+++..++.++.||+.||.|||+.   +++||||+|+||+++. ++.+||+|||++.
T Consensus        85 ~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          85 FEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             eeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            999975 898888654321 124689999999999999999999998   9999999999999998 8899999999987


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~  311 (386)
                      .......  ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||..........       ..+...+
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         160 AFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             ecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            5533211  11123467889999988653 357899999999999999999999997543211000       0000011


Q ss_pred             hhcC---------C---CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          312 KHIE---------P---GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       312 ~~i~---------~---~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+.         .   .........++.++.+++.+|+..++.-|+++.++..+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~  292 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP  292 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence            0000         0   000011235789999999999999999999888776654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=264.03  Aligned_cols=245  Identities=26%  Similarity=0.376  Sum_probs=202.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|++|.||++... +++.|++|.+.....   ..+.+.+|++++.+++|+|++++++++.+.+..+++|||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            34578999999999999764 578999999986543   34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          83 NGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999998543      4689999999999999999999998   99999999999999999999999999998665433


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..  .....++..|+|||...+.  .++.++||||||+++|+|++|+.||.....       ....++ +.......++.
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~  221 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFR-IVQDDHPPLPE  221 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH-HhccCCCCCCC
Confidence            21  1234578899999998654  478899999999999999999999975421       112222 22334456677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      .+++++.+++.+|+...+.-|+++.++..+
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            889999999999999999988887766544

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=265.33  Aligned_cols=240  Identities=29%  Similarity=0.417  Sum_probs=200.2

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           94 LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ||+|+||.||++... +++.+++|++.....    ....+..|+.+++.++|+||+++++.+......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999864 588999999876433    235788999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (250)
T cd05123          81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R  149 (250)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence            9999543      3588999999999999999999998   999999999999999999999999999986654321  1


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....++..|+|||...+.  ..+.++|+||||+++|+|++|+.||.....        ....+.+... ...++...+.
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~~~~~  218 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKD-PLRFPEFLSP  218 (250)
T ss_pred             ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcC-CCCCCCCCCH
Confidence            2234578899999998654  578899999999999999999999975422        2333344332 3567777899


Q ss_pred             HHHHHHHHHHHHHHHhcCCC---CCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGST---EDLQIPP  355 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~---~~~~~~p  355 (386)
                      +..+++.+|+..++.-|++.   +++..+|
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~  248 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGGAEEIKAHP  248 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCcccHHHHHhCC
Confidence            99999999999999999988   5665554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.4e-36  Score=272.11  Aligned_cols=256  Identities=24%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.++||.|++|.||+|... +|..||+|+++...  ...+.+.+|+.++++++|+||+++++++.+.+..++||||++ +
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   82 (284)
T cd07836           4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-K   82 (284)
T ss_pred             EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-c
Confidence            4578999999999999874 68899999987543  234677889999999999999999999999999999999997 5


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++.....   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        83 ~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          83 DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            88888755321   24589999999999999999999998   999999999999999999999999999975543221 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhcCCCc-
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHIEPGN-  318 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i~~~~-  318 (386)
                       ......++..|++||++.+. ..++.++|||||||++|+|++|+.||........-.       ......++.+.... 
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             11233467889999987653 357889999999999999999999997543210000       00001111111000 


Q ss_pred             ------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 ------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                  ...+...++.+..+++.+|++.++.-|++..++..+|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~  282 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP  282 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence                        0011234688899999999999999998877766554

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=283.15  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=199.0

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+...+|.|+|+.|-.+.. .+++..++|++.+..   .+-.+|+.++... +|+||+++.+++.+..+.|+|||.+.+
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            34556799999999999875 568899999998652   2234566555444 799999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe-CCCCceEEeeccCCcccCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +-|.+.+....       .....+..|+.+|+.++.|||++   |+|||||||+|||+ ++.++++|+|||.++..... 
T Consensus       401 ~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  401 GELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             cHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            88877775432       22267778999999999999998   99999999999999 68999999999999877655 


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                          ..+.+-|..|.|||++..+  .+++++||||||++||+|++|+.||......       .++...+..+.   ...
T Consensus       470 ----~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~---~s~  533 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPK---FSE  533 (612)
T ss_pred             ----hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCc---ccc
Confidence                2344578899999999754  8999999999999999999999999875431       45666776654   347


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+|+++++|++.||+++|.+|.++.++..+|--
T Consensus       534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            899999999999999999999999999888754

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.6e-35  Score=270.74  Aligned_cols=247  Identities=24%  Similarity=0.327  Sum_probs=196.7

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .++||+|+||.||+|+. .+|+.|++|.+.....    ..+.+.+|+++++.++|+|++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            36799999999999986 4688999999875322    12467889999999999999999999999999999999995 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++....     ..+++..++.++.||+.+|.|||+.   +++|+||+|+||+++.++.++|+|||++......  
T Consensus       105 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         105 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            67777775432     4588999999999999999999998   9999999999999999999999999998643322  


Q ss_pred             eeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                          ....|+..|+|||++.. ..+.++.++|||||||++|+|++|+.||......       .................
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~  243 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSN  243 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCcc
Confidence                13457889999999843 1235788999999999999999999998754221       11111111122222344


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSL  359 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~~  359 (386)
                      .++.++++++.+|+..++.-|++..++..+|--..
T Consensus       244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            57888999999999999999999998887776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.1e-36  Score=277.64  Aligned_cols=257  Identities=20%  Similarity=0.235  Sum_probs=192.4

Q ss_pred             hccCcC--CceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQG--GFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..||+|  +||+||++.. .+|+.||+|++......   .+.+.+|+.+++.++||||++++++|...+..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346766  8999999986 47899999998754433   25678899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+........
T Consensus        84 ~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          84 GSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            99999986542    23588899999999999999999998   999999999999999999999999986543222111


Q ss_pred             ee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC-------Ccccch------
Q 038768          246 FI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS-------SEIYFP------  307 (386)
Q Consensus       246 ~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-------~~~~~~------  307 (386)
                      ..     ......++..|+|||++.+....++.++|||||||++|||++|+.||.......       .....+      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            00     001123456799999987653457899999999999999999999997542110       000000      


Q ss_pred             -hh--hh----------------h-----hc-CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          308 -NS--IY----------------K-----HI-EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       308 -~~--~~----------------~-----~i-~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       ..  .+                .     .. ...........+++++.+++++|+..++.-|+++.++..+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence             00  00                0     00 00001112344678899999999999999999988877665

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=274.37  Aligned_cols=256  Identities=22%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|... +++.||+|.++...   ...+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   83 (288)
T cd07833           4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE   83 (288)
T ss_pred             eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence            45678999999999999875 58899999987532   234678999999999999999999999999999999999998


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ++.+..+....      ..+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          84 RTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            87776655332      4588999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhcCC-
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHIEP-  316 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i~~-  316 (386)
                      .. ......++..|+|||++.+. ..++.++||||||+++|+|++|+.||......+...       .++......... 
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            21 11234578889999998654 267899999999999999999999997542210000       000000000000 


Q ss_pred             ----C------c-----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 ----G------N-----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ----~------~-----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          +      .     ....+..++.++.+++++|+...+.-|++++++..+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  286 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP  286 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence                0      0     0123445689999999999999999999887765554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=272.92  Aligned_cols=241  Identities=23%  Similarity=0.311  Sum_probs=200.6

Q ss_pred             HHHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcC-CCCccceEEEEEEecCce
Q 038768           83 VKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        83 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  156 (386)
                      +.....+|..+||+|+||.|-+|.-+ +.+.+|||+++++-.    +.+--..|-++|... +-|.++.+..+|+.-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34445578899999999999999764 356899999987532    222334677777665 577899999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      |+||||+.||+|--.+++.      ..+.+..+..++.+||-||-+||++   +|++||||.+|||++.+|.+||+|||+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eeEEEEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence            9999999999999988664      5678889999999999999999999   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ++.---...  ...+.+||+.|+|||.+.-  ..|+..+|+|||||+||||+.|++||+..+.        .++++.|.+
T Consensus       497 cKEni~~~~--TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~e  564 (683)
T KOG0696|consen  497 CKENIFDGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIME  564 (683)
T ss_pred             ccccccCCc--ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHH
Confidence            984322221  2346789999999999965  4899999999999999999999999998754        678888877


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhc
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLE  345 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~  345 (386)
                      .+ ..++..+|.++.++...++...+.-|
T Consensus       565 hn-vsyPKslSkEAv~ickg~ltK~P~kR  592 (683)
T KOG0696|consen  565 HN-VSYPKSLSKEAVAICKGLLTKHPGKR  592 (683)
T ss_pred             cc-CcCcccccHHHHHHHHHHhhcCCccc
Confidence            65 77899999999999999988655544

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.7e-36  Score=271.99  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=194.5

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCCC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.||+|+||.||++... +|+.||+|.+.....  ....+.+|+.++.++. |+||+++++++......+++|||++ +
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence            467999999999999864 589999999875432  2356889999999996 9999999999999999999999985 4


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      ++.++...... .....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|+|||+++....... 
T Consensus        88 ~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  163 (288)
T cd06616          88 SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-  163 (288)
T ss_pred             CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence            65554321100 1125688999999999999999999974  2899999999999999999999999999875543221 


Q ss_pred             eeeccccCccccccccccchhc-CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc---
Q 038768          247 ISMLGARGTIGYIAPEVFCRNF-GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL---  322 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---  322 (386)
                        .....|+..|+|||++.+.. ..++.++|||||||++|||++|+.||.....      .-..+ ..+..+..+.+   
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~-~~~~~~~~~~~~~~  234 (288)
T cd06616         164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQL-TQVVKGDPPILSNS  234 (288)
T ss_pred             --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHH-hhhcCCCCCcCCCc
Confidence              12235788999999986431 2578899999999999999999999975421      01111 22222222222   


Q ss_pred             -cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          323 -AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       323 -~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                       +..++.++.+++.+|+..++.-|++.+++..+|.-
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence             23578999999999999999999999988777754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-36  Score=271.97  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=195.3

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEeC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  163 (386)
                      +.++||+|+||.||+|... +|+.+|+|.+....   ...+.+.+|+++++.++|+|++++++++.+.  +..++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4578999999999999865 58899999998653   2335788999999999999999999999988  7899999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      + ++|.+++....     ..+++..++.++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          83 D-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             c-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            6 58888885432     4688999999999999999999998   9999999999999999999999999999866544


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhcCC
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHIEP  316 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i~~  316 (386)
                      .. .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||+.......-.       ..+...|..+..
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             Cc-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence            31 111233467889999987654 357899999999999999999999997543210000       000000000000


Q ss_pred             ---------Cc------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 ---------GN------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ---------~~------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                               ..      ...+...++.+..+++++|+..++..|++++++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence                     00      0111222488999999999999999999887765544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-35  Score=273.49  Aligned_cols=259  Identities=21%  Similarity=0.278  Sum_probs=194.5

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecC-------
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-------  154 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  154 (386)
                      ..+.+.+.||.|+||.||+|... +|+.||+|.++...   .....+.+|++++++++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            34455688999999999999874 58899999997532   23356788999999999999999999987655       


Q ss_pred             ---ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEE
Q 038768          155 ---KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI  231 (386)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  231 (386)
                         ..++|+||+++ ++..++...     ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence               78999999975 777776543     24689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------  304 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------  304 (386)
                      +|||++......... ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||........-.       
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999866443211 11123457789999988643 356889999999999999999999997543210000       


Q ss_pred             cchhhhhhhcCCC--------------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          305 YFPNSIYKHIEPG--------------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       305 ~~~~~~~~~i~~~--------------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+...+..+...              ........++....+++.+|+..++..|++.+++..+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  300 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP  300 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            0000011111000              00011234689999999999999999999887766554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-35  Score=271.60  Aligned_cols=256  Identities=20%  Similarity=0.284  Sum_probs=192.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|++|.||+|... +|+.||+|.+.....   ..+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            34578999999999999864 688999999865332   23568899999999999999999999999999999999995


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~  243 (386)
                       ++|.+++....    ...+++..++.++.||+.||+|||+.   +++|+||+|+||+++. ++.+||+|||++......
T Consensus        85 -~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         85 -LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             -ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence             58888774432    13467888899999999999999998   9999999999999985 567999999999765432


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------chhhhhh----
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------FPNSIYK----  312 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~----  312 (386)
                      ..  ......++..|+|||++.+. ..++.++|||||||++|+|+||+.||......+....       .....|.    
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            11  11223467899999988653 3578899999999999999999999975432110000       0000000    


Q ss_pred             ---------hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          313 ---------HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       313 ---------~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                               .+...........+++++.+++.+|+..++.-|++.+++..+|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                     0000000112345789999999999999999999887766554

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.4e-36  Score=277.74  Aligned_cols=259  Identities=17%  Similarity=0.158  Sum_probs=196.2

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      ++.+|.|+++.||++.. +++.||+|+++...   ...+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            44566666666666665 78999999987542   233678999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc--
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES--  245 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  245 (386)
                      |.+++....    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+........  
T Consensus        86 l~~~l~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          86 CEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             HHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999986532    23578899999999999999999998   999999999999999999999999998875432211  


Q ss_pred             ---eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC--------------cccchh
Q 038768          246 ---FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS--------------EIYFPN  308 (386)
Q Consensus       246 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------------~~~~~~  308 (386)
                         ........++..|+|||++......++.++|+|||||++|||++|+.||........              ....+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence               011123346778999999865434578899999999999999999999975421100              000000


Q ss_pred             hh-----------hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          309 SI-----------YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       309 ~~-----------~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..           ...............++++..+++.+|+..++.-|++++++..+|.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence            00           00000111222344567889999999999999999999998888764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-35  Score=273.66  Aligned_cols=258  Identities=21%  Similarity=0.298  Sum_probs=191.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCc--------
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKK--------  155 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------  155 (386)
                      +.+.++||+|+||.||+|... +++.||+|.+.....   ....+.+|+.++++++||||++++++|.....        
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            344578999999999999864 689999999864322   23456789999999999999999999886543        


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .++||||+. ++|.+++....     ..+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence            489999995 58888875432     3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccc
Q 038768          236 LAKLSEKKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYF  306 (386)
Q Consensus       236 l~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~  306 (386)
                      ++.........  .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.........       ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99866433211  111233567889999988654 34678999999999999999999998754321000       000


Q ss_pred             hhhhhhhc---------C--CCc----cccc-cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          307 PNSIYKHI---------E--PGN----EFQL-AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       307 ~~~~~~~i---------~--~~~----~~~~-~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..++...         .  ...    ...+ +...+..+.+++.+|+..++.-|+++.++..+|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence            11111100         0  000    0001 122467889999999999999999988876655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-35  Score=271.36  Aligned_cols=250  Identities=20%  Similarity=0.292  Sum_probs=194.3

Q ss_pred             hhhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCC--ChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV--NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|...+ ++.||||.++....  ....+..|+.++.+.. |+||++++++|.+....++||||+ 
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   96 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-   96 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-
Confidence            456789999999999999754 89999999976432  2345677887776664 999999999999999999999998 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      .++|.+++...     ...+++..+..++.|++.||+|||+.  .+++||||+|+||++++++.+||+|||++.......
T Consensus        97 ~~~l~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          97 STCLDKLLKRI-----QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             CcCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            45777776442     24688999999999999999999973  289999999999999999999999999987654332


Q ss_pred             ceeeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ..   ....++..|+|||++....  +.++.++||||||+++|+|++|+.||.....   +    ......+.....+..
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~----~~~~~~~~~~~~~~~  239 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E----FEVLTKILQEEPPSL  239 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H----HHHHHHHhcCCCCCC
Confidence            21   1234778899999986442  3478899999999999999999999975311   0    111222222221222


Q ss_pred             --cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          323 --AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       323 --~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                        ...+++++.+++.+|+..++.-|++.+++..+|-
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence              2347899999999999999999999988877764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-35  Score=275.89  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=195.5

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---------------HHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---------------EEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      .+.||.|+||+||+|... +++.||+|.++......               ..+.+|+++++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999864 68999999987533221               24778999999999999999999999999


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ..++||||++ |+|.+++...      ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence            9999999996 6899988542      4588999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCcccc------------eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC
Q 038768          235 GLAKLSEKKES------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS  302 (386)
Q Consensus       235 gl~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  302 (386)
                      |++........            ........++..|+|||.+.+. ..++.++|||||||++|||++|+.||........
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99976541110            0111123467889999998654 3578899999999999999999999975532110


Q ss_pred             ------------cccchhhh-------hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          303 ------------EIYFPNSI-------YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       303 ------------~~~~~~~~-------~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                                  ...++...       +...............++++.+++.+|+..++..|++++++..+|--
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence                        00000000       00000000111234568899999999999999999999888777654

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.2e-35  Score=277.52  Aligned_cols=250  Identities=24%  Similarity=0.302  Sum_probs=190.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  158 (386)
                      ...+.||+|+||.||+|.. .+|+.||+|.+....   .....+.+|+.+++.++|+||+++++++....      ..++
T Consensus        19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   98 (353)
T cd07850          19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL   98 (353)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence            3457899999999999986 468999999986532   22356778999999999999999999886443      4689


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+. ++|.+.+..        .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        99 v~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          99 VMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             EEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            999995 588887732        278889999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------ccc-chhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------EIY-FPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------~~~-~~~~~~  311 (386)
                      .......   .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||...+....      ... .+....
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         167 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            6644322   1234578899999998664  688999999999999999999999975431100      000 000000


Q ss_pred             h----------------------hcCCCc-----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          312 K----------------------HIEPGN-----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       312 ~----------------------~i~~~~-----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .                      .+.+..     ........+++.++++.+|+..++.-|+++.++..+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence            0                      000000     0000223566789999999999999999999988777

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.6e-35  Score=269.18  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             hhhccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEE
Q 038768           90 FSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK-----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.||+|+||.||++..    .+++.||||+++...     ...+.+.+|+.++.++ +|+||+++++.+......++|
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   83 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI   83 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence            457899999999999874    357899999987532     2235678999999999 599999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++...      ..+++..+..++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||+++.
T Consensus        84 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          84 LDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999998542      4578899999999999999999998   999999999999999999999999999876


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ........ .....|+..|+|||.+.+.....+.++||||||+++|||++|..||......    .......+.+... .
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~-~  228 (288)
T cd05583         155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKS-K  228 (288)
T ss_pred             cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHcc-C
Confidence            54432211 1234578899999998654334788999999999999999999999643211    1122222333222 2


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +..+..++.+..+++.+|+..++.-|+++.+
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~  259 (288)
T cd05583         229 PPFPKTMSAEARDFIQKLLEKDPKKRLGANG  259 (288)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence            4456678899999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.1e-36  Score=269.67  Aligned_cols=249  Identities=26%  Similarity=0.351  Sum_probs=198.7

Q ss_pred             hhhhccCcCCceEEEEEEeCC-CcEEEEEEecCCC------CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSK------VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.++||+|+||.||++.... +..+++|+++...      .....+..|+.+++.++||||+++++++.+....++|||
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence            456789999999999998643 4556666655321      223456789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++++|.+++....  .....+++..++.++.|++.||.|||+.   +++|+||+|+||++++ +.++|+|||++....
T Consensus        83 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          83 YCEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             eCCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999886532  1235689999999999999999999998   9999999999999975 569999999987654


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      .....  .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.....        ......+..+..+.
T Consensus       157 ~~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~  224 (260)
T cd08222         157 GSCDL--ATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVEGPTPS  224 (260)
T ss_pred             CCccc--ccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCCCCC
Confidence            33221  1234578899999988543  678899999999999999999999975421        22334444555566


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++..++.++.+++.+|+..++.-|++..++..+|
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  258 (260)
T cd08222         225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP  258 (260)
T ss_pred             CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence            7778899999999999999999999888776665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-36  Score=279.45  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=205.3

Q ss_pred             ccccHHHHHHHHhhh-----hhccCcCCceEEEEEE-eCCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccce
Q 038768           76 KRYNYSDVKRMTNSF-----SNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVS  145 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~  145 (386)
                      +.-+|..++++.-+-     .+.||-|+||.|.++. .++...+|.|.+++...    .....+.|-+||...+.+.||+
T Consensus       614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr  693 (1034)
T KOG0608|consen  614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR  693 (1034)
T ss_pred             hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence            334444555544332     3679999999999985 55677899999986432    2245678999999999999999


Q ss_pred             EEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 038768          146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~  225 (386)
                      ||-.|.+.+.+|+||+|++||++-.+|.+.      +-+.+..++.++.++..|+++.|.-   |+|||||||+|||||.
T Consensus       694 LyySFQDkdnLYFVMdYIPGGDmMSLLIrm------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDr  764 (1034)
T KOG0608|consen  694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDR  764 (1034)
T ss_pred             EEEEeccCCceEEEEeccCCccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEcc
Confidence            999999999999999999999999999765      4688888999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCcccC---------ccc-----------ce--------------------eeeccccCccccccccccc
Q 038768          226 DFCPKISDFGLAKLSE---------KKE-----------SF--------------------ISMLGARGTIGYIAPEVFC  265 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~---------~~~-----------~~--------------------~~~~~~~g~~~y~aPE~~~  265 (386)
                      +|.+||+||||+.-+.         ..+           .+                    +.....+||+.|+|||++.
T Consensus       765 dGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~  844 (1034)
T KOG0608|consen  765 DGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA  844 (1034)
T ss_pred             CCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc
Confidence            9999999999986321         000           00                    0011235999999999997


Q ss_pred             hhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHH-HHHHh
Q 038768          266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-VLEML  344 (386)
Q Consensus       266 ~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~-v~~~L  344 (386)
                      ..  .+++.+|+||.|||||||+.|+.||.........+..     ..|..-.++...+.+|.+..++|.++-. .+..|
T Consensus       845 r~--g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv-----~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RL  917 (1034)
T KOG0608|consen  845 RT--GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKV-----INWRNFLHIPYQGNLSKEALDLIQKLCCSADSRL  917 (1034)
T ss_pred             cc--CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeee-----eehhhccccccccccCHHHHHHHHHHhcChhhhh
Confidence            65  7999999999999999999999999877654332222     2334444677888999999999998664 55555


Q ss_pred             cC-CCCCCCCCCC
Q 038768          345 EG-STEDLQIPPK  356 (386)
Q Consensus       345 ~~-~~~~~~~~p~  356 (386)
                      -. -++++..||-
T Consensus       918 Gkng~d~vKaHpf  930 (1034)
T KOG0608|consen  918 GKNGADQVKAHPF  930 (1034)
T ss_pred             cccchhhhhcCcc
Confidence            32 2344555553

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-35  Score=272.19  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=195.6

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +...+.||+|+||.||+|+.. ++..+|+|.+.....    ..+++.+|+++++.++|+|++++++++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            334577999999999999864 678999999864321    224678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +. |+|.+++....     ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        97 ~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          97 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             cC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            96 68877775332     4578999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccceeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc-
Q 038768          243 KESFISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF-  320 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~-  320 (386)
                      ..      ...++..|+|||++.+ ....++.++|||||||++|+|++|+.||.....        .....++..+..+ 
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~  233 (308)
T cd06634         168 AN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPA  233 (308)
T ss_pred             cc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHHhhcCCCC
Confidence            22      2347889999999753 113578899999999999999999999865321        1111222222222 


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .....++..+.+++.+|+..++.-|++.+++..+|-
T Consensus       234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            234468889999999999999999998888766654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=294.29  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=206.9

Q ss_pred             HHHHHHHHhhhhhccCcCCceEEEEEEeC----C----CcEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEE
Q 038768           80 YSDVKRMTNSFSNKLGQGGFGSVYKGKLP----D----GRLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLG  148 (386)
Q Consensus        80 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~  148 (386)
                      ..++.+....+.+.||+|+||.|++|...    .    ...||||.++....  ..+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34455555566679999999999999742    1    34799999986443  357899999999998 5999999999


Q ss_pred             EEEecCceeEEEEeCCCCCHHHHhcccc-cc--ccc-------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 038768          149 FCYEKKKRALIYEFMPNGSLDQFIYDEE-SS--NIN-------RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP  218 (386)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~--~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~  218 (386)
                      +|...+..++|+||+..|+|.+++...+ ..  ...       ..+...+++.++.|||.||+||++.   ++|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998876 11  111       2388999999999999999999998   999999999


Q ss_pred             CCeEeCCCCceEEeeccCCcccCcccceeeecc-ccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCccc
Q 038768          219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLG-ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEV  296 (386)
Q Consensus       219 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~  296 (386)
                      +|||++.+..+||+|||+++.......+....+ ..-+..|||||.+...  .++.++|||||||+||||+| |..|+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999997766655442211 1245679999999764  89999999999999999999 7788875


Q ss_pred             ccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          297 KVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      .       .....+++.+.+|.....+..++++.-++.+.|-..++.-||
T Consensus       525 ~-------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP  567 (609)
T KOG0200|consen  525 I-------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP  567 (609)
T ss_pred             C-------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence            2       223556788999998889999999998888887754444444

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=276.25  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecC-----ceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-----KRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~  160 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|.+....  .....+.+|+.++++++|+||+++++++....     ..++|+
T Consensus         8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   87 (336)
T cd07849           8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ   87 (336)
T ss_pred             EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence            3457899999999999975 468999999986422  23356788999999999999999999876543     478999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||++ ++|..++..       ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        88 e~~~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          88 ELME-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             hhcc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            9995 588877743       3588999999999999999999998   9999999999999999999999999998765


Q ss_pred             Cccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------cc-chhhhhh
Q 038768          241 EKKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------IY-FPNSIYK  312 (386)
Q Consensus       241 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~-~~~~~~~  312 (386)
                      ....... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||........-      .. .+.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            4322111 11234578899999987543 35789999999999999999999999654211000      00 0001111


Q ss_pred             hcCC------------Ccc---ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          313 HIEP------------GNE---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       313 ~i~~------------~~~---~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+..            ...   ......++++..+++.+|+..++.-|++..++..+|-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            1110            000   0112356889999999999999999999888877764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.7e-35  Score=272.52  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC---CCChHHHHHHHHHhhcC-CCCccceEEEEEEecC--ceeEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS---KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKK--KRALI  159 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~--~~~lv  159 (386)
                      .+.+.+.||+|+||.||+|... +|+.+|+|++...   ......+.+|+.+++++ +|+||++++++|...+  ..++|
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            3445678999999999999864 5889999988542   22335677899999999 9999999999987543  57999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||++ ++|..++..       ..+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        88 ~e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          88 FEYME-TDLHAVIRA-------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             ecccc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99996 699888843       2578889999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccce---eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC--------cc----
Q 038768          240 SEKKESF---ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS--------EI----  304 (386)
Q Consensus       240 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~----  304 (386)
                      .......   .......|+..|+|||.+.+. ..++.++||||||+++|+|++|+.||........        ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            5433211   112234578899999988653 3578899999999999999999999965432100        00    


Q ss_pred             -------cchhhhhhhcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          305 -------YFPNSIYKHIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       305 -------~~~~~~~~~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                             ......+..+....   .......++.++.+++.+|+..++.-|++..++..+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence                   00011111111111   1122234789999999999999999999888776665

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=266.00  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=190.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcC---CCCccceEEEEEEecCc-----ee
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKT---SHVNVVSFLGFCYEKKK-----RA  157 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~~  157 (386)
                      +.+.||+|+||.||+|+.. +++.||+|+++.....   ...+.+|+.++.++   +|+|++++++++.+.+.     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            4578999999999999975 4899999999743222   24566787776655   69999999999998876     89


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      ++|||++ ++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        83 l~~e~~~-~~l~~~l~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          83 LVFEHVD-QDLATYLSKCP----KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             EEehhcc-cCHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            9999996 58988886532    13588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------ccc
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EIY  305 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~~  305 (386)
                      .........   ....++..|+|||++.+.  .++.++|+|||||++|||++|+.||........            ...
T Consensus       155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence            876443221   223478889999998664  688899999999999999999999875432100            000


Q ss_pred             chh------hhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          306 FPN------SIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       306 ~~~------~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.      ..+..............++++..+++.+|+..++.-|++.+++..+|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~  285 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP  285 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence            000      00000000000111224578889999999999999999888776554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-35  Score=273.00  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=194.7

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRALI  159 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv  159 (386)
                      ..+.||+|+||.||++.. .+|..||+|.+.....   ..+.+.+|+.+++.++|+||+++++++....      ..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            357899999999999975 4689999999865322   2356789999999999999999999987654      35899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+ +++|..++..       ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        99 ~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          99 MPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            9999 7899888743       3588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhhh
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIYK  312 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~  312 (386)
                      .....     ....++..|+|||++.+. ..++.++|+||||+++|+|++|+.||........       ....+....+
T Consensus       168 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         168 TDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            54322     234578899999998653 3578899999999999999999999975422100       0001111111


Q ss_pred             hcCCC---------------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          313 HIEPG---------------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       313 ~i~~~---------------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+...               ....+...++.++.+++.+|+..++.-|++..++..+|--
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~  301 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF  301 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence            11111               1112235678899999999999999999998887777653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.8e-35  Score=274.72  Aligned_cols=256  Identities=20%  Similarity=0.262  Sum_probs=194.8

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEe----cCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYE----KKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e  161 (386)
                      +.+.||+|+||.||+|.. .+|+.||+|++....   .....+.+|+.+++.++|+||+++++++..    ....++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e   88 (334)
T cd07855           9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD   88 (334)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence            347799999999999986 468999999987532   233567889999999999999999998763    346789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+. ++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        89 ~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          89 LME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             hhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            995 6898888543      4589999999999999999999998   99999999999999999999999999997654


Q ss_pred             cccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhhh
Q 038768          242 KKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIYK  312 (386)
Q Consensus       242 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~  312 (386)
                      .....  .......++..|+|||.+.+. ..++.++|||||||++|||++|+.||........       ....+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            32211  111234688899999998653 3578999999999999999999999975432100       0000111111


Q ss_pred             ------------hcCCCccc---cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          313 ------------HIEPGNEF---QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       313 ------------~i~~~~~~---~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                  ........   .+....++++.+++++|++.++.-|+++.++..+|-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  296 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF  296 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence                        11111111   122457899999999999999999999888766654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.5e-35  Score=274.17  Aligned_cols=258  Identities=21%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEec-------------
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEK-------------  153 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------------  153 (386)
                      .+.+.||.|+||.||+|.. .+|+.||+|.+..... ..+.+.+|+++++.++||||+++++++...             
T Consensus         8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (342)
T cd07854           8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE   87 (342)
T ss_pred             EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence            4457899999999999986 4688999999865433 346788999999999999999999876644             


Q ss_pred             -CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceEE
Q 038768          154 -KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKI  231 (386)
Q Consensus       154 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl  231 (386)
                       ...++||||++ ++|.+++..       ..+++..++.++.||+.||.|||+.   +++||||||+||+++ +++.++|
T Consensus        88 ~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          88 LNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence             35789999996 688888743       3578999999999999999999998   999999999999997 5667999


Q ss_pred             eeccCCcccCccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------
Q 038768          232 SDFGLAKLSEKKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------  303 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------  303 (386)
                      +|||+++......... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.........       
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999997654321111 11123478889999987543 35788999999999999999999999754321000       


Q ss_pred             -c-----------cchhhhhhhcCCCc--cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          304 -I-----------YFPNSIYKHIEPGN--EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       304 -~-----------~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                       .           ..+...........  ...+...++.+..+++.+|+..++.-|++++++..+|-..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence             0           00000000000000  0112345789999999999999999999999887777653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-34  Score=271.72  Aligned_cols=249  Identities=23%  Similarity=0.280  Sum_probs=189.9

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeEEE
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRALIY  160 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~  160 (386)
                      .+.||+|+||.||+|.. .+|+.||+|.+....   .....+.+|+.+++.++|+||+++++++....      ..++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            47899999999999986 468999999987532   22356789999999999999999999987543      458999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+. .+|..+..        ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++..
T Consensus       100 e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         100 PYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             cccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            9995 47766551        3578899999999999999999998   9999999999999999999999999999765


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhh
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKH  313 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~  313 (386)
                      ....     ....++..|+|||.+.+. ..++.++|||||||++|||++|+.||........-       ...+....+.
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         168 DAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            3321     234577889999998653 35788999999999999999999999754321000       0000000000


Q ss_pred             cC---------------CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          314 IE---------------PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       314 i~---------------~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      +.               ...........+.++.+++.+|+..++.-|++.+++..+|--
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f  300 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF  300 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence            00               000011123467889999999999999999999888877753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=267.36  Aligned_cols=254  Identities=23%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..+.||+|++|.||++... +|+.+++|.+......   ...+.+|+.++++++|+||+++++++.+.+..++|+||++ 
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-   81 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-
Confidence            3467999999999999864 6889999998754333   4678899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          82 TDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             CCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            48888875532     4688999999999999999999998   999999999999999999999999999986655431


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------cc-chhhhhhhcCC--
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------IY-FPNSIYKHIEP--  316 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~-~~~~~~~~i~~--  316 (386)
                        ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+..+.-      .. .....+..+..  
T Consensus       154 --~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         154 --PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             --cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence              11233477889999998653 36889999999999999999999999754321100      00 00011111111  


Q ss_pred             ---------Cc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 ---------GN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ---------~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                               ..   ...+...++.++.+++.+|+..++.-|++++++..+|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~  281 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP  281 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence                     00   0112345789999999999999999999888776655

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-34  Score=272.06  Aligned_cols=249  Identities=24%  Similarity=0.287  Sum_probs=191.1

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEec------CceeEEE
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEK------KKRALIY  160 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~  160 (386)
                      .+.||+|+||.||+|.. .+|+.||+|++.....   ..+.+.+|+.++.+++|+||+++++++...      ...++++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  101 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  101 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence            46899999999999975 5689999999875322   235678899999999999999999988643      3467888


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      +++ +++|.+++..       ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++..
T Consensus       102 ~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         102 HLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             hhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            877 7899888743       3488999999999999999999998   9999999999999999999999999998765


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhhhh
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIYKH  313 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~  313 (386)
                      ....     ....++..|+|||.+.+. ..++.++|||||||++|||++|+.||........       ....+......
T Consensus       171 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         171 DDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cccc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            4321     234578899999987653 3578899999999999999999999965432100       00001111111


Q ss_pred             cCCC---------------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 IEPG---------------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 i~~~---------------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +...               .........+++..+++.+|+..++.-|+++.++..+|-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            1110               000112246889999999999999999999888877764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-35  Score=273.31  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=194.8

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCC---CCChHHHHHHHHHhhcCCCCccceEEEEEEecC-----ceeEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-----KRALIY  160 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~  160 (386)
                      ..+.||+|+||+||+|.. .+|+.||||.+...   ......+.+|+.+++.++|+||+++++++....     ..++|+
T Consensus         9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858           9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence            356899999999999985 46899999998753   223456778999999999999999999887543     479999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+. ++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        89 e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          89 ELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             eCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            9995 7898888543      4688999999999999999999998   9999999999999999999999999999866


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC--------------Ccc-c
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS--------------SEI-Y  305 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--------------~~~-~  305 (386)
                      ......  .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.......              ... .
T Consensus       159 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKGDF--MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCccc--ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            443211  1233578899999988643 357889999999999999999999997542100              000 0


Q ss_pred             -chhh---hhhhcCCCcc---ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          306 -FPNS---IYKHIEPGNE---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       306 -~~~~---~~~~i~~~~~---~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                       ....   ..+.+.....   ......++++..+++.+|+..++.-|++.+++..+|--
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence             0000   0011111111   11234578999999999999999999999988777653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-34  Score=257.00  Aligned_cols=219  Identities=21%  Similarity=0.224  Sum_probs=178.5

Q ss_pred             CCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHHHhccc
Q 038768           97 GGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE  175 (386)
Q Consensus        97 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  175 (386)
                      |.||.||++.. .+|+.+|+|.+....    .+..|...+....||||+++++++.+.+..++||||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            89999999986 468899999997643    2334555555667999999999999999999999999999999998543


Q ss_pred             ccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCc
Q 038768          176 ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT  255 (386)
Q Consensus       176 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~  255 (386)
                            ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.......     ....++
T Consensus        80 ------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~  145 (237)
T cd05576          80 ------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE  145 (237)
T ss_pred             ------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence                  3588999999999999999999998   99999999999999999999999999886554321     133456


Q ss_pred             cccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHH
Q 038768          256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAK  335 (386)
Q Consensus       256 ~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  335 (386)
                      ..|+|||.+...  .++.++|+||+|+++|||++|+.|+.....         .    +.......++..+++++++++.
T Consensus       146 ~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~---------~----~~~~~~~~~~~~~~~~~~~li~  210 (237)
T cd05576         146 NMYCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPS---------G----INTHTTLNIPEWVSEEARSLLQ  210 (237)
T ss_pred             ccccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCch---------h----cccccccCCcccCCHHHHHHHH
Confidence            789999988543  678899999999999999999988764311         0    1111123356678999999999


Q ss_pred             HHHHHHHHhcCCC
Q 038768          336 KMILVLEMLEGST  348 (386)
Q Consensus       336 ~ml~v~~~L~~~~  348 (386)
                      +|+..++.-|.++
T Consensus       211 ~~l~~dp~~R~~~  223 (237)
T cd05576         211 QLLQFNPTERLGA  223 (237)
T ss_pred             HHccCCHHHhcCC
Confidence            9999999988765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=266.39  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=194.1

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||+|+||.||+|... +++.|+||.+.....  ......+|+..+++++ |+|++++++++.+.+..++||||+ +
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~   81 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E   81 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence            4578999999999999875 578999999875433  2234567999999999 999999999999999999999999 8


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++....    ...+++..++.++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          82 GNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             CCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            89999886542    24689999999999999999999998   999999999999999999999999999986654322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc------------ccchhhh--h
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE------------IYFPNSI--Y  311 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------------~~~~~~~--~  311 (386)
                      .   ....++..|+|||++.+. ..++.++|+||||+++|||++|+.||......+..            ..++...  .
T Consensus       155 ~---~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 Y---TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             c---CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence            1   123478889999988654 35789999999999999999999999654321100            0000000  0


Q ss_pred             hhc----CCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          312 KHI----EPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       312 ~~i----~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+    ....   ........+.+..+++++|+..++.-|++++++..+|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~  281 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP  281 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence            000    0000   0011122368899999999999999999887765554

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9e-35  Score=266.44  Aligned_cols=250  Identities=17%  Similarity=0.164  Sum_probs=176.2

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCCCh------------HHHHHHHHHhhcCCCCccceEEEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNG------------EEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      .+.+.+.||+|+||.||+|...+    +..+|+|+........            .....+...+..++|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            34556789999999999998644    3466777643222111            1122344456677899999999987


Q ss_pred             EecC----ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          151 YEKK----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       151 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      ....    ..++++|++ ..++.+.+...      ...++..+..++.|++.||+|||+.   +++||||||+|||++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         93 SFKRCRMYYRFILLEKL-VENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eEecCCceEEEEEEehh-ccCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            6554    336778877 44666665332      2356788899999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC
Q 038768          227 FCPKISDFGLAKLSEKKESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS  301 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  301 (386)
                      +.++|+|||+++........     .......||+.|+|||+..+.  .++.++|||||||++|||++|+.||.......
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            99999999999865432211     111224699999999998654  68999999999999999999999998653221


Q ss_pred             Cccc-chhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          302 SEIY-FPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       302 ~~~~-~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .... ......+.+..+. . ....++....+++..|+...+.-||+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~  288 (294)
T PHA02882        241 NLIHAAKCDFIKRLHEGK-I-KIKNANKFIYDFIECVTKLSYEEKPDYDA  288 (294)
T ss_pred             HHHHHhHHHHHHHhhhhh-h-ccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence            1100 0111233443332 1 23345788999999999888777765543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=280.09  Aligned_cols=252  Identities=26%  Similarity=0.338  Sum_probs=213.8

Q ss_pred             hhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEe-----cCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYE-----KKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~~~~lv~e  161 (386)
                      .|.+.||.|.+|.||+++ .++++.+|+|++.......+++..|.++++.+ .|||++.++|++..     ++.++||||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME  101 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME  101 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence            456789999999999997 46799999999988887888999999999888 59999999999874     468899999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      ||.+||.-++++...    ...+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.+||+|||++.-+.
T Consensus       102 fC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             ccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            999999999997754    46799999999999999999999998   99999999999999999999999999987554


Q ss_pred             cccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ..-  ....+..||+.|||||++...   ...|+..+|+||||++..||--|.+|+.+.+.        ....-+|.+..
T Consensus       175 sT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------mraLF~IpRNP  244 (953)
T KOG0587|consen  175 STV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFLIPRNP  244 (953)
T ss_pred             ccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------hhhhccCCCCC
Confidence            432  233467799999999999543   23578899999999999999999999987644        33334455555


Q ss_pred             cccc--cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          319 EFQL--AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       319 ~~~~--~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+.+  +...+.++-++|..||..+..-|+.+.++..||--
T Consensus       245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence            4554  66789999999999999999999999888887753

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.3e-35  Score=268.60  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=189.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecC--------ce
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKK--------KR  156 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~  156 (386)
                      .+.+.||+|+||.||+|... +++.+|+|++.....   ....+.+|+++++.++|+||+++++++.+..        ..
T Consensus        11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   90 (311)
T cd07866          11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV   90 (311)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence            34578999999999999864 688999999864322   2346789999999999999999999876543        35


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++|+||+. ++|...+...     ...+++..+..++.|+++||.|||+.   +++|+||||+||++++++.++|+|||+
T Consensus        91 ~lv~~~~~-~~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          91 YMVTPYMD-HDLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             EEEEecCC-cCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence            89999995 5777776543     24689999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCccccee---------eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-----
Q 038768          237 AKLSEKKESFI---------SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-----  302 (386)
Q Consensus       237 ~~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-----  302 (386)
                      ++.........         ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||........     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            97654322110         11123467889999987643 3578899999999999999999999975432110     


Q ss_pred             -------cccchhhhhhhcCC--------Ccccc---ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          303 -------EIYFPNSIYKHIEP--------GNEFQ---LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       303 -------~~~~~~~~~~~i~~--------~~~~~---~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                             +..++  .+..+..        .....   ....++++..+++.+|+..++.-|+++.++..+|
T Consensus       241 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~  309 (311)
T cd07866         241 KLCGTPTEETWP--GWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP  309 (311)
T ss_pred             HHhCCCChhhch--hhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence                   00000  0000000        00000   1134557889999999999999998887766554

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=263.58  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=195.8

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.||+|.||.||+|+.. +++.+|+|.+....   ...+.+..|+.+++.++|+|++++++++.+.+..++|+||++ +
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   82 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M   82 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence            467999999999999865 58999999998642   233678899999999999999999999999999999999997 6


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||+++....... 
T Consensus        83 ~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          83 DLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             CHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            9999996532     4688999999999999999999998   999999999999999999999999999986644322 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhc-----
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHI-----  314 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i-----  314 (386)
                       ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||........-       .......|..+     
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence             11223456789999998654 36788999999999999999999999754321000       00001111111     


Q ss_pred             --------CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 --------EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 --------~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                              ...........++.++.+++.+|+..++.-|++++++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence                    00000011223488999999999999999999888766554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-35  Score=292.14  Aligned_cols=250  Identities=26%  Similarity=0.338  Sum_probs=192.9

Q ss_pred             HHhhhh--hccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEe--------
Q 038768           86 MTNSFS--NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYE--------  152 (386)
Q Consensus        86 ~~~~~~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  152 (386)
                      ...+|.  +.||+||||.||+++.+ ||+.+|||++....  .....+.+|+..+++|+|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            334443  57999999999999864 89999999997653  233568899999999999999999855432        


Q ss_pred             --------------------------------------------------------------------------------
Q 038768          153 --------------------------------------------------------------------------------  152 (386)
Q Consensus       153 --------------------------------------------------------------------------------  152 (386)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------c--------CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHH
Q 038768          153 -----------------------K--------KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE  201 (386)
Q Consensus       153 -----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~  201 (386)
                                             .        ..+|+-||||+..+|.+++..+...     -.....++++.+|+.||.
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHH
Confidence                                   0        1246788999888888887654211     146789999999999999


Q ss_pred             HHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC----c------------ccceeeeccccCccccccccccc
Q 038768          202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE----K------------KESFISMLGARGTIGYIAPEVFC  265 (386)
Q Consensus       202 ~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~----~------------~~~~~~~~~~~g~~~y~aPE~~~  265 (386)
                      |+|++   |+|||||||.||+++++..|||+|||++....    .            ........+.+||.-|+|||++.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999998722    0            01111234568999999999997


Q ss_pred             hhcC-CCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc---cccCChHHHHHHHHHHHHH
Q 038768          266 RNFG-GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL---AGVVTEEEKEMAKKMILVL  341 (386)
Q Consensus       266 ~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~ml~v~  341 (386)
                      +... .|+.|+|+||||||++||+.   ||....       -...+...++.+..+.-   ...--+..+.+|+.|+..+
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchH-------HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence            6532 69999999999999999997   566442       13456667776664433   3344567889999999999


Q ss_pred             HHhcCCCCCCCC
Q 038768          342 EMLEGSTEDLQI  353 (386)
Q Consensus       342 ~~L~~~~~~~~~  353 (386)
                      +.=||++.++..
T Consensus       859 P~kRPtA~eLL~  870 (1351)
T KOG1035|consen  859 PSKRPTATELLN  870 (1351)
T ss_pred             CccCCCHHHHhh
Confidence            999999887643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=271.57  Aligned_cols=226  Identities=26%  Similarity=0.350  Sum_probs=195.2

Q ss_pred             hccCcCCceEEEEEEeCCCc-EEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGR-LVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ..||-|+||.|=+...+... .+|+|++++..    ...+.+..|-++|...+.|.||++|-.|.+....|++||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            46999999999999875433 48999998632    33456889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      .|...|.+.      +.++......++..+.+|++|||++   +||+|||||+|++++.+|-+||.|||+|+.+..... 
T Consensus       506 ElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-  575 (732)
T KOG0614|consen  506 ELWTILRDR------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-  575 (732)
T ss_pred             hhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence            999999665      5688899999999999999999999   999999999999999999999999999998876644 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-ccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-EFQLAGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~  325 (386)
                        ..+.+||+.|.|||.+.++  ..+.++|.||||+++|||++|++||...+.        ...+..|.+|- ...+|..
T Consensus       576 --TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~ILkGid~i~~Pr~  643 (732)
T KOG0614|consen  576 --TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLILKGIDKIEFPRR  643 (732)
T ss_pred             --eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHHHhhhhhhhcccc
Confidence              4578899999999999886  678899999999999999999999987633        44555565554 3456889


Q ss_pred             CChHHHHHHHHHHH
Q 038768          326 VTEEEKEMAKKMIL  339 (386)
Q Consensus       326 ~s~~~~~li~~ml~  339 (386)
                      ++..+.+|++++-.
T Consensus       644 I~k~a~~Lik~LCr  657 (732)
T KOG0614|consen  644 ITKTATDLIKKLCR  657 (732)
T ss_pred             cchhHHHHHHHHHh
Confidence            99999999988654

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=270.41  Aligned_cols=257  Identities=22%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecC-----ceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-----KRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  159 (386)
                      .+.+.||+|+||.||+|... +|+.||+|.+....   ...+.+.+|+.+++.++|+||+++++++.+..     ..++|
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            34578999999999999874 48999999987532   23467899999999999999999999998775     78999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||++ ++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++..
T Consensus        83 ~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          83 TELME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ecchh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99996 5888888543      3688999999999999999999998   999999999999999999999999999987


Q ss_pred             cCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------c-ccchhhhh
Q 038768          240 SEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------E-IYFPNSIY  311 (386)
Q Consensus       240 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------~-~~~~~~~~  311 (386)
                      ....... .......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||........      . ...+...+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            6544210 112234578889999998764 2688999999999999999999999975432100      0 00000000


Q ss_pred             ------------hhcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 ------------KHIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ------------~~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                  .......   .......++.++.+++.+|+..++.-|++.+++..+|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  291 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY  291 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence                        0000000   11123447899999999999999999999998877764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.7e-34  Score=266.35  Aligned_cols=249  Identities=24%  Similarity=0.323  Sum_probs=191.8

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEe-cCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYE-KKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  164 (386)
                      +.+.||.|+||.||++... +|+.||+|++....   ...+.+.+|+.+++.++||||+++++++.. ....++|+||+ 
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence            3578999999999999754 78999999886422   234678899999999999999999999876 45788999998 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|..++..       ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        93 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~  162 (328)
T cd07856          93 GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM  162 (328)
T ss_pred             ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence            6789888753       3477888889999999999999998   99999999999999999999999999987553321


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhhhcCCC
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYKHIEPG  317 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~i~~~  317 (386)
                           ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........-       ...+..+.+.+..+
T Consensus       163 -----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         163 -----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             -----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence                 233577889999987542 36789999999999999999999999754321000       00111111111111


Q ss_pred             ------------ccc---cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          318 ------------NEF---QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       318 ------------~~~---~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                  ...   .....++++..+++++|+..++.-|++++++..+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence                        000   11235789999999999999999999888876665

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=255.54  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=197.0

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhc-CCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      ..||.|+||+|++-.. +.|+..|||.++....  ..++++.|.+...+ -+.||||+++|.+..++..++.||.| ..|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            5799999999999875 4699999999986544  34568888876544 47999999999999999999999999 667


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |..+.+.. .......+++.-+-.|......||.||-..  ..|||||+||+|||++..|.+||||||.+-.+...-.  
T Consensus       149 lDklYk~v-y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  149 LDKLYKRV-YSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             HHHHHHHH-HHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            76554221 112235688888888999999999999886  5899999999999999999999999999865443221  


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-----
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-----  322 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----  322 (386)
                       .....|-..|||||-+......|+.+|||||||++|||+.||+.|+...+..       .+-..++..|..+.+     
T Consensus       224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-------feql~~Vv~gdpp~l~~~~~  295 (361)
T KOG1006|consen  224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-------FEQLCQVVIGDPPILLFDKE  295 (361)
T ss_pred             -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-------HHHHHHHHcCCCCeecCccc
Confidence             1234577889999999766456999999999999999999999999865321       111233445554544     


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .-.+|..+..++..|+..++..|+...++.-.|.
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f  329 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF  329 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence            2348999999999999999999999888776664

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-34  Score=267.49  Aligned_cols=257  Identities=22%  Similarity=0.227  Sum_probs=192.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-C--CcEEEEEEecCCC---CChHHHHHHHHHhhcC-CCCccceEEEEEEec----Ccee
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-D--GRLVAVKVLKNSK---VNGEEFINEVASMSKT-SHVNVVSFLGFCYEK----KKRA  157 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~  157 (386)
                      .+.+.||+|+||.||++... +  +..||+|.+....   ...+.+.+|+.++.++ +|+||+++++.+...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            34578999999999999864 3  7799999987532   2245678899999999 599999999976533    3567


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +++||+. ++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          83 LYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            8889884 7899888543      4688999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchh
Q 038768          238 KLSEKKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPN  308 (386)
Q Consensus       238 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~  308 (386)
                      +........  .......|+..|+|||++.+. ..++.++|||||||++|+|++|+.||........       -...+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            865432211  111234688999999987543 3578999999999999999999999975431000       000011


Q ss_pred             hhhhhcCC------------Cc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          309 SIYKHIEP------------GN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       309 ~~~~~i~~------------~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+..+..            ..   .......++.++.+++.+|+..++.-|+++.++..+|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~  294 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY  294 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            11111110            00   11123346889999999999999999999888877763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=270.60  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=193.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCc------eeEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK------RALI  159 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv  159 (386)
                      +.+.||+|+||.||+|... +++.||+|++....   ...+.+.+|+.+++.++|+|++++++++...+.      .++|
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence            3578999999999999874 57899999986532   223567789999999999999999998776554      8999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      +||+ +++|.+++..       ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        99 ~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          99 THLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            9998 6799998853       3588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhhh
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIYK  312 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~  312 (386)
                      ....     .....++..|+|||.+.+. ..++.++|||||||++|||++|+.||........       ....+...+.
T Consensus       168 ~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         168 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            5433     1234578889999998653 2578899999999999999999999975432100       0000111111


Q ss_pred             hcCC------------Ccc---ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          313 HIEP------------GNE---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       313 ~i~~------------~~~---~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ++..            ...   ......+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~  300 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY  300 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence            1110            000   1112346899999999999999999999999877764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=232.55  Aligned_cols=255  Identities=21%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .++||+|.||+||+|+. .+++.||+|.++-+..   -....++|+-+++.++|.|||+++++...+....+|+||| ..
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence            36899999999999985 4588999999975433   3467899999999999999999999999999999999999 67


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..+....     ++.++.+.+..++.|+++||.|+|+.   ++.|||+||.|.||+.+|+.|++|||+++-+.-+-..
T Consensus        86 dlkkyfdsl-----ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   86 DLKKYFDSL-----NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHHHHHhc-----CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            888887543     36789999999999999999999998   9999999999999999999999999999977655322


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCccc--------chhhhhhhcCCC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIY--------FPNSIYKHIEPG  317 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~--------~~~~~~~~i~~~  317 (386)
                      .  ...+.|..|.+|.++.+. .-|+...|+||-|||+.|+.. |++-|...+.. +...        ..+.-|..+.+.
T Consensus       158 y--saevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  158 Y--SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             e--eceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccC
Confidence            1  234578999999999876 468899999999999999987 56556554321 1000        001111111111


Q ss_pred             cc-------------ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          318 NE-------------FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       318 ~~-------------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                      .+             .++...++..-++++++++...+.-|-++++...+|..+
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~  287 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS  287 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence            11             112334567788999999988888888888777777653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.5e-34  Score=286.24  Aligned_cols=141  Identities=26%  Similarity=0.422  Sum_probs=125.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.++||.|+||.||+|... +++.||+|+++.....    ...+..|+.++..++|+||+++++++...+..|+||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            34578999999999999875 6899999999754322    256788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ++++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999998543      3578889999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=253.37  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=208.5

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEec-C
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEK-K  154 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~  154 (386)
                      .+.+......+-+|.||.||+|.+.      +.+.|.+|.++..  ..+...++.|...+..+.|||+....+++.+. +
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            3444444567899999999999653      3456888988764  34446789999999999999999999999865 4


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccc--cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESS--NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      ..++++.++.-|+|..+|...+..  ...+.++..+...++.|++.|++|||+.   ++||.||.++|++||+..++||+
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence            667889999999999999844432  2235577788889999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |=.+++.+...+..+-..+.-.+..||+||.+.+.  .|+.++|||||||+||||+| |+.|+...        .|.++.
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeI--------DPfEm~  508 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEI--------DPFEME  508 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCcccc--------CHHHHH
Confidence            99999987766554433334467789999999775  89999999999999999999 88888754        357888


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .-+++|.....+-++++++-....-|=.+.+.-||+-++
T Consensus       509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q  547 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ  547 (563)
T ss_pred             HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence            889999988899999999888888888888877776543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=233.42  Aligned_cols=219  Identities=27%  Similarity=0.390  Sum_probs=173.8

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC--hHHHHHHHHHhhc-CCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN--GEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      ...||+|++|.|-+-++ .+|+..|+|.+...-.+  ..+.+.|+++..+ ..+|.+|.++|...+....++.||.| ..
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence            46799999999988764 58999999999864333  3567788887655 47999999999999999999999999 67


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      ||..+..+.-  ..+..+++..+-+|+..+..||.|||++  ..++|||+||+||||+.+|++|+||||.+-.+.+.-. 
T Consensus       130 Sldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-  204 (282)
T KOG0984|consen  130 SLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-  204 (282)
T ss_pred             hHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence            8877754322  2336789999999999999999999998  5999999999999999999999999999876654322 


Q ss_pred             eeeccccCccccccccccchhc--CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNF--GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                        .....|-..|||||.+....  ..|+-++||||||+.+.||.+++.||+.-       ..|.+..+++-+...+.++.
T Consensus       205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w-------~tpF~qLkqvVeep~P~Lp~  275 (282)
T KOG0984|consen  205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW-------GTPFQQLKQVVEEPSPQLPA  275 (282)
T ss_pred             --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc-------CCHHHHHHHHhcCCCCCCcc
Confidence              11234777899999985321  26889999999999999999999999853       23455556666655555543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-33  Score=268.62  Aligned_cols=264  Identities=22%  Similarity=0.255  Sum_probs=183.3

Q ss_pred             hhhhccCcCCceEEEEEEe-----------------CCCcEEEEEEecCCCCC-hHH--------------HHHHHHHhh
Q 038768           89 SFSNKLGQGGFGSVYKGKL-----------------PDGRLVAVKVLKNSKVN-GEE--------------FINEVASMS  136 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~-~~~--------------~~~E~~~l~  136 (386)
                      .+.++||+|+||.||+|..                 .+++.||||.+...... .++              ...|+.++.
T Consensus       148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence            3458899999999999963                 23568999998643221 122              334667777


Q ss_pred             cCCCCcc-----ceEEEEEEe--------cCceeEEEEeCCCCCHHHHhcccccc------------------cccccCC
Q 038768          137 KTSHVNV-----VSFLGFCYE--------KKKRALIYEFMPNGSLDQFIYDEESS------------------NINRKLE  185 (386)
Q Consensus       137 ~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~  185 (386)
                      +++|.++     ++++++|..        .+..++||||+++++|.++++.....                  .....++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            7766554     677787753        35679999999999999998753210                  0112356


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccc
Q 038768          186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC  265 (386)
Q Consensus       186 ~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  265 (386)
                      +..++.++.|++.+|.|||+.   +++||||||+|||++.++.+||+|||++.......... .....+++.|+|||.+.
T Consensus       308 ~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELV  383 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhc
Confidence            788999999999999999998   99999999999999999999999999997654332211 11233578999999975


Q ss_pred             hhcC--------------------CCCccchhHhHHHHHHHHHhCCC-CcccccccCCccc---chhhhhhhcCCCc-cc
Q 038768          266 RNFG--------------------GVSHKSDVYSYGMMILEMVVGRK-NAEVKVSLSSEIY---FPNSIYKHIEPGN-EF  320 (386)
Q Consensus       266 ~~~~--------------------~~~~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~---~~~~~~~~i~~~~-~~  320 (386)
                      ....                    ....+.||||+||++|+|++|.. ||........+..   .....|+.+.... ++
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            3210                    11235799999999999999975 6654322221111   1112233332222 34


Q ss_pred             cccccCChHHHHHHHHHHHHHH---HhcCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLE---MLEGSTEDLQIPPK  356 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~---~L~~~~~~~~~~p~  356 (386)
                      ......+++.++++++||..++   .-|.+++++..||-
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            4456689999999999999765   34667777776664

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=279.56  Aligned_cols=251  Identities=28%  Similarity=0.353  Sum_probs=196.2

Q ss_pred             hccCcCCceE-EEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGS-VYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      +.+|.|+-|+ ||+|.. +|+.||||++-.+.  ..-..+|+..|+.- +|||||++++.-.+....|+..|.| ..+|.
T Consensus       515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~  590 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ  590 (903)
T ss_pred             HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence            5689999875 799999 88999999886432  23456899999877 5999999999999999999999999 78999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---C--CceEEeeccCCcccCccc
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---D--FCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++.......  ........+.+..|+++||++||+.   +||||||||.||||+.   +  .+++|+|||+++.+..+.
T Consensus       591 dlie~~~~d~--~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  591 DLIESSGLDV--EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHhccccch--hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9997641111  1111145577889999999999997   9999999999999975   2  579999999999876543


Q ss_pred             -ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhC-CCCcccccccCCcccchhhhhhhcCCCcc--c
Q 038768          245 -SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG-RKNAEVKVSLSSEIYFPNSIYKHIEPGNE--F  320 (386)
Q Consensus       245 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~i~~~~~--~  320 (386)
                       .+....+..||.+|+|||++...  ..+.++|||||||++|+.++| ..||......+.          +|..+..  .
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~L~  733 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYTLV  733 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCcccee
Confidence             33445677899999999999765  556799999999999999986 899987644332          2323321  1


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPR  363 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~~~~~~  363 (386)
                      .+...-..++++||.+|+..++.+|+++.++..||.-+....+
T Consensus       734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr  776 (903)
T KOG1027|consen  734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR  776 (903)
T ss_pred             eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence            1112122289999999999999999999999999988766655

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=245.15  Aligned_cols=241  Identities=19%  Similarity=0.283  Sum_probs=195.6

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCC
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+||+|+|.+|-.+++ ++.+.+|+|++++.-.    +.+-...|-.+..+. +||.+|.+..+|..+..+++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            46899999999999986 4578999999986432    223345566666555 69999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.-++++.      ..++++.++.+..+|+.||.|||+.   |||.||||.+|||+|..|.+||+|+|+++.--.+.
T Consensus       335 ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  335 GGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             Ccceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            99998777543      5799999999999999999999999   99999999999999999999999999998543332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .  ...+.+||+.|+|||.+.+.  .|...+|+|+|||+++||+.|+.||+--...+.+......+++-|.+.. ..++.
T Consensus       406 d--~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-iripr  480 (593)
T KOG0695|consen  406 D--TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-IRIPR  480 (593)
T ss_pred             c--ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-ccccc
Confidence            2  23467899999999999886  7899999999999999999999999855433334444455666666555 66778


Q ss_pred             cCChHHHHHHHHHHHHHHHhc
Q 038768          325 VVTEEEKEMAKKMILVLEMLE  345 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~  345 (386)
                      .+|-.+...++..|..++.-|
T Consensus       481 slsvkas~vlkgflnkdp~er  501 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKER  501 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHh
Confidence            888888888888777665543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=250.24  Aligned_cols=269  Identities=21%  Similarity=0.292  Sum_probs=206.8

Q ss_pred             ccccHHHHHHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCC--C----ccceEEE
Q 038768           76 KRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSH--V----NVVSFLG  148 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~  148 (386)
                      ..|...|....++.+.+.+|+|.||.|-.+.+. .+..||||+++.-..-.+..+-|++++.++.+  |    -++.+.+
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            456666777777777889999999999999764 47899999999766666778889999999842  2    3788889


Q ss_pred             EEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC----
Q 038768          149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG----  224 (386)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~----  224 (386)
                      +|...++.|+|+|.+ |-|+.+++..+.    -.+++...+..++.|+++++.|||+.   +++|.||||+|||+.    
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccce
Confidence            999999999999998 779999997643    36788999999999999999999998   999999999999982    


Q ss_pred             ----------------CCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHH
Q 038768          225 ----------------EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV  288 (386)
Q Consensus       225 ----------------~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ell  288 (386)
                                      .+..++++|||.|+.......     ..+.|..|.|||++.+-  ++++.+||||+||||+|+.
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~Ely  303 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELY  303 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheecc--CcCCccCceeeeeEEEEee
Confidence                            134589999999987665543     45678999999999986  7999999999999999999


Q ss_pred             hCCCCcccccccCC-------cccchhhhhhhc------CCCc-----------------------cccc-cccCChHHH
Q 038768          289 VGRKNAEVKVSLSS-------EIYFPNSIYKHI------EPGN-----------------------EFQL-AGVVTEEEK  331 (386)
Q Consensus       289 tg~~p~~~~~~~~~-------~~~~~~~~~~~i------~~~~-----------------------~~~~-~~~~s~~~~  331 (386)
                      ||..-|.......-       --.+|..+..+-      ..+.                       .... ...-..++-
T Consensus       304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf  383 (415)
T KOG0671|consen  304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF  383 (415)
T ss_pred             ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence            99988875542110       001222221111      0000                       0000 111234577


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCCCCCC
Q 038768          332 EMAKKMILVLEMLEGSTEDLQIPPKPSL  359 (386)
Q Consensus       332 ~li~~ml~v~~~L~~~~~~~~~~p~~~~  359 (386)
                      ||+++||.++|.-|.++.|+..||--..
T Consensus       384 DLl~~mL~fDP~~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  384 DLLRRMLEFDPARRITLREALSHPFFAR  411 (415)
T ss_pred             HHHHHHHccCccccccHHHHhcCHHhhc
Confidence            8999999999999999999888886543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.9e-32  Score=239.72  Aligned_cols=237  Identities=29%  Similarity=0.438  Sum_probs=193.6

Q ss_pred             CceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHHHhcc
Q 038768           98 GFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD  174 (386)
Q Consensus        98 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  174 (386)
                      +||.||+|... +|+.+++|++......  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999875 4899999999764433  57899999999999999999999999999999999999999999999865


Q ss_pred             cccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccC
Q 038768          175 EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG  254 (386)
Q Consensus       175 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  254 (386)
                      .      ..+++..++.++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+.......   ......+
T Consensus        81 ~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~  148 (244)
T smart00220       81 R------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG  148 (244)
T ss_pred             c------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence            3      2378899999999999999999998   99999999999999999999999999998765542   1224457


Q ss_pred             ccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc--CChHHHH
Q 038768          255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV--VTEEEKE  332 (386)
Q Consensus       255 ~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~s~~~~~  332 (386)
                      +..|++||.+...  .++.++||||||+++|+|++|..||.....       ...+.+.+..+........  ++.+..+
T Consensus       149 ~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (244)
T smart00220      149 TPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKIGKPKPPFPPPEWKISPEAKD  219 (244)
T ss_pred             CcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhccCCCCccccccCCHHHHH
Confidence            8899999998643  678899999999999999999999975311       1333444443332222222  8899999


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCC
Q 038768          333 MAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       333 li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.+|+..++.-|+++.++..+|
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~~~  242 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQHP  242 (244)
T ss_pred             HHHHHccCCchhccCHHHHhhCC
Confidence            99999999999888877665443

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=9.4e-32  Score=264.83  Aligned_cols=263  Identities=22%  Similarity=0.272  Sum_probs=169.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-C----CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEE------EEecCcee
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-D----GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF------CYEKKKRA  157 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~~~~  157 (386)
                      .+.+.||+|+||.||+|.+. +    +..||+|.+..... .+....|  .+....+.++..+...      +......+
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            34588999999999999874 4    68999998864322 1112221  1122222222222211      24566789


Q ss_pred             EEEEeCCCCCHHHHhccccccc--------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          158 LIYEFMPNGSLDQFIYDEESSN--------------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      +||||+++++|.+++.......              .........+..++.||+.||.|||+.   +|+||||||+|||+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl  288 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIF  288 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEE
Confidence            9999999999999986532100              001112345668999999999999998   99999999999999


Q ss_pred             CC-CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcC--------------------CCCccchhHhHHH
Q 038768          224 GE-DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG--------------------GVSHKSDVYSYGM  282 (386)
Q Consensus       224 ~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--------------------~~~~~~DvwslGv  282 (386)
                      ++ ++.+||+|||+++.+....... .....+++.|+|||.+.....                    .++.++|||||||
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            85 6799999999998654432221 124568899999997632211                    2345679999999


Q ss_pred             HHHHHHhCCCCccccccc-C---Ccccchhhhhhhc-CCCcc------ccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          283 MILEMVVGRKNAEVKVSL-S---SEIYFPNSIYKHI-EPGNE------FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       283 il~elltg~~p~~~~~~~-~---~~~~~~~~~~~~i-~~~~~------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++|||+++..|++..... .   .....+...|... .....      +.+......+.++++.+||+.++.-|+++.++
T Consensus       368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~  447 (566)
T PLN03225        368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA  447 (566)
T ss_pred             HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence            999999987765432100 0   0000011112111 11110      11112234456799999999999999999999


Q ss_pred             CCCCCCC
Q 038768          352 QIPPKPS  358 (386)
Q Consensus       352 ~~~p~~~  358 (386)
                      ..||-..
T Consensus       448 L~Hpff~  454 (566)
T PLN03225        448 LAHPYFD  454 (566)
T ss_pred             hCCcCcC
Confidence            8887653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.5e-33  Score=236.30  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=191.0

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecC---CCCChHHHHHHHHHhhcCCCCccceEEEEEEec--------CceeEE
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK--------KKRALI  159 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv  159 (386)
                      .+||+|.||.||+|+.. +|+.||+|.+--   .+.-....++|+++|..++|+|++.+++.|...        ...|+|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            57999999999999854 577888876532   222346778999999999999999999888642        357899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |.+|+ .+|..+|...     ...++..++..+..++.+||.|+|..   .|+|||+|+.|+||+.++.+||+|||+++.
T Consensus       103 f~~ce-hDLaGlLsn~-----~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen  103 FDFCE-HDLAGLLSNR-----KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             HHHhh-hhHHHHhcCc-----cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            99994 5888888543     25688899999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccee--eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC---------C---ccc
Q 038768          240 SEKKESFI--SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS---------S---EIY  305 (386)
Q Consensus       240 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~---~~~  305 (386)
                      +.......  .....+.|..|.+||.+.+. ..++++.|||+-|||+.||+||.+-+..+....         +   ...
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            65433211  12234568999999999886 589999999999999999999998886654210         0   111


Q ss_pred             chh----hhhhhcCCC-----ccccc-----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          306 FPN----SIYKHIEPG-----NEFQL-----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       306 ~~~----~~~~~i~~~-----~~~~~-----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      +|+    .+++.|...     ....+     +-.-++++.+|+.+|+..++.-|..+++...|
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            221    133333211     11111     12235689999999999999888777666444

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=250.15  Aligned_cols=191  Identities=23%  Similarity=0.313  Sum_probs=164.6

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHH---------HHHHHHHhhcCC---CCccceEEEEEEecCcee
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEE---------FINEVASMSKTS---HVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~  157 (386)
                      .+.+|.|+||.|+.|.++ +...|+||.+.+++.-.+.         +-.|+.+|..++   |+||++++++|++++.+|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            478999999999999875 4568999999876543322         346999999997   999999999999999999


Q ss_pred             EEEEeC-CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          158 LIYEFM-PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       158 lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      |+||-. ++-+|.+++..      +..+++.++..|+.||+.|+++||++   +|||||||-+||.++.+|.+||+|||.
T Consensus       646 l~te~hg~gIDLFd~IE~------kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEF------KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             EEecCCCCCcchhhhhhc------cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence            999975 45689999944      36799999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcc
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE  295 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~  295 (386)
                      +.+......    -..+||.+|.|||++.+. ......-|||+||++||-++....||.
T Consensus       717 aa~~ksgpf----d~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSGPF----DVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCCCc----ceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            987765532    245799999999999876 345777899999999999999888886

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.3e-31  Score=221.61  Aligned_cols=252  Identities=17%  Similarity=0.270  Sum_probs=197.2

Q ss_pred             hhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecC--ceeEEEEeC
Q 038768           88 NSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKK--KRALIYEFM  163 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~e~~  163 (386)
                      +.+.+++|+|.++.||.|. ..+++.++||+++.  ...+.+.+|+.+|..|. ||||+.++++..+..  ...||+||+
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v  117 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV  117 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence            4456789999999999997 56788999999984  45678999999999997 999999999998764  456999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEK  242 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~  242 (386)
                      .+.+...+.         ..++...+..++.+++.||.|+|+.   ||.|||+||.|++||. ...++|+|+|+|.+...
T Consensus       118 ~n~Dfk~ly---------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  118 NNTDFKQLY---------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             ccccHHHHh---------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999988776         5678889999999999999999998   9999999999999995 45699999999998876


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC--------------------
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS--------------------  302 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------------------  302 (386)
                      ...+...   +.+..|.-||.+.+- ..|+...|+|||||++..|+..+.||-...+..+                    
T Consensus       186 ~~eYnVR---VASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEYNVR---VASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cceeeee---eehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            6554322   355678899999764 5788999999999999999999999853322111                    


Q ss_pred             -cccchhhhh---hhcCCCcc-----ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          303 -EIYFPNSIY---KHIEPGNE-----FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       303 -~~~~~~~~~---~~i~~~~~-----~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                       .+.++....   ....+..+     ..-...+++++-+++.++|..+-.-|.++.+...||..
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence             111111110   11111111     11133467999999999999999989999988888864

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-33  Score=236.49  Aligned_cols=196  Identities=28%  Similarity=0.407  Sum_probs=164.8

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCC---CCChHHHHHHHHHhhcCCCCccceEEEEEEec-----CceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGFCYEK-----KKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~  162 (386)
                      +-||-|+||.||-..+ ++|+.||+|.+.+-   -...+.+.+|+++|.-++|.|++..++...-.     .+.|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            4599999999999876 57999999988642   23346789999999999999999999876543     356788998


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      + ..+|+.++-.      ...++.+.+.-++.||++||.|||+.   +|.||||||.|.|+++|-.+||||||+++..+.
T Consensus       139 m-QSDLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  139 M-QSDLHKIIVS------PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             H-Hhhhhheecc------CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence            8 5688887733      46788899999999999999999999   999999999999999999999999999997765


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                      ++. ..+...+-|..|.|||.+.+. ..|+.+.||||.|||+.||+..+.-|...+.
T Consensus       209 d~~-~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  209 RDR-LNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             hhh-hhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            543 223445578899999999887 5899999999999999999998888865543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=7.7e-30  Score=223.82  Aligned_cols=213  Identities=34%  Similarity=0.500  Sum_probs=175.4

Q ss_pred             hhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.||.|++|.||++...+ ++.+++|.+.....  ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45789999999999998765 88999999986543  3578889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        83 ~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       83 DLFDYLRKKG-----GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999986532     1178899999999999999999998   9999999999999999999999999999876544200


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                       ......++..|++||.+. ....++.++|+|+||+++++|++|+.||+....      ....+.+.|..+.
T Consensus       155 -~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~------~~~~~~~~~~~~~  218 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGE------FTSLLSDVWSFGV  218 (225)
T ss_pred             -cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccch------hHHHHHHHHhcCC
Confidence             112344778899999984 224677899999999999999999999975111      1235556666555

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-31  Score=222.53  Aligned_cols=233  Identities=17%  Similarity=0.295  Sum_probs=176.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEE-EEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGF-CYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~~~  164 (386)
                      +++.+.||+|.||.+-+++.+ ..+.+++|.+........+|.+|..---.| .|.||+.-|++ |+..+.+.+++||+|
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            455688999999999999875 467899999998878889999998765555 49999998876 455667778999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCceEEeeccCCcccCc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG--EDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~  242 (386)
                      .|+|.+-+..       ..+.+.....++.|+++|+.|||++   ++||||||.+||||-  +..++||||||+.+..+.
T Consensus       106 ~gdL~snv~~-------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  106 RGDLRSNVEA-------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cchhhhhcCc-------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999988744       3577888899999999999999999   999999999999993  445899999999986554


Q ss_pred             ccceeeeccccCccccccccccchhc---CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNF---GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      .-..     ..-+..|.+||......   -...+.+|+|.||+++|.++||+.||..... .+.-++.   |.++..+..
T Consensus       176 tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~---~~~w~~rk~  246 (378)
T KOG1345|consen  176 TVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWE---WEQWLKRKN  246 (378)
T ss_pred             eehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHH---HHHHhcccC
Confidence            3221     12345689999874321   1346779999999999999999999984433 3332333   334444443


Q ss_pred             cc---ccccCChHHHHHHHHHHH
Q 038768          320 FQ---LAGVVTEEEKEMAKKMIL  339 (386)
Q Consensus       320 ~~---~~~~~s~~~~~li~~ml~  339 (386)
                      +.   .-..+|+.+..+.++-+.
T Consensus       247 ~~~P~~F~~fs~~a~r~Fkk~lt  269 (378)
T KOG1345|consen  247 PALPKKFNPFSEKALRLFKKSLT  269 (378)
T ss_pred             ccCchhhcccCHHHHHHHHHhcC
Confidence            33   344567777777766443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-30  Score=232.09  Aligned_cols=150  Identities=27%  Similarity=0.420  Sum_probs=127.3

Q ss_pred             HhhhccCCCccccHHHHHH-HHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-----
Q 038768           67 IRNYVSLAPKRYNYSDVKR-MTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-----  139 (386)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----  139 (386)
                      ...|...+.....+.|+-. .+|...++||-|.|++||++.+ .+.+.||+|+.+....-.+..++||++|++++     
T Consensus        58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~  137 (590)
T KOG1290|consen   58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPN  137 (590)
T ss_pred             hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCC
Confidence            3456666667777777765 7888889999999999999975 46789999999987766788899999998874     


Q ss_pred             ---CCccceEEEEEEec----CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 038768          140 ---HVNVVSFLGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV  212 (386)
Q Consensus       140 ---h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv  212 (386)
                         ..+||+|+++|...    .+.|+|+|++ |.+|..++.....    +.++...+.+|+.||+.||.|||..|  +||
T Consensus       138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gII  210 (590)
T KOG1290|consen  138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GII  210 (590)
T ss_pred             CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--Ccc
Confidence               24799999999864    4789999999 8899999976542    56889999999999999999999986  999


Q ss_pred             ecCCCCCCeEe
Q 038768          213 HFDIKPHNILL  223 (386)
Q Consensus       213 H~dlk~~Nill  223 (386)
                      |.||||+|||+
T Consensus       211 HTDlKPENvLl  221 (590)
T KOG1290|consen  211 HTDLKPENVLL  221 (590)
T ss_pred             ccCCCcceeee
Confidence            99999999996

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=222.76  Aligned_cols=249  Identities=26%  Similarity=0.330  Sum_probs=187.1

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCC---CCChHHHHHHHHHhhcCCCCccceEEEEEEec------CceeEEEE
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGFCYEK------KKRALIYE  161 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  161 (386)
                      +.+|.|+- .|.-+.+ -.+++||+|.+...   ....+...+|...+..++|+||++++.++.-.      ...|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            34777776 4555532 25889999987643   22335678899999999999999999998743      36789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      +| ..+|...++.        .++-.++..++.|++.|++|||+.   +|+||||||+||++..+..+||.|||+++.-.
T Consensus       102 ~m-~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen  102 LM-DANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             hh-hhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence            99 7899988852        366788999999999999999998   99999999999999999999999999998544


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------------ccc---
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------------EIY---  305 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------------~~~---  305 (386)
                      ..   ..+...+.+..|.|||++.+.  .+.+.+||||+||++.||++|+--|.+....+.             .++   
T Consensus       170 ~~---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  170 TD---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cc---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            33   234456788999999999886  599999999999999999999988765533210             000   


Q ss_pred             ----------chhhhh---hhcCCCcccc----ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          306 ----------FPNSIY---KHIEPGNEFQ----LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       306 ----------~~~~~~---~~i~~~~~~~----~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                                .|....   ..+-+...+.    -...-+..+++++.+||.+++.-|-+++++..||.-.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                      000000   0000000010    1122356789999999999999999999999999754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=8.2e-31  Score=239.64  Aligned_cols=211  Identities=22%  Similarity=0.294  Sum_probs=180.5

Q ss_pred             CCccccHHHHHHHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC------CCccceE
Q 038768           74 APKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS------HVNVVSF  146 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~  146 (386)
                      +..++.+.|+....|......|+|-|++|.+|.. ..|+.||||++.+.+...+.=+.|+++|++|+      --|++++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            4467888899999998888999999999999985 35889999999988776677789999999996      3489999


Q ss_pred             EEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      +..|...+++|||+|-+ .-+|.++|+..+.   +..|....+..++.|+.-||..|-..   +|+|.||||+|||+++.
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence            99999999999999988 7799999987642   35677889999999999999999987   99999999999999875


Q ss_pred             -CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          227 -FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       227 -~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                       ..+||||||.|.....++..    ....+..|.|||.+.+.  .|+...|+||.||+||||.||+.-|.+.
T Consensus       573 k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             cceeeeccCcccccccccccc----HHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCC
Confidence             46899999999877665431    22245679999999986  7899999999999999999999877543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=8.6e-28  Score=207.93  Aligned_cols=183  Identities=38%  Similarity=0.634  Sum_probs=157.9

Q ss_pred             cCcCCceEEEEEEeCC-CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHH
Q 038768           94 LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ  170 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  170 (386)
                      ||+|.+|.||++...+ |+.+++|++......  .+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999999865543  5789999999999999999999999999999999999999999999


Q ss_pred             HhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCcccceeee
Q 038768          171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       171 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      ++....     ..+++..++.++.+++.++++||+.   +++|+||+|.||+++. ++.++|+|||.+........  ..
T Consensus        81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (215)
T cd00180          81 LLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL  150 (215)
T ss_pred             HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence            986532     3578899999999999999999998   9999999999999999 89999999999986654421  11


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHH
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM  287 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~el  287 (386)
                      ....+...|++||.+... ...+.+.|+|+||+++++|
T Consensus       151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             hcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH
Confidence            234477889999998653 3678899999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=242.82  Aligned_cols=259  Identities=23%  Similarity=0.294  Sum_probs=204.0

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      ..+.+|+|.||.|||+++ ..++..|+|+++-...+ ..-..+|+-+++..+|+||+.++|.+...+..+++||||.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            347899999999999985 46899999999875543 3556789999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+.-+.      ..++++.++...+++.++||.|||+.   +-+|||||-.|||+++.|.+|++|||.+-.+...  ..
T Consensus        99 lQdiy~~------TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~  167 (829)
T KOG0576|consen   99 LQDIYHV------TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA  167 (829)
T ss_pred             ccceeee------cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence            9998854      36899999999999999999999998   9999999999999999999999999988644322  22


Q ss_pred             eeccccCccccccccccc-hhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFC-RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~-~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......||+.|||||+.. +..+.|.+++|||++|+...|+-.-++|....+....-+......++-..    ..-+...
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~----lkDk~kw  243 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT----LKDKTKW  243 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc----ccCCccc
Confidence            234567999999999973 33467999999999999999998888886544433222222222222111    1114456


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPR  363 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~~~~~~  363 (386)
                      ++-+.++++..+...+--|++++.+..||....+-++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~  280 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSR  280 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccchhh
Confidence            8888888888888888888887776667765544444

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3e-27  Score=243.90  Aligned_cols=199  Identities=19%  Similarity=0.170  Sum_probs=139.9

Q ss_pred             cCCC-CccceEEEEE-------EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038768          137 KTSH-VNVVSFLGFC-------YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN  208 (386)
Q Consensus       137 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  208 (386)
                      .++| .||++++++|       .+.+..++++||+ +++|.+++...     ...+++..++.++.||+.||.|||++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~--   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQ--   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhC--
Confidence            4556 6888888887       2334567788987 67999999643     24589999999999999999999998  


Q ss_pred             CCeeecCCCCCCeEeCCC-------------------CceEEeeccCCcccCcccc--------------eeeeccccCc
Q 038768          209 IRIVHFDIKPHNILLGED-------------------FCPKISDFGLAKLSEKKES--------------FISMLGARGT  255 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~-------------------~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~g~  255 (386)
                       +|+||||||+||||+..                   +.+|++|||+++.......              ........||
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             99999999999999654                   4455666666543211000              0001123578


Q ss_pred             cccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHH
Q 038768          256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAK  335 (386)
Q Consensus       256 ~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  335 (386)
                      +.|||||++.+.  .++.++|||||||+||||++|..|+......      ...+...+.+   +.. .....+..+++.
T Consensus       179 ~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~------~~~~~~~~~~---~~~-~~~~~~~~~~~~  246 (793)
T PLN00181        179 SWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSRT------MSSLRHRVLP---PQI-LLNWPKEASFCL  246 (793)
T ss_pred             cceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHHH------HHHHHHhhcC---hhh-hhcCHHHHHHHH
Confidence            889999998764  6899999999999999999999887643110      0111111111   111 112456678888


Q ss_pred             HHHHHHHHhcCCCCCCCCCCC
Q 038768          336 KMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       336 ~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +|+..++.-|+++.++..+|.
T Consensus       247 ~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        247 WLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             HhCCCChhhCcChHHHhhchh
Confidence            999999999999998877764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.2e-26  Score=208.26  Aligned_cols=255  Identities=23%  Similarity=0.310  Sum_probs=192.5

Q ss_pred             hhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..++||.|.|++||++.+.    ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++...+...+|+||++
T Consensus        40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            3578999999999999753    46789999987543 4456899999999985 9999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~  243 (386)
                      .....++.         ..++...+..++..++.||.++|.+   |||||||||+|+|.+. .+.-.|.|||+|......
T Consensus       119 H~~f~~l~---------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  119 HDRFRDLY---------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             ccCHHHHH---------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            99999988         4577889999999999999999999   9999999999999974 567899999998721100


Q ss_pred             ---------------------------------cceee---------eccccCccccccccccchhcCCCCccchhHhHH
Q 038768          244 ---------------------------------ESFIS---------MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG  281 (386)
Q Consensus       244 ---------------------------------~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG  281 (386)
                                                       ..+..         .....||++|.|||++... +..+.++||||.|
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~G  265 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeecc
Confidence                                             00000         1123599999999999765 5778899999999


Q ss_pred             HHHHHHHhCCCCcccccc-c---------------------C--------Ccccchhhh---h-----hhcCCCcc----
Q 038768          282 MMILEMVVGRKNAEVKVS-L---------------------S--------SEIYFPNSI---Y-----KHIEPGNE----  319 (386)
Q Consensus       282 vil~elltg~~p~~~~~~-~---------------------~--------~~~~~~~~~---~-----~~i~~~~~----  319 (386)
                      ||++.+++++.||-.... .                     -        +++..-.+.   +     ..+.+...    
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            999999999999842211 0                     0        000000000   0     11111111    


Q ss_pred             -ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          320 -FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       320 -~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                       .......+...-+++.+|+++.+.=|.++++...||...
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence             011223455788999999999999999999998888754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.6e-25  Score=207.01  Aligned_cols=160  Identities=21%  Similarity=0.208  Sum_probs=123.1

Q ss_pred             hhhhhccCcCCceEEEEEEeC--CCcEEEEEEecCCC------CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP--DGRLVAVKVLKNSK------VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||+||+|...  +++.||||++....      ...+.+.+|+++|++++|+|++..+..   .+..++|
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence            344678999999999999764  57888999875321      123568999999999999999853322   2468999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEeCCCCceEEeeccCCc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDI-KPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      |||+++++|.... .         ..   ...++.|++.+|.|||+.   +|+|||| ||+|||++.++.+||+|||+++
T Consensus        97 mE~~~G~~L~~~~-~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         97 RGWTEGVPLHLAR-P---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEccCCCCHHHhC-c---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            9999999996321 0         00   146788999999999998   9999999 9999999999999999999999


Q ss_pred             ccCcccceee------eccccCccccccccccch
Q 038768          239 LSEKKESFIS------MLGARGTIGYIAPEVFCR  266 (386)
Q Consensus       239 ~~~~~~~~~~------~~~~~g~~~y~aPE~~~~  266 (386)
                      ..........      .....++..|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            7654321111      134568888999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1e-24  Score=184.39  Aligned_cols=160  Identities=20%  Similarity=0.193  Sum_probs=119.5

Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...+     ..+++..++.++.||+.||+|||+.   +      ||+|||++.++.+|+  ||++....... 
T Consensus         1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence            68999986432     4699999999999999999999997   5      999999999999999  99988654432 


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc--cccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE--FQLA  323 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~  323 (386)
                            ..|++.|+|||++.+.  .++.++|||||||++|||++|+.||.........   ...+.........  ...+
T Consensus        64 ------~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  132 (176)
T smart00750       64 ------SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELSAI---LEILLNGMPADDPRDRSNL  132 (176)
T ss_pred             ------CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhcHH---HHHHHHHhccCCccccccH
Confidence                  2588999999999764  6889999999999999999999999754322111   0111111111110  0112


Q ss_pred             ccCCh--HHHHHHHHHHHHHHHhcCCCCCCCC
Q 038768          324 GVVTE--EEKEMAKKMILVLEMLEGSTEDLQI  353 (386)
Q Consensus       324 ~~~s~--~~~~li~~ml~v~~~L~~~~~~~~~  353 (386)
                      ..+++  ++++++.+|+..++.-|+++.++..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~  164 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLA  164 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHH
Confidence            23344  6999999999999999988766543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=5.7e-23  Score=190.23  Aligned_cols=202  Identities=23%  Similarity=0.283  Sum_probs=161.8

Q ss_pred             HhhhhhccCcCCceEEEEEEeCCC--cEEEEEEecCCCCC-hHHHHHHHHHhhcCCC----CccceEEEEE-EecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPDG--RLVAVKVLKNSKVN-GEEFINEVASMSKTSH----VNVVSFLGFC-YEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l  158 (386)
                      .+.+.++||+|+||.||.+.....  ..+|+|+....... ...+..|..++..+..    .++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            344568899999999999986543  58999988764322 2367888888888863    6889999988 47778899


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-----CceEEee
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-----FCPKISD  233 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~D  233 (386)
                      ||+.+ |.+|.++.....    ...++..++..++.|++.+|++||+.   |++||||||.|+++...     ..+.|.|
T Consensus        99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99988 899999875543    36789999999999999999999998   99999999999999754     4699999


Q ss_pred             ccCCc--ccCcccc----ee-e-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccc
Q 038768          234 FGLAK--LSEKKES----FI-S-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV  298 (386)
Q Consensus       234 fgl~~--~~~~~~~----~~-~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  298 (386)
                      ||+++  .......    .. . ....+||.+|+++....+.  ..+.+.|+||++.++.|++.|..||....
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            99998  3221111    01 1 2345699999999987664  78899999999999999999999996543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.7e-23  Score=178.18  Aligned_cols=139  Identities=17%  Similarity=0.197  Sum_probs=108.4

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCC---C-------hHH-----------------HHHHHHHhhcCCCCccc
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV---N-------GEE-----------------FINEVASMSKTSHVNVV  144 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~E~~~l~~l~h~niv  144 (386)
                      ..||+|+||.||+|...+|+.||||+++....   .       ...                 ...|+..+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            57999999999999987899999999975421   1       011                 23499999999887775


Q ss_pred             eEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeEe
Q 038768          145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~dlk~~Nill  223 (386)
                      ....+.  ....++||||++++++.......      ..+++..+..++.|++.+|.|| |+.   +++||||||+|||+
T Consensus        83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli  151 (190)
T cd05147          83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY  151 (190)
T ss_pred             CCcEEE--ecCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            443332  22348999999887776543221      3578899999999999999999 687   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCc
Q 038768          224 GEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~  242 (386)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             E-CCcEEEEEccccccCCC
Confidence            8 47899999999975433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=6.2e-23  Score=179.04  Aligned_cols=199  Identities=23%  Similarity=0.349  Sum_probs=163.9

Q ss_pred             hhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +..+++||+|+||..+.|+ +-++++||||.-.. .....++..|.+..+.|. .++|...+-+...+-+-.||+|.+ |
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            3457899999999999997 45899999997543 233457788999888885 789998888877777888999998 8


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-----CceEEeeccCCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-----FCPKISDFGLAKLS  240 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgl~~~~  240 (386)
                      -+|+++..-..     ..++..++..++.|++.-++|+|++   .+|.|||||+|.||..-     ..+.++|||+|+..
T Consensus       108 PSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  108 PSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             cCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            89998875443     6789999999999999999999999   99999999999999643     35899999999977


Q ss_pred             Ccccc-----eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccc
Q 038768          241 EKKES-----FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV  298 (386)
Q Consensus       241 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  298 (386)
                      .++.+     +.......||.+||+-....+.  ..+.+.|+-|||-+++..|-|..||..-.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            65432     2223345699999998877665  67889999999999999999999997653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=4.9e-22  Score=183.78  Aligned_cols=246  Identities=31%  Similarity=0.397  Sum_probs=186.7

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCC-ccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHV-NVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.||.|+||.||++...  ..+++|.+.....    ....+.+|+.++..+.|+ +++++.+++......+++++++.
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            3567999999999999875  8899999876433    256789999999999988 79999999977777899999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~  243 (386)
                      ++++.+++......   ..+.......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        82 ~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          82 GGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            99999766443210   2688899999999999999999998   999999999999999988 7999999999855543


Q ss_pred             ccee----eeccccCccccccccccchhc-CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          244 ESFI----SMLGARGTIGYIAPEVFCRNF-GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       244 ~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ....    ......|+..|+|||.+.+.. ...+...|+||+|++++++++|..||......    .......+.+....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence            3211    224567999999999987631 36788999999999999999999997654321    01122233332222


Q ss_pred             cc----ccccc----CChHHHHHHHHHHHHHHHhcCC
Q 038768          319 EF----QLAGV----VTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       319 ~~----~~~~~----~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ..    .....    ......+++..++...+..|..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~  268 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS  268 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCC
Confidence            11    11111    1257888888888876666644

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.5e-23  Score=179.27  Aligned_cols=172  Identities=13%  Similarity=0.117  Sum_probs=130.5

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHH----------HHHHHHHhhcCCCCccceEEEEEE
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE----------FINEVASMSKTSHVNVVSFLGFCY  151 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~~~~~~~  151 (386)
                      ++.+..+...+.+|.|+||.||+... ++..+|+|++.......+.          +.+|+..+.+++|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34444555568999999999999766 5778999999754332222          578999999999999999999866


Q ss_pred             ec--------CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          152 EK--------KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       152 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      ..        +..++||||++|.+|.++..          ++.    ....+++.+|..||+.   +++|||++|+|+++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili  168 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV  168 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence            44        35789999999999987741          222    2456899999999998   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHH
Q 038768          224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV  288 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ell  288 (386)
                      +.++ ++|+|||............              .+....  .+..++|+||||+.+..+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhHH--------------HHHHHh--HhcccccccceeEeehHHH
Confidence            9988 9999999887553322110              022222  3557899999999877654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.6e-22  Score=172.80  Aligned_cols=140  Identities=21%  Similarity=0.204  Sum_probs=110.7

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---------------------------hHHHHHHHHHhhcCCCCccc
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---------------------------GEEFINEVASMSKTSHVNVV  144 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~niv  144 (386)
                      ..||+|+||+||+|...+|+.||||+++.....                           ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            569999999999999778999999999864211                           11235788999999999886


Q ss_pred             eEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEe
Q 038768          145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill  223 (386)
                      ....+...  ..++||||++++++.......      ..++......++.|++.++.+||+ .   +++||||||+||++
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            55544333  348999999888554332111      346778899999999999999999 7   99999999999999


Q ss_pred             CCCCceEEeeccCCcccCcc
Q 038768          224 GEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      + ++.++|+|||++......
T Consensus       152 ~-~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             E-CCCEEEEEcccceecCCC
Confidence            8 789999999999866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2e-24  Score=212.40  Aligned_cols=249  Identities=24%  Similarity=0.265  Sum_probs=186.6

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecC---CCCChH----HHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKN---SKVNGE----EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ...+|.|++|.|+.... ......+.|....   .....+    .+..|+-+-..++|+|++..+..+.+....+-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            46799999997777753 2334344443321   111111    255677777889999998888777777766667999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |++ +|..++...      ..+...++..++.|++.|+.|||+.   |+.|||+|++|++++.+|.+||+|||.+..+..
T Consensus       403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999 999998653      3578889999999999999999998   999999999999999999999999999987655


Q ss_pred             ccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-ccchhhhhhhcCCCcc
Q 038768          243 KESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPNSIYKHIEPGNE  319 (386)
Q Consensus       243 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~i~~~~~  319 (386)
                      ....  ....+.+|+..|+|||++.+. .......||||.|+++..|.+|+.||......+.. .......+..+..+. 
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~-~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~-  550 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK-EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP-  550 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc-ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh-
Confidence            4332  445578899999999999765 23355789999999999999999999765443322 111122223333333 


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+...+....+.++.+||++++.-|.+++++
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i  582 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQI  582 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence            44566788999999999999999988877664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=169.50  Aligned_cols=200  Identities=23%  Similarity=0.337  Sum_probs=161.7

Q ss_pred             hhhhhccCcCCceEEEEEE-eCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +...++||+|+||.+|.|. ..+|..||||+-.+.. ...++..|..+...|+ ...|..+.-+..+...-.+||+.+ |
T Consensus        17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G   94 (341)
T ss_pred             eEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence            3456899999999999997 5789999999876533 3346778888888887 457777777888888889999998 8


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~  242 (386)
                      .+|.+++.-..     ..++..+++-++-|++.-++|+|.+   +++||||||+|.|..-+   ..+.++|||+++.+.+
T Consensus        95 PsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   95 PSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            89999886543     5688889999999999999999999   99999999999999644   4688999999987654


Q ss_pred             ccc-----eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          243 KES-----FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       243 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                      ...     +.......||.+|.+-....+.  ..+.+.|+-|+|.+|....-|..||.+...
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            321     1222345699999987766543  457789999999999999999999986543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=8.9e-22  Score=166.09  Aligned_cols=185  Identities=17%  Similarity=0.103  Sum_probs=139.7

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChH-----HHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE-----EFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..|++|+||+||.+.. .+..++.+.+.......+     .+.+|+++|++|+ |+++++++++    +..+++|||+.|
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            5699999999998766 778888888876655333     5789999999995 5889999886    456999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDI-KPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      .+|...+..             ....++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|||++.......
T Consensus        83 ~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         83 AAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            888654311             1134678999999999999   9999999 7999999999999999999998554332


Q ss_pred             ceee-----------eccccCccccccccccchhcCCCC-ccchhHhHHHHHHHHHhCCCCccccc
Q 038768          245 SFIS-----------MLGARGTIGYIAPEVFCRNFGGVS-HKSDVYSYGMMILEMVVGRKNAEVKV  298 (386)
Q Consensus       245 ~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~  298 (386)
                      ....           ..-...++.|++|+...-. ...+ ...+.++.|.-+|.++|++.++-.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            1100           0012256778888764322 1223 46789999999999999998865443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-23  Score=195.42  Aligned_cols=216  Identities=25%  Similarity=0.330  Sum_probs=176.7

Q ss_pred             ccCcCCceEEEEEE----eCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCC
Q 038768           93 KLGQGGFGSVYKGK----LPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+|+|+||.|+++.    .+.|..+|.|++++....   ......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999864    245788999998763221   124456778888887 9999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|.|...+...      ..+++.....+...++-+++++|+.   +++|||+|++||+++.+|.+++.|||+++..-...
T Consensus        81 gg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccccC------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            99998888554      4577788888899999999999998   99999999999999999999999999998654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .      .+||..|||||++.    .....+|.||||++++||+||..||..            ++...|.+.. +..+.
T Consensus       152 ~------~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~-~~~p~  208 (612)
T KOG0603|consen  152 I------ACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE-LEMPR  208 (612)
T ss_pred             h------cccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc-cCCch
Confidence            2      16999999999985    356789999999999999999999985            2334444332 66788


Q ss_pred             cCChHHHHHHHHHHHH
Q 038768          325 VVTEEEKEMAKKMILV  340 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v  340 (386)
                      .++..+++++..|..-
T Consensus       209 ~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKR  224 (612)
T ss_pred             hhhHHHHHHHHHHHhh
Confidence            8899999999888873

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-22  Score=172.07  Aligned_cols=239  Identities=19%  Similarity=0.319  Sum_probs=182.7

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ++..+|.....|..|+|++ .|..++.|+++-..   .-.++|..|.-.|+-+.||||+.++|.|....+..++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            4556799999999999999 45556667776433   2336899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|...|+...    .-..+..++.+++.+|++|++|||+. .+-|.---|.+..|+||++.+.+|+- +-+++...   
T Consensus       272 gslynvlhe~t----~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq---  342 (448)
T KOG0195|consen  272 GSLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ---  342 (448)
T ss_pred             hHHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee---
Confidence            99999998753    24567788999999999999999996 33455567999999999999888752 22222111   


Q ss_pred             eeeeccccCccccccccccchhcCC-CCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGG-VSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                         ..+..-.+.||+||.+...... .-.++|+|||++++|||.|..-||..-+...-.       .+--.+|..+.++.
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkialeglrv~ipp  412 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIALEGLRVHIPP  412 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhhccccccCCC
Confidence               1233346789999998654222 235789999999999999999999865432211       12235666788899


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      .++.....++.-|+.-++.-|+.
T Consensus       413 gis~hm~klm~icmnedpgkrpk  435 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPK  435 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCC
Confidence            99999999999888766655543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=9.7e-23  Score=201.58  Aligned_cols=241  Identities=24%  Similarity=0.268  Sum_probs=178.5

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCC--CCChHHHHHHHHH--hhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNS--KVNGEEFINEVAS--MSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||++.|=+|.+|+.++|. |+||++-+.  ...-+.|.++++-  ....+|||++.+.-+-......|||-+|. 
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv-  103 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV-  103 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence            34577999999999999998887 889998543  2333444443333  45568999999888877777888999998 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      .-+|.+.+...      .-+..-+.+-|+.|++.||.-+|..   +|+|||||.+||||+.-.-+.|+||..-+....++
T Consensus       104 khnLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  104 KHNLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             hhhhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            66899988443      4566778888999999999999998   99999999999999999999999998876543221


Q ss_pred             c----ee-eeccccCccccccccccchhc--------CC-CCccchhHhHHHHHHHHHh-CCCCccccccc---CCcccc
Q 038768          245 S----FI-SMLGARGTIGYIAPEVFCRNF--------GG-VSHKSDVYSYGMMILEMVV-GRKNAEVKVSL---SSEIYF  306 (386)
Q Consensus       245 ~----~~-~~~~~~g~~~y~aPE~~~~~~--------~~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~---~~~~~~  306 (386)
                      .    +. -.-+...-.+|+|||-+....        .. .+++.||||+||++.||++ |++||+...-.   .++-+.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            1    10 011122345799999985421        11 5678999999999999988 79999865432   122334


Q ss_pred             hhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          307 PNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       307 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++.+.++|.           +...++++..|++.++.-|-++++.
T Consensus       255 ~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedy  288 (1431)
T KOG1240|consen  255 PEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDY  288 (1431)
T ss_pred             HHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHH
Confidence            444444443           5689999999999888888776653

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.9e-21  Score=194.19  Aligned_cols=197  Identities=22%  Similarity=0.246  Sum_probs=155.4

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEEE
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  160 (386)
                      ....+.+.+.||+|+||+||+|...+|+.||+|+-+....+.  |.--.+++.+|+   -+.|+.+...+...+..+||+
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            334445567899999999999998889999999987654432  222223333443   345555555566677889999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-------CCCceEEee
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-------EDFCPKISD  233 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~D  233 (386)
                      ||.+.|+|.+++.      ....++|..++.++.|++..++.||..   +|||+||||+|.||.       +...++|+|
T Consensus       774 ey~~~Gtlld~~N------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eccccccHHHhhc------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999996      346799999999999999999999998   999999999999994       344689999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCC
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKN  293 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p  293 (386)
                      ||.+..+..-..-......++|..+-.+|+..++  .++.+.|.|.|+.+++.||.|+.-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999766433322334466789999999999886  799999999999999999999743

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=1.5e-20  Score=166.84  Aligned_cols=230  Identities=19%  Similarity=0.227  Sum_probs=144.4

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCC----------CccceEEEEEEec--
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSH----------VNVVSFLGFCYEK--  153 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~~--  153 (386)
                      ++.||.|+++.||.+.+. +|+.+|+|+......    .-+++.+|.-....+.+          -.++-.++.....  
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            467999999999999874 589999999754321    22556666655544322          2333333333211  


Q ss_pred             ----------C-----ceeEEEEeCCCCCHHHHhcccccc-cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 038768          154 ----------K-----KRALIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIK  217 (386)
Q Consensus       154 ----------~-----~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk  217 (386)
                                .     +.+++|+-+ .++|.+++..-... .....+.....+.+..|+.+.+++||+.   |++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                      1     335677777 67888875321100 1122344455677789999999999999   99999999


Q ss_pred             CCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchh------cCCCCccchhHhHHHHHHHHHhCC
Q 038768          218 PHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN------FGGVSHKSDVYSYGMMILEMVVGR  291 (386)
Q Consensus       218 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~~DvwslGvil~elltg~  291 (386)
                      |+|++++.+|.+.|+||+.....+....     ....+..|.+||.....      .-.++.+.|.|+||+++|.|+||+
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999987765544221     12345779999987542      124688999999999999999999


Q ss_pred             CCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHH
Q 038768          292 KNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLE  342 (386)
Q Consensus       292 ~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~  342 (386)
                      .||+........    ..         ++.....+++..++||+.||+..+
T Consensus       248 lPf~~~~~~~~~----~~---------~f~~C~~~Pe~v~~LI~~lL~~~~  285 (288)
T PF14531_consen  248 LPFGLSSPEADP----EW---------DFSRCRDMPEPVQFLIRGLLQRNP  285 (288)
T ss_dssp             -STCCCGGGSTS----GG---------GGTTSS---HHHHHHHHHHT-SSG
T ss_pred             CCCCCCCccccc----cc---------cchhcCCcCHHHHHHHHHHccCCc
Confidence            999966432221    11         233444789999999999987554

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=5.3e-20  Score=158.17  Aligned_cols=132  Identities=21%  Similarity=0.311  Sum_probs=102.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCC-CCChHHHHHHHHHhhcC-----CCCccceEEEEEEecC---c-eeEEEE
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNS-KVNGEEFINEVASMSKT-----SHVNVVSFLGFCYEKK---K-RALIYE  161 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e  161 (386)
                      +.||+|+||.||. .-.++.. +||++... ....+.+.+|+.+++.+     +||||++++|++.++.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5799999999996 2224444 68888653 23456799999999999     5799999999998874   3 237899


Q ss_pred             e--CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeEeCC----CCceEEeec
Q 038768          162 F--MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL-EYLHRGCNIRIVHFDIKPHNILLGE----DFCPKISDF  234 (386)
Q Consensus       162 ~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df  234 (386)
                      |  +++++|.+++.+.       .+++.  ..++.|++.++ +|||++   +|+||||||+|||++.    ++.++|+||
T Consensus        86 ~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         86 FDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             CCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            9  5579999999542       24444  35677888887 999998   9999999999999973    347999995


Q ss_pred             cCC
Q 038768          235 GLA  237 (386)
Q Consensus       235 gl~  237 (386)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=9.9e-20  Score=160.30  Aligned_cols=140  Identities=18%  Similarity=0.192  Sum_probs=108.4

Q ss_pred             hhhhccCcCCceEEEEEE--eCCCcEEEEEEecCCCCC-------------------------hHHHHHHHHHhhcCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGK--LPDGRLVAVKVLKNSKVN-------------------------GEEFINEVASMSKTSHV  141 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~  141 (386)
                      .+.+.||+|+||.||+|.  ..+|+.||+|+++.....                         ...+..|+..+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            345789999999999998  568999999998753210                         02256899999999753


Q ss_pred             c--cceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCC
Q 038768          142 N--VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR-IVHFDIKP  218 (386)
Q Consensus       142 n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~dlk~  218 (386)
                      +  +...+++    ...++||||+++.+|.......      ..+....+..++.|++.++++||+.   + ++||||||
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            3  4444443    2458999999998887654221      2345566789999999999999998   8 99999999


Q ss_pred             CCeEeCCCCceEEeeccCCcccCc
Q 038768          219 HNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       219 ~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +||+++ ++.++|+|||.+.....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCC
Confidence            999999 88999999999875443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.7e-19  Score=155.75  Aligned_cols=133  Identities=20%  Similarity=0.282  Sum_probs=113.3

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.||+|++|.||+|.. +|..|++|........         ...+.+|+.++..++|+++.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 7788999986543211         13577899999999999998888888888889999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      ++|++|.+++...         .+ ....++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998432         12 7788999999999999998   999999999999999 78899999999864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-19  Score=171.43  Aligned_cols=206  Identities=22%  Similarity=0.359  Sum_probs=151.6

Q ss_pred             hhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 038768          135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHF  214 (386)
Q Consensus       135 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~  214 (386)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+...     ...+++.....+.++|+.||+|||+.  +...|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-----~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-----DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-----ccCccHHHHHHHHHHHHHHHHHHhcC--cceeee
Confidence            46789999999999999999999999999999999999763     25688999999999999999999997  223999


Q ss_pred             CCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhc--CC---CCccchhHhHHHHHHHHHh
Q 038768          215 DIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF--GG---VSHKSDVYSYGMMILEMVV  289 (386)
Q Consensus       215 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~---~~~~~DvwslGvil~ellt  289 (386)
                      .+++.|++++..+.+||+|||+....................-|.|||.+....  ..   .+++.||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            999999999999999999999988765311111111223455799999996531  11   4778999999999999999


Q ss_pred             CCCCcccccccCCcccchhhhhhhcCC-Cccccccc-----cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          290 GRKNAEVKVSLSSEIYFPNSIYKHIEP-GNEFQLAG-----VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       290 g~~p~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~-----~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+.||+......+    +.++...+.. +..+..|.     ...++...++.+|-.-++.-||+.+.+
T Consensus       154 r~~~~~~~~~~~~----~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i  217 (484)
T KOG1023|consen  154 RSGPFDLRNLVED----PDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQI  217 (484)
T ss_pred             ccCccccccccCC----hHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHH
Confidence            9999986533222    2344444444 22111111     334456666666666666666654433

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=6.3e-19  Score=151.99  Aligned_cols=129  Identities=22%  Similarity=0.324  Sum_probs=106.9

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCC--C-------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV--N-------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .||+|+||.||+|.+ +|..|++|.......  .       ...+.+|++++..++|+++.....++.+.+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 678899998654221  1       145678999999999887766666666777789999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      ++++|.+++....          .   .++.+++.+|.+||+.   +++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998874321          0   7899999999999998   999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=7.5e-19  Score=151.33  Aligned_cols=136  Identities=21%  Similarity=0.217  Sum_probs=107.2

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC-----------------------hHHHHHHHHHhhcCCCC--c
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-----------------------GEEFINEVASMSKTSHV--N  142 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~--n  142 (386)
                      +.+.+.||+|+||.||++...+|+.||||++......                       ...+..|+.++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            3445789999999999999888999999987643210                       12356788888888777  4


Q ss_pred             cceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       143 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      +...++    ....++||||+++++|......            .....++.+++.++.++|+.   +++|+||+|+||+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil  157 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL  157 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence            444443    3456899999999998765421            23457889999999999998   9999999999999


Q ss_pred             eCCCCceEEeeccCCcccCc
Q 038768          223 LGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++.++|+|||++.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.8e-18  Score=170.75  Aligned_cols=130  Identities=18%  Similarity=0.288  Sum_probs=107.6

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEE-ecCCCC--------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKV-LKNSKV--------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.||+|+||+||+|.+.+.. +++|+ ..+...        ..+.+.+|++++..++|++++....++.+....++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            578999999999999875444 44443 322111        12457899999999999999988888888888899999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |+++++|.+++.              ....++.+++.+|.|||+.   +++||||||+|||+ +++.++|+|||+++.
T Consensus       417 ~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        417 YIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999998873              3467899999999999998   99999999999999 677999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=3.9e-18  Score=152.63  Aligned_cols=190  Identities=18%  Similarity=0.247  Sum_probs=140.3

Q ss_pred             CCCccceEEEEEEe---------------------------cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHH
Q 038768          139 SHVNVVSFLGFCYE---------------------------KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ  191 (386)
Q Consensus       139 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~  191 (386)
                      +|||||++++.|.+                           ...+|+||.-+ ..+|++++...       ..+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-------~~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-------HRSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-------CCchHHHHH
Confidence            59999999988865                           23568999877 56899998553       355677788


Q ss_pred             HHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe--CCCC--ceEEeeccCCcccCccc---ce-eeeccccCccccccccc
Q 038768          192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILL--GEDF--CPKISDFGLAKLSEKKE---SF-ISMLGARGTIGYIAPEV  263 (386)
Q Consensus       192 i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfgl~~~~~~~~---~~-~~~~~~~g~~~y~aPE~  263 (386)
                      ++.|+++|+.|||.+   ++.|||+|++|||+  ++|+  .+.|+|||.+--.+...   .+ ......-|...-||||+
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            999999999999998   99999999999999  4444  47899999875322210   00 11123347778999999


Q ss_pred             cchhcCCC----CccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHH
Q 038768          264 FCRNFGGV----SHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL  339 (386)
Q Consensus       264 ~~~~~~~~----~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~  339 (386)
                      .....+..    -.|+|.|+.|.+.||+++...||...    +++.+...   ..++..-+.++..+.+..++++..+|.
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r----Gem~L~~r---~Yqe~qLPalp~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR----GEMLLDTR---TYQESQLPALPSRVPPVARQLVFDLLK  495 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc----chheechh---hhhhhhCCCCcccCChHHHHHHHHHhc
Confidence            85443321    35899999999999999999999863    33333332   245556688899999999999998887


Q ss_pred             HHHHhcC
Q 038768          340 VLEMLEG  346 (386)
Q Consensus       340 v~~~L~~  346 (386)
                      -++.-|.
T Consensus       496 r~pskRv  502 (598)
T KOG4158|consen  496 RDPSKRV  502 (598)
T ss_pred             CCccccC
Confidence            5554443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=1.3e-18  Score=172.32  Aligned_cols=200  Identities=23%  Similarity=0.347  Sum_probs=136.6

Q ss_pred             hhccCcCCceEEEEEEeCC-CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           91 SNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .+.|..|+||.||..+++. .+..|+|+-++.-     +.+-  ++.....|.+|                     |+=.
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcccccch-----hhhc--cccccCCccee---------------------chhh
Confidence            4779999999999998753 5677774332211     1110  22222233332                     3333


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc----
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES----  245 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----  245 (386)
                      ..++..      .+++.        +++.+++|||+.   +|+|||+||+|.+|+.-|.+|+.|||+.+..-....    
T Consensus       140 tllk~~------g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  140 TLLKNI------GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhcccC------CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            444321      22322        237889999998   999999999999999999999999999874311100    


Q ss_pred             ---------eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          246 ---------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       246 ---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                               .......+||+.|+|||++..+  .|...+|+|++|+|+||.+-|..||..+        .|++++.++..
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGd--------tpeelfg~vis  272 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELFGQVIS  272 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCC--------CHHHHHhhhhh
Confidence                     0011245799999999999765  7999999999999999999999999876        23555544322


Q ss_pred             Cc--cccccccCChHHHHHHHHHHHHHHHhc
Q 038768          317 GN--EFQLAGVVTEEEKEMAKKMILVLEMLE  345 (386)
Q Consensus       317 ~~--~~~~~~~~s~~~~~li~~ml~v~~~L~  345 (386)
                      ..  ++.-+..+..++++++.++|...+.-|
T Consensus       273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~R  303 (1205)
T KOG0606|consen  273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCR  303 (1205)
T ss_pred             hhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence            22  233355678899999999998665554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=8.1e-18  Score=143.56  Aligned_cols=137  Identities=21%  Similarity=0.250  Sum_probs=98.6

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHH----------------------HHHHHHhhcCCCC--cc
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEF----------------------INEVASMSKTSHV--NV  143 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~--ni  143 (386)
                      .+.||+|+||+||+|...+|+.||||+++......   ..+                      ..|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999987543211   111                      3455555555433  24


Q ss_pred             ceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeE
Q 038768          144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       144 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nil  222 (386)
                      .+.+++    ...++||||++++++.......      ... ......++.+++.++.++|. .   +++|+||||+||+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~------~~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil  147 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD------VRL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL  147 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh------hhh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence            444443    3468999999985542211110      001 15678899999999999999 7   9999999999999


Q ss_pred             eCCCCceEEeeccCCcccCc
Q 038768          223 LGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ++ ++.++|+|||.+.....
T Consensus       148 i~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         148 VD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EE-CCcEEEEECcccccccC
Confidence            99 88999999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=7.2e-19  Score=163.06  Aligned_cols=170  Identities=23%  Similarity=0.297  Sum_probs=128.8

Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ..|+.|++|...+|.+++.+.+.   ....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence            47899999999999999975532   2456778899999999999999   5   9999999999999999999999999


Q ss_pred             cCCcccCccc----ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhh
Q 038768          235 GLAKLSEKKE----SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNS  309 (386)
Q Consensus       235 gl~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  309 (386)
                      |+........    .........||..||+||++.++  .|+.++||||||+||+|++. =..+++..           .
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~  467 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFERI-----------A  467 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHHH-----------H
Confidence            9998666554    22344567799999999999876  79999999999999999998 34444422           1


Q ss_pred             hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       310 ~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ....+..+..+.....--++...++.+|+...+.-||
T Consensus       468 t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP  504 (516)
T KOG1033|consen  468 TLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERP  504 (516)
T ss_pred             hhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCc
Confidence            2233444443322122235556777787776666665

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.1e-16  Score=131.08  Aligned_cols=133  Identities=23%  Similarity=0.201  Sum_probs=112.7

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCC--CccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH--VNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      +.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++|  .+++++++++...+..+++|||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            569999999999999844 7899999876543 5678899999999976  58999999888888899999999887765


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      .+             +......++.+++.+|.+||.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        82 ~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          82 EV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            43             3456677899999999999986434799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.9e-18  Score=170.38  Aligned_cols=255  Identities=23%  Similarity=0.246  Sum_probs=194.5

Q ss_pred             hhhccCcCCceEEEEEEeCC--CcEEEEEEecCCCCC---hHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeC
Q 038768           90 FSNKLGQGGFGSVYKGKLPD--GRLVAVKVLKNSKVN---GEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      +.+.||+|+|+.|-.....+  ...+|+|.+......   ......|..+-..+. |.|++.+++...+.+..+++++|.
T Consensus        24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s  103 (601)
T KOG0590|consen   24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS  103 (601)
T ss_pred             ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence            34569999999998886533  445666666543322   233445777777776 999999999999999999999999


Q ss_pred             CCCCHHHHhc-ccccccccccCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCccc
Q 038768          164 PNGSLDQFIY-DEESSNINRKLEWRTMCQIAVGIARGLEYLH-RGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLS  240 (386)
Q Consensus       164 ~~gsL~~~l~-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~  240 (386)
                      .++++.+-+. ...     ...+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|...
T Consensus       104 ~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  104 DGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999988873 221     24556677888999999999999 66   999999999999999999 9999999999877


Q ss_pred             Cc-ccceeeeccccC-ccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          241 EK-KESFISMLGARG-TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       241 ~~-~~~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .. +.........+| ++.|+|||...+. ....+..|+||.|+++.-+++|..|++........+    .-|.......
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----~~~~~~~~~~  250 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----SSWKSNKGRF  250 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccc----eeeccccccc
Confidence            66 444444455667 9999999998764 356788999999999999999999998765443221    1112222222


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .......++....+++.+|+...+..|.+.+++...|--
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~  289 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWL  289 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhccccccccccccc
Confidence            355677889999999999998888888887777666544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.6e-16  Score=138.84  Aligned_cols=133  Identities=16%  Similarity=0.187  Sum_probs=104.0

Q ss_pred             hccC-cCCceEEEEEEeCCCcEEEEEEecCCC--------------CChHHHHHHHHHhhcCCCCcc--ceEEEEEEecC
Q 038768           92 NKLG-QGGFGSVYKGKLPDGRLVAVKVLKNSK--------------VNGEEFINEVASMSKTSHVNV--VSFLGFCYEKK  154 (386)
Q Consensus        92 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~  154 (386)
                      ..|| .|+.|+||.... ++..+++|.+....              .....+.+|++++..++|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 899999999987 47788998875311              122457889999999998875  67777654432


Q ss_pred             c----eeEEEEeCCC-CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCce
Q 038768          155 K----RALIYEFMPN-GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP  229 (386)
Q Consensus       155 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  229 (386)
                      .    .++|||++++ .+|.+++...       .++..    .+.+++.+|.+||+.   ||+|+||||.|||++.++.+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence            2    2599999997 6898887432       23433    356899999999998   99999999999999998899


Q ss_pred             EEeeccCCcc
Q 038768          230 KISDFGLAKL  239 (386)
Q Consensus       230 kl~Dfgl~~~  239 (386)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=8.5e-15  Score=140.22  Aligned_cols=140  Identities=25%  Similarity=0.270  Sum_probs=97.4

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---------------------------h--------------HHHHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---------------------------G--------------EEFIN  130 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~~~~~  130 (386)
                      +.||.|++|+||+|++.+|+.||||+.+..-..                           .              -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998643100                           0              01344


Q ss_pred             HHHHhhcC----CCCccceEEEEE-EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHH-HHHHHH
Q 038768          131 EVASMSKT----SHVNVVSFLGFC-YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR-GLEYLH  204 (386)
Q Consensus       131 E~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH  204 (386)
                      |...+.++    +|.+-+.+-.++ ...+..++||||++|++|.++.....     ...+   ...++.+++. .+..+|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCCC---HHHHHHHHHHHHHHHHH
Confidence            55544444    222222222222 23456799999999999988764321     1122   3345555655 467888


Q ss_pred             hcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       205 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ..   |++|+|++|.||+++.++.++++|||++..+..
T Consensus       275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            87   999999999999999999999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=1.7e-13  Score=114.90  Aligned_cols=130  Identities=21%  Similarity=0.169  Sum_probs=96.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccc-eEEEEEEecCceeEEEEeCCCCCHHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV-SFLGFCYEKKKRALIYEFMPNGSLDQ  170 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~  170 (386)
                      +.|+.|.++.||++.. .+..+++|...........+..|+..+..+.+.+++ +++.+  +....++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence            4688999999999987 478899999865443334567899999888655544 44443  3345689999999988754


Q ss_pred             HhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC--NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       171 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      ..              .....+..+++.+|..||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED--------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc--------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            30              011235678999999999972  12369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=3e-14  Score=138.10  Aligned_cols=141  Identities=21%  Similarity=0.248  Sum_probs=91.8

Q ss_pred             hccCcCCceEEEEEEeCC-CcEEEEEEecCCCC---------------------------Ch--------H------HHH
Q 038768           92 NKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---------------------------NG--------E------EFI  129 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------------------------~~--------~------~~~  129 (386)
                      +.||+|++|+||+|++++ |+.||||+.+..-.                           ..        +      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            479999999999999877 99999999974310                           00        1      133


Q ss_pred             HHHHHhhcCC----CCccceEEEEEEe-cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Q 038768          130 NEVASMSKTS----HVNVVSFLGFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH  204 (386)
Q Consensus       130 ~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH  204 (386)
                      +|+..+.+++    +.+.+.+=.++.+ ....+|||||++|+.+.++-.-...+.....+....+..++.|+.       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence            3444443332    3333333333332 456789999999999977532111000011233334444444543       


Q ss_pred             hcCCCCeeecCCCCCCeEeCCCC----ceEEeeccCCcccCc
Q 038768          205 RGCNIRIVHFDIKPHNILLGEDF----CPKISDFGLAKLSEK  242 (386)
Q Consensus       205 ~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~~~~  242 (386)
                      ..   |++|+|++|.||+++.++    .+++.|||++..+..
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34   999999999999999888    999999999986654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=4e-14  Score=134.07  Aligned_cols=253  Identities=23%  Similarity=0.231  Sum_probs=183.6

Q ss_pred             HHHHHHHhhhhhccCc--CCceEEEEEEe---CCCcEEEEEEecCC---CCChHHHHHHHHHhhcCC-CCccceEEEEEE
Q 038768           81 SDVKRMTNSFSNKLGQ--GGFGSVYKGKL---PDGRLVAVKVLKNS---KVNGEEFINEVASMSKTS-HVNVVSFLGFCY  151 (386)
Q Consensus        81 ~~~~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  151 (386)
                      .+..+....+.+.+|.  |.+|.||.+..   .++..+|+|.-+..   ......=.+|+.....++ |+|.++.+..+.
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            3455555666788999  99999999976   35788999875432   122223346666666664 999999999999


Q ss_pred             ecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeEeCCC-
Q 038768          152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR----GLEYLHRGCNIRIVHFDIKPHNILLGED-  226 (386)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~dlk~~Nill~~~-  226 (386)
                      ..+..++-+|+| +.+|..+.+...     ..++...++....+...    ||.++|+.   +++|-|+||.||++..+ 
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence            999999999999 588888876542     34667778888888888    99999998   99999999999999999 


Q ss_pred             CceEEeeccCCcccCcccc---eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc
Q 038768          227 FCPKISDFGLAKLSEKKES---FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE  303 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  303 (386)
                      ...+++|||+...+....-   ........|...|++||...+   -++...|+|+||.++.+..+|...+-..-     
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----  331 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGK-----  331 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCC-----
Confidence            8899999999987765431   111123357889999999864   57889999999999999999876554220     


Q ss_pred             ccchhhhhhhcCCCc-cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          304 IYFPNSIYKHIEPGN-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                          ...|..+..+. ...+....+.+....+..|+.-++.++.+.+.+...
T Consensus       332 ----~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  332 ----NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ----CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                11222322222 122344456666778888888777777765554433

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=6.4e-13  Score=127.28  Aligned_cols=165  Identities=21%  Similarity=0.251  Sum_probs=125.3

Q ss_pred             eCCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCC
Q 038768          107 LPDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE  185 (386)
Q Consensus       107 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~  185 (386)
                      -.++.+|.|...+.... ..+...+.++.|+.++||||+++++.+...+..|+|+|-+.  -|..++..         +.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence            34788999998876544 23457788899999999999999999999999999999873  56666633         33


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccc
Q 038768          186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC  265 (386)
Q Consensus       186 ~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  265 (386)
                      ...+...+.||+.||.|||+.+  +++|++|....|+++..|..||++|.++........  .......--.|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            5666777899999999999764  999999999999999999999999998864433221  000111122366666542


Q ss_pred             hhcCCCCccchhHhHHHHHHHHHhC
Q 038768          266 RNFGGVSHKSDVYSYGMMILEMVVG  290 (386)
Q Consensus       266 ~~~~~~~~~~DvwslGvil~elltg  290 (386)
                      ..    .-..|.|.||+++||++.|
T Consensus       179 ~s----~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PS----EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc----ccchhhhhHHHHHHHHhCc
Confidence            21    1346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=6.7e-12  Score=102.62  Aligned_cols=130  Identities=21%  Similarity=0.256  Sum_probs=100.6

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEe-cCCCCCh--------HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVL-KNSKVNG--------EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+++|+-+.+|.+.+. |..+++|.- ++.-...        +.-.+|..++.+++--.|...+=+..+.+...++|||.
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999773 444666653 3332221        34568999998887666666666677888999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      +|..|.+++...             ...++..+-.-+.-||..   +|+|+||+++||++..+. +.++|||++...
T Consensus        82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999888442             245667777788889998   999999999999998765 999999999743

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=4.2e-12  Score=107.36  Aligned_cols=136  Identities=18%  Similarity=0.175  Sum_probs=98.7

Q ss_pred             hccCcCCceEEEEEEeCC-------CcEEEEEEecCCCC----------------------C-hHHH----HHHHHHhhc
Q 038768           92 NKLGQGGFGSVYKGKLPD-------GRLVAVKVLKNSKV----------------------N-GEEF----INEVASMSK  137 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~-~~~~----~~E~~~l~~  137 (386)
                      ..||.|--+.||.|...+       +..+|||+.+.+..                      + .+.+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       47999999863210                      0 1122    278999988


Q ss_pred             CCC--CccceEEEEEEecCceeEEEEeCCCCCHHH-HhcccccccccccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeee
Q 038768          138 TSH--VNVVSFLGFCYEKKKRALIYEFMPNGSLDQ-FIYDEESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVH  213 (386)
Q Consensus       138 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH  213 (386)
                      +..  -++...+++    ...++||||+.++.+.. .+..       ..++......+..+++.+|..| |..   ++||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH  148 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH  148 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            853  466666654    56789999997654322 2211       1244456677889999999999 777   9999


Q ss_pred             cCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          214 FDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       214 ~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +||++.||+++ ++.+.|+|||.+.....
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999999997 46799999998875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=3.1e-13  Score=118.73  Aligned_cols=155  Identities=25%  Similarity=0.356  Sum_probs=114.4

Q ss_pred             HHhhcCCCCccceEEEEEEecC-----ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC
Q 038768          133 ASMSKTSHVNVVSFLGFCYEKK-----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC  207 (386)
Q Consensus       133 ~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  207 (386)
                      .-+-++-|.|||++..|+.+..     ...++.||+..|+|..+|++...  ....+......+|+.||+.||.|||+ |
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs-~  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHS-C  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence            3455567999999999887653     35689999999999999987653  23557778888999999999999999 5


Q ss_pred             CCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHH
Q 038768          208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL  285 (386)
Q Consensus       208 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~  285 (386)
                      .+.++|+++..+.|++..+|-+|+.--.-..........  .......+-++|.+||+-..  ...+.++|||+||+..+
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCAL  273 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHH
Confidence            789999999999999999998888432111110000000  00111236678999997532  35677899999999999


Q ss_pred             HHHhCCC
Q 038768          286 EMVVGRK  292 (386)
Q Consensus       286 elltg~~  292 (386)
                      ||-.|..
T Consensus       274 emailEi  280 (458)
T KOG1266|consen  274 EMAILEI  280 (458)
T ss_pred             HHHHhee
Confidence            9988753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.35  E-value=1.6e-11  Score=99.93  Aligned_cols=141  Identities=22%  Similarity=0.308  Sum_probs=108.2

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEe-cCCC--------CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVL-KNSK--------VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      ..+-+|+-+.|+++.+ .|+...||.- .+..        .......+|++.+.+++--.|....-++.+...-.++|||
T Consensus        13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            4588999999999998 6787777753 3321        1235678899999988766777666778888889999999


Q ss_pred             CCC-CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ceEEeeccCCc
Q 038768          163 MPN-GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISDFGLAK  238 (386)
Q Consensus       163 ~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~  238 (386)
                      .++ .++.+++.....    ..........++..|-..+.-||.+   ++||+||..+||++..++   .+.++|||++.
T Consensus        92 ~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             ccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            976 478888865432    2223334478889999999999998   999999999999996544   45899999986


Q ss_pred             cc
Q 038768          239 LS  240 (386)
Q Consensus       239 ~~  240 (386)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            44

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.35  E-value=1.3e-11  Score=107.94  Aligned_cols=141  Identities=19%  Similarity=0.206  Sum_probs=107.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCC--CccceEEEEEEecC---ceeEEEEeCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSH--VNVVSFLGFCYEKK---KRALIYEFMP  164 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~  164 (386)
                      +.|+.|..+.||++...+|..+++|.......  ....+..|.+++..+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45899999999999887778999999875433  34678899999999875  44677777766542   5689999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-------------------------------------  207 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------  207 (386)
                      +.++...+..       ..++......++.+++..|..||+..                                     
T Consensus        84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9888765521       23556667777777777777777421                                     


Q ss_pred             ----------------CCCeeecCCCCCCeEeCC--CCceEEeeccCCcc
Q 038768          208 ----------------NIRIVHFDIKPHNILLGE--DFCPKISDFGLAKL  239 (386)
Q Consensus       208 ----------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~  239 (386)
                                      ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            246799999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=4.9e-13  Score=126.80  Aligned_cols=240  Identities=23%  Similarity=0.234  Sum_probs=176.2

Q ss_pred             hhccCcCCceEEEEEEe--CCCcEEEEEEecCCCCCh-H--HHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCC
Q 038768           91 SNKLGQGGFGSVYKGKL--PDGRLVAVKVLKNSKVNG-E--EFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...||.|.|+.|+....  .++..+++|.+.+.-... .  .-..|+.+...+ .|.++++.+..+...+..|+--|||.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            36799999999999864  467889999887643222 1  224566655555 48899998888888888889999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++.....      ....+++...+++..|++.++.++|+.   .++|+|++|+||++..+ +..++.|||.+..+...
T Consensus       350 ~~s~~l~~~------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  350 GGSSSLRSV------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             CcchhhhhH------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence            998877662      225577888999999999999999997   99999999999999876 78899999998642221


Q ss_pred             cceeeeccccCccccc-cccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYI-APEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ..     ......++. ..|.+... ..+-.+.|++|||.-+.|..+|..--+.           ..-|..|..+..+..
T Consensus       421 ~~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----------~~~~~~i~~~~~p~~  483 (524)
T KOG0601|consen  421 SG-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSES-----------GVQSLTIRSGDTPNL  483 (524)
T ss_pred             cc-----cccccccccccchhhccc-cccccccccccccccccccccCcccCcc-----------cccceeeecccccCC
Confidence            11     111233444 25555444 3677899999999999999998643332           122456666765666


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ++.. .+++.+.+.|+.-++..++...++..+++.
T Consensus       484 ~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  484 PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             CchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            6655 888888888888888888877777766653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.24  E-value=6.5e-12  Score=125.56  Aligned_cols=236  Identities=17%  Similarity=0.178  Sum_probs=167.5

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +-+-+|.++.++.+.-. .|...++|+......    ..+....+-.++-..++|-++....-+.-....+|+++|+.++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            45778899999887532 354455554433211    1222333333333345677776655555667889999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc---
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK---  243 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---  243 (386)
                      +|...++...      ..+..-.......+..+++|||+.   .+.|+|++|.|.|+..++..+++|||........   
T Consensus       890 ~~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  890 DLPSKLHNSG------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             CchhhhhcCC------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            9999987653      344445556677788999999997   6999999999999999999999999843321100   


Q ss_pred             ---------------------cce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          244 ---------------------ESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       244 ---------------------~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                                           ...     .......||+.|.+||...+.  .....+|+|++|++++|.++|..||+..
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                 000     112235689999999999775  5677899999999999999999999976


Q ss_pred             cccCCcccchhhhhhhcCCCc--cccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          298 VSLSSEIYFPNSIYKHIEPGN--EFQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                              .+..+++.|..+.  ++.-+...+.+.++++.+.+...+.-|.
T Consensus      1039 --------tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1039 --------TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             --------chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhcc
Confidence                    3466777776666  3444667899999999988876666553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=2.4e-10  Score=96.38  Aligned_cols=125  Identities=25%  Similarity=0.312  Sum_probs=82.1

Q ss_pred             EEEEEEeCCCcEEEEEEecCCCCC---------------------------hHHHHHHHHHhhcCCCC--ccceEEEEEE
Q 038768          101 SVYKGKLPDGRLVAVKVLKNSKVN---------------------------GEEFINEVASMSKTSHV--NVVSFLGFCY  151 (386)
Q Consensus       101 ~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~--niv~~~~~~~  151 (386)
                      .||.|...+|..+|+|+.+.....                           .....+|.+.|.++...  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999889999999998642110                           02356799999999765  56666654  


Q ss_pred             ecCceeEEEEeCC--CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCeEeCCCCc
Q 038768          152 EKKKRALIYEFMP--NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY-LHRGCNIRIVHFDIKPHNILLGEDFC  228 (386)
Q Consensus       152 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~dlk~~Nill~~~~~  228 (386)
                        ....+||||++  +..+..+....        ++......++.+++..+.. +|..   |++|+||.+.||+++++ .
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence              25689999998  54444333211        1123455667777776555 4677   99999999999999988 9


Q ss_pred             eEEeeccCCcccC
Q 038768          229 PKISDFGLAKLSE  241 (386)
Q Consensus       229 ~kl~Dfgl~~~~~  241 (386)
                      +.++|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999887544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=2.2e-09  Score=95.94  Aligned_cols=138  Identities=16%  Similarity=0.084  Sum_probs=98.4

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCC------------ChHHHHHHHHHhhcCCCCc--cceEEEEEEe-----c
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV------------NGEEFINEVASMSKTSHVN--VVSFLGFCYE-----K  153 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~  153 (386)
                      .+-......|++..+ +|+.+.||.......            ....+.+|...+.++...+  ++..+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333334445677766 778999997753221            1114778888887774333  3444555543     2


Q ss_pred             CceeEEEEeCCCC-CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-------
Q 038768          154 KKRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-------  225 (386)
Q Consensus       154 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------  225 (386)
                      ...++|+|++++. +|.+++....    ....+......++.+++..+.-||..   |++|+|++++|||++.       
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence            3468999999876 8998874321    12345567778999999999999999   9999999999999975       


Q ss_pred             CCceEEeeccCCc
Q 038768          226 DFCPKISDFGLAK  238 (386)
Q Consensus       226 ~~~~kl~Dfgl~~  238 (386)
                      +..+.++||+.+.
T Consensus       181 ~~~~~LIDl~r~~  193 (268)
T PRK15123        181 DLKLSVIDLHRAQ  193 (268)
T ss_pred             CceEEEEECCccc
Confidence            4689999999885

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.06  E-value=2.6e-09  Score=99.93  Aligned_cols=171  Identities=19%  Similarity=0.296  Sum_probs=128.8

Q ss_pred             ceEEEEEEe-CCCcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceEEEEEEe----cCceeEEEEeCCC-CCHHHH
Q 038768           99 FGSVYKGKL-PDGRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSFLGFCYE----KKKRALIYEFMPN-GSLDQF  171 (386)
Q Consensus        99 ~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~~  171 (386)
                      -.+.|++.. .||..+++|++...... ......-++.++++.|.|+|++.+++..    +...++||+|+|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357788864 48999999999432211 1233456788999999999999998873    3467899999985 578777


Q ss_pred             hccccccc---------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          172 IYDEESSN---------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       172 l~~~~~~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ........         .+...++..+|.++.|+..||.++|+.   |+..+-|.+.+|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            65433221         234578899999999999999999998   999999999999999999999998887665544


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCC
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKN  293 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p  293 (386)
                      +..                |-+.+     -++-|.=.||.+++.|.||...
T Consensus       446 d~~----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES-----QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH-----HhhhhHHHHHHHHHHHhhcccc
Confidence            320                11211     2456999999999999999543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=6.7e-09  Score=90.27  Aligned_cols=135  Identities=24%  Similarity=0.258  Sum_probs=95.3

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC-----------------------ChHHHHHHHHHhhcCCCC--c
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV-----------------------NGEEFINEVASMSKTSHV--N  142 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~--n  142 (386)
                      +.++++||-|--+.||.|..++|..+|||.=+....                       ......+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            346789999999999999999999999997643111                       112356799999988644  6


Q ss_pred             cceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       143 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      |.+.+++    +...+||||.++--|...-           ++....-.++..|+.-+.-+-..   |+||+|+.+-||+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl  234 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL  234 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence            7776654    4567999999886554332           11222233333444444433344   9999999999999


Q ss_pred             eCCCCceEEeeccCCccc
Q 038768          223 LGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~  240 (386)
                      +++||.+.++||--+...
T Consensus       235 V~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         235 VTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EecCCCEEEEeCcccccC
Confidence            999999999999766533

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.90  E-value=8.3e-09  Score=99.81  Aligned_cols=141  Identities=18%  Similarity=0.206  Sum_probs=92.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---------------------------h----H----------HHHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---------------------------G----E----------EFIN  130 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~----~----------~~~~  130 (386)
                      +-|+.++-|+||+|++++|+.||||+.+.+-..                           .    +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            468899999999999999999999998753110                           0    0          1334


Q ss_pred             HHHHhhcCC-----CCccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Q 038768          131 EVASMSKTS-----HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR  205 (386)
Q Consensus       131 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  205 (386)
                      |...+.+++     .+++.-..=|..-.+...|+|||++|..+.+......     ...+...+.....++..-.-+-  
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~k~ia~~~~~~f~~q~~~--  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDRKELAELLVRAFLRQLLR--  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHh--
Confidence            444444432     3333322223334567889999999988888853322     2234333333332222222222  


Q ss_pred             cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       206 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      .   |++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2   999999999999999999999999999876654

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=8e-08  Score=81.63  Aligned_cols=138  Identities=14%  Similarity=0.073  Sum_probs=101.8

Q ss_pred             cCcCCceEEEEEEeCCCcEEEEEEecC----C---CCChHHHHHHHHHhhcCCCC--ccceEEEEEEec----CceeEEE
Q 038768           94 LGQGGFGSVYKGKLPDGRLVAVKVLKN----S---KVNGEEFINEVASMSKTSHV--NVVSFLGFCYEK----KKRALIY  160 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~  160 (386)
                      -|+|+.+.|++-.+ +|+.+-+|.-.+    +   +.....|.+|+..+.++...  .+.+........    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56789999999877 555788887752    1   34557899999999888532  344444222111    1356999


Q ss_pred             EeCCC-CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc--eEEeeccCC
Q 038768          161 EFMPN-GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC--PKISDFGLA  237 (386)
Q Consensus       161 e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~  237 (386)
                      |-+++ -+|.+++.....    ...+......++.+++..+.-||+.   |+.|+|+.+.|||++.++.  ++++||.-+
T Consensus       105 e~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            97754 588888754321    3456677789999999999999999   9999999999999986666  999999877


Q ss_pred             cc
Q 038768          238 KL  239 (386)
Q Consensus       238 ~~  239 (386)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            63

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.83  E-value=7e-08  Score=88.45  Aligned_cols=197  Identities=15%  Similarity=0.190  Sum_probs=125.9

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC-hHHHHHHHHHhhcC-CCCccceEEEEE------EecCc-eeEEEE
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-GEEFINEVASMSKT-SHVNVVSFLGFC------YEKKK-RALIYE  161 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~------~~~~~-~~lv~e  161 (386)
                      +..||+|+-+.+|-.--- +. .+-|++....-. ..+.   +..|... .||-+..-+.+=      -+.+. .-++|+
T Consensus        16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            567999999999964211 12 234665543222 2222   2223222 455433211111      11222 456777


Q ss_pred             eCCCC-CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          162 FMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       162 ~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      .+++. -...++........-...+|+.+++.++.++.+.+.||..   |.+-+|++++|+|+++++.+.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            77654 2333332221122234578999999999999999999998   9999999999999999999999986544333


Q ss_pred             CcccceeeeccccCccccccccccc-hhc--CCCCccchhHhHHHHHHHHHhC-CCCccccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFC-RNF--GGVSHKSDVYSYGMMILEMVVG-RKNAEVKV  298 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~--~~~~~~~DvwslGvil~elltg-~~p~~~~~  298 (386)
                      ....   ...+.+|...|++||... ...  ..-+...|.|.|||++++++.| +.||....
T Consensus       168 ~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         168 ANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             cCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            2221   233567899999999864 111  1346789999999999999887 89997553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=5.8e-08  Score=83.90  Aligned_cols=107  Identities=21%  Similarity=0.261  Sum_probs=83.0

Q ss_pred             hHHHHHHHHHhhcCC--CCccceEEEEEEecC----ceeEEEEeCCCC-CHHHHhcccccccccccCCHHHHHHHHHHHH
Q 038768          125 GEEFINEVASMSKTS--HVNVVSFLGFCYEKK----KRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIA  197 (386)
Q Consensus       125 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~  197 (386)
                      .....+|...+..+.  .-.+...+++.....    ..++|+|++++. +|.+++....      ..+......++.+++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA  128 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence            346778888877775  334556666665432    357999999874 7999885421      245567788999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ceEEeeccCCccc
Q 038768          198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISDFGLAKLS  240 (386)
Q Consensus       198 ~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~  240 (386)
                      ..+.-||..   |++|+|+++.|||++.+.   .+.++||+.++..
T Consensus       129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999   999999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.77  E-value=1.9e-09  Score=104.26  Aligned_cols=150  Identities=22%  Similarity=0.321  Sum_probs=104.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee-ee------ccccCccccccccccc
Q 038768          193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SM------LGARGTIGYIAPEVFC  265 (386)
Q Consensus       193 ~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~------~~~~g~~~y~aPE~~~  265 (386)
                      +.+++.||.|+|..  .++||++|.|++|.++.++.+||+.|+.+.....+..+. ..      .-......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            44566999999987  599999999999999999999999999886544421110 00      0122456899999997


Q ss_pred             hhcCCCCccchhHhHHHHHHHHH-hCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHh
Q 038768          266 RNFGGVSHKSDVYSYGMMILEMV-VGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEML  344 (386)
Q Consensus       266 ~~~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L  344 (386)
                      ..  ..+.++|+|||||++|.+. .|+.-+....... .    ..................+..++++-+.+|+..+...
T Consensus       183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~----~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~  255 (700)
T KOG2137|consen  183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-S----YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV  255 (700)
T ss_pred             cc--cccccccceeeeeEEEEEecCCcchhhccCCcc-h----hhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence            64  6788999999999999999 4555455442211 0    0111111111123334678899999999999999998


Q ss_pred             cCCCCCC
Q 038768          345 EGSTEDL  351 (386)
Q Consensus       345 ~~~~~~~  351 (386)
                      |+...++
T Consensus       256 rp~~~~l  262 (700)
T KOG2137|consen  256 RPTLDLL  262 (700)
T ss_pred             Ccchhhh
Confidence            8855444

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.65  E-value=6.7e-07  Score=78.30  Aligned_cols=140  Identities=14%  Similarity=0.183  Sum_probs=85.9

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc--cceEEEEEEecCceeEEEEeCCCCC-H
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN--VVSFLGFCYEKKKRALIYEFMPNGS-L  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L  168 (386)
                      ..||+|..+.||+.   .|..+++|..... .......+|.+++..+..-.  +.+.++++.+.+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984   2456778887643 34456789999998886433  4677888877777889999998863 2


Q ss_pred             HHHh---------------------cccccccccccCCH--HHHHHHHH-------HHHH-HHHHHHhc-CCCCeeecCC
Q 038768          169 DQFI---------------------YDEESSNINRKLEW--RTMCQIAV-------GIAR-GLEYLHRG-CNIRIVHFDI  216 (386)
Q Consensus       169 ~~~l---------------------~~~~~~~~~~~l~~--~~~~~i~~-------qi~~-~L~~LH~~-~~~~ivH~dl  216 (386)
                      ...+                     |.....  ...+..  ......+.       .+.. ...+|... ....++|+|+
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            2111                     110000  001110  00000000       0111 12222211 1236799999


Q ss_pred             CCCCeEeCCCCceEEeeccCCc
Q 038768          217 KPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       217 k~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.63  E-value=4e-07  Score=78.55  Aligned_cols=137  Identities=24%  Similarity=0.276  Sum_probs=94.2

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh--------------------HH-----HHHHHHHhhcCC--CCccce
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG--------------------EE-----FINEVASMSKTS--HVNVVS  145 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~-----~~~E~~~l~~l~--h~niv~  145 (386)
                      .|.+|-...||+|...++..+|+|+++......                    ++     ...|...|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            577888999999988789999999997532211                    11     235677777663  445555


Q ss_pred             EEEEEEecCceeEEEEeCCCCC-HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 038768          146 FLGFCYEKKKRALIYEFMPNGS-LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG  224 (386)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~  224 (386)
                      .+++.    .-.|||||+.... -.-.|..       ..+.......+..++++.+.-|-..  .++||+||..=|||+.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD-------v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~  201 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD-------VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH  201 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc-------CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE
Confidence            55543    3479999995431 1111111       1233335667777888888877762  2999999999999999


Q ss_pred             CCCceEEeeccCCcccCcc
Q 038768          225 EDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       225 ~~~~~kl~Dfgl~~~~~~~  243 (386)
                       ++.+.|+|||-+....++
T Consensus       202 -~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             -CCeEEEEECccccccCCC
Confidence             889999999988765543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=3.4e-07  Score=88.46  Aligned_cols=140  Identities=20%  Similarity=0.216  Sum_probs=90.4

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh----------------------------H----------HHHHHHH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG----------------------------E----------EFINEVA  133 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~----------~~~~E~~  133 (386)
                      +-||.-+.|+||+|++++|+.||||+-+..-...                            +          +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5689999999999999999999999987531100                            0          1344443


Q ss_pred             Hhhc----CCCCc------cceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHH
Q 038768          134 SMSK----TSHVN------VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL  203 (386)
Q Consensus       134 ~l~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L  203 (386)
                      -..+    +.|-+      |.+++-  .-.....|+||||+|..+.+...-.+     ..++...+..-+.++..-+-+-
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHHHHHh
Confidence            3322    33444      333322  22456789999999987766542221     2344444444333333222222


Q ss_pred             HhcCCCCeeecCCCCCCeEeCC----CCceEEeeccCCcccCcc
Q 038768          204 HRGCNIRIVHFDIKPHNILLGE----DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       204 H~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgl~~~~~~~  243 (386)
                      |     |++|+|-.|.||+++.    ++.+.+-|||+.......
T Consensus       320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             c-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            2     8999999999999983    678999999998766543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=2.6e-06  Score=72.77  Aligned_cols=128  Identities=16%  Similarity=0.162  Sum_probs=80.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHH----------HHHHHHHhhcCC---CCccceEEEEEEe-----c
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE----------FINEVASMSKTS---HVNVVSFLGFCYE-----K  153 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~---h~niv~~~~~~~~-----~  153 (386)
                      +.+-......|.+-.. +|..+++|..+......+.          ..+++..+.+++   -.....++.+...     .
T Consensus        37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~  115 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT  115 (229)
T ss_pred             EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence            3444445555555555 6788899987753322221          223334333332   3333333333322     2


Q ss_pred             CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          154 KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                      ...+++|||++|..|.++..          +++    .+...+..++.-||+.   |+.|+|..|.|+++++++ +++.|
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEE
Confidence            34568999999988866531          222    2445677889999998   999999999999998654 89999


Q ss_pred             ccCCc
Q 038768          234 FGLAK  238 (386)
Q Consensus       234 fgl~~  238 (386)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.45  E-value=3.7e-06  Score=74.70  Aligned_cols=140  Identities=13%  Similarity=0.092  Sum_probs=85.6

Q ss_pred             cCcCCc-eEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCCCCHHHH
Q 038768           94 LGQGGF-GSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF  171 (386)
Q Consensus        94 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  171 (386)
                      |-.|.. ..||+.... +..+++|......  ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            444554 789999764 4788889876543  345678888887774 44466778777766678999999998887644


Q ss_pred             hc-------------------ccccccccccCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 038768          172 IY-------------------DEESSNINRKLEWR--TMCQIAV--------------------GIARGLEYLHR----G  206 (386)
Q Consensus       172 l~-------------------~~~~~~~~~~l~~~--~~~~i~~--------------------qi~~~L~~LH~----~  206 (386)
                      ..                   ....  ...++...  .......                    .+...+..|-.    .
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPV--ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCc--ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            21                   1000  00011100  0000000                    01112222211    1


Q ss_pred             CCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       207 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23469999999999999998778999998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.40  E-value=5.7e-08  Score=93.32  Aligned_cols=183  Identities=21%  Similarity=0.137  Sum_probs=131.4

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc-cceEEEEEEecCceeEEEEeCCCC-CH
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN-VVSFLGFCYEKKKRALIYEFMPNG-SL  168 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL  168 (386)
                      ...+++|++++++|.+....+....+.+...    ....-++++|.+++||| .+..++-+..++...++++++.++ +-
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            3567889999999987533344446655433    34557889999999999 777777777777888999999776 22


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .....     .....+.......+.+.-++++++||+.   .-+|+|    ||+..+ +..+..||+....+....   .
T Consensus       323 ~~~~~-----~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~  386 (829)
T KOG0576|consen  323 ALEMT-----VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K  386 (829)
T ss_pred             cccCC-----hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---c
Confidence            11111     1112344555666777888999999986   568998    777765 578999999887665443   2


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcc
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE  295 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~  295 (386)
                      .....+++.|+|||+....  .+....|.|++|+-..++--|-.|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence            3356689999999987553  68889999999987777777766543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=1.1e-05  Score=66.11  Aligned_cols=128  Identities=20%  Similarity=0.227  Sum_probs=87.6

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccce-EEEEEEecCceeEEEEeCCCCCHH
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVS-FLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .+.|++|.+|.||+|.+ .|..+|+|+-+.+ .....+..|.++|..+.-.++.. ++.|-    ...+.|||..|-.|.
T Consensus        27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~  100 (201)
T COG2112          27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhhcccccEEEEeec-cCceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence            36799999999999999 5568999987643 45678899999998887666643 44433    234559999888887


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCCeEeCCCCceEEeeccCCccc
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIK-PHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      +.-..         .+...+..    +++.---|...   ||-|+.|. |...++..++.+.|+||..|+.-
T Consensus       101 ~~~~~---------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         101 KLEIG---------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhc---------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            76522         12233333    33432233333   88898886 55555555559999999998743

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=3.1e-06  Score=74.44  Aligned_cols=143  Identities=21%  Similarity=0.182  Sum_probs=83.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC--ccceEEEEEEec---CceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV--NVVSFLGFCYEK---KKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~~g  166 (386)
                      +.|+.|..+.||+....+ ..+++|..... .....+..|..++..+...  .+.+++.++...   ...+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            458899999999999866 69999997654 3446778888888877533  356777655433   3467899999998


Q ss_pred             CHHH----------------Hh---cccccccccccCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 038768          167 SLDQ----------------FI---YDEESSNINRKLEWRT---------MCQI------------AVGIAR-GLEYLHR  205 (386)
Q Consensus       167 sL~~----------------~l---~~~~~~~~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH~  205 (386)
                      .+..                .+   +.... . ........         ....            ...+.. .++.+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPP-P-FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHT-T-CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccc-c-ccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            8877                11   11100 0 00001000         0000            112222 3333332


Q ss_pred             c----CCCCeeecCCCCCCeEeC-CCCceEEeeccCCc
Q 038768          206 G----CNIRIVHFDIKPHNILLG-EDFCPKISDFGLAK  238 (386)
Q Consensus       206 ~----~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~  238 (386)
                      .    ....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1    234799999999999999 66677899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK10593 hypothetical protein; Provisional

Probab=98.29  E-value=1.8e-05  Score=72.45  Aligned_cols=75  Identities=11%  Similarity=0.074  Sum_probs=56.9

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCC---CccceEEEEEEec---CceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH---VNVVSFLGFCYEK---KKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~~~  165 (386)
                      +.||.|..+.||+....++ .+++|..+. ......+..|.+.|+.+.-   -.+.+.+++|.+.   +..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            5699999999999986555 466677443 2244688999999988853   4688889888653   568999999988


Q ss_pred             CCH
Q 038768          166 GSL  168 (386)
Q Consensus       166 gsL  168 (386)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>PLN02876 acyl-CoA dehydrogenase

Probab=98.27  E-value=1.5e-05  Score=83.10  Aligned_cols=149  Identities=15%  Similarity=0.232  Sum_probs=92.5

Q ss_pred             hccCcCCceEEEEEEeCCC---cEEEEEEecCCC--CChHHHHHHHHHhhcCC-CCcc--ceEEEEEEec---CceeEEE
Q 038768           92 NKLGQGGFGSVYKGKLPDG---RLVAVKVLKNSK--VNGEEFINEVASMSKTS-HVNV--VSFLGFCYEK---KKRALIY  160 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~  160 (386)
                      +.++.|.++.+|+....++   ..+++|+.....  .....+.+|.++++.+. |.++  .+.+.+|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            5688999999999876554   367777765432  23357889999999985 6665  7888888765   4678999


Q ss_pred             EeCCCCCHHHH-----------------------hccccccc-----ccccCC--HHHHHHHH---------------HH
Q 038768          161 EFMPNGSLDQF-----------------------IYDEESSN-----INRKLE--WRTMCQIA---------------VG  195 (386)
Q Consensus       161 e~~~~gsL~~~-----------------------l~~~~~~~-----~~~~l~--~~~~~~i~---------------~q  195 (386)
                      ||+++..+.+.                       ||......     ...+..  ...+..+.               ..
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            99987653210                       11111000     001111  11121111               12


Q ss_pred             HHHHHHHHHhcCC--------CCeeecCCCCCCeEeCC-CCc-eEEeeccCCccc
Q 038768          196 IARGLEYLHRGCN--------IRIVHFDIKPHNILLGE-DFC-PKISDFGLAKLS  240 (386)
Q Consensus       196 i~~~L~~LH~~~~--------~~ivH~dlk~~Nill~~-~~~-~kl~Dfgl~~~~  240 (386)
                      +...+.+|..+..        +.+||+|+++.||+++. +.. .-|.||+++..-
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            3344667754321        35999999999999985 333 579999988754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.26  E-value=5.5e-06  Score=70.16  Aligned_cols=105  Identities=22%  Similarity=0.227  Sum_probs=82.4

Q ss_pred             HHHHHhhcCCC-CccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038768          130 NEVASMSKTSH-VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN  208 (386)
Q Consensus       130 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  208 (386)
                      .|.-+++.+++ +++.+++|+|    ..++|.||.+.+++...-..   -..-...+|..+.+|+.++++.+.+|++...
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~---l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP---LSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc---cccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            57788888875 6999999999    34779999987766432000   0011246799999999999999999998655


Q ss_pred             CCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      ..+.-.|++++|+-+++++++|+.|...+....
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            468999999999999999999999998776443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.22  E-value=1.4e-05  Score=70.65  Aligned_cols=72  Identities=13%  Similarity=0.138  Sum_probs=45.5

Q ss_pred             ccCcCCce-EEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC---ccceEEEEEEecC---ceeEEEEeCCC
Q 038768           93 KLGQGGFG-SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV---NVVSFLGFCYEKK---KRALIYEFMPN  165 (386)
Q Consensus        93 ~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~---~~~lv~e~~~~  165 (386)
                      .|+.|+.. .||+.    +..+++|.... ......+.+|.+.+..+...   .+...++.....+   ..+++|++++|
T Consensus         4 ~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           4 PVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             eccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            46766665 58875    23567787554 23445788999998877532   3444554443322   34789999998


Q ss_pred             CCHH
Q 038768          166 GSLD  169 (386)
Q Consensus       166 gsL~  169 (386)
                      .++.
T Consensus        79 ~~l~   82 (235)
T cd05155          79 ETAT   82 (235)
T ss_pred             CCCC
Confidence            7764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.19  E-value=2.2e-05  Score=69.26  Aligned_cols=73  Identities=21%  Similarity=0.186  Sum_probs=48.1

Q ss_pred             hccCcCCceEEEEEEeCC--CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeCCCCCH
Q 038768           92 NKLGQGGFGSVYKGKLPD--GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.|..|-...+|+....+  +..+++|+........-+..+|+.++..+...++ .++++.+.    ..+||||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            457778888999998754  6789999776432222233578888888754333 44444322    2489999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.09  E-value=0.00013  Score=62.22  Aligned_cols=126  Identities=22%  Similarity=0.343  Sum_probs=87.7

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCC-----------------CChHHHHHHHHHhhcCC------CCccceEEE
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK-----------------VNGEEFINEVASMSKTS------HVNVVSFLG  148 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~~~~  148 (386)
                      ..||+|+.-.||.-  ++.....||+.....                 ...++..+|+.-...+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            46999999888874  456678889887644                 12355666766555554      889999999


Q ss_pred             EEEecCceeEEEEeCCC------CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          149 FCYEKKKRALIYEFMPN------GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       149 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      +..++...-+|+|.+.+      -+|.+++...       .++. ...+.   +-.-.+||-+.   .|+.+|++|.||+
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-------~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG-------GLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcC-------CccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEE
Confidence            99999888888887532      3677777432       2444 33333   33444567776   9999999999999


Q ss_pred             eCCC---C-ceEEee
Q 038768          223 LGED---F-CPKISD  233 (386)
Q Consensus       223 l~~~---~-~~kl~D  233 (386)
                      +..+   . .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532   2 466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.05  E-value=3.6e-05  Score=79.41  Aligned_cols=197  Identities=21%  Similarity=0.209  Sum_probs=131.9

Q ss_pred             HHHHHHhhcCCCCccceEEEEEEecCce----eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Q 038768          129 INEVASMSKTSHVNVVSFLGFCYEKKKR----ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH  204 (386)
Q Consensus       129 ~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH  204 (386)
                      .-|+..+..+.|+|++.++.|.......    .+..+++...++...+...      ...+....+.+..++..||.|+|
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhhHHHHH
Confidence            3466677888999999999988765432    3456888888888888543      56788899999999999999999


Q ss_pred             hcCCCCeeecCCCCC---CeEeCCCCceEEe--eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHh
Q 038768          205 RGCNIRIVHFDIKPH---NILLGEDFCPKIS--DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYS  279 (386)
Q Consensus       205 ~~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  279 (386)
                      +.   ...|.-+..+   +-..+..+.+.++  ||+...........   .....+..|.++|.........+...|+|+
T Consensus       304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence            97   5666555555   4445566667766  88888766554321   122345568888887665444555679999


Q ss_pred             HHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          280 YGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       280 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +|..+..+..|..+-.....       +...           ++........+...+|+.-+...|-.+.++..++
T Consensus       378 lgll~~~~~~~~~i~~~~~~-------~~~~-----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAV-------PVSL-----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHHHhhhhhcCcccccccc-------hhhh-----------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99999999998765543211       1111           1111112566667777766666666555554444

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.03  E-value=0.00023  Score=67.22  Aligned_cols=74  Identities=14%  Similarity=0.192  Sum_probs=54.3

Q ss_pred             hccCcCCceEEEEEEeCCC-cEEEEEEecC------C--CCChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEE
Q 038768           92 NKLGQGGFGSVYKGKLPDG-RLVAVKVLKN------S--KVNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~------~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.||.|.+..||+....+| +.|+||.-..      .  ....+.+..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5699999999999998777 4899998531      1  234466777888887763   2456777766  55668899


Q ss_pred             EEeCCCCC
Q 038768          160 YEFMPNGS  167 (386)
Q Consensus       160 ~e~~~~gs  167 (386)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998644

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.96  E-value=5.8e-05  Score=67.60  Aligned_cols=139  Identities=11%  Similarity=0.069  Sum_probs=79.5

Q ss_pred             cCcCCceEEEEEEeCCCcEEEEEEecCCCCCh-HHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeCCCCCHHHH
Q 038768           94 LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG-EEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFMPNGSLDQF  171 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~  171 (386)
                      +..|-.+.+|+... ++..+++|......... -+..+|..+++.+....+ .+++..+    ...+||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            56688889999874 66788888765432211 235678888888864333 3444433    23689999988665321


Q ss_pred             -----------------hcccccccccccCCHH-HHHHHHHH---------HHHHHHHHHhc-----CCCCeeecCCCCC
Q 038768          172 -----------------IYDEESSNINRKLEWR-TMCQIAVG---------IARGLEYLHRG-----CNIRIVHFDIKPH  219 (386)
Q Consensus       172 -----------------l~~~~~~~~~~~l~~~-~~~~i~~q---------i~~~L~~LH~~-----~~~~ivH~dlk~~  219 (386)
                                       +|....  ...+++.. .+..+..+         +...+..+-..     ....++|+|+.|.
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPR--FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence                             111110  01112211 11111111         11112222211     1236899999999


Q ss_pred             CeEeCCCCceEEeeccCCccc
Q 038768          220 NILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       220 Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||++++++ +.++||+.+...
T Consensus       157 Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cEEEeCCC-CEEEeccccCcC
Confidence            99999877 789999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.90  E-value=0.00012  Score=67.37  Aligned_cols=143  Identities=24%  Similarity=0.261  Sum_probs=84.2

Q ss_pred             hccCcCCceEEEEEEeCC-------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPD-------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  163 (386)
                      +.+..|-...+|+....+       ++.+++|+.........+..+|.+++..+....+ .++++++.    -.+|+||+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence            345667777999988654       5789999976644333456778888777753333 34555543    23689999


Q ss_pred             CCCCHHHH-----------------hccccccc-c----cccCCHHHHH--------------------------HHHHH
Q 038768          164 PNGSLDQF-----------------IYDEESSN-I----NRKLEWRTMC--------------------------QIAVG  195 (386)
Q Consensus       164 ~~gsL~~~-----------------l~~~~~~~-~----~~~l~~~~~~--------------------------~i~~q  195 (386)
                      +|..+...                 +|...... .    ....-+..+.                          .+...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 11111100 0    0000011110                          11222


Q ss_pred             HHHHHHHHHh------cCCCCeeecCCCCCCeEeCCC----CceEEeeccCCc
Q 038768          196 IARGLEYLHR------GCNIRIVHFDIKPHNILLGED----FCPKISDFGLAK  238 (386)
Q Consensus       196 i~~~L~~LH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~  238 (386)
                      +...+.+|-.      .....++|+|+.+.||+++++    +.+.++||+.+.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3333444432      134578999999999999975    789999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.88  E-value=0.00014  Score=66.51  Aligned_cols=144  Identities=18%  Similarity=0.140  Sum_probs=84.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC--ccceEEEE------EEecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV--NVVSFLGF------CYEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~  163 (386)
                      +.+..|....+|+....+ ..+++|+...  .....+..|++++..+.+.  .+.+++..      ....+..++|++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            457778888999987644 4688898764  3445667788877777433  24444432      12345668999999


Q ss_pred             CCCCHHH----H----------hcccccc-c----ccccCCHHHHH----------HHHHHHHHHHHHHHh----cCCCC
Q 038768          164 PNGSLDQ----F----------IYDEESS-N----INRKLEWRTMC----------QIAVGIARGLEYLHR----GCNIR  210 (386)
Q Consensus       164 ~~gsL~~----~----------l~~~~~~-~----~~~~l~~~~~~----------~i~~qi~~~L~~LH~----~~~~~  210 (386)
                      +|..+..    .          +|..... .    ......|....          .....+...+.++..    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            8876532    0          1111000 0    00111221110          011123334444443    12347


Q ss_pred             eeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          211 IVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       211 ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ++|+|+.|.||++++++.+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999998778899998774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.86  E-value=0.00021  Score=60.50  Aligned_cols=123  Identities=28%  Similarity=0.465  Sum_probs=86.5

Q ss_pred             HhhhhhccCcCCc-eEEEEEEeCCCcEEEEEEecC-----C-----CC------------ChHHHHHHHHHhhcCC---C
Q 038768           87 TNSFSNKLGQGGF-GSVYKGKLPDGRLVAVKVLKN-----S-----KV------------NGEEFINEVASMSKTS---H  140 (386)
Q Consensus        87 ~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~-----~-----~~------------~~~~~~~E~~~l~~l~---h  140 (386)
                      ...|.+.||.|.- |.||+++. +|+.+|+|+.+.     .     ..            ....|..|.+...+|+   +
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            3456688999999 99999999 788999999431     0     00            0124778888777664   5


Q ss_pred             Ccc--ceEEEEEEecC------------------ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHH
Q 038768          141 VNV--VSFLGFCYEKK------------------KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL  200 (386)
Q Consensus       141 ~ni--v~~~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L  200 (386)
                      .++  |+.+||..-..                  .+.+|.||.+...               .+.    ..-+.+|.+-|
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~----~~~~~~~~~dl  177 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQ----IRDIPQMLRDL  177 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccc----hhHHHHHHHHH
Confidence            566  88999875321                  1246777765432               111    22356677788


Q ss_pred             HHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       201 ~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      ..+|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            889998   9999999999988     3489999865

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.0011  Score=61.03  Aligned_cols=145  Identities=19%  Similarity=0.231  Sum_probs=81.2

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC--ccceEEEEE------EecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV--NVVSFLGFC------YEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~e~~  163 (386)
                      +.++.|....+|+....+| .+++|+.... ...+....|.+++..|...  .+.+++...      ...+..++++||+
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            4577777789999876555 5677876542 2344556677776666322  234444321      1234568999999


Q ss_pred             CCCCHHH--------------Hhccccccc-cc--c---cCCHHHHH------------HHHHHHHHHHHHHHh----cC
Q 038768          164 PNGSLDQ--------------FIYDEESSN-IN--R---KLEWRTMC------------QIAVGIARGLEYLHR----GC  207 (386)
Q Consensus       164 ~~gsL~~--------------~l~~~~~~~-~~--~---~l~~~~~~------------~i~~qi~~~L~~LH~----~~  207 (386)
                      +|..+..              .++....+- ..  .   .-.|....            .....+...++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            8854321              011110000 00  0   01111100            011223344555532    22


Q ss_pred             CCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       208 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ..+++|+|+.+.||++++++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3589999999999999988877899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.65  E-value=0.0012  Score=61.06  Aligned_cols=144  Identities=17%  Similarity=0.189  Sum_probs=77.1

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC--ccceEEE------EEEecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV--NVVSFLG------FCYEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e~~  163 (386)
                      +.|+.|....+|+....+| .+++|+..  ....+....|+..+..|...  .+.+.+.      +....+..++++||+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            3467788789999886555 68888875  22334444555555544211  2333332      122345678999999


Q ss_pred             CCCCHHH-----------H---hccccccc-----ccccCCH-HHHHH------------HH-HHHHHHHHHHHh----c
Q 038768          164 PNGSLDQ-----------F---IYDEESSN-----INRKLEW-RTMCQ------------IA-VGIARGLEYLHR----G  206 (386)
Q Consensus       164 ~~gsL~~-----------~---l~~~~~~~-----~~~~l~~-~~~~~------------i~-~qi~~~L~~LH~----~  206 (386)
                      +|..+..           .   +|....+-     ....+.| .....            .. ..+...++.+..    .
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            8874311           1   11110000     0001111 11111            11 111122233321    1


Q ss_pred             CCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       207 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ...++||+|+.+.||+++.+...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            23489999999999999977666899999875

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.64  E-value=1.3e-05  Score=84.49  Aligned_cols=206  Identities=12%  Similarity=0.021  Sum_probs=141.1

Q ss_pred             HHHHHHHhhcCCCCccceEEEEEEe--cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Q 038768          128 FINEVASMSKTSHVNVVSFLGFCYE--KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR  205 (386)
Q Consensus       128 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  205 (386)
                      ...|.+.++...|+++.....-...  ....+.+++|+.+|.+.+.+.+....  ...++..-+...-.+......-+|+
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee--~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE--SPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc--CCcchhchHHHHHHHHHhccchhhh
Confidence            4455556666789888765543332  23567899999999999998765322  2334443333333333555555555


Q ss_pred             cCCC--CeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHH
Q 038768          206 GCNI--RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMM  283 (386)
Q Consensus       206 ~~~~--~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvi  283 (386)
                      ..+.  -.+|+++|+-|.+|..+..+|++++|+.+........  .....+++.|++|+....-  .++.++|+|..|+.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLS 1429 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHH
Confidence            4322  3689999999999999999999999999833222211  1234577789999887543  67888999999999


Q ss_pred             HHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          284 ILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       284 l~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      +|+..-|..+|-....        ......+..+....++...+.+.......|+.+..+-|+.
T Consensus      1430 ly~rs~~n~~fi~flq--------~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFFLQ--------PALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             HHHHhcccHHHHHHHH--------HHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcch
Confidence            9999999988865422        3333445566666677777888888888888887777763

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.56  E-value=0.00044  Score=62.62  Aligned_cols=72  Identities=19%  Similarity=0.308  Sum_probs=48.2

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.++.|....+|+.. .+++.+.||+-.  ......|..|.+-|+.|.   --.+.+.+++....+..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            568889999999988 578899999876  233456888888877773   456788999888888889999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.53  E-value=0.00053  Score=62.83  Aligned_cols=140  Identities=20%  Similarity=0.252  Sum_probs=96.4

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCC----------------------ChHH-----HHHHHHHhhcCCCCccc
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV----------------------NGEE-----FINEVASMSKTSHVNVV  144 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~-----~~~E~~~l~~l~h~niv  144 (386)
                      ..|..|--..||.+.-.+|..+|||+++.+-.                      +.+.     ...|++-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            46778888999999988999999999874310                      1111     34578888887655554


Q ss_pred             eEEEEEEecCceeEEEEeCCCCCHH-HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          145 SFLGFCYEKKKRALIYEFMPNGSLD-QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      ..--...  ....|||+|+.+..-. -.|       ....++...+..+-.|++.-|.-|-..|  ++||.||.-=|+|+
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw~aPkL-------Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGWAAPKL-------KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCCcCccc-------ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            3222222  2346899999532211 111       1244666778888888888888888775  89999999999998


Q ss_pred             CCCCceEEeeccCCcccCcc
Q 038768          224 GEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       224 ~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      . +|.+.|+|-+-+.....+
T Consensus       299 h-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             E-CCEEEEEEccccccCCCh
Confidence            5 558899998877655443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.51  E-value=0.00011  Score=66.10  Aligned_cols=132  Identities=17%  Similarity=0.173  Sum_probs=88.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC-----------------------hHHHHHHHHHhhcCC-CC-c
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-----------------------GEEFINEVASMSKTS-HV-N  142 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~-h~-n  142 (386)
                      ..++++||-|--+.+|.+...+|++.++|.-+.....                       +-...+|...|+.|. |- -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            3567899999999999999989999999864321110                       012446777777764 22 3


Q ss_pred             cceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       143 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      |.+.+++    +..++|||++.+..|...-+-         .+...+..   .+..-+--|...   |+||+|..-=||+
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNim  234 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV---------EDPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIM  234 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec---------CChHHHHH---HHHHHHHHHHHc---CceecccchheeE
Confidence            4444443    456899999988777654321         22222222   222223344455   9999999999999


Q ss_pred             eCCCCceEEeeccCCc
Q 038768          223 LGEDFCPKISDFGLAK  238 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~  238 (386)
                      +++++.++++||--..
T Consensus       235 v~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  235 VKDDDKIVVIDFPQMV  250 (465)
T ss_pred             EecCCCEEEeechHhh
Confidence            9999999999997554

>PLN02236 choline kinase

Probab=97.37  E-value=0.0028  Score=59.23  Aligned_cols=143  Identities=19%  Similarity=0.200  Sum_probs=80.9

Q ss_pred             ccCcCCceEEEEEEeCC-----CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccc-eEEEEEEecCceeEEEEeCCCC
Q 038768           93 KLGQGGFGSVYKGKLPD-----GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV-SFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .|-.|-...+|+....+     ++.|++|+........-+..+|..++..+...++. ++++.+.. +   .|+||+++.
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~  118 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHAR  118 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCC
Confidence            45557778899987533     36899998865432222235788888777544443 45555432 2   589999876


Q ss_pred             CHHHH-----------------hcccccccccccCCHHHHHHHHHH-----------------HHHHHHHH----Hh-cC
Q 038768          167 SLDQF-----------------IYDEESSNINRKLEWRTMCQIAVG-----------------IARGLEYL----HR-GC  207 (386)
Q Consensus       167 sL~~~-----------------l~~~~~~~~~~~l~~~~~~~i~~q-----------------i~~~L~~L----H~-~~  207 (386)
                      +|...                 +|............+..+..+..+                 +...+..|    .. ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            66421                 111111000111122333233211                 11112222    21 12


Q ss_pred             CCCeeecCCCCCCeEeCC-CCceEEeeccCCcc
Q 038768          208 NIRIVHFDIKPHNILLGE-DFCPKISDFGLAKL  239 (386)
Q Consensus       208 ~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~  239 (386)
                      ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            336899999999999986 57899999988763

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.24  E-value=0.0052  Score=57.03  Aligned_cols=79  Identities=13%  Similarity=0.133  Sum_probs=52.1

Q ss_pred             ccCcCCceEEEEEEeCCC-cEEEEEEecC--------CCCChHHHHHHHHHhhcCC--CC-ccceEEEEEEecCceeEEE
Q 038768           93 KLGQGGFGSVYKGKLPDG-RLVAVKVLKN--------SKVNGEEFINEVASMSKTS--HV-NVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  160 (386)
                      +||.|....||++..++| +.|+||.-..        -+...++..-|.+.|+...  -| .+.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            589999999999997655 5899997531        1233455667777776653  34 3445543  3666778999


Q ss_pred             EeCCCC-CHHHHhc
Q 038768          161 EFMPNG-SLDQFIY  173 (386)
Q Consensus       161 e~~~~g-sL~~~l~  173 (386)
                      |+++.. .|+..|.
T Consensus        80 EdL~~~~ilR~~Li   93 (370)
T TIGR01767        80 EDLSHHKIARKGLI   93 (370)
T ss_pred             hhCccchHHHHHHH
Confidence            999653 3545443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.23  E-value=0.0032  Score=56.91  Aligned_cols=31  Identities=35%  Similarity=0.500  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCCeEeCCCCc-eEEeeccCCcc
Q 038768          209 IRIVHFDIKPHNILLGEDFC-PKISDFGLAKL  239 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~  239 (386)
                      +.++|+|+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.0078  Score=55.06  Aligned_cols=144  Identities=15%  Similarity=0.164  Sum_probs=80.2

Q ss_pred             CCceEEEEEEeCCCcEEEEEEecC-C--CCChHHHHHHHHHhhcCCC--CccceEEEEEEecC--ceeEEEEeCCCCCHH
Q 038768           97 GGFGSVYKGKLPDGRLVAVKVLKN-S--KVNGEEFINEVASMSKTSH--VNVVSFLGFCYEKK--KRALIYEFMPNGSLD  169 (386)
Q Consensus        97 G~~g~Vy~~~~~~~~~vavK~~~~-~--~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~  169 (386)
                      |.--.+|.... +++..+++ ... .  ........+|+.+++.+.-  .-+...+++|.++.  ..+.||+|++|..+.
T Consensus        36 G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~  113 (321)
T COG3173          36 GWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW  113 (321)
T ss_pred             CcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence            33334455544 37788888 331 1  1223456678888877743  33455667777666  678999999884333


Q ss_pred             HHhcccccc------------------------ccc--ccCCHHHHHHHHH--------------HHHHHHHHHHhcC--
Q 038768          170 QFIYDEESS------------------------NIN--RKLEWRTMCQIAV--------------GIARGLEYLHRGC--  207 (386)
Q Consensus       170 ~~l~~~~~~------------------------~~~--~~l~~~~~~~i~~--------------qi~~~L~~LH~~~--  207 (386)
                      +.+......                        ...  ......++..+..              ....-..||+...  
T Consensus       114 ~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~  193 (321)
T COG3173         114 SALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPP  193 (321)
T ss_pred             CcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCC
Confidence            222110000                        000  0000001111111              1222344554432  


Q ss_pred             ---CCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          208 ---NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       208 ---~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                         .+.++|+|+.+.|++++.++-+-+.||+++.+-..
T Consensus       194 ~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         194 WAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             cCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence               24699999999999999988899999999976544

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.11  E-value=0.011  Score=55.84  Aligned_cols=78  Identities=13%  Similarity=0.115  Sum_probs=52.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecC-----CC---CChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEEE
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKN-----SK---VNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.||.|....||+... ++..++||.-..     ..   .....-..|.+.|..+.   ..++.+++.++.  +..+++|
T Consensus        38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            5789999999999876 455788998651     11   13334445566665553   347888888776  5578899


Q ss_pred             EeCCC--CCHHHHh
Q 038768          161 EFMPN--GSLDQFI  172 (386)
Q Consensus       161 e~~~~--gsL~~~l  172 (386)
                      ||+++  ..+.+.+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99976  3455544

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.06  E-value=0.0055  Score=56.96  Aligned_cols=145  Identities=14%  Similarity=0.174  Sum_probs=79.2

Q ss_pred             hccCcCCceEEEEEEeCC----CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.|..|-...+|+....+    +..|++|+........-+-.+|..+++.+...++ .++++++ ..+   +|.+|+++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcCC
Confidence            345557677889887543    2378999876533222233578888888765555 3455554 222   589999776


Q ss_pred             CHHHH-----------------hcccccccccccCCHHHHHHHHHHH----------------------HHHHHH---HH
Q 038768          167 SLDQF-----------------IYDEESSNINRKLEWRTMCQIAVGI----------------------ARGLEY---LH  204 (386)
Q Consensus       167 sL~~~-----------------l~~~~~~~~~~~l~~~~~~~i~~qi----------------------~~~L~~---LH  204 (386)
                      +|..-                 +|..........--+..+..+..++                      ..-+..   +.
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            65221                 1111100000111122222222111                      111111   11


Q ss_pred             -h-cCCCCeeecCCCCCCeEeCC-CCceEEeeccCCccc
Q 038768          205 -R-GCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLS  240 (386)
Q Consensus       205 -~-~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~  240 (386)
                       . ....-++|+|+.+.||++++ ++.++++||+.+-..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence             1 11124799999999999974 578999999988643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.95  E-value=0.014  Score=53.98  Aligned_cols=142  Identities=22%  Similarity=0.318  Sum_probs=82.8

Q ss_pred             cCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc---ce---EEEEEE--ecC--ceeEEEEeC
Q 038768           94 LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV---VS---FLGFCY--EKK--KRALIYEFM  163 (386)
Q Consensus        94 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni---v~---~~~~~~--~~~--~~~lv~e~~  163 (386)
                      |.+ .-..+|+....+|+. ++|+.... ....++..|+..+..|.-..|   +.   +=|-..  -.+  ..+-+++|+
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 456789988877777 99999877 677777888888777632211   11   111111  122  566789999


Q ss_pred             CCCCHHH-H--------------hcccccc------cccccCCHHH-------------HHHHHHHHHHHHHHHHhc---
Q 038768          164 PNGSLDQ-F--------------IYDEESS------NINRKLEWRT-------------MCQIAVGIARGLEYLHRG---  206 (386)
Q Consensus       164 ~~gsL~~-~--------------l~~~~~~------~~~~~l~~~~-------------~~~i~~qi~~~L~~LH~~---  206 (386)
                      +|..+.. .              ++....+      .......|..             -.....++...+..+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9887772 1              1110000      0011222320             011223344444444432   


Q ss_pred             -CCCC---eeecCCCCCCeEeCCCCc-eEEeeccCCc
Q 038768          207 -CNIR---IVHFDIKPHNILLGEDFC-PKISDFGLAK  238 (386)
Q Consensus       207 -~~~~---ivH~dlk~~Nill~~~~~-~kl~Dfgl~~  238 (386)
                       ....   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             1123   899999999999998875 8999998774

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.94  E-value=0.029  Score=52.08  Aligned_cols=71  Identities=20%  Similarity=0.174  Sum_probs=46.1

Q ss_pred             CCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC--ccceEE---E--EEEecCceeEEEEeCCCCC
Q 038768           97 GGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV--NVVSFL---G--FCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        97 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.-..||+....+|..+++|+.+.......++..|++.+..|...  .++...   |  +...++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            345679998887888999999875555666777888877665321  122211   1  1223456778999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.86  E-value=0.0031  Score=54.63  Aligned_cols=125  Identities=20%  Similarity=0.221  Sum_probs=61.1

Q ss_pred             CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeCCCCCHHHH-----------------
Q 038768          110 GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFMPNGSLDQF-----------------  171 (386)
Q Consensus       110 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~-----------------  171 (386)
                      ++.|+||+.......--....|..+++.+...++ .++++++..    ..|++|+++.+|..-                 
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678899987765555566788888888764444 445555422    257799976665321                 


Q ss_pred             hccccc-ccccccCCHHHHHHH----------------------HHHHHHHHHHHHh---c--CCCCeeecCCCCCCeEe
Q 038768          172 IYDEES-SNINRKLEWRTMCQI----------------------AVGIARGLEYLHR---G--CNIRIVHFDIKPHNILL  223 (386)
Q Consensus       172 l~~~~~-~~~~~~l~~~~~~~i----------------------~~qi~~~L~~LH~---~--~~~~ivH~dlk~~Nill  223 (386)
                      +|.... ......--+..+..+                      ...+..-+..+..   .  ....++|+|+.+.||++
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence            011100 000000011222222                      1112222222221   1  11268999999999999


Q ss_pred             -CCCCceEEeeccCCc
Q 038768          224 -GEDFCPKISDFGLAK  238 (386)
Q Consensus       224 -~~~~~~kl~Dfgl~~  238 (386)
                       +.++.++++||..+.
T Consensus       158 ~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             TSSSSCEEE--GTT-E
T ss_pred             ccCCCeEEEecHHHHh
Confidence             888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.80  E-value=0.029  Score=51.67  Aligned_cols=29  Identities=31%  Similarity=0.330  Sum_probs=25.5

Q ss_pred             CCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 578999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.60  E-value=0.03  Score=51.55  Aligned_cols=30  Identities=20%  Similarity=0.161  Sum_probs=27.5

Q ss_pred             CCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      .+++|+|+.+.|+|++.++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            479999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.57  E-value=0.03  Score=53.05  Aligned_cols=74  Identities=18%  Similarity=0.135  Sum_probs=44.8

Q ss_pred             hccCcCCceEEEEEEeCCC--c-----EEEEEEecCCCCChHHHHHHHHHhhcCCCCccc-eEEEEEEecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDG--R-----LVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV-SFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~  163 (386)
                      +.|..|-...+|++...++  .     .|+++.........-+-.+|+.+++.+...++. ++++.+.    -.+|+||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence            3455677889999976443  1     245554322211112235788898888765554 4555543    25999999


Q ss_pred             CCCCHH
Q 038768          164 PNGSLD  169 (386)
Q Consensus       164 ~~gsL~  169 (386)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            887664

>PRK06148 hypothetical protein; Provisional

Probab=96.43  E-value=0.074  Score=56.99  Aligned_cols=145  Identities=18%  Similarity=0.192  Sum_probs=78.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcC-------CCCccceEE-----EEEEe-cC--ce
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-------SHVNVVSFL-----GFCYE-KK--KR  156 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~-----~~~~~-~~--~~  156 (386)
                      +.|+ |..-.+|+....+|..+++|+.+... .......|...|..|       .-|.+++..     ..... ++  ..
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3464 45678899887788899999998642 333334454455433       233333321     11111 22  34


Q ss_pred             eEEEEeCCCCCHHHHhc-----------------c----cccccccccCCHH-----------------HHHHHHHHHHH
Q 038768          157 ALIYEFMPNGSLDQFIY-----------------D----EESSNINRKLEWR-----------------TMCQIAVGIAR  198 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~-----------------~----~~~~~~~~~l~~~-----------------~~~~i~~qi~~  198 (386)
                      +-+++|++|..+.+...                 .    -........+.|.                 ....++.++..
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            56899999987765110                 0    0000001112221                 11222233333


Q ss_pred             HHH-----HHHhcCCCCeeecCCCCCCeEeCCCC--ceE-EeeccCCcc
Q 038768          199 GLE-----YLHRGCNIRIVHFDIKPHNILLGEDF--CPK-ISDFGLAKL  239 (386)
Q Consensus       199 ~L~-----~LH~~~~~~ivH~dlk~~Nill~~~~--~~k-l~Dfgl~~~  239 (386)
                      ...     .+.+ ...++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     1222 234799999999999999775  444 999998763

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.36  E-value=0.026  Score=53.22  Aligned_cols=79  Identities=15%  Similarity=0.149  Sum_probs=53.4

Q ss_pred             hccCcCCceEEEEEEeCC-CcEEEEEEecC----C---CCChHHHHHHHHHhhcCC--CC-ccceEEEEEEecCceeEEE
Q 038768           92 NKLGQGGFGSVYKGKLPD-GRLVAVKVLKN----S---KVNGEEFINEVASMSKTS--HV-NVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  160 (386)
                      +.||.|.-.-||++...+ ++.|+||.-..    .   +...++..-|.+.|+...  -| .+.+++.  .+.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence            579999999999998743 56899987531    1   334466677777777653  34 4555554  3667778999


Q ss_pred             EeCCCC-CHHHHh
Q 038768          161 EFMPNG-SLDQFI  172 (386)
Q Consensus       161 e~~~~g-sL~~~l  172 (386)
                      |+++.. .|+..|
T Consensus       113 EdL~~~~ilR~~L  125 (409)
T PRK12396        113 EDLSDHTILRTAL  125 (409)
T ss_pred             HhCcccHHHHHHH
Confidence            999653 354444

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.33  E-value=0.017  Score=53.12  Aligned_cols=110  Identities=17%  Similarity=0.194  Sum_probs=73.0

Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ..|++|++. |+++. .+         ..-.+.++..++.+.+.-+.-+..+  ...=|||+...||||+ +|.+.|+||
T Consensus       300 y~yl~~kdh-gt~is-~i---------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         300 YLYLHFKDH-GTPIS-II---------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             EEEEEEecC-Cceee-ee---------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEe
Confidence            445677765 44442 22         3356788899999988888888776  4889999999999999 999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR  291 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~  291 (386)
                      -++++...... .      .-...--|-.+.+   .-+.+-|||-+   |--|+.|.
T Consensus       366 klsRl~~~q~~-i------sy~rldhp~lF~G---~dd~QFeIYrl---Mr~l~~g~  409 (488)
T COG5072         366 KLSRLSYSQGI-I------SYNRLDHPDLFNG---VDDYQFEIYRL---MRRLLKGR  409 (488)
T ss_pred             eeeecccCCce-e------eccccCchhhhcC---ccceeeeHHHH---HHHHhcCc
Confidence            99995433321 1      1112233444443   23667788874   44445454

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=96.27  E-value=0.031  Score=49.57  Aligned_cols=77  Identities=21%  Similarity=0.208  Sum_probs=54.8

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC-CCCCHHHH
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM-PNGSLDQF  171 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~gsL~~~  171 (386)
                      .+..|..+.|+.++..+|+++++|+.........+...+ ..|+..+-...|++++.  +.....+++|.+ ++.+|.+.
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L~~~   85 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSLASL   85 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecc--ccccchhhhhhccCCCchhhc
Confidence            466789999999998899999999987544322222122 44777777788898875  344567888988 55577665


Q ss_pred             h
Q 038768          172 I  172 (386)
Q Consensus       172 l  172 (386)
                      .
T Consensus        86 ~   86 (253)
T PF04655_consen   86 P   86 (253)
T ss_pred             c
Confidence            4

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.89  E-value=0.052  Score=46.63  Aligned_cols=137  Identities=15%  Similarity=0.162  Sum_probs=82.6

Q ss_pred             EEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHH
Q 038768          114 AVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ  191 (386)
Q Consensus       114 avK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~  191 (386)
                      .+|.+...+.  ...-|.++.+++.+++  .|+++..-  +.-.+-++.|+|..-..               .   . ..
T Consensus        89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------------~---~-~N  145 (308)
T PF07387_consen   89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------------N---F-SN  145 (308)
T ss_pred             hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------------c---h-hH
Confidence            3444443332  4456788888887764  46666521  22244588998832110               0   1 11


Q ss_pred             HHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCC
Q 038768          192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV  271 (386)
Q Consensus       192 i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  271 (386)
                      ++.-=+++|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|-+..-  ..            +.-|.--|+     ...
T Consensus       146 ~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~------------~V~~vN~~Y-----~~l  205 (308)
T PF07387_consen  146 FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN------------QVNMVNIEY-----ESL  205 (308)
T ss_pred             HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh------------eeeEEeeec-----ccc
Confidence            122224667788864 3489999999999999999999999976432  11            112333221     245


Q ss_pred             CccchhHhHHHHHHHHHhCCCC
Q 038768          272 SHKSDVYSYGMMILEMVVGRKN  293 (386)
Q Consensus       272 ~~~~DvwslGvil~elltg~~p  293 (386)
                      ++++.+-+|=.-++++......
T Consensus       206 T~~aE~~~fv~s~l~~v~~~~~  227 (308)
T PF07387_consen  206 TQEAEVKVFVKSCLKLVEKQRS  227 (308)
T ss_pred             ChHHHHHHHHHHHHHHHHHHhc
Confidence            7778887877777777775443

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=95.82  E-value=0.13  Score=49.78  Aligned_cols=72  Identities=15%  Similarity=0.151  Sum_probs=44.0

Q ss_pred             ccCcCCceEEEEEEeCC---------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccc-eEEEEEEecCceeEEEEe
Q 038768           93 KLGQGGFGSVYKGKLPD---------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV-SFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~  162 (386)
                      .|..|-.-.+|+....+         ++.|++|+.......--.-.+|..++..+...+|- ++++.+.    -..|.||
T Consensus       112 ~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ef  187 (442)
T PTZ00296        112 QILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEEW  187 (442)
T ss_pred             EecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEEe
Confidence            45556667788887542         45788888765332222335677777776544443 4555442    3568999


Q ss_pred             CCCCCH
Q 038768          163 MPNGSL  168 (386)
Q Consensus       163 ~~~gsL  168 (386)
                      +++.+|
T Consensus       188 i~g~~l  193 (442)
T PTZ00296        188 LYGDPL  193 (442)
T ss_pred             eCCccC
Confidence            988744

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.36  E-value=0.15  Score=44.20  Aligned_cols=74  Identities=16%  Similarity=0.294  Sum_probs=50.3

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcC---CCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT---SHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .+-.|.--..|.... +..++.||+-...  ....|..|+.-|..+   +.-++.+.+.+..+.+..|+|+||++-+.+.
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            344454455555543 5678888874322  234677787666555   4566888888888899999999999886664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	386
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-43
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-33
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-33
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-31
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-24
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-24
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-24
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-24
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-24
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-24
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-24
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-24
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-24
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-24
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-24
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-23
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-23
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-23
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-23
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-23
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-23
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-23
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-23
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-23
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-23
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-23
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-22
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-22
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-22
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-18
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-18
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-18
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-18
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-17
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-17
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 164/297 (55%), Gaps = 30/297 (10%)
Query: 76  KRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE--FINE 131
           KR++  +++  +++FSNK  LG+GGFG VYKG+L DG LVAVK LK  +  G E  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
           V  +S   H N++   GFC    +R L+Y +M NGS+   + +   S     L+W    +
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP--PLDWPKRQR 143
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           IA+G ARGL YLH  C+ +I+H D+K  NILL E+F   + DFGLAKL + K+  +    
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-A 202
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV-KVSLSSEIYFPNSI 310
            RGTIG+IAPE    + G  S K+DV+ YG+M+LE++ G++  ++ +++   ++   + +
Sbjct: 203 VRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 311 --------------------YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS 347
                               YK  E     Q+A + T+       KM  V+ MLEG 
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/221 (42%), Positives = 136/221 (61%), Gaps = 9/221 (4%)
Query: 76  KRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE--FINE 131
           KR++  +++  +++F NK  LG+GGFG VYKG+L DG LVAVK LK  +  G E  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
           V  +S   H N++   GFC    +R L+Y +M NGS+   + +   S     L+W    +
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--PPLDWPKRQR 135
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           IA+G ARGL YLH  C+ +I+H D+K  NILL E+F   + DFGLAKL + K+  +    
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-A 194
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
            RG IG+IAPE    + G  S K+DV+ YG+M+LE++ G++
Sbjct: 195 VRGXIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQR 233

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 149/277 (53%), Gaps = 17/277 (6%)
Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKLPDG 110
           +  N+ N+   ++++   V     R    D++  TN+F +K  +G G FG VYKG L DG
Sbjct: 7   KATNSINDALSSSYL---VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 111 RLVAVKVLKNSKVNGEEFINEVAS-MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
             VA+K        G E        +S   H ++VS +GFC E+ +  LIY++M NG+L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP 229
           + +Y  +   ++  + W    +I +G ARGL YLH      I+H D+K  NILL E+F P
Sbjct: 124 RHLYGSDLPTMS--MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 230 KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           KI+DFG++K   + +        +GT+GYI PE F +  G ++ KSDVYS+G+++ E++ 
Sbjct: 179 KITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLC 236
Query: 290 GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV 326
            R  + +  SL  E+   N     +E  N  QL  +V
Sbjct: 237 AR--SAIVQSLPREMV--NLAEWAVESHNNGQLEQIV 269

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 86/226 (38%), Positives = 123/226 (54%), Gaps = 23/226 (10%)
Query: 78  YNYSDVKRMTNSFS--------NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE-- 127
           +++ ++K +TN+F         NK+G+GGFG VYKG + +  +   K+     +  EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 128 --FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKL 184
             F  E+  M+K  H N+V  LGF  +     L+Y +MPNGSL     D  S  +    L
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLSCLDGTPPL 130
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
            W   C+IA G A G+ +LH   +I   H DIK  NILL E F  KISDFGLA+ SEK  
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +      GT  Y+APE      G ++ KSD+YS+G+++LE++ G
Sbjct: 188 QTVMXXRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 86/226 (38%), Positives = 123/226 (54%), Gaps = 23/226 (10%)
Query: 78  YNYSDVKRMTNSFS--------NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE-- 127
           +++ ++K +TN+F         NK+G+GGFG VYKG + +  +   K+     +  EE  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 128 --FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKL 184
             F  E+  M+K  H N+V  LGF  +     L+Y +MPNGSL     D  S  +    L
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLSCLDGTPPL 124
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
            W   C+IA G A G+ +LH   +I   H DIK  NILL E F  KISDFGLA+ SEK  
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +      GT  Y+APE      G ++ KSD+YS+G+++LE++ G
Sbjct: 182 QXVMXXRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITG 224

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/278 (34%), Positives = 153/278 (55%), Gaps = 19/278 (6%)
Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKLPDG 110
           +  N+ N+   ++++   V     R    D++  TN+F +K  +G G FG VYKG L DG
Sbjct: 7   KATNSINDALSSSYL---VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 111 RLVAVKVLKNSKVNGEEFINEVAS-MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
             VA+K        G E        +S   H ++VS +GFC E+ +  LIY++M NG+L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP 229
           + +Y  +   ++  + W    +I +G ARGL YLH      I+H D+K  NILL E+F P
Sbjct: 124 RHLYGSDLPTMS--MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 230 KISDFGLAKL-SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           KI+DFG++K  +E  ++ +  +  +GT+GYI PE F +  G ++ KSDVYS+G+++ E++
Sbjct: 179 KITDFGISKKGTELGQTHLXXV-VKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVL 235
Query: 289 VGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV 326
             R  + +  SL  E+   N     +E  N  QL  +V
Sbjct: 236 CAR--SAIVQSLPREMV--NLAEWAVESHNNGQLEQIV 269

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/226 (38%), Positives = 123/226 (54%), Gaps = 23/226 (10%)
Query: 78  YNYSDVKRMTNSFS--------NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE-- 127
           +++ ++K +TN+F         NK+G+GGFG VYKG + +  +   K+     +  EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 128 --FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKL 184
             F  E+  M+K  H N+V  LGF  +     L+Y +MPNGSL     D  S  +    L
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLSCLDGTPPL 130
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
            W   C+IA G A G+ +LH   +I   H DIK  NILL E F  KISDFGLA+ SEK  
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +      GT  Y+APE      G ++ KSD+YS+G+++LE++ G
Sbjct: 188 QTVMXSRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/226 (37%), Positives = 119/226 (52%), Gaps = 23/226 (10%)
Query: 78  YNYSDVKRMTNSFS--------NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE-- 127
           +++ ++K +TN+F         NK G+GGFG VYKG + +  +   K+     +  EE  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 128 --FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKL 184
             F  E+   +K  H N+V  LGF  +     L+Y + PNGSL     D  S  +    L
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL----LDRLSCLDGTPPL 121
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
            W   C+IA G A G+ +LH   +I   H DIK  NILL E F  KISDFGLA+ SEK  
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             +      GT  Y APE      G ++ KSD+YS+G+++LE++ G
Sbjct: 179 QXVXXSRIVGTTAYXAPEAL---RGEITPKSDIYSFGVVLLEIITG 221

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 118/215 (54%), Gaps = 15/215 (6%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFI---NEVASMS 136
           Y +++      S ++G G FG+VYKGK      VAVK+LK      E+F    NEVA + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           KT HVN++ F+G+   K   A++ ++    SL + ++ +E+     K +   +  IA   
Sbjct: 88  KTRHVNILLFMGYM-TKDNLAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQT 141
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           A+G++YLH      I+H D+K +NI L E    KI DFGLA +  +      +    G++
Sbjct: 142 AQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 257 GYIAPEVF-CRNFGGVSHKSDVYSYGMMILEMVVG 290
            ++APEV   ++    S +SDVYSYG+++ E++ G
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 118/211 (55%), Gaps = 12/211 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKT 138
           D+     +   K+G G FG+V++ +   G  VAVK+L     + E   EF+ EVA M + 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
            H N+V F+G   +    +++ E++  GSL + ++    S    +L+ R    +A  +A+
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH---KSGAREQLDERRRLSMAYDVAK 148
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           G+ YLH   N  IVH ++K  N+L+ + +  K+ DFGL++L  K  +F+S   A GT  +
Sbjct: 149 GMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEW 205
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           +APEV  R+    + KSDVYS+G+++ E+  
Sbjct: 206 MAPEVL-RDEPS-NEKSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 116/211 (54%), Gaps = 12/211 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKT 138
           D+     +   K+G G FG+V++ +   G  VAVK+L     + E   EF+ EVA M + 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
            H N+V F+G   +    +++ E++  GSL + ++    S    +L+ R    +A  +A+
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH---KSGAREQLDERRRLSMAYDVAK 148
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           G+ YLH   N  IVH D+K  N+L+ + +  K+ DFGL++L  K   F+    A GT  +
Sbjct: 149 GMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEW 205
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           +APEV  R+    + KSDVYS+G+++ E+  
Sbjct: 206 MAPEVL-RDEPS-NEKSDVYSFGVILWELAT 234

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 116/222 (52%), Gaps = 13/222 (5%)
Query: 71  VSLAPKRYNYS--DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEE 127
            S+ P   NY   +++R   +  +KLG G +G VY+G      L VAVK LK   +  EE
Sbjct: 1   TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           F+ E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +   
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV--- 117
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +  +A  I+  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ 
Sbjct: 118 -LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYT 172
Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           +  GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 173 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 116/222 (52%), Gaps = 13/222 (5%)
Query: 71  VSLAPKRYNYS--DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEE 127
            S+ P   NY   +++R   +  +KLG G +G VY+G      L VAVK LK   +  EE
Sbjct: 1   TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           F+ E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +   
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV--- 117
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +  +A  I+  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ 
Sbjct: 118 -LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYT 172
Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           +  GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 173 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 114/207 (55%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 72
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E + +  IA   ARG++YLH 
Sbjct: 73  FMGYS-TKPQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHA 126
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 127 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 118/236 (50%), Gaps = 22/236 (9%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL-EWRTMCQIAVGIARGLEYLHRGC 207
            C E+    L++EFM +G L  ++         R L    T+  + + +  G+ YL   C
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--S 175
Query: 268 FGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
           F   S KSDV+S+G+++ E+          R N+EV   +S+   +Y P     H+
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 118/236 (50%), Gaps = 22/236 (9%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL-EWRTMCQIAVGIARGLEYLHRGC 207
            C E+    L++EFM +G L  ++         R L    T+  + + +  G+ YL   C
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--S 177
Query: 268 FGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
           F   S KSDV+S+G+++ E+          R N+EV   +S+   +Y P     H+
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 233

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 117/235 (49%), Gaps = 20/235 (8%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C E+    L++EFM +G L  ++  +            T+  + + +  G+ YL   C 
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLEEAC- 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +F
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SF 181
Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
              S KSDV+S+G+++ E+          R N+EV   +S+   +Y P     H+
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 236

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 116/221 (52%), Gaps = 13/221 (5%)
Query: 72  SLAPKRYNYS--DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEF 128
           ++ P   NY   +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
           + E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV---- 117
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +  +A  I+  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +
Sbjct: 118 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTA 173
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 174 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 65
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 121
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 122 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPI 177
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 178 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 208

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 77
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 133
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 134 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 189
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 190 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 220

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 122
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 178
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 179 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 122
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 178
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 179 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 117/235 (49%), Gaps = 20/235 (8%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K +K   ++ ++FI E   M K SH  +V   G
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C E+    L++EFM +G L  ++  +            T+  + + +  G+ YL   C 
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +F
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SF 198
Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
              S KSDV+S+G+++ E+          R N+EV   +S+   +Y P     H+
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 253

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  ++ R +     +LG G FG V+ G   +   VAVK LK   ++ + F+ E   
Sbjct: 2   PWDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANL 61
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M    H  +V        ++   +I E+M  GSL  F+  +E      K+    +   + 
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGG----KVLLPKLIDFSA 117
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ Y+ R      +H D++  N+L+ E    KI+DFGLA++ E  E + +  GA+ 
Sbjct: 118 QIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKF 173
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFP 307
            I + APE    NFG  + KSDV+S+G+++ E+V        GR NA+V  +LS     P
Sbjct: 174 PIKWTAPEAI--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 68
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 124
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 180
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 181 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 211

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 122
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPI 178
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 179 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E + +  IA   ARG++YLH 
Sbjct: 85  FMGYS-TKPQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHA 138
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA    +           G+I ++APEV  
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 116/235 (49%), Gaps = 20/235 (8%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C E+    L+ EFM +G L  ++  +            T+  + + +  G+ YL   C 
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLEEAC- 124
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +F
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SF 179
Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
              S KSDV+S+G+++ E+          R N+EV   +S+   +Y P     H+
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 17/233 (7%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLG G FG V+ G   +   VAVK LK   ++ + F+ E   M    H 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       +++   +I EFM  GSL  F+  +E      K+    +   +  IA G+ 
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGG----KVLLPKLIDFSAQIAEGMA 123
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R      +H D++  N+L+ E    KI+DFGLA++ E  E + +  GA+  I + AP
Sbjct: 124 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 179
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFP 307
           E    NFG  + KS+V+S+G+++ E+V        GR NA+V  +LS     P
Sbjct: 180 EAI--NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMP 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 13/221 (5%)
Query: 72  SLAPKRYNYS--DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEF 128
           ++ P   NY   +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
           + E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV---- 117
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +  +A  I+  +EYL +      +H D+   N L+GE+   K++DFGL++L    ++  +
Sbjct: 118 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTA 173
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 174 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    +I E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 240 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMA 294
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 350
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 351 EAAL--YGRFTIKSDVWSFGILLTELTT 376

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 13/221 (5%)
Query: 72  SLAPKRYNYS--DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEF 128
           ++ P   NY   +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
           + E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV---- 117
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +  +A  I+  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +
Sbjct: 118 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTA 173
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 174 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 240 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMA 294
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 350
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 351 EAAL--YGRFTIKSDVWSFGILLTELTT 376

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 65
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N  +    +  +A  I
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 121
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    ++  +  GA+  I
Sbjct: 122 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPI 177
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 178 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 64
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 65  KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 119
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 120 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 175
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 176 EAAL--YGRFTIKSDVWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 62
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 63  KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 117
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 118 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 173
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 174 EAAL--YGRFTIKSDVWSFGILLTELTT 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 323 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMA 377
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 378 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 433
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 434 EAAL--YGRFTIKSDVWSFGILLTELTT 459

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 11/213 (5%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMS 136
           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +  H N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           +  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            + APE    N    S KSDV+++G+++ E+  
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIY-IVCEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 66
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 67  KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMA 121
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 122 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 177
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 178 EAAL--YGRFTIKSDVWSFGILLTELTT 203

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+     + A++ ++    SL   ++  E+     K E + +  IA   ARG++YLH 
Sbjct: 85  FMGYS-TAPQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHA 138
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA    +           G+I ++APEV  
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 240 KLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMA 294
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 350
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 351 EAAL--YGRFTIKSDVWSFGILLTELTT 376

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMSKTSH 140
           +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M +  H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I+  +
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAM 122
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL +      +H D+   N L+GE+   K++DFGL++L    ++F +  GA+  I + A
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTA 178
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           PE    N    S KSDV+++G+++ E+  
Sbjct: 179 PESLAYN--KFSIKSDVWAFGVLLWEIAT 205

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    +I E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E   +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D+   NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 38  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 95
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 96  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 149
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 150 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 63
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  +A  IA G+ 
Sbjct: 64  KLVQLYAVVSEEPI-XIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMA 118
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E   +  GA+  I + AP
Sbjct: 119 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAP 174
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 175 EAAL--YGRFTIKSDVWSFGILLTELTT 200

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 117/228 (51%), Gaps = 22/228 (9%)
Query: 74  APKR-----------YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNS 121
           APKR           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK  
Sbjct: 236 APKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 295
Query: 122 KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN 181
            +  EEF+ E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     +N
Sbjct: 296 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 355
Query: 182 RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
             +    +  +A  I+  +EYL +      +H ++   N L+GE+   K++DFGL++L  
Sbjct: 356 AVV----LLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM- 407
Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             +++ +  GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 408 TGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 453

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 97  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 150
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHE 240
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E    + + L    +  +A  IA G+ 
Sbjct: 241 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 295
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGL +L E  E + +  GA+  I + AP
Sbjct: 296 YVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAP 351
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 352 EAAL--YGRFTIKSDVWSFGILLTELTT 377

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 70
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 71  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 124
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 125 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 74  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 127
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 22/236 (9%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL-EWRTMCQIAVGIARGLEYLHRGC 207
            C E+    L++EFM +G L  ++         R L    T+  + + +  G+ YL    
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEA- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +
Sbjct: 123 --SVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--S 177
Query: 268 FGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS--EIYFPNSIYKHI 314
           F   S KSDV+S+G+++ E+          R N+EV   +S+   +Y P     H+
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 233

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  G L  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIY-IVMEYMSKGCLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 74  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 127
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 69  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 122
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  G L  F+  E    + + L    +  +A  IA G+ 
Sbjct: 74  KLVQLYAVVSEEPIY-IVTEYMSKGCLLDFLKGE----MGKYLRLPQLVDMAAQIASGMA 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 185 EAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 112/204 (54%), Gaps = 20/204 (9%)
Query: 94  LGQGGFGSVYKG-KLPDGRLV----AVKVLKNS---KVNGEEFINEVASMSKTSHVNVVS 145
           LG G FG+VYKG  +P+G  V    A+K+L  +   K N  EF++E   M+   H ++V 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHLVR 81
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            LG C     + L+ + MP+G L ++++ E   NI  +L    +    V IA+G+ YL  
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVH-EHKDNIGSQL----LLNWCVQIAKGMMYLEE 135
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
               R+VH D+   N+L+      KI+DFGLA+L E  E   +  G +  I ++A E  C
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 190
Query: 266 RNFGGVSHKSDVYSYGMMILEMVV 289
            ++   +H+SDV+SYG+ I E++ 
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  ++  IA G+ 
Sbjct: 71  KLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGE----TGKYLRLPQLVDMSAQIASGMA 125
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 126 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 181
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 182 EAAL--YGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+  E      + L    +  ++  IA G+ 
Sbjct: 71  KLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGE----TGKYLRLPQLVDMSAQIASGMA 125
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + AP
Sbjct: 126 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAP 181
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+  
Sbjct: 182 EAAL--YGRFTIKSDVWSFGILLTELTT 207

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMSKTSH 140
           +++R   +  +KLG G FG VY+G      L VAVK LK   +  EEF+ E A M +  H
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I+  +
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAM 122
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL +      +H D+   N L+GE+   K++DFGL++L    ++  +  GA+  I + A
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           PE    N    S KSDV+++G+++ E+  
Sbjct: 179 PESLAYN--KFSIKSDVWAFGVLLWEIAT 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMSKTSH 140
           +++R   +  +KLG G +G VY G      L VAVK LK   +  EEF+ E A M +  H
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 87
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V  LG C  +    ++ E+MP G+L  ++ +     +   +    +  +A  I+  +
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV----LLYMATQISSAM 143
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I + A
Sbjct: 144 EYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 199
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           PE    N    S KSDV+++G+++ E+  
Sbjct: 200 PESLAYN--TFSIKSDVWAFGVLLWEIAT 226

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 88
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 89  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 142
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA    +           G+I ++APEV  
Sbjct: 143 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 20/203 (9%)
Query: 94  LGQGGFGSVYKG-KLPDGRLV----AVKVLKNS---KVNGEEFINEVASMSKTSHVNVVS 145
           LG G FG+VYKG  +P+G  V    A+K+L  +   K N  EF++E   M+   H ++V 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHLVR 104
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            LG C     + L+ + MP+G L ++++ E   NI  +L    +    V IA+G+ YL  
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVH-EHKDNIGSQL----LLNWCVQIAKGMMYLEE 158
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
               R+VH D+   N+L+      KI+DFGLA+L E  E   +  G +  I ++A E  C
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 213
Query: 266 RNFGGVSHKSDVYSYGMMILEMV 288
            ++   +H+SDV+SYG+ I E++
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELM 236

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 117/228 (51%), Gaps = 22/228 (9%)
Query: 74  APKR-----------YNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNS 121
           APKR           Y+  +++R   +  +KLG G +G VY+G      L VAVK LK  
Sbjct: 197 APKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 256
Query: 122 KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN 181
            +  EEF+ E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +     ++
Sbjct: 257 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316
Query: 182 RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
             +    +  +A  I+  +EYL +      +H ++   N L+GE+   K++DFGL++L  
Sbjct: 317 AVV----LLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM- 368
Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             +++ +  GA+  I + APE    N    S KSDV+++G+++ E+  
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 414

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 97  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 150
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA    +           G+I ++APEV  
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++ R +     +LG G FG V+ G       VA+K LK   ++ E F+ E   M K  H 
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD 64
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V       E+    ++ E+M  GSL  F+ D E     R L+   +  +A  +A G+ 
Sbjct: 65  KLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMA 119
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           Y+ R   +  +H D++  NIL+G     KI+DFGLA+L E  E   +  GA+  I + AP
Sbjct: 120 YIER---MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEX-TARQGAKFPIKWTAP 175
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           E     +G  + KSDV+S+G+++ E+V 
Sbjct: 176 EAAL--YGRFTIKSDVWSFGILLTELVT 201

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+   K + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 69  FMGYS-TKPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 122
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA    +           G+I ++APEV  
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMSKTSH 140
           +++R   +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M +  H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V  LG C  +    +I EFM  G+L  ++ +     ++  +    +  +A  I+  +
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAM 122
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           EYL +      +H D+   N L+GE+   K++DFGL++L    ++  +  GA+  I + A
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           PE    N    S KSDV+++G+++ E+  
Sbjct: 179 PESLAYN--KFSIKSDVWAFGVLLWEIAT 205

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           +   ++G G FG+VYKGK      VAVK+L  +    ++   F NEV  + KT HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F+G+     + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH 
Sbjct: 69  FMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA 122
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV  
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++    S +SDVY++G+++ E++ G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 124/236 (52%), Gaps = 20/236 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           ++KR   +   +LG G FG V  GK      VAVK++K   ++ +EF  E  +M K SH 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V F G C ++    ++ E++ NG L  ++      +  + LE   + ++   +  G+ 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-----RSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           +L    + + +H D+   N L+  D C K+SDFG+ +     + ++S +G +  + + AP
Sbjct: 119 FLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAP 174
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMV-VGR------KNAEV--KVSLSSEIYFPN 308
           EVF  ++   S KSDV+++G+++ E+  +G+       N+EV  KVS    +Y P+
Sbjct: 175 EVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 5   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 64
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V        ++   +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 65  ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 119
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E + +  G
Sbjct: 120 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREG 175
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEI 304
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV  +L    
Sbjct: 176 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG- 232
Query: 305 YFPNSIYKHIEPGN 318
                 Y+ + P N
Sbjct: 233 ------YRMVRPDN 240

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 21/232 (9%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 4   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 63
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V        ++   +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 64  ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 118
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E + +  G
Sbjct: 119 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREG 174
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 175 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 21/232 (9%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 9   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 68
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V        ++   +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 69  ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 123
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E + +  G
Sbjct: 124 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREG 179
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 180 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 229

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 120/251 (47%), Gaps = 25/251 (9%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  +V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E   
Sbjct: 2   PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M +  H  +V        ++   +I E+M NGSL  F+  +  S I  KL    +  +A 
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAA 116
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E + +  GA+ 
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKF 172
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFP 307
            I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV  +L       
Sbjct: 173 PIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---- 226
Query: 308 NSIYKHIEPGN 318
              Y+ + P N
Sbjct: 227 ---YRMVRPDN 234

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 118/244 (48%), Gaps = 25/244 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           +V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E   M +  H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V        ++   +I E+M NGSL  F+  +  S I  KL    +  +A  IA G+ 
Sbjct: 64  RLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAAQIAEGMA 118
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           ++        +H D++  NIL+ +    KI+DFGLA+L E  E + +  GA+  I + AP
Sbjct: 119 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAP 174
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFPNSIYKHI 314
           E    N+G  + KSDV+S+G+++ E+V        G  N EV  +L          Y+ +
Sbjct: 175 EAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMV 225
Query: 315 EPGN 318
            P N
Sbjct: 226 RPDN 229

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 112/233 (48%), Gaps = 18/233 (7%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  ++ R +     KLG G FG V+         VAVK +K   ++ E F+ E   
Sbjct: 4   PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 63
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M    H  +V  L     K+   +I EFM  GSL  F+  +E S    K     +   + 
Sbjct: 64  MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSA 118
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++ +      +H D++  NIL+      KI+DFGLA++ E  E + +  GA+ 
Sbjct: 119 QIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKF 174
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSL 300
            I + APE    NFG  + KSDV+S+G++++E+V        G  N EV  +L
Sbjct: 175 PIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 114/232 (49%), Gaps = 21/232 (9%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 5   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 64
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 65  ANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 119
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  G
Sbjct: 120 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREG 175
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 176 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 225

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 121/254 (47%), Gaps = 28/254 (11%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 60
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 61  ANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 115
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  G
Sbjct: 116 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREG 171
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEI 304
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV  +L    
Sbjct: 172 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG- 228
Query: 305 YFPNSIYKHIEPGN 318
                 Y+ + P N
Sbjct: 229 ------YRMVRPDN 236

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 114/232 (49%), Gaps = 21/232 (9%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 7   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 66
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 67  ANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 121
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  G
Sbjct: 122 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREG 177
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 178 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 227

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 112/233 (48%), Gaps = 18/233 (7%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  ++ R +     KLG G FG V+         VAVK +K   ++ E F+ E   
Sbjct: 177 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 236
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M    H  +V  L     K+   +I EFM  GSL  F+  +E S    K     +   + 
Sbjct: 237 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSA 291
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++ +      +H D++  NIL+      KI+DFGLA++ E  E + +  GA+ 
Sbjct: 292 QIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKF 347
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSL 300
            I + APE    NFG  + KSDV+S+G++++E+V        G  N EV  +L
Sbjct: 348 PIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 114/232 (49%), Gaps = 21/232 (9%)
Query: 75  PKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE 131
           P++  + D   V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 67
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
              M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  
Sbjct: 68  ANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGI--KLTINKLLD 122
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           +A  IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  G
Sbjct: 123 MAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREG 178
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           A+  I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 179 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 228

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 119/251 (47%), Gaps = 25/251 (9%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  +V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E   
Sbjct: 3   PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 62
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  +A 
Sbjct: 63  MKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAA 117
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  GA+ 
Sbjct: 118 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKF 173
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFP 307
            I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV  +L       
Sbjct: 174 PIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---- 227
Query: 308 NSIYKHIEPGN 318
              Y+ + P N
Sbjct: 228 ---YRMVRPDN 235

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 119/251 (47%), Gaps = 25/251 (9%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  +V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E   
Sbjct: 2   PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  +A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAA 116
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  GA+ 
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKF 172
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFP 307
            I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV  +L       
Sbjct: 173 PIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---- 226
Query: 308 NSIYKHIEPGN 318
              Y+ + P N
Sbjct: 227 ---YRMVRPDN 234

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 112/229 (48%), Gaps = 18/229 (7%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  +V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E   
Sbjct: 2   PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M +  H  +V        ++   +I E+M NGSL  F+  +  S I  KL    +  +A 
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAA 116
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  GA+ 
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKF 172
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 173 PIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 118/244 (48%), Gaps = 25/244 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           +V R T     +LG G FG V+ G       VAVK LK   ++ + F+ E   M +  H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V        ++   +I E+M NGSL  F+  +  S I  KL    +  +A  IA G+ 
Sbjct: 65  RLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAAQIAEGMA 119
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           ++        +H +++  NIL+ +    KI+DFGLA+L E  E + +  GA+  I + AP
Sbjct: 120 FIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAP 175
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSSEIYFPNSIYKHI 314
           E    N+G  + KSDV+S+G+++ E+V        G  N EV  +L          Y+ +
Sbjct: 176 EAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMV 226
Query: 315 EPGN 318
            P N
Sbjct: 227 RPDN 230

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 94  LGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G  KLP  R   VA+K LK+     +  +F++E + M +  H NV+   
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +     +I EFM NGSLD F+   +      +L       +  GIA G++YL    
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL---A 152
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES---FISMLGARGTIGYIAPEVF 264
           ++  VH D+   NIL+  +   K+SDFGL++  E   S   + S LG +  I + APE  
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
              +   +  SDV+SYG+++ E++
Sbjct: 213 --QYRKFTSASDVWSYGIVMWEVM 234

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 18/229 (7%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  +V R T     +LG G  G V+ G       VAVK LK   ++ + F+ E   
Sbjct: 2   PWWEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M +  H  +V       ++    +I E+M NGSL  F+  +  S I  KL    +  +A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFL--KTPSGI--KLTINKLLDMAA 116
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++        +H D++  NIL+ +    KI+DFGLA+L E  E   +  GA+ 
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX-TAREGAKF 172
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            I + APE    N+G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 173 PIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 90  FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGE--------EFINEVASMSKTSH 140
           +  ++G+GGFG V+KG+L  D  +VA+K L      GE        EF  EV  MS  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V   G  +   +  ++ EF+P G L   + D+        ++W    ++ + IA G+
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGI 135
Query: 201 EYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           EY+    N  IVH D++  NI L         C K++DFGL++     +S  S+ G  G 
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++APE         + K+D YS+ M++  ++ G
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 30/268 (11%)
Query: 94  LGQGGFGSVYKGKLPDGR-----LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSF 146
           +G G FG VYKG L          VA+K LK      +  +F+ E   M + SH N++  
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G   + K   +I E+M NG+LD+F+ +++      +     +  +  GIA G++YL   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYL--- 163
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC 265
            N+  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + APE   
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 266 -RNFGGVSHKSDVYSYGMMILE-MVVGRK------NAEVKVSLSSEIYFPNSIYKHIEPG 317
            R F   +  SDV+S+G+++ E M  G +      N EV  +++     P  +     P 
Sbjct: 224 YRKF---TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC---PS 277
Query: 318 NEFQLAGVVTEEEKEMAKKMILVLEMLE 345
             +QL     ++E+    K   ++ +L+
Sbjct: 278 AIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           P   +  ++ R +     KLG G FG V+         VAVK +K   ++ E F+ E   
Sbjct: 171 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 230
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           M    H  +V  L     K+   +I EFM  GSL  F+  +E S    K     +   + 
Sbjct: 231 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSA 285
Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            IA G+ ++ +      +H D++  NIL+      KI+DFGLA+           +GA+ 
Sbjct: 286 QIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR-----------VGAKF 331
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSL 300
            I + APE    NFG  + KSDV+S+G++++E+V        G  N EV  +L
Sbjct: 332 PIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 90  FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGE--------EFINEVASMSKTSH 140
           +  ++G+GGFG V+KG+L  D  +VA+K L      GE        EF  EV  MS  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V   G  +   +  ++ EF+P G L   + D+        ++W    ++ + IA G+
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGI 135
Query: 201 EYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           EY+    N  IVH D++  NI L         C K++DFG ++     +S  S+ G  G 
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGN 189
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++APE         + K+D YS+ M++  ++ G
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 90  FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGE--------EFINEVASMSKTSH 140
           +  ++G+GGFG V+KG+L  D  +VA+K L      GE        EF  EV  MS  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N+V   G  +   +  ++ EF+P G L   + D+        ++W    ++ + IA G+
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGI 135
Query: 201 EYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           EY+ +  N  IVH D++  NI L         C K++DF L++     +S  S+ G  G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGN 189
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++APE         + K+D YS+ M++  ++ G
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 90  FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSF 146
              ++G+G FG V+ G+L  D  LVAVK  + +       +F+ E   + + SH N+V  
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G C +K+   ++ E +  G    F+  E +     +L  +T+ Q+    A G+EYL   
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK 232
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEVFC 265
           C I   H D+   N L+ E    KISDFG+++  E    + +  G R   + + APE   
Sbjct: 233 CCI---HRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEAL- 287
Query: 266 RNFGGVSHKSDVYSYGMMILE 286
            N+G  S +SDV+S+G+++ E
Sbjct: 288 -NYGRYSSESDVWSFGILLWE 307

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 94  LGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G  KLP  R   VA+K LK+     +  +F++E + M +  H NV+   
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +     +I EFM NGSLD F+   +      +L       +  GIA G++YL    
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL---A 126
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES---FISMLGARGTIGYIAPEVF 264
           ++  VH  +   NIL+  +   K+SDFGL++  E   S   + S LG +  I + APE  
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
              +   +  SDV+SYG+++ E++
Sbjct: 187 --QYRKFTSASDVWSYGIVMWEVM 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 90  FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSF 146
              ++G+G FG V+ G+L  D  LVAVK  + +       +F+ E   + + SH N+V  
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G C +K+   ++ E +  G    F+  E +     +L  +T+ Q+    A G+EYL   
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK 232
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA--RGTIGYIAPEVF 264
           C I   H D+   N L+ E    KISDFG+++  E+ +   +  G   +  + + APE  
Sbjct: 233 CCI---HRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 265 CRNFGGVSHKSDVYSYGMMILE 286
             N+G  S +SDV+S+G+++ E
Sbjct: 288 --NYGRYSSESDVWSFGILLWE 307

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 79  NYSDVKRMTNSFSNKL-----------GQGGFGSVYKG--KLPDGRLVAVKVLKNSKVNG 125
            Y D  R  + F+ +L           G G FG V  G  KLP  R VAV + K  KV  
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAI-KTLKVGY 83
Query: 126 EE-----FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESS 178
            E     F+ E + M +  H NVV   G     K   ++ EFM NG+LD F+  +D + +
Sbjct: 84  TEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 179 NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
            I        +  +  GIA G+ YL    ++  VH D+   NIL+  +   K+SDFGL++
Sbjct: 144 VIQ-------LVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSR 193
Query: 239 LSE-KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           + E   E+  +  G +  + + APE     +   +  SDV+SYG+++ E++
Sbjct: 194 VIEDDPEAVYTTTGGKIPVRWTAPEAI--QYRKFTSASDVWSYGIVMWEVM 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +PDG      VA+KVL+   S    +E ++E   M+      V   
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           LG C     + L+ + MP G L     D    N  R L  + +    + IA+G+ YL   
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCL----LDHVRENRGR-LGSQDLLNWCMQIAKGMSYLE-- 136
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE-VFC 265
            ++R+VH D+   N+L+      KI+DFGLA+L +  E+     G +  I ++A E +  
Sbjct: 137 -DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 266 RNFGGVSHKSDVYSYGMMILEMV 288
           R F   +H+SDV+SYG+ + E++
Sbjct: 196 RRF---THQSDVWSYGVTVWELM 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 111/220 (50%), Gaps = 11/220 (5%)
Query: 68  RNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE 127
           +N  S A   Y   ++     +F  +LG G FG V  GK      VA+K++K   ++ +E
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE 65
Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           FI E   M   SH  +V   G C +++   +I E+M NG L  ++ +     +  + + +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-----MRHRFQTQ 120
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            + ++   +   +EYL    + + +H D+   N L+ +    K+SDFGL++     E + 
Sbjct: 121 QLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 176
Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           S +G++  + +  PEV    +   S KSD++++G+++ E+
Sbjct: 177 SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 23/204 (11%)
Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK K  + G L A KV++  S+   E++I E+  ++   H  +V  LG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y   K  ++ EF P G++D  + +     ++R L   T  QI V   + LE L+   + R
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLE-----LDRGL---TEPQIQVVCRQMLEALNFLHSKR 137
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  N+L+  +   +++DFG++    K  +K++SFI      GT  ++APE V C
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMC 191
Query: 266 RNFGGVS--HKSDVYSYGMMILEM 287
                    +K+D++S G+ ++EM
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH  +V   G
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   +I E+M NG L  ++       +  + + + + ++   +   +EYL    +
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAMEYLE---S 122
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+ +    K+SDFGL++     E + S +G++  + +  PEV    +
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--Y 179
Query: 269 GGVSHKSDVYSYGMMILEM 287
              S KSD++++G+++ E+
Sbjct: 180 SKFSSKSDIWAFGVLMWEI 198

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 115/226 (50%), Gaps = 29/226 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL---VAVKVLKN--SKVNGEEFINEVA 133
           +++D+K     F + +G+G FG V K ++    L    A+K +K   SK +  +F  E+ 
Sbjct: 13  DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 67
Query: 134 SMSKTSH-VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----------SSNINR 182
            + K  H  N+++ LG C  +    L  E+ P+G+L  F+              +++   
Sbjct: 68  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L  + +   A  +ARG++YL +    + +H D+   NIL+GE++  KI+DFG   LS  
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG---LSRG 181
Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +E ++     R  + ++A E    N+   +  SDV+SYG+++ E+V
Sbjct: 182 QEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 160
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGLA+ L +  E+  +  G +  I + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 218 SPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 115/226 (50%), Gaps = 29/226 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL---VAVKVLKN--SKVNGEEFINEVA 133
           +++D+K     F + +G+G FG V K ++    L    A+K +K   SK +  +F  E+ 
Sbjct: 23  DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 77
Query: 134 SMSKTSH-VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----------SSNINR 182
            + K  H  N+++ LG C  +    L  E+ P+G+L  F+              +++   
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L  + +   A  +ARG++YL +    + +H D+   NIL+GE++  KI+DFG   LS  
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG---LSRG 191
Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +E ++     R  + ++A E    N+   +  SDV+SYG+++ E+V
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 235

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH  +V   G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   +I E+M NG L  ++       +  + + + + ++   +   +EYL    +
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+ +    K+SDFGL++     E + S +G++  + +  PEV    +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--Y 175
Query: 269 GGVSHKSDVYSYGMMILEM 287
              S KSD++++G+++ E+
Sbjct: 176 SKFSSKSDIWAFGVLMWEI 194

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 119/243 (48%), Gaps = 38/243 (15%)
Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKL-----------GQGGFGSVYKG--KLPDGR-- 111
           +R YV      + Y D  +  + F+ +L           G G FG V  G  KLP  +  
Sbjct: 17  LRTYVD----PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 72
Query: 112 LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
            VA+K LK      +  +F+ E + M +  H N++   G   + K   ++ E+M NGSLD
Sbjct: 73  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 170 QFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF 227
            F+  +D + + I        +  +  GIA G++YL    ++  VH D+   NIL+  + 
Sbjct: 133 SFLRKHDAQFTVIQ-------LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNL 182
Query: 228 CPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC-RNFGGVSHKSDVYSYGMMIL 285
             K+SDFGL++ L +  E+  +  G +  I + +PE    R F   +  SDV+SYG+++ 
Sbjct: 183 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLW 239
Query: 286 EMV 288
           E++
Sbjct: 240 EVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 119/243 (48%), Gaps = 38/243 (15%)
Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKL-----------GQGGFGSVYKG--KLPDGR-- 111
           +R YV      + Y D  +  + F+ +L           G G FG V  G  KLP  +  
Sbjct: 19  LRTYVD----PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 112 LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
            VA+K LK      +  +F+ E + M +  H N++   G   + K   ++ E+M NGSLD
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 170 QFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF 227
            F+  +D + + I        +  +  GIA G++YL    ++  VH D+   NIL+  + 
Sbjct: 135 SFLRKHDAQFTVIQ-------LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNL 184
Query: 228 CPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC-RNFGGVSHKSDVYSYGMMIL 285
             K+SDFGL++ L +  E+  +  G +  I + +PE    R F   +  SDV+SYG+++ 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLW 241
Query: 286 EMV 288
           E++
Sbjct: 242 EVM 244

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH  +V   G
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   +I E+M NG L  ++       +  + + + + ++   +   +EYL    +
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAMEYLE---S 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+ +    K+SDFGL++     E + S +G++  + +  PEV    +
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLM--Y 180
Query: 269 GGVSHKSDVYSYGMMILEM 287
              S KSD++++G+++ E+
Sbjct: 181 SKFSSKSDIWAFGVLMWEI 199

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 144
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 145 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVV 289
                  +H+SDV+SYG+ + E++ 
Sbjct: 202 LHRI--YTHQSDVWSYGVTVWELMT 224

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 23/204 (11%)
Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK K  + G L A KV++  S+   E++I E+  ++   H  +V  LG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y   K  ++ EF P G++D  + +     ++R L   T  QI V   + LE L+   + R
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-----LDRGL---TEPQIQVVCRQMLEALNFLHSKR 129
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  N+L+  +   +++DFG++    K  +K++SFI      GT  ++APE V C
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMC 183
Query: 266 RNFGGVS--HKSDVYSYGMMILEM 287
                    +K+D++S G+ ++EM
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV 141
           D K +T  F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH 
Sbjct: 13  DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 70
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V   G C +++   +I E+M NG L  ++       +  + + + + ++   +   +E
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAME 125
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL    + + +H D+   N L+ +    K+SDFGL++     E + S +G++  + +  P
Sbjct: 126 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 181
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           EV    +   S KSD++++G+++ E+
Sbjct: 182 EVLM--YSKFSSKSDIWAFGVLMWEI 205

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 192 LHRI--YTHQSDVWSYGVTVWELM 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVV 289
                  +H+SDV+SYG+ + E++ 
Sbjct: 195 LHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 135
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 193 LHRI--YTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 194 LHRI--YTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 159
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 160 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVV 289
                  +H+SDV+SYG+ + E++ 
Sbjct: 217 LHRI--YTHQSDVWSYGVTVWELMT 239

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 138
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 196 LHRI--YTHQSDVWSYGVTVWELM 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 140
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 141 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 198 LHRI--YTHQSDVWSYGVTVWELM 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 195 LHRI--YTHQSDVWSYGVTVWELM 216

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 94  LGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G  KLP  R   VA+K LK      +  +F+ E + M +  H N++   
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   + K   ++ E+M NGSLD F+   +      +L       +  GI+ G++YL    
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL-----VGMLRGISAGMKYLS--- 141
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
           ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + APE    
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA- 200
Query: 267 NFGGVSHKSDVYSYGMMILEMV 288
            F   +  SDV+SYG+++ E+V
Sbjct: 201 -FRKFTSASDVWSYGIVMWEVV 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 135
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 193 LHRI--YTHQSDVWSYGVTVWELM 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 192 LHRI--YTHQSDVWSYGVTVWELM 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 194 LHRI--YTHQSDVWSYGVTVWELM 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 195 LHRI--YTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 199 LHRI--YTHQSDVWSYGVTVWELM 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 192 LHRI--YTHQSDVWSYGVTVWELM 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 195 LHRI--YTHQSDVWSYGVTVWELM 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 160
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 218 SPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 192 LHRI--YTHQSDVWSYGVTVWELM 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 186 LHRI--YTHQSDVWSYGVTVWELM 207

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 131
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 189 SPEAIAYRKF---TSASDVWSYGIVLWEVM 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 11/220 (5%)
Query: 68  RNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE 127
           +N  S A   Y   ++     +F  +LG G FG V  GK      VA+K++K   ++ +E
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE 65
Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           FI E   M   SH  +V   G C +++   +I E+M NG L  ++ +     +  + + +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-----MRHRFQTQ 120
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            + ++   +   +EYL    + + +H D+   N L+ +    K+SDFGL++     E   
Sbjct: 121 QLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE-T 176
Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           S +G++  + +  PEV    +   S KSD++++G+++ E+
Sbjct: 177 SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEI 214

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 36  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 95
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 148
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 149 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 206 SPEAIAYRKF---TSASDVWSYGIVLWEVM 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 78  YNYSDVKRMTNSFSNKL-----------GQGGFGSVYKG--KLPDGR--LVAVKVLKNSK 122
           + Y D  +  + F+ +L           G G FG V  G  KLP  +   VA+K LK   
Sbjct: 26  HTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 123 VNGE--EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESS 178
              +  +F+ E + M +  H N++   G   + K   ++ E+M NGSLD F+  +D + +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 179 NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
            I        +  +  GIA G++YL    ++  VH D+   NIL+  +   K+SDFGL++
Sbjct: 146 VIQ-------LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 239 -LSEKKESFISMLGARGTIGYIAPEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
            L +  E+  +  G +  I + +PE    R F   +  SDV+SYG+++ E++
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVL------KNSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G  V + V         S    +E ++E   M+   + +V   
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 168
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 169 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 226 LHRI--YTHQSDVWSYGVTVWELM 247

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 160
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 218 SPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 160
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 218 SPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G FG V +G+L  P  +   VA+K LK   ++    EF++E + M +  H N++   
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIY--DEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           G         ++ EFM NG+LD F+   D + + I        +  +  GIA G+ YL  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ-------LVGMLRGIASGMRYL-- 132
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES---FISMLGARGTIGYIAPE 262
              +  VH D+   NIL+  +   K+SDFGL++  E+  S   + S LG +  I + APE
Sbjct: 133 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV 288
                F   +  SD +SYG+++ E++
Sbjct: 192 AIA--FRKFTSASDAWSYGIVMWEVM 215

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH  +V   G
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   +I E+M NG L  ++       +  + + + + ++   +   +EYL    +
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAMEYLE---S 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+ +    K+SDFGL++     E + S  G++  + +  PEV    +
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLM--Y 180
Query: 269 GGVSHKSDVYSYGMMILEM 287
              S KSD++++G+++ E+
Sbjct: 181 SKFSSKSDIWAFGVLMWEI 199

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E+M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 160
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL + L +  E+  +  G +  I + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 218 SPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 34/218 (15%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE--VASMSKTSHVNVVSFLG--- 148
           +G+G +G+VYKG L D R VAVKV   S  N + FINE  +  +    H N+  F+    
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 149 --FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-- 204
                 + +  L+ E+ PNGSL +++    S       +W + C++A  + RGL YLH  
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVTRGLAYLHTE 130
Query: 205 --RGCNIR--IVHFDIKPHNILLGEDFCPKISDFGLA------KLSEKKESFISMLGARG 254
             RG + +  I H D+   N+L+  D    ISDFGL+      +L    E   + +   G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 255 TIGYIAPEVF-----CRNFGGVSHKSDVYSYGMMILEM 287
           TI Y+APEV       R+      + D+Y+ G++  E+
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 118/243 (48%), Gaps = 38/243 (15%)
Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKL-----------GQGGFGSVYKG--KLPDGR-- 111
           +R YV      + Y D  +  + F+ +L           G G FG V  G  KLP  +  
Sbjct: 19  LRTYVD----PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 112 LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
            VA+K LK      +  +F+ E + M +  H N++   G   + K   ++ E M NGSLD
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 170 QFI--YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF 227
            F+  +D + + I        +  +  GIA G++YL    ++  VH D+   NIL+  + 
Sbjct: 135 SFLRKHDAQFTVIQ-------LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNL 184
Query: 228 CPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFC-RNFGGVSHKSDVYSYGMMIL 285
             K+SDFGL++ L +  E+  +  G +  I + +PE    R F   +  SDV+SYG+++ 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLW 241
Query: 286 EMV 288
           E++
Sbjct: 242 EVM 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA G+ YL 
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAEGMNYLE 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 132 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 189 LHRI--YTHQSDVWSYGVTVWELM 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 115/226 (50%), Gaps = 29/226 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRL---VAVKVLKN--SKVNGEEFINEVA 133
           +++D+K     F + +G+G FG V K ++    L    A+K +K   SK +  +F  E+ 
Sbjct: 20  DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 74
Query: 134 SMSKTSH-VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----------SSNINR 182
            + K  H  N+++ LG C  +    L  E+ P+G+L  F+              +++   
Sbjct: 75  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 134
Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L  + +   A  +ARG++YL +    + +H ++   NIL+GE++  KI+DFG   LS  
Sbjct: 135 TLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFG---LSRG 188
Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           +E ++     R  + ++A E    N+   +  SDV+SYG+++ E+V
Sbjct: 189 QEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 27/207 (13%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G+L  P  R   VA+K LK    + +  +F++E + M +  H N++   
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR-TMCQIA---VGIARGLEYL 203
           G   + K   +I E+M NGSLD F+         RK + R T+ Q+     GI  G++YL
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFL---------RKNDGRFTVIQLVGMLRGIGSGMKYL 147
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
               ++  VH D+   NIL+  +   K+SDFG+++ L +  E+  +  G +  I + APE
Sbjct: 148 S---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 204
Query: 263 VFC-RNFGGVSHKSDVYSYGMMILEMV 288
               R F   +  SDV+SYG+++ E++
Sbjct: 205 AIAYRKF---TSASDVWSYGIVMWEVM 228

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 27/207 (13%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G+L  P  R   VA+K LK    + +  +F++E + M +  H N++   
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR-TMCQIA---VGIARGLEYL 203
           G   + K   +I E+M NGSLD F+         RK + R T+ Q+     GI  G++YL
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFL---------RKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
               ++  VH D+   NIL+  +   K+SDFG+++ L +  E+  +  G +  I + APE
Sbjct: 133 S---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 189
Query: 263 VFC-RNFGGVSHKSDVYSYGMMILEMV 288
               R F   +  SDV+SYG+++ E++
Sbjct: 190 AIAYRKF---TSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 27/207 (13%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G FG V  G+L  P  R   VA+K LK    + +  +F++E + M +  H N++   
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR-TMCQIA---VGIARGLEYL 203
           G   + K   +I E+M NGSLD F+         RK + R T+ Q+     GI  G++YL
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFL---------RKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
               ++  VH D+   NIL+  +   K+SDFG+++ L +  E+  +  G +  I + APE
Sbjct: 127 S---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 183
Query: 263 VFC-RNFGGVSHKSDVYSYGMMILEMV 288
               R F   +  SDV+SYG+++ E++
Sbjct: 184 AIAYRKF---TSASDVWSYGIVMWEVM 207

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 160
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 218 SPEAIAYRKF---TSASDVWSYGIVLWEVM 244

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK      +  +F+ E + M +  H N
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFI--YDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++   G   + K   ++ E M NGSLD F+  +D + + I        +  +  GIA G+
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ-------LVGMLRGIASGM 131
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
           +YL    ++  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + 
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 260 APEVFC-RNFGGVSHKSDVYSYGMMILEMV 288
           +PE    R F   +  SDV+SYG+++ E++
Sbjct: 189 SPEAIAYRKF---TSASDVWSYGIVLWEVM 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           L  G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 192 LHRI--YTHQSDVWSYGVTVWELM 213

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           L  G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 199 LHRI--YTHQSDVWSYGVTVWELM 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFG AKL   +E      G +  I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVV 289
                  +H+SDV+SYG+ + E++ 
Sbjct: 194 LHRI--YTHQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           L  G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 199 LHRI--YTHQSDVWSYGVTVWELM 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFG AKL   +E      G +  I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 194 LHRI--YTHQSDVWSYGVTVWELM 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFG AKL   +E      G +  I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVV 289
                  +H+SDV+SYG+ + E++ 
Sbjct: 194 LHRI--YTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFG AKL   +E      G +  I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 192 LHRI--YTHQSDVWSYGVTVWELM 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFG AKL   +E      G +  I ++A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 199 LHRI--YTHQSDVWSYGVTVWELM 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGR----LVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+VYKG  +P+G      VA+K L+   S    +E ++E   M+   + +V   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK--LEWRTMCQIAVGIARGLEYLH 204
           LG C     + LI + MP G L  ++  E   NI  +  L W       V IA+G+ YL 
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 138
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              + R+VH D+   N+L+      KI+DFG AKL   +E      G +  I ++A E  
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
                  +H+SDV+SYG+ + E++
Sbjct: 196 LHRI--YTHQSDVWSYGVTVWELM 217

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G FG V +G+L  P  +   VA+K LK   ++    EF++E + M +  H N++   
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIY--DEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           G         ++ EFM NG+LD F+   D + + I        +  +  GIA G+ YL  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ-------LVGMLRGIASGMRYL-- 134
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF---ISMLGARGTIGYIAPE 262
              +  VH D+   NIL+  +   K+SDFGL++  E+  S     S LG +  I + APE
Sbjct: 135 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV 288
                F   +  SD +SYG+++ E++
Sbjct: 194 AIA--FRKFTSASDAWSYGIVMWEVM 217

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 114/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           +    R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE----------SSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++   E          S N   +L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 94  LGQGGFGSVYKGKLP--DGRL--VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FGSV +G L   DG    VAVK +K   +S+   EEF++E A M   SH NV+  
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 147 LGFCYEK-----KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           LG C E       K  +I  FM  G L  ++         + +  +T+ +  V IA G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL    N   +H D+   N +L +D    ++DFGL+K     + +     A+  + +IA 
Sbjct: 162 YLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEM 287
           E         + KSDV+++G+ + E+
Sbjct: 219 ESLADRV--YTSKSDVWAFGVTMWEI 242

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     +   
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N++  LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 21/232 (9%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +        D  LVAVK LK++  N  ++F  E   +
Sbjct: 10  IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 69
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE-------ESSNINRKLEWRT 188
           +   H ++V F G C E     +++E+M +G L++F+             N   +L    
Sbjct: 70  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ 129
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M  IA  IA G+ YL    +   VH D+   N L+GE+   KI DFG+++     + +  
Sbjct: 130 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS 299
                  I ++ PE +  R F   + +SDV+S G+++ E+    K    ++S
Sbjct: 187 GGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEIFTYGKQPWYQLS 235

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   +I+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     +   
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE F         I + A
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 186 PESLTESKFSVA--SDVWSFGVVLYEL 210

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 25  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 84
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 85  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 145 DLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI EF+P GSL +++   +      +++   + Q    I +G+E
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE-----RIDHIKLLQYTSQICKGME 131
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 189 PESLTESKFSVA--SDVWSFGVVLYEL 213

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 30  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 89
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 90  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 150 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 27  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 86
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I E+   G+L +++        E S +INR    ++ ++
Sbjct: 87  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 147 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 147
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 205 LESLQTQKF---TTKSDVWSFGVLLWELM 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 148
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 206 LESLQTQKF---TTKSDVWSFGVLLWELM 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 147
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 205 LESLQTQKF---TTKSDVWSFGVLLWELM 230

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 146
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 204 LESLQTQKF---TTKSDVWSFGVLLWELM 229

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 148
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 206 LESLQTQKF---TTKSDVWSFGVLLWELM 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 140
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 198 LESLQTQKF---TTKSDVWSFGVLLWELM 223

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 145
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 203 LESLQTQKF---TTKSDVWSFGVLLWELM 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 166
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 224 LESLQTQKF---TTKSDVWSFGVLLWELM 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 167
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 225 LESLQTQKF---TTKSDVWSFGVLLWELM 250

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G++Y
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKY 143
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 201 LESLQTQKF---TTKSDVWSFGVLLWELM 226

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 198 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG-----EEFINEVASMSKTSHVNVVSFLG 148
           +G GGFG VY+     G  VAVK  ++          E    E    +   H N+++  G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C ++    L+ EF   G L++ +         +++    +   AV IARG+ YLH    
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 209 IRIVHFDIKPHNILLGEDF--------CPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           + I+H D+K  NIL+ +            KI+DFGLA+   +     + + A G   ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMA 182
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PEV   +    S  SDV+SYG+++ E++ G
Sbjct: 183 PEVIRASM--FSKGSDVWSYGVLLWELLTG 210

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 201 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 149
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+  L ++ +S  +  GA+  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 207 LESLQTQKF---TTKSDVWSFGVLLWELM 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 202 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I  +   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 115/214 (53%), Gaps = 40/214 (18%)
Query: 94  LGQGGFGSVY---KGKLPD-GRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSF 146
           LGQG FG V+   K   PD G L A+KVLK + +   + +    E   ++  +H  VV  
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK- 94
Query: 147 LGFCYEKK-KRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           L + ++ + K  LI +F+  G L      + ++ EE            + ++A+G    L
Sbjct: 95  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-------LAELALG----L 143
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS---EKKE-SFISMLGARGTI 256
           ++LH   ++ I++ D+KP NILL E+   K++DFGL+K +   EKK  SF       GT+
Sbjct: 144 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC------GTV 194
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            Y+APEV  R   G SH +D +SYG+++ EM+ G
Sbjct: 195 EYMAPEVVNRQ--GHSHSADWWSYGVLMFEMLTG 226

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 90  FSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSH 140
           F  +LG+  FG VYKG L         + VA+K LK+ K  G   EEF +E    ++  H
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQH 88
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----------DEESSNINRKLEWRTMC 190
            NVV  LG   + +  ++I+ +  +G L +F+            ++   +   LE     
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 191 QIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML 250
            +   IA G+EYL    +  +VH D+   N+L+ +    KISD GL +     + +  + 
Sbjct: 149 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            +   I ++APE     +G  S  SD++SYG+++ E+
Sbjct: 206 NSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 240

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 194 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 127
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 128 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 185 PESLTESKFSVA--SDVWSFGVVLYEL 209

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 90  FSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSH 140
           F  +LG+  FG VYKG L         + VA+K LK+ K  G   EEF +E    ++  H
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQH 71
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----------DEESSNINRKLEWRTMC 190
            NVV  LG   + +  ++I+ +  +G L +F+            ++   +   LE     
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 191 QIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML 250
            +   IA G+EYL    +  +VH D+   N+L+ +    KISD GL +     + +  + 
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            +   I ++APE     +G  S  SD++SYG+++ E+
Sbjct: 189 NSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 148
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 206 LESLQTQKF---TTKSDVWSFGVLLWELM 231

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 149
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 207 LESLQTQKF---TTKSDVWSFGVLLWELM 232

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 73  LAPK-RYNYSDVKRMTNSFSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNG 125
           L P+  +N +  +     F  +LG+G FGSV   +   L D  G +VAVK L++S + + 
Sbjct: 14  LVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 73
Query: 126 EEFINEVASMSKTSHVNVVSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRK 183
            +F  E+  +    H N+V + G CY   +R   LI E++P GSL  ++   +      +
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----R 128
Query: 184 LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEK 242
           ++   + Q    I +G+EYL      R +H D+   NIL+  +   KI DFGL K L + 
Sbjct: 129 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 185
Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           KE           I + APE    +   V+  SDV+S+G+++ E+
Sbjct: 186 KEXXKVKEPGESPIFWYAPESLTESKFSVA--SDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 73  LAPK-RYNYSDVKRMTNSFSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNG 125
           L P+  +N +  +     F  +LG+G FGSV   +   L D  G +VAVK L++S + + 
Sbjct: 14  LVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 73
Query: 126 EEFINEVASMSKTSHVNVVSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRK 183
            +F  E+  +    H N+V + G CY   +R   LI E++P GSL  ++   +      +
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----R 128
Query: 184 LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEK 242
           ++   + Q    I +G+EYL      R +H D+   NIL+  +   KI DFGL K L + 
Sbjct: 129 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 185
Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           KE           I + APE    +   V+  SDV+S+G+++ E+
Sbjct: 186 KEXXKVKEPGESPIFWYAPESLTESKFSVA--SDVWSFGVVLYEL 228

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 126
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 127 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 184 PESLTESKFSVA--SDVWSFGVVLYEL 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 131
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 189 PESLTESKFSVA--SDVWSFGVVLYEL 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 134
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 192 PESLTESKFSVA--SDVWSFGVVLYEL 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 132
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 133 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 190 PESLTESKFSVA--SDVWSFGVVLYEL 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 186 PESLTESKFSVA--SDVWSFGVVLYEL 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 133
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 134 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 191 PESLTESKFSVA--SDVWSFGVVLYEL 215

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 148
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 206 LESLQTQKF---TTKSDVWSFGVLLWELM 231

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 89  SFSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKT 138
           +    LG+G FG V         K K  +   VAVK+LK+     +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD------EESSNINR----KLEWR 187
             H N+++ LG C +     +I  +   G+L +++        E S +INR    ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
                R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 146
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 204 LESLQTQKF---TTKSDVWSFGVLLWELM 229

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 159
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 217 PESLTESKFSVA--SDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 135
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 136 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 193 PESLTESKFSVA--SDVWSFGVVLYEL 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 186 PESLTESKFSVA--SDVWSFGVVLYEL 210

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 153
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 211 LESLQTQKF---TTKSDVWSFGVLLWELM 236

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 28/212 (13%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFCY 151
           +G G +G VYKG+ +  G+L A+KV+  +    EE   E+  + K SH  N+ ++ G   
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           +K          L+ EF   GS+   I + + + +  K EW  +  I   I RGL +LH+
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL--KEEW--IAYICREILRGLSHLHQ 147
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAP 261
               +++H DIK  N+LL E+   K+ DFG+ A+L     ++ +FI      GT  ++AP
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 198
Query: 262 EVF-CRNFGGVSH--KSDVYSYGMMILEMVVG 290
           EV  C      ++  KSD++S G+  +EM  G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 92  NKLGQGGFGSVYKGKLPDGRL---VAVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           +KLG GG  +VY  +  D  L   VA+K +       EE    F  EV + S+ SH N+V
Sbjct: 17  DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           S +    E     L+ E++   +L ++I   ES      L   T       I  G+++ H
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG---PLSVDTAINFTNQILDGIKHAH 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              ++RIVH DIKP NIL+  +   KI DFG+AK LSE   S        GT+ Y +PE 
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET--SLTQTNHVLGTVQYFSPE- 182
Query: 264 FCRNFGGVSHK-SDVYSYGMMILEMVVGRK--NAEVKVSLS 301
             +  G  + + +D+YS G+++ EM+VG    N E  VS++
Sbjct: 183 --QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 90  FSNKLGQGGFGSVYKGKLPD--GRLV--AVKVLKNSKVNGE--EFINEVASMSKTSHVNV 143
           F+  +G+G FG VY G L D  G+ +  AVK L      GE  +F+ E   M   SH NV
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 144 VSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +S LG C   +   L+   +M +G L  FI +E  +   + L         + +A+G+++
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKF 207
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIA 260
           L    + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA+  + ++A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMV 288
            E    + F   + KSDV+S+G+++ E++
Sbjct: 265 LESLQTQKF---TTKSDVWSFGVLLWELM 290

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 90  FSNKLGQGGFGSVY--------KGKLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTS 139
               LG+G FG V         K K      VAVK+LK+     +  + I+E+  M    
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE----------ESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     +    
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
               R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 129
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H ++   NIL+  +   KI DFGL K L + KE +         I + A
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 187 PESLTESKFSVA--SDVWSFGVVLYEL 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +   L D  G +VAVK L++S + +  +F  E+  +    H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 144 VSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++          +++   + Q    I +G+E
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-----RIDHIKLLQYTSQICKGME 131
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE           I + A
Sbjct: 132 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    +   V+  SDV+S+G+++ E+
Sbjct: 189 PESLTESKFSVA--SDVWSFGVVLYEL 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK 154
            +G FG V+K +L +   VAVK+         +   EV S+    H N++ F+G   EK+
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG--AEKR 89
Query: 155 KRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR--- 205
             +      LI  F   GSL  F+     +N+   + W  +C IA  +ARGL YLH    
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL----KANV---VSWNELCHIAETMARGLAYLHEDIP 142
Query: 206 ----GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
               G    I H DIK  N+LL  +    I+DFGLA   E  +S     G  GT  Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 262 EVF--CRNFGGVSH-KSDVYSYGMMILEMV 288
           EV     NF   +  + D+Y+ G+++ E+ 
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 25/255 (9%)
Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +      GK      VAVK+LK
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
           ++    E+   ++E+  MS    H N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKA 145
Query: 177 SSNIN----RKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKI 231
            ++++    R LE R +   +  +A+G+ +L  + C    +H D+   N+LL      KI
Sbjct: 146 EADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKI 201
Query: 232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEMVVG 290
            DFGLA+      ++I    AR  + ++APE     F  V + +SDV+SYG+++ E+   
Sbjct: 202 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWEIFSL 258
Query: 291 RKNAEVKVSLSSEIY 305
             N    + ++S+ Y
Sbjct: 259 GLNPYPGILVNSKFY 273

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 25/255 (9%)
Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +      GK      VAVK+LK
Sbjct: 18  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 77
Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
           ++    E+   ++E+  MS    H N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 78  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKA 137
Query: 177 SSNIN----RKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKI 231
            ++++    R LE R +   +  +A+G+ +L  + C    +H D+   N+LL      KI
Sbjct: 138 EADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKI 193
Query: 232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEMVVG 290
            DFGLA+      ++I    AR  + ++APE     F  V + +SDV+SYG+++ E+   
Sbjct: 194 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWEIFSL 250
Query: 291 RKNAEVKVSLSSEIY 305
             N    + ++S+ Y
Sbjct: 251 GLNPYPGILVNSKFY 265

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 118/241 (48%), Gaps = 31/241 (12%)
Query: 70  YVSLAPKRYNYSDV--------KRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVA 114
           Y S+ P+ ++ +DV         R   + S +LGQG FG VY+G         P+ R VA
Sbjct: 23  YASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VA 81
Query: 115 VKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI 172
           +K +  +    E  EF+NE + M + +  +VV  LG   + +   +I E M  G L  ++
Sbjct: 82  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
Query: 173 Y----DEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC 228
                + E++ +        M Q+A  IA G+ YL+     + VH D+   N ++ EDF 
Sbjct: 142 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 198
Query: 229 PKISDFGLAKLSEKKESFISMLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
            KI DFG+ +  +  E+     G +G   + +++PE      G  +  SDV+S+G+++ E
Sbjct: 199 VKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWE 254
Query: 287 M 287
           +
Sbjct: 255 I 255

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           K+GQG  G+VY    +  G+ VA++ +    +   E  INE+  M +  + N+V++L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ E++  GSL   + +         ++   +  +     + LE+LH     +
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  NILLG D   K++DFG  A+++ ++    +M+   GT  ++APEV  R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 193
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   K D++S G+M +EM+ G
Sbjct: 194 G--PKVDIWSLGIMAIEMIEG 212

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 135/312 (43%), Gaps = 41/312 (13%)
Query: 69  NYVSLAPKRYNYSDVK---RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLK 119
           NY S A K  + SD+K   R   +    LG G FG VY+G++      P    VAVK L 
Sbjct: 12  NY-SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 70
Query: 120 N--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES 177
              S+ +  +F+ E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +   
Sbjct: 71  EVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 130
Query: 178 -SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------K 230
             +    L    +  +A  IA G +YL        +H DI   N LL    CP      K
Sbjct: 131 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAK 184
Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-- 288
           I DFG+A+   +   +     A   + ++ PE F    G  + K+D +S+G+++ E+   
Sbjct: 185 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL 242
Query: 289 -----VGRKNAEVK--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL 341
                  + N EV   V+    +  P +      PG  +++     + + E      ++L
Sbjct: 243 GYMPYPSKSNQEVLEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIIL 297
Query: 342 EMLEGSTEDLQI 353
           E +E  T+D  +
Sbjct: 298 ERIEYCTQDPDV 309

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G  G V  G+L  P  R   VA+K LK   ++    +F++E + M +  H N++   
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G     +   ++ E+M NGSLD F+   +      +L       +  G+  G+ YL    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-----VGMLRGVGAGMRYL---S 168
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
           ++  VH D+   N+L+  +   K+SDFGL++ L +  ++  +  G +  I + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA- 227
Query: 267 NFGGVSHKSDVYSYGMMILEMVV 289
            F   S  SDV+S+G+++ E++ 
Sbjct: 228 -FRTFSSASDVWSFGVVMWEVLA 249

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 64
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXX 179
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 180 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 218

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 94  LGQGGFGSVYKGKL--PDGR--LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSFL 147
           +G G  G V  G+L  P  R   VA+K LK      +  +F++E + M +  H N++   
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G     +   ++ E+M NGSLD F+   +      +L       +  G+  G+ YL    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-----VGMLRGVGAGMRYL---S 168
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
           ++  VH D+   N+L+  +   K+SDFGL++ L +  ++  +  G +  I + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA- 227
Query: 267 NFGGVSHKSDVYSYGMMILEMVV 289
            F   S  SDV+S+G+++ E++ 
Sbjct: 228 -FRTFSSASDVWSFGVVMWEVLA 249

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 135/312 (43%), Gaps = 41/312 (13%)
Query: 69  NYVSLAPKRYNYSDVK---RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLK 119
           NY S A K  + SD+K   R   +    LG G FG VY+G++      P    VAVK L 
Sbjct: 12  NY-SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 70
Query: 120 N--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES 177
              S+ +  +F+ E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +   
Sbjct: 71  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 130
Query: 178 -SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------K 230
             +    L    +  +A  IA G +YL        +H DI   N LL    CP      K
Sbjct: 131 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAK 184
Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-- 288
           I DFG+A+   +   +     A   + ++ PE F    G  + K+D +S+G+++ E+   
Sbjct: 185 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL 242
Query: 289 -----VGRKNAEVK--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL 341
                  + N EV   V+    +  P +      PG  +++     + + E      ++L
Sbjct: 243 GYMPYPSKSNQEVLEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIIL 297
Query: 342 EMLEGSTEDLQI 353
           E +E  T+D  +
Sbjct: 298 ERIEYCTQDPDV 309

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 135/312 (43%), Gaps = 41/312 (13%)
Query: 69  NYVSLAPKRYNYSDVK---RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLK 119
           NY S A K  + SD+K   R   +    LG G FG VY+G++      P    VAVK L 
Sbjct: 38  NY-SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 96
Query: 120 N--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES 177
              S+ +  +F+ E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +   
Sbjct: 97  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 156
Query: 178 -SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------K 230
             +    L    +  +A  IA G +YL        +H DI   N LL    CP      K
Sbjct: 157 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAK 210
Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-- 288
           I DFG+A+   +   +     A   + ++ PE F    G  + K+D +S+G+++ E+   
Sbjct: 211 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL 268
Query: 289 -----VGRKNAEVK--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL 341
                  + N EV   V+    +  P +      PG  +++     + + E      ++L
Sbjct: 269 GYMPYPSKSNQEVLEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIIL 323
Query: 342 EMLEGSTEDLQI 353
           E +E  T+D  +
Sbjct: 324 ERIEYCTQDPDV 335

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 135/312 (43%), Gaps = 41/312 (13%)
Query: 69  NYVSLAPKRYNYSDVK---RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLK 119
           NY S A K  + SD+K   R   +    LG G FG VY+G++      P    VAVK L 
Sbjct: 18  NY-SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 76
Query: 120 N--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES 177
              S+ +  +F+ E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +   
Sbjct: 77  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 136
Query: 178 -SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------K 230
             +    L    +  +A  IA G +YL        +H DI   N LL    CP      K
Sbjct: 137 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAK 190
Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-- 288
           I DFG+A+   +   +     A   + ++ PE F    G  + K+D +S+G+++ E+   
Sbjct: 191 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL 248
Query: 289 -----VGRKNAEVK--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL 341
                  + N EV   V+    +  P +      PG  +++     + + E      ++L
Sbjct: 249 GYMPYPSKSNQEVLEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIIL 303
Query: 342 EMLEGSTEDLQI 353
           E +E  T+D  +
Sbjct: 304 ERIEYCTQDPDV 315

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +        D  LVAVK LK+  +   ++F  E   +
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLE 185
           +   H ++V F G C +     +++E+M +G L++F          + D +      +L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
              M  IA  IA G+ YL    +   VH D+   N L+G +   KI DFG+++     + 
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 246 FISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS 299
           +         I ++ PE +  R F   + +SDV+S+G+++ E+    K    ++S
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQPWFQLS 240

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 73
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXX 188
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 189 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 227

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 135/312 (43%), Gaps = 41/312 (13%)
Query: 69  NYVSLAPKRYNYSDVK---RMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLK 119
           NY S A K  + SD+K   R   +    LG G FG VY+G++      P    VAVK L 
Sbjct: 12  NY-SFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 70
Query: 120 N--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES 177
              S+ +  +F+ E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +   
Sbjct: 71  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 130
Query: 178 -SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------K 230
             +    L    +  +A  IA G +YL        +H DI   N LL    CP      K
Sbjct: 131 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAK 184
Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-- 288
           I DFG+A+   +   +     A   + ++ PE F    G  + K+D +S+G+++ E+   
Sbjct: 185 IGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL 242
Query: 289 -----VGRKNAEVK--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL 341
                  + N EV   V+    +  P +      PG  +++     + + E      ++L
Sbjct: 243 GYMPYPSKSNQEVLEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIIL 297
Query: 342 EMLEGSTEDLQI 353
           E +E  T+D  +
Sbjct: 298 ERIEYCTQDPDV 309

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           K+GQG  G+VY    +  G+ VA++ +    +   E  INE+  M +  + N+V++L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ E++  GSL   + +         ++   +  +     + LE+LH     +
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  NILLG D   K++DFG  A+++ ++     M+   GT  ++APEV  R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV---GTPYWMAPEVVTRKAY 193
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   K D++S G+M +EM+ G
Sbjct: 194 G--PKVDIWSLGIMAIEMIEG 212

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 98  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 211
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 270 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           K+GQG  G+VY    +  G+ VA++ +    +   E  INE+  M +  + N+V++L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ E++  GSL   + +         ++   +  +     + LE+LH     +
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---Q 137
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  NILLG D   K++DFG  A+++ ++     M+   GT  ++APEV  R   
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV---GTPYWMAPEVVTRKAY 194
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   K D++S G+M +EM+ G
Sbjct: 195 G--PKVDIWSLGIMAIEMIEG 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           K+GQG  G+VY    +  G+ VA++ +    +   E  INE+  M +  + N+V++L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ E++  GSL   + +         ++   +  +     + LE+LH     +
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  NILLG D   K++DFG  A+++ ++     M+   GT  ++APEV  R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV---GTPYWMAPEVVTRKAY 193
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   K D++S G+M +EM+ G
Sbjct: 194 G--PKVDIWSLGIMAIEMIEG 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 94  LGQGGFGSVYK-GKLPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           LG+G FG   K      G ++ +K +++  +     F+ EV  M    H NV+ F+G  Y
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
           + K+   I E++  G+L   I      +++ +  W      A  IA G+ YLH   ++ I
Sbjct: 78  KDKRLNFITEYIKGGTLRGII-----KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 212 VHFDIKPHNILLGEDFCPKISDFGLAKL------------SEKKESFISMLGARGTIGYI 259
           +H D+  HN L+ E+    ++DFGLA+L            S KK          G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
           APE+   N      K DV+S+G+++ E ++GR NA+
Sbjct: 190 APEMI--NGRSYDEKVDVFSFGIVLCE-IIGRVNAD 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           LGQG FG V K +   D R  A+K +++++      ++EV  ++  +H  VV +     E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 153 K----------KKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           +          KK++ ++   E+  NG+L   I+  E+ N  R   WR   QI       
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQIL----EA 128
Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI------------ 247
           L Y+H      I+H D+KP NI + E    KI DFGLAK   +    +            
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           ++  A GT  Y+A EV     G  + K D+YS G++  EM+
Sbjct: 186 NLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 211
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 270 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM 97
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 211
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 270 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 40  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 99
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 100 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 159
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 160 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 213
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 271
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 272 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 325

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 196
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 255 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 15  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 74
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 75  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 134
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 135 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 188
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 246
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 247 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 300

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 79
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL----EWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     +  N  +        
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 194
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 195 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 233

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 196
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 255 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 79
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 194
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             G +G   + +++PE      G  +  SDV+S+G+++ E+  
Sbjct: 195 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 69
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL----EWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     +  N  +        
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 130 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 184
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 185 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 223

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 72
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 187
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 188 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 70
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 185
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 186 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 224

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 72
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 187
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 188 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 73
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 188
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             G +G   + +++PE      G  +  SDV+S+G+++ E+  
Sbjct: 189 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 66
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +  +  E+   
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYY 181
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             G +G   + +++PE      G  +  SDV+S+G+++ E+  
Sbjct: 182 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V K K    + VA+K ++ S+   + FI E+  +S+ +H N+V   G C   
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 154 KKRALIYEFMPNGSLDQFIYDEES---SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               L+ E+   GSL   ++  E          + W   C      ++G+ YLH      
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPKA 126
Query: 211 IVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H D+KP N+LL       KI DFG A   +       M   +G+  ++APEVF     
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVF--EGS 179
Query: 270 GVSHKSDVYSYGMMILEMVVGRK 292
             S K DV+S+G+++ E++  RK
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRK 202

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG   E+
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 154 KKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
           K    ++ E+M  GSL  ++     S +        + + ++ +   +EYL  G N   V
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLE-GNNF--V 130
Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   N+L+ ED   K+SDFGL      KE+  +    +  + + APE         S
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEAL--REAAFS 183
Query: 273 HKSDVYSYGMMILEM 287
            KSDV+S+G+++ E+
Sbjct: 184 TKSDVWSFGILLWEI 198

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 27/241 (11%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGK----LP--DGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +    LP  D  LVAVK LK +  +  ++F  E   +
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSN---------INRKLEW 186
           +   H ++V F G C E +   +++E+M +G L++F+                    L  
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
             +  +A  +A G+ YL     +  VH D+   N L+G+    KI DFG+++     + +
Sbjct: 135 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 191
Query: 247 ISMLGARG--TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE 303
              +G R    I ++ PE +  R F   + +SDV+S+G+++ E+    K    ++S +  
Sbjct: 192 --RVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 246
Query: 304 I 304
           I
Sbjct: 247 I 247

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 27/241 (11%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGK----LP--DGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +    LP  D  LVAVK LK +  +  ++F  E   +
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSN---------INRKLEW 186
           +   H ++V F G C E +   +++E+M +G L++F+                    L  
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
             +  +A  +A G+ YL     +  VH D+   N L+G+    KI DFG+++     + +
Sbjct: 129 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 185
Query: 247 ISMLGARG--TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE 303
              +G R    I ++ PE +  R F   + +SDV+S+G+++ E+    K    ++S +  
Sbjct: 186 --RVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 240
Query: 304 I 304
           I
Sbjct: 241 I 241

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V K K    + VA+K ++ S+   + FI E+  +S+ +H N+V   G C   
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 154 KKRALIYEFMPNGSLDQFIYDEES---SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               L+ E+   GSL   ++  E          + W   C      ++G+ YLH      
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPKA 125
Query: 211 IVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H D+KP N+LL       KI DFG A   +       M   +G+  ++APEVF     
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVF--EGS 178
Query: 270 GVSHKSDVYSYGMMILEMVVGRK 292
             S K DV+S+G+++ E++  RK
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRK 201

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           K+GQG  G+VY    +  G+ VA++ +    +   E  INE+  M +  + N+V++L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ E++  GSL   + +         ++   +  +     + LE+LH     +
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---Q 137
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H +IK  NILLG D   K++DFG  A+++ ++    +M+   GT  ++APEV  R   
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 194
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   K D++S G+M +EM+ G
Sbjct: 195 G--PKVDIWSLGIMAIEMIEG 213

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 119/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   ++R  E RT   I   +A  L Y H   +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYR-----ELQKLSRFDEQRTATYI-TELANALSYCH---S 130
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG +   KI+DFG +    S ++++        GT+ Y+ PE+   
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC------GTLDYLPPEM--- 181
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG    E               Y+ I    EF    
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY--------QETYRRIS-RVEFTFPD 231
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 232 FVTEGARDLISRLL 245

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 27/241 (11%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGK----LP--DGRLVAVKVLKNSKVNG-EEFINEVASM 135
           +KR       +LG+G FG V+  +    LP  D  LVAVK LK +  +  ++F  E   +
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSN---------INRKLEW 186
           +   H ++V F G C E +   +++E+M +G L++F+                    L  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
             +  +A  +A G+ YL     +  VH D+   N L+G+    KI DFG+++     + +
Sbjct: 158 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 247 ISMLGARG--TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE 303
              +G R    I ++ PE +  R F   + +SDV+S+G+++ E+    K    ++S +  
Sbjct: 215 --RVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 304 I 304
           I
Sbjct: 270 I 270

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 41  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 100
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 101 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 160
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 161 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 214
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 272
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 273 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 326

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 119/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 127
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++++        GT+ Y+ PE+   
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC------GTLDYLPPEM--- 178
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 228
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 229 FVTEGARDLISRLL 242

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG   E+
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 154 KKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
           K    ++ E+M  GSL  ++     S +        + + ++ +   +EYL  G N   V
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLE-GNNF--V 124
Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   N+L+ ED   K+SDFGL      KE+  +    +  + + APE         S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFS 177
Query: 273 HKSDVYSYGMMILEM 287
            KSDV+S+G+++ E+
Sbjct: 178 TKSDVWSFGILLWEI 192

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 37/299 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFIN 130
           +  +V R   +    LG G FG VY+G++      P    VAVK L    S+ +  +F+ 
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 123
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTM 189
           E   +SK +H N+V  +G   +   R ++ E M  G L  F+ +     +    L    +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKK 243
             +A  IA G +YL        +H DI   N LL    CP      KI DFG+A+   + 
Sbjct: 184 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRA 237
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
             +     A   + ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 297 K--VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQI 353
              V+    +  P +      PG  +++     + + E      ++LE +E  T+D  +
Sbjct: 296 LEFVTSGGRMDPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG   E+
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 154 KKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
           K    ++ E+M  GSL  ++     S +        + + ++ +   +EYL  G N   V
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYL-EGNNF--V 311
Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   N+L+ ED   K+SDFGL      KE+  +    +  + + APE         S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFS 364
Query: 273 HKSDVYSYGMMILEM 287
            KSDV+S+G+++ E+
Sbjct: 365 TKSDVWSFGILLWEI 379

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG   E+
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 154 KKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIV 212
           K    ++ E+M  GSL  ++     S +        + + ++ +   +EYL  G N   V
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLE-GNNF--V 139
Query: 213 HFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS 272
           H D+   N+L+ ED   K+SDFGL      KE+  +    +  + + APE         S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFS 192
Query: 273 HKSDVYSYGMMILEM 287
            KSDV+S+G+++ E+
Sbjct: 193 TKSDVWSFGILLWEI 207

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 93  KLGQGGFGSVYKGKLPDGR-LVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK +  +   L A KV+   S+   E+++ E+  ++   H N+V  L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y +    ++ EF   G++D  + +     + R L   T  QI V   + L+ L+   + +
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-----LERPL---TESQIQVVCKQTLDALNYLHDNK 155
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  NIL   D   K++DFG++    +  ++++SFI      GT  ++APE V C
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMC 209
Query: 266 RNFGG--VSHKSDVYSYGMMILEM 287
                    +K+DV+S G+ ++EM
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 93  KLGQGGFGSVYKGKLPDGR-LVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK +  +   L A KV+   S+   E+++ E+  ++   H N+V  L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y +    ++ EF   G++D  + +     + R L   T  QI V   + L+ L+   + +
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-----LERPL---TESQIQVVCKQTLDALNYLHDNK 155
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  NIL   D   K++DFG++    +  ++++SFI      GT  ++APE V C
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMC 209
Query: 266 RNFGG--VSHKSDVYSYGMMILEM 287
                    +K+DV+S G+ ++EM
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 89  SFSNKLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNG---EEFINEVASMSKTSHV 141
           +    LG+G FGSV + +L   DG  V  AVK+LK   +     EEF+ E A M +  H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 142 NVVSFLGFCYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
           +V   +G     + +       +I  FM +G L  F+           L  +T+ +  V 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           IA G+EYL    +   +H D+   N +L ED    ++DFGL++     + +     ++  
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           + ++A E    N   V   SDV+++G+ + E++        G +NAE+
Sbjct: 203 VKWLALESLADNLYTV--HSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 70  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR 184
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 185 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR 187
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 188 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR 187
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 188 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G     +Y +E   +++  E RT   I   +A  L Y H   +
Sbjct: 81  YFHDATRVYLILEYAPRGE----VY-KELQKLSKFDEQRTATYI-TELANALSYCH---S 131
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 182
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 232
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 233 FVTEGARDLISRLL 246

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 35/253 (13%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 77  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 127
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPEVFCRN 267
            R++H DIKP N+LLG     KI+DFG +      + + +S     GT+ Y+ PE+    
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS-----GTLDYLPPEM---- 178
Query: 268 FGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV 325
             G  H  K D++S G++  E +VG+   E               YK I    EF     
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPDF 229
Query: 326 VTEEEKEMAKKMI 338
           VTE  +++  +++
Sbjct: 230 VTEGARDLISRLL 242

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL-------PDGRLVAVKVLKNSKVNGE--EFINEV 132
           +V R   + S +LGQG FG VY+G         P+ R VA+K +  +    E  EF+NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 66
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRT 188
           + M + +  +VV  LG   + +   +I E M  G L  ++     + E++ +        
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           M Q+A  IA G+ YL+     + VH D+   N  + EDF  KI DFG+ +  +  E+   
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYY 181
Query: 249 MLGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             G +G   + +++PE      G  +  SDV+S+G+++ E+
Sbjct: 182 RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 220

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   ++R  E RT   I   +A  L Y H   +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYR-----ELQKLSRFDEQRTATYI-TELANALSYCH---S 130
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG +   KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 181
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG    E               Y+ I    EF    
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY--------QETYRRIS-RVEFTFPD 231
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 232 FVTEGARDLISRLL 245

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 102 YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 152
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S +++         GT+ Y+ PE+   
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEM--- 203
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 204 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 253
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 254 FVTEGARDLISRLL 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 180
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 230
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 231 FVTEGARDLISRLL 244

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 93  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 143
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 194
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 195 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 244
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 245 FVTEGARDLISRLL 258

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVSF 146
           K+G+G +G VYK K   GR+VA   LK  +++ E+       I E++ + +  H N+VS 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVA---LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYL 203
           +   + ++   L++EFM      + + DE  + +          QI +    + RG+ + 
Sbjct: 85  IDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDS-------QIKIYLYQLLRGVAHC 135
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H+    RI+H D+KP N+L+  D   K++DFGLA+       S+   +    T+ Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV---VTLWYRAPD 189
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           V   +    S   D++S G +  EM+ G+
Sbjct: 190 VLMGS-KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 75  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 125
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 176
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 177 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 226
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 227 FVTEGARDLISRLL 240

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 42/273 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFI 129
           P+++   D +         LG+G FG+VY  +    + + A+KVL  +++       +  
Sbjct: 2   PRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTM 189
            EV   S   H N++   G+ ++  +  LI E+ P G++ +     E   +++  E RT 
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTA 111
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFI 247
             I   +A  L Y H   + R++H DIKP N+LLG     KI+DFG +    S ++ +  
Sbjct: 112 TYI-TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 167
Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY 305
                 GT+ Y+ PE+      G  H  K D++S G++  E +VG+   E          
Sbjct: 168 ------GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------ 211
Query: 306 FPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMI 338
                YK I    EF     VTE  +++  +++
Sbjct: 212 --QETYKRIS-RVEFTFPDFVTEGARDLISRLL 241

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVSF 146
           K+G+G +G VYK K   GR+VA   LK  +++ E+       I E++ + +  H N+VS 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVA---LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYL 203
           +   + ++   L++EFM      + + DE  + +          QI +    + RG+ + 
Sbjct: 85  IDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDS-------QIKIYLYQLLRGVAHC 135
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H+    RI+H D+KP N+L+  D   K++DFGLA+       S+   +    T+ Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV---VTLWYRAPD 189
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           V   +    S   D++S G +  EM+ G+
Sbjct: 190 VLMGS-KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 81  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 131
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 182
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 232
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 233 FVTEGARDLISRLL 246

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 180
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 230
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 231 FVTEGARDLISRLL 244

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTLDYLPPEM--- 177
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 227
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 228 FVTEGARDLISRLL 241

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S +++         GT+ Y+ PE+   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEM--- 180
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 230
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 231 FVTEGARDLISRLL 244

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 108 PDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN 165
           P    VA+K   L+  + + +E + E+ +MS+  H N+VS+      K +  L+ + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 166 GSLDQFIYD-----EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           GS+   I       E  S +   L+  T+  I   +  GLEYLH+   I   H D+K  N
Sbjct: 98  GSVLDIIKHIVAKGEHKSGV---LDESTIATILREVLEGLEYLHKNGQI---HRDVKAGN 151
Query: 221 ILLGEDFCPKISDFGLAKL---------SEKKESFISMLGARGTIGYIAPEVFCRNFGGV 271
           ILLGED   +I+DFG++           ++ +++F+      GT  ++APEV      G 
Sbjct: 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTPCWMAPEVM-EQVRGY 204
Query: 272 SHKSDVYSYGMMILEMVVG 290
             K+D++S+G+  +E+  G
Sbjct: 205 DFKADIWSFGITAIELATG 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 102 YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 152
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 203
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 204 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 253
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 254 FVTEGARDLISRLL 267

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 131
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE    
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPE---- 181
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 232
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 233 FVTEGARDLISRLL 246

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTLDYLPPEM--- 180
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 230
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 231 FVTEGARDLISRLL 244

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 108 PDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN 165
           P    VA+K   L+  + + +E + E+ +MS+  H N+VS+      K +  L+ + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 166 GSLDQFIYD-----EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           GS+   I       E  S +   L+  T+  I   +  GLEYLH+   I   H D+K  N
Sbjct: 93  GSVLDIIKHIVAKGEHKSGV---LDESTIATILREVLEGLEYLHKNGQI---HRDVKAGN 146
Query: 221 ILLGEDFCPKISDFGLAKL---------SEKKESFISMLGARGTIGYIAPEVFCRNFGGV 271
           ILLGED   +I+DFG++           ++ +++F+      GT  ++APEV      G 
Sbjct: 147 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTPCWMAPEVM-EQVRGY 199
Query: 272 SHKSDVYSYGMMILEMVVG 290
             K+D++S+G+  +E+  G
Sbjct: 200 DFKADIWSFGITAIELATG 218

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 130
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 181
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 231
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 232 FVTEGARDLISRLL 245

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYR 187
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 188 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 78  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 128
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC------GTLDYLPPEM--- 179
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 229
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 230 FVTEGARDLISRLL 243

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G     +Y +E   +++  E RT   I   +A  L Y H   +
Sbjct: 81  YFHDATRVYLILEYAPRGE----VY-KELQKLSKFDEQRTATYI-TELANALSYCH---S 131
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX------GTLDYLPPEM--- 182
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 232
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 233 FVTEGARDLISRLL 246

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEM--- 177
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 227
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 228 FVTEGARDLISRLL 241

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 81  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 131
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEM--- 182
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 232
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 233 FVTEGARDLISRLL 246

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 127
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEM--- 178
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 228
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 229 FVTEGARDLISRLL 242

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G+    +Y  E   +++  E RT   I   +A  L Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGT----VY-RELQKLSKFDEQRTATYI-TELANALSYCH---S 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEM--- 177
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 227
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 228 FVTEGARDLISRLL 241

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 73  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 174
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 175 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 224
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 225 FVTEGARDLISRLL 238

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKV-LKNSKVNGEE-----FINEVASMSKTSHVNVVSF 146
           KLG G + +VYKG     +   V V LK  K++ EE      I E++ M +  H N+V  
Sbjct: 12  KLGNGTYATVYKGL---NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               + + K  L++EFM N  L +++      N  R LE   +      + +GL + H  
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF- 264
              +I+H D+KP N+L+ +    K+ DFGLA+       +F S +    T+ Y AP+V  
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV---VTLWYRAPDVLM 181
Query: 265 -CRNFGGVSHKSDVYSYGMMILEMVVGR 291
             R +   S   D++S G ++ EM+ G+
Sbjct: 182 GSRTY---STSIDIWSCGCILAEMITGK 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 44/274 (16%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFI 129
           P+++   D +         LG+G FG+VY  +    + + A+KVL  +++       +  
Sbjct: 2   PRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTM 189
            EV   S   H N++   G+ ++  +  LI E+ P G++ +     E   +++  E RT 
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTA 111
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL---AKLSEKKESF 246
             I   +A  L Y H   + R++H DIKP N+LLG     KI+DFG    A  S + E  
Sbjct: 112 TYI-TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC 167
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEI 304
                  GT+ Y+ PE+      G  H  K D++S G++  E +VG+   E         
Sbjct: 168 -------GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----- 211
Query: 305 YFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMI 338
                 YK I    EF     VTE  +++  +++
Sbjct: 212 ---QETYKRIS-RVEFTFPDFVTEGARDLISRLL 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           LGQG FG V K +   D R  A+K +++++      ++EV  ++  +H  VV +     E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 153 K----------KKRALIY---EFMPNGSLDQFIYDEESSNINRKLE--WRTMCQIAVGIA 197
           +          KK++ ++   E+  N +L   I+ E   N+N++ +  WR   QI     
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE---NLNQQRDEYWRLFRQIL---- 126
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI---------- 247
             L Y+H      I+H D+KP NI + E    KI DFGLAK   +    +          
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 248 --SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
             ++  A GT  Y+A EV     G  + K D+YS G++  EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC------GTLDYLPPEM--- 180
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 230
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 231 FVTEGARDLISRLL 244

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR 186
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 187 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH D+   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR 187
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 188 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 93  KLGQGGFGSVYKGKLPDGR-LVAVKVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG VYK +  +   L A KV+   S+   E+++ E+  ++   H N+V  L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           Y +    ++ EF   G++D  + +     + R L   T  QI V   + L+ L+   + +
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-----LERPL---TESQIQVVCKQTLDALNYLHDNK 155
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLA----KLSEKKESFISMLGARGTIGYIAPE-VFC 265
           I+H D+K  NIL   D   K++DFG++    +  ++++ FI      GT  ++APE V C
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMC 209
Query: 266 RNFGG--VSHKSDVYSYGMMILEM 287
                    +K+DV+S G+ ++EM
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC------GTLDYLPPEM--- 177
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 227
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 228 FVTEGARDLISRLL 241

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI+DFG +    S ++          GT+ Y+ PE+   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC------GTLDYLPPEM--- 177
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 227
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 228 FVTEGARDLISRLL 241

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +  + + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            +++H DIKP N+LLG     KI+DFG +    S ++ +        GT+ Y+ PE+   
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTLDYLPPEM--- 177
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QDTYKRIS-RVEFTFPD 227
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 228 FVTEGARDLISRLL 241

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 22/204 (10%)
Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           KLG+G +GSVYK    + G++VA+K +   + + +E I E++ M +    +VV + G  +
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
           +     ++ E+   GS+   I        N+ L    +  I     +GLEYLH    +R 
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLR-----NKTLTEDEIATILQSTLKGLEYLH---FMRK 146
Query: 212 VHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEVFCRN 267
           +H DIK  NILL  +   K++DFG+A +L++   K+   I      GT  ++APEV    
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI------GTPFWMAPEVIQEI 200
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
             G +  +D++S G+  +EM  G+
Sbjct: 201 --GYNCVADIWSLGITAIEMAEGK 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNSKVNGE-EFINEVASMSKTSHVNV 143
           + ++LG+G FGSV   +   L D  G LVAVK L++S  + + +F  E+  +       +
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 144 VSFLGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G  Y   +++L  + E++P+G L  F+    +     +L+   +   +  I +G+E
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 128
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE-KKESFISMLGARGTIGYIA 260
           YL    + R VH D+   NIL+  +   KI+DFGLAKL    K+ ++     +  I + A
Sbjct: 129 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    N    S +SDV+S+G+++ E+
Sbjct: 186 PESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 93  KLGQGGFGSVY--KGKLPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSF 146
           KLG G +G V   K KL  G   A+K++K S V    N    ++EVA + +  H N++  
Sbjct: 11  KLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 147 LGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             F  +K+   L+ E    G L D+ I  ++ S ++  +       I   +  G  YLH+
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVLSGTTYLHK 122
Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
                IVH D+KP N+LL     D   KI DFGL+   E        L   GT  YIAPE
Sbjct: 123 H---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAPE 176
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V  + +     K DV+S G+++  ++ G
Sbjct: 177 VLRKKY---DEKCDVWSCGVILYILLCG 201

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNSKVNGE-EFINEVASMSKTSHVNV 143
           + ++LG+G FGSV   +   L D  G LVAVK L++S  + + +F  E+  +       +
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 144 VSFLGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G  Y   +++L  + E++P+G L  F+    +     +L+   +   +  I +G+E
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 129
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE-KKESFISMLGARGTIGYIA 260
           YL    + R VH D+   NIL+  +   KI+DFGLAKL    K+ ++     +  I + A
Sbjct: 130 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    N    S +SDV+S+G+++ E+
Sbjct: 187 PESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNSKVNGE-EFINEVASMSKTSHVNV 143
           + ++LG+G FGSV   +   L D  G LVAVK L++S  + + +F  E+  +       +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 144 VSFLGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G  Y   +++L  + E++P+G L  F+    +     +L+   +   +  I +G+E
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 141
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE-KKESFISMLGARGTIGYIA 260
           YL    + R VH D+   NIL+  +   KI+DFGLAKL    K+ ++     +  I + A
Sbjct: 142 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    N    S +SDV+S+G+++ E+
Sbjct: 199 PESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 36/214 (16%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           +G GGFG V+K K   DG+     V+K  K N E+   EV +++K  HVN+V + G C++
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTY---VIKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWD 74
Query: 153 ---------------KKKRALI--YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
                           K + L    EF   G+L+Q+I       +++ L      Q    
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ---- 130
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           I +G++Y+H   + ++++ D+KP NI L +    KI DFGL   S K +       ++GT
Sbjct: 131 ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDG--KRXRSKGT 184
Query: 256 IGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMV 288
           + Y++PE +  +++G    + D+Y+ G+++ E++
Sbjct: 185 LRYMSPEQISSQDYG---KEVDLYALGLILAELL 215

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 29/259 (11%)
Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +      GK      VAVK+LK
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI---- 172
           ++    E+   ++E+  MS    H N+V+ LG C       +I E+   G L  F+    
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 173 ----YDEESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDF 227
                D   +  N  L  R +   +  +A+G+ +L  + C    +H D+   N+LL    
Sbjct: 146 RVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGH 201
Query: 228 CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILE 286
             KI DFGLA+      ++I    AR  + ++APE     F  V + +SDV+SYG+++ E
Sbjct: 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWE 258
Query: 287 MVVGRKNAEVKVSLSSEIY 305
           +     N    + ++S+ Y
Sbjct: 259 IFSLGLNPYPGILVNSKFY 277

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 78  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 128
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI++FG +    S ++ +        GT+ Y+ PE+   
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 179
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 229
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 230 FVTEGARDLISRLL 243

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              + R +H D+   N+LL      KI DFGL + L +  + ++     +    + APE 
Sbjct: 133 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 190 LKTRTF---SHASDTWMFGVTLWEM 211

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  +++       +   EV   S   H N++   G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + ++  +  LI E+ P G++ +     E   +++  E RT   I   +A  L Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYR-----ELQKLSKFDEQRTATYI-TELANALSYCH---S 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            R++H DIKP N+LLG     KI++FG +    S ++ +        GT+ Y+ PE+   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC------GTLDYLPPEM--- 180
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
              G  H  K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFTFPD 230
Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 231 FVTEGARDLISRLL 244

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 18/222 (8%)
Query: 73  LAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR----LVAVKVLKNSKV--NGE 126
           L P+      + R     +  LG+G FG VY+G   + +     VAVK  K      N E
Sbjct: 11  LVPRGSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE 70
Query: 127 EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEW 186
           +F++E   M    H ++V  +G   E++   +I E  P G L  ++  E + N  + L  
Sbjct: 71  KFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVL-- 125
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
            T+   ++ I + + YL    +I  VH DI   NIL+    C K+ DFGL++  E ++ +
Sbjct: 126 -TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 181
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            + +  R  I +++PE    NF   +  SDV+ + + + E++
Sbjct: 182 KASV-TRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEIL 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 89  SFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH 140
           +    LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 141 -VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK------LEWRTMCQI 192
            +NVV+ LG C +      +I EF   G+L  ++  + +  +  K      L    +   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+   K   ++    A
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 207 RLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 239

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              + R +H D+   N+LL      KI DFGL + L +  + ++     +    + APE 
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 186 LKTRTF---SHASDTWMFGVTLWEM 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              + R +H D+   N+LL      KI DFGL + L +  + ++     +    + APE 
Sbjct: 133 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 190 LKTRTF---SHASDTWMFGVTLWEM 211

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 116/274 (42%), Gaps = 58/274 (21%)
Query: 93  KLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNG--------------EEFINEVASMSK 137
           KLG G +G V   K  +G    A+KV+K S+ +               EE  NE++ +  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGI 196
             H N++       +KK   L+ EF   G L + I       INR K +      I   I
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-------INRHKFDECDAANIMKQI 155
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKISDFGLAKLSEKKESFISMLGAR 253
             G+ YLH+     IVH DIKP NILL         KI DFGL+    K       L   
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--- 209
Query: 254 GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP------ 307
           GT  YIAPEV  + +   + K DV+S G+++  ++ G              Y P      
Sbjct: 210 GTAYYIAPEVLKKKY---NEKCDVWSCGVIMYILLCG--------------YPPFGGQND 252
Query: 308 NSIYKHIEPGN---EFQLAGVVTEEEKEMAKKMI 338
             I K +E G    +F     +++E KE+ K M+
Sbjct: 253 QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              + R +H D+   N+LL      KI DFGL + L +  + ++     +    + APE 
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 186 LKTRTF---SHASDTWMFGVTLWEM 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 138
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              + R +H D+   N+LL      KI DFGL + L +  + ++     +    + APE 
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 196 LKTRTF---SHASDTWMFGVTLWEM 217

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK 154
            +G FG V+K +L +   VAVK+         +   E+ S     H N++ F+    EK+
Sbjct: 24  ARGRFGCVWKAQLMND-FVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIA--AEKR 80
Query: 155 ------KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR--- 205
                 +  LI  F   GSL  ++      NI   + W  +C +A  ++RGL YLH    
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL----KGNI---ITWNELCHVAETMSRGLSYLHEDVP 133
Query: 206 -----GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                G    I H D K  N+LL  D    ++DFGLA   E  +      G  GT  Y+A
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 261 PEVF--CRNFGGVSH-KSDVYSYGMMILEMVVGRKNAEVKV 298
           PEV     NF   +  + D+Y+ G+++ E+V   K A+  V
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPV 234

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 94  LGQGGFGSVYKGKLPDGR----LVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG VY+G   + +     VAVK  K      N E+F++E   M    H ++V  +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E++   +I E  P G L  ++  E + N  + L   T+   ++ I + + YL    
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVL---TLVLYSLQICKAMAYLE--- 126
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           +I  VH DI   NIL+    C K+ DFGL++  E ++ + + +  R  I +++PE    N
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESI--N 183
Query: 268 FGGVSHKSDVYSYGMMILEMV 288
           F   +  SDV+ + + + E++
Sbjct: 184 FRRFTTASDVWMFAVCMWEIL 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEE-----FINEVASMSKTS---HVNV 143
           ++G G +G+VYK + P  G  VA+K ++    NGEE      + EVA + +     H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 144 VSFLGFCYEKK-----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           V  +  C   +     K  L++E      +DQ +           L   T+  +     R
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           GL++LH  C   IVH D+KP NIL+      K++DFGLA++   + +   ++    T+ Y
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV---VTLWY 177
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            APEV  ++    +   D++S G +  EM
Sbjct: 178 RAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 35/226 (15%)
Query: 90  FSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHV 141
           +   +G+G FG V++ + P         +VAVK+LK   S     +F  E A M++  + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNI----NRKLEWRT--------- 188
           N+V  LG C   K   L++E+M  G L++F+       +    +  L  R          
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 189 ------MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
                 +C IA  +A G+ YL      + VH D+   N L+GE+   KI+DFGL++    
Sbjct: 171 LSCAEQLC-IARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 243 KESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            + + +       I ++ PE +F   +   + +SDV++YG+++ E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEI 269

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 93  KLGQGGFGSVY--KGKLPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSF 146
           KLG G +G V   K KL  G   A+K++K S V    N    ++EVA + +  H N++  
Sbjct: 28  KLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 147 LGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             F  +K+   L+ E    G L D+ I  ++ S ++  +       I   +  G  YLH+
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVLSGTTYLHK 139
Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
                IVH D+KP N+LL     D   KI DFGL+   E        L   GT  YIAPE
Sbjct: 140 H---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAPE 193
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V  + +     K DV+S G+++  ++ G
Sbjct: 194 VLRKKY---DEKCDVWSCGVILYILLCG 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEE-----FINEVASMSKTS---HVNV 143
           ++G G +G+VYK + P  G  VA+K ++    NGEE      + EVA + +     H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 144 VSFLGFCYEKK-----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           V  +  C   +     K  L++E      +DQ +           L   T+  +     R
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           GL++LH  C   IVH D+KP NIL+      K++DFGLA++   + +   ++    T+ Y
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVV---VTLWY 177
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            APEV  ++    +   D++S G +  EM
Sbjct: 178 RAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 93  KLGQGGFGSVYKG--KLPDGRL-VAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +LG G FGSV +G  ++   ++ VA+KVLK    K + EE + E   M +  +  +V  +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEES----SNINRKLEWRTMCQIAVGIARGLEYL 203
           G C + +   L+ E    G L +F+  +      SN+   L           ++ G++YL
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---------QVSMGMKYL 126
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA-RGTIGYIAPE 262
                   VH D+   N+LL      KISDFGL+K     +S+ +   A +  + + APE
Sbjct: 127 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV 288
             C NF   S +SDV+SYG+ + E +
Sbjct: 184 --CINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 33/245 (13%)
Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLK 119
           NYV + P +  Y    +  R   SF   LG G FG V +       K      VAVK+LK
Sbjct: 26  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 85
Query: 120 NSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 86  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 145
Query: 177 SSNINRKLEWRTMC------------QIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILL 223
            S I  K     M               +  +A+G+ +L  + C    +H D+   NILL
Sbjct: 146 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILL 201
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGM 282
                 KI DFGLA+  +   +++    AR  + ++APE     F  V + +SDV+SYG+
Sbjct: 202 THGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGI 258
Query: 283 MILEM 287
            + E+
Sbjct: 259 FLWEL 263

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 94  LGQGGFGSVYKGKLPDGR----LVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG VY+G   + +     VAVK  K      N E+F++E   M    H ++V  +
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E++   +I E  P G L  ++  E + N  + L   T+   ++ I + + YL    
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVL---TLVLYSLQICKAMAYLE--- 130
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           +I  VH DI   NIL+    C K+ DFGL++  E ++ + + +  R  I +++PE    N
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESI--N 187
Query: 268 FGGVSHKSDVYSYGMMILEMV 288
           F   +  SDV+ + + + E++
Sbjct: 188 FRRFTTASDVWMFAVCMWEIL 208

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 33/245 (13%)
Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLK 119
           NYV + P +  Y    +  R   SF   LG G FG V +       K      VAVK+LK
Sbjct: 21  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 80
Query: 120 NSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 81  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 140
Query: 177 SSNINRKLEWRTMC------------QIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILL 223
            S I  K     M               +  +A+G+ +L  + C    +H D+   NILL
Sbjct: 141 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILL 196
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGM 282
                 KI DFGLA+  +   +++    AR  + ++APE     F  V + +SDV+SYG+
Sbjct: 197 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGI 253
Query: 283 MILEM 287
            + E+
Sbjct: 254 FLWEL 258

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVL------KNSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+V+KG  +P+G  + + V       K+ + + +   + + ++    H ++V  
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           LG C       L+ +++P GSL   +     +     L  + +    V IA+G+ YL   
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWGVQIAKGMYYLEEH 152
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               +VH ++   N+LL      +++DFG+A L    +  +    A+  I ++A E    
Sbjct: 153 G---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-- 207
Query: 267 NFGGVSHKSDVYSYGMMILEMV 288
           +FG  +H+SDV+SYG+ + E++
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELM 229

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 33/245 (13%)
Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLK 119
           NYV + P +  Y    +  R   SF   LG G FG V +       K      VAVK+LK
Sbjct: 26  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 85
Query: 120 NSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 86  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 145
Query: 177 SSNINRKLEWRTMC------------QIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILL 223
            S I  K     M               +  +A+G+ +L  + C    +H D+   NILL
Sbjct: 146 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILL 201
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGM 282
                 KI DFGLA+  +   +++    AR  + ++APE     F  V + +SDV+SYG+
Sbjct: 202 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGI 258
Query: 283 MILEM 287
            + E+
Sbjct: 259 FLWEL 263

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH ++   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR 187
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 188 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVL------KNSKVNGEEFINEVASMSKTSHVNVVSF 146
           LG G FG+V+KG  +P+G  + + V       K+ + + +   + + ++    H ++V  
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           LG C       L+ +++P GSL   +     +     L  + +    V IA+G+ YL   
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWGVQIAKGMYYLEEH 134
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               +VH ++   N+LL      +++DFG+A L    +  +    A+  I ++A E    
Sbjct: 135 G---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-- 189
Query: 267 NFGGVSHKSDVYSYGMMILEMV 288
           +FG  +H+SDV+SYG+ + E++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELM 211

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVNGE--EFINEVA 133
           +V R   +   +LGQG FG VY+G   D         VAVK +  S    E  EF+NE +
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD---EESSNINRKLE-WRTM 189
            M   +  +VV  LG   + +   ++ E M +G L  ++     E  +N  R     + M
Sbjct: 74  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
            Q+A  IA G+ YL+     + VH ++   N ++  DF  KI DFG+ +  +  E+    
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR 188
Query: 250 LGARG--TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            G +G   + ++APE      G  +  SD++S+G+++ E+ 
Sbjct: 189 KGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEIT 227

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 31/261 (11%)
Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +      GK      VAVK+LK
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE- 175
           ++    E+   ++E+  MS    H N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKR 145
Query: 176 ---------ESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGE 225
                     S N   +L  R +   +  +A+G+ +L  + C    +H D+   N+LL  
Sbjct: 146 PPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTN 201
Query: 226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMI 284
               KI DFGLA+      ++I    AR  + ++APE     F  V + +SDV+SYG+++
Sbjct: 202 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILL 258
Query: 285 LEMVVGRKNAEVKVSLSSEIY 305
            E+     N    + ++S+ Y
Sbjct: 259 WEIFSLGLNPYPGILVNSKFY 279

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 33/245 (13%)
Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLK 119
           NYV + P +  Y    +  R   SF   LG G FG V +       K      VAVK+LK
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 120 NSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 177 SSNINRKLEWRTMC------------QIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILL 223
            S I  K     M               +  +A+G+ +L  + C    +H D+   NILL
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILL 178
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGM 282
                 KI DFGLA+  +   +++    AR  + ++APE     F  V + +SDV+SYG+
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGI 235
Query: 283 MILEM 287
            + E+
Sbjct: 236 FLWEL 240

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 89  SFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH 140
           +    LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 141 -VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK------LEWRTMCQI 192
            +NVV+ LG C +      +I EF   G+L  ++  + +  +  K      L    +   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+   K   ++    A
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 207 RLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 239

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 92  NKLGQGGFGSVYKGK--LPDGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSFL 147
           +KLG+G + +VYKGK  L D  LVA+K ++     G     I EV+ +    H N+V+  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + +K   L++E++ +  L Q++  ++  NI   +    +      + RGL Y HR  
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNI---INMHNVKLFLFQLLRGLAYCHRQ- 119
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             +++H D+KP N+L+ E    K++DFGLA+   K     +      T+ Y  P++   +
Sbjct: 120 --KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               S + D++  G +  EM  GR
Sbjct: 176 -TDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEE-----FINEVASMSKTS---HVNV 143
           ++G G +G+VYK + P  G  VA+K ++    NGEE      + EVA + +     H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 144 VSFLGFCYEKK-----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           V  +  C   +     K  L++E      +DQ +           L   T+  +     R
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           GL++LH  C   IVH D+KP NIL+      K++DFGLA++   + +   ++    T+ Y
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVV---VTLWY 177
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
            APEV  ++    +   D++S G +  EM
Sbjct: 178 RAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFIN-EV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K +    + G+ F N E+
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNREL 64
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 121
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 179 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 141 VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFI---------YDEESSNINRK-LEWRTM 189
           +NVV+ LG C +      +I EF   G+L  ++         Y E   ++ +  L    +
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 190 CQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              +  +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++ 
Sbjct: 153 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 209 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 245

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFIN-EV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K +    + G+ F N E+
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNREL 64
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 121
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 179 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFIN-EV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K +    + G+ F N E+
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNREL 64
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATV---YRVARHYSRAKQTLPV 121
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 179 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEV 263
              + R +H D+   N+LL      KI DFGL +   + +    M   R     + APE 
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 186 LKTRTF---SHASDTWMFGVTLWEM 207

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 93  KLGQGGFGSVYKGKL--PDGRLV--AVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           KLG G FG V +G+   P G+ V  AVK LK   ++  E    FI EV +M    H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G       + ++ E  P GSL   +   +   +       T+ + AV +A G+ YL 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG-----TLSRYAVQVAEGMGYLE 138
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEV 263
              + R +H D+   N+LL      KI DFGL +   + +    M   R     + APE 
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 264 F-CRNFGGVSHKSDVYSYGMMILEM 287
              R F   SH SD + +G+ + EM
Sbjct: 196 LKTRTF---SHASDTWMFGVTLWEM 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 38/268 (14%)
Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +      GK      VAVK+LK
Sbjct: 11  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 70
Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
           ++    E+   ++E+  MS    H N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 71  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKA 130
Query: 177 SSNIN-----------------RKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKP 218
            + +                  R LE R +   +  +A+G+ +L  + C    +H D+  
Sbjct: 131 EAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAA 186
Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDV 277
            N+LL      KI DFGLA+      ++I    AR  + ++APE     F  V + +SDV
Sbjct: 187 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDV 243
Query: 278 YSYGMMILEMVVGRKNAEVKVSLSSEIY 305
           +SYG+++ E+     N    + ++S+ Y
Sbjct: 244 WSYGILLWEIFSLGLNPYPGILVNSKFY 271

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKT-SH 140
           F   LG G FG V         K      VAVK+LK    + E    ++E+  M++  SH
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSL-------------DQFIYD-----EESSNINR 182
            N+V+ LG C       LI+E+   G L             D+  Y+     EE  ++N 
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN- 167
Query: 183 KLEWRTMCQIAVGIARGLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
            L +  +   A  +A+G+E+L  + C    VH D+   N+L+      KI DFGLA+   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEM 287
              +++    AR  + ++APE     F G+ + KSDV+SYG+++ E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESL---FEGIYTIKSDVWSYGILLWEI 267

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 19/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGK---LPD--GRLVAVKVLKNSKVNGE-EFINEVASMSKTSHVNV 143
           + ++LG+G FGSV   +   L D  G LVAVK L++S  + + +F  E+  +       +
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 144 VSFLGFCYE--KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G  Y   + +  L+ E++P+G L  F+    +     +L+   +   +  I +G+E
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 125
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE-KKESFISMLGARGTIGYIA 260
           YL    + R VH D+   NIL+  +   KI+DFGLAKL    K+  +     +  I + A
Sbjct: 126 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEM 287
           PE    N    S +SDV+S+G+++ E+
Sbjct: 183 PESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 29/259 (11%)
Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYK------GKLPDGRLVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +      GK      VAVK+LK
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 120 NSKVNGEE--FINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI---- 172
           ++    E+   ++E+  MS    H N+V+ LG C       +I E+   G L  F+    
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 173 ----YDEESSNINRKLEWRTMCQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDF 227
                D   +  N     R +   +  +A+G+ +L  + C    +H D+   N+LL    
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGH 201
Query: 228 CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILE 286
             KI DFGLA+      ++I    AR  + ++APE     F  V + +SDV+SYG+++ E
Sbjct: 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDVWSYGILLWE 258
Query: 287 MVVGRKNAEVKVSLSSEIY 305
           +     N    + ++S+ Y
Sbjct: 259 IFSLGLNPYPGILVNSKFY 277

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 25  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 72
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 73  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 129
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 130 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 186
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 187 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 51  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 98
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 155
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 213 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 36  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 83
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 84  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 140
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 141 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 197
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 198 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 121
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 179 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 29  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 76
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 77  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 133
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 134 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 190
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 191 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVL--KNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           LG+G +G VY G+ L +   +A+K +  ++S+ + +    E+A      H N+V +LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E     +  E +P GSL   +    S     K   +T+      I  GL+YLH   + +
Sbjct: 89  SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142
Query: 211 IVHFDIKPHNILLGE-DFCPKISDFG----LAKLSEKKESFISMLGARGTIGYIAPEVFC 265
           IVH DIK  N+L+       KISDFG    LA ++   E+F       GT+ Y+APE+  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMAPEIID 196
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
           +   G    +D++S G  I+EM  G+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 29  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 76
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 77  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 133
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 134 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 190
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 191 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 30  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 77
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 78  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 134
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 135 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 191
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 192 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH-VNVV 144
           LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 145 SFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTMCQIA 193
           + LG C +      +I EF   G+L  ++  + +  +  K          L    +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 194 VGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
             +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++    A
Sbjct: 146 FQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 202 RLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 133 ASMSKTSHVNVVSFLGFCYEK-KKRALIYEFMPNGSLDQFIY--DEESSNINRKLEWRTM 189
             M K  H N+V    F Y   +K+ ++Y  +    + + +Y      S   + L    +
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKESFIS 248
                 + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 182 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 121
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 179 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 18  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 65
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 66  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 122
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 123 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 179
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 180 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 45  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 92
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 93  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 149
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 150 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 206
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 207 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH-VNVV 144
           LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 145 SFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTMCQIA 193
           + LG C +      +I EF   G+L  ++  + +  +  K          L    +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 194 VGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
             +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++    A
Sbjct: 146 FQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 202 RLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 94  LGQGGFGSVYKGKL--PDGR----LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVS 145
           LG+G FG V K       GR     VAVK+LK +    E  + ++E   + + +H +V+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN--------------------RKLE 185
             G C +     LI E+   GSL  F+   ES  +                     R L 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
              +   A  I++G++YL     +++VH D+   NIL+ E    KISDFGL++   +++S
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           ++     R  + ++A E    +    + +SDV+S+G+++ E+V 
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 141 VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK--------LEWRTMCQ 191
           +NVV+ LG C +      +I EF   G+L  ++  + +  +  K        L    +  
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
            +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+   K    +    
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 252 ARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 210 ARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 22  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 69
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 126
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 127 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 183
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 184 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 51  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 98
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 155
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 213 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 121
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 179 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 21  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 68
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 125
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 126 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 182
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 183 NVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 49/227 (21%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           +G GGFG V+K K   DG+     V++  K N E+   EV +++K  HVN+V + G C++
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTY---VIRRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWD 75
Query: 153 ----------------------------KKKRALI--YEFMPNGSLDQFIYDEESSNINR 182
                                        K + L    EF   G+L+Q+I       +++
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L      QI     +G++Y+H   + +++H D+KP NI L +    KI DFGL   S K
Sbjct: 136 VLALELFEQIT----KGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLV-TSLK 187
Query: 243 KESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMV 288
            +       ++GT+ Y++PE +  +++G    + D+Y+ G+++ E++
Sbjct: 188 NDG--KRTRSKGTLRYMSPEQISSQDYG---KEVDLYALGLILAELL 229

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 141 VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTM 189
           +NVV+ LG C +      +I EF   G+L  ++  + +  +  K          L    +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 CQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              +  +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++ 
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 53  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 100
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 101 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 157
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 158 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 214
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 215 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVL--KNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           LG+G +G VY G+ L +   +A+K +  ++S+ + +    E+A      H N+V +LG  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E     +  E +P GSL   +    S     K   +T+      I  GL+YLH   + +
Sbjct: 75  SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 128
Query: 211 IVHFDIKPHNILLGE-DFCPKISDFG----LAKLSEKKESFISMLGARGTIGYIAPEVFC 265
           IVH DIK  N+L+       KISDFG    LA ++   E+F       GT+ Y+APE+  
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMAPEIID 182
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
           +   G    +D++S G  I+EM  G+
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 55  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 102
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 103 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 159
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 160 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 216
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 217 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 141 VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTM 189
           +NVV+ LG C +      +I EF   G+L  ++  + +  +  K          L    +
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 190 CQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              +  +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++ 
Sbjct: 188 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 244 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 280

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 22  YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 80
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 81  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELV 133
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 191 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 22  YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 80
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 81  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELV 133
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 191 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 29/243 (11%)
Query: 90  FSNKLGQGGFGSV-YKGKLPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           F  KLG+GGF  V     L DG   A+K +L + + + EE   E       +H N++  +
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 148 GFCYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
            +C      K +  L+  F   G+L   I  E   +    L    +  + +GI RGLE +
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 204 H-RGCNIRIVHFDIKPHNILLGEDFCPKISDFG-------LAKLSEKKESFISMLGARGT 255
           H +G      H D+KP NILLG++  P + D G         + S +  +       R T
Sbjct: 151 HAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 256 IGYIAPEVF-CRNFGGVSHKSDVYSYGMMILEMVVG--------RKNAEVKVSLSSEIYF 306
           I Y APE+F  ++   +  ++DV+S G ++  M+ G        +K   V +++ +++  
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 307 PNS 309
           P S
Sbjct: 267 PQS 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLK 119
           N V + P +  Y    +  R   SF   LG G FG V +       K      VAVK+LK
Sbjct: 19  NXVXIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 78
Query: 120 NSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE 176
            S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  + 
Sbjct: 79  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 138
Query: 177 SSNINRKLEWRTMC------------QIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILL 223
            S I  K     M               +  +A+G+ +L  + C    +H D+   NILL
Sbjct: 139 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILL 194
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGM 282
                 KI DFGLA+  +   +++    AR  + ++APE     F  V + +SDV+SYG+
Sbjct: 195 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGI 251
Query: 283 MILEM 287
            + E+
Sbjct: 252 FLWEL 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEF 128
           P   +Y +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F
Sbjct: 380 PSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
           + E  +M +  H ++V  +G   E     +I E    G L  F+   + S     L+  +
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS-----LDLAS 492
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  ++  L YL      R VH DI   N+L+  + C K+ DFGL++  E    + +
Sbjct: 493 LILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             G +  I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 550 SKG-KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 587

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVK-VLKNSKVNGEEFINEV 132
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K VL++ +    E    +
Sbjct: 96  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 143
Query: 133 ASMSKTSHVNVVSFLGFCY---EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M K  H N+V    F Y   EKK      L+ +++P      +      S   + L  
Sbjct: 144 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPV 200
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +  I H DIKP N+LL  D    K+ DFG AK   + E 
Sbjct: 201 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 257
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGRK 292
            +S + +R    Y APE+    FG   + S  DV+S G ++ E+++G+ 
Sbjct: 258 NVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 89  SFSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH 140
           +    LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 141 -VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK---------LEWRTM 189
            +NVV+ LG C +      +I EF   G+L  ++  + +  +  K         L    +
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 190 CQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              +  +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K    + 
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           LGQG FG V K +   D R  A+K +++++      ++EV  ++  +H  VV +     E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 153 K----------KKRALIY---EFMPNGSLDQFIYDEESSNINRKLE--WRTMCQIAVGIA 197
           +          KK++ ++   E+  N +L   I+ E   N+N++ +  WR   QI     
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE---NLNQQRDEYWRLFRQIL---- 126
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI---------- 247
             L Y+H      I+H ++KP NI + E    KI DFGLAK   +    +          
Sbjct: 127 EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 248 --SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
             ++  A GT  Y+A EV     G  + K D YS G++  E +
Sbjct: 184 SDNLTSAIGTAXYVATEVL-DGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 20  YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 78
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 79  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELV 131
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 132 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 188
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 189 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH-VNVV 144
           LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 145 SFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTMCQIA 193
           + LG C +      +I EF   G+L  ++  + +  +  K          L    +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 194 VGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
             +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K    +    A
Sbjct: 146 FQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 202 RLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 12  YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 71  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 123
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 181 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 2   YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 61  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELV 113
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 171 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 202

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH-VNVV 144
           LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 145 SFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTMCQIA 193
           + LG C +      +I EF   G+L  ++  + +  +  K          L    +   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 194 VGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
             +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K    +    A
Sbjct: 146 FQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 253 RGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
           R  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 202 RLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 27/219 (12%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFI-NEVASMS 136
           +  D + + +S+  K+G+G  G V   +    GR VAVK++   K    E + NEV  M 
Sbjct: 39  DQGDPRLLLDSYV-KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
              H NVV         ++  ++ EF+  G+L   +       +N + +  T+C+    +
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEE-QIATVCE---AV 150
Query: 197 ARGLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFG----LAKLSEKKESFISMLG 251
            + L YLH +G    ++H DIK  +ILL  D   K+SDFG    ++K   K++  +    
Sbjct: 151 LQALAYLHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV---- 202
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             GT  ++APEV  R+    + + D++S G+M++EMV G
Sbjct: 203 --GTPYWMAPEVISRSL--YATEVDIWSLGIMVIEMVDG 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 77  RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR---LVAVKVLKNSKVNGEE--FINE 131
           R+  ++  R    F + LG G F  V   +  D R   LVA+K +    + G+E    NE
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI----YDEESSNINRKLEW 186
           +A + K  H N+V+            LI + +  G L D+ +    Y E           
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----------- 115
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL---LGEDFCPKISDFGLAKLSEKK 243
           R   ++   +   ++YLH   ++ IVH D+KP N+L   L ED    ISDFGL+K+ E  
Sbjct: 116 RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            S +S   A GT GY+APEV  +     S   D +S G++   ++ G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 27/251 (10%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVL---KNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G+G +G V K +  D GR+VA+K      + K+  +  + E+  + +  H N+V+ L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
           C +KK+  L++EF+ +  LD     E   N    L+++ + +    I  G+ + H     
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDL---ELFPN---GLDYQVVQKYLFQIINGIGFCHSH--- 143
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            I+H DIKP NIL+ +    K+ DFG A+ L+   E +   +  R    Y APE+     
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---WYRAPELL---V 197
Query: 269 GGVSH--KSDVYSYGMMILEMVVGRK----NAEVKVSLSSEIYFPNSIYKHIEPGNEFQL 322
           G V +    DV++ G ++ EM +G      ++++       +   N I +H E  N+  +
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 323 -AGVVTEEEKE 332
            AGV   E KE
Sbjct: 258 FAGVRLPEIKE 268

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 66  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 119
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 175
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 63  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 116
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 117 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 172
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 173 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 204

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 68  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 121
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 122 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 177
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 178 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 69  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 122
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 123 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 178
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 179 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 6   YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 64
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 65  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 117
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 174
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 175 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 66  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 119
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 175
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 77  RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR---LVAVKVLKNSKVNGEE--FINE 131
           R+  ++  R    F + LG G F  V   +  D R   LVA+K +    + G+E    NE
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI----YDEESSNINRKLEW 186
           +A + K  H N+V+            LI + +  G L D+ +    Y E           
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----------- 115
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL---LGEDFCPKISDFGLAKLSEKK 243
           R   ++   +   ++YLH   ++ IVH D+KP N+L   L ED    ISDFGL+K+ E  
Sbjct: 116 RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            S +S   A GT GY+APEV  +     S   D +S G++   ++ G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 93  KLGQGGFGSVYKG--KLPDGRL-VAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +LG G FGSV +G  ++   ++ VA+KVLK    K + EE + E   M +  +  +V  +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G C + +   L+ E    G L +F+  +       ++    + ++   ++ G++YL    
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA-RGTIGYIAPEVFCR 266
               VH ++   N+LL      KISDFGL+K     +S+ +   A +  + + APE  C 
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CI 511
Query: 267 NFGGVSHKSDVYSYGMMILEMV 288
           NF   S +SDV+SYG+ + E +
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 141 VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTM 189
           +NVV+ LG C +      +I EF   G+L  ++  + +  +  K          L    +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 CQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              +  +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K    + 
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 77  RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR---LVAVKVLKNSKVNGEE--FINE 131
           R+  ++  R    F + LG G F  V   +  D R   LVA+K +    + G+E    NE
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI----YDEESSNINRKLEW 186
           +A + K  H N+V+            LI + +  G L D+ +    Y E           
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----------- 115
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL---LGEDFCPKISDFGLAKLSEKK 243
           R   ++   +   ++YLH   ++ IVH D+KP N+L   L ED    ISDFGL+K+ E  
Sbjct: 116 RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            S +S   A GT GY+APEV  +     S   D +S G++   ++ G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 6   YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 64
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 65  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 117
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K L   +  + +    
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 175 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 40/214 (18%)
Query: 94  LGQGGFGSVYKGKLPDG----RLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSF 146
           LGQG FG V+  K   G    +L A+KVLK + +   + +    E   + + +H  +V  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK- 90
Query: 147 LGFCYEKK-KRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           L + ++ + K  LI +F+  G L      + ++ EE            + ++A+     L
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-------LAELALA----L 139
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS---EKKE-SFISMLGARGTI 256
           ++LH   ++ I++ D+KP NILL E+   K++DFGL+K S   EKK  SF       GT+
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTV 190
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            Y+APEV  R   G +  +D +S+G+++ EM+ G
Sbjct: 191 EYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVVSFL 147
           +LG+G +G V K + +P G+++AVK ++ + VN +E     ++   SM        V+F 
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G  + +    +  E M + SLD+F   ++  +  + +    + +IAV I + LE+LH   
Sbjct: 117 GALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 171
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR- 266
            + ++H D+KP N+L+      K+ DFG++      +S    + A G   Y+APE     
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSVAKTIDA-GCKPYMAPERINPE 228
Query: 267 -NFGGVSHKSDVYSYGMMILEMVVGR 291
            N  G S KSD++S G+ ++E+ + R
Sbjct: 229 LNQKGYSVKSDIWSLGITMIELAILR 254

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 19/221 (8%)
Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEF 128
           P   +Y +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F
Sbjct: 380 PSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
           + E  +M +  H ++V  +G   E     +I E    G L  F+   + S     L+  +
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS-----LDLAS 492
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  ++  L YL      R VH DI   N+L+    C K+ DFGL++  E    + +
Sbjct: 493 LILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA 549
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
             G +  I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 550 SKG-KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 587

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 77  RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR---LVAVKVLKNSKVNGEE--FINE 131
           R+  ++  R    F + LG G F  V   +  D R   LVA+K +    + G+E    NE
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 132 VASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI----YDEESSNINRKLEW 186
           +A + K  H N+V+            LI + +  G L D+ +    Y E           
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----------- 115
Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL---LGEDFCPKISDFGLAKLSEKK 243
           R   ++   +   ++YLH   ++ IVH D+KP N+L   L ED    ISDFGL+K+ E  
Sbjct: 116 RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            S +S   A GT GY+APEV  +     S   D +S G++   ++ G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 40/214 (18%)
Query: 94  LGQGGFGSVYKGKLPDG----RLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSF 146
           LGQG FG V+  K   G    +L A+KVLK + +   + +    E   + + +H  +V  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK- 90
Query: 147 LGFCYEKK-KRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           L + ++ + K  LI +F+  G L      + ++ EE            + ++A+     L
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALA----L 139
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS---EKKE-SFISMLGARGTI 256
           ++LH   ++ I++ D+KP NILL E+   K++DFGL+K S   EKK  SF       GT+
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTV 190
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            Y+APEV  R   G +  +D +S+G+++ EM+ G
Sbjct: 191 EYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 222

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKV-----LKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           K+G+G F  VY+   L DG  VA+K      L ++K   +  I E+  + + +H NV+ +
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPNVIKY 97
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
                E  +  ++ E    G L + I  +      R +  RT+ +  V +   LE++H  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMH-- 153
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            + R++H DIKP N+ +      K+ D GL +    K +    L   GT  Y++PE    
Sbjct: 154 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHE 210
Query: 267 NFGGVSHKSDVYSYGMMILEMVV 289
           N  G + KSD++S G ++ EM  
Sbjct: 211 N--GYNFKSDIWSLGCLLYEMAA 231

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 94  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 147
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 148 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 203
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 204 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 235

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 40/214 (18%)
Query: 94  LGQGGFGSVYKGKLPDG----RLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSF 146
           LGQG FG V+  K   G    +L A+KVLK + +   + +    E   + + +H  +V  
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK- 91
Query: 147 LGFCYEKK-KRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           L + ++ + K  LI +F+  G L      + ++ EE            + ++A+     L
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALA----L 140
Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS---EKKE-SFISMLGARGTI 256
           ++LH   ++ I++ D+KP NILL E+   K++DFGL+K S   EKK  SF       GT+
Sbjct: 141 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTV 191
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            Y+APEV  R   G +  +D +S+G+++ EM+ G
Sbjct: 192 EYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 71  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQ 124
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  
Sbjct: 125 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLP 180
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 181 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 212

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 93  KLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSF 146
           +LG G FG+V KG        + VAVK+LKN   +    +E + E   M +  +  +V  
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G C E +   L+ E    G L++++        NR ++ + + ++   ++ G++YL   
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEES 124
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGARGTIGYIAPEVFC 265
                VH D+   N+LL      KISDFGL+K     E++  +    +  + + APE  C
Sbjct: 125 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE--C 179
Query: 266 RNFGGVSHKSDVYSYGMMILE 286
            N+   S KSDV+S+G+++ E
Sbjct: 180 INYYKFSSKSDVWSFGVLMWE 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           ++G G FG+VY  + + +  +VA+K +    K S    ++ I EV  + K  H N + + 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
           G CY ++  A L+ E+    + D          +++K L+   +  +  G  +GL YLH 
Sbjct: 121 G-CYLREHTAWLVMEYCLGSASDLL-------EVHKKPLQEVEIAAVTHGALQGLAYLH- 171
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV-F 264
             +  ++H D+K  NILL E    K+ DFG A +      F+      GT  ++APEV  
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVIL 223
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
             + G    K DV+S G+  +E+ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 87  TNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVV 144
           T S +  LG G FG V+K +    G  +A K++K   + + EE  NE++ M++  H N++
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                   K    L+ E++  G L   I D ES N+        M QI  GI     ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGI----RHMH 204
Query: 205 RGCNIRIVHFDIKPHNIL-LGEDFCP-KISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           +   + I+H D+KP NIL +  D    KI DFGLA+  + +E         GT  ++APE
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPE 258
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V   N+  VS  +D++S G++   ++ G
Sbjct: 259 VV--NYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 83  VKRMTNSFSNK------LGQGGFGSVY--KGKLPDGRLVAVKVLKN----SKVNGEEFIN 130
           V+  T  FS++      LG+G FG V   K K+  G+  AVKV+       K + E  + 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTM 189
           EV  + +  H N++    F  +K    L+ E    G L D+ I  +  S ++        
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-------A 128
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESF 246
            +I   +  G+ Y+H+    +IVH D+KP N+LL    +D   +I DFG   LS   E+ 
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEAS 182
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             M    GT  YIAPEV     G    K DV+S G+++  ++ G
Sbjct: 183 KKMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           ++G G FG+VY  + + +  +VA+K +    K S    ++ I EV  + K  H N + + 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 148 GFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
           G CY ++  A L+ E+    + D          +++K L+   +  +  G  +GL YLH 
Sbjct: 82  G-CYLREHTAWLVMEYCLGSASDLL-------EVHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV-F 264
             +  ++H D+K  NILL E    K+ DFG A +      F+      GT  ++APEV  
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVIL 184
Query: 265 CRNFGGVSHKSDVYSYGMMILEMV 288
             + G    K DV+S G+  +E+ 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELA 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 35/224 (15%)
Query: 94  LGQGGFGSVYKGKL--PDGR----LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVS 145
           LG+G FG V K       GR     VAVK+LK +    E  + ++E   + + +H +V+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN--------------------RKLE 185
             G C +     LI E+   GSL  F+   ES  +                     R L 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
              +   A  I++G++YL     +++VH D+   NIL+ E    KISDFGL++   +++S
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            +     R  + ++A E    +    + +SDV+S+G+++ E+V 
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 141 VNVVSFLGFCYEKK-KRALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTM 189
           +NVV+ LG C +      +I EF   G+L  ++  + +  +  K          L    +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 CQIAVGIARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              +  +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K    + 
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
              AR  + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYK------GKLPDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K      GK    + +  + L +S+  V+ EE   EV  + +  H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      Q    I  G+ YLH
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLH 125
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              + RI HFD+KP NI+L +   P    K+ DFG+A   E    F ++    GT  ++A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVA 179
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 180 PEIV--NYEPLGLEADMWSIGVITYILLSG 207

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 364 YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 422
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 423 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 475
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 476 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 533 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 564

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 93  KLGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLG 148
           KLG G +G V   +     +  A+K+++ + V+     + + EVA +    H N++    
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 149 FCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F  +K+   L+ E    G L D+ I+  + + ++  +       I   +  G+ YLH+  
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------IIKQVLSGVTYLHKH- 155
Query: 208 NIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              IVH D+KP N+LL    +D   KI DFGL+ + E ++     L   GT  YIAPEV 
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVL 210
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            + +     K DV+S G+++  ++ G
Sbjct: 211 RKKY---DEKCDVWSIGVILFILLAG 233

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 66  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQ 119
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+    C K+ DFGL++  E    + +  G +  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-KLP 175
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYK------GKLPDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K      GK    + +  + L +S+  V+ EE   EV  + +  H N++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      Q    I  G+ YLH
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                RI HFD+KP NI+L +   P    K+ DFG+A   E    F ++    GT  ++A
Sbjct: 133 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG---KLPDGRLVAVKVLKNSKVNG---EEFINEVA 133
           Y D K +T     +LG G FG+V KG        + VAVK+LKN   +    +E + E  
Sbjct: 365 YLDRKLLTLE-DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 423
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
            M +  +  +V  +G C E +   L+ E    G L++++        NR ++ + + ++ 
Sbjct: 424 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 476
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI-SMLGA 252
             ++ G++YL        VH D+   N+LL      KISDFGL+K     E++  +    
Sbjct: 477 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 533
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
           +  + + APE  C N+   S KSDV+S+G+++ E
Sbjct: 534 KWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 565

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 83  VKRMTNSFSNK------LGQGGFGSVY--KGKLPDGRLVAVKVLKN----SKVNGEEFIN 130
           V+  T  FS++      LG+G FG V   K K+  G+  AVKV+       K + E  + 
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 98
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTM 189
           EV  + +  H N++    F  +K    L+ E    G L D+ I  +  S ++        
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-------A 151
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESF 246
            +I   +  G+ Y+H+    +IVH D+KP N+LL    +D   +I DFG   LS   E+ 
Sbjct: 152 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEAS 205
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             M    GT  YIAPEV     G    K DV+S G+++  ++ G
Sbjct: 206 KKMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 246

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V K +  P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 22  SELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ + +       +++    + ++++ + RGL YL     
Sbjct: 82  AFYSDGEISICMEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE--K 133
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y+APE    
Sbjct: 134 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMAPERLQG 187
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++E+ VGR
Sbjct: 188 THYSV--QSDIWSMGLSLVELAVGR 210

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKL--PD--GRLVAVKVLKNSKVNG--EEFINEVASM 135
           +++R        +G+G FG V++G    P+     VA+K  KN   +   E+F+ E  +M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            +  H ++V  +G   E     +I E    G L  F+   + S     L+  ++   A  
Sbjct: 66  RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQ 119
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           ++  L YL    + R VH DI   N+L+  + C K+ DFGL++  E      +  G +  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG-KLP 175
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           I ++APE    NF   +  SDV+ +G+ + E+++
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYK------GKLPDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K      GK    + +  + L +S+  V+ EE   EV  + +  H N++
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      Q    I  G+ YLH
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLH 146
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              + RI HFD+KP NI+L +   P    K+ DFG+A   E    F ++    GT  ++A
Sbjct: 147 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVA 200
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 201 PEIV--NYEPLGLEADMWSIGVITYILLSG 228

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 33/224 (14%)
Query: 83  VKRMTNSFSNK------LGQGGFGSVY--KGKLPDGRLVAVKVLKNSKV----NGEEFIN 130
           V+  T  FS++      LG+G FG V   K K+  G+  AVKV+   +V    + E  + 
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 81
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTM 189
           EV  + +  H N++    F  +K    L+ E    G L D+ I  +  S ++        
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-------A 134
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESF 246
            +I   +  G+ Y+H+    +IVH D+KP N+LL    +D   +I DFG   LS   E+ 
Sbjct: 135 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEAS 188
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             M    GT  YIAPEV     G    K DV+S G+++  ++ G
Sbjct: 189 KKMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 36/236 (15%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE--VASMSKTSHVNVVSF 146
           +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE  + S+  T     +  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 147 LGFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           + + +    K + I + M  G L    Y      +  + + R     A  I  GLE++H 
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF---YAAEIILGLEHMH- 308
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
             N  +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT GY+APEV  
Sbjct: 309 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 362
Query: 266 RNFGGVSHKS--DVYSYGMMILEMVVGR----------KNAEVKVSLSSEIYFPNS 309
           +   GV++ S  D +S G M+ +++ G           K+   +++L+  +  P+S
Sbjct: 363 K---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 415

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 83  VKRMTNSFSNK------LGQGGFGSVY--KGKLPDGRLVAVKVLKN----SKVNGEEFIN 130
           V+  T  FS++      LG+G FG V   K K+  G+  AVKV+       K + E  + 
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 99
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTM 189
           EV  + +  H N++    F  +K    L+ E    G L D+ I  +  S ++        
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-------A 152
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESF 246
            +I   +  G+ Y+H+    +IVH D+KP N+LL    +D   +I DFG   LS   E+ 
Sbjct: 153 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEAS 206
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             M    GT  YIAPEV     G    K DV+S G+++  ++ G
Sbjct: 207 KKMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 247

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 117/244 (47%), Gaps = 38/244 (15%)
Query: 88  NSFS--NKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE--VASMSKT 138
           N FS    +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE  + S+  T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 SHVNVVSFLGFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
                +  + + +    K + I + M  G L    Y      +  + + R     A  I 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF---YAAEII 302
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
            GLE++H   N  +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT G
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 355
Query: 258 YIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGR----------KNAEVKVSLSSEIY 305
           Y+APEV  +   GV++ S  D +S G M+ +++ G           K+   +++L+  + 
Sbjct: 356 YMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 306 FPNS 309
            P+S
Sbjct: 413 LPDS 416

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 117/244 (47%), Gaps = 38/244 (15%)
Query: 88  NSFS--NKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE--VASMSKT 138
           N FS    +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE  + S+  T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 SHVNVVSFLGFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
                +  + + +    K + I + M  G L    Y      +  + + R     A  I 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF---YAAEII 302
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
            GLE++H   N  +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT G
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 355
Query: 258 YIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGR----------KNAEVKVSLSSEIY 305
           Y+APEV  +   GV++ S  D +S G M+ +++ G           K+   +++L+  + 
Sbjct: 356 YMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 306 FPNS 309
            P+S
Sbjct: 413 LPDS 416

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 36/236 (15%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE--VASMSKTSHVNVVSF 146
           +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE  + S+  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 147 LGFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           + + +    K + I + M  G L    Y      +  + + R     A  I  GLE++H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEADMRF---YAAEIILGLEHMH- 309
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
             N  +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT GY+APEV  
Sbjct: 310 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 363
Query: 266 RNFGGVSHKS--DVYSYGMMILEMVVGR----------KNAEVKVSLSSEIYFPNS 309
           +   GV++ S  D +S G M+ +++ G           K+   +++L+  +  P+S
Sbjct: 364 K---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 93  KLGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+ VAVK +   K    E + NEV  M    H NVV      
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + R L YLH   N  
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIATVCLSVLRALSYLH---NQG 161
Query: 211 IVHFDIKPHNILLGEDFCPKISDFG----LAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
           ++H DIK  +ILL  D   K+SDFG    ++K   K++  +      GT  ++APEV  R
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISR 215
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
              G   + D++S G+M++EM+ G
Sbjct: 216 LPYGT--EVDIWSLGIMVIEMIDG 237

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 94  LGQGGFGSVY--KGKLPDGRLVAVKV-LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           LG+GGFG V+  K K+ D      ++ L N ++  E+ + EV +++K  H  +V +    
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEW-----------RTMC-QIAVGIAR 198
            EK     +    P   L  +I  +     N K +W           R++C  I + IA 
Sbjct: 73  LEKNTTEKLQPSSPKVYL--YIQMQLCRKENLK-DWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 199 GLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML------- 250
            +E+LH +G    ++H D+KP NI    D   K+ DFGL    ++ E   ++L       
Sbjct: 130 AVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 251 ---GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
              G  GT  Y++PE    N    SHK D++S G+++ E++
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLSFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 9   KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 176
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 177 CKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 11  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 124 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 178
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 179 CKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 9   KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 176
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 177 CKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 14  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 73  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 126
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 127 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 181
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 182 CKYY---STAVDIWSLGCIFAEMVTRR 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 9   KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 176
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 177 CKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 17  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 76  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 129
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 130 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 184
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 185 CKYY---STAVDIWSLGCIFAEMVTRR 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 9   KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 176
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 177 CKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 94  LGQGGFGSVYKGKL--PDGR----LVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVS 145
           LG+G FG V K       GR     VAVK+LK +    E  + ++E   + + +H +V+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN--------------------RKLE 185
             G C +     LI E+   GSL  F+   ES  +                     R L 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES 245
              +   A  I++G++YL     + +VH D+   NIL+ E    KISDFGL++   +++S
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
            +     R  + ++A E    +    + +SDV+S+G+++ E+V 
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 12  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 124
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 125 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 180 CKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 13  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 125
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 181 CKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 13  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 125
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 181 CKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 12  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 124
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 125 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 180 CKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 11  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 124 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 178
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 179 CKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 11  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 124 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 178
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 179 CKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 14  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 73  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 126
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 127 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 181
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 182 CKYY---STAVDIWSLGCIFAEMVTRR 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 94  LGQGGFGSVYKGKL-PDG----RLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSF 146
           LG+G FG V   +  P+G      VAVK LK         +   E+  +    H N+V +
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 147 LGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G C E       LI EF+P+GSL +++      N N K+  +   + AV I +G++YL 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKN-KINLKQQLKYAVQICKGMDYLG 143
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEV 263
              + + VH D+   N+L+  +   KI DFGL K  E  +   ++   R + + + APE 
Sbjct: 144 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVV 289
             ++   ++  SDV+S+G+ + E++ 
Sbjct: 201 LMQSKFYIA--SDVWSFGVTLHELLT 224

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 41  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 145 SFLGFCYEKKKRALI-YEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIAR 198
             L FC++  ++      +  NG L ++I     +DE  +                 I  
Sbjct: 101 K-LYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVS 148
Query: 199 GLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
            LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  
Sbjct: 149 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           Y++PE+           SD+++ G +I ++V G
Sbjct: 205 YVSPELLTEK--SACKSSDLWALGCIIYQLVAG 235

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE--FINEVASMSKT 138
           D+K++   F   LG G F  V   +    G+L AVK +    + G+E    NE+A + K 
Sbjct: 19  DIKKIFE-FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSL------DQFIYDEESSNINRKLEWRTMCQI 192
            H N+V+            L+ + +  G L        F  ++++S + R+         
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ--------- 128
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISM 249
              +   + YLHR   + IVH D+KP N+L     E+    ISDFGL+K+  K +    M
Sbjct: 129 ---VLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VM 179
Query: 250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             A GT GY+APEV  +     S   D +S G++   ++ G
Sbjct: 180 STACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 218

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 94  LGQGGFGSVYKGKL-PDG----RLVAVKVLKNSKVNGE--EFINEVASMSKTSHVNVVSF 146
           LG+G FG V   +  P+G      VAVK LK         +   E+  +    H N+V +
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 147 LGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G C E       LI EF+P+GSL +++      N N K+  +   + AV I +G++YL 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKN-KINLKQQLKYAVQICKGMDYLG 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-IGYIAPEV 263
              + + VH D+   N+L+  +   KI DFGL K  E  +   ++   R + + + APE 
Sbjct: 132 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVV 289
             ++   ++  SDV+S+G+ + E++ 
Sbjct: 189 LMQSKFYIA--SDVWSFGVTLHELLT 212

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 11  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 124 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 178
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 179 CKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 12  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 124
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 125 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 180 CKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 13  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L  F+     + I   L    + Q+     +GL + H   
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 125
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 181 CKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVVSFL 147
           +LG+G +G V K + +P G+++AVK ++ + VN +E     ++   SM        V+F 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G  + +    +  E M + SLD+F   ++  +  + +    + +IAV I + LE+LH   
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
            + ++H D+KP N+L+      K+ DFG++  L +     I      G   Y+APE    
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKPYMAPERINP 183
Query: 267 --NFGGVSHKSDVYSYGMMILEMVVGR 291
             N  G S KSD++S G+ ++E+ + R
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR 210

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAV-KVLKNSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+ K+  +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAV-KVLKNSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+ K+  +++  G     I E++ + + +H N+V  L
Sbjct: 9   KIGEGTYGVVYKARNKL-TGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 176
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 177 CKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 11  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 70  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 124 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 178
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 179 CKYY---STAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L  F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 177
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 178 CKYY---STAVDIWSLGCIFAEMVTRR 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 93  KLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEF------INEVASMSKTS---HVN 142
           ++G G +G+VYK + P  G  VA+K ++     G         + EVA + +     H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 143 VVSFLGFCYEKK-----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           VV  +  C   +     K  L++E      +DQ +           L   T+  +     
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL++LH  C   IVH D+KP NIL+      K++DFGLA++   + +   ++    T+ 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV---VTLW 184
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           Y APEV  ++    +   D++S G +  EM
Sbjct: 185 YRAPEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 12  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L  F+     + I   L    + Q+     +GL + H   
Sbjct: 71  DVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 124
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 125 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 179
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 180 CKYY---STAVDIWSLGCIFAEMVTRR 203

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 134 AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 185
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 186 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 239
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 240 THYSV--QSDIWSMGLSLVEMAVGR 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 150
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 204
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 205 THYSV--QSDIWSMGLSLVEMAVGR 227

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 13  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 72  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 125
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 126 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 181 CKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 13  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L  F+     + I   L    + Q+     +GL + H   
Sbjct: 72  DVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 125
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 181 CKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 126
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   + E    F+      GT  Y++PE    
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPERLQG 180
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 181 THYSV--QSDIWSMGLSLVEMAVGR 203

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 142
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 143 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 196
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 197 THYSV--QSDIWSMGLSLVEMAVGR 219

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 84  KRMTNSFSNKLGQGGFGSVYKGKLPD---GRL-VAVKVLK--NSKVNGEEFINEVASMSK 137
           +R+       +G+G FG VY G+  D    R+  A+K L         E F+ E   M  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 138 TSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
            +H NV++ +G     +    ++  +M +G L QFI   + +   + L         + +
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQV 133
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARG 254
           ARG+EYL      + VH D+   N +L E F  K++DFGLA+  L  +  S      AR 
Sbjct: 134 ARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            + + A E         + KSDV+S+G+++ E++
Sbjct: 191 PVKWTALESL--QTYRFTTKSDVWSFGVLLWELL 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 177
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 178 THYSV--QSDIWSMGLSLVEMAVGR 200

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNGE----EFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  S++  E    +   E+   S   H N++    
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           + +++K+  L+ EF P G L + +     +DE+ S                 +A  L Y 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-----------ATFMEELADALHYC 131
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H     +++H DIKP N+L+G     KI+DFG +  +      +      GT+ Y+ PE+
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEM 184
Query: 264 FCRNFGGVSH--KSDVYSYGMMILEMVVG 290
                 G +H  K D++  G++  E +VG
Sbjct: 185 ----IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 177
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 178 THYSV--QSDIWSMGLSLVEMAVGR 200

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKVNGE----EFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +    + + A+KVL  S++  E    +   E+   S   H N++    
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           + +++K+  L+ EF P G L + +     +DE+ S                 +A  L Y 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-----------ATFMEELADALHYC 130
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H     +++H DIKP N+L+G     KI+DFG +  +      +      GT+ Y+ PE+
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEM 183
Query: 264 FCRNFGGVSH--KSDVYSYGMMILEMVVG 290
                 G +H  K D++  G++  E +VG
Sbjct: 184 ----IEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 177
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 178 THYSV--QSDIWSMGLSLVEMAVGR 200

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 83  VKRMTNSFSNK------LGQGGFGSVY--KGKLPDGRLVAVKVLKN----SKVNGEEFIN 130
           V+  T  FS++      LG+G FG V   K K+  G+  AVKV+       K + E  + 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTM 189
           EV  + +  H N+     F  +K    L+ E    G L D+ I  +  S ++        
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-------A 128
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESF 246
            +I   +  G+ Y H+    +IVH D+KP N+LL    +D   +I DFGL+   E  +  
Sbjct: 129 ARIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX 185
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
              +   GT  YIAPEV     G    K DV+S G+++  ++ G
Sbjct: 186 KDKI---GTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 177
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 178 THYSV--QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 92  NKLGQGGFGSVYK-GKLPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           ++LG G  G V+K    P G ++A K+  L+       + I E+  + + +   +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             Y   + ++  E M  GSLDQ +  +++  I  ++    + ++++ + +GL YL     
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQI----LGKVSIAVIKGLTYLRE--K 123
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAPEVFCR 266
            +I+H D+KP NIL+      K+ DFG++   +     SF+      GT  Y++PE    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 177
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
               V  +SD++S G+ ++EM VGR
Sbjct: 178 THYSV--QSDIWSMGLSLVEMAVGR 200

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-----------YTAEIVSA 144
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 145 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+        S  SD+++ G +I ++V G
Sbjct: 201 VSPELLTEK--SASKSSDLWALGCIIYQLVAG 230

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   Y+    D + V A KV+  S +      E+   E+A      + +VV F G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           F  +     ++ E     SL +     +      + E R   +  +   +G++YLH   N
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI---QGVQYLH---N 160
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPEVF 264
            R++H D+K  N+ L +D   KI DFGLA       E+K++        GT  YIAPEV 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC------GTPNYIAPEVL 214
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN---SIYKHIEP 316
           C+   G S + D++S G ++  ++VG+   E      + I       S+ +HI P
Sbjct: 215 CKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINP 267

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 10  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILL- 176
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
                S   D++S G +  EMV  R
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   Y+    D + V A KV+  S +      E+   E+A      + +VV F G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           F  +     ++ E     SL +     +      + E R   +  +   +G++YLH   N
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI---QGVQYLH---N 144
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPEVF 264
            R++H D+K  N+ L +D   KI DFGLA       E+K+         GT  YIAPEV 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC------GTPNYIAPEVL 198
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN---SIYKHIEP 316
           C+   G S + D++S G ++  ++VG+   E      + I       S+ +HI P
Sbjct: 199 CKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINP 251

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +LG GGFG V +    D G  VA+K  +   S  N E +  E+  M K +H NVVS    
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 150 CYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
               +K A      L  E+   G L +++   E+    ++   RT+      I+  L YL
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---DISSALRYL 138
Query: 204 HRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           H     RI+H D+KP NI+L    +    KI D G AK  ++ E     +   GT+ Y+A
Sbjct: 139 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLA 192
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+  +    V+   D +S+G +  E + G
Sbjct: 193 PELLEQKKYTVT--VDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +LG GGFG V +    D G  VA+K  +   S  N E +  E+  M K +H NVVS    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 150 CYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
               +K A      L  E+   G L +++   E+    ++   RT+      I+  L YL
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---DISSALRYL 137
Query: 204 HRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           H     RI+H D+KP NI+L    +    KI D G AK  ++ E     +   GT+ Y+A
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLA 191
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+  +    V+   D +S+G +  E + G
Sbjct: 192 PELLEQKKYTVT--VDYWSFGTLAFECITG 219

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   Y+    D + V A KV+  S +      E+   E+A      + +VV F G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           F  +     ++ E     SL +     +      + E R   +  +   +G++YLH   N
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI---QGVQYLH---N 160
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPEVF 264
            R++H D+K  N+ L +D   KI DFGLA       E+K+         GT  YIAPEV 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC------GTPNYIAPEVL 214
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN---SIYKHIEP 316
           C+   G S + D++S G ++  ++VG+   E      + I       S+ +HI P
Sbjct: 215 CKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINP 267

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 17  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+ +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 76  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 129
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 130 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILL- 183
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
                S   D++S G +  EMV  R
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 141
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 142 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 198 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 227

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSF 146
           N LG+G F  VY+ + +  G  VA+K++    +     +    NEV    +  H +++  
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEE---SSNINRKLEWRTMCQIAVGIARGLEYL 203
             +  +     L+ E   NG +++++ +     S N  R      M QI  G+     YL
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF----MHQIITGML----YL 128
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSEKKESFISMLGARGTIGYIAPE 262
           H      I+H D+   N+LL  +   KI+DFGLA +L    E   ++    GT  YI+PE
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPE 182
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +  R+  G+  +SDV+S G M   +++GR
Sbjct: 183 IATRSAHGL--ESDVWSLGCMFYTLLIGR 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 108 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRW 207
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 208 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 94  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 194 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 120
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 121 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 177 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 142
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 143 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 199 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 11  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 71  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 119
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 120 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 176 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 205

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 35/212 (16%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 150 CYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IARG 199
                       F P  SL++F     +     +++N  ++ + +    V      I RG
Sbjct: 100 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           L+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  Y 
Sbjct: 148 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 199
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+   N+   +   D++S G ++ E++ GR
Sbjct: 200 APEIML-NWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   Y+    D + V A KV+  S +      E+   E+A      + +VV F G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           F  +     ++ E     SL +     +      + E R   +  +   +G++YLH   N
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI---QGVQYLH---N 160
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPEVF 264
            R++H D+K  N+ L +D   KI DFGLA       E+K+         GT  YIAPEV 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC------GTPNYIAPEVL 214
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN---SIYKHIEP 316
           C+   G S + D++S G ++  ++VG+   E      + I       S+ +HI P
Sbjct: 215 CKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINP 267

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 14  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 74  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 122
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 123 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 179 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 208

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 13  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 73  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 121
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 122 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 178 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 207

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH      
Sbjct: 218 LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQG--- 267
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  +ILL  D   K+SDFG  A++S++      ++   GT  ++APE+  R   
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV---GTPYWMAPELISRLPY 324
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   + D++S G+M++EMV G
Sbjct: 325 G--PEVDIWSLGIMVIEMVDG 343

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH      
Sbjct: 98  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQG--- 147
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  +ILL  D   K+SDFG  A++S++      ++   GT  ++APE+  R   
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV---GTPYWMAPELISRLPY 204
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   + D++S G+M++EMV G
Sbjct: 205 G--PEVDIWSLGIMVIEMVDG 223

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH      
Sbjct: 96  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQG--- 145
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  +ILL  D   K+SDFG  A++S++      ++   GT  ++APE+  R   
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV---GTPYWMAPELISRLPY 202
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   + D++S G+M++EMV G
Sbjct: 203 G--PEVDIWSLGIMVIEMVDG 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 33  SPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 93  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 193 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 141
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 142 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 198 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 18  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 78  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 126
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 127 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 183 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 212

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 145
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 146 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 202 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 84  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 184 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 107 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 155 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 206
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 207 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 93  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 193 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 108 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 207
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 208 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF--------IYDEESSNI--NRKLEWRTMCQIAVGIA 197
                         F P  SL++F        +   + +NI   +KL    +  +   I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 130
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 184
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 185 PEIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVV 144
             + LG G FG V  GK    G  VAVK+L   K+   + +     E+ ++    H +++
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                        ++ E++  G L  F Y  ++  ++ K   R   QI  G+    +Y H
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESRRLFQQILSGV----DYCH 133
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           R     +VH D+KP N+LL      KI+DFGL+ +    E    +  + G+  Y APEV 
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVI 187
Query: 265 C-RNFGGVSHKSDVYSYGMMILEMVVG 290
             R + G   + D++S G+++  ++ G
Sbjct: 188 SGRLYAGP--EVDIWSSGVILYALLCG 212

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 13  KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++E + +  L +F+     + I   L    + Q+     +GL + H   
Sbjct: 72  DVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH--- 123
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
           + R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLG 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 181 CKYY---STAVDIWSLGCIFAEMVTRR 204

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 93  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 193 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH      
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQG--- 136
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  +ILL  D   K+SDFG  A++S++      ++   GT  ++APE+  R   
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV---GTPYWMAPELISRLPY 193
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   + D++S G+M++EMV G
Sbjct: 194 G--PEVDIWSLGIMVIEMVDG 212

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV     +  G  +AVK L     S ++ +    E+  +    H NV+  L
Sbjct: 57  SPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 117 DV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 164
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 165 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 216
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 217 YRAPEIML-NWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH      
Sbjct: 91  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQG--- 140
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  +ILL  D   K+SDFG  A++S++      ++   GT  ++APE+  R   
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV---GTPYWMAPELISRLPY 197
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   + D++S G+M++EMV G
Sbjct: 198 G--PEVDIWSLGIMVIEMVDG 216

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 27  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 87  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 134
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 135 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 186
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 187 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 142
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 143 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 199 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 130
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 184
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 185 PEIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 142
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 143 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 199 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 99  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 147 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 198
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 199 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFC 150
           K+G+G  G V    +   G+LVAVK +   K    E + NEV  M    H NVV      
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
               +  ++ EF+  G+L   +        + ++    +  + + + + L  LH      
Sbjct: 141 LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQG--- 190
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGL-AKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           ++H DIK  +ILL  D   K+SDFG  A++S++      ++   GT  ++APE+  R   
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV---GTPYWMAPELISRLPY 247
Query: 270 GVSHKSDVYSYGMMILEMVVG 290
           G   + D++S G+M++EMV G
Sbjct: 248 G--PEVDIWSLGIMVIEMVDG 266

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 95  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 194
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 195 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VVS L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY    +      E R +   A  I  GLE LHR  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVF-YAAEICCGLEDLHRE- 305
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             RIV+ D+KP NILL +    +ISD GLA    + +   ++ G  GT+GY+APEV  +N
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVV-KN 359
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D ++ G ++ EM+ G+
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 90  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 190 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 144
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 145 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 201 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VVS L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY    +      E R +   A  I  GLE LHR  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVF-YAAEICCGLEDLHRE- 305
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             RIV+ D+KP NILL +    +ISD GLA    + +   ++ G  GT+GY+APEV  +N
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVV-KN 359
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D ++ G ++ EM+ G+
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF--------IYDEESSNI--NRKLEWRTMCQIAVGIA 197
                         F P  SL++F        +   + +NI   +KL    +  +   I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF--------IYDEESSNINR--KLEWRTMCQIAVGIA 197
                         F P  SL++F        +   + +NI +  KL    +  +   I 
Sbjct: 84  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQIL 131
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 184 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 92  NKLGQGGFGSVYKGKLPDGR-LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +++G+G FG VYKG     + +VA+K+  L+ ++   E+   E+  +S+     +  + G
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +  K  +I E++  GS    +           LE   +  I   I +GL+YLH   +
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPGP-------LEETYIATILREILKGLDYLH---S 134
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEVF 264
            R +H DIK  N+LL E    K++DFG+A +L++   K+  F+      GT  ++APEV 
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVI 188
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            ++      K+D++S G+  +E+  G
Sbjct: 189 KQS--AYDFKADIWSLGITAIELAKG 212

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 100 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 200 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 94  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 194 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 100 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 200 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 90  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 190 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 94  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 194 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 90  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 190 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 111 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 159 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRW 210
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 211 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 144
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 145 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 201 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 84  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRW 183
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 184 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 100 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 200 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 93  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 193 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 144
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 145 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 201 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 85  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 133 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 184
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 185 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 99  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 147 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 198
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 199 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 144
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 145 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 201 VSPELLTEK--SAXKSSDLWALGCIIYQLVAG 230

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 106/239 (44%), Gaps = 37/239 (15%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++    D + V A K++  S +      E+   E++     +H +VV F G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 149 FCYEKKKRALIYEFMPNGSLDQF------IYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           F  +     ++ E     SL +       + + E+    R+            I  G +Y
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ------------IVLGCQY 130
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LHR    R++H D+K  N+ L ED   KI DFGLA   E       +L   GT  YIAPE
Sbjct: 131 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE 185
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-----PNSIYKHIEP 316
           V  +   G S + DV+S G ++  ++VG+   E   S   E Y        SI KHI P
Sbjct: 186 VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINP 240

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 145
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 146 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 202 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 231

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 94  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 194 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 90  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 190 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 23/207 (11%)
Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLK-NSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           K+G+G +G VYK   KL  G +VA+K ++ +++  G     I E++ + + +H N+V  L
Sbjct: 9   KIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++E + +  L  F+     + I   L    + Q+     +GL + H   
Sbjct: 68  DVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF-- 264
             R++H D+KP N+L+  +   K++DFGLA+       ++   +    T+ Y APE+   
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLG 176
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C+ +   S   D++S G +  EMV  R
Sbjct: 177 CKYY---STAVDIWSLGCIFAEMVTRR 200

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 84  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 184 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 144
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 145 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 201 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++    D + V A K++  S +      E+   E++     +H +VV F G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 149 FCYEKKKRALIYEFMPNGSLDQF------IYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           F  +     ++ E     SL +       + + E+    R+            I  G +Y
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ------------IVLGCQY 132
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGY 258
           LHR    R++H D+K  N+ L ED   KI DFGLA       E+K++        GT  Y
Sbjct: 133 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC------GTPNY 183
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-----PNSIYKH 313
           IAPEV  +   G S + DV+S G ++  ++VG+   E   S   E Y        SI KH
Sbjct: 184 IAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKH 239
Query: 314 IEP 316
           I P
Sbjct: 240 INP 242

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 85  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 133 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 184
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 185 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 39  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 99  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 147
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 148 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 204 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 233

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 106/239 (44%), Gaps = 37/239 (15%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++    D + V A K++  S +      E+   E++     +H +VV F G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 149 FCYEKKKRALIYEFMPNGSLDQF------IYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           F  +     ++ E     SL +       + + E+    R+            I  G +Y
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ------------IVLGCQY 154
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LHR    R++H D+K  N+ L ED   KI DFGLA   E       +L   GT  YIAPE
Sbjct: 155 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE 209
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-----PNSIYKHIEP 316
           V  +   G S + DV+S G ++  ++VG+   E   S   E Y        SI KHI P
Sbjct: 210 VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINP 264

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++    D + V A K++  S +      E+   E++     +H +VV F G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 149 FCYEKKKRALIYEFMPNGSLDQF------IYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           F  +     ++ E     SL +       + + E+    R+            I  G +Y
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ------------IVLGCQY 136
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGY 258
           LHR    R++H D+K  N+ L ED   KI DFGLA       E+K++        GT  Y
Sbjct: 137 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC------GTPNY 187
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-----PNSIYKH 313
           IAPEV  +   G S + DV+S G ++  ++VG+   E   S   E Y        SI KH
Sbjct: 188 IAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKH 243
Query: 314 IEP 316
           I P
Sbjct: 244 INP 246

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 107 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 155 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 206
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 207 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 26  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 86  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 133
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 134 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 185
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 186 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAV-KVLKN-----SKVNGEEFINEVASMSKTSHVNV 143
           F  KLG G FG V+   L + R   + +V+K      S+V  E+   E+  +    H N+
Sbjct: 26  FKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +       +     ++ E    G L + I   ++    + L    + ++   +   L Y 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYF 140
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYI 259
           H   +  +VH D+KP NIL  +D  P    KI DFGLA+L +  E   +   A GT  Y+
Sbjct: 141 H---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYM 193
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           APEVF R+   V+ K D++S G+++  ++ G
Sbjct: 194 APEVFKRD---VTFKCDIWSAGVVMYFLLTG 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 111 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 159 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 210
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 211 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 34/212 (16%)
Query: 93  KLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNGEE-----FINEVASMSKTS---H 140
           ++G+G +G V+K +  D    GR VA+K ++     GEE      I EVA +       H
Sbjct: 18  EIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEH 73
Query: 141 VNVVSFLGFCY-----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            NVV     C       + K  L++E +     D   Y ++        E  T+  +   
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTE--TIKDMMFQ 128
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           + RGL++LH   + R+VH D+KP NIL+      K++DFGLA++   + +  S++    T
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VT 182
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           + Y APEV  ++    +   D++S G +  EM
Sbjct: 183 LWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 108 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 207
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 208 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 93  KLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNGEE-----FINEVASMSKTS---H 140
           ++G+G +G V+K +  D    GR VA+K ++     GEE      I EVA +       H
Sbjct: 18  EIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEH 73
Query: 141 VNVVSFLGFCY-----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            NVV     C       + K  L++E      +DQ +           +   T+  +   
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           + RGL++LH   + R+VH D+KP NIL+      K++DFGLA++   + +  S++    T
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VT 182
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           + Y APEV  ++    +   D++S G +  EM
Sbjct: 183 LWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 34/212 (16%)
Query: 93  KLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNGEE-----FINEVASMSKTS---H 140
           ++G+G +G V+K +  D    GR VA+K ++     GEE      I EVA +       H
Sbjct: 18  EIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEH 73
Query: 141 VNVVSFLGFCY-----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            NVV     C       + K  L++E +     D   Y ++        E  T+  +   
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTE--TIKDMMFQ 128
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           + RGL++LH   + R+VH D+KP NIL+      K++DFGLA++   + +  S++    T
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VT 182
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
           + Y APEV  ++    +   D++S G +  EM
Sbjct: 183 LWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK+  +K +    E    E+   +  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 106/239 (44%), Gaps = 37/239 (15%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++    D + V A K++  S +      E+   E++     +H +VV F G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 149 FCYEKKKRALIYEFMPNGSLDQF------IYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           F  +     ++ E     SL +       + + E+    R+            I  G +Y
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ------------IVLGCQY 156
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LHR    R++H D+K  N+ L ED   KI DFGLA   E       +L   GT  YIAPE
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE 211
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-----PNSIYKHIEP 316
           V  +   G S + DV+S G ++  ++VG+   E   S   E Y        SI KHI P
Sbjct: 212 VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINP 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++    D + V A K++  S +      E+   E++     +H +VV F G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 149 FCYEKKKRALIYEFMPNGSLDQF------IYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           F  +     ++ E     SL +       + + E+    R+            I  G +Y
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ------------IVLGCQY 132
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGY 258
           LHR    R++H D+K  N+ L ED   KI DFGLA       E+K++        GT  Y
Sbjct: 133 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC------GTPNY 183
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-----PNSIYKH 313
           IAPEV  +   G S + DV+S G ++  ++VG+   E   S   E Y        SI KH
Sbjct: 184 IAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKH 239
Query: 314 IEP 316
           I P
Sbjct: 240 INP 242

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLK-NSKVNGEEFIN-----EVASMSKTSHVNVVSF 146
           LG+G F +VYK +  +  ++VA+K +K   +   ++ IN     E+  + + SH N++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           L     K   +L+++FM    L+  I D         ++   +  +     +GLEYLH+ 
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL-----QGLEYLHQH 131
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF- 264
               I+H D+KP+N+LL E+   K++DFGLAK       ++   +  R    Y APE+  
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR---WYRAPELLF 185
Query: 265 -CRNFG-GVSHKSDVYSYGMMILEMVV 289
             R +G GV    D+++ G ++ E+++
Sbjct: 186 GARMYGVGV----DMWAVGCILAELLL 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 90  FSNKLGQGGFGS-VYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVV 144
           F   LG+G F + V   +L   R  A+K+L+   +  E  +  V      MS+  H   V
Sbjct: 34  FGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARG 199
                  + +K      +  NG L ++I     +DE  +                 I   
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-----------YTAEIVSA 142
Query: 200 LEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           LEYLH +G    I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y
Sbjct: 143 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++PE+           SD+++ G +I ++V G
Sbjct: 199 VSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 94  LGQGGFGSVYKGKLPDGR-LVAVKVLKNSK-VNGEEFIN---EVASMSKTSHVNVVSFLG 148
           +G+G FG V   +  D + + A+K +   K V   E  N   E+  M    H  +V+   
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +++   ++ + +  G L   +      N++ K E  T+      +   L+YL    N
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEE--TVKLFICELVMALDYLQ---N 133
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-CRN 267
            RI+H D+KP NILL E     I+DF +A +  ++    +M G +    Y+APE+F  R 
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK---PYMAPEMFSSRK 190
Query: 268 FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS 302
             G S   D +S G+   E++ GR+   ++ S SS
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 95  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ +  +     M G   T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 195 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 29/207 (14%)
Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           K+G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  + 
Sbjct: 14  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +  K  +I E++  GS    +   E   ++       +  I   I +GL+YLH   
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDE----TQIATILREILKGLDYLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEV 263
           + + +H DIK  N+LL E    K++DFG+A +L++   K+ +F+      GT  ++APEV
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 175
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++      K+D++S G+  +E+  G
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARG 200

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 85  RMTNSFSNKLGQGGFGSVY--KGKLPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHV 141
           R T  F   LG G F  V+  K +L  G+L A+K +K S    +  + NE+A + K  H 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGI 196
           N+V+            L+ + +  G L     ++ +Y E+ +++           +   +
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-----------VIQQV 115
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGAR 253
              ++YLH      IVH D+KP N+L     E+    I+DFGL+K+ +       M  A 
Sbjct: 116 LSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTAC 168
Query: 254 GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           GT GY+APEV  +     S   D +S G++   ++ G
Sbjct: 169 GTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 13  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 70  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 120
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 178
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 179 RREFH--AEPVDVWSCGIVLTAMLAG 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ E+   EV+ + +  H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ ++ES      L      +    I  G+ YLH
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH 131
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
              +++I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 186 PEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 95  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ +  +     M G   T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 195 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 95  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ +  +     M G   T  
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 195 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI D+GLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLG 148
           ++G+G +GSV K    P G+++AVK ++++    E+    ++    M  +    +V F G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             + +    +  E M + S D+F Y    S ++  +    + +I +   + L +L    N
Sbjct: 89  ALFREGDCWICMELM-STSFDKF-YKYVYSVLDDVIPEEILGKITLATVKALNHLKE--N 144
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           ++I+H DIKP NILL      K+ DFG   +S +    I+     G   Y+APE    + 
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 269 G--GVSHKSDVYSYGMMILEMVVGR 291
              G   +SDV+S G+ + E+  GR
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           K+G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  + 
Sbjct: 34  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +  K  +I E++  GS    +   E   ++       +  I   I +GL+YLH   
Sbjct: 92  GSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDE----TQIATILREILKGLDYLHSE- 143
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEV 263
             + +H DIK  N+LL E    K++DFG+A +L++   K+ +F+      GT  ++APEV
Sbjct: 144 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 195
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++      K+D++S G+  +E+  G
Sbjct: 196 IKQS--AYDSKADIWSLGITAIELARG 220

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF--------IYDEESSNI--NRKLEWRTMCQIAVGIA 197
                         F P  SL++F        +   + +NI  ++KL    +  +   I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGL + ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G +G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 180
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 181 RREFH--AEPVDVWSCGIVLTAMLAG 204

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N    +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           K+G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  + 
Sbjct: 29  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +  K  +I E++  GS    +   E   ++       +  I   I +GL+YLH   
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDE----TQIATILREILKGLDYLH--- 136
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEV 263
           + + +H DIK  N+LL E    K++DFG+A +L++   K+  F+      GT  ++APEV
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 190
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++      K+D++S G+  +E+  G
Sbjct: 191 IKQS--AYDSKADIWSLGITAIELARG 215

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ EE   EV+ + +  H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       +    LI E +  G L  F+  +ES      L           I  G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGVNYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++    GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 45/261 (17%)
Query: 94  LGQGGFGSVYKGKLPDGRLV----AVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSF 146
           LG+G FG V K K    R+     AVKV+  +    ++    + EV  + K  H N++  
Sbjct: 30  LGKGSFGEVLKCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
                +     ++ E    G L    +DE    I RK        +I   +  G+ Y+H+
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDE---IIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
                IVH D+KP NILL    +D   KI DFGL+   ++      M    GT  YIAPE
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE 193
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN--SIYKHIEPGN-E 319
           V     G    K DV+S G+++  ++ G          +   Y  N   I K +E G   
Sbjct: 194 VL---RGTYDEKCDVWSAGVILYILLSG----------TPPFYGKNEYDILKRVETGKYA 240
Query: 320 FQLAG--VVTEEEKEMAKKMI 338
           F L     ++++ K++ +KM+
Sbjct: 241 FDLPQWRTISDDAKDLIRKML 261

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ EE   EV+ + +  H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       +    LI E +  G L  F+  +ES      L           I  G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGVNYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++    GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ EE   EV+ + +  H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       +    LI E +  G L  F+  +ES      L           I  G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGVNYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++    GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           K+G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  + 
Sbjct: 14  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   +  K  +I E++  GS    +   E   ++       +  I   I +GL+YLH   
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDE----TQIATILREILKGLDYLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYIAPEV 263
           + + +H DIK  N+LL E    K++DFG+A +L++   K+  F+      GT  ++APEV
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 175
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVG 290
             ++      K+D++S G+  +E+  G
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARG 200

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ EE   EV+ + +  H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       +    LI E +  G L  F+  +ES      L           I  G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGVNYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++    GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 28/206 (13%)
Query: 94  LGQGGFGSVYKGKLPDGR-LVAVKVLKNSKVNGE----EFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +      +VA+KVL  S++  E    +   E+   +   H N++    
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + Y++++  LI E+ P G L + +  ++S   +   E RT   I   +A  L Y H    
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL--QKSCTFD---EQRT-ATIMEELADALMYCH---G 141
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA--KLSEKKESFISMLGARGTIGYIAPEVFCR 266
            +++H DIKP N+LLG     KI+DFG +    S ++++        GT+ Y+ PE+   
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC------GTLDYLPPEM--- 192
Query: 267 NFGGVSH--KSDVYSYGMMILEMVVG 290
              G  H  K D++  G++  E++VG
Sbjct: 193 -IEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V  EE   EV+ + +  H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       +    LI E +  G L  F+  +ES      L           I  G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGVNYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++    GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI DF LA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +       V+ EE   EV+ + +  H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       +    LI E +  G L  F+  +ES      L           I  G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGVNYLH 132
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++    GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE+   N+  +  ++D++S G++   ++ G
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 37/211 (17%)
Query: 93  KLGQGGFGSVYKGKLPDGR---LVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           ++G+G FG V+KG   D R   +VA+K+  L+ ++   E+   E+  +S+     V  + 
Sbjct: 30  RIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFI----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           G   +  K  +I E++  GS    +    +DE         +  TM +    I +GL+YL
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE--------FQIATMLK---EILKGLDYL 136
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE---KKESFISMLGARGTIGYI 259
           H   + + +H DIK  N+LL E    K++DFG+A +L++   K+ +F+      GT  ++
Sbjct: 137 H---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWM 187
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           APEV  ++      K+D++S G+  +E+  G
Sbjct: 188 APEVIQQS--AYDSKADIWSLGITAIELAKG 216

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V+  +   +GR  A+KVLK   V      E   +E   +S  +H  ++   G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + ++  +I +++  G L   +   +   N   K         A  +   LEYLH   
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-------YAAEVCLALEYLHSK- 125
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              I++ D+KP NILL ++   KI+DFG AK        +      GT  YIAPEV    
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTK 178
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
               +   D +S+G++I EM+ G
Sbjct: 179 --PYNKSIDWWSFGILIYEMLAG 199

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL----VAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFL 147
           LG+G  G V   +L   R+    VAVK++   + V+  E I +   ++K  +H NVV F 
Sbjct: 14  LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G   E   + L  E+   G L  F   E    +      R   Q+  G+     YLH   
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 121
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFC 265
            I I H DIKP N+LL E    KISDFGLA +     +E  ++ +   GT+ Y+APE+  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLK 179
Query: 266 -RNFGGVSHKSDVYSYGMMILEMVVG 290
            R F   +   DV+S G+++  M+ G
Sbjct: 180 RREFH--AEPVDVWSCGIVLTAMLAG 203

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G +GSV      D RL   VAVK L     S ++      E+  +    H NV+  L
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQ-----IAVGIA 197
                         F P  S++ F     +     +++N  ++ + +       +   + 
Sbjct: 86  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   +I DFGLA+ ++++     M G   T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRW 185
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ G+
Sbjct: 186 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGF 149
           K+G+G +G VYK +   G   A+K ++  K +       I E++ + +  H N+V     
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
            + KK+  L++E + +  L + +   E       LE  T     + +  G+ Y H   + 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCH---DR 119
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAK---LSEKKESFISMLGARGTIGYIAPEVFCR 266
           R++H D+KP N+L+  +   KI+DFGLA+   +  +K +   +     T+ Y AP+V   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMG 174
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
           +    S   D++S G +  EMV G
Sbjct: 175 S-KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGF 149
           K+G+G +G VYK +   G   A+K ++  K +       I E++ + +  H N+V     
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
            + KK+  L++E + +  L + +   E       LE  T     + +  G+ Y H   + 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCH---DR 119
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAK---LSEKKESFISMLGARGTIGYIAPEVFCR 266
           R++H D+KP N+L+  +   KI+DFGLA+   +  +K +   +     T+ Y AP+V   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMG 174
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
           +    S   D++S G +  EMV G
Sbjct: 175 S-KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI D GLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGF 149
           K+G+G +G VYK +   G   A+K ++  K +       I E++ + +  H N+V     
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
            + KK+  L++E + +  L + +   E       LE  T     + +  G+ Y H   + 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCH---DR 119
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAK---LSEKKESFISMLGARGTIGYIAPEVFCR 266
           R++H D+KP N+L+  +   KI+DFGLA+   +  +K +   +     T+ Y AP+V   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVLMG 174
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
           +    S   D++S G +  EMV G
Sbjct: 175 S-KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 33/272 (12%)
Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVS 145
           +F  KL +   G ++KG+   G  + VKVLK    S     +F  E   +   SH NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 146 FLGFCYEKKK--RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
            LG C         LI  +MP GSL    Y+      N  ++     + A+ +ARG+ +L
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSL----YNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H      I    +   ++++ ED   +IS      +++ K SF S  G      ++APE 
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQSP-GRMYAPAWVAPEA 179
Query: 264 FCRNFGGVSHKS-DVYSYGMMILEMVV------GRKNAEVKVSLSSE---IYFPNSIYKH 313
             +     + +S D++S+ +++ E+V          N E+ + ++ E      P  I  H
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLE 345
           +      +L  +   E+     K  +++ +LE
Sbjct: 240 VS-----KLMKICMNEDPAKRPKFDMIVPILE 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 45/261 (17%)
Query: 94  LGQGGFGSVYKGKLPDGRLV----AVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSF 146
           LG+G FG V K K    R+     AVKV+  +    ++    + EV  + K  H N++  
Sbjct: 30  LGKGSFGEVLKCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
                +     ++ E    G L    +DE    I RK        +I   +  G+ Y+H+
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDE---IIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
                IVH D+KP NILL    +D   KI DFGL+   ++      M    GT  YIAPE
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE 193
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN--SIYKHIEPGN-E 319
           V     G    K DV+S G+++  ++ G          +   Y  N   I K +E G   
Sbjct: 194 VL---RGTYDEKCDVWSAGVILYILLSG----------TPPFYGKNEYDILKRVETGKYA 240
Query: 320 FQLAG--VVTEEEKEMAKKMI 338
           F L     ++++ K++ +KM+
Sbjct: 241 FDLPQWRTISDDAKDLIRKML 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 94  LGQGGFGSVYKGK----LPDGRLVAVKVLKNSKV--NGEEFINEVAS---MSKTSHVNVV 144
           LG+GG+G V++ +       G++ A+KVLK + +  N ++  +  A    + +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             +       K  LI E++  G L  F+  E            T C     I+  L +LH
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED----TACFYLAEISMALGHLH 138
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           +     I++ D+KP NI+L      K++DFGL K S    +        GTI Y+APE+ 
Sbjct: 139 QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC--GTIEYMAPEIL 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            R+  G +   D +S G ++ +M+ G
Sbjct: 194 MRS--GHNRAVDWWSLGALMYDMLTG 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI  FGLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 108/236 (45%), Gaps = 42/236 (17%)
Query: 90  FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKN----SKVNGEEFINEVASMSKTSHVNVV 144
            S+ LGQG   +V++G+    G L A+KV  N      V+ +  + E   + K +H N+V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHKNIV 70
Query: 145 SFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNIN--RKLEWRTMCQIAVGIARGL 200
                  E   R   LI EF P GSL  +   EE SN     + E+  + +  VG   G+
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSNAYGLPESEFLIVLRDVVG---GM 125
Query: 201 EYLHRGCNIRIVHFDIKPHNIL--LGED--FCPKISDFGLAKLSEKKESFISMLGARGTI 256
            +L       IVH +IKP NI+  +GED     K++DFG A+  E  E F+S+    GT 
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTE 179
Query: 257 GYIAPEVFCRNFGGVSHKS------DVYSYGMMILEMVVG----------RKNAEV 296
            Y+ P+++ R      H+       D++S G+       G          R+N EV
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 45/261 (17%)
Query: 94  LGQGGFGSVYKGKLPDGRLV----AVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSF 146
           LG+G FG V K K    R+     AVKV+  +    ++    + EV  + K  H N++  
Sbjct: 30  LGKGSFGEVLKCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEYLHR 205
                +     ++ E    G L    +DE    I RK        +I   +  G+ Y+H+
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDE---IIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
                IVH D+KP NILL    +D   KI DFGL+   ++      M    GT  YIAPE
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE 193
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN--SIYKHIEPGN-E 319
           V     G    K DV+S G+++  ++ G          +   Y  N   I K +E G   
Sbjct: 194 VL---RGTYDEKCDVWSAGVILYILLSG----------TPPFYGKNEYDILKRVETGKYA 240
Query: 320 FQLAG--VVTEEEKEMAKKMI 338
           F L     ++++ K++ +KM+
Sbjct: 241 FDLPQWRTISDDAKDLIRKML 261

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G +GSV      D RL   VAVK L     S ++      E+  +    H NV+  L
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQ-----IAVGIA 197
                         F P  S++ F     +     +++N  ++ + +       +   + 
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   +I DFGLA+ ++++     M G   T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRW 193
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ G+
Sbjct: 194 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI D GLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 94  LGQGGFGSVYKGK----LPDGRLVAVKVLKNSKV--NGEEFINEVAS---MSKTSHVNVV 144
           LG+GG+G V++ +       G++ A+KVLK + +  N ++  +  A    + +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             +       K  LI E++  G L  F+  E            T C     I+  L +LH
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED----TACFYLAEISMALGHLH 138
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           +     I++ D+KP NI+L      K++DFGL K S    +        GTI Y+APE+ 
Sbjct: 139 QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC--GTIEYMAPEIL 193
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            R+  G +   D +S G ++ +M+ G
Sbjct: 194 MRS--GHNRAVDWWSLGALMYDMLTG 217

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 89  SFSNK--LGQGGFGS-VYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS--HVNV 143
           SF  K  LG G  G+ VY+G   D R VAVK +     +   F +    + + S  H NV
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFS---FADREVQLLRESDEHPNV 80
Query: 144 VSFLGFCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + +  FC EK ++   I   +   +L +++  ++ +++   LE  T+ Q       GL +
Sbjct: 81  IRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLG--LEPITLLQQTTS---GLAH 133
Query: 203 LHRGCNIRIVHFDIKPHNILLGED-----FCPKISDFGLA-KLSEKKESFISMLGARGTI 256
           LH   ++ IVH D+KPHNIL+            ISDFGL  KL+  + SF    G  GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 257 GYIAPEVFCRNFG-GVSHKSDVYSYGMM 283
           G+IAPE+   +     ++  D++S G +
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCV 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +G G +GSV      D RL   VAVK L     S ++      E+  +    H NV+  L
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQ-----IAVGIA 197
                         F P  S++ F     +     +++N  ++ + +       +   + 
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   +I DFGLA+ ++++     M G   T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRW 193
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ G+
Sbjct: 194 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 48  GFGRFRKKNTENENAEAAFIRNYVSLAPKRYNY-SDVKRMTNSFSNKLGQGGFGSVYKGK 106
           G  + ++   E E+ E   +     L P  Y Y  +V  MT+    +LG+G FG V++ K
Sbjct: 37  GSAKLQRLGPETEDNEGVLLTE--KLKPVDYEYREEVHWMTHQ--PRLGRGSFGEVHRMK 92
Query: 107 -LPDGRLVAVKVLKNSKVNGEEF-INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP 164
               G   AVK     KV  E F + E+ + +  S   +V   G   E     +  E + 
Sbjct: 93  DKQTGFQCAVK-----KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 147
Query: 165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA-RGLEYLHRGCNIRIVHFDIKPHNILL 223
            GSL Q I        +R L +       +G A  GLEYLH     RI+H D+K  N+LL
Sbjct: 148 GGSLGQLIKQMGCLPEDRALYY-------LGQALEGLEYLH---TRRILHGDVKADNVLL 197
Query: 224 GEDFC-PKISDFGLAKLSEKKESFISMLGA---RGTIGYIAPEVFCRNFGGVSHKSDVYS 279
             D     + DFG A   +      S+L      GT  ++APEV          K D++S
Sbjct: 198 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWS 255
Query: 280 YGMMILEMVVG 290
              M+L M+ G
Sbjct: 256 SCCMMLHMLNG 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  GR VA+K++  +++N    ++   EV  M   +H N+V     
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   LI E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 80  IETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKEARSKFRQIVSAV----QYCHQK--- 130
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
           RIVH D+K  N+LL  D   KI+DFG +    +  K ++F       G+  Y APE+F  
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC------GSPPYAAPELFQG 184
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 185 KKYDG--PEVDVWSLGVILYTLVSG 207

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 92  NKLGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 148 GFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQIAVG-----IA 197
                         F P  SL++F     +     +++N  ++ + +    V      I 
Sbjct: 88  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           RGL+Y+H      I+H D+KP N+ + ED   KI D GLA+ ++ +     M G   T  
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRW 187
Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y APE+   N+   +   D++S G ++ E++ GR
Sbjct: 188 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 89  SFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFIN---------EVASMSKT 138
           S  + LG G FG V+     +  + V VK +K  KV  + +I          E+A +S+ 
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQI--AVGI 196
            H N++  L     +    L+ E   +G LD F + +    ++  L      Q+  AVG 
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
            R  + +HR         DIK  NI++ EDF  K+ DFG A   E+ + F +     GTI
Sbjct: 146 LRLKDIIHR---------DIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193
Query: 257 GYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKN-AEVKVSLSSEIYFPNSIYKHI 314
            Y APEV   N + G   + +++S G+ +  +V       E++ ++ + I+ P  + K +
Sbjct: 194 EYCAPEVLMGNPYRG--PELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKEL 251

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAV-KVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY- 151
           +G G FG V++ KL +   VA+ KVL++ +        E+  M    H NVV    F Y 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS 103
Query: 152 --EKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV-----GIARGLE 201
             +KK      L+ E++P     + +Y   +S    KL+ +TM  + +      + R L 
Sbjct: 104 NGDKKDEVFLNLVLEYVP-----ETVY--RASRHYAKLK-QTMPMLLIKLYMYQLLRSLA 155
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           Y+H   +I I H DIKP N+LL       K+ DFG AK+    E  +S + +R    Y A
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR---YYRA 209
Query: 261 PEVFCRNFGGVSHKS--DVYSYGMMILEMVVGR 291
           PE+    FG  ++ +  D++S G ++ E++ G+
Sbjct: 210 PELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 109/267 (40%), Gaps = 80/267 (29%)
Query: 94  LGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTSH-VNVV 144
           LG+G FG V +       K P  R VAVK+LK      E    + E+  ++   H +NVV
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 145 SFLG--------------FC-------YEKKKRALIY----------------------- 160
           + LG              +C       Y K KR L +                       
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQG 154
Query: 161 -----------------EFMPNGSLDQFIYDEESSNINRK-LEWRTMCQIAVGIARGLEY 202
                             F  + SL     +E+S    ++ +    +   +  +ARG+E+
Sbjct: 155 KKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEF 214
Query: 203 LH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           L  R C    +H D+   NILL E+   KI DFGLA+   K   ++     R  + ++AP
Sbjct: 215 LSSRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAP 270
Query: 262 E-VFCRNFGGVSHKSDVYSYGMMILEM 287
           E +F + +   S KSDV+SYG+++ E+
Sbjct: 271 ESIFDKIY---STKSDVWSYGVLLWEI 294

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 92  NKLGQGGFG-SVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFL 147
            K+G+G FG ++      DGR   +K +  S+++    EE   EVA ++   H N+V + 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESS--NINRKLEWRTMCQIAVGIARGLEYLHR 205
               E     ++ ++   G L + I  ++      ++ L+W       V I   L+++H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVH- 142
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG---YIAPE 262
             + +I+H DIK  NI L +D   ++ DFG+A++            AR  IG   Y++PE
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-----ARACIGTPYYLSPE 195
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVV 289
           + C N    ++KSD+++ G ++ E+  
Sbjct: 196 I-CEN-KPYNNKSDIWALGCVLYELCT 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  GR VA+K++  +++N    ++   EV  M   +H N+V     
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   LI E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 83  IETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKEARSKFRQIVSAV----QYCHQK--- 133
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
           RIVH D+K  N+LL  D   KI+DFG +    +  K ++F       G   Y APE+F  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC------GAPPYAAPELFQG 187
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 188 KKYDG--PEVDVWSLGVILYTLVSG 210

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 48  GFGRFRKKNTENENAEAAFIRNYVSLAPKRYNY-SDVKRMTNSFSNKLGQGGFGSVYKGK 106
           G  + ++   E E+ E   +     L P  Y Y  +V  MT+    ++G+G FG V++ K
Sbjct: 39  GSAKLQRLGPETEDNEGVLLTE--KLKPVDYEYREEVHWMTHQ--PRVGRGSFGEVHRMK 94
Query: 107 -LPDGRLVAVKVLKNSKVNGEEF-INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP 164
               G   AVK     KV  E F + E+ + +  S   +V   G   E     +  E + 
Sbjct: 95  DKQTGFQCAVK-----KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 149
Query: 165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA-RGLEYLHRGCNIRIVHFDIKPHNILL 223
            GSL Q I        +R L +       +G A  GLEYLH     RI+H D+K  N+LL
Sbjct: 150 GGSLGQLIKQMGCLPEDRALYY-------LGQALEGLEYLH---TRRILHGDVKADNVLL 199
Query: 224 GEDFC-PKISDFGLAKLSEKKESFISMLGA---RGTIGYIAPEVFCRNFGGVSHKSDVYS 279
             D     + DFG A   +      S+L      GT  ++APEV          K D++S
Sbjct: 200 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWS 257
Query: 280 YGMMILEMVVG 290
              M+L M+ G
Sbjct: 258 SCCMMLHMLNG 268

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVN-VVSFL 147
           +LG+G +G V K + +P G++ AVK ++ + VN +E    + ++    +T      V+F 
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNSQEQKRLLXDLDISXRTVDCPFTVTFY 99
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G  + +    +  E   + SLD+F   ++  +  + +    + +IAV I + LE+LH   
Sbjct: 100 GALFREGDVWICXELX-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 154
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCR 266
            + ++H D+KP N+L+      K  DFG++  L +     I      G   Y APE    
Sbjct: 155 KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA----GCKPYXAPERINP 210
Query: 267 --NFGGVSHKSDVYSYGMMILEMVVGR 291
             N  G S KSD++S G+  +E+ + R
Sbjct: 211 ELNQKGYSVKSDIWSLGITXIELAILR 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 48  GFGRFRKKNTENENAEAAFIRNYVSLAPKRYNY-SDVKRMTNSFSNKLGQGGFGSVYKGK 106
           G  + ++   E E+ E   +     L P  Y Y  +V  MT+    ++G+G FG V++ K
Sbjct: 23  GSAKLQRLGPETEDNEGVLLTE--KLKPVDYEYREEVHWMTHQ--PRVGRGSFGEVHRMK 78
Query: 107 -LPDGRLVAVKVLKNSKVNGEEF-INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP 164
               G   AVK     KV  E F + E+ + +  S   +V   G   E     +  E + 
Sbjct: 79  DKQTGFQCAVK-----KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA-RGLEYLHRGCNIRIVHFDIKPHNILL 223
            GSL Q I        +R L +       +G A  GLEYLH     RI+H D+K  N+LL
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYY-------LGQALEGLEYLH---TRRILHGDVKADNVLL 183
Query: 224 GEDFC-PKISDFGLAKLSEKKESFISMLGA---RGTIGYIAPEVFCRNFGGVSHKSDVYS 279
             D     + DFG A   +      S+L      GT  ++APEV          K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP--CDAKVDIWS 241
Query: 280 YGMMILEMVVG 290
              M+L M+ G
Sbjct: 242 SCCMMLHMLNG 252

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 39/216 (18%)
Query: 92  NKLGQGGFGSVYKGKLPDGRL---VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVS 145
             +G G +G+V      DGR    VA+K L     S++  +    E+  +    H NV+ 
Sbjct: 31  QPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQF-----IYDEESSNINRKLEWRTMCQ-----IAVG 195
            L              F P+ +LD F     +     +++ + ++   + +     +   
Sbjct: 89  LLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           + +GL Y+H      I+H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVT 188
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             Y APEV   N+   +   D++S G ++ EM+ G+
Sbjct: 189 RWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGFG V+  ++   G+L A K L   ++      +  + E   ++K     +VS L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G +   IY+ +  N   + E R +   A  I  GLE+LH+  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              I++ D+KP N+LL +D   +ISD GLA   E K       G  GT G++APE+    
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
                   D ++ G+ + EM+  R
Sbjct: 365 --EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 94  LGQGGFG--SVYKGKLPD---GRLVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FG  S+Y     +   G +VAVK LK      +   +  E+  +    H +++ +
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 147 LGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G C ++ +++L  + E++P GSL  ++    S  + + L        A  I  G+ YLH
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLL------LFAQQICEGMAYLH 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
              +   +H ++   N+LL  D   KI DFGLAK + E  E +         + + APE 
Sbjct: 135 ---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE- 190
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVV 289
            C       + SDV+S+G+ + E++ 
Sbjct: 191 -CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGFG V+  ++   G+L A K L   ++      +  + E   ++K     +VS L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G +   IY+ +  N   + E R +   A  I  GLE+LH+  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              I++ D+KP N+LL +D   +ISD GLA   E K       G  GT G++APE+    
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
                   D ++ G+ + EM+  R
Sbjct: 365 --EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGFG V+  ++   G+L A K L   ++      +  + E   ++K     +VS L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G +   IY+ +  N   + E R +   A  I  GLE+LH+  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              I++ D+KP N+LL +D   +ISD GLA   E K       G  GT G++APE+    
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
                   D ++ G+ + EM+  R
Sbjct: 365 --EYDFSVDYFALGVTLYEMIAAR 386

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 107/236 (45%), Gaps = 42/236 (17%)
Query: 90  FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKN----SKVNGEEFINEVASMSKTSHVNVV 144
            S+ LGQG   +V++G+    G L A+KV  N      V+ +  + E   + K +H N+V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHKNIV 70
Query: 145 SFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNIN--RKLEWRTMCQIAVGIARGL 200
                  E   R   LI EF P GSL  +   EE SN     + E+  + +  VG   G+
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSNAYGLPESEFLIVLRDVVG---GM 125
Query: 201 EYLHRGCNIRIVHFDIKPHNIL--LGED--FCPKISDFGLAKLSEKKESFISMLGARGTI 256
            +L       IVH +IKP NI+  +GED     K++DFG A+  E  E F+ +    GT 
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY---GTE 179
Query: 257 GYIAPEVFCRNFGGVSHKS------DVYSYGMMILEMVVG----------RKNAEV 296
            Y+ P+++ R      H+       D++S G+       G          R+N EV
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGFG V+  ++   G+L A K L   ++      +  + E   ++K     +VS L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 149 FCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G +   IY+ +  N   + E R +   A  I  GLE+LH+  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              I++ D+KP N+LL +D   +ISD GLA   E K       G  GT G++APE+    
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
                   D ++ G+ + EM+  R
Sbjct: 365 --EYDFSVDYFALGVTLYEMIAAR 386

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV---SFLG- 148
           LG+G FG V+  +     +  A+K LK   V  ++ +    +M +   +++     FL  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE--CTMVEKRVLSLAWEHPFLTH 82
Query: 149 -FCYEKKKRALIY--EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH- 204
            FC  + K  L +  E++  G L   +Y  +S +   K +       A  I  GL++LH 
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDL---MYHIQSCH---KFDLSRATFYAAEIILGLQFLHS 136
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK---LSEKKESFISMLGARGTIGYIAP 261
           +G    IV+ D+K  NILL +D   KI+DFG+ K   L + K +        GT  YIAP
Sbjct: 137 KG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-----GTPDYIAP 187
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           E+        +H  D +S+G+++ EM++G+
Sbjct: 188 EILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 90  FSNKLGQGGFGSVYKG---KLPD-GRL----VAVKVLKNSKVN-GEEFINEVASMSKTSH 140
           F+  LGQG F  ++KG   ++ D G+L    V +KVL  +  N  E F    + MSK SH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARG 199
            ++V   G C+   +  L+ EF+  GSLD ++   ++  NI  KLE      +A  +A  
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE------VAKQLAWA 125
Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG---ARGTI 256
           + +L       ++H ++   NILL  +   K  +    KLS+   S I++L     +  I
Sbjct: 126 MHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERI 181
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            ++ PE    N   ++  +D +S+G  + E+  G
Sbjct: 182 PWVPPECI-ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSFLG 148
           LG GG   V+  + L D R VAVKVL+        F      E  + +  +H  +V+   
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 149 FCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLE-WRTMCQIAVGIARGLEYL 203
               +        ++ E++   +L   ++ E      R +E     CQ        L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ-------ALNFS 132
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H+     I+H D+KP NIL+      K+ DFG+A+ +++   S        GT  Y++PE
Sbjct: 133 HQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +   V  +SDVYS G ++ E++ G
Sbjct: 190 QARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 94  LGQGGFG--SVYKGKLPD---GRLVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FG  S+Y     +   G +VAVK LK      +   +  E+  +    H +++ +
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 147 LGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G C ++ +++L  + E++P GSL  ++    S  + + L        A  I  G+ YLH
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLL------LFAQQICEGMAYLH 134
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
                  +H ++   N+LL  D   KI DFGLAK + E  E +         + + APE 
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE- 190
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVV 289
            C       + SDV+S+G+ + E++ 
Sbjct: 191 -CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVV 144
             + LG G FG V  G+    G  VAVK+L   K+   + +     E+ ++    H +++
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                        ++ E++  G L  +I          ++E R + Q    I   ++Y H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARRLFQ---QILSAVDYCH 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           R     +VH D+KP N+LL      KI+DFGL+ +    E   +   + G+  Y APEV 
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAPEVI 182
Query: 265 C-RNFGGVSHKSDVYSYGMMILEMVVG 290
             R + G   + D++S G+++  ++ G
Sbjct: 183 SGRLYAGP--EVDIWSCGVILYALLCG 207

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   +    R V A+K+L       + +   F  E   M+  +   VV    
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              + +   ++ E+MP G L   +     SN +   +W       V +A  L+ +H   +
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWARFYTAEVVLA--LDAIH---S 186
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  +H D+KP N+LL +    K++DFG   +   KE  +    A GT  YI+PEV  ++ 
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVL-KSQ 244
Query: 269 GGVSH---KSDVYSYGMMILEMVVG 290
           GG  +   + D +S G+ + EM+VG
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   +    R V A+K+L       + +   F  E   M+  +   VV    
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              + +   ++ E+MP G L   +     SN +   +W       V +A  L+ +H   +
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWARFYTAEVVLA--LDAIH---S 191
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  +H D+KP N+LL +    K++DFG   +   KE  +    A GT  YI+PEV  ++ 
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVL-KSQ 249
Query: 269 GGVSH---KSDVYSYGMMILEMVVG 290
           GG  +   + D +S G+ + EM+VG
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   +    R V A+K+L       + +   F  E   M+  +   VV    
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              + +   ++ E+MP G L   +     SN +   +W       V +A  L+ +H   +
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWARFYTAEVVLA--LDAIH---S 191
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  +H D+KP N+LL +    K++DFG   +   KE  +    A GT  YI+PEV  ++ 
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVL-KSQ 249
Query: 269 GGVSH---KSDVYSYGMMILEMVVG 290
           GG  +   + D +S G+ + EM+VG
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 90  FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVV 144
             + LG G FG V  G+    G  VAVK+L   K+   + +     E+ ++    H +++
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                        ++ E++  G L  +I          ++E R + Q    I   ++Y H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARRLFQ---QILSAVDYCH 128
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           R     +VH D+KP N+LL      KI+DFGL+ +    E    +  + G+  Y APEV 
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVI 182
Query: 265 C-RNFGGVSHKSDVYSYGMMILEMVVG 290
             R + G   + D++S G+++  ++ G
Sbjct: 183 SGRLYAGP--EVDIWSCGVILYALLCG 207

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 41/241 (17%)
Query: 114 AVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL----- 168
           AVKV+  SK +  E I  +    +  H N+++      + K   L+ E M  G L     
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 169 -DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---- 223
             +F  + E+S +               I + +EYLH   +  +VH D+KP NIL     
Sbjct: 114 RQKFFSEREASFVLHT------------IGKTVEYLH---SQGVVHRDLKPSNILYVDES 158
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMM 283
           G   C +I DFG AK    +     ++    T  ++APEV  R   G     D++S G++
Sbjct: 159 GNPECLRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGIL 214
Query: 284 ILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG----VVTEEEKEMAKKMIL 339
           +  M+ G        S +     P  I   I  G +F L+G     V+E  K++  KM+ 
Sbjct: 215 LYTMLAGYTPFANGPSDT-----PEEILTRIGSG-KFTLSGGNWNTVSETAKDLVSKMLH 268
Query: 340 V 340
           V
Sbjct: 269 V 269

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSFLG 148
           LG GG   V+  + L D R VAVKVL+        F      E  + +  +H  +V+   
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 149 FCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLE-WRTMCQIAVGIARGLEYL 203
               +        ++ E++   +L   ++ E      R +E     CQ        L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ-------ALNFS 132
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H+     I+H D+KP NI++      K+ DFG+A+ +++   S        GT  Y++PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +   V  +SDVYS G ++ E++ G
Sbjct: 190 QARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 37/213 (17%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV---SFLG- 148
           LG+G FG V+  +     +  A+K LK   V  ++ +    +M +   +++     FL  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE--CTMVEKRVLSLAWEHPFLTH 83
Query: 149 -FCYEKKKRALIY--EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH- 204
            FC  + K  L +  E++  G L   +Y  +S +   K +       A  I  GL++LH 
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDL---MYHIQSCH---KFDLSRATFYAAEIILGLQFLHS 137
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR------GTIGY 258
           +G    IV+ D+K  NILL +D   KI+DFG+ K         +MLG        GT  Y
Sbjct: 138 KG----IVYRDLKLDNILLDKDGHIKIADFGMCK--------ENMLGDAKTNEFCGTPDY 185
Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           IAPE+        +H  D +S+G+++ EM++G+
Sbjct: 186 IAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 31/249 (12%)
Query: 51  RFRKKNTENENAEAAFIRNYVSLAPKRYNY-SDVKRMTNSFSNKLGQGGFGSVYKGKLPD 109
           R R+ + + E+ E   +     L P  Y Y  +V   T+    +LG+G FG V++  + D
Sbjct: 61  RSREPSPKTEDNEGVLLTE--KLKPVDYEYREEVHWATHQL--RLGRGSFGEVHR--MED 114
Query: 110 ---GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG 166
              G   AVK ++      EE +    + +  +   +V   G   E     +  E +  G
Sbjct: 115 KQTGFQCAVKKVRLEVFRAEELM----ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGG 170
Query: 167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIA-RGLEYLHRGCNIRIVHFDIKPHNILLGE 225
           SL Q + ++     +R L +       +G A  GLEYLH   + RI+H D+K  N+LL  
Sbjct: 171 SLGQLVKEQGCLPEDRALYY-------LGQALEGLEYLH---SRRILHGDVKADNVLLSS 220
Query: 226 DFC-PKISDFGLAKLSEKKESFISMLGA---RGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
           D     + DFG A   +      S+L      GT  ++APEV          K DV+S  
Sbjct: 221 DGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSC 278
Query: 282 MMILEMVVG 290
            M+L M+ G
Sbjct: 279 CMMLHMLNG 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 94  LGQGGFG--SVYKGKLPD---GRLVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSF 146
           LG+G FG  S+Y     +   G +VAVK LK      +   +  E+  +    H +++ +
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 147 LGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            G C +    +L  + E++P GSL  ++    S  + + L        A  I  G+ YLH
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLL------LFAQQICEGMAYLH 151
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEV 263
                  +H D+   N+LL  D   KI DFGLAK + E  E +         + + APE 
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE- 207
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVV 289
            C       + SDV+S+G+ + E++ 
Sbjct: 208 -CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 41/241 (17%)
Query: 114 AVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL----- 168
           AVKV+  SK +  E I  +    +  H N+++      + K   L+ E M  G L     
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 169 -DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---- 223
             +F  + E+S +               I + +EYLH   +  +VH D+KP NIL     
Sbjct: 114 RQKFFSEREASFVLHT------------IGKTVEYLH---SQGVVHRDLKPSNILYVDES 158
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMM 283
           G   C +I DFG AK    +     ++    T  ++APEV  R   G     D++S G++
Sbjct: 159 GNPECLRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGIL 214
Query: 284 ILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG----VVTEEEKEMAKKMIL 339
           +  M+ G        S +     P  I   I  G +F L+G     V+E  K++  KM+ 
Sbjct: 215 LYTMLAGYTPFANGPSDT-----PEEILTRIGSG-KFTLSGGNWNTVSETAKDLVSKMLH 268
Query: 340 V 340
           V
Sbjct: 269 V 269

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSFLG 148
           LG GG   V+  + L D R VAVKVL+        F      E  + +  +H  +V+   
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 149 FCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLE-WRTMCQIAVGIARGLEYL 203
               +        ++ E++   +L   ++ E      R +E     CQ        L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ-------ALNFS 132
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H+     I+H D+KP NI++      K+ DFG+A+ +++   S        GT  Y++PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
               +   V  +SDVYS G ++ E++ G
Sbjct: 190 QARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  GR VAVK++  +++N    ++   EV  M   +H N+V     
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 83  IETEKTLYLVMEYASGGEV--FDYLVAHGRMKEKEARAKFRQIVSAV----QYCHQKY-- 134
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +    +  K ++F       G+  Y APE+F  
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC------GSPPYAAPELFQG 187
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 188 KKYDG--PEVDVWSLGVILYTLVSG 210

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 126 EEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRK 183
           E+   E+A + K  H NVV  +    +  +  L  ++E +  G + +    +  S    +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 184 LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK 243
             ++ +        +G+EYLH     +I+H DIKP N+L+GED   KI+DFG++   +  
Sbjct: 141 FYFQDLI-------KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKS-DVYSYGMMILEMVVGR 291
           ++ +S     GT  ++APE         S K+ DV++ G+ +   V G+
Sbjct: 191 DALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +GSV        G  VA+K L     S++  +    E+  +    H NV+  L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 150 CYEKKKRALIYEF---MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
                     Y+F   MP      F+  +    +  K     +  +   + +GL+Y+H  
Sbjct: 92  FTPASSLRNFYDFYLVMP------FMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA 145
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               +VH D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  Y APEV   
Sbjct: 146 G---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVIL- 196
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
           ++   +   D++S G ++ EM+ G+
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 126 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTG 182
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 183 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 126 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG 182
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 183 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 126 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG 182
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 183 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 130 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG 186
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 187 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 74  APKRYNYSDVKRMTNS----FSNKLGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEE 127
           AP      D+  M +S    F   +G G FG   + + KL    LVAVK ++      E 
Sbjct: 4   APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDEN 62
Query: 128 FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLE 185
              E+ +     H N+V F          A+I E+   G L + I      N  R  + E
Sbjct: 63  VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-----CNAGRFSEDE 117
Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKK 243
            R   Q    +  G+ Y H   +++I H D+K  N LL     P  KI DFG +K S   
Sbjct: 118 ARFFFQ---QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 244 ESFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVG 290
               S +   GT  YIAPEV  R  + G    +DV+S G+ +  M+VG
Sbjct: 172 SQPKSTV---GTPAYIAPEVLLRQEYDG--KIADVWSCGVTLYVMLVG 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 94  LGQGGFG--SVYKGKLPD---GRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           LG+G FG  S+Y     +   G +VAVK LK     G +    +  E+  +    H ++V
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLYHEHIV 73
Query: 145 SFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
            + G C ++ +++  L+ E++P GSL  ++       + + L        A  I  G+ Y
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLL------LFAQQICEGMAY 126
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAP 261
           LH       +H  +   N+LL  D   KI DFGLAK + E  E +         + + AP
Sbjct: 127 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 262 EVF--CRNFGGVSHKSDVYSYGMMILEMVV 289
           E    C+ +    + SDV+S+G+ + E++ 
Sbjct: 184 ECLKECKFY----YASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 94  LGQGGFG--SVYKGKLPD---GRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           LG+G FG  S+Y     +   G +VAVK LK     G +    +  E+  +    H ++V
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLYHEHIV 74
Query: 145 SFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
            + G C ++ +++  L+ E++P GSL  ++       + + L        A  I  G+ Y
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLL------LFAQQICEGMAY 127
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAP 261
           LH       +H  +   N+LL  D   KI DFGLAK + E  E +         + + AP
Sbjct: 128 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 262 EVF--CRNFGGVSHKSDVYSYGMMILEMVV 289
           E    C+ +    + SDV+S+G+ + E++ 
Sbjct: 185 ECLKECKFY----YASDVWSFGVTLYELLT 210

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 43/271 (15%)
Query: 82  DVKRMTNSFS--NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK- 137
           D K   N F     LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+ 
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 63
Query: 138 ---TSHVNVVSFLGFCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRT 188
              T H   ++ L + ++   R   + E+   G L      + ++ EE +          
Sbjct: 64  LQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------- 114
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
                  I   LEYLH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +
Sbjct: 115 ---YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGAT 166
Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLS 301
           M    GT  Y+APEV   N  G     D +  G+++ EM+ GR     ++ E   ++ L 
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 224
Query: 302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKE 332
            EI FP +    + P  +  LAG++ ++ K+
Sbjct: 225 EEIRFPRT----LSPEAKSLLAGLLKKDPKQ 251

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAVK++  +++N    ++   EV  M   +H N+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 82  IETEKTLYLVMEYASGGEV--FDYLVAHGRMKEKEARAKFRQIVSAV----QYCHQKF-- 133
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +       K ++F       G+  Y APE+F  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------GSPPYAAPELFQG 186
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 187 KKYDG--PEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAVK++  +++N    ++   EV  M   +H N+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 82  IETEKTLYLVMEYASGGEV--FDYLVAHGRMKEKEARAKFRQIVSAV----QYCHQKF-- 133
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +       K ++F       G+  Y APE+F  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------GSPPYAAPELFQG 186
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 187 KKYDG--PEVDVWSLGVILYTLVSG 209

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 130 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG 186
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 187 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 90  FSNKLGQGGFGSVYKG---KLPD-GRL----VAVKVLKNSKVN-GEEFINEVASMSKTSH 140
           F+  LGQG F  ++KG   ++ D G+L    V +KVL  +  N  E F    + MSK SH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARG 199
            ++V   G C    +  L+ EF+  GSLD ++   ++  NI  KLE      +A  +A  
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE------VAKQLAAA 125
Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG---ARGTI 256
           + +L       ++H ++   NILL  +   K  +    KLS+   S I++L     +  I
Sbjct: 126 MHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERI 181
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            ++ PE    N   ++  +D +S+G  + E+  G
Sbjct: 182 PWVPPECI-ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 126 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 182
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 183 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 130 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 187 FLXEXVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 131 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 187
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 188 FLXEXVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 124 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 180
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 181 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 134 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 190
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 191 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 126 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 182
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 183 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 41/257 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+    T H   ++ L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 71
Query: 149 FCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + ++   R   + E+   G L      + ++ EE +                 I   LEY
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----------YGAEIVSALEY 120
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +M    GT  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 175
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIE 315
           V   N  G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + 
Sbjct: 176 VLEDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS 229
Query: 316 PGNEFQLAGVVTEEEKE 332
           P  +  LAG++ ++ K+
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 128 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 184
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 185 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 90  FSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           F  ++G+G F +VYKG   +  + VA   L++ K+   E   F  E   +    H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 146 FLGFCYE-----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           F    +E     KK   L+ E   +G+L  ++   +   I     W   C+    I +GL
Sbjct: 90  FYD-SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW---CR---QILKGL 142
Query: 201 EYLHRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           ++LH      I+H D+K  NI + G     KI D GLA L  K+ SF   +   GT  + 
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAV--IGTPEFX 197
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
           APE +   +       DVY++G   LE   
Sbjct: 198 APEXYEEKY---DESVDVYAFGXCXLEXAT 224

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 41/257 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+    T H   ++ L 
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 74
Query: 149 FCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + ++   R   + E+   G L      + ++ EE +                 I   LEY
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----------YGAEIVSALEY 123
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +M    GT  Y+APE
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 178
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIE 315
           V   N  G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + 
Sbjct: 179 VLEDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS 232
Query: 316 PGNEFQLAGVVTEEEKE 332
           P  +  LAG++ ++ K+
Sbjct: 233 PEAKSLLAGLLKKDPKQ 249

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 130 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 187 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 128 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 184
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 185 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 41/257 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+    T H   ++ L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 71
Query: 149 FCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + ++   R   + E+   G L      + ++ EE +                 I   LEY
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----------YGAEIVSALEY 120
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +M    GT  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPE 175
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIE 315
           V   N  G +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + 
Sbjct: 176 VLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS 229
Query: 316 PGNEFQLAGVVTEEEKE 332
           P  +  LAG++ ++ K+
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 131 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 187
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 188 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 132 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 188
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 189 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 123 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 179
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 180 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 130 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 187 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 124 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 180
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 181 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 146 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG 202
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 203 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 41/257 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+    T H   ++ L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 71
Query: 149 FCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + ++   R   + E+   G L      + ++ EE +                 I   LEY
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----------YGAEIVSALEY 120
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +M    GT  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 175
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIE 315
           V   N  G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + 
Sbjct: 176 VLEDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS 229
Query: 316 PGNEFQLAGVVTEEEKE 332
           P  +  LAG++ ++ K+
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 130 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 187 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAVK++  +++N    ++   EV  M   +H N+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 82  IETEKTLYLVMEYASGGEV--FDYLVAHGRMKEKEARAKFRQIVSAV----QYCHQKF-- 133
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +       K ++F       G   Y APE+F  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC------GAPPYAAPELFQG 186
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 187 KKYDG--PEVDVWSLGVILYTLVSG 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 41/257 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+    T H   ++ L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 71
Query: 149 FCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + ++   R   + E+   G L      + ++ EE +                 I   LEY
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----------YGAEIVSALEY 120
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +M    GT  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPE 175
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIE 315
           V   N  G +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + 
Sbjct: 176 VLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS 229
Query: 316 PGNEFQLAGVVTEEEKE 332
           P  +  LAG++ ++ K+
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+L+      KI DFGLA++++ +     
Sbjct: 146 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTG 202
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 203 FLTEXVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAVK++  +++N    ++   EV  M   +H N+V     
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  ++    +    ++ E R   +    I   ++Y H+    
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLV---AHGWMKEKEARAKFR---QIVSAVQYCHQKF-- 126
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +       K ++F       G+  Y APE+F  
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------GSPPYAAPELFQG 179
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 180 KKYDG--PEVDVWSLGVILYTLVSG 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 41/257 (15%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK----TSHVNVVSFLG 148
           LG+G FG V   +    GR  A+K+L+   +  ++ +    + S+    T H   ++ L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 71
Query: 149 FCYEKKKR-ALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           + ++   R   + E+   G L      + ++ EE +                 I   LEY
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----------YGAEIVSALEY 120
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  +V+ DIK  N++L +D   KI+DFGL K  E      +M    GT  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPE 175
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIE 315
           V   N  G     D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + 
Sbjct: 176 VLEDNDYG--RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS 229
Query: 316 PGNEFQLAGVVTEEEKE 332
           P  +  LAG++ ++ K+
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 128 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTG 184
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 185 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +C     I RGL+Y+H      ++H D+KP N+LL      KI DFGLA++++       
Sbjct: 146 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 202
Query: 249 MLGAR-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            L     T  Y APE+   N  G +   D++S G ++ EM+  R
Sbjct: 203 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 140/309 (45%), Gaps = 43/309 (13%)
Query: 38  KKTENDQNDFGFGRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFS--NKLG 95
           KK E ++ DF  G      ++N  AE       VSLA  ++  +      N F     LG
Sbjct: 114 KKQEEEEMDFRSG----SPSDNSGAEEM----EVSLAKPKHRVT-----MNEFEYLKLLG 160
Query: 96  QGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT---SHVNVVSFLGFCY 151
           +G FG V   K    GR  A+K+LK   +  ++ +    + ++    S    ++ L + +
Sbjct: 161 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 220
Query: 152 EKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
           +   R   + E+   G L   +  E   + +R   +         I   L+YLH   N+ 
Sbjct: 221 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLHSEKNV- 273
Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG 270
            V+ D+K  N++L +D   KI+DFGL K  E  +   +M    GT  Y+APEV   N  G
Sbjct: 274 -VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 271 VSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIEPGNEFQLA 323
            +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + P  +  L+
Sbjct: 331 RA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLS 384
Query: 324 GVVTEEEKE 332
           G++ ++ K+
Sbjct: 385 GLLKKDPKQ 393

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAV+++  +++N    ++   EV  M   +H N+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 82  IETEKTLYLVMEYASGGEV--FDYLVAHGRMKEKEARAKFRQIVSAV----QYCHQKF-- 133
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +       K ++F       G+  Y APE+F  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------GSPPYAAPELFQG 186
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 187 KKYDG--PEVDVWSLGVILYTLVSG 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 108/249 (43%), Gaps = 31/249 (12%)
Query: 51  RFRKKNTENENAEAAFIRNYVSLAPKRYNY-SDVKRMTNSFSNKLGQGGFGSVYKGKLPD 109
           R R+ + + E+ E   +     L P  Y Y  +V   T+    +LG+G FG V++  + D
Sbjct: 42  RSREPSPKTEDNEGVLLTE--KLKPVDYEYREEVHWATHQL--RLGRGSFGEVHR--MED 95
Query: 110 ---GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG 166
              G   AVK ++      EE +    + +  +   +V   G   E     +  E +  G
Sbjct: 96  KQTGFQCAVKKVRLEVFRAEELM----ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGG 151
Query: 167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIA-RGLEYLHRGCNIRIVHFDIKPHNILLGE 225
           SL Q + ++     +R L +       +G A  GLEYLH   + RI+H D+K  N+LL  
Sbjct: 152 SLGQLVKEQGCLPEDRALYY-------LGQALEGLEYLH---SRRILHGDVKADNVLLSS 201
Query: 226 DFC-PKISDFGLAKLSEKKESFISMLGA---RGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
           D     + DFG A   +       +L      GT  ++APEV          K DV+S  
Sbjct: 202 DGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSC 259
Query: 282 MMILEMVVG 290
            M+L M+ G
Sbjct: 260 CMMLHMLNG 268

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 94  LGQGGFGSV------YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG V        G+    +++  KVL  S + G     E++ +    H +++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 80
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                K +  ++ E+  N   D  +  ++ S    + E R   Q    I   +EY HR  
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMS----EQEARRFFQ---QIISAVEYCHRH- 132
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
             +IVH D+KP N+LL E    KI+DFGL+ +     +F+    + G+  Y APEV   +
Sbjct: 133 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT--SCGSPNYAAPEVISGK 187
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
            + G   + DV+S G+++  M+  R
Sbjct: 188 LYAG--PEVDVWSCGVILYVMLCRR 210

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 94  LGQGGFGSVYK-GKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLGF 149
           +G G +G   K  +  DG+++  K L    +   E    ++EV  + +  H N+V +   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 150 CYEKKKRAL--IYEFMPNGSLDQFIY--DEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             ++    L  + E+   G L   I    +E   ++ +   R M Q+ +     L+  HR
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA----LKECHR 129
Query: 206 GCN--IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
             +    ++H D+KP N+ L      K+ DFGLA++     SF       GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQ 187
Query: 264 FCRNFGGVSHKSDVYSYGMMILEM 287
              N    + KSD++S G ++ E+
Sbjct: 188 M--NRMSYNEKSDIWSLGCLLYEL 209

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 94  LGQGGFGSVYK-GKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLGF 149
           +G G +G   K  +  DG+++  K L    +   E    ++EV  + +  H N+V +   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 150 CYEKKKRAL--IYEFMPNGSLDQFIY--DEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             ++    L  + E+   G L   I    +E   ++ +   R M Q+ +     L+  HR
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA----LKECHR 129
Query: 206 GCN--IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
             +    ++H D+KP N+ L      K+ DFGLA++    E F       GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV--GTPYYMSPEQ 187
Query: 264 FCRNFGGVSHKSDVYSYGMMILEM 287
              N    + KSD++S G ++ E+
Sbjct: 188 M--NRMSYNEKSDIWSLGCLLYEL 209

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +GSV        G  VA+K L     S++  +    E+  +    H NV+  L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 150 CYEKKKRALIYEF---MPNGSLD-QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
                     Y+F   MP    D Q I   E S    K+++     +   + +GL+Y+H 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSE--EKIQY-----LVYQMLKGLKYIHS 162
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                +VH D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  Y APEV  
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVIL 214
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++   +   D++S G ++ EM+ G+
Sbjct: 215 -SWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 94  LGQGGFGSVYK-GKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLGF 149
           +G G +G   K  +  DG+++  K L    +   E    ++EV  + +  H N+V +   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 150 CYEKKKRAL--IYEFMPNGSLDQFIY--DEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
             ++    L  + E+   G L   I    +E   ++ +   R M Q+ +     L+  HR
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA----LKECHR 129
Query: 206 GCN--IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
             +    ++H D+KP N+ L      K+ DFGLA++     SF       GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQ 187
Query: 264 FCRNFGGVSHKSDVYSYGMMILEM 287
              N    + KSD++S G ++ E+
Sbjct: 188 M--NRMSYNEKSDIWSLGCLLYEL 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 94  LGQGGFGSV------YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG V        G+    +++  KVL  S + G     E++ +    H +++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 79
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                K +  ++ E+  N   D  +  ++ S    + E R   Q    I   +EY HR  
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMS----EQEARRFFQ---QIISAVEYCHRH- 131
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
             +IVH D+KP N+LL E    KI+DFGL+ +     +F+    + G+  Y APEV   +
Sbjct: 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT--SCGSPNYAAPEVISGK 186
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
            + G   + DV+S G+++  M+  R
Sbjct: 187 LYAG--PEVDVWSCGVILYVMLCRR 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 94  LGQGGFGSV------YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG V        G+    +++  KVL  S + G     E++ +    H +++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 70
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                K +  ++ E+  N   D  +  ++ S    + E R   Q    I   +EY HR  
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMS----EQEARRFFQ---QIISAVEYCHRH- 122
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
             +IVH D+KP N+LL E    KI+DFGL+ +     +F+    + G+  Y APEV   +
Sbjct: 123 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT--SCGSPNYAAPEVISGK 177
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
            + G   + DV+S G+++  M+  R
Sbjct: 178 LYAG--PEVDVWSCGVILYVMLCRR 200

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 37/241 (15%)
Query: 94  LGQGGFGSVYKGK----LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT--SHVNVVSFL 147
           LG G +G V+  +       G+L A+KVLK + +  +    E     +    H+    FL
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 148 GFCY----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG-IARGLEY 202
              +     + K  LI +++  G L   +   E    +         QI VG I   LE+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-------VQIYVGEIVLALEH 174
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIA 260
           LH+   + I++ DIK  NILL  +    ++DFGL+K  ++++ E      G   TI Y+A
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG---TIEYMA 228
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVV--------GRKNAEVKVS---LSSEIYFPNS 309
           P++      G     D +S G+++ E++         G KN++ ++S   L SE  +P  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 310 I 310
           +
Sbjct: 289 M 289

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 94  LGQGGFGSV------YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG V        G+    +++  KVL  S + G     E++ +    H +++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 74
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                K +  ++ E+  N   D  +  ++ S    + E R   Q    I   +EY HR  
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFDYIVQRDKMS----EQEARRFFQ---QIISAVEYCHRH- 126
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
             +IVH D+KP N+LL E    KI+DFGL+ +     +F+    + G+  Y APEV   +
Sbjct: 127 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT--SCGSPNYAAPEVISGK 181
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
            + G   + DV+S G+++  M+  R
Sbjct: 182 LYAG--PEVDVWSCGVILYVMLCRR 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAV+++  +++N    ++   EV  M   +H N+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              +K   L+ E+   G +  F Y      +  K       QI   +    +Y H+    
Sbjct: 82  IETEKTLYLVMEYASGGEV--FDYLVAHGRMKEKEARAKFRQIVSAV----QYCHQKF-- 133
Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF-C 265
            IVH D+K  N+LL  D   KI+DFG +       K + F       G+  Y APE+F  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC------GSPPYAAPELFQG 186
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVG 290
           + + G   + DV+S G+++  +V G
Sbjct: 187 KKYDG--PEVDVWSLGVILYTLVSG 209

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 39/241 (16%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFIN-------EVASMSKT----SHV 141
           LG+GGFG+V+ G +L D   VA+KV+  ++V G   ++       EVA + K      H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            V+  L +   ++   L+ E  P  + D F Y  E   +    E  + C     +A  ++
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLG---EGPSRCFFGQVVA-AIQ 153
Query: 202 YLH-RGCNIRIVHFDIKPHNILLG-EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           + H RG    +VH DIK  NIL+     C K+ DFG   L    E +    G R    Y 
Sbjct: 154 HCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTR---VYS 205
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG----RKNAEVKVSLSSEIYFPNSIYKHIE 315
            PE   R+    +  + V+S G+++ +MV G     ++ E+   L +E++FP     H+ 
Sbjct: 206 PPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQEI---LEAELHFP----AHVS 257
Query: 316 P 316
           P
Sbjct: 258 P 258

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 30/255 (11%)
Query: 46  DFGFGRFRK-KNTEN-ENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVY 103
           D  F   RK KN +N  N     ++    L  K  +Y  VK         +G+G FG V 
Sbjct: 41  DLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVK--------VIGRGAFGEVQ 92
Query: 104 KGKLPDGRLV-AVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL 158
             +    + V A+K+L       + +   F  E   M+  +   VV       + K   +
Sbjct: 93  LVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 152
Query: 159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP 218
           + E+MP G L   +     SN +   +W       V +A  L+ +H   ++ ++H D+KP
Sbjct: 153 VMEYMPGGDLVNLM-----SNYDVPEKWAKFYTAEVVLA--LDAIH---SMGLIHRDVKP 202
Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSH---KS 275
            N+LL +    K++DFG   +   +   +    A GT  YI+PEV  ++ GG  +   + 
Sbjct: 203 DNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPDYISPEVL-KSQGGDGYYGREC 260
Query: 276 DVYSYGMMILEMVVG 290
           D +S G+ + EM+VG
Sbjct: 261 DWWSVGVFLFEMLVG 275

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 92  NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           ++LG+G    VY+ K     +  A+KVLK + V+ +    E+  + + SH N++      
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 151 YEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
               + +L+ E +  G L D+ +     S        R        I   + YLH     
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE-------RDAADAVKQILEAVAYLHEN--- 167
Query: 210 RIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-- 264
            IVH D+KP N+L      D   KI+DFGL+K+ E +   + M    GT GY APE+   
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRG 224
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
           C        + D++S G++   ++ G
Sbjct: 225 C----AYGPEVDMWSVGIITYILLCG 246

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSF 146
           LG GG   V+  +  D RL   VAVKVL+        F      E  + +  +H  +V+ 
Sbjct: 20  LGFGGMSEVHLAR--DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 147 LGFCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLE-WRTMCQIAVGIARGLE 201
                 +        ++ E++   +L   ++ E      R +E     CQ        L 
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ-------ALN 130
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           + H+     I+H D+KP NI++      K+ DFG+A+ +++   S        GT  Y++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE    +   V  +SDVYS G ++ E++ G
Sbjct: 188 PEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 93  KLGQGGFGSVYKGKLPD-GRLVAVKVL---KNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           K+G+G +G V+K +  D G++VA+K     ++  V  +  + E+  + +  H N+V+ L 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEE--SSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               K++  L++E+  +  L +    +     ++ + + W+T+        + + + H+ 
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL--------QAVNFCHKH 121
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
                +H D+KP NIL+ +    K+ DFG A+L      +        T  Y +PE+   
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD--DEVATRWYRSPELLVG 176
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
           +        DV++ G +  E++ G
Sbjct: 177 D-TQYGPPVDVWAIGCVFAELLSG 199

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 53/277 (19%)
Query: 86  MTNSFS--NKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTS 139
           MT+ +    +LG+G F  V +  K+P G+  A K++   K++    ++   E        
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           H N+V       E+    L+++ +  G L + I       + R  E+ +    +  I + 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI-------VAR--EYYSEADASHCIQQI 112
Query: 200 LEYLHRGCNIR-IVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           LE ++  C++  IVH D+KP N+LL    +    K++DFGLA   +  +   +  G  GT
Sbjct: 113 LESVNH-CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGT 169
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP------NS 309
            GY++PEV  ++  G     D+++ G+++  ++VG              Y P      + 
Sbjct: 170 PGYLSPEVLRKDPYG--KPVDMWACGVILYILLVG--------------YPPFWDEDQHR 213
Query: 310 IYKHIE------PGNEFQLAGVVTEEEKEMAKKMILV 340
           +Y+ I+      P  E+     VT E K++  KM+ +
Sbjct: 214 LYQQIKAGAYDFPSPEWD---TVTPEAKDLINKMLTI 247

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 94  LGQGGFGSV-----YKGKLPDG-RLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           LG+G FG V     YK +     + ++ ++LK S ++      E++ +    H +++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEE--SSNINRKLEWRTMCQIAVGIARGLEYLHR 205
                     ++ E+   G L  +I +++  + +  R+   + +C I        EY HR
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI--------EYCHR 126
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
               +IVH D+KP N+LL ++   KI+DFGL+ +     +F+    + G+  Y APEV  
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLK--TSCGSPNYAAPEVIN 180
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            + + G   + DV+S G+++  M+VGR
Sbjct: 181 GKLYAG--PEVDVWSCGIVLYVMLVGR 205

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT---SHVNVVSFLGF 149
           LG+G FG V   K    GR  A+K+LK   +  ++ +    + ++    S    ++ L +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 150 CYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            ++   R   + E+   G L   +  E   + +R   +         I   L+YLH   N
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLHSEKN 269
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  V+ D+K  N++L +D   KI+DFGL K  E  +   +M    GT  Y+APEV   N 
Sbjct: 270 V--VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 269 GGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIEPGNEFQ 321
            G +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + P  +  
Sbjct: 326 YGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSL 379
Query: 322 LAGVVTEEEKE 332
           L+G++ ++ K+
Sbjct: 380 LSGLLKKDPKQ 390

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 91  SNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTSHVNVVSF 146
           S +LG+G F  V +      G+  A K LK  +   +   E ++E+A +        V  
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 147 LGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           L   YE      LI E+   G +      E +  ++     R + QI      G+ YLH+
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL----EGVYYLHQ 149
Query: 206 GCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
                IVH D+KP NILL   + P    KI DFG+++   K      +    GT  Y+AP
Sbjct: 150 N---NIVHLDLKPQNILLSSIY-PLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAP 202
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMV------VGRKNAEVKVSLS 301
           E+   N+  ++  +D+++ G++   ++      VG  N E  +++S
Sbjct: 203 EIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 53/277 (19%)
Query: 86  MTNSFS--NKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTS 139
           MT+ +    +LG+G F  V +  K+P G+  A K++   K++    ++   E        
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           H N+V       E+    L+++ +  G L + I       + R  E+ +    +  I + 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI-------VAR--EYYSEADASHCIQQI 112
Query: 200 LEYLHRGCNIR-IVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           LE ++  C++  IVH D+KP N+LL    +    K++DFGLA   +  +   +  G  GT
Sbjct: 113 LESVNH-CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGT 169
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP------NS 309
            GY++PEV  ++  G     D+++ G+++  ++VG              Y P      + 
Sbjct: 170 PGYLSPEVLRKDPYG--KPVDMWACGVILYILLVG--------------YPPFWDEDQHR 213
Query: 310 IYKHIE------PGNEFQLAGVVTEEEKEMAKKMILV 340
           +Y+ I+      P  E+     VT E K++  KM+ +
Sbjct: 214 LYQQIKAGAYDFPSPEWD---TVTPEAKDLINKMLTI 247

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 93  KLGQGGFGSVYK-GKLPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG V++  +   G   A K V+   + + E    E+ +MS   H  +V+     
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            +  +  +IYEFM  G L + + DE +     K+      +    + +GL ++H      
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---N 169
Query: 211 IVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            VH D+KP NI+         K+ DFGL    + K+   S+    GT  + APEV     
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEV--AEG 224
Query: 269 GGVSHKSDVYSYGMMILEMVVG 290
             V + +D++S G++   ++ G
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSG 246

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSF 146
           LG GG   V+  +  D RL   VAVKVL+        F      E  + +  +H  +V+ 
Sbjct: 20  LGFGGMSEVHLAR--DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 147 LGFCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLE-WRTMCQIAVGIARGLE 201
                 +        ++ E++   +L   ++ E      R +E     CQ        L 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ-------ALN 130
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           + H+     I+H D+KP NI++      K+ DFG+A+ +++   S        GT  Y++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE    +   V  +SDVYS G ++ E++ G
Sbjct: 188 PEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT---SHVNVVSFLGF 149
           LG+G FG V   K    GR  A+K+LK   +  ++ +    + ++    S    ++ L +
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 150 CYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            ++   R   + E+   G L   +  E   + +R   +         I   L+YLH   N
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLHSEKN 129
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  V+ D+K  N++L +D   KI+DFGL K  E  +   +M    GT  Y+APEV   N 
Sbjct: 130 V--VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 269 GGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIEPGNEFQ 321
            G +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + P  +  
Sbjct: 186 YGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSL 239
Query: 322 LAGVVTEEEKE 332
           L+G++ ++ K+
Sbjct: 240 LSGLLKKDPKQ 250

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT---SHVNVVSFLGF 149
           LG+G FG V   K    GR  A+K+LK   +  ++ +    + ++    S    ++ L +
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 150 CYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            ++   R   + E+   G L   +  E   + +R   +         I   L+YLH   N
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLHSEKN 130
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  V+ D+K  N++L +D   KI+DFGL K  E  +   +M    GT  Y+APEV   N 
Sbjct: 131 V--VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 269 GGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIEPGNEFQ 321
            G +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + P  +  
Sbjct: 187 YGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSL 240
Query: 322 LAGVVTEEEKE 332
           L+G++ ++ K+
Sbjct: 241 LSGLLKKDPKQ 251

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKT---SHVNVVSFLGF 149
           LG+G FG V   K    GR  A+K+LK   +  ++ +    + ++    S    ++ L +
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 150 CYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            ++   R   + E+   G L   +  E   + +R   +         I   L+YLH   N
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLHSEKN 131
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           +  V+ D+K  N++L +D   KI+DFGL K  E  +   +M    GT  Y+APEV   N 
Sbjct: 132 V--VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 269 GGVSHKSDVYSYGMMILEMVVGR-----KNAE--VKVSLSSEIYFPNSIYKHIEPGNEFQ 321
            G +   D +  G+++ EM+ GR     ++ E   ++ L  EI FP +    + P  +  
Sbjct: 188 YGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSL 241
Query: 322 LAGVVTEEEKE 332
           L+G++ ++ K+
Sbjct: 242 LSGLLKKDPKQ 252

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 12/179 (6%)
Query: 126 EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE 185
           ++F NE+  ++   +   ++  G      +  +IYE+M N S+ +F  DE    +++   
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF--DEYFFVLDKNYT 145
Query: 186 WRTMCQIAVGIARGL----EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
                Q+   I + +     Y+H   NI   H D+KP NIL+ ++   K+SDFG ++   
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL 300
            K+    + G+RGT  ++ PE F         K D++S G+ +  M        +K+SL
Sbjct: 204 DKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 95  GQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY- 151
           GQG FG+V  GK    G  VA+K V+++ +    E +  +  ++   H N+V    + Y 
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 152 --EKKKRAL----IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEY 202
             E+ +R +    + E++P+             N  R+        I V    + R +  
Sbjct: 91  LGERDRRDIYLNVVMEYVPD------TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 203 LHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           LH   ++ + H DIKPHN+L+ E D   K+ DFG AK     E  ++ + +R    Y AP
Sbjct: 145 LHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYRAP 200
Query: 262 EVFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           E+    FG   + +  D++S G +  EM++G
Sbjct: 201 ELI---FGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 26/236 (11%)
Query: 90  FSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVV 144
           F   LG+G FG V   ++ + G L AVKVLK   +    + E  + E   +S   +   +
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 145 SFLGFCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           + L  C++   R   + EF+  G L   ++  + S   R+ +       A  I   L +L
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKS---RRFDEARARFYAAEIISALMFL 140
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H   +  I++ D+K  N+LL  +   K++DFG+ K  E   + ++     GT  YIAPE+
Sbjct: 141 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEI 195
Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV-------KVSLSSEIYFPNSIYK 312
                 G +   D ++ G+++ EM+ G    E        +  L+ E+ +P  +++
Sbjct: 196 LQEMLYGPA--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 94  LGQGGFGSVYKGKLPDGRL---VAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVSF 146
           LG GG   V+  +  D RL   VAVKVL+        F      E  + +  +H  +V+ 
Sbjct: 37  LGFGGMSEVHLAR--DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 147 LGFCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLE-WRTMCQIAVGIARGLE 201
                 +        ++ E++   +L   ++ E      R +E     CQ        L 
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ-------ALN 147
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           + H+     I+H D+KP NI++      K+ DFG+A+ +++   S        GT  Y++
Sbjct: 148 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 204
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PE    +   V  +SDVYS G ++ E++ G
Sbjct: 205 PEQARGD--SVDARSDVYSLGCVLYEVLTG 232

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEF--INEVASMSKTSHVNVVSFLG 148
           K+GQG FG V+K +    G+ VA+K VL  ++  G     + E+  +    H NVV+ + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 149 FC------YEKKKRA--LIYEFMPN---GSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
            C      Y + K +  L+++F  +   G L   +     S I R ++          + 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ---------MLL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGAR-GT 255
            GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  +    R  T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 256 IGYIAPEVFC--RNFGGVSHKSDVYSYGMMILEM 287
           + Y  PE+    R++G      D++  G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 94  PQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLC--------GIKHLHS 144
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 198
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 199 ----GMGYKENVDIWSVGCIMGEMV 219

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 93  KLGQGGFGSVYK-GKLPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG V++  +   G   A K V+   + + E    E+ +MS   H  +V+     
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            +  +  +IYEFM  G L + + DE     + K+      +    + +GL ++H      
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 211 IVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            VH D+KP NI+         K+ DFGL    + K+   S+    GT  + APEV     
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEV--AEG 330
Query: 269 GGVSHKSDVYSYGMMILEMVVG 290
             V + +D++S G++   ++ G
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG 352

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L+   M  +   +  G+++LH 
Sbjct: 94  PQKTLEEFQDVYLVMELM-DANLXQVIQME--------LDHERMSYLLYQMLXGIKHLHS 144
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 198
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 199 ----GMGYKENVDIWSVGCIMGEMV 219

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEF--INEVASMSKTSHVNVVSFLG 148
           K+GQG FG V+K +    G+ VA+K VL  ++  G     + E+  +    H NVV+ + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 149 FC------YEKKKRA--LIYEFMPN---GSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
            C      Y + K +  L+++F  +   G L   +     S I R ++          + 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM---------LL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGAR-GT 255
            GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  +    R  T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 256 IGYIAPEVFC--RNFGGVSHKSDVYSYGMMILEM 287
           + Y  PE+    R++G      D++  G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 74/279 (26%)
Query: 94  LGQGGFGSVY--KGKLPDGRLVAVKV-LKNSKVNGEEFINEVASMSKTSHVNVV----SF 146
           +G+GGFG V+  K K+ D      ++ L N ++  E+ + EV +++K  H  +V    ++
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRT------------- 188
           L    EK +  +   ++ + S D  +      D  S  I R   + T             
Sbjct: 74  LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 189 --------MCQ------------------------IAVGIARGLEYLH-RGCNIRIVHFD 215
                   +C+                        I + IA  +E+LH +G    ++H D
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG----LMHRD 189
Query: 216 IKPHNILLGEDFCPKISDFGLAKLSEKKE----------SFISMLGARGTIGYIAPEVFC 265
           +KP NI    D   K+ DFGL    ++ E          ++ +  G  GT  Y++PE   
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIH 249
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI 304
            N    SHK D++S G+++ E++        +V + +++
Sbjct: 250 GN--NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDV 286

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G +  V   +L    R+ A+KV+K   VN +E I+ V +      + S+   +  L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++ + R   + E++  G L  F    +     RKL        +  I+  L YLH RG
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL-MFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG 141
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  +   K++D+G+ K   +     S     GT  YIAPE+   
Sbjct: 142 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRG 195
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              G S   D ++ G+++ EM+ GR   ++
Sbjct: 196 EDYGFS--VDWWALGVLMFEMMAGRSPFDI 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           +G G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+MP G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           +G G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+MP G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLGFC 150
           +G+G FG VY G+   G  VA++++   + N ++   F  EV +  +T H NVV F+G C
Sbjct: 41  IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEE-SSNINRKLEWRTMCQIAVGIARGLEYLH-RGCN 208
                 A+I       +L   + D +   ++N+        QIA  I +G+ YLH +G  
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR------QIAQEIVKGMGYLHAKG-- 150
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLS-----EKKESFISMLGARGTIGYIAPEV 263
             I+H D+K  N+   ++    I+DFGL  +S      ++E  + +    G + ++APE+
Sbjct: 151 --ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRI--QNGWLCHLAPEI 205
Query: 264 FCRNFG--------GVSHKSDVYSYGMMILEM 287
             R             S  SDV++ G +  E+
Sbjct: 206 I-RQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEF--INEVASMSKTSHVNVVSFLG 148
           K+GQG FG V+K +    G+ VA+K VL  ++  G     + E+  +    H NVV+ + 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 149 FC------YEKKKRA--LIYEFMPN---GSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
            C      Y + K +  L+++F  +   G L   +     S I R ++          + 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ---------MLL 134
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGAR-GT 255
            GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  +    R  T
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 256 IGYIAPEVFC--RNFGGVSHKSDVYSYGMMILEM 287
           + Y  PE+    R++G      D++  G ++ EM
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  G+ VAVK++  +++N    ++   EV      +H N+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 150 CYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +K   L+ E+   G + D  +          + ++R        I   ++Y H+   
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ-------IVSAVQYCHQKF- 133
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLA---KLSEKKESFISMLGARGTIGYIAPEVF- 264
             IVH D+K  N+LL  D   KI+DFG +       K ++F       G   Y APE+F 
Sbjct: 134 --IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC------GAPPYAAPELFQ 185
Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            + + G   + DV+S G+++  +V G
Sbjct: 186 GKKYDG--PEVDVWSLGVILYTLVSG 209

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK 153
           +G+G +G V++G L  G  VAVK+  +          E+ +     H N++ F+      
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 154 KKRA----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH----- 204
           +  +    LI  +  +GSL  F+         + LE     ++AV  A GL +LH     
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFLQ-------RQTLEPHLALRLAVSAACGLAHLHVEIFG 127
Query: 205 -RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--GTIGYIAP 261
            +G    I H D K  N+L+  +    I+D GLA +  +   ++ +      GT  Y+AP
Sbjct: 128 TQG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 262 EVF---CRNFGGVSHK-SDVYSYGMMILEM 287
           EV     R     S+K +D++++G+++ E+
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEF--INEVASMSKTSHVNVVSFLG 148
           K+GQG FG V+K +    G+ VA+K VL  ++  G     + E+  +    H NVV+ + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 149 FC------YEKKKRA--LIYEFMPN---GSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
            C      Y + K +  L+++F  +   G L   +     S I R ++          + 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ---------MLL 135
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGAR-GT 255
            GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  +    R  T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 256 IGYIAPEVFC--RNFGGVSHKSDVYSYGMMILEM 287
           + Y  PE+    R++G      D++  G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G +  V   +L    R+ A+KV+K   VN +E I+ V +      + S+   +  L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++ + R   + E++  G L  F    +     RKL        +  I+  L YLH RG
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL-MFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG 126
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  +   K++D+G+ K   +     S     GT  YIAPE+   
Sbjct: 127 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRG 180
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              G S   D ++ G+++ EM+ GR   ++
Sbjct: 181 EDYGFS--VDWWALGVLMFEMMAGRSPFDI 208

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 49/267 (18%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
           +LG+G F  V +  K+  G+  A K++   K++    ++   E        H N+V    
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              E+    LI++ +  G L + I       + R  E+ +    +  I + LE +     
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDI-------VAR--EYYSEADASHCIQQILEAVLHCHQ 139
Query: 209 IRIVHFDIKPHNILLGEDF---CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
           + +VH D+KP N+LL         K++DFGLA   E ++   +  G  GT GY++PEV  
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLR 197
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP------NSIYKHIE---- 315
           ++  G     D+++ G+++  ++VG              Y P      + +Y+ I+    
Sbjct: 198 KDPYG--KPVDLWACGVILYILLVG--------------YPPFWDEDQHRLYQQIKAGAY 241
Query: 316 --PGNEFQLAGVVTEEEKEMAKKMILV 340
             P  E+     VT E K++  KM+ +
Sbjct: 242 DFPSPEWD---TVTPEAKDLINKMLTI 265

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           ++G+G +G V+ GK   G  VAVKV   ++        E+       H N++ F+    +
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 153 ----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC- 207
                 +  LI ++  NGSL  ++   +S+ ++ K    +M ++A     GL +LH    
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYL---KSTTLDAK----SMLKLAYSSVSGLCHLHTEIF 155
Query: 208 ----NIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAP 261
                  I H D+K  NIL+ ++    I+D GLA   +S+  E  I      GT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 262 EV----FCRNFGGVSHKSDVYSYGMMILEM 287
           EV      RN       +D+YS+G+++ E+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF--------IYDEESSN-INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F        + D   S  I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G+++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 94  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 144
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 198
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 199 ----GMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF--------IYDEESSN-INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F        + D   S  I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G+++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G +  V   +L    R+ A+KV+K   VN +E I+ V +      + S+   +  L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++ + R   + E++  G L  F    +     RKL        +  I+  L YLH RG
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL-MFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG 130
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  +   K++D+G+ K   +     S     GT  YIAPE+   
Sbjct: 131 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRG 184
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              G S   D ++ G+++ EM+ GR   ++
Sbjct: 185 EDYGFS--VDWWALGVLMFEMMAGRSPFDI 212

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 32/200 (16%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK 154
           G G F +    +L +  L  V +L+  KV+G      +  +  T   N   FL       
Sbjct: 54  GGGSFSAEEVQELREATLKEVDILR--KVSGHP---NIIQLKDTYETNTFFFL------- 101
Query: 155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHF 214
               +++ M  G L  F Y  E   ++ K E R + +  + +   L  L+      IVH 
Sbjct: 102 ----VFDLMKKGEL--FDYLTEKVTLSEK-ETRKIMRALLEVICALHKLN------IVHR 148
Query: 215 DIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-CR---NFGG 270
           D+KP NILL +D   K++DFG +   +  E   S+    GT  Y+APE+  C    N  G
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC---GTPSYLAPEIIECSMNDNHPG 205
Query: 271 VSHKSDVYSYGMMILEMVVG 290
              + D++S G+++  ++ G
Sbjct: 206 YGKEVDMWSTGVIMYTLLAG 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  +L++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMV 288
           V      G+ +K   D++S G ++ EMV
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMV 219

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 35/279 (12%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKT 138
           D K++  +F  KL +   G ++KG+   G  + VKVLK    S     +F  E   +   
Sbjct: 8   DFKQL--NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 139 SHVNVVSFLGFCYEKKK--RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           SH NV+  LG C         LI  + P GSL    Y+      N  ++     + A+  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWXPYGSL----YNVLHEGTNFVVDQSQAVKFALDX 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           ARG  +LH      I    +   ++ + ED   +IS       ++ K SF S  G     
Sbjct: 121 ARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARIS------XADVKFSFQSP-GRXYAP 172
Query: 257 GYIAPEVFCRNFGGVSHKS-DVYSYGMMILEMVVGR------KNAEV--KVSLSS-EIYF 306
            ++APE   +     + +S D +S+ +++ E+V          N E+  KV+L       
Sbjct: 173 AWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTI 232
Query: 307 PNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLE 345
           P  I  H+      +L  +   E+     K   ++ +LE
Sbjct: 233 PPGISPHVS-----KLXKICXNEDPAKRPKFDXIVPILE 266

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 29  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV-- 84
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  +L++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 85  ----------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 134
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 188
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMV 288
           V      G+ +K   D++S G ++ EMV
Sbjct: 189 VIL----GMGYKENVDIWSVGCIMGEMV 212

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVAS----MSKTSHVNVVSFLG 148
           +G+G +  V   +L    R+ A++V+K   VN +E I+ V +      + S+   +  L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 149 FCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RG 206
            C++ + R   + E++  G L  F    +     RKL        +  I+  L YLH RG
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL-MFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG 173
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+K  N+LL  +   K++D+G+ K   +     S     GT  YIAPE+   
Sbjct: 174 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPEILRG 227
Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              G S   D ++ G+++ EM+ GR   ++
Sbjct: 228 EDYGFS--VDWWALGVLMFEMMAGRSPFDI 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    K++DFGLAK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++    AR 
Sbjct: 207 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 255 TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 263 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 293

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++    AR 
Sbjct: 202 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 255 TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 258 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++    AR 
Sbjct: 209 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 255 TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 265 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 196 IARGLEYL-HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
           +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   K   ++    AR 
Sbjct: 200 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 255 TIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            + ++APE +F R +   + +SDV+S+G+++ E+
Sbjct: 256 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 286

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 37  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 95  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 145
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 146 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVI- 198
Query: 266 RNFG-GVSHKSDVYSYGMMILEMV 288
              G G     D++S G ++ EMV
Sbjct: 199 --LGMGYKENVDIWSVGCIMGEMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 94  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 144
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 198
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 199 ----GMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 94  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 144
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 198
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 199 ----GMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 35  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 92
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 93  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 143
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 144 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 197
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 198 ----GMGYKENVDIWSVGCIMGEMV 218

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 108
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 215 --GYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 37  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 95  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 145
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 146 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 199
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 200 ----GMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 30  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 88  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 138
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 139 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 192
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 193 ----GMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 29  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 87  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 137
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 191
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 192 ----GMGYKENVDIWSVGCIMGEMV 212

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 35/250 (14%)
Query: 54  KKNTENEN-------AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK 106
           KK +E E+       A+  F++ + S A    +    +R+       LG G FG V   K
Sbjct: 8   KKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVK 62
Query: 107 LPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIY 160
             + G   A+K+L   KV      E  +NE   +   +   +V  L F ++      ++ 
Sbjct: 63  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVM 121
Query: 161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           E++P G +   +       I R  E       A  I    EYLH   ++ +++ D+KP N
Sbjct: 122 EYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSY 280
           +L+ +    +++DFG AK  + +   +      GT  Y+APE+      G +   D ++ 
Sbjct: 173 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWAL 225
Query: 281 GMMILEMVVG 290
           G++I EM  G
Sbjct: 226 GVLIYEMAAG 235

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 74  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 132 PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 182
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 183 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVI- 235
Query: 266 RNFG-GVSHKSDVYSYGMMILEMV 288
              G G     D++S G ++ EMV
Sbjct: 236 --LGMGYKENVDIWSVGCIMGEMV 257

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 30  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 88  PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 138
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 139 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVIL 192
Query: 266 RNFGGVSHKS--DVYSYGMMILEMV 288
               G+ +K   D++S G ++ EMV
Sbjct: 193 ----GMGYKENVDIWSVGCIMGEMV 213

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 35/250 (14%)
Query: 54  KKNTENEN-------AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK 106
           KK +E E+       A+  F++ + S A    +    +R+       LG G FG V   K
Sbjct: 8   KKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVK 62
Query: 107 LPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIY 160
             + G   A+K+L   KV      E  +NE   +   +   +V  L F ++      ++ 
Sbjct: 63  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVM 121
Query: 161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           E++P G +   +       I R  E       A  I    EYLH   ++ +++ D+KP N
Sbjct: 122 EYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSY 280
           +L+ +    +++DFG AK  + +   +      GT  Y+APE+      G +   D ++ 
Sbjct: 173 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWAL 225
Query: 281 GMMILEMVVG 290
           G++I EM  G
Sbjct: 226 GVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)
Query: 62  AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKN 120
           A+  F++ + S A    +    +R+       LG G FG V   K  + G   A+K+L  
Sbjct: 15  AKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKHKETGNHYAMKILDK 69
Query: 121 SKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDE 175
            KV      E  +NE   +   +   +V  L F ++      ++ E++P G +   +   
Sbjct: 70  QKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHL--- 125
Query: 176 ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
               I R  E       A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG
Sbjct: 126 --RRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            AK  + +   +      GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 227

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF--------IYDEESSN-INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F        + D   S  I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++S L    
Sbjct: 74  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 152 EKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +K         L+ E M + +L Q I  E        L ++ +C        G+++LH 
Sbjct: 132 PQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHS 182
Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APEV  
Sbjct: 183 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPEVI- 235
Query: 266 RNFG-GVSHKSDVYSYGMMILEMV 288
              G G     D++S G ++ EMV
Sbjct: 236 --LGMGYKENVDIWSVGCIMGEMV 257

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 35/250 (14%)
Query: 54  KKNTENEN-------AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK 106
           KK +E E+       A+  F++ + S A    +    +R+       LG G FG V   K
Sbjct: 28  KKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVK 82
Query: 107 LPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIY 160
             + G   A+K+L   KV      E  +NE   +   +   +V  L F ++      ++ 
Sbjct: 83  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVM 141
Query: 161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           E++P G +   +       I R  E       A  I    EYLH   ++ +++ D+KP N
Sbjct: 142 EYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPEN 192
Query: 221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSY 280
           +L+ +    +++DFG AK  + +   +      GT  Y+APE+      G +   D ++ 
Sbjct: 193 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWAL 245
Query: 281 GMMILEMVVG 290
           G++I EM  G
Sbjct: 246 GVLIYEMAAG 255

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFC 150
           L +GGF  VY+ + +  GR  A+K +L N +      I EV  M K S H N+V F    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 151 YEKKKRA-------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
              K+ +       L+   +  G L +F+   ES      L   T+ +I     R ++++
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQHM 152
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA---------KLSEKKESFISMLGARG 254
           HR     I+H D+K  N+LL      K+ DFG A           S ++ + +     R 
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 255 TIG-YIAPEV--FCRNFGGVSHKSDVYSYGMMI 284
           T   Y  PE+     NF  +  K D+++ G ++
Sbjct: 212 TTPMYRTPEIIDLYSNF-PIGEKQDIWALGCIL 243

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 35/250 (14%)
Query: 54  KKNTENEN-------AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK 106
           KK +E E+       A+  F++ + S A    +    +R+       LG G FG V   K
Sbjct: 8   KKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVK 62
Query: 107 LPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIY 160
             + G   A+K+L   KV      E  +NE   +   +   +V  L F ++      ++ 
Sbjct: 63  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVM 121
Query: 161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
           E+ P G +   +       I R  E       A  I    EYLH   ++ +++ D+KP N
Sbjct: 122 EYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSY 280
           +++ +    K++DFG AK  + +   +      GT  Y+APE+      G +   D ++ 
Sbjct: 173 LMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWAL 225
Query: 281 GMMILEMVVG 290
           G++I EM  G
Sbjct: 226 GVLIYEMAAG 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           H ++++ +          L+++ M  G L  F Y  E   ++ K E R+   I   +   
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGEL--FDYLTEKVALSEK-ETRS---IMRSLLEA 212
Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           + +LH      IVH D+KP NILL ++   ++SDFG +   E  E    +    GT GY+
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYL 266
Query: 260 APEVF-C---RNFGGVSHKSDVYSYGMMILEMVVG 290
           APE+  C       G   + D+++ G+++  ++ G
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF--------IYDEESSN-INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F        + D   S  I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           +G G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 108
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 215 --GYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   + +  +   ++ L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQAVNFPFLTKLE 108
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 215 --GYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    +++DFGLAK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK 154
           G G F +    +L +  L  V +L+  KV+G      +  +  T   N   FL       
Sbjct: 54  GGGSFSAEEVQELREATLKEVDILR--KVSGHP---NIIQLKDTYETNTFFFL------- 101
Query: 155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHF 214
               +++ M  G L  F Y  E   ++ K E R + +  + +   L  L+      IVH 
Sbjct: 102 ----VFDLMKKGEL--FDYLTEKVTLSEK-ETRKIMRALLEVICALHKLN------IVHR 148
Query: 215 DIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-CR---NFGG 270
           D+KP NILL +D   K++DFG +   +  E    +    GT  Y+APE+  C    N  G
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMNDNHPG 205
Query: 271 VSHKSDVYSYGMMILEMVVG 290
              + D++S G+++  ++ G
Sbjct: 206 YGKEVDMWSTGVIMYTLLAG 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK 154
           G G F +    +L +  L  V +L+  KV+G      +  +  T   N   FL       
Sbjct: 41  GGGSFSAEEVQELREATLKEVDILR--KVSGHP---NIIQLKDTYETNTFFFL------- 88
Query: 155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHF 214
               +++ M  G L  F Y  E   ++ K E R + +  + +   L  L+      IVH 
Sbjct: 89  ----VFDLMKKGEL--FDYLTEKVTLSEK-ETRKIMRALLEVICALHKLN------IVHR 135
Query: 215 DIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-CR---NFGG 270
           D+KP NILL +D   K++DFG +   +  E    +    GT  Y+APE+  C    N  G
Sbjct: 136 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMNDNHPG 192
Query: 271 VSHKSDVYSYGMMILEMVVG 290
              + D++S G+++  ++ G
Sbjct: 193 YGKEVDMWSTGVIMYTLLAG 212

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF--------IYDEESSN-INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F        + D   S  I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)
Query: 62  AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKN 120
           A+  F++ + S A    +    +R+       LG G FG V   K  + G   A+K+L  
Sbjct: 23  AKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 121 SKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDE 175
            KV      E  +NE   +   +   +V  L F ++      ++ E++P G +   +   
Sbjct: 78  QKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHL--- 133
Query: 176 ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
               I R  E       A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG
Sbjct: 134 --RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            AK  + +   +      GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 188 FAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV--SFLGF 149
           KLG G F +V+  K + +   VA+K+++  KV  E   +E+  + + +  +      +G 
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNI--------NRKLEWRTMCQIAVGIARGLE 201
            +  K         PNG     +++    N+        +R +    + QI+  +  GL+
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKKESFISMLGARGT 255
           Y+HR C   I+H DIKP N+L+     P      KI+D G A   +  E + + +  R  
Sbjct: 146 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTR-- 199
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             Y +PEV      G    +D++S   +I E++ G
Sbjct: 200 -EYRSPEVLLGAPWGCG--ADIWSTACLIFELITG 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)
Query: 62  AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKN 120
           A+  F++ + S A    +    +R+       LG G FG V   K  + G   A+K+L  
Sbjct: 15  AKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKHKETGNHYAMKILDK 69
Query: 121 SKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDE 175
            KV      E  +NE   +   +   +V  L F ++      ++ E++P G +   +   
Sbjct: 70  QKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHL--- 125
Query: 176 ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
               I R  E       A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG
Sbjct: 126 --RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            AK  + +   +      GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 227

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF--------IYDEESSN-INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F        + D   S  I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVV--SFLGF 149
           KLG G F +V+  K + +   VA+K+++  KV  E   +E+  + + +  +      +G 
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNI--------NRKLEWRTMCQIAVGIARGLE 201
            +  K         PNG     +++    N+        +R +    + QI+  +  GL+
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145
Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLAKLSEKKESFISMLGARGT 255
           Y+HR C   I+H DIKP N+L+     P      KI+D G A   +  E + + +  R  
Sbjct: 146 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTR-- 199
Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
             Y +PEV      G    +D++S   +I E++ G
Sbjct: 200 -EYRSPEVLLGAPWGCG--ADIWSTACLIFELITG 231

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 108
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIILSK 214
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 215 --GYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 93
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E++P G +   +       I R  E       A  I    EYLH   
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 144
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIILSK 199
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 200 --GYNKAVDWWALGVLIYEMAAG 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 44/228 (19%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVK----VLKNSKVNGEEFINEVASMSKTS-HVNVVSF 146
           KLG+G +G V+K      G +VAVK      +NS  + +    E+  +++ S H N+V+ 
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNL 74
Query: 147 LGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           L        R   L++++M    L   I     +NI   LE      +   + + ++YLH
Sbjct: 75  LNVLRADNDRDVYLVFDYM-ETDLHAVI----RANI---LEPVHKQYVVYQLIKVIKYLH 126
Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK---------------LSEKKESFIS- 248
            G    ++H D+KP NILL  +   K++DFGL++               ++E  E+F   
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 249 ---MLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYGMMILEMVVGR 291
              +     T  Y APE+     G   +    D++S G ++ E++ G+
Sbjct: 184 QPILTDYVATRWYRAPEIL---LGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 28/235 (11%)
Query: 62  AEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKN 120
           A+  F++ + S A    +    +R+       LG G FG V   K  + G   A+K+L  
Sbjct: 23  AKEDFLKKWESPAQNTAHLDQFERIRT-----LGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 121 SKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDE 175
            KV      E  +NE   + +  +   +  L F ++      ++ E+ P G +   +   
Sbjct: 78  QKVVKLKQIEHTLNE-KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL--- 133
Query: 176 ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
               I R  E       A  I    EYLH   ++ +++ D+KP N+L+ +    K++DFG
Sbjct: 134 --RRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFG 187
Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            AK  + +   +      GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 188 FAKRVKGRTWXLC-----GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 94  LGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           +G G FG   + + K  +  LVAVK ++  +   E    E+ +     H N+V F     
Sbjct: 27  IGAGNFGVARLMRDKQAN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEYLHRGCNI 209
                A++ E+   G L + I      N  R  + E R   Q  +    G+ Y H    +
Sbjct: 86  TPTHLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLIS---GVSYAH---AM 134
Query: 210 RIVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
           ++ H D+K  N LL     P  KI+DFG +K S       S   A GT  YIAPEV   +
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS---AVGTPAYIAPEVLLKK 191
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
            + G    +DV+S G+ +  M+VG
Sbjct: 192 EYDG--KVADVWSCGVTLYVMLVG 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 37/248 (14%)
Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGR 111
           R+ +   E +E      Y    P+ +     +R++     +LG G +G V+K +   DGR
Sbjct: 29  RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS-----RLGHGSYGEVFKVRSKEDGR 83
Query: 112 LVAVK----VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS 167
           L AVK      +  K    + + EV S  K         L   +E+     +   +   S
Sbjct: 84  LYAVKRSMSPFRGPKDRARK-LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPS 142
Query: 168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF 227
           L Q   +   +++     W  +    + +A    +LH   +  +VH D+KP NI LG   
Sbjct: 143 LQQHC-EAWGASLPEAQVWGYLRDTLLALA----HLH---SQGLVHLDVKPANIFLGPRG 194
Query: 228 CPKISDFGL------AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
             K+ DFGL      A   E +E         G   Y+APE+   ++G     +DV+S G
Sbjct: 195 RCKLGDFGLLVELGTAGAGEVQE---------GDPRYMAPELLQGSYGTA---ADVFSLG 242
Query: 282 MMILEMVV 289
           + ILE+  
Sbjct: 243 LTILEVAC 250

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   + +  +   ++ L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQAVNFPFLTKLE 108
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 215 --GYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   + +  +   ++ L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQAVNFPFLTKLE 108
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    K++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 215 --GYNKAVDWWALGVLIYEMAAG 235

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 38  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 93
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 94  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 143
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +      +  +  R    Y APE
Sbjct: 144 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTR---YYRAPE 197
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 198 VIL----GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPEVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 45/237 (18%)
Query: 71  VSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLK----NSKVNG 125
           VS AP   +    +R+T     KLG+G +G VYK         VA+K ++       V G
Sbjct: 24  VSAAPSATSIDRYRRIT-----KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG 78
Query: 126 EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE 185
              I EV+ + +  H N++      +   +  LI+E+  N  L +++      + N  + 
Sbjct: 79  TA-IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM------DKNPDVS 130
Query: 186 WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKISDFGLAK-- 238
            R +      +  G+ + H   + R +H D+KP N+LL      E    KI DFGLA+  
Sbjct: 131 MRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
Query: 239 ---LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKS---DVYSYGMMILEMVV 289
              + +     I       T+ Y  PE+      G  H S   D++S   +  EM++
Sbjct: 188 GIPIRQFTHEII-------TLWYRPPEILL----GSRHYSTSVDIWSIACIWAEMLM 233

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 112/253 (44%), Gaps = 36/253 (14%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVSF 146
           K+G+G +G+V+K K  +     +  LK  +++ ++       + E+  + +  H N+V  
Sbjct: 9   KIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               +  KK  L++EF  +  L ++       + N  L+   +      + +GL + H  
Sbjct: 67  HDVLHSDKKLTLVFEFC-DQDLKKYF-----DSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            +  ++H D+KP N+L+  +   K++DFGLA+         S      T+ Y  P+V   
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS--AEVVTLWYRPPDVL-- 173
Query: 267 NFGG--VSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
            FG    S   D++S G +  E+     NA   +   +++   +   K I     F+L G
Sbjct: 174 -FGAKLYSTSIDMWSAGCIFAELA----NAARPLFPGNDV---DDQLKRI-----FRLLG 220
Query: 325 VVTEEEKEMAKKM 337
             TEE+     K+
Sbjct: 221 TPTEEQWPSMTKL 233

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K  + G   A+K+L   KV      E  +NE   +   +   +V    
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +     ++ E++P G +   +       I R  E       A  I    EYLH   +
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---S 159
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           + +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+     
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK- 213
Query: 269 GGVSHKSDVYSYGMMILEMVVG 290
            G +   D ++ G++I EM  G
Sbjct: 214 -GYNKAVDWWALGVLIYEMAAG 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSFLG 148
           +LG+G F  V +      G   A K++   K++  +F     E     K  H N+V    
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
              E+    L+++ +  G L + I     Y E  ++         + QI   IA    Y 
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIA----YC 144
Query: 204 HRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           H      IVH ++KP N+LL    +    K++DFGLA      E++    G  GT GY++
Sbjct: 145 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLS 198
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PEV  ++    S   D+++ G+++  ++VG
Sbjct: 199 PEVLKKD--PYSKPVDIWACGVILYILLVG 226

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K  + G   A+K+L   KV      E  +NE   +   +   +V    
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +     ++ E++P G +   +       I R  E       A  I    EYLH   +
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---S 159
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           + +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+     
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK- 213
Query: 269 GGVSHKSDVYSYGMMILEMVVG 290
            G +   D ++ G++I EM  G
Sbjct: 214 -GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K  + G   A+K+L   KV      E  +NE   +   +   +V    
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              +     ++ E++P G +   +       I R  E       A  I    EYLH   +
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH---S 159
Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           + +++ D+KP N+L+ +    +++DFG AK  + +   +      GT  Y+APE+     
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK- 213
Query: 269 GGVSHKSDVYSYGMMILEMVVG 290
            G +   D ++ G++I EM  G
Sbjct: 214 -GYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 195
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 196 VIL----GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 37  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 92
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 93  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 196
Query: 263 VFCRNFGGVSHKS--DVYSYGMMILEMVVG 290
           V      G+ +K   D++S G ++ EM+ G
Sbjct: 197 VIL----GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 87  TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           T      +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F
Sbjct: 4   TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 147 LGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGIARGLE 201
           +    +      +  L+ ++  +GSL  F Y      +NR  +    M ++A+  A GL 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSL--FDY------LNRYTVTVEGMIKLALSTASGLA 114
Query: 202 YLHR---GCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--G 254
           +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +     I +      G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 255 TIGYIAPEVFCRNFGGVSH-----KSDVYSYGMMILEMV 288
           T  Y+APEV   +   + H     ++D+Y+ G++  E+ 
Sbjct: 175 TKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 87  TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           T      +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F
Sbjct: 5   TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 63
Query: 147 LGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGIARGLE 201
           +    +      +  L+ ++  +GSL  F Y      +NR  +    M ++A+  A GL 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSL--FDY------LNRYTVTVEGMIKLALSTASGLA 115
Query: 202 YLHR---GCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--G 254
           +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +     I +      G
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 175
Query: 255 TIGYIAPEVFCRNFGGVSH-----KSDVYSYGMMILEMV 288
           T  Y+APEV   +   + H     ++D+Y+ G++  E+ 
Sbjct: 176 TKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 87  TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           T      +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F
Sbjct: 10  TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 68
Query: 147 LGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGIARGLE 201
           +    +      +  L+ ++  +GSL  F Y      +NR  +    M ++A+  A GL 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSL--FDY------LNRYTVTVEGMIKLALSTASGLA 120
Query: 202 YLHR---GCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--G 254
           +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +     I +      G
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 180
Query: 255 TIGYIAPEVFCRNFGGVSH-----KSDVYSYGMMILEMV 288
           T  Y+APEV   +   + H     ++D+Y+ G++  E+ 
Sbjct: 181 TKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 87  TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           T      +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F
Sbjct: 43  TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 147 LGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGIARGLE 201
           +    +      +  L+ ++  +GSL  F Y      +NR  +    M ++A+  A GL 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSL--FDY------LNRYTVTVEGMIKLALSTASGLA 153
Query: 202 YLHR---GCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--G 254
           +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +     I +      G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 255 TIGYIAPEVFCRNFGGVSH-----KSDVYSYGMMILEMV 288
           T  Y+APEV   +   + H     ++D+Y+ G++  E+ 
Sbjct: 214 TKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V   K +  G   A+K+L   KV      E  +NE   +   +   +V  L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LE 107
Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++      ++ E+ P G +   +       I R  E       A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           ++ +++ D+KP N+++ +    +++DFG AK  + +   +      GT  Y+APE+    
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 268 FGGVSHKSDVYSYGMMILEMVVG 290
             G +   D ++ G++I EM  G
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSFLG 148
           +LG+G F  V +      G   A K++   K++  +F     E     K  H N+V    
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
              E+    L+++ +  G L + I     Y E  ++         + QI   IA    Y 
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIA----YC 121
Query: 204 HRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           H      IVH ++KP N+LL    +    K++DFGLA      E++    G  GT GY++
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLS 175
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PEV  ++    S   D+++ G+++  ++VG
Sbjct: 176 PEVLKKD--PYSKPVDIWACGVILYILLVG 203

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 87  TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           T      +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F
Sbjct: 30  TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 88
Query: 147 LGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGIARGLE 201
           +    +      +  L+ ++  +GSL  F Y      +NR  +    M ++A+  A GL 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSL--FDY------LNRYTVTVEGMIKLALSTASGLA 140
Query: 202 YLHR---GCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--G 254
           +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +     I +      G
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 200
Query: 255 TIGYIAPEVFCRNFGGVSH-----KSDVYSYGMMILEMV 288
           T  Y+APEV   +   + H     ++D+Y+ G++  E+ 
Sbjct: 201 TKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSFLG 148
           +LG+G F  V +      G   A K++   K++  +F     E     K  H N+V    
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
              E+    L+++ +  G L + I     Y E  ++         + QI   IA    Y 
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIA----YC 121
Query: 204 HRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           H      IVH ++KP N+LL    +    K++DFGLA      E++    G  GT GY++
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLS 175
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PEV  ++    S   D+++ G+++  ++VG
Sbjct: 176 PEVLKKD--PYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSFLG 148
           +LG+G F  V +      G   A K++   K++  +F     E     K  H N+V    
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
              E+    L+++ +  G L + I     Y E  ++         + QI   IA    Y 
Sbjct: 72  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIA----YC 120
Query: 204 HRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           H      IVH ++KP N+LL    +    K++DFGLA      E++    G  GT GY++
Sbjct: 121 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLS 174
Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           PEV  ++    S   D+++ G+++  ++VG
Sbjct: 175 PEVLKKD--PYSKPVDIWACGVILYILLVG 202

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 86  MTNSFS--NKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTS 139
           MT+ +     +G+G F  V +  KL  G   A K++   K++    ++   E        
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           H N+V       E+    L+++ +  G L + I       + R  E+ +    +  I + 
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI-------VAR--EYYSEADASHCIQQI 112
Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISDFGLAKLSEKKESFISMLGARGTI 256
           LE +     + +VH D+KP N+LL         K++DFGLA   +  +   +  G  GT 
Sbjct: 113 LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTP 170
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           GY++PEV  +   G     D+++ G+++  ++VG
Sbjct: 171 GYLSPEVLRKEAYG--KPVDIWACGVILYILLVG 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR----LVAVKVLKNSKVNGEEFIN---- 130
           N   VK    +F   LG+G FG V    L D +    L A+K+LK   V  ++ +     
Sbjct: 12  NLDRVKLTDFNFLMVLGKGSFGKVM---LADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTM 189
           E   ++       ++ L  C++   R   + E++  G L   +Y  +      K +    
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVG---KFKEPQA 122
Query: 190 CQIAVGIARGLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
              A  I+ GL +LH RG    I++ D+K  N++L  +   KI+DFG+      KE  + 
Sbjct: 123 VFYAAEISIGLFFLHKRG----IIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMMD 173
Query: 249 MLGAR---GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            +  R   GT  YIAPE+      G S   D ++YG+++ EM+ G+
Sbjct: 174 GVTTREFCGTPDYIAPEIIAYQPYGKS--VDWWAYGVLLYEMLAGQ 217

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRT 188
            E+  + K +H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKES 245
           M          ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+  +   
Sbjct: 248 M-------LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 246 FISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLS 301
             ++    GT  Y+APEV       G +   D +S G+++   + G         +VSL 
Sbjct: 298 MRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
Query: 302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
            +I   +  Y  I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 355 DQI--TSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 396

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 87  TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF 146
           T      +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F
Sbjct: 7   TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 65
Query: 147 LGFCYEK----KKRALIYEFMPNGSLDQFIYDEESSNINR-KLEWRTMCQIAVGIARGLE 201
           +    +      +  L+ ++  +GSL  F Y      +NR  +    M ++A+  A GL 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSL--FDY------LNRYTVTVEGMIKLALSTASGLA 117
Query: 202 YLHR---GCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR--G 254
           +LH    G   +  I H D+K  NIL+ ++    I+D GLA   +     I +      G
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 177
Query: 255 TIGYIAPEVFCRNFGGVSH-----KSDVYSYGMMILEMV 288
           T  Y+APEV   +   + H     ++D+Y+ G++  E+ 
Sbjct: 178 TKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   ++    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRT 188
            E+  + K +H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKES 245
           M          ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+  +   
Sbjct: 262 M-------LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311
Query: 246 FISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLS 301
             ++    GT  Y+APEV       G +   D +S G+++   + G         +VSL 
Sbjct: 312 MRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 368
Query: 302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
            +I   +  Y  I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 369 DQI--TSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 410

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ E    +++DFG AK  + +   +     
Sbjct: 134 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---- 186
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 187 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 221

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 114 AVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI 172
           AVK++  SK +  E I  +    +  H N+++      + K   ++ E M  G L D+ +
Sbjct: 51  AVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL 108
Query: 173 YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL-LGEDFCP-- 229
             +  S        R    +   I + +EYLH      +VH D+KP NIL + E   P  
Sbjct: 109 RQKFFSE-------REASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPES 158
Query: 230 -KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
            +I DFG AK    +     ++    T  ++APEV  R   G     D++S G+++  M+
Sbjct: 159 IRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTML 214
Query: 289 VG 290
            G
Sbjct: 215 TG 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 78  YNYSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFI--NEVAS 134
           Y+Y D+         +LG G FG V++  +   GR+   K + N+    +++   NE++ 
Sbjct: 50  YDYYDI-------LEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISI 101
Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE-----ESSNINRKLEWRTM 189
           M++  H  +++      +K +  LI EF+  G L   I  E     E+  IN     R  
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM---RQA 158
Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP--KISDFGLA-KLSEKKESF 246
           C+       GL+++H      IVH DIKP NI+         KI DFGLA KL+   +  
Sbjct: 159 CE-------GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEI 206
Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMM 283
           + +  A  T  + APE+  R    V   +D+++ G++
Sbjct: 207 VKVTTA--TAEFAAPEIVDRE--PVGFYTDMWAIGVL 239

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV------NGEEFIN---EVASMSKTS 139
            S  LG G  G V    +    + VA+K++   K         +  +N   E+  + K +
Sbjct: 13  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 72
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  M         
Sbjct: 73  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM-------LL 124
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGT 255
            ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+   + S +  L   GT
Sbjct: 125 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC--GT 178
Query: 256 IGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLSSEIYFPNSIY 311
             Y+APEV       G +   D +S G+++   + G         +VSL  +I   +  Y
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKY 236
Query: 312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
             I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 237 NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 270

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 27/190 (14%)
Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           LG G  G+V ++G    GR VAVK +     +    + E+  ++++  H NV+ +  +C 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA--LMEIKLLTESDDHPNVIRY--YCS 77
Query: 152 EKKKRALIYEF-MPNGSLDQFIYDEESSNINRKLEWR-TMCQIAVGIARGLEYLHRGCNI 209
           E   R L     + N +L   +  +  S+ N KL+       +   IA G+ +LH   ++
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 210 RIVHFDIKPHNILL-------------GEDFCPKISDFGLA-KLSEKKESFISML-GARG 254
           +I+H D+KP NIL+              E+    ISDFGL  KL   + SF + L    G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 255 TIGYIAPEVF 264
           T G+ APE+ 
Sbjct: 195 TSGWRAPELL 204

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MEPEVVTRYYRAPE 195
Query: 263 VFCRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           V     G G     D++S G ++ EMV  +
Sbjct: 196 VI---LGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV------NGEEFIN---EVASMSKTS 139
            S  LG G  G V    +    + VA+K++   K         +  +N   E+  + K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  M         
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM-------LL 125
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGT 255
            ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+   + S +  L   GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC--GT 179
Query: 256 IGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLSSEIYFPNSIY 311
             Y+APEV       G +   D +S G+++   + G         +VSL  +I   +  Y
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKY 237
Query: 312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
             I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 238 NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV------NGEEFIN---EVASMSKTS 139
            S  LG G  G V    +    + VA+K++   K         +  +N   E+  + K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  M         
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM-------LL 125
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGT 255
            ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+  +     ++    GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 256 IGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLSSEIYFPNSIY 311
             Y+APEV       G +   D +S G+++   + G         +VSL  +I   +  Y
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKY 237
Query: 312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
             I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 238 NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV------NGEEFIN---EVASMSKTS 139
            S  LG G  G V    +    + VA+K++   K         +  +N   E+  + K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  M         
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM-------LL 125
Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKESFISMLGARGT 255
            ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+   + S +  L   GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC--GT 179
Query: 256 IGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLSSEIYFPNSIY 311
             Y+APEV       G +   D +S G+++   + G         +VSL  +I   +  Y
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKY 237
Query: 312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
             I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 238 NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 115/267 (43%), Gaps = 49/267 (18%)
Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
           +LG+G F  V +  K+  G+  A  ++   K++    ++   E        H N+V    
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              E+    LI++ +  G L + I   E         + +    +  I + LE +     
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQ 128
Query: 209 IRIVHFDIKPHNILLGEDF---CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
           + +VH ++KP N+LL         K++DFGLA   E ++   +  G  GT GY++PEV  
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLR 186
Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP------NSIYKHIE---- 315
           ++  G     D+++ G+++  ++VG              Y P      + +Y+ I+    
Sbjct: 187 KDPYG--KPVDLWACGVILYILLVG--------------YPPFWDEDQHRLYQQIKAGAY 230
Query: 316 --PGNEFQLAGVVTEEEKEMAKKMILV 340
             P  E+     VT E K++  KM+ +
Sbjct: 231 DFPSPEWD---TVTPEAKDLINKMLTI 254

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 30  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 85
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 86  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 136 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 189
Query: 263 VFCRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           V     G G     D++S G ++ EMV  +
Sbjct: 190 VI---LGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV------NGEEFIN-- 130
           Y    R     S  LG G  G V    +    + VA+K++   K         +  +N  
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 131 -EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFIYDEESSNINRKLEWRT 188
            E+  + K +H  ++    F ++ +   ++ E M  G L D+ + ++       KL +  
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKKES 245
           M          ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+  +   
Sbjct: 129 M-------LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178
Query: 246 FISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRK---NAEVKVSLS 301
             ++    GT  Y+APEV       G +   D +S G+++   + G         +VSL 
Sbjct: 179 MRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 235
Query: 302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED 350
            +I   +  Y  I      ++   V+E+  ++ KK+++V      +TE+
Sbjct: 236 DQIT--SGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 277

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 30/189 (15%)
Query: 113 VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA------LIYEFM 163
           VAVK L     ++ + +    E+  +   +H N++S L     +K         L+ E M
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL 223
            + +L Q I+ E        L ++ +C        G+++LH      I+H D+KP NI++
Sbjct: 110 -DANLCQVIHMELDHERMSYLLYQMLC--------GIKHLHSA---GIIHRDLKPSNIVV 157
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKS--DVYSYG 281
             D   KI DFGLA+ +         +  R    Y APEV      G+ +K   D++S G
Sbjct: 158 KSDCTLKILDFGLARTASTNFMMTPYVVTR---YYRAPEVIL----GMGYKENVDIWSVG 210
Query: 282 MMILEMVVG 290
            ++ E+V G
Sbjct: 211 CIMGELVKG 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 41  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 96
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 97  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 146
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 147 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MTPYVVTRYYRAPE 200
Query: 263 VFCRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           V     G G     D++S G ++ EMV  +
Sbjct: 201 VI---LGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +G V   +    G+ VA+K + N+     N +  + E+  +    H N+++    
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 150 CY------EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                   E K   ++ + M    L Q I+       ++ L    +      + RGL+Y+
Sbjct: 122 LRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS------SQPLTLEHVRYFLYQLLRGLKYM 174
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAP 261
           H   + +++H D+KP N+L+ E+   KI DFG+A+   +   E    M     T  Y AP
Sbjct: 175 H---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           E+   +    +   D++S G +  EM+  R+
Sbjct: 232 ELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 95  GQGGFGSVYKGKLPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            QG   + Y   L   R VA+K L     ++ + +    E+  M   +H N++  L    
Sbjct: 36  AQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 152 EKKKRALIYEFMPNGSLDQF-----IYDEESSN----INRKLEWRTMCQIAVGIARGLEY 202
                     F P  SL++F     + +   +N    I  +L+   M  +   +  G+++
Sbjct: 92  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH      I+H D+KP NI++  D   KI DFGLA+ +    SF+ M     T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM-MEPEVVTRYYRAPE 195
Query: 263 VFCRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           V     G G     D++S G ++ EMV  +
Sbjct: 196 VI---LGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 94  LGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           +G G FG   + + K     LVAVK ++  +   E    E+ +     H N+V F     
Sbjct: 26  IGSGNFGVARLMRDKQ-SNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEYLHRGCNI 209
                A++ E+   G L + I      N  R  + E R   Q  +    G+ Y H    +
Sbjct: 85  TPTHLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLIS---GVSYCHA---M 133
Query: 210 RIVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
           ++ H D+K  N LL     P  KI DFG +K S       S +   GT  YIAPEV   +
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKK 190
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
            + G    +DV+S G+ +  M+VG
Sbjct: 191 EYDG--KVADVWSCGVTLYVMLVG 212

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 142 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 194
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 195 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 109/257 (42%), Gaps = 46/257 (17%)
Query: 75  PKRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKL-PDGRLVAVKVLK--NSKVNGEEFI 129
           PKR  Y+    +++ F  K  LG+G +G V      P G +VA+K ++  +  +     +
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 130 NEVASMSKTSHVNVVSFLGF----CYEKKKRALIYEFMPNGSLDQFIYDEESSNIN-RKL 184
            E+  +    H N+++         +E      I + +    L + I  +  S+ + +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----- 239
            ++T+        R ++ LH G N+  +H D+KP N+L+  +   K+ DFGLA++     
Sbjct: 118 IYQTL--------RAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 240 ---SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              SE       M     T  Y APEV   +    S   DV+S G ++ E+ + R     
Sbjct: 167 ADNSEPTGQQSGMTEXVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRP---- 221
Query: 297 KVSLSSEIYFPNSIYKH 313
                    FP   Y+H
Sbjct: 222 --------IFPGRDYRH 230

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 94  LGQGGFGSVYKGKLP-DGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +G V   +    G+ VA+K + N+     N +  + E+  +    H N+++    
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 150 CY------EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                   E K   ++ + M    L Q I+       ++ L    +      + RGL+Y+
Sbjct: 123 LRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS------SQPLTLEHVRYFLYQLLRGLKYM 175
Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK--LSEKKESFISMLGARGTIGYIAP 261
           H   + +++H D+KP N+L+ E+   KI DFG+A+   +   E    M     T  Y AP
Sbjct: 176 H---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           E+   +    +   D++S G +  EM+  R+
Sbjct: 233 ELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 113 VAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA------LIYEFM 163
           VAVK L     ++ + +    E+  +   +H N++S L     +K         L+ E M
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL 223
            + +L Q I+ E        L ++ +C        G+++LH      I+H D+KP NI++
Sbjct: 112 -DANLCQVIHMELDHERMSYLLYQMLC--------GIKHLHSA---GIIHRDLKPSNIVV 159
Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG-GVSHKSDVYSYGM 282
             D   KI DFGLA+ +         +  R    Y APEV     G G +   D++S G 
Sbjct: 160 KSDCTLKILDFGLARTACTNFMMTPYVVTR---YYRAPEVI---LGMGYAANVDIWSVGC 213
Query: 283 MILEMVVG 290
           ++ E+V G
Sbjct: 214 IMGELVKG 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 46/257 (17%)
Query: 75  PKRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKL-PDGRLVAVKVLK--NSKVNGEEFI 129
           PKR  Y+    +++ F  K  LG+G +G V      P G +VA+K ++  +  +     +
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 130 NEVASMSKTSHVNVVSFLGF----CYEKKKRALIYEFMPNGSLDQFIYDEESSNIN-RKL 184
            E+  +    H N+++         +E      I + +    L + I  +  S+ + +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----- 239
            ++T+        R ++ LH G N+  +H D+KP N+L+  +   K+ DFGLA++     
Sbjct: 118 IYQTL--------RAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 240 ---SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              SE       M+    T  Y APEV   +    S   DV+S G ++ E+ + R     
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRP---- 221
Query: 297 KVSLSSEIYFPNSIYKH 313
                    FP   Y+H
Sbjct: 222 --------IFPGRDYRH 230

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 111/255 (43%), Gaps = 40/255 (15%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVSF 146
           K+G+G +G+V+K K  +     +  LK  +++ ++       + E+  + +  H N+V  
Sbjct: 9   KIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               +  KK  L++EF  +  L ++       + N  L+   +      + +GL + H  
Sbjct: 67  HDVLHSDKKLTLVFEFC-DQDLKKYF-----DSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            +  ++H D+KP N+L+  +   K+++FGLA+         S      T+ Y  P+V   
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS--AEVVTLWYRPPDVL-- 173
Query: 267 NFGG--VSHKSDVYSYGMMILEMV-VGRKNAEVKVSLSSEIYFP-NSIYKHIEPGNEFQL 322
            FG    S   D++S G +  E+   GR              FP N +   ++    F+L
Sbjct: 174 -FGAKLYSTSIDMWSAGCIFAELANAGRP------------LFPGNDVDDQLK--RIFRL 218
Query: 323 AGVVTEEEKEMAKKM 337
            G  TEE+     K+
Sbjct: 219 LGTPTEEQWPSMTKL 233

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 109/257 (42%), Gaps = 46/257 (17%)
Query: 75  PKRYNYSDVKRMTNSFSNK--LGQGGFGSVYKGKL-PDGRLVAVKVLK--NSKVNGEEFI 129
           PKR  Y+    +++ F  K  LG+G +G V      P G +VA+K ++  +  +     +
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 130 NEVASMSKTSHVNVVSFLGF----CYEKKKRALIYEFMPNGSLDQFIYDEESSNIN-RKL 184
            E+  +    H N+++         +E      I + +    L + I  +  S+ + +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----- 239
            ++T+        R ++ LH G N+  +H D+KP N+L+  +   K+ DFGLA++     
Sbjct: 118 IYQTL--------RAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 240 ---SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEV 296
              SE       M     T  Y APEV   +    S   DV+S G ++ E+ + R     
Sbjct: 167 ADNSEPTGQQSGMTEYVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRP---- 221
Query: 297 KVSLSSEIYFPNSIYKH 313
                    FP   Y+H
Sbjct: 222 --------IFPGRDYRH 230

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I +M  G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYQMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+++ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPEIIISK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYK--GKLPDGRLVAVKVLKNSKVNGE------EFINEVA 133
           DV        + LG+G FG V +       GR VAVK++KN     E      + +  + 
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
           +    S    V  L +        +++E +    L  + + +E+  +  +L+   + ++A
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLD--HIRKMA 124
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKIS--------------DF 234
             I + + +LH     ++ H D+KP NIL       E + PKI               DF
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           G A   ++  S  +++  R    Y APEV      G S   DV+S G +++E  +G
Sbjct: 182 GSATYDDEHHS--TLVSTR---HYRAPEVILA--LGWSQPCDVWSIGCILIEYYLG 230

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 85  RMTNSFSN--KLGQGGFGSVYKG-KLPDGRLVAVKVLKNS---KVNGEEFINEV-ASMSK 137
           R T  F    K+G G FGSV+K  K  DG + A+K  K      V+ +  + EV A    
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             H +VV +     E     +  E+   GSL   I   E+  I    +   +  + + + 
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVG 121
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-------------------KISDFG-LA 237
           RGL Y+H   ++ +VH DIKP NI +     P                   KI D G + 
Sbjct: 122 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 178
Query: 238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
           ++S  +          G   ++A EV   N+  +  K+D+++  + ++
Sbjct: 179 RISSPQVE-------EGDSRFLANEVLQENYTHLP-KADIFALALTVV 218

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  +     +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC---- 220
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APE+      G +   D ++ G++I EM  G
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 94  LGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           +G G FG   + + K     LVAVK ++  +        E+ +     H N+V F     
Sbjct: 27  IGSGNFGVARLMRDKQ-SNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEYLHRGCNI 209
                A++ E+   G L + I      N  R  + E R   Q  +    G+ Y H    +
Sbjct: 86  TPTHLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLIS---GVSYCHA---M 134
Query: 210 RIVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
           ++ H D+K  N LL     P  KI DFG +K S       S +   GT  YIAPEV   +
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKK 191
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
            + G    +DV+S G+ +  M+VG
Sbjct: 192 EYDG--KVADVWSCGVTLYVMLVG 213

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 85  RMTNSFSN--KLGQGGFGSVYKG-KLPDGRLVAVKVLKNS---KVNGEEFINEV-ASMSK 137
           R T  F    K+G G FGSV+K  K  DG + A+K  K      V+ +  + EV A    
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             H +VV +     E     +  E+   GSL   I   E+  I    +   +  + + + 
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVG 123
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-------------------KISDFG-LA 237
           RGL Y+H   ++ +VH DIKP NI +     P                   KI D G + 
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
           ++S  +          G   ++A EV   N+  +  K+D+++  + ++
Sbjct: 181 RISSPQVE-------EGDSRFLANEVLQENYTHLP-KADIFALALTVV 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 85  RMTNSFS--NKLGQGGFGSVYKG--KLPDGRLVAVKVLKNSKVNG---EEFINEVASMSK 137
           R T+ +    +LG+G F  V +   K P     A K++   K++    ++   E      
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAA-KIINTKKLSARDHQKLEREARICRL 86
Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             H N+V       E+    L+++ +  G L + I       + R  E+ +    +  I 
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI-------VAR--EYYSEADASHCIH 137
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISDFGLAKLSEKKESFISMLGARG 254
           + LE ++      IVH D+KP N+LL         K++DFGLA   + ++   +  G  G
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ--AWFGFAG 195
Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           T GY++PEV  ++  G     D+++ G+++  ++VG
Sbjct: 196 TPGYLSPEVLRKDPYG--KPVDIWACGVILYILLVG 229

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 85  RMTNSFSN--KLGQGGFGSVYKG-KLPDGRLVAVKVLKNS---KVNGEEFINEV-ASMSK 137
           R T  F    K+G G FGSV+K  K  DG + A+K  K      V+ +  + EV A    
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             H +VV +     E     +  E+   GSL   I   E+  I    +   +  + + + 
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVG 125
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-------------------KISDFG-LA 237
           RGL Y+H   ++ +VH DIKP NI +     P                   KI D G + 
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
           ++S  +          G   ++A EV   N+  +  K+D+++  + ++
Sbjct: 183 RISSPQVE-------EGDSRFLANEVLQENYTHLP-KADIFALALTVV 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  IA  L YLH   ++ IV+ D+KP NILL       ++DFGL K + +  S  S    
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC- 200
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+APEV  +         D +  G ++ EM+ G
Sbjct: 201 -GTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYG 235

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 85  RMTNSFSN--KLGQGGFGSVYKG-KLPDGRLVAVKVLKNS---KVNGEEFINEV-ASMSK 137
           R T  F    K+G G FGSV+K  K  DG + A+K  K      V+ +  + EV A    
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             H +VV +     E     +  E+   GSL   I   E+  I    +   +  + + + 
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVG 123
Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-------------------KISDFG-LA 237
           RGL Y+H   ++ +VH DIKP NI +     P                   KI D G + 
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
           ++S  +          G   ++A EV   N+  +  K+D+++  + ++
Sbjct: 181 RISSPQVE-------EGDSRFLANEVLQENYTHLP-KADIFALALTVV 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTS 139
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 25  VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVGI 196
             +      + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M       
Sbjct: 85  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------- 136
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              LE +H      IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+
Sbjct: 137 ---LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 257 GYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
            Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+    
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 248
Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
             ++  I+P +E +   +  ++ +++ K
Sbjct: 249 --LHAIIDPNHEIEFPDIPEKDLQDVLK 274

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 82  DVKRMTNSFSNKLGQGGFGSVYK--GKLPDGRLVAVKVLKNSKVNGE------EFINEVA 133
           DV        + LG+G FG V +       GR VAVK++KN     E      + +  + 
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
           +    S    V  L +        +++E +    L  + + +E+  +  +L+   + ++A
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLD--HIRKMA 124
Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKIS--------------DF 234
             I + + +LH     ++ H D+KP NIL       E + PKI               DF
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           G A   ++  S  +++  R    Y APEV      G S   DV+S G +++E  +G
Sbjct: 182 GSATYDDEHHS--TLVXXR---HYRAPEVILA--LGWSQPCDVWSIGCILIEYYLG 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 26/225 (11%)
Query: 80  YSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVL-KNSKVNGEEFINEVASMSK 137
           + D+ ++T+     LG+G +  V     L +G+  AVK++ K +  +      EV ++ +
Sbjct: 10  FEDMYKLTSEL---LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 138 TS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
              + N++  + F  +  +  L++E +  GS+   I  ++  N       R   ++   +
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE------REASRVVRDV 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILL--GEDFCP-KISDFGLA---KLSEKKESFIS-- 248
           A  L++LH      I H D+KP NIL    E   P KI DF L    KL+       +  
Sbjct: 121 AAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 249 MLGARGTIGYIAP---EVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +    G+  Y+AP   EVF         + D++S G+++  M+ G
Sbjct: 178 LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTS 139
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 6   VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVGI 196
             +      + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M       
Sbjct: 66  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------- 117
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              LE +H      IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+
Sbjct: 118 ---LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 257 GYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
            Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+    
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 229
Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
             ++  I+P +E +   +  ++ +++ K
Sbjct: 230 --LHAIIDPNHEIEFPDIPEKDLQDVLK 255

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTS 139
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 53  VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVGI 196
             +      + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M       
Sbjct: 113 QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------- 164
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              LE +H      IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+
Sbjct: 165 ---LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 257 GYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
            Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+    
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 276
Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
             ++  I+P +E +   +  ++ +++ K
Sbjct: 277 --LHAIIDPNHEIEFPDIPEKDLQDVLK 302

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTS 139
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 9   VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 68
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVGI 196
             +      + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M       
Sbjct: 69  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------- 120
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              LE +H      IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+
Sbjct: 121 ---LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 257 GYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
            Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+    
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 232
Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
             ++  I+P +E +   +  ++ +++ K
Sbjct: 233 --LHAIIDPNHEIEFPDIPEKDLQDVLK 258

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           LG G  G+V ++G    GR VAVK +     +    + E+  ++++  H NV+ +  +C 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA--LMEIKLLTESDDHPNVIRY--YCS 95
Query: 152 EKKKRALIYEF-MPNGSLDQFIYDEESSNINRKLEWR-TMCQIAVGIARGLEYLHRGCNI 209
           E   R L     + N +L   +  +  S+ N KL+       +   IA G+ +LH   ++
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 152
Query: 210 RIVHFDIKPHNILL-------------GEDFCPKISDFGLA-KLSEKKESFISML-GARG 254
           +I+H D+KP NIL+              E+    ISDFGL  KL   +  F   L    G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 255 TIGYIAPEVF 264
           T G+ APE+ 
Sbjct: 213 TSGWRAPELL 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT  Y+AP +      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEYLAPAIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           LG G  G+V ++G    GR VAVK +     +    + E+  ++++  H NV+ +  +C 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA--LMEIKLLTESDDHPNVIRY--YCS 95
Query: 152 EKKKRALIYEF-MPNGSLDQFIYDEESSNINRKLEWR-TMCQIAVGIARGLEYLHRGCNI 209
           E   R L     + N +L   +  +  S+ N KL+       +   IA G+ +LH   ++
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 152
Query: 210 RIVHFDIKPHNILL-------------GEDFCPKISDFGLA-KLSEKKESFISML-GARG 254
           +I+H D+KP NIL+              E+    ISDFGL  KL   +  F   L    G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 255 TIGYIAPEVF 264
           T G+ APE+ 
Sbjct: 213 TSGWRAPELL 222

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTS 139
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 5   VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 64
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVGI 196
             +      + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M       
Sbjct: 65  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------- 116
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              LE +H      IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+
Sbjct: 117 ---LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 257 GYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
            Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+    
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 228
Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
             ++  I+P +E +   +  ++ +++ K
Sbjct: 229 --LHAIIDPNHEIEFPDIPEKDLQDVLK 254

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 94  LGQGGFGSV-YKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           LG G  G+V ++G    GR VAVK +     +    + E+  ++++  H NV+ +  +C 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA--LMEIKLLTESDDHPNVIRY--YCS 77
Query: 152 EKKKRALIYEF-MPNGSLDQFIYDEESSNINRKLEWR-TMCQIAVGIARGLEYLHRGCNI 209
           E   R L     + N +L   +  +  S+ N KL+       +   IA G+ +LH   ++
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 210 RIVHFDIKPHNILL-------------GEDFCPKISDFGLA-KLSEKKESFISML-GARG 254
           +I+H D+KP NIL+              E+    ISDFGL  KL   +  F   L    G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 194
Query: 255 TIGYIAPEVF 264
           T G+ APE+ 
Sbjct: 195 TSGWRAPELL 204

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 122/269 (45%), Gaps = 35/269 (13%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSK-T 138
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 53  VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVG 195
            H + +  L + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M      
Sbjct: 113 QHSDKIIRL-YDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------ 164
Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
               LE +H      IVH D+KP N L+ +    K+ DFG+A   +   + +      GT
Sbjct: 165 ----LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 256 IGYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF 306
           + Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+   
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 276
Query: 307 PNSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
              ++  I+P +E +   +  ++ +++ K
Sbjct: 277 ---LHAIIDPNHEIEFPDIPEKDLQDVLK 302

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 126
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR---VYS 179
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 180 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 128
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R      
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR----VY 180
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +P  + R        + V+S G+++ +MV G
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 128
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 181
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 182 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 127
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR---VYS 180
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 181 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 118/268 (44%), Gaps = 33/268 (12%)
Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTS 139
           VK    S   ++G GG   V++      ++ A+K +   + + +    + NE+A ++K  
Sbjct: 25  VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN---RKLEWRTMCQIAVGI 196
             +      + YE   +  IY  M  G++D   + ++  +I+   RK  W+ M       
Sbjct: 85  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM------- 136
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              LE +H      IVH D+KP N L+ +    K+ DFG+A   +     +      GT+
Sbjct: 137 ---LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTV 192
Query: 257 GYIAPEVF-----CRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP 307
            Y+ PE        R  G     +S KSDV+S G ++  M  G+   +  ++  S+    
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 248
Query: 308 NSIYKHIEPGNEFQLAGVVTEEEKEMAK 335
             ++  I+P +E +   +  ++ +++ K
Sbjct: 249 --LHAIIDPNHEIEFPDIPEKDLQDVLK 274

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 128
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR---VYS 181
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 182 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 123
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR---VYS 176
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 177 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 155
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 208
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 209 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 170
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 223
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 224 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 123
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR---VYS 176
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 177 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 142
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 195
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 196 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 143
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R      
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR----VY 195
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +P  + R        + V+S G+++ +MV G
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 156
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 209
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 210 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 143
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 196
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 197 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 143
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 196
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 197 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 142
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 195
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 196 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 150
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R      
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR----VY 202
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +P  + R        + V+S G+++ +MV G
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 123
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR---VYS 176
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 177 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 156
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 209
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 210 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 170
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 223
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 224 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 41/267 (15%)
Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEF--INEVASMSKTSHVNVVSF--LG 148
           K+G+G +G VYK K  DG+      LK  +  G       E+A + +  H NV+S   + 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRK---LEWRTMCQIAVGIARGLEYLHR 205
             +  +K  L++++     L   I    +S  N+K   L    +  +   I  G+ YLH 
Sbjct: 88  LSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 206 GCNIRIVHFDIKPHNIL-LGEDFCP-----KISDFGLAKL-SEKKESFISMLGARGTIGY 258
                ++H D+KP NIL +GE   P     KI+D G A+L +   +    +     T  Y
Sbjct: 147 NW---VLHRDLKPANILVMGEG--PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 259 IAPEVFCRNFGGVSHKS---DVYSYGMMILEMVVGR-----KNAEVKVSLSSEIYFPNSI 310
            APE+      G  H +   D+++ G +  E++        +  ++K S         + 
Sbjct: 202 RAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS---------NP 248
Query: 311 YKHIEPGNEFQLAGVVTEEEKEMAKKM 337
           Y H +    F + G   +++ E  KKM
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKM 275

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 155
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 208
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 209 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 96/242 (39%), Gaps = 48/242 (19%)
Query: 94  LGQGGFGSVYKGKLPDGRLV-AVKVLKNSKV------NGEEFINEVASMSKTSHVNVVSF 146
           +GQG +G V        R + A+K++  +K+      + E    EV  M K  H N+   
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 147 LGFCYEKKKRALIYEFMPNG----SLDQFIYD---------------------EESSN-- 179
                +++   L+ E    G     L+ FI D                     EE+ N  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 180 ---INRKLEW----RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED--FCPK 230
                  L++    + +  I   I   L YLH   N  I H DIKP N L   +  F  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 231 ISDFGLAKLSEKKES--FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           + DFGL+K   K  +  +  M    GT  ++APEV          K D +S G+++  ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 289 VG 290
           +G
Sbjct: 271 MG 272

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 156
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 209
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 210 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 94  LGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           +G G FG   + + K     LVAVK ++  +   E    E+ +     H N+V F     
Sbjct: 27  IGSGNFGVARLMRDKQ-SNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEYLHRGCNI 209
                A++ E+   G L + I      N  R  + E R   Q  +    G+ Y H    +
Sbjct: 86  TPTHLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLIS---GVSYCHA---M 134
Query: 210 RIVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC-R 266
           ++ H D+K  N LL     P  KI  FG +K S       S +   GT  YIAPEV   +
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKK 191
Query: 267 NFGGVSHKSDVYSYGMMILEMVVG 290
            + G    +DV+S G+ +  M+VG
Sbjct: 192 EYDG--KVADVWSCGVTLYVMLVG 213

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 156
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 209
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 210 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 155
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 208
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 209 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 155
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R    Y 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR---VYS 208
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            PE + R        + V+S G+++ +MV G
Sbjct: 209 PPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 162
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R      
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR----VY 214
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +P  + R        + V+S G+++ +MV G
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       LE +
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQV-------LEAV 175
Query: 204 HRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
               N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R      
Sbjct: 176 RHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALL-KDTVYTDFDGTR----VY 227
Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +P  + R        + V+S G+++ +MV G
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 82  DVKRMTN-SFSNKLGQGGFGSVY----KGKLPDGRLVAVKVLKNSKVNGEEFIN----EV 132
           D  ++T+ +F   LG+G FG V     KG      L AVK+LK   V  ++ +     E 
Sbjct: 15  DRMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
             ++       ++ L  C++   R   + E++  G L   I       + R  E   +  
Sbjct: 72  RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFKEPHAVF- 125
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
            A  IA GL +L    +  I++ D+K  N++L  +   KI+DFG+ K  E     ++   
Sbjct: 126 YAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKX 180
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
             GT  YIAPE+      G S   D +++G+++ EM+ G+   E
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFE 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 119/265 (44%), Gaps = 44/265 (16%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVL-KNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           LG+G F    K       +  AVK++ K  + N ++ I  +       H N+V      +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE--GHPNIVKLHEVFH 76
Query: 152 EKKKRALIYEFMPNGSLDQFI------YDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           ++    L+ E +  G L + I       + E+S I RKL               + ++H 
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------------VSAVSHMH- 123
Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
             ++ +VH D+KP N+L     ++   KI DFG A+L  K      +     T+ Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPE 179
Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR---KNAEVKVSLSSEIYFPNSIYKHIEPGNE 319
           +  +N  G     D++S G+++  M+ G+   ++ +  ++ +S +     I K I+ G +
Sbjct: 180 LLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV----EIMKKIKKG-D 232
Query: 320 FQLAGV----VTEEEKEMAKKMILV 340
           F   G     V++E K++ + ++ V
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTV 257

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
           A  I    EYLH   ++ +++ D+KP N+L+ +    +++DFG AK  + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            GT   +APE+      G +   D ++ G++I EM  G
Sbjct: 200 -GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSH--VNV 143
           LG GGFGSVY G ++ D   VA+K ++  ++       NG     EV  + K S     V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 144 VSFLGFCYEKKKRALIYEFM-PNGSLDQFIYDEES--SNINRKLEWRTMCQIAVGIARGL 200
           +  L +        LI E M P   L  FI +  +    + R   W+            L
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV-----------L 124
Query: 201 EYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           E +    N  ++H DIK  NIL+    GE    K+ DFG   L  K   +    G R   
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALL-KDTVYTDFDGTR--- 177
Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
            Y  PE + R        + V+S G+++ +MV G
Sbjct: 178 VYSPPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 94  LGQGGFGSVYKG-KLPDGRLVAVKVLKNSK------VNGEEFINEVASMSKTSHVNVVSF 146
           +G+G F  V +      G+  AVK++  +K      ++ E+   E +      H ++V  
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 147 LGFCYEKKKRALIYEFMPNGSL---------DQFIYDEE-SSNINRKLEWRTMCQIAVGI 196
           L          +++EFM    L           F+Y E  +S+  R+            I
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ------------I 139
Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLG--EDFCP-KISDFGLAKLSEKKESFISMLGAR 253
              L Y H   +  I+H D+KP N+LL   E+  P K+ DFG+A   +  ES +   G  
Sbjct: 140 LEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRV 194
Query: 254 GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           GT  ++APEV  R   G     DV+  G+++  ++ G
Sbjct: 195 GTPHFMAPEVVKREPYG--KPVDVWGCGVILFILLSG 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 70  YVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEF 128
           Y+++  +RY  +++  + N    ++G G  G V+K +    G ++AVK ++ S  N EE 
Sbjct: 12  YLTIGGQRYQ-AEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEEN 67
Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLE--- 185
              +  +      +   ++  C+          F+ N   D FI  E       KL+   
Sbjct: 68  KRILMDLDVVLKSHDCPYIVQCFGT--------FITN--TDVFIAMELMGTCAEKLKKRM 117
Query: 186 -----WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA-KL 239
                 R + ++ V I + L YL     +  +H D+KP NILL E    K+ DFG++ +L
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 240 SEKKESFISMLGARGTIGYIAPEVF---CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            + K    S     G   Y+APE              ++DV+S G+ ++E+  G+
Sbjct: 176 VDDKAKDRSA----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 94  LGQGGFG--SVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           +G G FG   + + K     LVAVK ++  +   E    E+ +     H N+V F     
Sbjct: 27  IGSGNFGVARLMRDKQ-SNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINR--KLEWRTMCQIAVGIARGLEYLHRGCNI 209
                A++ E+   G L + I      N  R  + E R   Q  +    G+ Y H    +
Sbjct: 86  TPTHLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLIS---GVSYCHA---M 134
Query: 210 RIVHFDIKPHNILLGEDFCP--KISDFGLAKL----SEKKESFISMLGARGTIGYIAPEV 263
           ++ H D+K  N LL     P  KI  FG +K     S+ K++        GT  YIAPEV
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV-------GTPAYIAPEV 187
Query: 264 FC-RNFGGVSHKSDVYSYGMMILEMVVG 290
              + + G    +DV+S G+ +  M+VG
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVG 213

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 82  DVKRMTN-SFSNKLGQGGFGSVY----KGKLPDGRLVAVKVLKNSKVNGEEFIN----EV 132
           D  ++T+ +F   LG+G FG V     KG      L AVK+LK   V  ++ +     E 
Sbjct: 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEK 392
Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
             ++       ++ L  C++   R   + E++  G L   I       + R  E   +  
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFKEPHAVF- 446
Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
            A  IA GL +L    +  I++ D+K  N++L  +   KI+DFG+ K  E     ++   
Sbjct: 447 YAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKX 501
Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
             GT  YIAPE+      G S   D +++G+++ EM+ G+   E
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFE 543

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 39/262 (14%)
Query: 94  LGQGGFGSVYKGKLPDG-RLVAVKVLKNSKVNGEEFIN--EVASMSKTSHVNV------V 144
           +G+G FG V   K+ +  R+ A+K+L     N  E +   E A   +   V V      +
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKIL-----NKWEMLKRAETACFREERDVLVNGDCQWI 152
Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG-IARGLEY 202
           + L + ++ +    L+ ++   G L   +     S    KL    M +  +G +   ++ 
Sbjct: 153 TALHYAFQDENHLYLVMDYYVGGDLLTLL-----SKFEDKLP-EDMARFYIGEMVLAIDS 206
Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           +H+   +  VH DIKP N+LL  +   +++DFG + L    +  +    A GT  YI+PE
Sbjct: 207 IHQ---LHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPE 262
Query: 263 VFCR---NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE 319
           +        G    + D +S G+ + EM+ G    E      S +     I  H E    
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG----ETPFYAESLVETYGKIMNHEE---R 315
Query: 320 FQLAGVVT---EEEKEMAKKMI 338
           FQ    VT   EE K++ +++I
Sbjct: 316 FQFPSHVTDVSEEAKDLIQRLI 337
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	386
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-99
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-84
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-69
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-52
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-46
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-44
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-43
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-42
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-42
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-42
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-41
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-38
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-06
1qzv_F	154	Plant photosystem I: subunit PSAF; photosynthesis,	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  296 bits (761), Expect = 3e-99
 Identities = 104/297 (35%), Positives = 162/297 (54%), Gaps = 30/297 (10%)

Query: 75  PKRYNYSDVKRMTNSFS--NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE--EFIN 130
            KR++  +++  +++FS  N LG+GGFG VYKG+L DG LVAVK LK  +  G   +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 131 EVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMC 190
           EV  +S   H N++   GFC    +R L+Y +M NGS+   + +   S     L+W    
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP--LDWPKRQ 134

Query: 191 QIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML 250
           +IA+G ARGL YLH  C+ +I+H D+K  NILL E+F   + DFGLAKL + K++ ++  
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT- 193

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPNS 309
             RGTIG+IAPE      G  S K+DV+ YG+M+LE++ G++  ++    + + +   + 
Sbjct: 194 AVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 310 IYKHIEPGNEFQLA------GVVTEEEKEMAK--------------KMILVLEMLEG 346
           +   ++      L           EE +++ +              KM  V+ MLEG
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  263 bits (675), Expect = 3e-86
 Identities = 90/245 (36%), Positives = 134/245 (54%), Gaps = 12/245 (4%)

Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFS--NKLGQGGFGSVYKGKLPDG 110
           +     N   +A      V     R    D++  TN+F     +G G FG VYKG L DG
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 111 RLVAVKVLKNSKVNGE-EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD 169
             VA+K        G  EF  E+ ++S   H ++VS +GFC E+ +  LIY++M NG+L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123

Query: 170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP 229
           + +Y   S      + W    +I +G ARGL YLH      I+H D+K  NILL E+F P
Sbjct: 124 RHLYG--SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178

Query: 230 KISDFGLAKL-SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           KI+DFG++K  +E  ++ +S    +GT+GYI PE F +  G ++ KSDVYS+G+++ E++
Sbjct: 179 KITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVL 235

Query: 289 VGRKN 293
             R  
Sbjct: 236 CARSA 240

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  259 bits (663), Expect = 1e-84
 Identities = 84/239 (35%), Positives = 127/239 (53%), Gaps = 31/239 (12%)

Query: 72  SLAPKRYNYSDVKRMTNSFS--------NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV 123
                 +++ ++K +TN+F         NK+G+GGFG VYKG + +   VAVK L     
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67

Query: 124 NG-----EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESS 178
                  ++F  E+  M+K  H N+V  LGF  +     L+Y +MPNGSL   +   + +
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

Query: 179 NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
                L W   C+IA G A G+ +LH   +I   H DIK  NILL E F  KISDFGLA+
Sbjct: 128 ---PPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLAR 181

Query: 239 LS-EKKESFIS---MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKN 293
            S +  ++ ++   +    GT  Y+APE      G ++ KSD+YS+G+++LE++ G   
Sbjct: 182 ASEKFAQTVMTSRIV----GTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPA 233

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  218 bits (558), Expect = 6e-69
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 12/205 (5%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSF 146
              K+G G FG+V++ +   G  VAVK+L     +     EF+ EVA M +  H N+V F
Sbjct: 41  IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G   +    +++ E++  GSL + ++   +     +L+ R    +A  +A+G+ YLH  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLH-N 155

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            N  IVH ++K  N+L+ + +  K+ DFGL++   K  +F+S   A GT  ++APEV   
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
                + KSDVYS+G+++ E+   +
Sbjct: 214 E--PSNEKSDVYSFGVILWELATLQ 236

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  214 bits (548), Expect = 2e-67
 Identities = 65/224 (29%), Positives = 91/224 (40%), Gaps = 22/224 (9%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
                  +G FG V+K +      VAVK+         +   EV S+    H N++ F+G
Sbjct: 27  QLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85

Query: 149 FCYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                        LI  F   GSL  F+           + W  +C IA  +ARGL YLH
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLK-------ANVVSWNELCHIAETMARGLAYLH 138

Query: 205 -------RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
                   G    I H DIK  N+LL  +    I+DFGLA   E  +S     G  GT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 258 YIAPEVF---CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV 298
           Y+APEV             + D+Y+ G+++ E+      A+  V
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (526), Expect = 2e-64
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--------EEFI 129
             ++++     +  ++G+GGFG V+KG+ + D  +VA+K L      G        +EF 
Sbjct: 17  ADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 130 NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTM 189
            EV  MS  +H N+V   G         ++ EF+P G L   + D+        ++W   
Sbjct: 72  REVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK-----AHPIKWSVK 124

Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-----DFCPKISDFGLAKLSEKKE 244
            ++ + IA G+EY+    N  IVH D++  NI L         C K++DFGL++ S    
Sbjct: 125 LRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-- 181

Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
              S+ G  G   ++APE         + K+D YS+ M++  ++ G  
Sbjct: 182 ---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (522), Expect = 1e-63
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 20/215 (9%)

Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT 138
           +Y +++         +G+G FG V K K    + VA+K +++     + FI E+  +S+ 
Sbjct: 6   DYKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER-KAFIVELRQLSRV 58

Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           +H N+V   G C       L+ E+   GSL   ++  E                 +  ++
Sbjct: 59  NHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQ 113

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKKESFISMLGARGTIG 257
           G+ YLH      ++H D+KP N+LL       KI DFG A   +       M   +G+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAA 168

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
           ++APEVF  +    S K DV+S+G+++ E++  RK
Sbjct: 169 WMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRK 201

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  199 bits (508), Expect = 5e-62
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 24/219 (10%)

Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASM 135
           ++  +      F  KL +   G ++KG+   G  + VKVLK    +     +F  E   +
Sbjct: 8   DFKQLN-----FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 136 SKTSHVNVVSFLGFCYE--KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIA 193
              SH NV+  LG C         LI  +MP GSL   +++      N  ++     + A
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT----NFVVDQSQAVKFA 117

Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR 253
           + +ARG+ +LH      I    +   ++++ ED   +IS   +              G  
Sbjct: 118 LDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRM 169

Query: 254 GTIGYIAPEVFC-RNFGGVSHKSDVYSYGMMILEMVVGR 291
               ++APE    +        +D++S+ +++ E+V   
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  196 bits (501), Expect = 7e-61
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG-----EEFINEVASMSKTSHVNVV 144
               +G GGFG VY+     G  VAVK  ++          E    E    +   H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +  G C ++    L+ EF   G L++ +         +++    +   AV IARG+ YLH
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLH 122

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP--------KISDFGLAKLSEKKESFISMLGARGTI 256
               + I+H D+K  NIL+ +            KI+DFGLA+   +       + A G  
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAY 178

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            ++APEV        S  SDV+SYG+++ E++ G 
Sbjct: 179 AWMAPEVI--RASMFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (500), Expect = 1e-60
 Identities = 70/206 (33%), Positives = 110/206 (53%), Gaps = 15/206 (7%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGE---EFINEVASMSKTSHVNVVSF 146
              ++G G FG+VYKGK   G  VAVK+L  +    +    F NEV  + KT HVN++ F
Sbjct: 28  VGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G+     + A++ ++    SL   ++  E      K E + +  IA   ARG++YLH  
Sbjct: 86  MGYST-APQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA- 138

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC- 265
               I+H D+K +NI L ED   KI DFGLA    +           G+I ++APEV   
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
           ++    S +SDVY++G+++ E++ G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  192 bits (490), Expect = 1e-58
 Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 34/229 (14%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINE--VASMSKTSHVNVVSF 146
                +G+G +G+VYKG L D R VAVKV   S  N + FINE  +  +    H N+  F
Sbjct: 16  KLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 147 LGFCYE-----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           +          + +  L+ E+ PNGSL +++            +W + C++A  + RGL 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------HTSDWVSSCRLAHSVTRGLA 125

Query: 202 YLH------RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK------LSEKKESFISM 249
           YLH            I H D+   N+L+  D    ISDFGL+       L    E   + 
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 250 LGARGTIGYIAPEVF-----CRNFGGVSHKSDVYSYGMMILEMVVGRKN 293
           +   GTI Y+APEV       R+      + D+Y+ G++  E+ +   +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  190 bits (485), Expect = 5e-58
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSF 146
               +G+G FG VY G+   G  VA++++   + N    + F  EV +  +T H NVV F
Sbjct: 37  IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G C      A+I       +L   + D +       L+     QIA  I +G+ YLH  
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI---SMLGARGTIGYIAPEV 263
               I+H D+K  N+         I+DFGL  +S   ++      +    G + ++APE+
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 264 FCRNFGGV-------SHKSDVYSYGMMILEMVVGR 291
             +            S  SDV++ G +  E+    
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  184 bits (468), Expect = 2e-55
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 29/224 (12%)

Query: 79  NYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKN-SKVNGEEFINEVASMS 136
             SD+          LG+G FG   K      G ++ +K L    +     F+ EV  M 
Sbjct: 8   RPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62

Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
              H NV+ F+G  Y+ K+   I E++  G+L   I        + +  W      A  I
Sbjct: 63  CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDI 117

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE------------KKE 244
           A G+ YLH   N  I+H D+  HN L+ E+    ++DFGLA+L              KK 
Sbjct: 118 ASGMAYLHS-MN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV 288
                    G   ++APE+   N      K DV+S+G+++ E++
Sbjct: 175 DRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEII 216

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (469), Expect = 2e-55
 Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 29/255 (11%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
              ++G+G +G V+ GK   G  VAVKV   ++        E+       H N++ F+  
Sbjct: 41  MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 150 CYEKKKR----ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH- 204
             +         LI ++  NGSL  ++        +  L+ ++M ++A     GL +LH 
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-------STTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 205 ----RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGY 258
                     I H D+K  NIL+ ++    I+D GLA    S+  E  I      GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 259 IAPEVF-----CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH 313
           + PEV        +F      +D+YS+G+++ E+        V   +  E   P      
Sbjct: 213 MPPEVLDESLNRNHF-QSYIMADMYSFGLILWEVARR----CVSGGIVEEYQLPYHDLVP 267

Query: 314 IEPGNEFQLAGVVTE 328
            +P  E     V  +
Sbjct: 268 SDPSYEDMREIVCIK 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  177 bits (450), Expect = 5e-53
 Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 23/214 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
               +G+G +G V++G    G  VAVK+  +          E+ +     H N++ F+  
Sbjct: 12  LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 150 CYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH- 204
               +  +    LI  +   GSL  ++           L+  +  +I + IA GL +LH 
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQ-------LTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 205 ----RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGY 258
                     I H D+K  NIL+ ++    I+D GLA +      +  +      GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 259 IAPEVF----CRNFGGVSHKSDVYSYGMMILEMV 288
           +APEV       +      + D++++G+++ E+ 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 1e-52
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 23/214 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
               +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F+  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 150 CYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH- 204
             +         L+ ++  +GSL  ++           +    M ++A+  A GL +LH 
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 205 ----RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIGY 258
                     I H D+K  NIL+ ++    I+D GLA    S      I+     GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 259 IAPEVFCRNFGG----VSHKSDVYSYGMMILEMV 288
           +APEV   +          ++D+Y+ G++  E+ 
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  160 bits (407), Expect = 2e-46
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 25/228 (10%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKL--PDGRL---VAVKVLKN--SKVNGEEFINEVASM 135
           +K         LG G FG+VYKG       ++   VA+K L+   S    +E ++E   M
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
           +   + +V   LG C       LI + MP G L  ++ + +       +  + +    V 
Sbjct: 72  ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQ 125

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           IA+G+ YL      R+VH D+   N+L+      KI+DFGLAKL   +E      G +  
Sbjct: 126 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           I ++A E         +H+SDV+SYG+ + E++        G   +E+
Sbjct: 183 IKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  155 bits (393), Expect = 3e-44
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 25/228 (10%)

Query: 83  VKRMTNSFSNKLGQGGFGSVYKGKL--PDGRL---VAVKVLKN--SKVNGEEFINEVASM 135
           +K         LG G FG+VYKG       ++   VA+K L+   S    +E ++E   M
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 136 SKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
           +   + +V   LG C       LI + MP G L  ++ + +       +  + +    V 
Sbjct: 72  ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQ 125

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           IA+G+ YL    + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           I ++A E         +H+SDV+SYG+ + E++        G   +E+
Sbjct: 183 IKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  152 bits (387), Expect = 4e-44
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 18/215 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +   +LG G FG V  GK      VAVK++K   ++ +EF  E  +M K SH  +V F G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C ++    ++ E++ NG L  ++         + LE   + ++   +  G+ +L     
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES--- 122

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+  D C K+SDFG+ +     + ++S +G +  + + APEVF  ++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVF--HY 179

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
              S KSDV+++G+++ E+            N+EV
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  151 bits (384), Expect = 1e-43
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 18/215 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C E+    L+ EFM +G L  ++  +            T+  + + +  G+ YL     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEE--- 122

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
             ++H D+   N L+GE+   K+SDFG+ +     + + S  G +  + + +PEVF  +F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF--SF 179

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
              S KSDV+S+G+++ E+          R N+EV
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  151 bits (383), Expect = 3e-43
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 18/215 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           +F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH  +V   G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C +++   +I E+M NG L  ++ +        + + + + ++   +   +EYL     
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES--- 138

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            + +H D+   N L+ +    K+SDFGL++     E + S +G++  + +  PEV    +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVL--MY 195

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
              S KSD++++G+++ E+            N+E 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  152 bits (386), Expect = 3e-43
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 25/221 (11%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRL-----VAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
               LG G FG+V+KG            V +KV+++   + + +   + + ++    H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +V  LG C       L+ +++P GSL   +           L  + +    V IA+G+ Y
Sbjct: 77  IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYY 130

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           L       +VH ++   N+LL      +++DFG+A L    +  +    A+  I ++A E
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
               +FG  +H+SDV+SYG+ + E++        G + AEV
Sbjct: 188 SI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  150 bits (381), Expect = 5e-43
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 18/215 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
               +LG G FG V+ G       VAVK LK   ++ + F+ E   M +  H  +V    
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
               ++   +I E+M NGSL  F+          KL    +  +A  IA G+ ++     
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
              +H D++  NIL+ +    KI+DFGLA+L E  E + +  GA+  I + APE    N+
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NY 184

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           G  + KSDV+S+G+++ E+V        G  N EV
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (386), Expect = 1e-42
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)

Query: 89  SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLK--NSKVNGEEFINEVASMSKTSHVNVVS 145
               ++G+G FG V+ G+L  D  LVAVK  +         +F+ E   + + SH N+V 
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +G C +K+   ++ E +  G    F+  E       +L  +T+ Q+    A G+EYL  
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES 231

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
                 +H D+   N L+ E    KISDFG+++         S    +  + + APE   
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL- 287

Query: 266 RNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEVK 297
            N+G  S +SDV+S+G+++ E             N + +
Sbjct: 288 -NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  153 bits (388), Expect = 2e-42
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 18/220 (8%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
              KLG G FG V+         VAVK +K   ++ E F+ E   M    H  +V     
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              K+   +I EFM  GSL  F+  +E      K     +   +  IA G+ ++ +    
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---R 303

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             +H D++  NIL+      KI+DFGLA++ E  E + +  GA+  I + APE    NFG
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFG 360

Query: 270 GVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS 302
             + KSDV+S+G++++E+V        G  N EV  +L  
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  150 bits (380), Expect = 2e-42
 Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 23/229 (10%)

Query: 90  FSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLK--NSKVNGEEFINEVASMSKTSHVN 142
               LG+G FG V            G +VAVK LK      +   +  E+  +    H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 143 VVSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
           ++ + G C +    +  L+ E++P GSL  ++           +    +   A  I  G+
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PRHSIGLAQLLLFAQQICEGM 147

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
            YLH       +H D+   N+LL  D   KI DFGLAK + E  E +         + + 
Sbjct: 148 AYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMV-VGRKNAEVKVSLSSEIYFP 307
           APE  C       + SDV+S+G+ + E++     +          I   
Sbjct: 205 APE--CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  149 bits (378), Expect = 2e-42
 Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 24/251 (9%)

Query: 71  VSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLK--N 120
           +    K     D    ++        LG+G FG V   +        G  VAVK LK  +
Sbjct: 3   IVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62

Query: 121 SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESS 178
              +  +   E+  +    H N+V + G C E       LI EF+P+GSL +++   +  
Sbjct: 63  GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-- 120

Query: 179 NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
               K+  +   + AV I +G++YL      + VH D+   N+L+  +   KI DFGL K
Sbjct: 121 ---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174

Query: 239 -LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-VGRKNAEV 296
            +   KE +         + + APE  C         SDV+S+G+ + E++     ++  
Sbjct: 175 AIETDKEYYTVKDDRDSPVFWYAPE--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232

Query: 297 KVSLSSEIYFP 307
                  I   
Sbjct: 233 MALFLKMIGPT 243

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  148 bits (377), Expect = 2e-42
 Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 18/216 (8%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRL-VAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
           +  +KLG G +G VY+G      L VAVK LK   +  EEF+ E A M +  H N+V  L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G C  +    +I EFM  G+L  ++ +       +++    +  +A  I+  +EYL +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK-- 129

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
               +H D+   N L+GE+   K++DFGL++L    +++ +  GA+  I + APE     
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL--A 185

Query: 268 FGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           +   S KSDV+++G+++ E+         G   ++V
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 221

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  148 bits (377), Expect = 2e-42
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 24/217 (11%)

Query: 93  KLGQGGFGSVYKGKL--PDGRL-VAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFL 147
           +LG G FGSV +G       ++ VA+KVLK    K + EE + E   M +  +  +V  +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G C + +   L+ E    G L +F+  +       ++    + ++   ++ G++YL    
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE-- 128

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM-LGARGTIGYIAPEVFCR 266
               VH D+   N+LL      KISDFGL+K     +S+ +     +  + + APE    
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-- 185

Query: 267 NFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           NF   S +SDV+SYG+ + E +          K  EV
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  148 bits (376), Expect = 3e-42
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 90  FSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +        G +VAVK L+ +++ +  +F  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 144 VSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 128

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE F         I + A
Sbjct: 129 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           PE         S  SDV+S+G+++ E+ 
Sbjct: 186 PE--SLTESKFSVASDVWSFGVVLYELF 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (375), Expect = 5e-42
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 26/218 (11%)

Query: 93  KLGQGGFGSVYKGKLPDGRL---VAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSF 146
           +LG G FG+V KG     ++   VAVK+LKN        +E + E   M +  +  +V  
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G C E +   L+ E    G L++++        NR ++ + + ++   ++ G++YL   
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEE- 135

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM-LGARGTIGYIAPEVFC 265
                VH D+   N+LL      KISDFGL+K     E++       +  + + APE   
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI- 192

Query: 266 RNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
            N+   S KSDV+S+G+++ E          G K +EV
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  152 bits (386), Expect = 6e-42
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 18/221 (8%)

Query: 90  FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
             +KLG G +G VY+G        VAVK LK   +  EEF+ E A M +  H N+V  LG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            C  +    +I EFM  G+L  ++ +       +++    +  +A  I+  +EYL +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEK--- 336

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
              +H ++   N L+GE+   K++DFGL++L      + +  GA+  I + APE     +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESL--AY 393

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS 302
              S KSDV+++G+++ E+         G   ++V   L  
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (376), Expect = 8e-42
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 90  FSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLKNSKVNGE-EFINEVASMSKTSHVNV 143
           + ++LG+G FGSV   +        G LVAVK L++S  + + +F  E+  +       +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 144 VSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G  Y   +++  L+ E++P+G L  F+    +     +L+   +   +  I +G+E
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGME 141

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R VH D+   NIL+  +   KI+DFGLAK L   K+ ++     +  I + A
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           PE    +    S +SDV+S+G+++ E+ 
Sbjct: 199 PE--SLSDNIFSRQSDVWSFGVVLYELF 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (373), Expect = 9e-42
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 27/224 (12%)

Query: 89  SFSNKLGQGGFGSVYKG--KLPDGRL--VAVKVLK----NSKVNGEEFINEVASMSKTSH 140
               KLG G FG V +G    P G+   VAVK LK    +     ++FI EV +M    H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            N++   G         ++ E  P GSL   +   +           T+ + AV +A G+
Sbjct: 81  RNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGM 134

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYI 259
            YL      R +H D+   N+LL      KI DFGL + L +  + ++     +    + 
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           APE         SH SD + +G+ + EM        +G   +++
Sbjct: 192 APESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (373), Expect = 9e-42
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
           F  ++G+G F +VYKG        VA   L++ K+   E   F  E   +    H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 146 FLGFCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           F        K      L+ E M +G+L  ++         + ++ + +      I +GL+
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR------FKVMKIKVLRSWCRQILKGLQ 143

Query: 202 YLHRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           +LH      I+H D+K  NI + G     KI D GLA L     +  ++    GT  ++A
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AV---IGTPEFMA 198

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE++           DVY++GM +LEM    
Sbjct: 199 PEMYEE---KYDESVDVYAFGMCMLEMATSE 226

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  148 bits (375), Expect = 1e-41
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 90  FSNKLGQGGFGSVYKGKLP-----DGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNV 143
           F  +LG+G FGSV   +        G +VAVK L+ +++ +  +F  E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 144 VSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           V + G CY   +R   LI E++P GSL  ++   +      +++   + Q    I +G+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGME 159

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL      R +H D+   NIL+  +   KI DFGL K L + KE +         I + A
Sbjct: 160 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMV 288
           PE         S  SDV+S+G+++ E+ 
Sbjct: 217 PE--SLTESKFSVASDVWSFGVVLYELF 242

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (371), Expect = 1e-41
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)

Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
                +G+G FG V++G    P+     VA+K  KN  S    E+F+ E  +M +  H +
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +V  +G    +    +I E    G L  F+   +       L+  ++   A  ++  L Y
Sbjct: 78  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAY 131

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           L      R VH DI   N+L+  + C K+ DFGL++  E    + +    +  I ++APE
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPE 187

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
               NF   +  SDV+ +G+ + E++        G KN +V
Sbjct: 188 SI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  145 bits (369), Expect = 3e-41
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 25/221 (11%)

Query: 89  SFSNKLGQGGFGSVYKGKL--PDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
             +  LG+G FG VY+G      G    VAVK  K   +  N E+F++E   M    H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           +V  +G   E++   +I E  P G L  ++   +       L+  T+   ++ I + + Y
Sbjct: 75  IVKLIGII-EEEPTWIIMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAY 128

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           L     I  VH DI   NIL+    C K+ DFGL++  E ++ +      R  I +++PE
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPE 184

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
               NF   +  SDV+ + + + E++          +N +V
Sbjct: 185 SI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (379), Expect = 3e-41
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 18/220 (8%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
              KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H  +V     
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              ++   ++ E+M  GSL  F+  E      + L    +  +A  IA G+ Y+ R   +
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---M 299

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + APE     +G
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAA--LYG 356

Query: 270 GVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS 302
             + KSDV+S+G+++ E+         G  N EV   +  
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  146 bits (370), Expect = 5e-41
 Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 25/222 (11%)

Query: 90  FSNKLGQGGFGSVYKG--KLPDGR---LVAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
               +G G FG VYKG  K   G+    VA+K LK   ++    +F+ E   M + SH N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           ++   G   + K   +I E+M NG+LD+F+ +++      +     +  +  GIA G++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKY 162

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAP 261
           L     +  VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + AP
Sbjct: 163 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           E    ++   +  SDV+S+G+++ E++           N EV
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (380), Expect = 6e-41
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 18/220 (8%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
              KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H  +V     
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              ++   ++ E+M  GSL  F+  E      + L    +  +A  IA G+ Y+ R   +
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---M 382

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + APE     +G
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAA--LYG 439

Query: 270 GVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS 302
             + KSDV+S+G+++ E+         G  N EV   +  
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  146 bits (370), Expect = 2e-40
 Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 24/222 (10%)

Query: 89  SFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVN 142
           S    +G G FG V  G  KLP  +   VA+K LK   ++    +F+ E + M +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           ++   G   + K   ++ E+M NGSLD F+   +      +     +  +  GIA G++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKY 162

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAP 261
           L     +  VH D+   NIL+  +   K+SDFGL + L +  E+  +  G +  I + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           E     +   +  SDV+SYG+++ E++           N +V
Sbjct: 220 EAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  144 bits (366), Expect = 2e-40
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 24/221 (10%)

Query: 90  FSNKLGQGGFGSVYKGKL--PDGR--LVAVKVLKN--SKVNGEEFINEVASMSKTSHVNV 143
               +G G  G V  G+L  P  R   VA+K LK   ++    +F++E + M +  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +   G     +   ++ E+M NGSLD F+   +      +     +  +  G+  G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYL 167

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
                +  VH D+   N+L+  +   K+SDFGL++ L +  ++  +  G +  I + APE
Sbjct: 168 SD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
                F   S  SDV+S+G+++ E++           N +V
Sbjct: 225 AI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  143 bits (362), Expect = 4e-40
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 26/228 (11%)

Query: 85  RMTNSFSNKLGQGGFGSVYKGKLPDGR----LVAVKVLKN--SKVNGEEFINEVASMSKT 138
           R+       +G+G FG VY G+  D        A+K L         E F+ E   M   
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79

Query: 139 SHVNVVSFLGFCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           +H NV++ +G     +    +   +M +G L QFI   +     R    + +    + +A
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVA 134

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT-- 255
           RG+EYL      + VH D+   N +L E F  K++DFGLA+    +E +           
Sbjct: 135 RGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           + + A E         + KSDV+S+G+++ E++             ++
Sbjct: 192 VKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  149 bits (377), Expect = 4e-40
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)

Query: 93  KLGQGGFGSVYKGKL--PDGRL-VAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFL 147
           +LG G FGSV +G       ++ VA+KVLK    K + EE + E   M +  +  +V  +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G C + +   L+ E    G L +F+  +       ++    + ++   ++ G++YL    
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE-- 454

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM-LGARGTIGYIAPEVFCR 266
               VH ++   N+LL      KISDFGL+K     +S+ +     +  + + APE    
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-- 511

Query: 267 NFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           NF   S +SDV+SYG+ + E +          K  EV
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  143 bits (362), Expect = 5e-40
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 24/227 (10%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGR----LVAVKVLKN---SKVNGEEFINEVASMSKTSHV 141
                LG+G FGSV +G L         VAVK +K    S+   EEF++E A M   SH 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 142 NVVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           NV+  LG C E   +      +I  FM  G L  ++         + +  +T+ +  V I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           A G+EYL    N   +H D+   N +L +D    ++DFGL+K     + +     A+  +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
            +IA E         + KSDV+++G+ + E+         G +N E+
Sbjct: 214 KWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  143 bits (362), Expect = 7e-40
 Identities = 59/228 (25%), Positives = 104/228 (45%), Gaps = 25/228 (10%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDG----RLVAVKVLK---NSKVNGEEFINEVASMSKTSHV 141
           +    LG+G FGSV + +L         VAVK+LK    +  + EEF+ E A M +  H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 142 NVVSFLGFCYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
           +V   +G     + +       +I  FM +G L  F+           L  +T+ +  V 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           IA G+EYL    +   +H D+   N +L ED    ++DFGL++     + +     ++  
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
           + ++A E         +  SDV+++G+ + E++        G +NAE+
Sbjct: 203 VKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (355), Expect = 3e-39
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 24/216 (11%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
                +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG
Sbjct: 24  KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG 81

Query: 149 FCYEKKKRALI-YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              E+K    I  E+M  GSL  ++           L    + + ++ +   +EYL    
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG-- 135

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
               VH D+   N+L+ ED   K+SDFGL K +   +        +  + + APE     
Sbjct: 136 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--R 187

Query: 268 FGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
               S KSDV+S+G+++ E+              +V
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  140 bits (355), Expect = 9e-39
 Identities = 58/258 (22%), Positives = 112/258 (43%), Gaps = 31/258 (12%)

Query: 65  AFIRNYVSLAPKRYNYSDVK---RMTNSFSNKLGQGGFGSVYKGKLPDGR------LVAV 115
           + ++ ++   P+ ++ + V    R       +LG+G FG V+  +  +        LVAV
Sbjct: 17  SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76

Query: 116 KVLKN-SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF--- 171
           K LK  S+   ++F  E   ++   H ++V F G C E +   +++E+M +G L++F   
Sbjct: 77  KALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136

Query: 172 ------IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE 225
                 +           L    +  +A  +A G+ YL     +  VH D+   N L+G+
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQ 193

Query: 226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMIL 285
               KI DFG+++     + +         I ++ PE     +   + +SDV+S+G+++ 
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLW 251

Query: 286 EMVV-------GRKNAEV 296
           E+            N E 
Sbjct: 252 EIFTYGKQPWYQLSNTEA 269

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (354), Expect = 1e-38
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 24/226 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGR------LVAVKVLKN--SKVNGEEFINEVASMSKTSHV 141
            S +LGQG FG VY+G             VA+K +    S     EF+NE + M + +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFI----YDEESSNINRKLEWRTMCQIAVGIA 197
           +VV  LG   + +   +I E M  G L  ++        ++ +        M Q+A  IA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
            G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   + + +         + 
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
           +++PE      G  +  SDV+S+G+++ E+         G  N +V
Sbjct: 206 WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  139 bits (352), Expect = 1e-38
 Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 28/232 (12%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGR----LVAVKVLKN--SKVNGEEFINEVASM 135
               +   F+  +G+G FG VY G L D        AVK L          +F+ E   M
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80

Query: 136 SKTSHVNVVSFLGFCYEKKKRAL-IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
              SH NV+S LG C   +   L +  +M +G L  FI +E           + +    +
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGL 135

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            +A+G++YL    + + VH D+   N +L E F  K++DFGLA+    KE + S+    G
Sbjct: 136 QVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY-SVHNKTG 191

Query: 255 T---IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
               + ++A E         + KSDV+S+G+++ E++             ++
Sbjct: 192 AKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  138 bits (349), Expect = 2e-38
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 30/233 (12%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLKN--SKVNGEEFINEVASMSKTSH 140
            F  +LG+  FG VYKG L           VA+K LK+       EEF +E    ++  H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLEWRTMC 190
            NVV  LG   + +  ++I+ +  +G L +F             ++   +   LE     
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 191 QIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML 250
            +   IA G+EYL       +VH D+   N+L+ +    KISD GL +     + +  + 
Sbjct: 132 HLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            +   I ++APE     +G  S  SD++SYG+++ E+         G  N +V
Sbjct: 189 NSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (365), Expect = 3e-38
 Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 33/297 (11%)

Query: 21  IVILVILLLVGLRHIRKKKTENDQNDFG-FGRFRKKNTENENAEAAFIRNYVSLAPKRYN 79
              LV           +K+ E             K+   +     +   +Y  +  +   
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT 376

Query: 80  YSD-------VKRMTNSFSNKLGQGGFGSVYKG--KLPDGR--LVAVKVLKN--SKVNGE 126
           Y+        ++R        +G+G FG V++G    P+     VA+K  KN  S    E
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436

Query: 127 EFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEW 186
           +F+ E  +M +  H ++V  +G    +    +I E    G L  F+   +       L+ 
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK-----FSLDL 490

Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF 246
            ++   A  ++  L YL      R VH DI   N+L+  + C K+ DFGL++  E   ++
Sbjct: 491 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTY 546

Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
                 +  I ++APE    NF   +  SDV+ +G+ + E++        G KN +V
Sbjct: 547 YKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (358), Expect = 3e-38
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 24/221 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
               +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG 
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 150 CYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             E+K    ++ E+M  GSL  ++     S +        + + ++ +   +EYL     
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLEG--- 307

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
              VH D+   N+L+ ED   K+SDFGL K +   +        +  + + APE      
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--RE 360

Query: 269 GGVSHKSDVYSYGMMILEMVV-------GRKNAEVKVSLSS 302
              S KSDV+S+G+++ E+              +V   +  
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  137 bits (347), Expect = 9e-38
 Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 31/245 (12%)

Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLK 119
           NYV + P +  Y       R   SF   LG G FG V +              VAVK+LK
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62

Query: 120 NSKVNGE--EFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----- 171
            S    E    ++E+  +S   +H+N+V+ LG C       +I E+   G L  F     
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122

Query: 172 -------IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG 224
                         +    L+   +   +  +A+G+ +L        +H D+   NILL 
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179

Query: 225 EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMM 283
                KI DFGLA+  +   +++    AR  + ++APE +F   +   + +SDV+SYG+ 
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY---TFESDVWSYGIF 236

Query: 284 ILEMV 288
           + E+ 
Sbjct: 237 LWELF 241

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  137 bits (347), Expect = 1e-37
 Identities = 60/239 (25%), Positives = 112/239 (46%), Gaps = 26/239 (10%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDG---RLVAVKVLKN--S 121
             ++    P    Y  +      F + +G+G FG V K ++         A+K +K   S
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65

Query: 122 KVNGEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF--------- 171
           K +  +F  E+  + K   H N+++ LG C  +    L  E+ P+G+L  F         
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125

Query: 172 -IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK 230
                 +++    L  + +   A  +ARG++YL      + +H D+   NIL+GE++  K
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 182

Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMV 288
           I+DFGL++    +E ++     R  + ++A E +    +   +  SDV+SYG+++ E+V
Sbjct: 183 IADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV 235

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  136 bits (345), Expect = 1e-37
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 29/232 (12%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLKN-SKVNGEEFINEVASMSKTSHV 141
               +LG+G FG V+  +  +        LVAVK LK+ +    ++F  E   ++   H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLEWRTMCQ 191
           ++V F G C +     +++E+M +G L++F          + D +      +L    M  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLG 251
           IA  IA G+ YL        VH D+   N L+G +   KI DFG+++     + +     
Sbjct: 138 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
               I ++ PE     +   + +SDV+S+G+++ E+            N EV
Sbjct: 195 TMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (350), Expect = 1e-37
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 26/231 (11%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPDGR----LVAVKVLKN--SKVNGEEFINEVASM 135
               +   F+  +G+G FG VY G L D        AVK L          +F+ E   M
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144

Query: 136 SKTSHVNVVSFLGFCYEKKK-RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
              SH NV+S LG C   +    ++  +M +G L  FI +E           + +    +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGL 199

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
            +A+G+++L    + + VH D+   N +L E F  K++DFGLA+    KE          
Sbjct: 200 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

Query: 255 T--IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
              + ++A E         + KSDV+S+G+++ E++             ++
Sbjct: 257 KLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (343), Expect = 2e-37
 Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 42/271 (15%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            LGQG FG V K +   D R  A+K +++++      ++EV  ++  +H  VV +     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 152 EK----------KKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           E+          KK++ ++   E+  NG+L   I   E+ N  R   WR   QI      
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQIL----E 127

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR----- 253
            L Y+H   +  I+H D+KP NI + E    KI DFGLAK   +    + +         
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 254 -------GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF 306
                  GT  Y+A EV     G  + K D+YS G++  EM+        +V++  ++  
Sbjct: 185 DNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL-- 241

Query: 307 PNSIYKHIEPGNEFQLAGVVTEEEKEMAKKM 337
                + +             + EK++ + +
Sbjct: 242 -----RSVSIEFPPDFDDNKMKVEKKIIRLL 267

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  135 bits (342), Expect = 3e-37
 Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 39/232 (16%)

Query: 89  SFSNKLGQGGFGSVYKGKL--------PDGRLVAVKVLKNSKVNG-EEFINEVASMSKTS 139
            F+  LGQG F  ++KG               V +KVL  +  N  E F    + MSK S
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           H ++V   G C    +  L+ EF+  GSLD ++   ++      +      ++A  +A  
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAA 125

Query: 200 LEYLHRGCNIRIVHFDIKPHNILL--------GEDFCPKISDFGLAKLSEKKESFISMLG 251
           + +L       ++H ++   NILL        G     K+SD G++     K+       
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------I 176

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMV-------VGRKNAEV 296
            +  I ++ PE    N   ++  +D +S+G  + E+            +   
Sbjct: 177 LQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  136 bits (344), Expect = 4e-37
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 27/241 (11%)

Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLK 119
           +Y  + P +  Y++     R    F   LG G FG V +              VAVK+LK
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85

Query: 120 NSKVNGE--EFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----- 171
           ++    E    ++E+  MS    H N+V+ LG C       +I E+   G L  F     
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145

Query: 172 ---IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC 228
                D   +  N     R +   +  +A+G+ +L        +H D+   N+LL     
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202

Query: 229 PKISDFGLAKLSEKKESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEM 287
            KI DFGLA+      ++I    AR  + ++APE +F   +   + +SDV+SYG+++ E+
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI 259

Query: 288 V 288
            
Sbjct: 260 F 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (341), Expect = 7e-37
 Identities = 66/256 (25%), Positives = 108/256 (42%), Gaps = 28/256 (10%)

Query: 60  ENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGR------LV 113
            N    F     S++  +    +V R   +    LG G FG VY+G++           V
Sbjct: 8   HNPNYCFAGKTSSISDLK----EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV 63

Query: 114 AVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF 171
           AVK L    S+ +  +F+ E   +SK +H N+V  +G   +   R ++ E M  G L  F
Sbjct: 64  AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123

Query: 172 IYDEE-SSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDF 227
           + +     +    L    +  +A  IA G +YL        +H DI   N LL   G   
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR 180

Query: 228 CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM 287
             KI DFG+A+   +   +     A   + ++ PE F    G  + K+D +S+G+++ E+
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEI 238

Query: 288 VV-------GRKNAEV 296
                     + N EV
Sbjct: 239 FSLGYMPYPSKSNQEV 254

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  133 bits (337), Expect = 2e-36
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
            LG+GGFG V++ K   D    A+K   L N ++  E+ + EV +++K  H  +V +   
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 150 CYEK---------KKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
             EK           +  +Y   +     +L  ++          + E      I + IA
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQIA 128

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR---- 253
             +E+LH   +  ++H D+KP NI    D   K+ DFGL    ++ E   ++L       
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 254 ------GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV 289
                 GT  Y++PE    N    SHK D++S G+++ E++ 
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (334), Expect = 5e-36
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 13/202 (6%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           LG+G +G VY G+ L +   +A+K + +      +    E+A      H N+V +LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
           E     +  E +P GSL   +    S     K   +T+      I  GL+YLH     +I
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143

Query: 212 VHFDIKPHNILLG-EDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
           VH DIK  N+L+       KISDFG +K L+       +     GT+ Y+APE+  +   
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGPR 200

Query: 270 GVSHKSDVYSYGMMILEMVVGR 291
           G    +D++S G  I+EM  G+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  131 bits (332), Expect = 7e-36
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 32/230 (13%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF- 149
             +G GGFG V+K K   DG+   +K +K +    E+   EV +++K  HVN+V + G  
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCW 73

Query: 150 ------------CYEKKKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
                          + K   ++   EF   G+L+Q+I       +++ L      QI  
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT- 132

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG 254
              +G++Y+H   + ++++ D+KP NI L +    KI DFGL    +            G
Sbjct: 133 ---KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---G 183

Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI 304
           T+ Y++PE           + D+Y+ G+++ E++     A       +++
Sbjct: 184 TLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  131 bits (332), Expect = 1e-35
 Identities = 56/209 (26%), Positives = 82/209 (39%), Gaps = 28/209 (13%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEE---FINEVASMSK-TSHVNVVSFL 147
           +LG G +G V+K     DGRL AVK   +     ++    + EV S  K   H   V   
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 148 GFCYEKKKRALIY-EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
              +E+     +  E     SL Q             L    +          L +LH  
Sbjct: 124 Q-AWEEGGILYLQTELC-GPSLQQHCEAW-----GASLPEAQVWGYLRDTLLALAHLH-- 174

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL---SEKKESFISMLGARGTIGYIAPEV 263
            +  +VH D+KP NI LG     K+ DFGL      +   E         G   Y+APE+
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRYMAPEL 227

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
              ++G     +DV+S G+ ILE+    +
Sbjct: 228 LQGSYG---TAADVFSLGLTILEVACNME 253

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (334), Expect = 1e-35
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLG 148
           K+G+G FG     K   DGR   +K +  S+++ +E      EVA ++   H N+V +  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              E     ++ ++   G L + I  ++              QI       L+++H    
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC----LALKHVHDR-- 144

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPEVF 264
            +I+H DIK  NI L +D   ++ DFG+A++     E   + I      GT  Y++PE+ 
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI------GTPYYLSPEI- 196

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           C N    ++KSD+++ G ++ E+   +
Sbjct: 197 CEN-KPYNNKSDIWALGCVLYELCTLK 222

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (334), Expect = 2e-35
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 24/227 (10%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLKN--SKVNGEEFINEVASMSKTSH 140
           +    LG G FG VY+G++           VAVK L    S+ +  +F+ E   +SK +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE-SSNINRKLEWRTMCQIAVGIARG 199
            N+V  +G   +   R ++ E M  G L  F+ +     +    L    +  +A  IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 200 LEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
            +YL        +H DI   N LL   G     KI DFG+A+   +   +     A   +
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
            ++ PE F    G  + K+D +S+G+++ E+          + N EV
Sbjct: 251 KWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (330), Expect = 2e-35
 Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 28/242 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
           KLG+GGF  V   + L DG   A+K +L + + + EE   E       +H N++  + +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 151 YEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
             ++       L+  F   G+L   I  E   +    L    +  + +GI RGLE +H  
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA-------RGTIGYI 259
                 H D+KP NILLG++  P + D G    +                   R TI Y 
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 260 APEVF-CRNFGGVSHKSDVYSYGMMILEMVVGR--------KNAEVKVSLSSEIYFP-NS 309
           APE+F  ++   +  ++DV+S G ++  M+ G         K   V +++ +++  P + 
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP 270

Query: 310 IY 311
            +
Sbjct: 271 RH 272

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (331), Expect = 2e-35
 Identities = 64/247 (25%), Positives = 96/247 (38%), Gaps = 23/247 (9%)

Query: 50  GRFRKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK-LP 108
            + ++   E E+ E   +   +      Y   +V  MT     ++G+G FG V++ K   
Sbjct: 25  AKLQRLGPETEDNEGVLLTEKLKPVDYEYR-EEVHWMT--HQPRVGRGSFGEVHRMKDKQ 81

Query: 109 DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL 168
            G   AVK ++      EE    + + +  S   +V   G   E     +  E +  GSL
Sbjct: 82  TGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC 228
            Q I           L              GLEYLH     RI+H D+K  N+LL  D  
Sbjct: 138 GQLI------KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGS 188

Query: 229 P-KISDFGLAKLSEKKESFISMLGA---RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMI 284
              + DFG A   +      S+L      GT  ++APEV          K D++S   M+
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMM 246

Query: 285 LEMVVGR 291
           L M+ G 
Sbjct: 247 LHMLNGC 253

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  131 bits (331), Expect = 3e-35
 Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 36/250 (14%)

Query: 69  NYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLK 119
            Y  +  + Y Y       R    F   LG G FG V                VAVK+LK
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84

Query: 120 N--SKVNGEEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----- 171
                   E  ++E+  M++  SH N+V+ LG C       LI+E+   G L  +     
Sbjct: 85  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144

Query: 172 ------------IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPH 219
                           E       L +  +   A  +A+G+E+L        VH D+   
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201

Query: 220 NILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE-VFCRNFGGVSHKSDVY 278
           N+L+      KI DFGLA+      +++    AR  + ++APE +F   +   + KSDV+
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY---TIKSDVW 258

Query: 279 SYGMMILEMV 288
           SYG+++ E+ 
Sbjct: 259 SYGILLWEIF 268

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (329), Expect = 3e-35
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFL 147
           K+G+G F  VY+   L DG  VA+K ++   +       + I E+  + + +H NV+ + 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
               E  +  ++ E    G L + I  +      R +  RT+ +  V +   LE++H   
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIAPEV 263
             R++H DIKP N+ +      K+ D GL +     +    S +      GT  Y++PE 
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV------GTPYYMSPER 207

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                 G + KSD++S G ++ EM   +
Sbjct: 208 -IHE-NGYNFKSDIWSLGCLLYEMAALQ 233

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  130 bits (329), Expect = 5e-35
 Identities = 56/237 (23%), Positives = 111/237 (46%), Gaps = 35/237 (14%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGR--------LVAVKVLKN--SKVNGEEFINEVASMSK- 137
           +    LG+G FG V   +              VAVK+LK+  ++ +  + ++E+  M   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLEWR 187
             H N+++ LG C +     +I E+   G+L ++             + +     ++ ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 248 SMLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
                R  + ++APE +F R +   +H+SDV+S+G+++ E+         G    E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (330), Expect = 7e-35
 Identities = 56/236 (23%), Positives = 109/236 (46%), Gaps = 35/236 (14%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGR--------LVAVKVLK--NSKVNGEEFINEVASMSK-T 138
               LG+G FG V   +              VAVK+LK   ++ +  + ++E+  M    
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L ++             + +     ++ ++ 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +      +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+     + +  
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
               R  + ++APE +F R +   +H+SDV+S+G+++ E+         G    E+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (333), Expect = 7e-35
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFL 147
              + LG G  G++    + D R VAVK +     +  +   EV  + ++  H NV+ + 
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYF 84

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
               +++ + +  E     +L +++  ++ +++  +     + Q       GL +LH   
Sbjct: 85  CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP-ITLLQQ----TTSGLAHLH--- 135

Query: 208 NIRIVHFDIKPHNILLGE-----DFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAP 261
           ++ IVH D+KPHNIL+            ISDFGL K L+  + SF    G  GT G+IAP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 262 EVFCRNF-GGVSHKSDVYSYGMMILEMVVG 290
           E+   +     ++  D++S G +   ++  
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  130 bits (328), Expect = 9e-35
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 38/241 (15%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLKN--SKVNGEEFINEVASMSKTSH 140
            +   +G+G FG V++ + P         +VAVK+LK   S     +F  E A M++  +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQF------------------IYDEESSNINR 182
            N+V  LG C   K   L++E+M  G L++F                       SS    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
            L       IA  +A G+ YL      + VH D+   N L+GE+   KI+DFGL++    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAE 295
            + + +       I ++ PE     +   + +SDV++YG+++ E+         G  + E
Sbjct: 227 ADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284

Query: 296 V 296
           V
Sbjct: 285 V 285

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  128 bits (324), Expect = 1e-34
 Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 38/224 (16%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTS-HVNVVSFL 147
           K+G G FGSV+K  K  DG + A+K  K       +    + EV + +    H +VV + 
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 148 GFCYEKKKRALIY-EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
              + +    LI  E+   GSL   I   E+  I    +   +  + + + RGL Y+H  
Sbjct: 78  S-AWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132

Query: 207 CNIRIVHFDIKPHNILLGEDFCP-------------------KISDFGLAKLSEKKESFI 247
            ++ +VH DIKP NI +     P                   KI D G        +   
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                 G   ++A EV  +       K+D+++  + ++      
Sbjct: 192 ------GDSRFLANEV-LQENYTHLPKADIFALALTVVCAAGAE 228

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (325), Expect = 1e-34
 Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 41/263 (15%)

Query: 70  YVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKLPDGR------LVAVKVLKN 120
            +S+   +          R        LG+G FG V K      +       VAVK+LK 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63

Query: 121 --SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF------- 171
             S     + ++E   + + +H +V+   G C +     LI E+   GSL  F       
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 172 -----------IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN 220
                                R L    +   A  I++G++YL     +++VH D+   N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARN 180

Query: 221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSY 280
           IL+ E    KISDFGL++   +++S++     R  + ++A E         + +SDV+S+
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVWSF 238

Query: 281 GMMILEMVV-------GRKNAEV 296
           G+++ E+V        G     +
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPERL 261

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (322), Expect = 2e-34
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 14/207 (6%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLG 148
            +G G +G   K +   DG+++  K L    +   E    ++EV  + +  H N+V +  
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 149 FCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-- 204
              ++    L  + E+   G L   I   + +   + L+   + ++   +   L+  H  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                 ++H D+KP N+ L      K+ DFGLA++     SF       GT  Y++PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGTPYYMSPEQ- 187

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                  + KSD++S G ++ E+    
Sbjct: 188 MNR-MSYNEKSDIWSLGCLLYELCALM 213

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  130 bits (328), Expect = 2e-34
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 33/236 (13%)

Query: 89  SFSNKLGQGGFGSVYKGKLPD--------GRLVAVKVLKN--SKVNGEEFINEVASMSK- 137
                LG+G FG V   +              VAVK+LK+  ++ +  + I+E+  M   
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 138 TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQF----------IYDEESSNINRKLEWR 187
             H N+++ LG C +     +I E+   G+L ++               S N   +L  +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI 247
            +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + + 
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-------GRKNAEV 296
                R  + ++APE         +H+SDV+S+G+++ E+         G    E+
Sbjct: 249 KTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (324), Expect = 2e-34
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 89  SFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKN--SKVNGEEFINEVASMSK-TS 139
                LG+G FG V +            R VAVK+LK   +       ++E+  +     
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 140 HVNVVSFLGFCYEKKK-RALIYEFMPNGSLDQF----------IYDEESSNINRKLEWRT 188
           H+NVV+ LG C +      +I EF   G+L  +                      L    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+   K   ++ 
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 249 MLGARGTIGYIAPE-VFCRNFGGVSHKSDVYSYGMMILEMV 288
              AR  + ++APE +F R +   + +SDV+S+G+++ E+ 
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIF 244

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (322), Expect = 2e-34
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 93  KLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVS 145
           KLG GG  +VY  +  D      VA+K +       EE +     EV + S+ SH N+VS
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +    E     L+ E++   +L ++I        +  L   T       I  G+++ H 
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIES------HGPLSVDTAINFTNQILDGIKHAHD 129

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEVF 264
              +RIVH DIKP NIL+  +   KI DFG+AK     E+ ++      GT+ Y +PE  
Sbjct: 130 ---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQA 184

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                     +D+YS G+++ EM+VG 
Sbjct: 185 KG--EATDECTDIYSIGIVLYEMLVGE 209

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (323), Expect = 2e-34
 Identities = 41/214 (19%), Positives = 89/214 (41%), Gaps = 25/214 (11%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSH--VNVVSF 146
            ++G GG   V++      ++ A+K +   + + +    + NE+A ++K       ++  
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
             +    +   ++ E   N  L+ ++         + ++          +   +  +H+ 
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKK------KKSIDPWERKSYWKNMLEAVHTIHQ- 145

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-- 264
               IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+ Y+ PE    
Sbjct: 146 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 265 -------CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                   ++   +S KSDV+S G ++  M  G+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (321), Expect = 8e-34
 Identities = 46/215 (21%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSH--VNVVSF 146
            ++G GG   V++      ++ A+K +   + + +    + NE+A ++K       ++  
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN-RKLEWRTMCQIAVGIARGLEYLHR 205
             +    +   ++ E   N  L+ ++  ++S +   RK  W+ M +        +  +H+
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIHQ 126

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                IVH D+KP N L+ +    K+ DFG+A   +   + +      GT+ Y+ PE   
Sbjct: 127 ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 265 --------CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                    ++   +S KSDV+S G ++  M  G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (319), Expect = 8e-34
 Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 25/211 (11%)

Query: 93  KLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVS 145
            LG GG   V+  +  D    R VAVKVL+        F      E  + +  +H  +V+
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 146 FLGFCYEKKKRALIY----EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
                  +     +     E++   +L   ++ E        +  +   ++     + L 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALN 130

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIA 260
           + H+     I+H D+KP NI++      K+ DFG+A+      + ++   A  GT  Y++
Sbjct: 131 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE        V  +SDVYS G ++ E++ G 
Sbjct: 188 PEQARG--DSVDARSDVYSLGCVLYEVLTGE 216

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  130 bits (329), Expect = 2e-33
 Identities = 64/309 (20%), Positives = 113/309 (36%), Gaps = 56/309 (18%)

Query: 93  KLGQGGFGSVYKGK---LPDGRLVAVKVLKNSKVNGEE-----FINEVASMSKTSHVNVV 144
            +  GG G +Y      + +GR V +K L +S   G+       + E   +++  H ++V
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 145 SFL--GFCYEKKKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
                    ++    + Y   E++   SL +           +KL         + I   
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--------GQKLPVAEAIAYLLEILPA 194

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           L YLH    I +V+ D+KP NI+L E+   K+ D G                  GT G+ 
Sbjct: 195 LSYLHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY------GTPGFQ 244

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK--NAEVKVSL---SSEIYFPNSIYKHI 314
           APE+  R   G +  +D+Y+ G  +  + +     N      L      +   +S  + +
Sbjct: 245 APEI-VR--TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301

Query: 315 ------EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPRRSAQQ 368
                 +P   F  A        EM+ ++  VL  +      +  P   ++ SP RS   
Sbjct: 302 RRAIDPDPRQRFTTAE-------EMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFG 354

Query: 369 SPPASLSTE 377
                  T+
Sbjct: 355 VDLLVAHTD 363

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (315), Expect = 3e-33
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 28/220 (12%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSHVNVVS 145
             S+ LGQG   +V++G+    G L A+KV  N          + E   + K +H N+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 146 FLGFCYEKKKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRT-MCQIAVGIARGLE 201
                 E+          EF P GSL   + +  ++    + E+   +  +      G+ 
Sbjct: 72  LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMN 126

Query: 202 YLHRGCNIRIVHFDIKPHNILLG----EDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           +L       IVH +IKP NI+           K++DFG A+  E  E F+S+    GT  
Sbjct: 127 HLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEE 180

Query: 258 YIAPEVFCRNFGGV------SHKSDVYSYGMMILEMVVGR 291
           Y+ P+++ R               D++S G+       G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  124 bits (314), Expect = 6e-33
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 38/212 (17%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGF 149
            K+G+G  G V   +    GR VAVK++   K    E + NEV  M    H NVV     
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 150 CYEKKKRALIYEFMPNGSL----DQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEY 202
               ++  ++ EF+  G+L     Q   +EE              QIA     + + L Y
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEE--------------QIATVCEAVLQALAY 156

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGY 258
           LH      ++H DIK  +ILL  D   K+SDFG  A++S+   K++S +      GT  +
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYW 207

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           +APEV  R+    + + D++S G+M++EMV G
Sbjct: 208 MAPEVISRS--LYATEVDIWSLGIMVIEMVDG 237

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  125 bits (316), Expect = 8e-33
 Identities = 45/215 (20%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSH--VNVVSF 146
            ++G GG   V++      ++ A+K +   + + +    + NE+A ++K       ++  
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN-RKLEWRTMCQIAVGIARGLEYLHR 205
             +    +   ++ E   N  L+ ++  ++S +   RK  W+ M +        +  +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIHQ 173

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF- 264
                IVH D+KP N L+ +    K+ DFG+A   +   + +      G + Y+ PE   
Sbjct: 174 ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 265 --------CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                    ++   +S KSDV+S G ++  M  G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (311), Expect = 1e-32
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 40/213 (18%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
            K+GQG  G+VY    +  G+ VA++ +    +   E  INE+  M +  + N+V++L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD- 84

Query: 150 CYEKKKRA-LIYEFMPNGSL----DQFIYDEESSNINRKLEWRTMCQIAV---GIARGLE 201
            Y       ++ E++  GSL     +   DE               QIA       + LE
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------------QIAAVCRECLQALE 130

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIG 257
           +LH   + +++H DIK  NILLG D   K++DFG  A+++    K+ + +      GT  
Sbjct: 131 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPY 181

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           ++APEV  R       K D++S G+M +EM+ G
Sbjct: 182 WMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEG 212

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (309), Expect = 2e-32
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLK-NSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
            +LG G FG VYK K    G L A KV++  S+   E++I E+  ++   H  +V  LG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYLHRG 206
            Y   K  ++ EF P G++D  I  E    +          QI V    +   L +LH  
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEP-------QIQVVCRQMLEALNFLH-- 134

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPE 262
            + RI+H D+K  N+L+  +   +++DFG+ AK  +   K++SFI      GT  ++APE
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPE 187

Query: 263 VFCRNF---GGVSHKSDVYSYGMMILEMVVG 290
           V            +K+D++S G+ ++EM   
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 2e-32
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 31/210 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+G F  VY+ + +  G  VA+K++    +      +   NEV    +  H +++    
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIARGLEYLHR 205
           +  +     L+ E   NG +         + +    E      M QI      G+ YLH 
Sbjct: 79  YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQII----TGMLYLHS 130

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR----GTIGYIAP 261
                I+H D+   N+LL  +   KI+DFGLA   +                GT  YI+P
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK------HYTLCGTPNYISP 181

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           E+  R+      +SDV+S G M   +++GR
Sbjct: 182 EIATRS--AHGLESDVWSLGCMFYTLLIGR 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 3e-32
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 18/203 (8%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++        + A K++  S +      E+   E++     +H +VV F G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           F  +     ++ E     SL     +       + L           I  G +YLHR   
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRR--KALTEPEARYYLRQIVLGCQYLHRN-- 160

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            R++H D+K  N+ L ED   KI DFGLA   E       +L   GT  YIAPEV  +  
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKK- 216

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
            G S + DV+S G ++  ++VG+
Sbjct: 217 -GHSFEVDVWSIGCIMYTLLVGK 238

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (308), Expect = 3e-32
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 30/208 (14%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
            KLG+G +GSVYK      G++VA+K +     + +E I E++ M +    +VV + G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYG-S 92

Query: 151 YEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYLHRG 206
           Y K     ++ E+   GS+   I    +  +          +IA       +GLEYLH  
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTED-------EIATILQSTLKGLEYLH-- 142

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPE 262
             +R +H DIK  NILL  +   K++DFG+  +L++   K+ + I      GT  ++APE
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPE 195

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V      G +  +D++S G+  +EM  G
Sbjct: 196 VIQE--IGYNCVADIWSLGITAIEMAEG 221

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 5e-32
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 18/203 (8%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           LG+GGF   ++        + A K++  S +      E+   E++     +H +VV F G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           F  +     ++ E     SL     +       + L           I  G +YLHR   
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKRR--KALTEPEARYYLRQIVLGCQYLHR--- 133

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            R++H D+K  N+ L ED   KI DFGLA   E       +L   GT  YIAPEV  +  
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKK- 190

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
            G S + DV+S G ++  ++VG+
Sbjct: 191 -GHSFEVDVWSIGCIMYTLLVGK 212

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (309), Expect = 5e-32
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSF 146
            ++G G FG+VY  + + +  +VA+K +    K S    ++ I EV  + K  H N + +
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 147 LGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEY 202
            G CY ++  A L+ E+    + D  + +     +          +IA    G  +GL Y
Sbjct: 120 RG-CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEV-------EIAAVTHGALQGLAY 169

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH   +  ++H D+K  NILL E    K+ DFG A +     SF+      GT  ++APE
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPE 220

Query: 263 V-FCRNFGGVSHKSDVYSYGMMILEMVVG 290
           V    + G    K DV+S G+  +E+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (307), Expect = 6e-32
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 36/217 (16%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFC 150
            +G G +G VYKG+ +  G+L A+KV+  +    EE   E+  + K S H N+ ++ G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG-A 89

Query: 151 YEKKKRA-------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGL 200
           + KK          L+ EF   GS+   I + + + +  +        IA     I RGL
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE-------WIAYICREILRGL 142

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTI 256
            +LH     +++H DIK  N+LL E+   K+ DFG+ A+L     ++ +FI      GT 
Sbjct: 143 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTP 193

Query: 257 GYIAPEVFCRNFGGVS---HKSDVYSYGMMILEMVVG 290
            ++APEV   +    +    KSD++S G+  +EM  G
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  122 bits (308), Expect = 9e-32
 Identities = 42/211 (19%), Positives = 81/211 (38%), Gaps = 18/211 (8%)

Query: 92  NKLGQG--GFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---INEVASMSKTSHVNVVS 145
             +G+G     +V   +  P G  V V+ +     + E       E+      +H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           +        +  ++  FM  GS    I     ++    +    +  I  G+ + L+Y+H 
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFG----LAKLSEKKESFISMLGAR-GTIGYIA 260
              +  VH  +K  +IL+  D    +S       +    +++             + +++
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV  +N  G   KSD+YS G+   E+  G 
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  120 bits (303), Expect = 1e-31
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---INEVA-SMSKTSHVNVVSF 146
            +LG+G +G V K + +P G+++AVK +  + VN +E    + ++  SM        V+F
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G  + +    +  E M + SLD+F   ++  +  + +    + +IAV I + LE+LH  
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS- 127

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKL--SEKKESFISMLGARGTIGYIAPEV 263
             + ++H D+KP N+L+      K+ DFG+   L     K+         G   Y+APE 
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA------GCKPYMAPER 180

Query: 264 FCRNFGGV--SHKSDVYSYGMMILEMVVGR 291
                     S KSD++S G+ ++E+ + R
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR 210

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (303), Expect = 1e-31
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 27/206 (13%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           K+G+G FG V+KG      ++VA+K+  L+ ++   E+   E+  +S+     V  + G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG- 87

Query: 150 CYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
            Y K  +  +I E++  GS    +           L+   +  I   I +GL+YLH   +
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLE-------PGPLDETQIATILREILKGLDYLH---S 137

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE---KKESFISMLGARGTIGYIAPEVF 264
            + +H DIK  N+LL E    K++DFG+  +L++   K+ +F+      GT  ++APEV 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 191

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVG 290
            +       K+D++S G+  +E+  G
Sbjct: 192 KQ--SAYDSKADIWSLGITAIELARG 215

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (306), Expect = 1e-31
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 23/206 (11%)

Query: 92  NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEF---INEVASMSKTSHVNVVSFL 147
           ++LG G  G V+K    P G ++A K++ + ++        I E+  + + +   +V F 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G  Y   + ++  E M  GSLDQ +          ++  + + ++++ + +GL YL    
Sbjct: 98  GAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLRE-- 149

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA-KLSE-KKESFISMLGARGTIGYIAPEVFC 265
             +I+H D+KP NIL+      K+ DFG++ +L +    SF+      GT  Y++PE   
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ 203

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
                 S +SD++S G+ ++EM VGR
Sbjct: 204 GT--HYSVQSDIWSMGLSLVEMAVGR 227

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (308), Expect = 1e-31
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 28/220 (12%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSHVNVVS 145
             S+ LGQG   +V++G+    G L A+KV  N          + E   + K +H N+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 146 FLGFCYEKKKRALIY---EFMPNGSLDQFIYDEESSNINRKLEWRT-MCQIAVGIARGLE 201
                 E+          EF P GSL   + +  ++    + E+   +  +      G+ 
Sbjct: 72  LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMN 126

Query: 202 YLHRGCNIRIVHFDIKPHNILLG----EDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
           +L       IVH +IKP NI+           K++DFG A+  E  E F+S+    GT  
Sbjct: 127 HLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEE 180

Query: 258 YIAPEVFCRNFGGVSH------KSDVYSYGMMILEMVVGR 291
           Y+ P+++ R      H        D++S G+       G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  120 bits (302), Expect = 1e-31
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 30/210 (14%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSF 146
             LG+G FG+VY  +      ++A+KVL  +++       +   EV   S   H N++  
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G+ ++  +  LI E+ P G++    Y E       K + +        +A  L Y H  
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKL--SKFDEQRTATYITELANALSYCHS- 127

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-----GTIGYIAP 261
              R++H DIKP N+LLG     KI+DFG +  +           +R     GT+ Y+ P
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---------SSRRTDLCGTLDYLPP 176

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           E+          K D++S G++  E +VG+
Sbjct: 177 EMIEGR--MHDEKVDLWSLGVLCYEFLVGK 204

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 3e-31
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
            +G G    V      P    VA+K   L+  + + +E + E+ +MS+  H N+VS+   
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV---GIARGLEYLHRG 206
              K +  L+ + +  GS+   I     +    K        IA     +  GLEYLH+ 
Sbjct: 82  FVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGL-AKLSE--------KKESFISMLGARGTIG 257
                +H D+K  NILLGED   +I+DFG+ A L+          +++F+      GT  
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTPC 191

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           ++APEV  +   G   K+D++S+G+  +E+  G 
Sbjct: 192 WMAPEVMEQV-RGYDFKADIWSFGITAIELATGA 224

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  123 bits (310), Expect = 3e-31
 Identities = 62/253 (24%), Positives = 104/253 (41%), Gaps = 34/253 (13%)

Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTN--SFSNKLGQGGFGSVYKGK-LPD 109
              +  +   E  + +  +   P  +  S    ++       KLG G +G V   +    
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 110 GRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG 166
               A+K+++ + V+       + EVA +    H N++    F  +K+   L+ E    G
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 167 SLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNI 221
            L   I     ++E                I   +  G+ YLH      IVH D+KP N+
Sbjct: 122 ELFDEIIHRMKFNE-----------VDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENL 167

Query: 222 LL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVY 278
           LL    +D   KI DFGL+ + E ++     L   GT  YIAPEV  + +     K DV+
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVLRKKYD---EKCDVW 221

Query: 279 SYGMMILEMVVGR 291
           S G+++  ++ G 
Sbjct: 222 SIGVILFILLAGY 234

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 3e-31
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 31/221 (14%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFI------------------NEVAS 134
            L QG F  +   +  D +  A+K  + S +  +                     NE+  
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 135 MSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
           ++   +   ++  G      +  +IYE+M N S+    +DE    +++        Q+  
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI--LKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 195 GIAR----GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML 250
            I +       Y+H   NI   H D+KP NIL+ ++   K+SDFG ++    K+    + 
Sbjct: 155 CIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IK 208

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           G+RGT  ++ PE F         K D++S G+ +  M    
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (307), Expect = 3e-31
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 36/227 (15%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLG 148
               LG G  G+V       GR VAVK +       +  + E+  ++++  H NV+ +  
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESDDHPNVIRYYC 76

Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                +   +  E   N +L   +      DE             + Q    IA G+ +L
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ----IASGVAHL 131

Query: 204 HRGCNIRIVHFDIKPHNILL-------------GEDFCPKISDFGLAK-LSEKKESFISM 249
           H   +++I+H D+KP NIL+              E+    ISDFGL K L   + SF + 
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 250 LGAR-GTIGYIAPEVFCRNFGGVSHKS-----DVYSYGMMILEMVVG 290
           L    GT G+ APE+   +    + +      D++S G +   ++  
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  119 bits (300), Expect = 6e-31
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---INEVA-SMSKTSHVNVVSFL 147
           ++G+G +GSV K    P G+++AVK +  S V+ +E    + ++   M  +    +V F 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G  + +    +  E M + S D+  Y    S ++  +    + +I +   + L +L    
Sbjct: 88  GALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-- 143

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGL-AKL--SEKKESFISMLGARGTIGYIAPEVF 264
           N++I+H DIKP NILL      K+ DFG+  +L  S  K          G   Y+APE  
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA------GCRPYMAPERI 197

Query: 265 --CRNFGGVSHKSDVYSYGMMILEMVVGR 291
               +  G   +SDV+S G+ + E+  GR
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR 226

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  120 bits (302), Expect = 3e-30
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 33/216 (15%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNV 143
                LG+G FG V   K    G+  AVKV+   +V  +      + EV  + +  H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIAR 198
           +    F  +K    L+ E    G L   I     + E               +I   +  
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-----------VDAARIIRQVLS 137

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           G+ Y+H     +IVH D+KP N+LL    +D   +I DFGL+   E  +     +   GT
Sbjct: 138 GITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GT 191

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             YIAPEV    +     K DV+S G+++  ++ G 
Sbjct: 192 AYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGC 224

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (296), Expect = 3e-30
 Identities = 40/249 (16%), Positives = 81/249 (32%), Gaps = 24/249 (9%)

Query: 90  FSNKLGQGGFGSVYKGK------LPDGRLVAVKVLKNSKVNGEEFINEVAS-MSKTSHVN 142
             + LG+G F  VY+          + +   +KV K +         ++   +  +    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
            + F      +    L+ E    G+L   I +   +   + +    +   A+ +   +E 
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCP-----------KISDFGLAKLSEKKESFISMLG 251
           +H   +  I+H DIKP N +LG  F              + D G +   +          
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIY 311
              T G+   E+        +++ D +     +  M+ G            +        
Sbjct: 245 KCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302

Query: 312 KHIEPGNEF 320
            H++  NEF
Sbjct: 303 PHLDMWNEF 311

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (301), Expect = 5e-30
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVV 144
           +    LG+G FG V K K     +  AVKV+  +    ++    + EV  + K  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 145 SFLGFCYEKKKRALIYEFMPNGSL-----DQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
                  +     ++ E    G L      +  + E               +I   +  G
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----------HDAARIIKQVFSG 133

Query: 200 LEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           + Y+H      IVH D+KP NILL    +D   KI DFGL+   ++       +G   T 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG---TA 187

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            YIAPEV    +     K DV+S G+++  ++ G 
Sbjct: 188 YYIAPEVLRGTYD---EKCDVWSAGVILYILLSGT 219

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (292), Expect = 6e-30
 Identities = 47/220 (21%), Positives = 84/220 (38%), Gaps = 49/220 (22%)

Query: 93  KLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVNGEEFI----NEVASMSKTSHVNVVS 145
            +G+GG G VY+ +  D    R+VA+K++  +  +   F      E  +  +    +VV 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 146 FLGFCYEKKKRALIY-------------EFMPNGSLDQFIYDEESSNINRKLEWRTMCQI 192
                        I+               +    L   +  +        L       I
Sbjct: 99  -------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ------GPLAPPRAVAI 139

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
              I   L+  H        H D+KP NIL+  D    + DFG+A  +   +  ++ LG 
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGN 194

Query: 253 R-GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             GT+ Y+APE F       ++++D+Y+   ++ E + G 
Sbjct: 195 TVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGS 232

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 8e-30
 Identities = 30/275 (10%), Positives = 66/275 (24%), Gaps = 39/275 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVL----KNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
           L  G    V+  + +      A+KV     +NS+   E       + ++    +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 149 FC-----------------------YEKKKRALIYEFMP--NGSLDQFI-YDEESSNINR 182
                                     +    A     MP  +  L+      +       
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 183 KLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK 242
                 +  +   + R    L       +VH    P N+ +  D    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS 302
           +    S       + Y   E    +    +H  + +  G+ I  +        +      
Sbjct: 247 RGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKM 337
             +   S+         F     + +  K +  + 
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  114 bits (288), Expect = 1e-29
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 30/208 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLG 148
           LG+G FG+VY  +   +  ++A+KVL  S++       +   E+   S   H N++    
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
           + +++K+  L+ EF P G L    Y E   +   + + +        +A  L Y H    
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL----YKELQKH--GRFDEQRSATFMEELADALHYCHE--- 132

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-----GTIGYIAPEV 263
            +++H DIKP N+L+G     KI+DFG +  +            R     GT+ Y+ PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---------SLRRRTMCGTLDYLPPEM 183

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                     K D++  G++  E +VG 
Sbjct: 184 IEGK--THDEKVDLWCAGVLCYEFLVGM 209

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  117 bits (296), Expect = 2e-29
 Identities = 68/226 (30%), Positives = 92/226 (40%), Gaps = 43/226 (19%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--------------EEFINEVA 133
               KLG G +G V   K        A+KV+K S+ +               EE  NE++
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 134 SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI----YDEESSNINRKLEWRT 188
            +    H N++       +KK   L+ EF   G L +Q I    +DE             
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE-----------CD 147

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKES 245
              I   I  G+ YLH      IVH DIKP NILL         KI DFGL+    K   
Sbjct: 148 AANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
               L   GT  YIAPEV  + +     K DV+S G+++  ++ G 
Sbjct: 205 LRDRL---GTAYYIAPEVLKKKYN---EKCDVWSCGVIMYILLCGY 244

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  113 bits (285), Expect = 4e-29
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 36/230 (15%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTN--SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV 123
           + ++   +  R N           +    LG+G FG V K K     +  AVKV+  +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 124 NGEE---FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL-DQFI----YDE 175
             ++    + EV  + K  H N++       +     ++ E    G L D+ I    + E
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 176 -ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKI 231
            +++ I ++            +  G+ Y+H      IVH D+KP NILL    +D   KI
Sbjct: 121 HDAARIIKQ------------VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKI 165

Query: 232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
            DFGL+   ++       +   GT  YIAPEV    +     K DV+S G
Sbjct: 166 IDFGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTYD---EKCDVWSAG 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (283), Expect = 2e-28
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 25/220 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEFINEVASMSK-TSHVNVVSFLGF 149
            L +GGF  VY+ + +  GR  A+K +L N +      I EV  M K + H N+V F   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 150 CYEKKKRA-------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
               K+ +       L+   +  G L +F+   ES      L   T+ +I     R +++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQH 151

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA---------KLSEKKESFISMLGAR 253
           +HR     I+H D+K  N+LL      K+ DFG A           S ++ + +     R
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 254 -GTIGYIAPEVF-CRNFGGVSHKSDVYSYGMMILEMVVGR 291
             T  Y  PE+    +   +  K D+++ G ++  +   +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (279), Expect = 2e-28
 Identities = 43/203 (21%), Positives = 76/203 (37%), Gaps = 32/203 (15%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE-FINEVASMSKTSHVNVVSFL 147
             N +G+G +G V            A K +    V   + F  E+  M    H N++   
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARGLE 201
               +     L+ E    G L + +     + E +++ I +             +   + 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD------------VLSAVA 120

Query: 202 YLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           Y H    + + H D+KP N L      D   K+ DFGLA   +  +   + +   GT  Y
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYY 174

Query: 259 IAPEVFCRNFGGVSHKSDVYSYG 281
           ++P+V    +G    + D +S G
Sbjct: 175 VSPQVLEGLYG---PECDEWSAG 194

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 3e-28
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 17/199 (8%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVS 145
            F  KLG G FG V+  +    G    +K +   +     E+   E+  +    H N++ 
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
                 +     ++ E    G L + I    +    + L    + ++   +   L Y H 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERI--VSAQARGKALSEGYVAELMKQMMNALAYFH- 141

Query: 206 GCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
             +  +VH D+KP NIL          KI DFGLA+L +  E   +     GT  Y+APE
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPE 196

Query: 263 VFCRNFGGVSHKSDVYSYG 281
           VF R+      K D++S G
Sbjct: 197 VFKRDVT---FKCDIWSAG 212

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 4e-28
 Identities = 32/240 (13%), Positives = 66/240 (27%), Gaps = 52/240 (21%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE------------------------- 127
           LGQ    +  +      G    V V   ++                              
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 128 ----FINEVASMSKTSHVNVVSFLGFC--YEKKKRALIYEFMPNGSLDQFIYDEESSNIN 181
               FI     +       ++             R  +Y  M +            S+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 182 RKLEWRTMCQIAVGIARGLEYLH-RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS 240
           + L      Q+ + + R L  LH  G    +VH  ++P +I+L +     ++ F      
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 241 EKKESFISMLGARGTIGYIAPEVFCRNFG---------GVSHKSDVYSYGMMILEMVVGR 291
             +           + G+  PE+  R             ++   D ++ G++I  +    
Sbjct: 257 GARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  110 bits (278), Expect = 5e-28
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 32/203 (15%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFL 147
           F   LG G F  V+  K    G+L A+K +K S    +  + NE+A + K  H N+V+  
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARGLE 201
                     L+ + +  G L   I     Y E ++S + ++            +   ++
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------------VLSAVK 120

Query: 202 YLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           YLH      IVH D+KP N+L     E+    I+DFGL+K+ +       M  A GT GY
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGY 173

Query: 259 IAPEVFCRNFGGVSHKSDVYSYG 281
           +APEV  +     S   D +S G
Sbjct: 174 VAPEVLAQK--PYSKAVDCWSIG 194

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  109 bits (276), Expect = 6e-28
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 33/205 (16%)

Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
              +LG+G F  V +      G   A K++   K++  +      E     K  H N+V 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARG 199
                 E+    L+++ +  G L + I     Y E ++S+  ++            I   
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------------ILES 117

Query: 200 LEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           + Y H   +  IVH ++KP N+LL    +    K++DFGLA      E++       GT 
Sbjct: 118 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTP 171

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYG 281
           GY++PEV  ++        D+++ G
Sbjct: 172 GYLSPEVLKKDPYS--KPVDIWACG 194

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (281), Expect = 8e-28
 Identities = 30/234 (12%), Positives = 66/234 (28%), Gaps = 41/234 (17%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINE--------------------- 131
           LGQ    +  +      G    V V   ++      I +                     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 132 -----VASMSKTSHVNVVSFLGFCYEKKKRALIYEFM----PNGSLDQFI-YDEESSNIN 181
                +              +    +++   ++  F        +L  F       S+ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 182 RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE 241
           + L      Q+ + + R L  LH      +VH  ++P +I+L +     ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 242 KKESFISMLGAR-GTIGYIAPEVFCRNFGG---VSHKSDVYSYGMMILEMVVGR 291
              S +S +G         A  +          ++   D ++ G+ I  +    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (277), Expect = 1e-27
 Identities = 54/247 (21%), Positives = 83/247 (33%), Gaps = 48/247 (19%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG------EEFINEVASMSKTSHVN 142
               +GQG +G V          + A+K++  +K+        E    EV  M K  H N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG------- 195
           +        +++   L+ E    G L   +      +  +        QI          
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 196 ---------------------------IARGLEYLHRGCNIRIVHFDIKPHNILLG--ED 226
                                      I   L YLH   N  I H DIKP N L    + 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206

Query: 227 FCPKISDFGLAKL--SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMI 284
           F  K+ DFGL+K         +  M    GT  ++APEV          K D +S G+++
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 285 LEMVVGR 291
             +++G 
Sbjct: 267 HLLLMGA 273

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (283), Expect = 2e-27
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 27/216 (12%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSF 146
              +LG GGFG V +      G  VA+K  +      N E +  E+  M K +H NVVS 
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 147 LGFCYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRT-MCQIAVGIARG 199
                  +K A      L  E+   G L +++   E+    ++   RT +  I+      
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS----SA 133

Query: 200 LEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           L YLH     RI+H D+KP NI+L    +    KI D G AK  ++ E     +   GT+
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTL 187

Query: 257 GYIAPEVF-CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            Y+APE+   + +       D +S+G +  E + G 
Sbjct: 188 QYLAPELLEQKKYT---VTVDYWSFGTLAFECITGF 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (276), Expect = 3e-27
 Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 37/246 (15%)

Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSN------KLGQGGFGSVYKGK 106
            K   + +  +      +     K+Y    V+    S  +      +LG G FG V++  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 107 -LPDGRLVAVKVLKNSKVNG-EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP 164
               GR+   K +            NE++ M++  H  +++      +K +  LI EF+ 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 165 NGSL------DQFIYDE-ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIK 217
            G L      + +   E E  N       R  C+       GL+++H      IVH DIK
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINY-----MRQACE-------GLKHMH---EHSIVHLDIK 176

Query: 218 PHNILLG--EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKS 275
           P NI+    +    KI DFGLA      E          T  + APE+   +   V   +
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV--DREPVGFYT 231

Query: 276 DVYSYG 281
           D+++ G
Sbjct: 232 DMWAIG 237

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  109 bits (274), Expect = 3e-27
 Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 30/203 (14%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFL 147
             +  LG+G FG V++       +    K +K    +      E++ ++   H N++   
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 148 GFCYEKKKRALIYEFMPNGSL------DQFIYDE-ESSNINRKLEWRTMCQIAVGIARGL 200
                 ++  +I+EF+    +        F  +E E  +         + Q    +   L
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQ----VCEAL 115

Query: 201 EYLHRGCNIRIVHFDIKPHNILLG--EDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           ++LH   +  I HFDI+P NI+         KI +FG A+  +  ++F  +        Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEY 169

Query: 259 IAPEVFCRNFGGVSHKSDVYSYG 281
            APEV       VS  +D++S G
Sbjct: 170 YAPEVH--QHDVVSTATDMWSLG 190

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (275), Expect = 4e-27
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 27/241 (11%)

Query: 54  KKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNK--------LGQGGFGSVYKG 105
            +    ++   + +   +   P  +++  V     + ++         LG G FG V+K 
Sbjct: 49  TERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108

Query: 106 K-LPDGRLVAVKVLKNSKVNG-EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM 163
           +    G  +A K++K   +   EE  NE++ M++  H N++        K    L+ E++
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168

Query: 164 PNGSL-DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL 222
             G L D+ I  +ES N+        M Q    I  G+ ++H    + I+H D+KP NIL
Sbjct: 169 DGGELFDRII--DESYNLTELDTILFMKQ----ICEGIRHMH---QMYILHLDLKPENIL 219

Query: 223 LG--EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSY 280
               +    KI DFGLA+  + +E         GT  ++APEV   +F  VS  +D++S 
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDF--VSFPTDMWSV 274

Query: 281 G 281
           G
Sbjct: 275 G 275

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  107 bits (270), Expect = 6e-27
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 38/211 (18%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-------EEFINEVASMSKTSH 140
               +LG G F  V K +    G+  A K +K  +++        EE   EV  + +  H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEES------SNINRKLEWRTMCQIAV 194
            N+++       K    LI E +  G L  F+ ++ES      +          + Q   
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--------LKQ--- 116

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISML 250
            I  G+ YLH     RI HFD+KP NI+L      +   K+ DFG+A   E    F ++ 
Sbjct: 117 -ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
              GT  ++APE+   N+  +  ++D++S G
Sbjct: 173 ---GTPEFVAPEIV--NYEPLGLEADMWSIG 198

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (271), Expect = 7e-27
 Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 26/210 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF---INEVA-SMSKTSHVNVVSFL 147
           ++G G  G V+K +    G ++AVK +     N EE    + ++   +       +V   
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G         +  E M     ++         +   +  R + ++ V I + L YL    
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLKK-----RMQGPIPERILGKMTVAIVKALYYLKE-- 142

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGL-AKL--SEKKESFISMLGARGTIGYIAPEVF 264
              ++H D+KP NILL E    K+ DFG+  +L   + K+         G   Y+APE  
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA------GCAAYMAPERI 196

Query: 265 ---CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                       ++DV+S G+ ++E+  G+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (271), Expect = 7e-27
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 20/197 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHV-NVVSFL 147
           +LG+G F  V +      G+  A K LK  +       E ++E+A +        V++  
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                  +  LI E+   G +      E +  ++     R + QI  G+     YLH   
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV----YYLH--- 148

Query: 208 NIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
              IVH D+KP NILL         KI DFG+++          ++   GT  Y+APE+ 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYLAPEIL 205

Query: 265 CRNFGGVSHKSDVYSYG 281
             N+  ++  +D+++ G
Sbjct: 206 --NYDPITTATDMWNIG 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  107 bits (270), Expect = 8e-27
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 38/211 (18%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-------EEFINEVASMSKTSH 140
               +LG G F  V K +    G   A K +K  +          EE   EV+ + +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSL-----DQFIYDE-ESSNINRKLEWRTMCQIAV 194
            NV++       +    LI E +  G L      +    E E+++         + Q   
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQ--- 123

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISML 250
            I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++ 
Sbjct: 124 -ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
              GT  ++APE+   N+  +  ++D++S G
Sbjct: 180 ---GTPEFVAPEIV--NYEPLGLEADMWSIG 205

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  110 bits (277), Expect = 9e-27
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 23/239 (9%)

Query: 53  RKKNTENENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSN------KLGQGGFGSVYKGK 106
           + K    +   ++   NYV    K+Y    V+   +   +      +LG G FG V++  
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177

Query: 107 -LPDGRLVAVKVLKNSKVNGEEFI-NEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP 164
               G   A K +     + +E +  E+ +MS   H  +V+      +  +  +IYEFM 
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237

Query: 165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG 224
            G L + + DE +  ++       M Q    + +GL ++H       VH D+KP NI+  
Sbjct: 238 GGELFEKVADEHNK-MSEDEAVEYMRQ----VCKGLCHMH---ENNYVHLDLKPENIMFT 289

Query: 225 --EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
                  K+ DFGL    + K+S        GT  + APEV       V + +D++S G
Sbjct: 290 TKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA--EGKPVGYYTDMWSVG 343

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  107 bits (270), Expect = 2e-26
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 33/205 (16%)

Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVS 145
              +LG+G F  V +      G   A K++   K++  +      E     K  H N+V 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARG 199
                 E+    L+++ +  G L + I     Y E ++S+  ++            I   
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------------ILES 140

Query: 200 LEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           + Y H   +  IVH ++KP N+LL    +    K++DFGLA      E++       GT 
Sbjct: 141 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTP 194

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYG 281
           GY++PEV  ++    S   D+++ G
Sbjct: 195 GYLSPEVLKKD--PYSKPVDIWACG 217

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (270), Expect = 2e-26
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 38/211 (18%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-------EEFINEVASMSKTSH 140
               +LG G F  V K +    G   A K +K  +          EE   EV+ + +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSL-----DQFIYDE-ESSNINRKLEWRTMCQIAV 194
            N+++       +    LI E +  G L      +    E E+++         + Q   
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQ--- 123

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISML 250
            I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA   E    F ++ 
Sbjct: 124 -ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
              GT  ++APE+   N+  +  ++D++S G
Sbjct: 180 ---GTPEFVAPEIV--NYEPLGLEADMWSIG 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 3e-26
 Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 37/211 (17%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---------FINEVASMSKTS 139
            S  LG G  G V         + VA++++   K                 E+  + K +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAV 194
           H  ++    F ++ +   ++ E M  G L   +       E           +       
Sbjct: 199 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--------TCKLYFYQ-- 247

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLG 251
            +   ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+  +     ++  
Sbjct: 248 -MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC- 302

Query: 252 ARGTIGYIAPEVFC-RNFGGVSHKSDVYSYG 281
             GT  Y+APEV       G +   D +S G
Sbjct: 303 --GTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (268), Expect = 3e-26
 Identities = 51/213 (23%), Positives = 78/213 (36%), Gaps = 41/213 (19%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFI------NEVASMSKTSHVN 142
               +G+G F  V +      G+  AVK++  +K      +       E +      H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSL---------DQFIYDE-ESSNINRKLEWRTMCQI 192
           +V  L          +++EFM    L           F+Y E  +S+         M QI
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--------MRQI 139

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAK-LSEKKESFIS 248
                  L Y H   +  I+H D+KPH +LL         K+  FG+A  L E       
Sbjct: 140 L----EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192

Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
            +   GT  ++APEV  R         DV+  G
Sbjct: 193 RV---GTPHFMAPEVVKRE--PYGKPVDVWGCG 220

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 9e-26
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-------EEFINEVASMSKTSH 140
               +LG G F  V K +    G   A K +K  +          E+   EV+ + +  H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
            NV++       K    LI E +  G L  F+ ++ES  +  +     + Q    I  G+
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQ----ILNGV 127

Query: 201 EYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
            YLH   +++I HFD+KP NI+L          KI DFGLA   +    F ++    GT 
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTP 181

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYG 281
            ++APE+   N+  +  ++D++S G
Sbjct: 182 EFVAPEIV--NYEPLGLEADMWSIG 204

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  105 bits (265), Expect = 2e-25
 Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVV 144
               +LG+G F  V +   +  G+  A  ++   K++    ++   E        H N+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIAR 198
                  E+    LI++ +  G L + I     Y E ++S+  ++            I  
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ------------ILE 121

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
            + + H    + +VH ++KP N+LL    +    K++DFGLA   E ++      G  GT
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGT 176

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYG 281
            GY++PEV  ++  G     D+++ G
Sbjct: 177 PGYLSPEVLRKDPYG--KPVDLWACG 200

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (259), Expect = 3e-25
 Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 37/211 (17%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---------FINEVASMSKTS 139
            S  LG G  G V         + VA+K++   K                 E+  + K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAV 194
           H  ++    F ++ +   ++ E M  G L   +       E           +       
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--------TCKLYFYQ-- 122

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLG 251
            +   ++YLH      I+H D+KP N+LL    ED   KI+DFG +K+  +     ++  
Sbjct: 123 -MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC- 177

Query: 252 ARGTIGYIAPEVFC-RNFGGVSHKSDVYSYG 281
             GT  Y+APEV       G +   D +S G
Sbjct: 178 --GTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (255), Expect = 7e-25
 Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 38/213 (17%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----------EEFINEVASMSKT 138
               LG+G    V +    P  +  AVK++  +              E  + EV  + K 
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 139 S-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQI 192
           S H N++             L+++ M  G L  ++       E+        E R + + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK--------ETRKIMRA 132

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
              +   +  LH    + IVH D+KP NILL +D   K++DFG +   +  E    +   
Sbjct: 133 ---LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-- 184

Query: 253 RGTIGYIAPEVFCRNFGGVSH----KSDVYSYG 281
            GT  Y+APE+   +          + D++S G
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (257), Expect = 1e-24
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 31/202 (15%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLG 148
             ++LG+G    VY+ K     +  A+KVLK +  + +    E+  + + SH N++    
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 149 FCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARGLEY 202
                 + +L+ E +  G L   I     Y E ++++  ++            I   + Y
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------------ILEAVAY 163

Query: 203 LHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           LH      IVH D+KP N+L      D   KI+DFGL+K+ E +    ++    GT GY 
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYC 217

Query: 260 APEVFCRNFGGVSHKSDVYSYG 281
           APE+          + D++S G
Sbjct: 218 APEILRGC--AYGPEVDMWSVG 237

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  101 bits (253), Expect = 3e-24
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 34/204 (16%)

Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFL 147
               +G G +    +          AVK++  SK +  E   E+  + +   H N+++  
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARGLE 201
               + K   ++ E M  G L   I     + E E+S +        +  I     + +E
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTIT----KTVE 130

Query: 202 YLHRGCNIRIVHFDIKPHNILL---GEDFCP-KISDFGLAKLSEKKESFISMLGARGTIG 257
           YLH      +VH D+KP NIL      +    +I DFG AK    +     ++    T  
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTAN 185

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYG 281
           ++APEV  R   G     D++S G
Sbjct: 186 FVAPEVLERQ--GYDAACDIWSLG 207

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (252), Expect = 3e-24
 Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 45/277 (16%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE-FINEVASMSK-TSHVNVVSFLGFC 150
           LG+G    V     L   +  AVK+++    +       EV  + +   H NV+  + F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 151 YEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            E+ +  L++E M  GS+   I     ++E E+S + +             +A  L++LH
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD------------VASALDFLH 128

Query: 205 RGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFI-----SMLGARGTI 256
              N  I H D+KP NIL     +    KI DF L    +            +L   G+ 
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 257 GYIAPEVFCRNFGGVSH---KSDVYSYGMMILEMVVG-------RKNAEVKVSLSSEIYF 306
            Y+APEV        S    + D++S G+++  ++ G         +        +    
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 307 PNSIYKHIEPGN-EFQLA--GVVTEEEKEMAKKMILV 340
            N +++ I+ G  EF       ++   K++  K+++ 
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVR 282

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 37/212 (17%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---------EEFINEVASMSKTS 139
             + +G+G    V +      G   AVK+++ +             E    E   + + +
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 140 -HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIA 193
            H ++++ +          L+++ M  G L  ++       E+        E R++ +  
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK--------ETRSIMRS- 208

Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR 253
             +   + +LH      IVH D+KP NILL ++   ++SDFG +   E  E    +    
Sbjct: 209 --LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--- 260

Query: 254 GTIGYIAPEVFCRNFGGV----SHKSDVYSYG 281
           GT GY+APE+   +          + D+++ G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---------EVASMSKTSHVNV 143
           LG G FG V+        + V VK +K  KV  + +I          E+A +S+  H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L     +    L+ E   +G LD F + +    ++  L      Q+   +     YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAV----GYL 146

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
                  I+H DIK  NI++ EDF  K+ DFG A   E+ + F +     GTI Y APEV
Sbjct: 147 RLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPEV 200

Query: 264 FCRN-FGGVSHKSDVYSYGMMILEMVVGR 291
              N + G   + +++S G+ +  +V   
Sbjct: 201 LMGNPYRG--PELEMWSLGVTLYTLVFEE 227

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 50/259 (19%), Positives = 89/259 (34%), Gaps = 66/259 (25%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKV--LKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
            +G+GGFG V++ K   D    A+K   L N ++  E+ + EV +++K  H  +V +   
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG---------- 199
             E        E       D+      SS          + ++     +           
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 200 -------LEYLHRGC----------------------------------NIRIVHFDIKP 218
                  ++   +                                    +  ++H D+KP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR----------GTIGYIAPEVFCRNF 268
            NI    D   K+ DFGL    ++ E   ++L             GT  Y++PE    N 
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN- 251

Query: 269 GGVSHKSDVYSYGMMILEM 287
              SHK D++S G+++ E+
Sbjct: 252 -NYSHKVDIFSLGLILFEL 269

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 48/234 (20%)

Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV-NGEEFIN-EV 132
            +   Y++ K         +G G FG V++ KL +   VA+K     KV   + F N E+
Sbjct: 37  QREIAYTNCK--------VIGNGSFGVVFQAKLVESDEVAIK-----KVLQDKRFKNREL 83

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEW 186
             M    H NVV    F Y    +       L+ E++P  ++ +       + + + +  
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRH--YAKLKQTMPM 140

Query: 187 RTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKES 245
             +      + R L Y+H   +I I H DIKP N+LL       K+ DFG AK+    E 
Sbjct: 141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197

Query: 246 FISMLGARGTIGYI------APEVFCRNFGGV--SHKSDVYSYGMMILEMVVGR 291
            +S         YI      APE+    FG    +   D++S G ++ E++ G+
Sbjct: 198 NVS---------YICSRYYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 41/217 (18%)

Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFIN-EVASMSKTSHVNVVSFLGF 149
            +G G FG VY+ KL   G LVA+K     KV   + F N E+  M K  H N+V    F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 150 CYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
            Y   ++       L+ +++P  ++ +       +   + L    +      + R L Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYI 172

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKESFISMLGARGTIGYI--- 259
           H   +  I H DIKP N+LL  D    K+ DFG AK   + E  +S         YI   
Sbjct: 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---------YICSR 220

Query: 260 ---APEVFCRNFGGV--SHKSDVYSYGMMILEMVVGR 291
              APE+    FG    +   DV+S G ++ E+++G+
Sbjct: 221 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =   99 bits (249), Expect = 5e-23
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INE---VASMSKTSHVNVVS 145
           +G+GGFG VY  +  D G++ A+K L   ++    GE   +NE   ++ +S      +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 146 FLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            + + +    +   I + M  G L   +                M   A  I  GLE++H
Sbjct: 257 -MSYAFHTPDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMH 309

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGARGTIGYIAPE 262
                 +V+ D+KP NILL E    +ISD GLA    KK+  + +      GT GY+APE
Sbjct: 310 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPE 360

Query: 263 VFCRNFGGVSHKSDV--YSYGMMILEMVVGR 291
           V  +      + S    +S G M+ +++ G 
Sbjct: 361 VLQKGVA---YDSSADWFSLGCMLFKLLRGH 388

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 39/217 (17%)

Query: 76  KRYNYSDVKRMTNSFSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVAS 134
           + Y+     +        LG+G F    K       +  AVK++            E+ +
Sbjct: 8   QHYDLDLKDK-------PLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITA 58

Query: 135 MSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFI-----YDE-ESSNINRKLEWR 187
           +     H N+V      +++    L+ E +  G L + I     + E E+S I RK    
Sbjct: 59  LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK---- 114

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKE 244
                   +   + ++H   ++ +VH D+KP N+L     ++   KI DFG A+L     
Sbjct: 115 --------LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163

Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
               +     T+ Y APE+  +N  G     D++S G
Sbjct: 164 Q--PLKTPCFTLHYAAPELLNQN--GYDESCDLWSLG 196

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 36/216 (16%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV----NGEEFIN-EVASMSKTSHVNVVSFL 147
           LG+G +G V +          AVK+LK  K+    NGE  +  E+  + +  H NV+   
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71

Query: 148 GFCYE------KKKRALIYEFMPNGSLDQFIYDEESSNINRKL-EW---RTMCQIAVGIA 197
               +      K+K  ++ E+   G  +            ++          CQ+   I 
Sbjct: 72  ---VDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-----PEKRFPVCQAHGYFCQL---ID 120

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
            GLEYLH      IVH DIKP N+LL      KIS  G+A+      +  +   ++G+  
Sbjct: 121 -GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 258 YIAPEVF--CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +  PE+      F G   K D++S G+ +  +  G 
Sbjct: 177 FQPPEIANGLDTFSGF--KVDIWSAGVTLYNITTGL 210

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 64/202 (31%), Positives = 88/202 (43%), Gaps = 15/202 (7%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLGFC 150
           LG+G +G V           VAVK++   +     E    E+      +H NVV F G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E   + L  E+   G L  F   E    +      R   Q+   +A G+ YLH    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQL---MA-GVVYLHG---IG 125

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-CRNFG 269
           I H DIKP N+LL E    KISDFGLA +         +    GT+ Y+APE+   R F 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 270 GVSHKSDVYSYGMMILEMVVGR 291
                 DV+S G+++  M+ G 
Sbjct: 186 A--EPVDVWSCGIVLTAMLAGE 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 30/212 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN-------EVASMSKTSHV--NV 143
           LG GGFGSVY G  + D   VA+K ++  +++    +        EV  + K S     V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +  L +        LI E  P    D F +  E   +  +L      Q+       + + 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHC 165

Query: 204 HRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKK--ESFISMLGARGTIGYIA 260
           H      ++H DIK  NIL+       K+ DFG   L +      F       GT  Y  
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSP 216

Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE      + G    + V+S G+++ +MV G 
Sbjct: 217 PEWIRYHRYHG--RSAAVWSLGILLYDMVCGD 246

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 7e-22
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V+  ++   G+L A K L   ++    G +  + E   ++K     +VS L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + +E K    L+   M  G +   IY+ +  N     +          I  GLE+LH+  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLHQ-- 307

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              I++ D+KP N+LL +D   +ISD GLA   +  ++     G  GT G++APE+    
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGTPGFMAPELLLGE 364

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
                   D ++ G+ + EM+  R
Sbjct: 365 --EYDFSVDYFALGVTLYEMIAAR 386

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 64/202 (31%), Positives = 88/202 (43%), Gaps = 15/202 (7%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLGFC 150
           LG+G +G V           VAVK++   +     E    E+      +H NVV F G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E   + L  E+   G L  F   E    +      R   Q+   +A G+ YLH    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQL---MA-GVVYLHG---IG 125

Query: 211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-CRNFG 269
           I H DIKP N+LL E    KISDFGLA +         +    GT+ Y+APE+   R F 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 270 GVSHKSDVYSYGMMILEMVVGR 291
                 DV+S G+++  M+ G 
Sbjct: 186 A--EPVDVWSCGIVLTAMLAGE 205

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 28/212 (13%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN-------EVASMSK----TSHV 141
           LG+GGFG+V+ G  L D   VA+KV+  ++V G   ++       EVA + K      H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            V+  L +   ++   L+ E       D F Y  E   +          Q+   I    +
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQ-DLFDYITEKGPLGEGPSRCFFGQVVAAI----Q 153

Query: 202 YLHRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           + H      +VH DIK  NIL+     C K+ DFG   L   +          GT  Y  
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSP 206

Query: 261 PEVF-CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE      +      + V+S G+++ +MV G 
Sbjct: 207 PEWISRHQYHA--LPATVWSLGILLYDMVCGD 236

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 60/211 (28%), Positives = 85/211 (40%), Gaps = 36/211 (17%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
           +G G FG     +      LVAVK ++      E    E+ +     H N+V F     E
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF----KE 83

Query: 153 ----KKKRALIYEFMPNGSLDQFI-----YDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                   A+I E+   G L + I     + E+ +   R        Q+  G+     Y 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA---RFFFQ----QLLSGV----SYC 132

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGAR-GTIGYIA 260
           H    ++I H D+K  N LL     P  KI DFG +K S       S   +  GT  YIA
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIA 185

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV  R        +DV+S G+ +  M+VG 
Sbjct: 186 PEVLLRQ-EYDGKIADVWSCGVTLYVMLVGA 215

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 13/152 (8%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN-----EVASMSKTSHVNVVS 145
            KLG G + +VYKG     G  VA+K +K   ++ EE        E++ M +  H N+V 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVR 67

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
                + + K  L++EFM N  L +++      N  R LE   +      + +GL + H 
Sbjct: 68  LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
               +I+H D+KP N+L+ +    K+ DFGLA
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 59/237 (24%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---------------------- 130
           +G+G +G V       D    A+KVL   K+  +                          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 131 -----EVASMSKTSHVNVVSFLGFCYE------KKKRALIYEFMPNGSLDQFI----YDE 175
                E+A + K  H NVV       E      +    +++E +  G + +        E
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136

Query: 176 ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
           + +             +  GI    EYLH     +I+H DIKP N+L+GED   KI+DFG
Sbjct: 137 DQA-------RFYFQDLIKGI----EYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVS-HKSDVYSYGMMILEMVVGR 291
           ++   +  ++ +S     GT  ++APE         S    DV++ G+ +   V G+
Sbjct: 183 VSNEFKGSDALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.1 bits (234), Expect = 4e-21
 Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV---NGEEF-INEVASMSKTSHVNVVSFLG 148
           LG+GGFG V   ++   G++ A K L+  ++    GE   +NE   + K +   VVS L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + YE K    L+   M  G L   IY    +      E R +   A  I  GLE LHR  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAA-EICCGLEDLHR-- 304

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
             RIV+ D+KP NILL +    +ISD GLA    + ++    +G   T+GY+APEV    
Sbjct: 305 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG---TVGYMAPEVVKNE 360

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D ++ G ++ EM+ G+
Sbjct: 361 --RYTFSPDWWALGCLLYEMIAGQ 382

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 56/213 (26%), Positives = 84/213 (39%), Gaps = 46/213 (21%)

Query: 93  KLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFC 150
            LG G  G V +      G+  A+K+L +S    +E    V    + S   ++V  L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCILDV- 90

Query: 151 YEKKKRA-----LIYEFMPNGSLDQFI-------YDE-ESSNINRKLEWRTMCQIAVGIA 197
           YE          +I E M  G L   I       + E E++ I R             I 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD------------IG 138

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARG 254
             +++LH   +  I H D+KP N+L     +D   K++DFG AK + +      +     
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCY 191

Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYG--MMIL 285
           T  Y+APEV            D++S G  M IL
Sbjct: 192 TPYYVAPEVLGP--EKYDKSCDMWSLGVIMYIL 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   +  D  ++ A+K +   K            E+  M    H  +V+ L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN-LW 81

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIARGLEYLH 204
           + ++ ++   ++ + +  G L   +            E      +C++ +     L+YL 
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMA----LDYLQ 132

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                RI+H D+KP NILL E     I+DF +A +  ++    +M    GT  Y+APE+F
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMF 186

Query: 265 CRNFG-GVSHKSDVYSYGMMILEMVVGR 291
               G G S   D +S G+   E++ GR
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 26/207 (12%), Positives = 56/207 (27%), Gaps = 53/207 (25%)

Query: 93  KLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVS 145
             G       ++    D    R VA+  +    V      +E ++    +S+     V  
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            L   + +    ++ E++  GSL +          +         +    +A   +  HR
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA--------DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 206 -GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
            G    +      P  + +  D        G   L                   +     
Sbjct: 148 AG----VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPD--- 178

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                  + + D+   G  +  ++V R
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNR 199

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 31/215 (14%)

Query: 93  KLGQGGFGSVYKGKL-PDGRLVAVK-VLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC 150
             GQG FG+V  GK    G  VA+K V+++ +    E +  +  ++   H N+V    + 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYF 88

Query: 151 YEKKKRA-------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           Y   +R        ++ E++P+ +L +                  +      + R +  L
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPILIKVFLFQLIRSIGCL 145

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKESFISMLGARGTIGYI--- 259
           H    + + H DIKPHN+L+ E     K+ DFG AK     E  ++         YI   
Sbjct: 146 HLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---------YICSR 195

Query: 260 ---APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
              APE+        +   D++S G +  EM++G 
Sbjct: 196 YYRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 29/208 (13%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---EVASMSKTSHVNVVSFLGF 149
           +G+G F  V   + +  GR VA+K++  +++N         EV  M   +H N+V     
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79

Query: 150 CYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +E    +K   LI E+   G +  ++        + +++ +        I   ++Y H+
Sbjct: 80  -FEVIETEKTLYLIMEYASGGEVFDYLVA------HGRMKEKEARSKFRQIVSAVQYCHQ 132

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEVF 264
               RIVH D+K  N+LL  D   KI+DFG +            L A  G   Y APE+F
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELF 185

Query: 265 C-RNFGGVSHKSDVYSYGMMILEMVVGR 291
             + + G   + DV+S G+++  +V G 
Sbjct: 186 QGKKYDG--PEVDVWSLGVILYTLVSGS 211

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 43/210 (20%)

Query: 90  FSNKLGQGGFGSVYKG-KLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFL 147
            S  LG G  G V +          A+K+L++      +   EV    + S   ++V  +
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121

Query: 148 GFCYEKKKRA-----LIYEFMPNGSL-------DQFIYDE-ESSNINRKLEWRTMCQIAV 194
              YE          ++ E +  G L           + E E+S I +            
Sbjct: 122 DV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----------- 169

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLG 251
            I   ++YLH   +I I H D+KP N+L      +   K++DFG AK +    S  +   
Sbjct: 170 -IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC- 224

Query: 252 ARGTIGYIAPEVFCRNFGGVSHKSDVYSYG 281
              T  Y+APEV            D++S G
Sbjct: 225 --YTPYYVAPEVLGP--EKYDKSCDMWSLG 250

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN-GEEFIN--EVASMSKTSHVNVVSFL 147
            K+G+G +G V+K +    G++VA+K    S+ +   + I   E+  + +  H N+V+ L
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                K++  L++E+  + ++   + D     +   L      Q      + + + H+  
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTL----QAVNFCHKH- 121

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
               +H D+KP NIL+ +    K+ DFG A
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFA 149

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)

Query: 82  DVKRMTNSFS--NKLGQGGFGSVYKGK-LPDGRLVAVKVLK-NSKVNGEEFIN-----EV 132
           DVK     +   + LG+G F +VYK +     ++VA+K +K   +   ++ IN     E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQI 192
             + + SH N++  L     K   +L+++FM    L+  I  + S  +        M   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMT 121

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
                +GLEYLH+     I+H D+KP+N+LL E+   K++DFGLAK
Sbjct: 122 L----QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 86.8 bits (216), Expect = 2e-19
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 18/154 (11%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVV 144
            K+G+G +G VYK +    G +VA   LK  +++ E        I E++ + + +H N+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVA---LKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             L   + + K  L++EF+    L +F+     + I   L    + Q+     +GL + H
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
                R++H D+KP N+L+  +   K++DFGLA+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 59/271 (21%), Positives = 100/271 (36%), Gaps = 77/271 (28%)

Query: 89  SFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNGE--EFINEVASMSK-TS 139
                LG+G FG V +            R VAVK+LK    + E    ++E+  +     
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 140 HVNVV--------------------------------------------------SFLGF 149
           H+NVV                                                   ++G 
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEW-----------RTMCQIAVGIAR 198
                KR L        S      +E+S +   + E              +   +  +A+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           G+E+L    + + +H D+   NILL E    KI DFGLA+   K   ++    AR  + +
Sbjct: 205 GMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261

Query: 259 IAPE-VFCRNFGGVSHKSDVYSYGMMILEMV 288
           +APE +F R +   + +SDV+S+G+++ E+ 
Sbjct: 262 MAPETIFDRVY---TIQSDVWSFGVLLWEIF 289

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 46/153 (30%), Positives = 83/153 (54%), Gaps = 18/153 (11%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVVS 145
            K+G+G +G VYK K   GR+VA+K ++   ++ E+       I E++ + +  H N+VS
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELHHPNIVS 83

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +   + ++   L++EFM    L + + DE  + +        + Q+     RG+ + H+
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLL----RGVAHCHQ 137

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
               RI+H D+KP N+L+  D   K++DFGLA+
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLAR 167

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 32/211 (15%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFIN-EVASMSKTSHVNVVSFLG 148
           LG+G F +V   +     R  A+K+L+   +   N   ++  E   MS+  H   V    
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIARGLEYLHR 205
              + +K      +  NG L ++I            E  T     +I       LEYLH 
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVS----ALEYLH- 147

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-----GTIGYIA 260
                I+H D+KP NILL ED   +I+DFG AK+   +        AR     GT  Y++
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-----QARANSFVGTAQYVS 200

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE+           SD+++ G +I ++V G 
Sbjct: 201 PELLTEK--SACKSSDLWALGCIIYQLVAGL 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 85.6 bits (213), Expect = 4e-19
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFIN-----EVASMSKTSHVNVVSF 146
            K+G+G +G VYK +   G   A+K ++      +E I      E++ + +  H N+V  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               + KK+  L++E +    L + + D     +        + Q+      G+ Y H  
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQLL----NGIAYCHDR 119

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
              R++H D+KP N+L+  +   KI+DFGLA+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVVSFLG 148
           LG G FG V  G+    G  VAVK+L   K+   + +     E+ ++    H +++    
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 149 FCYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             Y+         ++ E++  G L  F Y  +   +      R   QI   +    +Y H
Sbjct: 77  --YQVISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEARRLFQQILSAV----DYCH 128

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEV 263
           R     +VH D+KP N+LL      KI+DFGL+ +    E     L    G+  Y APEV
Sbjct: 129 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEV 181

Query: 264 FC-RNFGGVSHKSDVYSYGMMILEMVVGR 291
              R + G   + D++S G+++  ++ G 
Sbjct: 182 ISGRLYAG--PEVDIWSCGVILYALLCGT 208

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 85.7 bits (213), Expect = 7e-19
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 38/215 (17%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVN-GEEFIN--EVASMSKTSHVNVVSFL 147
             +G+G +G V K +    GR+VA+K    S  +   + I   E+  + +  H N+V+ L
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
             C +KK+  L++EF+ + ++   + +   + ++ ++  + + QI      G+ + H   
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQII----NGIGFCHSH- 143

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARG--------TIGYI 259
              I+H DIKP NIL+ +    K+ DFG A+           L A G        T  Y 
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFAR----------TLAAPGEVYDDEVATRWYR 191

Query: 260 APEVF--CRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           APE+      +G  V    DV++ G ++ EM +G 
Sbjct: 192 APELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.3 bits (212), Expect = 8e-19
 Identities = 49/153 (32%), Positives = 82/153 (53%), Gaps = 18/153 (11%)

Query: 92  NKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEE-----FINEVASMSKTSHVNVVS 145
           +KLG+G + +VYKGK      LVA+K ++   +  EE      I EV+ +    H N+V+
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
                + +K   L++E++    L Q++ D+  + IN       + Q+     RGL Y HR
Sbjct: 65  LHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLL----RGLAYCHR 118

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
               +++H D+KP N+L+ E    K++DFGLA+
Sbjct: 119 Q---KVLHRDLKPQNLLINERGELKLADFGLAR 148

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 36/154 (23%), Positives = 79/154 (51%), Gaps = 19/154 (12%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE------FINEVASMSKTSHVNVV 144
            K+G+G +G+V+K K      +VA+K ++   ++ ++       + E+  + +  H N+V
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                 +  KK  L++EF     L ++  D  + +++ ++    + Q+     +GL + H
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLL----KGLGFCH 118

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
                 ++H D+KP N+L+  +   K+++FGLA+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 83.2 bits (206), Expect = 8e-18
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 40/223 (17%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGE---------EFINEVASMSKTS--H 140
           KLG G F +V+  K + +   VA+K+++  KV  E         + +N+  +  + S   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 141 VNVVSFLG-FCYEKKKRA---LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
            +++  L  F ++        +++E +   +L   I        +R +    + QI+  +
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK----YEHRGIPLIYVKQISKQL 140

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP------KISDFGLA-KLSEKKESFISM 249
             GL+Y+HR C I  +H DIKP N+L+     P      KI+D G A    E   + I  
Sbjct: 141 LLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197

Query: 250 LGARGTIGYIAPEVFCRNFG-GVSHKSDVYSYGMMILEMVVGR 291
                T  Y +PEV     G      +D++S   +I E++ G 
Sbjct: 198 -----TREYRSPEVL---LGAPWGCGADIWSTACLIFELITGD 232

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 21/157 (13%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEF----INEVASMSKTSHVNVVSF 146
            KLG+G +G VYK         VA+K ++      E      I EV+ + +  H N++  
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
               +   +  LI+E+  N  L +++  +++ +++ ++    + Q+      G+ + H  
Sbjct: 99  KSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLI----NGVNFCHSR 151

Query: 207 CNIRIVHFDIKPHNILLGEDFCP-----KISDFGLAK 238
              R +H D+KP N+LL           KI DFGLA+
Sbjct: 152 ---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.7 bits (207), Expect = 9e-18
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVVSFLG 148
           LG G FG V  GK    G  VAVK+L   K+   + +     E+ ++    H +++    
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 149 FCYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             Y+         ++ E++  G L  F Y  ++  ++ K   R   QI  G+    +Y H
Sbjct: 82  --YQVISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESRRLFQQILSGV----DYCH 133

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEV 263
           R     +VH D+KP N+LL      KI+DFGL+ +    E     L    G+  Y APEV
Sbjct: 134 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEV 186

Query: 264 FC-RNFGGVSHKSDVYSYGMMILEMVVGR 291
              R + G   + D++S G+++  ++ G 
Sbjct: 187 ISGRLYAGP--EVDIWSSGVILYALLCGT 213

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 23/162 (14%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLK--NSKVNGEEF----INEVA---SMSKTSHV 141
            ++G G +G+VYK +    G  VA+K ++  N    G       + EVA    +    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 142 NVVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           NVV  +  C   +        L++E +    L  ++       +  +     M Q     
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL--- 130

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
            RGL++LH      IVH D+KP NIL+      K++DFGLA+
Sbjct: 131 -RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 33/211 (15%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM-------SKTSHVNVVS 145
           LG+G FG V   K    GR  A+K+LK   +  +   +EVA           + H  + +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTA 212

Query: 146 FLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            L + ++   R   + E+   G L   +  E      R             I   L+YLH
Sbjct: 213 -LKYSFQTHDRLCFVMEYANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLH 265

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIA 260
              N+  V+ D+K  N++L +D   KI+DFGL K         ++F       GT  Y+A
Sbjct: 266 SEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC------GTPEYLA 317

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV   N        D +  G+++ EM+ GR
Sbjct: 318 PEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 346

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 51/247 (20%), Positives = 93/247 (37%), Gaps = 69/247 (27%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVK-VLKNSKVNGEEFIN-EVASMSKTSHVNVVSFLGF 149
            LG G FG V +   +  G+  A+K VL++ +     + N E+  M    HVN++  + +
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDY 68

Query: 150 CYEKKKRA--------------------------------------LIYEFMPNGSLDQF 171
            Y                                            +I E++P+ +L + 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127

Query: 172 IYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-K 230
           +     S   R +    +      + R + ++H   ++ I H DIKP N+L+       K
Sbjct: 128 LKSFIRSG--RSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182

Query: 231 ISDFGLAKLSEKKESFISMLGARGTIGYI------APEVFCRNFGGVSHKSDVYSYGMMI 284
           + DFG AK     E  ++         YI      APE+        +   D++S G + 
Sbjct: 183 LCDFGSAKKLIPSEPSVA---------YICSRFYRAPELML-GATEYTPSIDLWSIGCVF 232

Query: 285 LEMVVGR 291
            E+++G+
Sbjct: 233 GELILGK 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 34/211 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM-------SKTSHVNVVS 145
           LG+G FG V   +    GR  A+K+L+   +  +   +EVA           T H  + +
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESRVLQNTRHPFLTA 69

Query: 146 FLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            L + ++   R   + E+   G L   +  E      R             I   LEYLH
Sbjct: 70  -LKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIA 260
              +  +V+ DIK  N++L +D   KI+DFGL K         ++F       GT  Y+A
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLA 173

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV   N        D +  G+++ EM+ GR
Sbjct: 174 PEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   +     ++ A+K+L   ++    +   F  E   M+  +   VV  L 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ-LF 135

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQI-AVGIARGLEYLHRG 206
           + ++  +   ++ E+MP G L   + + +              +     +   L+ +H  
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--------KWARFYTAEVVLALDAIH-- 185

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
            ++  +H D+KP N+LL +    K++DFG      K+        A GT  YI+PEV   
Sbjct: 186 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKS 243

Query: 267 NFGGVSHKSDV--YSYGMMILEMVVGR 291
             G   +  +   +S G+ + EM+VG 
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 31/209 (14%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN----EVASMSKTSHVNVVSFLG 148
           LG+G FG V         + VA+K +    +   +       E++ +    H +++    
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 149 FCYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             Y+         ++ E+   G L  F Y  E   +      R   QI   I    EY H
Sbjct: 75  --YDVITTPTDIVMVIEYA-GGEL--FDYIVEKKRMTEDEGRRFFQQIICAI----EYCH 125

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEV 263
           R    +IVH D+KP N+LL ++   KI+DFGL+ +          L    G+  Y APEV
Sbjct: 126 R---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPEV 178

Query: 264 FC-RNFGGVSHKSDVYSYGMMILEMVVGR 291
              + + G   + DV+S G+++  M+VGR
Sbjct: 179 INGKLYAG--PEVDVWSCGIVLYVMLVGR 205

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 50/238 (21%), Positives = 93/238 (39%), Gaps = 28/238 (11%)

Query: 60  ENAEAAFIRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVL 118
             A+  F++ + + +          R+       LG G FG V   K    G   A+K+L
Sbjct: 20  AKAKEDFLKKWETPSQNTAQLDQFDRIKT-----LGTGSFGRVMLVKHKESGNHYAMKIL 74

Query: 119 KNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD 174
              KV      E  +NE   +   +   +V       +     ++ E++  G +   +  
Sbjct: 75  DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134

Query: 175 EESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF 234
                   +         A  I    EYLH   ++ +++ D+KP N+L+ +    +++DF
Sbjct: 135 I------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 235 GLAK-LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           G AK +  +  +        GT   +APE+      G +   D ++ G++I EM  G 
Sbjct: 186 GFAKRVKGRTWTL------CGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGY 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 36/213 (16%)

Query: 94  LGQGGFGSVY---KGKLPD-GRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSF 146
           LGQG FG V+   K    D  +L A+KVLK + +   +      E   + + +H  +V  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK- 90

Query: 147 LGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIARGLEY 202
           L + ++ + +  LI +F+  G L   +  E         E      + ++A+     L++
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALA----LDH 141

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS----EKKESFISMLGARGTIGY 258
           LH   ++ I++ D+KP NILL E+   K++DFGL+K S    +K  SF       GT+ Y
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEY 192

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +APEV  R   G +  +D +S+G+++ EM+ G 
Sbjct: 193 MAPEVVNRR--GHTQSADWWSFGVLMFEMLTGT 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 19/207 (9%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G FG V   KL +  ++ A+K+L   ++        F  E   +       + + L 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LH 140

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           + ++      L+ ++   G L   +     S    +L           +   ++ +H   
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL-----SKFEDRLPEEMARFYLAEMVIAIDSVH--- 192

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
            +  VH DIKP NIL+  +   +++DFG      +  +  S + A GT  YI+PE+    
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAM 251

Query: 268 FGGVSH--KS-DVYSYGMMILEMVVGR 291
            GG        D +S G+ + EM+ G 
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 21/209 (10%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           +G+G F  V   K+   G++ A+K++    +        F  E   +       +   L 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LH 127

Query: 149 FCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           F ++ +    L+ E+   G L   +         R         +A  I   ++ +H   
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLA-EIVMAIDSVH--- 179

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
            +  VH DIKP NILL      +++DFG         +  S++ A GT  Y++PE+    
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAV 238

Query: 268 FGGVSHKS-----DVYSYGMMILEMVVGR 291
            GG    S     D ++ G+   EM  G+
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 58/262 (22%), Positives = 94/262 (35%), Gaps = 78/262 (29%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVA-----SMSKTSHVN---V 143
           KLG G F +V+    +   + VA+KV+K+++   E  ++E+        S  +  N   V
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 144 VSFLG-FCYEKKK---RALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
           V  L  F           +++E +  G  L ++I      +  + L    + +I   + +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWII----KSNYQGLPLPCVKKIIQQVLQ 157

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLG---------------------------------- 224
           GL+YLH  C I  +H DIKP NILL                                   
Sbjct: 158 GLDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 225 ---------------EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
                          E    KI+D G A    K  +         T  Y + EV   +  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGS-- 268

Query: 270 GVSHKSDVYSYGMMILEMVVGR 291
           G +  +D++S   M  E+  G 
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 93  KLGQGGFGSVYKGK---LPDGRLVAVKVLKNSKVNGEEF----INEVASMSKTSHVNVVS 145
           K+G+G +G VYK K     D +  A+K     ++ G         E+A + +  H NV+S
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSACREIALLRELKHPNVIS 82

Query: 146 FLGFCYEKKKRA--LIYEFMPN--GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
                     R   L++++  +    + +F    +++    +L    +  +   I  G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDF----CPKISDFGLAKL-SEKKESFISMLGARGTI 256
           YLH      ++H D+KP NIL+  +       KI+D G A+L +   +    +     T 
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 257 GYIAPEVF--CRNFG-GVSHKSDVYSYGMMILEMVVGR 291
            Y APE+    R++   +    D+++ G +  E++   
Sbjct: 200 WYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 6e-16
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 42/217 (19%)

Query: 94  LGQGGFGSVY---KGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM-------SKTSHVN 142
           LG+GG+G V+   K    + G++ A+KVLK + +       + A          +  H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHPF 82

Query: 143 VVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIAR 198
           +V  L + ++   +  LI E++  G L   +  E        +E      + +I++    
Sbjct: 83  IVD-LIYAFQTGGKLYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISM---- 132

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS----EKKESFISMLGARG 254
            L +LH      I++ D+KP NI+L      K++DFGL K S        +F       G
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------G 183

Query: 255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           TI Y+APE+  R+  G +   D +S G ++ +M+ G 
Sbjct: 184 TIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGA 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM--------SKTSHVNVV 144
           LG+G FG V   +      L AVK+LK   V  +   ++V                  + 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKRVLALPGKPPFLT 405

Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
             L  C++   R   + E++  G L   I          + +       A  IA GL +L
Sbjct: 406 Q-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFL 458

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYI 259
               +  I++ D+K  N++L  +   KI+DFG+ K         ++F       GT  YI
Sbjct: 459 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------GTPDYI 509

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+            D +++G+++ EM+ G+
Sbjct: 510 APEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 539

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 46/226 (20%), Positives = 94/226 (41%), Gaps = 31/226 (13%)

Query: 80  YSDVKRMTNSFSN--------KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN 130
           Y D +     + N        KLG+G +  V++   + +   V VK+LK   V  ++   
Sbjct: 22  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKR 79

Query: 131 EVASMSK-TSHVNVVSFLGFCY--EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           E+  +       N+++          +  AL++E + N    Q +Y   +    R     
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY--- 135

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKESF 246
            M +I     + L+Y H      I+H D+KPHN+++  +    ++ D+GLA+     +  
Sbjct: 136 -MYEIL----KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185

Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
                   +  +  PE+   ++    +  D++S G M+  M+  ++
Sbjct: 186 -EYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKE 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 27/163 (16%)

Query: 92  NKLGQGGFGSVYKGK--LPDGRLVAVKVLKNSKVNGEE------FINEVA---SMSKTSH 140
            ++G+G +G V+K +     GR VA   LK  +V   E       I EVA    +    H
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73

Query: 141 VNVVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            NVV     C   +        L++E +    L  ++       +  +     M Q+   
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL-- 130

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK 238
             RGL++LH     R+VH D+KP NIL+      K++DFGLA+
Sbjct: 131 --RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM--------SKTSHVNVV 144
           LG+G FG V   ++ + G L AVKVLK   +  +   ++V              +H  + 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLT 87

Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
             L  C++   R   + EF+  G L   I         R+ +       A  I   L +L
Sbjct: 88  Q-LFCCFQTPDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFL 140

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYI 259
           H      I++ D+K  N+LL  +   K++DFG+ K          +F       GT  YI
Sbjct: 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC------GTPDYI 191

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+            D ++ G+++ EM+ G 
Sbjct: 192 APEILQEM--LYGPAVDWWAMGVLLYEMLCGH 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)

Query: 94  LGQGGFGSVY---KGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM-------SKTSHVN 142
           LG G +G V+   K    D G+L A+KVLK + +  +                       
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSP 119

Query: 143 VVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRT---MCQIAVGIAR 198
            +  L + ++ + +  LI +++  G L   +   E     R  E      + +I +    
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLA--- 171

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE-----SFISMLGAR 253
            LE+LH    + I++ DIK  NILL  +    ++DFGL+K     E      F       
Sbjct: 172 -LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------ 221

Query: 254 GTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           GTI Y+AP++      G     D +S G+++ E++ G 
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM--------SKTSHVNVV 144
           LG+G FG V   +      L AVK+LK   V  +   ++V                  + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKRVLALPGKPPFLT 84

Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
             L  C++   R   + E++  G L   I          + +       A  IA GL +L
Sbjct: 85  Q-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFL 137

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS----EKKESFISMLGARGTIGYI 259
               +  I++ D+K  N++L  +   KI+DFG+ K +       ++F       GT  YI
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------GTPDYI 188

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+            D +++G+++ EM+ G+
Sbjct: 189 APEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 218

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 33/164 (20%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLK--NSKVNGEEF----INEVASMSKTSHVNVV 144
            K+GQG FG V+K +    G+ VA+K +   N K   E F    + E+  +    H NVV
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVV 79

Query: 145 SFLGFCYEKKKRA--------LIYEFMPN---GSLDQFIYDEESSNINRKLEWRTMCQIA 193
           + +  C  K            L+++F  +   G L          N+  K     + ++ 
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---------NVLVKFTLSEIKRVM 130

Query: 194 VGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
             +  GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM--------SKTSHVNVV 144
           +G+G +  V   +L    R+ A+KV+K   VN +    ++  +          ++H  +V
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 73

Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
             L  C++ + R   + E++  G L   +  +      RKL        +  I+  L YL
Sbjct: 74  G-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYL 126

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYI 259
           H      I++ D+K  N+LL  +   K++D+G+ K      +   +F       GT  YI
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------GTPNYI 177

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+            D ++ G+++ EM+ GR
Sbjct: 178 APEILRGE--DYGFSVDWWALGVLMFEMMAGR 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 94  LGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLG 148
           LG G FG V+  +   +GR  A+KVLK   V      E   +E   +S  +H  ++   G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              + ++  +I +++  G L   +         ++         A  +   LEYLH   +
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLH---S 124

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK-ESFISMLGARGTIGYIAPEVFCRN 267
             I++ D+KP NILL ++   KI+DFG AK       +        GT  YIAPEV    
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC------GTPDYIAPEVVSTK 178

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               +   D +S+G++I EM+ G 
Sbjct: 179 --PYNKSIDWWSFGILIYEMLAGY 200

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM--------SKTSHVNVV 144
           +G+G FG V   +        AVKVL+   +  +    E   +            H  +V
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLV 102

Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
             L F ++   +   + +++  G L   +  E      R          A  IA  L YL
Sbjct: 103 G-LHFSFQTADKLYFVLDYINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYL 155

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYI 259
           H   ++ IV+ D+KP NILL       ++DFGL K     +    +F       GT  Y+
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC------GTPEYL 206

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APEV  +         D +  G ++ EM+ G 
Sbjct: 207 APEVLHKQ--PYDRTVDWWCLGAVLYEMLYGL 236

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 37/213 (17%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASM--------SKTSHVNVV 144
           LG+G FG V+  +     +  A+K LK   V  +   ++V               H  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLT 81

Query: 145 SFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
             +   ++ K+    + E++  G L   I          K +       A  I  GL++L
Sbjct: 82  H-MFCTFQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFL 134

Query: 204 HRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLS----EKKESFISMLGARGTIGY 258
           H   +  IV+ D+K  NILL +D    KI+DFG+ K +     K  +F       GT  Y
Sbjct: 135 H---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC------GTPDY 184

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           IAPE+        +H  D +S+G+++ EM++G+
Sbjct: 185 IAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 215

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 40/167 (23%), Positives = 64/167 (38%), Gaps = 38/167 (22%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFL 147
            S  LG G  G V +          A+K+L++      +   EV    + S   ++V  +
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77

Query: 148 GFCYEKKKRA-----LIYEFMPNGSL-------DQFIYDE-ESSNINRKLEWRTMCQIAV 194
              YE          ++ E +  G L           + E E+S I +            
Sbjct: 78  DV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----------- 125

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAK 238
            I   ++YLH   +I I H D+KP N+L      +   K++DFG AK
Sbjct: 126 -IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 33/211 (15%)

Query: 94  LGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSF------ 146
           +G+G +  V   +L    R+ A++V+K   VN +    ++  +    HV   +       
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 116

Query: 147 -LGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
            L  C++ + R   + E++  G L   +  +      RKL        +  I+  L YLH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLH 170

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL----SEKKESFISMLGARGTIGYIA 260
                 I++ D+K  N+LL  +   K++D+G+ K      +   +F       GT  YIA
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------GTPNYIA 221

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE+            D ++ G+++ EM+ GR
Sbjct: 222 PEILRGE--DYGFSVDWWALGVLMFEMMAGR 250

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 34/169 (20%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKN---------------SKVNGEEFINEVASMS 136
           K+G GGFG +Y           A  V+K                 +V  ++ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 137 KTSHVNVVSFLGF----CYEKKKRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQ 191
           +  ++ +  F G        +  R ++ E +  G  L +          N   +  T+ Q
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS------GQNGTFKKSTVLQ 155

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI--SDFGLAK 238
           + + +   LEY+H       VH DIK  N+LLG     ++  +D+GL+ 
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 30/216 (13%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEE---FIN---------EVASMSKTSH 140
            +  G +G+V  G   +G  VA+K + N+  +G       +         E+  ++   H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 141 VNVVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVG 195
            N++         ++ A     L+ E M    L Q I+D+        +  + +      
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-----RIVISPQHIQYFMYH 142

Query: 196 IARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT 255
           I  GL  LH      +VH D+ P NILL ++    I DF LA+         +       
Sbjct: 143 ILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTH 196

Query: 256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             Y APE+    F G +   D++S G ++ EM   +
Sbjct: 197 RWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 21/209 (10%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKN--SKVNGEEFINEVASMSKTSHVNVVSFLG 148
           + +G+G +G V       +   VA+K +     +   +  + E+  + +  H N++    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92

Query: 149 FCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                         ++ + M    L + +  +  SN +       + QI     RGL+Y+
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY---FLYQIL----RGLKYI 144

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H      ++H D+KP N+LL      KI DFGLA+      +    +     T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +   N  G +   D++S G ++ EM+  R
Sbjct: 202 IML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 39/154 (25%), Positives = 63/154 (40%), Gaps = 19/154 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFC 150
           K+G G FG +  GK L     VA+K+    K    +   E     +      +     F 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 151 YEKKKRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              K  A++ E +  G SL+           +R    +T+  IA+ +   +EY+H   + 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLF-----DLCDRTFSLKTVLMIAIQLISRMEYVH---SK 124

Query: 210 RIVHFDIKPHNILLGEDFCPK-----ISDFGLAK 238
            +++ D+KP N L+G           I DF LAK
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVA------SMSKTSHVNVVSF 146
           +G+G FG V K       + VA+K+++N K    +   E+          K + +NV+  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           L     +    + +E      L   +Y+    N  +      + + A  I + L+ LH+ 
Sbjct: 165 LENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK- 218

Query: 207 CNIRIVHFDIKPHNILLGEDFCP--KISDFGLA-KLSEKKESFISMLGARGTIGYIAPEV 263
              RI+H D+KP NILL +      K+ DFG +    ++  ++I       +  Y APEV
Sbjct: 219 --NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ------SRFYRAPEV 270

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                       D++S G ++ E++ G 
Sbjct: 271 ILG--ARYGMPIDMWSLGCILAELLTGY 296

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 35/171 (20%)

Query: 93  KLGQGGFGSVYKG------KLPDGRLVAVKVLKNS------------KVNGEEFINEVAS 134
            +GQGGFG +Y         +       VKV  +             +    E I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 135 MSKTSHVNVVSFLGF----CYEKKKRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTM 189
             K  ++ V  + G        K  R +I +    G  L +           ++   +T+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY-----EANAKRFSRKTV 154

Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI--SDFGLAK 238
            Q+++ I   LEY+H       VH DIK  N+LL      ++   D+GLA 
Sbjct: 155 LQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 27/208 (12%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +G+V        G  VA+K L     S++  +    E+  +    H NV+  L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 150 CYEKKKRA------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
               +         L+  FM    L + +        + KL    +  +   + +GL Y+
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGT-DLGKLMK-------HEKLGEDRIQFLVYQMLKGLRYI 144

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H      I+H D+KP N+ + ED   KI DFGLA+ ++       M G   T  Y APEV
Sbjct: 145 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEV 196

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
              N+   +   D++S G ++ EM+ G+
Sbjct: 197 IL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 30/171 (17%), Positives = 67/171 (39%), Gaps = 33/171 (19%)

Query: 92  NKLGQGGFGSVYKGK---------LPDGRLVAVKV-LKNSKVNGE----------EFINE 131
           +   +   G +Y+            P  +  ++K+  K+ ++  E            +N+
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 132 VASMSKTSHVNVVSFLGF-CYEKKKRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTM 189
              +  T  + + + +GF  ++ K R L+   +  G SL   +      +    L  R++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL----DVSPKHVLSERSV 161

Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI--SDFGLAK 238
            Q+A  +   LE+LH       VH ++   NI +  +   ++  + +G A 
Sbjct: 162 LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 32/153 (20%), Positives = 64/153 (41%), Gaps = 17/153 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK-TSHVNVVSFLGFC 150
           ++G+G FG +++G  L + + VA+K     + +  +  +E  +         + +   F 
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E     L+ + +   SL+  +         RK   +T+   A  +   ++ +H      
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIH---EKS 126

Query: 211 IVHFDIKPHNILLGEDFCPK-----ISDFGLAK 238
           +V+ DIKP N L+G           + DFG+ K
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 34/213 (15%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFL 147
             +G G +GSV        G  VA+K L     S++  +    E+  +    H NV+   
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG-- 87

Query: 148 GFCYEKKKRALIYEFMPNGSLDQF--IY------DEESSNINR-KLEWRTMCQIAVGIAR 198
                     L+  F P  SL  F   Y        +   I   K     +  +   + +
Sbjct: 88  ----------LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK 137

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           GL+Y+H      +VH D+KP N+ + ED   KI DFGLA+ ++       M G   T  Y
Sbjct: 138 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWY 189

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            APEV   ++   +   D++S G ++ EM+ G+
Sbjct: 190 RAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 40/222 (18%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN------EVASMSKTSHVNVVS 145
            LG GG G V+        + VA+K     K+   +  +      E+  + +  H N+V 
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 146 FLGFCYEKKKRA--------------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQ 191
                     +               ++ E+M    L   +        + +L    M Q
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARL---FMYQ 128

Query: 192 IAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKESFISML 250
           +     RGL+Y+H      ++H D+KP N+ +  +    KI DFGLA++ +   S    L
Sbjct: 129 LL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 251 -GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                T  Y +P +   +    +   D+++ G +  EM+ G+
Sbjct: 182 SEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 35/212 (16%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG---- 92

Query: 150 CYEKKKRALIYEFMPNGSLDQF--IY------DEESSNINR--KLEWRTMCQIAVGIARG 199
                   L+  F P  SL++F  +Y        + +NI +  KL    +  +   I RG
Sbjct: 93  --------LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           L+Y+H      I+H D+KP N+ + ED   KI DFGLA+ +        M G   T  Y 
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYR 196

Query: 260 APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+   N+   +   D++S G ++ E++ GR
Sbjct: 197 APEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 33/211 (15%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           +G G  G V         R VA+K L     ++ + +    E+  M   +H N++     
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG---- 88

Query: 150 CYEKKKRALIYEFMPNGSLDQF--IY------DEESSN-INRKLEWRTMCQIAVGIARGL 200
                   L+  F P  SL++F  +Y      D      I  +L+   M  +   +  G+
Sbjct: 89  --------LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           ++LH      I+H D+KP NI++  D   KI DFGLA+ +        M     T  Y A
Sbjct: 141 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRA 194

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV      G     D++S G ++ EM+ G 
Sbjct: 195 PEVILGM--GYKENVDIWSVGCIMGEMIKGG 223

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 26/211 (12%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEV------ASMSKTSHVNVV 144
           + +G+G FG V K     +   VA+K++KN K    +   EV                +V
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                   +    L++E      L   +YD   +   R +      + A  +   L +L 
Sbjct: 120 HLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP--KISDFGLA-KLSEKKESFISMLGARGTIGYIAP 261
               + I+H D+KP NILL        KI DFG + +L ++   +I       +  Y +P
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ------SRFYRSP 227

Query: 262 EVFCRNFG-GVSHKSDVYSYGMMILEMVVGR 291
           EV     G       D++S G +++EM  G 
Sbjct: 228 EVL---LGMPYDLAIDMWSLGCILVEMHTGE 255

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFL 147
             +G G  G V         R VA+K L     ++ + +    E+  M   +H N++S  
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS-- 125

Query: 148 GFCYEKKKRALIYEFMPNGSLDQF--IY------DEESSNINRKLEWRTMCQIAV-GIAR 198
                     L+  F P  +L++F  +Y      D     + +           +  +  
Sbjct: 126 ----------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGY 258
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +        M     T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 229

Query: 259 IAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
            APEV      G     D++S G ++ EMV  +
Sbjct: 230 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHK 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 17/152 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFC 150
           K+G G FG +Y G  +  G  VA+K+    K    +   E          V + +     
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 151 YEKKKRALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
            E     ++ E +  G SL+        +  +RK   +T+  +A  +   +EY+H   + 
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLF-----NFCSRKFSLKTVLLLADQMISRIEYIH---SK 124

Query: 210 RIVHFDIKPHNILLGEDFCPK---ISDFGLAK 238
             +H D+KP N L+G         I DFGLAK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 15/151 (9%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK-TSHVNVVSFLGFC 150
           K+G G FG +Y G  +     VA+K+    K    + + E            + +   F 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            E     L+ + +   SL+        +  +RKL  +T+  +A  +   +E++H   +  
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLF-----NFCSRKLSLKTVLMLADQMINRVEFVH---SKS 123

Query: 211 IVHFDIKPHNILLGEDFCPK---ISDFGLAK 238
            +H DIKP N L+G         I DFGLAK
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 42/222 (18%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---------EVASMSKTSHVN 142
            LG+G +G V      P G +VA+K     K+    F           E+  +    H N
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIK-----KIE--PFDKPLFALRTLREIKILKHFKHEN 70

Query: 143 VVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           +++                 +I E M    L + I    S+ +   L    +        
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQM---LSDDHIQYFIYQTL 122

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI- 256
           R ++ LH      ++H D+KP N+L+  +   K+ DFGLA++ ++  +  S    + +  
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 257 -GYI------APEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             ++      APEV        S   DV+S G ++ E+ + R
Sbjct: 180 VEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.9 bits (144), Expect = 3e-10
 Identities = 31/187 (16%), Positives = 54/187 (28%), Gaps = 44/187 (23%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVL---KNSKVNGE------EFINEVASMSK------ 137
           K+G+G FG V++    D   VA+K++       VNG       E + E+    +      
Sbjct: 27  KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 138 ---TSHVNVVSFLGF--CYEKKKRALIYEFM----PNGSLDQFIYDEESSNINRKLE--- 185
                    +               L+  +       GS +      +   +   LE   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 186 --------------WRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI 231
                           T   I   +   L       ++R  H D+   N+LL +    K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKL 203

Query: 232 SDFGLAK 238
                 K
Sbjct: 204 HYTLNGK 210

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 31/160 (19%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---------EVASMSKTSHVN 142
            +G G +G V +     + R+VA+K     K+    F +         E+A +++ +H +
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIK-----KIL-RVFEDLIDCKRILREIAILNRLNHDH 113

Query: 143 VVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           VV  L     K         ++ E   +    +       + +   L    +  +   + 
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPV--YLTELHIKTLLYNLL 166

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA 237
            G++Y+H      I+H D+KP N L+ +D   K+ DFGLA
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 53/326 (16%), Positives = 112/326 (34%), Gaps = 71/326 (21%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---------EVASMSKTSHVN 142
            +G+G +G VY        + VA+K  K +++    F +         E+  +++     
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIK--KVNRM----FEDLIDCKRILREITILNRLKSDY 86

Query: 143 VVSFLGFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIA 197
           ++                  ++ E   +  L +       + I   L    +  I   + 
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK----TPI--FLTEEHIKTILYNLL 139

Query: 198 RGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG 257
            G  ++H      I+H D+KP N LL +D   K+ DFGLA+    ++    +        
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 258 --------------------YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK 297
                               Y APE+        +   D++S G +  E++   ++    
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 298 VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEG--STEDLQIPP 355
            +    + FP S    + P    +        EK    ++ ++  ++ G  + +DL+   
Sbjct: 256 PTNRFPL-FPGSSCFPLSPDRNSK-----KVHEKSNRDQLNIIFNII-GTPTEDDLK--- 305

Query: 356 KPSLSSPR-----RSAQQSPPASLST 376
             +++ P      +      P +L  
Sbjct: 306 --NINKPEVIKYIKLFPHRKPINLKQ 329

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 50/232 (21%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN---------EVASMSK-TSH 140
            KLG+G +G V+K      G +VAVK  K        F N         E+  +++ + H
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDA----FQNSTDAQRTFREIMILTELSGH 68

Query: 141 VNVVSFLGFCYEKKKRA--LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIAR 198
            N+V+ L        R   L++++M    L   I       ++++     + Q+     +
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY---VVYQLI----K 120

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIG- 257
            ++YLH G    ++H D+KP NILL  +   K++DFGL++         + +        
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 258 ------------------YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                             Y APE+        +   D++S G ++ E++ G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 3e-08
 Identities = 58/423 (13%), Positives = 120/423 (28%), Gaps = 136/423 (32%)

Query: 17  VVGIIVILVILLLVGLRHIRKKKTENDQNDFGF--GRFRKKNTENENAEAAFI--RNYVS 72
           V G + +   LL      ++K   E  + ++ F     + +  +       +I  R+ + 
Sbjct: 61  VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 73  LAPKRYNYSDVKR--MTNSFSNKL------------GQGGFG-SVYKGKLPDGRLVAVKV 117
              + +   +V R          L            G  G G +           VA+ V
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW----------VALDV 170

Query: 118 LKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE-----KKKRALIYEFMPNGS--LDQ 170
             + KV   +   ++  ++          L  C       +  + L+Y+  PN +   D 
Sbjct: 171 CLSYKVQ-CKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 171 FI-----YDEESSNINRKLE-------------------WRTM---CQIAV-----GIAR 198
                       + + R L+                   W      C+I +      +  
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 199 GLEYLHRGCNIRIVHFDIKPHNILLGED----FCPKISDFGLAKLSEKKES----FISML 250
            L            H  +  H++ L  D       K  D     L  +  +     +S++
Sbjct: 280 FLSAATT------THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333

Query: 251 GARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------E 303
                          R+        D + +      +   +    ++ SL+        +
Sbjct: 334 AES-----------IRDG---LATWDNWKH------VNCDKLTTIIESSLNVLEPAEYRK 373

Query: 304 IY-----FPNSIYKHIEPGNEFQL--AGVVTEEEKEMAKKMI---LVLEMLEGST---ED 350
           ++     FP S   HI P     L    V+  +   +  K+    LV +  + ST     
Sbjct: 374 MFDRLSVFPPSA--HI-PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS 430

Query: 351 LQI 353
           + +
Sbjct: 431 IYL 433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 53/293 (18%), Positives = 90/293 (30%), Gaps = 88/293 (30%)

Query: 93  KLGQGGFGSVYKG--KLPDGRLVAVKVLKNSK---------VNGEEFINEVASMSKTSHV 141
            LG+G FG V +          VA+K+++N           +N  + I E    +K    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF--- 82

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
             V    +        + +E      L +  ++    N  +      +  +A  +   L 
Sbjct: 83  LCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCP-------------------KISDFGLA-KLSE 241
           +LH     ++ H D+KP NIL                          +++DFG A    E
Sbjct: 138 FLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFG-GVSHKSDVYSYGMMILEMVVGRKNAEVKVSL 300
              + ++      T  Y  PEV       G +   DV+S G ++ E   G          
Sbjct: 195 HHTTIVA------TRHYRPPEVI---LELGWAQPCDVWSIGCILFEYYRG---------- 235

Query: 301 SSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL-----EMLEGST 348
                F                    T E +E    M  +L      M+  + 
Sbjct: 236 --FTLFQ-------------------THENREHLVMMEKILGPIPSHMIHRTR 267

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 86/294 (29%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSK-----TSHVNVVSF 146
           K+G G FG V   + + + +  AVKV++N K        E   + K      ++ N+V +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G         LI+E      L   +Y+  + N         +    + I + L YL + 
Sbjct: 102 HGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK- 155

Query: 207 CNIRIVHFDIKPHNILLGEDFCP-------------------------KISDFGLA-KLS 240
             + + H D+KP NILL + +                           K+ DFG A   S
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213

Query: 241 EKKESFISMLGARGTIGYIAPEVFCRNFG-GVSHKSDVYSYGMMILEMVVGRKNAEVKVS 299
           +   S I+      T  Y APEV       G    SD++S+G ++ E+  G         
Sbjct: 214 DYHGSIIN------TRQYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTG--------- 255

Query: 300 LSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL-----EMLEGST 348
               + F                    T E  E    M  ++      ML  +T
Sbjct: 256 ---SLLFR-------------------THEHMEHLAMMESIIQPIPKNMLYEAT 287

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 64/293 (21%), Positives = 97/293 (33%), Gaps = 88/293 (30%)

Query: 93  KLGQGGFGSVYKGK--LPDGRLVAVKVLKNSK---------VNGEEFINEVASMSKTSHV 141
            LG+G FG V +       GR VAVK++KN           +   E +N        S  
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT---TDPNSTF 77

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
             V  L +        +++E      L    YD    N         + ++A  I + + 
Sbjct: 78  RCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCP-------------------KISDFGLA-KLSE 241
           +LH     ++ H D+KP NIL  +                       K+ DFG A    E
Sbjct: 133 FLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 242 KKESFISMLGARGTIGYIAPEVFCRNFG-GVSHKSDVYSYGMMILEMVVGRKNAEVKVSL 300
              + +S      T  Y APEV       G S   DV+S G +++E  +G          
Sbjct: 190 HHSTLVS------TRHYRAPEVI---LALGWSQPCDVWSIGCILIEYYLG---------- 230

Query: 301 SSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVL-----EMLEGST 348
                FP                   T + KE    M  +L      M++ + 
Sbjct: 231 --FTVFP-------------------THDSKEHLAMMERILGPLPKHMIQKTR 262

>1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154

 Score = 38.8 bits (89), Expect = 8e-04
 Identities = 14/53 (26%), Positives = 22/53 (41%), Gaps = 23/53 (43%)

Query: 330 EKEMAKKMILVLEMLEGSTEDLQIPPKPSLSSPRRSAQQSPPASLSTELASLE 382
           EK+  KK       L+ S   L+      L +       S PA L+ + A++E
Sbjct: 18  EKQALKK-------LQAS---LK------LYAD-----DSAPA-LAIK-ATME 47

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	386
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.27
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.59
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.59
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.52
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.29
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.12
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.91
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.72
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.71
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.68
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.54
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.53
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.0
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.86
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.29
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.1
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.79
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.71
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.38
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.68
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.32
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.17
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	90.12
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.98
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.49
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	86.43
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	83.66
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	82.98
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	81.52

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.2e-58  Score=417.92  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=215.9

Q ss_pred             HHHHHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           83 VKRMTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        83 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      +...+..|.++||+|+||+||+|.+.      +++.||||+++...  ...++|.+|+.++++++|||||+++|+|.+.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            33344567889999999999999862      46789999997543  34578999999999999999999999999999


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG  224 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~  224 (386)
                      ..++|||||++|+|.++|......          .....++|..++.++.|||.||+|||++   +||||||||+||||+
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence            999999999999999999654321          1235699999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCc
Q 038768          225 EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSE  303 (386)
Q Consensus       225 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  303 (386)
                      +++.+||+|||+++...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||.....    
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----  253 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----  253 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999977655444334456799999999999764  79999999999999999998 8999986532    


Q ss_pred             ccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          304 IYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                          .++.+.+..+..+..+..+++++.+++.+|+..++..||+..++
T Consensus       254 ----~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei  297 (308)
T 4gt4_A          254 ----QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI  297 (308)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                45667777777677888999999999999999999888876543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-57  Score=410.87  Aligned_cols=244  Identities=24%  Similarity=0.355  Sum_probs=214.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||+||+|+. .+|+.||||++.+.    ....+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            45678999999999999986 46899999999742    34457899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |++|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999653      5699999999999999999999998   999999999999999999999999999998765


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ........+.+||+.|||||++.+.  .++.++|||||||++|||+||+.||...+.        ..+.++|..+. +.+
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~-~~~  253 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLE-YDF  253 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC-CCC
T ss_pred             CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-CCC
Confidence            4433334567899999999999775  789999999999999999999999986532        45566665554 567


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+|+++++++.+||+.++.-|.+++++
T Consensus       254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          254 PEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             CTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             CcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence            88899999999999999999999998875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-57  Score=420.22  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      |.+.++||+|+||+||+|+. .+|+.||||++.......   +.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            34568899999999999986 469999999998655443   56889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...+    ...+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~gg~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          106 EGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             TTCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCcHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999996542    24578999999999999999999998   9999999999999999999999999999877543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ...  ....+||+.|||||++.+.  .|+.++|||||||++|||+||+.||...+.        ..+..++..+..+.++
T Consensus       179 ~~~--~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~~~  246 (350)
T 4b9d_A          179 VEL--ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSFPPVS  246 (350)
T ss_dssp             HHH--HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCCC
T ss_pred             ccc--ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCC
Confidence            221  2245699999999999764  789999999999999999999999986532        4555666666666778


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQ  352 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~  352 (386)
                      ..+|+++++++.+||+.++.-|++++++.
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l  275 (350)
T 4b9d_A          247 LHYSYDLRSLVSQLFKRNPRDRPSVNSIL  275 (350)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            88999999999999998888888766653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-57  Score=413.20  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=211.6

Q ss_pred             hhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.++||+|+||+||+|++.      ++..||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++|||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            45688999999999999863      477899999986432 24679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccccc-------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          162 FMPNGSLDQFIYDEES-------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ||++|+|.++|+....       ......++|..++.++.||+.||+|||++   +||||||||+|||+++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence            9999999999976431       12235799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhh
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      |+++...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||....        +.++...
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~~~  242 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVIEC  242 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHH
Confidence            999877655544444445699999999999764  79999999999999999999 899998653        2556677


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..+..+..+++++.+++.+|+..++..|++.+++
T Consensus       243 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i  280 (299)
T 4asz_A          243 ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI  280 (299)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            77777677888999999999999999999888876554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-56  Score=412.82  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=203.0

Q ss_pred             hhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.++||+|+||+||+|++.      +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++|||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45688999999999999864      478999999976432 34679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccc---------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          162 FMPNGSLDQFIYDEESS---------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      ||++|+|.++++.....         ....+++|..++.|+.||+.||+|||+.   +||||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence            99999999999765321         1235699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||+++...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||.....        .++.
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~  270 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAI  270 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHH
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999977655443333456799999999999764  79999999999999999999 8999986432        4566


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+..+..+..+++++.+++.+|+..++.-|++.+++
T Consensus       271 ~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  310 (329)
T 4aoj_A          271 DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV  310 (329)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence            6777777777888999999999999999888888775544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.8e-56  Score=410.92  Aligned_cols=248  Identities=25%  Similarity=0.316  Sum_probs=211.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC-CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.++||+|+||+||+|... +|+.||||++... ....+.+.+|+++|+.++|||||++++++.+.+..|||||||++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            344578999999999999874 6999999999753 33456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++..       ..+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+++.......
T Consensus       156 g~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          156 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999854       3589999999999999999999998   999999999999999999999999999987654432


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc--ccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF--QLA  323 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~  323 (386)
                      .  ....+||+.|||||++.+.  .|+.++|||||||++|||++|+.||.....        ..+.+.|..+..+  ..+
T Consensus       226 ~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~~~~~  293 (346)
T 4fih_A          226 R--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPRLKNL  293 (346)
T ss_dssp             C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSSCCCCSCG
T ss_pred             c--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCCcc
Confidence            1  2356799999999998764  789999999999999999999999986532        3444555444322  335


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..+|+++++++.+||..++.-|++++++..||--
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~  327 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL  327 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            6789999999999999999999999998888753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-55  Score=401.81  Aligned_cols=245  Identities=31%  Similarity=0.457  Sum_probs=195.2

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.++||+|+||+||+|++++  .||||+++......   +.|.+|+.++++++|||||+++|+|. .+..++|||||+
T Consensus        38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~  114 (307)
T 3omv_A           38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCE  114 (307)
T ss_dssp             CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCS
T ss_pred             eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCC
Confidence            3467899999999999998743  59999997544333   57899999999999999999999885 467899999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.++|+...     ..+++..++.|+.|||.||+|||++   +||||||||+|||+++++.+||+|||+|+......
T Consensus       115 gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          115 GSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             SCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             CCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999996542     4699999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC----cc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG----NE  319 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~----~~  319 (386)
                      .........||+.|||||++.+. .+.++.++|||||||++|||+||+.||.....       ...+...+..+    ..
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-------RDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHTTCCCCCS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCCc
Confidence            33334456799999999998643 24589999999999999999999999975422       12222222222    22


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..++..+++++.+++.+|+..++.-||+..+
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  290 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQ  290 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            3456788999999999999988888877554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-55  Score=395.85  Aligned_cols=243  Identities=28%  Similarity=0.390  Sum_probs=205.1

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEe----cCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYE----KKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e  161 (386)
                      |.++||+|+||+||+|... ++..||+|++......   .+.|.+|++++++++|||||+++++|.+    .+..|+|||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            4568999999999999864 5889999999754433   3568999999999999999999999876    345799999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeC-CCCceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLG-EDFCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~  238 (386)
                      ||++|+|.+++...      ..+++..+..++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+|+
T Consensus       110 y~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          110 LMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999653      5689999999999999999999997   6  99999999999998 48999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ......    ..+.+||+.|||||++.+   .++.++|||||||++|||+||+.||.....       ...+.+.+..+.
T Consensus       181 ~~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~  246 (290)
T 3fpq_A          181 LKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGV  246 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTC
T ss_pred             eCCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCC
Confidence            654432    234579999999999853   589999999999999999999999975321       244556666554


Q ss_pred             c-ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 E-FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ~-~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      . ..++..+++++++++.+|+..++.-|++++++..||
T Consensus       247 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp  284 (290)
T 3fpq_A          247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            3 356778899999999999999999999988877665

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-55  Score=395.02  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=197.6

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++.+..    ...+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            44568899999999999986 469999999997543    2345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      | +|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        95 ~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           95 A-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             C-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             C-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9 78999998653      5699999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...   ..+.+||+.|||||++.+. ..++.++|||||||++|||+||+.||...+.        ..+.+.+..+. +.+
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~-~~~  231 (275)
T 3hyh_A          165 GNF---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGV-YTL  231 (275)
T ss_dssp             -------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC-CCC
T ss_pred             CCc---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCC-CCC
Confidence            332   2346799999999999765 2356899999999999999999999986432        44556665554 567


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..+|+++++++.+||+.++.-|++++++..||
T Consensus       232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence            788999999999999999999999888775554

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5e-55  Score=412.24  Aligned_cols=247  Identities=25%  Similarity=0.329  Sum_probs=211.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.++||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+..|||||||++|
T Consensus       154 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG  233 (423)
T 4fie_A          154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  233 (423)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCC
Confidence            3457899999999999986 469999999997543 34567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++..       ..+++..+..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       234 ~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          234 ALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             EHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             cHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            99999854       3589999999999999999999999   999999999999999999999999999987654432 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc--cccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF--QLAG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~  324 (386)
                       .....+||+.|||||++.+.  .|+.++|||||||++|||++|+.||.....        ..+.+.|..+..+  ....
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~~~~~~  371 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPRLKNLH  371 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCSCTT
T ss_pred             -cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCcccc
Confidence             12356799999999999764  789999999999999999999999976532        3344555444322  3356


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+|+++++++.+||..++.-|++++++..||--
T Consensus       372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~  404 (423)
T 4fie_A          372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL  404 (423)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence            789999999999999999999999998887753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-55  Score=400.05  Aligned_cols=239  Identities=24%  Similarity=0.255  Sum_probs=198.3

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.++||+|+||+||+|+. .+|+.||||+++.....    .+|+.+++.++|||||++++++.+.+..|||||||++|+|
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            357899999999999986 46899999999865432    4799999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCcccCcccce-
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEKKESF-  246 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~-  246 (386)
                      .+++...      ..+++..++.++.||+.||+|||++   +||||||||+||||+.++ .+||+|||+++........ 
T Consensus       138 ~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          138 GQLIKQM------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999653      4699999999999999999999998   999999999999999887 6999999999876543221 


Q ss_pred             --eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--cccc
Q 038768          247 --ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EFQL  322 (386)
Q Consensus       247 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~  322 (386)
                        ......+||+.|||||++.+.  .++.++|||||||++|||+||+.||.....        ..+..+|..+.  ...+
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~  278 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--------GPLCLKIASEPPPIREI  278 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--------SCCHHHHHHSCCGGGGS
T ss_pred             ceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHcCCCCchhc
Confidence              122345799999999999765  789999999999999999999999986533        12223332222  2346


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++++++++.+|+..++.-|+++.++
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el  307 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMEL  307 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            77899999999999999999999887664

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-55  Score=400.80  Aligned_cols=246  Identities=26%  Similarity=0.330  Sum_probs=201.6

Q ss_pred             hhhhhccCcCCceEEEEEEe----CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.+.+.||+|+||+||+|+.    .+++.||||++++...   ....+.+|++++++++|||||++++++.+.+..|+||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            34568899999999999975    2478999999975322   2346889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      |||++|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       106 Ey~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             CCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999653      5699999999999999999999998   9999999999999999999999999999865


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .....  ...+.+||+.|||||++.+.  .++.++|||||||++|||+||+.||...+.        .++...|..+. +
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~-~  243 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKAK-L  243 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-C
T ss_pred             cCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcCC-C
Confidence            43322  12356799999999999764  789999999999999999999999986532        44555655544 5


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCC-----CCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTE-----DLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~-----~~~~~p  355 (386)
                      .++..+|+++++++.+||+.++.-|+++.     ++..||
T Consensus       244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp  283 (304)
T 3ubd_A          244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS  283 (304)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence            67788999999999999999999998753     455554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-54  Score=400.78  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=215.1

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeCC------CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCC-CccceEEEEEEe
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVN--GEEFINEVASMSKTSH-VNVVSFLGFCYE  152 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h-~niv~~~~~~~~  152 (386)
                      |+.+..+.+.++||+|+||+||+|.+..      ++.||||+++.....  .++|.+|+++|.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            4555566678999999999999998532      358999999865432  3579999999999965 899999999976


Q ss_pred             c-CceeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 038768          153 K-KKRALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNI  221 (386)
Q Consensus       153 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Ni  221 (386)
                      . +..++|||||++|+|.++|+.....          .....+++..++.++.|||.||+|||++   +||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence            5 5689999999999999999764321          1234589999999999999999999998   999999999999


Q ss_pred             EeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCccccccc
Q 038768          222 LLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSL  300 (386)
Q Consensus       222 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~  300 (386)
                      |+++++.+||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||..... 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-  293 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-  293 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCH-
Confidence            9999999999999999987665555555567799999999999764  79999999999999999998 9999986422 


Q ss_pred             CCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          301 SSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       301 ~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                            ...+.+.+..+..+..+..+++++.+++.+|+..++..|++..++
T Consensus       294 ------~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei  338 (353)
T 4ase_A          294 ------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  338 (353)
T ss_dssp             ------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence                  244556666677777888999999999999999999988876543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-52  Score=379.55  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=192.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCc---------
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKK---------  155 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---------  155 (386)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++....  ..+.+.+|+++|++++|||||++++++.+.+.         
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            34468899999999999986 4689999999975432  23678999999999999999999999986553         


Q ss_pred             ---eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          156 ---RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       156 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                         .|+|||||++|+|.+++.....   ....++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence               6899999999999999976432   23456778899999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccce----------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC
Q 038768          233 DFGLAKLSEKKESF----------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS  302 (386)
Q Consensus       233 Dfgl~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  302 (386)
                      |||+|+........          ....+.+||+.|||||++.+.  .++.++|||||||++|||++   ||.....   
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~---  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME---  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH---
Confidence            99999876543221          122345799999999999764  78999999999999999997   7764321   


Q ss_pred             cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       303 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                          .......+.....+......+++..+++.+|++.+|.-|+++.++..+|
T Consensus       233 ----~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~  281 (299)
T 4g31_A          233 ----RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA  281 (299)
T ss_dssp             ----HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ----HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence                1223334444444555556678899999999999999999988876655

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.3e-52  Score=379.68  Aligned_cols=254  Identities=20%  Similarity=0.256  Sum_probs=188.9

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecC----ceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK----KRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~  164 (386)
                      .+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|+|.+.+    ..+||||||+
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            3457899999999999998 6899999999754332233445666778899999999999998765    4789999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-----NIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      +|+|.++++.       ..++|..+.+++.|++.||+|||+++     .++|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           85 HGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             TCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999964       35889999999999999999999752     34899999999999999999999999999987


Q ss_pred             cCccccee--eeccccCccccccccccchhc----CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cc
Q 038768          240 SEKKESFI--SMLGARGTIGYIAPEVFCRNF----GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YF  306 (386)
Q Consensus       240 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~  306 (386)
                      ........  ......||+.|||||++.+..    ..++.++|||||||++|||+||+.||.........+       ..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            65443221  223457999999999986531    136789999999999999999998876443221110       01


Q ss_pred             hhhhhhhcC-CCccccccccC-----ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          307 PNSIYKHIE-PGNEFQLAGVV-----TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       307 ~~~~~~~i~-~~~~~~~~~~~-----s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+.+.+. .+..+.++...     .+.+.+++.+|+..++..|+++.+
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  287 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence            122333332 22234443322     246778888888888888876544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=380.38  Aligned_cols=258  Identities=21%  Similarity=0.254  Sum_probs=202.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEec------Ccee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEK------KKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  157 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++++.....   +.+.+|+++|+.++|||||++++++...      +..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            44568999999999999986 469999999998654433   5678999999999999999999998643      5689


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +|||||+ |+|.+++...      ..+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||++
T Consensus       136 ivmE~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            9999995 7899999653      5799999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccc--eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchh
Q 038768          238 KLSEKKES--FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPN  308 (386)
Q Consensus       238 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~  308 (386)
                      +.+.....  .....+.+||+.|||||++.+. ..++.++||||+||++|||++|+.||...+....       ....+.
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            87643321  1223456899999999998764 3679999999999999999999999976532110       000000


Q ss_pred             hhhh------------hcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          309 SIYK------------HIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       309 ~~~~------------~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+.            .+....   ...+...+++++.+|+.+||..++.-|.+++++..||-
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  347 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF  347 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence            0110            010000   11123457999999999999999999999999888874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-49  Score=391.39  Aligned_cols=246  Identities=25%  Similarity=0.325  Sum_probs=202.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHH---HHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFIN---EVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.||+|+||+||+|+.. +|+.||||++.+.    ......+.+   ++.+++.++|||||++++++.+.+..|+|||
T Consensus       193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE  272 (689)
T 3v5w_A          193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD  272 (689)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence            3578999999999999864 6999999999742    223333334   4677788899999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      ||+||+|.+++...      ..+++..++.++.||+.||+|||++   +||||||||+||||+.+|.+||+|||+|+...
T Consensus       273 y~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          273 LMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             CCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999653      5699999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...    ..+.+||+.|||||++.+. ..|+.++|||||||++|||++|+.||.......     ...+.+.+... .+.
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~-~~~  412 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTM-AVE  412 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHC-CCC
T ss_pred             CCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCC-CCC
Confidence            543    2356799999999998643 368999999999999999999999998653321     12333443333 255


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      ++..+|+++++++.+||..++.-|.+     ++++..||
T Consensus       413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence            77889999999999999999998865     34555555

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-49  Score=371.59  Aligned_cols=254  Identities=19%  Similarity=0.285  Sum_probs=196.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.++||+|+||+||+|+.+    .++.||+|.+... .....+.+|+++|..+ +||||+++++++.+.+..|+||||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~  101 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY  101 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence            445689999999999999752    4678999998754 3456788999999988 699999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCcccC
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSE  241 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~  241 (386)
                      |++|+|.+++         ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       102 ~~g~~L~~~~---------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          102 LEHESFLDIL---------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CCCCCHHHHH---------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCcccHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999998         3488999999999999999999998   99999999999999876 799999999998654


Q ss_pred             cccc--------------------------eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcc
Q 038768          242 KKES--------------------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE  295 (386)
Q Consensus       242 ~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~  295 (386)
                      ....                          .......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            3211                          0112235799999999998764 368999999999999999999999995


Q ss_pred             cccccCC---------------------------cccch----hhhhhhcCCC---------------ccccccccCChH
Q 038768          296 VKVSLSS---------------------------EIYFP----NSIYKHIEPG---------------NEFQLAGVVTEE  329 (386)
Q Consensus       296 ~~~~~~~---------------------------~~~~~----~~~~~~i~~~---------------~~~~~~~~~s~~  329 (386)
                      .......                           ....|    ....+.+...               ........+|++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            3321000                           00000    0001111100               011224568999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          330 EKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       330 ~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +.+|+.+||+.+|.-|.+++++..||
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp  354 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHP  354 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCc
Confidence            99999999999999999988877776

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.5e-49  Score=387.82  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=209.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||+|++..... ..+.+.+|+++|+.++|||||++++++.+.+..|+|||||++
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            45568999999999999986 4699999999976443 346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC--CceEEeeccCCcccCcc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED--FCPKISDFGLAKLSEKK  243 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~  243 (386)
                      |+|.+++....     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       239 g~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          239 GELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999986432     4689999999999999999999998   99999999999999854  89999999999987655


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EF  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~  320 (386)
                      ...   ...+||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        .++...|..+.   ..
T Consensus       311 ~~~---~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~  377 (573)
T 3uto_A          311 QSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDD  377 (573)
T ss_dssp             SEE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCCCCS
T ss_pred             Cce---eeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCCCCCCc
Confidence            432   245699999999999775  789999999999999999999999986532        34455554443   22


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .....+|++++++|.+||..++.-|+++.++..||
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp  412 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  412 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            34567899999999999999999998877765554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3e-46  Score=346.07  Aligned_cols=246  Identities=22%  Similarity=0.373  Sum_probs=209.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   97 (328)
T 3fe3_A           18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence            3457899999999999986 57999999999764433   3568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++...      ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           98 GGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             TCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999653      4689999999999999999999998   99999999999999999999999999998665443


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .   .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.....        ..+.+.+..+. ..++.
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-~~~p~  235 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGK-YRIPF  235 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCCCT
T ss_pred             c---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCCCC
Confidence            2   2345799999999999765 2345899999999999999999999986532        34444444443 45677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .++++..+++.+|+..++.-|++++++..+|-
T Consensus       236 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          236 YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence            89999999999999999999999998877764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-45  Score=341.27  Aligned_cols=236  Identities=25%  Similarity=0.324  Sum_probs=200.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||+||+|+.. +|+.||+|++++.    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~   87 (337)
T 1o6l_A            8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            34578999999999999864 6899999999752    345567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|..++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           88 NGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             TTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999998643      4689999999999999999999998   9999999999999999999999999999864332


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+..+. ..++
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-~~~p  225 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-IRFP  225 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCCC
T ss_pred             CC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-CCCC
Confidence            21  12345699999999998764  689999999999999999999999975432        33444443332 4567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ..+++++++++.+|+..++.-|.
T Consensus       226 ~~~s~~~~~li~~lL~~dP~~R~  248 (337)
T 1o6l_A          226 RTLSPEAKSLLAGLLKKDPKQRL  248 (337)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTST
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhc
Confidence            78999999999999999988886

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-45  Score=338.09  Aligned_cols=252  Identities=24%  Similarity=0.283  Sum_probs=204.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||+||+|... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~   89 (323)
T 3tki_A           10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   89 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence            34578999999999999875 789999999865432  236688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus        90 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           90 GELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999998543      4689999999999999999999998   999999999999999999999999999987654433


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      ........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.......      ..................
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~  233 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKK  233 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------HHHHHHHTTCTTSTTGGG
T ss_pred             ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhcccccCCcccc
Confidence            2223356799999999998654 234789999999999999999999998653311      111111222222333467


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +++++.+++.+|+..++.-|++++++..+|-
T Consensus       234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          234 IDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            8999999999999999999998887766653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.8e-45  Score=344.50  Aligned_cols=250  Identities=23%  Similarity=0.425  Sum_probs=207.2

Q ss_pred             hhhhhccCcCCceEEEEEEe--------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCce
Q 038768           88 NSFSNKLGQGGFGSVYKGKL--------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  156 (386)
                      +.+.+.||+|+||.||+|..        .++..||||+++.....  .+.+.+|+.+++.+ +||||++++++|.+.+..
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  162 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  162 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence            34568899999999999975        23567999999865332  25789999999999 899999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      ++||||+++|+|.+++......          .....+++..++.++.||+.||+|||++   +|+||||||+|||++.+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence            9999999999999999764321          1124588999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCccc
Q 038768          227 FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIY  305 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  305 (386)
                      +.+||+|||+++...............+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||.....      
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~------  311 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------  311 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            99999999999876554433333345678899999998664  78999999999999999999 9999976432      


Q ss_pred             chhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          306 FPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       306 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                        ..+...+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       312 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  354 (370)
T 2psq_A          312 --EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ  354 (370)
T ss_dssp             --GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence              3455556666666678889999999999999988888876544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5e-45  Score=341.93  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=208.0

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|+++....       ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            345688999999999999874 689999999976432       246799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----ceEEeecc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF----CPKISDFG  235 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  235 (386)
                      |||+++|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        94 ~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           94 LELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999543      4689999999999999999999998   999999999999998776    79999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++........   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ......+.
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~  231 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANIT  231 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHH
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            9987655432   2345699999999998654  689999999999999999999999976432        33444444


Q ss_pred             CCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 PGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 ~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+.   .......+++++++++.+|+..++.-|+++.++..||-
T Consensus       232 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          232 AVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             hcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            333   22334678999999999999999999999888776664

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.3e-45  Score=340.31  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|+.. +|+.||+|++++.    ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            34578999999999999874 6899999999753    34456788899999876 899999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A          100 LNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            9999999999653      4689999999999999999999998   999999999999999999999999999986433


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+++.+..+. +.+
T Consensus       171 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-~~~  237 (345)
T 1xjd_A          171 GDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN-PFY  237 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCC
T ss_pred             CCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-CCC
Confidence            221  12346799999999999764  689999999999999999999999986432        44555554443 556


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCC-CCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTE-DLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~-~~~~~p  355 (386)
                      +..+++++++++.+|+..++.-|+++. ++..||
T Consensus       238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp  271 (345)
T 1xjd_A          238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  271 (345)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence            778999999999999999999998876 665554

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=344.00  Aligned_cols=238  Identities=24%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||+||+|+.. +|+.||+|++++.    ....+.+.+|..++..+ +||||+++++++.+.+..|+||||
T Consensus        26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~  105 (353)
T 3txo_A           26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF  105 (353)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence            44688999999999999864 5899999999753    23446688999999988 699999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|..++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          106 VNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999653      4689999999999999999999998   999999999999999999999999999985433


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+++.+..+. ..+
T Consensus       177 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~-~~~  243 (353)
T 3txo_A          177 NGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE-VVY  243 (353)
T ss_dssp             -----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCC
T ss_pred             CCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-CCC
Confidence            221  12345799999999999765  689999999999999999999999986532        44555554443 556


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      +..+++++++++.+|+..++.-|.++
T Consensus       244 p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          244 PTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            77899999999999999999988876

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-45  Score=335.74  Aligned_cols=242  Identities=27%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+++.. +|+.||+|++++.    ....+.+.+|..+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   88 (318)
T 1fot_A            9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   88 (318)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence            34578999999999999874 6899999999753    234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           89 EGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999653      4688999999999999999999998   9999999999999999999999999999866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...++.+..+. ..++
T Consensus       160 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-~~~p  223 (318)
T 1fot_A          160 T-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE-LRFP  223 (318)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC-CCCC
T ss_pred             c-----ccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCCC
Confidence            2     245699999999998764  689999999999999999999999976432        33344443332 4567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p  355 (386)
                      ..+++++++++.+|+..++.-|.     +++++..||
T Consensus       224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp  260 (318)
T 1fot_A          224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  260 (318)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence            78999999999999998888876     455554444

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-44  Score=330.99  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC-CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||+||+|.. .+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  102 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence            3457899999999999985 57899999998643 345677899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++..       ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.........
T Consensus       103 ~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A          103 SLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             BHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            99999854       3588999999999999999999998   9999999999999999999999999999866543321


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC--CCccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE--PGNEFQLAG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~--~~~~~~~~~  324 (386)
                        .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+.  .......+.
T Consensus       173 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  240 (297)
T 3fxz_A          173 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTPELQNPE  240 (297)
T ss_dssp             --BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSCCCSCGG
T ss_pred             --cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCCcc
Confidence              2345699999999998664  689999999999999999999999975432        11111111  111234467


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+++.+++++.+|+..++.-|++++++..+|--
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  273 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL  273 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence            789999999999999999999999988877654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-45  Score=351.67  Aligned_cols=245  Identities=22%  Similarity=0.280  Sum_probs=196.8

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.++||+|+||+||+|+.. +++.||+|++++.    ....+.+.+|..++..++||||++++++|.+.+..++||||++
T Consensus        78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~  157 (437)
T 4aw2_A           78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV  157 (437)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence            3578999999999999875 4789999999742    2233458899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       158 gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          158 GGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             TCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999996532     4689999999999999999999998   99999999999999999999999999998665443


Q ss_pred             ceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---
Q 038768          245 SFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---  318 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---  318 (386)
                      .. .....+||+.|+|||++...   ...++.++|||||||++|||++|+.||.....        ......|....   
T Consensus       230 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          230 TV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKERF  300 (437)
T ss_dssp             CE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHHHC
T ss_pred             Cc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHHhhhhccccc
Confidence            32 22345799999999998631   23588999999999999999999999986532        33334433221   


Q ss_pred             -cccccccCChHHHHHHHHHHHHHHHh--cCCCCCC
Q 038768          319 -EFQLAGVVTEEEKEMAKKMILVLEML--EGSTEDL  351 (386)
Q Consensus       319 -~~~~~~~~s~~~~~li~~ml~v~~~L--~~~~~~~  351 (386)
                       .+.....+++++++++++||...+.-  |++++++
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei  336 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF  336 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence             12223458999999999999755443  3444333

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-44  Score=332.84  Aligned_cols=260  Identities=25%  Similarity=0.322  Sum_probs=212.8

Q ss_pred             CccccHHHHHHHHhh------------hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC-CChHHHHHHHHHhhcCCC
Q 038768           75 PKRYNYSDVKRMTNS------------FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK-VNGEEFINEVASMSKTSH  140 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~------------~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h  140 (386)
                      +..+++.++..++..            ..+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            345677777666643            3468999999999999875 79999999997543 345678999999999999


Q ss_pred             CccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 038768          141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN  220 (386)
Q Consensus       141 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~N  220 (386)
                      |||+++++++...+..++||||+++++|.+++..       ..+++..+..++.|++.||.|||+.   +++||||||+|
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  171 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS  171 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence            9999999999999999999999999999999853       3589999999999999999999998   99999999999


Q ss_pred             eEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc
Q 038768          221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL  300 (386)
Q Consensus       221 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~  300 (386)
                      ||++.++.+||+|||++.........  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..... 
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~-  246 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSP-  246 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred             EEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            99999999999999999876543221  2345699999999998653  688999999999999999999999975432 


Q ss_pred             CCcccchhhhhhhcCCCccc--cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          301 SSEIYFPNSIYKHIEPGNEF--QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       301 ~~~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                             ......+.....+  .....+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       247 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          247 -------VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             -------HHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             -------HHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                   2222333222222  234568999999999999999999999888776654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.2e-45  Score=344.57  Aligned_cols=246  Identities=20%  Similarity=0.293  Sum_probs=201.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||+||+|+.. +++.||+|++++...    ..+.+..|..++.++ +||||+++++++.+.+..++||||
T Consensus        55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~  134 (396)
T 4dc2_A           55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY  134 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence            45688999999999999875 578999999976422    234578899999876 899999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|..++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       135 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          135 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999653      4689999999999999999999998   999999999999999999999999999985332


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-ccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~i~~~~~~~  321 (386)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||......... ......+.+.+.... ..
T Consensus       206 ~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~  280 (396)
T 4dc2_A          206 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR  280 (396)
T ss_dssp             TTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-CC
T ss_pred             CCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-cC
Confidence            221  12356799999999999764  7899999999999999999999999754322111 112233444444333 56


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ++..++.++++++.+||..++.-|.++
T Consensus       281 ~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            778899999999999999999988765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.6e-45  Score=326.86  Aligned_cols=243  Identities=25%  Similarity=0.458  Sum_probs=209.5

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.+.||+|+||.||+|...+++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence            44578999999999999988889999999998877888999999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....... ..
T Consensus        93 ~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  163 (269)
T 4hcu_A           93 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  163 (269)
T ss_dssp             HHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred             HHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence            99996542     4589999999999999999999998   999999999999999999999999999986654322 12


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      .....++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ......+..+.....+..++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~  233 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRLAS  233 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTTSC
T ss_pred             ccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCccCCCCCcCC
Confidence            2344577889999998654  78999999999999999999 9999986432        44555566665566677889


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +++.+++.+|+..++.-|+++.+
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~  256 (269)
T 4hcu_A          234 THVYQIMNHCWRERPEDRPAFSR  256 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHH
Confidence            99999999999999988887554

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.2e-45  Score=338.03  Aligned_cols=245  Identities=22%  Similarity=0.386  Sum_probs=207.0

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|++...    ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA   91 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence            3457899999999999986 57899999998642    233467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                       +|+|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+|||+++++.+||+|||++......
T Consensus        92 -~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           92 -GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             -CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             -CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence             78999988553      4689999999999999999999999   9999999999999999999999999999876554


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..   .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.....        ..+.+.+..+. ..++
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~-~~~p  228 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--------PNLFKKVNSCV-YVMP  228 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS--------TTCBCCCCSSC-CCCC
T ss_pred             cc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCC-CCCc
Confidence            32   2245699999999999764 2347899999999999999999999986432        22334444333 4567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+++++++++.+|+..++.-|++++++..+|-
T Consensus       229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            789999999999999999999999988877763

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.9e-45  Score=338.79  Aligned_cols=242  Identities=21%  Similarity=0.298  Sum_probs=206.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+++.. +|+.||+|++.+.    ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  123 (350)
T 1rdq_E           44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence            34578999999999999874 6899999999653    234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          124 AGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             TTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999653      4589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+..+. ..++
T Consensus       195 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-~~~p  258 (350)
T 1rdq_E          195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK-VRFP  258 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCCC
T ss_pred             c-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCC-CCCC
Confidence            2     245689999999998764  689999999999999999999999986432        44555555443 5567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p  355 (386)
                      ..+++++++++.+|+..++.-|++     ++++..||
T Consensus       259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            789999999999999999988876     44444444

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.5e-45  Score=347.32  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||+||+|+.. +++.||+|++++.    ....+.+.+|+.++..++||||++++++|.+.+..|+||||++
T Consensus        73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  152 (410)
T 3v8s_A           73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP  152 (410)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            3578999999999999875 5889999999652    2334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++..       ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       153 gg~L~~~l~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          153 GGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             TEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            9999999854       3488999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ceeeeccccCccccccccccchhcC--CCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-c--
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFG--GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-E--  319 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-~--  319 (386)
                      . ......+||+.|+|||++.+...  .++.++|||||||++|||++|+.||.....        ....+.|..+. .  
T Consensus       223 ~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~  293 (410)
T 3v8s_A          223 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHKNSLT  293 (410)
T ss_dssp             E-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHHHCC
T ss_pred             c-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHHhcccccc
Confidence            2 22335679999999999975421  278899999999999999999999986532        34445554432 1  


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHh--cCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEML--EGSTEDLQIP  354 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L--~~~~~~~~~~  354 (386)
                      +.....+++++++++++||...+.-  |++++++..|
T Consensus       294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            2223468999999999999855543  4444444333

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-45  Score=337.25  Aligned_cols=246  Identities=20%  Similarity=0.295  Sum_probs=205.5

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      .+.+.||+|+||.||+|... +|+.||+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus         8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence            44678999999999999864 58899999998665556678999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCceEEeeccCCcccCcccc
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE--DFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.  ++.+||+|||+++.......
T Consensus        88 L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           88 IFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             HHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999996432     4689999999999999999999998   9999999999999987  78999999999987765443


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EFQL  322 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~~~  322 (386)
                      .   ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ..+...+..+.   ....
T Consensus       160 ~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~  226 (321)
T 1tki_A          160 F---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEEA  226 (321)
T ss_dssp             E---EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHHH
T ss_pred             c---ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCCCChhh
Confidence            2   234589999999998654  578999999999999999999999976432        22333333222   1122


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ...+++++.+++.+|+..++.-|+++.++..+|
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            356899999999999999999998887765554

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-44  Score=324.81  Aligned_cols=244  Identities=25%  Similarity=0.452  Sum_probs=209.7

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||+|...++..||+|+++......+++.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            34568899999999999999888899999999887788899999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......... 
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  160 (268)
T 3sxs_A           90 LLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-  160 (268)
T ss_dssp             HHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred             HHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence            999996542     4589999999999999999999998   9999999999999999999999999999876554332 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ......+..+.....+..+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  230 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVSQGHRLYRPHLA  230 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCCCCCCTTS
T ss_pred             cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHHcCCCCCCCCcC
Confidence            23345577889999998654  68899999999999999999 9999975432        3344455555556667788


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++++.+++.+|+..++.-|+++.+
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~  254 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQ  254 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHH
Confidence            999999999999998888887554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.8e-44  Score=330.38  Aligned_cols=245  Identities=26%  Similarity=0.430  Sum_probs=194.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.+.||+|+||+||+|+. +|+.||||++.......   +.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS  117 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred             ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence            34568899999999999987 68899999998655443   468899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +|+|.+++....   ....+++..++.++.||+.||+|||+.   +  ++||||||+|||++.++.+||+|||+++....
T Consensus       118 ~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          118 RGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             TCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             CCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999996542   123489999999999999999999998   8  99999999999999999999999999986543


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc-CCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI-EPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i-~~~~~~~  321 (386)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+ .......
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~~~~  259 (309)
T 3p86_A          192 TFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKCKRLE  259 (309)
T ss_dssp             ------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHSCCCCC
T ss_pred             ccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCCCCC
Confidence            321  12345689999999998764  688999999999999999999999985432        2222222 1333456


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++..+++++.+++.+|+..++.-|+++.++
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  289 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATI  289 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            778899999999999999888888775544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=338.40  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=204.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++... +|+.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   97 (384)
T 4fr4_A           18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL   97 (384)
T ss_dssp             EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence            44688999999999999864 5889999998642    344578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|..++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           98 LGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             TTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999653      4689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             cceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ..   .....||+.|+|||++... ...++.++|||||||++|||++|+.||.......     ...+...+... ...+
T Consensus       169 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~~~-~~~~  239 (384)
T 4fr4_A          169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFETT-VVTY  239 (384)
T ss_dssp             CC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHHHC-CCCC
T ss_pred             Cc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhhc-ccCC
Confidence            32   2345799999999998643 2357899999999999999999999997543211     12233333222 2456


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCC-CCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGS-TEDLQIP  354 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~-~~~~~~~  354 (386)
                      +..+++++.+++.+|+..++.-|++ ++++..+
T Consensus       240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            7789999999999999999998876 3444333

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.2e-44  Score=335.64  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=206.5

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      ..+.+.+.||+|+||.||+|... +|+.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34556789999999999999864 68999999998654433   568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~  238 (386)
                      |+++|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+   +.+||+|||++.
T Consensus       109 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          109 LVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             CCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             cCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999998543      4689999999999999999999998   99999999999999864   459999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ..++..+..+.
T Consensus       180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~  246 (362)
T 2bdw_A          180 EVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGA  246 (362)
T ss_dssp             CCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred             EecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCC
Confidence            7664432   2345699999999998654  689999999999999999999999975432        33344443332


Q ss_pred             ---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 ---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         .......+++++++++.+|+..++.-|+++.++..+|
T Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          247 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence               1122356899999999999999999999888876664

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.6e-44  Score=325.43  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=207.4

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||++...++..||+|++.......+++.+|++++.+++|+||+++++++.+.+..++||||+++++
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            34568899999999999999888899999999887788899999999999999999999999999999999999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....... .
T Consensus       106 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          106 LLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             HHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             HHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            999996532     4689999999999999999999998   999999999999999999999999999986654322 1


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....        ......+..+.....+..+
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  246 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLRLYRPHLA  246 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCCCCCCTTC
T ss_pred             cccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhcccCCCCCCcC
Confidence            22344577889999998754  68999999999999999998 9999986532        3445556666656677888


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++++.+++.+|+..++.-|+++.+
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~  270 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKI  270 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHH
Confidence            999999999999999888887554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-44  Score=335.26  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=201.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC----hHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN----GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|+.. +|+.||+|++++....    .+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~   91 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   91 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence            34578999999999999874 5889999999864322    24578899999887 899999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           92 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999643      4689999999999999999999998   999999999999999999999999999986432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-ccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~i~~~~~~~  321 (386)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......... ......+++.+.... ..
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~  237 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR  237 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-CC
T ss_pred             CCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-CC
Confidence            221  12345799999999999764  6899999999999999999999999753221111 112233444444333 55


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ++..++.++++++.+|+..++.-|.++
T Consensus       238 ~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            678899999999999999999988875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.4e-45  Score=342.79  Aligned_cols=246  Identities=24%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.+.||+|+||.||+|.+. +++.||||+++.....  .+.+.+|++++++++||||++++++|.+.+..++||||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  194 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV  194 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence            3345688999999999999985 6899999999754222  246889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....     ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       195 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          195 QGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999996532     4588999999999999999999998   9999999999999999999999999999865443


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ..........++..|+|||.+...  .++.++|||||||++|||++ |+.||.....        ..+.+.+..+.....
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~  336 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPC  336 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCC
T ss_pred             ceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence            221111122357789999998653  68999999999999999998 9999976432        344455555655667


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +..+++++.+++.+|+..++.-|++..+
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~  364 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFST  364 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            7889999999999999999988886544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=332.17  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=202.9

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      ..+.+.+.||+|+||.||+|.+.    .+..||||+++....  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            34455688999999999999873    345799999986432  235789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++|+|.+++....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eeCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999996532     4689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCC
Q 038768          240 SEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       240 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ...... ........+|..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+..+
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~  270 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEG  270 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcC
Confidence            654322 1222334567889999998654  68899999999999999999 9999975432        4455566666


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .....+..+++++.+++.+|+..++.-|+++.+
T Consensus       271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  303 (325)
T 3kul_A          271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ  303 (325)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence            666677889999999999999988888876544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3e-44  Score=335.62  Aligned_cols=237  Identities=22%  Similarity=0.293  Sum_probs=201.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|+.. +|+.||+|++++.    ....+.+..|..++..+ +||||+++++++.+.+..|+||||
T Consensus        23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~  102 (353)
T 2i0e_A           23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  102 (353)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence            44578999999999999875 4789999999753    33456788999999988 799999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A          103 VNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999653      4689999999999999999999998   999999999999999999999999999986432


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+.+.+..+. +.+
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~-~~~  240 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN-VAY  240 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCC
T ss_pred             CCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC-CCC
Confidence            221  12345799999999998764  689999999999999999999999986432        44555554443 556


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      +..+++++++++.+|+..++.-|.+
T Consensus       241 p~~~s~~~~~li~~lL~~dP~~R~~  265 (353)
T 2i0e_A          241 PKSMSKEAVAICKGLMTKHPGKRLG  265 (353)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTSCTT
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCC
Confidence            7789999999999999988888774

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4e-44  Score=329.75  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.++||+|+||+||+|...+|+.||+|++......   .+.+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus        25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~  103 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-K  103 (311)
T ss_dssp             EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-E
T ss_pred             hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-C
Confidence            45789999999999999988999999999754332   3678899999999999999999999999999999999996 5


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       104 ~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          104 DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            8888875532     4589999999999999999999998   999999999999999999999999999987653322 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh-------------
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH-------------  313 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------  313 (386)
                       ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........    ...+...             
T Consensus       175 -~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----LPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----HHHHHHHHCCCCTTTSGGGT
T ss_pred             -cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHHCCCChHHhhhhh
Confidence             12234689999999998654 3689999999999999999999999975432210    0001000             


Q ss_pred             ------------cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 ------------IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 ------------i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                  ........+...+++++.+++.+|+..++.-|++++++..||-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  303 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY  303 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence                        0111112234567899999999999999999999888777664

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-44  Score=330.67  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=206.7

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      .+.+.+.||+|+||.||+|... +|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3556789999999999999874 689999999975432       35779999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----ceEEeec
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF----CPKISDF  234 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df  234 (386)
                      ||||+++++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++    .+||+||
T Consensus        92 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999543      4689999999999999999999998   999999999999999887    7999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      |+++.......   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ......+
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~  229 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANV  229 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHH
T ss_pred             CCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHH
Confidence            99987654332   2245699999999998654  689999999999999999999999975432        2222222


Q ss_pred             CCC---ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          315 EPG---NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       315 ~~~---~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ...   ........+++++++++.+|+..++.-|+++.++..+|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          230 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            211   122334578999999999999999999999888877664

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.7e-44  Score=333.17  Aligned_cols=239  Identities=26%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             hhhhhccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK-----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      +.+.+.||+|+||.||+++.    .+|+.||+|++++..     .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            34568899999999999986    478999999998642     223567889999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++++|.+++...      ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           99 ILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999643      4588999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+....
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~  237 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCK  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCC
Confidence            5433222  12345699999999998664  689999999999999999999999986432        23333333332


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                       ..++..++.++++++.+|+..++.-|+++
T Consensus       238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~  266 (327)
T 3a62_A          238 -LNLPPYLTQEARDLLKKLLKRNAASRLGA  266 (327)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSCGGGSTTS
T ss_pred             -CCCCCCCCHHHHHHHHHHHhcCHhhccCC
Confidence             45667889999999999999999988743

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-44  Score=331.60  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCc---------
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK---------  155 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---------  155 (386)
                      +.+.+.||+|+||.||+|+.. +|+.||||+++...  ...+.+.+|+.++++++||||++++++|.+...         
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            345688999999999999875 78999999997533  334779999999999999999999999876542         


Q ss_pred             ------------------------------------------------eeEEEEeCCCCCHHHHhcccccccccccCCHH
Q 038768          156 ------------------------------------------------RALIYEFMPNGSLDQFIYDEESSNINRKLEWR  187 (386)
Q Consensus       156 ------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~  187 (386)
                                                                      .++||||+++++|.+++.....   ....++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~  164 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDREHG  164 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGGSCHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccchhhH
Confidence                                                            7899999999999999976532   2456777


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce----------eeeccccCccc
Q 038768          188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF----------ISMLGARGTIG  257 (386)
Q Consensus       188 ~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~g~~~  257 (386)
                      .++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            8999999999999999998   9999999999999999999999999999876554211          11234569999


Q ss_pred             cccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHH
Q 038768          258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKM  337 (386)
Q Consensus       258 y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~m  337 (386)
                      |+|||++.+.  .++.++|||||||++|||++|..|+...          ......+.....+......+++..+++.+|
T Consensus       242 y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  309 (332)
T 3qd2_B          242 YMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRNLKFPLLFTQKYPQEHMMVQDM  309 (332)
T ss_dssp             GSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHTTCCCHHHHHHCHHHHHHHHHH
T ss_pred             ccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhccCCCcccccCChhHHHHHHHH
Confidence            9999998664  7899999999999999999998876533          223333334444445556788999999999


Q ss_pred             HHHHHHhcCCCCCCCCCC
Q 038768          338 ILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       338 l~v~~~L~~~~~~~~~~p  355 (386)
                      +..++.-|+++.++..+|
T Consensus       310 l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          310 LSPSPTERPEATDIIENA  327 (332)
T ss_dssp             HCSSGGGSCCHHHHHHST
T ss_pred             ccCCCCcCCCHHHHhhch
Confidence            999999999887765554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-43  Score=327.87  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=196.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||.||+|... +|+.||+|+++...  ...+.+.+|+.++++++||||+++++++.+.+..++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-   86 (317)
T 2pmi_A            8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-   86 (317)
T ss_dssp             -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred             eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence            44578999999999999864 68999999997543  234678999999999999999999999999999999999997 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...........+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            69999987654333345689999999999999999999998   999999999999999999999999999987654322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhcCC--
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHIEP--  316 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i~~--  316 (386)
                        ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||..........       ..+...|..+..  
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          164 --TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             --CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             --cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence              12244689999999998653 368999999999999999999999997543210000       000000000000  


Q ss_pred             --------C--------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          317 --------G--------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       317 --------~--------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                              .        ..+.....+++++.+++.+|+..++.-|++++++..+|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence                    0        011223468899999999999999999999998887764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.3e-44  Score=347.09  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=208.1

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      ....+.+.+.||+|+||.||+|.+.++..||||+++......+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            33444566899999999999999988899999999987777889999999999999999999999986 66789999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++....    ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       265 ~~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          265 AKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             TTCBHHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             CCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999996532    23578899999999999999999998   9999999999999999999999999999876543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      .. .......++..|+|||++...  .++.++|||||||++|||++ |+.||.....        .++.+.+..+.....
T Consensus       338 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~  406 (454)
T 1qcf_A          338 EY-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYRMPR  406 (454)
T ss_dssp             HH-HTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHTCCCCC
T ss_pred             ce-eccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence            21 112234567889999998653  78999999999999999999 9999975422        344455555544556


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++++.+++.+|+..++.-|++.+++
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i  435 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEYI  435 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            77899999999999999888888765443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-43  Score=326.32  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=188.9

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      +.||+|+||.||+|... +|+.||||++...  ....+.+|+.++..+. ||||+++++++.+....++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            67999999999999874 6899999999743  3467889999999997 999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ceEEeeccCCcccCcccce
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +++...      ..+++..++.++.||+.||+|||++   +++||||||+|||++.++   .+||+|||+++........
T Consensus        95 ~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           95 ERIKKK------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             HHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            999653      5689999999999999999999998   999999999999997665   8999999999865543221


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc---ccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF---QLA  323 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~  323 (386)
                        .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....... ......++.+.+..+...   ...
T Consensus       166 --~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~~~~~~~~~~  240 (325)
T 3kn6_A          166 --LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKGDFSFEGEAW  240 (325)
T ss_dssp             --------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred             --ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcCCCCCCcccc
Confidence              2245689999999998664  68999999999999999999999998653211 111223455666655422   123


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..+++++++++.+|+..++.-|++++++..+|--
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~  274 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL  274 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence            4689999999999999999999999998877643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=343.09  Aligned_cols=238  Identities=20%  Similarity=0.253  Sum_probs=193.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||+||+++.. +|+.||+|++++..    ...+.+.+|..++..++||||+++++++.+.+..|+||||++
T Consensus        65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            3578999999999999874 68999999997522    122457899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       145 gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          145 GGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             SCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            999999996532     3689999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ceeeeccccCccccccccccchh-----cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-
Q 038768          245 SFISMLGARGTIGYIAPEVFCRN-----FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-  318 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-  318 (386)
                      .. .....+||+.|+|||++...     ...++.++|||||||++|||++|+.||.....        ...+.+|.... 
T Consensus       217 ~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~  287 (412)
T 2vd5_A          217 TV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AETYGKIVHYKE  287 (412)
T ss_dssp             CE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHH
T ss_pred             cc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccc
Confidence            21 22345799999999998642     13578999999999999999999999986532        33334443321 


Q ss_pred             ---cccccccCChHHHHHHHHHHHHHHHhc
Q 038768          319 ---EFQLAGVVTEEEKEMAKKMILVLEMLE  345 (386)
Q Consensus       319 ---~~~~~~~~s~~~~~li~~ml~v~~~L~  345 (386)
                         .+..+..+++++++++++||. ++.-|
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~R  316 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETR  316 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGC
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-Chhhc
Confidence               223346799999999999997 65554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-44  Score=345.25  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=208.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +|+.||||++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~   98 (476)
T 2y94_A           19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV   98 (476)
T ss_dssp             EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            34578999999999999874 7999999999643    233467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        99 ~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           99 SGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             SSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999543      4689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..   .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.....        ..+.+.+..+. +..+
T Consensus       170 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~-~~~p  236 (476)
T 2y94_A          170 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDGI-FYTP  236 (476)
T ss_dssp             CC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTTC-CCCC
T ss_pred             cc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCC-cCCC
Confidence            32   2345699999999998764 2347899999999999999999999986532        34455555554 4567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+++++.+++.+|+..++.-|++++++..+|
T Consensus       237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence            77899999999999999999998877776554

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=342.80  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=206.4

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.+.||+|+||.||+|.. .+|+.+|+|++......   .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            455668999999999999976 47899999999865433   35688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCceEEeeccCCcc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKL  239 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~  239 (386)
                      +++|+|.+++...      ..+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++..
T Consensus        92 ~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           92 VTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999998653      4689999999999999999999998   999999999999998   567899999999987


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ......  ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ..+.+.+..+..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~  230 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGAY  230 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCC
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCCC
Confidence            654432  12345799999999998654  689999999999999999999999975432        334444443331


Q ss_pred             ---ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          320 ---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       320 ---~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                         ......+++++++++.+|+..++.-|+++.++..+|-
T Consensus       231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence               1223468999999999999999999999888777664

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.5e-44  Score=335.44  Aligned_cols=250  Identities=24%  Similarity=0.296  Sum_probs=195.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||+||++... +|+.||+|++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            345688999999999999875 7899999999877666788999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc--eEEeeccCCcccCccc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC--PKISDFGLAKLSEKKE  244 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~~~~  244 (386)
                      +|.+++...      ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.  +||+|||+++......
T Consensus       102 ~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          102 ELYERICNA------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            999998543      4689999999999999999999998   9999999999999987765  9999999997443322


Q ss_pred             ceeeeccccCccccccccccchhcCCC-CccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc-CCCccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGV-SHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI-EPGNEFQL  322 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i-~~~~~~~~  322 (386)
                      .   .....||+.|+|||++.+.  .+ +.++|||||||++|+|++|+.||........   + ....+.+ ........
T Consensus       173 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~-~~~~~~~~~~~~~~~~  243 (361)
T 3uc3_A          173 Q---PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---Y-RKTIQRILSVKYSIPD  243 (361)
T ss_dssp             -----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---H-HHHHHHHHTTCCCCCT
T ss_pred             C---CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---H-HHHHHHHhcCCCCCCC
Confidence            1   2234699999999998664  44 4459999999999999999999986533211   1 1222222 22222233


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ...+++++++++.+|+..++.-|+++.++..||
T Consensus       244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          244 DIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            446899999999999999999999888776665

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=323.55  Aligned_cols=247  Identities=23%  Similarity=0.339  Sum_probs=198.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||+||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence            34578999999999999874 68999999886532 33467899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus        93 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           93 TLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             BHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999996532     4689999999999999999999998   9999999999999999999999999999876543221


Q ss_pred             e------------eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          247 I------------SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       247 ~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      .            ......||+.|+|||++.+.  .++.++||||||+++|||++|..|+...............  .. 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~--~~-  239 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--GF-  239 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--HH-
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--cc-
Confidence            1            11145699999999999764  7899999999999999999999998764332221111111  10 


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                         .....+..+++++.+++.+|+..++.-|+++.++
T Consensus       240 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  273 (310)
T 3s95_A          240 ---LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL  273 (310)
T ss_dssp             ---HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence               1122456788999999999999888888765543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-44  Score=325.09  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=196.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---------------------------ChHHHHHHHHHhhcCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---------------------------NGEEFINEVASMSKTSH  140 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~h  140 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++.....                           ..+.+.+|++++++++|
T Consensus        16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   95 (298)
T 2zv2_A           16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH   95 (298)
T ss_dssp             EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence            4467899999999999986 4688999999975431                           12468899999999999


Q ss_pred             CccceEEEEEEe--cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 038768          141 VNVVSFLGFCYE--KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP  218 (386)
Q Consensus       141 ~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~  218 (386)
                      |||+++++++.+  .+..++||||+++++|.+++..       ..+++..++.++.||+.||+|||+.   +++||||||
T Consensus        96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            999999999987  5678999999999999876532       4689999999999999999999998   999999999


Q ss_pred             CCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCC-CCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGG-VSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       219 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                      +|||++.++.+||+|||+++........  .....||+.|+|||++.+.... ++.++|||||||++|+|++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999876544322  2345699999999998754211 378899999999999999999999754


Q ss_pred             cccCCcccchhhhhhhcCCCc-cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          298 VSLSSEIYFPNSIYKHIEPGN-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..        ..+...+.... .......+++++++++.+|+..++.-|+++.++..||
T Consensus       244 ~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          244 RI--------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             SH--------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             cH--------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            22        22222222211 2223457899999999999999999999888776654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-43  Score=328.50  Aligned_cols=252  Identities=33%  Similarity=0.555  Sum_probs=199.2

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .+.||+|+||.||+|.+.+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.
T Consensus        44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (321)
T 2qkw_B           44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK  123 (321)
T ss_dssp             CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred             cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence            478999999999999988899999999876543 3467899999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM  249 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  249 (386)
                      +++.....  ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++...........
T Consensus       124 ~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          124 RHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             GGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             HHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99965432  224689999999999999999999998   9999999999999999999999999999865433222222


Q ss_pred             ccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh---------cCCCccc
Q 038768          250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH---------IEPGNEF  320 (386)
Q Consensus       250 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------i~~~~~~  320 (386)
                      ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......... .........         +......
T Consensus       199 ~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  275 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLAD  275 (321)
T ss_dssp             CCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred             cccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccccccHHHhcChhhcc
Confidence            334589999999998654  6899999999999999999999999765332111 111111111         1111112


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+...++.++.+++.+|+..++.-|+++.+
T Consensus       276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  305 (321)
T 2qkw_B          276 KIRPESLRKFGDTAVKCLALSSEDRPSMGD  305 (321)
T ss_dssp             CSCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            233445677889999999988888876554

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=336.51  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=211.1

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeC--------CCcEEEEEEecCCCCCh--HHHHHHHHHhhcC-CCCccceEEEEEEe
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKVNG--EEFINEVASMSKT-SHVNVVSFLGFCYE  152 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~  152 (386)
                      ....+.+.+.||+|+||.||+|...        ++..||+|+++......  +.+.+|+++++++ +||||++++++|.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3344556789999999999999852        33589999998653322  5688999999999 89999999999999


Q ss_pred             cCceeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                      .+..++||||+++|+|.+++......          .....+++..++.++.||+.||+|||+.   +|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence            99999999999999999999765321          1124589999999999999999999998   9999999999999


Q ss_pred             eCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccC
Q 038768          223 LGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLS  301 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~  301 (386)
                      ++.++.+||+|||+++...............+|..|+|||++.+.  .++.++|||||||++|||++ |+.||....   
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~---  298 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  298 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            999999999999999877654433334455678899999998654  78999999999999999999 999997543   


Q ss_pred             CcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          302 SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       302 ~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                           ...+.+.+..+.....+..+++++.+++.+|+..++.-|+++.++
T Consensus       299 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  343 (382)
T 3tt0_A          299 -----VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  343 (382)
T ss_dssp             -----HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                 245566666666677788899999999999999888777765443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-43  Score=331.68  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=205.1

Q ss_pred             HHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecC------CCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKN------SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      ..+.+.+.||+|+||.||+|.. .+|+.||||++..      .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3456678999999999999986 4689999999853      12346789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc---eEEeecc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC---PKISDFG  235 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg  235 (386)
                      ||||+++++|.+++.....  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||
T Consensus       104 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999988865321  124589999999999999999999998   9999999999999986554   9999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++.........  .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....         ..++..+.
T Consensus       179 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~  245 (351)
T 3c0i_A          179 VAIQLGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGII  245 (351)
T ss_dssp             TCEECCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHH
T ss_pred             ceeEecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHH
Confidence            99876553321  2245699999999998764  68999999999999999999999997642         22333332


Q ss_pred             CCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 PGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 ~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+.   .+.....+++++++++.+|+..++.-|+++.++..+|
T Consensus       246 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          246 KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             HTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence            222   1223357899999999999999999888877765554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-43  Score=329.01  Aligned_cols=272  Identities=34%  Similarity=0.605  Sum_probs=210.9

Q ss_pred             CccccHHHHHHHHhhh--hhccCcCCceEEEEEEeCCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           75 PKRYNYSDVKRMTNSF--SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~--~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      ...+++.++.....+|  .+.||+|+||.||+|...+|+.||||++.....  ....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567777777666655  478999999999999988899999999976432  234789999999999999999999999


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      .+.+..++||||+++|+|.+++.....  ....+++..++.++.|++.||.|||+.+.++++||||||+|||++.++.+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            999999999999999999999976542  235699999999999999999999997666999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-ccchhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-IYFPNS  309 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~  309 (386)
                      |+|||+++......... .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||+........ ......
T Consensus       175 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             ECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             eccCccccccCcccccc-cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999998765433221 2345699999999998654  6899999999999999999999999744322211 111111


Q ss_pred             hhhhcCCCc---------cccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          310 IYKHIEPGN---------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       310 ~~~~i~~~~---------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +...+....         ........+.++.+++.+|+..++.-|+++.++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  302 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV  302 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence            111111111         112233345778899999998888888766554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=337.97  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=207.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      ..+.+.+.||+|+||.||+|.+.      +++.||||+++....  ....+.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            34456688999999999999853      466899999975432  2356889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccc-cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ceEEee
Q 038768          158 LIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CPKISD  233 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D  233 (386)
                      +||||+++|+|.+++...... .....+++..++.++.||+.||+|||++   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999999765321 1224589999999999999999999998   999999999999999554   599999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||+++...............||+.|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+.+
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~  297 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE  297 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence            9999865433222223345678999999998764  78999999999999999998 9999986532        44556


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+.....+..+++++.+++.+|+..++.-|+++.++
T Consensus       298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei  336 (367)
T 3l9p_A          298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII  336 (367)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            666666666778899999999999999888888876554

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.4e-44  Score=348.45  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=211.9

Q ss_pred             HHHHHhhhhhccCcCCceEEEEEEeCC-CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           83 VKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        83 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +....+.+.++||+|+||.||+|.+.+ +..||||+++......++|.+|+.++++++||||++++++|.+.+..++|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            344445567899999999999999754 8899999998877778899999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       297 ~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          297 FMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             CCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             ccCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999996532    24588999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .... .......++..|+|||++...  .++.++|||||||++|||++ |+.||.....        ..+.+.+..+...
T Consensus       370 ~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  438 (495)
T 1opk_A          370 GDTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKDYRM  438 (495)
T ss_dssp             TCCE-ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHHHHTTCCC
T ss_pred             CCce-eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            4322 222344567899999998654  68999999999999999999 9999986432        3444555555556


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+++++.+++.+|+..++.-|+++.++
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el  469 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEI  469 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            6678899999999999999888888765543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.6e-44  Score=331.75  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=190.5

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC-C---cEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCce---
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD-G---RLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKR---  156 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  156 (386)
                      .+.+.+.||+|+||.||+|.... +   ..||||+++...   ...+.+.+|+.++++++||||+++++++.+....   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            34556889999999999998643 2   279999997643   2346789999999999999999999999887665   


Q ss_pred             ---eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          157 ---ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       157 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                         ++||||+++|+|.+++...........+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence               89999999999999997654333334689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||+++...............+++.|+|||.+.+.  .++.++|||||||++|||++ |+.||.....        ..+..
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~  250 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AEIYN  250 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHH
T ss_pred             ccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccCh--------HHHHH
Confidence            9999876554433333345578899999998764  68999999999999999999 9999986532        34445


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      .+..+.....+..+++++.+++.+|+..++.-|++
T Consensus       251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  285 (323)
T 3qup_A          251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS  285 (323)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred             HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcC
Confidence            55555556677889999999999999999998887

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-43  Score=332.20  Aligned_cols=239  Identities=24%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHH-hhcCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVAS-MSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|+.. +++.||+|++++...    ....+..|..+ ++.++||||+++++++.+.+..|+|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            345689999999999999874 588999999976432    23456677776 577899999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          120 YINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999653      4688999999999999999999998   99999999999999999999999999998543


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ....  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+++.+.... ..
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~-~~  257 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-LQ  257 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSC-CC
T ss_pred             cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcc-cC
Confidence            2221  12356799999999998764  689999999999999999999999976432        34445554332 45


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ++..++.++++++.+|+..++.-|.++
T Consensus       258 ~~~~~~~~~~~li~~lL~~dp~~R~~~  284 (373)
T 2r5t_A          258 LKPNITNSARHLLEGLLQKDRTKRLGA  284 (373)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSGGGSTTT
T ss_pred             CCCCCCHHHHHHHHHHcccCHHhCCCC
Confidence            677899999999999999988888765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-44  Score=332.47  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=205.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||.||+|...      +++.||+|+++.....  .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  128 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL  128 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence            344678999999999999874      3478999999864322  35789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccccccc------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 038768          160 YEFMPNGSLDQFIYDEESSN------------------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNI  221 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Ni  221 (386)
                      |||+++|+|.+++.......                  ....+++..++.++.||+.||.|||+.   +++||||||+||
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  205 (343)
T 1luf_A          129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  205 (343)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence            99999999999997642110                  125689999999999999999999998   999999999999


Q ss_pred             EeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCccccccc
Q 038768          222 LLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSL  300 (386)
Q Consensus       222 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~  300 (386)
                      |++.++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..... 
T Consensus       206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  282 (343)
T 1luf_A          206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-  282 (343)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred             EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence            9999999999999999866544333333345688999999998754  68999999999999999999 9999975422 


Q ss_pred             CCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          301 SSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       301 ~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                             ..+...+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       283 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  325 (343)
T 1luf_A          283 -------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS  325 (343)
T ss_dssp             -------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence                   4455566666666678889999999999999988888876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-43  Score=327.02  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=207.9

Q ss_pred             hhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||.||+|..      .+++.||+|++......  .+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            34567899999999999975      24579999999754322  35788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccccccc------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 038768          160 YEFMPNGSLDQFIYDEESSN------------------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNI  221 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Ni  221 (386)
                      |||+++++|.+++.......                  ....+++..++.++.||+.||.|||+.   +++||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence            99999999999997643210                  123488999999999999999999998   999999999999


Q ss_pred             EeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCccccccc
Q 038768          222 LLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSL  300 (386)
Q Consensus       222 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~  300 (386)
                      |++.++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||..... 
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  258 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-  258 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            9999999999999999877655444334455678899999998664  68899999999999999999 9999976432 


Q ss_pred             CCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          301 SSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       301 ~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                             ..+...+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       259 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          259 -------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             -------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence                   3455556666666677889999999999999999988887554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-43  Score=323.03  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=197.9

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||+||+|...+|+.||+|++.....   ..+.+.+|+.++++++||||+++++++.+.+..++||||++ 
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-   83 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-
Confidence            34578999999999999988899999999975432   23678899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           84 QDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            49999886532     4688999999999999999999998   999999999999999999999999999986543221


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc-----------
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI-----------  314 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i-----------  314 (386)
                        ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........    ...+.+.+           
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHHCCCChhhchhh
Confidence              12234689999999998654 3589999999999999999999999975432100    00000000           


Q ss_pred             -------------CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 -------------EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 -------------~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                   ...........+++++.+++.+|+..++.-|++++++..+|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  282 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                         00111123356899999999999999999999887766554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-43  Score=340.68  Aligned_cols=238  Identities=26%  Similarity=0.430  Sum_probs=201.0

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecC-ceeEEEEeCCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK-KRALIYEFMPNGS  167 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gs  167 (386)
                      .+.+.||+|+||.||+|.+ +|+.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||+++|+
T Consensus       196 ~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            4457899999999999998 57899999998654 5678999999999999999999999988765 7899999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++......   
T Consensus       274 L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          274 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             HHHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            999997542    13478999999999999999999998   99999999999999999999999999998544322   


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                        ....++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+.+.+..+.....+..+
T Consensus       344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~p~~~  411 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPDGC  411 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--------TTHHHHHHTTCCCCCCTTC
T ss_pred             --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCcC
Confidence              123578899999998654  78999999999999999998 9999986432        3344556666666678889


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++++.+++.+|+..++.-|++..+
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~  435 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQ  435 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHH
Confidence            999999999999998888886543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-43  Score=336.39  Aligned_cols=261  Identities=16%  Similarity=0.163  Sum_probs=201.4

Q ss_pred             hhhhccCcC--CceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQG--GFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|  +||.||+|... +|+.||||++.......   +.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  107 (389)
T 3gni_B           28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF  107 (389)
T ss_dssp             EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence            446789999  99999999875 68999999997654333   5678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++....    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||.+.....
T Consensus       108 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          108 MAYGSAKDLICTHF----MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             CTTCBHHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             cCCCCHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999996542    24589999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh----
Q 038768          243 KESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH----  313 (386)
Q Consensus       243 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----  313 (386)
                      ....     .......||..|+|||++.+....++.++|||||||++|||++|+.||............-......    
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            2111     1112246899999999997643468999999999999999999999997643211000000000000    


Q ss_pred             ---------------------------------cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 ---------------------------------IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 ---------------------------------i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                                       .........+..+++++.+++.+|+..++.-|++++++..+|-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                             0000011245668999999999999999999999888877763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.2e-44  Score=345.11  Aligned_cols=246  Identities=24%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++...    ......+.+|+.+++.++||||++++++|.+.+..++||||+
T Consensus       151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  230 (446)
T 4ejn_A          151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA  230 (446)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred             EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence            3457899999999999986 46899999999742    233456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      ++|+|.+++...      ..+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++....
T Consensus       231 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          231 NGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             SSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999998553      468999999999999999999998 7   999999999999999999999999999986433


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+.... ..+
T Consensus       302 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-~~~  368 (446)
T 4ejn_A          302 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE-IRF  368 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCC
T ss_pred             CCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCC-CCC
Confidence            322  12346799999999998654  789999999999999999999999975432        33334433332 456


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPPK  356 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p~  356 (386)
                      +..+++++.+++.+|+..++.-|+     +++++..||-
T Consensus       369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~  407 (446)
T 4ejn_A          369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF  407 (446)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence            778999999999999999999997     6666666653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-43  Score=318.42  Aligned_cols=243  Identities=25%  Similarity=0.449  Sum_probs=207.8

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.+.||+|+||.||+|...+++.||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            34578999999999999988889999999998777788999999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ ..
T Consensus        91 ~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  161 (267)
T 3t9t_A           91 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  161 (267)
T ss_dssp             HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred             HHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence            99996542     4588999999999999999999998   999999999999999999999999999986644321 11


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      .....++..|+|||++.+.  .++.++||||||+++|+|++ |+.||.....        ......+..+.....+..++
T Consensus       162 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~~~  231 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRLAS  231 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTTSC
T ss_pred             cccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCcCCCCccCc
Confidence            2234577889999998654  68999999999999999999 8999986422        34445555555556677889


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +++.+++.+|+..++.-|+++.+
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~  254 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSR  254 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHH
Confidence            99999999999998888876544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-43  Score=343.40  Aligned_cols=247  Identities=30%  Similarity=0.441  Sum_probs=203.2

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..+.+.++||+|+||.||+|.+.++..||||+++......++|.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~  262 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  262 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence            3345568899999999999999888889999998777777899999999999999999999999866 778999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++....    ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus       263 gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          263 GSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999996432    24588999999999999999999998   999999999999999999999999999987654322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                       .......++..|+|||.+...  .++.++|||||||++|||++ |+.||....        ..++...+..+.....+.
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~~~~~  404 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMPCPP  404 (452)
T ss_dssp             --------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCCCCCT
T ss_pred             -ecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCCCCC
Confidence             122234577899999998654  78999999999999999999 999997542        244556666665566778


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++++.+++.+|+..++.-|++.+++
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l  431 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYL  431 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            899999999999999888888765543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=323.55  Aligned_cols=248  Identities=25%  Similarity=0.262  Sum_probs=199.0

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcC-CCCccceEEEEEEecCce
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKT-SHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  156 (386)
                      ++....+...++||+|+||+||+|... +|+.||||++.......   ..+..|+..+..+ +|+||++++++|.+.+..
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            444455666789999999999999875 79999999987654333   3445566555554 899999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++||||+ +++|.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             EEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcccee
Confidence            9999999 779999886542     4699999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      +........   .....||+.|+|||++.+   .++.++|||||||++|||++|..|+....           .+..+..
T Consensus       204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~  266 (311)
T 3p1a_A          204 LVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQ  266 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTT
T ss_pred             eeecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhc
Confidence            987654332   223458999999999864   58999999999999999999977765431           1222222


Q ss_pred             Cc-cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 GN-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ~~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +. ...++..+++++.+++.+|+..++.-|++++++..+|
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence            22 3345677899999999999999999999888776655

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=333.57  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=204.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|++..... ....+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            445688999999999999864 689999999976432 345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCceEEeeccCCcccCcc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE--DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~  243 (386)
                      |+|.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       133 g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          133 GELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999986532     4689999999999999999999998   9999999999999974  577999999999877654


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EF  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~  320 (386)
                      ...   ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+....   ..
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~~~  271 (387)
T 1kob_A          205 EIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWEFDE  271 (387)
T ss_dssp             SCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCCCCS
T ss_pred             cce---eeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc
Confidence            332   234589999999998654  689999999999999999999999986432        12222222211   22


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .....+++++++++.+|+..++.-|+++.++..+|
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence            33456899999999999999999999888776665

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-43  Score=347.51  Aligned_cols=249  Identities=26%  Similarity=0.358  Sum_probs=206.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||.||+|... +|+.||+|++.+.    ......+.+|++++..++||||+++++++.+.+..++||||++
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~  267 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN  267 (576)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence            3478999999999999874 6899999999642    3345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       268 gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          268 GGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             SCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            999999986542    23589999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+.+.+... ...++.
T Consensus       341 ~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~-~~~~p~  410 (576)
T 2acx_A          341 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEV-PEEYSE  410 (576)
T ss_dssp             C---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHC-CCCCCT
T ss_pred             c---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcc-cccCCc
Confidence            2   2245799999999999764  68999999999999999999999998653211    223344444332 244667


Q ss_pred             cCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEG-----STEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p  355 (386)
                      .+++++++++.+|+..++.-|.     +++++..||
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp  446 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP  446 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred             cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence            8999999999999999999887     345555554

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-43  Score=334.76  Aligned_cols=245  Identities=25%  Similarity=0.404  Sum_probs=189.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|+..    ++..||||+++....  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            345678999999999999864    577899999976432  23578999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       127 ~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          127 YMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             CCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999996542     4689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          242 KKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       242 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ..... .......++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+.+.+..+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~~~  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEGYR  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTTEE
T ss_pred             cCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            43221 112233457789999998654  78999999999999999998 9999975422        344455555554


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+..++.++.+++.+|+..++.-|+++.+
T Consensus       269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~  299 (373)
T 2qol_A          269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ  299 (373)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccccHHHHHHHHHHhCcChhhCcCHHH
Confidence            5556678899999999999877777765443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=329.03  Aligned_cols=250  Identities=20%  Similarity=0.313  Sum_probs=199.3

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCC--CccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSH--VNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++...+++.||||++.......   +.+.+|+.++..++|  +||+++++++.+.+..++||| +
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~   90 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C   90 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred             EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence            3457899999999999998889999999998654443   568899999999976  999999999999999999999 5


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      .+++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.....
T Consensus        91 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           91 GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             CSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            588999999653      4688999999999999999999998   999999999999997 578999999999877554


Q ss_pred             cceeeeccccCccccccccccchh---------cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN---------FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      ..........||+.|+|||++.+.         ...++.++|||||||++|||++|+.||.....      ........+
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHHHHHh
Confidence            332223345799999999998641         13688999999999999999999999975321      112233344


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .......++...+.++.+++.+|+..++.-|+++.++..+|
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            44445667778889999999999999999998877765443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.5e-43  Score=318.35  Aligned_cols=240  Identities=26%  Similarity=0.330  Sum_probs=192.6

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||.||+|.. .+++.||+|++......    .+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            34467899999999999986 46899999998654332    25688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           93 IEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999543      4689999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---c
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---E  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~  319 (386)
                      .... ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......       ....+.+....   .
T Consensus       164 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~  233 (294)
T 4eqm_A          164 TSLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDSVPNVT  233 (294)
T ss_dssp             ------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSCCCCHH
T ss_pred             cccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhccCCCcc
Confidence            3221 12235689999999998764  6889999999999999999999999865321       11222232222   1


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ......+++.+.+++.+|+..++.-|+
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~dp~~R~  260 (294)
T 4eqm_A          234 TDVRKDIPQSLSNVILRATEKDKANRY  260 (294)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             hhcccCCCHHHHHHHHHHhcCCHhHcc
Confidence            234567899999999999998888776

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=333.85  Aligned_cols=243  Identities=28%  Similarity=0.353  Sum_probs=196.9

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      +.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            5799999999999986 468999999998644 23467899999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe--CCCCceEEeeccCCcccCccccee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL--GEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      +++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++........ 
T Consensus       175 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-  245 (373)
T 2x4f_A          175 DRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-  245 (373)
T ss_dssp             HHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence            9886532     4689999999999999999999998   99999999999999  67789999999999876554322 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cccccc
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EFQLAG  324 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~~~~~  324 (386)
                        ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ......+....   ......
T Consensus       246 --~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~  313 (373)
T 2x4f_A          246 --KVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWDLEDEEFQ  313 (373)
T ss_dssp             --CCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCSCSGGGT
T ss_pred             --ccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCCCChhhhc
Confidence              234699999999998653  688999999999999999999999976532        22222222211   122345


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+++++++++.+|+..++.-|+++.++..+|
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp  344 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALKHP  344 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            6899999999999999999999888776655

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.6e-44  Score=336.57  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=205.6

Q ss_pred             HHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCc-
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKK-  155 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-  155 (386)
                      ..+.+.+.||+|+||.||+|.+      .+++.||||+++.....  .+.+.+|++++.++ +||||++++++|.+.+. 
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            3445568999999999999973      24679999999864332  25689999999999 79999999999988654 


Q ss_pred             eeEEEEeCCCCCHHHHhccccccc--------------------------------------------------------
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSN--------------------------------------------------------  179 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  179 (386)
                      .++||||+++|+|.+++.......                                                        
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            889999999999999997653210                                                        


Q ss_pred             ----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCc
Q 038768          180 ----INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGT  255 (386)
Q Consensus       180 ----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~  255 (386)
                          ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...............||
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                012288999999999999999999998   9999999999999999999999999999876554443334456688


Q ss_pred             cccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHH
Q 038768          256 IGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMA  334 (386)
Q Consensus       256 ~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  334 (386)
                      +.|+|||++.+.  .++.++|||||||++|||++ |+.||.....       ...+...+..+.....+..+++++.+++
T Consensus       259 ~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          259 LKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             GGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-------SHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             ceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccch-------hHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            999999998764  78999999999999999998 9999976432       2334445555555667788999999999


Q ss_pred             HHHHHHHHHhcCCCCC
Q 038768          335 KKMILVLEMLEGSTED  350 (386)
Q Consensus       335 ~~ml~v~~~L~~~~~~  350 (386)
                      .+|+..++.-|+++.+
T Consensus       330 ~~~l~~dP~~Rps~~e  345 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSE  345 (359)
T ss_dssp             HHHTCSSGGGSCCHHH
T ss_pred             HHHccCChhhCCCHHH
Confidence            9999999888887654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-43  Score=333.44  Aligned_cols=251  Identities=20%  Similarity=0.306  Sum_probs=200.0

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCC--CCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTS--HVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||.||++...+++.||||++.......   +.+.+|+.++..++  |+||+++++++...+..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            34568899999999999998789999999997654433   56889999999996  5999999999999999999999 


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +.+++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++....
T Consensus       137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            5689999999653      4688899999999999999999998   999999999999996 57899999999987754


Q ss_pred             ccceeeeccccCccccccccccchh---------cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRN---------FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ...........||+.|+|||++.+.         ...++.++|||||||++|||++|+.||......      ...+...
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~  280 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  280 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHH
Confidence            4332223355799999999998541         125889999999999999999999999753210      1222233


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +.......++...+.++++++.+|+..++.-|+++.++..+|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            344444556777789999999999999999999877765554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-42  Score=313.75  Aligned_cols=252  Identities=24%  Similarity=0.282  Sum_probs=205.9

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence            445688999999999999875 68999999986432  234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           89 GGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             TEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999998543      4688999999999999999999998   99999999999999999999999999998664433


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC-CCcccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE-PGNEFQLA  323 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~  323 (386)
                      .........|+..|+|||.+.+. ...+.++||||||+++|+|++|+.||.......       ..+..+. ........
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~  231 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYLNPW  231 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-------HHHHHHHTTCTTSTTG
T ss_pred             chhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHhhhcccccCch
Confidence            22223345689999999998654 234789999999999999999999998653211       1111111 11222234


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..++++..+++.+|+..++.-|++++++..+|-
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence            578999999999999999999999988877764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-43  Score=322.96  Aligned_cols=246  Identities=28%  Similarity=0.433  Sum_probs=208.7

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.+.||+|+||.||+|... ++..||+|++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   93 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   93 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence            3445688999999999999875 488999999987766678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        94 ~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           94 GNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EEHHHHHHHCC----TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CcHHHHHHhcc----cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999996532    24589999999999999999999999   999999999999999999999999999987654432


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                       .......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        ..+.+.+........+.
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~  235 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKDYRMERPE  235 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHHHHTTCCCCCCT
T ss_pred             -ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhccCCCCCCC
Confidence             223345578899999998654  78999999999999999999 9999976532        33444455555566677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+++++.+++.+|+..++.-|+++.+
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~  261 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAE  261 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHH
Confidence            89999999999999988888876554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-43  Score=327.34  Aligned_cols=244  Identities=28%  Similarity=0.443  Sum_probs=196.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCc----EEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.||+|+||+||+|.+. +|+    .||+|.+...  ....+.+.+|+.++++++||||++++++|.+. ..++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e   96 (327)
T 3poz_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   96 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEE
T ss_pred             ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence            44578999999999999863 444    3688887643  23457899999999999999999999999875 4789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           97 LMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             CCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             ecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999996542     4689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ............+|..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+..+...
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~  238 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  238 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCC
T ss_pred             CCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------HHHHHHHHcCCCC
Confidence            54443333445678899999999764  78999999999999999999 9999986532        3344555555556


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..++.++.+++.+|+..++.-|+++.++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  269 (327)
T 3poz_A          239 PQPPICTIDVYMIMVKCWMIDADSRPKFREL  269 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            6777899999999999999888888776554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-42  Score=339.93  Aligned_cols=244  Identities=23%  Similarity=0.319  Sum_probs=204.1

Q ss_pred             hhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.||+|+||.||+|+.. +|+.||+|++.+.    ....+.+.+|++++.+++||||+++++++.+.+..|+||||+++
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g  269 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG  269 (543)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence            367999999999999874 6999999999653    23456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++.....  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       270 g~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          270 GDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            999999865431  124689999999999999999999998   999999999999999999999999999987654432


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+.+.+.... ..++..
T Consensus       345 ~--~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~~~~-~~~p~~  415 (543)
T 3c4z_A          345 K--TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVLEQA-VTYPDK  415 (543)
T ss_dssp             C--BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHHHCC-CCCCTT
T ss_pred             c--cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHhhcc-cCCCcc
Confidence            1  2235799999999999764  78999999999999999999999998653211    2233444443332 456778


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      +++++++++.+|+..++.-|++.
T Consensus       416 ~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          416 FSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             cCHHHHHHHHHhccCCHhHCCCC
Confidence            99999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.9e-43  Score=319.01  Aligned_cols=253  Identities=19%  Similarity=0.305  Sum_probs=198.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.++||+|+||+||+|... +|+.||+|++......   .+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            34578999999999999874 6899999999754332   3678899999999999999999999999999999999996


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      + +|.+++...     ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++......
T Consensus        85 ~-~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           85 Q-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             E-EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             C-CHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            5 666665432     25689999999999999999999998   99999999999999999999999999998765432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc----------
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI----------  314 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i----------  314 (386)
                      ..  .....||+.|+|||++.+. ..++.++|||||||++|||++|..||........   .-..+.+..          
T Consensus       156 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~---~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTT
T ss_pred             cc--ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhhhh
Confidence            21  2245689999999998654 3479999999999999999999888632211100   000011100          


Q ss_pred             -C-------------CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          315 -E-------------PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       315 -~-------------~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                       .             ..........++++.++++.+|+..++.-|++++++..||-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence             0             00011223468899999999999999999999888777664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=327.09  Aligned_cols=254  Identities=27%  Similarity=0.369  Sum_probs=205.4

Q ss_pred             HHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCC--CChHHHHHHHHHhhcC-CCCccceEEEEEEecCce
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSK--VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  156 (386)
                      ..+.+.+.||+|+||.||+|..      .++..||+|++....  ...+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            3445568999999999999985      245689999997532  3346799999999999 899999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccc-----------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESS-----------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPH  219 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~  219 (386)
                      ++||||+++|+|.+++......                 .....+++..++.++.||+.||+|||+.   +++||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence            9999999999999999764321                 0113478999999999999999999998   9999999999


Q ss_pred             CeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCccccc
Q 038768          220 NILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKV  298 (386)
Q Consensus       220 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~  298 (386)
                      |||++.++.+||+|||++................||+.|+|||++.+.  .++.++||||||+++|||+| |+.||....
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999876554443333445678899999998664  78999999999999999998 999997653


Q ss_pred             ccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          299 SLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       299 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .       .....+.+..+..+..+..+++++.+++.+|+..++.-|+++.++
T Consensus       280 ~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  325 (344)
T 1rjb_A          280 V-------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  325 (344)
T ss_dssp             C-------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             c-------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            2       123334444555556677889999999999999888888875543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.9e-43  Score=325.52  Aligned_cols=246  Identities=24%  Similarity=0.353  Sum_probs=202.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh----HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +...+.||+|+||+||+|.. .+|+.||||++.......    +.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            44457899999999999986 578999999997654332    4688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +. |+|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus       136 ~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          136 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             CS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            96 78888875432     5689999999999999999999998   999999999999999999999999999986654


Q ss_pred             ccceeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ..      ...||+.|+|||++.. ..+.++.++|||||||++|||++|+.||......       ..+...........
T Consensus       207 ~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~  273 (348)
T 1u5q_A          207 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPAL  273 (348)
T ss_dssp             BC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCC
T ss_pred             CC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCC
Confidence            32      3468999999999853 1246889999999999999999999999754321       11222222222233


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....+++++++++.+|+..++.-|++++++..+|
T Consensus       274 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          274 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            4567899999999999999999999988877665

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.8e-43  Score=316.85  Aligned_cols=244  Identities=27%  Similarity=0.414  Sum_probs=205.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+++++.++||||+++++++. .+..++||||+++++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~   93 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS   93 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence            3456889999999999999888889999999887777889999999999999999999999876 556899999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++........ .
T Consensus        94 L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           94 LVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             HHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             HHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            999996532    13689999999999999999999998   999999999999999999999999999987654432 1


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ..+.+.+..+.....+..+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCTTC
T ss_pred             cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhcccCCCCcccc
Confidence            22344577889999998653  68899999999999999999 9999975422        3444555555555667789


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++++.+++.+|+..++.-|+++.+
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~  259 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDY  259 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHH
Confidence            999999999999988888876544

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-43  Score=326.54  Aligned_cols=254  Identities=27%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCc----eeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK----RALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~  164 (386)
                      .+.+.||+|+||+||+|+. .++.||||++.........+..|+.++++++||||+++++++.+...    .++||||++
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~  105 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE  105 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             hhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence            3457899999999999988 48999999997655445567779999999999999999999988653    699999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-------NIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +|+|.+++..       ..+++..++.++.|++.||+|||+..       ..+++||||||+|||++.++.+||+|||++
T Consensus       106 ~g~L~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          106 KGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             TCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            9999999954       34899999999999999999999741       238999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhc---CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--------cc
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNF---GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--------YF  306 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------~~  306 (386)
                      +...............||+.|+|||++.+..   ..++.++|||||||++|||++|+.||..........        ..
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            8765544333334467999999999986521   135678899999999999999999997643321100        01


Q ss_pred             hhhhhhhc-CCCccccccc-----cCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          307 PNSIYKHI-EPGNEFQLAG-----VVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       307 ~~~~~~~i-~~~~~~~~~~-----~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+...+ .....+.+..     ..++++.+++.+|+..++.-|+++.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            11122222 1222222222     22345999999999999988887654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-43  Score=327.62  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=196.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcE----EEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRL----VAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.||+|+||+||+|.+. +++.    ||+|.+....  ...+.+.+|+.++++++||||++++++|. .+..++||||
T Consensus        17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   95 (325)
T 3kex_A           17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY   95 (325)
T ss_dssp             EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred             eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence            4578999999999999863 4443    8888876432  23356789999999999999999999885 5678999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        96 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           96 LPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             CTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             CCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999996542     4688899999999999999999998   999999999999999999999999999987755


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...........++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+..+....
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------AEVPDLLEKGERLA  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------THHHHHHHTTCBCC
T ss_pred             ccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCC
Confidence            4433333345678899999999654  78999999999999999999 9999986532        34445555666666


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+..++.++.+++.+|+..++.-|+++.+
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e  266 (325)
T 3kex_A          238 QPQICTIDVYMVMVKCWMIDENIRPTFKE  266 (325)
T ss_dssp             CCTTBCTTTTHHHHHHTCSCTTTSCCHHH
T ss_pred             CCCcCcHHHHHHHHHHcCCChhhCcCHHH
Confidence            77788999999999999877777766444

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.6e-43  Score=323.35  Aligned_cols=245  Identities=21%  Similarity=0.312  Sum_probs=190.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh----HHHHHHHHHhhcCCCCccceEEEEEEecCce----eE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLGFCYEKKKR----AL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~l  158 (386)
                      +.+.+.||+|+||.||+|.. .+++.||||++.......    ..+.+|+.++.+++||||+++++++......    ++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            34467899999999999986 578999999998653322    4678999999999999999999999876544    99


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++++|.+++...      ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++
T Consensus        94 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            99999999999999643      4689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          239 LSEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       239 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ........ .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ....+.+...
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~  235 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRED  235 (311)
T ss_dssp             -----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC
Confidence            66543221 122335689999999998664  7899999999999999999999999765321       1122222222


Q ss_pred             c--cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          318 N--EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       318 ~--~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .  .......+++++.+++.+|+..++.-|+++.+
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~  270 (311)
T 3ork_A          236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA  270 (311)
T ss_dssp             CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence            2  12234568999999999999988888875444

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=328.89  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=190.4

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  133 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG  133 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence            344578999999999999875 57899999998643 4467889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccCcc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~  243 (386)
                      +|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+|||++.   ++.+||+|||+++.....
T Consensus       134 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          134 ELFDRIVEK------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             BHHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999653      4589999999999999999999998   9999999999999975   889999999999866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc---c
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE---F  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~---~  320 (386)
                      ..   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....       .....+.+.....   .
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~i~~~~~~~~~  272 (349)
T 2w4o_A          205 VL---MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRRILNCEYYFIS  272 (349)
T ss_dssp             -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHHHHTTCCCCCT
T ss_pred             cc---cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHHHHhCCCccCC
Confidence            22   2235689999999998764  689999999999999999999999975422       1223333333321   1


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .....++.++++++.+|+..++.-|+++.++..+|--
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  309 (349)
T 2w4o_A          273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV  309 (349)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            2345689999999999999999999998887776643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=314.08  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=187.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|++...    ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC   93 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence            3457899999999999986 57899999999642    233467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           94 HNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             TTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999996532     4689999999999999999999998   9999999999999999999999999999866533


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..  ......|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||......        .....+... ....+
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~~~  232 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVVLA-DYEMP  232 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSS-CCCCC
T ss_pred             CC--cceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHhhc-ccCCc
Confidence            22  11234689999999998764  6788999999999999999999999864321        111222222 24456


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..++.++.+++.+|+..++.-|++++++..+|--
T Consensus       233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  266 (278)
T 3cok_A          233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM  266 (278)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred             cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence            7789999999999999999999999988777654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-42  Score=317.15  Aligned_cols=266  Identities=33%  Similarity=0.513  Sum_probs=208.9

Q ss_pred             CccccHHHHHHHHhhhh--------hccCcCCceEEEEEEeCCCcEEEEEEecCCC-----CChHHHHHHHHHhhcCCCC
Q 038768           75 PKRYNYSDVKRMTNSFS--------NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK-----VNGEEFINEVASMSKTSHV  141 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~  141 (386)
                      ...|++.++...+.+|.        +.||+|+||.||+|.. +++.||+|++....     ...+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            46788899999988885        4699999999999987 68999999987532     2246789999999999999


Q ss_pred             ccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 038768          142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNI  221 (386)
Q Consensus       142 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Ni  221 (386)
                      ||+++++++.+.+..++||||+++++|.+++....   ....+++..++.++.|++.||.|||+.   +++||||||+||
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni  164 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI  164 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence            99999999999999999999999999999996542   124689999999999999999999998   999999999999


Q ss_pred             EeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC
Q 038768          222 LLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS  301 (386)
Q Consensus       222 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  301 (386)
                      +++.++.+||+|||++................|++.|+|||.+.+   .++.++||||||+++|+|++|+.||.......
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            999999999999999987654433222334568999999998854   47889999999999999999999998654322


Q ss_pred             Ccccchhhhh------hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          302 SEIYFPNSIY------KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       302 ~~~~~~~~~~------~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ....+.....      ..+........+..+++++.+++.+|+..++.-|+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  296 (307)
T 2nru_A          242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK  296 (307)
T ss_dssp             BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            1111111100      011111112233445677889999999888887776543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.7e-43  Score=320.74  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             hhhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCCC-hHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKVN-GEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  159 (386)
                      +.+.+.||+|+||+||+|++     .+++.||||++...... .+.+.+|++++++++||||+++++++...  ...++|
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   91 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI   91 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence            34568899999999999984     36889999999754322 36788999999999999999999998654  458999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++|+|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        92 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            99999999999996542     4589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc--------CCcccchhhh
Q 038768          240 SEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL--------SSEIYFPNSI  310 (386)
Q Consensus       240 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~--------~~~~~~~~~~  310 (386)
                      ....... .......++..|+|||.+.+.  .++.++||||||+++|||++|..|+......        .........+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            6544322 122234577889999998764  7899999999999999999999998643210        0011112234


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+.+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  281 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD  281 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence            4455555556678889999999999999999888887654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6e-43  Score=325.13  Aligned_cols=253  Identities=23%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC--------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKK  154 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  154 (386)
                      ..+.+.+.||+|+||.||+|...        ++..||+|+++.....  .+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            34455689999999999999863        4678999999864322  35688999999999 8999999999999999


Q ss_pred             ceeEEEEeCCCCCHHHHhccccccc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSN----------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG  224 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~  224 (386)
                      ..++||||+++|+|.+++.......          ....+++..++.++.||+.||.|||+.   +++||||||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence            9999999999999999997653210          123588999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCc
Q 038768          225 EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSE  303 (386)
Q Consensus       225 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  303 (386)
                      .++.+||+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |+.||.....    
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~----  265 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  265 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence            9999999999999877655443334445678899999998654  68899999999999999999 9999975422    


Q ss_pred             ccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          304 IYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                          ..+.+.+..+.....+..++.++.+++.+|+..++.-|+++.++
T Consensus       266 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  309 (334)
T 2pvf_A          266 ----EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL  309 (334)
T ss_dssp             ----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                34445555555556677899999999999999888877765443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.1e-43  Score=351.70  Aligned_cols=238  Identities=22%  Similarity=0.291  Sum_probs=203.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|... +++.||||++++.    ....+.+..|..++..+ +|+||+.+++++.+.+..|+||||
T Consensus       344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~  423 (674)
T 3pfq_A          344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  423 (674)
T ss_dssp             EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence            44578999999999999864 5889999999752    33456788999999987 799999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++|+|..++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       424 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          424 VNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999653      4689999999999999999999998   999999999999999999999999999985433


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+++.|..+. ..+
T Consensus       495 ~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~-~~~  561 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN-VAY  561 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSC-CCC
T ss_pred             CCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC-CCC
Confidence            221  12356799999999999654  789999999999999999999999986532        45666666554 567


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      +..+++++++++.+||..++.-|.+.
T Consensus       562 p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          562 PKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CccCCHHHHHHHHHHccCCHHHCCCC
Confidence            78899999999999999988888765

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.6e-43  Score=317.37  Aligned_cols=244  Identities=24%  Similarity=0.382  Sum_probs=190.4

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.+.||+|+||.||+|....    +..||+|.+......  .+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   94 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIM   94 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEE
Confidence            34456889999999999998632    457999998764322  35788999999999999999999997 456789999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        95 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999996532     4689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ...... ......+++.|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ......+..+..
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~~~i~~~~~  235 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGER  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCC
T ss_pred             Cccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHHHHHHcCCC
Confidence            543321 12234567899999998654  78999999999999999997 9999986432        334455555555


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..++..+++++.+++.+|+..++.-|+++.+
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  266 (281)
T 1mp8_A          236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  266 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            6677889999999999999999988886544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=346.82  Aligned_cols=247  Identities=30%  Similarity=0.443  Sum_probs=208.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..+.+.++||+|+||.||+|.+.++..||||+++......++|.+|+++|++++|+||+++++++.+ +..++||||+++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~  345 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  345 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence            3345568899999999999999888899999998877777899999999999999999999999866 778999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++....    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       346 gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          346 GSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             EEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             CcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999996532    24588999999999999999999998   999999999999999999999999999987654321


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                       .......++..|+|||++...  .++.++|||||||++|||++ |+.||.....        .++.+.+..+.....+.
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCPP  487 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT
T ss_pred             -ecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence             112234577899999998654  78999999999999999999 9999975422        44556666665566677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++++.+++.+|+..++.-|++.+++
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l  514 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYL  514 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            899999999999999888888765543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.5e-42  Score=320.12  Aligned_cols=245  Identities=27%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++... +++.||+|++.....    ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus        44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  123 (335)
T 2owb_A           44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC  123 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence            34578999999999999874 578999999875422    2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus       124 ~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          124 RRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             TTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999998543      4689999999999999999999998   9999999999999999999999999999876533


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ...  .....|+..|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ...+..+..+ ...++
T Consensus       195 ~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~-~~~~~  261 (335)
T 2owb_A          195 GER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKN-EYSIP  261 (335)
T ss_dssp             TCC--BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT-CCCCC
T ss_pred             ccc--ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhcC-CCCCC
Confidence            221  2235689999999998654  678999999999999999999999975432        2222333222 24566


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+++++.+++.+|+..++.-|++++++..+|
T Consensus       262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          262 KHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            78899999999999999999999998886664

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=324.73  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=195.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||+||+|... +++.||+|++......  ...+.+|+.+++.++||||+++++++.+.+..++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            34578999999999999875 6899999999754322  1245679999999999999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           84 KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            69999886542     4688999999999999999999998   999999999999999999999999999986543322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------cccchhh----
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EIYFPNS----  309 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~~~~~~----  309 (386)
                        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........            ...++..    
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             --ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence              12234689999999998654 3689999999999999999999999976532110            0000000    


Q ss_pred             hhhh-----cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          310 IYKH-----IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       310 ~~~~-----i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+..     ............+++++.+++.+|+..++.-|++++++..+|-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence            0000     0001111224468999999999999999999999998887774

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.8e-43  Score=330.65  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=190.2

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCC-CCccceEEEEEEecC--ceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTS-HVNVVSFLGFCYEKK--KRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~  160 (386)
                      +.+.+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+.++..+. ||||+++++++...+  ..|+||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            34568899999999999986 46899999998754333   356789999999997 999999999998654  689999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||++ ++|..++..       ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        91 e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           91 DYME-TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             ECCS-EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             cccC-cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9996 689998854       3588999999999999999999998   9999999999999999999999999999865


Q ss_pred             Cccc-------------------ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC
Q 038768          241 EKKE-------------------SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS  301 (386)
Q Consensus       241 ~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  301 (386)
                      ....                   .........||+.|+|||++.+. ..++.++|||||||++|||++|+.||...+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            3211                   01112345799999999998764 468999999999999999999999997653211


Q ss_pred             Cc------ccch-hhhhhhcCCC------------------c-------------cccccccCChHHHHHHHHHHHHHHH
Q 038768          302 SE------IYFP-NSIYKHIEPG------------------N-------------EFQLAGVVTEEEKEMAKKMILVLEM  343 (386)
Q Consensus       302 ~~------~~~~-~~~~~~i~~~------------------~-------------~~~~~~~~s~~~~~li~~ml~v~~~  343 (386)
                      .-      ...| ...+..+...                  .             .......+++++.+++.+||..++.
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            00      0000 0000000000                  0             0001236799999999999999999


Q ss_pred             hcCCCCCCCCCCCC
Q 038768          344 LEGSTEDLQIPPKP  357 (386)
Q Consensus       344 L~~~~~~~~~~p~~  357 (386)
                      -|++++++..||--
T Consensus       319 ~R~t~~e~l~Hp~~  332 (388)
T 3oz6_A          319 KRISANDALKHPFV  332 (388)
T ss_dssp             GSCCHHHHTTSTTT
T ss_pred             cCCCHHHHhCCHHH
Confidence            99999998888763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=321.00  Aligned_cols=258  Identities=22%  Similarity=0.283  Sum_probs=199.5

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecC--ceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK--KRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  163 (386)
                      .+.+.||+|+||+||+|... +|+.||||++....  ...+.+.+|++++++++||||+++++++...+  ..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence            34578999999999999875 48999999997532  34577889999999999999999999998765  678999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCceEEeeccCCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKL  239 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~~  239 (386)
                      ++++|.+++.....   ...+++..++.++.||+.||+|||+.   +++||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           92 PCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             TTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999976431   23489999999999999999999998   99999999999999    7888899999999987


Q ss_pred             cCcccceeeeccccCccccccccccchh------cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRN------FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .......   ....||..|+|||++...      ...++.++|||||||++|||++|+.||............-..+...
T Consensus       166 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            6554332   245689999999998531      2468899999999999999999999997543221111110111110


Q ss_pred             cCC--------------------CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          314 IEP--------------------GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       314 i~~--------------------~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ...                    .....+...+++.+.+++++||..++.-|++++++..+|
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            000                    001123345567888999999999998888877664444

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.9e-43  Score=322.20  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=207.1

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      .+.+.+.||+|+||.||+|... +|+.||+|++.....       ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4556789999999999999874 689999999975332       35679999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----ceEEeec
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF----CPKISDF  234 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df  234 (386)
                      ||||+++++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++    .+||+||
T Consensus        93 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999643      4588999999999999999999998   999999999999999887    7999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      |++........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i  230 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANI  230 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHH
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence            99987655432   2244689999999998654  689999999999999999999999975432        2223333


Q ss_pred             CCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          315 EPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       315 ~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ....   .......+++++.+++.+|+..++..|++++++..+|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          231 TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             HhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            3222   22334678999999999999999999999888766654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.4e-43  Score=320.78  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=192.7

Q ss_pred             hhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCc-----
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKK-----  155 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  155 (386)
                      +.+.+.||+|+||.||+|...    ++..||+|+++......   +.+.+|+.++++++||||+++++++.+.+.     
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            345678999999999999753    34589999998654433   568899999999999999999999987653     


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .++||||+++++|.+++...........+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence            489999999999999996544333346799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhc
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      +++...............+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ......+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~  262 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------HEMYDYL  262 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHHH
T ss_pred             cceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHH
Confidence            99876554332223344578899999998654  78999999999999999999 8899976432        3344455


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+..+..+..+++++.+++.+|+..++.-|+++.+
T Consensus       263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  298 (313)
T 3brb_A          263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV  298 (313)
T ss_dssp             HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence            555556677889999999999999998888876554

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=330.20  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=203.7

Q ss_pred             hhhhhccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----CChHHHHHHHHHhhcC-CCCccceEEEEEEecCcee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSK-----VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  157 (386)
                      +.+.+.||+|+||.||+++.    .+|+.||||+++...     ...+.+.+|+.++..+ +||||+++++++.+.+..+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            34568899999999999986    378999999987532     3345677899999999 6999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||+++++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       136 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999653      4688999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      +........ ......||+.|+|||++.+....++.++|||||||++|||++|+.||........    ...+.+.+...
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~  281 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS  281 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHC
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhcc
Confidence            866433221 1224569999999999875434578999999999999999999999975433221    12222332222


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPP  355 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p  355 (386)
                       .+.++..++..+++++.+|+..++.-|+     +++++..+|
T Consensus       282 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             2456778899999999999999999998     666665555

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.5e-43  Score=321.63  Aligned_cols=252  Identities=26%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             HhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEEEEEecCcee
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  157 (386)
                      .+.+.+.||+|+||.||+|..      .+++.||+|++.....  ..+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            344568899999999999974      3467999999986543  236789999999999 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccc------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESS------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~  225 (386)
                      +||||+++|+|.+++......            .....+++..++.++.||+.||.|||+.   +++||||||+||+++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence            999999999999999765321            1123589999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcc
Q 038768          226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEI  304 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  304 (386)
                      ++.+||+|||++................+++.|+|||++.+.  .++.++||||||+++|||++ |+.||.....     
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  253 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPV-----  253 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-----
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccc-----
Confidence            999999999999877655443333345578899999998664  78999999999999999999 9999976432     


Q ss_pred             cchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          305 YFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       305 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                        .....+.+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       254 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          254 --DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             --SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence              12233333333344456778999999999999988888876554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.6e-42  Score=312.22  Aligned_cols=246  Identities=19%  Similarity=0.249  Sum_probs=204.4

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC-CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT   89 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence            3455688999999999999874 4779999998753 3456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCceEEeeccCCcccC
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~  241 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++....
T Consensus        90 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           90 GGELFERVVHK------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             SCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999998653      4589999999999999999999998   99999999999999   788999999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc-
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF-  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~-  320 (386)
                      ....   .....||+.|+|||++.+   .++.++||||||+++|+|++|+.||.....        ......+..+... 
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~  226 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTFTF  226 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC
T ss_pred             Cccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence            4432   224568999999999854   488999999999999999999999976432        2333333333211 


Q ss_pred             --cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 --QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 --~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                        .....+++++.+++.+|+..++.-|+++.++..+|
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  263 (277)
T 3f3z_A          227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE  263 (277)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence              11236899999999999999999999888776654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.4e-43  Score=324.84  Aligned_cols=248  Identities=23%  Similarity=0.346  Sum_probs=201.2

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||+|... +|+.||+|++......   ..+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            3455689999999999999874 6889999999865432   35688888887 79999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC----CceEEeeccCCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED----FCPKISDFGLAKLS  240 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~  240 (386)
                      +|+|.+++...      ..+++..+..++.||+.||+|||+.   +|+||||||+|||+.++    +.+||+|||+++..
T Consensus       100 gg~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A          100 GGELLDKILRQ------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             SCBHHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999653      4689999999999999999999998   99999999999998543    35999999999866


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ......  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....     ....++...+..+...
T Consensus       171 ~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          171 RAENGL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKFS  241 (342)
T ss_dssp             BCTTCC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCCC
T ss_pred             cCCCCc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCcc
Confidence            543221  2345689999999999764  578899999999999999999999975321     1234455555444321


Q ss_pred             ---cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 ---QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ---~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         ..+..+++++++++.+|+..++.-|+++.++..||
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence               22457899999999999999999998877665554

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=320.54  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=201.1

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC-----CCChHHHHHHHHHhhcCCCCccceEEEEEE--ecCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS-----KVNGEEFINEVASMSKTSHVNVVSFLGFCY--EKKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~  160 (386)
                      .+.+.||+|+||.||++.. .+++.||+|+++..     ....+.+.+|+.++++++||||+++++++.  +....++||
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            4467899999999999986 46889999999753     233467899999999999999999999985  345789999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||++++ |.+++....    ...+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        88 e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           88 EYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             ECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             hhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999766 777775432    24689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .............|+..|+|||++.+....++.++||||||+++|||++|+.||.....        ....+.+..+. .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~~-~  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIGKGS-Y  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCC-C
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHhcCC-C
Confidence            54332223345568999999999865423347899999999999999999999986422        33344444333 4


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++..+++++.+++.+|+..++.-|++++++..+|
T Consensus       231 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            56778999999999999999999998877765443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-42  Score=312.93  Aligned_cols=243  Identities=26%  Similarity=0.405  Sum_probs=196.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh--------HHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG--------EEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      +.+.+.||+|+||.||+|.. .+++.||+|++.......        +.+.+|+.++++++||||+++++++.+..  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            34467899999999999987 478999999987533221        57889999999999999999999985544  79


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCc-----eEE
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLGEDFC-----PKI  231 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl  231 (386)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||+.   +  ++||||||+|||++.++.     +||
T Consensus        99 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             EEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            999999999999886542     4689999999999999999999998   8  999999999999988776     999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhh
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  311 (386)
                      +|||+++.....     .....||+.|+|||++......++.++|||||||++|||++|+.||.......     .....
T Consensus       171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~  240 (287)
T 4f0f_A          171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFIN  240 (287)
T ss_dssp             CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHH
T ss_pred             CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHH
Confidence            999999854432     22456899999999985443467899999999999999999999997543211     01111


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .....+..+.++..+++++.+++.+|+..++.-|+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            122233345677889999999999999999998887654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=322.99  Aligned_cols=242  Identities=26%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---------ChHHHHHHHHHhhcCCCCccceEEEEEEecCce
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  156 (386)
                      .+.+.+.||+|+||.||+|.. .+|+.||||++.....         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            344568899999999999985 4688999999986532         223577899999999999999999999999999


Q ss_pred             eEEEEeCCCC-CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          157 ALIYEFMPNG-SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       157 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      ++||||+.+| +|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999777 999998653      4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      +++........   ....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.....          ...   
T Consensus       176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~---  238 (335)
T 3dls_A          176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVE---  238 (335)
T ss_dssp             TCEECCTTCCB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTT---
T ss_pred             cceECCCCCce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHh---
Confidence            99876654332   234589999999998764 2348899999999999999999999975321          001   


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                        .....+..+++++.+++.+|+..++.-|++++++..+|-
T Consensus       239 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          239 --AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             --TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             --hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence              112335568999999999999999999999888766664

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2e-42  Score=314.39  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=198.5

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.+.||+|+||.||++.. .++..||+|++...  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            455678999999999999986 46889999998753  344578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCceEEeeccCCccc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLS  240 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~  240 (386)
                      ++|+|.+++.....  ....+++..++.++.|++.||.|||+.   +++||||||+|||+   +.++.+||+|||++...
T Consensus       103 ~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          103 EGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             SCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999865321  125689999999999999999999998   99999999999999   45678999999999866


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc--CCCc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI--EPGN  318 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i--~~~~  318 (386)
                      .....   .....|++.|+|||++.+   .++.++||||||+++|||++|+.||.....        ......+  ....
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~  243 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEPN  243 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC
T ss_pred             CCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCcc
Confidence            54332   224568999999999753   588999999999999999999999976432        1221211  1111


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .......+++++.+++.+|+..++.-|+++.++..+|
T Consensus       244 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  280 (285)
T 3is5_A          244 YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE  280 (285)
T ss_dssp             CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            1222344789999999999999999999887765554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.5e-42  Score=311.27  Aligned_cols=244  Identities=26%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||.||++... +++.||+|++.....    ..+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   98 (294)
T 2rku_A           19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence            4578999999999999875 588999999875432    23568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           99 RRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             TCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999988543      4689999999999999999999998   99999999999999999999999999998765332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ..  .....|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ...+..+..+. ..++.
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~~  236 (294)
T 2rku_A          170 ER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNE-YSIPK  236 (294)
T ss_dssp             CC--BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC-CCCCT
T ss_pred             cc--cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhcc-CCCcc
Confidence            21  2234689999999998654  678999999999999999999999976432        22233333332 45677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+++++.+++.+|+..++.-|++++++..+|
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          237 HINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            8899999999999999999999999887765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-42  Score=338.20  Aligned_cols=247  Identities=28%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      ..+.+.+.||+|+||+||+|... ++..||+|++....   .....+.+|+.+++.++||||++++++|.+....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34556789999999999999874 68899999997642   335788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~  238 (386)
                      ||++|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||++.
T Consensus       117 ~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          117 CYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999988543      4688999999999999999999998   9999999999999976   4559999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......   .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.....        ..+...+..+.
T Consensus       188 ~~~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~  253 (494)
T 3lij_A          188 VFENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGK  253 (494)
T ss_dssp             ECBTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred             ECCCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence            7655432   234569999999999853   588999999999999999999999986532        33444443333


Q ss_pred             c---ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 E---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ~---~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .   ......+++++++++.+|+..++.-|+++.++..+|
T Consensus       254 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp  293 (494)
T 3lij_A          254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP  293 (494)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence            1   222356899999999999999999999988877665

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-42  Score=329.30  Aligned_cols=244  Identities=23%  Similarity=0.283  Sum_probs=189.7

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhh-cCCCCccceEEEEEEe----cCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMS-KTSHVNVVSFLGFCYE----KKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~~~lv~e~~~~  165 (386)
                      +.||+|+||+||++... +|+.||||++..    ...+.+|+.++. ..+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            57999999999999864 689999999973    346778888874 4589999999999876    5678999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~  242 (386)
                      |+|.+++....    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++....
T Consensus       144 g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          144 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             CcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            99999997542    24589999999999999999999998   9999999999999997   78999999999986654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---c
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---E  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~  319 (386)
                      ...   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........    ......+..+.   .
T Consensus       217 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          217 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQYEFP  287 (400)
T ss_dssp             -------------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC----CSHHHHHHHTCCCCC
T ss_pred             CCc---cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc----HHHHHHHHcCcccCC
Confidence            322   2345689999999998654  7899999999999999999999999865432211    11122222222   1


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ......+++++++++.+|+..++.-|+++.++..+|
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            112356899999999999999999998877765554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.4e-43  Score=316.95  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||++... +|+.||+|++......   .+.+.+|+.++++++||||+++++++.+  ....++||||
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   88 (279)
T 2w5a_A            9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   88 (279)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred             eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence            34578999999999999874 6899999999865433   3568899999999999999999998865  4678999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR-----IVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +++++|.+++.....  ....+++..++.++.|++.||.|||+.   +     ++||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           89 CEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             CTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             CCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999965431  124589999999999999999999998   7     999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      +........  .....|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ..+...+..+
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~  231 (279)
T 2w5a_A          164 RILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG  231 (279)
T ss_dssp             HHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred             eeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhc
Confidence            866543221  1234589999999998654  688999999999999999999999986532        3444555555


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ....++..+++++.+++.+|+..++.-|+++.++..++..
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            5556777899999999999999999999998887666554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-42  Score=339.45  Aligned_cols=249  Identities=29%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      ...+.+.+.||+|+||.||+|... +|+.||||++...    ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            345566789999999999999875 7899999999653    23457899999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCceEEeeccC
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGL  236 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl  236 (386)
                      |||+.+|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+
T Consensus       105 ~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             ECCCCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999998653      4688999999999999999999998   99999999999999   5678999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ++.......   .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.....        ..+...+..
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~  241 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEK  241 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred             eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHc
Confidence            986654432   224469999999999854   588999999999999999999999986532        333344433


Q ss_pred             Cc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          317 GN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       317 ~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +.   .......+++++++++.+|+..++.-|+++.++..||-
T Consensus       242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence            32   12234568999999999999999999999888877763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-42  Score=314.19  Aligned_cols=241  Identities=25%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             hccCcCCceEEEEEEeC---CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||+|.+.   ++..||+|+++....  ..+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            37999999999999753   577899999986432  236788999999999999999999999 566789999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        95 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           95 PLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            9999996432     4689999999999999999999998   9999999999999999999999999999877544322


Q ss_pred             e-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          247 I-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       247 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      . ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ..+...+..+..+..+.
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~  236 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRMECPP  236 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCCCCCCT
T ss_pred             eeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHhcCCcCCCCC
Confidence            1 22234568899999998654  68899999999999999998 9999976432        34445566666667788


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++++.+++.+|+..++.-|+++.++
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l  263 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTV  263 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            899999999999999988888876554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.8e-42  Score=313.34  Aligned_cols=248  Identities=24%  Similarity=0.308  Sum_probs=205.8

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.+.||+|+||.||+|... +++.||+|++.....   ....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            3445689999999999999875 789999999986432   335788999999998 89999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---------------
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---------------  226 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---------------  226 (386)
                      |+++++|.+++....  .....+++..++.++.||+.||.|||++   +++||||||+|||++.+               
T Consensus        92 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           92 YCNGGSLADAISENY--RIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             CCTTCBHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             ecCCCcHHHHHHhhc--ccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999996542  1124689999999999999999999998   99999999999999844               


Q ss_pred             ----CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC
Q 038768          227 ----FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS  302 (386)
Q Consensus       227 ----~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  302 (386)
                          ..+||+|||++.......      ...||..|+|||++.+. ..++.++|||||||++|+|++|..++...     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                479999999998765432      23489999999998754 35678999999999999999998876532     


Q ss_pred             cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          303 EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       303 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                            ..+..+..+..+.++..+++++.+++.+|+..++.-|+++.++..+|--
T Consensus       235 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  283 (289)
T 1x8b_A          235 ------DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL  283 (289)
T ss_dssp             ------HHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred             ------hHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence                  2234445555566788899999999999999999999998887776643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=317.25  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=190.4

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.+.||+|+||.||+|.. .++.||+|.+... ...+.+.+|++++++++||||+++++++.  +..++||||+++|+|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L   86 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBH
T ss_pred             eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCH
Confidence            3457899999999999998 5789999998743 34567999999999999999999999876  458999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc-eEEeeccCCcccCccccee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC-PKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~~  247 (386)
                      .+++.....   ...+++..++.++.|++.||+|||+....+++||||||+|||++.++. +||+|||++.......   
T Consensus        87 ~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---  160 (307)
T 2eva_A           87 YNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---  160 (307)
T ss_dssp             HHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             HHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence            999975431   235788999999999999999999932128999999999999988876 7999999997654322   


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                        ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......      ...+...+..+..+.....++
T Consensus       161 --~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  230 (307)
T 2eva_A          161 --TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVHNGTRPPLIKNLP  230 (307)
T ss_dssp             ------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHHTTCCCCCBTTCC
T ss_pred             --ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHhcCCCCCcccccC
Confidence              234589999999998654  7899999999999999999999999754221      112223333444556677899


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +++.+++.+|+..++.-|+++.++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~el  254 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEI  254 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHH
Confidence            999999999999888888765443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-42  Score=338.44  Aligned_cols=247  Identities=27%  Similarity=0.400  Sum_probs=205.5

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecC---CCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      ..+.+.+.||+|+||+||+|... +|+.||||++..   .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            34566789999999999999874 689999999864   23456789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~  238 (386)
                      |+++|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||+++
T Consensus       102 ~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          102 LYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999988553      4689999999999999999999998   999999999999995   45679999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......   .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.....        ..+.+.+..+.
T Consensus       173 ~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~  238 (486)
T 3mwu_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGK  238 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred             ECCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence            7654432   234569999999999864   589999999999999999999999976532        23334443332


Q ss_pred             ---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 ---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 ---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         .......+++++++++.+|+..++..|+++.++..+|
T Consensus       239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence               1223456899999999999999999999888876665

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.7e-43  Score=322.25  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=206.0

Q ss_pred             HhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      .+.+.+.||+|+||.||+|...      +++.||+|.+......  ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  105 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  105 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence            3445688999999999999753      3678999999754332  3468899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccc----cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          159 IYEFMPNGSLDQFIYDEESS----NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ||||+++|+|.+++......    .....+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+||
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df  182 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  182 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence            99999999999999653211    1113568999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhh
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      |+++...............+++.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....        ..+...
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~  252 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRF  252 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHHH
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH--------HHHHHH
Confidence            999876554433333344578899999998654  68999999999999999999 8999975422        344455


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+.....+..+++++.+++.+|+..++.-|+++.++
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~  290 (322)
T 1p4o_A          253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  290 (322)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            55555556677899999999999999888888775544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=317.32  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=199.4

Q ss_pred             HHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC------CChHHHHHHHHHhhcCC---CCccceEEEEEEecC-
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK------VNGEEFINEVASMSKTS---HVNVVSFLGFCYEKK-  154 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-  154 (386)
                      ..+.+.+.||+|+||+||+|.. .+|+.||+|++....      .....+.+|+.+++.++   ||||++++++|.+.. 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            3455668999999999999986 568999999987422      22356778888777764   999999999998765 


Q ss_pred             ----ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          155 ----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       155 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                          ..++||||++ ++|.+++....    ...+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence                4789999996 69999996643    23489999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      |+|||+++.......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+
T Consensus       161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i  231 (308)
T 3g33_A          161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKI  231 (308)
T ss_dssp             ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHH
T ss_pred             EeeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence            999999987654332   2345689999999998664  68999999999999999999999997543211    00011


Q ss_pred             hhhc----------------------CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 YKHI----------------------EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~~~i----------------------~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+.+                      .......+...+++++.+++.+|+..++.-|+++.++..||-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence            1110                      001111234568999999999999999999999888776664

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.1e-43  Score=317.88  Aligned_cols=243  Identities=26%  Similarity=0.417  Sum_probs=202.0

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (279)
T 3fdn_A           13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence            4578999999999999864 5779999998642    2334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        93 ~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           93 LGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             TEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            99999998553      4588999999999999999999998   99999999999999999999999999986544332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .    ....|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ....+.+... ...++.
T Consensus       164 ~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~  228 (279)
T 3fdn_A          164 R----TDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRV-EFTFPD  228 (279)
T ss_dssp             --------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT-CCCCCT
T ss_pred             c----cccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHHHhC-CCCCCC
Confidence            1    234689999999998664  678999999999999999999999985432        2333333332 245677


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+++++.+++.+|+..++.-|++++++..+|-
T Consensus       229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            79999999999999999999999888877753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=320.79  Aligned_cols=244  Identities=28%  Similarity=0.449  Sum_probs=193.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCc----EEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.||+|+||.||+|... +++    .||+|.+...  ....+.+.+|+.+++.++||||++++++|.+.. .++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~   96 (327)
T 3lzb_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ   96 (327)
T ss_dssp             EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred             eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence            34578999999999999863 444    3577777543  345578999999999999999999999998654 889999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           97 LMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             CCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             ecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999996542     4688999999999999999999998   99999999999999999999999999998775


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ............+|..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+.+.+..+...
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~  238 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  238 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCC
T ss_pred             CccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            54433333445678899999999764  78999999999999999999 9999986532        3344555555556


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..++.++.+++.+|+..++.-|+++.++
T Consensus       239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  269 (327)
T 3lzb_A          239 PQPPICTIDVYMIMRKCWMIDADSRPKFREL  269 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            6778899999999999999888888765544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-42  Score=315.28  Aligned_cols=244  Identities=23%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   96 (284)
T 2vgo_A           17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA   96 (284)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence            34578999999999999875 5789999998642    234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           97 PRGELYKELQKH------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999653      4588999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..    ....|+..|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+... ...++
T Consensus       168 ~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~-~~~~~  232 (284)
T 2vgo_A          168 RR----RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNV-DLKFP  232 (284)
T ss_dssp             CB----CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT-CCCCC
T ss_pred             cc----ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhcc-ccCCC
Confidence            21    234689999999998764  678999999999999999999999975432        2223333332 24566


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..++++.++++.+|+..++.-|++++++..+|-
T Consensus       233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~  265 (284)
T 2vgo_A          233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW  265 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred             CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence            789999999999999999999999888777653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.5e-42  Score=316.81  Aligned_cols=260  Identities=19%  Similarity=0.268  Sum_probs=207.2

Q ss_pred             cccHHHHHHHHhhhh-hccCcCCceEEEEEEeC-CCcEEEEEEecCCC---CChHHHHHHHHHhhcCC-CCccceEEEEE
Q 038768           77 RYNYSDVKRMTNSFS-NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK---VNGEEFINEVASMSKTS-HVNVVSFLGFC  150 (386)
Q Consensus        77 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~  150 (386)
                      .|...+.-...+.+. +.||+|+||.||+|... +|+.||+|++....   .....+.+|+.++..+. ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344444444444444 78999999999999864 68999999997533   23578899999999995 69999999999


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CC
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DF  227 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~  227 (386)
                      .+.+..++||||+++|+|.+++....    ...+++..++.++.|++.||+|||+.   +++||||||+|||++.   ++
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999985432    25689999999999999999999998   9999999999999987   78


Q ss_pred             ceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccch
Q 038768          228 CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFP  307 (386)
Q Consensus       228 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  307 (386)
                      .+||+|||+++.......   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.....        
T Consensus       172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------  238 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDN--------  238 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred             cEEEeeCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------
Confidence            999999999987654432   2235699999999998654  789999999999999999999999976432        


Q ss_pred             hhhhh---hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          308 NSIYK---HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       308 ~~~~~---~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .....   .............+++++.+++.+|+..++.-|++++++..+|-
T Consensus       239 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            11111   12222223345678999999999999999999999988877764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-42  Score=338.83  Aligned_cols=245  Identities=31%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--------------CChHHHHHHHHHhhcCCCCccceEEEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--------------VNGEEFINEVASMSKTSHVNVVSFLGFCYE  152 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  152 (386)
                      +.+.++||+|+||+||+|... +++.||+|++....              ...+.+.+|+.++++++||||+++++++.+
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  117 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED  117 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            344688999999999999874 57899999997543              234678999999999999999999999999


Q ss_pred             cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---ce
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF---CP  229 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~  229 (386)
                      ....++|||||++|+|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .+
T Consensus       118 ~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          118 KKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            99999999999999999998553      4689999999999999999999998   999999999999998775   69


Q ss_pred             EEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhh
Q 038768          230 KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNS  309 (386)
Q Consensus       230 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  309 (386)
                      ||+|||++........   .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.....        ..
T Consensus       189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~  254 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QD  254 (504)
T ss_dssp             EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH
T ss_pred             EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HH
Confidence            9999999987655432   234569999999999853   588999999999999999999999986532        33


Q ss_pred             hhhhcCCCcc---ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          310 IYKHIEPGNE---FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       310 ~~~~i~~~~~---~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +...+..+..   ......+++++++++.+|+..++.-|++++++..+|
T Consensus       255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            4444444431   122357899999999999999999999988877665

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-43  Score=325.79  Aligned_cols=259  Identities=21%  Similarity=0.246  Sum_probs=199.0

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC------CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS------KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      .+.+.+.||+|+||.||+|.. .++..||+|++...      ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            345568999999999999986 46889999998642      23346789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccc----------------------------------cccccCCHHHHHHHHHHHHHHHHHHHh
Q 038768          160 YEFMPNGSLDQFIYDEESS----------------------------------NINRKLEWRTMCQIAVGIARGLEYLHR  205 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~  205 (386)
                      |||+++|+|.+++......                                  .....+++..++.++.||+.||+|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998531110                                  001234677889999999999999999


Q ss_pred             cCCCCeeecCCCCCCeEeCCCC--ceEEeeccCCcccCcccc--eeeeccccCccccccccccchhcCCCCccchhHhHH
Q 038768          206 GCNIRIVHFDIKPHNILLGEDF--CPKISDFGLAKLSEKKES--FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYG  281 (386)
Q Consensus       206 ~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG  281 (386)
                      .   +++||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||++.+....++.++||||||
T Consensus       187 ~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             T---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             C---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            8   999999999999998776  899999999986543221  112234569999999999865435788999999999


Q ss_pred             HHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc--ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          282 MMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE--FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       282 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      |++|||++|+.||......       ....+.+.....  ......+++++.+++.+|+..++.-|+++.++..+|
T Consensus       264 ~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred             HHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence            9999999999999755321       111122222211  122335899999999999999999888877665444

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.3e-42  Score=316.76  Aligned_cols=257  Identities=22%  Similarity=0.276  Sum_probs=199.2

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            5699999999999985 468999999997643 3457889999999885 799999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc---eEEeeccCCcccCcccc
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC---PKISDFGLAKLSEKKES  245 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~~  245 (386)
                      .+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.   +||+|||++........
T Consensus        99 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           99 LSHIHKR------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            9999653      4688999999999999999999998   9999999999999988765   99999999986543211


Q ss_pred             -----eeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccc-------hhhh
Q 038768          246 -----FISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF-------PNSI  310 (386)
Q Consensus       246 -----~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~  310 (386)
                           ........||+.|+|||++.+.   ...++.++|||||||++|||++|+.||.........+..       ...+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                 1112234589999999998641   124788999999999999999999999865432211110       1223


Q ss_pred             hhhcCCCccc---cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          311 YKHIEPGNEF---QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       311 ~~~i~~~~~~---~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+.+..+...   .....+++++++++.+|+..++.-|+++.++..+|--
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence            3333333211   1124689999999999999999999998888777653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-42  Score=317.73  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=204.2

Q ss_pred             hhhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  158 (386)
                      +.+.+.||+|+||.||+|.+     .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            34568899999999999983     468899999997543  3447899999999999999999999999877  66899


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++++|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus       103 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999995532     4589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc-------CCcccchhhh
Q 038768          239 LSEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL-------SSEIYFPNSI  310 (386)
Q Consensus       239 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-------~~~~~~~~~~  310 (386)
                      ........ .......||..|+|||++.+.  .++.++||||||+++|+|++|+.|+......       .........+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            77654332 222345688889999998664  6789999999999999999999987543210       0111122334


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  292 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN  292 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHH
Confidence            4555666666778889999999999999999998887654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3e-42  Score=310.71  Aligned_cols=241  Identities=27%  Similarity=0.416  Sum_probs=188.1

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC-----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV-----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|.. .|+.||||+++....     ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred             eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence            3457899999999999998 589999999875422     2367899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--------CCceEEeecc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE--------DFCPKISDFG  235 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg  235 (386)
                      ++++|.+++..       ..+++..++.++.|++.||.|||++...+++||||||+|||++.        ++.+||+|||
T Consensus        89 ~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           89 RGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             TTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             CCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            99999999843       46889999999999999999999981112999999999999986        7789999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      ++........    ....|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       ........
T Consensus       162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~  228 (271)
T 3dtc_A          162 LAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGVAM  228 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHT
T ss_pred             cccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhhhc
Confidence            9986654332    234589999999998664  6899999999999999999999999864321       12222233


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .......+..+++++.+++.+|+..++.-|+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  263 (271)
T 3dtc_A          229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTN  263 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence            33345567788999999999999999988887654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4e-42  Score=312.04  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=203.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++.......   +.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   88 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   88 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence            34578999999999999864 58999999997644333   567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc---eEEeeccCCcccC
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC---PKISDFGLAKLSE  241 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~~~  241 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.   +||+|||++....
T Consensus        89 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           89 GGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999988553      4689999999999999999999998   9999999999999976655   9999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---  318 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---  318 (386)
                      ....   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+..+.   
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~  226 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYDY  226 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCC
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhccccC
Confidence            5433   2245689999999998664  689999999999999999999999975432        22223322222   


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .......+++++.+++.+|+..++.-|++++++..+|-
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (284)
T 3kk8_A          227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  264 (284)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred             CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence            12223568999999999999999999999888877763

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=344.28  Aligned_cols=239  Identities=25%  Similarity=0.396  Sum_probs=196.7

Q ss_pred             ccCcCCceEEEEEEeC---CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           93 KLGQGGFGSVYKGKLP---DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +||+|+||.||+|.+.   ++..||||+++...  ...+++.+|++++++++||||++++++|.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999763   46689999998643  345789999999999999999999999976 56899999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce-
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF-  246 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  246 (386)
                      |.+++....     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999996532     5689999999999999999999998   9999999999999999999999999999876543321 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .......++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        .++.+.+..+.....+..
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~  563 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRMECPPE  563 (613)
T ss_dssp             --------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHHHHHTTCCCCCCTT
T ss_pred             eeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCc
Confidence            112233467899999998654  78999999999999999998 9999986532        445667777776777888


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +++++.+++.+|+..++.-|++..+
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~  588 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLT  588 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHH
Confidence            9999999999999877777765443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.5e-42  Score=309.97  Aligned_cols=240  Identities=21%  Similarity=0.301  Sum_probs=198.1

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEec--CceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|++ +|+.||+|++.......   +.+.+|+.++++++||||+++++++.+.  +..++||||+
T Consensus        13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence            3457899999999999998 58999999998654333   5689999999999999999999999887  7789999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      ++|+|.+++....    ...+++..++.++.|++.||.|||+.   +  ++||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           92 PYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             TTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             CCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999997542    23589999999999999999999998   7  9999999999999999999999999876433


Q ss_pred             cccceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ..       ...||+.|+|||.+.+. ...++.++||||||+++|||++|+.||.....       ..........+..+
T Consensus       165 ~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~  230 (271)
T 3kmu_A          165 SP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRP  230 (271)
T ss_dssp             CT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCCCC
T ss_pred             cc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCCCC
Confidence            32       34589999999998653 12344589999999999999999999975432       12222333344456


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .++..+++++.+++.+|+..++..|+++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (271)
T 3kmu_A          231 TIPPGISPHVSKLMKICMNEDPAKRPKFDM  260 (271)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            677889999999999999999998886543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-42  Score=323.62  Aligned_cols=254  Identities=23%  Similarity=0.268  Sum_probs=200.9

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-----CCccceEEEEEEecCceeEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-----HVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.++||+|+||+||+|.. .+++.||||+++......+.+..|+.++..++     ||||+++++++...+..++||
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~  115 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF  115 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence            445568999999999999987 46899999999865545567888999998886     999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---------------
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---------------  225 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---------------  225 (386)
                      ||+ +++|.+++....    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.               
T Consensus       116 e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          116 EPL-GPSLYEIITRNN----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             CCC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             cCC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccc
Confidence            999 999999997643    13588999999999999999999998   9999999999999975               


Q ss_pred             ----------CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcc
Q 038768          226 ----------DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE  295 (386)
Q Consensus       226 ----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~  295 (386)
                                ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCC
Confidence                      7899999999998654432     245689999999999764  68999999999999999999999997


Q ss_pred             cccccCC-------cccchhhhhhhcCCC------------------------------ccccccccCChHHHHHHHHHH
Q 038768          296 VKVSLSS-------EIYFPNSIYKHIEPG------------------------------NEFQLAGVVTEEEKEMAKKMI  338 (386)
Q Consensus       296 ~~~~~~~-------~~~~~~~~~~~i~~~------------------------------~~~~~~~~~s~~~~~li~~ml  338 (386)
                      .......       ....|..........                              ..+.+....++++.+++.+|+
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            5432100       000111111100000                              001122334578889999999


Q ss_pred             HHHHHhcCCCCCCCCCC
Q 038768          339 LVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       339 ~v~~~L~~~~~~~~~~p  355 (386)
                      ..++..|+++.++..+|
T Consensus       341 ~~dP~~Rpta~elL~hp  357 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHK  357 (360)
T ss_dssp             CSSGGGSCCHHHHTTSG
T ss_pred             cCChhhCCCHHHHhcCc
Confidence            99999999988876665

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=326.24  Aligned_cols=244  Identities=27%  Similarity=0.424  Sum_probs=186.7

Q ss_pred             hhhhccCcCCceEEEEEEeC--CC--cEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEe-cCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP--DG--RLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYE-KKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  161 (386)
                      .+.+.||+|+||.||+|.+.  ++  ..||+|.++....  ..+.+.+|+.++++++||||++++++|.+ .+..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            34578999999999999853  32  3689999875433  23678999999999999999999999765 457899999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....     ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       172 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          172 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999996532     4578899999999999999999998   99999999999999999999999999998664


Q ss_pred             cccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          242 KKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       242 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .....  .......++..|+|||++.+.  .++.++|||||||++|||++ |..||.....        ..+...+..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--------~~~~~~~~~~~  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVYLLQGR  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--------SCHHHHHHTTC
T ss_pred             ccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--------HHHHHHHHcCC
Confidence            43211  112234578899999998754  78999999999999999999 6777765432        12223444444


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ....+..+++++.+++.+|+..++.-|+++.+
T Consensus       314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~e  345 (373)
T 3c1x_A          314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  345 (373)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            55567788999999999999988887776544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.3e-42  Score=313.40  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=208.0

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ...+.||+|+||.||+|.. .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  104 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG  104 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence            3457899999999999986 468999999997543  3457899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++..       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus       105 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          105 GSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999853       4588999999999999999999998   999999999999999999999999999987654322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                        ......|+..|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+..+..+.++..
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  242 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKNNPPTLEGN  242 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCCSS
T ss_pred             --ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhhcCCCCCCccc
Confidence              12345689999999998654  688999999999999999999999975422        223333444445567778


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.++.+++.+|+..++.-|+++.++..+|
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            999999999999999999999988876665

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-41  Score=309.12  Aligned_cols=243  Identities=27%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec----CceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK----KKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~lv~e  161 (386)
                      +.+.||+|+||.||+|.. .++..||+|.+......   .+.+.+|+.+++.++||||+++++++...    ...++|||
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence            456799999999999986 46789999999754333   35688999999999999999999998763    45789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeC-CCCceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLG-EDFCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~  238 (386)
                      |+++++|.+++...      ..+++..++.++.||+.||.|||+.   +  ++||||||+|||++ .++.+||+|||++.
T Consensus       110 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          110 LMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999643      4688999999999999999999998   7  99999999999997 78999999999997


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......    ....|++.|+|||.+.+   .++.++||||||+++|+|++|+.||.....       .......+..+.
T Consensus       181 ~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~  246 (290)
T 1t4h_A          181 LKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGV  246 (290)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTC
T ss_pred             ccccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHHHhccC
Confidence            6544322    23458999999998853   588999999999999999999999975422       233344444433


Q ss_pred             -cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 -EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 -~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       ...++...++++.+++.+|+..++.-|++++++..+|
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence             3445777889999999999999999999888776655

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=322.50  Aligned_cols=201  Identities=19%  Similarity=0.218  Sum_probs=171.2

Q ss_pred             hhhhccCcCCceEEEEEE------eCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGK------LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  159 (386)
                      .+.+.||+|+||+||+|.      ..+++.||+|++...  ...++..|+.++..++   |+||+.+++++...+..++|
T Consensus        68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv  145 (365)
T 3e7e_A           68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV  145 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred             EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence            345789999999999994      446889999999753  4667888888888887   99999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----------CCc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-----------DFC  228 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----------~~~  228 (386)
                      |||+++|+|.+++..... .....+++..++.++.||+.||+|||+.   +|+||||||+|||++.           ++.
T Consensus       146 ~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence            999999999999975322 1235699999999999999999999998   9999999999999998           899


Q ss_pred             eEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          229 PKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       229 ~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                      +||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+||+.||...
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccC
Confidence            999999999765433222334456799999999999764  6899999999999999999999999754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-42  Score=312.37  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=201.9

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-------NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      .+.+.+.||+|+||.||+|... +|+.||+|+++....       ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4556789999999999999875 689999999875322       35789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----ceEEeec
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF----CPKISDF  234 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df  234 (386)
                      ||||+++++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++    .+||+||
T Consensus        86 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999543      4689999999999999999999998   999999999999998877    8999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      |++........   .....|++.|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~  223 (283)
T 3bhy_A          157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNI  223 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred             ccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHh
Confidence            99987654332   1234589999999998654  688999999999999999999999976432        2222332


Q ss_pred             CCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 EPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 ~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....   .......+++++.+++.+|+..++.-|+++.++..+|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred             HhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence            2222   2233467899999999999999999998877665544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=317.14  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=197.1

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||+||+|... +|+.||+|++......   .+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD   85 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence            34578999999999999874 5899999998765443   3567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           86 HTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999887543      4589999999999999999999998   99999999999999999999999999998765433


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc--------chhh--hh---
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY--------FPNS--IY---  311 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~--------~~~~--~~---  311 (386)
                      ..  .....||..|+|||++.+. ..++.++||||||+++|+|++|+.||...........        .+..  .+   
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          157 DY--YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc--cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            21  1234689999999998654 3679999999999999999999999976532110000        0000  00   


Q ss_pred             ---hhcCCCc------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 ---KHIEPGN------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ---~~i~~~~------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                         .......      .......+++++.+++.+|+..++.-|++++++..+|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  287 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY  287 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence               0000000      00112468899999999999999999999888877764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.6e-42  Score=311.08  Aligned_cols=245  Identities=23%  Similarity=0.386  Sum_probs=197.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence            34578999999999999875 6899999998642    234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           94 SGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             CCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999653      4588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..   .....|++.|+|||.+.+. ...+.++||||||+++|+|++|+.||.....        ....+.+..+. ..++
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~  231 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKKIRGGV-FYIP  231 (276)
T ss_dssp             ---------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCCC
T ss_pred             cc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcCc-ccCc
Confidence            32   1234589999999998754 2346899999999999999999999975422        33344443333 3456


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..++.++.+++.+|+..++.-|+++.++..+|
T Consensus       232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~  263 (276)
T 2h6d_A          232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHE  263 (276)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             hhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence            77899999999999999999999888775554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-42  Score=314.58  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      ..+.+.+.||+|+||.||++... +|+.||+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            34455689999999999999874 689999999986433 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCceEEeeccCCccc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLS  240 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~  240 (386)
                      ++++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++...
T Consensus        89 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           89 SGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             CCccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999998543      4688999999999999999999998   99999999999999   78899999999999765


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--  318 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--  318 (386)
                      ....    .....|++.|+|||++.+.  .++.++||||||+++|+|++|+.||.....        ......+..+.  
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~  225 (304)
T 2jam_A          160 QNGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYYE  225 (304)
T ss_dssp             CCBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCCC
T ss_pred             CCCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            4332    1234589999999998654  689999999999999999999999975432        22333333222  


Q ss_pred             -cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 -EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 -~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       .......+++++.+++.+|+..++.-|++++++..+|
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence             1233467899999999999999999999888876665

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.3e-42  Score=322.51  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---------hHHHHHHHHHhhcC-CCCccceEEEEEEecCcee
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---------GEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  157 (386)
                      .+.+.||+|+||.||+|... +|+.||||++......         .+.+.+|+.++.++ +||||+++++++...+..+
T Consensus        97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  176 (365)
T 2y7j_A           97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF  176 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEE
T ss_pred             ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEE
Confidence            33478999999999999875 6999999999754321         24578899999999 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||+++++|.+++...      ..+++..+..++.||+.||.|||+.   +++|+||||+|||++.++.+||+|||++
T Consensus       177 lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          177 LVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS  247 (365)
T ss_dssp             EEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence            999999999999999643      4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchh----cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRN----FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ........   .....||+.|+|||++.+.    ...++.++|||||||++|+|++|+.||.....        ......
T Consensus       248 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~~~~~  316 (365)
T 2y7j_A          248 CHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------ILMLRM  316 (365)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             cccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence            87654432   2345699999999998642    12578899999999999999999999975422        222222


Q ss_pred             cCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          314 IEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       314 i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..+.   .......++.++.+++.+|+..++.-|+++.++..+|
T Consensus       317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            22222   1112356889999999999999999998877655443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-42  Score=334.98  Aligned_cols=258  Identities=19%  Similarity=0.270  Sum_probs=183.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec-----CceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK-----KKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  158 (386)
                      +.+.+.||+|+||+||+|... +|+.||||++......   .+.+.+|+.+++.++||||+++++++...     ...|+
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            445688999999999999864 6899999999764333   35688999999999999999999999544     46899


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+ +++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       135 v~e~~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EECCC-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEecc-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            99998 67999998543      4689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccce-------------------------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh----
Q 038768          239 LSEKKESF-------------------------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV----  289 (386)
Q Consensus       239 ~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt----  289 (386)
                      ........                         ......+||+.|+|||++... ..++.++|||||||++|||++    
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccc
Confidence            76432210                         122345689999999987543 468999999999999999999    


Q ss_pred             -------CCCCcccccccCC--------ccc-------------------chhhhhhhcC------------CC---ccc
Q 038768          290 -------GRKNAEVKVSLSS--------EIY-------------------FPNSIYKHIE------------PG---NEF  320 (386)
Q Consensus       290 -------g~~p~~~~~~~~~--------~~~-------------------~~~~~~~~i~------------~~---~~~  320 (386)
                             |+.+|........        ...                   .+.+.+..+.            ..   ...
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   5555544321100        000                   0000001100            00   011


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .....+++++.+++.+||..++.-|++++++..||-
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~  399 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF  399 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence            223456999999999999999999998887766664

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.7e-42  Score=311.47  Aligned_cols=238  Identities=26%  Similarity=0.439  Sum_probs=193.8

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEec-CceeEEEEeCCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK-KKRALIYEFMPNGS  167 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gs  167 (386)
                      .+.+.||+|+||.||++.. +|+.||+|+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~  101 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  101 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence            4567899999999999988 58999999997543 557899999999999999999999997655 47899999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus       102 L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  172 (278)
T 1byg_A          102 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--  172 (278)
T ss_dssp             HHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc--
Confidence            999996532    13478999999999999999999998   999999999999999999999999999986544321  


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                         ...++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ..+...+..+..+..+..+
T Consensus       173 ---~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  239 (278)
T 1byg_A          173 ---TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPDGC  239 (278)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTTTCCCCCCTTC
T ss_pred             ---CCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCcccC
Confidence               23478899999998654  78999999999999999998 9999975432        3344556666666778889


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++++.+++.+|+..++.-|+++.+
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~  263 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQ  263 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHH
Confidence            999999999999999888876543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-42  Score=326.19  Aligned_cols=252  Identities=12%  Similarity=0.024  Sum_probs=181.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC----hHHHHHH---HHHhhcCCCCccceEE-------EEEEec
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN----GEEFINE---VASMSKTSHVNVVSFL-------GFCYEK  153 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E---~~~l~~l~h~niv~~~-------~~~~~~  153 (386)
                      .+.+.||+|+||.||+|... +|+.||||++......    .+.+.+|   +..++. +||||++++       +++...
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEET
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecC
Confidence            34578999999999999864 7899999999875532    2456677   455566 799977755       555543


Q ss_pred             C-----------------ceeEEEEeCCCCCHHHHhcccccccccccCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 038768          154 K-----------------KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTM------CQIAVGIARGLEYLHRGCNIR  210 (386)
Q Consensus       154 ~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~  210 (386)
                      +                 ..++||||++ |+|.+++....     ..+.+..+      +.++.||+.||+|||++   +
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            3                 3799999998 89999997642     23444455      67889999999999998   9


Q ss_pred             eeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhC
Q 038768          211 IVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG  290 (386)
Q Consensus       211 ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg  290 (386)
                      |+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+....++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998665332     13446799999999965223689999999999999999999


Q ss_pred             CCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          291 RKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       291 ~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +.||...............................+++++.+++.+|+..++.-|+++.++..+|
T Consensus       290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            99998764321111110000011111112223457899999999999999999999888776655

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.1e-42  Score=311.71  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=197.8

Q ss_pred             hhh-ccCcCCceEEEEEEe---CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSN-KLGQGGFGSVYKGKL---PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+ .||+|+||.||+|.+   .+++.||||+++.....   .+.+.+|+++++.++||||+++++++ ..+..++||||
T Consensus        20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   98 (291)
T 1xbb_A           20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM   98 (291)
T ss_dssp             EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence            344 899999999999964   34688999999764322   46789999999999999999999999 66788999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        99 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           99 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999653      4588999999999999999999998   999999999999999999999999999987655


Q ss_pred             cccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          243 KESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       243 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ..+...+..+..+
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERM  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCC
T ss_pred             CCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            43322 22234567889999998654  67899999999999999999 9999986432        3455566666666


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+..+++++.+++.+|+..++.-|+++.+
T Consensus       240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  269 (291)
T 1xbb_A          240 GCPAGCPREMYDLMNLCWTYDVENRPGFAA  269 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            778889999999999999988888876544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-42  Score=321.62  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=205.9

Q ss_pred             hhhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  159 (386)
                      +.+.+.||+|+||.||+|.+     .+++.||||++..... ..+.+.+|++++++++|+||+++++++..  ....++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            34567899999999999984     4688999999976532 23568999999999999999999999874  4568899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            99999999999996532     4589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc-------CCcccchhhhh
Q 038768          240 SEKKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL-------SSEIYFPNSIY  311 (386)
Q Consensus       240 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-------~~~~~~~~~~~  311 (386)
                      ........ ......|+..|+|||++.+.  .++.++||||||+++|+|++|+.||......       .........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            65443221 22334588889999998664  6789999999999999999999998754321       11111223445


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+.....+..+++++.+++.+|+..++.-|+++.++
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  294 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL  294 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence            5566666667788899999999999999888888876554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-42  Score=322.20  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=194.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  158 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++....      ..|+
T Consensus        28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  107 (367)
T 1cm8_A           28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  107 (367)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence            3457899999999999987 46899999999754333   356889999999999999999999998663      4599


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+ +++|.+++..       ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       108 v~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          108 VMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             EEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            99999 8899999854       3588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~  311 (386)
                      .....     .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||........       ....+.+.+
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            75543     2245689999999998763 3689999999999999999999999986532110       000111111


Q ss_pred             hhcC---------------CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 KHIE---------------PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~~i~---------------~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +.+.               ......+...+++++.+++.+||..++.-|++++++..||-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence            1111               11122334567999999999999999999998888766664

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.1e-42  Score=312.27  Aligned_cols=244  Identities=27%  Similarity=0.427  Sum_probs=194.5

Q ss_pred             hhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEe-cCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYE-KKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  161 (386)
                      .+.+.||+|+||.||+|...+    +..||+|.+......  .+.+.+|+.++++++||||++++++|.+ .+..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            445789999999999998632    236899998764332  3578899999999999999999999754 457789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus       108 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          108 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999996532     4578999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          242 KKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       242 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .....  .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        ......+..+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~~~~~~~~  249 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVYLLQGR  249 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHHHHHHTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhcCC
Confidence            43321  122345678899999998664  78999999999999999999 5556654322        22333444445


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ....+..+++++.+++.+|+..++.-|+++.+
T Consensus       250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  281 (298)
T 3f66_A          250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  281 (298)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            55567788999999999999988888876544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.1e-42  Score=318.95  Aligned_cols=241  Identities=21%  Similarity=0.226  Sum_probs=189.2

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++.+ +|+||+++++++.+.+..++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP   89 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence            3457899999999999986 578999999987543 234688999999999 8999999999999999999999999 99


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc-----eEEeeccCCcccC
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC-----PKISDFGLAKLSE  241 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~~~~  241 (386)
                      +|.+++...     ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++...
T Consensus        90 ~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           90 SLEDLFDLC-----DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             BHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            999999653     25689999999999999999999998   9999999999999998887     9999999998764


Q ss_pred             ccccee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          242 KKESFI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       242 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ......     ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......     ..+..+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~  234 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-----LKERYQKIGD  234 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-----HHHHHHHHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCcccccccc-----HHHHHHHHHh
Confidence            432211     12346799999999998764  68999999999999999999999998653211     1122222211


Q ss_pred             Ccc----ccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          317 GNE----FQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       317 ~~~----~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ...    ..+...++ ++.+++..|+..++.-|++
T Consensus       235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~  268 (330)
T 2izr_A          235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPD  268 (330)
T ss_dssp             HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCC
T ss_pred             hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCC
Confidence            110    11122233 8889999888855554443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4e-42  Score=318.63  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=201.4

Q ss_pred             HHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCcee
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  157 (386)
                      ..+.+.+.||+|+||.||+|.+      .+++.||||++.....  ...++.+|+.++++++||||+++++++.+.+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            3445568899999999999984      2467899999975332  2357889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccc-cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEee
Q 038768          158 LIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISD  233 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  233 (386)
                      +||||+++++|.+++...... .....+++..++.++.||+.||.|||+.   +++||||||+|||++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence            999999999999999765321 1224588999999999999999999998   9999999999999984   45699999


Q ss_pred             ccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhh
Q 038768          234 FGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       234 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ||++................|++.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....        ..+.+
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~  256 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE  256 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHH
Confidence            9999765443332223345678899999998654  78999999999999999998 9999975422        34445


Q ss_pred             hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          313 HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       313 ~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+.....+..+++++.+++.+|+..++.-|+++.++
T Consensus       257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  295 (327)
T 2yfx_A          257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII  295 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            555555566778899999999999999988888876654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.6e-42  Score=311.63  Aligned_cols=245  Identities=18%  Similarity=0.233  Sum_probs=197.3

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+.++..+ +|+|++++++++.+....++||||+ ++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   90 (298)
T 1csn_A           13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   90 (298)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence            3457899999999999985 578999999987543 345688999999999 7999999999999999999999999 99


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc-----eEEeeccCCcccC
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC-----PKISDFGLAKLSE  241 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~~~~  241 (386)
                      +|.+++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.     +||+|||+++...
T Consensus        91 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           91 SLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            9999996542     4589999999999999999999998   9999999999999987765     9999999998765


Q ss_pred             cccce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          242 KKESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       242 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      .....     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........     ......+..
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~  235 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGE  235 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-----HHHHHHHHh
Confidence            43221     112345699999999998664  689999999999999999999999986533211     111122111


Q ss_pred             ----CccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          317 ----GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       317 ----~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                          .....+...+++++.+++.+|+..++.-|+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~  273 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY  273 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHH
Confidence                1123345578999999999999988877776443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-41  Score=315.24  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=196.8

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++.......   +.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  107 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD  107 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence            34578999999999999874 58999999987654443   457899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++......
T Consensus       108 ~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          108 HTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99998886433      4589999999999999999999998   99999999999999999999999999998665432


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc--------chh--hhhhh-
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY--------FPN--SIYKH-  313 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~--------~~~--~~~~~-  313 (386)
                      ..  .....|+..|+|||++.+. ..++.++|||||||++|+|++|+.||...........        .+.  ..+.. 
T Consensus       179 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 EV--YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             cc--cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            21  2234689999999998654 3678999999999999999999999976532110000        000  00000 


Q ss_pred             ----------c-CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          314 ----------I-EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       314 ----------i-~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                + ...........+++++.+++.+|+..++.-|+++.++..+|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                      0 00001112346799999999999999999999998887665

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.5e-42  Score=311.26  Aligned_cols=246  Identities=29%  Similarity=0.439  Sum_probs=185.1

Q ss_pred             HhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.++||+|+||+||+|...  ..||+|+++......   +.+.+|+.++++++||||+++++++ .....++||||+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~  101 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC  101 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred             ceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence            3455688999999999999863  359999997654433   5688999999999999999999965 566789999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus       102 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          102 EGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             CCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999996542     5689999999999999999999998   9999999999999999999999999999865543


Q ss_pred             cceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC----Cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP----GN  318 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~----~~  318 (386)
                      ..........||+.|+|||++... ...++.++||||||+++|+|++|+.||......       ..+.+.+..    ..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGSLSPD  246 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTSCCCC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccccCcc
Confidence            222223345689999999998521 246788999999999999999999999754221       122222211    11


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+...+++++.+++.+|+..++.-|+++.+
T Consensus       247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  278 (289)
T 3og7_A          247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPR  278 (289)
T ss_dssp             TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence            23345678999999999999999888886543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.2e-42  Score=329.76  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=193.0

Q ss_pred             HHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---------ChHHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---------NGEEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      ...+.+.+.||+|+||.||+|.. .+++.||||++.....         ....+.+|+.++++++||||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            33455568999999999999986 4589999999875321         1134789999999999999999999975 55


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CceEE
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKI  231 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl  231 (386)
                      ..++||||+++|+|.+++...      ..+++..++.++.|++.||+|||+.   +++||||||+|||++.+   +.+||
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             ceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            689999999999999988543      5689999999999999999999998   99999999999999754   45999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      +|||+++.......   .....||+.|+|||++.+ ....++.++|||||||++|+|++|+.||......       ..+
T Consensus       284 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~  353 (419)
T 3i6u_A          284 TDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSL  353 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-------CCH
T ss_pred             eecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-------HHH
Confidence            99999987654332   224569999999999853 2246788999999999999999999999754221       112


Q ss_pred             hhhcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          311 YKHIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       311 ~~~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+.+..+.   .+.....+++++.+++.+|+..++.-|++++++..||
T Consensus       354 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          354 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            22232222   1233457899999999999999999999887766554

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-42  Score=319.45  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=197.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|++......      .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   91 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence            445688999999999999874 5899999999753221      246889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++ +|..++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        92 e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           92 DFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             ECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            99975 8888886532     4578889999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC-----
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE-----  315 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~-----  315 (386)
                      .....  ......||+.|+|||++.+. ..++.++|||||||++|||++|..||.......    .-..+++...     
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEE  235 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTT
T ss_pred             cCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCCChh
Confidence            54322  12345689999999998654 358899999999999999999999997653210    0001111100     


Q ss_pred             ------CC-------c-----cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 ------PG-------N-----EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 ------~~-------~-----~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                            ..       .     ...+...+++++.+++.+|+..++.-|++++++..+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence                  00       0     0012356789999999999999999999988876655

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.2e-42  Score=345.15  Aligned_cols=239  Identities=25%  Similarity=0.399  Sum_probs=197.3

Q ss_pred             hccCcCCceEEEEEEe---CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKL---PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ++||+|+||.||+|.+   ..++.||||+++....   ..+++.+|++++.+++||||++++++|. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            4799999999999965   2467899999976433   2478999999999999999999999986 4568899999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            9999999543      4688999999999999999999998   999999999999999999999999999987654432


Q ss_pred             e-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          246 F-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       246 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      . .......+|..|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+..+.....+
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~~~p  594 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP  594 (635)
T ss_dssp             ----------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred             ccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            2 222334577899999999654  78999999999999999998 9999986532        4566677777767778


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+++++.+++.+|+..++.-|+++.+
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~  621 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAA  621 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            899999999999999988888876543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-42  Score=317.05  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=204.3

Q ss_pred             HhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecC-ce
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKK-KR  156 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~  156 (386)
                      .+.+.+.||+|+||.||+|..      .+++.||||++......  .+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  107 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  107 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence            344568899999999999974      35689999999865432  25688999999999 7999999999988765 48


Q ss_pred             eEEEEeCCCCCHHHHhccccccc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSN----------INRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      ++||||+++++|.+++.......          ....+++..++.++.|++.||.|||+.   +++||||||+||+++.+
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK  184 (316)
T ss_dssp             EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence            99999999999999997653211          012378999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCccc
Q 038768          227 FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIY  305 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  305 (386)
                      +.+||+|||+++...............||+.|+|||++.+.  .++.++||||||+++|+|++ |+.||.....      
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------  256 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------  256 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccch------
Confidence            99999999999876554443334455678899999998664  78999999999999999998 9999975432      


Q ss_pred             chhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          306 FPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       306 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                       .......+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       257 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  300 (316)
T 2xir_A          257 -DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  300 (316)
T ss_dssp             -SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence             13344444444455667788999999999999988888876554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.6e-42  Score=328.94  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=194.5

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec-----CceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK-----KKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  159 (386)
                      .+.+.||+|+||.||+|... +|+.||||++......   .+.+.+|+.+++.++|+||+++++++...     ...|+|
T Consensus        29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  108 (432)
T 3n9x_A           29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV  108 (432)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence            34578999999999999864 5889999999764333   35788999999999999999999999876     568999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||++ ++|.+++...      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          109 LEIAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EECCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            99985 6999999543      4689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCcccce--------------------eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          240 SEKKESF--------------------ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       240 ~~~~~~~--------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                      .......                    .......||+.|+|||++... ..++.++|||||||++|||++|..||.....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence            6543211                    112456789999999987543 4689999999999999999997666543211


Q ss_pred             cCCcc-----cc------------------------------hhhhhhhc------------CCCcc---ccccccCChH
Q 038768          300 LSSEI-----YF------------------------------PNSIYKHI------------EPGNE---FQLAGVVTEE  329 (386)
Q Consensus       300 ~~~~~-----~~------------------------------~~~~~~~i------------~~~~~---~~~~~~~s~~  329 (386)
                      .....     .+                              +.+.+..+            .....   ......++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence            10000     00                              00000000            00000   0112458999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          330 EKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       330 ~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +.+++.+||..++.-|++++++..||-
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~  364 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPY  364 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChh
Confidence            999999999999999999888877764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-41  Score=314.14  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=201.7

Q ss_pred             hhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEec--CceeEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEK--KKRALI  159 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  159 (386)
                      .+.+.||+|+||+||++.+     .+|+.||||+++....  ..+.+.+|++++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            4467899999999999864     2678999999986532  235689999999999999999999999884  567899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++|+|.+++..       ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       114 ~e~~~~~~L~~~l~~-------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             ECCCTTCBHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EecccCCcHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            999999999999954       2488999999999999999999998   999999999999999999999999999987


Q ss_pred             cCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc-------CCcccchhhhh
Q 038768          240 SEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL-------SSEIYFPNSIY  311 (386)
Q Consensus       240 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-------~~~~~~~~~~~  311 (386)
                      ....... .......++..|+|||++.+.  .++.++||||||+++|+|++|+.||......       .........+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            7654332 122345578889999998764  6789999999999999999999999754211       00001112234


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+.....+..+++++.+++.+|+..++..|+++.++
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  301 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL  301 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence            4455555666788899999999999999998888876543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-42  Score=317.98  Aligned_cols=243  Identities=27%  Similarity=0.420  Sum_probs=192.4

Q ss_pred             hhhccCcCCceEEEEEEeCC-----CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLPD-----GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.||+|+||.||+|....     +..||+|+++.....  ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  127 (333)
T 1mqb_A           48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY  127 (333)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence            35789999999999997632     236999999764322  35688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus       128 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          128 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999996532     4689999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          243 KESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       243 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .... .......++..|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ..+.+.+..+...
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~~  269 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFRL  269 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCC
T ss_pred             ccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCCcC
Confidence            3221 112234467889999998653  78999999999999999999 9999975422        3445555555555


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+..+++++.+++.+|+..++.-|+++.+
T Consensus       270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  299 (333)
T 1mqb_A          270 PTPMDCPSAIYQLMMQCWQQERARRPKFAD  299 (333)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            567788999999999999877777765443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3e-42  Score=319.74  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=192.1

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA  115 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence            34458899999999999985 46899999999754322   356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe-----CCCCceEEeeccCCc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL-----GEDFCPKISDFGLAK  238 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfgl~~  238 (386)
                      + |+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||+     +.++.+||+|||+++
T Consensus       116 ~-~~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          116 E-NDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             S-EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             C-CCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            6 5999998653      4589999999999999999999998   99999999999999     455669999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC---
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE---  315 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~---  315 (386)
                      .......  ......||..|+|||++.+. ..++.++|||||||++|||++|+.||........    -..+.+.+.   
T Consensus       186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~  258 (329)
T 3gbz_A          186 AFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ----LFKIFEVLGLPD  258 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCC
T ss_pred             ccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH----HHHHHHHhCCCc
Confidence            6643322  12234589999999998764 3589999999999999999999999975432110    000000000   


Q ss_pred             ----------------------CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 ----------------------PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 ----------------------~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                            ......+...+++++.+++.+|+..++.-|++++++..||-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  321 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY  321 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence                                  00011223448899999999999999999999888776663

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-42  Score=336.77  Aligned_cols=251  Identities=25%  Similarity=0.280  Sum_probs=187.7

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecC------cee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  157 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++....      ..|
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            33457899999999999986 4689999999976432   2356889999999999999999999997653      469


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||+++ +|.+.+.        ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       144 lv~E~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             EEEeCCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            99999965 5666663        2488999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSI  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~  310 (386)
                      +.......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+....-.       ..+.+.
T Consensus       212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          212 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             -----CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eecCCCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            87654322   2345699999999999764  78999999999999999999999998653210000       000000


Q ss_pred             hhhc--------CCC---ccccc---------------cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          311 YKHI--------EPG---NEFQL---------------AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       311 ~~~i--------~~~---~~~~~---------------~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++.+        ...   ....+               ....++++.+++.+||..++.-|++++++..||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence            1110        000   00000               011257799999999999999999988877666

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=310.04  Aligned_cols=243  Identities=24%  Similarity=0.381  Sum_probs=196.5

Q ss_pred             hhccCcCCceEEEEEEeC-CC---cEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCce-eEEEEeC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DG---RLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKR-ALIYEFM  163 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~  163 (386)
                      .+.||+|+||+||+|.+. ++   ..||+|.+......  .+.+.+|+.+++.++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            478999999999999753 22   37999999764332  36788999999999999999999999877665 8999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      .+|+|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          106 CHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             TTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999996532     5678999999999999999999998   9999999999999999999999999999866443


Q ss_pred             cce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          244 ESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       244 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      ...  .......++..|+|||.+.+.  .++.++||||||+++|+|++|..|+.....       +..+...+..+....
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~  248 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFDLTHFLAQGRRLP  248 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------GGGHHHHHHTTCCCC
T ss_pred             cccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCC-------HHHHHHHhhcCCCCC
Confidence            221  122345678899999998654  689999999999999999996655432211       233444555555566


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+..+++++.+++.+|+..++.-|+++.+
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHH
Confidence            67789999999999999988888876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=309.88  Aligned_cols=252  Identities=26%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      ..||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4799999999999986 468899999997643 33577899999999999999999999999999999999999999999


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeeccCCcccCcccceee
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      +++.....   ...+++..++.++.|++.||.|||+.   +++|+||||+||+++. ++.+||+|||++.........  
T Consensus       108 ~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--  179 (295)
T 2clq_A          108 ALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--  179 (295)
T ss_dssp             HHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred             HHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence            99965421   23567889999999999999999998   9999999999999987 899999999999866543221  


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCCh
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE  328 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~  328 (386)
                      .....|+..|+|||++.+....++.++||||||+++|+|++|+.||.......      ............+.++..+++
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHHCCCCCCCTTSCH
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhccccccccccccCCH
Confidence            22456899999999987643347899999999999999999999997542211      111111111223456778999


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          329 EEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       329 ~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ++.+++.+|+..++.-|+++.++..+|--
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence            99999999999999999998887666543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-41  Score=316.71  Aligned_cols=259  Identities=20%  Similarity=0.274  Sum_probs=197.6

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEec--------Cc
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--------KK  155 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~  155 (386)
                      +.+.+.||+|+||.||+|.. .+|+.||+|++....   .....+.+|+.+++.++||||+++++++.+.        +.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   98 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence            34457899999999999987 578999999986533   2245788999999999999999999999874        46


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .++||||++ ++|.+.+....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        99 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           99 IYLVFDFCE-HDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             EEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            789999996 57777775432     4589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccc--eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccc
Q 038768          236 LAKLSEKKES--FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYF  306 (386)
Q Consensus       236 l~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~  306 (386)
                      +++.......  ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||.........       ...
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9986643221  1122345689999999998654 35799999999999999999999999865321000       000


Q ss_pred             hhhhhhhcCCC-----------ccccc-----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          307 PNSIYKHIEPG-----------NEFQL-----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       307 ~~~~~~~i~~~-----------~~~~~-----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +...+..+...           ....+     ....++++.+++.+||..++.-|++++++..+|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            00000000000           00000     0113788999999999999999999988877764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-42  Score=319.81  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=202.1

Q ss_pred             hhhhhccCcCCceEEEEEEeCC-C-----cEEEEEEecCCCC--ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD-G-----RLVAVKVLKNSKV--NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  158 (386)
                      +.+.+.||+|+||.||+|.... +     ..||+|.+.....  ..+.+.+|+.++..+ +||||+++++++.+.+..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            3456889999999999998632 2     4899999976543  235788999999999 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccc--------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          159 IYEFMPNGSLDQFIYDEESS--------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                      ||||+++|+|.+++......        .....+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence            99999999999999654210        0124578999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNS  309 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  309 (386)
                      |+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..||.....       ...
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~  275 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILV-------NSK  275 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-------SHH
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccch-------hHH
Confidence            9999999876544433333345578899999998764  78999999999999999999 9999975432       122


Q ss_pred             hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       310 ~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+.+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  316 (333)
T 2i1m_A          276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ  316 (333)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            23333333334456678999999999999999888887654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.7e-42  Score=312.72  Aligned_cols=246  Identities=21%  Similarity=0.312  Sum_probs=187.3

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhc--CCCCccceEEEEEEec----CceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK--TSHVNVVSFLGFCYEK----KKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~e~  162 (386)
                      .+.+.||+|+||+||+|+. +|+.||||++...  ....+..|.+++..  ++||||+++++++.+.    ...++||||
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~   87 (301)
T 3q4u_A           11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY   87 (301)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence            3467899999999999998 7899999998753  34556666666655  7999999999997754    457899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH--------RGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      +++|+|.+++..       ..+++..++.++.||+.||+|||        +.   +++||||||+|||++.++.+||+||
T Consensus        88 ~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           88 HEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence            999999999943       35889999999999999999999        76   9999999999999999999999999


Q ss_pred             cCCcccCccccee--eeccccCccccccccccchhcC----CCCccchhHhHHHHHHHHHhC----------CCCccccc
Q 038768          235 GLAKLSEKKESFI--SMLGARGTIGYIAPEVFCRNFG----GVSHKSDVYSYGMMILEMVVG----------RKNAEVKV  298 (386)
Q Consensus       235 gl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~----~~~~~~DvwslGvil~elltg----------~~p~~~~~  298 (386)
                      |+++.........  ......||+.|+|||++.+...    .++.++|||||||++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998655433221  1223469999999999865411    234789999999999999999          77776443


Q ss_pred             ccCCcccchhhhhhhc-CCCccccc-----cccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          299 SLSSEIYFPNSIYKHI-EPGNEFQL-----AGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       299 ~~~~~~~~~~~~~~~i-~~~~~~~~-----~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .....   .....+.+ .....+.+     ...+++++.+++.+|+..++.-|+++.+
T Consensus       238 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  292 (301)
T 3q4u_A          238 PNDPS---FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR  292 (301)
T ss_dssp             CSSCC---HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCcc---hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence            22111   11111111 11112222     2335678999999999999998887654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.8e-41  Score=307.57  Aligned_cols=240  Identities=26%  Similarity=0.445  Sum_probs=198.4

Q ss_pred             HHHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEe----------
Q 038768           84 KRMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE----------  152 (386)
Q Consensus        84 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------  152 (386)
                      ....+...+.||+|+||.||+|... +|+.||+|++....   +.+.+|++++++++||||+++++++..          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            3444556689999999999999875 78999999997543   467899999999999999999999865          


Q ss_pred             ------cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          153 ------KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       153 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                            ....++||||+++++|.+++....    ...+++..++.++.||+.||.|||+.   +++|+||||+|||++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                  345789999999999999996542    24689999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccc
Q 038768          227 FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYF  306 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~  306 (386)
                      +.+||+|||++........   .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..|+...         
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~---------  224 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET---------  224 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence            9999999999987655432   2234689999999998654  6899999999999999999999988643         


Q ss_pred             hhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          307 PNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       307 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                       ...+..+..+   .++..++.++++++.+|+..++.-|+++.++
T Consensus       225 -~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~  265 (284)
T 2a19_B          225 -SKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEI  265 (284)
T ss_dssp             -HHHHHHHHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -HHHHHHhhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence             1222333222   2456689999999999999998888876655

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.2e-43  Score=329.24  Aligned_cols=243  Identities=15%  Similarity=0.134  Sum_probs=187.5

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHH---HHhhcCCCCccceEE-------EEEEecC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEV---ASMSKTSHVNVVSFL-------GFCYEKK  154 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~~~  154 (386)
                      +.+.||+|+||+||+|.. .+|+.||||++...    ....+.+.+|+   +.+++++||||++++       +++.+.+
T Consensus        77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~  156 (377)
T 3byv_A           77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  156 (377)
T ss_dssp             EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred             EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence            357899999999999986 56999999999743    22346788999   556666899999998       7776654


Q ss_pred             c-----------------eeEEEEeCCCCCHHHHhcccccc-cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 038768          155 K-----------------RALIYEFMPNGSLDQFIYDEESS-NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDI  216 (386)
Q Consensus       155 ~-----------------~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dl  216 (386)
                      .                 .++||||+ +|+|.+++...... .....+++..++.++.||+.||+|||+.   +|+||||
T Consensus       157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi  232 (377)
T 3byv_A          157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL  232 (377)
T ss_dssp             SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            3                 78999999 68999999754211 1112345688889999999999999998   9999999


Q ss_pred             CCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchh---------cCCCCccchhHhHHHHHHHH
Q 038768          217 KPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN---------FGGVSHKSDVYSYGMMILEM  287 (386)
Q Consensus       217 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslGvil~el  287 (386)
                      ||+|||++.++.+||+|||+++.....     .....| +.|+|||++.+.         ...++.++|||||||++|||
T Consensus       233 kp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          233 RPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            999999999999999999999854332     224457 999999998754         01588999999999999999


Q ss_pred             HhCCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          288 VVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       288 ltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ++|+.||.......        ....+.     .....+++++.+++.+|+..++.-|+++.++..+|
T Consensus       307 ltg~~Pf~~~~~~~--------~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          307 WCADLPITKDAALG--------GSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             HHSSCCC------C--------CSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             HHCCCCCccccccc--------chhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            99999997653211        111111     12356899999999999999999999877765543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-41  Score=315.48  Aligned_cols=248  Identities=26%  Similarity=0.448  Sum_probs=199.1

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcE--EEEEEecCC--CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRL--VAVKVLKNS--KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||+|... +|..  ||+|.++..  ....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            345688999999999999864 5554  599998753  23346789999999999 89999999999999999999999


Q ss_pred             eCCCCCHHHHhccccc----------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEE
Q 038768          162 FMPNGSLDQFIYDEES----------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI  231 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  231 (386)
                      |+++++|.+++.....          ......+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence            9999999999976431          01124689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhh
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  310 (386)
                      +|||+++.......   .....++..|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ..+
T Consensus       184 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~  250 (327)
T 1fvr_A          184 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL  250 (327)
T ss_dssp             CCTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH
T ss_pred             cccCcCcccccccc---ccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHH
Confidence            99999874432211   1234578899999998654  67899999999999999998 9999976532        344


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ...+..+.....+..+++++.+++.+|+..++.-|++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  291 (327)
T 1fvr_A          251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  291 (327)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            55565555566677899999999999999888777765443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-41  Score=309.00  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             hhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.+.||+|+||.||+|.+.+    +..||+|.+.....  ..+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   93 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL   93 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence            345789999999999998532    34699999976432  34678999999999999999999999764 567899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           94 YPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             CTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999996532     4588999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      .... ......++..|+|||++.+.  .++.++||||||+++|||++ |+.||.....        ......+..+....
T Consensus       166 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~~~~~~~~~~~~  234 (281)
T 3cc6_A          166 EDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDVIGVLEKGDRLP  234 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGHHHHHHHTCCCC
T ss_pred             cccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHHHHHHhcCCCCC
Confidence            3321 12234578899999998654  78999999999999999998 9999975422        22333444444455


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+..+++++.+++.+|+..++.-|+++.+
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~e  263 (281)
T 3cc6_A          235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTE  263 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            66778999999999999999988887554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=310.17  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++..++||||+++++++.+.+..++||||++++
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  109 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG  109 (314)
T ss_dssp             EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence            345688999999999999875 58999999997643 4567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++...     ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ 
T Consensus       110 ~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          110 SVSDIIRLR-----NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             EHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            999998632     25689999999999999999999998   999999999999999999999999999986654322 


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc--CCCccccccc
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI--EPGNEFQLAG  324 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i--~~~~~~~~~~  324 (386)
                       ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||......        .....+  ........+.
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~  249 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTNPPPTFRKPE  249 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCSSGG
T ss_pred             -ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCCCcccCCcc
Confidence             12245689999999998654  6889999999999999999999999754321        111111  1111233466


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            78999999999999999999999888877653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.8e-42  Score=318.59  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=203.2

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC----h--------------HHHHHHHHHhhcCCCCccceEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN----G--------------EEFINEVASMSKTSHVNVVSFLGF  149 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~E~~~l~~l~h~niv~~~~~  149 (386)
                      +.+.+.||+|+||.||+|.. +|+.||+|++......    .              +.+.+|+.++.+++||||++++++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            34467899999999999998 9999999998742111    1              789999999999999999999999


Q ss_pred             EEecCceeEEEEeCCCCCHHHHhccccc--ccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCC
Q 038768          150 CYEKKKRALIYEFMPNGSLDQFIYDEES--SNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~  226 (386)
                      +.+.+..++||||+++++|.+++.....  ......+++..++.++.|++.||.|||+ .   +++||||||+||+++.+
T Consensus       112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred             EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence            9999999999999999999998321100  0113678999999999999999999999 7   99999999999999999


Q ss_pred             CceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCc-cchhHhHHHHHHHHHhCCCCcccccccCCccc
Q 038768          227 FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSH-KSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY  305 (386)
Q Consensus       227 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~-~~DvwslGvil~elltg~~p~~~~~~~~~~~~  305 (386)
                      +.+||+|||++......    ......|+..|+|||.+.+. ..++. ++||||||+++|||++|+.||......     
T Consensus       189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----  258 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----  258 (348)
T ss_dssp             SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----
T ss_pred             CcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----
Confidence            99999999999876443    12345689999999998654 24555 999999999999999999999865321     


Q ss_pred             chhhhhhhcCCCccccc-------------------cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          306 FPNSIYKHIEPGNEFQL-------------------AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       306 ~~~~~~~~i~~~~~~~~-------------------~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                        ....+.+..+. ..+                   ...+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       259 --~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          259 --VELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             --HHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             --HHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence              22333333332 112                   2678999999999999999999999888766653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-41  Score=322.59  Aligned_cols=256  Identities=20%  Similarity=0.258  Sum_probs=195.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecC------------
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------------  154 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------------  154 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++......   ..+|+++++.++||||+++++++...+            
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            34568899999999999986 57899999998754322   247999999999999999999985432            


Q ss_pred             --------------------------ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038768          155 --------------------------KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN  208 (386)
Q Consensus       155 --------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  208 (386)
                                                ..++||||++ |+|.+.+....  .....+++..++.++.||+.||.|||+.  
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             ------------------------CCEEEEEECCCS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      3789999997 68887775422  1225689999999999999999999998  


Q ss_pred             CCeeecCCCCCCeEeC-CCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHH
Q 038768          209 IRIVHFDIKPHNILLG-EDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEM  287 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~el  287 (386)
                       +|+||||||+|||++ .++.+||+|||+++.......   .....+|+.|+|||++.+. ..++.++|||||||++|||
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHH
Confidence             999999999999997 688999999999987654432   2244689999999998754 3589999999999999999


Q ss_pred             HhCCCCcccccccCCccc-------chhhhhhhc------------CCC-ccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          288 VVGRKNAEVKVSLSSEIY-------FPNSIYKHI------------EPG-NEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       288 ltg~~p~~~~~~~~~~~~-------~~~~~~~~i------------~~~-~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ++|+.||......+.-..       .+.+.+...            ... -...++..+++++.+++.+|+..++.-|++
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            999999986532110000       000000000            000 012245668999999999999999999999


Q ss_pred             CCCCCCCCC
Q 038768          348 TEDLQIPPK  356 (386)
Q Consensus       348 ~~~~~~~p~  356 (386)
                      +.++..||-
T Consensus       316 ~~e~l~hp~  324 (383)
T 3eb0_A          316 PYEAMAHPF  324 (383)
T ss_dssp             HHHHHTSGG
T ss_pred             HHHHhcCHH
Confidence            888877764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=313.49  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=197.8

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEe------cCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYE------KKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~  160 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|++.......+.+.+|+.++.++ +||||+++++++..      .+..++||
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~  106 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM  106 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence            3457899999999999987 4789999999987766778899999999998 79999999999987      45789999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++++|.+++....    ...+++..++.++.||+.||.|||+.   +++|+||||+|||++.++.+||+|||++...
T Consensus       107 e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          107 EFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             ECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            9999999999996542    24688999999999999999999998   9999999999999999999999999999866


Q ss_pred             CcccceeeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC-
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP-  316 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~-  316 (386)
                      .....  ......|+..|+|||++...   ...++.++|||||||++|+|++|+.||.....        ......+.. 
T Consensus       180 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~  249 (326)
T 2x7f_A          180 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFLIPRN  249 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS
T ss_pred             CcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcC
Confidence            43321  12234689999999998621   23678999999999999999999999975432        111111111 


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .........+++++.+++.+|+..++.-|+++.++..+|
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence            112223567899999999999999999999888776665

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-41  Score=320.04  Aligned_cols=246  Identities=20%  Similarity=0.220  Sum_probs=184.1

Q ss_pred             hhhhhccCcCCceEEEEEEeCC------CcEEEEEEecCCCCC------------hHHHHHHHHHhhcCCCCccceEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLKNSKVN------------GEEFINEVASMSKTSHVNVVSFLGF  149 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~  149 (386)
                      +.+.+.||+|+||.||+|.+.+      ++.||||++......            ...+..|+..+..++|+||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            3456889999999999998754      478999998764321            1234456667788899999999999


Q ss_pred             EEec----CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-
Q 038768          150 CYEK----KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-  224 (386)
Q Consensus       150 ~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-  224 (386)
                      +...    ...++||||+ +++|.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            9875    4479999999 999999996532     5689999999999999999999998   999999999999998 


Q ss_pred             -CCCceEEeeccCCcccCccccee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccc
Q 038768          225 -EDFCPKISDFGLAKLSEKKESFI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV  298 (386)
Q Consensus       225 -~~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  298 (386)
                       .++.+||+|||+++.........     ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence             88999999999998765432211     11234599999999998764  68999999999999999999999998542


Q ss_pred             ccCCcccchhhhhhhcCCCc----cccc-cccCChHHHHHHHHHHHHHHHhcCC
Q 038768          299 SLSSEIYFPNSIYKHIEPGN----EFQL-AGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       299 ~~~~~~~~~~~~~~~i~~~~----~~~~-~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ....   .............    +..+ ...+++++.+++..|+..++.-|++
T Consensus       266 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~  316 (364)
T 3op5_A          266 KDPK---YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPL  316 (364)
T ss_dssp             TCHH---HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             cCHH---HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCC
Confidence            2110   0000000000000    0001 2567889999999988755555544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=318.01  Aligned_cols=249  Identities=19%  Similarity=0.212  Sum_probs=187.0

Q ss_pred             HhhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCC------------ChHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKV------------NGEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      .+.+.+.||+|+||.||+|...    ++..||+|+......            ....+.+|+..+..++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            3455688999999999999875    577899999876532            123467888899999999999999999


Q ss_pred             Ee----cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 038768          151 YE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED  226 (386)
Q Consensus       151 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  226 (386)
                      .+    ....++||||+ +++|.+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++.+
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            88    67889999999 99999999653      3689999999999999999999998   99999999999999887


Q ss_pred             C--ceEEeeccCCcccCccccee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          227 F--CPKISDFGLAKLSEKKESFI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       227 ~--~~kl~Dfgl~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                      +  .+||+|||+++.........     ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.....
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            7  99999999998765432211     11345699999999998764  689999999999999999999999975322


Q ss_pred             cCCcccchhhhhhhcCCCcccc-----ccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          300 LSSEIYFPNSIYKHIEPGNEFQ-----LAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       300 ~~~~~~~~~~~~~~i~~~~~~~-----~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ....  . ......+.......     ....+++++.+++.+|+..++..|+++++
T Consensus       266 ~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  318 (345)
T 2v62_A          266 DPVA--V-QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQA  318 (345)
T ss_dssp             CHHH--H-HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ccHH--H-HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence            1100  0 00111111110000     12278999999999999988887776444

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-41  Score=310.23  Aligned_cols=238  Identities=19%  Similarity=0.266  Sum_probs=187.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||+|... +++.||+|++......    .+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 2h34_A           37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI  116 (309)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence            34578999999999999864 6889999999754322    267889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus       117 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          117 NGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             CCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999653      4689999999999999999999998   9999999999999999999999999999866543


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--ccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EFQ  321 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~~  321 (386)
                      .. .......|+..|+|||++.+.  .++.++||||||+++|||++|+.||.....        ..+...+....  ...
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~  256 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIPRPST  256 (309)
T ss_dssp             ----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCCCGGG
T ss_pred             cc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCCCccc
Confidence            21 112244689999999998764  688999999999999999999999986432        12222222211  224


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      .+..+++++.+++.+|+..++.-|+
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp  281 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRY  281 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHH
Confidence            4667899999999999998888887

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.5e-42  Score=320.62  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.+.||+|+||.||+|... +|+.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  114 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD  114 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence            345678999999999999875 689999999986532  23678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++...      ..+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||++.......
T Consensus       115 ~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          115 GGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             TCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999653      4688999999999999999999983  179999999999999999999999999997553321


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--------------------
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--------------------  304 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--------------------  304 (386)
                          .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..........                    
T Consensus       187 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          187 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             --------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                1234689999999998764  78999999999999999999999997543210000                    


Q ss_pred             --------------cchhhhhhhcCCCcccc-ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          305 --------------YFPNSIYKHIEPGNEFQ-LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       305 --------------~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                    .......+.+.....+. ....+++++.+++.+|+..++.-|++++++..||-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                          00001111111111122 23457999999999999999999999888877763

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-41  Score=312.61  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=197.9

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC---------ChHHHHHHHHHhhcCCCCccceEEEEEEecC
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV---------NGEEFINEVASMSKTSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  154 (386)
                      ...+.+.+.||+|+||.||+|... +++.||||++.....         ....+.+|++++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            345566789999999999999864 588999999875321         1235789999999999999999999987654


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc---eEE
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC---PKI  231 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl  231 (386)
                       .++||||+++++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.   +||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             -eEEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence             89999999999999998543      4689999999999999999999998   9999999999999987654   999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      +|||+++.......   .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.......       .+
T Consensus       159 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~  228 (322)
T 2ycf_A          159 TDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------SL  228 (322)
T ss_dssp             CCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-------CH
T ss_pred             ccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-------HH
Confidence            99999987654322   123458999999999742 12468899999999999999999999997543211       11


Q ss_pred             hhhcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          311 YKHIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       311 ~~~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ...+..+.   .+.....+++++.+++.+|+..++.-|+++.++..+|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence            12222121   2233467899999999999999999998887776665

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-41  Score=325.39  Aligned_cols=255  Identities=20%  Similarity=0.218  Sum_probs=200.3

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcC------CCCccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKT------SHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      +.+.+.||+|+||+||+|... +++.||||+++......+.+.+|+.++..+      +|+||+++++++...+..++||
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  178 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF  178 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence            445689999999999999864 588999999986554456778888887776      5779999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc--eEEeeccCCc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC--PKISDFGLAK  238 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~  238 (386)
                      ||+. ++|.+++....    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||++.
T Consensus       179 e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          179 ELLS-MNLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             CCCC-CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eccC-CCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9995 79999986643    24589999999999999999999999   9999999999999999887  9999999997


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~  311 (386)
                      ......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........-       ...+..++
T Consensus       251 ~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          251 YEHQRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             ETTCCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ecCCcc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            654332     245689999999999765  6899999999999999999999999765321000       00001111


Q ss_pred             hhcCC-------Cc------------------------------------cccccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          312 KHIEP-------GN------------------------------------EFQLAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       312 ~~i~~-------~~------------------------------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      .....       ..                                    ...+....++++.+++.+||..++.-|+++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence            10000       00                                    011233457889999999999999999999


Q ss_pred             CCCCCCCCC
Q 038768          349 EDLQIPPKP  357 (386)
Q Consensus       349 ~~~~~~p~~  357 (386)
                      +++..||--
T Consensus       404 ~e~L~Hpw~  412 (429)
T 3kvw_A          404 GQALRHPWL  412 (429)
T ss_dssp             HHHHTSTTT
T ss_pred             HHHhCChhh
Confidence            998887754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.3e-41  Score=306.80  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=202.5

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC----------ChHHHHHHHHHhhcCC-CCccceEEEEEEecCcee
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV----------NGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  157 (386)
                      +.+.||+|+||.||+|... +|+.||||++.....          ..+.+.+|+++++++. ||||+++++++.+.+..+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (298)
T 1phk_A           21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF  100 (298)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence            4578999999999999874 689999999975431          1245789999999995 999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      +||||+++++|.+++...      ..+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus       101 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A          101 LVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence            999999999999999643      4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchh----cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRN----FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ........   .....|++.|+|||++.+.    ...++.++||||||+++|+|++|+.||.....        ......
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~  240 (298)
T 1phk_A          172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRM  240 (298)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             hhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HHHHHH
Confidence            87654432   2245689999999998532    23578899999999999999999999975422        222222


Q ss_pred             cCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 IEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +..+.   .......+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence            22222   11223468999999999999999999999888777663

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.7e-41  Score=307.59  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=188.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||.||+|.. .+|+.||+|++.....    ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            44568899999999999986 4789999999975322    235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++.....  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus       114 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             CCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             CCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999865321  125688999999999999999999998   999999999999999999999999999986654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ....  .....|+..|+|||++.+.  .++.++||||||+++|+|++|+.||......      .....+.+.....+..
T Consensus       189 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  258 (310)
T 2wqm_A          189 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPL  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTCSCCC
T ss_pred             CCcc--ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcccCCCC
Confidence            3221  1234589999999998654  6899999999999999999999999754221      1223333433332322


Q ss_pred             -cccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          323 -AGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       323 -~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                       ...+++++.+++.+|+..++.-|+++.+
T Consensus       259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~  287 (310)
T 2wqm_A          259 PSDHYSEELRQLVNMCINPDPEKRPDVTY  287 (310)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence             3678999999999999988888876554

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-41  Score=320.94  Aligned_cols=256  Identities=21%  Similarity=0.272  Sum_probs=192.9

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCc------eeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK------RALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e  161 (386)
                      +.+.+.||+|+||+||+|+..++..||+|.+......   ..+|+++++.++||||+++++++...+.      .++|||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            3456789999999999999877777999888653322   2379999999999999999999976554      789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceEEeeccCCccc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKISDFGLAKLS  240 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~  240 (386)
                      |++++.+.......   .....+++..++.++.||+.||+|||+.   +|+||||||+|||++ .++.+||+|||+++..
T Consensus       119 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          119 YVPETVYRASRHYA---KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             CCSEEHHHHHHHHH---HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ccCccHHHHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            99765443333211   1235689999999999999999999998   999999999999998 7999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------chhhhhhh
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------FPNSIYKH  313 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~~  313 (386)
                      .....   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-..       .+...+..
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGEP---NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTCC---CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCCC---CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            44332   2245689999999998654 3589999999999999999999999986532110000       00000000


Q ss_pred             c------------CCCc-cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 I------------EPGN-EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 i------------~~~~-~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .            .... ...+...+++++.+++.+|+..++.-|+++.++..||-
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence            0            0000 11234458899999999999999999998887766664

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=312.14  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             hhhhhccCcCCceEEEEEEe-----CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecC--ceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-----PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKK--KRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  159 (386)
                      +.+.+.||+|+||.||++.+     .+|+.||+|++..... ..+.+.+|++++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            34568899999999999984     3688999999976433 2367899999999999999999999987654  68999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       123 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999996542     4589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCcccceee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccccc--------CCcccchhhh
Q 038768          240 SEKKESFIS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSL--------SSEIYFPNSI  310 (386)
Q Consensus       240 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~--------~~~~~~~~~~  310 (386)
                      ......... .....++..|+|||.+.+.  .++.++||||||+++|||++|..|+......        .........+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            765433221 2234577889999998664  6789999999999999999999998743110        0000111123


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .+.+..+.....+..+++++.+++.+|+..++.-|+++.+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  312 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD  312 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence            3444444445567789999999999999998888886544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.7e-42  Score=313.99  Aligned_cols=240  Identities=23%  Similarity=0.332  Sum_probs=192.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCC-C-------cEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD-G-------RLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      +.+.+.||+|+||.||+|.... +       ..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            3456889999999999997532 3       479999986543 345779999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc--------eE
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC--------PK  230 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~k  230 (386)
                      ||||+++|+|.+++....     ..+++..++.++.||+.||.|||++   +++||||||+|||++.++.        +|
T Consensus        90 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             EEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999996542     3489999999999999999999998   9999999999999988877        99


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      |+|||++.......      ...|+..|+|||++.+. ..++.++||||||+++|||++|..|+......       ...
T Consensus       162 l~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~  227 (289)
T 4fvq_A          162 LSDPGISITVLPKD------ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRK  227 (289)
T ss_dssp             ECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred             eccCcccccccCcc------ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHH
Confidence            99999997654432      23478899999998753 36899999999999999999965544322110       111


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ......  ...++...++++.+++.+|+..++.-|+++.++
T Consensus       228 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  266 (289)
T 4fvq_A          228 LQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAI  266 (289)
T ss_dssp             HHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            111111  234556678999999999999888888876554

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-41  Score=307.15  Aligned_cols=253  Identities=24%  Similarity=0.303  Sum_probs=188.4

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|+++......   +.+..+...++.++||||+++++++.+.+..++||||++
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (290)
T 3fme_A           10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD   89 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred             hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence            4467899999999999986 578999999997643322   234455556888899999999999999999999999996


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                       |+|.+++....  .....+++..++.++.|++.||.|||++  .+++||||||+||+++.++.+||+|||++.......
T Consensus        90 -~~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           90 -TSLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             -EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             -cchHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence             58888775422  1225689999999999999999999985  289999999999999999999999999998665443


Q ss_pred             ceeeeccccCccccccccccch--hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCR--NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      .   .....||+.|+|||++..  ....++.++||||||+++|+|++|+.||......      .....+.+........
T Consensus       165 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  235 (290)
T 3fme_A          165 A---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEEPSPQLP  235 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHSCCCCCC
T ss_pred             c---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhccCCCCcc
Confidence            2   123358999999999731  1236889999999999999999999999753211      1222233333333333


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ...+++++.+++.+|+..++.-|+++.++..+|
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence            457899999999999999999999988877765

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-41  Score=323.80  Aligned_cols=253  Identities=23%  Similarity=0.297  Sum_probs=188.4

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e  161 (386)
                      ...+.||+|+||.||+|++. +|+.||||++.....   ...+|+++++.++|+||++++++|....      ..++|||
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            34578999999999999874 589999999875432   2347999999999999999999986532      3678999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCccc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLS  240 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~  240 (386)
                      |+++ +|...+....  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.+ +.+||+|||+++..
T Consensus       134 ~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          134 YVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             CCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            9965 6666654321  1235689999999999999999999998   99999999999999954 67899999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------chhhhhhh
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------FPNSIYKH  313 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~~  313 (386)
                      .....   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-..       ...+.+..
T Consensus       208 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          208 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CTTCC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCCC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54332   2245689999999998654 3689999999999999999999999986532110000       00000111


Q ss_pred             cCCC----ccc---------cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          314 IEPG----NEF---------QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       314 i~~~----~~~---------~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      +...    ..+         .+...+++++.+++.+||..++.-|+++.++..|
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            1100    000         1244678999999999999888888776554333

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=322.66  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=192.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecC--ceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKK--KRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  163 (386)
                      .+.+.||+|+||+||+|... +|+.||||++....  ...+.+.+|++++++++||||+++++++.+.+  ..++||||+
T Consensus        12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~   91 (396)
T 4eut_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred             EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence            34578999999999999875 58999999997532  34577889999999999999999999998765  679999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCceEEeeccCCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAKL  239 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~~  239 (386)
                      ++|+|.+++.....   ...+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           92 PCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             TTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             CCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999976431   23489999999999999999999998   99999999999999    7788899999999987


Q ss_pred             cCcccceeeeccccCccccccccccchh------cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRN------FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .......   ....||..|+|||++.+.      ...++.++|||||||++|||++|+.||.........    ..+...
T Consensus       166 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~----~~~~~~  238 (396)
T 4eut_A          166 LEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----KEVMYK  238 (396)
T ss_dssp             CCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----HHHHHH
T ss_pred             ccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----HHHHHH
Confidence            6554332   245699999999998641      024678999999999999999999999754322211    111111


Q ss_pred             cCCCc------------------------cccccccCChHHHHHHHHHHHHHHHhcCCCC
Q 038768          314 IEPGN------------------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTE  349 (386)
Q Consensus       314 i~~~~------------------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~  349 (386)
                      +..+.                        ...+...++..+.+++.+|+..++.-|+++.
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence            11111                        0112344566788888898887776666544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-41  Score=318.63  Aligned_cols=251  Identities=24%  Similarity=0.280  Sum_probs=182.0

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec------CceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK------KKRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  158 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+.+++.++||||+++++++...      ...++
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l  111 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  111 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence            3457899999999999985 46899999999764333   35688999999999999999999999754      45789


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      |+||+ +++|.+++..       ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       112 v~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          112 VTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             Eeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            99999 7899888853       3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~  311 (386)
                      .....     .....||..|+|||++.+. ..++.++|||||||++|||++|+.||........-       ...+.+.+
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            65432     2245689999999998753 36899999999999999999999999765321100       00001111


Q ss_pred             hhcC------------C---CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 KHIE------------P---GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~~i~------------~---~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..+.            .   .....+...+++++.+++.+||..++.-|+++.++..||-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence            1111            1   1111223457899999999999999999999888877764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-41  Score=312.93  Aligned_cols=251  Identities=18%  Similarity=0.286  Sum_probs=197.7

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEe--cCceeEEEEeC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYE--KKKRALIYEFM  163 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~  163 (386)
                      +.+.+.||+|+||.||+|.. .+++.||+|+++.  ...+.+.+|+.++++++ ||||+++++++.+  ....++||||+
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            34568899999999999985 5789999999974  34678999999999997 9999999999998  56789999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCcccCc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSEK  242 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~  242 (386)
                      ++++|.+++         ..+++..++.++.||+.||+|||+.   +++||||||+|||++.++ .+||+|||+++....
T Consensus       116 ~~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          116 NNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             CchhHHHHH---------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999988         3478899999999999999999998   999999999999999766 899999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc------cchhhhhhh---
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI------YFPNSIYKH---  313 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~------~~~~~~~~~---  313 (386)
                      ...   .....|+..|+|||++.+. ..++.++|||||||++|+|++|+.||..........      .-+....+.   
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            432   2234689999999998653 468999999999999999999999995322110000      000000000   


Q ss_pred             ------------cCCC--------ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          314 ------------IEPG--------NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       314 ------------i~~~--------~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                  +...        ........+++++.+++.+|+..++.-|++++++..||-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence                        0000        011123348999999999999999999999888776653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.9e-41  Score=310.35  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=200.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC-CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus        22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (302)
T 2j7t_A           22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG  101 (302)
T ss_dssp             EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred             eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence            44578999999999999875 5899999998754 344578999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus       102 ~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  172 (302)
T 2j7t_A          102 AVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-  172 (302)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred             cHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence            9999986532     4589999999999999999999998   999999999999999999999999998764322111 


Q ss_pred             eeeccccCccccccccccch---hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--ccc
Q 038768          247 ISMLGARGTIGYIAPEVFCR---NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EFQ  321 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~~  321 (386)
                       ......|+..|+|||++..   ....++.++||||||+++|+|++|+.||.....        ......+....  ...
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  243 (302)
T 2j7t_A          173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSDPPTLL  243 (302)
T ss_dssp             -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCS
T ss_pred             -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccCCcccC
Confidence             1123458999999999842   124678999999999999999999999986432        11222222222  123


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+..++.++.+++.+|+..++.-|+++.++..+|--
T Consensus       244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred             CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence            466789999999999999999999998888777653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=322.54  Aligned_cols=259  Identities=21%  Similarity=0.287  Sum_probs=182.1

Q ss_pred             hhccCcCCceEEEEEEeC---CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEEEEeCCC
Q 038768           91 SNKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALIYEFMPN  165 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  165 (386)
                      +++||+|+||+||+|...   +++.||+|++.... ....+.+|+.++++++||||+++++++..  ....++||||++ 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            458999999999999864   57899999997543 34578899999999999999999999965  567899999995 


Q ss_pred             CCHHHHhcccccc---cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCceEEeeccCCc
Q 038768          166 GSLDQFIYDEESS---NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL----GEDFCPKISDFGLAK  238 (386)
Q Consensus       166 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~  238 (386)
                      ++|.+++......   .....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            6888887543211   1123589999999999999999999998   99999999999999    678899999999998


Q ss_pred             ccCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC--cccc---------
Q 038768          239 LSEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS--EIYF---------  306 (386)
Q Consensus       239 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--~~~~---------  306 (386)
                      ....... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||........  ....         
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            7654321 1222345689999999998764 3589999999999999999999999975432100  0000         


Q ss_pred             -----hhhhhhhc-------------CCCcc---------ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          307 -----PNSIYKHI-------------EPGNE---------FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       307 -----~~~~~~~i-------------~~~~~---------~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                           +...|..+             .....         .......++++.+++.+||..++.-|++++++..||
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                 00001111             00000         001122378899999999999999999887775555

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-42  Score=312.83  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=186.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||.||+|.. .+++.||||++....  ...+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            3467899999999999985 468999999987532  3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccccc--ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          166 GSLDQFIYDEES--SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       166 gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|.+++.....  ......+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            999999864211  11235689999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cce---eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC---
Q 038768          244 ESF---ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG---  317 (386)
Q Consensus       244 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~---  317 (386)
                      ...   .......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.......       .....+...   
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~  246 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDPPS  246 (303)
T ss_dssp             -------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSSCCC
T ss_pred             CCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccCCCc
Confidence            211   111234689999999998653 257899999999999999999999998653211       111111110   


Q ss_pred             -----ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          318 -----NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       318 -----~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                           ........+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence                 122344678899999999999999999999888777664

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.2e-41  Score=315.78  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=200.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecC-----ceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKK-----KRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~  160 (386)
                      .+.+.||+|+||.||+|... +++.||||++......  .+.+.+|++++.+++||||+++++++....     ..++||
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  109 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ  109 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence            34578999999999999864 6889999999754322  267889999999999999999999997653     678999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||++ |+|.+++..       ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus       110 e~~~-~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          110 DLME-TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             ECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccC-cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            9996 699998854       3588999999999999999999998   9999999999999999999999999999876


Q ss_pred             Ccccceee-eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------chhhhhh
Q 038768          241 EKKESFIS-MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------FPNSIYK  312 (386)
Q Consensus       241 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~  312 (386)
                      ........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........-..       .+.+.+.
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            54432211 2345799999999987654 3589999999999999999999999976532110000       0000000


Q ss_pred             hc------------CCC---ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          313 HI------------EPG---NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       313 ~i------------~~~---~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+            ...   ....+...+++++.+++.+||..++.-|+++.++..+|-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            00            000   011234568999999999999999999999888877764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3e-41  Score=317.09  Aligned_cols=254  Identities=22%  Similarity=0.236  Sum_probs=191.8

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC------------hHHHHHHHHHhhcCCCCccceEEEEEEecC---
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN------------GEEFINEVASMSKTSHVNVVSFLGFCYEKK---  154 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---  154 (386)
                      +.+.||+|+||.||+|...+|+.||||++......            .+.+.+|++++++++||||+++++++...+   
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (362)
T 3pg1_A           26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA  105 (362)
T ss_dssp             EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred             EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence            35789999999999999888999999998643221            167899999999999999999999986533   


Q ss_pred             --ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          155 --KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       155 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                        ..++||||++ |+|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+
T Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          106 MHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEE
Confidence              5789999996 68888886432     4689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc---------
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE---------  303 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~---------  303 (386)
                      |||+++.......   .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........-         
T Consensus       177 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          177 DFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             CTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999975544322   2234688999999998753 36899999999999999999999999764321000         


Q ss_pred             ccc-------hhhhhh-------hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          304 IYF-------PNSIYK-------HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       304 ~~~-------~~~~~~-------~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ...       ......       .............+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            000       000000       00111112334567899999999999999999999988877764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.1e-41  Score=308.74  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=198.1

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCC--CCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---GEEFINEVASMSKTS--HVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||.||++...+++.||+|++......   .+.+.+|+.++.+++  |+||+++++++.+.+..++||| +
T Consensus        31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~  109 (313)
T 3cek_A           31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C  109 (313)
T ss_dssp             EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred             EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence            345789999999999999888999999999765433   256889999999997  5999999999999999999999 5


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      .+++|.+++...      ..+++..++.++.|++.||.|||+.   +++||||||+|||+++ +.+||+|||++......
T Consensus       110 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          110 GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             CSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            689999999653      4688999999999999999999998   9999999999999964 89999999999876544


Q ss_pred             cceeeeccccCccccccccccchh---------cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRN---------FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      ..........|++.|+|||.+.+.         ...++.++||||||+++|||++|+.||......      .......+
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~~  253 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  253 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHHHH
Confidence            332222345689999999998641         135788999999999999999999999754211      12233334


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .......++...++++.+++.+|+..++.-|+++.++..+|
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            44444556777899999999999999999999888876665

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-41  Score=319.03  Aligned_cols=250  Identities=24%  Similarity=0.283  Sum_probs=185.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecC------ceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKK------KRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  158 (386)
                      .+.+.||+|+||.||+|... +|+.||||++.......   +.+.+|+.+++.++||||+++++++...+      ..++
T Consensus        28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l  107 (371)
T 2xrw_A           28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  107 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred             eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence            34578999999999999864 68899999997643332   56889999999999999999999998665      6799


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||++ ++|.+++.        ..+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++
T Consensus       108 v~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          108 VMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEECCS-EEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEcCC-CCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            999996 57888873        3488899999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------c-ccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------E-IYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------~-~~~~~~~~  311 (386)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........      . .......+
T Consensus       176 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccc---cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6654322   2245689999999999764  689999999999999999999999976532100      0 00000000


Q ss_pred             hhcC--------CCc------------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          312 KHIE--------PGN------------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       312 ~~i~--------~~~------------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +.+.        ...                  ........++++++++.+||..++.-|++++++..+|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            0000        000                  0000112267899999999999999999988886666

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=309.60  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=189.7

Q ss_pred             cccHHHHHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhc--CCCCccceEEEEEEec-
Q 038768           77 RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK--TSHVNVVSFLGFCYEK-  153 (386)
Q Consensus        77 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~-  153 (386)
                      .....+.....+.+.+.||+|+||.||+|+. +|+.||||++....  ...+..|.+++..  ++||||+++++++.+. 
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3344444555667789999999999999998 48999999986542  3445555555554  4899999999999987 


Q ss_pred             ---CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEeCC
Q 038768          154 ---KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-----NIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       154 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~dlk~~Nill~~  225 (386)
                         ...++||||+++|+|.+++..       ..+++..++.++.|++.||.|||+..     ..+++||||||+|||++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence               678999999999999999954       35889999999999999999999751     238999999999999999


Q ss_pred             CCceEEeeccCCcccCccccee--eeccccCccccccccccchhcCCCCc------cchhHhHHHHHHHHHhC-------
Q 038768          226 DFCPKISDFGLAKLSEKKESFI--SMLGARGTIGYIAPEVFCRNFGGVSH------KSDVYSYGMMILEMVVG-------  290 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~------~~DvwslGvil~elltg-------  290 (386)
                      ++.+||+|||+++.........  ......||+.|+|||++.+.  ..+.      ++|||||||++|||++|       
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            9999999999997665433211  11245699999999998654  2333      49999999999999999       


Q ss_pred             ---CCCcccccccCCcccchhhhhhhc-CCCcccccc-----ccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          291 ---RKNAEVKVSLSSEIYFPNSIYKHI-EPGNEFQLA-----GVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       291 ---~~p~~~~~~~~~~~~~~~~~~~~i-~~~~~~~~~-----~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                         +.||.........   .......+ .....+.++     ..+++++.+++.+|+..++.-|+++.+
T Consensus       256 ~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPS---YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             CCCCCTTTTTSCSSCC---HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccccHhhhcCCCCc---hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence               5555433221111   11111111 111122222     245677999999999998888887554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.1e-41  Score=303.76  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC---CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS---KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      ...+.+.+.||+|+||.||+|... +++.||+|++...   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            345566789999999999999875 6899999998653   335578999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CceEEeeccCC
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED---FCPKISDFGLA  237 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~  237 (386)
                      ||+++++|.+++...      ..+++..++.++.||+.||.|||+.   +++|+||||+||+++.+   +.+||+|||++
T Consensus       101 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A          101 ELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             CCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999988543      4688999999999999999999998   99999999999999754   47999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      .........   ....|++.|+|||.+.+   .++.++||||||+++|+|++|+.||.....        ..+.+.+..+
T Consensus       172 ~~~~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~  237 (287)
T 2wei_A          172 TCFQQNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETG  237 (287)
T ss_dssp             GTBCCCSSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred             eeecCCCcc---ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence            866543321   23358899999999854   488999999999999999999999976432        2233333333


Q ss_pred             c---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          318 N---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       318 ~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      .   .......+++++.+++.+|+..++..|+++.++..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            2   122235689999999999999999999887765444

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.6e-41  Score=314.90  Aligned_cols=258  Identities=21%  Similarity=0.260  Sum_probs=188.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCc-------eeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKK-------RALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~~lv~  160 (386)
                      .+.+.||+|+||.||+|.. .+|+.||||++.........+.+|++.+..++||||+++++++...+.       .++||
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~  105 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM  105 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence            3457899999999999987 468999999998766666678889999999999999999999987544       78999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCeEeCC-CCceEEeeccCC
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH--RGCNIRIVHFDIKPHNILLGE-DFCPKISDFGLA  237 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~  237 (386)
                      ||+++ +|...+....  .....+++..++.++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+|||++
T Consensus       106 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          106 EYVPD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             ECCSC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             ecccc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            99975 5555443211  12356889999999999999999999  77   9999999999999996 899999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhh
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSI  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~  310 (386)
                      +.......   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-       ...+...
T Consensus       180 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          180 KKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             BCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            87655432   2245689999999998654 35899999999999999999999999865321100       0001111


Q ss_pred             hhhcCCCc----------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 YKHIEPGN----------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 ~~~i~~~~----------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +..+....                .......+++++.+++.+|+..++.-|+++.++..||-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            11111110                01112235789999999999999999999998888775

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=310.50  Aligned_cols=253  Identities=25%  Similarity=0.315  Sum_probs=195.2

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEe----cCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYE----KKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e  161 (386)
                      +.+.+.||+|+||.||++.. .+|+.||+|++.... ...+.+.+|+++++.++||||+++++++..    ....++|||
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            34568899999999999986 578999999986532 234678899999999999999999999973    347789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++.....  ....+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       111 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          111 FFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             CCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             eCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            9999999999965321  235689999999999999999999998   99999999999999999999999999987654


Q ss_pred             cccce-------eeeccccCccccccccccchhc-CCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhh
Q 038768          242 KKESF-------ISMLGARGTIGYIAPEVFCRNF-GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKH  313 (386)
Q Consensus       242 ~~~~~-------~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .....       .......||+.|+|||++.+.. ..++.++||||||+++|||++|+.||........      .....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~  259 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------SVALA  259 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS------CHHHH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc------hhhHH
Confidence            22110       0011234789999999986431 1368899999999999999999999975322111      11112


Q ss_pred             cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          314 IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       314 i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +...........+++++.+++.+|+..++.-|+++.++
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  297 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL  297 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            22222233456789999999999999999988876554

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-40  Score=322.33  Aligned_cols=245  Identities=20%  Similarity=0.210  Sum_probs=188.1

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCC-CccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.++||+|+||.||+|.. .+++.||||++..... .+++..|++++..++| +++..+..++.+.+..++||||+ ++
T Consensus        10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~   87 (483)
T 3sv0_A           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP   87 (483)
T ss_dssp             ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence            3467899999999999986 5689999999875432 3458899999999986 55666666777778889999999 99


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCceEEeeccCCcccCcc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      +|.+++....     ..+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        88 sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           88 SLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9999996432     4689999999999999999999998   99999999999999   58899999999999876544


Q ss_pred             cce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          244 ESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       244 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ...     .......||..|+|||++.+.  .++.++|||||||++|||++|+.||...........+.......+ ...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~  236 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATS  236 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSC
T ss_pred             ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-ccc
Confidence            321     112245799999999998764  689999999999999999999999986533211111111111111 111


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ...+...+++++.+++..|+..++..|+
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RP  264 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKP  264 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCC
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCc
Confidence            2234467889999999999874444443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-40  Score=303.18  Aligned_cols=249  Identities=20%  Similarity=0.222  Sum_probs=193.5

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEE-EecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC-YEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+.++..++|++++..++++ .+.+..++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence            3457899999999999986 578999999987543 335789999999999988877766665 4566779999999 99


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCceEEeeccCCcccCcc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~  243 (386)
                      +|.+++....     ..+++..++.++.|++.||+|||++   +++||||||+|||++   .++.+||+|||++......
T Consensus        90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           90 SLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9999996432     4689999999999999999999998   999999999999994   8889999999999876544


Q ss_pred             cce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          244 ESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       244 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...........+.. +........
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~  238 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-ISEKKMSTP  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH-HHHHHHHSC
T ss_pred             ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh-hcccccCCc
Confidence            321     112345699999999998764  689999999999999999999999986543222111111 111111111


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ...+...+++++.+++.+|+..++.-|+++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  270 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHH
Confidence            12344678999999999999988777776443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-41  Score=305.83  Aligned_cols=250  Identities=26%  Similarity=0.333  Sum_probs=194.2

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEe-------------c
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE-------------K  153 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------------~  153 (386)
                      +.+.+.||+|+||.||+|.. .+|+.||+|++.......+.+.+|+.++++++||||+++++++.+             .
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK   87 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence            34568899999999999986 478999999997654445678999999999999999999999875             4


Q ss_pred             CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEee
Q 038768          154 KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISD  233 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  233 (386)
                      +..++||||+++++|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           88 STLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence            56789999999999999996532     4578899999999999999999998   999999999999999999999999


Q ss_pred             ccCCcccCcccc------------eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC
Q 038768          234 FGLAKLSEKKES------------FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS  301 (386)
Q Consensus       234 fgl~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  301 (386)
                      ||++........            ........|+..|+|||++.+. +.++.++|||||||++|||++   ||.....  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            999986643211            1112244689999999998654 368899999999999999998   4442211  


Q ss_pred             CcccchhhhhhhcCCC---ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          302 SEIYFPNSIYKHIEPG---NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       302 ~~~~~~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                           .....+.+...   ....++...++.+++++.+|+..++.-|+++.++..+|-
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  286 (303)
T 1zy4_A          234 -----RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW  286 (303)
T ss_dssp             -----HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred             -----HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence                 11222222221   223345667788999999999999999999888766654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-40  Score=303.48  Aligned_cols=251  Identities=19%  Similarity=0.208  Sum_probs=193.0

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEE-EecCceeEEEEeCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC-YEKKKRALIYEFMP  164 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~  164 (386)
                      .+.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.++..++|++++..++.+ .+.+..++||||+ 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            345568899999999999986 578999999876543 224588999999999988877777666 5566779999999 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCceEEeeccCCcccC
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~  241 (386)
                      +++|.+++....     ..+++..++.++.||+.||.|||+.   +++||||||+|||+   +.++.+||+|||+++...
T Consensus        88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           88 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999999986432     4589999999999999999999998   99999999999999   788999999999998765


Q ss_pred             cccce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          242 KKESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       242 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      .....     .......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.................... .
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~  236 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-S  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-H
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-c
Confidence            43321     112245689999999998764  689999999999999999999999986543222111111111111 1


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .....+...+++++.+++.+|+..++.-|+++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  270 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHH
Confidence            1112234678999999999999988887776543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-40  Score=306.79  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=197.7

Q ss_pred             hhhhccCcCCceEEEEEEe--CCCcEEEEEEecCCC---CChHHHHHHHHHhhcC---CCCccceEEEEEE-----ecCc
Q 038768           89 SFSNKLGQGGFGSVYKGKL--PDGRLVAVKVLKNSK---VNGEEFINEVASMSKT---SHVNVVSFLGFCY-----EKKK  155 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~  155 (386)
                      .+.+.||+|+||.||+|..  .+|+.||+|++....   .....+.+|+.+++.+   +||||+++++++.     ....
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   93 (326)
T 1blx_A           14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   93 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence            3457899999999999987  468899999986422   2234567787777666   8999999999998     4567


Q ss_pred             eeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          156 RALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .++||||++ |+|.+++....    ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           94 LTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEECCS-CBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             EEEEEecCC-CCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            899999997 69999986542    23588999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------------
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------------  302 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------------  302 (386)
                      +++.......   .....|+..|+|||++.+.  .++.++|||||||++|+|++|+.||........             
T Consensus       166 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          166 LARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             SCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             ccccccCCCC---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            9987654332   2245689999999998664  689999999999999999999999975432100             


Q ss_pred             -----cccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          303 -----EIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       303 -----~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                           ....+...+..........+...+++++++++.+|+..++.-|+++.++..+|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                 000000000000111112345678999999999999999999999888776654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-40  Score=310.77  Aligned_cols=256  Identities=20%  Similarity=0.284  Sum_probs=197.3

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEec-----CceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEK-----KKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~  160 (386)
                      .+.+.||+|+||.||+|... +|+.||||++......  ...+.+|+.++++++||||+++++++...     ...++||
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            34578999999999999874 6899999999754322  35678999999999999999999998764     5789999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||++ ++|.+++..       ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        94 e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           94 ELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            9996 699998854       3588999999999999999999998   9999999999999999999999999999876


Q ss_pred             Cccccee--------eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC----------
Q 038768          241 EKKESFI--------SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS----------  302 (386)
Q Consensus       241 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----------  302 (386)
                      .......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........          
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            5332111        11234689999999987543 4689999999999999999999999976532100          


Q ss_pred             ----c---ccchh---hhhhhcC---CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          303 ----E---IYFPN---SIYKHIE---PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       303 ----~---~~~~~---~~~~~i~---~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                          .   .....   ...+.+.   ..........+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY  308 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence                0   00000   0001110   01111234578999999999999999999999998877764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-40  Score=314.59  Aligned_cols=250  Identities=24%  Similarity=0.296  Sum_probs=195.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCce------eE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKR------AL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~l  158 (386)
                      .+.+.||+|+||.||+|... +|+.||||++......   .+.+.+|+.+++.++||||+++++++...+..      ++
T Consensus        45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  124 (371)
T 4exu_A           45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  124 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred             EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence            34578999999999999864 6899999999865433   35788999999999999999999999877655      99


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+. ++|.+++.        ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       125 v~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          125 VMPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             EEECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEcccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            999996 78888872        3488999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~  311 (386)
                      .....     .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........-       ...+...+
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            65433     2245689999999998653 36899999999999999999999999764321000       00001111


Q ss_pred             h------------hcCC---CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 K------------HIEP---GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~------------~i~~---~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .            .+..   .....+...+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            1            1111   1112234567999999999999999999999888877764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=310.68  Aligned_cols=245  Identities=25%  Similarity=0.343  Sum_probs=195.9

Q ss_pred             HHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC-------hHHHHHHHHHhhcC----CCCccceEEEEEEe
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN-------GEEFINEVASMSKT----SHVNVVSFLGFCYE  152 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l----~h~niv~~~~~~~~  152 (386)
                      ...+.+.+.||+|+||.||+|.. .+|+.||+|++......       ...+.+|+.++.++    +|+||+++++++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            44456678999999999999986 46889999999754321       23456788888888    89999999999999


Q ss_pred             cCceeEEEEe-CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceE
Q 038768          153 KKKRALIYEF-MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPK  230 (386)
Q Consensus       153 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k  230 (386)
                      .+..++|+|| +.+++|.+++...      ..+++..++.++.||+.||.|||+.   +++||||||+||+++ .++.+|
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999 7899999999653      4589999999999999999999999   999999999999999 889999


Q ss_pred             EeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhh
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSI  310 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  310 (386)
                      |+|||++........    ....|+..|+|||++.+. ...+.++||||||+++|||++|+.||....          .+
T Consensus       181 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~  245 (312)
T 2iwi_A          181 LIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQ----------EI  245 (312)
T ss_dssp             ECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH
T ss_pred             EEEcchhhhcccCcc----cccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChH----------HH
Confidence            999999987654322    245589999999998654 234568999999999999999999997542          11


Q ss_pred             hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 038768          311 YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKPS  358 (386)
Q Consensus       311 ~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~~  358 (386)
                      ...     ...++..++.++.+++.+|+..++.-|++++++..+|--.
T Consensus       246 ~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          246 LEA-----ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             HHT-----CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             hhh-----ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            111     1335667899999999999999999999988877666543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=309.35  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=183.3

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHH--hhcCCCCccceEEEEEEec-----CceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVAS--MSKTSHVNVVSFLGFCYEK-----KKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~-----~~~~lv~e  161 (386)
                      .+.+.||+|+||.||+|+. +++.||||++....  .+.+..|.++  +..++|+||+++++.+...     ...++|||
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            3457899999999999987 78999999997543  3444444444  5568999999999876532     25689999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC------NIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      |+++|+|.+++...       ..++..++.++.||+.||.|||+..      ..+|+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           93 YYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             CCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             cCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999543       3578899999999999999999852      2389999999999999999999999999


Q ss_pred             CCcccCcccc------eeeeccccCccccccccccchhc-----CCCCccchhHhHHHHHHHHHhCCCCcccccccCC-c
Q 038768          236 LAKLSEKKES------FISMLGARGTIGYIAPEVFCRNF-----GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-E  303 (386)
Q Consensus       236 l~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~  303 (386)
                      +++.......      ........||+.|+|||++.+..     ..++.++|||||||++|||++|..||........ .
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987654321      11122446999999999986521     1456789999999999999999877653322111 0


Q ss_pred             ccc---------hhhhhhh-cCCCcccccccc------CChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          304 IYF---------PNSIYKH-IEPGNEFQLAGV------VTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       304 ~~~---------~~~~~~~-i~~~~~~~~~~~------~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+         ....... ......+.++..      +++++.+++.+|+..++.-|+++.++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~  309 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA  309 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence            000         0111111 112222333333      34479999999999888888876654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-40  Score=333.88  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeC----CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeE
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  158 (386)
                      ...+.+.+.||+|+||.||+|.+.    .+..||+|.++.....  .+.+.+|+.++++++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            334455688999999999999863    2457999998754322  367899999999999999999999984 567899


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       468 v~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            999999999999996532     4588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCC
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ........ ......+++.|+|||++.+.  .++.++|||||||++|||++ |..||.....        ..+...+..+
T Consensus       540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~~~  608 (656)
T 2j0j_A          540 YMEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENG  608 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHHT
T ss_pred             ecCCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcC
Confidence            76544322 12234577899999998654  78999999999999999997 9999975432        3444555555


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      .....+..+++++.+++.+|+..++.-|+++.+
T Consensus       609 ~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e  641 (656)
T 2j0j_A          609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  641 (656)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            556677889999999999999999988887554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-41  Score=323.34  Aligned_cols=265  Identities=23%  Similarity=0.291  Sum_probs=200.3

Q ss_pred             cccHHHHHHHHhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC--------CCccceEE
Q 038768           77 RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS--------HVNVVSFL  147 (386)
Q Consensus        77 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~  147 (386)
                      .+...++....+.+.++||+|+||+||+|.. .+++.||||+++......+.+.+|+.+++.++        |+||++++
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            3444444444566678999999999999986 46889999999865545577889999998885        78899999


Q ss_pred             EEEE----ecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 038768          148 GFCY----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL  223 (386)
Q Consensus       148 ~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill  223 (386)
                      +++.    +....++||||+ +++|.+++....    ...+++..++.++.||+.||+|||+++  +|+||||||+|||+
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll  180 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL  180 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence            9998    456789999999 667777665432    245899999999999999999999852  89999999999999


Q ss_pred             CCCC-------------------------------------------------ceEEeeccCCcccCcccceeeeccccC
Q 038768          224 GEDF-------------------------------------------------CPKISDFGLAKLSEKKESFISMLGARG  254 (386)
Q Consensus       224 ~~~~-------------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~g  254 (386)
                      +.++                                                 .+||+|||++.......     ....|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~g  255 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQ  255 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCS
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCC
Confidence            9775                                                 79999999998765432     24468


Q ss_pred             ccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--c-----------chhhhhhh--------
Q 038768          255 TIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--Y-----------FPNSIYKH--------  313 (386)
Q Consensus       255 ~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--~-----------~~~~~~~~--------  313 (386)
                      |..|+|||++.+.  .++.++|||||||++|||++|+.||..........  .           .|...+..        
T Consensus       256 t~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          256 TRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            9999999999764  68999999999999999999999998653221100  0           00000000        


Q ss_pred             --------cCCCc----------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          314 --------IEPGN----------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       314 --------i~~~~----------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                              +....          ....+...++++.+++.+|+..++.-|+++.++..||
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP  393 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence                    00000          0112334456788999999999999999888776655

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=313.11  Aligned_cols=246  Identities=16%  Similarity=0.164  Sum_probs=190.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCC---------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccce-------------
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPD---------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVS-------------  145 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------  145 (386)
                      +.+.+.||+|+||.||+|....         ++.||+|++...    +.+.+|++++++++||||++             
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            4456889999999999998753         789999999754    46889999999999999987             


Q ss_pred             --EEEEEEe-cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 038768          146 --FLGFCYE-KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       146 --~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nil  222 (386)
                        +++++.. .+..++||||+ +++|.+++....    ...+++..++.++.||+.||.|||++   +++||||||+|||
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             cchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence              6788876 67889999999 999999997542    25699999999999999999999998   9999999999999


Q ss_pred             eCCCC--ceEEeeccCCcccCccccee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcc
Q 038768          223 LGEDF--CPKISDFGLAKLSEKKESFI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE  295 (386)
Q Consensus       223 l~~~~--~~kl~Dfgl~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~  295 (386)
                      ++.++  .+||+|||+++.........     ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99998  89999999998765433211     11234699999999998764  68999999999999999999999998


Q ss_pred             cccccCCcccchhhhhhhcCCCccc-----cccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          296 VKVSLSSEIYFPNSIYKHIEPGNEF-----QLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ........  . ......+......     .....+++++.+++.+|+..++.-|+++++
T Consensus       270 ~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          270 NCLPNTED--I-MKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             GGTTCHHH--H-HHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             cCCcCHHH--H-HHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence            65321111  0 0111111111100     112357899999999999877777765443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-40  Score=301.61  Aligned_cols=245  Identities=25%  Similarity=0.367  Sum_probs=188.6

Q ss_pred             hhhhhccCcCCceEEEEEEeC--CCc--EEEEEEecCCC----CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP--DGR--LVAVKVLKNSK----VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||.||+|.+.  +++  .||+|+++...    ...+.+.+|++++++++||||+++++++.+.. .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            345678999999999999853  333  69999987542    22367889999999999999999999987654 8899


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||+++++|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        99 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            99999999999996532     4588999999999999999999998   999999999999999999999999999987


Q ss_pred             cCccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhc-CC
Q 038768          240 SEKKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHI-EP  316 (386)
Q Consensus       240 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i-~~  316 (386)
                      ........ ......++..|+|||++.+.  .++.++||||||+++|+|++ |+.||.....        ......+ ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~  240 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE  240 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHcc
Confidence            65443221 12234577889999998654  67899999999999999999 9999976532        2233333 22


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ......+..+++++.+++.+|+..++.-|+++.++
T Consensus       241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  275 (291)
T 1u46_A          241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  275 (291)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence            33345567889999999999999888888775543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=307.93  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=193.9

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCc------eeEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKK------RALI  159 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv  159 (386)
                      +.+.||+|+||.||+|... +|+.||||++......   .+.+.+|+.+++.++||||+++++++...+.      .++|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence            4578999999999999864 6899999999764433   2568899999999999999999999987654      4999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      |||++ ++|.+++.        ..+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus       108 ~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          108 MPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             EECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             ecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            99996 68887763        3488999999999999999999998   999999999999999999999999999986


Q ss_pred             cCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhhh
Q 038768          240 SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIYK  312 (386)
Q Consensus       240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~  312 (386)
                      ....     .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........-       ...+...++
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5433     1244689999999998653 36889999999999999999999999865321000       000011111


Q ss_pred             hc------------CC---CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          313 HI------------EP---GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       313 ~i------------~~---~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+            ..   .....+...+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            11            11   1112234568999999999999999999999888777664

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=305.26  Aligned_cols=255  Identities=21%  Similarity=0.284  Sum_probs=189.7

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEE--------------e
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCY--------------E  152 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------------~  152 (386)
                      ...+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.              +
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence            34578999999999999875 48999999987543 22367889999999999999999999874              3


Q ss_pred             cCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceEE
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKI  231 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl  231 (386)
                      ....++||||++ |+|.+++..       ..+++..++.++.|++.||+|||+.   +++||||||+|||++ +++.+||
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence            467789999997 699999853       3588999999999999999999998   999999999999997 6779999


Q ss_pred             eeccCCcccCcccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------
Q 038768          232 SDFGLAKLSEKKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------  303 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------  303 (386)
                      +|||+++........ .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.........       
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999876432211 112234578999999988653 36899999999999999999999999865321100       


Q ss_pred             ccchhh------------hhhhcCCC--ccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          304 IYFPNS------------IYKHIEPG--NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       304 ~~~~~~------------~~~~i~~~--~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ......            +.......  ....+...+++++.+++.+|+..++.-|++++++..+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP  307 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence            000000            00000000  01123456899999999999999999999988876665

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-40  Score=309.21  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             HhhhhhccCcCCceEEEEEEe--CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc------cceEEEEEEecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL--PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN------VVSFLGFCYEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~l  158 (386)
                      .+.+.+.||+|+||.||+|..  .+|+.||+|+++......+.+.+|+.++..++|++      ++++++++.+.+..++
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l   94 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI   94 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence            344568899999999999986  36889999999865444567889999998887654      9999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-------------
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-------------  225 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------------  225 (386)
                      ||||+ +++|.+++....    ...+++..++.++.||+.||+|||+.   +++||||||+|||++.             
T Consensus        95 v~e~~-~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           95 VFELL-GLSTYDFIKENG----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEcCC-CCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999 899999996542    13588999999999999999999998   9999999999999987             


Q ss_pred             ------CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          226 ------DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       226 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                            ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                  6689999999998654432     245689999999998764  689999999999999999999999975432


Q ss_pred             cCC-------cccchhhhhhhcCCCcc----------------------------ccccccCChHHHHHHHHHHHHHHHh
Q 038768          300 LSS-------EIYFPNSIYKHIEPGNE----------------------------FQLAGVVTEEEKEMAKKMILVLEML  344 (386)
Q Consensus       300 ~~~-------~~~~~~~~~~~i~~~~~----------------------------~~~~~~~s~~~~~li~~ml~v~~~L  344 (386)
                      ...       ....|..+++.......                            .......++++.+++.+|+..++.-
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            110       00112222222111110                            0112234577899999999999999


Q ss_pred             cCCCCCCCCCC
Q 038768          345 EGSTEDLQIPP  355 (386)
Q Consensus       345 ~~~~~~~~~~p  355 (386)
                      |+++.++..+|
T Consensus       320 Rpt~~ell~hp  330 (339)
T 1z57_A          320 RITLREALKHP  330 (339)
T ss_dssp             SCCHHHHTTSG
T ss_pred             ccCHHHHhcCH
Confidence            99988877665

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-40  Score=305.86  Aligned_cols=240  Identities=25%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCC--CCccceEEEEEEecCcee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTS--HVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  157 (386)
                      +.+.+.||+|+||.||+|.. .+|+.||||++.....       ..+.+.+|+.++++++  |+||+++++++.+.+..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            44568899999999999985 4689999999975432       2245778999999996  599999999999999999


Q ss_pred             EEEEeCCC-CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCceEEeecc
Q 038768          158 LIYEFMPN-GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG-EDFCPKISDFG  235 (386)
Q Consensus       158 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg  235 (386)
                      +|||++.+ ++|.+++...      ..+++..++.++.||+.||+|||+.   +++||||||+|||++ +++.+||+|||
T Consensus       125 lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          125 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999976 8999998653      4688999999999999999999998   999999999999999 78999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      +++.......    ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||....          .....  
T Consensus       196 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~~~~--  258 (320)
T 3a99_A          196 SGALLKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRG--  258 (320)
T ss_dssp             TCEECCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHC--
T ss_pred             cccccccccc----cCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChh----------hhhcc--
Confidence            9987654322    234689999999998654 234788999999999999999999997542          11111  


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                         ...++..+++++.+++.+|+..++..|++++++..+|-
T Consensus       259 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          259 ---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             ---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             ---cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence               12345678999999999999999999999888776653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=306.28  Aligned_cols=244  Identities=24%  Similarity=0.309  Sum_probs=190.6

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.+.||+|+||.||+|...+  .||+|+++...   ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            3456789999999999998743  49999987532   233567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|.+++....     ..+++..++.++.||+.||+|||+.   +++||||||+|||++ ++.+||+|||++.......
T Consensus       113 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          113 GRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             SEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999996532     4688999999999999999999998   999999999999998 6799999999987653221


Q ss_pred             c---eeeeccccCccccccccccchh-------cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhc
Q 038768          245 S---FISMLGARGTIGYIAPEVFCRN-------FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       245 ~---~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      .   ........|+..|+|||.+...       ...++.++||||||+++|||++|+.||.....        ......+
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~  255 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAIIWQM  255 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHHHHHH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHh
Confidence            1   1112234589999999998642       13578899999999999999999999986432        3333344


Q ss_pred             CCCccccc-cccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          315 EPGNEFQL-AGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       315 ~~~~~~~~-~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+..+.. ...++.++.+++.+|+..++.-|+++.+
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  292 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTK  292 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHH
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            33333333 3468899999999999988877776544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.2e-39  Score=301.85  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             cccHHHHHHHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhc--CCCCccceEEEEEEecC
Q 038768           77 RYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSK--TSHVNVVSFLGFCYEKK  154 (386)
Q Consensus        77 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~  154 (386)
                      .+...+.....+.+.+.||+|+||.||+|+. +|+.||||++...  ..+.+.+|.+++..  ++||||+++++++....
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            3444455556677789999999999999998 6899999999643  34677888888877  78999999999998876


Q ss_pred             ----ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeE
Q 038768          155 ----KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH--------RGCNIRIVHFDIKPHNIL  222 (386)
Q Consensus       155 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~dlk~~Nil  222 (386)
                          ..++||||+++|+|.+++..       ..+++..++.++.|++.||.|||        +.   +++||||||+|||
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             CccceeEEEEeecCCCcHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence                78999999999999999954       35889999999999999999999        66   9999999999999


Q ss_pred             eCCCCceEEeeccCCcccCccccee--eeccccCccccccccccchhcC----CCCccchhHhHHHHHHHHHhC------
Q 038768          223 LGEDFCPKISDFGLAKLSEKKESFI--SMLGARGTIGYIAPEVFCRNFG----GVSHKSDVYSYGMMILEMVVG------  290 (386)
Q Consensus       223 l~~~~~~kl~Dfgl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~----~~~~~~DvwslGvil~elltg------  290 (386)
                      ++.++.+||+|||++..........  ......||+.|+|||++.+...    .++.++|||||||++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999998665443221  1234569999999999865311    123689999999999999999      


Q ss_pred             ----CCCcccccccCCcccchhhhhhhcCC-Cccccccc-----cCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          291 ----RKNAEVKVSLSSEIYFPNSIYKHIEP-GNEFQLAG-----VVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       291 ----~~p~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~-----~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                          +.||........   ....+.+.+.. ...+.++.     .+++.+.+++.+|+..++.-|+++.+
T Consensus       260 ~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDP---SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             CCCCCCTTTTTSCSSC---CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccccccCccccCcCcc---cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                667764422111   11222233322 22222322     33457889999999988888876554

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=306.44  Aligned_cols=246  Identities=24%  Similarity=0.297  Sum_probs=175.0

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCC-CCccceEEEEEEe--------cCce
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTS-HVNVVSFLGFCYE--------KKKR  156 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--------~~~~  156 (386)
                      +.+.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|+.++.++. ||||+++++++..        ....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            34568899999999999986 468999999986543 23467889999999996 9999999999953        3347


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCceEEeec
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ++||||+. |+|.+++.....   ...+++..++.++.||+.||.|||+.   +  ++||||||+|||++.++.+||+||
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             EEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence            89999994 899998865321   24689999999999999999999998   7  999999999999999999999999


Q ss_pred             cCCcccCccccee----------eeccccCccccccccccch-hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc
Q 038768          235 GLAKLSEKKESFI----------SMLGARGTIGYIAPEVFCR-NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE  303 (386)
Q Consensus       235 gl~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  303 (386)
                      |+++.........          ......||+.|+|||++.. ....++.++|||||||++|+|++|+.||......   
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---  259 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---  259 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence            9998765432211          1113458999999999832 1236789999999999999999999999754321   


Q ss_pred             ccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          304 IYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       304 ~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                              ..+............+..+.+++.+|+..++.-|+++.++
T Consensus       260 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  299 (337)
T 3ll6_A          260 --------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV  299 (337)
T ss_dssp             --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred             --------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHH
Confidence                    1111111223345667889999999998888877765544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.2e-40  Score=312.41  Aligned_cols=197  Identities=24%  Similarity=0.315  Sum_probs=165.1

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CC-----ccceEEEEEEecCceeEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HV-----NVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~  160 (386)
                      +.+.+.||+|+||+||+|... +++.||||+++......+++..|+.++..++ |+     +|+++++++...+..++||
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  135 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF  135 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence            344678999999999999864 6889999999865444466778888888774 44     4999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCceEEeeccCCc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG--EDFCPKISDFGLAK  238 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~  238 (386)
                      ||++ ++|.+++.....    ..+++..++.++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       136 e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          136 EMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             ECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             ecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            9995 699999966431    4588999999999999999999952 12899999999999995  47789999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                      ......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       210 ~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          210 QLGQRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             ETTCCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            765432     245689999999999764  6899999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-39  Score=301.74  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=179.0

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC--hHHHHHHHH-HhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN--GEEFINEVA-SMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.||+|+||.||+|... +|+.||||++......  ..++..|+. +++.++||||+++++++.+.+..++||||++ 
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-  104 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-  104 (327)
T ss_dssp             C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-
Confidence            3578999999999999874 6899999999864332  235556666 6778899999999999999999999999996 


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      ++|.+++..... .....+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||+++.......
T Consensus       105 ~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          105 TSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             EEHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             CChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence            588887753211 1135689999999999999999999984  2899999999999999999999999999986654322


Q ss_pred             eeeeccccCccccccccccch--hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc-
Q 038768          246 FISMLGARGTIGYIAPEVFCR--NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL-  322 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  322 (386)
                         .....||..|+|||++..  ....++.++||||||+++|+|++|+.||......       ......+..+..+.+ 
T Consensus       182 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          182 ---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVKGDPPQLS  251 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCCCC
T ss_pred             ---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhcCCCCCCC
Confidence               123358999999999842  1135889999999999999999999999754221       111122223332222 


Q ss_pred             ---cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 ---AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ---~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         ...+++++.+++.+|+..++..|+++.++..+|
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence               346899999999999999999999988887776

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.8e-40  Score=304.00  Aligned_cols=244  Identities=22%  Similarity=0.291  Sum_probs=169.7

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEe----cCceeEEEEeCCCC
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE----KKKRALIYEFMPNG  166 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g  166 (386)
                      +.||+|+||.||+|... +|+.||||++....   .........+..++||||+++++++..    ....++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999875 68999999997532   222223334566799999999999986    44578999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccCcc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~  243 (386)
                      +|.+++....    ...+++..++.++.||+.||.|||+.   +++||||||+|||++.   ++.+||+|||+++.....
T Consensus       112 ~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~  184 (336)
T 3fhr_A          112 ELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN  184 (336)
T ss_dssp             EHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             CHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence            9999997542    24689999999999999999999998   9999999999999976   455999999999865533


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EF  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~  320 (386)
                      .    .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........    .......+..+.   ..
T Consensus       185 ~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          185 A----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI----SPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             -----------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCT
T ss_pred             c----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhh----hhhHHHhhhccccccCc
Confidence            2    1234589999999998553  678899999999999999999999976533211    111111221111   11


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .....+++++.+++.+|+..++.-|++++++..+|
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            22356899999999999999999999988876665

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=298.76  Aligned_cols=248  Identities=19%  Similarity=0.257  Sum_probs=180.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.+.||+|+||.||+|... +|+.||||++.......   +.+..+..+++.++||||+++++++.+.+..++||||+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-  106 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-  106 (318)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence            34578999999999999874 68999999998654332   23344555788889999999999999999999999999 


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++.+..+....     ...+++..++.++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||++......
T Consensus       107 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          107 GTCAEKLKKRM-----QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             SEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             CCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            55665555332     2568999999999999999999998 5   8999999999999999999999999999766543


Q ss_pred             cceeeeccccCccccccccccch---hcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCR---NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ..   .....|++.|+|||++..   ....++.++||||||+++|||++|+.||.....       .......+..+..+
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~  248 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQEEPP  248 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHHSCCC
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhccCCC
Confidence            22   123458999999999853   123678899999999999999999999975321       12222333223222


Q ss_pred             cc--cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QL--AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~--~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+  ...+++++.+++.+|+..++.-|+++.++..+|
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence            23  345899999999999999999999988877765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.5e-40  Score=315.64  Aligned_cols=255  Identities=23%  Similarity=0.271  Sum_probs=186.8

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .+.||+|+||+||.+...+|+.||||++...  ..+.+.+|+.++.++ +||||+++++++.+.+..++||||++ |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            3679999999998776668999999998653  245678999999876 89999999999999999999999995 6999


Q ss_pred             HHhccccccccc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-------------CceEEeecc
Q 038768          170 QFIYDEESSNIN-RKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-------------FCPKISDFG  235 (386)
Q Consensus       170 ~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl~Dfg  235 (386)
                      +++......... ....+..++.++.||+.||+|||+.   +|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            999764321111 1123345678999999999999998   99999999999999654             489999999


Q ss_pred             CCcccCccccee--eeccccCccccccccccchh-----cCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccch
Q 038768          236 LAKLSEKKESFI--SMLGARGTIGYIAPEVFCRN-----FGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFP  307 (386)
Q Consensus       236 l~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  307 (386)
                      +++.........  ......||+.|+|||++.+.     ...++.++|||||||++|||++ |+.||.......      
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------  247 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------  247 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence            998775543211  12245699999999998651     1368899999999999999999 999997542210      


Q ss_pred             hhhhhhcCCCcc--ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          308 NSIYKHIEPGNE--FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       308 ~~~~~~i~~~~~--~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ..+.........  ......+++++.+++.+|+..++.-|+++.++..||--
T Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            111121111110  11123456889999999999999999999888777643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.9e-40  Score=305.81  Aligned_cols=256  Identities=18%  Similarity=0.267  Sum_probs=198.2

Q ss_pred             HhhhhhccCcCCceEEEEEEeC-CC-cEEEEEEecCCCCChHHHHHHHHHhhcCCCCc------cceEEEEEEecCceeE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP-DG-RLVAVKVLKNSKVNGEEFINEVASMSKTSHVN------VVSFLGFCYEKKKRAL  158 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~l  158 (386)
                      .+.+.+.||+|+||+||+|... ++ +.||+|+++......+.+.+|+.+++.++|++      ++.+++++...+..++
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l   99 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI   99 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence            3445688999999999999864 34 78999999865545577889999999987766      9999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---------------
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL---------------  223 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill---------------  223 (386)
                      ||||+ +++|.+++....    ...+++..++.++.||+.||+|||+.   +|+||||||+|||+               
T Consensus       100 v~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A          100 AFELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence            99999 677777775432    14689999999999999999999998   99999999999999               


Q ss_pred             ----CCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 038768          224 ----GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVS  299 (386)
Q Consensus       224 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  299 (386)
                          +.++.+||+|||+++......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                567899999999998654432     245689999999999754  689999999999999999999999976432


Q ss_pred             cCC-------cccchhhhhhhcCCCcc----------------------------ccccccCChHHHHHHHHHHHHHHHh
Q 038768          300 LSS-------EIYFPNSIYKHIEPGNE----------------------------FQLAGVVTEEEKEMAKKMILVLEML  344 (386)
Q Consensus       300 ~~~-------~~~~~~~~~~~i~~~~~----------------------------~~~~~~~s~~~~~li~~ml~v~~~L  344 (386)
                      ...       ....|...+........                            .......+.++.+++.+|+..++.-
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            110       00112222111111100                            0011223457889999999999999


Q ss_pred             cCCCCCCCCCCCC
Q 038768          345 EGSTEDLQIPPKP  357 (386)
Q Consensus       345 ~~~~~~~~~~p~~  357 (386)
                      |+++.++..+|--
T Consensus       325 Rpt~~e~l~hp~f  337 (355)
T 2eu9_A          325 RITLAEALLHPFF  337 (355)
T ss_dssp             SCCHHHHTTSGGG
T ss_pred             CcCHHHHhcChhh
Confidence            9999988877653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.8e-40  Score=309.41  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=196.0

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-----------CCccceEEEEEEecC-
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-----------HVNVVSFLGFCYEKK-  154 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~-  154 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++.......+.+.+|+.++.+++           |+||+++++++...+ 
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~  100 (373)
T 1q8y_A           21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP  100 (373)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence            44568899999999999986 56899999999865555677889999998876           899999999998765 


Q ss_pred             ---ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC------C
Q 038768          155 ---KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG------E  225 (386)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~------~  225 (386)
                         ..++||||+ +++|.+++....    ...+++..++.++.||+.||+|||+++  +|+||||||+|||++      .
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A          101 NGVHVVMVFEVL-GENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             TEEEEEEEECCC-CEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             CCceEEEEEecC-CCCHHHHHHHhh----ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence               688999999 999999996543    245889999999999999999999942  899999999999994      4


Q ss_pred             CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-
Q 038768          226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-  304 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-  304 (386)
                      ++.+||+|||++.......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......... 
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             EEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence            4589999999998765432     234689999999999764  68999999999999999999999998553211000 


Q ss_pred             ------------cchhhhh----------------hhcCCCc----------cccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          305 ------------YFPNSIY----------------KHIEPGN----------EFQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       305 ------------~~~~~~~----------------~~i~~~~----------~~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                                  ..|...+                +.+....          ...++..+++++.+++.+|+..++.-|+
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence                        0011000                0000000          1123445678899999999999999999


Q ss_pred             CCCCCCCCCC
Q 038768          347 STEDLQIPPK  356 (386)
Q Consensus       347 ~~~~~~~~p~  356 (386)
                      ++.++..+|-
T Consensus       327 t~~ell~hp~  336 (373)
T 1q8y_A          327 DAGGLVNHPW  336 (373)
T ss_dssp             CHHHHHTCGG
T ss_pred             CHHHHhhChh
Confidence            9888877764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=313.10  Aligned_cols=249  Identities=23%  Similarity=0.267  Sum_probs=185.9

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ..+.||+|+||+|+.....+|+.||||++....  ...+.+|+.+++++ +||||+++++++.+....++||||++ |+|
T Consensus        28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L  104 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL  104 (432)
T ss_dssp             EEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred             cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence            346899999999665555589999999997533  23456899999999 79999999999999999999999995 699


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----CCceEEeeccCCcccCcc
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-----DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~  243 (386)
                      .+++....     ....+..++.++.||+.||.|||+.   +|+||||||+|||++.     ...+||+|||+++.....
T Consensus       105 ~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          105 QEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             HHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             HHHHHhcC-----CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            99997643     2234445678999999999999998   9999999999999953     335889999999876543


Q ss_pred             c-ceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCc--
Q 038768          244 E-SFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGN--  318 (386)
Q Consensus       244 ~-~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~--  318 (386)
                      . .........||+.|+|||++.+. ...++.++|||||||++|||++ |..||.....        ......+....  
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~~  248 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGACSLD  248 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTCCCCT
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhccCCcc
Confidence            2 11223356799999999998642 2357889999999999999999 8999964322        11111111111  


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ........+..+++++.+|+..++.-|+++.++..||--
T Consensus       249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence            111223345668999999999999999999888877754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.2e-39  Score=320.13  Aligned_cols=259  Identities=25%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             HhhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEe------cCcee
Q 038768           87 TNSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYE------KKKRA  157 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~  157 (386)
                      .+.+.+.||+|+||.||+|.. .+|+.||||++.....  ..+.+.+|++++++++||||+++++++..      .+..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            455678999999999999986 4689999999876432  23568899999999999999999998765      66789


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCc---eEEeec
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFC---PKISDF  234 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df  234 (386)
                      +||||+++|+|.+++.....   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.   +||+||
T Consensus        95 LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            99999999999999976431   23588899999999999999999998   9999999999999987664   999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC-----------Cc
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS-----------SE  303 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-----------~~  303 (386)
                      |++........   .....||..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......           ..
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred             ccccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence            99987655432   2245689999999998654  78999999999999999999999996531100           00


Q ss_pred             ccchhhhhhhcCC----CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          304 IYFPNSIYKHIEP----GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       304 ~~~~~~~~~~i~~----~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ..........+.-    .....+...+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~  300 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC  300 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence            0000000000000    0011234457889999999999999999999998877773

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-38  Score=304.08  Aligned_cols=241  Identities=15%  Similarity=0.110  Sum_probs=177.2

Q ss_pred             hhccCcCCceEEEEEEe-CCCcEEEEEEecCCC----CChHHHHHHHHHhhcCCC-Ccc---------ceEE--------
Q 038768           91 SNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK----VNGEEFINEVASMSKTSH-VNV---------VSFL--------  147 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-~ni---------v~~~--------  147 (386)
                      .+.||+|+||.||+|.+ .+|+.||||++....    ...+.+.+|+.++..++| +|.         +...        
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            46899999999999985 569999999988422    224678999999999987 221         1111        


Q ss_pred             ----EEEEe-----cCceeEEEEeCCCCCHHHHhccccc-ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 038768          148 ----GFCYE-----KKKRALIYEFMPNGSLDQFIYDEES-SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIK  217 (386)
Q Consensus       148 ----~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk  217 (386)
                          .++..     ....+++|+++ +++|.+++..... ......+++..++.++.||+.||+|||++   +|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence                11111     12356677765 7899998842210 11235678889999999999999999998   99999999


Q ss_pred             CCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchh--------cCCCCccchhHhHHHHHHHHHh
Q 038768          218 PHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN--------FGGVSHKSDVYSYGMMILEMVV  289 (386)
Q Consensus       218 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~~~DvwslGvil~ellt  289 (386)
                      |+|||++.++.+||+|||+++.....     .....| +.|+|||++...        ...++.++|||||||++|||++
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999999865543     234457 999999998421        1247789999999999999999


Q ss_pred             CCCCcccccccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038768          290 GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIP  354 (386)
Q Consensus       290 g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~  354 (386)
                      |+.||.......        ....+.     .....+++++.+++.+|+..++.-|+++.++..+
T Consensus       313 g~~Pf~~~~~~~--------~~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          313 ADLPNTDDAALG--------GSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             SSCCCCTTGGGS--------CSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCcchhh--------hHHHHH-----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999998653211        111111     1123678999999999999888888876555444

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-37  Score=282.56  Aligned_cols=212  Identities=11%  Similarity=0.039  Sum_probs=169.9

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh----HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||.||+|... +|+.||||++.......    +.+.+|+.++.+++||||+++++++.+.+..|+||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            445678999999999999875 48999999998654432    6789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +++++|.+++...        .....+..++.|++.||+|||++   +|+||||||+|||++.++.+||+++|       
T Consensus       113 ~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          113 IRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             CCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             cCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999998431        34557889999999999999998   99999999999999999999997443       


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc--cc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN--EF  320 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~--~~  320 (386)
                                     |++         .++.++|||||||++|||++|+.||.........    ....+.+....  ..
T Consensus       175 ---------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~  226 (286)
T 3uqc_A          175 ---------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL----APAERDTAGQPIEPA  226 (286)
T ss_dssp             ---------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS----EECCBCTTSCBCCHH
T ss_pred             ---------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh----HHHHHHhccCCCChh
Confidence                           332         3678999999999999999999999865432110    00001111111  11


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhc
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLE  345 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~  345 (386)
                      .+...+++++++++.+|+..++..|
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R  251 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR  251 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC
Confidence            3456789999999999998666555

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-37  Score=314.22  Aligned_cols=226  Identities=20%  Similarity=0.239  Sum_probs=179.9

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC--CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCc-----e
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP--DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKK-----R  156 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~  156 (386)
                      ..+.+.+.||+|+||.||+|.+.  +|+.||||++.....  ..+.+.+|+.++.+++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            34556688999999999999874  689999999875432  23568899999999999999999999998776     6


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      |+||||+++++|.+++.        ..+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||+
T Consensus       160 ~lv~E~~~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEECCCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence            99999999999988763        2589999999999999999999998   99999999999999986 899999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCC
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~  316 (386)
                      ++.....      ....||+.|+|||++.+.   ++.++|||||||++|+|++|..||.......    .+.        
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----~~~--------  286 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPE--------  286 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----CCT--------
T ss_pred             chhcccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccccc----ccc--------
Confidence            9876543      234699999999998653   4889999999999999999999887542211    000        


Q ss_pred             CccccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          317 GNEFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       317 ~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                         .......++++.+++.+|+..++.-|++
T Consensus       287 ---~~~~~~~~~~l~~li~~~l~~dP~~R~~  314 (681)
T 2pzi_A          287 ---DDPVLKTYDSYGRLLRRAIDPDPRQRFT  314 (681)
T ss_dssp             ---TCHHHHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred             ---cccccccCHHHHHHHhhhccCChhhCCC
Confidence               0011123567788888888766666654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7e-39  Score=297.95  Aligned_cols=233  Identities=16%  Similarity=0.137  Sum_probs=179.1

Q ss_pred             HHHhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC---------ChHHHHHHHHHhhcCC---------CCccceE
Q 038768           85 RMTNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV---------NGEEFINEVASMSKTS---------HVNVVSF  146 (386)
Q Consensus        85 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------h~niv~~  146 (386)
                      ...+.+.+.||+|+||+||+|+. +|+.||||++.....         ..+.+.+|+.+++.++         |+||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34556678999999999999998 789999999975422         2267889999988875         8888888


Q ss_pred             EEEEE------------------------------ecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHH
Q 038768          147 LGFCY------------------------------EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI  196 (386)
Q Consensus       147 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi  196 (386)
                      .+++.                              +.+..++||||+++|++.+.+..       ..+++..++.++.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQL  170 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHH
Confidence            87754                              25788999999999977666633       357899999999999


Q ss_pred             HHHHHHHH-hcCCCCeeecCCCCCCeEeCCCC--------------------ceEEeeccCCcccCcccceeeeccccCc
Q 038768          197 ARGLEYLH-RGCNIRIVHFDIKPHNILLGEDF--------------------CPKISDFGLAKLSEKKESFISMLGARGT  255 (386)
Q Consensus       197 ~~~L~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~g~  255 (386)
                      +.||+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....       ...||
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt  240 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC  240 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence            99999999 88   999999999999999887                    8999999999866543       23589


Q ss_pred             cccccccccchhcCCCCccchhHhHHHH-HHHHHhCCCCcccccccCCcccchhhhhhhcCC--CccccccccCChHHHH
Q 038768          256 IGYIAPEVFCRNFGGVSHKSDVYSYGMM-ILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP--GNEFQLAGVVTEEEKE  332 (386)
Q Consensus       256 ~~y~aPE~~~~~~~~~~~~~DvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~s~~~~~  332 (386)
                      +.|+|||++.+.   .+.++||||||++ .+++++|..||.......   .....+.+.+..  .........+++++++
T Consensus       241 ~~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          241 DVSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YLTDKMLKQMTFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CCTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred             ecccChhhhcCC---CccceehhhhhCCCCcccccccCCCcchhhhh---HHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence            999999999764   3889999998776 778999999996421000   011112211111  1122334568899999


Q ss_pred             HHHHHHHHH
Q 038768          333 MAKKMILVL  341 (386)
Q Consensus       333 li~~ml~v~  341 (386)
                      ++.+||..+
T Consensus       315 li~~~L~~d  323 (336)
T 2vuw_A          315 FHRTMLNFS  323 (336)
T ss_dssp             HHHHGGGSS
T ss_pred             HHHHHhccC
Confidence            999999843

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-37  Score=283.16  Aligned_cols=224  Identities=21%  Similarity=0.268  Sum_probs=178.6

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHh-hcCCCCccceEEEEEEe----cCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASM-SKTSHVNVVSFLGFCYE----KKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~  165 (386)
                      +.||+|+||.||++.. .+|+.||+|+++.    ...+.+|+.++ +.++||||+++++++.+    ....++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            6799999999999986 4689999999974    34677888887 56689999999999987    6778999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~  242 (386)
                      |+|.+++....    ...+++..++.++.|++.||.|||+.   +++||||||+|||++.   ++.+||+|||++.....
T Consensus       100 ~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  172 (299)
T 3m2w_A          100 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG  172 (299)
T ss_dssp             CBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred             CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence            99999997642    24689999999999999999999998   9999999999999998   78999999999863221


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc---
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE---  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~---  319 (386)
                                                ..++.++|||||||++|||++|+.||.........    ......+..+..   
T Consensus       173 --------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          173 --------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQYEFP  222 (299)
T ss_dssp             --------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCSCCSSCTTCCSSC
T ss_pred             --------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----HHHHHHHhhccccCC
Confidence                                      24678899999999999999999999765332110    111111221111   


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      ......+++++.+++.+|+..++.-|+++.++..+|-
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence            1112568999999999999999999999888877653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.1e-33  Score=276.24  Aligned_cols=186  Identities=16%  Similarity=0.145  Sum_probs=130.7

Q ss_pred             hccCcCCceEEEEEE-eCCCcEEEEEEecCCCC-----------ChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeE
Q 038768           92 NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV-----------NGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRAL  158 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  158 (386)
                      ...+.|++|.+..++ .-.|+.+++|++.+...           +.++|.+|+++|+++ .|+||+++++++.+++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345667777666553 23588999999976421           125689999999999 69999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||++|++|.+++...      .+++..   +|+.||+.||+|||++   |||||||||+|||+++++.+||+|||+++
T Consensus       320 VMEyv~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EEECCCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EEecCCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCe
Confidence            99999999999999654      345553   5889999999999999   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNA  294 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~  294 (386)
                      .......  ...+.+||+.|||||++.+   .+..++|+||+|++++++.+|..++
T Consensus       388 ~~~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          388 TTPQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             SCC---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHHHH
T ss_pred             eCCCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccchh
Confidence            7654432  1234679999999999965   4667899999999988877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=5.6e-30  Score=251.61  Aligned_cols=185  Identities=17%  Similarity=0.173  Sum_probs=147.0

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC---------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN---------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.||+|+||.||+|.. .++.+++|........         .+.+.+|++++++++||||+.+..++.+.+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999965 6788899886543221         2347899999999999999977777778888999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++++|.+++..              +..++.|++.||+|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999843              458899999999999998   9999999999999998  99999999999876


Q ss_pred             ccccee-----eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcc
Q 038768          242 KKESFI-----SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE  295 (386)
Q Consensus       242 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~  295 (386)
                      ......     ......||+.|||||++......|+..+|+|+..+-..+-+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            543211     112456999999999997643467888999999998888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=8.6e-26  Score=204.03  Aligned_cols=139  Identities=17%  Similarity=0.087  Sum_probs=113.3

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCCC-------------------ChHHHHHHHHHhhcCCCCccceEEEEEE
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV-------------------NGEEFINEVASMSKTSHVNVVSFLGFCY  151 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~  151 (386)
                      .+.||+|+||.||+|...+|+.||+|+++....                   ....+.+|+.++++++  | +++.+++ 
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~-  170 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY-  170 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE-
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE-
Confidence            478999999999999987799999999964321                   1346889999999998  4 5555544 


Q ss_pred             ecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEE
Q 038768          152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKI  231 (386)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  231 (386)
                      +.+..++||||+++++|.+ +..            .....++.|++.||.|||+.   +++||||||+|||++ ++.+||
T Consensus       171 ~~~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          171 AWEGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             EEETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred             eccceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence            3456799999999999988 421            12346999999999999998   999999999999999 999999


Q ss_pred             eeccCCcccCcccceeeeccccCccccccccccc
Q 038768          232 SDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC  265 (386)
Q Consensus       232 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  265 (386)
                      +|||+++.               +..++|||++.
T Consensus       234 ~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          234 IDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EECCCCeE---------------CCCCCHHHHHH
Confidence            99999862               34478899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=6.6e-22  Score=176.35  Aligned_cols=134  Identities=19%  Similarity=0.203  Sum_probs=104.4

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcE--EEEEEecCCCCC-------------------------hHHHHHHHHHhhcCCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRL--VAVKVLKNSKVN-------------------------GEEFINEVASMSKTSHV  141 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~  141 (386)
                      +.+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..+.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999987 68888  999997643211                         12578899999999887


Q ss_pred             cc--ceEEEEEEecCceeEEEEeCCC-C----CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 038768          142 NV--VSFLGFCYEKKKRALIYEFMPN-G----SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH-RGCNIRIVH  213 (386)
Q Consensus       142 ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH  213 (386)
                      ++  ...+++    +..++||||+.+ |    +|.++...         .++..+..++.|++.+|.||| +.   +|+|
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            64  444432    467899999942 4    66665422         123456789999999999999 87   9999


Q ss_pred             cCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          214 FDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       214 ~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |||||+|||++.  .++|+|||++....
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999999999998  99999999997543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=4.5e-19  Score=164.54  Aligned_cols=136  Identities=15%  Similarity=0.165  Sum_probs=98.0

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC---------------ChHH--------HHHHHHHhhcCCCCccce
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV---------------NGEE--------FINEVASMSKTSHVNVVS  145 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~E~~~l~~l~h~niv~  145 (386)
                      .+.+.||+|+||.||+|...+|+.||||+++....               ....        ...|...|.++.+.++..
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v  177 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV  177 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred             EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            34578999999999999988999999999864211               0111        134666666665544432


Q ss_pred             EEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 038768          146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~  225 (386)
                      ..-+.  ....+|||||+++++|..+...            .....++.|++.+|.|||+.   +||||||||.|||+++
T Consensus       178 p~p~~--~~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          178 PEPIA--QSRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CCEEE--EETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             Ceeee--ccCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            22221  1234799999998888655421            12356789999999999998   9999999999999987


Q ss_pred             CC----------ceEEeeccCCcccC
Q 038768          226 DF----------CPKISDFGLAKLSE  241 (386)
Q Consensus       226 ~~----------~~kl~Dfgl~~~~~  241 (386)
                      ++          .+.|+||+-+....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCcccccccccceEEEEeCCcccCC
Confidence            76          38999999776433

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=3.8e-13  Score=119.72  Aligned_cols=136  Identities=15%  Similarity=0.032  Sum_probs=106.4

Q ss_pred             hhccCcCCceEEEEEEeCCCcEEEEEEecCCC-CChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           91 SNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK-VNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      ...++.|+.+.||+... +++.+++|+..... .....+.+|+.+++.+. +..+.++++++.+.+..++||||++|.+|
T Consensus        19 ~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   97 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             EECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             EeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence            35677888899999986 46899999987421 23346889999998884 67888999999988899999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-----------------------------------------  207 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------------  207 (386)
                      .+.+..           ......++.+++.+|..||+..                                         
T Consensus        98 ~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           98 SEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             HHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             hhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            876411           1123467889999999999810                                         


Q ss_pred             ---------------CCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          208 ---------------NIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       208 ---------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                                     ...++|+|+++.||+++++..+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           1358999999999999876667799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=1.8e-12  Score=115.03  Aligned_cols=130  Identities=17%  Similarity=0.117  Sum_probs=97.3

Q ss_pred             ccC-cCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc--cceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           93 KLG-QGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN--VVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        93 ~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .++ .|..+.||+....+|..+++|+....  ....+..|+.+++.+.+.+  +.+++++..+.+..++||||++|.+|.
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            344 55669999998777888999997654  3346788999988885444  566888888878889999999998884


Q ss_pred             HHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 038768          170 QFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC------------------------------------------  207 (386)
Q Consensus       170 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------------  207 (386)
                        ...         .+   ...++.+++..|..||+..                                          
T Consensus       104 --~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A          104 --SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             --TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             --cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence              211         11   1256677777788887642                                          


Q ss_pred             -------------CCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          208 -------------NIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       208 -------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                                   ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                         1139999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.27  E-value=1.7e-11  Score=114.30  Aligned_cols=140  Identities=19%  Similarity=0.205  Sum_probs=105.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEec--CCC--CChHHHHHHHHHhhcCC--CCccceEEEEEEec---CceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLK--NSK--VNGEEFINEVASMSKTS--HVNVVSFLGFCYEK---KKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~  162 (386)
                      +.|+.|.++.||+.... +..+++|+..  ...  .....+.+|..+++.+.  +..+.+++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            56899999999999874 4678888776  332  22356788999998886  45688899988776   458899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-----------------------------------  207 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------  207 (386)
                      ++|..+.+..        ...++......++.+++..|..||+..                                   
T Consensus       123 v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          123 VSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             CCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             cCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9988774321        134677888889999999999999731                                   


Q ss_pred             --------------------CCCeeecCCCCCCeEeCCCCc--eEEeeccCCccc
Q 038768          208 --------------------NIRIVHFDIKPHNILLGEDFC--PKISDFGLAKLS  240 (386)
Q Consensus       208 --------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~  240 (386)
                                          ...++|+|+++.||+++.++.  +.|.||+.+...
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                247999999999999987653  689999998743

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=3.3e-11  Score=109.58  Aligned_cols=189  Identities=20%  Similarity=0.201  Sum_probs=121.0

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcC-CCCc--cceEEEEEEecC---ceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKT-SHVN--VVSFLGFCYEKK---KRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~~~~  165 (386)
                      +.++.|....||+..    ..+++|+.... .....+.+|..+++.+ .+..  +.+.+......+   ..|+|||+++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458889999999863    55888886532 2346788999999877 3333  445555443333   34789999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG---------------------------------------  206 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------------  206 (386)
                      .+|.....        ..++..+...++.+++..|..||+.                                       
T Consensus       101 ~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A          101 VPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             eECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            88865331        2356667777788888888888851                                       


Q ss_pred             ----------------CCCCeeecCCCCCCeEeCC--CCceEEeeccCCcccCcccceeeeccccCcccccccccc---c
Q 038768          207 ----------------CNIRIVHFDIKPHNILLGE--DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF---C  265 (386)
Q Consensus       207 ----------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~---~  265 (386)
                                      ..+.++|+|+++.||++++  +..+.|+||+.+................   .-..|+..   .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l  249 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHH
Confidence                            1135899999999999988  5568899999987543221110000000   00122221   1


Q ss_pred             hhcCCC---------CccchhHhHHHHHHHHHhCCCCccc
Q 038768          266 RNFGGV---------SHKSDVYSYGMMILEMVVGRKNAEV  296 (386)
Q Consensus       266 ~~~~~~---------~~~~DvwslGvil~elltg~~p~~~  296 (386)
                      ..++..         ....+.|++|.++|.+.+|+.+|..
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            111111         1235899999999999999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=1.8e-07  Score=84.88  Aligned_cols=137  Identities=18%  Similarity=0.141  Sum_probs=90.3

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC---ccceEEEEEE-ecCceeEEEEeCCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV---NVVSFLGFCY-EKKKRALIYEFMPNGS  167 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~gs  167 (386)
                      +.++.|....||+.    |..+++|+... ......+.+|..+|..+.+.   .+.+.+.++. ..+..++||||++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899987    56688887532 12235788999999988642   3667777765 3456789999999988


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG-----------------------------------------  206 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------------------------------------  206 (386)
                      |.....        ..++......++.+++..|..||+.                                         
T Consensus       100 l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A          100 LGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             Cchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            765321        1122233333333343333333321                                         


Q ss_pred             ----------------CCCCeeecCCCCCCeEeCC---CCc-eEEeeccCCcccC
Q 038768          207 ----------------CNIRIVHFDIKPHNILLGE---DFC-PKISDFGLAKLSE  241 (386)
Q Consensus       207 ----------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgl~~~~~  241 (386)
                                      ..+.++|+|+++.||+++.   ++. +.|+||+.+....
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                            2336799999999999987   355 5899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.59  E-value=1.9e-07  Score=82.98  Aligned_cols=133  Identities=17%  Similarity=0.122  Sum_probs=93.1

Q ss_pred             cCcCCce-EEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCCCCHHH
Q 038768           94 LGQGGFG-SVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQ  170 (386)
Q Consensus        94 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  170 (386)
                      +..|..| .||+.... ++..+++|+-...  ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445544 68987654 4678999986532  3456788999888774 4457788999999999999999999988876


Q ss_pred             HhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 038768          171 FIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-------------------------------------------  207 (386)
Q Consensus       171 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------------  207 (386)
                      ......          .....+..+++..|.-||+..                                           
T Consensus       110 ~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          110 VLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            542211          112234445555555555310                                           


Q ss_pred             ------------CCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          208 ------------NIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       208 ------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                                  .+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1237999999999999988777899998875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.52  E-value=1.7e-07  Score=86.90  Aligned_cols=78  Identities=6%  Similarity=-0.041  Sum_probs=55.5

Q ss_pred             hcc-CcCCceEEEEEEeC-------CCcEEEEEEecCCC---C-ChHHHHHHHHHhhcCC-C--CccceEEEEEEec---
Q 038768           92 NKL-GQGGFGSVYKGKLP-------DGRLVAVKVLKNSK---V-NGEEFINEVASMSKTS-H--VNVVSFLGFCYEK---  153 (386)
Q Consensus        92 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~---  153 (386)
                      +.| +.|....+|+....       ++..+++|......   . ....+.+|..+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 88889999998764       26788999875432   1 2346778888888774 2  3577788887655   


Q ss_pred             CceeEEEEeCCCCCHH
Q 038768          154 KKRALIYEFMPNGSLD  169 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~  169 (386)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=4.4e-06  Score=76.60  Aligned_cols=144  Identities=13%  Similarity=0.143  Sum_probs=80.5

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-----CCccceEE-E--EEEecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-----HVNVVSFL-G--FCYEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~~  163 (386)
                      +.|+.|..+.||+....+| .+++|+...   ....+..|..++..+.     .|.++... |  +....+..+++|||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            3466677899999987555 488998875   2344445555554442     34443310 0  123456778999999


Q ss_pred             CCCCHH--------------HHhccccccc--c------cccCCHHH-------------------------------HH
Q 038768          164 PNGSLD--------------QFIYDEESSN--I------NRKLEWRT-------------------------------MC  190 (386)
Q Consensus       164 ~~gsL~--------------~~l~~~~~~~--~------~~~l~~~~-------------------------------~~  190 (386)
                      +|..+.              ..+|......  .      .....|..                               ..
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              1111111000  0      00112211                               11


Q ss_pred             HHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          191 QIAVGIARGLEYLHR----------GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       191 ~i~~qi~~~L~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                      .+..++..++.+|++          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            112234446666653          1234899999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.29  E-value=3.5e-06  Score=79.16  Aligned_cols=73  Identities=11%  Similarity=0.089  Sum_probs=49.5

Q ss_pred             hccCcCCceEEEEEEeC-CCcEEEEEEecCCC--------CChHHHHHHHHHhhcCCC--C-ccceEEEEEEecCceeEE
Q 038768           92 NKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK--------VNGEEFINEVASMSKTSH--V-NVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~lv  159 (386)
                      +.||.|.++.||++... +++.+++|......        ...+.+..|.+++..+..  + .+.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            57999999999999754 46889999865321        223456788888877632  3 34455543  45667899


Q ss_pred             EEeCCCC
Q 038768          160 YEFMPNG  166 (386)
Q Consensus       160 ~e~~~~g  166 (386)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.12  E-value=1.1e-05  Score=72.92  Aligned_cols=140  Identities=16%  Similarity=0.170  Sum_probs=91.8

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC---CCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS---HVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.|+.|....+|+... ++..+++|+....  ....+..|...|+.|.   ...+.+.++++...+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4688999999999886 5678889987643  3567888988888774   36788899998888889999999998764


Q ss_pred             HH-----------Hhccccc-cccc---------------ccCCHHHHH---HHH----------------HHHHHHH-H
Q 038768          169 DQ-----------FIYDEES-SNIN---------------RKLEWRTMC---QIA----------------VGIARGL-E  201 (386)
Q Consensus       169 ~~-----------~l~~~~~-~~~~---------------~~l~~~~~~---~i~----------------~qi~~~L-~  201 (386)
                      ..           .++.... ....               -.-+|....   ++.                ..+...+ .
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            21           1222211 0000               012344321   111                1111111 2


Q ss_pred             HHHh-cCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          202 YLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       202 ~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      .|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 2346899999999999999887 8899984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.04  E-value=2.5e-05  Score=69.95  Aligned_cols=73  Identities=21%  Similarity=0.263  Sum_probs=53.7

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCC-CChHHHHHHHHHhhcCC-C--CccceEEEEEEecCceeEEEEeCCCCC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK-VNGEEFINEVASMSKTS-H--VNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+|.|..+.||+.+..+|+.|++|+..... .....|..|...|+.|. .  --+.+.+++    +..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            5689999999999999999999999876433 23356788999888774 2  234455543    24578999998765


Q ss_pred             H
Q 038768          168 L  168 (386)
Q Consensus       168 L  168 (386)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=4.6e-05  Score=72.08  Aligned_cols=80  Identities=10%  Similarity=0.072  Sum_probs=47.6

Q ss_pred             CCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcC-CCCccchhHhHHHHHHHH
Q 038768          209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG-GVSHKSDVYSYGMMILEM  287 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~~DvwslGvil~el  287 (386)
                      ..++|+|+++.|||++.++ ++++||+.+.............. .-...|.+|+....... ......++..+...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4899999999999998876 99999999875432211100000 00123555554321100 112234556788888888


Q ss_pred             HhC
Q 038768          288 VVG  290 (386)
Q Consensus       288 ltg  290 (386)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.91  E-value=2.9e-05  Score=69.93  Aligned_cols=70  Identities=9%  Similarity=0.113  Sum_probs=43.6

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeC-CCCCH
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFM-PNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL  168 (386)
                      +.|+.|....+|+.     ..+++|+............+|..+++.+...++ .+++++  +.+..++|+||+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            56888999999998     558888876432111223467777766642233 455543  455568999999 65544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.72  E-value=0.00029  Score=64.05  Aligned_cols=144  Identities=14%  Similarity=0.119  Sum_probs=82.2

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCC--ccceEEEE-----EEecCceeEEEEeCCC
Q 038768           93 KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHV--NVVSFLGF-----CYEKKKRALIYEFMPN  165 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~~  165 (386)
                      .++ |....||+....+|+.+++|...........+..|..++..+...  .+++++..     ....+..+++|+|++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            355 777899998776787899999875444566777888887766421  23444332     1224556789999987


Q ss_pred             CCHH-----HH---------hcccccc---cccccCCHHHH----HHH---------------HHHHHHHHHHHHhc---
Q 038768          166 GSLD-----QF---------IYDEESS---NINRKLEWRTM----CQI---------------AVGIARGLEYLHRG---  206 (386)
Q Consensus       166 gsL~-----~~---------l~~~~~~---~~~~~l~~~~~----~~i---------------~~qi~~~L~~LH~~---  206 (386)
                      ..+.     .+         ++.....   ......++...    ..+               ...+...++.+...   
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            5432     11         1111000   00011222110    000               11111223333221   


Q ss_pred             -CCCCeeecCCCCCCeEeCCCCceEEeeccCCcc
Q 038768          207 -CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL  239 (386)
Q Consensus       207 -~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~  239 (386)
                       ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             234689999999999999 4 899999988764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.71  E-value=9.4e-05  Score=68.71  Aligned_cols=143  Identities=17%  Similarity=0.199  Sum_probs=83.5

Q ss_pred             hccCcCCceEEEEEEeC--------CCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.|..|-...+|+....        +++.+++|+..........+.+|..+++.+. +.-..++++++.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            45777888899999864        2478999987443334567778999888774 2223566666533    299999


Q ss_pred             CCCCCHHHH-----------------hcccccccccccC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 038768          163 MPNGSLDQF-----------------IYDEESSNINRKL--EWRTMCQIAVGIAR-------------------GLEYLH  204 (386)
Q Consensus       163 ~~~gsL~~~-----------------l~~~~~~~~~~~l--~~~~~~~i~~qi~~-------------------~L~~LH  204 (386)
                      ++|.+|..-                 ||..... .....  -+..+.++..++..                   .+..|.
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~-~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMP-FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS-SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC-CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            987655311                 1111100 11112  23455555443322                   233332


Q ss_pred             ----hc-CCCCeeecCCCCCCeEeCCC----CceEEeeccCCcc
Q 038768          205 ----RG-CNIRIVHFDIKPHNILLGED----FCPKISDFGLAKL  239 (386)
Q Consensus       205 ----~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~  239 (386)
                          .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 22368999999999999876    7899999998863

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.68  E-value=0.00029  Score=64.21  Aligned_cols=145  Identities=14%  Similarity=0.124  Sum_probs=74.0

Q ss_pred             ccCcCCceE-EEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCC--CccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           93 KLGQGGFGS-VYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSH--VNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        93 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      .|+.|+... +|+....+|..+++|......  ...+..|+.++..+..  -.+.+++.+.  .+..+++||++++..+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcchH
Confidence            455554444 667765446777777654332  1234456666655532  2355666653  33347899999777776


Q ss_pred             HHhcccccc--------------------cccccCCHHHHH-------H-------------HHHHHHHHHHHHHh---c
Q 038768          170 QFIYDEESS--------------------NINRKLEWRTMC-------Q-------------IAVGIARGLEYLHR---G  206 (386)
Q Consensus       170 ~~l~~~~~~--------------------~~~~~l~~~~~~-------~-------------i~~qi~~~L~~LH~---~  206 (386)
                      +++......                    .....++.....       .             ....+...+..+..   .
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            544321100                    000111111100       0             00111222223311   1


Q ss_pred             CCCCeeecCCCCCCeEeCCC----CceEEeeccCCcccC
Q 038768          207 CNIRIVHFDIKPHNILLGED----FCPKISDFGLAKLSE  241 (386)
Q Consensus       207 ~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~~  241 (386)
                      ....++|+|+.+.||+++.+    +.+.|+||+.+....
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            23479999999999999874    678999999887543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.59  E-value=0.00038  Score=66.36  Aligned_cols=73  Identities=15%  Similarity=0.000  Sum_probs=46.6

Q ss_pred             hccCcCCceEEEEEEeCC-CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEeCCCCCH
Q 038768           92 NKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      +.|+.|....+|+....+ +..+++|+........-+..+|..++..|...++ .++++++.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            357778889999998755 4788899875432111122578888888764444 56777652  2  359999987544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.54  E-value=0.00019  Score=65.07  Aligned_cols=145  Identities=13%  Similarity=0.116  Sum_probs=78.4

Q ss_pred             hccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc--cceEEEE------EEecCceeEEEEeC
Q 038768           92 NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN--VVSFLGF------CYEKKKRALIYEFM  163 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~  163 (386)
                      +.|+.|....+|+....+| .+++|..... ...+.+..|..++..+...+  +.+++..      ....+..+++++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            3567788899999987655 5778988752 22345666777766553211  2333311      12345678999999


Q ss_pred             CCCCHHH--------------Hhcccccc--ccc----ccCCHHHHHH------------HHHHHHHHHHHHHhc----C
Q 038768          164 PNGSLDQ--------------FIYDEESS--NIN----RKLEWRTMCQ------------IAVGIARGLEYLHRG----C  207 (386)
Q Consensus       164 ~~gsL~~--------------~l~~~~~~--~~~----~~l~~~~~~~------------i~~qi~~~L~~LH~~----~  207 (386)
                      +|..+..              .++.....  ...    ....|.....            +...+...++++...    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8865321              01111000  000    0011222110            011244455555532    1


Q ss_pred             CCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       208 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ..+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            2479999999999999887666899998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.53  E-value=0.00039  Score=65.84  Aligned_cols=72  Identities=15%  Similarity=0.266  Sum_probs=49.6

Q ss_pred             hccCcCCceEEEEEEeCC--------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPD--------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  162 (386)
                      +.|+.|....+|+....+        +..+++|+.... ...+.+.+|..++..+...++ .++++.+.+    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            457788889999998753        578999988432 222567789998887753333 566765432    389999


Q ss_pred             CCCCCH
Q 038768          163 MPNGSL  168 (386)
Q Consensus       163 ~~~gsL  168 (386)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.45  E-value=0.00021  Score=66.30  Aligned_cols=73  Identities=14%  Similarity=0.121  Sum_probs=43.7

Q ss_pred             hccCcCCceEEEEEEeCC---------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc-cceEEEEEEecCceeEEEE
Q 038768           92 NKLGQGGFGSVYKGKLPD---------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN-VVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  161 (386)
                      +.|+.|....+|+....+         +..+++|+.........+...|..++..+...+ +.++++..  .  .++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            457788888999998654         268899987543211112357777777764333 44666543  2  378999


Q ss_pred             eCCCCCH
Q 038768          162 FMPNGSL  168 (386)
Q Consensus       162 ~~~~gsL  168 (386)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.11  E-value=0.0033  Score=57.38  Aligned_cols=32  Identities=28%  Similarity=0.394  Sum_probs=28.2

Q ss_pred             CCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ..++|+|+.+.||++++++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999887643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.86  E-value=0.0073  Score=50.77  Aligned_cols=124  Identities=11%  Similarity=0.018  Sum_probs=80.1

Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      -+|.++|...     +.+++++++|.++.|.+.+|.-+-.+.  .-..+=+.|..|++..+|.|.+.+ ..+.       
T Consensus        33 vSL~eIL~~~-----~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLY-----NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHc-----CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-------
Confidence            4788888654     378999999999999999988773211  111333457899999999888764 1110       


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                             .....+.|||...   ...+.+.=|||||+++|.-+-=..|                          ......
T Consensus        98 -------~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~--------------------------e~eE~e  141 (229)
T 2yle_A           98 -------AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK--------------------------ENEERE  141 (229)
T ss_dssp             ----------------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC--------------------------TTEEEC
T ss_pred             -------ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC--------------------------cccchh
Confidence                   0123467888763   2457888999999999998742111                          112345


Q ss_pred             CChHHHHHHHHHHHH
Q 038768          326 VTEEEKEMAKKMILV  340 (386)
Q Consensus       326 ~s~~~~~li~~ml~v  340 (386)
                      +|+++..||..|..-
T Consensus       142 LS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          142 LSPPLEQLIDHMANT  156 (229)
T ss_dssp             CCHHHHHHHHHHTTC
T ss_pred             hCHHHHHHHHHHHhc
Confidence            789999999998643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.29  E-value=0.014  Score=54.80  Aligned_cols=73  Identities=11%  Similarity=0.087  Sum_probs=47.2

Q ss_pred             hccCcCCceEEEEEEeCC--------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCc-cceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPD--------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVN-VVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+..|-...+|+....+        +..+++|+........-+..+|..+++.+.-.+ ..++++.+  .  .++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            457778888999998753        578999987543222223357887777764222 35555533  2  3789999


Q ss_pred             CCCCCH
Q 038768          163 MPNGSL  168 (386)
Q Consensus       163 ~~~gsL  168 (386)
                      ++|.+|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.10  E-value=0.0075  Score=36.36  Aligned_cols=29  Identities=28%  Similarity=0.440  Sum_probs=15.4

Q ss_pred             eeeeehHHHHHHHHHHHHHHHHHHHHhhc
Q 038768           10 SFGIAAGVVGIIVILVILLLVGLRHIRKK   38 (386)
Q Consensus        10 ~~~i~~~~~~~~~~~~~~~~~~~~~~r~~   38 (386)
                      .-.|++|+++.+++++++++.++...|+|
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cceEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence            34677888775555444444433333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.79  E-value=0.0097  Score=35.77  Aligned_cols=27  Identities=44%  Similarity=0.438  Sum_probs=13.7

Q ss_pred             eeeehHHHHHHHHHHHHHHHHHHHHhh
Q 038768           11 FGIAAGVVGIIVILVILLLVGLRHIRK   37 (386)
Q Consensus        11 ~~i~~~~~~~~~~~~~~~~~~~~~~r~   37 (386)
                      -.|++|+++.+++++++++.++...|+
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RR   36 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRR   36 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhh
Confidence            357777777555444443333333333

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.71  E-value=0.009  Score=35.83  Aligned_cols=26  Identities=31%  Similarity=0.614  Sum_probs=11.4

Q ss_pred             eeehHHHHHHHHHHHHHHHHHHHHhh
Q 038768           12 GIAAGVVGIIVILVILLLVGLRHIRK   37 (386)
Q Consensus        12 ~i~~~~~~~~~~~~~~~~~~~~~~r~   37 (386)
                      .|+++++++++++++.+.++++.+||
T Consensus        13 ~Ia~~vVGvll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           13 SIISAVVGILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHhheehh
Confidence            45666666443333333333333333

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.38  E-value=0.085  Score=49.17  Aligned_cols=30  Identities=30%  Similarity=0.328  Sum_probs=25.5

Q ss_pred             CeeecCCCCCCeEe------CCCCceEEeeccCCcc
Q 038768          210 RIVHFDIKPHNILL------GEDFCPKISDFGLAKL  239 (386)
Q Consensus       210 ~ivH~dlk~~Nill------~~~~~~kl~Dfgl~~~  239 (386)
                      .++|+|+.+.|||+      +++..+.++||.++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.68  E-value=0.42  Score=39.95  Aligned_cols=120  Identities=13%  Similarity=0.134  Sum_probs=80.0

Q ss_pred             CCCccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 038768          139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKP  218 (386)
Q Consensus       139 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~  218 (386)
                      .||+.+.. .+-.+.+...+.++.-+  +...+-.       -..++....++++.+|+....++++.     +|--|.|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P  107 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP  107 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence            58888865 45555665555555433  2222211       14577889999999999988666643     8889999


Q ss_pred             CCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCccccc
Q 038768          219 HNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKV  298 (386)
Q Consensus       219 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  298 (386)
                      +|++++.++.+++.-.|+-.                   -++|.-       .+...=.-.+=+++..+++++..|+.--
T Consensus       108 ~NL~f~~~~~p~i~~RGik~-------------------~l~P~~-------~~ee~fL~qyKAliiall~~K~~Fe~l~  161 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQN-------------------VVDPLP-------VSEAEFLTRYKALVICAFNEKQSFDALV  161 (215)
T ss_dssp             GGEEECTTSCEEESCCEETT-------------------TBSCCC-------CCHHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred             ceEEEcCCCCEEEEEccCcc-------------------CCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence            99999999999998766532                   123321       1222223357788999999999998553


Q ss_pred             c
Q 038768          299 S  299 (386)
Q Consensus       299 ~  299 (386)
                      .
T Consensus       162 ~  162 (215)
T 4ann_A          162 E  162 (215)
T ss_dssp             H
T ss_pred             c
Confidence            3

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.32  E-value=0.2  Score=30.07  Aligned_cols=30  Identities=7%  Similarity=0.197  Sum_probs=17.8

Q ss_pred             eeeeehHHHHHHHHHHHHHHHHHHHHhhccc
Q 038768           10 SFGIAAGVVGIIVILVILLLVGLRHIRKKKT   40 (386)
Q Consensus        10 ~~~i~~~~~~~~~~~~~~~~~~~~~~r~~~~   40 (386)
                      ..+++.|+++++ ++++++++++++++++++
T Consensus        14 A~gVVgGv~~~~-ii~~~~~~~~RRr~~~~k   43 (44)
T 2ks1_B           14 ATGMVGALLLLL-VVALGIGLFMRRRHIVRK   43 (44)
T ss_dssp             THHHHHHHHHHH-HHHHHHHHHHHTTTCCSC
T ss_pred             EeehhHHHHHHH-HHHHHHHHHhhhhHhhcc
Confidence            344555555555 444666677777777654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.17  E-value=0.67  Score=38.89  Aligned_cols=117  Identities=11%  Similarity=0.129  Sum_probs=78.1

Q ss_pred             CCCccceEEEEEEecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCC
Q 038768          139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE-YLHRGCNIRIVHFDIK  217 (386)
Q Consensus       139 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~ivH~dlk  217 (386)
                      .||++  -...-.+.+...+.++.-+++.=...+         ..++....++++.+|+.... +++     .-+|--+.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~  111 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVC  111 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEe
Confidence            57777  344445666666666654333222233         34677889999999888666 555     45888999


Q ss_pred             CCCeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 038768          218 PHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK  297 (386)
Q Consensus       218 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  297 (386)
                      |+|++++.++.+++.-.|+-.                   -++|..+       +..-=.-.+=+++..++.++..|+.-
T Consensus       112 P~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~-------~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGVKE-------------------SLPPDEW-------DDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             GGGEEECTTCCEEESCCEETT-------------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             CceEEEeCCCcEEEEEcCCcc-------------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            999999999999998766532                   2444322       11112335678889999999888754

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=90.12  E-value=0.073  Score=30.10  Aligned_cols=22  Identities=36%  Similarity=0.717  Sum_probs=10.9

Q ss_pred             eeehHHHHHHHHHHHHHHHHHH
Q 038768           12 GIAAGVVGIIVILVILLLVGLR   33 (386)
Q Consensus        12 ~i~~~~~~~~~~~~~~~~~~~~   33 (386)
                      .|+++++++++++++.+.+.+.
T Consensus         9 sIaagVvglll~vii~l~~~~~   30 (35)
T 1iij_A            9 FIIATVVGVLLFLILVVVVGIL   30 (35)
T ss_dssp             HHHHHHHHHHHHHHHTTTTTHH
T ss_pred             EeHHHHHHHHHHHHHHHHhheE
Confidence            4677777744333333333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.98  E-value=0.21  Score=29.95  Aligned_cols=28  Identities=25%  Similarity=0.390  Sum_probs=16.5

Q ss_pred             eeehHHHHHHHHHHHHHHHHHHHHhhccc
Q 038768           12 GIAAGVVGIIVILVILLLVGLRHIRKKKT   40 (386)
Q Consensus        12 ~i~~~~~~~~~~~~~~~~~~~~~~r~~~~   40 (386)
                      +++.|+++++ ++++++++++|+++++++
T Consensus        15 gVVgGv~~v~-ii~~~~~~~~RRRr~~~k   42 (44)
T 2l2t_A           15 GVIGGLFILV-IVGLTFAVYVRRKSIKKK   42 (44)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHHTTCSSCC
T ss_pred             eehHHHHHHH-HHHHHHHHHhhhhhhhhc
Confidence            4444455444 445666777777777654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.49  E-value=0.066  Score=50.95  Aligned_cols=59  Identities=7%  Similarity=0.029  Sum_probs=18.1

Q ss_pred             hhccCcCCceEEEEEEeCC-CcEEEE------EEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEe
Q 038768           91 SNKLGQGGFGSVYKGKLPD-GRLVAV------KVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYE  152 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~  152 (386)
                      .++||   ||.||+|.+.. ..+||+      |..+.....   ...+.+|..++..++|+|+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45676   99999998854 367888      766543322   2467889999999999999999887654

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=86.43  E-value=0.41  Score=28.63  Aligned_cols=31  Identities=16%  Similarity=0.285  Sum_probs=24.5

Q ss_pred             ceeeeehHHHHHHHHHHHHHHHHHHHHhhcc
Q 038768            9 TSFGIAAGVVGIIVILVILLLVGLRHIRKKK   39 (386)
Q Consensus         9 ~~~~i~~~~~~~~~~~~~~~~~~~~~~r~~~   39 (386)
                      ...++++|++.+++++++++++.-|++.++|
T Consensus        13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~~~~k   43 (44)
T 2jwa_A           13 SIISAVVGILLVVVLGVVFGILIKRRQQKIR   43 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCSCCC
T ss_pred             chHHHHHHHHHHHHHHHHHHhheehhhhhcc
Confidence            3777788888888888888888888877755

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=83.66  E-value=0.31  Score=28.82  Aligned_cols=15  Identities=27%  Similarity=0.505  Sum_probs=7.2

Q ss_pred             eeeehHHHHHHHHHH
Q 038768           11 FGIAAGVVGIIVILV   25 (386)
Q Consensus        11 ~~i~~~~~~~~~~~~   25 (386)
                      ..|++++++.+++++
T Consensus        13 ~~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLL   27 (41)
T ss_dssp             THHHHHHHHHHHHHH
T ss_pred             EEEEeehhHHHHHHH
Confidence            345555554444443

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=82.98  E-value=1  Score=28.17  Aligned_cols=14  Identities=7%  Similarity=0.299  Sum_probs=5.4

Q ss_pred             eeeeehHHHHHHHH
Q 038768           10 SFGIAAGVVGIIVI   23 (386)
Q Consensus        10 ~~~i~~~~~~~~~~   23 (386)
                      |+.++.++.+++++
T Consensus        10 WiIi~svl~GLLLL   23 (54)
T 2l8s_A           10 WVILLSAFAGLLLL   23 (54)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHH
Confidence            34333333333333

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=81.52  E-value=0.41  Score=27.78  Aligned_cols=19  Identities=16%  Similarity=0.183  Sum_probs=10.8

Q ss_pred             eeeeehHHHHHHHHHHHHH
Q 038768           10 SFGIAAGVVGIIVILVILL   28 (386)
Q Consensus        10 ~~~i~~~~~~~~~~~~~~~   28 (386)
                      ..+|++|+++.+++++.++
T Consensus        13 IAGiVvG~v~gv~li~~l~   31 (38)
T 2k1k_A           13 IVAVIFGLLLGAALLLGIL   31 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHH
T ss_pred             eeeeehHHHHHHHHHHHHH
Confidence            3577777765555444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	386
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-58
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 71/271 (26%), Positives = 128/271 (47%), Gaps = 29/271 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSF 146
              ++G G FG+VYKGK      VAVK+L  +       + F NEV  + KT HVN++ F
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G+     + A++ ++    SL   ++  E+     K E   +  IA   A+G++YLH  
Sbjct: 70  MGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF-C 265
               I+H D+K +NI L ED   KI DFGLA +  +           G+I ++APEV   
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV 325
           ++    S +SDVY++G+++ E++ G+       ++++       + +     +  ++   
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 326 VTEEEKEMAKKMIL-----------VLEMLE 345
             +  K +  + +            +L  +E
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 7e-60
 Identities = 65/267 (24%), Positives = 117/267 (43%), Gaps = 29/267 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           F  ++G G FG V+ G   +   VA+K ++   ++ E+FI E   M K SH  +V   G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
           C E+    L++EFM +G L  ++  +            T+  + + +  G+ YL   C  
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEEAC-- 121

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
            ++H D+   N L+GE+   K+SDFG+ +     +   S  G +  + + +PEVF  +F 
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFS 177

Query: 270 GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEE 329
             S KSDV+S+G+++ E+    K       +  E    + + + I  G       + +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK-------IPYENRSNSEVVEDISTGFRLYKPRLASTH 230

Query: 330 EKEMAKKMIL-----------VLEMLE 345
             ++                 +L  L 
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-59
 Identities = 60/249 (24%), Positives = 112/249 (44%), Gaps = 18/249 (7%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
           F  +LG G FG V  GK      VA+K++K   ++ +EFI E   M   SH  +V   G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
           C +++   +I E+M NG L  ++ +        + + + + ++   +   +EYL      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             +H D+   N L+ +    K+SDFGL++     E   S +G++  + +  PEV      
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY--S 176

Query: 270 GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEE 329
             S KSD++++G+++ E+    K       +  E +  +   +HI  G       + +E+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-------MPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 330 EKEMAKKMI 338
              +     
Sbjct: 230 VYTIMYSCW 238

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-59
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 32/274 (11%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
              +LG G FG V+ G       VAVK LK   ++ + F+ E   M +  H  +V     
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              ++   +I E+M NGSL  F+          KL    +  +A  IA G+ ++      
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             +H D++  NIL+ +    KI+DFGLA+L E  E   +  GA+  I + APE    N+G
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYG 185

Query: 270 GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEE 329
             + KSDV+S+G+++ E+V   +     ++          + +++E G          EE
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE 238

Query: 330 EKEMAKKMIL-----------VLEMLEG---STE 349
             ++ +               +  +LE    +TE
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-58
 Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 29/280 (10%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
              KLGQG FG V+ G       VA+K LK   ++ E F+ E   M K  H  +V     
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 150 CYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNI 209
              ++   ++ E+M  GSL  F+  E      + L    +  +A  IA G+ Y+     +
Sbjct: 81  V-SEEPIYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVE---RM 132

Query: 210 RIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
             VH D++  NIL+GE+   K++DFGLA+L E  E + +  GA+  I + APE      G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALY--G 189

Query: 270 GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEE 329
             + KSDV+S+G+++ E+    +     +           +   +E G          E 
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 242

Query: 330 EKEMAKKMI-----------LVLEMLEGSTEDLQIPPKPS 358
             ++  +              +   LE      +   +P 
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-57
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVS 145
              ++LG G  G V+K    P G ++A K++          + I E+  + + +   +V 
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
           F G  Y   + ++  E M  GSLDQ +          ++  + + ++++ + +GL YL  
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLKK------AGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFC 265
               +I+H D+KP NIL+      K+ DFG++       +   +    GT  Y++PE   
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERL- 175

Query: 266 RNFGGVSHKSDVYSYGMMILEMVVGR 291
                 S +SD++S G+ ++EM VGR
Sbjct: 176 -QGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (466), Expect = 7e-56
 Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 28/256 (10%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNV 143
           S   ++G G FG+VY  + + +  +VA+K +  S     E     I EV  + K  H N 
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           + + G    +    L+ E+    + D            + L+   +  +  G  +GL YL
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYL 131

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H      ++H D+K  NILL E    K+ DFG A +     SF+      GT  ++APEV
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEV 182

Query: 264 F-CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL 322
               + G    K DV+S G+  +E+   +            +   +++Y   +  +    
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERK-------PPLFNMNAMSALYHIAQNESPALQ 235

Query: 323 AGVVTEEEKEMAKKMI 338
           +G  +E  +      +
Sbjct: 236 SGHWSEYFRNFVDSCL 251

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 8e-55
 Identities = 74/297 (24%), Positives = 134/297 (45%), Gaps = 31/297 (10%)

Query: 72  SLAPKRYNYSD--VKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEF 128
           ++ P   NY    ++R   +  +KLG G +G VY+G        VAVK LK   +  EEF
Sbjct: 1   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60

Query: 129 INEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRT 188
           + E A M +  H N+V  LG C  +    +I EFM  G+L  ++ +       +++    
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN----RQEVSAVV 116

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +  +A  I+  +EYL +      +H D+   N L+GE+   K++DFGL++L    +++ +
Sbjct: 117 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 172

Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN 308
             GA+  I + APE         S KSDV+++G+++ E+     +    + LS       
Sbjct: 173 HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------- 223

Query: 309 SIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLEGSTEDLQIP 354
            +Y+ +E     +      E+  E+ +               + +  E   ++  I 
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 7e-54
 Identities = 54/255 (21%), Positives = 103/255 (40%), Gaps = 22/255 (8%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE---FINEVASMSKTSHVNVVSFL 147
             +G G +G   K +   DG+++  K L    +   E    ++EV  + +  H N+V + 
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 148 GFCYEKKKRAL--IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
               ++    L  + E+   G L   I     +   + L+   + ++   +   L+  HR
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 206 --GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
                  ++H D+KP N+ L      K+ DFGLA++     SF       GT  Y++PE 
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQ 185

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA 323
              N    + KSD++S G ++ E+                 +    +   I  G   ++ 
Sbjct: 186 M--NRMSYNEKSDIWSLGCLLYELCALM--------PPFTAFSQKELAGKIREGKFRRIP 235

Query: 324 GVVTEEEKEMAKKMI 338
              ++E  E+  +M+
Sbjct: 236 YRYSDELNEIITRML 250

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 31/259 (11%)

Query: 90  FSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVS 145
           F  ++G+G F +VYKG   +    VA   L++ K+     + F  E   +    H N+V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 146 FLGFCYE----KKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           F          KK   L+ E M +G+L  ++         + ++ + +      I +GL+
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR------FKVMKIKVLRSWCRQILKGLQ 126

Query: 202 YLHRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           +LH      I+H D+K  NI + G     KI D GLA L     +        GT  ++A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMA 181

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE- 319
           PE++           DVY++GM +LEM              SE      IY+ +  G + 
Sbjct: 182 PEMYE---EKYDESVDVYAFGMCMLEMATSEY-------PYSECQNAAQIYRRVTSGVKP 231

Query: 320 FQLAGVVTEEEKEMAKKMI 338
                V   E KE+ +  I
Sbjct: 232 ASFDKVAIPEVKEIIEGCI 250

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-53
 Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 35/268 (13%)

Query: 90  FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGF 149
               +G+G FG V  G    G  VAVK +KN     + F+ E + M++  H N+V  LG 
Sbjct: 11  LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV 68

Query: 150 CYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             E+K    ++ E+M  GSL  ++           L    + + ++ +   +EYL     
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG--- 121

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
              VH D+   N+L+ ED   K+SDFGL K +   +        +  + + APE      
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE-- 174

Query: 269 GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE 328
              S KSDV+S+G+++ E+    +    ++           +   +E G +         
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDGCPP 227

Query: 329 EEKEMAKKMIL-----------VLEMLE 345
              E+ K               + E LE
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-53
 Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 29/254 (11%)

Query: 90  FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVV 144
               LG+G FG+VY  +      ++A+KVL  +++       +   EV   S   H N++
Sbjct: 10  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
              G+ ++  +  LI E+ P G++ + +          K + +        +A  L Y H
Sbjct: 70  RLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYITELANALSYCH 123

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                R++H DIKP N+LLG     KI+DFG +  +             GT+ Y+ PE+ 
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMI 176

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
                    K D++S G++  E +VG+   E               YK I    EF    
Sbjct: 177 EG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRV-EFTFPD 225

Query: 325 VVTEEEKEMAKKMI 338
            VTE  +++  +++
Sbjct: 226 FVTEGARDLISRLL 239

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 75/314 (23%), Positives = 127/314 (40%), Gaps = 46/314 (14%)

Query: 68  RNYVSLAPKRYNYSD---VKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVL 118
            NYV + P +  Y       R   SF   LG G FG V +              VAVK+L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 119 KNSKVNG--EEFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE 175
           K S      E  ++E+  +S   +H+N+V+ LG C       +I E+   G L  F+  +
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 176 ESSNINRK------------LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILL 223
             S I  K            L+   +   +  +A+G+ +L    +   +H D+   NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178

Query: 224 GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMM 283
                 KI DFGLA+  +   +++    AR  + ++APE         + +SDV+SYG+ 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIF 236

Query: 284 ILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL---- 339
           + E+     +    + + S+       YK I+ G           E  ++ K        
Sbjct: 237 LWELFSLGSSPYPGMPVDSK------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290

Query: 340 -------VLEMLEG 346
                  +++++E 
Sbjct: 291 KRPTFKQIVQLIEK 304

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 6e-53
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 20/222 (9%)

Query: 80  YSDVKRMTN-----SFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNG-EEFINEV 132
           Y  V R  N         +LG G FG VYK +  +   L A KV+        E+++ E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 133 ASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQI 192
             ++   H N+V  L   Y +    ++ EF   G++D  + + E     R L    +  +
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVV 115

Query: 193 AVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA 252
                  L YLH     +I+H D+K  NIL   D   K++DFG++  + +          
Sbjct: 116 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-- 170

Query: 253 RGTIGYIAPEVF---CRNFGGVSHKSDVYSYGMMILEMVVGR 291
            GT  ++APEV            +K+DV+S G+ ++EM    
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 3e-52
 Identities = 66/299 (22%), Positives = 112/299 (37%), Gaps = 48/299 (16%)

Query: 78  YNYSDVKRMTNSFS-----------NKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSK 122
           + + D       F+             +G G FG V  G L         VA+K LK+  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 123 VNG--EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNI 180
                 +F++E + M +  H NV+   G   +     +I EFM NGSLD F+        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----- 121

Query: 181 NRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL- 239
           + +     +  +  GIA G++YL        VH D+   NIL+  +   K+SDFGL++  
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 240 --SEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVK 297
                  ++ S LG +  I + APE     +   +  SDV+SYG+++ E++   +     
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGE----- 231

Query: 298 VSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLE 345
                       +   IE                ++                 ++  L+
Sbjct: 232 --RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 4e-52
 Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 26/254 (10%)

Query: 92  NKLGQGGFGSVYKGKLPD---GRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVS 145
            +LG G FG+V KG        + VAVK+LKN   +    +E + E   M +  +  +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 146 FLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR 205
            +G C E +   L+ E    G L++++        NR ++ + + ++   ++ G++YL  
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLE- 124

Query: 206 GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPEVF 264
                 VH D+   N+LL      KISDFGL+K L   +  + +    +  + + APE  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG 324
                  S KSDV+S+G+++ E     +     +         + +   +E G       
Sbjct: 183 NY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPA 233

Query: 325 VVTEEEKEMAKKMI 338
               E  ++     
Sbjct: 234 GCPREMYDLMNLCW 247

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 2e-51
 Identities = 61/250 (24%), Positives = 93/250 (37%), Gaps = 19/250 (7%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLG 148
             LG+G +G V           VAVK++   +     E    E+      +H NVV F G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
              E   + L  E+   G L   I        +  +      +    +  G+ YLH    
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHG--- 121

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           I I H DIKP N+LL E    KISDFGLA +         +    GT+ Y+APE+  +  
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRR 180

Query: 269 GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTE 328
              +   DV+S G+++  M+ G    +       E           E          +  
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKIDS 234

Query: 329 EEKEMAKKMI 338
               +  K++
Sbjct: 235 APLALLHKIL 244

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 24/252 (9%)

Query: 93  KLGQGGFGSVYKGKL---PDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFL 147
           +LG G FGSV +G          VA+KVLK        EE + E   M +  +  +V  +
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
           G C + +   L+ E    G L +F+  +       ++    + ++   ++ G++YL    
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLE--- 126

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGA-RGTIGYIAPEVFCR 266
               VH D+   N+LL      KISDFGL+K     +S+ +   A +  + + APE    
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-- 184

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV 326
           NF   S +SDV+SYG+ + E +   +    K+           +   IE G   +     
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRMECPPEC 237

Query: 327 TEEEKEMAKKMI 338
             E   +     
Sbjct: 238 PPELYALMSDCW 249

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 2e-51
 Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 49/293 (16%)

Query: 90  FSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHV 141
           +   +G+G FG V++ + P         +VAVK+LK         +F  E A M++  + 
Sbjct: 17  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNIN------------------RK 183
           N+V  LG C   K   L++E+M  G L++F+       +                     
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 184 LEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK 243
           L       IA  +A G+ YL      + VH D+   N L+GE+   KI+DFGL++     
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE 303
           + + +       I ++ PE    N    + +SDV++YG+++ E+          ++    
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA---- 247

Query: 304 IYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLE 345
                 +  ++  GN          E   + +               +  +L+
Sbjct: 248 ---HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-51
 Identities = 53/238 (22%), Positives = 95/238 (39%), Gaps = 23/238 (9%)

Query: 93  KLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYE 152
            +G+G FG V++GK   G  VAVK+  + +        E+       H N++ F+    +
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 153 K----KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC- 207
                 +  L+ ++  +GSL  ++           +    M ++A+  A GL +LH    
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 208 ----NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISML--GARGTIGYIAP 261
                  I H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 262 EVFCRNF----GGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE 315
           EV   +          ++D+Y+ G++  E+        +        Y        +E
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-51
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 40/299 (13%)

Query: 69  NYVSLAPKRYNYS---DVKRMTNSFSNKLGQGGFGSVYKGKLPD------GRLVAVKVLK 119
            Y  +  + Y Y    +  R    F   LG G FG V                VAVK+LK
Sbjct: 17  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76

Query: 120 NSKVNGE--EFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDE- 175
               + E    ++E+  M++  SH N+V+ LG C       LI+E+   G L  ++  + 
Sbjct: 77  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136

Query: 176 ----------------ESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPH 219
                           E       L +  +   A  +A+G+E+L        VH D+   
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193

Query: 220 NILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYS 279
           N+L+      KI DFGLA+      +++    AR  + ++APE      G  + KSDV+S
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWS 251

Query: 280 YGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMI 338
           YG+++ E+     N    + + +        YK I+ G +       TEE   + +   
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKMDQPFYATEEIYIIMQSCW 304

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 6e-50
 Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 37/284 (13%)

Query: 82  DVKRMTNSFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNGE--EFINEVASM 135
               +   F+  +G+G FG VY G L D        AVK L      GE  +F+ E   M
Sbjct: 23  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 136 SKTSHVNVVSFLGFCYEKKKRA-LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAV 194
              SH NV+S LG C   +    ++  +M +G L  FI +E           + +    +
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGL 137

Query: 195 GIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE--SFISMLGA 252
            +A+G+       + + VH D+   N +L E F  K++DFGLA+    KE  S  +  GA
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 253 RGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYK 312
           +  + ++A E         + KSDV+S+G+++ E++         V+          I  
Sbjct: 195 KLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITV 245

Query: 313 HIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLE 345
           ++  G          +   E+  K              ++  + 
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 9e-50
 Identities = 70/316 (22%), Positives = 138/316 (43%), Gaps = 50/316 (15%)

Query: 75  PKRY---NYSDVKRMTNSFSNKLGQGGFGSVYKGKLPDG---RLVAVKVLK--NSKVNGE 126
           P  Y   +++D+K     F + +G+G FG V K ++         A+K +K   SK +  
Sbjct: 1   PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 127 EFINEVASMSK-TSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEE--------- 176
           +F  E+  + K   H N+++ LG C  +    L  E+ P+G+L  F+             
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 177 -SSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG 235
            +++    L  + +   A  +ARG++YL      + +H D+   NIL+GE++  KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172

Query: 236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAE 295
           L++    +E ++     R  + ++A E    N+   +  SDV+SYG+++ E+V       
Sbjct: 173 LSRG---QEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227

Query: 296 VKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEML 344
             ++          +Y+ +  G   +      +E  ++ ++              +L  L
Sbjct: 228 CGMT-------CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

Query: 345 EGSTEDLQIPPKPSLS 360
               E+ +     +L 
Sbjct: 281 NRMLEERKTYVNTTLY 296

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 5e-49
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 24/227 (10%)

Query: 67  IRNYVSLAPKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG 125
           +R+ VS+   +  Y+  +        K+GQG  G+VY    +  G+ VA++ +   +   
Sbjct: 9   LRSIVSVGDPKKKYTRFE--------KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 126 EE-FINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKL 184
           +E  INE+  M +  + N+V++L       +  ++ E++  GSL   +           +
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-------ETCM 113

Query: 185 EWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE 244
           +   +  +     + LE+LH     +++H DIK  NILLG D   K++DFG       ++
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           S  S +   GT  ++APEV  R       K D++S G+M +EM+ G 
Sbjct: 171 SKRSTM--VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGE 213

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 8e-49
 Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 36/277 (12%)

Query: 89  SFSNKLGQGGFGSVYKGKLPDG-----RLVAVKVLKNSKVNGE--EFINEVASMSKTSHV 141
           +    +G G FG VYKG L          VA+K LK      +  +F+ E   M + SH 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           N++   G   + K   +I E+M NG+LD+F+ ++     + +     +  +  GIA G++
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMK 124

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIA 260
           YL        VH D+   NIL+  +   K+SDFGL++ L +  E+  +  G +  I + A
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF 320
           PE    ++   +  SDV+S+G+++ E++   +    ++S        + + K I  G   
Sbjct: 182 PEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRL 232

Query: 321 QLAGVVTEEEKEMAKKMIL-----------VLEMLEG 346
                      ++  +              ++ +L+ 
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 7e-48
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 16/207 (7%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVV 144
           F   LG+G F +V   + L   R  A+K+L+   +  E        E   MS+  H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
                  + +K      +  NG L ++I            +          I   LEYLH
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRK------IGSFDETCTRFYTAEIVSALEYLH 125

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
                 I+H D+KP NILL ED   +I+DFG AK+   +          GT  Y++PE+ 
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                     SD+++ G +I ++V G 
Sbjct: 183 --TEKSACKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (412), Expect = 2e-47
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-EEFINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG V++      G   A K +     +  E    E+ +MS   H  +V+     
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            +  +  +IYEFM  G L + + DE     + K+      +    + +GL ++H      
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHENN--- 144

Query: 211 IVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            VH D+KP NI+         K+ DFGL    + K+S        GT  + APEV     
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEG-- 199

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
             V + +D++S G++   ++ G 
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGL 222

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-46
 Identities = 73/320 (22%), Positives = 126/320 (39%), Gaps = 42/320 (13%)

Query: 89  SFSNKLGQGGFGSVYKGK-LPDGRL----VAVKVLKNSKVNG--EEFINEVASMSKTSHV 141
                LG G FG+VYKG  +P+G      VA+K L+ +      +E ++E   M+   + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
           +V   LG C     + LI + MP G L  ++ +         +  + +    V IA+G+ 
Sbjct: 72  HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMN 125

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           YL    + R+VH D+   N+L+      KI+DFGLAKL   +E      G +  I ++A 
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ 321
           E         +H+SDV+SYG+ + E++         +         + I   +E G    
Sbjct: 183 ESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGERLP 233

Query: 322 LAGVVTEEEKEMAKKMIL-----------VLEMLEGSTED------LQIPPKPSLSSPRR 364
              + T +   +  K  +           ++        D      +Q   +  L SP  
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 293

Query: 365 SAQQSPPASLSTELASLESS 384
           S               +++ 
Sbjct: 294 SNFYRALMDEEDMDDVVDAD 313

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-46
 Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 35/284 (12%)

Query: 89  SFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVNGE--EFINEVASMSKTSH 140
           + S +LGQG FG VY+G             VA+K +  +    E  EF+NE + M + + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIY----DEESSNINRKLEWRTMCQIAVGI 196
            +VV  LG   + +   +I E M  G L  ++        ++ +        M Q+A  I
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
           A G+ YL      + VH D+   N ++ EDF  KI DFG+ +   + + +         +
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEP 316
            +++PE      G  +  SDV+S+G+++ E+    +     +S          + + +  
Sbjct: 200 RWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVME 250

Query: 317 GNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLEGSTE 349
           G          +   E+ +               ++  ++   E
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-46
 Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 25/252 (9%)

Query: 93  KLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSF 146
            +G+G FG V++G           VA+K  KN   +   E+F+ E  +M +  H ++V  
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
           +G   E     +I E    G L  F+           L+  ++   A  ++  L YL   
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLES- 126

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
              R VH DI   N+L+  + C K+ DFGL++  E    + +  G +  I ++APE    
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESI-- 181

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV 326
           NF   +  SDV+ +G+ + E+++             +    N +   IE G    +    
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGV-------KPFQGVKNNDVIGRIENGERLPMPPNC 234

Query: 327 TEEEKEMAKKMI 338
                 +  K  
Sbjct: 235 PPTLYSLMTKCW 246

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 9e-46
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 44/288 (15%)

Query: 90  FSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKVNGE--EFINEVASMSK-T 138
               LG+G FG V   +              VAVK+LK+     +  + I+E+  M    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 139 SHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD----------EESSNINRKLEWRT 188
            H N+++ LG C +     +I E+   G+L +++              S N   +L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 189 MCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS 248
           +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+     + +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPN 308
               R  + ++APE         +H+SDV+S+G+++ E+     +    V          
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 244

Query: 309 SIYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLE 345
            ++K ++ G+        T E   M +               ++E L+
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-45
 Identities = 67/287 (23%), Positives = 118/287 (41%), Gaps = 42/287 (14%)

Query: 90  FSNKLGQGGFGSVYKG------KLPDGRLVAVKVLKNSKVNGE--EFINEVASMSKTSH- 140
               LG+G FG V +       K    R VAVK+LK    + E    ++E+  +    H 
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 141 VNVVSFLGFCYEKKKR-ALIYEFMPNGSLDQFIYDEESSNINRK----------LEWRTM 189
           +NVV+ LG C +      +I EF   G+L  ++  + +  +  K          L    +
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 190 CQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISM 249
              +  +A+G+E+L    + + +H D+   NILL E    KI DFGLA+   K   ++  
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 250 LGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNS 309
             AR  + ++APE         + +SDV+S+G+++ E+     +    V +  E      
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------ 245

Query: 310 IYKHIEPGNEFQLAGVVTEEEKEMAKKMIL-----------VLEMLE 345
             + ++ G   +     T E  +                  ++E L 
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-45
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 92  NKLGQGGFGSVYKGKLP----DGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNV 143
            KLG G FG V +G+          VAVK LK   ++     ++FI EV +M    H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           +   G       + ++ E  P GSL   +   +           T+ + AV +A G+ YL
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYL 127

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
               + R +H D+   N+LL      KI DFGL + L +  + ++     +    + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGRK 292
                    SH SD + +G+ + EM    +
Sbjct: 185 SL--KTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 51/205 (24%), Positives = 82/205 (40%), Gaps = 14/205 (6%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE--FINEVASMSKTSHVNVVSF 146
           F + LG G F  V   +     +LVA+K +    + G+E    NE+A + K  H N+V+ 
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
                      LI + +  G L   I +            R   ++   +   ++YLH  
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
             +             L ED    ISDFGL+K+ +      +     GT GY+APEV  +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAPEVLAQ 183

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
                S   D +S G++   ++ G 
Sbjct: 184 --KPYSKAVDCWSIGVIAYILLCGY 206

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (391), Expect = 3e-44
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 89  SFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEE-------FINEVASMSKTSH 140
           S    +G+GGFG VY  +  D G++ A+K L   ++  ++           ++ +S    
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 141 VNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGL 200
             +V      +   K + I + M  G L   +        +       M   A  I  GL
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ------HGVFSEADMRFYAAEIILGL 120

Query: 201 EYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           E++H      +V+ D+KP NILL E    +ISD GLA    KK+   S+    GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV  +        +D +S G M+ +++ G 
Sbjct: 174 PEVLQKG-VAYDSSADWFSLGCMLFKLLRGH 203

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 9e-44
 Identities = 45/202 (22%), Positives = 84/202 (41%), Gaps = 16/202 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
            LG+G FG V++       +    K +K    +      E++ ++   H N++       
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
             ++  +I+EF+    + + I          +L  R +      +   L++LH      I
Sbjct: 72  SMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNI 123

Query: 212 VHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFG 269
            HFDI+P NI+         KI +FG A+  +  ++F  +        Y APEV      
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQH--D 178

Query: 270 GVSHKSDVYSYGMMILEMVVGR 291
            VS  +D++S G ++  ++ G 
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  150 bits (380), Expect = 2e-43
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 28/216 (12%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----------EEFINEVASMSKTS- 139
             LG+G    V +    P  +  AVK++  +              E  + EV  + K S 
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 140 HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
           H N++             L+++ M  G L  ++ +         L  +   +I   +   
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE------KVTLSEKETRKIMRALLEV 122

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYI 259
           +  LH+   + IVH D+KP NILL +D   K++DFG +   +  E    +    GT  Y+
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV---CGTPSYL 176

Query: 260 APEVF----CRNFGGVSHKSDVYSYGMMILEMVVGR 291
           APE+       N  G   + D++S G+++  ++ G 
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 17/203 (8%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE-FINEVASMSKTSHVNVVSFLGFC 150
           +LG G FG V++      GR+   K +       +    NE++ M++  H  +++     
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR 210
            +K +  LI EF+  G L   I  E     + K+    +         GL+++H      
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HS 147

Query: 211 IVHFDIKPHNILLGEDFCP--KISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           IVH DIKP NI+         KI DFGLA      E          T  + APE+  R  
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDR-- 202

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
             V   +D+++ G++   ++ G 
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGL 225

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 8e-42
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 19/208 (9%)

Query: 90  FSNKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKT-SHVNV 143
               LG+G FG V+  +     +  A+K LK   V  ++     + E   +S    H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                    K+    + E++  G L   I          K +       A  I  GL++L
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQS------CHKFDLSRATFYAAEIILGLQFL 119

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H      IV+ D+K  NILL +D   KI+DFG+ K +   ++  +     GT  YIAPE+
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEI 174

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                   +H  D +S+G+++ EM++G+
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQ 200

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 21/209 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVVSFL 147
            LG GG   V+  + L   R VAVKVL+            F  E  + +  +H  +V+  
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 148 GFCYEKKKRA----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
                +        ++ E++   +L   ++          +  +   ++     + L + 
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIEVIADACQALNFS 127

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK-LSEKKESFISMLGARGTIGYIAPE 262
           H+     I+H D+KP NI++      K+ DFG+A+ +++   S        GT  Y++PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                   V  +SDVYS G ++ E++ G 
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGE 211

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-41
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 29/225 (12%)

Query: 75  PKRYNYSDVKRMTNSFSNKLGQGGFGSVYKGKLPD-GRLVAVKVLKNSKVNGEEFINEVA 133
           P+  +Y+D K         +G G FG VY+ KL D G LVA+K +   K        E+ 
Sbjct: 17  PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 134 SMSKTSHVNVVSFLGFCYEKKKR------ALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
            M K  H N+V    F Y   ++       L+ +++P             S   + L   
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA---RHYSRAKQTLPVI 122

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESF 246
            +      + R L Y+H      I H DIKP N+LL  D    K+ DFG AK   + E  
Sbjct: 123 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +S + +R    Y APE+        +   DV+S G ++ E+++G+
Sbjct: 180 VSYICSR---YYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-40
 Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 11/204 (5%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLG 148
           + +G+G +G V       +   VA+K +   +     +  + E+  + +  H N++    
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
                    +   ++    +   +Y        + L    +C     I RGL+Y+H    
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA-- 128

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGAR-GTIGYIAPEVFCRN 267
             ++H D+KP N+LL      KI DFGLA++++        L     T  Y APE+   +
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
            G  +   D++S G ++ EM+  R
Sbjct: 188 KGY-TKSIDIWSVGCILAEMLSNR 210

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (357), Expect = 4e-40
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)

Query: 92  NKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
            K+G+G +G VYK +   G   A+K ++  K +       I E++ + +  H N+V    
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
             + KK+  L++E +           E        LE  T     + +  G+ Y H    
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD--- 118

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
            R++H D+KP N+L+  +   KI+DFGLA+                T+ Y AP+V     
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVL-MGS 175

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
              S   D++S G +  EMV G 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (356), Expect = 6e-40
 Identities = 36/210 (17%), Positives = 81/210 (38%), Gaps = 22/210 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           ++G+G FG +++G  L + + VA+K       +  +  +E  +    +    +  + +  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
           ++    ++   +   SL+  +         RK   +T+   A  +   ++ +H      +
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHE---KSL 122

Query: 212 VHFDIKPHNILLGEDFCP-----KISDFGLAKLSEKKES-----FISMLGARGTIGYIAP 261
           V+ DIKP N L+G           + DFG+ K      +     +       GT  Y++ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
                     S + D+ + G + +  + G 
Sbjct: 183 NTHLGR--EQSRRDDLEALGHVFMYFLRGS 210

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG------EEFINEVASMSKTSHVNVV 144
           + LG+G F +VYK +     ++VA+K +K    +          + E+  + + SH N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
             L     K   +L+++FM          +      +  L    +    +   +GLEYLH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
           +     I+H D+KP+N+LL E+   K++DFGLAK         +      T  Y APE+ 
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPEL- 171

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                      D+++ G ++ E+++  
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRV 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 3e-39
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)

Query: 92  NKLGQGGFGSVYKGK--LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTS---HVNV 143
            ++G+G +G V+K +     GR VA+K ++            I EVA +       H NV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 144 VSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYL 203
           V     C   +        +    +DQ +           +   T+  +   + RGL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 204 HRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEV 263
           H      +VH D+KP NIL+      K++DFGLA++   + +  S+     T+ Y APEV
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEV 186

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGR 291
             +     +   D++S G +  EM   +
Sbjct: 187 LLQ--SSYATPVDLWSVGCIFAEMFRRK 212

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (351), Expect = 6e-39
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 21/206 (10%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSF 146
             LG G FG V+  +   +GR  A+KVLK   V      E   +E   +S  +H  ++  
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
            G   + ++  +I +++  G L   +        +++         A  +   LEYLH  
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRK------SQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               I++ D+KP NILL ++   KI+DFG AK        +      GT  YIAPEV   
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEVVST 175

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGRK 292
                +   D +S+G++I EM+ G  
Sbjct: 176 --KPYNKSIDWWSFGILIYEMLAGYT 199

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 7e-39
 Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 15/204 (7%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFL 147
            K+G+G +G VYK +    G +VA+K ++            I E++ + + +H N+V  L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              + + K  L++EF+              ++    +    +      + +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMD-----ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
              ++H D+KP N+L+  +   K++DFGLA+         +      T+ Y APE+    
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC 177

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
               S   D++S G +  EMV  R
Sbjct: 178 -KYYSTAVDIWSLGCIFAEMVTRR 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 2e-38
 Identities = 47/254 (18%), Positives = 86/254 (33%), Gaps = 21/254 (8%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCY 151
           K+G G FG +Y G  +  G  VA+K+      +  +   E            +  + +C 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 152 EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRI 211
            +    ++   +   SL+           +RK   +T+  +A  +   +EY+H       
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHS---KNF 124

Query: 212 VHFDIKPHNIL---LGEDFCPKISDFGLAKLSEKKESFISMLGAR-----GTIGYIAPEV 263
           +H D+KP N L     +     I DFGLAK      +   +         GT  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 264 FCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA 323
                   S + D+ S G +++   +G    +   + +    +     K +    E  L 
Sbjct: 185 HLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VLC 241

Query: 324 GVVTEEEKEMAKKM 337
                E        
Sbjct: 242 KGYPSEFATYLNFC 255

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 5e-38
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG-------EEFINEVASMSKTSHVNVV 144
           +LG G F  V K +    G   A K +K  +          E+   EV+ + +  H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 145 SFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLH 204
           +       K    LI E +  G L  F+ +         L      +    I  G+ YLH
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYLH 130

Query: 205 RGCNIRIVHFDIKPHNILLGEDFCP----KISDFGLAKLSEKKESFISMLGARGTIGYIA 260
                 I HFD+KP NI+L +   P    KI DFGLA   +    F ++    GT  ++A
Sbjct: 131 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI---FGTPEFVA 184

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PE+   N+  +  ++D++S G++   ++ G 
Sbjct: 185 PEIV--NYEPLGLEADMWSIGVITYILLSGA 213

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-37
 Identities = 52/210 (24%), Positives = 77/210 (36%), Gaps = 24/210 (11%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTS--HVN 142
            LG GGFGSVY G  + D   VA+K ++  ++       NG     EV  + K S     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 143 VVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
           V+  L +        LI E             E        L+          +   + +
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRH 125

Query: 203 LHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
                N  ++H DIK  NIL+  +    K+ DFG   L +            GT  Y  P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           E   R        + V+S G+++ +MV G 
Sbjct: 179 EWI-RYHRYHGRSAAVWSLGILLYDMVCGD 207

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-37
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 24/214 (11%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFL 147
            K+GQG FG V+K +    G+ VA+K +             + E+  +    H NVV+ +
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 148 GFCYEKKKRA--------LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARG 199
             C  K            L+++F  +             N+  K     + ++   +  G
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLLNG 129

Query: 200 LEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKL--SEKKESFISMLGARGTIG 257
           L Y+HR    +I+H D+K  N+L+  D   K++DFGLA+     K            T+ 
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 258 YIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           Y  PE+            D++  G ++ EM    
Sbjct: 187 YRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRS 219

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-37
 Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 25/207 (12%)

Query: 94  LGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCY 151
           LG G  G V +          A+K+L++      +   EV    + S   ++V  +    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 152 ----EKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
                +K   ++ E +  G L   I D      ++    R   +I   I   ++YLH   
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGEAIQYLHS-- 129

Query: 208 NIRIVHFDIKPHNILL---GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVF 264
            I I H D+KP N+L      +   K++DFG AK +    S  +      T  Y+APEV 
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVL 185

Query: 265 CRNFGGVSHKSDVYSYGMMILEMVVGR 291
                      D++S G+++  ++ G 
Sbjct: 186 GP--EKYDKSCDMWSLGVIMYILLCGY 210

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-36
 Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEE----FINEVASMSKTSHVNVVSF 146
             LG+G FG V   +    GR  A+K+L+   +  ++     + E   +  T H  + + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 147 LGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRG 206
                   +   + E+   G L   +         R             I   LEYLH  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSR------ERVFTEERARFYGAEIVSALEYLHS- 123

Query: 207 CNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCR 266
               +V+ DIK  N++L +D   KI+DFGL K      + +      GT  Y+APEV   
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLED 179

Query: 267 NFGGVSHKSDVYSYGMMILEMVVGR 291
                    D +  G+++ EM+ GR
Sbjct: 180 --NDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 1e-35
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 16/205 (7%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFL 147
            K+G+G +G+V+K K      +VA+K ++   + +      + E+  + +  H N+V   
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
              +  KK  L++EF        F         N  L+   +      + +GL + H   
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
           +  ++H D+KP N+L+  +   K+++FGLA+         S      T+ Y  P+V    
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPPDVLFGA 176

Query: 268 FGGVSHKSDVYSYGMMILEMVVGRK 292
               S   D++S G +  E+    +
Sbjct: 177 -KLYSTSIDMWSAGCIFAELANAGR 200

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 31/225 (13%)

Query: 80  YSDVKRMTNSFSN--------KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFIN 130
           Y D +     + N        KLG+G +  V++   + +   V VK+LK  K   ++   
Sbjct: 21  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKR 78

Query: 131 EVASMSKTS-HVNVVSFLGFCYEKKKR--ALIYEFMPNGSLDQFIYDEESSNINRKLEWR 187
           E+  +       N+++      +   R  AL++E + N    Q           + L   
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDY 129

Query: 188 TMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCP-KISDFGLAKLSEKKESF 246
            +      I + L+Y H      I+H D+KPHN+++  +    ++ D+GLA+     + +
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

Query: 247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
              +    +  +  PE+   ++    +  D++S G M+  M+  +
Sbjct: 187 NVRV---ASRYFKGPEL-LVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (317), Expect = 9e-34
 Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 21/204 (10%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFL 147
            LG G FG V   K    G   A+K+L   KV      E  +NE   +   +   +V   
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 148 GFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC 207
               +     ++ E++  G +   +          +         A  I    EYLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQIVLTFEYLHS-- 159

Query: 208 NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRN 267
            + +++ D+KP N+L+ +    +++DFG AK  + +   +      GT   +APE+    
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIILS- 212

Query: 268 FGGVSHKSDVYSYGMMILEMVVGR 291
             G +   D ++ G++I EM  G 
Sbjct: 213 -KGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLK---NSKVNGEEFINEVASMSKTSHVNVVSFLG 148
            +G G +G+V        G  VA+K L     S++  +    E+  +    H NV+  L 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 149 FCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCN 208
                +      +F            +     + KL    +  +   + +GL Y+H    
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGI 142

Query: 209 IRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNF 268
           I   H D+KP N+ + ED   KI DFGLA+ ++ +     M G   T  Y APEV   N+
Sbjct: 143 I---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNW 193

Query: 269 GGVSHKSDVYSYGMMILEMVVGR 291
              +   D++S G ++ EM+ G+
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 9e-33
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 20/210 (9%)

Query: 92  NKLGQGGFGSVYKGKL----PDGRLVAVKVLKNSKVNG-----EEFINEVASMSKTSHV- 141
             LG G +G V+  +       G+L A+KVLK + +       E    E   +       
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 142 NVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
            +V+       + K  LI +++  G L   +          +     +      I   LE
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ------RERFTEHEVQIYVGEIVLALE 143

Query: 202 YLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAP 261
           +LH+   + I++ DIK  NILL  +    ++DFGL+K     E+  +     GTI Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAP 199

Query: 262 EVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           ++      G     D +S G+++ E++ G 
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 6e-32
 Identities = 47/211 (22%), Positives = 86/211 (40%), Gaps = 16/211 (7%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFC- 150
           KLG G F +V+  K + +   VA+K+++  KV  E   +E+  + + +  +         
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 151 ---------YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLE 201
                    +  K    ++  M    L + +        +R +    + QI+  +  GL+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 202 YLHRGCNIRIVHFDIKPHNILL-GEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIA 260
           Y+HR C   I+H DIKP N+L+   D    +    +A L            +  T  Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 261 PEVFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           PEV           +D++S   +I E++ G 
Sbjct: 198 PEVLLG--APWGCGADIWSTACLIFELITGD 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-29
 Identities = 54/209 (25%), Positives = 80/209 (38%), Gaps = 27/209 (12%)

Query: 93  KLGQGGFGSVYKGK-LPDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLG 148
            +G G  G V         R VA+K L     N    +    E+  M   +H N++S L 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 149 FC------YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
                    E +   L+ E M                I  +L+   M  +   +  G+++
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGIKH 134

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           LH    I   H D+KP NI++  D   KI DFGLA+ +              T  Y APE
Sbjct: 135 LHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPE 188

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           V      G     D++S G ++ EMV  +
Sbjct: 189 VILGM--GYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 92  NKLGQGGFGSVYKGK-LPDGRLVAVKVLKN---SKVNGEEFINEVASMSKTSHVNVVSFL 147
           + +G G +GSV        G  VAVK L     S ++ +    E+  +    H NV+  L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 148 GFCYEKKKRA-----LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEY 202
                 +         +   +    L+  +         +KL    +  +   I RGL+Y
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-------CQKLTDDHVQFLIYQILRGLKY 136

Query: 203 LHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPE 262
           +H    I   H D+KP N+ + ED   KI DFGLA+ ++ + +         T  Y APE
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPE 188

Query: 263 VFCRNFGGVSHKSDVYSYGMMILEMVVGR 291
           +   N+   +   D++S G ++ E++ GR
Sbjct: 189 IM-LNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 97.5 bits (242), Expect = 1e-24
 Identities = 32/210 (15%), Positives = 66/210 (31%), Gaps = 31/210 (14%)

Query: 88  NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-----------GEEFINEVASMS 136
           ++    +G+G   +V+           VK  K    +              F       +
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 137 KTSHVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGI 196
           +     +    G    K     +Y +  N  L + I  +       ++      ++   I
Sbjct: 62  RNEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAK----ELYRVRVENPDEVLDMI 112

Query: 197 ARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTI 256
              +   +      IVH D+  +N+L+  +    I DF  +     +E +  +L     +
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV-EVGEEGWREIL--ERDV 165

Query: 257 GYIAPEVFCRNFGGVSHKSDVYSYGMMILE 286
             I    F R +     + D+ S    IL+
Sbjct: 166 RNII-TYFSRTYR---TEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	386
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.26
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.05
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.69
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.25
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.37

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-55  Score=390.20  Aligned_cols=252  Identities=24%  Similarity=0.278  Sum_probs=207.5

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.+.||+|+||+||+|+. .+|+.||||++....  ...+.+.+|++++++++||||+++++++.+.+..|+|||||++
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g   87 (271)
T d1nvra_           8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence            3468899999999999987 468999999997543  2335789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        88 g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          88 GELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999543      5699999999999999999999998   999999999999999999999999999997755443


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                      .......+||+.|||||++.+. ..++.++|||||||++|||++|+.||.......      ..................
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~  231 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKK  231 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCTTSTTGGG
T ss_pred             cccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCCCCCcccc
Confidence            3334456799999999998764 235688999999999999999999997543211      111112222223334567


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      +++++.+++.+|+..++.-|++++++..||-
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         232 IDSAPLALLHKILVENPSARITIPDIKKDRW  262 (271)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            8999999999999999999999998887764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-55  Score=388.60  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecC----CCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||+||+|+.. +|+.||+|++.+    .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            345689999999999999874 689999999864    234557889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |++|+|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999653      5689999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...    ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+        +..+++.+..+. +.+
T Consensus       159 ~~~----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~-~~~  223 (263)
T d2j4za1         159 SRR----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE-FTF  223 (263)
T ss_dssp             CCC----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC-CCC
T ss_pred             Ccc----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-CCC
Confidence            432    245699999999999764  68999999999999999999999998653        245556665554 567


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      +..+++++++++.+|+..++.-|++++++..||
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp  256 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  256 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence            788999999999999999999999888776664

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-55  Score=390.08  Aligned_cols=253  Identities=22%  Similarity=0.349  Sum_probs=201.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEe--cCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYE--KKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  162 (386)
                      .+.+.||+|+||+||+|+. .+|+.||+|++.......   +.+.+|++++++++||||+++++++.+  .+..|+||||
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy   86 (269)
T d2java1           7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   86 (269)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence            4468899999999999986 468999999998655443   568899999999999999999999975  4567899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC--NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      |++|+|.+++....  .....+++..++.++.||+.||+|||++.  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~g~L~~~i~~~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          87 CEGGDLASVITKGT--KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             CTTEEHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             CCCCcHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            99999999986532  12357999999999999999999999861  124999999999999999999999999999877


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ......  .....||+.|+|||++.+.  .++.++|||||||++|||+||+.||...+.        .++...+..+...
T Consensus       165 ~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~~  232 (269)
T d2java1         165 NHDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKFR  232 (269)
T ss_dssp             -------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCC
T ss_pred             ccCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            554322  2345799999999999664  789999999999999999999999986432        4566667666666


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .++..+|+++++++.+|+..++.-|++++++..||
T Consensus       233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp  267 (269)
T d2java1         233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  267 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence            77888999999999999999999999988876665

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=388.25  Aligned_cols=244  Identities=24%  Similarity=0.354  Sum_probs=208.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecC----CCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKN----SKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++.+    .....+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            34568899999999999987 4689999999864    234457799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |++|+|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999998543      5699999999999999999999998   999999999999999999999999999997765


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ...........||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+        +..+.+++..+. +.+
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~-~~~  229 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLE-YDF  229 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTC-CCC
T ss_pred             CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCC-CCC
Confidence            4433333456799999999999764  78999999999999999999999998653        245566666554 567


Q ss_pred             cccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+++++++++.+||+.++.-|++++++
T Consensus       230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~  258 (288)
T d1uu3a_         230 PEKFFPKARDLVEKLLVLDATKRLGCEEM  258 (288)
T ss_dssp             CTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            78899999999999999999999998875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=384.02  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=209.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC-CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS-KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.++||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+.+..|+|||||++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            44568899999999999986 46999999998753 34567899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++..       ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       102 g~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999998754       3589999999999999999999998   999999999999999999999999999987654332


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC-ccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG-NEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~  324 (386)
                      .  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       ..+...+..+ .....+.
T Consensus       172 ~--~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~  240 (293)
T d1yhwa1         172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQNPE  240 (293)
T ss_dssp             C--BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCCSSGG
T ss_pred             c--ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCCCCCcc
Confidence            1  2345799999999999764  6899999999999999999999999754321       1122222111 1244567


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      .+++++++++.+|+..++.-|++++++..||--
T Consensus       241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            899999999999999999999999998887643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-54  Score=382.26  Aligned_cols=243  Identities=25%  Similarity=0.444  Sum_probs=199.6

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.++||+|+||+||+|.+.+++.||||+++......++|.+|++++++++||||++++|+|.+.+..++||||+++|+|
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            35678999999999999998889999999998877889999999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      .+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++........ .
T Consensus        88 ~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  158 (263)
T d1sm2a_          88 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S  158 (263)
T ss_dssp             HHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             HHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence            99986542     5688999999999999999999998   9999999999999999999999999999876554332 2


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhC-CCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG-RKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      .....||..|+|||++.+.  .++.++|||||||++|||+|| ++||....        ...+.+.+..+.....+..++
T Consensus       159 ~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~~i~~~~~~~~p~~~~  228 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFRLYKPRLAS  228 (263)
T ss_dssp             ------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHHHHHHTCCCCCCTTSC
T ss_pred             ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHhcCCCCCccccC
Confidence            2345689999999999764  789999999999999999995 55554321        244556666666666788899


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +++.+++.+|+..++.-|+++++
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~  251 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSR  251 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHH
Confidence            99999999999999988887654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-54  Score=386.35  Aligned_cols=249  Identities=27%  Similarity=0.428  Sum_probs=214.1

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ..+.+.++||+|+||+||+|.+. +|+.||||+++.+....++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            34456789999999999999875 58899999999887788899999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....    ...+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        97 ~g~l~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          97 YGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             TCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             CcchHHHhhhcc----ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999996542    25689999999999999999999998   99999999999999999999999999999776543


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      .. ...+..|++.|+|||++.+.  .++.++|||||||++|||++|..||.....       ...+++.+..+..+..+.
T Consensus       170 ~~-~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~~~~~~~~  239 (287)
T d1opja_         170 YT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMERPE  239 (287)
T ss_dssp             SE-EETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCCCT
T ss_pred             ce-eeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHHHHHhcCCCCCCCc
Confidence            32 23345688999999998764  789999999999999999998777653321       244566666666677888


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++++++++.+|+..++.-|+++.++
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei  266 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEI  266 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            999999999999999999999876654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=384.26  Aligned_cols=246  Identities=27%  Similarity=0.399  Sum_probs=210.3

Q ss_pred             hhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +.+.++||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||+++|++. .+..++||||+++|+
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred             eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCc
Confidence            4456889999999999999988899999999887778889999999999999999999999875 466799999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.||+.||+|||++   +|+||||||+||||++++.+||+|||+++........ 
T Consensus        94 L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-  165 (272)
T d1qpca_          94 LVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-  165 (272)
T ss_dssp             HHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred             HHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc-
Confidence            999886542    24689999999999999999999998   9999999999999999999999999999977654332 


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      ......||+.|+|||++.+.  .++.++|||||||++|||+||..|+....       ....+.+.+..+..+..+..++
T Consensus       166 ~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~~~~~i~~~~~~~~p~~~~  236 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLERGYRMVRPDNCP  236 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcCCCCCcccCh
Confidence            23356789999999998654  68999999999999999999765554321       1245667777777777888999


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +++.+++.+|+..++.-|++++++
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei  260 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYL  260 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHH
Confidence            999999999999999999876543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=374.60  Aligned_cols=243  Identities=25%  Similarity=0.416  Sum_probs=214.9

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCCH
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGSL  168 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  168 (386)
                      .+.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++||||++++|+|.+.+..++||||+++|+|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            35688999999999999998888999999998888889999999999999999999999999999999999999999999


Q ss_pred             HHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccceee
Q 038768          169 DQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFIS  248 (386)
Q Consensus       169 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  248 (386)
                      ..++....     ..+++..+++++.||++||.|||+.   +|+||||||+|||+++++.+||+|||+++........ .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  157 (258)
T d1k2pa_          87 LNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  157 (258)
T ss_dssp             HHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred             HHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence            99976543     5688999999999999999999998   9999999999999999999999999999876554332 2


Q ss_pred             eccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccCC
Q 038768          249 MLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVVT  327 (386)
Q Consensus       249 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~s  327 (386)
                      .....||..|+|||.+.+.  .++.++|||||||++|||+| |+.||.....        .++.+++..+.....+..++
T Consensus       158 ~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~~~  227 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLRLYRPHLAS  227 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCCCCCCTTCC
T ss_pred             ecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHhCCCCCCccccc
Confidence            3346689999999999764  78999999999999999998 8999986532        45667777777777888999


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCC
Q 038768          328 EEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       328 ~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +++++++.+|+..++.-|++.++
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~~e  250 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTFKI  250 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHH
Confidence            99999999999999999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=375.68  Aligned_cols=243  Identities=27%  Similarity=0.386  Sum_probs=204.1

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEec----CceeEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEK----KKRALIYE  161 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~lv~e  161 (386)
                      |.++||+|+||+||+|... +++.||+|++......   .+.+.+|+++|++++|||||++++++.+.    ...++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            4567999999999999874 6889999998764433   35688999999999999999999998763    45789999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeC-CCCceEEeeccCCc
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIR--IVHFDIKPHNILLG-EDFCPKISDFGLAK  238 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~  238 (386)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+++
T Consensus        93 ~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          93 LMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999653      5689999999999999999999997   6  99999999999996 57899999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN  318 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~  318 (386)
                      .......    ....||+.|||||++.+   .++.++|||||||++|||++|+.||.....       ...+.+.+..+.
T Consensus       164 ~~~~~~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~  229 (270)
T d1t4ha_         164 LKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGV  229 (270)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTC
T ss_pred             eccCCcc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCC
Confidence            6544322    24579999999999854   589999999999999999999999974321       244556666554


Q ss_pred             -cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          319 -EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       319 -~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       ...++..+++++++++.+|+..++.-|++++++..||
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  267 (270)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence             3456778899999999999999999999888876665

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=384.58  Aligned_cols=250  Identities=25%  Similarity=0.327  Sum_probs=209.1

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++|||||++|
T Consensus        15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence            3457899999999999986 468999999997643 33478899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|.+++....     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        95 ~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          95 AVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            9999986432     4699999999999999999999998   999999999999999999999999999976543321 


Q ss_pred             eeeccccCccccccccccchh---cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc--cc
Q 038768          247 ISMLGARGTIGYIAPEVFCRN---FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE--FQ  321 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~--~~  321 (386)
                       ......||+.|+|||++...   ...++.++|||||||++|||+||+.||.....        .++..++..+..  ..
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~~~~~~  236 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPTLA  236 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSCCCCCS
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence             12345799999999998432   23578999999999999999999999986532        233344433332  33


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+..+++++++++.+|++.++.-|++++++..||-
T Consensus       237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~  271 (288)
T d2jfla1         237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF  271 (288)
T ss_dssp             SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            46689999999999999999999999999887763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=379.89  Aligned_cols=249  Identities=28%  Similarity=0.400  Sum_probs=194.8

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.++||+|+||+||+|+++  ..||||+++....   ..+.|.+|+.++++++|||||+++|++. .+..++|||||++
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~   87 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEG   87 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCE
T ss_pred             EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCC
Confidence            44678999999999999864  3599999975432   3367899999999999999999999875 4568999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...+     ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+++.......
T Consensus        88 g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          88 SSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999996543     4689999999999999999999998   999999999999999999999999999987765443


Q ss_pred             eeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccc
Q 038768          246 FISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAG  324 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  324 (386)
                      ........||+.|||||++... .+.++.++|||||||++|||+||+.||.......   .....+.+..........+.
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHHTSCCCCGGGSCT
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCCCcchhccc
Confidence            3334456799999999998643 2358999999999999999999999998543210   11111222222222344567


Q ss_pred             cCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          325 VVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       325 ~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+++++++++.+|+..++..|+++.++
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~i  263 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQI  263 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            789999999999999999988876543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-53  Score=382.60  Aligned_cols=242  Identities=28%  Similarity=0.422  Sum_probs=192.8

Q ss_pred             hhccCcCCceEEEEEEeC-CC---cEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           91 SNKLGQGGFGSVYKGKLP-DG---RLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        91 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      .+.||+|+||+||+|.+. +|   ..||||.+......  .++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            468999999999999864 23   36899998754332  3579999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|+|.+++....     ..+++..++.++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus       111 ~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         111 NGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             TEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999886542     4689999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ce---eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          245 SF---ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       245 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ..   ....+..||+.|||||++.+  +.++.++|||||||++|||+| |+.||.....        ..+...+..+..+
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~~~  252 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDYRL  252 (299)
T ss_dssp             -------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCC
T ss_pred             CcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            22   12223467899999999865  378999999999999999998 8999976432        4556667666667


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+..+++++.+++.+|+..++.-|+++.+
T Consensus       253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~e  282 (299)
T d1jpaa_         253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQ  282 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            778889999999999999988888887544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-52  Score=381.73  Aligned_cols=245  Identities=25%  Similarity=0.331  Sum_probs=206.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh----HHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG----EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +...++||+|+||+||+|+. .+|+.||||++.......    +.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            44568899999999999986 468899999998654433    4688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      |++|+|..++...      ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          97 CLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             cCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999997766432      5689999999999999999999998   999999999999999999999999999986554


Q ss_pred             ccceeeeccccCccccccccccchh-cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc-cc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRN-FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN-EF  320 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~-~~  320 (386)
                      ..      ...||+.|||||++.+. .+.++.++|||||||++|||++|+.||.....        .....++..+. ..
T Consensus       168 ~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~~~~~  233 (309)
T d1u5ra_         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPA  233 (309)
T ss_dssp             BC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCC
T ss_pred             CC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence            32      35699999999998643 24688999999999999999999999975422        22333333333 23


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ..+..+|+++++++.+|+..++.-|++++++..||
T Consensus       234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence            34567899999999999999999999999887775

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.8e-53  Score=382.99  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=194.0

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.+.+.||+|+||+||+|... +|+.||||++.....  ....+.+|+.++++++||||+++++++.+.+..|+|||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            455688999999999999874 689999999976432  33567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCceEEeeccCCcccC
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSE  241 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~  241 (386)
                      +|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||+.   +++.+||+|||+++...
T Consensus        91 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          91 GGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             SCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             CCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999653      5699999999999999999999998   999999999999994   57899999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---  318 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---  318 (386)
                      ....   .....||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+..+.   
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~  228 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAEYEF  228 (307)
T ss_dssp             --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTCCCC
T ss_pred             CCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhccCCCC
Confidence            4432   2345699999999999764  689999999999999999999999986432        33444444333   


Q ss_pred             cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          319 EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       319 ~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .......+|+++++++.+|+..++.-|++++++..||-
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  266 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW  266 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            22345678999999999999999999999998877764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=375.82  Aligned_cols=239  Identities=25%  Similarity=0.406  Sum_probs=200.3

Q ss_pred             hccCcCCceEEEEEEeC---CCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ++||+|+||+||+|.+.   .++.||||+++....+   .++|.+|+++|++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999764   3468999999754332   3679999999999999999999999864 567899999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      |+|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            9999998653      5689999999999999999999998   999999999999999999999999999987655433


Q ss_pred             ee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          246 FI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       246 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .. ......||+.|+|||++.+.  .++.++|||||||++|||+| |+.||....        ..++...+..+..+..+
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~~~~p  232 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGERMGCP  232 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCCCCC
T ss_pred             ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHHHHHcCCCCCCC
Confidence            22 22345689999999998764  68999999999999999998 899998643        24566777777777888


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ..+++++.+++.+|+..++..||+..+
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~  259 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAA  259 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            999999999999999999999887654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=374.77  Aligned_cols=239  Identities=26%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             ccCcCCceEEEEEEeC---CCcEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCCC
Q 038768           93 KLGQGGFGSVYKGKLP---DGRLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        93 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  167 (386)
                      +||+|+||+||+|.+.   ++..||||+++....  ..++|.+|+++|++++|||||+++|+|.+ +..++|||||++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999763   355899999976432  23679999999999999999999999864 56899999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++...+     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        95 L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          95 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             HHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            999985432     5689999999999999999999998   99999999999999999999999999999776543322


Q ss_pred             -eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcccccccc
Q 038768          248 -SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGV  325 (386)
Q Consensus       248 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  325 (386)
                       ......||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        .++...+..+..+..+..
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~  236 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRMECPPE  236 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCCCCCCTT
T ss_pred             ccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCc
Confidence             22345689999999998654  78999999999999999998 9999986432        456677778877888899


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          326 VTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       326 ~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      +++++.+++.+|+..++.-||+..+
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~  261 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLT  261 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            9999999999999988888876543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=381.29  Aligned_cols=237  Identities=24%  Similarity=0.324  Sum_probs=205.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||+||+|+. .+|+.||||++++.    ....+.+.+|+.+|+.++||||+++++++.+.+..|+|||||
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~   87 (337)
T d1o6la_           8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence            4568999999999999986 57999999999752    334577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+++.....
T Consensus        88 ~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          88 NGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             TTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999998654      5689999999999999999999999   9999999999999999999999999999866443


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      ..  .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+.        ..+.+.+..+. +.++
T Consensus       159 ~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~-~~~p  225 (337)
T d1o6la_         159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-IRFP  225 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCCC
T ss_pred             Cc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCC-CCCC
Confidence            22  12346799999999999765  789999999999999999999999986532        44555555554 6678


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                      ..+|++++++|.+||+.++.-|.+
T Consensus       226 ~~~s~~~~dli~~~L~~dP~~R~~  249 (337)
T d1o6la_         226 RTLSPEAKSLLAGLLKKDPKQRLG  249 (337)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred             ccCCHHHHHHHHhhccCCchhhcc
Confidence            889999999999999998888864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-52  Score=378.12  Aligned_cols=242  Identities=27%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFM  163 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  163 (386)
                      .+.+.||+|+||+||+|+. .+|+.||||++++.    ....+.+.+|+.++++++||||+++++++.+.+..|+|||||
T Consensus         7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~   86 (316)
T d1fota_           7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   86 (316)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence            4568899999999999987 46999999999742    344578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  243 (386)
                      ++|+|..++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          87 EGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCcccccccccc------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999998654      5678899999999999999999998   9999999999999999999999999999876544


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccccc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLA  323 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  323 (386)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+.        .++.+++..+. ..++
T Consensus       158 ~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~-~~~p  221 (316)
T d1fota_         158 T-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE-LRFP  221 (316)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC-CCCC
T ss_pred             c-----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCC-CCCC
Confidence            3     246799999999999764  688999999999999999999999986532        44555555444 5567


Q ss_pred             ccCChHHHHHHHHHHHHHHHhcC-----CCCCCCCCC
Q 038768          324 GVVTEEEKEMAKKMILVLEMLEG-----STEDLQIPP  355 (386)
Q Consensus       324 ~~~s~~~~~li~~ml~v~~~L~~-----~~~~~~~~p  355 (386)
                      ..+++++++++.+|+..++.-|.     +++++..||
T Consensus       222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp  258 (316)
T d1fota_         222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  258 (316)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence            88999999999999998887774     566665555

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-51  Score=382.18  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=207.9

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.+.||+|+||+||+|+. .+|+.||||++..... ..+.+.+|+.+|++++|||||++++++.+.+..|+|||||++
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            45568899999999999986 4689999999976433 346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCceEEeeccCCcccCcc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE--DFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~  243 (386)
                      |+|.+++....     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       108 g~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         108 GELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999985432     4699999999999999999999998   9999999999999964  678999999999877655


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EF  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~  320 (386)
                      ...   ....||+.|||||++.+.  .++.++|||||||++|||++|+.||...+.        .++.+.+..+.   ..
T Consensus       180 ~~~---~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~  246 (350)
T d1koaa2         180 QSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDD  246 (350)
T ss_dssp             SCE---EEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSCC
T ss_pred             ccc---ceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc
Confidence            432   245699999999999764  688999999999999999999999976532        33444443332   23


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .....+|+++++++.+||..++.-|++++++..||
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp  281 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  281 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            34467899999999999999999999888876655

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=385.68  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=202.5

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC--CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK--VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      .+.++||+|+||+||+|.. .+|+.||+|+++...  ...+.+.+|+.+|++++|||||+++++|.+.+..++||||+++
T Consensus         9 ~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g   88 (322)
T d1s9ja_           9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   88 (322)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            3457899999999999986 468999999997543  2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      |+|.+++.+.      ..+++..++.++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        89 g~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          89 GSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             EEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            9999999653      468999999999999999999997 5   89999999999999999999999999998654332


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc-------------------
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY-------------------  305 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------------------  305 (386)
                          ....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........                   
T Consensus       160 ----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         160 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             ----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             ----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence                1245799999999999764  799999999999999999999999975432110000                   


Q ss_pred             ---------------chhhhhhhcCCCccccc-cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          306 ---------------FPNSIYKHIEPGNEFQL-AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       306 ---------------~~~~~~~~i~~~~~~~~-~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                                     ........+.....+.+ ...+|.++++++.+||..+|.-|++++++..||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence                           00001111111111222 234789999999999999999999988877665

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=383.39  Aligned_cols=254  Identities=27%  Similarity=0.371  Sum_probs=208.5

Q ss_pred             HHhhhhhccCcCCceEEEEEEeCC-C-----cEEEEEEecCC--CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCce
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLPD-G-----RLVAVKVLKNS--KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  156 (386)
                      ..+.+.++||+|+||+||+|++.. +     ..||+|.+...  ......+.+|+.++.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            344567899999999999998632 2     36999998653  33446789999999998 899999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccc-----------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESS-----------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPH  219 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~  219 (386)
                      ++|||||++|+|.++++.....                 .....+++..++.++.||+.||+|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            9999999999999999765321                 1124589999999999999999999998   9999999999


Q ss_pred             CeEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCccccc
Q 038768          220 NILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKV  298 (386)
Q Consensus       220 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~  298 (386)
                      |||++.++.+||+|||+++............+..||+.|||||++.+.  .++.++|||||||++|||+| |+.||....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999877665554444556789999999998764  78999999999999999998 899997543


Q ss_pred             ccCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          299 SLSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       299 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .       ...+.+.+..+..+..+..+++++++++.+|+..++.-|++++++
T Consensus       272 ~-------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         272 V-------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             C-------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             H-------HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            2       133445555555667788899999999999999999999876654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-51  Score=381.08  Aligned_cols=247  Identities=23%  Similarity=0.318  Sum_probs=208.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.+|++++||||+++++++.+.+..|+|||||++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            45568999999999999986 4699999999976432 345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCceEEeeccCCcccCcc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG--EDFCPKISDFGLAKLSEKK  243 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~  243 (386)
                      |+|.+++....     ..+++..++.++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+++.....
T Consensus       111 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         111 GELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             ChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99998875432     4699999999999999999999998   999999999999997  6789999999999987655


Q ss_pred             cceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---cc
Q 038768          244 ESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EF  320 (386)
Q Consensus       244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~  320 (386)
                      ...   ....||+.|+|||++.+.  .++.++|||||||++|||+||+.||.....        ..+...+..+.   ..
T Consensus       183 ~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~  249 (352)
T d1koba_         183 EIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWEFDE  249 (352)
T ss_dssp             SCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCCCCS
T ss_pred             Cce---eeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc
Confidence            432   234689999999999764  789999999999999999999999986532        33344443332   22


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .....+++++++++.+||..++..|++++++..||
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp  284 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  284 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            34567999999999999999999999888876665

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=372.74  Aligned_cols=247  Identities=24%  Similarity=0.344  Sum_probs=209.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC-------CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK-------VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++++..       ...+.+.+|+.+|++++|||||++++++.+.+..|+|
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45568899999999999987 468999999996532       2346799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----ceEEeecc
Q 038768          160 YEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF----CPKISDFG  235 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  235 (386)
                      ||||++|+|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        92 ~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          92 LELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999653      4699999999999999999999998   999999999999998776    49999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      +++.......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        .+....+.
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~  229 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVS  229 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence            9987755433   2345689999999999764  689999999999999999999999986532        33444444


Q ss_pred             CCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          316 PGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       316 ~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .+.   ....+..+|+++++++.+|+..++.-|++++++..||-
T Consensus       230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            443   23345678999999999999999999999988877663

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=373.64  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=204.5

Q ss_pred             HhhhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      .+.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++|+|. .+..++||||+++|
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g   96 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG   96 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCC
Confidence            34567899999999999999988889999999888778889999999999999999999999985 56689999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccce
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESF  246 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  246 (386)
                      +|..++....    ...++|..++.++.||+.||+|||++   +|+||||||+||||+.++++||+|||+++........
T Consensus        97 ~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          97 SLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             BHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             chhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999986542    24689999999999999999999998   9999999999999999999999999999876544322


Q ss_pred             eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          247 ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|..|+.....       ..++...+..+..+..+..+
T Consensus       170 -~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~~~~~~~~  239 (285)
T d1fmka3         170 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPEC  239 (285)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCTTS
T ss_pred             -eeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCCccc
Confidence             22345689999999999764  789999999999999999997666554321       24455666666667788899


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ++++++++.+|++.++.-|++++++
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i  264 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYL  264 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHH
Confidence            9999999999999888888877664

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=370.28  Aligned_cols=246  Identities=25%  Similarity=0.351  Sum_probs=209.0

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCC----CCChHHHHHHHHHhh-cCCCCccceEEEEEEecCceeEEEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNS----KVNGEEFINEVASMS-KTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      +.+.+.||+|+||+||+|+.. +|+.||||++++.    ....+.+..|..++. .++||||+++++++.+.+..|+|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            345689999999999999874 6899999999742    334456777777765 6899999999999999999999999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++...
T Consensus        84 y~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          84 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             ecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999653      5688999999999999999999998   99999999999999999999999999998665


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      .....  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+.        ..+++.+..+. +.
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~-~~  221 (320)
T d1xjda_         155 LGDAK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN-PF  221 (320)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CC
T ss_pred             ccccc--ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-CC
Confidence            43322  2345799999999999764  789999999999999999999999986532        45666665554 66


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCC-CCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTE-DLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~-~~~~~p  355 (386)
                      ++..+|+++++++++|+..++.-|++++ ++..||
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp  256 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  256 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence            7888999999999999999999998875 565554

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.7e-51  Score=375.93  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=207.6

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCC----CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNS----KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.++||+|+||+||+|+. .+|+.||||++.+.    ....+.+.+|+++|+.++||||+++++++.+....++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            44568999999999999987 46999999998642    33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +.+|+|..++...      ..+++..++.++.||+.||.|||+.   +||||||||+|||++.++.+||+|||+++....
T Consensus       123 ~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999654      4689999999999999999999998   999999999999999999999999999987754


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccccc
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQL  322 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  322 (386)
                      ..     ....||+.|||||++.+.  .++.++|||||||++|||+||+.||.....        ..+...+..+. +..
T Consensus       194 ~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~-~~~  257 (350)
T d1rdqe_         194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK-VRF  257 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-CCC
T ss_pred             cc-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCC-CCC
Confidence            32     245699999999999764  689999999999999999999999986432        44455555443 556


Q ss_pred             cccCChHHHHHHHHHHHHHHHhc-----CCCCCCCCCC
Q 038768          323 AGVVTEEEKEMAKKMILVLEMLE-----GSTEDLQIPP  355 (386)
Q Consensus       323 ~~~~s~~~~~li~~ml~v~~~L~-----~~~~~~~~~p  355 (386)
                      +..+++++.+++++||..++.-|     ++++++..||
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp  295 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence            77899999999999999887766     3566665555

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=365.77  Aligned_cols=245  Identities=26%  Similarity=0.412  Sum_probs=196.5

Q ss_pred             hhhccCcCCceEEEEEEeCCC-----cEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLPDG-----RLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      +.+.||+|+||+||+|.++++     ..||||+++.....  ..+|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            457899999999999986432     37999999754332  35689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCc
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  242 (386)
                      +.++++.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus        91 ~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          91 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999876542     5689999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcccc
Q 038768          243 KESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQ  321 (386)
Q Consensus       243 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~  321 (386)
                      .... .......||+.|+|||++.+.  .++.++|||||||++|||++|..|+....       ....+.+.+..+..+.
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~~~  233 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGFRLP  233 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHHhccCCCC
Confidence            3321 223345689999999998654  78999999999999999999766654331       1245667777777777


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      .+..+++++.+++.+|+..++..||++.++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ei  263 (283)
T d1mqba_         234 TPMDCPSAIYQLMMQCWQQERARRPKFADI  263 (283)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence            888899999999999999888888765543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.3e-50  Score=373.54  Aligned_cols=247  Identities=25%  Similarity=0.328  Sum_probs=202.2

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCC----CChHHHHH---HHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSK----VNGEEFIN---EVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.||+|+||.||+|+.. +|+.||||++.+..    .....+.+   |+.+++.++||||+++++++.+.+..|+||
T Consensus         7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm   86 (364)
T d1omwa3           7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   86 (364)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence            34688999999999999864 69999999986421    22333444   477788889999999999999999999999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      |||++|+|.+++...      ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          87 DLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             CCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999653      5688999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      .....    ....||+.|+|||++... ..++.++|||||||++|||+||+.||.......     ...+.+.+... .+
T Consensus       158 ~~~~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~-~~  226 (364)
T d1omwa3         158 SKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTM-AV  226 (364)
T ss_dssp             SSSCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSC-CC
T ss_pred             CCCcc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccC-CC
Confidence            55432    345699999999998643 368999999999999999999999998653211     12333333333 35


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCC-----CCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGST-----EDLQIPP  355 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~-----~~~~~~p  355 (386)
                      .++..+|++++++|.+||..++.-|++.     +++..||
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp  266 (364)
T d1omwa3         227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  266 (364)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence            6677899999999999999999999873     4554444

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.9e-50  Score=358.95  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=207.3

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----------hHHHHHHHHHhhcCC-CCccceEEEEEEecCce
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----------GEEFINEVASMSKTS-HVNVVSFLGFCYEKKKR  156 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  156 (386)
                      .+.+.||+|+||+||+|+. .+|+.||||++......          .+.+.+|+.++++++ ||||+++++++.+++..
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~   85 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   85 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence            4568899999999999986 57899999999764322          135789999999997 99999999999999999


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      |+|||||++|+|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        86 ~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999643      5699999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccceeeeccccCccccccccccchh----cCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhh
Q 038768          237 AKLSEKKESFISMLGARGTIGYIAPEVFCRN----FGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYK  312 (386)
Q Consensus       237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  312 (386)
                      ++.......   .....||+.|+|||.+.+.    ...++.++||||+||++|||++|+.||.....        ....+
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~  225 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLR  225 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHH
Confidence            987765432   2345699999999998642    23468899999999999999999999986532        33334


Q ss_pred             hcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          313 HIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       313 ~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      .+..+.   .......+|+++++++.+||+.++.-|++++++..||
T Consensus       226 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            443332   1223457999999999999999999999988877765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=371.71  Aligned_cols=247  Identities=20%  Similarity=0.290  Sum_probs=207.1

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPNG  166 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  166 (386)
                      |.+.+.||+|+||+||+|... +|+.||||+++........+.+|+++|+.++||||+++++++.+.+..|+|||||++|
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg   86 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence            345688999999999999874 6889999999876655667889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC--CceEEeeccCCcccCccc
Q 038768          167 SLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED--FCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       167 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~  244 (386)
                      +|.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.+  ..+||+|||+++......
T Consensus        87 ~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          87 DIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             BHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999996532     4689999999999999999999998   99999999999999854  589999999998765544


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCc---ccc
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGN---EFQ  321 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~---~~~  321 (386)
                      ..   ....+|+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.....        ..+...|..+.   ...
T Consensus       159 ~~---~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         159 NF---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             EE---EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHH
T ss_pred             cc---cccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCChh
Confidence            32   234589999999998664  689999999999999999999999986532        34445554333   122


Q ss_pred             ccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          322 LAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       322 ~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....+|+++++++.+|+..++.-|++++++..||
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp  259 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            3446899999999999999999998877765443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=363.72  Aligned_cols=245  Identities=24%  Similarity=0.383  Sum_probs=195.3

Q ss_pred             HhhhhhccCcCCceEEEEEEeCC----CcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLPD----GRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.+.||+|+||+||+|.+..    +..||||.++.....  .+.+.+|+.++++++||||++++|+|. .+..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence            34567899999999999998642    357899998754332  357899999999999999999999985 56789999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++|+|.+++....     ..+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        87 E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          87 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999875532     5689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          241 EKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ...... ......||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        .++.+.+..+..
T Consensus       159 ~~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i~~~~~  227 (273)
T d1mp8a_         159 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGER  227 (273)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCC
T ss_pred             cCCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            544332 22345689999999999764  78999999999999999998 8999986533        456667777777


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..+++++++++.+|+..++.-|++++++
T Consensus       228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei  259 (273)
T d1mp8a_         228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  259 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            77888999999999999999999999876543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=357.96  Aligned_cols=238  Identities=26%  Similarity=0.439  Sum_probs=197.8

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEec-CceeEEEEeCCCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEK-KKRALIYEFMPNGS  167 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gs  167 (386)
                      .+.+.||+|+||.||+|.+ .|+.||||+++++ ...+.+.+|++++++++||||++++|+|.+. +..++||||+++|+
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            4568899999999999998 5789999999764 3457899999999999999999999999654 56899999999999


Q ss_pred             HHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccccee
Q 038768          168 LDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKESFI  247 (386)
Q Consensus       168 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  247 (386)
                      |.+++....    ...+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.......  
T Consensus        88 L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~--  158 (262)
T d1byga_          88 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--  158 (262)
T ss_dssp             HHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCc--
Confidence            999996532    24589999999999999999999998   999999999999999999999999999986554322  


Q ss_pred             eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccccccccC
Q 038768          248 SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEFQLAGVV  326 (386)
Q Consensus       248 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  326 (386)
                         ...++..|+|||++.+.  .++.++|||||||++|||+| |+.||.....        ..+...+..+..+.++..+
T Consensus       159 ---~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i~~~~~~~~~~~~  225 (262)
T d1byga_         159 ---TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPDGC  225 (262)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTTTCCCCCCTTC
T ss_pred             ---cccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCCCCccC
Confidence               34578999999998764  78999999999999999998 6777775422        4566777777778889999


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          327 TEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       327 s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ++++++++.+|+..++.-|+++.+
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~  249 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQ  249 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHH
Confidence            999999999999999999887654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=367.16  Aligned_cols=244  Identities=28%  Similarity=0.443  Sum_probs=199.9

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCc----EEEEEEecCC--CCChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGR----LVAVKVLKNS--KVNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  161 (386)
                      .+.+.||+|+||+||+|.+. +|+    .||+|.++..  ....++|.+|++++++++|||||+++|+|.+ +..++++|
T Consensus        12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e   90 (317)
T d1xkka_          12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQ   90 (317)
T ss_dssp             EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEE
Confidence            44588999999999999863 444    6899988653  3345789999999999999999999999976 45778899


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+.+|+|.+++....     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          91 LMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             CCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            999999999886542     5689999999999999999999998   99999999999999999999999999999876


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhcCCCccc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHIEPGNEF  320 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~  320 (386)
                      ............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||+....        .++...+..+..+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~  232 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  232 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHHHHHHTCCC
T ss_pred             cccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            65444444456789999999999764  78999999999999999998 7888876532        3455566666666


Q ss_pred             cccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          321 QLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       321 ~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+++++.+++.+|+..++.-|++..++
T Consensus       233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  263 (317)
T d1xkka_         233 PQPPICTIDVYMIMVKCWMIDADSRPKFREL  263 (317)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence            7788899999999999999999999876654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-50  Score=364.93  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             hhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.++||+|+||+||+|++.      +++.||||+++.....  .++|.+|++++++++||||++++++|.+.+..++|
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            345689999999999999863      3578999999764333  35799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccc------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 038768          160 YEFMPNGSLDQFIYDEESS------------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNI  221 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Ni  221 (386)
                      |||+++|+|.+++......                  .....+++..++.++.|++.||+|||++   ++|||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence            9999999999999653211                  1123588999999999999999999998   999999999999


Q ss_pred             EeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC-CCccccccc
Q 038768          222 LLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR-KNAEVKVSL  300 (386)
Q Consensus       222 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~  300 (386)
                      |++.++.+||+|||+++...............|++.|+|||.+.+.  .++.++|||||||++|||++|. .||....  
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~--  247 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA--  247 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCC--
Confidence            9999999999999999876555444444456789999999999764  7999999999999999999996 5676542  


Q ss_pred             CCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          301 SSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       301 ~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                            +.++...+.++..+..+..+++++.+++.+|+..++.-|+++.+
T Consensus       248 ------~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         248 ------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             ------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence                  24566777777777788899999999999999999998887654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=363.06  Aligned_cols=253  Identities=22%  Similarity=0.290  Sum_probs=197.5

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC------hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN------GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      +.||+|+||+||+|+. .+|+.||||+++.....      .+.+.+|+.++++++|||||++++++.+.+..|+||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999986 46899999999753321      2468899999999999999999999999999999999998


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      ++++..+...      ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~~~~~~~------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          84 TDLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEHHHHHTTC------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             chHHhhhhhc------ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            8877766633      25688899999999999999999998   99999999999999999999999999998765543


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------cccchhh---
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EIYFPNS---  309 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~~~~~~---  309 (386)
                      ..  .....||+.|+|||++... ..++.++|||||||++|||++|+.||......+.            ...++..   
T Consensus       155 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 RA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             CC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             cc--ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            21  2345699999999998654 3679999999999999999999999975432110            0000000   


Q ss_pred             ----hhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          310 ----IYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       310 ----~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                          .++.........+...+++++.+++.+||+.++.-|++++++..||-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence                00000000011223467899999999999999999999998877763

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=364.28  Aligned_cols=244  Identities=23%  Similarity=0.288  Sum_probs=196.3

Q ss_pred             hccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhc-CCCCccceEEEEEEe----cCceeEEEEeCCC
Q 038768           92 NKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSK-TSHVNVVSFLGFCYE----KKKRALIYEFMPN  165 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e~~~~  165 (386)
                      +.||+|+||+||+|.. .+|+.||||+++.    ...+.+|+.++.+ .+||||+++++++.+    ....|+|||||++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            4699999999999986 5689999999974    3567889998755 589999999999876    4568999999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE---DFCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~  242 (386)
                      |+|.+++....    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++....
T Consensus        94 g~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          94 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             EEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence            99999996532    24689999999999999999999998   9999999999999985   56799999999987655


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc---
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE---  319 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~---  319 (386)
                      ...   .....||+.|+|||++.+.  .++.++|||||||++|+|+||+.||.......    ....+...+..+..   
T Consensus       167 ~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~----~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         167 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSSCC
T ss_pred             CCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH----HHHHHHHHHhcCCCCCC
Confidence            433   2345799999999999765  68999999999999999999999998654322    11222233333321   


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ......+|+++++++++||..++.-|+++.++..||
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  273 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  273 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            112346899999999999999999999888776554

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=352.98  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=191.6

Q ss_pred             hhhhccCcCCceEEEEEEeC--CC--cEEEEEEecCCCC----ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP--DG--RLVAVKVLKNSKV----NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIY  160 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  160 (386)
                      .+.+.||+|+||+||+|++.  ++  ..||||+++....    ..++|.+|+.++++++||||++++|+|.+ ...++||
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~   89 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT   89 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence            45678999999999999853  23  3789999875432    23578999999999999999999999965 5678999


Q ss_pred             EeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          161 EFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      ||+++|+|.+++....     ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        90 e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             ECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999886542     5699999999999999999999998   9999999999999999999999999999977


Q ss_pred             Cccccee-eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcccchhhhhhhc-CCC
Q 038768          241 EKKESFI-SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEIYFPNSIYKHI-EPG  317 (386)
Q Consensus       241 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~i-~~~  317 (386)
                      ....... ......|+..|+|||++.+.  .++.++|||||||++|||+| |+.||...+.        .++...+ ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEG  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCC
Confidence            5543322 22334578899999999764  78999999999999999998 8999986533        3333343 444


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+..+++++++++.+|+..++..||+..++
T Consensus       232 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei  265 (273)
T d1u46a_         232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  265 (273)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            5566778899999999999999999999876543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=356.27  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=200.2

Q ss_pred             hhhhccCcCCceEEEEEEeCCC----cEEEEEEecCCCC--ChHHHHHHHHHhhcCCCCccceEEEEEEec-CceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDG----RLVAVKVLKNSKV--NGEEFINEVASMSKTSHVNVVSFLGFCYEK-KKRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e  161 (386)
                      +|.++||+|+||+||+|.+.++    ..||||+++....  ..++|.+|++++++++||||++++|+|.+. ...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999986432    2699999975332  236799999999999999999999998765 57899999


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      ||++|+|.+++....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus       110 ~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EeecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            999999999986543     4577888999999999999999998   99999999999999999999999999998765


Q ss_pred             ccccee--eeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCCcc
Q 038768          242 KKESFI--SMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPGNE  319 (386)
Q Consensus       242 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~~~  319 (386)
                      ......  ......||..|+|||.+...  .++.++||||||+++|||+||+.||.....       ...+...+..+..
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i~~g~~  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRR  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCC
T ss_pred             ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCC
Confidence            443221  22345689999999998654  789999999999999999998888865422       1233445555666


Q ss_pred             ccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          320 FQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       320 ~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +..+..+++++.+++.+|+..++..||++.++
T Consensus       253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei  284 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL  284 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            67788899999999999999998888876544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=356.82  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=207.3

Q ss_pred             HhhhhhccCcCCceEEEEEEeC--------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecCc
Q 038768           87 TNSFSNKLGQGGFGSVYKGKLP--------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKKK  155 (386)
Q Consensus        87 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  155 (386)
                      .+.+.+.||+|+||.||+|+..        ++..||||+++.....  ..++.+|...+.++ +|||||+++++|.+++.
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            3455688999999999999752        2347999999765432  36788899998888 79999999999999999


Q ss_pred             eeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 038768          156 RALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~  225 (386)
                      .++||||+++|+|.+++......          .....+++..++.++.||+.||+|||+.   ++|||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence            99999999999999999765321          1235689999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHh-CCCCcccccccCCcc
Q 038768          226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVV-GRKNAEVKVSLSSEI  304 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  304 (386)
                      ++.+||+|||+++...............|++.|+|||.+.+.  .++.++|||||||++|||++ |+.||.....     
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            999999999999977665444444456789999999999764  79999999999999999998 6888875432     


Q ss_pred             cchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          305 YFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       305 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                         ..+++.+..+..+..+..+++++++++.+|++.++.-|+++.++
T Consensus       244 ---~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei  287 (299)
T d1fgka_         244 ---EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  287 (299)
T ss_dssp             ---HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence               55677777888888899999999999999999999999876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=360.90  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=197.0

Q ss_pred             HHhhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEecC-c
Q 038768           86 MTNSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYEKK-K  155 (386)
Q Consensus        86 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~  155 (386)
                      ..+.+.++||+|+||.||+|.+.      +++.||||+++.....  .+.+.+|...+.++ +|+||+.+++++.+.+ .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            34556789999999999999852      3468999999754332  35678888888776 6899999999987654 5


Q ss_pred             eeEEEEeCCCCCHHHHhcccccc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 038768          156 RALIYEFMPNGSLDQFIYDEESS----------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE  225 (386)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~  225 (386)
                      .++|||||++|+|.+++......          .....+++..++.++.||+.||+|||++   +|+||||||+|||+++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            78999999999999999764321          1124589999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC-CCcccccccCCcc
Q 038768          226 DFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR-KNAEVKVSLSSEI  304 (386)
Q Consensus       226 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~  304 (386)
                      ++.+||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+||. .||.....     
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-----  242 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----  242 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-----
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCH-----
Confidence            999999999999876655444344456799999999999764  7899999999999999999975 57764422     


Q ss_pred             cchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          305 YFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       305 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                        ...+.+.+..+..+..+..+++++.+++.+|+..++.-|++++++
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ei  287 (299)
T d1ywna1         243 --DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  287 (299)
T ss_dssp             --SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence              234455566666677788899999999999999999988876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3e-48  Score=348.99  Aligned_cols=241  Identities=21%  Similarity=0.297  Sum_probs=191.2

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC----hHHHHHHHHHhhcCCCCccceEEEEEEecCc----eeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN----GEEFINEVASMSKTSHVNVVSFLGFCYEKKK----RAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~l  158 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||+++.....    .+.+.+|+++++.++||||+++++++.+.+.    .|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            34568899999999999986 57999999999865432    2468899999999999999999999987653    789


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+++++|.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++..+++|||.+.
T Consensus        89 vmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            99999999999988543      5689999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCcccc-eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          239 LSEKKES-FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       239 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ....... ........||+.|+|||++.+.  .++.++|||||||++|||+||+.||......       ....+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~  230 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRED  230 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcC
Confidence            6543322 1223345799999999998764  7899999999999999999999999865321       2222333333


Q ss_pred             cc--ccccccCChHHHHHHHHHHHHHHHhcC
Q 038768          318 NE--FQLAGVVTEEEKEMAKKMILVLEMLEG  346 (386)
Q Consensus       318 ~~--~~~~~~~s~~~~~li~~ml~v~~~L~~  346 (386)
                      ..  ......+|+++++++.+|+..++.-|+
T Consensus       231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~  261 (277)
T d1o6ya_         231 PIPPSARHEGLSADLDAVVLKALAKNPENRY  261 (277)
T ss_dssp             CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCchhccCCCHHHHHHHHHHccCCHhHCH
Confidence            22  234567899999999999999999887

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=359.43  Aligned_cols=257  Identities=26%  Similarity=0.366  Sum_probs=210.2

Q ss_pred             HHHHHHhhhhhccCcCCceEEEEEEe------CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcC-CCCccceEEEEEEe
Q 038768           82 DVKRMTNSFSNKLGQGGFGSVYKGKL------PDGRLVAVKVLKNSKVN--GEEFINEVASMSKT-SHVNVVSFLGFCYE  152 (386)
Q Consensus        82 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~  152 (386)
                      |+....+.+.++||+|+||.||+|++      .+++.||||+++.....  ..++.+|+.+++.+ +|||||+++|+|.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            34444556778999999999999975      24568999999865432  35688999999999 69999999999999


Q ss_pred             cCceeEEEEeCCCCCHHHHhcccccc------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 038768          153 KKKRALIYEFMPNGSLDQFIYDEESS------------NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHN  220 (386)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~N  220 (386)
                      .+..++|||||++|+|.++++.....            .....+++..+..++.||+.||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            99999999999999999999764321            1224689999999999999999999999   99999999999


Q ss_pred             eEeCCCCceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhC-CCCcccccc
Q 038768          221 ILLGEDFCPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVG-RKNAEVKVS  299 (386)
Q Consensus       221 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~  299 (386)
                      ||++.++.+|++|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+|+ ++||.....
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987765554445567799999999999754  789999999999999999995 555544322


Q ss_pred             cCCcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          300 LSSEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       300 ~~~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                             ...+.+.+..+..+..+..+++++.+++.+|+..++.-|+++++
T Consensus       254 -------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         254 -------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             -------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence                   13344455555556677889999999999999998888887654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=354.45  Aligned_cols=239  Identities=25%  Similarity=0.305  Sum_probs=198.9

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC-------ChHHHHHHHHHhhcCC--CCccceEEEEEEecCcee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV-------NGEEFINEVASMSKTS--HVNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  157 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++++...       ....+.+|+.++++++  ||||+++++++.+.+..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            34568899999999999986 4789999999975321       1234678999999986  899999999999999999


Q ss_pred             EEEEeCCC-CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCceEEeecc
Q 038768          158 LIYEFMPN-GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-DFCPKISDFG  235 (386)
Q Consensus       158 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg  235 (386)
                      +||||+.+ +++.+++...      ..+++..++.++.||+.||+|||++   +|+||||||+|||++. ++.+||+|||
T Consensus        86 lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999975 6788887543      5689999999999999999999998   9999999999999985 5799999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      +++......    .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....          .+.+.  
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~--  219 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRG--  219 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHC--
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCch----------HHhhc--
Confidence            998665432    2345699999999998764 245778999999999999999999997542          22111  


Q ss_pred             CCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          316 PGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       316 ~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                         ...++..+|+++++++.+|+..++..|++++++..||
T Consensus       220 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp  256 (273)
T d1xwsa_         220 ---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  256 (273)
T ss_dssp             ---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ---ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence               1345677899999999999999999999999887775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=356.04  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=202.6

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCc--EEEEEEecCC--CCChHHHHHHHHHhhcC-CCCccceEEEEEEecCceeEEEEe
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGR--LVAVKVLKNS--KVNGEEFINEVASMSKT-SHVNVVSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  162 (386)
                      .+.++||+|+||+||+|.+. +|.  .||||.++..  ....++|.+|+++|.++ +||||++++|+|.+.+..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            34688999999999999874 344  5788887643  23446799999999998 799999999999999999999999


Q ss_pred             CCCCCHHHHhccccc----------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEe
Q 038768          163 MPNGSLDQFIYDEES----------SNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKIS  232 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  232 (386)
                      +++|+|.++++....          ......+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence            999999999976421          12236799999999999999999999998   99999999999999999999999


Q ss_pred             eccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCC-CcccccccCCcccchhhhh
Q 038768          233 DFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRK-NAEVKVSLSSEIYFPNSIY  311 (386)
Q Consensus       233 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~  311 (386)
                      |||+++.......   .....||..|+|||.+.+.  .++.++|||||||++|||++|.. ||....        ...+.
T Consensus       170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~~  236 (309)
T d1fvra_         170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY  236 (309)
T ss_dssp             CTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred             ccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHHH
Confidence            9999986544322   2244689999999999764  78999999999999999999764 666442        35566


Q ss_pred             hhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          312 KHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       312 ~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      +.+..+..+..+..+++++++++.+|+..++.-|++++++
T Consensus       237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei  276 (309)
T d1fvra_         237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  276 (309)
T ss_dssp             HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            7777777788888999999999999999888888876554

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=355.15  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=209.9

Q ss_pred             hhhhhccCcCCceEEEEEEeC------CCcEEEEEEecCCCCCh--HHHHHHHHHhhcCCCCccceEEEEEEecCceeEE
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP------DGRLVAVKVLKNSKVNG--EEFINEVASMSKTSHVNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  159 (386)
                      +.+.++||+|+||+||+|.+.      +++.||||+++......  ..|.+|++++++++||||++++|+|...+..++|
T Consensus        22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv  101 (308)
T d1p4oa_          22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  101 (308)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence            345688999999999999763      35789999997643322  4588999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcccccc----cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeecc
Q 038768          160 YEFMPNGSLDQFIYDEESS----NINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFG  235 (386)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  235 (386)
                      |||+++|+|.+++......    .....+++..+..++.|++.||.|||++   +|+||||||+|||+++++++||+|||
T Consensus       102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecc
Confidence            9999999999998654211    1123478999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCC-CCcccccccCCcccchhhhhhhc
Q 038768          236 LAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGR-KNAEVKVSLSSEIYFPNSIYKHI  314 (386)
Q Consensus       236 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~i  314 (386)
                      +++...............||+.|+|||.+.+.  .++.++||||||+++|||+||. .||....        ..++.+.+
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~~~~~i  248 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQVLRFV  248 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHHHHHHH
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH
Confidence            99977665554444456789999999998764  7899999999999999999985 6675442        24556667


Q ss_pred             CCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCC
Q 038768          315 EPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDL  351 (386)
Q Consensus       315 ~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~  351 (386)
                      ..+..+..+..+++++.+++.+|++.++.-||+++++
T Consensus       249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i  285 (308)
T d1p4oa_         249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  285 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            6777677788899999999999999988888876554

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=353.99  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=198.7

Q ss_pred             hhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCC---ChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKV---NGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ..++||+|+||+||+|+. .+|+.||||+++....   ..+.+.+|++++++++||||+++++++.+.+..|+||||+.+
T Consensus         6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~   85 (298)
T d1gz8a_           6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ   85 (298)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence            457899999999999986 5689999999975432   346889999999999999999999999999999999999965


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                       ++..++....    ...+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+++.......
T Consensus        86 -~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          86 -DLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             -EHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             -chhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence             4445543321    25699999999999999999999998   999999999999999999999999999986654332


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC------------Ccccchhhh---
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS------------SEIYFPNSI---  310 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~------------~~~~~~~~~---  310 (386)
                        ......||+.|+|||.+... ..++.++|||||||++|+|++|+.||...+...            .+..++...   
T Consensus       158 --~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              22345699999999998654 356899999999999999999999997543210            000010000   


Q ss_pred             -----hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          311 -----YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       311 -----~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                           ...............+|+++++++.+||..++.-|++++++..||-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f  285 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF  285 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence                 0000111111223467899999999999999999999998877754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.7e-48  Score=348.91  Aligned_cols=255  Identities=24%  Similarity=0.288  Sum_probs=200.0

Q ss_pred             hhhhccCcCCceEEEEEEeCCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCCC
Q 038768           89 SFSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      ...++||+|+||+||+|+.++|+.||||+++...   ...+.+.+|+.+|++++||||+++++++.+.+..++++||+.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            3457899999999999999899999999997643   2346899999999999999999999999999999999999977


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCcccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKES  245 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  245 (386)
                      +.+..+...      ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||.+........
T Consensus        85 ~~~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          85 DLKKLLDVC------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EHHHHHHTS------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             hhHHHHHhh------cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            766666533      25699999999999999999999998   999999999999999999999999999987654322


Q ss_pred             eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC------------cccchhh--h-
Q 038768          246 FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS------------EIYFPNS--I-  310 (386)
Q Consensus       246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------------~~~~~~~--~-  310 (386)
                        ......+++.|+|||.+.+. ..++.++|||||||++|||++|+.||...+..+.            ...++..  . 
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence              12234588999999998754 4679999999999999999999999975421100            0000000  0 


Q ss_pred             -----hhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          311 -----YKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       311 -----~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                           ...............+++++.+++.+||+.++.-|++++++..||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                 000011112234567899999999999999999999988877665

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=348.44  Aligned_cols=256  Identities=23%  Similarity=0.338  Sum_probs=197.3

Q ss_pred             hhhhhccCcCCceEEEEEEe-CC-CcEEEEEEecCC---CCChHHHHHHHHHhhcC---CCCccceEEEEEEec-----C
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PD-GRLVAVKVLKNS---KVNGEEFINEVASMSKT---SHVNVVSFLGFCYEK-----K  154 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~  154 (386)
                      +.+.++||+|+||+||+|+. .+ ++.||||+++..   ......+.+|+.+++.+   +||||++++++|...     .
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            34457899999999999986 33 678999998642   22334566777776655   799999999998643     4


Q ss_pred             ceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeec
Q 038768          155 KRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDF  234 (386)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  234 (386)
                      ..+++|||++++++.......     ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             eEEEEEEeccCCchhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence            678999999887765554332     25688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccC-------------
Q 038768          235 GLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLS-------------  301 (386)
Q Consensus       235 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-------------  301 (386)
                      |+++.......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......             
T Consensus       161 g~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         161 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhhhhccccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            99986654432   2356799999999999764  78999999999999999999999997553210             


Q ss_pred             -----CcccchhhhhhhcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          302 -----SEIYFPNSIYKHIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       302 -----~~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                           .....+...+..........+...+++++++++.+||..+|.-|++++++..||-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence                 0011111111111222233456678999999999999999999999888877763

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=345.97  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=185.4

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecC----ceeEEEEeCCC
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK----KRALIYEFMPN  165 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  165 (386)
                      +.++||+|+||+||+|++ +|+.||||+++...........|+..+.+++||||++++++|.+.+    ..++||||+++
T Consensus         7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            457899999999999997 7899999999754322223344556667889999999999998765    57899999999


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEeCCCCceEEeeccCCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-----NIRIVHFDIKPHNILLGEDFCPKISDFGLAKLS  240 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~  240 (386)
                      |+|.+++++       ..++|..++.++.|++.||+|||+..     ..+|+||||||+||||+.++.+||+|||+++..
T Consensus        86 g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          86 GSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999964       35889999999999999999999621     239999999999999999999999999999876


Q ss_pred             Cccccee--eeccccCccccccccccchhcC----CCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cch
Q 038768          241 EKKESFI--SMLGARGTIGYIAPEVFCRNFG----GVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFP  307 (386)
Q Consensus       241 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~  307 (386)
                      .......  ......||+.|+|||++.+...    .++.++|||||||++|||+||..||..........       ...
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            5443222  2234679999999999865311    25778999999999999999998876433221111       111


Q ss_pred             hhhhhhcCC-Ccccccccc-----CChHHHHHHHHHHHHHHHhcCCCCC
Q 038768          308 NSIYKHIEP-GNEFQLAGV-----VTEEEKEMAKKMILVLEMLEGSTED  350 (386)
Q Consensus       308 ~~~~~~i~~-~~~~~~~~~-----~s~~~~~li~~ml~v~~~L~~~~~~  350 (386)
                      ....+.+.. +..+.++..     ...++.+++.+|+..++.-|+++.+
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  287 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence            222222222 212222222     2245778888888877777776543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=345.17  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=192.3

Q ss_pred             hhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccceEEEEEEecC------ceeEEEEe
Q 038768           90 FSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVSFLGFCYEKK------KRALIYEF  162 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~  162 (386)
                      ..++||+|+||+||+|+.. +|+.||||++......   ..+|+++|++++|+||++++++|....      ..++||||
T Consensus        24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            3478999999999999874 6999999999765432   347999999999999999999986532      46899999


Q ss_pred             CCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-ceEEeeccCCcccC
Q 038768          163 MPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDF-CPKISDFGLAKLSE  241 (386)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~  241 (386)
                      |+++.+..+....   .....+++..++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++...
T Consensus       101 ~~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_         101 VPETVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             CSEEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             cCCccHHHHHhhh---hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            9766444433221   1235699999999999999999999998   999999999999999765 89999999998765


Q ss_pred             cccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc-------cchhhhhhhc
Q 038768          242 KKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI-------YFPNSIYKHI  314 (386)
Q Consensus       242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~i  314 (386)
                      ....   .....|+..|+|||.+.+. ..++.++|||||||++|||++|+.||......+.-.       ..+.+.+...
T Consensus       175 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         175 RGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             TTSC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCcc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            5433   2245699999999998654 468999999999999999999999997553211000       0001111111


Q ss_pred             CCCc-------------cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          315 EPGN-------------EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       315 ~~~~-------------~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                      ....             .......+++++.+++.+||..++.-|+++.++..||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            1100             0112345799999999999999999999988887665

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=343.23  Aligned_cols=254  Identities=22%  Similarity=0.272  Sum_probs=204.8

Q ss_pred             hhhhhccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CCChHHHHHHHHHhhcCCC-CccceEEEEEEecCcee
Q 038768           88 NSFSNKLGQGGFGSVYKGKL----PDGRLVAVKVLKNS-----KVNGEEFINEVASMSKTSH-VNVVSFLGFCYEKKKRA  157 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~  157 (386)
                      +.+.++||+|+||+||+|+.    .+|+.||||+++..     ....+.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            45678999999999999974    24789999998642     2344678899999999976 89999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCC
Q 038768          158 LIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLA  237 (386)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~  237 (386)
                      ++|||+.+|+|.+++...      ..+.+..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       106 ~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999654      4577889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          238 KLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      +.+....... .....|++.|+|||.+.+....++.++|||||||+||||++|+.||.......    ....+.+.....
T Consensus       177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~  251 (322)
T d1vzoa_         177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKS  251 (322)
T ss_dssp             EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHC
T ss_pred             hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccC
Confidence            8765433221 23456999999999997654467889999999999999999999998664322    223333332222


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCC-----CCCCCCCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGS-----TEDLQIPPK  356 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~-----~~~~~~~p~  356 (386)
                       .+.++..+++++.+++.+|+..++.-|.+     ++++..||-
T Consensus       252 -~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         252 -EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             -CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence             24566789999999999999999999975     455655553

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=344.20  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=194.9

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEecC------ceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEKK------KRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  158 (386)
                      ...++||+|+||+||+|.. .+|+.||||+++......   +.+.+|+++|++++|||||+++++|...+      ..++
T Consensus        21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  100 (346)
T d1cm8a_          21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  100 (346)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence            3457899999999999986 469999999998654443   56889999999999999999999998665      4689


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      ||||+ +.+|..+...       ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|++|||+++
T Consensus       101 v~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_         101 VMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             EEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence            99999 6678777643       4699999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~  311 (386)
                      ......     ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........       ....+...+
T Consensus       170 ~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            765442     345699999999998754 3678999999999999999999999975432110       000011111


Q ss_pred             h------------h---cCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 K------------H---IEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~------------~---i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .            .   +...........+++++.+++.+||..++.-|++++++..||-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~  303 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  303 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence            1            1   1112223345678999999999999999999999988877663

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-46  Score=343.00  Aligned_cols=257  Identities=21%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC--hHHHHHHHHHhhcCCCCccceEEEEEEecC----ceeEEEE
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN--GEEFINEVASMSKTSHVNVVSFLGFCYEKK----KRALIYE  161 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  161 (386)
                      ...++||+|+||+||+|.. .+|+.||||+++.....  .+.+.+|+.+|+.++||||+++++++....    ..+++++
T Consensus        11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~   90 (345)
T d1pmea_          11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT   90 (345)
T ss_dssp             EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence            3458899999999999986 57999999999764432  357889999999999999999999997654    2345566


Q ss_pred             eCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccC
Q 038768          162 FMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSE  241 (386)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  241 (386)
                      |+.+|+|.+++..       ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          91 HLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             ECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            6779999999954       3589999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccce-eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc------cch-------
Q 038768          242 KKESF-ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI------YFP-------  307 (386)
Q Consensus       242 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~------~~~-------  307 (386)
                      ..... .......||+.|+|||++... ..++.++||||+||++|||++|+.||......+...      ..+       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            43322 122345699999999998654 467899999999999999999999997643210000      000       


Q ss_pred             -----h-hhhhhcCCCc---cccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          308 -----N-SIYKHIEPGN---EFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       308 -----~-~~~~~i~~~~---~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                           . .....+....   ...+...+|.++.+++.+||..++..|++++++..||-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                 0 0000011111   11234567899999999999999999999998877764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-45  Score=336.88  Aligned_cols=251  Identities=18%  Similarity=0.254  Sum_probs=197.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-CCccceEEEEEEec--CceeEEEEeC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-HVNVVSFLGFCYEK--KKRALIYEFM  163 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~  163 (386)
                      +.+.++||+|+||+||+|+. .+|+.||||+++..  ..+.+.+|+++|+.++ ||||+++++++...  ...++|||||
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            45568999999999999986 56899999999753  4678899999999995 99999999999854  4688999999


Q ss_pred             CCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CceEEeeccCCcccCc
Q 038768          164 PNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGED-FCPKISDFGLAKLSEK  242 (386)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~  242 (386)
                      ++++|..+.         ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++....
T Consensus       115 ~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         115 NNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             CSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             CCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999997664         4589999999999999999999998   99999999999999865 4699999999987655


Q ss_pred             ccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCccc---------chhhhhh-
Q 038768          243 KESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIY---------FPNSIYK-  312 (386)
Q Consensus       243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~---------~~~~~~~-  312 (386)
                      ...   .....+|+.|+|||.+.+. ..++.++|||||||++|||++|+.||...........         .+..... 
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            433   2345689999999998764 3578999999999999999999999965422100000         0000000 


Q ss_pred             ----------hc----CC-----CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          313 ----------HI----EP-----GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       313 ----------~i----~~-----~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                                .+    ..     .........+++++.+++++||..++.-|++++++..||-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                      00    00     0011123457899999999999999999999998877763

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=336.61  Aligned_cols=259  Identities=20%  Similarity=0.255  Sum_probs=193.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCC---CChHHHHHHHHHhhcCCCCccceEEEEEEec--------Cce
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSK---VNGEEFINEVASMSKTSHVNVVSFLGFCYEK--------KKR  156 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~  156 (386)
                      .+.++||+|+||+||+|+. .+|+.||||++....   ...+.+.+|+++|+.++|+||+++++++...        +..
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~   92 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   92 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence            3457899999999999986 479999999986532   2346789999999999999999999998653        457


Q ss_pred             eEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccC
Q 038768          157 ALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGL  236 (386)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  236 (386)
                      ++||||+.++++..+...      ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        93 ~iv~e~~~~~~~~~~~~~------~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSNV------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             EEEEECCCEEHHHHHTCT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCccchhhhc------ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence            899999987776655432      25688899999999999999999998   999999999999999999999999999


Q ss_pred             CcccCcccce--eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccch
Q 038768          237 AKLSEKKESF--ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFP  307 (386)
Q Consensus       237 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~  307 (386)
                      ++........  .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.........       ...+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9866543221  122345699999999998754 36889999999999999999999999754321100       0000


Q ss_pred             hhhhh---------hcCCCc--cccc-----cccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038768          308 NSIYK---------HIEPGN--EFQL-----AGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPKP  357 (386)
Q Consensus       308 ~~~~~---------~i~~~~--~~~~-----~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~~  357 (386)
                      ...+.         .+....  ....     ....++++.+++.+||+.++.-|++++++..||--
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            00000         000000  0000     12247888999999999999999999998877753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=329.92  Aligned_cols=255  Identities=19%  Similarity=0.275  Sum_probs=202.7

Q ss_pred             hhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCC---hHHHHHHHHHhhcCCCCccceEEEEEEecCceeEEEEeCC
Q 038768           89 SFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVN---GEEFINEVASMSKTSHVNVVSFLGFCYEKKKRALIYEFMP  164 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  164 (386)
                      ...++||+|+||+||+|+. .+|+.||||+++.....   ...+.+|+.+++.++||||+++++++.+....++|+|++.
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~   84 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence            3457899999999999986 57899999999754332   3678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCcccCccc
Q 038768          165 NGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAKLSEKKE  244 (386)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  244 (386)
                      +++|..++...      ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++......
T Consensus        85 ~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          85 QDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccccccc------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99988887543      5688999999999999999999998   99999999999999999999999999998765543


Q ss_pred             ceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------------cccchhhh-
Q 038768          245 SFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------------EIYFPNSI-  310 (386)
Q Consensus       245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------------~~~~~~~~-  310 (386)
                      ..  .....++..|+|||.+.+. ..++.++|||||||++|||++|+.||........             +..++... 
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             cc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            32  1234577889999998764 3578999999999999999999999743211100             00000000 


Q ss_pred             -hh------hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 038768          311 -YK------HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPP  355 (386)
Q Consensus       311 -~~------~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p  355 (386)
                       ..      .............+++++.+++.+|++.++.-|++++++..||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp  284 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence             00      0001112334556789999999999999999999999988876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=333.43  Aligned_cols=253  Identities=22%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEec-----CceeE
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEK-----KKRAL  158 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  158 (386)
                      +...++||+|+||+||+|+. .+|+.||||+++....+.   +.+.+|+++|++++||||+++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            34457899999999999986 579999999998654443   4688999999999999999999998743     34467


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      +++|+.+|+|.+++..       ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++.
T Consensus       100 i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             EEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence            7788889999999853       3589999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCC-------cccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSS-------EIYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~  311 (386)
                      ......     .+..|++.|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....       ....+....
T Consensus       170 ~~~~~~-----~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         170 HTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             CCTGGG-----SSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCccc-----ccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            655432     245689999999987654 3578999999999999999999999975432100       000000110


Q ss_pred             h------------hcCC---CccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 K------------HIEP---GNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~------------~i~~---~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .            .+..   .........+++++++++.+||..++.-|++++++..||-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~  303 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  303 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence            0            0001   0111123468999999999999999999999999877763

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-43  Score=320.59  Aligned_cols=248  Identities=19%  Similarity=0.187  Sum_probs=186.4

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCccce-EEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNVVS-FLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.+.||+|+||+||+|.. .+|+.||||++.... ..+++..|+++++.++|+|++. +.+++.+.+..++||||+ +
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~   86 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   86 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence            44568899999999999986 468999999987643 3346789999999998776555 455556777888999999 5


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCceEEeeccCCcccCc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLG---EDFCPKISDFGLAKLSEK  242 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~~  242 (386)
                      ++|...+...     ...+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++....
T Consensus        87 ~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          87 PSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             Cchhhhhhhc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            6776666443     25689999999999999999999998   999999999999986   355799999999997654


Q ss_pred             ccce-----eeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcCCC
Q 038768          243 KESF-----ISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIEPG  317 (386)
Q Consensus       243 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~~~  317 (386)
                      ....     .......||+.|+|||.+.+.  .++.++|||||||++|||+||+.||................ ......
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~~~  235 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-EKKMST  235 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-HHHHHS
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-cccCCC
Confidence            3321     122345799999999998765  68999999999999999999999997654322211111111 111111


Q ss_pred             ccccccccCChHHHHHHHHHHHHHHHhcCCC
Q 038768          318 NEFQLAGVVTEEEKEMAKKMILVLEMLEGST  348 (386)
Q Consensus       318 ~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~  348 (386)
                      ....+...+++++.+++.+|+..++.-||+.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~  266 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDY  266 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCH
Confidence            1233456789999999999998776666543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.5e-43  Score=319.01  Aligned_cols=236  Identities=18%  Similarity=0.269  Sum_probs=185.5

Q ss_pred             hhhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCChHHHHHHHHHhhcCCC-CccceEEEEEEecCceeEEEEeCCC
Q 038768           88 NSFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNGEEFINEVASMSKTSH-VNVVSFLGFCYEKKKRALIYEFMPN  165 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~  165 (386)
                      +.+.++||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.+..++| +|++.+++++.+....++||||+ +
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~   84 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   84 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence            345688999999999999864 68999999986543 33467889999998875 89999999999999999999999 7


Q ss_pred             CCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----CCceEEeeccCCccc
Q 038768          166 GSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGE-----DFCPKISDFGLAKLS  240 (386)
Q Consensus       166 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~  240 (386)
                      ++|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+++..
T Consensus        85 ~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          85 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            89999886542     4689999999999999999999998   9999999999999974     578999999999876


Q ss_pred             Ccccc-----eeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcccchhhhhhhcC
Q 038768          241 EKKES-----FISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEIYFPNSIYKHIE  315 (386)
Q Consensus       241 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~i~  315 (386)
                      .....     ........||+.|||||++.+.  .++.++|||||||++|||+||+.||........     .....++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-----~~~~~~i~  229 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIG  229 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-----HHHHHHHH
Confidence            43321     1122345799999999999764  789999999999999999999999985533211     11111111


Q ss_pred             C----CccccccccCChHHHHHHHHHHHH
Q 038768          316 P----GNEFQLAGVVTEEEKEMAKKMILV  340 (386)
Q Consensus       316 ~----~~~~~~~~~~s~~~~~li~~ml~v  340 (386)
                      .    .....+...+++++.+++..|...
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~  258 (293)
T d1csna_         230 EKKQSTPLRELCAGFPEEFYKYMHYARNL  258 (293)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             hccCCCChHHhcCCCCHHHHHHHHHHhcC
Confidence            1    112234556788888888877653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-44  Score=331.38  Aligned_cols=250  Identities=25%  Similarity=0.278  Sum_probs=185.0

Q ss_pred             hhhhccCcCCceEEEEEEeC-CCcEEEEEEecCCCCCh---HHHHHHHHHhhcCCCCccceEEEEEEec------CceeE
Q 038768           89 SFSNKLGQGGFGSVYKGKLP-DGRLVAVKVLKNSKVNG---EEFINEVASMSKTSHVNVVSFLGFCYEK------KKRAL  158 (386)
Q Consensus        89 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  158 (386)
                      ...++||+|+||+||+|.+. +|+.||||+++......   ..+.+|+.++++++||||+++++++...      ...|+
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence            34578999999999999874 69999999998755443   4578999999999999999999999743      57799


Q ss_pred             EEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          159 IYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      |||||.++ +.+.+.        ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+++
T Consensus       100 v~Ey~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1         100 VMELMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEECCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEeccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence            99999655 444442        3588999999999999999999998   99999999999999999999999999988


Q ss_pred             ccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCc-------ccchhhhh
Q 038768          239 LSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSE-------IYFPNSIY  311 (386)
Q Consensus       239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~  311 (386)
                      .......   .....+|+.|+|||++.+.  .++.++||||+||++|||++|+.||...+.....       .....+.+
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         168 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            6654432   2345689999999999764  7899999999999999999999999654311000       00000000


Q ss_pred             h---------------------------hcCCCccccccccCChHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 038768          312 K---------------------------HIEPGNEFQLAGVVTEEEKEMAKKMILVLEMLEGSTEDLQIPPK  356 (386)
Q Consensus       312 ~---------------------------~i~~~~~~~~~~~~s~~~~~li~~ml~v~~~L~~~~~~~~~~p~  356 (386)
                      .                           ..... ........++++.+++++||..+|.-|++++++..||-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw  313 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  313 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCC-SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccc-cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence            0                           00000 01112335788999999999999999999999988874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-39  Score=300.13  Aligned_cols=256  Identities=22%  Similarity=0.279  Sum_probs=187.5

Q ss_pred             hhhhhccCcCCceEEEEEEe-CCCcEEEEEEecCCCCChHHHHHHHHHhhcCC-----------CCccceEEEEEEec--
Q 038768           88 NSFSNKLGQGGFGSVYKGKL-PDGRLVAVKVLKNSKVNGEEFINEVASMSKTS-----------HVNVVSFLGFCYEK--  153 (386)
Q Consensus        88 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~--  153 (386)
                      +.+.++||+|+||+||+|+. .+|+.||||++++.....+.+.+|+++++.++           |+||+++++++...  
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            45678999999999999986 57999999999876555677888999888775           57899999988754  


Q ss_pred             CceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCC-----
Q 038768          154 KKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHR-GCNIRIVHFDIKPHNILLGEDF-----  227 (386)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~-----  227 (386)
                      ...+++++++..+.........   .....+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++     
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             cceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence            4556677776555433332221   223568889999999999999999998 5   999999999999997654     


Q ss_pred             -ceEEeeccCCcccCcccceeeeccccCccccccccccchhcCCCCccchhHhHHHHHHHHHhCCCCcccccccCCcc--
Q 038768          228 -CPKISDFGLAKLSEKKESFISMLGARGTIGYIAPEVFCRNFGGVSHKSDVYSYGMMILEMVVGRKNAEVKVSLSSEI--  304 (386)
Q Consensus       228 -~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--  304 (386)
                       .++++|||.+.......     ....||+.|+|||++.+.  .++.++||||+||++++|++|+.||..........  
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence             39999999998654432     245699999999998754  78999999999999999999999997543211100  


Q ss_pred             -----------cchhhhhh----------------hcCCCc----------cccccccCChHHHHHHHHHHHHHHHhcCC
Q 038768          305 -----------YFPNSIYK----------------HIEPGN----------EFQLAGVVTEEEKEMAKKMILVLEMLEGS  347 (386)
Q Consensus       305 -----------~~~~~~~~----------------~i~~~~----------~~~~~~~~s~~~~~li~~ml~v~~~L~~~  347 (386)
                                 ..+.....                .+....          ........++++.+++.+||..++.-|++
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence                       00111110                011100          11223446788999999999999999999


Q ss_pred             CCCCCCCCC
Q 038768          348 TEDLQIPPK  356 (386)
Q Consensus       348 ~~~~~~~p~  356 (386)
                      ++++..||-
T Consensus       322 a~e~L~Hp~  330 (362)
T d1q8ya_         322 AGGLVNHPW  330 (362)
T ss_dssp             HHHHHTCGG
T ss_pred             HHHHhcCcc
Confidence            988877763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.9e-26  Score=194.31  Aligned_cols=159  Identities=18%  Similarity=0.135  Sum_probs=117.8

Q ss_pred             hhhccCcCCceEEEEEEeCCCcEEEEEEecCCCCC-------------------hHHHHHHHHHhhcCCCCccceEEEEE
Q 038768           90 FSNKLGQGGFGSVYKGKLPDGRLVAVKVLKNSKVN-------------------GEEFINEVASMSKTSHVNVVSFLGFC  150 (386)
Q Consensus        90 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~~~~~~  150 (386)
                      ++++||+|+||+||+|...+|+.||||+++.....                   ......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46889999999999999889999999987632110                   12245688889999999999988653


Q ss_pred             EecCceeEEEEeCCCCCHHHHhcccccccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCceE
Q 038768          151 YEKKKRALIYEFMPNGSLDQFIYDEESSNINRKLEWRTMCQIAVGIARGLEYLHRGCNIRIVHFDIKPHNILLGEDFCPK  230 (386)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  230 (386)
                          ..+++|||+++..+..             ++......++.|++.+|.|||+.   +|+||||||+|||++++ .++
T Consensus        84 ----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence                3479999998755432             33344567899999999999998   99999999999999865 489


Q ss_pred             EeeccCCcccCcccceeeeccccCcccccc------ccccchhcCCCCccchhHhHHH
Q 038768          231 ISDFGLAKLSEKKESFISMLGARGTIGYIA------PEVFCRNFGGVSHKSDVYSYGM  282 (386)
Q Consensus       231 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~~~DvwslGv  282 (386)
                      |+|||++.....+...          .|..      .+.+..   .|+.++|+||..-
T Consensus       143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~  187 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYFSR---TYRTEKDINSAID  187 (191)
T ss_dssp             ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHH---HHCCCCCHHHHHH
T ss_pred             EEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcC---CCCCcccHHHHHH
Confidence            9999999766533210          1111      122222   4678899999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=2e-07  Score=80.30  Aligned_cols=130  Identities=17%  Similarity=0.075  Sum_probs=86.6

Q ss_pred             CCceEEEEEEeCCCcEEEEEEecCC-CCChHHHHHHHHHhhcCC-CCccceEEEEEEecCceeEEEEeCCCCCHHHHhcc
Q 038768           97 GGFGSVYKGKLPDGRLVAVKVLKNS-KVNGEEFINEVASMSKTS-HVNVVSFLGFCYEKKKRALIYEFMPNGSLDQFIYD  174 (386)
Q Consensus        97 G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  174 (386)
                      ++.+.||+... +++.+++|+.... ......+.+|...+..+. +--+.+++.++.+++..++||+++++.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            34468999875 5566777877542 233445678888877663 44467788888888899999999999888655421


Q ss_pred             cccccccccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 038768          175 EESSNINRKLEWRTMCQIAVGIARGLEYLHRGC-----------------------------------------------  207 (386)
Q Consensus       175 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------------------  207 (386)
                      ..           ....++.+++..+..||+..                                               
T Consensus       104 ~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (263)
T d1j7la_         104 EQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD  172 (263)
T ss_dssp             CS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred             cc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence            10           11123334444444444210                                               


Q ss_pred             ---------CCCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          208 ---------NIRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       208 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                               ...++|+|+.|.|||+++++.+.|.||+.+.
T Consensus       173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                     1247999999999999987767799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.26  E-value=1.9e-06  Score=73.47  Aligned_cols=74  Identities=19%  Similarity=0.144  Sum_probs=53.8

Q ss_pred             cCcCCc-eEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCC--CCccceEEEEEEecCceeEEEEeCCCCCHH
Q 038768           94 LGQGGF-GSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTS--HVNVVSFLGFCYEKKKRALIYEFMPNGSLD  169 (386)
Q Consensus        94 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  169 (386)
                      +..|.. +.||+...+++..+++|......  ...+..|...++.+.  .-.+.++++++.+.+..++||+|++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444443 67999988788889999876543  234667777776653  334677888888888899999999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.05  E-value=1.1e-05  Score=73.33  Aligned_cols=74  Identities=12%  Similarity=0.116  Sum_probs=48.7

Q ss_pred             hccCcCCceEEEEEEeCC-CcEEEEEEecC--------CCCChHHHHHHHHHhhcCC-C--CccceEEEEEEecCceeEE
Q 038768           92 NKLGQGGFGSVYKGKLPD-GRLVAVKVLKN--------SKVNGEEFINEVASMSKTS-H--VNVVSFLGFCYEKKKRALI  159 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv  159 (386)
                      +.||.|....||+....+ ++.+++|.-..        -....+....|.+.|+.+. +  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            579999999999998644 67899996532        1123345566877776552 2  345556544  56677899


Q ss_pred             EEeCCCCC
Q 038768          160 YEFMPNGS  167 (386)
Q Consensus       160 ~e~~~~gs  167 (386)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.69  E-value=6.6e-05  Score=66.21  Aligned_cols=69  Identities=12%  Similarity=0.087  Sum_probs=48.2

Q ss_pred             ceEEEEEEeCCCcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc--ceEE-----EEEEecCceeEEEEeCCCCC
Q 038768           99 FGSVYKGKLPDGRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV--VSFL-----GFCYEKKKRALIYEFMPNGS  167 (386)
Q Consensus        99 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~gs  167 (386)
                      --.||+....+|+.+++|+.+......+++..|...+..|....+  +..+     ..+...+..+.++++++|..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            357999999899999999998777777888899888877642222  1111     12234556778999997643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.25  E-value=0.00043  Score=62.56  Aligned_cols=72  Identities=15%  Similarity=0.260  Sum_probs=49.9

Q ss_pred             hccCcCCceEEEEEEeCC--------CcEEEEEEecCCCCChHHHHHHHHHhhcCCCCcc-ceEEEEEEecCceeEEEEe
Q 038768           92 NKLGQGGFGSVYKGKLPD--------GRLVAVKVLKNSKVNGEEFINEVASMSKTSHVNV-VSFLGFCYEKKKRALIYEF  162 (386)
Q Consensus        92 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  162 (386)
                      +.|+.|-.-.+|+....+        .+.|++++... ........+|..+++.+.-.++ .++++++.    -.+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence            568888889999998654        34677777763 3344566788888887753344 56777763    2689999


Q ss_pred             CCCCCH
Q 038768          163 MPNGSL  168 (386)
Q Consensus       163 ~~~gsL  168 (386)
                      +++.+|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.37  E-value=0.008  Score=51.90  Aligned_cols=30  Identities=23%  Similarity=0.303  Sum_probs=26.9

Q ss_pred             CCeeecCCCCCCeEeCCCCceEEeeccCCc
Q 038768          209 IRIVHFDIKPHNILLGEDFCPKISDFGLAK  238 (386)
Q Consensus       209 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~  238 (386)
                      .++||+|+.++||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999874